PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Ramkumar, PN; Navarro, SM; Haeberle, HS; Pettit, RW; Miles, TJ; Frangiamore, SJ; Mont, MA; Farrow, LD; Schickendantz, MS				Ramkumar, Prem N.; Navarro, Sergio M.; Haeberle, Heather S.; Pettit, Rowland W.; Miles, Travis J.; Frangiamore, Salvatore J.; Mont, Michael A.; Farrow, Lutul D.; Schickendantz, Mark S.			Short-Term Outcomes of Concussions in Major League Baseball: A Historical Cohort Study of Return to Play, Performance, Longevity, and Financial Impact	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; baseball; financial loss; return to play	INJURY	Background: The short-term outcomes of concussions within Major League Baseball (MLB) warrant further consideration beyond a medical standpoint given that performance, career, and financial data remain unknown. The perception of this injury directly affects decision making from the perspective of both player and franchise. Purpose: To evaluate the effect of concussion on MLB players by (1) establishing return-to-play (RTP) time after concussion; (2) comparing the career length and performance of players with concussion versus those who took nonmedical leave; and (3) analyzing player financial impact after concussion. Study Design: Cohort study; Level of evidence, 3. Methods: Contracts, transactions, injury reports, and performance statistics from 2005 to 2017 were analyzed by comparing matched players who sustained a concussion versus those who took nonmedical leave. Of the 4186 eligible MLB players, 145 sustained concussions resulting in the activation of concussion protocol and 538 took nonmedical leave. RTP time was recorded. Career length was analyzed in reference to an experience-based stratification of full seasons remaining after the concussion. Changes in player performance and salary before and after concussion were compared with the same parameters for players who took nonmedical leave. Results: The mean RTP time was 26 days (95% CI, 20-32 days) for athletes with concussion and 8 days (95% CI, 6-10 days) for those who took nonmedical leave. Athletes with concussion had a mean of 2.8 full seasons remaining, whereas athletes who took nonmedical leave had 3.1 seasons remaining (P = .493). The probability of playing in the MLB after concussion compared with the nonmedical leave pool was not significantly lower (P = .534, log-rank test; hazard ratio, 1.108). Postconcussion performance decreased significantly in position players, including a lower batting average and decreased on-base percentage in the players with concussion compared with those returning from nonmedical leave. Players who sustained a concussion lost a mean of US$654,990 annually compared with players who took nonmedical leave. Conclusion: This study of the short-term outcomes after concussion in limited-contact MLB athletes demonstrates that concussions may not decrease career spans but may result in decreased performance in addition to financial loss when compared with matched controls who took nonmedical leave. In sports such as baseball that are not subject to repetitive head trauma, career spans may not decrease after a single concussive event. However, sentinel concussions have deleterious short-term effects on performance and compensation among MLB players.	[Ramkumar, Prem N.; Navarro, Sergio M.; Haeberle, Heather S.; Pettit, Rowland W.; Miles, Travis J.; Frangiamore, Salvatore J.; Mont, Michael A.; Farrow, Lutul D.; Schickendantz, Mark S.] Cleveland Clin, Cleveland, OH 44106 USA; [Ramkumar, Prem N.; Farrow, Lutul D.; Schickendantz, Mark S.] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA; [Navarro, Sergio M.; Haeberle, Heather S.; Pettit, Rowland W.; Miles, Travis J.] Baylor Coll Med, Dept Orthopaed Surg, Houston, TX 77030 USA; [Frangiamore, Salvatore J.] Summa Hlth, Dept Orthopaed Surg, Uniontown, OH USA; [Mont, Michael A.] Lenox Hill Hosp, Dept Orthopaed Surg, New York, NY 10021 USA		Ramkumar, PN (corresponding author), 2049 E 100th St, Cleveland, OH 44195 USA.	premramkumar@gmail.com	Navarro, Sergio M/K-8923-2019; Navarro, Sergio M/B-4287-2019	Navarro, Sergio M/0000-0003-3455-1567; Navarro, Sergio M/0000-0003-3455-1567; Pettit, Rowland/0000-0003-0011-8714; Haeberle, Heather/0000-0001-8341-8389			Anderson R, 2017, YEAR CATCHER CONCUSS; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Camp CL, 2017, AM J SPORT MED, V45, P2372, DOI 10.1177/0363546517704835; Gaines C, 2015, BUSINESS INSIDER; Gary G., 2017, BR J SPORTS MED, V51, pA64, DOI [10.1136/bjsports-2016-097270.167, DOI 10.1136/BJSPORTS-2016-097270.167]; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Hadley L., 2005, Journal of Sports Economics, V6, P379, DOI 10.1177/1527002504267435; Hutchinson MR., 2014, ANN ORTHOP RHEUMATOL, V2, P1022; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Laby Daniel M, 2005, Optometry, V76, P647, DOI 10.1016/j.optm.2005.09.003; Major League Baseball, 2011, MAJ LEAG BAS MAJ LEA; Major League Baseball, MLB MISC RUL REG STA; Major League Baseball, 2014, MLB MLBPA AD EXP RUL; Major League Baseball Players, COLL BARG AGR 2017 2; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Nowak J, 2011, FMLA INSIGHTS; Poling A, 2011, J EXP ANAL BEHAV, V96, P283, DOI 10.1901/jeab.2011.96-283; Pollack KM, 2016, AM J EPIDEMIOL, V183, P490, DOI 10.1093/aje/kwv348; Shiner D, 2008, 9 J BASEBALL HIST CU, V16, P126; van der List JP, 2018, AM J SPORT MED, V46, P487, DOI 10.1177/0363546517697690; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956	25	5	5	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC 13	2018	6	12							2325967118814238	10.1177/2325967118814238			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HE0OB	WOS:000452965300001	30560144	gold, Green Published			2022-02-06	
J	Peny-Pahlstrand, M; Bergqvist, L; Hofgren, C; Himmelmann, K; Ohrvall, AM				Peny-Pahlstrand, Marie; Bergqvist, Lena; Hofgren, Caisa; Himmelmann, Kate; Ohrvall, Ann-Marie			Potential benefits of the cognitive orientation to daily occupational performance approach in young adults with spina bifida or cerebral palsy: a feasibility study	DISABILITY AND REHABILITATION			English	Article						Client centred therapy; metacognition; executive functions; activities of daily living; cerebral palsy; myelomeningocele	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CO-OP; EXECUTIVE DYSFUNCTION; SELF-REGULATION; CHILDREN; STRATEGY; REHABILITATION; VALIDITY; PARTICIPATION	Purpose: People with cerebral palsy (CP) or spina bifida (SB) often struggle to perform everyday-life activities. Both groups frequently also have difficulties in creating and using strategies effectively when performing tasks. The cognitive orientation to daily occupational performance (CO-OP) Approach combines the learning of cognitive strategies with task-specific approaches through a client-centred procedure. The aim of this study was to investigate whether the CO-OP Approach is feasible for and potentially beneficial to adolescents and young adults with CP or SB in Sweden by analysing four areas of feasibility (acceptability, efficacy, adaptation, and expansion). Methods: Exploratory multiple-case study using mixed methods. Ten persons aged 16-28, five with each condition, participated in an intervention period. Assessments were performed on three occasions: baseline, post-intervention, and six-month follow-up. Results: The result demonstrates that the CO-OP Approach has the potential to enable adolescents and young adults with either condition to achieve personal goals and to enhance their planning skills and their ability to use strategies when performing activities. This approach is also compatible with the core values of habilitation in Sweden and was found by the participants to be highly meaningful and useful. Conclusions: The CO-OP Approach is feasible for adolescents and young adults with SB or CP in Sweden. Implications for rehabilitation The Cognitive Orientation to daily Occupational Performance center dot is a feasible approach for adolescents and young adults with spina bifida and with cerebral palsy. center dot is a promising approach when it comes to enabling the achievement of personal goals. center dot might have potential to enhance executive functioning through strategy use. center dot is in line with the fundamental core values of disability rights of inclusion, empowerment, and participation.	[Peny-Pahlstrand, Marie; Bergqvist, Lena; Hofgren, Caisa] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Box 455, SE-40530 Gothenburg, Sweden; [Peny-Pahlstrand, Marie; Himmelmann, Kate] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Reg Rehabil Ctr, Gothenburg, Sweden; [Bergqvist, Lena; Hofgren, Caisa] Vastra Gotalandsregionen, Habilitat & Hlth, Boras, Sweden; [Himmelmann, Kate] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Ohrvall, Ann-Marie] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Occupat Therapy, Stockholm, Sweden; [Ohrvall, Ann-Marie] Res & Dev Unit Northeast, Stockholm, Sweden		Peny-Pahlstrand, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Box 455, SE-40530 Gothenburg, Sweden.	marie.peny-dahlstrand@gu.se		Peny-Dahlstrand, Marie/0000-0002-6026-1136; Ohrvall, Ann-Marie/0000-0002-3746-1295	Promobilia foundation; RBU Research Foundation; Norrbacka Eugenia Foundation; Folke Bernadotte Foundation; Habilitation Health; Vastra Gotalandsregionen; Uppsala Hemsysterskolas fund; Foundation Sunnerdahl Handikapp fund	The study was supported financially by the Promobilia foundation, the RBU Research Foundation, the Norrbacka Eugenia Foundation, the Folke Bernadotte Foundation, Habilitation & Health, Vastra Gotalandsregionen, the Uppsala Hemsysterskolas fund, and the Foundation Sunnerdahl Handikapp fund.	Andren E, 2004, DISABIL REHABIL, V26, P528, DOI 10.1080/09638280410001672490; Bandura A., 1997, SELF EFFICACY EXERCI; Barclay-Goddard R, 2009, QUAL LIFE RES, V18, P335, DOI 10.1007/s11136-009-9450-x; Barker RN, 2017, DISABIL REHABIL, V39, P1136, DOI 10.1080/09638288.2016.1185803; Baron K, 2012, MIN MENING SJALVSKAT; Baron K, 2006, OCCUPATIONAL SELF AS; Baum C., 2012, COOP FIDELITY CHECKL; Bergqvist L, 2019, DISABIL REHABIL, V41, P341, DOI 10.1080/09638288.2017.1390696; Beswick K, 2013, APPROACHES PROBLEM S; Bodimeade HL, 2013, DEV MED CHILD NEUROL, V55, P926, DOI 10.1111/dmcn.12195; Bottcher L, 2010, CHILD NEUROPSYCHOL, V16, P209, DOI 10.1080/09297040903559630; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cameron D, 2017, PHYS OCCUP THER PEDI, V37, P183, DOI 10.1080/01942638.2016.1185500; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Curtin M, 2007, AUST OCCUP THER J, V54, P88, DOI 10.1111/j.1440-1630.2007.00661.x; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; Donlau M, 2013, SCAND J OCCUP THER, V20, P64, DOI 10.3109/11038128.2012.700729; Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; Fisher AG, 2011, ASSESSMENTS MOTOR PR; Gharebaghy S, 2015, PHYS OCCUP THER PEDI, V35, P13, DOI 10.3109/01942638.2014.957428; Habilitering & Halsa, 2016, HAB ANDR INS; Hammell Karen Whalley, 2004, Can J Occup Ther, V71, P296; Harvey S, 2007, STRATEGIES WORK TEAC; Jackman M, 2017, DISABIL REHABIL, V39, P1018, DOI 10.1080/09638288.2016.1179350; Jacobson LA, 2013, REHABIL PSYCHOL, V58, P98, DOI 10.1037/a0031555; Jokic CS, 2013, ADAPT PHYS ACT Q, V30, P103, DOI 10.1123/apaq.30.2.103; Kielhofner G., 2001, SCAND J OCCUP THER, V8, P131, DOI [DOI 10.1080/110381201750464485, https://doi.org/10.1080/110381201750464485]; Kielhofner G, 2010, OTJR-OCCUP PART HEAL, V30, P11, DOI 10.3928/15394492-20091214-03; Kim YR, 2013, J MATH BEHAV, V32, P377, DOI 10.1016/j.jmathb.2013.04.002; Kingsnorth S, 2007, J ADOLESCENT HEALTH, V41, P323, DOI 10.1016/j.jadohealth.2007.06.007; Kottorp A, 2003, J INTELL DISABIL RES, V47, P597, DOI 10.1046/j.1365-2788.2003.00475.x; Law M, 2006, COPM CANADIAN OCCUPA; Law M., 2014, COPM CANADIAN OCCUPA, V5th; Law MC, 2011, DEV MED CHILD NEUROL, V53, P621, DOI 10.1111/j.1469-8749.2011.03962.x; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lindsay S, 2017, DISABIL REHABIL, V39, P641, DOI 10.3109/09638288.2016.1153161; Lowing K, 2009, DISABIL REHABIL, V31, P1808, DOI 10.1080/09638280902822278; Mandich, 2004, ENABLING OCCUPATION; Martini R, 1998, OCCUP THER J RES, V18, P157, DOI 10.1177/153944929801800403; Martini R, 2015, DISABIL REHABIL, V37, P231, DOI 10.3109/09638288.2014.913702; McEwen S, 2015, NEUROREHAB NEURAL RE, V29, P526, DOI 10.1177/1545968314558602; McEwen SE, 2010, DISABIL REHABIL, V32, P540, DOI 10.3109/09638280903180189; Miller CK, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0509-x; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Peny-Dahlstrand M, 2017, J PEDIAT REHABIL MED, V10, pS23; Polatajko Helene J., 2001, Physical and Occupational Therapy in Pediatrics, V20, P107, DOI 10.1300/J006v20n02_07; Poulin V, 2017, DISABIL REHABIL, V39, P1, DOI 10.3109/09638288.2015.1123303; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Sandstrom K, 2007, CLIN REHABIL, V21, P432, DOI 10.1177/0269215507073489; Scammell EM, 2016, CAN J OCCUP THER, V83, P216, DOI 10.1177/0008417416651277; Schwartz CE, 2007, ARCH PHYS MED REHAB, V88, P529, DOI 10.1016/j.apmr.2006.12.032; Skidmore ER, 2011, NEUROPSYCHOL REHABIL, V21, P208, DOI 10.1080/09602011.2011.552559; Stubberud J, 2014, NEUROPSYCHOL REHABIL, V24, P26, DOI 10.1080/09602011.2013.847847; Stubberud J, 2012, DISABIL REHABIL, V34, P740, DOI 10.3109/09638288.2011.619617; Thornton A, 2016, DISABIL REHABIL, V38, P979, DOI 10.3109/09638288.2015.1070298; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; Tuminello ER, 2012, CHILD NEUROPSYCHOL, V18, P105, DOI 10.1080/09297049.2011.590470; United Nations, 2006, UN CONV RIGHTS PERS; van der Slot WMA, 2010, J REHABIL MED, V42, P528, DOI 10.2340/16501977-0555; Wechsler D., 2008, WAIS 4 TECHNICAL INT; Wolf TJ, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.017293; World Health Organisation, 2007, INT CLASS FUNT DIS H; Yin R.K., 2013, CASE STUDY RES DESIG	68	5	5	2	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JAN 16	2020	42	2					228	239		10.1080/09638288.2018.1496152		DEC 2018	12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	KC6BK	WOS:000453665700001	30296847	hybrid			2022-02-06	
J	Alkathiry, AA; Sparto, PJ; Freund, B; Whitney, SL; Mucha, A; Furman, JM; Collins, MW; Kontos, AP				Alkathiry, Abdulaziz A.; Sparto, Patrick J.; Freund, Brin; Whitney, Susan L.; Mucha, Anne; Furman, Joseph M.; Collins, Michael W.; Kontos, Anthony P.			Using Accelerometers to Record Postural Sway in Adolescents With Concussion: A Cross-Sectional Study	JOURNAL OF ATHLETIC TRAINING			English	Article						balance; vestibular system; dizziness	SPORT-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; ERROR SCORING SYSTEM; MILD HEAD-INJURY; BALANCE; RECOVERY; COLLEGIATE; STABILITY; CHILDREN; EPIDEMIOLOGY	Objective: To investigate the magnitude of postural sway induced by different balance tasks in adolescents with concussion and to examine the associations of postural sway with concussion symptoms. Design: Cross-sectional study. Patients or Other Participants: Fifty-six adolescents (20 girls, 36 boys) between 13 and 17 years of age who sustained a concussion within the past 44 days and were still symptomatic. Main Outcome Measure(s): Anterior-posterior postural sway was measured using an accelerometer attached to the participant's lower back while he or she performed 6 static-balance tasks that varied the visual input, type of surface, and foot stance. Participants self-reported symptoms that occurred at the time of the concussion (eg, dizziness, confusion, amnesia) as well as at the time of balance testing (eg, eye and head movement-induced dizziness). Results: The normalized path length of postural sway during the different balance tasks was greater with the eyes closed (mean = 19.3 mG/s) compared with the eyes open (mean = 12.4 mG/s; P < .001). Furthermore, sway while standing with the feet together on a foam surface (mean = 17.9 mG/s) or while tandem standing on a firm surface (mean = 19.4 mG/s) was greater than sway while standing with the feet together on a firm surface (mean = 10.3 mG/s; P < .001).Greater sway was associated with dizziness and confusion reported at the time of injury (P < .05).Dizziness and headache symptoms at rest were positively correlated with sway (P < .05). Conclusions: Using accelerometers to measure postural sway during different challenging balance conditions in adolescents with concussion may provide an objective means of quantifying balance impairments in clinical environments. Furthermore, the association of these measurements with symptoms suggests a need to account for symptom severity at the time of testing.	[Alkathiry, Abdulaziz A.] Majmaah Univ, Dept Phys Therapy, Main Campus, Riyadh 11952, Saudi Arabia; [Sparto, Patrick J.; Whitney, Susan L.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15260 USA; [Mucha, Anne] Univ Pittsburgh, Ctr Rehabil Serv, Pittsburgh, PA 15260 USA; [Furman, Joseph M.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Freund, Brin] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA		Alkathiry, AA (corresponding author), Majmaah Univ, Dept Phys Therapy, Main Campus, Riyadh 11952, Saudi Arabia.	a.alkathiry@mu.edu.sa	Alkathiry, Abdulaziz A/Z-4078-2019	Alkathiry, Abdulaziz A/0000-0001-7715-6773	Albert B. Ferguson Jr MD Orthopaedic Fund of the Pittsburgh Foundation; National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; Deanship of Scientific Research at Majmaah University [1440-19]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	The study was supported in part by grants from the Albert B. Ferguson Jr MD Orthopaedic Fund of the Pittsburgh Foundation and from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to Dr Kontos. We thank the Deanship of Scientific Research at Majmaah University for supporting this work under Project No 1440-19.	Barozzi S, 2014, EUR ARCH OTO-RHINO-L, V271, P2069, DOI 10.1007/s00405-014-2930-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaszczyk JW, 2014, ACTA NEUROBIOL EXP, V74, P433; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Marchetti GF, 2013, J VESTIBUL RES-EQUIL, V23, P227, DOI 10.3233/VES-130490; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pan CS, 2009, APPL ERGON, V40, P781, DOI 10.1016/j.apergo.2008.08.003; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	34	5	5	2	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2018	53	12					1166	1172		10.4085/1062-6050-518-17			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HK4AE	WOS:000457860600005	30605371	Green Published, gold			2022-02-06	
J	Almeida, AA; Lorincz, MT; Hashikawa, AN				Almeida, Andrea Ana; Lorincz, Matthew Thomas; Hashikawa, Andrew Nobuhide			Recent Advances in Pediatric Concussion and Mild Traumatic Brain Injury	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Pediatric; Concussion; Traumatic brain injury; Sports injury; Children; Adolescent; Head injury	SPORT-RELATED CONCUSSION; HIGH-SCHOOL FOOTBALL; ATHLETE; RETURN; RECOMMENDATIONS; EPIDEMIOLOGY; ASSOCIATION; MANAGEMENT; STATEMENT; KNOWLEDGE	Concussions after a head injury among children continues to be a substantial public health concern. An increasing number of concussions are being managed initially by primary care physicians. The diagnosis of concussion remains a clinical diagnosis despite the availability of ancillary tests such as computerized neuropsychological testing, advanced imaging, and blood biomarkers. Clinically, overlooking other injuries and comorbidities may lead to prolonged recovery for the patient. Addressing concussions in a multidisciplinary approach may help in reducing recovery time for patients. Retirement from sport in the pediatric population remains a controversial issue lacking evidenced-based studies.	[Almeida, Andrea Ana; Lorincz, Matthew Thomas] Michigan NeuroSport, Dept Neurol, Michigan Med, 2301 Commonwealth Blvd,Suite 1022, Ann Arbor, MI 48105 USA; [Hashikawa, Andrew Nobuhide] Univ Michigan, Dept Emergency Med, Childrens Emergency Serv, Michigan Med,Injury Ctr, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48105 USA		Hashikawa, AN (corresponding author), Univ Michigan, Dept Emergency Med, Childrens Emergency Serv, Michigan Med,Injury Ctr, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48105 USA.	Drewhash@med.umich.edu	Lorincz, Matthew Thomas/P-7785-2019				Almeida A, 2016, BRADLEYS NEUROLOGY C, P860; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Arbogast KB, 2017, CLIN PEDIATR, V56, P854, DOI 10.1177/0009922817709555; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; CDC, 2015, C TRAUM BRAIN INJ US; Centers for Disease Control and Prevention (CDC), HEADS UP HLTH CAR PR; Cheng TA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2721; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dreer LE, 2017, HEALTH PROMOT PRACT, V18, P428, DOI 10.1177/1524839916650865; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guay JL, 2016, AM PSYCHOL, V71, P875, DOI 10.1037/a0040430; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McManemy J, 2016, FLEISHER LUDWIGS TXB, P1280; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; NCAA and Sport Science Institute Interassociation Consensus, 2016, DIAGN MAN SPORT REL; O'Neill JA, 2017, REHABIL PSYCHOL, V62, P300, DOI 10.1037/rep0000155; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schutzman S., 2016, FLEISHER LUDWIGS TXB, V7th ed, P247; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zonfrillo MR, 2016, FLEISHER LUDWIGS TXB, P595	45	5	6	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	DEC	2018	65	6					1151	+		10.1016/j.pcl.2018.07.006			17	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	HF8CP	WOS:000454468800007	30446054				2022-02-06	
J	Amanullah, S; Schlichting, LE; Linakis, SW; Steele, DW; Linakis, JG				Amanullah, Siraj; Schlichting, Lauren E.; Linakis, Seth W.; Steele, Dale W.; Linakis, James G.			Emergency Department Visits Owing to Intentional and Unintentional Traumatic Brain Injury among Infants in the United States: A Population-Based Assessment	JOURNAL OF PEDIATRICS			English	Article							ABUSIVE HEAD TRAUMA; YOUNG-CHILDREN; NONACCIDENTAL TRAUMA; PEDIATRIC-PATIENTS; HOSPITALIZATION; RATES; DIAGNOSIS; MORTALITY; FALLS; COST	Objective To examine national trends of emergency department (ED) visits owing to traumatic brain injury (TBI) among infants (age <12 months), specifically in the context of intentional and unintentional mechanisms. Study design National Electronic Injury Surveillance System-All Injury Program data documenting nonfatal ED visits from 2003 to 2012 were analyzed. TBI was defined as ED visits resulting in a diagnosis of concussion, or fracture, or internal injury of the head. Intentional and unintentional injury mechanisms were compared using multivariable models. Joinpoint regression was used to identify significant time trends. Results TBI-related ED visits (estimated n = 713 124) accounted for 28% of all injury-related ED visits by infants in the US, yielding an average annual rate of 1722 TBI-related ED visits per 100 000 infants. Trend analysis showed an annual increase of 9.48% in the rate of TBI-related ED visits over 10 years (P < .05). For these visits, an estimated 701 757 (98.4%) were attributed to unintentional mechanisms and 11 367 (1.6%) to intentional mechanisms. Unintentional TBI-related ED visit rates increased by 9.52% annually (P< .05) and the rates of intentional TBI were relatively stable from 2003 to 2012. Infants with intentional TBI were more likely to be admitted (aOR, 11.44; 95% CI, 3.02-21.75) compared with those with unintentional TBI. Conclusions The rate of TBI-related ED visits in infants increased primarily owing to unintentional mechanisms and intentional TBI-related ED visits remained stable over the decade. Improved strategies to reduce both intentional and unintentional injuries in infants are required.	[Amanullah, Siraj; Steele, Dale W.; Linakis, James G.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Amanullah, Siraj; Steele, Dale W.; Linakis, James G.] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA; [Amanullah, Siraj; Steele, Dale W.] Brown Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI USA; [Amanullah, Siraj; Schlichting, Lauren E.; Linakis, James G.] Brown Sch Publ Hlth, Hassenfeld Child Hlth Innovat Inst, Providence, RI USA; [Amanullah, Siraj; Linakis, James G.] Rhode Isl Hosp, Injury Prevent Ctr, Providence, RI USA; [Linakis, Seth W.] Nationwide Childrens Hosp, Div Pediat Emergency Med, Columbus, OH USA; [Steele, Dale W.] Brown Sch Publ Hlth, Ctr Evidence Synth Hlth, Providence, RI USA		Amanullah, S (corresponding author), Dept Emergency Med, 55 Claverick St,Suite 100, Providence, RI 02903 USA.	siral_amanullah@brown.edu	Schlichting, Lauren/AAB-4373-2020; Steele, Dale/D-8304-2015	Schlichting, Lauren/0000-0003-4895-2302; Steele, Dale/0000-0002-5689-0255			Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; American Academy of Pediatrics (AAP), BRIGHT FUT PROM SAF; Boop S, 2016, J NEUROSURG-PEDIATR, V18, P542, DOI 10.3171/2016.1.PEDS15583; Burrows P, 2015, ARCH DIS CHILD, V100, P1032, DOI 10.1136/archdischild-2014-307119; Centers for Disease Control and Prevention (CDC), 2001, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention (CDC), 2012, PED AB HEAD TRAUM; Centers for Disease Control and Prevention (CDC), 2016, WISQARS NONF INJ QUE; Crowe LM, 2012, INJURY, V43, P2141, DOI 10.1016/j.injury.2012.07.195; Farst K, 2013, PEDIATRICS, V131, pE1796, DOI 10.1542/peds.2012-1464; Forjuoh SN, 2000, CHILD ABUSE NEGLECT, V24, P1019, DOI 10.1016/S0145-2134(00)00163-0; Kelly P, 2015, ARCH DIS CHILD, V100, P1123, DOI 10.1136/archdischild-2014-306960; Kim HJ, 2001, STAT MED, V20, P655, DOI 10.1002/sim.811; King AJ, 2015, CHILD MALTREATMENT, V20, P151, DOI 10.1177/1077559514567176; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Marcin JP, 2003, AM J PUBLIC HEALTH, V93, P461, DOI 10.2105/AJPH.93.3.461; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Nuno M, 2015, J NEUROSURG PEDIAT, P1; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Paul AR, 2014, TRANSL PEDIATR, V3, P195, DOI 10.3978/j.issn.2224-4336.2014.06.01; Payne Francesca Louise, 2017, Br J Nurs, V26, P974, DOI 10.12968/bjon.2017.26.17.974; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Pontarelli EM, 2014, PEDIATR EMERG CARE, V30, P677, DOI 10.1097/PEC.0000000000000226; Schroeder T., NEISS SAMPLE DESIGN; Shein SL, 2012, J PEDIATR-US, V161, P716, DOI 10.1016/j.jpeds.2012.03.046; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; University of Michigan Institute of Social Research, 2012, NAT EL INJ SURV SYST; US Consumer Product Safety Commission (CPSC), 2017, NEISS COD MAN; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Xiang J, 2013, BRAIN INJURY, V27, P1555, DOI 10.3109/02699052.2013.831126	32	5	5	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	DEC	2018	203						259	+		10.1016/j.jpeds.2018.08.023			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HA9PI	WOS:000450636400040	30266505				2022-02-06	
J	Bohanna, I; Fitts, MS; Bird, K; Fleming, J; Gilroy, J; Esterman, A; Maruff, P; Clough, AR				Bohanna, India; Fitts, Michelle S.; Bird, Katrina; Fleming, Jennifer; Gilroy, John; Esterman, Adrian; Maruff, Paul; Clough, Alan R.			The Transition from Hospital to Home: Protocol for a Longitudinal Study of Australian Aboriginal and Torres Strait Islander Traumatic Brain Injury (TBI)	BRAIN IMPAIRMENT			English	Article						Aboriginal; Indigenous; Aboriginal and Torres Strait Islander; traumatic brain injury; rehabilitation; Australia	COMMUNITY INTEGRATION; NORTHERN-TERRITORY; SENTINEL EVENTS; INDIVIDUALS; EXPERIENCES; VALIDITY; OUTCOMES; PEOPLE; CARE	Background: Traumatic brain injury (TBI) is a leading cause of disability in Australia. Evidence shows that multidisciplinary rehabilitation and support in the six months following TBI is important for successful independent living and social re-integration. Despite this, access to services and supports during this period is often limited by environmental, socio-economic, geographic and cultural factors. Australian studies on outcomes after brain injury have reported primarily on non-Indigenous people. This study will investigate key sentinel events during the transition from hospital to home after a TBI in the first longitudinal study with Indigenous Australians. Method: Indigenous Australians admitted to one of three major trauma hospitals in northern Australia with a TBI, and their care givers, will be recruited. Clinical and brain injury risk factor information, along with measures of cognitive function, transition events, mental health and community re-integration will be collected at three time points prior to hospital discharge, and at three and six months post-discharge. Qualitative interviews will also be conducted. Data will be analysed using regression methods for the quantitative component, and situational analysis for the qualitative component. Annual rates of brain injury will be calculated for patients admitted to tertiary hospital facilities in the study region with a diagnosis of TBI. Discussion: Understanding the experience and events which shape the transition period is critical to determining the services and supports that may enhance transition outcomes, and ensure that such services are culturally appropriate and endorsed by Indigenous families and communities.	[Bohanna, India; Bird, Katrina] James Cook Univ, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Cairns, Qld, Australia; [Fitts, Michelle S.] James Cook Univ, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Gilroy, John] Univ Sydney, Fac Hlth Sci, Ctr Disabil Res & Policy, Sydney, NSW, Australia; [Esterman, Adrian] Univ South Australia, Sans Inst Hlth Res, Cairns, Qld 4870, Australia; [Esterman, Adrian] Univ South Australia, Sch Nursing & Midwifery, Cairns, Qld 4870, Australia; [Esterman, Adrian] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld 4870, Australia; [Maruff, Paul] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia; [Maruff, Paul] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Clough, Alan R.] James Cook Univ, Australian Inst Trop Hlth & Med, Community Based Hlth Promot & Prevent Studies Grp, Cairns, Qld 4870, Australia		Bohanna, I (corresponding author), James Cook Univ, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Cairns, Qld, Australia.	india.bohanna@jcu.edu.au	Maruff, Paul/AAD-2454-2021; Fleming, Jennifer/AAH-5108-2020; Maruff, Paul/ABA-1673-2020; Esterman, Adrian J/D-1042-2009	Maruff, Paul/0000-0002-6947-9537; gilroy, john/0000-0002-7934-8485; Esterman, Adrian/0000-0001-7324-9171	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1081947]	The study is funded by National Health and Medical Research Council Project Grant 1081947.	Aboriginal Health and Medical Research Council of New South Wales Ethics Committee, 2013, GUID RES AB HLTH; ABS, 2004, NAT AB TORR STRAIT I; Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Australian Institute of Health and Welfare, 2012, HOSP SEP DUE INJ POI; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bohanna I, 2013, ASSESSMENT ACQUIRED; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown ADH, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-271; Cairney S, 2013, ADDICTION, V108, P1107, DOI 10.1111/add.12124; Clarke A.E., 2005, SITUATIONAL ANAL GRO; Clough AR, 2004, ADDICT RES THEORY, V12, P261, DOI 10.1080/16066350410001667143; Clough AR, 2002, AUST NZ J PUBL HEAL, V26, P52, DOI 10.1111/j.1467-842X.2002.tb00271.x; Conneeley AL., 2002, BRIT J OCCUP THER, V65, P356; Council of Australian Governments (COAG), 2011, NAT DIS STRAT 2010 2; Creswell JW, 2017, DESIGNING CONDUCTING, V3rd; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fleming J, 1999, BRAIN INJURY, V13, P417; Foster M, 2000, BRAIN INJURY, V14, P1035; Gilroy J, 2012, PARTICIPATION ABORIG; Gilroy J, 2013, AUST ABORIG STUD, P42; Gowing CJ, 2015, INT EMERG NURS, V23, P17, DOI 10.1016/j.ienj.2014.09.006; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Harrison J, 2008, INJURY RES STAT SERI, V45; Helps YLM, 2006, HOSP INJURY AUSTR AB; Hunter BH, 2002, AUSTR EC REV, V35, P261, DOI DOI 10.1111/1467-8462.00242; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Kowal Emma, 2007, Int J Equity Health, V6, P18, DOI 10.1186/1475-9276-6-18; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Lee KSK, 2009, DRUG ALCOHOL REV, V28, P623, DOI 10.1111/j.1465-3362.2009.00067.x; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Nalder E, 2012, J REHABIL MED, V44, P837, DOI 10.2340/16501977-1033; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Nalder E, 2012, BRAIN IMPAIR, V13, P108, DOI 10.1017/BrImp.2012.4; National Health and Medical Research Council, 2015, NAT STAT ETH COND HU; Pointer S, 2016, INJURY RES STAT SERI, V96; Productivity Commission, 2011, 54 PROD COMM COMM AU; Rabe-Hesketh S, 2004, PSYCHOMETRIKA, V69, P167, DOI 10.1007/BF02295939; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2	46	5	5	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2018	19	3					246	257		10.1017/BrImp.2018.1			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	HF2OK	WOS:000454075700005					2022-02-06	
J	Castano-Leon, AM; Navarro-Main, B; Gomez, PA; Gil, A; Soler, MD; Lagares, A; Bernabeu, M; von Steinbuchel, N; Real, RGL				Castano-Leon, Ana M.; Navarro-Main, Blanca; Gomez, Pedro A.; Gil, Angel; Soler, M. Dolors; Lagares, Alfonso; Bernabeu, Montserrat; von Steinbuechel, Nicole; Real, Ruben G. L.			Quality of Life After Brain Injury: Psychometric Properties of the Spanish Translation of the QoLIBRI	EVALUATION & THE HEALTH PROFESSIONS			English	Article						traumatic brain injury; quality of life; QoLIBRI; Spanish; item response theory	HOSPITAL ANXIETY; SCALE	Traumatic brain injury (TBI) is frequently followed by a variety of physical, emotional, and cognitive symptoms, which affect the patient's daily life, their social relations, and their work/educational status. In addition to function measures, health-related quality of life (HRQoL) has received increasing attention as an important outcome after TBI, as it may guide rehabilitation and evaluate treatment success. Here, we report on psychometric properties of a Spanish translation of the quality of life after brain injury (QoLIBRI) questionnaire, a disease-specific instrument to assess HRQoL in patients after TBI. Classical test theory, item response theory, and structural equation modeling were used to evaluate psychometric properties of the Spanish QoLIBRI translation in a convenience sample of N = 155 patients with TBI. A subset of n = 23 patients were tested twice with a test-retest interval of <= 2 weeks. Internal consistency and test-retest reliabilities were high (Cronbach's alpha: 0.78-0.96; ICCs: 0.81-0.96). Rasch analysis infit (range 0.52-1.20) and outfit indices (range 0.50-1.17) supported unidimensionality of subscales, whereas SEM analysis tended to support a correlated six-factor model (CFI = .88, RMSEA = .068, 95% confidence interval [.061, .075]). Results show favorable psychometric properties of the Spanish translation of the QoLIBRI, comparable to the international version. It is, thus, a useful instrument for clinicians and researchers assessing the impact of TBI on quality of life, the outcomes of rehabilitation, and may be included in epidemiological surveys.	[Castano-Leon, Ana M.; Navarro-Main, Blanca; Gomez, Pedro A.; Lagares, Alfonso] Hosp 12 Octubre, Dept Neurosurg, Madrid, Spain; [Gil, Angel; Soler, M. Dolors; Bernabeu, Montserrat] Neurorehabil Hosp, Inst Guttmann, Badalona, Spain; [von Steinbuechel, Nicole; Real, Ruben G. L.] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany		Real, RGL (corresponding author), Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Waldweg 37, D-37073 Gottingen, Germany.	ruben.real@med.uni-goettingen.de	Gil, Angel/ABA-7621-2020; Lagares, Alfonso/B-2969-2011; Gomez, Pedro/N-5051-2019; Castano-Leon, Ana M/ABF-6322-2020	Gil, Angel/0000-0001-7663-0939; Lagares, Alfonso/0000-0003-3996-0554; Gomez, Pedro/0000-0002-4185-5238; Castano-Leon, Ana M/0000-0002-7918-5049			Acquadro C, 1996, QUALITY LIFE PHARMAC, P575; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; BREETVELT IS, 1991, SOC SCI MED, V32, P981, DOI 10.1016/0277-9536(91)90156-7; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Fleiss JL, 2003, WILEY SERIES PROBABI, V3rd, DOI [10.1002/0471445428, DOI 10.1002/0471445428]; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; NINDS, 2016, PROJECT OVERVIEW; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; TEASDALE G, 1974, LANCET, V2, P81; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Van de Vijver F., 2004, EUR REV APPL PSYCHOL, V54, P119, DOI DOI 10.1016/J.ERAP.2003.12.004; von Steinbuchel Nicole, 2006, Eur J Ageing, V3, P116, DOI 10.1007/s10433-006-0024-2; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	5	5	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0163-2787	1552-3918		EVAL HEALTH PROF	Eval. Health Prof.	DEC	2018	41	4					456	473		10.1177/0163278717702696			18	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GZ9KW	WOS:000449819100002	30376738				2022-02-06	
J	Clark, JM; Post, A; Hoshizaki, TB; Gilchrist, MD				Clark, J. Michio; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Distribution of Brain Strain in the Cerebrum for Laboratory Impacts to Ice Hockey Goaltender Masks	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						concussion; head impact biomechanics; finite element modeling	LOADING CURVE CHARACTERISTICS; AMERICAN FOOTBALL HELMETS; LATERAL TEMPORAL-LOBE; FINITE-ELEMENT MODELS; DEFORMATION METRICS; NEURONAL-ACTIVITY; INJURY; HEAD; CONCUSSION; RECONSTRUCTION	Concussions are among the most common injuries sustained by goaltenders. Concussive injuries are characterized by impairment to neurological function which can affect many different brain regions. Understanding how different impact loading conditions (event type and impact site) affect the brain tissue response may help identify what kind of impacts create a high risk of injury to specific brain regions. The purpose of this study was to examine the influence of different impact conditions on the distribution of brain strain for ice hockey goaltender impacts. An instrumented headform was fitted with an ice hockey goaltender mask and impacted under a protocol which was developed using video analysis of real world ice hockey goaltender concussions for three different impact events (collision, puck, and fall). The resulting kinematic response served as input into the University College Dublin Brain Trauma Model (UCDBTM), which calculated maximum principal strain (MPS) in the cerebrum. Strain subsets were then determined and analyzed. Resulting peak strains (0.124-0.328) were found to be within the range for concussion reported in the literature. The results demonstrated that falls and collisions produced larger strain subsets in the cerebrum than puck impacts which is likely a reflection of longer impact duration for falls and collisions than puck impacts. For each impact event, impact site was also found to produce strain subsets of varying size and configuration. The results of this study suggest that the location and number of brain regions which can be damaged depend on the loading conditions of the impact.	[Clark, J. Michio; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Clark, J. Michio; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada; [Post, Andrew] St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada		Clark, JM (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.; Clark, JM (corresponding author), Univ Ottawa, Sch Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	michio.clark@ucd.ie			H2020 Marie Sklodowska-Curie Actions [642662]	H2020 Marie Sklodowska-Curie Actions (642662).	Agel J, 2007, J ATHL TRAINING, V42, P241; [Anonymous], 2009, Z262109 CSA; ASTM, 2014, F158712A ASTM; Baeck, 2013, BIOMECHANICAL MODELI; Beusenberg MC., 2000, P INT RES C BIOM IMP; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Clark J.M., 2016, IRCOBI C MAL, P205; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Clark J.W.G., 2015, THESIS; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P451, DOI 10.1007/BF00249600; CSA, 2009, Z262209 CSA; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Ejima S, 2011, 22 INT TECHN C ENH S, P1; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA., 1987, 872197 SAE; Giordano C., 2014, 2014220002 SAE; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; ISO, 2003, 10256 ISO; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kendall M., 2016, THESIS; Kendall M., 2012, INT RES COUNC BIOM I, P430, DOI DOI 10.1016/J.JECP.2012.07.001; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kleiven S, 2002, P IRCOBI, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Longhitano D, 2005, 19 INT TECHN C ENH S; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Miller R. T., 1998, 983154 SAE; Nahum A, 1977, 770922 SAE; Nur Sarah, 2015, Sports Biomech, V14, P459, DOI 10.1080/14763141.2015.1084035; Ouckama R., 2014, IRCOBI P, P62; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pashby T, 2001, CLIN J SPORT MED, V11, P211, DOI 10.1097/00042752-200110000-00001; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Piantini S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-3; Post A, 2018, SPORTS ENG; Post A., 2014, P IRCOBI C BERL GERM, P72; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2014, P I MECH ENG P-J SPO, V228, P276, DOI 10.1177/1754337114527742; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Powell JW, 2001, J ATHL TRAINING, V36, P307; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Purves D, 2001, NEUROSCIENCE, V3; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Ruan J, 1994, THESIS; Seemann M. R., 1986, 861892 SAE; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Tierney GJ, 2018, SPORT BIOMECH, V17, P33, DOI 10.1080/14763141.2016.1271905; Trosseille X, 1992, 922527 SAE; Walsh E. S., 2012, ASTM S MECH CONC SPO; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Wijdicks C, 2011, BRIT J SPORT MED, V45, P383; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yang Y, 2009, MOL PSYCHIATR, V14, P561, DOI 10.1038/mp.2009.12; Zhang J, 2006, BIOMED SCI INSTRUM, V43, P24; ZHANG L, 2001, 2001220017 SAE; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C., 1995, 952714 SAE	84	5	5	1	13	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2018	140	12							121007	10.1115/1.4040605			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	GY2TF	WOS:000448395600007					2022-02-06	
J	Cubon, VA; Murugavel, M; Holmes, KW; Dettwiler, A				Cubon, Valerie A.; Murugavel, Murali; Holmes, Katharine W.; Dettwiler, Annegret			Preliminary evidence from a prospective DTI study suggests a posterior-to-anterior pattern of recovery in college athletes with sports-related concussion	BRAIN AND BEHAVIOR			English	Article						diffusion tensor imaging; mean diffusivity; mTBI; radial diffusivity; sports-related concussion	WHITE-MATTER INTEGRITY; TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT SIMULATIONS; DIFFUSION-TENSOR; BIOMECHANICAL DETERMINANTS; SPATIAL STATISTICS; IMPACT; CHILDHOOD; ADOLESCENCE; THRESHOLD	Objectives We compared the integrity of white matter (WM) microstructure to the course of recovery in athletes who sustained one sports-related concussion (SRC), assessing individual longitudinal changes in WM fiber tracts following SRC using pre- and post-injury measurements. Materials and Methods Baseline diffusion tensor imaging (DTI) scans and neuropsychological tests were collected on 53 varsity contact-sport college athletes. Participants (n = 13) who subsequently sustained an SRC underwent DTI scans and neuropsychological testing at 2 days, 2 weeks, and 2 months following injury. Results Relying on tract-based spatial statistics (TBSS) analyses, we found that radial diffusivity (RD) and mean diffusivity (MD) were significantly increased at 2 days post-injury compared to the same-subject baseline (corrected p < 0.02). These alterations were visible in anterior/posterior WM regions spanning both hemispheres, demonstrating a diffuse pattern of injury after concussion. Implicated WM fiber tracts at 2 days include the following: right superior/inferior longitudinal fasciculus; right/left inferior fronto-occipital fasciculus; right corticospinal tract; right acoustic radiation; right/left anterior thalamic radiations; right/left uncinate fasciculus; and forceps major/minor. At 2 weeks post-injury, persistently elevated RD and MD were observed solely in prefrontal portions of WM fiber tracts (using same-subject contrasts). No significant differences were found for FA in any of the post-injury comparisons to baseline. Plots of individual subject RD and MD in prefrontal WM demonstrated homogenous increases from baseline to just after SRC; thereafter, trajectories became more variable. Most subjects' diffusivity values remained elevated at 2 months post-injury relative to their own baseline. Over the 2-month period after SRC, recovery of WM fiber tracts appeared to follow a posterior-to-anterior trend, paralleling the posterior-anterior pattern of WM maturation previously identified in the normal population. Conclusion These results suggest greater vulnerability of prefrontal regions to SRC, underline the importance of an individualized approach to concussion management, and show promise for using RD and MD for imaging-based diagnosis of SRC.	[Cubon, Valerie A.] Kent State Univ Trumbull, Dept Chem & Biochem, Warren, OH USA; [Murugavel, Murali; Holmes, Katharine W.; Dettwiler, Annegret] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA		Dettwiler, A (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	adettwil@princeton.edu		Dettwiler, Annegret/0000-0003-4007-6088	National Operating Committee on Standards for Athletic Equipment, NOCSAE grant [22-12]; Goldstein Family Fund; Peter and Cynthia Kellogg Foundation; SPOUT foundation	The authors would like to thank Daniel Osherson PhD, for all his advice and support. The authors would also like to acknowledge Margot Putukian MD (Director of Athletic Medicine University Health Services at Princeton University) for her support with subject recruitment as well as Tawny Meredith-Duliba and the athletic trainers of University Health Services for their assistance with subject recruitment and NP testing. This work was funded by the National Operating Committee on Standards for Athletic Equipment, NOCSAE grant number 22-12, the Goldstein Family Fund, the Peter and Cynthia Kellogg Foundation, and the SPOUT foundation. This study was not preregistered with or without an analysis plan in an independent, institutional registry. As of now, the investigators have no plans to make these data available to other researchers.	Achterberg M, 2016, J NEUROSCI, V36, P1954, DOI 10.1523/JNEUROSCI.3459-15.2016; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Ben Bashat D, 2005, J MAGN RESON IMAGING, V21, P503, DOI 10.1002/jmri.20281; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giorgio A, 2008, NEUROIMAGE, V39, P52, DOI 10.1016/j.neuroimage.2007.07.043; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iwasaki N, 1997, NEURORADIOLOGY, V39, P841, DOI 10.1007/s002340050517; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lao Y., 2015, P SPIE INT SOC OPTIC, V9287; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lovell M. R., 2007, IMMEDIATE POSTCONCUS; Madhyastha T, 2014, HUM BRAIN MAPP, V35, P4544, DOI 10.1002/hbm.22493; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steen RG, 1997, AM J NEURORADIOL, V18, P819; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; TEASDALE G, 1974, LANCET, V2, P81; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; van den Bos W, 2015, P NATL ACAD SCI USA, V112, pE3765, DOI 10.1073/pnas.1423095112; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yakovlev PI, 1967, REGIONAL DEV BRAIN E, P3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	63	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2018	8	12							e01165	10.1002/brb3.1165			13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	HF5VC	WOS:000454301200011	30566282	Green Published, gold			2022-02-06	
J	Dai, YX; Jin, W; Cheng, LY; Yu, C; Chen, C; Ni, HB				Dai, Yuxiang; Jin, Wei; Cheng, Longyang; Yu, Chen; Chen, Cheng; Ni, Hongbin			Nur77 is a promoting factor in traumatic brain injury-induced nerve cell apoptosis	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Traumatic brain injury; Apoptosis; Nur77; Bcl-2; Cyto C; Caspase 3	MITOCHONDRIAL TRANSLOCATION; DEATH; RECEPTOR; BCL-2; RELEASE; APOPTIN; DOMAIN	Traumatic brain injury (TBI) poses a serious threat to human health. TBI has a high mortality rate, resulting in a great burden on the affected individual's family as well as society as a whole. The incidence of craniocerebral fractures continues to rise as both the economy and transportation options grow, making it imperative that the mortality and disability rate of craniocerebral trauma be reduced. Nur77 is a transcription factor of the nuclear receptor superfamily. Following stimulation of extracellular apoptosis, Nur77 is involved in a variety of diseases as a powerful pro-apoptotic molecule. Here, we determined the effect and mechanism of Nur77 in TBI-induced nerve cell apoptosis in vitro and in vivo. We found that Nur77 and Bcl-2 protein expression increased as nerve cell apoptosis increased in TBI tissues. Furthermore, inhibition of Nur77 improved nerve cell injury by regulation of Bcl-2 and downstream pathways in vitro and in vivo.	[Dai, Yuxiang; Jin, Wei; Cheng, Longyang; Yu, Chen; Chen, Cheng; Ni, Hongbin] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China		Ni, HB (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China.	nihongbin0517@163.com					Balasubramanian S, 2012, J AM SOC NEPHROL, V23, P674, DOI 10.1681/ASN.2011070646; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Chaabane W, 2014, NEOPLASIA, V16, P679, DOI 10.1016/j.neo.2014.08.001; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Cooper DJ, 2012, J NEUROTRAUM, V29, P2595, DOI 10.1089/neu.2011.2279; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Han J., 2014, OXID MED CELL LONGEV, V2014, P1; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kiss B, 2015, BBA-MOL CELL RES, V1853, P660, DOI 10.1016/j.bbamcr.2014.12.035; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Maddika S, 2005, J CELL SCI, V118, P4485, DOI 10.1242/jcs.02580; Niu GM, 2014, INT REV CEL MOL BIO, V313, P219, DOI 10.1016/B978-0-12-800177-6.00007-4; Renault TT, 2014, J BIOL CHEM, V289, P26481, DOI 10.1074/jbc.M114.569632; RINK A, 1995, AM J PATHOL, V147, P1575; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sakurada K, 2002, J BIOL CHEM, V277, P45473, DOI 10.1074/jbc.M206673200; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; World Health Organization, 2014, TOP 10 CAUS DEATH FA; Xu AB, 2014, BIOCHEM BIOPH RES CO, V446, P1184, DOI 10.1016/j.bbrc.2014.03.089; Yang H, 2011, HEPATOLOGY, V53, P865, DOI 10.1002/hep.24101	25	5	5	1	8	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	DEC	2018	108						774	782		10.1016/j.biopha.2018.09.091			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	HA2UZ	WOS:000450101800089	30248546	hybrid			2022-02-06	
J	Desai, M; Morris, NA				Desai, Masoom; Morris, Nicholas A.			Prolonged Post-Traumatic Vasospasm Resulting in Delayed Cerebral Ischemia After Mild Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article							RISK-FACTORS		[Desai, Masoom; Morris, Nicholas A.] Univ Maryland, Sch Med, Dept Neurol, Program Trauma, Baltimore, MD 21201 USA		Morris, NA (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Program Trauma, Baltimore, MD 21201 USA.	Nicholas.Morris@umm.edu	Morris, Nicholas/S-7475-2019	Morris, Nicholas/0000-0002-1270-9805	ABPN Factulty Innovation in Education Award	Dr. Morris receives support from the ABPN Factulty Innovation in Education Award.	Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Berry C, 2014, AM SURGEON, V80, P310; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ogami K, 2017, WORLD NEUROSURG, V101, DOI 10.1016/j.wneu.2017.03.039; Razumovsky A, 2013, ACTA NEUROCHIR SUPPL, V115, P87, DOI 10.1007/978-3-7091-1192-5_19; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Zubkov ZY, 2000, SURG NEUROL, V53, P126	11	5	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2018	29	3					512	518		10.1007/s12028-018-0542-8			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HD4SH	WOS:000452517800025	29700693				2022-02-06	
J	Donnell, Z; Hoffman, R; Myers, G; Sarmiento, K				Donnell, Zoe; Hoffman, Roseanne; Myers, Gaya; Sarmiento, Kelly			Seeking to improve care for young patients: Development of tools to support the implementation of the CDC Pediatric mTBI Guideline	JOURNAL OF SAFETY RESEARCH			English	Article						Concussion; Traumatic brain injury; Children; Guideline; Health care provider		Introduction: The Centers for Disease Control and Prevention (CDC) Pediatric Mild Traumatic Brain Injury (mTBI) Guideline was created to help standardize diagnosis, prognosis, and management and treatment of pediatric mTBI. This paper describes the process CDC used to develop educational tools, and a dissemination and implementation strategy, in support of the CDC Pediatric mTBI Guideline. Methods: Two qualitative data collection projects with healthcare providers who care for pediatric patients were conducted. In-depth interviews were used in both projects. Project One examined healthcare providers' guideline use and dissemination preferences. Project Two assessed perceptions of the CDC Pediatric mTBI Guideline educational tools. Results: Project One brought to light four key areas related to Guideline usage and dissemination preferences, specifically a need for: (1) partnership with professional medical societies; (2) integration into electronic health records, mobile apps, and websites; (3) development of continuing medical education (CME) opportunities; and (4) dissemination through healthcare system leadership. In Project Two, healthcare providers reported that the CDC Pediatric mTBI Guideline educational tools were well-organized, clear and easy to navigate, and informative. Healthcare providers also requested more information on the Guideline methodology. Discussion: Assessment of pediatric healthcare providers' current use of clinical guidelines and preferences for educational tools yielded important insights that helped inform CDC's dissemination and implementation strategy for the Pediatric mTBI Guideline. Practical applications: The findings from these data collection projects can also inform other guideline implementation and dissemination efforts among healthcare providers. (C) 2018 National Safety Council and Elsevier Ltd. All rights reserved.	[Donnell, Zoe; Hoffman, Roseanne] ICF, 530 Gaither Rd, Rockville, MD 20850 USA; [Myers, Gaya; Sarmiento, Kelly] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA		Donnell, Z (corresponding author), ICF, 530 Gaither Rd, Rockville, MD 20850 USA.	zoe.donnell@icf.com			Intramural CDC HHS [CC999999] Funding Source: Medline		Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Centers for Disease Control and Prevention, 2017, MORB MORT WEEKL REP; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lumba-Brown A, 2018, JAMA PEDIAT; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; Rose S. C, 2015, J PEDIAT, V166	11	5	5	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	DEC	2018	67				SI		203	209		10.1016/j.jsr.2018.09.006			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	HG6AZ	WOS:000455064700025	30553425	Green Accepted			2022-02-06	
J	Gise, R; Truong, T; Poulsen, DM; Soliman, Y; Parsikia, A; Mbekeani, JN				Gise, Ryan; Truong, Timothy; Poulsen, David M.; Soliman, Yssra; Parsikia, Afshin; Mbekeani, Joyce N.			Pediatric traumatic brain injury and ocular injury	JOURNAL OF AAPOS			English	Article							HEAD-INJURY; CHILDREN; MANIFESTATIONS; COMPLICATIONS; OUTCOMES	PURPOSE Traumatic brain injury (TBI) is a leading cause of pediatric disability and mortality. Together with sight-threatening ocular injuries, TBIs may lead to devastating consequences in developing children and complicate rehabilitation. We sought to investigate this relationship in pediatric patients admitted with major trauma. METHODS The records of pediatric patients admitted with ocular injury and concomitant TBI were reviewed retrospectively using the National Trauma Data Bank (2008-2014). RESULTS Of 58,765 pediatric patients admitted for trauma and also had ocular injuries, 32,173 were diagnosed with TBI. Mean patient age was 12.3 +/- 7 years. Most were male (69.8%) and White (61.2%). The most frequent injuries were contusion of the eye/adnexa (39.1%) and orbital fractures (35.8%). The youngest age groups had greatest odds of falls in home locations, whereas older groups were more likely to suffer motor vehicle trauma as occupants (MVTO), struck by or against (SBA) injuries, and firearms injuries in street locations (P < 0.001). Blacks and Hispanics were most likely to suffer assault (P < 0.001) and Whites, unintentional (P < 0.001) and self-inflicted (P < 0.012) injury. Blacks were at a higher risk of firearms injury, Whites of MVTO, and Hispanics of motor vehicles as pedestrians (P < 0.001). CONCLUSIONS TBI frequently is experienced by trauma patients with concomitant ocular injury and should be considered in children admitted with major trauma. Resultant demographic patterns may help identify patients that have a higher risk of TBI leading to earlier diagnosis and treatment.	[Gise, Ryan; Poulsen, David M.; Mbekeani, Joyce N.] Montefiore Med Ctr, Albert Einstein Coll Med, Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Truong, Timothy; Soliman, Yssra] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Parsikia, Afshin] Jacobi Med Ctr, Dept Surg Trauma, Bronx, NY USA; [Mbekeani, Joyce N.] Jacobi Med Ctr, Dept Surg Ophthalmol, Bronx, NY USA		Gise, R (corresponding author), Montefiore Med Ctr, Ophthalmol Dept, 3332 Rochambeau Ave,3rd Floor, Bronx, NY 10467 USA.	Ryan.gise@gmail.com					Ament JD, 2017, J NEUROSURG-PEDIATR, V19, P668, DOI 10.3171/2017.2.PEDS16419; [Anonymous], 2018, C MAN TRAUM BRAIN IN; Barmparas G, 2017, INT J SURG, V43, P137, DOI 10.1016/j.ijsu.2017.05.068; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Garcia TA, 2005, J PEDIAT OPHTH STRAB, V42, P349; Garcia TA, 2005, J TRAUMA, V59, P169, DOI 10.1097/01.TA.0000174513.79115.7A; Gise R, 2018, PEDIATR NEUROL, V85, P43, DOI 10.1016/j.pediatrneurol.2018.04.003; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Holmes JM, 1999, AM J OPHTHALMOL, V127, P388, DOI 10.1016/S0002-9394(98)00424-3; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Lu K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020210; Odebode TO, 2005, EYE, V19, P561, DOI 10.1038/sj.eye.6701566; Phillipou A, 2014, DEV MED CHILD NEUROL, V56, P337, DOI 10.1111/dmcn.12345; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sharma B, 2014, INT OPHTHALMOL, V34, P893, DOI 10.1007/s10792-014-9898-8; SHOKUNBI T, 1991, CHILD NERV SYST, V7, P147, DOI 10.1007/BF00776710; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; STRAHLMAN E, 1990, ARCH OPHTHALMOL-CHIC, V108, P603, DOI 10.1001/archopht.1990.01070060151066; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Vasa RA, 2015, BRAIN INJURY, V29, P921, DOI 10.3109/02699052.2015.1005670; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Zahavi A, 2016, GRAEF ARCH CLIN EXP, V254, P765, DOI 10.1007/s00417-015-3199-4	25	5	5	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1091-8531	1528-3933		J AAPOS	J. AAPOS	DEC	2018	22	6					421	425		10.1016/j.jaapos.2018.07.351			5	Ophthalmology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology; Pediatrics	HE7RQ	WOS:000453638000004	30342183				2022-02-06	
J	Joshi, UM; Ramdurg, S; Saikar, S; Patil, S; Shah, K				Joshi, Udupikrishna M.; Ramdurg, Shashank; Saikar, Saujanya; Patil, Satishkumar; Shah, Kundan			Brain Injuries and Facial Fractures: A Prospective Study of Incidence of Head Injury Associated with Maxillofacial Trauma	JOURNAL OF MAXILLOFACIAL & ORAL SURGERY			English	Article						Facial fractures; Incidence; Head injury	CONCOMITANT INJURIES; ETIOLOGY; TRENDS; IMPACT	Background Presence of head injuries in patients with maxillofacial trauma is a lifethreatening condition. Prompt determination of head injury in these patients is crucial for improving patient survival and recovery. Hence, the need to know about the incidence of head injuries associated with maxillofacial trauma becomes an important aspect. Materials and Methods A total of 100 patients were included in the study. Patient with head injuries associated with maxillofacial fractures was accounted to determine the incidence and pattern of head injuries accompanying maxillofacial trauma. They were evaluated for epidemiological demographic and clinical characteristics. Results The present study had 91% predominance of male patients with age ranging from 1 to 75years. 91% cases were as a result of RTA. The most frequent maxillofacial injury represented was the fractured mandible. The incidence of head injuries associated with maxillofacial trauma was 67%. Among all the patterns of head injuries, concussion was the most common head injury associated with maxillofacial trauma. Conclusion In our study, the risk of head injury increased significantly as the Glasgow Coma Scale score decreased and with increase in the number of facial fractures. There was association between head injury and maxillofacial trauma.	[Joshi, Udupikrishna M.; Saikar, Saujanya; Patil, Satishkumar; Shah, Kundan] Hkess S Nijalingappa Inst Dent Sci & Res, Dept Oral & Maxillofacial Surg, Near Sedam Rd, Gulbarga, Karnataka, India; [Ramdurg, Shashank] Mahadevappa Rampure Med Coll, Dept Neurosurg, Gulbarga, Karnataka, India		Joshi, UM (corresponding author), Hkess S Nijalingappa Inst Dent Sci & Res, Dept Oral & Maxillofacial Surg, Near Sedam Rd, Gulbarga, Karnataka, India.	dr_udupijoshi@yahoo.com					Al Ahmed HE, 2004, ORAL SURG ORAL MED O, V98, P166, DOI 10.1016/j.tripleo.2004.01.020; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Arabion Hr, 2014, J Dent (Shiraz), V15, P15; Buchanan J, 2005, NZ MED J, V118, P1217; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Fasola AO, 2003, J ORAL MAXIL SURG, V61, P1140, DOI 10.1016/S0278-2391(03)00671-2; Follmar KE, 2007, J TRAUMA, V63, P831, DOI 10.1097/TA.0b013e3181492f41; Fonseca RJ, 2005, ORAL MAXILLOFACIAL T, P211; Grant AL, 2012, J CRANIOFAC SURG, V23, P1324, DOI 10.1097/SCS.0b013e31825e60ae; GWYN PP, 1971, PLAST RECONSTR SURG, V47, P225, DOI 10.1097/00006534-197103000-00004; Hassan NA, 2010, J FORENSIC LEG MED, V17, P26, DOI 10.1016/j.jflm.2009.07.008; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Hutchison IL, 1998, BRIT J ORAL MAX SURG, V36, P3, DOI 10.1016/S0266-4356(98)90739-2; Isik D, 2012, ULUS TRAVMA ACIL CER, V18, P200, DOI 10.5505/tjtes.2012.01047; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Khalighi Sigaroudi S. A., 2012, J DENT SHIRAZ, V13, P18; Kloss F, 2008, J CRANIO MAXILL SURG, V36, P372, DOI 10.1016/j.jcms.2007.12.002; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; LUCE EA, 1979, PLAST RECONSTR SURG, V63, P26, DOI 10.1097/00006534-197901000-00005; Martin RCG, 2002, AM SURGEON, V68, P477; MASON PN, 1990, PLASTIC SURG, P868; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Rahman Sajjad A, 2014, Dent Res J (Isfahan), V11, P336; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; TEASDALE G, 1974, LANCET, V2, P81; TELFER MR, 1991, BRIT J ORAL MAX SURG, V29, P250, DOI 10.1016/0266-4356(91)90192-8; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	32	5	5	0	2	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-8279	0974-942X		J MAXILLOFAC ORAL SU	J. Maxillofac. Oral. Surg.	DEC	2018	17	4					531	537		10.1007/s12663-017-1078-8			7	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	GW9HP	WOS:000447295300021	30344397	Green Published			2022-02-06	
J	Kauffman, JD; Litz, CN; Thiel, SA; Nguyen, ATH; Carey, A; Danielson, PD; Chandler, NM				Kauffman, Jeremy D.; Litz, Cristen N.; Thiel, Sasha A.; Nguyen, Anh Thy H.; Carey, Aaron; Danielson, Paul D.; Chandler, Nicole M.			To Scan or Not to Scan: Overutilization of Computed Tomography for Minor Head Injury at a Pediatric Trauma Center	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	13th Annual Meeting of the Academic-Surgical-Congress/Society-of-University-Surgeons/Association-for-Academic-Surgery	JAN 30-FEB 01, 2018	Jacksonville, FL	Acad Surg Congress, Soc Univ Surg, Assoc Acad Surg		CT; TBI; Loss of consciousness; Pediatrics; Trauma; Risk-benefit	UNITED-STATES; EMERGENCY-DEPARTMENTS; RADIATION-EXPOSURE; COST-EFFECTIVENESS; CHILDREN; CT; RULES; PREDICTION; MEDICINE; PECARN	Background: Degree of compliance with Pediatric Emergency Care Applied Research Network (PECARN) recommendations for radiographic evaluation following minor head injury in children is not well understood. The aim of this study was to assess PECARN compliance at a pediatric trauma center. The secondary aim was to determine whether children with indeterminate history of loss of consciousness (LOC) are at greater risk for clinically important traumatic brain injury (ciTBI) than those with no LOC. Materials and methods: We identified children aged 0-17 y who presented < 24 h after minor head injury with Glasgow Coma Scale >= 14 in our institutional trauma registry. Predictor variables for ciTBI (TBI resulting in admission >= 2 nights, intubation >= 24 h, neurosurgery, or death) were reviewed. Simple and multivariate logistic regressions were performed to estimate the independent effects of demographic and clinical characteristics on the outcome of ciTBI. Results: We included 739 children. Incidence of ciTBI was 5.4%. Only 5.6% did not undergo computed tomography (CT). PECARN compliance was 92.6% overall, but only 23.0% in those for whom CT was not indicated. Among those for whom either CT or observation was acceptable, 93.7% underwent CT. LOC history was indeterminate in 8.5%. On multivariate analysis, indeterminate LOC was not a risk factor for ciTBI. Vomiting and presence of occipital/ parietal/ temporal scalp hematoma were independent risk factors for ciTBI. Conclusions: CT is overutilized in pediatric trauma patients presenting to our institution after minor head injury when compared to PECARN criteria. Indeterminate LOC history was not a risk factor for ciTBI. Education of parents and clinicians regarding the risk to benefit ratio of CT in trauma patients with minor head injury is needed. (C) 2018 Elsevier Inc. All rights reserved.	[Kauffman, Jeremy D.; Litz, Cristen N.; Thiel, Sasha A.; Carey, Aaron; Danielson, Paul D.; Chandler, Nicole M.] Johns Hopkins All Childrens Hosp, Div Pediat Surg, St Petersburg, FL 33701 USA; [Nguyen, Anh Thy H.] Johns Hopkins All Childrens Hosp, Dept Hlth Informat, St Petersburg, FL 33701 USA		Kauffman, JD (corresponding author), Johns Hopkins All Childrens Hosp, Surg, 601 5th St South,Suite 306, St Petersburg, FL 33701 USA.	jkauff10@jhu.edu	Kauffman, Jeremy D./K-2113-2019	Nguyen, Anthony/0000-0002-7512-621X			Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dayan P, 2008, ACAD EMERG MED, V15, pS176; Dayan PS, 2008, PEDIATR EMERG CARE, V24, P727; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Heller RE, 2017, PEDIATR RADIOL, V47, P776, DOI 10.1007/s00247-017-3857-2; Hendee WR, 2010, RADIOLOGY, V257, P240, DOI 10.1148/radiol.10100063; Kadhim-Saleh A, 2018, CAN J EMERG MED, V20, P275, DOI 10.1017/cem.2017.45; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kuppermann N, 2008, ACAD EMERG MED, V15, pS82; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Li SH, 2017, J AM COLL RADIOL, V14, P149, DOI 10.1016/j.jacr.2016.10.002; Maclure M, 2001, EPIDEMIOLOGY, V12, P114, DOI 10.1097/00001648-200101000-00019; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Westra SJ, 2014, PEDIATR RADIOL, V44, P525, DOI 10.1007/s00247-014-3087-9	27	5	5	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2018	232						164	170		10.1016/j.jss.2018.06.005			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	GY1YP	WOS:000448333700024	30463714				2022-02-06	
J	Khan, M; Shunmugavel, A; Dhammu, TS; Khan, H; Singh, I; Singh, AK				Khan, Mushfiquddin; Shunmugavel, Anandakumar; Dhammu, Tajinder S.; Khan, Hamza; Singh, Inderjit; Singh, Avtar K.			Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						antioxidant activity; caffeic acid phenethyl ester; combination therapy; functional recovery; mitochondria quality; RRIDs; S-nitrosoglutathione; traumatic brain injury	ACID PHENETHYL ESTER; TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; CONTROLLED CORTICAL IMPACT; TAU HYPER-PHOSPHORYLATION; SPINAL-CORD-INJURY; CAFFEIC ACID; S-NITROSOGLUTATHIONE; NITRIC-OXIDE; RAT MODEL	Traumatic brain injury (TBI) is the major cause of physical disability and emotional vulnerability. Treatment of TBI is lacking due to its multimechanistic etiology, including derailed mitochondrial and cellular energy metabolism. Previous studies from our laboratory show that an endogenous nitric oxide (NO) metabolite S-nitrosoglutathione (GSNO) provides neuroprotection and improves neurobehavioral function via anti-inflammatory and anti-neurodegenerative mechanisms. To accelerate the rate and enhance the degree of recovery, we investigated combining GSNO with caffeic acid phenethyl ester (CAPE), a potent antioxidant compound, using a male mouse model of TBI, controlled cortical impact in mice. The combination therapy accelerated improvement of cognitive and depressive-like behavior compared with GSNO or CAPE monotherapy. Separately, both GSNO and CAPE improved mitochondrial integrity/function and decreased oxidative damage; however, the combination therapy had greater effects on Drp1 and MnSOD. Additionally, while CAPE alone activated AMPK, this activation was heightened in combination with GSNO. CAPE treatment of normal animals also significantly increased the expression levels of pAMPK, pACC (activation of AMPK substrate ACC), and pLKB1 (activation of upstream to AMPK kinase LKB1), indicating that CAPE activates AMPK via LKB1. These results show that while GSNO and CAPE provide neuroprotection and improve functional recovery separately, the combination treatment invokes greater recovery by significantly improving mitochondrial functions and activating the AMPK enzyme. Both GSNO and CAPE are in human consumption without any known adverse effects; therefore, a combination therapy-based multimechanistic approach is worthy of investigation in human TBI.	[Khan, Mushfiquddin; Shunmugavel, Anandakumar; Dhammu, Tajinder S.; Singh, Inderjit] Med Univ South Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA; [Khan, Hamza] Univ South Carolina, Coll Med, Columbia, SC USA; [Singh, Inderjit; Singh, Avtar K.] Ralph H Johnson VA Med Ctr, 109 Bee St, Charleston, SC 29401 USA; [Singh, Avtar K.] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA		Khan, M (corresponding author), Med Univ South Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA.; Singh, AK (corresponding author), Ralph H Johnson VA Med Ctr, 109 Bee St, Charleston, SC 29401 USA.	khanm@musc.edu; avtar.singh@va.gov		Khan, Mushfiquddin/0000-0001-7945-3237	VA merit awardUS Department of Veterans Affairs [BX003401]; VAUS Department of Veterans Affairs [RX002090]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [C06 RR018823]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR018823, C06RR015455] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002090, I01BX003401] Funding Source: NIH RePORTER	VA merit award, Grant/Award Number: BX003401; VA, Grant/Award Number: RX002090; NIH, Grant/Award Number: C06 RR018823; National Center for Research Resources, Grant/Award Number: C06 RR015455	Aladag MA, 2006, INT J DEV NEUROSCI, V24, P9, DOI 10.1016/j.ijdevneu.2005.12.002; Annamalai B, 2015, BIOCHEM BIOPH RES CO, V458, P214, DOI 10.1016/j.bbrc.2015.01.093; Avila MA, 2008, J CEREBR BLOOD F MET, V28, P1733, DOI 10.1038/jcbfm.2008.66; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; Celli N, 2004, J CHROMATOGR B, V810, P129, DOI 10.1016/j.jchromb.2004.07.024; Cengiz N, 2007, CLIN NEUROPATHOL, V26, P80; Chen QM, 2013, J APPL PHYSIOL, V114, P752, DOI 10.1152/japplphysiol.01302.2012; Chiueh CC, 1999, FREE RADICAL RES, V31, P641, DOI 10.1080/10715769900301211; Choi EY, 2015, J PERIODONTAL RES, V50, P737, DOI 10.1111/jre.12260; Chou PCT, 2011, J MAGN RESON IMAGING, V33, P1301, DOI 10.1002/jmri.22574; Corti A, 2014, ARCH BIOCHEM BIOPHYS, V562, P80, DOI 10.1016/j.abb.2014.08.002; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dhawan J, 2011, FUTUR NEUROL, V6, P823, DOI 10.2217/FNL.11.55; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Feng Y, 2008, BBA-GEN SUBJECTS, V1780, P659, DOI 10.1016/j.bbagen.2008.01.002; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fontanilla CV, 2012, NEUROSCIENCE, V205, P185, DOI 10.1016/j.neuroscience.2011.12.025; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; Higashi Y, 2014, J NEUROTRAUM, V31, P1689, DOI 10.1089/neu.2014.3331; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Ilhan A, 2004, FREE RADICAL BIO MED, V37, P386, DOI 10.1016/j.freeradbiomed.2004.04.022; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kerman M, 2012, J MOL HISTOL, V43, P49, DOI 10.1007/s10735-011-9376-9; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2018, BEHAV BRAIN RES, V340, P63, DOI 10.1016/j.bbr.2016.10.037; Khan M, 2017, NEURAL REGEN RES, V12, P696, DOI 10.4103/1673-5374.206632; Khan M, 2016, BRAIN RES, V1630, P159, DOI 10.1016/j.brainres.2015.11.015; Khan M, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0179-x; Khan M, 2015, DRUG DES DEV THER, V9, P2233, DOI 10.2147/DDDT.S77115; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kim H, 2013, FREE RADICAL BIO MED, V65, P552, DOI 10.1016/j.freeradbiomed.2013.07.015; Kim J, 2014, ANTIOXID REDOX SIGN, V20, P2514, DOI 10.1089/ars.2013.5223; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kluge I, 1997, J NEUROCHEM, V69, P2599; KONOREV EA, 1995, J PHARMACOL EXP THER, V274, P200; Lee ES, 2007, BIOCHEM BIOPH RES CO, V361, P854, DOI 10.1016/j.bbrc.2007.07.068; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Liao CC, 2014, J SCI FOOD AGR, V94, P1154, DOI 10.1002/jsfa.6386; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; Rassaf T, 2006, EUR HEART J, V27, P1699, DOI 10.1093/eurheartj/ehl096; Rauhala P, 1998, FASEB J, V12, P165, DOI 10.1096/fasebj.12.2.165; Sakakima H, 2012, RESTOR NEUROL NEUROS, V30, P383, DOI 10.3233/RNN-2012-110209; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Shunmugavel A, 2012, J SEX MED, V9, P148, DOI 10.1111/j.1743-6109.2011.02526.x; Shunmugavel A, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-17; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh J, 2013, BBA-MOL CELL BIOL L, V1831, P747, DOI 10.1016/j.bbalip.2013.01.004; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Son S, 2002, J AGR FOOD CHEM, V50, P468, DOI 10.1021/jf010830b; Suuronen T, 2003, J NEUROCHEM, V87, P407, DOI 10.1046/j.1471-4159.2003.02004.x; Teixeira Jose, 1800, Methods Mol Biol, V1265, P73, DOI 10.1007/978-1-4939-2288-8_6; Tolba MF, 2013, IUBMB LIFE, V65, P699, DOI 10.1002/iub.1189; Tsai CF, 2015, INT J MOL SCI, V16, P5572, DOI 10.3390/ijms16035572; Tsai SK, 2006, LIFE SCI, V78, P2758, DOI 10.1016/j.lfs.2005.10.017; Tsuda S, 2012, J NUTR BIOCHEM, V23, P1403, DOI 10.1016/j.jnutbio.2011.09.001; Wang CX, 2016, NATURE, V530, P288, DOI 10.1038/530288a; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang YJ, 2018, ANTIOXID REDOX SIGN, V28, P141, DOI 10.1089/ars.2017.7003; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wegiel B, 2014, ANTIOXID REDOX SIGN, V20, P1709, DOI 10.1089/ars.2013.5667; Wei X, 2004, BRAIN, V127, P2629, DOI 10.1093/brain/awh316; Won JS, 2015, BRAIN RES, V1624, P359, DOI 10.1016/j.brainres.2015.07.057; Wu H, 2007, J ALLERGY CLIN IMMUN, V120, P322, DOI 10.1016/j.jaci.2007.04.022; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhao J, 2012, J NEUROTRAUM, V29, P1209, DOI 10.1089/neu.2011.1858; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093334	87	5	5	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	DEC	2018	96	12					1900	1913		10.1002/jnr.24279			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GW8DO	WOS:000447203700007	30027580	Green Accepted			2022-02-06	
J	Marcellino, CR; Lapalme-Remis, S; Rabinstein, AA; Van Gompel, JJ; Worrell, GA; Payne, ET; Hocker, S				Marcellino, Chris R.; Lapalme-Remis, Samuel; Rabinstein, Alejandro A.; Van Gompel, Jamie J.; Worrell, Gregory A.; Payne, Eric T.; Hocker, Sara			Cortical surface intracranial electrodes identify clinically relevant seizures missed on scalp EEG after traumatic intracranial hemorrhage	EPILEPTIC DISORDERS			English	Article						traumatic brain injury; hematoma; subdural; trauma; intracranial EEG	ELECTROGRAPHIC SEIZURES; NONCONVULSIVE SEIZURES; RISK-FACTORS; DISCHARGES; EPILEPSY; IMPACT	Seizures and other electrophysiological disturbances are an under-recognized cause of coma, focal deficits, and prolonged encephalopathy following subdural hematoma evacuation. In these patients, it is possible that seizures remain unrecognized on scalp EEG. It has been shown that a high burden of seizures and other electrophysiological disturbances exist following surgical evacuation and underlie the encephalopathy commonly seen in this patient population, predisposing them to medical complications and confounding estimates of prognosis. As part of a research protocol, we are performing intraoperative placement of cortical surface (non-parenchyma penetrating) intracranial EEG on patients who present after trauma and require emergent decompressive hemicraniectomy. In this case report of a patient with high-velocity traumatic epidural, subdural, and subarachnoid hemorrhages, we identified frequent non-convulsive seizures or seizure-like SIRPIDs with intracranial cortical surface monitoring that were not identified on simultaneous scalp EEG. Stimulation consistently triggered these electrographic seizures in addition to rhythmic lateralized periodic discharges. His mental status improved rapidly after resolution of these electrographic seizures shortly after increasing antiseizure medications, suggesting that they may have been contributing to his encephalopathy. More research is needed to determine the frequency of this phenomenon and determine whether treatment of such seizures improves patient outcomes.	[Marcellino, Chris R.; Van Gompel, Jamie J.] Mayo Clin, Dept Neurol Surg, 200 First St SW, Rochester, MN 55905 USA; [Lapalme-Remis, Samuel; Rabinstein, Alejandro A.; Worrell, Gregory A.; Payne, Eric T.; Hocker, Sara] Mayo Clin, Dept Neurol, Rochester, MN USA		Marcellino, CR (corresponding author), Mayo Clin, Dept Neurol Surg, 200 First St SW, Rochester, MN 55905 USA.	marcellino.christopher@mayo.edu	Van Gompel, Jamie/AAW-4459-2020	Van Gompel, Jamie/0000-0001-8087-7870			Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hirsch LJ, 2004, EPILEPSIA, V45, P109, DOI 10.1111/j.0013-9580.2004.38103.x; Joseph JR, 2016, WORLD NEUROSURG, V92, P366, DOI 10.1016/j.wneu.2016.05.033; Mikell CB, 2016, SEIZURE-EUR J EPILEP, V41, P201, DOI 10.1016/j.seizure.2016.05.017; Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Rudzinski LA, 2011, J CLIN NEUROPHYSIOL, V28, P633, DOI 10.1097/WNP.0b013e31823cc494; Tao JX, 2005, EPILEPSIA, V46, P669, DOI 10.1111/j.1528-1167.2005.11404.x; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Young GB, 1996, NEUROLOGY, V47, P83	19	5	5	0	1	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	1294-9361	1950-6945		EPILEPTIC DISORD	Epileptic Disord.	DEC	2018	20	6					551	556		10.1684/epd.2018.1015			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HF7EM	WOS:000454402100013	30530419	Bronze			2022-02-06	
J	Marincowitz, C; Lecky, FE; Morris, E; Allgar, V; Sheldon, TA				Marincowitz, Carl; Lecky, Fiona E.; Morris, Eleanor; Allgar, Victoria; Sheldon, Trevor A.			Impact of the SIGN head injury guidelines and NHS 4-hour emergency target on hospital admissions for head injury in Scotland: an interrupted times series	BMJ OPEN			English	Article							HEALTH-CARE QUALITY; MANAGEMENT; ENGLAND; CHILDREN; TRENDS	Objectives Head injury is a common reason for emergency department (ED) attendance. Around 1% of patients have life-threatening injuries, while 80% of patients are discharged. National guidelines (Scottish Intercollegiate Guidelines Network (SIGN)) were introduced in Scotland with the aim of achieving early identification of those with acute intracranial lesions yet safely reducing hospital admissions. This study aims to assess the impact of these guidelines and any effect the national 4-hour ED performance target had on hospital admissions for head injury. Setting All Scottish hospitals between April 1998 and March 2016. Participants Patients admitted to hospital for head injury or traumatic brain injury (TBI) diagnosed by CT imaging identified using administrative Scottish Information Services Division data. There are 275 hospitals in Scotland. In 2015/2016, there were 571 221 emergency hospital admissions in Scotland. Interventions The SIGN head injury guidelines introduced in 2000 and 2009. The 4-hour ED target introduced in 2004. Outcomes The monthly rate of hospital admissions for head injury and traumatic brain injury. Study design An interrupted time series analysis. Results The first guideline was associated with a reduction in monthly admissions of 0.14 (95% CI 0.09 to 4.83) per 100 000 population. The 4-hour target was associated with a monthly increase in admissions of 0.13 (95% CI 0.06 to 0.20) per 100 000 population. The second guideline reduced monthly admissions by 0.09 (95% CI-0.13 to -0.05) per 100 000 population. These effects varied between age groups. The guidelines were associated with increased admissions for patients with injuries identified by CT imaging-guideline 1: 0.06 (95% CI 0.004 to 0.12); guideline 2: 0.05 (95% CI 0.04 to 0.06) per 100 000 population. Conclusion Increased CT imaging of head injured patients recommended by SIGN guidelines reduced hospital admissions. The 4-hour ED target and the increased identification of TBI by CT imaging acted to undermine this effect.	[Marincowitz, Carl; Morris, Eleanor] Univ Hull, Hull York Med Sch, Allam Med Bldg, Kingston Upon Hull, N Humberside, England; [Lecky, Fiona E.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Allgar, Victoria] Univ York, Hull York Med Sch, York, N Yorkshire, England; [Sheldon, Trevor A.] Univ York, Alcuin Res Resource Ctr, Dept Hlth Sci, York, N Yorkshire, England		Marincowitz, C (corresponding author), Univ Hull, Hull York Med Sch, Allam Med Bldg, Kingston Upon Hull, N Humberside, England.	Carl.Marincowitz@hyms.ac.uk	Sheldon, Trevor/AAK-7088-2021	Sheldon, Trevor/0000-0002-7479-5913; Marincowitz, Carl/0000-0003-3043-7564; Allgar, Victoria/0000-0002-5228-2623	National Institute for Health Research Doctoral Fellowship [DRF-2016-09-086]; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR)	Carl Marincowitz is funded by a National Institute for Health Research Doctoral Fellowship (DRF-2016-09-086). This study presents independent research funded by the National Institute for Health Research (NIHR).	af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; [Anonymous], 2010, ICD 10; Barnighausen T, 2017, J CLIN EPIDEMIOL, V89, P21, DOI 10.1016/j.jclinepi.2017.03.012; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Cooke MW, 2003, EMERG MED J, V20, P138, DOI 10.1136/emj.20.2.138; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; GENERAL DoHCAA, 2004, IMPR EM CAR ENGL; Goodacre S, 2008, EMERG MED J, V25, P556, DOI 10.1136/emj.2007.055723; Hamilton I, 2014, INT J DRUG POLICY, V25, P151, DOI 10.1016/j.drugpo.2013.05.016; Hand DJ, 2018, J R STAT SOC A STAT, V181, P555, DOI 10.1111/rssa.12315; Harley K, 1996, Health Bull (Edinb), V54, P410; Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; Kerr J, 2005, EMERG MED J, V22, P850, DOI 10.1136/emj.2004.022673; Kim J, 2013, J CLIN NEUROSCI, V20, P1697, DOI 10.1016/j.jocn.2013.02.021; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Marlow R, 2015, ARCH DIS CHILD, V100, P1136, DOI 10.1136/archdischild-2015-308615; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; National Clinical Coding Standards-OPCS-4, 2017, OPCS4 NAT CLIN COD S; NICE, 2014, CG 176 HEAD INJ TRIA; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Plumb J, 2009, BRIT J NEUROSURG, V23, P574, DOI 10.3109/02688690903419115; Rock DJ, 2008, INJURY, V39, P1047, DOI 10.1016/j.injury.2008.03.025; Sheldon T, 1998, QUAL HEALTH CARE, V7, pS45; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; SIGN Guideline 110, 2009, EARL MAN PAT HEAD IN; SIGN Guideline 46, 2000, EARL MAN PAT HEAD IN; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Terminology Services and Clinical Coding, COD TERM SYST; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Woodford, 2017, MAJ TRAUM OLD PEOPL	37	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	DEC	2018	8	12							e022279	10.1136/bmjopen-2018-022279			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HG9EM	WOS:000455309300041	30580260	Green Published, gold, Green Accepted			2022-02-06	
J	Podolsky-Gondim, GG; Furlanetti, LL; Viana, DC; Ballestero, MFM; de Oliveira, RS				Podolsky-Gondim, Guilherme Gozzoli; Furlanetti, Luciano Lopes; Viana, Dinark Conceicao; Manzolli Ballestero, Matheus Fernando; de Oliveira, Ricardo Santos			The role of coagulopathy on clinical outcome following traumatic brain injury in children: analysis of 66 consecutive cases in a single center institution	CHILDS NERVOUS SYSTEM			English	Article						Head trauma; Brain injury; Traumatic brain injury; Pediatric neurosurgery	PATHOGENESIS; MANAGEMENT; DISORDERS; MORTALITY	IntroductionHead injury is a significant economic, social, and medical problem in developing countries and remains one of the leading causes of pediatric morbidity and mortality. The association of traumatic brain injury and coagulopathy in children is linked with an increase in mortality and poor functional outcomes. However, its impact on long-term outcome has not been discussed in the literature so far.ObjectivesThe aim of this paper was to investigate the effect of coagulopathy diagnosed by routine laboratory tests on neurological outcome following traumatic brain injury in children.MethodsA retrospective review was carried out using medical records of children with a traumatic brain injury admitted at a level I trauma center, between January 2013 and December 2016, submitted to any neurosurgical procedures. Statistical analysis was performed accordingly to identify factors predicting unfavorable or favorable outcomes at 1- and 6-month follow-ups. Data regarding age, gender, trauma mechanism, Glasgow Coma Scale at admission and at discharge, highest and lowest stable intracranial pressure, serum glucose and coagulation assessment, radiological findings, and length of stay were analyzed.ResultsWe identified 66 children with surgical head trauma. Mean age was 10.9 years (ranges from 3 months to 17 years), with male predominance (77.3%). Common mechanisms were road traffic accidents (66.7%), falls (19.7%), and blunt trauma (10.6%). Brain edema was detected in 68.2% of the patients, surgical fractures or intracranial bleeding in 75.8%. ICP monitoring was performed in 24.2% of the patients, and of these, 18.7% underwent consecutive decompressive craniectomy. Mean length of in-patient treatment was 16.3 28.2 days. At 1- and 6-month follow-ups, favorable outcome was detected in 71.2 and 78.7% of the patients, respectively. The mortality rate was 12.1%. Routine coagulation assessments such as prothrombin time, fibrinogen levels, and thrombocyte count upon admission were potential prognostic variables identified.ConclusionsThe present study concluded that a trauma-related coagulopathy is an important predictor of unfavorable neurological outcome following TBI in pediatric patients. Initial GCS score, age, and neuroradiological findings, such as severe brain edema and different types of intracranial bleeding, correlated with GOS in the first 6 months following TBI. Sustained intracranial hypertension also predicted unfavorable outcome and death in this series.	[Podolsky-Gondim, Guilherme Gozzoli; Viana, Dinark Conceicao; Manzolli Ballestero, Matheus Fernando; de Oliveira, Ricardo Santos] Univ Sao Paulo, Div Pediat Neurosurg, Dept Surg & Anat, Univ Hosp,Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, Brazil; [Furlanetti, Luciano Lopes] Univ Saarland, Dept Neurosurg, Homburg, Germany		de Oliveira, RS (corresponding author), Univ Sao Paulo, Div Pediat Neurosurg, Dept Surg & Anat, Univ Hosp,Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, Brazil.	rsoliveira30@gmail.com	de Oliveira, Ricardo Santos/AAY-1993-2020; Furlanetti, Luciano/AAC-7039-2019; Ballestero, Matheus FM/B-8260-2018; Podolsky-Gondim, Guilherme Gozzoli/AAL-1611-2021; Ballestero, Matheus/ABD-4590-2020; de Oliveira, Ricardo Santos/AAW-7714-2020; Santos de Oliveira, Ricardo/A-2039-2010	Furlanetti, Luciano/0000-0003-0981-1179; Ballestero, Matheus FM/0000-0001-6643-1207; Podolsky-Gondim, Guilherme Gozzoli/0000-0002-9608-2607; Ballestero, Matheus/0000-0001-6643-1207; Santos de Oliveira, Ricardo/0000-0003-0390-5553			Abdelfattah K, 2016, INT J SURG, V33, P196, DOI 10.1016/j.ijsu.2015.09.036; Asehnoune K, 2017, INTENS CARE MED, V43, P1340, DOI 10.1007/s00134-017-4895-9; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; JENNETT B, 1975, LANCET, V1, P480; Kafaki SB, 2016, CLIN MED INSIGHTS-EN, V9, DOI 10.4137/CMEDED.S40330; Kukreti V, 2014, J PEDIATR NEUROSCI, V9, P207, DOI 10.4103/1817-1745.147572; Kushimoto S, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0196-6; Livingston M G, 1985, Int Rehabil Med, V7, P145; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; ORDOG GJ, 1985, ANN EMERG MED, V14, P650, DOI 10.1016/S0196-0644(85)80881-7; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; Wikkelso A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub3; World Health Organization, 2000, INJ LEAD CAUS GLOB B; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; 2003, J TRAUMA, V54, pS235	31	5	5	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2018	34	12					2455	2461		10.1007/s00381-018-3989-1			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HC0BF	WOS:000451459100017	30334071				2022-02-06	
J	Shrestha, S; Kamel, F; Umbach, DM; Fan, Z; Freeman, LEB; Koutros, S; Alavanja, M; Blair, A; Sandler, DP; Chen, HL				Shrestha, Srishti; Kamel, Freya; Umbach, David M.; Fan, Zheng; Freeman, Laura E. Beane; Koutros, Stella; Alavanja, Michael; Blair, Aaron; Sandler, Dale P.; Chen, Honglei			Factors associated with dream enacting behaviors among US farmers	PARKINSONISM & RELATED DISORDERS			English	Article						Dream enacting behavior; Risk factors; Pesticides; Farmers	RISK-FACTORS; PARKINSONS-DISEASE; HEAD-INJURY; DISORDER; COMMUNITY; QUESTIONNAIRE; UPDATE	Introduction: Dream enacting behavior (DEB) during REM sleep is a characteristic feature of REM sleep behavior disorder (RBD), the most specific prodromal symptom for Parkinson's disease (PD) and related synucleinopathies. Methods: We screened for DEB among 20,591 male farmers in 2013-2015 using a validated question, and examined its association with pesticide uses and other potential risk factors reported about twenty years ago in 1993-1997. We reported odds ratios (OR) and 95% confidence intervals (CI) from multivariable logistic regression models. Results: A total of 1623 (7.9%) farmers reported having had DEB. Farmers with DEB were more likely to report other nonmotor and motor symptoms of PD with age-adjusted ORs ranging from 1.9 to 3.0. DEB prevalence varied little by age, but was significantly associated with current smoking (adjusted OR: 1.4, 95%CI: 1.2, 1.6), daily alcohol drinking (OR: 1.4, 95%CI: 1.1, 1.6), a history of head injury (OR: 1.3, 95%CI: 1.2, 1.5), and being married (OR: 1.4, 95%CI: 1.1, 1.7). We identified significant associations for several pesticides, especially cyclodiene organochlorines and pyrethroids, with adjusted ORs ranging from 1.2 to 1.5. The results were similar after excluding PD cases or when farmers with at least three DEB episodes in life were considered as DEB cases. Conclusions: This study suggests that DEB are not rare among male farmers. Findings on potential risk factors for DEB are intriguing, and given the close link between RBD and PD, these associations should be further investigated.	[Shrestha, Srishti; Kamel, Freya; Sandler, Dale P.; Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Umbach, David M.] NIEHS, Btostat & Computat Biol Branch, POB 12233, Res Triangle Pk, NC 27709 USA; [Fan, Zheng] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27515 USA; [Freeman, Laura E. Beane; Koutros, Stella; Alavanja, Michael; Blair, Aaron] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chen, Honglei] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA		Chen, HL (corresponding author), Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	hchen@epi.msu.edu	Koutros, Stella/W-5788-2019; Shrestha, Srishti/ABF-6248-2021	Koutros, Stella/0000-0001-5294-5485; Chen, Honglei/0000-0003-3446-7779	National Institutes of Health, National Institute of Environmental Health SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01-ES-049030, Z01-ES-101986, Z01-ES-049028]; National Cancer InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [Z01-CP-010119]; Michigan State University [GE100455]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIACP010119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [ZIAES049030, ZIAES049004] Funding Source: NIH RePORTER	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01-ES-049030, Z01-ES-101986, Z01-ES-049028) and National Cancer Institute (Z01-CP-010119). Dr. Chen was also supported by a start-up grant from the Michigan State University (GE100455).	Abbott RD, 2016, NEUROLOGY, V86, P512, DOI 10.1212/WNL.0000000000002254; Alavanja MCR, 1996, ENVIRON HEALTH PERSP, V104, P362, DOI 10.2307/3432672; Ascherio A, 2016, LANCET NEUROL, V15, P1255, DOI 10.1016/S1474-4422(16)30230-7; Blair A, 2002, EPIDEMIOLOGY, V13, P94, DOI 10.1097/00001648-200201000-00015; Boot BP, 2012, ANN NEUROL, V71, P49, DOI 10.1002/ana.22655; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; FLEMING L, 1994, ANN NEUROL, V36, P100, DOI 10.1002/ana.410360119; Gao JJ, 2015, PARKINSONISM RELAT D, V21, P292, DOI 10.1016/j.parkreldis.2014.12.033; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Howell MJ, 2015, JAMA NEUROL, V72, P707, DOI 10.1001/jamaneurol.2014.4563; Jacobs ML, 2016, J PARKINSON DIS, V6, P231, DOI 10.3233/JPD-150725; Kang SH, 2013, SLEEP, V36, P1147, DOI 10.5665/sleep.2874; Ma JF, 2017, SLEEP MED, V30, P71, DOI 10.1016/j.sleep.2016.06.027; Mahlknecht P, 2015, MOVEMENT DISORD, V30, P1417, DOI 10.1002/mds.26350; Olson EJ, 2000, BRAIN, V123, P331, DOI 10.1093/brain/123.2.331; Postuma RB, 2012, NEUROLOGY, V79, P428, DOI 10.1212/WNL.0b013e31825dd383; Postuma RB, 2016, SLEEP MED, V21, P101, DOI 10.1016/j.sleep.2015.12.016; Postuma RB, 2015, ANN NEUROL, V77, P830, DOI 10.1002/ana.24385; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037; Pujol M, 2017, SLEEP MED, V40, P116, DOI 10.1016/j.sleep.2017.07.021; Richardson JR, 2011, NEUROTOXICOLOGY, V32, P640, DOI 10.1016/j.neuro.2011.04.002; Rocca WA, 1998, J CLIN EPIDEMIOL, V51, P517, DOI 10.1016/S0895-4356(98)00017-1; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Schenck CH, 2013, SLEEP MED, V14, P744, DOI 10.1016/j.sleep.2012.10.009; SCHENCK CH, 1993, J SLEEP RES, V2, P224, DOI 10.1111/j.1365-2869.1993.tb00093.x; Shrestha S., 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185510; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Wong JC, 2016, NEUROLOGY, V86, P1306, DOI 10.1212/WNL.0000000000002414	30	5	5	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	DEC	2018	57						9	15		10.1016/j.parkreldis.2018.07.003			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HG6AR	WOS:000455063900002	30007509	Green Accepted			2022-02-06	
J	Wang, S; Hu, LX; Cao, JL; Huang, WM; Sun, CZ; Zheng, DD; Wang, ZN; Gan, SQ; Niu, X; Gu, CH; Bai, GH; Ye, LM; Zhang, DB; Zhang, N; Yin, B; Zhang, M; Bai, LJ				Wang, Shan; Hu, Liuxun; Cao, Jieli; Huang, Wenmin; Sun, Chuanzhu; Zheng, Dongdong; Wang, Zhuonan; Gan, Shuoqiu; Niu, Xuan; Gu, Chenghui; Bai, Guanghui; Ye, Limei; Zhang, Danbin; Zhang, Nu; Yin, Bo; Zhang, Ming; Bai, Lijun			Sex Differences in Abnormal Intrinsic Functional Connectivity After Acute Mild Traumatic Brain Injury	FRONTIERS IN NEURAL CIRCUITS			English	Article						mild traumatic brain injury; sex difference; rs-fMRI; functional connectivity; independent component analysis	RESTING-STATE NETWORKS; COLLABORATING CENTER; CONCUSSION SYMPTOMS; SLEEP-DEPRIVATION; VISUAL FUNCTION; WORKING-MEMORY; TASK-FORCE; FMRI; PERFORMANCE; COMPONENTS	Mild traumatic brain injury (TBI) is considered to induce abnormal intrinsic functional connectivity within resting-state networks (RSNs). The objective of this study was to estimate the role of sex in intrinsic functional connectivity after acute mild TBI. We recruited a cohort of 54 patients (27 males and 27 females with mild TBI within 7 days post-injury) from the emergency department (ED) and 34 age-, education-matched healthy controls (HCs; 17 males and 17 females). On the clinical scales, there were no statistically significant differences between males and females in either control group or mild TBI group. To detect whether there was abnormal sex difference on functional connectivity in RSNs, we performed independent component analysis (ICA) and a dual regression approach to investigate the between-subject voxel-wise comparisons of functional connectivity within seven selected RSNs. Compared to female patients, male patients showed increased intrinsic functional connectivity in motor network, ventral stream network, executive function network, cerebellum network and decreased connectivity in visual network. Further analysis demonstrated a positive correlation between the functional connectivity in executive function network and insomnia severity index (ISI) scores in male patients (r = 0.515, P = 0.006). The abnormality of the functional connectivity of RSNs in acute mild TBI showed the possibility of brain recombination after trauma, mainly concerning male-specific.	[Wang, Shan; Cao, Jieli; Huang, Wenmin; Sun, Chuanzhu; Gan, Shuoqiu; Bai, Lijun] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian, Shaanxi, Peoples R China; [Hu, Liuxun; Zheng, Dongdong; Gu, Chenghui; Zhang, Nu; Yin, Bo] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Wenzhou, Peoples R China; [Hu, Liuxun; Zheng, Dongdong; Wang, Zhuonan; Gan, Shuoqiu; Niu, Xuan; Gu, Chenghui; Zhang, Nu; Yin, Bo; Zhang, Ming] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Wang, Zhuonan; Gan, Shuoqiu; Niu, Xuan; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian, Shaanxi, Peoples R China; [Bai, Guanghui; Ye, Limei; Zhang, Danbin] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China		Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian, Shaanxi, Peoples R China.; Yin, B (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Wenzhou, Peoples R China.; Yin, B; Zhang, M (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.	76yinbo@163.com; zhangming01@mail.xjtu.edu.cn; bailjun@xjtu.edu.cn	Niu, Xuan/AAD-7351-2022; Wang, Zhuonan/E-3691-2017; Bai, Lijun/C-5119-2015	Wang, Zhuonan/0000-0002-5745-4340; Bai, Lijun/0000-0001-8790-5424	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571752, 81771914]; National key research and development plan of China [2016YFC0100300]; Zhejiang Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY15H090016]; Wenzhou Municipal Sci-Tech Bureau [Y20140577]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [Xjj 2018229]	This research was supported by the National Natural Science Foundation of China under Grant Nos. 81571752, 81771914, National key research and development plan of China (2016YFC0100300), the Zhejiang Natural Science Foundation (Grant no. LY15H090016), Wenzhou Municipal Sci-Tech Bureau (Y20140577), and Fundamental Research Funds for the Central Universities (No. Xjj 2018229).	Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Cao X, 2019, J CHILD PSYCHOL PSYC, V60, P216, DOI 10.1111/jcpp.12963; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Crowther A, 2015, NEUROPSYCHOPHARMACOL, V40, P1659, DOI 10.1038/npp.2015.12; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dittinger E, 2018, HUM BRAIN MAPP, V39, P722, DOI 10.1002/hbm.23877; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Farace E, 2000, Neurosurg Focus, V8, pe6; Filippi M, 2013, HUM BRAIN MAPP, V34, P1330, DOI 10.1002/hbm.21514; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Harrison Y, 2000, SLEEP, V23, P1067; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaczkurkin AN, 2016, BIOL PSYCHIAT, V80, P775, DOI 10.1016/j.biopsych.2016.04.021; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreiner DS, 2001, CLIN NEUROPSYCHOL, V15, P109, DOI 10.1076/clin.15.1.109.1906; Kumar M, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12587; Mayer A, 2014, BRAIN INJURY, V28, P688; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; Muto V, 2012, J SLEEP RES, V21, P648, DOI 10.1111/j.1365-2869.2012.01020.x; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Stoffers D, 2014, BRAIN, V137, P610, DOI 10.1093/brain/awt329; Tamargo IA, 2017, EXP NEUROL, V288, P176, DOI 10.1016/j.expneurol.2016.11.005; Tinelli F, 2014, EARLY HUM DEV, V90, P45, DOI 10.1016/j.earlhumdev.2013.10.006; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	63	5	5	1	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5110			FRONT NEURAL CIRCUIT	Front. Neural Circuits	NOV 29	2018	12								107	10.3389/fncir.2018.00107			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HP6VK	WOS:000461824800001	30555304	gold, Green Published			2022-02-06	
J	Lai, JH; Karlsson, TE; Wu, JCC; Huang, CZ; Chen, YH; Kang, SJ; Brodin, ATS; Hoffer, BJ; Olson, L; Chiang, YH; Chen, KY				Lai, Jing-Huei; Karlsson, Tobias E.; Wu, John Chung-Che; Huang, Chi-Zong; Chen, Yen-Hua; Kang, Shuo-Jhen; Brodin, Alvin T. S.; Hoffer, Barry J.; Olson, Lars; Chiang, Yung-Hsiao; Chen, Kai-Yun			Role of Nogo Receptor-1 for Recovery of Balance, Cognition, and Emotion after Mild Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						cognition; emotion; memory; mTBI; NgR1; plasticity	WATER-MAZE; PLASTICITY; INHIBITION; DEFICITS	Mild traumatic brain injury (mTBI) constitutes 75 similar to 90% of all TBI cases and causes various physical, cognitive, emotional, and other psychological symptoms. Nogo receptor 1 (NgR1) is a regulator of structural brain plasticity during development and in adulthood. Here, we used mice that, in the absence of doxycycline, overexpress NgR1 in forebrain neurons (MemoFlex) to determine the role of NgR1 in recovery from mTBI with respect to balance, cognition, memory, and emotion. We compared wild-type (WT), MemoFlex, and MemoFlex + doxycycline mice to the same three groups subjected to mTBI. mTBI was induced by a controlled 30-g weight drop. We found that inability to downregulate NgR1 significantly impairs recovery from mTBI-induced impairments. When the NgR1 transgene was turned off, recovery was similar to that of WT mice. The results suggest that the ability to regulate NgR1 signaling is needed for optimal recovery of motor coordination and balance, spatial memory, cognition, and emotional functions after mTBI.	[Lai, Jing-Huei; Chiang, Yung-Hsiao] Taipei Med Univ, Off R&D, Core Lab Neurosci, Taipei, Taiwan; [Lai, Jing-Huei; Wu, John Chung-Che; Huang, Chi-Zong; Chen, Yen-Hua; Kang, Shuo-Jhen; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Lai, Jing-Huei; Wu, John Chung-Che; Huang, Chi-Zong; Chen, Yen-Hua; Kang, Shuo-Jhen; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Karlsson, Tobias E.; Brodin, Alvin T. S.; Olson, Lars] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Wu, John Chung-Che; Chen, Yen-Hua; Kang, Shuo-Jhen; Chiang, Yung-Hsiao] Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan; [Wu, John Chung-Che; Huang, Chi-Zong; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, 250 Wu Hsing St, Taipei 110, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA		Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, 250 Wu Hsing St, Taipei 110, Taiwan.	kychen08@tmu.edu.tw			Ministry of Science and Technology [MOST 103-2321-B-038-004, MOST 106-2314-B-038-029, MOST 107-2314-B-038-063]; Taipei Medical University [TMU102-AE1-B27, TMU105-AE1-B03]; ERC Advanced Investigator grant [322744]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2012-62x-03185-42-4]; StratNeuro; Swedish Brain Foundation	This study was supported, in part, by 1) the Ministry of Science and Technology, Grant numbers MOST 103-2321-B-038-004, MOST 106-2314-B-038-029, and MOST 107-2314-B-038-063; 2) Taipei Medical University TMU102-AE1-B27 and TMU105-AE1-B03, ERC Advanced Investigator grant (322744; to L.O.), Swedish Research Council (K2012-62x-03185-42-4; to L.O.), StratNeuro (to L.O.), and Swedish Brain Foundation (to L.O.).	Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Bhagat SM, 2016, MOL PSYCHIATR, V21, P1281, DOI 10.1038/mp.2015.179; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Finset A, 1999, PSYCHOSOM MED, V61, P576, DOI 10.1097/00006842-199907000-00024; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Karlsson TE, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00094; Karlsson TE, 2016, CEREB CORTEX, V26, P1804, DOI 10.1093/cercor/bhw007; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nordgren M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078778; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	30	5	6	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1054	1059		10.1089/neu.2018.5949		NOV 2018	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6CG	WOS:000450730300001	30226403				2022-02-06	
J	Zhang, NH; Kaizar, EE; Narad, ME; Kurowski, BG; Yeates, KO; Taylor, HG; Wade, SL				Zhang, Nanhua; Kaizar, Eloise E.; Narad, Megan E.; Kurowski, Brad G.; Yeates, Keith Owen; Taylor, H. Gerry; Wade, Shari L.			Examination of Injury, Host, and Social-Environmental Moderators of Online Family Problem Solving Treatment Efficacy for Pediatric Traumatic Brain Injury Using an Individual Participant Data Meta-Analytic Approach	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; heterogeneous treatment effects meta-analysis; precision medicine	BEHAVIORAL OUTCOMES; RANDOMIZED-TRIAL; COMPLICATED MILD; INTERVENTION; ADOLESCENTS; CHILDREN; PREVALENCE; DISORDER; MEDICINE	A series of five randomized controlled clinical trials (RCTs) conducted between 2002 and 2015 support the potential efficacy of online family problem-solving treatment (OFPST) in improving both child and parent/family outcomes after pediatric traumatic brain injury (TBI). However, small sample sizes and heterogeneity across individual studies have precluded examination of potentially important moderators. We jointly analyzed individual participant data (IPD) from these five RCTs, involving 359 children and adolescents between the ages of 5 and 18 years, to confirm the role of previously identified moderators (child's age and pre-treatment symptom levels, parental education) and to examine other potential moderators (race, sex, IQ), using IPD meta-analysis. This reanalysis revealed statistically strong evidence that parental education, child age at baseline, IQ, sex, and parental depression level pre-treatment moderated the effect of OFPST on various outcomes. In particular, children of parents with a less than high school education exhibited fewer internalizing problems and better social competence. Children injured at an older age exhibited fewer externalizing behaviors and less executive dysfunction following OFPST. Child IQ moderated the effect of OFPST on social competence, with significantly better competence for children with lower IQ who received OFPST. Lower levels of parental depression followed OFPST among subgroups with lower IQ, boys, and higher parental depression scores at baseline. Our findings indicate that the optimal application of OFPST is likely to involve older children, those with lower IQ scores, or those from families with lower socioeconomic status (SES).	[Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Narad, Megan E.; Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Kaizar, Eloise E.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Ctr Biobehav Hlth,Res Inst, Columbus, OH 43210 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020	Zhang, Nanhua/0000-0001-5796-3404; Yeates, Keith/0000-0001-7680-2892	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD089076-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089076] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health (NIH) grant 1R21HD089076-01. Data from the following clinical trials were used in this study: An On-Line Intervention for Families Following Pediatric TBI, conducted prior to trial registration; A Trial of Two On-Line Interventions for Child Brain Injury, NCT00178022, https://clinicaltrials.gov/ct2/show/NCT00178022? term= NCT00178022& rank=1; Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI (TOPS), NCT00409058, https://clinical trials. gov/ct2/show/NCT00409058? term= NCT00409058& rank=1; Improving Mental Health Outcomes of Childhood Brain Injury (CAPS), NCT00409448, https://clinicaltrials.gov/ct2/show/NCT00409448? term=NCT00409448& and Rehabilitation Research and Training Center for Traumatic Brain Injury Interventions -Teen Online Problem Solving Study (RRTC-TOPS), NCT01042899, https://clinicaltrials.gov/ct2/show/NCT01042899? term=NCT01042899&rank=1 We acknowledge the contributions of Amy Cassedy, Ph.D. and Nori Minich, B.S. to data cleaning and synthesis; the contributions of Jennifer Taylor, B.A. to regulatory oversight, and the contributions of Aimee Miley, B.A, B.S. to manuscript preparation.	Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Derogatis LR, 2000, HANDBOOK OF PSYCHOLOGICAL ASSESSMENT IN PRIMARY CARE SETTINGS, P297; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Merrell KM., 2002, HOME COMMUNITY SOCIA; Narad ME, 2017, J PEDIATR PSYCHOL, V42, P304, DOI 10.1093/jpepsy/jsw079; NINDS, 2013, NINDS COMM DAT EL TR; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj S.P., 2017, ONLINE FAMILY PROBLE, V33, P158; Simmonds M, 2015, CONTEMP CLIN TRIALS, V45, P76, DOI 10.1016/j.cct.2015.06.012; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Thompson A, 2009, EUR J EPIDEMIOL, V24, P727, DOI 10.1007/s10654-009-9412-1; Tonelli MR, 2017, JAMA-J AM MED ASSOC, V318, P1649, DOI 10.1001/jama.2017.11914; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2018, J DEV BEHAV PEDIATR, V39, P154, DOI 10.1097/DBP.0000000000000519; Wade SL, 2017, ARCH PHYS MED REHAB, V98, P1614, DOI 10.1016/j.apmr.2017.03.006; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	37	5	5	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1147	1155		10.1089/neu.2018.5885		NOV 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR6CL	WOS:000450731100001	30328749	Green Published			2022-02-06	
J	Seay, M; Akhand, O; Galetta, MS; Cobbs, L; Hasanaj, L; Amorapanth, P; Rizzo, JR; Nolan, R; Serrano, L; Rucker, JC; Galetta, SL; Balcer, LJ				Seay, Meagan; Akhand, Omar; Galetta, Matthew S.; Cobbs, Lucy; Hasanaj, Lisena; Amorapanth, Prin; Rizzo, John-Ross; Nolan, Rachel; Serrano, Liliana; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.			Mobile Universal Lexicon Evaluation System (MULES) in MS: Evaluation of a new visual test of rapid picture naming	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Multiple sclerosis (MS); Picture naming; Mobile Universal Lexicon Evaluation System (MULES); Saccades; Vision	QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; OBJECT RECOGNITION; COGNITIVE IMPAIRMENT; PERIRHINAL CORTEX; COLOR; CONCUSSION; ALEXIA; PROSOPAGNOSIA; NATALIZUMAB	Objective: The Mobile Universal Lexicon Evaluation System (MULES) is a test of rapid picture naming that is under investigation for concussion. MULES captures an extensive visual network, including pathways for eye movements, color perception, memory and object recognition. The purpose of this study was to introduce the MULES to visual assessment of patients with MS, and to examine associations with other tests of afferent and efferent visual function. Methods: We administered the MULES in addition to binocular measures of low-contrast letter acuity (LCLA), high-contrast visual acuity (VA) and the King-Devick (K-D) test of rapid number naming in an MS cohort and in a group of disease-free controls. Results: Among 24 patients with MS (median age 36 years, range 20-72, 64% female) and 22 disease-free controls (median age 34 years, range 19-59, 57% female), MULES test times were greater (worse) among the patients (60.0 vs. 40.0 s). Accounting for age, MS vs. control status was a predictor of MULES test times (P =.01, logistic regression). Faster testing times were noted among patients with MS who had greater (better) performance on binocular LCLA at 2.5% contrast (P <.001, linear regression, accounting for age), binocular high contrast VA (P <.001), and K-D testing (P <.001). Both groups demonstrated approximately 10-s improvements in MULES test times between trials 1 and 2 (P <.0001, paired t-tests). Conclusion: The MULES test, a complex task of rapid picture naming involves an extensive visual network that captures eye movements, color perception and the characterization of objects. Color recognition, a key component of this novel assessment, is early in object processing and requires area V4 and the inferior temporal projections. MULES scores reflect performance of LCLA, a widely-used measure of visual function in MS clinical trials. These results provide evidence that the MULES test can add efficient visual screening to the assessment of patients with MS.	[Seay, Meagan; Akhand, Omar; Galetta, Matthew S.; Cobbs, Lucy; Hasanaj, Lisena; Rizzo, John-Ross; Nolan, Rachel; Serrano, Liliana; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Neurol, 222 E 41 St,14th Floor, New York, NY 10017 USA; [Balcer, Laura J.] NYU, Sch Med, Populat Hlth, New York, NY USA; [Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Ophthalmol, New York, NY USA; [Amorapanth, Prin; Rizzo, John-Ross] NYU, Sch Med, Phys Med & Rehabil, New York, NY USA		Balcer, LJ (corresponding author), NYU, Sch Med, Dept Neurol, 222 E 41 St,14th Floor, New York, NY 10017 USA.	meagan.seay@nyumc.org; omar.akhand@nyumc.org; matthew.galetta@nyumc.org; lucy.cobbs@nyumc.org; lisena.hasanaj@nyumc.org; prin.amorapanth@nyumc.org; johnross.rizzo@nyumc.org; rachel.nolan@nyumc.org; liliana.serrano2@nyumc.org; janet.rucker@nyumc.org; steven.galetta@nyumc.org; laura.balcer@nyumc.org		Rucker, Janet/0000-0002-0397-0999; Amorapanth, Prin/0000-0002-4260-7826; Rizzo, John-Ross/0000-0002-4084-0085	NYU School of Medicine	This study was supported in part by the NYU School of Medicine.	Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Akhand O, 2018, J NEUROL SCI, V387, P199, DOI 10.1016/j.jns.2018.02.031; [Anonymous], 1993, NEUROPSYCHOLOGY, V7, P364, DOI [DOI 10.1037/0894-4105.7.3.364, 10.1037/0894-4105.7.3.364]; Balcer LJ, 2007, NEUROLOGY, V68, P1299, DOI 10.1212/01.wnl.0000259521.14704.a8; Balcer LJ, 2017, MULT SCLER J, V23, P734, DOI 10.1177/1352458517690822; Balcer LJ, 2003, NEUROLOGY, V61, P1367, DOI 10.1212/01.WNL.0000094315.19931.90; Bannert MM, 2018, J NEUROSCI, V38, P3657, DOI 10.1523/JNEUROSCI.2307-17.2018; Brouwer GJ, 2013, J NEUROSCI, V33, P15454, DOI 10.1523/JNEUROSCI.2472-13.2013; Buxbaum LJ, 1996, BRAIN COGNITION, V32, P202; Card MS, 1936, PEDAGOG SEMIN J GEN, V48, P149; Chahin S, 2015, J NEURO-OPHTHALMOL, V35, P6, DOI 10.1097/WNO.0000000000000173; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cobbs L, 2017, J NEUROL SCI, V372, P393, DOI 10.1016/j.jns.2016.10.044; Cole SR, 2000, INVEST OPHTH VIS SCI, V41, P1017; Conway BR, 2007, NEURON, V56, P560, DOI 10.1016/j.neuron.2007.10.008; Conway BR, 2006, CEREB CORTEX, V16, P1604, DOI 10.1093/cercor/bhj099; De Renzi E, 1998, CORTEX, V34, P403, DOI 10.1016/S0010-9452(08)70763-9; Denckla MB, 1999, ANN DYSLEXIA, V49, P29, DOI 10.1007/s11881-999-0018-9; Denney DR, 2005, ARCH CLIN NEUROPSYCH, V20, P967, DOI 10.1016/j.acn.2005.04.012; Drew MA, 2009, ARCH CLIN NEUROPSYCH, V24, P47, DOI 10.1093/arclin/acp007; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Frohman Teresa C, 2010, Continuum (Minneap Minn), V16, P122, DOI 10.1212/01.CON.0000389938.07532.67; Galetta SL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000135; GESCHWIND N, 1966, ARCH NEUROL-CHICAGO, V15, P137, DOI 10.1001/archneur.1966.00470140027004; Graves J, 2010, CLIN OPHTHALMOL, V4, P1409, DOI 10.2147/OPTH.S6383; Grossman M, 1997, BRAIN COGNITION, V33, P306, DOI 10.1006/brcg.1997.0876; Hainline C, 2017, J NEUROL, V264, P989, DOI 10.1007/s00415-017-8484-1; Hudson T. E., 2017, N AM NEUR SOC; JORDAN F M, 1990, Brain Injury, V4, P27; Martinez-Lapiscina EH, 2014, MULT SCLER J, V20, P1207, DOI 10.1177/1352458513517591; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Neuhaus M, 2018, MULT SCLER INT, V2018, DOI 10.1155/2018/7835952; Nguyen J., 2018, CURR EYE RES, P1; Nolan R., 2018, J NEURO-OPHTHALMOL, V38, P1; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Schinzel J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-31; Stockbridge MD, 2018, BRAIN INJURY, V32, P506, DOI 10.1080/02699052.2018.1429660; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Watson HC, 2013, J NEUROSCI, V33, P4192, DOI 10.1523/JNEUROSCI.2075-12.2013; Wells F. L., 1945, MENTAL EXAMINERS HDB, V78, P151	41	5	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	NOV 15	2018	394						1	5		10.1016/j.jns.2018.08.019			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GX1KC	WOS:000447475200001	30193154				2022-02-06	
J	Hipskind, SG; Grover, FL; Fort, TR; Helffenstein, D; Burke, TJ; Quint, SA; Bussiere, G; Stone, M; Hurtado, T				Hipskind, S. Gregory; Grover, Fred L., Jr.; Fort, T. Richard; Helffenstein, Dennis; Burke, Thomas J.; Quint, Shane A.; Bussiere, Garrett; Stone, Michael; Hurtado, Timothy			Pulsed Transcranial Red/Near-Infrared Light Therapy Using Light-Emitting Diodes Improves Cerebral Blood Flow and Cognitive Function in Veterans with Chronic Traumatic Brain Injury: A Case Series	PHOTOMEDICINE AND LASER SURGERY			English	Article; Early Access						photobiomodulation; transcranial; traumatic brain injury; quantitative; SPECT imaging; LED; cognitive function	LEVEL LASER THERAPY; TECHNETIUM-99M-HMPAO SPECT; NITRIC-OXIDE; MILD; HEAD; PERFORMANCE; PHOTOBIOMODULATION; RADIATION	Objective: This study explored the outcome of applying red/near-infrared light therapy using light-emitting diodes (LEDs) pulsed with three different frequencies transcranially to treat traumatic brain injury (TBI) in Veterans. Background: Photobiomodulation therapy (PBMT) using LEDs has been shown to have positive effects on TBI in humans and animal models. Materials and methods: Twelve symptomatic military Veterans diagnosed with chronic TBI >18 months post-trauma received pulsed transcranial PBMT (tPBMT) using two neoprene therapy pads containing 220 infrared and 180 red LEDs, generating a power output of 3.3W and an average power density of 6.4mW/cm(2) for 20min, thrice per week over 6 weeks. Outcome measures included standardized neuropsychological test scores and qualitative and quantitative single photon emission computed tomography (SPECT) measures of regional cerebral blood flow (rCBF). Results: Pulsed tPBMT significantly improved neuropsychological scores in 6 of 15 subscales (40.0%; p<0.05; two tailed). SPECT analysis showed increase in rCBF in 8 of 12 (66.7%) study participants. Quantitative SPECT analysis revealed a significant increase in rCBF in this subgroup of study participants and a significant difference between pre-treatment and post-treatment gamma ray counts per cubic centimeter [t=3.77, df=7, p=0.007, 95% confidence interval (95,543.21-21,931.82)]. This is the first study to report quantitative SPECT analysis of rCBF in regions of interest following pulsed tPBMT with LEDs in TBI. Conclusions: Pulsed tPBMT using LEDs shows promise in improving cognitive function and rCBF several years after TBI. Larger, controlled studies are indicated.	[Hipskind, S. Gregory] Brain Injury Consulting LLC, Dept Brain Res, Addison, TX USA; [Hipskind, S. Gregory] InLight Med, Med Advisory Dept, Addison, TX USA; [Grover, Fred L., Jr.] Revolutionary MD, Dept Med Res, Denver, CO USA; [Fort, T. Richard; Quint, Shane A.; Bussiere, Garrett] CereScan Corp, Dept Imaging Res, Littleton, CO USA; [Helffenstein, Dennis] Colorado Neuropsychol Associates, Testing Dept, Englewood, CO USA; [Burke, Thomas J.] Univ Colorado, Sch Med, Dept Physiol, Aurora, CO USA; [Stone, Michael] Vet Adm Hosp, Dept Radiol, Las Vegas, NV USA; [Hurtado, Timothy] Penrose St Francis Hlth Serv, Emergency Dept, Colorado Springs, CO USA		Hipskind, SG (corresponding author), Brain Injury Consulting LLC, 16200 Addison Rd,Suite 105, Addison, TX 75001 USA.	hippiedoc47@gmail.com			Tug McGraw Foundation of Yountville, CA	This research was supported by a grant from the Tug McGraw Foundation of Yountville, CA. The authors thank Dr. Fred Grover, and Jr. and Dr. Terry Smith for their professional care and treatment of the Veterans who participated in this study. They also thank Alicia Novak and the Colorado Neurological Institute for their study coordination and record keeping, Marybeth Lehto, PhD, for her help with statistics, article, and submission, and Jody Mittiga, ND, ANP, for her help with the article.	Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Bigler ED, 2015, NEUROPATHOLOGY MILD; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; Delis D.C., 2000, CALIFORNIA VERBAL LE; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferraresi C, 2015, J BIOPHOTONICS, V8, P740, DOI 10.1002/jbio.201400087; Gliner JA, 2009, RESEARCH METHODS IN APPLIED SETTTINGS: AN INTEGRATED APPROACH TO DESIGN AND ANALYSIS, 2ND EDITION, P1; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hamblin MR, 2016, VIRULENCE, V7, P836, DOI 10.1080/21505594.2016.1201348; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hashmi JT, 2010, LASER SURG MED, V42, P450, DOI 10.1002/lsm.20950; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Jonsson C, 2000, NUCL MED COMMUN, V21, P9, DOI 10.1097/00006231-200001000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kemp J, 2012, SUICIDE DATA REPORT, P1; Lapchak PA, 2012, EXPERT REV MED DEVIC, V9, P71, DOI 10.1586/ERD.11.64; LESSER IM, 1993, SCHIZOPHRENIA BULL, V19, P773, DOI 10.1093/schbul/19.4.773; Lewis R., 1995, DIGIT VIGILANCE TEST; Lohr NL, 2013, J MOL CELL CARDIOL, V62, P36, DOI 10.1016/j.yjmcc.2013.05.007; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mena FM, 1993, CLIN NUCL MED, V18, P924; NAESER MA, 2010, SPIE NEWSROOM, V7552; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron U, 2007, PHOTOMED LASER SURG, V25, P180, DOI 10.1089/pho.2007.2064; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Romero K, 2015, PSYCHIAT RES-NEUROIM, V231, P15, DOI 10.1016/j.pscychresns.2014.11.003; RUBIN RT, 1995, BIOL PSYCHIAT, V38, P429, DOI 10.1016/0006-3223(94)00305-M; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Wechsler D., 2008, WECHSLER ADULT INTEL; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Young AER, 2000, BRIT J ANAESTH, V84, P38, DOI 10.1093/oxfordjournals.bja.a013379	46	5	5	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-5418	1557-8550		PHOTOMED LASER SURG	Photomed. Laser Surg.												10.1089/pho.2018.4489		NOV 2018	8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GZ9FU	WOS:000449803500001	30418082	Green Published, hybrid			2022-02-06	
J	Riberholt, CG; Lindschou, J; Gluud, C; Mehlsen, J; Moller, K				Riberholt, Christian Gunge; Lindschou, Jane; Gluud, Christian; Mehlsen, Jesper; Moller, Kirsten			Early mobilisation by head-up tilt with stepping versus standard care after severe traumatic brain injury - Protocol for a randomised clinical feasibility trial	TRIALS			English	Article						Brain injury; Randomised feasibility trial; Cerebral autoregulation of blood flow; Rehabilitation; Tilt-table therapy	MINIMALLY CONSCIOUS STATE; CEREBRAL AUTOREGULATION; REHABILITATION; SCALE; RELIABILITY; SENSITIVITY; AWARENESS; OUTCOMES; AROUSAL; STROKE	BackgroundIntensive rehabilitation of patients with severe traumatic brain injury is generally applied in the subacute stages of the hospital stay. Few studies have assessed the association between early and intensive physical rehabilitation and functional outcomes. The aim of this trial is to assess the feasibility of an intensive physical rehabilitation intervention focusing on mobilisation to the upright position, starting as early as clinically possible versus standard care in the intensive care unit. The feasibility study is intended to inform a subsequent randomised clinical trial that will investigate benefits and harms of the intervention.MethodsThis randomised clinical feasibility trial with a follow-up period of 1 year will use blinded outcome assessors for the Coma Recovery Scale-Revised. A maximum of 60 patients admitted to the neurointensive care unit at Rigshospitalet, Denmark, with traumatic brain injury (ageof at least18years), a low level of consciousness, and stable intracranial pressure will be included in the trial. Patients will be randomly assigned to experimental intervention versus standard care (1:1) stratified according to their Glasgow Coma Score. The intervention group will receive daily mobilisation in a tilt table with an integrated stepping device (ERIGO((R))). Feasibility is declared if more than 60% (the lower 95% confidence interval of the proportion) of eligible patients are included in the trial and more than 52% (the lower 95% confidence interval of the proportion) of patients in the intervention group receive more than 60% of the planned interventions. Safety is assessed by the occurrence of adverse events and adverse reactions. Exploratory clinical outcomes consist of cerebral haemodynamics (blood flow velocity and pressure autoregulation) and baroreceptor sensitivity in the early phase as well as functional outcomes (Coma Recovery Scale-Revised, Early Functional Ability scale, and Functional Independence Measure).DiscussionOur findings will inform a future, larger-scale randomised clinical trial on early mobilisation using a tilt table early after severe traumatic brain injury.Trial registrationClinicalTrials.gov identifier: NCT02924649. Registered on 3 October 2016.	[Riberholt, Christian Gunge] Univ Copenhagen, Rigshosp, TBI Unit, Dept Neurorehabil, Kettegard Alle 30, DK-2650 Hvidovre, Denmark; [Lindschou, Jane; Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit,Dept 7812, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Mehlsen, Jesper] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Cardiol, Syncope Ctr, Nordre Fasanvej 57, DK-2000 Frederiksberg, Denmark; [Moller, Kirsten] Univ Copenhagen, Rigshosp, Dept Neuroanaesthesiol, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark		Riberholt, CG (corresponding author), Univ Copenhagen, Rigshosp, TBI Unit, Dept Neurorehabil, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	christian.riberholt@regionh.dk	Gluud, Christian/AAY-1027-2021; Riberholt, Christian Gunge/AAC-9574-2019; Mehlsen, Jesper/AAA-5848-2022; Moller, Kirsten/A-4751-2009	Gluud, Christian/0000-0002-8861-0799; Riberholt, Christian Gunge/0000-0002-6170-1869; Moller, Kirsten/0000-0003-3058-1072	Council of Danish Victims Fund [16-910-00043]; Research Fund of Rigshospitalet, Copenhagen University Hospital [R114-A4672]; Danish Physical Therapy Association [15242]	The trial has been funded by "The Council of Danish Victims Fund" (grant 16-910-00043), by the "Research Fund of Rigshospitalet, Copenhagen University Hospital" (R114-A4672), and the "Danish Physical Therapy Association" (15242). The funders had no influence on the design of the trial.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Berney SC, 2015, J CRIT CARE, V30, P658, DOI 10.1016/j.jcrc.2015.03.006; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chang AT, 2004, ARCH PHYS MED REHAB, V85, P1972, DOI 10.1016/j.apmr.2004.03.024; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Frazzitta G, 2015, J HEAD TRAUMA REHAB, V30, P290, DOI 10.1097/HTR.0000000000000135; Frazzitta G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158030; Gajek J, 2009, ACTA CARDIOL, V64, P505, DOI 10.2143/AC.64.4.2041616; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Hankemeier A, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0469-z; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Jarvinen TLN, 2014, J CLIN EPIDEMIOL, V67, P769, DOI 10.1016/j.jclinepi.2013.11.011; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Newman M, 2012, CLIN REHABIL, V26, P1059, DOI 10.1177/0269215512443373; Riberholt CG, 2013, DAN MED J, V60; Riberholt CG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154831; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Stubbs PW, 2014, DISABIL REHABIL, V36, P2278, DOI 10.3109/09638288.2014.904935; Nguyen TL, 2017, J CLIN EPIDEMIOL, V84, P105, DOI 10.1016/j.jclinepi.2017.02.010; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; van de Vooren H, 2007, J APPL PHYSIOL, V102, P1348, DOI 10.1152/japplphysiol.00158.2006; Verheyden B, 2008, EUR HEART J, V29, P1523, DOI 10.1093/eurheartj/ehn134; Wetterslev J, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0315-7; Wilson BA, 2013, BRAIN IMPAIR, V14, P475, DOI 10.1017/BrImp.2013.34; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	35	5	5	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	NOV 8	2018	19								612	10.1186/s13063-018-3004-x			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GZ9AV	WOS:000449789500001	30409170	gold, Green Published			2022-02-06	
J	Bernstein, JPK; Calamia, M				Bernstein, John P. K.; Calamia, Matthew			Assessing the Longer-Term Effects of Mild Traumatic Brain Injury on Self-Reported Driving Ability	PM&R			English	Article							NEUROCOGNITIVE PERFORMANCE; PROFESSIONAL FOOTBALL; DEPRESSIVE SYMPTOMS; DRIVER BEHAVIOR; CONCUSSION; VIOLATIONS; AGGRESSION; VEHICLE; HISTORY; PERSONALITY	Background: Mild traumatic brain injury (mTBI) can have long-term cognitive and functional consequences, and recent mTBI has been associated with impaired performance on measures related to driving ability. However, it remains unclear whether mTBI history is associated with poorer driving performance. Objective: To examine the longer-term effects of mTBI on self-reported driving ability. Design: Retrospective cross-sectional study. Setting: Online. Participants: Three hundred eighty-nine participants (169 who reported an mTBI history and 220 without an mTBI history). Intervention: Comparing participants who report a history of mTBI with those who do not report a history of mTBI. Outcomes: Self-report measures of mTBI history, frequency of aberrant driving behaviors, recent history of car accidents and citations, and previous psychological diagnoses and current symptoms. Results: Participants with a history of mTBI reported an overall higher frequency of aberrant driving behaviors and committing more driving violations that risked the safety of others than comparison participants. Participants with mTBI also were more likely to have been involved in a car accident within the past 6 months and the past 3 years. Of participants with mTBI, reports of driving violations decreased with longer time since the most recent injury. Driving violations and crash risk also decreased with increased age and years of driving experience. Conclusions: Individuals with a history of mTBI are more likely to deliberately drive in a manner that risks the safety of others and are at a heightened risk of being involved in a recent car crash. Future work should examine predictor variables in greater depth and incorporate performance-based measures of driving ability to further explore these topics.	[Bernstein, John P. K.; Calamia, Matthew] Louisiana State Univ, Dept Psychol, 217 Audubon Hall, Baton Rouge, LA 70803 USA		Bernstein, JPK (corresponding author), Louisiana State Univ, Dept Psychol, 217 Audubon Hall, Baton Rouge, LA 70803 USA.	jberns3@lsu.edu		Calamia, Matthew/0000-0002-7252-7181	Louisiana State University	Funding for this project was provided internally by the Louisiana State University. Findings from this study were presented at the annual conference of the American Congress of Rehabilitation Medicine; Chicago, IL; October 2016.	Abdoli N, 2015, NEUROPSYCH DIS TREAT, V11, P2071, DOI 10.2147/NDT.S88835; Aslaksen PM, 2013, EUR J NEUROL, V20, P1227, DOI 10.1111/ene.12172; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; BALL K, 1991, HUM FACTORS, V33, P583, DOI 10.1177/001872089103300509; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bernstein J, 2018, PM&R, V10, P45, DOI 10.1016/j.pmrj.2017.06.010; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Brouwer WH, 2002, J HEAD TRAUMA REHAB, V17, P1, DOI 10.1097/00001199-200202000-00003; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Bulmash EL, 2006, J AFFECT DISORDERS, V93, P213, DOI 10.1016/j.jad.2006.01.015; Burkhardt J.E., 1999, TRANSPORT RES REC, V1671, P11, DOI [DOI 10.3141/1671-03, https://doi.org/10.3141/1671-03]; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Clapp JD, 2011, J ANXIETY DISORD, V25, P592, DOI 10.1016/j.janxdis.2011.01.008; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Daly BP, 2014, J AUTISM DEV DISORD, V44, P3119, DOI 10.1007/s10803-014-2166-y; de Winter JCF, 2013, ACCIDENT ANAL PREV, V52, P71, DOI 10.1016/j.aap.2012.12.018; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dula CS, 2010, ACCIDENT ANAL PREV, V42, P2050, DOI 10.1016/j.aap.2010.06.016; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heiman S, 2015, ACCIDENT ANAL PREV, V75, P245, DOI 10.1016/j.aap.2014.12.008; Hilton MF, 2009, ACCIDENT ANAL PREV, V41, P453, DOI 10.1016/j.aap.2009.01.012; Ilie G, 2015, ACCIDENT ANAL PREV, V81, P1, DOI 10.1016/j.aap.2015.04.021; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2014, INT EPIDEMIOL, V1, P1; King Y, 2008, EUR REV APPL PSYCHOL, V58, P43, DOI 10.1016/j.erap.2006.05.001; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Krahe B, 2002, AGGRESSIVE BEHAV, V28, P21, DOI 10.1002/ab.90003; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Lajunen T, 2003, TRANSPORT RES F TRAF, V6, P97, DOI [DOI 10.1016/S1369-8478(03)00008-1, 10.1016/S1369-8478(03)00008-1, 10.1016/ S1369-8478(03)00008-1]; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Marcus CL, 1996, SLEEP, V19, P763, DOI 10.1093/sleep/19.10.763; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; Mazza S, 2006, EUR RESPIR J, V28, P1020, DOI 10.1183/09031936.06.00112905; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; PARKER D, 1995, ERGONOMICS, V38, P1036, DOI 10.1080/00140139508925170; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pizza F, 2010, J CLIN SLEEP MED, V6, P41; Preece MHW, 2016, BRAIN INJURY, V30, P1096, DOI 10.3109/02699052.2016.1165868; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Reger MA, 2004, RELATIONSHIP NEUROPS; Rike PO, 2015, TRANSPORT RES F-TRAF, V29, P34, DOI 10.1016/j.trf.2015.01.004; RUBINSZTEIN J, 1995, INT J GERIATR PSYCH, V10, P15, DOI 10.1002/gps.930100104; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Schwebel DC, 2006, ACCIDENT ANAL PREV, V38, P801, DOI 10.1016/j.aap.2006.02.004; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827	58	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2018	10	11					1153	1163		10.1016/j.pmrj.2018.05.008			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HC2PN	WOS:000451644500003	29777771				2022-02-06	
J	Chan, HH; Wathen, CA; Mathews, ND; Hogue, O; Modic, JP; Kundalia, R; Wyant, C; Park, HJ; Najm, IM; Trapp, BD; Machado, AG; Baker, KB				Chan, Hugh H.; Wathen, Connor A.; Mathews, Nicole D.; Hogue, Olivia; Modic, James P.; Kundalia, Ronak; Wyant, Cara; Park, Hyun-Joo; Najm, Imad M.; Trapp, Bruce D.; Machado, Andre G.; Baker, Kenneth B.			Lateral cerebellar nucleus stimulation promotes motor recovery and suppresses neuroinflammation in a fluid percussion injury rodent model	BRAIN STIMULATION			English	Article						Lateral cerebellar nucleus; Fluid percussion injury; Anti-inflammation; Anti-apoptosis; Dentatothalamocortical pathway; Crossed-cerebellar diaschisis	TRAUMATIC BRAIN-INJURY; MICROGLIAL ACTIVATION; CEREBRAL-CORTEX; ELECTRICAL-STIMULATION; CORTICAL STIMULATION; DENTATE NUCLEUS; SPINAL-CORD; MOUSE MODEL; HEAD-INJURY; IN-VIVO	Background: Many traumatic brain injury (TBI) survivors live with persistent disability from chronic motor deficits despite contemporary rehabilitation services, underscoring the need for novel treatment. Objective/Hypothesis: We have previously shown that deep brain stimulation (DBS) of the lateral cerebellar nucleus (LCN) can enhance post-stroke motor recovery and increase the expression of markers of long-term potentiation in perilesional cerebral cortex. We hypothesize that a similar beneficial effect will be for motor deficits induced by unilateral fluid percussion injury (FPI) in rodents through long-term potentiation- and anti-inflammatory based mechanisms. Methods: Male Long Evans rats with a DBS macroelectrode in the LCN underwent FPI over contralateral primary motor cortex. After 4 weeks of spontaneous recovery, DBS treatment was applied for 4 weeks, with the pasta matrix, cylinder, and horizontal ladder tests used to evaluate motor performance. All animals were euthanized and tissue harvested for further analysis by histology, immunohistochemistry, RNA microarray assay and Western Blot. Results: LCN DBS-treated animals experienced a significantly greater rate of motor recovery than untreated surgical controls, with treated animals showing enhanced expression of RNA and protein for excitability related genes, suppressed expression of pro-inflammatory genes, suppressed microglial and astrocytic activation, but proliferation of c-fos positive cells. Finally, our data suggest a possible role for anti-apoptotic effects with LCN DBS. Conclusion: LCN DBS enhanced the motor recovery following TBI, possibly by elevating the neuronal excitability at the perilesional area and mediating anti-apoptotic and anti-inflammatory effects. (C) 2018 Elsevier Inc. All rights reserved.	[Chan, Hugh H.; Mathews, Nicole D.; Modic, James P.; Kundalia, Ronak; Wyant, Cara; Trapp, Bruce D.; Machado, Andre G.; Baker, Kenneth B.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Wathen, Connor A.; Park, Hyun-Joo; Machado, Andre G.; Baker, Kenneth B.] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Hogue, Olivia] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Najm, Imad M.] Cleveland Clin, Epilepsy Ctr, Cleveland, OH 44106 USA		Baker, KB (corresponding author), Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave,Desk NC-30, Cleveland, OH 44195 USA.	Bakerk6@ccf.org	Najm, Imad/R-2143-2019	Baker, Kenneth/0000-0002-4435-7015	Research Program Committee (RPC) of Cleveland Clinic Foundation [RPC 196]	This work was supported by grants from Research Program Committee (RPC) of Cleveland Clinic Foundation [RPC 196, 2017].	Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Alavi A, 1997, J NUCL MED, V38, P1717; ALESCH F, 1995, ACTA NEUROCHIR, V136, P75, DOI 10.1007/BF01411439; ANDREWS K, 1979, RHEUMATOL REHABIL, V18, P43, DOI 10.1093/rheumatology/18.1.43; Bachstetter AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149451; Baker KB, 2010, EXP NEUROL, V226, P259, DOI 10.1016/j.expneurol.2010.08.019; Ballermann M, 2001, J NEUROSCI METH, V106, P39, DOI 10.1016/S0165-0270(01)00326-0; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Carvajal FJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2701526; Chan HH, 2018, NEUROSURGERY, V83, P1057, DOI 10.1093/neuros/nyx473; Chan HH, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00010; Chen AJW, 2014, SEMIN NEUROL, V34, P557, DOI 10.1055/s-0034-1396009; Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Conti AC, 1998, J NEUROSCI, V18, P5663; Cooperrider J, 2014, J NEUROSCI, V34, P9040, DOI 10.1523/JNEUROSCI.0953-14.2014; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dum RP, 2009, J NEUROSCI, V29, P14223, DOI 10.1523/JNEUROSCI.3398-09.2009; Dum RP, 2003, J NEUROPHYSIOL, V89, P634, DOI 10.1152/jn.00626.2002; Dum RP, 2002, ANN NY ACAD SCI, V978, P289, DOI 10.1111/j.1749-6632.2002.tb07575.x; Edwards P, 2005, LANCET, V365, P1957; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Ghatak A, 2014, METHODSX, V1, P269, DOI 10.1016/j.mex.2014.10.007; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; HARVEY RJ, 1979, J PHYSIOL-LONDON, V297, P559, DOI 10.1113/jphysiol.1979.sp013057; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Imaizumi T, 2011, J NEUROIMAGING, V21, P359, DOI 10.1111/j.1552-6569.2011.00593.x; Issar NM, 2013, PARKINSONISM RELAT D, V19, P1100, DOI 10.1016/j.parkreldis.2013.07.022; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Karthikeyan A, 2016, CURR MED CHEM, V23, P3528, DOI 10.2174/0929867323666160814001040; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Machado A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00020; Machado AG, 2013, NEUROSURGERY, V73, P344, DOI 10.1227/01.neu.0000430766.80102.ac; Machado AG, 2009, BRAIN RES, V1280, P107, DOI 10.1016/j.brainres.2009.05.007; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Miao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042318; Molinari M, 2002, NEUROSCIENCE, V111, P863, DOI 10.1016/S0306-4522(02)00024-6; Negandhi J, 2014, HEARING RES, V315, P34, DOI 10.1016/j.heares.2014.06.002; Nemes A, 2016, J NEUROTRAUM, V33, P1883, DOI 10.1089/neu.2015.4220; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Park HJ, 2015, BRAIN STIMUL, V8, P1043, DOI 10.1016/j.brs.2015.06.020; Park HJ, 2013, J NEUROSCI METH, V213, P76, DOI 10.1016/j.jneumeth.2012.12.010; Pavlovskaya M, 2007, BRAIN INJURY, V21, P489, DOI 10.1080/02699050701311117; PAXINOS G, 1998, RAT BRAIN STEREOTOXI; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Plow EB, 2009, STROKE, V40, P1926, DOI 10.1161/STROKEAHA.108.540823; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schonfeld LM, 2017, NEUROSCI BIOBEHAV R, V83, P298, DOI 10.1016/j.neubiorev.2017.10.021; Schonfeld LM, 2017, J NEUROTRAUM, V34, P505, DOI 10.1089/neu.2016.4440; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shin SS, 2014, J NEUROSURG, V121, P1219, DOI 10.3171/2014.7.JNS131826; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Slack SE, 2005, J COMP NEUROL, V489, P59, DOI 10.1002/cne.20606; Tabansky I, 2014, BEHAV BRAIN RES, V273, P123, DOI 10.1016/j.bbr.2014.07.026; Tan X, 2015, NEUROSCIENCE, V290, P552, DOI 10.1016/j.neuroscience.2015.01.054; Tefertiller C, 2011, J REHABIL RES DEV, V48, P387, DOI 10.1682/JRRD.2010.04.0055; THACH WT, 1975, BRAIN RES, V88, P233, DOI 10.1016/0006-8993(75)90387-X; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; TRACEY DJ, 1980, J NEUROPHYSIOL, V44, P532, DOI 10.1152/jn.1980.44.3.532; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Turunc E, 2010, J PHARM PHARMACOL, V62, P1010, DOI 10.1111/j.2042-7158.2010.01122.x; Wang M, 2014, J INTEGR NEUROSCI, V13, P579, DOI 10.1142/S0219635214500265; Wang TJ, 2014, MOL MED REP, V9, P509, DOI 10.3892/mmr.2013.1823; Wanke E, 2016, J NEUROPHYSIOL, V116, P2706, DOI 10.1152/jn.00509.2016; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xing CH, 2014, STROKE, V45, P2085, DOI 10.1161/STROKEAHA.114.005733; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009	89	5	5	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	NOV-DEC	2018	11	6					1356	1367		10.1016/j.brs.2018.07.051			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GY0LW	WOS:000448212900018	30061053				2022-02-06	
J	Chao, LL				Chao, Linda L.			The Relationship Between Traumatic Brain Injury and Rates of Chronic Symptomatic Illness in 202 Gulf War Veterans	MILITARY MEDICINE			English	Article							CHRONIC MULTISYMPTOM ILLNESS; II PSYCHIATRIC-DISORDERS; MENTAL-HEALTH; AXIS-I; PREVALENCE; MILITARY; POPULATION; DEPRESSION	Introduction: Although not a "signature injury" of Operation Desert Shield/Desert Storm (i.e., Gulf War, GW), some GW veterans have a history traumatic brain injury (TBI). For example, a previous study found that 12.2% of the GW veterans from the Fort Devens Cohort Study had self-reported TBIs. The present study sought to build upon this finding by examining the relationship between TBI and chronic symptomatic illness in a different sample of GW veterans. Materials and Methods: Participants were 202 GW veterans recruited from 2014 to 2018 at the San Francisco Veterans Affairs Medical Center as part of a VA-funded study on the effects of predicted exposure to low levels of sarin and cyclosarin on brain structure and function. The Ohio State University TBI identification method was used to determine lifetime history of TBI. The Kansas Gulf War Military History and Health Questionnaire was used to assess symptoms and to determine cases of Kansas Gulf War Illness (GWI) and Centers for Disease Control and Prevention (CDC) Chronic Multisymptom Illness (CMI). Results: Nearly half (47%) the sample had a history of TBI, but only 7% of the TBIs were sustained in injuries that occurred during the GW. Most of the TBIs were sustained in injuries that occurred prior to (73%) or after (34%) the GW. History of TBI was not associated with higher rates of symptomatic illness when it was narrowly defined (i.e., Kansas GWI cases or cases of severe CMI). History of TBI was only associated with higher rates of symptomatic illness when it is broadly defined (i.e., CDC CMI or mild-moderate CMI). There was suggestive evidence that veterans who sustained TBIs during the GW (only seven in the present sample) have poorer functional outcomes compared with GW veterans with nonGW related TBIs. Conclusions: While TBIs were uncommon during the GW, many GW veterans sustained TBIs prior or after the GW. Because TBI and GWI/CMI share some overlapping symptoms, history of TBI may appear to be associated with increased rates of chronic symptomatic illness in GW veterans if chronic symptomatic illness is defined broadly (i.e., CDC CMI or mild-moderate CMI). History of pre-GW TBI did not affect the veterans' response to exposures/experiences from the GW; however, there was suggestive evidence that veterans who sustained TBIs during the GW may have poorer functional outcomes that GW veterans without TBI or even GW veterans with non-GW-related TBIs. Future, better powered studies with randomly and systematically select participants from the larger population of GW veterans will need to confirm this finding.	[Chao, Linda L.] San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, 4150 Clement St,114 M, San Francisco, CA 94121 USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Chao, Linda L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA		Chao, LL (corresponding author), San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, 4150 Clement St,114 M, San Francisco, CA 94121 USA.; Chao, LL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.; Chao, LL (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.				 [CX000798]	VA grant No. CX000798 entitled "Longitudinal Assessment of Gulf War Veterans with Suspected Sarin Exposure"	Alexander MP, 1998, J HEAD TRAUMA REHAB, V8, P60; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; Faul M, 2010, TRAUMATIC BRAIN INJU; First MB, 1995, STRUCTURED CLIN INTE; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; *GOSS GILR INC, 1998, HLTH STUD CAN FORC P; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IOM (Institute of Medicine), 2014, CHRON MULT ILLN GULF; Kang HK, 2000, J OCCUP ENVIRON MED, V42, P491, DOI 10.1097/00043764-200005000-00006; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Langlois JA., 2004, TRAUMATIC BRAIN INJU; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; Nettleman Mary, 2015, Trans Am Clin Climatol Assoc, V126, P237; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nisenbaum R, 2000, J NERV MENT DIS, V188, P259, DOI 10.1097/00005053-200005000-00002; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Research Advisory Committee on Gulf War Veteran's Illnesses [RAC-GWVI], 2014, GULF WAR ILLN HLTH G; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Warner M, 2005, INJURY PREV, V11, P282, DOI 10.1136/ip.2004.006965; Warner M, 2000, Vital Health Stat 10, P1; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; White RF, 2001, AM J IND MED, V40, P42, DOI 10.1002/ajim.1070; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wolfe J, 1996, INSTRUMENTATION STRE, P144; Yee MK, 2016, J HEAD TRAUMA REHAB, V31, P230	39	5	5	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2018	183	11-12					E571	E579		10.1093/milmed/usy109			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HC4ZP	WOS:000451813600032	29788089	hybrid			2022-02-06	
J	Lytle, ME; West, J; Burkes, JN; Beteck, B; Fisher, T; Daoud, Y; Gable, DR; Shutze, WP				Lytle, Mark E.; West, James; Burkes, Jason N.; Beteck, Besem; Fisher, Tammy; Daoud, Yahya; Gable, Dennis R.; Shutze, William P.			Limited Clinical Relevance of Vertebral Artery Injury in Blunt Trauma	ANNALS OF VASCULAR SURGERY			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; 10-YEAR RETROSPECTIVE ANALYSIS; CEREBROVASCULAR INJURY; EARLY-DIAGNOSIS; NECK INJURIES; GRADE 1; ANGIOGRAPHY; OUTCOMES; IMPROVES; CENTER.	Background: Blunt cerebrovascular injury (BCVI), although rare, is more common than previously thought and carries a substantial stroke and mortality risk. The purpose of our study was to evaluate the differences between blunt carotid artery (CA) and vertebral artery (VA) injuries, assess the stroke and death rates related to these injuries, and identify the relationship of Injury Severity Score (ISS) with stroke and mortality in BCVI. Methods: Using a retrospective review of the trauma registry at a level I trauma center, we identified patients with BCVI. The study period began in January 2003 and ended in July 2014. Demographics, injuries reported, investigative studies performed, and outcomes data were obtained and analyzed. Radiographic images of both blunt CA and VA injuries were reviewed and graded by an independent radiologist, according to the current classification of blunt CA injuries. Results: BCVI involving 114 vessels was identified in 103 patients. This population consisted of 65 males and 38 females with an average age of 45 years (15-92, range). The average ISS was 22 (4-75, range). Cervical spine fracture occurred in 80% of VA injuries (64 total patients). Injuries involved the CA in 33, the VA in 59, and both in 11. The CA group had a higher incidence of traumatic brain injury (61% vs. 46%), ISS (27 vs. 18), and stroke (24% vs. 3%), compared to the VA group. Mortality in the CA group was 30% compared to 3% in the VA group. Patients with high ISS (>= 25) had increased stroke rates compared to those with lower (<25) ISS (19% vs. 6.7%). All mortalities occurred with ISS >25. Logistic regression revealed that vessel injured, ISS, and Glasgow Coma Scale (GCS) were significant risk factors for mortality. Multivariate analysis demonstrated carotid injury, and lowest GCS were independently associated with mortality. Conclusions: In this comparison of CA and VA injuries in BCVI, VA injuries were more common and more frequently found with cervical spine fractures than CA injuries. However, VA injuries had a lower incidence of CVA and mortality. A high ISS was associated with stroke and mortality while carotid injury and lowest GCS were independently associated with increased mortality.	[Lytle, Mark E.] US Air Force, Pensacola, FL USA; [West, James] Baylor Univ, Med Ctr, Dept Radiol, Dallas, TX USA; [Burkes, Jason N.] Texas A&M Coll Med, College Stn, TX USA; [Beteck, Besem; Fisher, Tammy] Baylor Univ, Med Ctr, Dept Surg, Dallas, TX 75246 USA; [Daoud, Yahya] Baylor Res Inst, Dallas, TX USA; [Gable, Dennis R.; Shutze, William P.] Texas Heart Hosp Baylor Plano, Plano, TX USA; [Gable, Dennis R.; Shutze, William P.] Texas Vasc Associates, Dallas, TX USA		Shutze, WP (corresponding author), 4716 Alliance Blvd Suite 200, Plano, TX 75093 USA.	willshut@sbcglobal.net		Shutze, William/0000-0002-1627-5434			Alterman DM, 2013, J VASC SURG, V57, P741, DOI 10.1016/j.jvs.2012.09.006; Anaya C, 2009, SEMIN ULTRASOUND CT, V30, P205, DOI 10.1053/j.sult.2009.02.003; Arthurs ZM, 2008, INJURY, V39, P1232, DOI 10.1016/j.injury.2008.02.042; Baker William E, 2006, Curr Treat Options Cardiovasc Med, V8, P167, DOI 10.1007/s11936-006-0009-7; Berne JD, 2004, J TRAUMA, V57, P11, DOI 10.1097/01.TA.0000135499.70048.C7; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 2002, J TRAUMA, V53, P850, DOI 10.1097/00005373-200211000-00008; Biffl WL, 2001, WORLD J SURG, V25, P1036, DOI 10.1007/s00268-001-0056-x; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Burlew CC, 2010, CURR OPIN CRIT CARE, V16, P587, DOI 10.1097/MCC.0b013e32833ee8b4; Chokshi FH, 2011, AM J ROENTGENOL, V196, pW309, DOI 10.2214/AJR.10.4548; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Cothren CC, 2003, J TRAUMA, V55, P811, DOI 10.1097/01.TA.0000092700.92587.32; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Fabian TC, 2013, J AM COLL SURGEONS, V216, P873, DOI 10.1016/j.jamcollsurg.2012.12.053; Fleck SK, 2011, NEUROSURGERY, V69, P615, DOI 10.1227/NEU.0b013e31821a8701; Fusco MR, 2011, NEUROSURGERY, V68, P517, DOI 10.1227/NEU.0b013e3181fe2fda; Goodwin RB, 2009, J TRAUMA, V67, P1046, DOI 10.1097/TA.0b013e3181b83b63; Liang T, 2013, CAN ASSOC RADIOL J, V64, P130, DOI 10.1016/j.carj.2013.02.002; Paulus EM, 2014, J TRAUMA ACUTE CARE, V76, P279, DOI 10.1097/TA.0000000000000101; Scott WW, 2015, J NEUROSURG, V122, P1196, DOI 10.3171/2015.1.JNS14642; Scott WW, 2015, J NEUROSURG, V122, P1202, DOI 10.3171/2014.9.JNS1461; Scott WW, 2015, J NEUROSURG, V122, P610, DOI 10.3171/2014.10.JNS14875; Scott WW, 2014, J NEUROSURG, V121, P450, DOI 10.3171/2014.4.JNS132235; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Wang AC, 2012, J TRAUMA ACUTE CARE, V72, P1599, DOI 10.1097/TA.0b013e318246ead4	31	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	NOV	2018	53						53	62		10.1016/j.avsg.2018.05.034			10	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	GW1WZ	WOS:000446674300004	30053545				2022-02-06	
J	Maiti, R; Mishra, BR; Jena, M; Mishra, A; Nath, S; Srinivasan, A				Maiti, Rituparna; Mishra, Biswa Ranjan; Jena, Monalisa; Mishra, Archana; Nath, Santanu; Srinivasan, Anand			Effect of anti-seizure drugs on serum S100B in patients with focal seizure: a randomized controlled trial	JOURNAL OF NEUROLOGY			English	Article						Focal seizure; S100B; Carbamazepine; Oxcarbazepine	NEURON-SPECIFIC ENOLASE; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; EF-HAND TYPE; FUNCTIONAL ROLES; ACUTE STROKE; PROTEIN; MARKER; DAMAGE; INHIBITION	Purpose S100B, a cytokine produced by astrocytes, has been studied as a biomarker of glial and neuronal damage in epilepsy. The present study investigated the reliability of serum S100B as a biomarker and the effect of carbamazepine and oxcarbazepine on serum S100B in patients with focal seizure. Methods The present randomized, open-label, active-controlled, parallel design clinical trial (NCT02705768) conducted on 60 patients with focal seizure. After recruitment, clinical evaluations were performed including Chalfont-National Hospital seizure severity scale (NHS3), Quality of Life in Epilepsy Inventory (QOLIE-31) and serum S100B was estimated. Thirty healthy individuals were recruited for evaluation of serum S100B at baseline only. After randomization, the study groups received either tablet oxcarbazepine or tablet carbamazepine. At follow-up after 2 weeks, clinical status was checked and at 4 weeks, NHS3 and QOLIE-31 were scored along with serum S100B level estimation. Results Serum S100B level in patients with focal seizure increased significantly in comparison to healthy volunteers. The decrease in serum S100B was significantly higher with carbamazepine group (0.004; 95% CI 0.001-0.006; p = 0.01) over oxcarbazepine group. In logistic regression analysis, there was an increase in the log odds of 0.17 for focal seizure positivity against healthy controls if S100B level increases by 1 pg and area under curve obtained by ROC analysis was 0.96 (p < 0.001). Conclusion Serum S100B increases in the patients with focal seizure and therapy with carbamazepine can decrease serum S100B level significantly over oxcarbazepine. Serum S100B can be used as a prognostic biomarker in a focal seizure.	[Maiti, Rituparna; Jena, Monalisa; Mishra, Archana; Srinivasan, Anand] AIIMS, Dept Pharmacol, Bhubaneswar, Odisha, India; [Mishra, Biswa Ranjan; Nath, Santanu] AIIMS, Dept Psychiat, Bhubaneswar, Odisha, India		Mishra, BR (corresponding author), AIIMS, Dept Psychiat, Bhubaneswar, Odisha, India.	rituparnamaiti@gmail.com; brm1678@gmail.com; drmonalisajena@gmail.com; archanapmv@gmail.com; beta.santanu@gmail.com; pharm_anand@aiimsbhubaneswar.edu.in	Jena, Monalisa/AAP-2944-2021	MAITI, RITUPARNA/0000-0003-4063-9178			Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Chang CC, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-15; Cramer JA, 2001, EPILEPSIA, V42, P119, DOI 10.1046/j.1528-1157.2001.19400.x; Cramer JA, 1998, EPILEPSIA, V39, P81, DOI 10.1111/j.1528-1157.1998.tb01278.x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; DUNCAN JS, 1991, J NEUROL NEUROSUR PS, V54, P873, DOI 10.1136/jnnp.54.10.873; Foerch C, 2007, STROKE, V38, P2491, DOI 10.1161/STROKEAHA.106.480111; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Goncalves DS, 2000, NEUROREPORT, V11, P807, DOI 10.1097/00001756-200003200-00030; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Jankowsky JL, 2001, PROG NEUROBIOL, V63, P125, DOI 10.1016/S0301-0082(00)00022-8; Kacinski M, 2012, PHARMACOL REP, V64, P1427, DOI 10.1016/S1734-1140(12)70940-4; Khurgel M, 1996, EPILEPSY RES, V26, P163, DOI 10.1016/S0920-1211(96)00051-4; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Leutmezer F, 2002, EPILEPSIA, V43, P1172, DOI 10.1046/j.1528-1157.2002.50101.x; Li BM, 2007, PSYCHOPHARMACOLOGY, V194, P333, DOI 10.1007/s00213-007-0853-5; Li BM, 2009, NEUROPHARMACOLOGY, V57, P375, DOI 10.1016/j.neuropharm.2009.07.004; Lins H, 2005, ACTA NEUROL SCAND, V112, P303, DOI 10.1111/j.1600-0404.2005.00484.x; Lu CF, 2010, NEUROSCI LETT, V484, P139, DOI 10.1016/j.neulet.2010.08.036; Lubrich B, 1999, NEUROPSYCHOPHARMACOL, V21, P519, DOI 10.1016/S0893-133X(99)00037-8; Mikkonen K, 2012, SEIZURE-EUR J EPILEP, V21, P144, DOI 10.1016/j.seizure.2011.10.006; Nash DL, 2008, NEUROCRIT CARE, V8, P301, DOI 10.1007/s12028-007-9019-x; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pfeifer R, 2005, RESUSCITATION, V65, P49, DOI 10.1016/j.resuscitation.2004.10.011; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Portela LVC, 2003, ACTA NEUROL SCAND, V108, P424, DOI 10.1034/j.1600-0404.2003.00159.x; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Song D, 2008, PSYCHOPHARMACOLOGY, V200, P187, DOI 10.1007/s00213-008-1194-8; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; Wolfson M, 2000, BRAIN RES, V855, P158, DOI 10.1016/S0006-8993(99)02371-9; Wong CH, 1999, ANN THORAC SURG, V67, P1911, DOI 10.1016/S0003-4975(99)00425-7	34	5	5	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	NOV	2018	265	11					2594	2601		10.1007/s00415-018-9026-1			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY3KN	WOS:000448450200011	30173303				2022-02-06	
J	Norman, RS; Jaramillo, CA; Eapen, BC; Amuan, ME; Pugh, MJ				Norman, Rocio S.; Jaramillo, Carlos A.; Eapen, Blessen C.; Amuan, Megan E.; Pugh, Mary Jo			Acquired Stuttering in Veterans of the Wars in Iraq and Afghanistan: The Role of Traumatic Brain Injury, Post-Traumatic Stress Disorder, and Medications	MILITARY MEDICINE			English	Article							SOCIAL ANXIETY DISORDER; QUALITY-OF-LIFE; COMMUNICATION DISORDERS; ADULTS; IMPACT; PHARMACOTHERAPY; EPIDEMIOLOGY; COMMUNITY; SEVERITY; FLUENCY	Introduction: Determine the association between acquired stuttering (AS), traumatic brain injury (TBI), and post-traumatic stress disorder (PTSD) in a cohort of 309,675 U.S. Iraq and Afghanistan veterans. The secondary aim was to determine the association between AS and medication patterns for veterans in the sample. Materials and Methods: Retrospective study using data from the Veterans Health Administration National Repository for veterans deployed in support of combat operations in Iraq and Afghanistan and who received Veterans Health Administration care in 2010 and 2011. We identified stuttering using ICD-9 codes to establish the association between AS, TBI, and PTSD, controlling for demographic characteristics and other comorbidities. Multivariable logistic regression was used to determine the association between comorbid conditions and potentially problematic medications associated with stuttering. Results: Two hundred thirty-five veterans (0.08%) were diagnosed with AS in the cohort. There was the greater likelihood of an AS diagnosis for veterans with concomitant TBI and PTSD when compared with veterans without these diagnoses. Over 66% of those with stuttering were prescribed at least one medication that affected speech fluency (antidepressants, anxiolytics, and antiepileptic drugs) compared with 35% of those without AS. Conclusion: Veterans with a comorbid diagnosis of TBI and PTSD were more likely to be diagnosed with AS AOR: 9.77 (95% CI = 6.93-13.78, p < 0.05) and more likely to have been prescribed medications known to affect speech production OR: 3.68 (95% CI = 2.81-4.82, p < 0.05). Clinicians treating veterans with these complex comorbid conditions should consider the impact of medications on speech fluency.	[Norman, Rocio S.] Univ Texas Hlth Sci Ctr San Antonio, Sch Hlth Profess, Speech Language Pathol Program, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Jaramillo, Carlos A.; Eapen, Blessen C.; Pugh, Mary Jo] Polytrauma Rehabil Ctr, South Texas Vet Hlth Care Syst, 7400 Merton Miner Dr, San Antonio, TX 78229 USA; [Amuan, Megan E.] Edith Nourse Rogers Mem Vet Hosp, Bedford Ctr Hlth Qual Outcomes & Econ Res, 200 Springs Rd, Bedford, MA 01730 USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA		Norman, RS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sch Hlth Profess, Speech Language Pathol Program, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.				Department of Veterans Affairs Health Services ResearchUS Department of Veterans Affairs [DHI 09-237 1I01HX000717-01, 1I01HX001056-01, 1I01HX001304-01]; National Center for Complementary and Integrative Health [1R01AT008422-01]; Department of Veterans Affairs Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [I01 CX001246, 1I21RX002060-01, W81XWH-13-2-0095-04]; Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095-04]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT008422] Funding Source: NIH RePORTER	MJP receives support from Department of Veterans Affairs Health Services Research DHI 09-237 1I01HX000717-01, 1I01HX001056-01, and 1I01HX001304-01; the National Center for Complementary and Integrative Health (1R01AT008422-01), Department of Veterans Affairs Rehabilitation Research and Development I01 CX001246, 1I21RX002060-01, W81XWH-13-2-0095-04; and the Department of Defense W81XWH-13-2-0095-04.	ANDREWS G, 1985, BEHAV MODIF, V9, P443, DOI 10.1177/01454455850094003; Balasubramanian V, 2003, BRAIN COGNITION, V53, P185, DOI 10.1016/S0278-2626(03)00106-4; Bar KJ, 2004, PHARMACOPSYCHIATRY, V37, P131, DOI 10.1055/s-2004-818992; Baumgartner J., 1997, J MED SPEECH-LANG PA, V5, P75; Beilby J, 2014, SEMIN SPEECH LANG, V35, DOI 10.1055/s-0034-1371756; Bernardy NC, 2014, PAIN MED, V15, P1083, DOI 10.1111/pme.12321; Blomgren M, 2005, J SPEECH LANG HEAR R, V48, P509, DOI 10.1044/1092-4388(2005/035); Bloodstein O., 2008, HDB STUTTERING, V6th; Blumgart E, 2010, J FLUENCY DISORD, V35, P203, DOI 10.1016/j.jfludis.2010.03.002; Blumgart E, 2010, DEPRESS ANXIETY, V27, P687, DOI 10.1002/da.20657; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; BRADY JP, 1994, CNS DRUGS, V1, P263, DOI 10.2165/00023210-199401040-00004; Brady JP, 1998, J CLIN PSYCHOPHARM, V18, P50, DOI 10.1097/00004714-199802000-00008; Church D, 2014, EXPLORE-NY, V10, P162, DOI 10.1016/j.explore.2014.02.005; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Cook S, 2013, J FLUENCY DISORD, V38, P124, DOI 10.1016/j.jfludis.2012.08.001; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Costa D, 2000, CAN MED ASSOC J, V162, P1849; Craig A, 2003, J SPEECH LANG HEAR R, V46, P1197, DOI 10.1044/1092-4388(2003/093); Craig A, 2002, J SPEECH LANG HEAR R, V45, P1097, DOI 10.1044/1092-4388(2002/088); CRAIG A, 1985, BEHAV MODIF, V9, P427, DOI 10.1177/01454455850094002; Craig A, 2014, J FLUENCY DISORD, V40, P35, DOI 10.1016/j.jfludis.2014.01.001; Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; ELLIOTT RL, 1985, J CLIN PSYCHOPHARM, V5, P159; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Ezrati-Vinacour R, 2004, J FLUENCY DISORD, V29, P135, DOI 10.1016/j.jfludis.2004.02.003; French DD, 2009, J REHABIL RES DEV, V46, P463, DOI 10.1682/JRRD.2008.09.0017; FRIEDMAN EH, 1990, J CLIN PSYCHIAT, V51, P310; Hermes E, 2014, SLEEP MED, V15, P508, DOI 10.1016/j.sleep.2013.12.010; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverach L, 2014, J FLUENCY DISORD, V40, P69, DOI 10.1016/j.jfludis.2013.08.003; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Kent RD, 2015, AM J SPEECH-LANG PAT, V24, P763, DOI 10.1044/2015_AJSLP-14-0179; Klein JF, 2004, J FLUENCY DISORD, V29, P255, DOI 10.1016/j.jfludis.2004.08.001; Koedoot C, 2011, J COMMUN DISORD, V44, P429, DOI 10.1016/j.jcomdis.2011.02.002; Krishnan G, 2011, J NEUROLINGUIST, V24, P383, DOI 10.1016/j.jneuroling.2011.01.001; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; Lundgren K, 2010, J NEUROLINGUIST, V23, P447, DOI 10.1016/j.jneuroling.2009.08.008; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MARKET KE, 1990, J FLUENCY DISORD, V15, P21, DOI 10.1016/0094-730X(90)90029-R; MCCLEAN MD, 1985, J FLUENCY DISORD, V10, P241, DOI 10.1016/0094-730X(85)90023-3; MCHENRY M, 1994, BRAIN INJURY, V8, P363, DOI 10.3109/02699059409150987; MENKES DB, 1993, J NERV MENT DIS, V181, P64; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menzies RG, 2009, J FLUENCY DISORD, V34, P187, DOI 10.1016/j.jfludis.2009.09.002; Meyers JE, 2014, APPL NEUROPSYCH-ADUL, V21, P60, DOI 10.1080/09084282.2012.737881; Morgan M, 2012, PSYCHIAT SERV, V63, P182, DOI 10.1176/appi.ps.201000531; Mouradian MS, 2000, BRAIN LANG, V73, P120, DOI 10.1006/brln.2000.2289; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Office of Public Health Veterans Health Administration, 2015, VA HLTH CAR UT OEF O; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parkes AJ, 1997, AUST NZ J PUBL HEAL, V21, P469, DOI 10.1111/j.1467-842X.1997.tb01737.x; Penttila N, 2015, PROCD SOC BEHV, V193, P310, DOI 10.1016/j.sbspro.2015.03.289; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Preskorn Sheldon H, 2005, J Psychiatr Pract, V11, P46, DOI 10.1097/00131746-200501000-00006; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Roth CR, 2015, NEUROREHABILITATION, V36, P415, DOI 10.3233/NRE-151230; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Sahin HA, 2005, BEHAV NEUROL, V16, P37, DOI 10.1155/2005/941926; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Silkey Beryl, 2005, J Psychiatr Pract, V11, P16, DOI 10.1097/00131746-200501000-00003; Stager SV, 2005, J FLUENCY DISORD, V30, P319, DOI 10.1016/j.jfludis.2005.09.004; Tanielian T.L., 2008, INVISIBLE WOUNDS WAR, V1; Theys C, 2011, J COMMUN DISORD, V44, P678, DOI 10.1016/j.jcomdis.2011.06.001; Theys C, 2008, J FLUENCY DISORD, V33, P1, DOI 10.1016/j.jfludis.2007.09.001; Tran Y, 2011, J FLUENCY DISORD, V36, P17, DOI 10.1016/j.jfludis.2010.12.003; Van Borsel J, 2001, J COMMUN DISORD, V34, P385, DOI 10.1016/S0021-9924(01)00057-0; Van Borsel J, 2014, J NEUROLINGUIST, V27, P41, DOI 10.1016/j.jneuroling.2013.09.003; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; White S, 2010, ASHA LEAD, V15, P8; WICKENS T. D., 1989, MULTIWAY CONTINGENCY; Yairi E, 2013, J FLUENCY DISORD, V38, P66, DOI 10.1016/j.jfludis.2012.11.002	76	5	5	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2018	183	11-12					E526	E534		10.1093/milmed/usy067			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HC4ZP	WOS:000451813600027		Bronze, Green Published			2022-02-06	
J	Ogunlade, J; Wiginton, JG; Ghanchi, H; Al-Atrache, Z; Wacker, M; Menoni, R; Miulli, D				Ogunlade, John; Wiginton, James G.; Ghanchi, Hammad; Al-Atrache, Zein; Wacker, Margaret; Menoni, Rosalinda; Miulli, Dan			Efficacy of platelet transfusion in the management of acute subdural hematoma	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Subdural hematoma; Acute subdural hematoma; Antiplatelet therapy; Aspirin; Clopidogrel; Reversal therapy	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; ANTITHROMBOTIC THERAPY; ANTIPLATELET AGENTS; REVERSAL; MORTALITY; RISK; COAGULOPATHY; PROGRESSION; PREDICTORS	Objective: Oral Antithrombotic Therapy has become a well documented predisposing risk factor in the development of traumatic intracranial hemorrhage. Currently, a reversal protocol for antiplatelet therapy remains ill-defined in the management of non-surgical traumatic subdural hematoma and there is no evidence to suggest a clear benefit of platelet transfusion to mitigate the effect of antiplatelet agents. This study aims to establish parameters in which platelet transfusion would be of benefit in patients with non-surgical traumatic subdural hematoma with preinjury antiplatelet therapy. Patients and methods: This study is a retrospective chart review of patents from 2015 to 2018 at two Level II trauma centers identifying consecutive patients with non-surgical acute traumatic subdural hematomas. Patients with use of aspirin and/or clopidogrel were categorized into subgroups based on transfusion of platelets for antiplatelet reversal therapy, and were compared to a control group. The primary outcome measure was the presence of subdural hematoma expansion. Results: A total of 72 patients met the criteria for inclusion in this study. The average age of the cohort was 75.4 with a median of 77.5. There were 40 males and 32 females. Chi-square analysis was performed which demonstrated statistical significance for difference between the aspirin and clopidogrel group for percent of hematoma expansion (p = 0.0284). Patients on antiplatelet therapy (n = 36) were grouped together and compared to patients without antiplatelet therapy (n = 36), this demonstrated that the transfusion of platelets for patients on antiplatelet agents (n = 19/36) still resulted in a significant hematoma expansion in (n = 7/19, 36.8%) compared to patients not on antiplatelet therapy (n = 3/36, 8.3%) (p = 0.0001). Conclusion: The results of this study suggest that patients with non-surgical traumatic subdural hematomas on presentation are less likely to expand, however the risk of expansion is greater when the patient is on antiplatelet therapy. There is no clear benefit in the use of platelet transfusion as a reversal agent to mitigate the effects of antiplatelet therapy in the setting of non-surgical traumatic subdural hematomas.	[Ogunlade, John; Wiginton, James G.; Ghanchi, Hammad; Wacker, Margaret; Menoni, Rosalinda; Miulli, Dan] Riverside Univ Hlth Syst Med Ctr, 26250 Cactus Ave, Moreno Valley, CA 92555 USA; [Ogunlade, John; Wiginton, James G.; Ghanchi, Hammad; Wacker, Margaret; Menoni, Rosalinda; Miulli, Dan] Arrowhead Reg Med Ctr, Colton, CA 92324 USA; [Al-Atrache, Zein] Philadelphia Coll Osteopath Med, Philadelphia, PA 19131 USA		Ogunlade, J (corresponding author), Riverside Univ Hlth Syst Med Ctr, 26250 Cactus Ave, Moreno Valley, CA 92555 USA.	j.ogunlade@ruhealth.org		Wiginton IV, James/0000-0001-9765-7145			Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; de Gans K, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-19; Foreman PM, 2018, WORLD NEUROSURG, V116, pE649, DOI 10.1016/j.wneu.2018.05.064; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; IUVARABOMMELI A, 1991, SCHWEIZ MED WSCHR, V121, P646; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P417, DOI 10.1097/TA.0000000000000372; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Kostic A, 2018, J CHIN MED ASSOC, V81, P781, DOI 10.1016/j.jcma.2018.03.010; Kwinta Borys, 2018, Folia Med Cracov, V58, P53; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marion DW, 2006, NEUROSURGERY, V58, P655; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Moussouttas M, 2012, THER ADV NEUROL DISO, V5, P43, DOI 10.1177/1756285611422267; Neau JP, 1997, NEUROLOGY, V49, P106, DOI 10.1212/WNL.49.1.106; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Pandya U, 2018, J CLIN NEUROSCI, V50, P88, DOI 10.1016/j.jocn.2018.01.073; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Trevisi G, 2018, WORLD NEUROSURG, V118, pE316, DOI 10.1016/j.wneu.2018.06.185; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116; Watson RDS, 2002, BMJ-BRIT MED J, V325, P1348, DOI 10.1136/bmj.325.7376.1348	29	5	5	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2018	174						163	166		10.1016/j.clineuro.2018.09.021			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA3FD	WOS:000450134600028	30245434				2022-02-06	
J	Petuchowksi, J; Kieras, K; Stein, K				Petuchowksi, Janese; Kieras, Kaitlin; Stein, Kristina			Rehabilitation Strategies Following Surgical Treatment of Upper Extremity Spasticity	HAND CLINICS			English	Article						Occupational therapy; Hand therapy; Postsurgical guidelines; Spasticity; Upper extremity; Postsurgical treatment; Upper extremity transfers	HEMIPLEGIC CEREBRAL-PALSY; MIRROR THERAPY; HAND FUNCTION; TENDON TRANSFERS; THUMB DEFORMITY; PASSIVE MOTION; CHILDREN; MANAGEMENT; STROKE; SCARS	Upper motor neuron injuries that occur in cases such as cerebral palsy, cerebrovascular accidents, and traumatic brain injury often result in upper extremity deformity and dysfunction. Multiple surgical options are available to improve upper extremity positioning, and, in some cases, motor control. Postoperative therapeutic management is imperative to assist the patient and caregiver in maximizing potential functional gains. This article provides an overview of postoperative guidelines for commonly performed surgeries to manage upper extremity dysfunction caused by spasticity and discusses acute management as well as therapeutic techniques for functional training and improved motor control.	[Petuchowksi, Janese] Solace Hlth Care, Occupat Therapy, 4500 Cherry Creek South Dr Suite 710, Denver, CO 80246 USA; [Kieras, Kaitlin; Stein, Kristina] Ann & Robert H Lurie Childrens Hosp Chicago, Occupat Therapy, 225 East Chicago Ave,Box 142, Chicago, IL 60611 USA; [Petuchowksi, Janese] 3498 East Ellsworth Ave Unit 801C, Denver, CO 80209 USA		Stein, K (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Occupat Therapy, 225 East Chicago Ave,Box 142, Chicago, IL 60611 USA.	kstein@luriechildrens.org					Anakwenze OA, 2013, J SHOULDER ELB SURG, V22, P318, DOI 10.1016/j.jse.2012.10.043; Arya KN, 2012, TOP STROKE REHABIL, V19, P193, DOI 10.1310/tsr1903-193; Bansal A, 2016, HAND CLIN, V32, P423, DOI 10.1016/j.hcl.2016.03.010; Barus D, 2006, J HAND THER, V19, P192, DOI 10.1197/j.jht.2006.02.012; Basu AP, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00281; Bednar JM, 2011, REHABILITATION HAND, P1024; Botte M, 2011, REHABILITATION HAND, P1659; Bunata RE, 2006, J HAND SURG-AM, V31A, P474, DOI 10.1016/j.jhsa.2005.11.009; Bunata R, 2014, J HAND SURG-AM, V39, P1425, DOI 10.1016/j.jhsa.2013.12.017; Burtner PA, 2014, DEV MED CHILD NEUROL, V56, P259, DOI 10.1111/dmcn.12364; Cannon NM, 2001, DIAGNOSIS TREATMENT; Carlson MG, 2007, J HAND SURG-AM, V32A, P1418, DOI 10.1016/j.jhsa.2007.07.002; Coopee RA, 2011, REHABILITATION HAND, P1529; Dahlin LB, 1998, J HAND SURG-BRIT EUR, V23B, P334, DOI 10.1016/S0266-7681(98)80053-3; Danikas D, 2015, MEDSCAPE, DOI [10.1080/09638288.2017.1360403, DOI 10.1080/09638288.2017.1360403]; Davids JR, 2009, J PEDIATR ORTHOPED, V29, P504, DOI 10.1097/BPO.0b013e3181aa2488; de Roode Carolien P, 2010, Tech Hand Up Extrem Surg, V14, P129, DOI 10.1097/BTH.0b013e3181e3d785; Deconinck FJA, 2015, NEUROREHAB NEURAL RE, V29, P349, DOI 10.1177/1545968314546134; dos Santos GL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170368; Duff SV, 2011, REHABILITATION HAND, P781; Ezendam D, 2009, DISABIL REHABIL, V31, P2135, DOI 10.3109/09638280902887768; Fedorczyk J., 2011, REHABILITATION HAND, P868; Footer Cheryl Burditt, 2006, Pediatr Phys Ther, V18, P245, DOI 10.1097/01.pep.0000233696.33675.37; Friden Jan, 2011, Tech Hand Up Extrem Surg, V15, P230, DOI 10.1097/BTH.0b013e31821b5896; GIUDICE ML, 1990, AM J OCCUP THER, V44, P914, DOI 10.5014/ajot.44.10.914; Giuffre JL, 2015, PLAST RECONSTR SURG, V135, p617E, DOI 10.1097/PRS.0000000000001071; Goldenberg G, 2001, NEUROPSYCHOL REHABIL, V11, P147, DOI 10.1080/09602010042000204; Guideice JA, 2005, PLAST RECONSTR SURG, V116, P1648; Ho JJT, 2015, J PEDIATR ORTHOPED, V35, P412, DOI 10.1097/BPO.0000000000000276; Kase K, 2003, CLIN THERAPEUTIC APP, VSecond; Keenan M. A., 2011, U PENNSYLVANIA ORTHO, V21, P90; Keklicek H, 2015, J HAND THER, V28, P27, DOI 10.1016/j.jht.2014.09.007; Keller JW, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0293-3; Kim Ji Young, 2016, J Phys Ther Sci, V28, P1565, DOI 10.1589/jpts.28.1565; Kim SM, 2014, J KOREAN MED SCI, V29, pS249, DOI 10.3346/jkms.2014.29.S3.S249; Koman LA, 2010, ORTHOP CLIN N AM, V41, P519, DOI 10.1016/j.ocl.2010.06.003; Koman LA, 2011, REHABILITATION HAND, P1651; Krumlinde-Sundholm L, 2002, DEV MED CHILD NEUROL, V44, P604; lddelkoop E, 2011, SCAR MANAGEMENT PRAC, P1; McCabe C, 2011, J HAND THER, V24, P170, DOI 10.1016/j.jht.2010.08.003; Meaume S, 2014, EUR J DERMATOL, V24, P435, DOI 10.1684/ejd.2014.2356; Morris D, 2013, PHYSIOTHER THEOR PR, V29, P259, DOI 10.3109/09593985.2012.731675; Namdari S, 2012, J SHOULDER ELB SURG, V21, P1357, DOI 10.1016/j.jse.2011.09.029; Namdari S, 2012, J SHOULDER ELB SURG, V21, P691, DOI 10.1016/j.jse.2011.03.026; Oishi S, 2016, J HAND SURG-AM, V41, pE389, DOI 10.1016/j.jhsa.2016.07.104; REIFFEL RS, 1995, PLAST RECONSTR SURG, V96, P1715, DOI 10.1097/00006534-199512000-00031; Robert MT, 2013, DEV MED CHILD NEUROL, V55, P1121, DOI 10.1111/dmcn.12219; Rothgangel AS, 2013, MIRROR THERAPY PRACT; Shah D, 2013, CYS J, V4, P121; Shamsoddini A, 2016, IRAN J NEUROL, V15, P219; Shin TM, 2012, DERMATOL SURG, V38, P414, DOI 10.1111/j.1524-4725.2011.02201.x; Skold A, 2007, J HAND THER, V20, P262, DOI 10.1197/j.jht.2007.04.003; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Tawde PN, 2002, INDIAN J OCCUP THER, V34, P3; Tonkin M, 2008, J HAND SURG-EUR VOL, V33E, P77, DOI 10.1177/1753193407087891; Tonkin Michael A, 2003, Tech Hand Up Extrem Surg, V7, P18, DOI 10.1097/00130911-200303000-00005; van Abswoude F, 2015, RES DEV DISABIL, V45-46, P353, DOI 10.1016/j.ridd.2015.08.008; van den Hoven J, 2017, DESIGNING IN ETHICS, P1; Van Heest AE, 2008, J PEDIATR ORTHOPED, V28, P679, DOI 10.1097/BPO.0b013e3181831eac; Wangdell J, 2016, ARCH PHYS MED REHAB, V97, pS316; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolfe SW, 2010, GREENS OPERATIVE HAN; Yasukawa A, 2006, AM J OCCUP THER, V60, P104, DOI 10.5014/ajot.60.1.104; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162; Yildizgoren MT, 2014, PEDIATR NEUROL, V51, P360, DOI 10.1016/j.pediatrneurol.2014.05.009	65	5	5	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0712	1558-1969		HAND CLIN	Hand Clin.	NOV	2018	34	4					567	+		10.1016/j.hcl.2018.06.013			17	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics	GY5QU	WOS:000448636400015	30286971				2022-02-06	
J	Pucks-Faes, E; Hitzenberger, G; Matzak, H; Verrienti, G; Schauer, R; Saltuari, L				Pucks-Faes, Elke; Hitzenberger, Gabriel; Matzak, Heinrich; Verrienti, Giulio; Schauer, Robert; Saltuari, Leopold			Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment	BRAIN AND BEHAVIOR			English	Article						autonomic nervous system diseases; baclofen; brain injuries; sympathetic nervous system; traumatic	TRAUMATIC BRAIN-INJURY; ALLEVIATES AUTONOMIC DYSFUNCTION; SUPRASPINAL SPASTICITY; CEREBRAL ORIGIN; PRACTICAL SCALE; DYSAUTONOMIA; INFUSION; THERAPY; HYPERTONIA	Introduction Intrathecal baclofen (ITB) is a commonly used treatment in severe spasticity. The main objective of this study was to assess the impact of ITB on reduction or withdrawal of oral drugs in patients with paroxysmal sympathetic hyperactivity (PSH) after severe traumatic brain injury. Methods Results We retrospectively evaluated 20 patients with PSH due to severe traumatic brain injury who were treated with ITB in a primary care and referral center of neurology. Rates of and time until complete withdrawal or possible reduction in oral baclofen and oral propranolol after ITB treatment were calculated. Moreover, vegetative parameters (heart rate and blood pressure) as well as hypertonic attacks were assessed. The median time of complete oral baclofen disposal was 5 +/- 3.7 (CI 95% [2.9-7.1], range 0-14) days after ITB pump implantation in 20 of 20 patients, and the median time of complete oral propranolol disposal was 24 +/- 62.97 (CI 95% [-7.87-55.87], range 5-191) in 15 of 20 patients. With ITB treatment, PSH improved promptly in all patients with alleviation of heart rate and blood pressure as well as reduction in attacks with motor phenomena. ITB treatment was safe and without complications. Conclusions ITB might facilitate cutting back or dispensing with other conventional oral drugs, such as oral baclofen and oral propranolol. Our study provides further evidence that ITB treatment should be considered in patients with otherwise medically refractory PSH in severe traumatic brain injury. Further prospective multicenter studies are needed to confirm the findings of this study.	[Pucks-Faes, Elke; Hitzenberger, Gabriel; Matzak, Heinrich; Verrienti, Giulio; Schauer, Robert; Saltuari, Leopold] Hochzirl Hosp, Dept Neurol, Zirl, Austria; [Saltuari, Leopold] Res Unit Neurorehabil, South Tyrol, Bolzano, Italy		Pucks-Faes, E (corresponding author), Hochzirl Hosp, Dept Neurol, Zirl, Austria.	elke.pucks-faes@tirol-kliniken.at					ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Dario A, 2002, ACTA NEUROL SCAND, V105, P83, DOI 10.1034/j.1600-0404.2002.1o042.x; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Francois B, 2001, J TRAUMA, V50, P158, DOI 10.1097/00005373-200101000-00035; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hoarau X, 2012, BRAIN INJURY, V26, P1451, DOI 10.3109/02699052.2012.694564; Hoarau X, 2012, BRAIN INJURY, V26, P927, DOI 10.3109/02699052.2012.661913; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; KNUTSSON E, 1974, J NEUROL SCI, V23, P473, DOI 10.1016/0022-510X(74)90163-4; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; PENN RD, 1985, LANCET, V2, P125; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733; Rifici C, 1994, Funct Neurol, V9, P29; TEASDALE G, 1974, LANCET, V2, P81; Turner MS, 2003, ACT NEUR S, V87, P81	33	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	NOV	2018	8	11							e01124	10.1002/brb3.1124			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	HA4WQ	WOS:000450266300009	30264872	Green Published, gold			2022-02-06	
J	Raj, SP; Shultz, EL; Zang, HY; Zhang, NH; Kirkwood, MW; Taylor, HG; Stancin, T; Yeates, KO; Wade, SL				Raj, Stacey P.; Shultz, Emily L.; Zang, Huaiyu; Zhang, Nanhua; Kirkwood, Michael W.; Taylor, H. Gerry; Stancin, Terry; Yeates, Keith Owen; Wade, Shari L.			Effects of Web-Based Parent Training on Caregiver Functioning Following Pediatric Traumatic Brain Injury: A Randomized Control Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregiver psychological functioning; parenting; parenting interventions; pediatric traumatic brain injury	BEHAVIOR PROBLEMS; PSYCHIATRIC-DISORDERS; MATERNAL DEPRESSION; YOUNG-CHILDREN; SKILLS PROGRAM; FAMILY BURDEN; EFFICACY; OUTCOMES; STRESS; ONLINE	Objective: To examine the effects of a Web-based parenting intervention (I-InTERACT), and an abbreviated version (Express), on caregiver depression, psychological distress, parenting stress, and parenting efficacy following pediatric traumatic brain injury (TBI). Setting: Four children's hospitals and 1 general hospital in the United States. Participants: 148 caregivers of 113 children aged 3 to 9 years with a moderate to severe TBI. Design: Multicenter randomized controlled trial. Participants were randomly assigned to I-InTERACT, Express, or an active control condition. Caregiver data were collected at baseline and postintervention (6 months later). Intervention: I-InTERACT (10-14 sessions) and Express (7 sessions) combine live coaching of parenting skills and positive parenting strategies. Main Measures: Center for Epidemiologic Studies Depression Scale (CES-D); Global Severity Index of the Symptom Checklist-90-R (GSI), Parenting Stress Index (PSI), and Caregiver Self-Efficacy Scale (CSES). Results: Analyses revealed no main effects of treatment on caregiver distress (GSI), parenting stress (PSI), or parenting efficacy (CSES). However, analyses examining baseline severity as a moderator found that caregivers with elevated levels of depression in I-InTERACT experienced significantly greater reductions in CES-D scores compared with caregivers in the active control condition. Conclusions: I-InTERACT reduced caregiver depression but no other facets of caregiver psychological functioning. Modifications to the treatment content may be necessary to reduce parenting stress and improve caregiver efficacy.	[Raj, Stacey P.; Shultz, Emily L.; Zang, Huaiyu; Zhang, Nanhua; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA; [Raj, Stacey P.] Xavier Univ, Cincinnati, OH 45207 USA; [Shultz, Emily L.; Zang, Huaiyu; Wade, Shari L.] Univ Cincinnati, Cincinnati, OH USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Ohio State Univ, Biobehav Hlth Ctr, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA; [Yeates, Keith Owen] Univ Calgary, Calgary, AB, Canada		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Zang, Huaiyu/AAY-6603-2021; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]	This study was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant number: H133B090010).	Abidin R, 1995, MANUAL PARENTING STR, V3rd; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Boothroyd RA, 1997, PRELIMINARY MANUAL C; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Cuijpers P, 2015, EUR CHILD ADOLES PSY, V24, P237, DOI 10.1007/s00787-014-0660-6; DeNavas-Walt C, 2015, CURRENT POPULATION R; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; EYBERG SM, 1995, PSYCHOPHARMACOL BULL, V31, P83; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hayes, 2018, INTRO MEDIATION MODE; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Heath CL, 2015, CHILD PSYCHIAT HUM D, V46, P118, DOI 10.1007/s10578-014-0458-2; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Luxton DD, 2011, PROF PSYCHOL-RES PR, V42, P505, DOI 10.1037/a0024485; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Narad ME, 2017, DIGITAL HLTH, V3, P1; Neece CL, 2012, AJIDD-AM J INTELLECT, V117, P48, DOI 10.1352/1944-7558-117.1.48; New Freedom Commission on Mental Health, 2004, DEP HLTH HUM SERV PU, VSMA-04-3890; Noss A, 2010, HOUSEHOLD INCOME STA; Noss A., 2011, HOUSEHOLD INCOME STA; Pincus, 1999, EYBERG CHILD BEHAV I; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Sanders MR, 2012, BEHAV RES THER, V50, P675, DOI 10.1016/j.brat.2012.07.004; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; US Census Bureau, 2015 AM HOUS SURV; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110	43	5	5	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E19	E29		10.1097/HTR.0000000000000388			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600003	29601344				2022-02-06	
J	Renaud, MI; van de Port, IGL; Catsman-Berrevoets, CE; Bovens, N; Lambregts, SAM; van Heugten, CM				Renaud, M. Irene; van de Port, Ingrid G. L.; Catsman-Berrevoets, Coriene E.; Bovens, Nicole; Lambregts, Suzanne A. M.; van Heugten, Caroline M.			The Brains Ahead! intervention for children and adolescents with mild traumatic brain injury and their caregivers: rationale and description of the treatment protocol	CLINICAL REHABILITATION			English	Article						Mild traumatic brain injury; children; intervention; activities and participation	POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; FOLLOW-UP; PARTICIPATION; CONCUSSION; YOUTH; REHABILITATION; OUTCOMES; SCHOOL	Purpose: Approximately 20% of the children and adolescents after mild traumatic brain injury will not fully recover. They suffer long-term postconcussive symptoms and may experience limitations in activities and participation. Research suggests that early psychoeducational interventions may prevent long-term postconcussive symptoms. The Brains Ahead! intervention was developed to prevent long-term symptoms and, furthermore, to establish a more successful return to activities and participation after mild traumatic brain injury in children and adolescents. The intervention is currently being evaluated in a multicenter randomized controlled trial. Rationale: Providing individualized information and personal advice in addition to standardized information about the injury and possible consequences early after the injury may enable patients and caregivers to recognize and anticipate on relevant symptoms at an early stage and to prevent problems in activities and participation. Theory into practice: The Brains Ahead! intervention is a psychoeducational intervention for children and adolescents who sustained a mild traumatic brain injury and for their caregivers. The patients will receive a partially standardized and partially individualized psychoeducational session and a telephone follow-up within the first two to eight weeks after the injury.	[Renaud, M. Irene; van de Port, Ingrid G. L.; Bovens, Nicole; Lambregts, Suzanne A. M.] Revant Rehabil Ctr Breda, Breda, Netherlands; [Renaud, M. Irene; Bovens, Nicole; van Heugten, Caroline M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands; [Renaud, M. Irene; van Heugten, Caroline M.] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Catsman-Berrevoets, Coriene E.] Sophia Childrens Univ Hosp, Dept Paediat Neurol, Erasmus Univ Hosp, Rotterdam, Netherlands; [Lambregts, Suzanne A. M.] Sophia Childrens Univ Hosp, Dept Rehabil Med, Erasmus Univ Hosp, Rotterdam, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands.	caroline.vanheugten@maastrichtuniversity.nl			Johanna Kinderfonds [2012/0040-1552]; Revalidatiefonds [R2012175]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by the Johanna Kinderfonds (Award Number 2012/0040-1552) and the Revalidatiefonds (Award Number R2012175).	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CASEY R, 1987, PEDIATRICS, V80, P159; Caskey Robert C, 2014, Adv Pediatr, V61, P271, DOI 10.1016/j.yapd.2014.03.006; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Nederlandse Vereniging voor Neurologie, 2010, RICHTL OPV PAT MET L; Nowacki R, 2017, EUR J PAEDIATR NEURO, V21, P382, DOI 10.1016/j.ejpn.2016.10.009; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 1999, PEDIATRICS, V12, P360; Renaud MI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1357-6; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Stulemeijer M, 2009, THESIS; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Van Heugten CM, 2017, CONCUSSION, V2, P1; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Winkler R, 2015, J HEAD TRAUMA REHAB, V30, P324, DOI 10.1097/HTR.0000000000000114	45	5	5	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	NOV	2018	32	11					1440	1448		10.1177/0269215518785418			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GZ3LP	WOS:000449288400003	29984603	hybrid			2022-02-06	
J	Rose, SR; Horne, VE; Bingham, N; Jenkins, T; Black, J; Inge, T				Rose, Susan R.; Horne, Vincent E.; Bingham, Nathan; Jenkins, Todd; Black, Jennifer; Inge, Thomas			Hypothalamic Obesity: 4 Years of the International Registry of Hypothalamic Obesity Disorders	OBESITY			English	Article							VAGUS NERVE-STIMULATION; GASTRIC BYPASS-SURGERY; BODY-MASS INDEX; WEIGHT-LOSS; CHILDHOOD CRANIOPHARYNGIOMA; BARIATRIC SURGERY; INSULIN DYNAMICS; CHILDREN; RISK; METAANALYSIS	ObjectiveMethodsHypothalamic obesity (HyOb) is a rare cause of rapid weight gain and early metabolic comorbidities. Effective treatment strategies are limited. The registry collected participant data and compared treatment approaches. The International Registry of Hypothalamic Obesity Disorders (IRHOD) was created as a registry portal to provide education. Data collected from the initial 4 years were evaluated. ResultsConclusionsEighty-seven participants were included for analysis (median age: 27 years, range: 3-71 years). A total of 96.5% had obesity, and 3.5% had overweight at maximal weight. Seventy-five had brain tumors (86%)the majority were craniopharyngiomas (72% of those with tumors). Nontumor etiologies included congenital brain malformation (4.6%), traumatic brain injury (3.4%), and genetic anomaly (2.3%). Ninety percent received obesity treatments including nutritional counseling (82%), pharmacotherapy (59%), bariatric surgery (8%), and vagal nerve stimulation (1%). Forty-six percent reported follow-up BMI results after obesity treatment. Surgery was most effective (median BMI decrease: -8.2 kg/m(2), median interval: 2.6 years), with lifestyle intervention (BMI: -3.4 kg/m(2), interval: 1.2 years) and pharmacological therapy (BMI: -2.3 kg/m(2), interval: 0.8 years) being less effective. Eighty percent of participants reporting follow-up weight remained in the obesity range. IRHOD identified a large cohort with self-reported HyOb. Surgical therapy was most effective at weight reduction. Nutritional counseling and pharmacotherapy modestly improved BMI. Stepwise treatment strategy for HyOb (including nutritional, pharmacological, and surgical therapies in an experienced center) may be most valuable.	[Rose, Susan R.; Horne, Vincent E.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Endocrinol, Cincinnati, OH 45229 USA; [Rose, Susan R.; Horne, Vincent E.; Jenkins, Todd; Black, Jennifer] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Bingham, Nathan] Vanderbilt Univ, Div Endocrinol, Memphis, TN USA; [Jenkins, Todd; Black, Jennifer] Cincinnati Childrens Hosp Med Ctr, Div Bariatr Surg, Cincinnati, OH 45229 USA; [Inge, Thomas] Childrens Hosp Colorado, Div Pediat Surg, Aurora, CO USA; [Inge, Thomas] Univ Colorado Denver, Aurora, CO USA		Rose, SR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Endocrinol, Cincinnati, OH 45229 USA.; Rose, SR (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA.	mslrose4@gmail.com	Inge, Thomas/AAG-3372-2020; Bingham, Nathan C/A-4825-2015; Jenkins, Todd/AAG-1901-2019	Inge, Thomas/0000-0001-7782-1112; Bingham, Nathan C/0000-0003-3343-0069; rose, susan/0000-0003-1328-1289	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U01 DK072493]; NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32 DK063929-09]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK063929, UM1DK095710, U01DK072493, UM1DK072493] Funding Source: NIH RePORTER	This study was conducted as a cooperative agreement and funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) with a grant to Cincinnati Children's Hospital Medical Center (Dr Thomas Inge, PI: U01 DK072493) and Supplement (American Recovery and Reinvestment Act of 2009) This publication was also made possible by an NIDDK-funded fellowship to Dr. Vincent Horne (T32 DK063929-09).	Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; Bodenlos JS, 2007, APPETITE, V48, P145, DOI 10.1016/j.appet.2006.07.080; Bretault M, 2013, J CLIN ENDOCR METAB, V98, P2239, DOI 10.1210/jc.2012-4184; Burneo JG, 2002, NEUROLOGY, V59, P463, DOI 10.1212/WNL.59.3.463; Deepak D, 2007, POSTGRAD MED J, V83, P277, DOI 10.1136/pgmj.2006.052241; Desilets AR, 2008, ANN PHARMACOTHER, V42, P817, DOI 10.1345/aph.1K656; Elfers Clinton Thomas, 2011, Front Endocrinol (Lausanne), V2, P78, DOI 10.3389/fendo.2011.00078; Elowe-Gruau E, 2013, J CLIN ENDOCR METAB, V98, P2376, DOI 10.1210/jc.2012-3928; Golay A, 2005, OBES RES, V13, P1701, DOI 10.1038/oby.2005.208; Gulati AK, 2012, PEDIATRICS, V130, P1136, DOI 10.1542/peds.2012-0596; Haliloglu B, 2015, J PEDIATR ENDOCR MET, V28, P503, DOI 10.1515/jpem-2014-0512; Hameed R, 2005, J PAEDIATR CHILD H, V41, P36, DOI 10.1111/j.1440-1754.2005.00533.x; Hamilton JK, 2011, INT J PEDIATR ENDOCR, DOI 10.1155/2011/417949; Inge TH, 2007, NAT CLIN PRACT ENDOC, V3, P606, DOI 10.1038/ncpendmet0579; Kanekar Amar, 2010, J Clin Med Res, V2, P105, DOI 10.4021/jocmr2010.05.288w; Katzmarzyk PT, 2014, INT J OBESITY, V38, P887, DOI 10.1038/ijo.2014.49; Kim Ja Hye, 2013, Ann Pediatr Endocrinol Metab, V18, P161, DOI 10.6065/apem.2013.18.4.161; Koren MS, 2006, EPILEPSY BEHAV, V8, P246, DOI 10.1016/j.yebeh.2005.10.001; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Lustig RH, 2006, J PEDIATR-US, V148, P23, DOI 10.1016/j.jpeds.2005.08.075; Lustig RH, 1999, J PEDIATR-US, V135, P162, DOI 10.1016/S0022-3476(99)70017-X; Lustig Robert H, 2011, Front Endocrinol (Lausanne), V2, P60, DOI 10.3389/fendo.2011.00060; Maahs David, 2006, Endocr Pract, V12, P18; Mason PW, 2002, ARCH PEDIAT ADOL MED, V156, P887, DOI 10.1001/archpedi.156.9.887; Muller HL, 2016, CURR OPIN ENDOCRINOL, V23, P81, DOI 10.1097/MED.0000000000000214; Muller HL, 2004, J CLIN ENDOCR METAB, V89, P3298, DOI 10.1210/jc.2003-031751; Ni WM, 2018, WORLD NEUROSURG, V118, pE59, DOI 10.1016/j.wneu.2018.06.121; Pardo JV, 2007, INT J OBESITY, V31, P1756, DOI 10.1038/sj.ijo.0803666; Parker JA, 2012, NEUROPHARMACOLOGY, V63, P18, DOI 10.1016/j.neuropharm.2012.02.004; Patel DK, 2018, POSTGRAD MED, V130, P173, DOI 10.1080/00325481.2018.1435129; Rakhshani N, 2010, OBESITY, V18, P1768, DOI 10.1038/oby.2009.491; Reinehr T, 2016, J CLIN ENDOCR METAB, V101, P3171, DOI 10.1210/jc.2016-1885; Roth CL, 2015, OBESITY, V23, P1226, DOI 10.1002/oby.21067; Rottembourg D, 2009, J PEDIATR ENDOCR MET, V22, P867; SARSON DL, 1981, INT J OBESITY, V5, P471; Vaughns JD, 2018, J CLIN PHARMACOL, V58, P650, DOI 10.1002/jcph.1054; Zoicas F, 2013, EUR J ENDOCRINOL, V168, P699, DOI 10.1530/EJE-12-0997	38	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	NOV	2018	26	11					1727	1732		10.1002/oby.22315			6	Endocrinology & Metabolism; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Nutrition & Dietetics	GY1JW	WOS:000448285800014	30296362	Green Accepted			2022-02-06	
J	Shenton, ME; Price, BH; Levin, L; Edersheim, JG				Shenton, Martha E.; Price, Bruce H.; Levin, Laura; Edersheim, Judith G.			Mild traumatic brain injury: Is DTI ready for the courtroom?	INTERNATIONAL JOURNAL OF LAW AND PSYCHIATRY			English	Article						Neuroscience and the law; Neurolaw; Mild traumatic brain injury; mTBI; Brain injury; Concussion; Daubert criteria; Neuroimaging; Diffusion tensor imaging; DTI; Diffusion weighted imaging; Federal rules of evidence; The brain and the law; Brain and criminal behavior; Brain overclaim syndrome; Admissibility standards	DIFFUSE AXONAL INJURY; WHITE-MATTER; NEUROIMAGING EVIDENCE; VOXELWISE ANALYSIS; EXPERT EVIDENCE; UNITED-STATES; HEAD-INJURY; DAUBERT; NEUROSCIENCE; EPIDEMIOLOGY	Important advances in neuroscience and neuroimaging have revolutionized our understanding of the human brain. Many of these advances provide new evidence regarding compensable injuries that have been used to support changes in legal policy. For example, we now know that regions of the brain involved in decision making continue to develop into the mid-20s, and this information weighs heavily in determining that execution or automatic sentence of life without the possibility of parole for someone younger than 18 years old, at the time of the crime, violates the 8th Amendment prohibition against "cruel and unusual punishment." The probative value of other testimony regarding neuroimaging, however, is less clear, particularly for mild traumatic brain injury (mTBI), also known as concussion. There is nonetheless some evidence that new imaging technologies, most notably diffusion tensor imaging (DTI), may be useful in detecting mTBI. More specifically, DTI is sensitive to detecting diffuse axonal brain injuries in white matter, the most common brain injury in mTBI. DTI is, in fact, the most promising technique available today for such injuries and it is beginning to be used clinically, although it remains largely within the purview of research. Its probative value is also not clear as it may be both prejudicial and misleading given that standardization is not yet established for use in either the clinic or the courtroom, and thus it may be premature for use in either. There are also concerns with the methods and analyses that have been used to provide quantitative evidence in legal cases. It is within this context that we provide a commentary on the use of neuroimaging in the courtroom, most particularly DTI, and the admissibility of evidence, as well as the definition and role of expert testimony. While there is a great deal of evidence demonstrating cognitive impairments in attention, processing speed, memory, and concentration from neuropsychological testing following mTBI, we focus here on the more recent introduction of DTI imaging in the courtroom. We also review definitions of mTBI followed by admissibility standards for scientific evidence in the courtroom, including Daubert criteria and two subsequent cases that comprise the so-called Daubert trilogy rulings on the admissibility of expert testimony. This is followed by a brief review of neuroimaging techniques available today, the latter with an emphasis on DTI and its application to mTBI. We then review some of the court rulings on the use of DTI. We end by highlighting the importance of neuroimaging in providing a new window on the brain, while cautioning against the premature use of new advances in imaging in the courtroom before standards are established in the clinical arena, which are informed by research. We also discuss further what is needed to reach a tipping point where such advances will provide important and meaningful data with respect to their probative value.	[Shenton, Martha E.; Levin, Laura] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02115 USA; [Shenton, Martha E.] Harvard Med Sch, Dept Psychiat & Radiol, Boston, MA USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA; [Price, Bruce H.] Harvard Med Sch, Massachusetts Gen Hosp, McLean Hosp, Dept Neurol, Boston, MA USA; [Price, Bruce H.; Edersheim, Judith G.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Ctr Law Brain & Behav, Boston, MA USA		Shenton, ME (corresponding author), Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02115 USA.	Shenton@bwh.harvard.edu	Shenton, Martha/V-8780-2019				Aguirre GK, 2014, HASTINGS CENT REP, V44, pS8, DOI 10.1002/hast.294; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; [Anonymous], 2008, NAT NEUROSCI, V11, P1231, DOI 10.1038/nn1108-1231; Appelbaum PS, 2009, PSYCHIAT SERV, V60, P21, DOI 10.1176/appi.ps.60.1.21; Baskin JH, 2007, AM J LAW MED, V33, P239, DOI 10.1177/009885880703300205; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Berger M.A, 2000, REFERENCE MANUAL SCI, V2nd, P9; Bertin J E, 1994, J Law Med Ethics, V22, P6, DOI 10.1111/j.1748-720X.1994.tb01270.x; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Boxier B. L, 2011, RICHMOND J LAW PUBLI, V14, P479; CDC, 2010, RAT TBI REL EM DEP V; Cecil JS, 2005, AM J PUBLIC HEALTH, V95, pS74, DOI 10.2105/AJPH.2004.044776; Denno DW, 2016, FORDHAM LAW REV, V85, P453; DENNO DW, 2015, BC L REV, V56, P493; Edersheim J, 2018, AMERICAN PSYCHIATRIC ASSOCIATION PUBLISHING TEXTBOOK OF FORENSIC PSYCHIATRY, 3RD EDITION, P93; Farah MJ, 2014, HASTINGS CENT REP, V44, pS19, DOI 10.1002/hast.295; Farwell LA, 2001, J FORENSIC SCI, V46, P135; Faul M, 2010, TRAUMATIC BRAIN INJU; Gatowski SI, 2001, LAW HUMAN BEHAV, V25, P433, DOI 10.1023/A:1012899030937; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Glasser O, 1931, RADIOLOGY, V17, P99; GOLD JA, 1993, JAMA-J AM MED ASSOC, V270, P2964, DOI 10.1001/jama.270.24.2964; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Granacher RP, 2008, J AM ACAD PSYCHIATRY, V36, P323; Green P, 2004, GREENS MED SYMPTOM V; Grey B. J, 2015, MICHIGAN STATE LAW R, P1911; Grivas CR, 2008, J FORENSIC SCI, V53, P771, DOI 10.1111/j.1556-4029.2008.00771.x; Grudzinskas AJ, 1998, J AM ACAD PSYCHIATRY, V26, P497; Haack S, 2014, EVIDENCE MATTERS SCI; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HALPERIN EC, 1988, INVEST RADIOL, V23, P639, DOI 10.1097/00004424-198808000-00020; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hughes V, 2010, NATURE, V464, P340, DOI 10.1038/464340a; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones O. D, 2009, STANDARDS TECHNICAL, V5; Jones OD, 2014, J LAW BIOSCI, V1, P224, DOI 10.1093/jlb/lsu012; Kaye D. H., 1992, JURIMETRICS J, V32, P313; Kerkmans J. P., 2016, NEW MEXICO LAW REV, V46, P383; Laibson D, 2015, AM ECON REV, V105, P385, DOI 10.1257/aer.p20151047; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Mayberg HS, 2014, HASTINGS CENT REP, V44, pS31, DOI 10.1002/hast.296; Meijer EH, 2013, COGN NEURODYNAMICS, V7, P155, DOI 10.1007/s11571-012-9217-x; Meltzer CC, 2014, AM J NEURORADIOL, V35, P632, DOI 10.3174/ajnr.A3711; Miller L, 1996, J COGNITIVE REHABILI, V14, P8; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moriarty JC, 2008, BEHAV SCI LAW, V26, P29, DOI 10.1002/bsl.795; Morse SJ, 2006, OHIO STATE J CRIMINA, V3, P397; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Parens E, 2014, HASTINGS CENT REP, V44, pS2, DOI 10.1002/hast.293; Patel P, 2007, NEUROIMAG CLIN N AM, V17, P557, DOI 10.1016/j.nic.2007.07.001; Pikus KM, 2014, NOTRE DAME LAW REV, V90, P453; Pustilnik AC., 2015, ALA L REV, V66, P1099; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roskies AL, 2013, TRENDS COGN SCI, V17, P99, DOI 10.1016/j.tics.2013.01.008; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sanders J., 2001, LAW CONTEMP PROBL, V64, P373; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Shen F X., 2010, INT J LEGAL INFO, V38, P352, DOI DOI 10.1017/S0731126500005916; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Slovenko R, 2003, INT J OFFENDER THER, V47, P240, DOI 10.1177/0306624X03251091; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stern S, 2000, CHRISTIAN SCI MONITO; Tanielian T., 2008, INVISIBLE WOUNDS WAR; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; TOMM Test of Memory Malingering, 2018, 2018 MHS ASSESSMENTS; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vidmar N, 2005, AM J PUBLIC HEALTH, V95, pS137, DOI 10.2105/AJPH.2004.044677; Wasserman D, 2014, HASTINGS CENT REP, V44, pS37, DOI 10.1002/hast.297; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Woodard B. A, 2016, FOR THE DEFENSE, P28; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242; [No title captured]	94	5	6	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0160-2527	1873-6386		INT J LAW PSYCHIAT	Int. J. Law Psychiatr.	NOV-DEC	2018	61						50	63		10.1016/j.ijlp.2018.09.002			14	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	HE0CX	WOS:000452935500007	30391039				2022-02-06	
J	Walker, JM; Mulatya, C; Hebert, D; Wilson, SH; Lindblad, AS; Weaver, LK				Walker, James M.; Mulatya, Caroline; Hebert, Donald; Wilson, Steffanie H.; Lindblad, Anne S.; Weaver, Lindell K.			Sleep assessment in a randomized trial of hyperbaric oxygen in US service members with post concussive mild traumatic brain injury compared to normal controls	SLEEP MEDICINE			English	Article						Sleep; TBI; Hyperbaric; Actigraphy; Self-report; PSQI	RESTLESS LEGS SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; PRACTICE PARAMETERS; CHRONIC INSOMNIA; QUALITY INDEX; QUESTIONNAIRE; VALIDATION; ACTIGRAPHY; APNEA; DISTURBANCES	Study objective: In this exploratory, double-blind, longitudinal sham-controlled trial of hyperbaric oxygen (HBO2) for military personnel with post concussive mild traumatic brain injury (mTBI), self-reports and objective measures of sleep-wake disturbances were assessed and compared to normals. Methods: Self-reports consisting of Pittsburg Sleep Quality Index (PSQI), sleep diary, screening for obstructive sleep apnea (OSA) risk, restless legs syndrome (RLS), cataplexy, and objective actigraphic measures of sleep-wake were obtained on 71 military personnel with mTBI [baseline, 13 weeks and six months post-randomization (post-intervention)], of which 35 met post-traumatic stress disorder (PTSD) criteria, and 75 healthy volunteers (baseline). Baseline between-group and follow-up changes from baseline overall and within subgroups were evaluated. Mild TBI was defined as consisting of head injury associated loss of consciousness (<24 h), post-traumatic amnesia, and neurological deficits. Results: Sleep quality by self-reports was markedly degraded in the mTBI group at baseline compared to a normative cohort; insomnia 87.3 versus 2.8%, OSA risk 70% versus 1.3%, RLS 32.4% versus and 2.7%. (all p-values <0.001), but actigraphy measures did not differentiate between groups. HBO2 compared to sham treatment improved self-reports of PSQI sleep measures, reports (five out of eight at 13-weeks and two out of eight at six-months). However, other sleep-wake measures were not different. Conclusions: Perceived sleep quality was markedly disrupted in mTBI military personnel and sleep-wake disturbances were prevalent compared to a normative cohort. HBO2 relative to sham improved some measures of sleep quality on the PSQI, but other measures of sleep were not significantly different. (C) 2018 Published by Elsevier B.V.	[Walker, James M.] PSG Profess Serv Inc, Farmington, UT USA; [Mulatya, Caroline; Hebert, Donald; Wilson, Steffanie H.; Lindblad, Anne S.] Emmes Corp, Rockville, MD USA; [Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT USA; [Weaver, Lindell K.] Intermt LDS Hosp, Div Hyperbar Med, Salt Lake City, UT USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA		Weaver, LK (corresponding author), LDS Hosp, Hyperbar Med, 8th Ave & C St, Salt Lake City, UT 84143 USA.	lindell.weaver@imail.org			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-D-0039-0003]	This work is supported by the US Army Medical Research and Materiel Command under Contract No. W81XWH-15-D-0039-0003. The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. In the conduct of research where humans are the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects). The authors thank Sharon A. Gilbert, PhD, (Tunnell Government Services) for her participation in data and manuscript review.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S; American Academy of Sleep Medicine, 2005, DIAGN COD MAN, P185; Anic-Labat S, 1999, SLEEP, V22, P77; Aurora RN, 2012, SLEEP, V35, P1039, DOI 10.5665/sleep.1988; Basco MR, 2000, AM J PSYCHIAT, V157, P1599, DOI 10.1176/appi.ajp.157.10.1599; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonnet MH, 1998, PSYCHOSOM MED, V60, P610, DOI 10.1097/00006842-199809000-00017; BONNET MH, 1995, SLEEP, V18, P581, DOI 10.1093/sleep/18.7.581; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Buysse D J, 1989, Psychiatry Res, V28, P193; Casscells SW, 2007, COMMUNICATION; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chao LL, 2014, SLEEP, V37, P445, DOI 10.5665/sleep.3472; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; Cole JC, 2006, SLEEP, V29, P112, DOI 10.1093/sleep/29.1.112; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Colvonen PJ, 2015, J CLIN SLEEP MED, V11, P513, DOI 10.5664/jcsm.4692; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cory-Slechta D.A, 2016, GULF WAR HLTH, V10, P1, DOI [10.17226/21840, DOI 10.17226/21840]; Farmer CF., 2016, UNDERSTANDING TREATM; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Hening WA, 2009, SLEEP MED, V10, P976, DOI 10.1016/j.sleep.2008.09.015; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Insana SP, 2013, J TRAUMA STRESS, V26, P192, DOI 10.1002/jts.21793; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Joo EY, 2014, SLEEP, V37, P1189, DOI 10.5665/sleep.3836; Kay DB, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7030023; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; Koo DL, 2017, SLEEP MED, V35, P23, DOI 10.1016/j.sleep.2017.04.002; Lack LC, 2008, SLEEP MED REV, V12, P307, DOI 10.1016/j.smrv.2008.02.003; Lamarche CH, 1997, SLEEP, V20, P724; Landry GJ, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00165; Lanfranchi PA, 2009, SLEEP, V32, P760, DOI 10.1093/sleep/32.6.760; Li YP, 2013, NEUROLOGY, V81, P52, DOI 10.1212/WNL.0b013e318297eee0; Lichstein KL, 2006, SLEEP, V29, P232; Long Y, 2017, NEUROL RES, V39, P239, DOI 10.1080/01616412.2016.1275454; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Moore WR, 2007, J CLIN SLEEP MED, V3, P37; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Noh HJ, 2012, J CLIN NEUROL, V8, P130, DOI 10.3988/jcn.2012.8.2.130; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Parrino L, 2012, SLEEP MED REV, V16, P27, DOI 10.1016/j.smrv.2011.02.003; Parthasarathy S, 2015, AM J MED, V128, P268, DOI 10.1016/j.amjmed.2014.10.015; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pollak CP, 2001, SLEEP, V24, P957, DOI 10.1093/sleep/24.8.957; Riemann D, 2007, SLEEP, V30, P955, DOI 10.1093/sleep/30.8.955; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Sturzenegger C, 2004, J SLEEP RES, V13, P395, DOI 10.1111/j.1365-2869.2004.00422.x; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, P1; Uezato A, 2017, PSYCHIAT CLIN NEUROS, V71, P73, DOI 10.1111/pcn.12478; Walker JM, 2016, UNDERSEA HYPERBAR M, V43, P549; Weaver LK, 2018, UNDERSEA HYPERBAR M, V45, P129; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P491; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P801; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Williams SG, 2015, SLEEP BREATH, V19, P175, DOI 10.1007/s11325-014-0984-y	73	5	5	2	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	NOV	2018	51						66	79		10.1016/j.sleep.2018.06.006			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GX5IF	WOS:000447778200011	30099354				2022-02-06	
J	Baker, EW; Henderson, WM; Kinder, HA; Hutcheson, JM; Platt, SR; West, FD				Baker, Emily W.; Henderson, W. Matthew; Kinder, Holly A.; Hutcheson, Jessica M.; Platt, Simon R.; West, Franklin D.			Scaled traumatic brain injury results in unique metabolomic signatures between gray matter, white matter, and serum in a piglet model	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; SYSTEMS BIOLOGY; CEREBRAL-CORTEX; PROFILE CHANGES; DRUG DISCOVERY; AMINO-ACIDS; DAMAGE; BIOMARKERS; ISCHEMIA; LACTATE	Traumatic brain injury (TBI) is a leading cause of death and long-term disability in the United States. The heterogeneity of the disease coupled with the lack of comprehensive, standardized scales to adequately characterize multiple types of TBI remain to be major challenges facing effective therapeutic development. A systems level approach to TBI diagnosis through the use of metabolomics could lead to a better understanding of cellular changes post-TBI and potential therapeutic targets. In the current study, we utilize a GC-MS untargeted metabolomics approach to demonstrate altered metabolism in response to TBI in a translational pig model, which possesses many neuroanatomical and pathophysiologic similarities to humans. TBI was produced by controlled cortical impact (CCI) in Landrace piglets with impact velocity and depth of depression set to 2m/s;6mm, 4m/s;6mm, 4m/s;12mm, or 4m/s;15mm resulting in graded neural injury. Serum samples were collected pre-TBI, 24 hours post-TBI, and 7 days post-TBI. Partial least squares discriminant analysis (PLS-DA) revealed that each impact parameter uniquely influenced the metabolomic profile after TBI, and gray and white matter responds differently to TBI on the biochemical level with evidence of white matter displaying greater metabolic change. Furthermore, pathway analysis revealed unique metabolic signatures that were dependent on injury severity and brain tissue type. Metabolomic signatures were also detected in serum samples which potentially captures both time after injury and injury severity. These findings provide a platform for the development of a more accurate TBI classification scale based unique metabolomic signatures.	[Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; Platt, Simon R.; West, Franklin D.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; West, Franklin D.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Henderson, W. Matthew] US EPA, Natl Exposure Res Lab, Off Res & Dev, Athens, GA USA; [Platt, Simon R.] Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA		West, FD (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.; West, FD (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA.	Westf@uga.edu		Kinder, Holly/0000-0001-8310-7265	Office for the Vice President of Research at the University of Georgia	This study was funded by the Office for the Vice President of Research at the University of Georgia. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ahmad AS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00172; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Armengou A, 2003, J CEREBR BLOOD F MET, V23, P978, DOI 10.1097/01.WCB.0000080651.64357.C6; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bourassa MW, 2016, NEUROSCI LETT, V625, P56, DOI 10.1016/j.neulet.2016.02.009; Bovo S, 2015, J ANIM SCI, V93, P5681, DOI 10.2527/jas.2015-9528; Callaway DW, 2009, J TRAUMA, V66, P1040, DOI 10.1097/TA.0b013e3181895e9e; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Furlow B., 2013, RADIOL TECHNOL, V84, p91CT; Furlow Bryant, 2013, Radiol Technol, V84, p273CT; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn Thomas C, 2013, Acta Neurochir Suppl, V118, P115, DOI 10.1007/978-3-7091-1434-6_20; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/NCHEMBIO.1158, 10.1038/nchembio.1158]; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hollenbeck PJ, 2005, NEURON, V47, P331, DOI 10.1016/j.neuron.2005.07.017; Irie M, 2014, METABOLOMICS, V10, P473, DOI 10.1007/s11306-013-0588-8; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Li ZS, 2015, ANAL BIOCHEM, V477, P105, DOI 10.1016/j.ab.2015.02.024; Lommen A, 2007, ANAL CHIM ACTA, V584, P43, DOI 10.1016/j.aca.2006.11.018; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2010, CELL CALCIUM, V47, P150, DOI 10.1016/j.ceca.2009.12.004; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Meng SZ, 2005, EXP BRAIN RES, V166, P56, DOI 10.1007/s00221-005-2340-8; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Niu WH, 2014, J CHROMATOGR A, V1374, P199, DOI 10.1016/j.chroma.2014.11.005; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; Quarles, 1999, CHARACTERISTIC COMPO; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sakuma S, 2012, J CLIN BIOCHEM NUTR, V51, P55, DOI 10.3164/jcbn.11-97; SHIMADA N, 1993, J NEUROCHEM, V60, P66, DOI 10.1111/j.1471-4159.1993.tb05823.x; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Stokum JA, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0239-6; Toczylowska B, 2006, BRAIN RES, V1104, P183, DOI 10.1016/j.brainres.2006.05.057; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Welle T, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1219-6; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; West FD, 2012, TOXICOL SCI, V129, P9, DOI 10.1093/toxsci/kfs185; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Wolahan SM, 2015, BRAIN NEUROTRAUMA MO; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16	74	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206481	10.1371/journal.pone.0206481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	WOS:000448823700121	30379914	Green Published, Green Submitted, gold			2022-02-06	
J	Kornguth, S; Rutledge, N				Kornguth, Steven; Rutledge, Neal			Integration of Biomarkers Into a Signature Profile of Persistent Traumatic Brain Injury Involving Autoimmune Processes Following Water Hammer Injury From Repetitive Head Impacts	BIOMARKER INSIGHTS			English	Article						Traumatic Brain Injury; Major Histocompatibility complex; Neuronal glial proteins; Signature of Vulnerability to TBI; Diffusion Tensor Imaging; Autoimmune disease	MHC CLASS-I; NEURON-SPECIFIC ENOLASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; FIBRILLARY ACIDIC PROTEIN; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; S-100 ANTIGEN; SERUM S100B; OPTIC-NERVE; GENES	OBJECTIVES: To assemble an algorithm that will describe a "Signature" predictive of an individual's vulnerability to persistent traumatic brain injury (TBI) SUBJECTS AND METHODS: Studies of athletes and warriors who are subjected to repeated head impacts with rapid acceleration/deceleration forces are used to assist in the diagnosis and management of TBI-affected individuals. Data from multiple areas, including clinical, anatomical, magnetic resonance imaging, cognitive function, and biochemical analyses, are integrated to provide a Signature of persistent TBI. RESULTS: Studies to date indicate that susceptibility to TBI results from an interaction between host genetic and structural vulnerability factors and force and torque of impact on the head and torso. The host factors include molecular markers affecting immune and inflammatory responses to stress/insult as well as anatomical features such as the degree of transcortical fiber projections and vascular malformations. The host response to forceful impact includes the release of intracellular neural proteins and nucleic acids into the cerebrospinal fluid and vascular compartment as well as mobilization of cytokines and macrophages into the central nervous system with subsequent activation of microglia and inflammatory responses including autoimmune processes. Maximum impact to the base of the sulci via a "water hammer effect" is consistent with the localization of microvascular and inflammatory responses in the affected brain region. CONCLUSIONS: An assessment of an individuals' predisposition to persistent TBI with delayed cognitive deficits and behavioral changes requires an understanding of host vulnerability (genetic factors and brain structure) and external stressors (force and torque of impact as well as repetitive head injury and time interval between impacts). An algorithm that has utility in predicting vulnerability to TBI will include qualitative and quantitative measures of the host factors weighted against post impact markers of neural injury. Implementation of the resulting "Signature" of vulnerability at early stages of injury will help inform athletes and warriors, along with commanders and management, of the risk/benefit approaches that will markedly diminish health care costs to the nation and suffering to this population. This report attempts to define a strategy to create such an algorithm.	[Kornguth, Steven] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Kornguth, Steven] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA; [Rutledge, Neal] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Rutledge, Neal] Austin Radiol Assoc, Austin, TX USA		Kornguth, S (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA.	steve_kornguth@utexas.edu					Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Bell KM, 2007, HDB BIOSENSORS BIOCH, P1085; Betthauser TJ, 2019, J NUCL MED, V60, P93, DOI 10.2967/jnumed.118.209650; Brill L, 2016, J NEUROIMMUNOL, V293, P65, DOI 10.1016/j.jneuroim.2016.02.006; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; CRABTREE JW, 1986, J NEUROSCI, V6, P1199; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRUNWALD GB, 1985, LANCET, V1, P658; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; JOHNSON JA, 1993, J NEUROSCI, V13, P2013; KORNGUTH S, 1991, BIOCHEM BIOPH RES CO, V179, P102, DOI 10.1016/0006-291X(91)91340-I; KORNGUTH S, 1995, SCIENCE, V270, P720; KORNGUTH SE, 1986, CANCER RES, V46, P2588; Kornguth S, 2017, JAMA NEUROL, V74, P360, DOI 10.1001/jamaneurol.2016.5908; Kornguth S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120164; Kornguth S, 2013, NAV ENG J, V125, P85; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; La Morgia C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00710; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; McCluskey LP, 2000, J NEUROPATH EXP NEUR, V59, P177, DOI 10.1093/jnen/59.3.177; McElroy JP, 2011, NEUROL CLIN, V29, P219, DOI 10.1016/j.ncl.2010.12.002; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MICHETTI F, 1980, J NEUROL SCI, V44, P259, DOI 10.1016/0022-510X(80)90133-1; MICHETTI F, 1979, NEUROSCI LETT, V11, P171, DOI 10.1016/0304-3940(79)90122-8; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; Niu ZL, 2015, INT J RHEUM DIS, V18, P17, DOI 10.1111/1756-185X.12528; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; North SH, 2012, ANNU REV ANAL CHEM, V5, P35, DOI 10.1146/annurev-anchem-062011-143105; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; ROBBINS ML, 1988, ARTHRITIS RHEUM, V31, P623, DOI 10.1002/art.1780310507; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shamran HA, 2014, INT J MED SCI, V11, P1147, DOI 10.7150/ijms.9412; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Siman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028938; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; SMOLEN JS, 1987, ANN RHEUM DIS, V46, P457, DOI 10.1136/ard.46.6.457; SPEAR PD, 1986, BRAIN RES, V368, P154, DOI 10.1016/0006-8993(86)91053-X; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vajtr D, 2012, Soud Lek, V57, P7; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; WILLIAMS RW, 1985, BRAIN RES, V336, P57, DOI 10.1016/0006-8993(85)90415-9; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	87	5	5	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1177-2719			BIOMARK INSIGHTS	Biomark. Insights	OCT 29	2018	13								1177271918808216	10.1177/1177271918808216			8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	HG1NT	WOS:000454725200001	30397383	Green Published, gold			2022-02-06	
J	Zhou, Y; Wen, LL; Wang, HD; Zhou, XM; Fang, J; Zhu, JH; Ding, K				Zhou, Yuan; Wen, Li-Li; Wang, Han-Dong; Zhou, Xiao-Ming; Fang, Jiang; Zhu, Jian-Hong; Ding, Ke			Blast-Induced Traumatic Brain Injury Triggered by Moderate Intensity Shock Wave Using a Modified Experimental Model of Injury in Mice	CHINESE MEDICAL JOURNAL			English	Article						Blast-Induced Traumatic Brain Injury; Brain Edema; Gliosis; Shock Tube; Subarachnoid Hemorrhage	MOUSE MODEL; APOPTOSIS; OVERPRESSURE; AUTOPHAGY; RISK; TBI	Background: The increasing fiequency of explosive injuries has increased interest in blast-induced traumatic brain injury (bTBI). Various shock tube models have been used to study bTBI. Mild-to-moderate explosions are often overlooked because of the slow onset or mildness of the symptoms. However, heavy gas cylinders and large volume chambers in the model may increase the complexity and danger. This study sought to design a modified model to explore the effect of moderate explosion on brain injury in mice. Methods: Pathology scoring system (PSS) was used to distinguish the graded intensity by the modified model. A total of 160 mice were randomly divided into control, sham, and bTBI groups with different time points. The clinical features, imaging features, neurobehavior, and neuropathology were detected after moderate explosion. One-way analysis of variance followed by Fisher's least significant difference posttest or Dunnett's t 3-test was performed for data analyses. Results: PSS of mild, moderate, and severe explosion was 13.4 +/- 2.2, 32.6 +/- 2.7 (t = 13.92, P < 0.001; vs. mild group), and 56.6 +/- 2.8 (t = 31.37, P < 0.001; vs. mild group), respectively. After moderate explosion, mice showed varied symptoms of malaise, anorexia, incontinence, apnea, or seizure. After bTBI, brain edema reached the highest peak at day 3 (82.5% +/- 2.1% vs. 73.8% + 0.6%, t = 7.76, P < 0.001), while the most serious neurological outcomes occurred at day 1 (Y-maze: 8.25 +/- 2.36 vs. 20.00 +/- 4.55, t = -4.59, P = 0.048; 29.58% +/- 2.84% vs. 49.09% +/- 11.63%, t = -3.08, P = 0.008; neurologic severity score: 2.50 +/- 0.58 vs. 0.00 +/- 0.00, t = 8.65, P = 0.016). We also found that apoptotic neurons (52.76% +/- 1.99% vs. 1.30% +/- 0.11%, t = 57.20, P < 0.001) and gliosis (2.98 +/- 0.24 vs. 1.00 +/- 0.00, t = 14.42, P = 0.021) in the frontal were significantly higher at day 3 post-bTBI than sham bTBI. Conclusions: We provide a reliable, reproducible bTBI model in mice that can produce a graded explosive waveform similar to the free-field shock wave in a controlled laboratory environment. Moderate explosion can trigger mild-to-moderate blast damage of the brain.	[Zhou, Yuan; Wen, Li-Li; Wang, Han-Dong; Zhou, Xiao-Ming; Fang, Jiang; Zhu, Jian-Hong; Ding, Ke] Nanjing Med Univ, Dept Neurosurg, Jinling Sch Clin Med, Jinling Hosp, Nanjing 210002, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Med Univ, Dept Neurosurg, Jinling Sch Clin Med, Jinling Hosp, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com			Youth Training Project [16QNP042]; Medical and Health Scientific Research Fund by Nanjing Military Region [ZX28]; Jinling Hospital of Nanjing [2016017]	This work was supported by grants from the Youth Training Project (No. 16QNP042), the Medical and Health Scientific Research Fund by Nanjing Military Region (No. ZX28), and the Jinling Hospital of Nanjing (No. 2016017).	Abdulbasit Amin, 2018, Pathophysiology, V25, P41, DOI 10.1016/j.pathophys.2017.12.002; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bowen LN, 2016, NEUROLOGIST, V21, P19, DOI 10.1097/NRL.0000000000000068; Canchi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175396; Cemak I, 2011, NEUROBIOL DIS, V41, P538; Cemak I, 2015, BRAIN NEUROTRAUMA MO; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Dams-O'Connor K, 2017, JAMA NEUROL, V74, P763, DOI 10.1001/jamaneurol.2017.0176; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Fang XX, 2018, NEUROREPORT, V29, P141, DOI 10.1097/WNR.0000000000000940; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Koyama Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164125; Lesperance RN, 2015, CRIT CARE NURS CLIN, V27, P277, DOI 10.1016/j.cnc.2015.02.007; Li T, 2015, NEUROCHEM RES, V40, P1829, DOI 10.1007/s11064-015-1672-4; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Miller AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173167; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Newsome MR, 2016, J INT NEUROPSYCH SOC, V22, P631, DOI 10.1017/S1355617716000448; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Parisian CM, 2017, J NAT SCI, V3, pe406; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Perez-Urrutia N, 2017, EXP NEUROL, V295, P211, DOI 10.1016/j.expneurol.2017.06.016; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wang YS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00413; Xu LY, 2016, EXP NEUROL, V277, P268, DOI 10.1016/j.expneurol.2016.01.010; Yelverton JT, 1996, J TRAUMA, V40, pS111, DOI 10.1097/00005373-199603001-00025; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Zander NE, 2016, J NEUROSCI RES, V94, P827, DOI 10.1002/jnr.23786; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131	44	5	6	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999	2542-5641		CHINESE MED J-PEKING	Chin. Med. J.	OCT 20	2018	131	20					2447	2460	PMID 30334530	10.4103/0366-6999.243558			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX6BE	WOS:000447840700008	30334530	Green Published, gold			2022-02-06	
J	Wu, L; Zhou, FQ; Zhang, Y; Li, J; Kuang, HM; Zhan, J; Peng, DC; He, LC; Zeng, XJ; Gong, HH				Wu, Lin; Zhou, Fuqing; Zhang, Yue; Li, Jian; Kuang, Hongmei; Zhan, Jie; Peng, Dechang; He, Laichang; Zeng, Xianjun; Gong, Honghan			Thalamic atrophy and dysfunction in patients with mild-to-moderate traumatic diffuse axonal injury: a short-term and mid-term MRI study	NEUROREPORT			English	Article						Diffeomorphic Anatomical Registration through Exponentiated Lie algebra-enhanced voxel-based morphometry; diffuse axonal injury; functional MRI; regional homogeneity; resting state	BRAIN-INJURY; STRUCTURAL CONNECTIVITY; LONGITUDINAL CHANGES; CORTEX; STATE; RESPONSES; VOLUME	Disrupted white matter structure has been established in patients with diffuse axonal injury (DAI), but morphological changes in gray matter and local intrinsic activity in the short and midterm (before 6 months) have not been documented in DAI patients. We hypothesized that regionally selective atrophy observed in deep gray matter in the short-term and mid-term periods in patients with mild-to-moderate DAI, local atrophy, and/or dysfunction would be related to clinical characteristics. We evaluated the changes in regional density and synchronization in 18 DAI patients separately using Diffeomorphic Anatomical Registration through Exponentiated Lie algebra-enhanced voxel-based morphometry and regional homogeneity (ReHo). Compared with the controls, DAI patients showed a decreased density in the bilateral thalami and decreased ReHo values in the ventral anterior and ventral lateral nuclei of the bilateral thalami. Pearson's correlation analysis showed that decreased density in the bilateral thalami was correlated negatively with time since injury and decreased ReHo values in the ventral anterior and ventral lateral nuclei of the bilateral thalami were associated with a worsened motor assessment scale. These findings suggest that mild-to-moderate traumatic DAI within the short and midterm could lead to thalamic atrophy and that dysfunction in the bilateral thalami is associated with declining motor function. This study could potentially provide complementary evidence as an important element in longitudinal studies.	[Wu, Lin; Zhou, Fuqing; Li, Jian; Kuang, Hongmei; Zhan, Jie; Peng, Dechang; He, Laichang; Zeng, Xianjun; Gong, Honghan] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Yongwaizhen St 17, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Yue] Nanchang Univ, Grad Coll, Dept Med, Nanchang, Jiangxi, Peoples R China; [Wu, Lin; Zhou, Fuqing; Li, Jian; Kuang, Hongmei; Zhan, Jie; Peng, Dechang; He, Laichang; Zeng, Xianjun; Gong, Honghan] Jiangxi Prov Med Imaging Res Inst, Nanchang, Jiangxi, Peoples R China		Zeng, XJ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Yongwaizhen St 17, Nanchang 330006, Jiangxi, Peoples R China.	xianjun-zeng@126.com			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81260217, 81460263, 81560284]; Science Foundation for Young Scientists of Jiangxi, China [20171BAB215048]	This study was supported by the National Science Foundation of China (grant nos 81260217, 81460263, 81560284) and the Science Foundation for Young Scientists of Jiangxi, China (grant no. 20171BAB215048).	Aamodt G, 2006, DISABIL REHABIL, V28, P1007, DOI 10.1080/09638280500476188; Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bruce ED, 2015, MOL CELL NEUROSCI, V66, P103, DOI 10.1016/j.mcn.2015.03.017; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Fair DA, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00010; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Goto M, 2013, NEURORADIOLOGY, V55, P869, DOI 10.1007/s00234-013-1193-2; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Iankova Andriana, 2006, Emerg Nurse, V14, P30; Jiang LL, 2016, NEUROSCIENTIST, V22, P486, DOI 10.1177/1073858415595004; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Li J, 2017, EUR RADIOL, V27, P325, DOI 10.1007/s00330-016-4302-x; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Pangman VC, 2000, APPL NURS RES, V13, P209, DOI 10.1053/apnr.2000.9231; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	32	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	OCT 17	2018	29	15					1282	1287		10.1097/WNR.0000000000001106			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GV1RG	WOS:000445857600008	30080741	Green Published			2022-02-06	
J	Costello, DM; Ernest, J; Kaye, AH; O'Brien, TJ; Shultz, SR				Costello, Daniel M.; Ernest, Joel; Kaye, Andrew H.; O'Brien, Terence J.; Shultz, Sandy R.			Concussion incidence in amateur Australian Rules Footballers	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Sport-related concussion; Mild traumatic brain injury; Incidence; Football; Athlete exposures	HIGH-SCHOOL; SPORT; STATEMENT; YOUTH	Australian Rules Football is a collision sport that is associated with increased sport-related concussion risk. Sport-related concussion is a common form of mild traumatic brain injury that is now recognised as a serious health issue. This study measured the concussion incidence rate for amateur Australian Rules players over 3 seasons (2015-2017) by athlete exposures a metric used widely in the literature. This study also reported concussion incidence based on player match hours, a less common yet more accurate method of reporting concussion incidence which takes match duration into account. Accurate concussion incidence reporting in amateur Australian Rules Football quantifies the problem of concussion in this sport. This may be necessary to inform players of their concussion injury risk and to help guide rule changes to protect players from this injury. (C) 2018 Elsevier Ltd. All rights reserved.	[Kaye, Andrew H.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3010, Australia; [Costello, Daniel M.; Ernest, Joel; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Alfred Hosp, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia; [O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Alfred Hosp, Cent Clin Sch, Dept Med, Melbourne, Vic 3004, Australia		Costello, DM (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia.	Daniel.Costello@svha.org.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Kaye, Andrew Henry/0000-0001-5049-8861; O'Brien, Terence/0000-0002-7198-8621	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia	National Health and Medical Research Council (NHMRC).	Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fortington Lauren V, 2015, Inj Epidemiol, V2, P20; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hecimovich MD, 2017, J PAEDIATR CHILD H, V53, P246, DOI 10.1111/jpc.13405; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2017, BR J SPORTS MED; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Orchard J, 2016, AUSTR FOOTBALL LEAGU; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Savage J, 2013, J SPORT MED, V2013; Saw R, 2017, SPORTS HLTH; Shawdon A, 1994, Aust J Sci Med Sport, V26, P59	21	5	5	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2018	56						88	89		10.1016/j.jocn.2018.07.003			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GZ2SK	WOS:000449238200015	30115504				2022-02-06	
J	Cuatrecasas, G; Kumru, H; Coves, MJ; Vidal, J				Cuatrecasas, Guillem; Kumru, Hatice; Josep Coves, M.; Vidal, Joan			GH deficiency in patients with spinal cord injury: efficacy/safety of GH replacement, a pilot study	ENDOCRINE CONNECTIONS			English	Article						growth hormone; GH deficiency; spinal cord injury; physical therapy; safety	ACTIVITY-DEPENDENT PLASTICITY; GROWTH-HORMONE; FUNCTIONAL RECOVERY; BRAIN; STIMULATION; RELIABILITY; INTERRATER; INTRARATER; PLASMA; MODEL	Objective: Growth hormone (GH) was shown to stimulate proliferation, migration and survival of neural cells in animal models. GH deficiency (GHD) was reported following traumatic brain lesions; however, there are not available data in spinal cord injury (SCI) patients. The aim of the study was to evaluate (1) the frequency of GHD in chronic SCI population; (2) the efficacy/safety of GH replacement in patients with SCI and suboptimal GH secretion. Design and methods: Nineteen consecutive patients with chronic thoracic complete SCI (AIS-A) were studied. Patients with low GH secretion were randomized in a double-blind, placebo-controlled study to receive either subcutaneous placebo injections or GH combined with physical therapy, for 6 months. Baseline cranial MRI, AIS motor and sensory scale, quality of life (spinal cord impact measurement) and modified Ashworth spasticity scale, quantitative sensory testing and neurophysiological exploration were assessed at baseline, 1, 3 and 6 months following treatment. Results: Thirteen had GH deficiency. Seven received GH, five placebo and one dropped out. Both groups were similar according to clinical and demographical data at baseline, except for greater GH deficiency in the GH treatment group. At 6th month, patients treated with GH showed a significant improvement in SLIM-III score and in electrical perception threshold up to the 5th level below SCI, on both sides compared to baseline. Conclusions: GHD seems to be frequent in traumatic SCI and GH replacement is safe without side effects. GH combined with physical therapy can improve quality of life of SCI patients and, strikingly, the sensory perception below lesion level.	[Cuatrecasas, Guillem; Josep Coves, M.] CPEN SL, Hosp Quiron Teknon, Endocrinol Dept, Barcelona, Spain; [Cuatrecasas, Guillem] Univ Oberta Catalunya, Barcelona, Spain; [Kumru, Hatice; Vidal, Joan] Inst Univ Neurorehabil Adscrit UAB, Inst Guttmann, Barcelona, Spain; [Kumru, Hatice; Vidal, Joan] Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain; [Kumru, Hatice; Vidal, Joan] Fundacio Inst Invest Ciencies Salut Germans Trias, Barcelona, Spain		Cuatrecasas, G (corresponding author), CPEN SL, Hosp Quiron Teknon, Endocrinol Dept, Barcelona, Spain.; Cuatrecasas, G (corresponding author), Univ Oberta Catalunya, Barcelona, Spain.	gcuatrecasas@cpen.cat	Joan, Vidal/AAR-5232-2021; Kumru, Hatice/ABB-1109-2021		Ipsen Pharma S.A.Ipsen	This research was partially financed as an external sponsored study, with a grant by Ipsen Pharma S.A. Recombinant GH and placebo were provided by Ipsen Pharma S.A.	Aberg ND, 2009, J ENDOCRINOL, V201, P141, DOI 10.1677/JOE-08-0495; Aguilar-Rodriguez M, 2015, SPINAL CORD, V53, P451, DOI 10.1038/sc.2014.225; Ansari NN, 2008, NEUROREHABILITATION, V23, P231; Baudet ML, 2009, ENDOCRINOLOGY, V150, P2758, DOI 10.1210/en.2008-1242; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Bauman WA, 2007, J SPINAL CORD MED, V30, P467, DOI 10.1080/10790268.2007.11754579; Chikani V, 2014, J MOL ENDOCRINOL, V52, pR107, DOI 10.1530/JME-13-0208; Cittadini A, 2009, J THROMB HAEMOST, V7, P1920, DOI 10.1111/j.1538-7836.2009.03607.x; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Cuatrecasas G, 2012, PAIN, V153, P1382, DOI 10.1016/j.pain.2012.02.012; Devesa J, 2009, J REHABIL MED, V41, P775, DOI 10.2340/16501977-0416; Dunlop SA, 2008, TRENDS NEUROSCI, V31, P410, DOI 10.1016/j.tins.2008.05.004; Fields DP, 2011, ANN NEUROSCI, V18, P118, DOI 10.5214/ans.0972.7531.1118309; Hamrahian AH, 2016, PITUITARY, V19, P332, DOI 10.1007/s11102-016-0712-7; Hilton BJ, 2016, J NEUROSCI, V36, P4080, DOI 10.1523/JNEUROSCI.3386-15.2016; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kretzer RM, 2016, SPINE, V41, pA27, DOI 10.1097/BRS.0000000000001432; Lynskey JV, 2008, J REHABIL RES DEV, V45, P229, DOI 10.1682/JRRD.2007.03.0047; Mazaira J., 1998, REHABILITACION, V32, P365; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Muresanu DF, 2015, MOL NEUROBIOL, V52, P837, DOI 10.1007/s12035-015-9298-8; Norrie BA, 2005, J NEUROPHYSIOL, V94, P255, DOI 10.1152/jn.00975.2004; Pellecchia MT, 2010, EUR J NEUROL, V17, P666, DOI 10.1111/j.1468-1331.2009.02896.x; Poljakovic Z, 2006, CLIN NEUROL NEUROSUR, V108, P255, DOI 10.1016/j.clineuro.2005.11.014; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sebastia-Alcacer V, 2014, SPINAL CORD, V52, P29, DOI 10.1038/sc.2013.128; SHETTY KR, 1993, AM J MED SCI, V305, P95, DOI 10.1097/00000441-199302000-00006; van Hedel HJA, 2012, NEUROREHAB NEURAL RE, V26, P497, DOI 10.1177/1545968311423669; Winkler T, 2000, AMINO ACIDS, V19, P363, DOI 10.1007/s007260070067	31	5	5	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	2049-3614			ENDOCR CONNECT	Endocr. Connect.	OCT	2018	7	10					1031	1039		10.1530/EC-18-0296			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	HJ0IH	WOS:000456842200004	30352393	Green Published, gold, Green Submitted			2022-02-06	
J	Galanis, DJ; Steinemann, S; Rosen, L; Bronstein, AC; Biffl, WL				Galanis, Daniel J.; Steinemann, Susan; Rosen, Linda; Bronstein, Alvin C.; Biffl, Walter L.			Rural Level III centers in an inclusive trauma system reduce the need for interfacility transfer	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma system; rural trauma; patient transfer	INJURED PATIENTS; INTERHOSPITAL TRANSFER; DEFINITIVE CARE; OUTCOMES; IMPACT; REGIONALIZATION; MORTALITY; SURVIVAL	BACKGROUND: Development of Level III trauma centers in a regionalized system facilitates early stabilization and prompt transfer to a higher level center. The resources to care for patients at Level III centers could also reduce the burden of interfacility transfers. We hypothesized that the development and designation of Level III centers in an inclusive trauma system resulted in lower rates of transfer, with no increase in morbidity or mortality among the non-transferred patients. METHODS: State trauma registry data from January 2009 through September 2015 were examined from five rural hospitals that transfer patients to our highest (Level II) trauma center and resource hospital. These five rural hospitals began receiving state support in 2010 to develop their trauma programs and were subsequently verified and designated Level III centers (three in 2011, two in 2013). Multivariate logistic regression was used to examine the adjusted odds of patient transfers and adverse outcomes, while controlling for age, gender, penetrating mechanism, presence of a traumatic brain injury, arrival by ambulance, and category of Injury Severity Score. The study period was divided into Before Level III center designation (2009-2010) and "After" (2011-2015). RESULTS: 7,481 patient records were reviewed. There was a decrease in the proportion of patients who were transferred After (1,281/5,737) compared to Before (516/1,744) periods (22% vs. 30%, respectively). After controlling for the various covariates, the odds of patient transfer were reduced by 32% (p < 0.0001) during the After period. Among non-transferred patients, there were no significant increases in adjusted odds of mortality, or hospitalizations of seven days or more, Before versus After. CONCLUSIONS: Development of rural Level III trauma centers in a regionalized system can significantly reduce the need for transfer to a remote, higher level trauma center. This may benefit the patient, family, and trauma system, with no adverse effect upon patient outcome. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.	[Galanis, Daniel J.; Bronstein, Alvin C.] Hawaii State Dept Hlth, Emergency Med Serv & Injury Prevent Syst Branch, 3675 Kilauea Ave,Trotter Bldg, Honolulu, HI 96816 USA; [Steinemann, Susan] Univ Hawaii, John A Burns Sch Med, Dept Surg, Honolulu, HI 96822 USA; [Steinemann, Susan] Queens Med Ctr, Honolulu, HI USA; [Rosen, Linda] Univ Hawaii, John A Burns Sch Med, Dept Pediat, Hawaii Hlth Syst Corp, Honolulu, HI 96822 USA; [Biffl, Walter L.] Scripps Mem Hosp, Trauma & Acute Care Surg, La Jolla, CA USA		Galanis, DJ (corresponding author), Hawaii State Dept Hlth, Emergency Med Serv & Injury Prevent Syst Branch, 3675 Kilauea Ave,Trotter Bldg, Honolulu, HI 96816 USA.	daniel.galanis@doh.hawaii.gov	Steinemann, Susan/L-2253-2015	Steinemann, Susan/0000-0003-0383-1590			Bailey J, 2012, SURG CLIN N AM, V92, P1009, DOI 10.1016/j.suc.2012.04.008; Billeter AT, 2014, AM J SURG, V207, P459, DOI 10.1016/j.amjsurg.2013.04.015; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; Demetriades D, 2005, ANN SURG, V242, P512, DOI 10.1097/01.sla.0000184169.73614.09; Eastman AB, 2006, J TRAUMA, V60, P535; Esposito T, 2007, J TRAUMA, V63, P126; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Gomez D, 2015, INJURY, V46, P1790, DOI 10.1016/j.injury.2015.05.047; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hill AD, 2011, J TRAUMA, V71, P1901; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Hoyt DB, 2007, SURG CLIN N AM, V87, P21, DOI 10.1016/j.suc.2006.09.012; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Mann NC, 2005, J TRAUMA, V58, P136, DOI 10.1097/01.TA.0000151181.44658.0A; Mann NC, 2001, MED CARE, V39, P643, DOI 10.1097/00005650-200107000-00001; Mann NC, 1999, J TRAUMA, V47, pS69, DOI 10.1097/00005373-199909001-00015; Mullins RJ, 2002, J TRAUMA, V52, P1019, DOI 10.1097/00005373-200206000-00002; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; Taheri PA, 2004, AM J SURG, V187, P7, DOI 10.1016/j.amjsurg.2003.06.002; Thomas KE, 2015, CTR DIS CONTROL PREV; Tinkoff GH, 2007, J TRAUMA, V63, P121, DOI 10.1097/TA.0b013e3180686548; Twijnstra MJ, 2010, ANN SURG, V251, P339, DOI 10.1097/SLA.0b013e3181c0e910; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e; Vanni AJ, 2012, J TRAUMA ACUTE CARE, V72, P385, DOI 10.1097/TA.0b013e3182411c67; Winchell RJ, 2015, J TRAUMA ACUTE CARE, V78, P1102, DOI 10.1097/TA.0000000000000653; Zafar SN, 2015, J TRAUMA ACUTE CARE, V78, P852, DOI 10.1097/TA.0000000000000557	28	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2018	85	4					747	751		10.1097/TA.0000000000002033			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GV6BK	WOS:000446191400015	30036262				2022-02-06	
J	Iampreechakul, P; Tanpun, A; Lertbusayanukul, P; Siriwimonmas, S				Iampreechakul, Prasert; Tanpun, Adisak; Lertbusayanukul, Punjama; Siriwimonmas, Somkiet			Contralateral extensive cerebral hemorrhagic venous infarction caused by retrograde venous reflux into the opposite basal vein of Rosenthal in posttraumatic carotid-cavernous fistula: A case report and literature review	INTERVENTIONAL NEURORADIOLOGY			English	Article						Venous infarction; venous congestion; traumatic carotid-cavernous fistula; direct carotid-cavernous fistula; basal vein of Rosenthal	SINUS; FEATURES; SYSTEM; EDEMA	We describe a patient with traumatic carotid-cavernous fistula (CCF), subsequently developing contralateral extensive hemorrhagic venous infarction from retrograde venous reflux into the opposite basal vein of Rosenthal. A 54-year-old woman was involved in a motor vehicle accident and sustained severe traumatic brain injury. Two months later, she developed bilateral proptosis and audible bruit. Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) of the brain demonstrated the right direct CCF. Fluid-attenuated inversion recovery (FLAIR) images showed a small hyperintense area at the left basal ganglia. Ten days later, she developed right-sided grade 2/5 hemiparesis, facial upper motor neuron weakness, and cognitive impairment. Follow-up MRI showed significant progression of hyperintensities involving the left-sided centrum semiovale, basal ganglia, thalamus, midbrain, pons, cerebellum, basal frontal, temporal lobes, especially subcortical white matter on FLAIR images, and multiple hypointense foci of hemorrhagic component on T2*-weighted gradient-echo images, representing hemorrhagic venous infarction. While waiting for embolization, she rapidly developed right hemiplegia and aphasia, and became somnolent. Under general anesthesia, emergency endovascular treatment was performed successfully to obliterate the fistula without surgical intervention. Five months after endovascular treatment, MRI and MRA confirmed no residual fistula and revealed nearly complete resolution of abnormal increased signal intensity. In the present case, the factors related to the presence of this rare condition were absence of the ipsilateral basal vein of Rosenthal (BVR), occlusion of posterior segment of the contralateral superior petrosal sinus, and a developed uncal vein with hypoplastic second and third segments of the contralateral BVR.	[Iampreechakul, Prasert; Tanpun, Adisak] Prasat Neurol Inst, Dept Neurosurg, Bangkok, Thailand; [Lertbusayanukul, Punjama] Prasat Neurol Inst, Dept Neuroradiol, Bangkok, Thailand; [Siriwimonmas, Somkiet] Bumrungrad Int Hosp, Dept Radiol, Bangkok, Thailand		Iampreechakul, P (corresponding author), Prasat Neurol Inst, Dept Neurol Surg, 312 Ratchawithi Rd, Bangkok 10400, Thailand.	bangruad@hotmail.com		Iampreechakul, Prasert/0000-0002-8241-7955			Aldea S, 2011, ACTA NEUROCHIR, V153, P1297, DOI 10.1007/s00701-011-0982-9; AMBLER MW, 1978, J NEUROSURG, V48, P117, DOI 10.3171/jns.1978.48.1.0117; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; Berenstein A, 2004, SURG NEUROANGIOGRAPH, V2, P277; BURGER PC, 1978, ARCH PATHOL LAB MED, V102, P40; Bussiere M, 2009, J NEURO-OPHTHALMOL, V29, P21, DOI 10.1097/WNO.0b013e31818e3db9; Chan FH, 2014, INTERV NEURORADIOL, V20, P487, DOI 10.15274/NRJ-2014-10038; Cullen S, 2005, INTERV NEURORADIOL, V11, P325, DOI 10.1177/159101990501100404; DANGELO VA, 1988, SURG NEUROL, V30, P387, DOI 10.1016/0090-3019(88)90202-9; Gobin YP, 1998, NEUROIMAG CLIN N AM, V8, P425; Herrera DA, 2011, J NEUROIMAGING, V21, P73, DOI 10.1111/j.1552-6569.2009.00400.x; HIGASHIDA RT, 1989, AM J ROENTGENOL, V153, P577, DOI 10.2214/ajr.153.3.577; Huang YP, 1976, RADIOLOGIC ANATOMY B, P127; Ide S, 2014, NEURORADIOLOGY, V56, P661, DOI 10.1007/s00234-014-1383-6; IIDA K, 1995, J TRAUMA, V39, P1015, DOI 10.1097/00005373-199511000-00037; Jagadeesan BD, 2011, STROKE, V42, P87, DOI 10.1161/STROKEAHA.110.584862; Kamio Y, 2017, J KOREAN NEUROSURG S, V60, P89, DOI 10.3340/jkns.2015.1206.001; Kamouchi M, 2006, INTERNAL MED, V45, P25, DOI 10.2169/internalmedicine.45.1430; KASAMA A, 1990, Neurological Surgery, V18, P631; Kiyosue H, 2009, NEURORADIOLOGY, V51, P175, DOI 10.1007/s00234-008-0486-3; Lau V, 2012, HONG KONG J RADIOL, V15, P170; Letourneau-Guillon L, 2012, AM J NEURORADIOL, V33, P301, DOI 10.3174/ajnr.A2777; LEWIS AI, 1995, NEUROSURGERY, V36, P239, DOI 10.1227/00006123-199502000-00001; MATSUSHIMA T, 1983, J NEUROSURG, V59, P63, DOI 10.3171/jns.1983.59.1.0063; Mitsuhashi Y, 2016, NEUROL MED-CHIR, V56, P326, DOI 10.2176/nmc.ra.2015-0346; Miyamoto N, 2009, NEURORADIOLOGY, V51, P53, DOI 10.1007/s00234-008-0468-5; Murata H, 2003, NEUROL MED-CHIR, V43, P255, DOI 10.2176/nmc.43.255; Ohshima Sachiko, 2006, Rinsho Shinkeigaku, V46, P261; PADGET DH, 1956, AM J ANAT, V98, P307, DOI 10.1002/aja.1000980302; Ract I, 2014, J NEUROSURG, V121, P63, DOI 10.3171/2014.1.JNS132016; Rhoton AL, 2002, NEUROSURGERY, V51, pS159, DOI 10.1227/01.NEU.0000028228.51706.2D; Ryu J, 2017, WORLD NEUROSURG, V98, DOI 10.1016/j.wneu.2016.06.091; Shimada R, 2013, AM J NEURORADIOL, V34, P609, DOI 10.3174/ajnr.A3252; Suzuki Y, 2001, AM J NEURORADIOL, V22, P670; TENG MMH, 1991, AM J NEURORADIOL, V12, P139; TERBRUGGE K, 1988, SURG RADIOL ANAT, V10, P243, DOI 10.1007/BF02115244; TURNER DM, 1983, J NEUROSURG, V59, P680, DOI 10.3171/jns.1983.59.4.0680; VAGHI MA, 1983, J NEUROSURG, V58, P435, DOI 10.3171/jns.1983.58.3.0435; Yu JL, 2015, EXP THER MED, V10, P445, DOI 10.3892/etm.2015.2507	39	5	5	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1591-0199	2385-2011		INTERV NEURORADIOL	Interv. Neuroradiol.	OCT	2018	24	5							1591019918776610	10.1177/1591019918776615			14	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GS2AN	WOS:000443341500011	29781369	Green Published			2022-02-06	
J	Metzger, RR; Sheng, XM; Niedzwecki, CM; Bennett, KS; Morita, DC; Zielinski, B; Schober, ME				Metzger, Ryan R.; Sheng, Xiaoming; Niedzwecki, Christian M.; Bennett, Kimberly S.; Morita, Denise C.; Zielinski, Brandon; Schober, Michelle E.			Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; cerebrospinal fluid; serum; biomarkers; pediatric; trauma	FIBRILLARY ACIDIC PROTEIN; CEREBROSPINAL-FLUID; BIOMARKER; EPIDEMIOLOGY; UCH-L1; MILD; L1	OBJECTIVE Traumatic brain injury (TBI) is the leading cause of acquired disability among children. Brain injury biomarkers may serve as useful diagnostic and prognostic indicators for TBI. Levels of ubiquitin C-terminal hydrolase-L1 (UCH-L1) and the 145-kDa alpha II-spectrin breakdown product (SBDP-145) correlate with outcome in adults after severe TBI. The authors conducted a pilot study of these biomarkers in children after severe TBI to inform future research exploring their utility in this population. METHODS The levels of UCH-L1 and SBDP-145 were measured in serum, and UCH-L1 in CSF from pediatric patients after severe TBI over 5 days after injury. Both biomarkers were also measured in age-matched control serum and CSF. RESULTS Adequate numbers of samples were obtained in serum, but not CSF, to assess biomarker temporal response profiles. Using patients with samples from all time points, UCH-L1 levels increased rapidly and transiently, peaking at 12 hours after injury. SBDP-145 levels showed a more gradual and sustained response, peaking at 48 hours. The median serum UCH-L1 concentration was greater in patients with TBI than in controls (median [IQR] = 361 [187, 1330] vs 147 [50, 241] pg/ml, respectively; p < 0.001). Receiver operating characteristic (ROC) analysis revealed an AUC of 0.77. Similarly, serum SBDP-145 was greater in children with TBI than in controls (median [IQR] = 172 [124, 257] vs 69 [40, 99] pg/ml, respectively; p < 0.001), with an ROC AUC of 0.85. When only time points of peak levels were used for ROC analysis, the discriminability of each serum biomarker increased (AUC for UCH-L1 at 12 hours = 1.0 and for SBDP-145 at 48 hours = 0.91). Serum and CSF UCH-L1 levels correlated well in patients with TBI (r = 0.70, p < 0.001). CONCLUSIONS Findings from this exploratory study reveal robust increases of UCH-L1 and SBDP-145 in serum and UCH-L1 in CSF obtained from children after severe TBI. In addition, important temporal profile differences were found between these biomarkers that can help guide optimal time point selection for future investigations of their potential to characterize injury or predict outcomes after pediatric TBI.	[Metzger, Ryan R.] Univ Utah, Div Pediat Surg, Salt Lake City, UT USA; [Sheng, Xiaoming] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Bennett, Kimberly S.; Schober, Michelle E.] Univ Utah, Div Pediat Crit Care, Salt Lake City, UT USA; [Morita, Denise C.; Zielinski, Brandon] Univ Utah, Div Pediat Neurol, Salt Lake City, UT USA; [Niedzwecki, Christian M.] Univ Utah, Dept Phys Med & Rehabil, Salt Lake City, UT USA		Schober, ME (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84112 USA.	michelle.schober@hsc.utah.edu			Primary Children's Hospital Foundation Integrated Science Award; University of Utah Clinical and Translational Sciences [CTSA 5UL1RR025764-01]	This study was supported by a Primary Children's Hospital Foundation Integrated Science Award (all authors) and by the University of Utah Clinical and Translational Sciences (grant no. CTSA 5UL1RR025764-01; Dr. Metzger). Study data were collected and managed using REDCap (Research Electronic Data Capture) tools hosted at the University of Utah.<SUP>15</SUP>	Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bishop P, 2016, BIOCHEM J, V473, P2453, DOI 10.1042/BCJ20160082; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brandner S, 2013, EUR NEUROL, V70, P189, DOI 10.1159/000352032; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cardali S, 2006, J Neurosurg Sci, V50, P25; Chen SY, 2016, EXP THER MED, V11, P2049, DOI 10.3892/etm.2016.3153; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Food and Drug Administration, 2018, FDA AUTH MARK 1 BLOO; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	33	5	7	2	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2018	22	4					369	374		10.3171/2018.4.PEDS17593			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GV6SL	WOS:000446245200008	29957142	Bronze			2022-02-06	
J	Mourouzis, C; Schoinohoriti, O; Krasadakis, C; Rallis, G				Mourouzis, C.; Schoinohoriti, O.; Krasadakis, C.; Rallis, G.			Cervical spine fractures associated with maxillofacial trauma: A 3-year-long study in the Greek population	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Cervical spine fractures (CSF); Maxillofacial trauma; Greek population	FACIAL FRACTURES; MANDIBULAR FRACTURES; BLUNT TRAUMA; INJURY; PATTERNS; MANAGEMENT; RULE	Background: Maxillofacial fractures have been recognized as high risk trauma for concomitant cervical spine or spinal cord injury. Objective: To investigate the incidence of concomitant cervical spine fractures (CSF) in patients with maxillofacial trauma and elucidate their relationship, guiding diagnosis and pointing their implications in maxillofacial trauma repair. Material and Methods: An analysis of 432 patients with maxillofacial fractures, treated at the Department of Oral and Maxillofacial Surgery of the "KAT" General Hospital of Attica during a three-year-long period, was conducted to investigate concomitant CSF. Results: 22 patients or 5.1% (14 male/8 female, mean age 39.81 years) sustained a total of 29 concomitant CSF. In 77.3% of the cases the injury mechanism was motor vehicle accidents. The most frequent levels of CSF were C6-C7 (55.17%) and C1-C2 (27.58%). Regarding the type/site of maxillofacial fractures, 5 patients (22.73%) had sustained isolated zygomatoorbital, 5 (22.73%) isolated mandibular and 12 (54.54%) combined fractures. Concomitant injuries (i.e. intracranial hemorrhage, cerebral concussion, etc) were registered in 14 patients; additional thoracic/lumbar spine fractures in 5. Hospital stay ranged from 6 to 86 days (mean 27.6 days). Conclusions: Maxillofacial surgeons should be aware of the relationship between CSF and maxillofacial fractures, having implications in their patients' treatment. (C) 2018 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Mourouzis, C.; Schoinohoriti, O.; Krasadakis, C.; Rallis, G.] KAT Gen Hosp Att, Dept Oral & Maxillofacial Surg, Athens, Greece		Schoinohoriti, O (corresponding author), 21 Panourgia St, Attiki 15343, Greece.	our_schoinohoriti@yahoo.com					Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Ardekian L, 1997, J Craniomaxillofac Trauma, V3, P18; Bayles SW, 1997, ARCH OTOLARYNGOL, V123, P1304; BEIRNE JC, 1995, INT J ORAL MAX SURG, V24, P26, DOI 10.1016/S0901-5027(05)80852-5; Besman A, 2003, AM SURGEON, V69, P1010; Chen Jeff W, 2008, Oral Maxillofac Surg Clin North Am, V20, P381, DOI 10.1016/j.coms.2008.03.006; Chu MW, 2016, J SURG RES, V206, P386, DOI 10.1016/j.jss.2016.08.019; DAVIDSON JSD, 1989, J TRAUMA, V29, P1276, DOI 10.1097/00005373-198909000-00016; Elahi MM, 2008, PLAST RECONSTR SURG, V121, P201, DOI 10.1097/01.prs.0000293763.82790.aa; Grogan EL, 2005, J AM COLL SURGEONS, V200, P160, DOI 10.1016/j.jamcollsurg.2004.10.019; Hackl W, 2001, ORAL SURG ORAL MED O, V92, P370, DOI 10.1067/moe.2001.116894; Halsey JN, 2016, J CRANIOFAC SURG, V27, P109, DOI 10.1097/SCS.0000000000002284; Hasler RM, 2012, J TRAUMA ACUTE CARE, V72, P975, DOI 10.1097/TA.0b013e31823f5e8e; HAUG RH, 1991, J ORAL MAXIL SURG, V49, P725, DOI 10.1016/S0278-2391(10)80236-8; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Hoppe IC, 2014, J CRANIOFAC SURG, V25, P1825, DOI 10.1097/SCS.0000000000001055; Jamal BT, 2009, J ORAL MAXIL SURG, V67, P559, DOI 10.1016/j.joms.2008.07.010; Lalani Z, 1997, BRIT J ORAL MAX SURG, V35, P243, DOI 10.1016/S0266-4356(97)90041-3; LEWIS VL, 1985, J TRAUMA, V25, P90, DOI 10.1097/00005373-198501000-00014; Merritt RM, 1997, AM J OTOLARYNG, V18, P235, DOI 10.1016/S0196-0709(97)90002-8; Mithani SK, 2009, PLAST RECONSTR SURG, V123, P1293, DOI 10.1097/PRS.0b013e31819e26f2; Mukherjee S, 2015, ANN ROY COLL SURG, V97, P66, DOI 10.1308/003588414X14055925059633; Mukherjee S, 2014, BRIT J HOSP MED, V75, P331, DOI 10.12968/hmed.2014.75.6.331; Mulligan RP, 2010, PLAST RECONSTR SURG, V126, P1648, DOI 10.1097/PRS.0b013e3181ef90e4; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Reich W, 2016, J CRANIO MAXILL SURG, V44, P1469, DOI 10.1016/j.jcms.2016.06.017; Robertson A, 2002, SPINE, V27, P2825, DOI 10.1097/00007632-200212150-00019; Roccia F, 2007, J CRANIOFAC SURG, V18, P1259, DOI 10.1097/scs.0b013e31814e0581; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Torretti Joel A, 2007, Indian J Orthop, V41, P255, DOI 10.4103/0019-5413.36985; Tu PH, 2010, J TRAUMA, V69, pE62, DOI 10.1097/TA.0b013e3181d7807d	31	5	5	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	OCT	2018	46	10					1712	1718		10.1016/j.jcms.2018.07.003			7	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	GW5QH	WOS:000446990500004	30049540				2022-02-06	
J	Nourallah, B; Menon, DK; Zeiler, FA				Nourallah, Basil; Menon, David K.; Zeiler, Frederick A.			Midline Shift is Unrelated to Subjective Pupillary Reactivity Assessment on Admission in Moderate and Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Midline shift; Basal cisterns; Pupillary reactivity	GLASGOW COMA SCALE; INTRACRANIAL-PRESSURE; HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; PROGNOSTIC VALUE; CT SCAN; CLASSIFICATION; IMPACT; COMPRESSION; SCORE	Background: This study aims to determine the relationship between pupillary reactivity, midline shift and basal cistern effacement on brain computed tomography (CT) in moderate-to-severe traumatic brain injury (TBI). All are important diagnostic and prognostic measures, but their relationship is unclear. Methods: A total of 204 patients with moderate-to-severe TBI, documented pupillary reactivity, and archived neuroimaging were included. Extent of midline shift and basal cistern effacement were extracted from admission brain CT. Mean midline shift was calculated for each ordinal category of pupillary reactivity and basal cistern effacement. Sequential Chi-square analysis was used to calculate a threshold midline shift for pupillary abnormalities and basal cistern effacement. Univariable and multiple logistic regression analyses were performed. Results: Pupils were bilaterally reactive in 163 patients, unilaterally reactive in 24, and bilaterally unreactive in 17, with mean midline shift (mm) of 1.96, 3.75, and 2.56, respectively (p = 0.14). Basal cisterns were normal in 118 patients, compressed in 45, and absent in 41, with mean midline shift (mm) of 0.64, 2.97, and 5.93, respectively (p < 0.001). Sequential Chi-square analysis identified a threshold for abnormal pupils at a midline shift of 7-7.25 mm (p = 0.032), compressed basal cisterns at 2 mm (p < 0.001), and completely effaced basal cisterns at 7.5 mm (p < 0.001). Logistic regression revealed no association between midline shift and pupillary reactivity. With effaced basal cisterns, the odds ratio for normal pupils was 0.22 (95% CI 0.08-0.56; p = 0.0016) and for at least one unreactive pupil was 0.061 (95% CI 0.012-0.24; p < 0.001). Basal cistern effacement strongly predicted midline shift (OR 1.27; 95% CI 1.17-1.40; p < 0.001). Conclusions: Basal cistern effacement alone is associated with pupillary reactivity and is closely associated with midline shift. It may represent a uniquely useful neuroimaging marker to guide intervention in traumatic brain injury.	[Nourallah, Basil; Menon, David K.; Zeiler, Frederick A.] Univ Cambridge, Dept Med, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada		Nourallah, B (corresponding author), Univ Cambridge, Dept Med, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.	basilnourallah@gmail.com		Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; European Union Framework Program 7 Grant (CENTER-TBI) [602150]; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery, and the University of Manitoba Clinician Investigator Program. These studies were supported by National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to DKM. Authors were also supported by a European Union Framework Program 7 Grant (CENTER-TBI; Grant Agreement No. 602150).	ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P13, DOI 10.1016/S0009-9260(89)80006-6; Hara M, 1998, NEUROL RES, V20, P225, DOI 10.1080/01616412.1998.11740510; Johnson PL, 2002, NEUROIMAG CLIN N AM, V12, P217, DOI 10.1016/S1052-5149(02)00008-4; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; MEMON MY, 1971, J NEUROSURG, V35, P461, DOI 10.3171/jns.1971.35.4.0461; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; MUNRO D, 1952, NEW ENGL J MED, V247, P699, DOI 10.1056/NEJM195211062471901; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Reid WL, 1939, J AMER MED ASSOC, V112, P2030, DOI 10.1001/jama.1939.02800200028008; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; SADHU VK, 1979, RADIOLOGY, V133, P507, DOI 10.1148/133.2.507; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TABADDOR K, 1982, SURG NEUROL, V18, P212, DOI 10.1016/0090-3019(82)90395-0; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Vagberg M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170018	28	5	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2018	29	2					203	213		10.1007/s12028-018-0526-8			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GY3QG	WOS:000448467900009	29619661	Green Published, hybrid			2022-02-06	
J	Peterson, RK; Ashford, JM; Scott, SM; Wang, F; Zhang, H; Bradley, JA; Merchant, TE; Conklin, HM				Peterson, Rachel K.; Ashford, Jason M.; Scott, Sarah M.; Wang, Fang; Zhang, Hui; Bradley, Julie A.; Merchant, Thomas E.; Conklin, Heather M.			Predicting parental distress among children newly diagnosed with craniopharyngioma	PEDIATRIC BLOOD & CANCER			English	Article						craniopharyngioma; parental distress; pediatric brain tumor	QUALITY-OF-LIFE; POSTTRAUMATIC STRESS SYMPTOMS; CHILDHOOD-CANCER SURVIVORS; TRAUMATIC BRAIN-INJURY; HYPOTHALAMIC INVOLVEMENT; PSYCHOLOGICAL DISTRESS; EMOTIONAL ADJUSTMENT; ADAPTIVE STYLE; SOCIAL SUPPORT; MOTHERS	BackgroundChildhood brain tumor diagnoses are stressful for families. Children diagnosed with craniopharyngioma (Cp) present with particularly challenging medical and cognitive problems due to tumor location and associated biophysiologic comorbidities. This study examined parental distress in a sample of families of patients with Cp treated with proton beam therapy to identify factors for targeting psychological intervention. ProcedurePrior to (n=96) and 1 year after (n=73) proton therapy, parents of children diagnosed with Cp (9.814.42 years at baseline; 49% male) completed a self-report measure of distress, the Brief Symptom Inventory (BSI). Children completed cognitive assessment measures at baseline; medical variables were extracted from the study database. ResultsAt baseline, t-tests revealed parents reported higher levels of distress than normative expectations on Anxiety, Depression, Global Severity, and Positive Symptom Distress BSI scales (P<0.05). Linear mixed effects models revealed parent report measures of child executive dysfunction and behavioral issues were more predictive of parental distress than patients' cognitive performance or medical status (P<0.05). Models also revealed a significant reduction only in Anxiety over time (t=-2.19, P<0.05). Extensive hypothalamic involvement at baseline predicted this reduction (P<0.05). ConclusionParents experience significant distress before their child begins adjuvant therapy for Cp, though parental distress appears largely unrelated to medical complications and more related to parent perceptions of child cognitive difficulties (vs. child performance). Importantly, this may be explained by a negative parent reporting style among distressed parents. Knowledge of socio-emotional functioning in parents related to patient characteristics is important for optimization of psychological intervention.	[Peterson, Rachel K.; Ashford, Jason M.; Scott, Sarah M.; Conklin, Heather M.] St Jude Childrens Res Hosp, Dept Psychol, Mail Stop 740,262 Danny Thomas Pl, Memphis, TN 38105 USA; [Wang, Fang; Zhang, Hui] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Bradley, Julie A.] Univ Florida, Hlth Proton Therapy Inst, Dept Radiat Oncol, Jacksonville, FL USA; [Merchant, Thomas E.] St Jude Childrens Res Hosp, Dept Radiat Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA		Conklin, HM (corresponding author), St Jude Childrens Res Hosp, Dept Psychol, Mail Stop 740,262 Danny Thomas Pl, Memphis, TN 38105 USA.	heather.conklin@stjude.org	Wang, Fang/ABB-2769-2021; Conklin, Heather M/N-2696-2018; Merchant, Thomas E/N-3344-2018	Wang, Fang/0000-0001-8764-9387; Merchant, Thomas E/0000-0002-0412-6255; Zhang, Hui/0000-0001-6825-5649	National Cancer Institute (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30-CA21765]; American Lebanese Syrian Associated CharitiesAmerican Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA021765] Funding Source: NIH RePORTER	Grant sponsor: National Cancer Institute (NIH), Grant number: P30-CA21765, Grant sponsor: American Lebanese Syrian Associated Charities	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Boman K, 2003, ACTA ONCOL, V42, P137, DOI 10.1080/02841860310004995; Brown RT, 2003, J TRAUMA STRESS, V16, P309, DOI 10.1023/A:1024465415620; Conners, 2004, CONNERS CONTINUOUS P; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Dobson K., 2009, HDB COGNITIVE BEHAV; Dockerty JD, 2000, MED PEDIATR ONCOL, V35, P475, DOI 10.1002/1096-911X(20001101)35:5<475::AID-MPO6>3.0.CO;2-U; Erickson SJ, 2008, CHILD PSYCHIAT HUM D, V39, P247, DOI 10.1007/s10578-007-0085-2; Fournier-Goodnight AS, 2017, J NEURO-ONCOL, V134, P97, DOI 10.1007/s11060-017-2492-y; Gioia GA IP, 2000, BEHAV RATING INVENTO; Grootenhuis MA, 1997, PSYCHO-ONCOL, V6, P115, DOI 10.1002/(SICI)1099-1611(199706)6:2<115::AID-PON252>3.3.CO;2-4; Harper FWK, 2013, PSYCHO-ONCOLOGY, V22, P1658, DOI 10.1002/pon.3199; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hoekstra-Weebers JEHM, 2001, J PEDIATR PSYCHOL, V26, P225, DOI 10.1093/jpepsy/26.4.225; Hoekstra-Weebers JEHM, 1999, J AM ACAD CHILD PSY, V38, P1526, DOI 10.1097/00004583-199912000-00014; Kahalley LS, 2016, J CLIN ONCOL, V34, P1043, DOI 10.1200/JCO.2015.62.1383; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022; Kazak AE, 1998, J AM ACAD CHILD PSY, V37, P823, DOI 10.1097/00004583-199808000-00012; Kazak AE., 2001, FAM SYST HEALTH, V19, P303, DOI [10.1037/h0089454, DOI 10.1037/H0089454]; Kearney JA, 2015, PEDIAT BLOOD CANC, V62, pS574; Kendall-Taylor P, 2005, EUR J ENDOCRINOL, V152, P557, DOI 10.1530/eje.1.01877; Lafayette Instrument, 2003, GROOV PEGB TASK; Manne S, 1996, CHILD HEALTH CARE, V25, P191, DOI 10.1207/s15326888chc2503_3; Maurice-Stam H, 2008, PSYCHO-ONCOLOGY, V17, P448, DOI 10.1002/pon.1260; McGrath Pam, 2002, Oncol Nurs Forum, V29, P988, DOI 10.1188/02.ONF.988-996; Nezu AM, 2003, J CONSULT CLIN PSYCH, V71, P1036, DOI 10.1037/0022-006X.71.6.1036; Nezu AM, 1998, HELPING CANC PATIENT; Noll RB, 1995, FAMILY SYSTEMS MED, V13, P11, DOI DOI 10.1037/H0089103; Norberg AL, 2006, PSYCHO-ONCOLOGY, V15, P335, DOI 10.1002/pon.960; Norberg AL, 2008, ACTA ONCOL, V47, P267, DOI 10.1080/02841860701558773; Ozyurt J, 2014, J PEDIATR-US, V164, P876, DOI 10.1016/j.jpeds.2013.12.010; Paquet L, 2018, PSYCHO-ONCOLOGY, V27, P171, DOI 10.1002/pon.4389; Pedreira CC, 2006, J PEDIATR ENDOCR MET, V19, P15; Pereira AM, 2005, CLIN ENDOCRINOL, V62, P197, DOI 10.1111/j.1365-2265.2004.02196.x; Phipps S, 2006, J PEDIATR PSYCHOL, V31, P298, DOI 10.1093/jpepsy/jsj033; Phipps S, 2007, J PEDIATR PSYCHOL, V32, P1055, DOI 10.1093/jpepsy/jsm060; Poretti A, 2004, DEV MED CHILD NEUROL, V46, P220, DOI 10.1017/S0012162204000374; Puget S, 2007, J NEUROSURG, V106, P3, DOI 10.3171/ped.2007.106.1.3; Pulsifer MB, 2015, INT J RADIAT ONCOL, V93, P400, DOI 10.1016/j.ijrobp.2015.06.012; Rabineau KM, 2008, J PEDIAT HEMATOL ONC, V30, P358, DOI 10.1097/MPH.0b013e318168e76b; Recklitis CJ, 2007, PSYCHO-ONCOLOGY, V16, P429, DOI 10.1002/pon.1069; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Sahin Nesrin H, 2002, Turk Psikiyatri Derg, V13, P125; Sahler OJZ, 2005, J CONSULT CLIN PSYCH, V73, P272, DOI 10.1037/0022-006X.73.2.272; Sahler OJZ, 2013, J CLIN ONCOL, V31, P1329, DOI 10.1200/JCO.2011.39.1870; Sands SA, 2005, J NEUROSURG, V103, P302, DOI 10.3171/ped.2005.103.4.0302; Sloper P, 2000, J PEDIATR PSYCHOL, V25, P79, DOI 10.1093/jpepsy/25.2.79; Stam H, 2001, SUPPORT CARE CANCER, V9, P489, DOI 10.1007/s005200100271; Stam H, 2006, PEDIATR BLOOD CANCER, V47, P312, DOI 10.1002/pbc.20661; STEFANEK ME, 1987, PSYCHOSOMATICS, V28, P530, DOI 10.1016/S0033-3182(87)72467-0; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2002, WECHSLER PRESCHOOL P; Wechsler D., 2008, WECHSLER ADULT INTEL; WEINBERGER DA, 1979, J ABNORM PSYCHOL, V88, P369, DOI 10.1037/0021-843X.88.4.369; WEINBERGER DA, 1990, REPRESSION DISSOCIAT, P337; Wijnberg-Williams BJ, 2006, J PEDIATR PSYCHOL, V31, P785, DOI 10.1093/jpepsy/jsj087; Yeh CH, 2002, J ADV NURS, V38, P598, DOI 10.1046/j.1365-2648.2000.02227.x; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541; Zeltzer LK, 2009, J CLIN ONCOL, V27, P2396, DOI 10.1200/JCO.2008.21.1433	64	5	5	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	OCT	2018	65	10							e27287	10.1002/pbc.27287			9	Oncology; Hematology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Hematology; Pediatrics	GR3NS	WOS:000442500600029	29932288	Green Accepted			2022-02-06	
J	Quinsey, C; Eaton, J; Northam, W; Gilleskie, M; Charles, A; Hadar, E				Quinsey, Carolyn; Eaton, Jessica; Northam, Weston; Gilleskie, Matt; Charles, Anthony; Hadar, Eldad			Challenges and opportunities for effective data collection in global neurosurgery: traumatic brain injury surveillance experience in Malawi	NEUROSURGICAL FOCUS			English	Article						global neurosurgery; traumatic brain injury; Malawi; real-time surveillance	SUB-SAHARAN AFRICA; INFANT HYDROCEPHALUS; INTERVENTION; OUTCOMES; QUALITY	Global health research can transform clinical and surgical practice worldwide. Partnerships between US academic centers and hospitals in low- and middle-income counties can improve clinical care at the host institution hospital and give the visiting institution access to a large volume of valuable research data. Recognizing the value of these partnerships, the University of North Carolina (UNC) formed a partnership with Kamuzu Central Hospital (KCH) in Lilongwe, Malawi. The Department of Neurosurgery joined the partnership with KCH and designed a Head Trauma Surveillance Registry. The success of this registry depended on the development of methods to accurately collect head injury data at KCH. Since medical record documentation is often unreliable in this setting, data collection teams were implemented to capture data from head trauma patients on a 24-hours-a-day, 7-days-a-week basis. As data collection improved, pilot groups tested methods to collect new variables and the registry expanded. UNC provided onsite and remote oversight to strengthen the accuracy of the data. Data accuracy still remains a hurdle in global research. Data collection teams, oversight from UNC, pilot group testing, and meaningful collaboration with local physicians improved the accuracy of the head trauma registry. Overall, these methods helped create a more accurate epidemiological and outcomes-centered analysis of brain injury patients at KCH to date.	[Quinsey, Carolyn; Northam, Weston; Hadar, Eldad] Dept Neurosurg, Chapel Hill, NC USA; [Charles, Anthony] Dept Surg, Chapel Hill, NC USA; [Gilleskie, Matt] Univ N Carolina, Chapel Hill, NC 27515 USA; [Eaton, Jessica] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA		Quinsey, C (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	carolyn_quinsey@med.unc.edu					Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Eaton J, 2018, WORLD J SURG, V42, P1248, DOI 10.1007/s00268-017-4285-z; Eaton J, 2017, WORLD NEUROSURG, V105, P257, DOI 10.1016/j.wneu.2017.05.153; Kombe F, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0071-3; Mphatswe W, 2012, B WORLD HEALTH ORGAN, V90, P176, DOI 10.2471/BLT.11.092759; Tomlinson J, 2013, TROP DOCT, V43, P27, DOI 10.1177/0049475513480773; Warf BC, 2017, NEUROSURGERY, V64, P37, DOI 10.1093/neuros/nyx246; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163	9	5	5	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	OCT	2018	45	4							E10	10.3171/2018.7.FOCUS18281			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GV6US	WOS:000446253400010	30269581	Green Submitted, gold			2022-02-06	
J	Sapkota, S; Kobau, R; Pastula, DM; Zack, MM				Sapkota, Sanjeeb; Kobau, Rosemarie; Pastula, Daniel M.; Zack, Matthew M.			Close to 1 million US adults aged 55 years or older have active epilepsy-National Health Interview Survey, 2010, 2013, and 2015	EPILEPSY & BEHAVIOR			English	Article						Active epilepsy; History of epilepsy; Older adults; Age-appropriate clinical and preventive services; Quality of life; NHIS; Population; Surveillance; Prevalence	UNITED-STATES; PREVALENCE	Epilepsy is common in older adults because known risk factors-such as traumatic brain injury, stroke, cerebrovascular disease, neurodegenerative disorders, and neoplasms-increase with age. This study uses the most recent data from the 2010, 2013, and 2015 National Health Interview Survey (NHIS) to provide updated national estimates of epilepsy prevalence among US adults aged 55 years or older to help guide public health action. We used the following validated surveillance case definition for active epilepsy: adults with self-reported doctor-diagnosed epilepsy or seizure disorder who reported either currently taking medications to treat their epilepsy or seizure disorder or at least one seizure during the past 12 months. We estimated the prevalence of active epilepsy to be 1.4% (about 529,000) among US adults aged 55-64, 0.9% (225,000) for those aged 65-74, and 1.0% (178,000) for those aged 75 years. The prevalence of a history of epilepsy and active epilepsy among adults aged 55-64 years was significantly higher than the prevalence in older age groups. Collectively, close to 1 million adults aged 55 years or older reported active epilepsy. Epilepsy stakeholders should ensure that older adults with epilepsy have access to age-appropriate clinical preventive services, chronic disease self-management support, specialty care for epilepsy and other comorbidities, and appropriate community services to promote quality of life. (C) 2018 Published by Elsevier Inc.	[Sapkota, Sanjeeb] Ctr Dis Control & Prevent CDC, G2S Corp, Epilepsy Program, Div Populat Hlth,Natl Ctr Chron Dis Prevent & Hlt, Mad Stop F-78,4770 Buford Hwy, Atlanta, GA 30341 USA; [Kobau, Rosemarie; Pastula, Daniel M.; Zack, Matthew M.] CDC, Epilepsy Program, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Mail Stop F-78,4770 Buford Hwy, Atlanta, GA 30341 USA; [Pastula, Daniel M.] Univ Colorado, Sch Med, Aurora, CO USA; [Pastula, Daniel M.] Colorado Sch Publ Hlth, Aurora, CO USA		Sapkota, S (corresponding author), Ctr Dis Control & Prevent CDC, Epilepsy Program, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Mail Stop F-78,4770 Buford Hwy, Atlanta, GA 30341 USA.	ssapkota@cdc.gov	Pastula, Daniel M./M-1325-2019	Pastula, Daniel M./0000-0001-9342-4459			Brodie MJ, 2009, LANCET NEUROL, V8, P1019, DOI 10.1016/S1474-4422(09)70240-6; Centers for Disease Control and Prevention AARP American Medical Association, 2009, PROM PREV SERV AD 50; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Hernandez-Ronquillo L, 2018, EPILEPSY RES, V140, P90, DOI 10.1016/j.eplepsyres.2017.12.016; Institute of Medicine, 2012, EPILEPSY SPECTRUM PR; Ip Q, 2018, EPILEPSY RES, V139, P107, DOI 10.1016/j.eplepsyres.2017.11.022; Kobau Rosemarie, 2012, Morbidity and Mortality Weekly Report, V61, P909; Martin RC, 2017, EPILEPSIA, V58, P548, DOI 10.1111/epi.13675; Nadimpalli V, 2012, SAS GLOB FOR 2012; National Center for Health Statistics, 2015, SURV DESCR NAT HLTH; Pugh MJV, 2005, EPILEPSIA, V46, P1820, DOI 10.1111/j.1528-1167.2005.00291.x; Waterhouse Elizabeth, 2005, Cleve Clin J Med, V72 Suppl 3, pS26; Zack MM, 2017, MMWR-MORBID MORTAL W, V66, P821, DOI 10.15585/mmwr.mm6631a1	13	5	5	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	OCT	2018	87						233	234		10.1016/j.yebeh.2018.06.030			2	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	GY7PW	WOS:000448805600034	30078516				2022-02-06	
J	Sun, ZP; Liu, SY; Kharlamov, EA; Miller, ER; Kelly, KM				Sun, Zhuopin; Liu, Shiying; Kharlamov, Elena A.; Miller, Eric R.; Kelly, Kevin M.			Hippocampal neuropeptide Y protein expression following controlled cortical impact and posttraumatic epilepsy	EPILEPSY & BEHAVIOR			English	Article						Rat; Traumatic brain injury; Controlled cortical impact; Hippocampus; Posttraumatic epilepsy; Neuropeptide Y	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; RAT HIPPOCAMPUS; SEIZURES; MICE; ANTICONVULSANT; SOMATOSTATIN; NEURONS; KAINATE; MODEL	This study assessed neuropeptide Y (NPY) expression in the hippocampus after long-term survival following traumatic brain injury (TBI) induced by controlled cortical impact (CCI) with or without the development of posttraumatic epilepsy (PTE). We hypothesized that following long-term survival after CCI, the severity of tissue injury and the development of Fit would correlate with the degree of hippocampal neurodegeneration as reflected by NPY+ and neuronal nuclear antigen (NeuN)+ cell loss. Adult Sprague-Dawley rats of 2-3 months of age were lesioned in the right parietal cortex and monitored for seizure activity by video and/or video-EEG. Neuropeptide Y and NeuN immunoreactivities (IRs) were quantified by light microscopy and semiautomatic image analysis approaches for unbiased quantification. Severely injured animals, marked by extensive tissue loss in the ipsilateral neocortex and adjacent hippocampus, resulted in significantly lower NeuN = hilar cell density and NPY + cell loss in the contralateral Cornu Ammonis (CA)-3 and dentate hilus (DH). The degree of NPY+ cell loss was more severe in CCI-injured animals with PTE than those animals that did not develop PTE. Mildly injured animals demonstrated no significant change of NPY expression compared with control animals. Our findings of long-term alterations of NPY expression in the hippocampus of severely brain-injured animals can provide important insights into the cellular and molecular consequences of severe TBI and posttraumatic epileptogenesis. (C) 2018 Elsevier Inc. All rights reserved.	[Kharlamov, Elena A.; Miller, Eric R.; Kelly, Kevin M.] Allegheny Gen Hosp, Dept Neurol, Pittsburgh, PA 15212 USA; [Kharlamov, Elena A.; Miller, Eric R.; Kelly, Kevin M.] Allegheny Gen Hosp, Allegheny Hlth Network Res Inst, Pittsburgh, PA 15212 USA; [Kharlamov, Elena A.; Kelly, Kevin M.] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA; [Kelly, Kevin M.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Sun, Zhuopin; Liu, Shiying; Miller, Eric R.] Carnegie Mellon Univ, Biomed Engn, Pittsburgh, PA 15213 USA		Kelly, KM (corresponding author), Allegheny Gen Hosp, 940 South Tower,320 E North Ave, Pittsburgh, PA 15212 USA.	kevin.kelly@ahn.org					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Colmers William F., 2003, Epilepsy Curr, V3, P53, DOI 10.1046/j.1535-7597.2003.03208.x; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eastman CL, 2011, J PHARMACOL EXP THER, V336, P779, DOI 10.1124/jpet.110.175133; Furtinger S, 2001, J NEUROSCI, V21, P5804, DOI 10.1523/JNEUROSCI.21-15-05804.2001; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Institute of Medicine, 2008, GULF WAR HLTH, V7, P1; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kharlamov EA, 2007, BRAIN RES, V1127, P151, DOI 10.1016/j.brainres.2006.09.107; Klapstein GJ, 1997, J NEUROPHYSIOL, V78, P1651, DOI 10.1152/jn.1997.78.3.1651; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Mazarati AM, 2002, NEUROSCI LETT, V331, P123, DOI 10.1016/S0304-3940(02)00847-9; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Noe F, 2010, GENE THER, V17, P643, DOI 10.1038/gt.2010.23; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Richichi C, 2004, J NEUROSCI, V24, P3051, DOI 10.1523/JNEUROSCI.4056-03.2004; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; SCHWARTZKROIN PA, 1994, HIPPOCAMPUS, V4, P239, DOI 10.1002/hipo.450040302; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Silva AP, 2005, CNS NEUROL DISORD-DR, V4, P331, DOI 10.2174/1568007054546153; Smialowska M, 2003, POL J PHARMACOL, V55, P979; Sorensen AT, 2009, EXP NEUROL, V215, P328, DOI 10.1016/j.expneurol.2008.10.015; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Sundstrom LE, 2001, BRAIN, V124, P688, DOI 10.1093/brain/124.4.688; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Takahashi Y, 2000, NEUROSCI LETT, V287, P105, DOI 10.1016/S0304-3940(00)01133-2; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xapelli S, 2007, PEPTIDES, V28, P288, DOI 10.1016/j.peptides.2006.09.031; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	43	5	5	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	OCT	2018	87						188	194		10.1016/j.yebeh.2018.08.002			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	GY7PW	WOS:000448805600028	30146352				2022-02-06	
J	van Loey, NE; Hofland, HWC; Vlig, M; Vandermeulen, E; Rose, T; Beelen, RHJ; Ulrich, MMW				van Loey, N. E.; Hofland, H. W. C.; Vlig, M.; Vandermeulen, E.; Rose, T.; Beelen, R. H. J.; Ulrich, M. M. W.			Associations between traumatic stress symptoms, pain and bio-active components in burn wounds	PSYCHONEUROENDOCRINOLOGY			English	Article						Pain; Acute traumatic stress; Oxytocin; Cytokine; Burn wounds; Skin	OXYTOCIN; BRAIN; SKIN; VASOPRESSIN; ADULTS	Objective: Pain and traumatic stress symptoms often co-occur. Evidence suggests that the neuropeptide oxytocine and pro-inflammatory cytokines are associated with both stress and pain. The aim of this pilot study was to explore relations between self-reported pain and traumatic stress, oxytocin and three cytokines in burn wounds. Methods: An observational study in three burn centres was performed. Patients were invited to participate in the study when deep dermal injury was suspected. Patients completed the Impact of Event Scale (IES), a self-report questionnaire assessing traumatic stress symptoms, and they rated their pain the day prior to surgery. During surgery, eschar (i.e., burned tissue) was collected and stored at -80 degrees C until analysis. When the data collection was complete, oxytocin and cytokine levels were analysed. Results: Eschar from 53 patients was collected. Pain and stress scores were available from 42 and 36 patients respectively. Spearman correlational analyses showed an association between lower oxytocin levels at wound site and a higher total IES score (r = -0.37) and pain (r = - 0.32). Mann-Whitney U tests comparing groups scoring high or low on pain or stress confirmed these associations. Conclusion: These analyses lend support to a hormonal pathway that may explain how psychological distress affects pain at skin level in patients with traumatic stress symptoms.	[van Loey, N. E.] Assoc Dutch Burn Ctr, Behav Res, POB 1015, Beverwijk, Netherlands; [van Loey, N. E.] Univ Utrecht, Clin Psychol, Utrecht, Netherlands; [Hofland, H. W. C.] Maasstad Hosp, Burn Ctr, Maasstadweg 21, NL-3079 DZ Rotterdam, Netherlands; [Vlig, M.; Ulrich, M. M. W.] Assoc Dutch Burn Ctr, Preclin Res, POB 1015EA, Beverwijk, Netherlands; [Vandermeulen, E.; Rose, T.] Queen Astrid Mil Hosp, Burn Ctr, Bruynstr 1, B-1120 Brussels, Belgium; [Beelen, R. H. J.] Vrije Univ Amsterdam, Med Ctr, Mol Cell Biol & Immunol, POB 7057, Amsterdam, Netherlands; [Ulrich, M. M. W.] Vrije Univ Amsterdam, Med Ctr, Plast Reconstruct & Hand Surg, Amsterdam, Netherlands		van Loey, NE (corresponding author), Assoc Dutch Burn Ctr, Behav Res, POB 1015, Beverwijk, Netherlands.	nvanloey@burns.nl; HoflandH@Maasstadziekenhuis.nl; mvlig@burns.nl; Els.vandermeulen@mil.be; Thomas.Rose@mil.be; RJH.Beelen@vumc.nl; mulrich@burns.nl	Ulrich, Magda/H-7744-2019; Van Loey, Nancy/Y-3936-2019; Vlig, Marcel/ABB-4001-2020	Ulrich, Magda/0000-0001-6369-2196; Vlig, Marcel/0000-0003-3280-5877	Dutch Burns Foundation [10.01]	The study was financially supported by the Dutch Burns Foundation, pilot study grant number 10.01.	Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Bakker A, 2013, HEALTH PSYCHOL, V32, P1076, DOI 10.1037/a0033983; Bizik G, 2012, EUR PSYCHIAT, V27; Bob P, 2010, J AFFECT DISORDERS, V120, P231, DOI 10.1016/j.jad.2009.03.017; Boll S, 2018, NEUROSCIENCE, V387, P149, DOI 10.1016/j.neuroscience.2017.09.041; Brom D., 1985, NEDERLANDS TIJDSCHRI, V40, P164; Brown EA, 2014, J PEDIATR PSYCHOL, V39, P512, DOI 10.1093/jpepsy/jsu014; Carter CS, 2014, ANNU REV PSYCHOL, V65, P17, DOI 10.1146/annurev-psych-010213-115110; de Jong AEE, 2015, BURNS, V41, P333, DOI 10.1016/j.burns.2014.07.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deing V, 2013, EXP DERMATOL, V22, P399, DOI 10.1111/exd.12155; Egberts MR, 2017, HEALTH PSYCHOL, V36, P419, DOI 10.1037/hea0000448; Finnerty CC, 2008, MOL MED, V14, P553, DOI 10.2119/2007-00132.Finnerty; Giannoni-Pastor A, 2016, J BURN CARE RES, V37, pE79, DOI 10.1097/BCR.0000000000000226; Gonzalez-Hernandez A, 2017, PAIN, V158, P2117, DOI 10.1097/j.pain.0000000000001024; Gouin JP, 2012, CRIT CARE NURS CLIN, V24, P201, DOI 10.1016/j.ccell.2012.03.006; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; Jenewein J, 2009, J PSYCHOSOM RES, V66, P119, DOI 10.1016/j.jpsychores.2008.07.011; Koch SBJ, 2014, PSYCHONEUROENDOCRINO, V40, P242, DOI 10.1016/j.psyneuen.2013.11.018; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Meguro Y, 2018, J PHARMACOL SCI, V137, P67, DOI 10.1016/j.jphs.2018.04.002; Melzack R, 2013, WIRES COGN SCI, V4, P1, DOI 10.1002/wcs.1201; Neumann ID, 2012, TRENDS NEUROSCI, V35, P649, DOI 10.1016/j.tins.2012.08.004; Olff M, 2013, PSYCHONEUROENDOCRINO, V38, P1883, DOI 10.1016/j.psyneuen.2013.06.019; Rash JA, 2014, CLIN J PAIN, V30, P453, DOI 10.1097/AJP.0b013e31829f57df; Richardson P, 2009, BURNS, V35, P921, DOI 10.1016/j.burns.2009.03.003; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Summer GJ, 2008, PAIN, V135, P98, DOI 10.1016/j.pain.2007.05.012; Summer GJ, 2007, J PAIN, V8, P533, DOI 10.1016/j.jpain.2007.02.426; Van Loey NE, 2018, EUR J PAIN, V22, P1151, DOI 10.1002/ejp.1203; van Zuiden M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029142; Vitalo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005523; Walburn J, 2009, J PSYCHOSOM RES, V67, P253, DOI 10.1016/j.jpsychores.2009.04.002; Wisely JA, 2010, BURNS, V36, P183, DOI 10.1016/j.burns.2009.08.008; Xin Q, 2017, NEUROCHEM INT, V103, P57, DOI 10.1016/j.neuint.2016.12.021; Zmijewski MA, 2011, DERM-ENDOCRINOL, V3, P3, DOI 10.4161/derm.3.1.14617	38	5	5	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530			PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	OCT	2018	96						1	5		10.1016/j.psyneuen.2018.05.037			5	Endocrinology & Metabolism; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	GV3GP	WOS:000445982700001	29864589	Green Published			2022-02-06	
J	Wang, H; Zhu, XY; Liao, ZK; Xiang, HY; Ren, ML; Xu, MH; Zhao, H				Wang, Hao; Zhu, Xiyan; Liao, Zhikang; Xiang, Hongyi; Ren, Mingliang; Xu, Minhui; Zhao, Hui			Novel-graded traumatic brain injury model in rats induced by closed head impacts	NEUROPATHOLOGY			English	Article						closed head impact; rat model; traumatic brain injury	AXONAL INJURY	Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Due to the heterogeneity of human TBI, none of the available animal models can reproduce the entire spectrum of TBI. This study was designed to develop a novel-graded TBI rat model which is induced by closed head impacts (CHI) with reproducible brain damage and neurological dysfunction. A total of 75 male Sprague-Dawley rats (200 +/- 20 g) were randomly equally divided into five groups: the Sham, 0.5, 0.6, 0.7 and 0.8 MPa groups. A custom-made, air-driven injury apparatus was used to induce CHIs (from 0.5 to 0.8 MPa). The kinematic parameters during the procedure were recorded by a force sensor and a high-speed camera. Mortality rate, duration of unconsciousness (latency period of righting reflex), modified neurological severity score (mNSS) and whole brain water content (BWC) were examined. Pathological changes were evaluated by hematoxylin-eosin (HE) stain and immunohistochemical stain for amyloid precursor protein (APP). The impact force and speed were 785.3 +/- 14.12 N and 5.71 m/s in the 0.5 MPa group, 837.72 +/- 10.41 N and 6.06 m/s in the 0.6 MPa group, 857.65 +/- 11.11 N and 6.25 m/s in the 0.7 MPa group, and 955.6 +/- 16.35 N and 6.67 m/s in the 0.8 MPa group. The periods of loss of righting reflex in 0.6-0.8 MPa groups were significantly higher than that in the Sham group. The mNSS score and BWC of the 0.8 MPa group remained higher 24 h after injury than other groups. Brain damage was indicated by increased APP expression in TBI rats. In conclusion, the newly developed CHI rat model was a highly controlled and reproducible graded TBI model, and provided a useful tool to investigate the underlying mechanism and therapeutic effects of TBI with various injury severities.	[Wang, Hao; Ren, Mingliang; Xu, Minhui] Third Mil Med Univ, Daping Hosp, Dept Neurosurg, 10 Changjiangzhi Rd, Chongqing 400042, Peoples R China; [Zhu, Xiyan; Liao, Zhikang; Xiang, Hongyi; Zhao, Hui] Third Mil Med Univ, Inst Traff Med, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Chongqing, Peoples R China		Xu, MH (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Neurosurg, 10 Changjiangzhi Rd, Chongqing 400042, Peoples R China.; Zhao, H (corresponding author), Third Mil Med Univ, Inst Traff Med, Chongqing Key Lab Vehicle Crash Bioimpact & Traff, Chongqing, Peoples R China.	xuminhui66@aliyun.com; box.zhaohui@163.com			National Key Research and Development Program [2016YFC0800702]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31470913]	This work was supported by grants from the National Key Research and Development Program (2016YFC0800702) and Natural Science Foundation of China (Grant: No. 31470913).	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mirzaei N, 2016, BRAIN INJURY, V30, P608; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	16	5	6	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	OCT	2018	38	5					484	492		10.1111/neup.12509			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GV7RP	WOS:000446328600005	30187543				2022-02-06	
J	Yamada, H; Kikuchi, R; Katayama, J; Nakamura, A; Miyazaki, H				Yamada, Hiroki; Kikuchi, Ryogo; Katayama, Jumpei; Nakamura, Akiyoshi; Miyazaki, Hiromichi			Paroxysmal Sympathetic Hyperactivity after Surgery for Cerebral Hemorrhagic Arteriovenous Malformation: A Case Report	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Arteriovenous malformation; gabapentin; paroxysmal sympathetic hyperactivity; propranolol; surgery	TRAUMATIC BRAIN-INJURY	Paroxysmal sympathetic hyperactivity is a condition involving a sudden increase in body temperature, heart rate, blood pressure, respiratory rate, sweating, and posturing followed by severe brain injury. Most of the reported preceding disorders involve head trauma, followed by anoxic brain injury, and stroke. Here, we report an extremely rare case of 17-year-old man diagnosed with hemorrhagic arteriovenous malformation, underwent emergent surgery, was on prolonged sedation due to postoperative complications, and subsequently developed paroxysmal sympathetic hyperactivity. We recommend monitoring for paroxysmal sympathetic hyperactivity occurrence with severe brain injury patients, even when sedating.	[Yamada, Hiroki; Kikuchi, Ryogo; Nakamura, Akiyoshi; Miyazaki, Hiromichi] Hiratsuka City Hosp, Dept Neurosurg, 1-19-1 Minamihara, Hiratsuka, Kanagawa 2540065, Japan; [Katayama, Jumpei] Hiratsuka City Hosp, Dept Cardiol, Hiratsuka, Kanagawa, Japan		Yamada, H (corresponding author), Hiratsuka City Hosp, Dept Neurosurg, 1-19-1 Minamihara, Hiratsuka, Kanagawa 2540065, Japan.	yhiroki08@gmail.com					Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Gao B, 2014, ANN CLIN TRANSL NEUR, V1, P215, DOI 10.1002/acn3.44; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Peng Y, 2017, ONCOTARGET, V8, P69012, DOI 10.18632/oncotarget.16920; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104	7	5	5	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2018	27	10					2768	2769		10.1016/j.jstrokecerebrovasdis.2018.06.002			2	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	GT9ON	WOS:000444872400034	30064867				2022-02-06	
J	Melinosky, C; Yang, SM; Hu, P; Li, H; Miller, CHT; Khan, I; Mackenzie, C; Chang, WT; Parikh, G; Stein, D; Badjatia, N				Melinosky, Christopher; Yang, Shiming; Hu, Peter; Li, HsiaoChi; Miller, Catriona H. T.; Khan, Imad; Mackenzie, Colin; Chang, Wan-Tsu; Parikh, Gunjan; Stein, Deborah; Badjatia, Neeraj			Continuous Vital Sign Analysis to Predict Secondary Neurological Decline After Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; machine learning; heart rate variability; photoplethysmogram; predictive model	HEART-RATE-VARIABILITY; GLASGOW COMA SCALE; COMPUTED-TOMOGRAPHY; INTRACRANIAL HYPERTENSION; AUTONOMIC CONTROL; DETERIORATION; CT; RELIABILITY; MORTALITY; TALK	Background: In the acute resuscitation period after traumatic brain injury (TBI), one of the goals is to identify those at risk for secondary neurological decline (ND), represented by a constellation of clinical signs that can be identified as objective events related to secondary brain injury and independently impact outcome. We investigated whether continuous vital sign variability and waveform analysis of the electrocardiogram (ECG) or photoplethysmogram (PPG) within the first hour of resuscitation may enhance the ability to predict ND in the initial 48 hours after traumatic brain injury (TBI). Methods: Retrospective analysis of ND in TBI patients enrolled in the prospective Oximetry and Noninvasive Predictors Of Intervention Need after Trauma (ONPOINT) study. ND was defined as any of the following occurring in the first 48 h: new asymmetric pupillary dilatation (>2mm), 2 point GCS decline, interval worsening of CT scan as assessed by the Marshall score, or intervention for cerebral edema. Beat-to-beat variation of ECG or PPG, as well as waveform features during the first 15 and 60min after arrival in the TRU were analyzed to determine physiologic parameters associated with future ND. Physiologic and admission clinical variables were combined in multivariable logistic regression models predicting ND and inpatient mortality. Results: There were 33 (17%) patients with ND among 191 patients (mean age 43 years old, GCS 13, ISS 12, 69% men) who met study criteria. ND was associated with ICU admission (P < 0.001) and inpatient mortality (P < 0.001). Both ECG (AUROC: 0.84, 95% CI: 0.76,0.93) and PPG (AUROC: 0.87, 95% CI: 0.80, 0.93) analyses during the first 15min of resuscitation demonstrated a greater ability to predict ND then clinical characteristics alone (AUROC: 0.69, 95% CI: 0.59, 0.8). Age (P = 0.02), Marshall score (P = 0.001), penetrating injury (P = 0.02), and predictive probability for ND by PPG analysis at 15min (P = 0.03) were independently associated with inpatient mortality. Conclusions: Analysis of variability and ECG or PPG waveform in the first minutes of resuscitation may represent a non-invasive early marker of future ND.	[Melinosky, Christopher; Yang, Shiming; Hu, Peter; Khan, Imad; Mackenzie, Colin; Chang, Wan-Tsu; Parikh, Gunjan; Stein, Deborah; Badjatia, Neeraj] Univ Maryland, Sch Med, Program Trauma, Baltimore, MD 21201 USA; [Melinosky, Christopher; Khan, Imad; Parikh, Gunjan; Badjatia, Neeraj] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Yang, Shiming; Hu, Peter; Li, HsiaoChi; Mackenzie, Colin] Univ Maryland, Dept Anesthesiol, Sch Med, Baltimore, MD 21201 USA; [Miller, Catriona H. T.] US Air Force Sch Aerosp Med, Dept Aeromed Res, Enroute Care Div, Wright Patterson AFB, OH USA; [Chang, Wan-Tsu] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [Stein, Deborah] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA		Badjatia, N (corresponding author), Univ Maryland, Sch Med, Program Trauma, Baltimore, MD 21201 USA.; Badjatia, N (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.	nbadjatia@som.umaryland.edu	Parikh, Gunjan/AAS-1375-2020; Yang, Shiming/I-3695-2015; Badjatia, Neeraj/AAS-4855-2021; Khan, Ilyas/C-8770-2019	Parikh, Gunjan/0000-0002-8447-1349; Yang, Shiming/0000-0003-0338-4268; Khan, Ilyas/0000-0002-2056-9371; Badjatia, Neeraj/0000-0003-1509-9034; Stein, Deborah/0000-0003-3683-3963	US Air ForceUnited States Department of Defense [FA8650-11-2-6D01]	This data used for analysis in this manuscript was obtained by data collection funded by US Air Force (FA8650-11-2-6D01) (ONPOINT I).	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Camm AJ, 1996, EUR HEART J, V17, P354; CDC, TBI AND CONC; Choudhry OJ, 2013, NEUROSURGERY, V73, P753, DOI 10.1227/NEU.0000000000000105; Elgendi M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-139; Ernst G., 2014, HEART RATE VARIABILI; Eroglu SE, 2013, EMERG MED INT, V2013, DOI 10.1155/2013/916253; Galvagno SM, 2015, J CLIN MONIT COMPUT, V29, P815, DOI 10.1007/s10877-015-9671-1; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Guzik P, 2006, BIOMED TECH, V51, P272, DOI 10.1515/BMT.2006.054; Johnson K., 2013, APPL PREDICTIVE MODE; Kahraman S, 2010, J NEUROSURG ANESTH, V22, P296, DOI 10.1097/ANA.0b013e3181e25fc3; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kibayashi K, 2000, Leg Med (Tokyo), V2, P175, DOI 10.1016/S1344-6223(00)80021-8; Kiselev AR, 2016, PHYSIOL MEAS, V37, P580, DOI 10.1088/0967-3334/37/4/580; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lu Sheng, 2008, J Clin Monit Comput, V22, P23, DOI 10.1007/s10877-007-9103-y; Mackenzie CF, 2014, J TRAUMA ACUTE CARE, V76, P1379, DOI 10.1097/TA.0000000000000235; Majidi S, 2013, AM J EMERG MED, V31, P1215, DOI 10.1016/j.ajem.2013.05.026; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Mowery NT, 2008, J TRAUMA, V65, P621, DOI 10.1097/TA.0b013e3181837980; Muakkassa FF, 2012, J AM COLL SURGEONS, V214, P965, DOI 10.1016/j.jamcollsurg.2012.02.004; Pinheiro N, 2016, IEEE ENG MED BIO, P2945, DOI 10.1109/EMBC.2016.7591347; RAMADAN A, 1986, NEUROCHIRURGIE, V32, P423; REILLY PL, 1975, LANCET, V2, P375; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Reith FCM, 2017, NEUROSURGERY, V80, P829, DOI 10.1093/neuros/nyw178; Sassi R, 2015, EUROPACE, V17, P1341, DOI 10.1093/europace/euv015; Shackelford S, 2015, J TRAUMA ACUTE CARE, V79, P105, DOI 10.1097/TA.0000000000000685; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sing RF, 2006, J TRAUMA, V60, P499; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010; Yousef Q, 2012, MEAS SCI REV, V12, P266, DOI 10.2478/v10048-012-0036-3	45	5	5	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 25	2018	9								761	10.3389/fneur.2018.00761			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU8WL	WOS:000445623800001	30319521	Green Published, gold			2022-02-06	
J	Spinelli, DJ; Plaisted, TA; Wetzel, ED				Spinelli, Devon J.; Plaisted, Thomas A.; Wetzel, Eric D.			Adaptive head impact protection via a rate-activated helmet suspension	MATERIALS & DESIGN			English	Article						Impact; Brain injury; Helmet; Head injury criterion; Shear thickening fluid; Rate-activated tether	SHEAR THICKENING FLUID; CHRONIC TRAUMATIC ENCEPHALOPATHY; COLLEGIATE FOOTBALL PLAYERS; BRAIN-INJURY; BALLISTIC PERFORMANCE; COLLOIDAL SUSPENSIONS; PROFESSIONAL FOOTBALL; AMERICAN FOOTBALL; CONCUSSION; FABRICS	The design of an adaptive helmet suspension system that provides optimized head protection under variable impact conditions is reported. The adaptive response is achieved through the use of rate activated tethers (RATs), a flexible strap-like material that uses shear thickening fluids to generate speed-sensitive extensional resistance. The RATs are integrated into a helmet by replacing the webbing system of a traditional construction hardhat with a network of RATs, and performing impact attenuation testing over a range of velocities. Impacts to the crown region of the helmet demonstrate a 50% reduction in peak acceleration experienced by the headform for impact velocities between 1.5 and 3.5 m/s compared to the conventional webbing system, and comparable response to the conventional systemat 4.5 m/s. Complementary RAT extensional testing and low velocity helmet compression tests confirm that the rate-sensitive response of the RATs contributes significantly to improved system performance. Additionally, calculations for suspension model systems show that the steady yield force exhibited by RATs over long strokes is a critical feature for minimizing head acceleration, and that the RAT suspension systems are achieving responses remarkably close to the ideal suspension response. (C) 2018 Elsevier Ltd. All rights reserved.	[Spinelli, Devon J.; Plaisted, Thomas A.; Wetzel, Eric D.] US Army Res Lab, Mat & Mfg Sci Div, Aberdeen Proving Ground, MD 21005 USA; [Spinelli, Devon J.] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA		Wetzel, ED (corresponding author), US Army Res Lab, Mat & Mfg Sci Div, Aberdeen Proving Ground, MD 21005 USA.	eric.d.wetzel2.civ@mail.mil					Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abueidda DW, 2017, MATER DESIGN, V122, P255, DOI 10.1016/j.matdes.2017.03.018; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Association I. S. E, 2014, Z8912014 ANSIISEA; ASTM_ International, 2013, F144613 ASTN INT; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Ballantyne EL, 2017, SPORTS ENG, V20, P171, DOI 10.1007/s12283-017-0226-1; Baumeister J, 1997, MATER DESIGN, V18, P217, DOI 10.1016/S0261-3069(97)00050-2; Begley MR, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4024992; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Bi DP, 2011, NATURE, V480, P355, DOI 10.1038/nature10667; Bird ET, 2018, MATER DESIGN, V137, P414, DOI 10.1016/j.matdes.2017.10.054; Brown E, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/4/046602; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cwalina CD, 2016, COMPOS SCI TECHNOL, V131, P61, DOI 10.1016/j.compscitech.2016.06.001; Dawson MA, 2009, J APPL MECH-T ASME, V76, DOI 10.1115/1.3130825; Decker MJ, 2007, COMPOS SCI TECHNOL, V67, P565, DOI 10.1016/j.compscitech.2006.08.007; Duoss EB, 2014, ADV FUNCT MATER, V24, P4905, DOI 10.1002/adfm.201400451; Egres RG, 2005, J RHEOL, V49, P719, DOI 10.1122/1.1895800; Fowler JN, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029982; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gimbel G, 2008, INT J SPORT SCI ENG, V2, P154; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; KrzeminskI DE., 2011, SPORTS TECHNOL, V4, P65; Larsen RJ, 2014, RHEOL ACTA, V53, P333, DOI 10.1007/s00397-014-0764-4; Lee YS, 2003, RHEOL ACTA, V42, P199, DOI 10.1007/s00397-002-0290-7; Lee YS, 2003, J MATER SCI, V38, P2825, DOI 10.1023/A:1024424200221; Maranzano BJ, 2001, J RHEOL, V45, P1205, DOI 10.1122/1.1392295; McEntire B.J., 2005, BLUNT IMPACT PERFORM; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mohsenizadeh M, 2018, MATER DESIGN, V139, P521, DOI 10.1016/j.matdes.2017.11.037; Nazarian O, 2015, INT J CRASHWORTHINES, V20, P483, DOI 10.1080/13588265.2015.1038866; Nenno PT, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/12/125019; NOCSAE D, 2017, DND00217M17A NOCSAE; Park JL, 2012, TEXT RES J, V82, P542, DOI 10.1177/0040517511420765; Park JL, 2012, TEXT RES J, V82, P527, DOI 10.1177/0040517511420753; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Ramirez BJ, 2018, MATER DESIGN, V137, P298, DOI 10.1016/j.matdes.2017.10.037; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; SAE, 2007, SJ2111 SAE; Schaedler TA, 2014, ADV ENG MATER, V16, P276, DOI 10.1002/adem.201300206; Smith MI, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1119; Sone JY, 2017, J NEUROSURG, V126, P768, DOI 10.3171/2016.2.JNS151972; Soutrenon M, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/3/035022; Stankovic T, 2015, J MECH DESIGN, V137, DOI 10.1115/1.4030995; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; TRANSPORTATION U. S. D. O, 2011, LAB TEST PROC FMVSS, P33; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Waitukaitis SR, 2012, NATURE, V487, P205, DOI 10.1038/nature11187; Zhang XZ, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/3/035027; Zhou H, 2016, J INTEL MAT SYST STR, V27, P208, DOI 10.1177/1045389X14563869	60	5	5	1	23	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	SEP 15	2018	154						153	169		10.1016/j.matdes.2018.04.083			17	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	GK7ZR	WOS:000436434900015					2022-02-06	
J	Wang, Q; Zhang, PZ; Li, PD; Song, XF; Hu, HJ; Li, X; Chen, WF; Wang, XY				Wang, Qing; Zhang, Peizhen; Li, Pengdong; Song, Xiangfen; Hu, Huijing; Li, Xuan; Chen, Wufan; Wang, Xiaoyun			Ultrasonography Monitoring of Trauma-Induced Heterotopic Ossification: Guidance for Rehabilitation Procedures	FRONTIERS IN NEUROLOGY			English	Article						heterotopic ossification; ultrasonography; trauma; rehabilitation; diagnosis	SPINAL-CORD-INJURY; BRAIN-INJURY; BEDSIDE ULTRASOUND; EARLY-DIAGNOSIS; CLASSIFICATION; NERVE; BONE	Traumatic injury is one of varying causes of heterotopic ossification (HO). After HO occurrence, rehabilitation training need alterations to avoid the aggravation of HO. Therefore, monitoring of HO development plays an important role in the rehabilitation procedure. The aims of this study are to evaluate the post-traumatic HO occurring at various joints, to describe the features of HO development in ultrasound images, and to provide a guidance for the orthopedist to make individualized rehabilitation therapy. Eight subjects with the post-traumatic HO were recruited in this study. The joints on the injured side was examined by plain radiography. The joints on the injured side and the corresponding sites on the uninjured sides were scanned by ultrsonography. The HO tissues were segmented automatically using a semi-supervised segmentation algorithm. Then the HO tissues were evaluated in comparison with the corresponding region of the uninjured side. During the development stage of immature HO, ultrasonography was sensitive to observe the involved soft tissue and the calcification of HO. The characteristics of HO tissues in ultrasound image included the hyperechoic mass occasionally accompanied with acoustic shadow and the irregular muscular architecture. It was found that the mean grayscale value of HO was significantly higher (p < 0.001) than that of the uninjured side at the middle and late stages. During the development period of HO, the HO grayscale value gradually increased and the mean grayscale of value of mature HO was significantly higher (o < 0.05) than that of immature HO. According to the information of HO provided by ultrasound, the orthopedist properly adjusted the rehabilitation treatment. The results demonstrated that the visualization of HO using ultrasonography revealed the development of HO in the muscle tissues around the injured joints and thus provide a guidance for the orthopedist to make individualized rehabilitation therapy. Ultrasound could be a useful imaging modality for quantitative evaluation of HO during the rehabilitation of traumatic injury.	[Wang, Qing; Zhang, Peizhen; Song, Xiangfen; Chen, Wufan] Southern Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Wang, Qing; Song, Xiangfen; Chen, Wufan] Southern Med Univ, Guangdong Prov Key Lab Med Image Proc, Guangzhou, Guangdong, Peoples R China; [Li, Pengdong; Hu, Huijing; Wang, Xiaoyun] Guangdong Work Injury Rehabil Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Xuan] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China		Wang, Q; Chen, WF (corresponding author), Southern Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.; Wang, Q; Chen, WF (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Med Image Proc, Guangzhou, Guangdong, Peoples R China.; Wang, XY (corresponding author), Guangdong Work Injury Rehabil Ctr, Guangzhou, Guangdong, Peoples R China.	wq8740@smu.edu.cn; chenwf@smu.edu.cn; xiaoyunwang77@hotmail.com			Project of Science and Technology Department of Guangdong province [2016A020216017, 2013B021800039]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371560]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [2014A030313329, 2015A0303 10527]	This work was supported in part by the Project of Science and Technology Department of Guangdong province (No. 2016A020216017 and No. 2013B021800039), the National Natural Science Foundation of China (No. 81371560), and Natural Science Foundation of Guangdong Province, China (No. 2014A030313329, No. 2015A0303 10527).	Al Mukaddam M, 2018, BONE, V109, P147, DOI 10.1016/j.bone.2017.08.011; Arduini M, 2015, BONE JOINT J, V97B, P899, DOI 10.1302/0301-620X.97B7.35031; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Chang KV, 2018, EXP GERONTOL, V108, P54, DOI 10.1016/j.exger.2018.03.019; Chang KV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113803; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Citak M, 2016, SPINAL CORD, V54, P368, DOI 10.1038/sc.2015.211; Ciurte A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100972; DELMAS PD, 1993, J BONE MINER RES, V8, pS549; Ekiz T, 2014, SINGAP MED J, V55, P604, DOI 10.11622/smedj.2014161; Falsetti P, 2011, CLIN NEUROL NEUROSUR, V113, P22, DOI 10.1016/j.clineuro.2010.08.012; Gugala Z, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00408; HASTINGS H, 1994, HAND CLIN, V10, P417; Jiang L, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5387948; Kara M, 2015, PAIN MED, V16, P1643, DOI 10.1111/pme.12749; Kara M, 2015, J BACK MUSCULOSKELET, V28, P415, DOI 10.3233/BMR-140519; Ledermann HP, 2002, RADIOLOGY, V222, P189, DOI 10.1148/radiol.2221010552; Mota JA, 2018, AGING CLIN EXP RES, V30, P861, DOI 10.1007/s40520-017-0829-1; Onat SS, 2017, MED ULTRASON, V19, P339, DOI 10.11152/mu-1121; Ozcakar L, 2015, AM J PHYS MED REHAB, V94, pE45, DOI 10.1097/PHM.0000000000000223; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Rajapakse CS, 2017, ACAD RADIOL, V24, P321, DOI 10.1016/j.acra.2016.10.010; Ranganathan K, 2018, BONE, V109, P49, DOI 10.1016/j.bone.2018.01.034; Rosteius T, 2017, SPINAL CORD, V55, P71, DOI 10.1038/sc.2016.93; Salisbury E, 2010, CRIT REV EUKAR GENE, V20, P313, DOI 10.1615/CritRevEukarGeneExpr.v20.i4.30; Stefanidis K, 2017, J HEAD TRAUMA REHAB, V32, pE54, DOI 10.1097/HTR.0000000000000293; Sun E, 2018, HETEROTOPIC OSSIFICA; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	29	5	5	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 13	2018	9								771	10.3389/fneur.2018.00771			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GT4HJ	WOS:000444464500001	30271377	Green Published, gold			2022-02-06	
J	Tauchi, M; de Rink, MMT; Fujioka, H; Okayama, S; Nakamura, K; Dietel, B; Achenbach, S; Kollmar, R; Schwab, S; Ushijima, K; Harada, H				Tauchi, Miyuki; de Rink, Maria Mercedes Tejada; Fujioka, Hiroshi; Okayama, Satoko; Nakamura, Kei-ichiro; Dietel, Barbara; Achenbach, Stephan; Kollmar, Rainer; Schwab, Stefan; Ushijima, Kazuo; Harada, Hideki			Targeted Temperature Management: Peltier's Element-Based Focal Brain Cooling Protects Penumbra Neurons from Progressive Damage in Experimental Cerebral Ischemia	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article						focal brain cooling; penumbra; targeted temperature management; rat; transient middle cerebral artery occlusion; permanent middle cerebral artery occlusion	POSTTRAUMATIC HYPOTHERMIA; INTRACEREBRAL HEMORRHAGE; 48 H; NEUROPROTECTION; MECHANISMS; SEIZURES; INJURY; CORTEX; MODEL	Targeted temperature management (TTM), or therapeutic hypothermia, is one of the most potent neuroprotective approaches after ischemic and traumatic brain injuries. TTM has been applied clinically with various methods, but effective achievement and maintenance of the target temperature remain challenging. Furthermore, timing of cooling and target body and brain temperature to optimize effectiveness for neuroprotection and to minimize side effects are yet to be standardized. Focal brain cooling is a potential strategy to minimize adverse effects of systemic TTM. In this study, we report on a focal brain cooling device for animals and its effectiveness of focal cooling in several animal models of ischemic cerebral stroke. A focal brain cooling device was constructed using a Peltier's element, a thermoelectric heat pump. The device was validated for its cooling ability, and optimal settings to induce an effective intracranial temperature were determined using male Sprague-Dawley rats. Transient and permanent middle cerebral artery occlusions were experimentally induced, and focal brain cooling was applied using the device varying the timing and duration of cooling. The stroke-induced infarct and edema volumes were evaluated from Nissl-stained cryosections. The focal brain cooling device was able to decrease and subsequently maintained cerebral hypothermia in free-moving rats without altering the core temperature. The device with validated intracranial temperatures produced neuroprotective effects in the acute phase of ischemic neural death, reperfusion injury, progressing damage to the penumbra, and edema formation. In conclusion, our validated focal cooling device enabled rapid and accurate cerebral TTM in rats. Using this device, we were able to test the neuroprotective effect of focal TTM in several pathological stages of cerebral ischemia, which warrants further studies to develop clinically feasible TTM procedures for patients with cerebral stroke.	[Tauchi, Miyuki; Kollmar, Rainer; Schwab, Stefan] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Neurol, Erlangen, Germany; Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Mol Neurol, Erlangen, Germany; [Tauchi, Miyuki; Dietel, Barbara; Achenbach, Stephan] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Med Cardiol & Angiol 2, Erlangen, Germany; [de Rink, Maria Mercedes Tejada; Ushijima, Kazuo; Harada, Hideki] Kurume Univ, Sch Med, Dept Anesthesiol, Kurume, Fukuoka, Japan; [de Rink, Maria Mercedes Tejada; Harada, Hideki] Kurume Univ, Sch Med, Cognit & Mol Inst Brain Dis, Neuroanesthesia Res Lab, Kurume, Fukuoka, Japan; [Fujioka, Hiroshi] Natl Hosp Org, Kanmon Med Ctr, Dept Neurosurg, Yamaguchi, Japan; [Okayama, Satoko; Nakamura, Kei-ichiro] Kurume Univ, Sch Med, Dept Anat, Div Microscop & Dev Anat, Kurume, Fukuoka, Japan; [Kollmar, Rainer] Darmstadt Acad Hosp, Dept Neurol, Darmstadt, Germany		Tauchi, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Med Cardiol & Angiol 2, Translat Res Ctr, Schwabachanlage 12, D-91054 Erlangen, Germany.	miyuki.tauchi@uk-erlangen.de		Fujioka, Hiroshi/0000-0002-2043-299X	ELAN foundation of University Hospital Erlangen; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [23659751]	We thank Ms. Regina Altendorf (Department of Medicine 2, Universitatsklinikum Erlangen) for her technical expertise and Mr. Henry Smith for editing services. This study was financially supported by ELAN foundation of University Hospital Erlangen and a Grant-in-Aid for Challenging Exploratory Research (23659751), Japan Society for the Promotion of Science.	Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Clark DL, 2008, EXP NEUROL, V212, P386, DOI 10.1016/j.expneurol.2008.04.016; Clark DL, 2009, EXP NEUROL, V220, P391, DOI 10.1016/j.expneurol.2009.10.002; Clark DL, 2007, J CEREBR BLOOD F MET, V27, P115, DOI 10.1038/sj.jcbfm.9600327; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Ding SH, 2009, GLIA, V57, P767, DOI 10.1002/glia.20804; Dinis D, 2017, 2017 IEEE 5 PORT M B; Fingas M, 2007, EXP NEUROL, V208, P277, DOI 10.1016/j.expneurol.2007.08.018; Fujii M, 2012, EPILEPSIA, V53, P485, DOI 10.1111/j.1528-1167.2011.03388.x; Fujioka H, 2010, NEUROL RES, V32, P666, DOI 10.1179/174313209X459138; Fujioka H, 2010, NEUROSCI RES, V66, P402, DOI 10.1016/j.neures.2009.12.014; GROME JJ, 1988, J CEREBR BLOOD F MET, V8, P89, DOI 10.1038/jcbfm.1988.11; Harada H, 2005, BRAIN RES PROTOC, V14, P165, DOI 10.1016/j.brainresprot.2004.12.007; Harris B, 2012, BRAIN INJURY, V26, P372, DOI 10.3310/hta16450; Hata K, 2017, P ANN INT IEEE EMBS, P283, DOI 10.1109/EMBC.2017.8036817; He Y, 2013, BRAIN RES, V1497, P53, DOI 10.1016/j.brainres.2012.11.041; Inoue T, 2017, NEUROSCI RES, V122, P35, DOI 10.1016/j.neures.2017.04.007; John RF, 2016, BRAIN RES, V1633, P27, DOI 10.1016/j.brainres.2015.12.033; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1108, DOI 10.1038/sj.jcbfm.9600410; Koizumi, 1986, JPN J STROKE, V8, P8, DOI [10.3995/jstroke.8.1, DOI 10.3995/jstroke.8.1]; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Kuroiwa T, 2009, STROKE, V40, P248, DOI 10.1161/STROKEAHA.108.527853; Labat-gest V, 2013, JOVE-J VIS EXP, DOI 10.3791/50370; Lu XCM, 2016, THER HYPOTHERMIA TEM, V6, P30, DOI 10.1089/ther.2015.0017; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Nomura S, 2014, EPILEPSIA, V55, P770, DOI 10.1111/epi.12600; Perman SM, 2014, CHEST, V145, P386, DOI 10.1378/chest.12-3025; Ren XY, 2014, NEUROL SCI, V35, P1401, DOI 10.1007/s10072-014-1726-4; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schmidt Antje, 2012, Exp Transl Stroke Med, V4, P13, DOI 10.1186/2040-7378-4-13; Silasi G, 2011, THER HYPOTHERMIA TEM, V1, P87, DOI 10.1089/ther.2011.0005; Steinberg GK, 2004, NEUROSURGERY, V55, P307, DOI 10.1227/01.NEU.0000129683.99430.8C; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Vieites-Prado A, 2016, STROKE, V47, P2386, DOI 10.1161/STROKEAHA.116.014067; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174	37	5	5	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	DEC 1	2018	8	4					225	233		10.1089/ther.2017.0055		SEP 2018	9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD5YK	WOS:000444106600001	30199348				2022-02-06	
J	Suto, Y; Nagata, K; Ahmed, SM; Jacovides, CL; Browne, KD; Cognetti, J; Johnson, VE; Leone, R; Kaplan, LJ; Smith, DH; Pascual, JL				Suto, Yujin; Nagata, Katsuhiro; Ahmed, Syed M.; Jacovides, Christina L.; Browne, Kevin D.; Cognetti, John; Johnson, Victoria E.; Leone, Ryan; Kaplan, Lewis J.; Smith, Douglas H.; Pascual, Jose L.			Cerebral Edema and Neurological Recovery after Traumatic Brain Injury Are Worsened if Accompanied by a Concomitant Long Bone Fracture	JOURNAL OF NEUROTRAUMA			English	Article						ENX; intravital microscopy; multiple trauma; TBI; tibial FX	HYPERTONIC SALINE; ENOXAPARIN; INFLAMMATION; HEPARIN; MOUSE; MODEL; NEUROINFLAMMATION; NEUTROPHILS; ACTIVATION; ADHESION	Progression of severe traumatic brain injury (TBI) is associated with worsening cerebral inflammation, but it is unknown how a concomitant bone fracture (FX) affects this progression. Enoxaparin (ENX), a low molecular weight heparin often used for venous thromboembolic prophylaxis, decreases penumbral leukocyte (LEU) mobilization in isolated TBI and improves neurological recovery. We investigated if TBI accompanied by an FX worsens LEU-mediated cerebral inflammation and if ENX alters this process. CD1 male mice underwent controlled cortical impact (CCI) or sham craniotomy with or without an open tibial FX, and received either ENX (1mg/kg, three times/day) or saline for 2 days following injury. Randomization defined four groups (Sham, CCI, CCI+FX, CCI+FX+ENX, n=10/group). Two days after CCI, neurological recovery was assessed with the Garcia Neurological Test (GNT); intravital microscopy (LEU rolling and adhesion, microvascular leakage) and blood hemoglobin levels were also evaluated. Penumbral cerebral neutrophil sequestration (Ly-6G immunohistochemistry [IHC]) were evaluated post-mortem. In vivo LEU rolling was greater in CCI+FX (45.2 +/- 4.8 LEUs/100m/min) than in CCI alone (26.5 +/- 3.1, p=0.007), and was suppressed by ENX (23.2 +/- 5.5, p=0.003 vs. CCI + FX). Neurovascular permeability was higher in CCI+FX (71.1 +/- 2.9%) than CCI alone (42.5 +/- 2.3, p<0.001). GNT scores were lower in CCI+FX (15.2 +/- 0.2) than in CCI alone (16.3 +/- 0.3, p<0.001). Hemoglobin was lowest in the CCI+FX+ENX group, lower than in Sham or CCI. IHC demonstrated greatest polymorphonuclear neutrophil (PMN) invasion in CCI+FX in uninjured cerebral territories. A concomitant long bone FX worsens TBI-induced cerebral LEU mobilization, microvascular leakage, and cerebral edema, and impairs neurological recovery at 48h. ENX suppresses this progression but may increase bleeding.	[Suto, Yujin; Ahmed, Syed M.; Jacovides, Christina L.; Leone, Ryan; Kaplan, Lewis J.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Div Traumatol Surg Clin Care & Emergency Surg, Philadelphia, PA 19104 USA; [Suto, Yujin; Ahmed, Syed M.; Jacovides, Christina L.; Browne, Kevin D.; Cognetti, John; Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Nagata, Katsuhiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Emergency & Crit Care Med, Tokyo, Japan		Pascual, JL (corresponding author), Univ Penn, Perelman Sch Med, Div Traumatol Surg Clin Care & Emergency Surg, 51 N 39th St,Med Off Bldg,1st Floor,Suite 120, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Leone, Ryan/ABC-1848-2020	Leone, Ryan/0000-0003-0549-9990; Ahmed, Syed Moiz/0000-0003-3922-5525	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398, R01 NS094003] Funding Source: Medline		Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Degos V, 2013, ANESTHESIOLOGY, V118, P1362, DOI 10.1097/ALN.0b013e31828c23f8; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Glassner S, 2013, RAMBAM MAIMONIDES ME, V4, DOI 10.5041/RMMJ.10101; Kubes P, 2000, BRAIN PATHOL, V10, P127; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P179, DOI 10.1007/978-3-7091-0693-8_30; Manduteanu I, 2003, EUR J PHARMACOL, V477, P269, DOI 10.1016/j.ejphar.2003.08.016; Manduteanu I, 2002, PHARMACOLOGY, V65, P32, DOI 10.1159/000056183; Marks JA, 2012, J TRAUMA ACUTE CARE, V73, P351, DOI 10.1097/TA.0b013e3182592f76; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pisetsky DS, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13256; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Rao SV, 2010, CIRCULATION, V121, P1713, DOI 10.1161/CIRCULATIONAHA.109.913277; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Sen O, 2011, TURK NEUROSURG, V21, P203, DOI 10.5137/1019-5149.JTN.3646-10.1; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Weber JR, 1997, J CEREBR BLOOD F MET, V17, P1221, DOI 10.1097/00004647-199711000-00011; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Yukata K, 2014, BONE, V62, P79, DOI 10.1016/j.bone.2014.02.002; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	47	5	5	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					609	618		10.1089/neu.2018.5812		SEP 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000444054100001	30084745	Green Published			2022-02-06	
J	Alves, AC; Hamamoto, PT; Goncalves, MP; Neto, AAP; Zanini, MA				Alves Junior, Aderaldo Costa; Hamamoto Filho, Pedro Tadao; Goncalves, Marcelo Pacheco; Palhares Neto, Aristides Augusto; Zanini, Marco Antonio			Cranioplasty: An Institutional Experience	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Neurosurgery; skull; traumatic brain injury	RECONSTRUCTION; COMPLICATIONS; BIOMATERIALS; INFECTIONS	Cranioplasty is a common procedure in neurosurgical practice, but associated with high complication rates. In the current study, the authors describe surgical characteristics and results of cranioplasty performed in a tertiary teaching hospital in Brazil. Data were obtained from electronic medical records of cranioplasties performed between January 2013 and November 2016. The sample comprised of 33 patients, and the mean follow-up time was 16 months. Patients presented most of the times a good preoperative status, with 84.8% of patients classified between 0 and 3 at modified Rankin scale and 78.7% with 4 or 5 points at Glasgow Outcome Scale. The most common initial diagnosis was vascular disease (48% of patients) followed by traumatic brain injury (36% of patients). The majority of cranioplasties used an autograft: the autologous bone flap removed during a previous surgery (craniectomy) and stored in the abdominal subcutaneous fat (67% of patients). In 3 patients, the polymethylmethacrylate prosthesis was custom-made prior to the operation using 3-dimensional printing, based on computed tomography images. Five patients (15% of patients) developed symptoms related to surgical site infection, manifesting at an average of 5 weeks following the procedure. Three of them presented scalp dehiscence before the infection symptoms. Cranioplasty should be performed early, as long as clinical conditions are good and the patient has overcome the acute phase of neurological injury.	[Alves Junior, Aderaldo Costa; Goncalves, Marcelo Pacheco; Zanini, Marco Antonio] Univ Estadual Paulista, Fac Med Botucatu, Botucatu, SP, Brazil; [Hamamoto Filho, Pedro Tadao] Hosp Clin, Fac Med Botucatu, Botucatu, SP, Brazil; [Palhares Neto, Aristides Augusto] UNESP, FMB, Dept Cirurgia & Ortopedia, Botucatu, SP, Brazil; [Zanini, Marco Antonio] UNESP, FMB, Dept Neurol Psicol & Psiquiatria, Botucatu, SP, Brazil		Alves, AC (corresponding author), Dept Neurol Psicol & Psiquiatria, Dist Rubido Jr S-N, BR-18618970 Botucatu, SP, Brazil.	aderaldoneuro@gmail.com	Zanini, Marco Antonio/L-9691-2019; Filho, Pedro Tadao Hamamoto/D-2800-2012; Junior, Aderaldo Alves/Q-1682-2019; Zanini, Marco Antonio/M-4898-2019; Neto, Augusto Jose Venancio/O-3065-2015	Zanini, Marco Antonio/0000-0002-5712-9783; Filho, Pedro Tadao Hamamoto/0000-0001-6436-9307; Junior, Aderaldo Alves/0000-0001-5784-8625; Neto, Augusto Jose Venancio/0000-0002-9936-3770			Alves AC, 2016, BRAZ NEUROSURG, V35, P291, DOI 10.1055/s-0036-1592411; Andrabi Syed M, 2017, Surg Neurol Int, V8, P91, DOI 10.4103/sni.sni_45_17; Arnaud E, 2000, CHILD NERV SYST, V16, P659, DOI 10.1007/s003810000321; Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9; Godil SS, 2011, J CRANIOFAC SURG, V22, P1307, DOI 10.1097/SCS.0b013e31821c6d37; Kimchi G, 2016, J CLIN NEUROSCI, V34, P182, DOI 10.1016/j.jocn.2016.06.007; Li A, 2017, WORLD NEUROSURG, V102, P209, DOI 10.1016/j.wneu.2017.03.022; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Oh JS, 2016, J KOREAN NEUROSURG S, V59, P492, DOI 10.3340/jkns.2016.59.5.492; Quah BL, 2016, WORLD NEUROSURG, V94, P13, DOI 10.1016/j.wneu.2016.06.081; Rotaru H, 2012, J ORAL MAXIL SURG, V70, pE169, DOI 10.1016/j.joms.2011.09.036; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; SILVA RAFAEL DENADAI PIGOZZI DA, 2017, Rev. Col. Bras. Cir., V44, P154, DOI 10.1590/0100-69912017002008; Worm P, 2016, SURG NEUROL INT, V7, P746, DOI DOI 10.4103/2152-7806.193725; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025	16	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2018	29	6					1402	1405		10.1097/SCS.0000000000004512			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GW0TW	WOS:000446583200051	29554074				2022-02-06	
J	Chanda, A; Graeter, R				Chanda, Arnab; Graeter, Rebecca			Human Skin-Like Composite Materials for Blast Induced Injury Mitigation	JOURNAL OF COMPOSITES SCIENCE			English	Article						blast; composite; skin; traumatic brain injury (TBI); finite element		Armors and military grade personal protection equipment (PPE) materials to date are bulky and are not designed to effectively mitigate blast impacts. In the current work, a human skin-like castable simulant material was developed and its blast mitigation characteristics (in terms of induced stress reduction at the bone and muscles) were characterized in the presence of composite reinforcements. The reinforcement employed was Kevlar 129 (commonly used in advanced combat helmets), which was embedded within the novel skin simulant material as the matrix and used to cover a representative extremity based human skin, muscle and bone section finite element (FE) model. The composite variations tested were continuous and short-fiber types, lay-ups (0/0, 90/0, and 45/45 orientations) and different fiber volume fractions. From the analyses, the 0/0 continuous fiber lay-up with a fiber volume fraction close to 0.1 (or 10%) was found to reduce the blast-induced dynamic stresses at the bone and muscle sections by 78% and 70% respectively. These findings indicate that this novel skin simulant material with Kevlar 129 reinforcement, with further experimental testing, may present future opportunities in blast resistant armor padding designing.	[Chanda, Arnab] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA; [Chanda, Arnab] Univ Alabama, Dept Aerosp Engn & Mech, Tuscaloosa, AL 35401 USA; [Graeter, Rebecca] Mississippi State Univ, Dept Chem Engn, Starkville, MS 39759 USA		Chanda, A (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA.; Chanda, A (corresponding author), Univ Alabama, Dept Aerosp Engn & Mech, Tuscaloosa, AL 35401 USA.	arc165@pitt.edu; rg814@msstate.edu					Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Abe T, 2000, EUR J APPL PHYSIOL O, V81, P174, DOI 10.1007/s004210050027; Annaidh AN, 2012, J MECH BEHAV BIOMED, V5, P139, DOI 10.1016/j.jmbbm.2011.08.016; BertucciLiao RJ, 2011, P ASM SUMM BIOENG C, P1035; Carey ME, 2000, NEUROSURGERY, V47, P678, DOI 10.1097/00006123-200009000-00031; Chanda A, 2015, COMPOS STRUCT, V122, P570, DOI 10.1016/j.compstruct.2014.11.069; Chanda A., 2017, MECH ADV MAT STRUCT; Chanda A., 2015, Provisional Patent, Patent No. [62/263,942, 62263942, 62/263, 942]; Chanda A., 2016, BIOFIDELIC HUMAN BRA; Chanda A., 2015, P SOC ENG SCI 52 ANN; Chanda A., 2017, BIOFIDELIC SOFT COMP; Chanda A., 2018, IEEE REV BIOMED ENG; Chanda A., 2018, U.S. Patent, Patent No. [15/646,046, 15646046]; Chanda A., 2017, P AM SOC COMP 32 TEC; Chanda A., 2015, U.S. Patent, Patent No. [15/204353, 15204353]; Chanda A., 2016, P ASME 2016 INT MECH; Chanda A, 2018, J MECH MED BIOL, V18, DOI 10.1142/S0219519417501007; Chanda A, 2018, APPL BIONICS BIOMECH, V2018, DOI 10.1155/2018/4838157; Chanda Arnab, 2018, Journal of Medical Engineering & Technology, V42, P88, DOI 10.1080/03091902.2018.1432711; Chanda A, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037222; Chanda A, 2015, AIMS MATER SCI, V2, P425, DOI 10.3934/matersci.2015.4.425; Chanda A, 2017, J MECH MED BIOL, V17, DOI 10.1142/S0219519417500257; Chanda A, 2017, P I MECH ENG H, V231, P80, DOI 10.1177/0954411916679438; Chanda A, 2016, INT J NUMER METH BIO, V32, DOI 10.1002/cnm.2767; Chanda A, 2015, APPL MECH REV, V67, DOI 10.1115/1.4030967; Chanda P, 2016, ENER SYST ELECTR ENG, P19, DOI 10.1007/978-81-322-2722-9_3; Daniel B, 2005, EUR J COMPUT MECH, V14, P559; de Boer MD, 2008, EUR J APPL PHYSIOL, V104, P401, DOI 10.1007/s00421-008-0703-0; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; Flynn C.O., 2007, DESIGN VALIDATION MU; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Ghoneim H., 2013, E P 19 INT C COMP MA, P7457; Gonzalez L.Y.S., 2005, HYPERELASTIC MAT MOD; Gray H., 1973, ANATOMY HUMAN BODY, Vninth; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Grujicic M, 2012, J MATER ENG PERFORM, V21, P167, DOI 10.1007/s11665-011-9954-8; Holzapfel G.A., 2000, NONLINEAR SOLID MECH, V24; Jenson D., 2014, P ASME 2014 INT MECH; Jenson D, 2015, COMPOS STRUCT, V121, P211, DOI 10.1016/j.compstruct.2014.08.028; Jones R.M., 1975, MECH COMPOSITE MAT, V1; KHALIL TB, 1974, INT J MECH SCI, V16, P609, DOI 10.1016/0020-7403(74)90061-7; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Lee HP, 2010, COMPUT METHOD BIOMEC, V13, P537, DOI 10.1080/10255840903337848; Li YQ, 2015, J APPL MECH-T ASME, V82, DOI 10.1115/1.4031095; Lim J, 2010, POLYM TEST, V29, P701, DOI 10.1016/j.polymertesting.2010.05.012; Martins PALS, 2006, STRAIN, V42, P135, DOI 10.1111/j.1475-1305.2006.00257.x; McGreevy J, 2010, ADV HIGH ENERGY PHYS, V2010, DOI 10.1155/2010/723105; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein M.K., 2010, P NATL ACAD SCI; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Rodriguez-Millan M, 2016, MATER DESIGN, V110, P391, DOI 10.1016/j.matdes.2016.08.015; Sarvghad-Moghaddam H, 2017, SHOCK WAVES, V27, P919, DOI 10.1007/s00193-017-0749-1; Sarvghad-Moghaddam H., 2014, P ASME 2014 INT MECH; Sarvghad-Moghaddam Hesam, 2017, Int J Numer Method Biomed Eng, V33, DOI 10.1002/cnm.2782; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sheean AJ, 2015, CURR REV MUSCULOSKE, V8, P265, DOI 10.1007/s12178-015-9275-x; Shergold OA, 2006, INT J IMPACT ENG, V32, P1384, DOI 10.1016/j.ijimpeng.2004.11.010; Singleton JAG, 2013, BONE JT J ORTHO B S8, V95-B, P2; TAN LB, 2012, INT J IMPACT ENG, V50, P99, DOI DOI 10.1016/j.ijimpeng.2012.06.003; Tucker CL, 1999, COMPOS SCI TECHNOL, V59, P655, DOI 10.1016/S0266-3538(98)00120-1; Unnikrishnan V., 2017, Biofidelic skin simulant, Patent No. [20170011657A1, United States Patent, 20170011657]; Van Hoof J, 1999, MODELLING IMPACT IND; van Hoof J, 2001, COMBINING HEAD MODEL; Wang E., 2004, P 2004 INT ANSYS C; Webster C., 2015, ORTHOPAEDIC P, V97, P14; Zhang T.G., 2013, P ASME 2013 INT MECH; Zhu DJ, 2011, J MATER CIVIL ENG, V23, P230, DOI 10.1061/(ASCE)MT.1943-5533.0000156	68	5	5	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2504-477X			J COMPOS SCI	J. Compos. Sci.	SEP	2018	2	3							44	10.3390/jcs2030044			20	Materials Science, Composites	Emerging Sources Citation Index (ESCI)	Materials Science	VJ4BV	WOS:000590925100008		Green Submitted, gold			2022-02-06	
J	Cox, M; Becker, TD; Motsumi, M				Cox, Megan; Becker, Timothy D.; Motsumi, Mpapho			Head injury burden in a major referral hospital emergency centre in Botswana	AFRICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMA	Introduction: This study describes the demographics, aetiology, emergency centre diagnosis and severity indicators of patients with head injuries presenting to the largest referral hospital emergency centre in Botswana. Methods: Cross-sectional retrospective data was collected from July 2015 to September 2015 for all emergency centre head injury presentations at Princess Marina Hospital. Information was extracted from emergency centre records regarding patient demographics, mechanism of injury, clinical observations, diagnosis, and treatment. Results: Three-hundred and sixty head injury patients presented to the emergency centre in the three months, averaging four per day. 80% were less than 40 years of age and males accounted for 69% of all presentations. 58% of injuries were listed as being accidental, 39% recorded from assaults and 38% from road traffic accidents. The most common emergency centre clinical diagnosis was concussion and the most common radiological diagnosis skull fracture. The median Glasgow Coma Scale was 15 with a range from 3 to 15; and, among patients for whom Revised Trauma Score could be calculated, 79% scored the lowest probability of death in the Revised Trauma Score. Discussion: Head injury disproportionately overburdened males in this study, and head injury aetiology and demographic picture was similar to regional data. Severity scoring using the Glasgow Coma Scale was only available among 66% of patients and Revised Trauma Score calculable in half of presentations. Only 55% of head injury patients were discharged from the emergency centre, despite the preponderance of low severity scores. Head CTs appear to have been over-utilised and implementation of a Traumatic Head CT guideline for our setting is proposed. This study improves understanding of the burden of head injury in Botswana and advocates for national referral guidelines for patients with head injury in Botswana.	[Cox, Megan] Univ Botswana, Fac Med, Dept Emergency Med, Gaborone, Botswana; [Becker, Timothy D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Motsumi, Mpapho] Univ Botswana, Fac Med, Dept Surg, Gaborone, Botswana		Motsumi, M (corresponding author), Univ Botswana, Fac Med, Dept Surg, Gaborone, Botswana.	mpapho.motsumi@mopipi.ub.bw	Cox, Megan/AAD-6746-2020	Cox, Megan/0000-0001-7781-1942; Becker, Timothy/0000-0002-8400-1312; MOTSUMI, MPAPHO/0000-0003-4340-0824			[Anonymous], 2013, MVA FUND ANN REP 201; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chandra A., 2014, AFR J EMERG MED; Evans R., 2006, NEUROLOGY AND TRAUMA; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; Lofvenmark I, 2015, SPINAL CORD, V53, P150, DOI 10.1038/sc.2014.203; Mbakile-Mahlanza L, 2017, NEUROPSYCHOL REHABIL, V27, P38, DOI 10.1080/09602011.2015.1053946; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thurman DJ., 1995, STANDARDS SURVEILLAN; World Health Organization, 2015, GLOB STAT REP ROAD S	15	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2211-419X	2211-4203		AFR J EMERG MED	Afr. J. Emerg. Med.	SEP	2018	8	3					100	105		10.1016/j.afjem.2018.02.003			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GR9AE	WOS:000443032600005	30456157	Green Published, gold			2022-02-06	
J	Crawford, TC; Lui, C; Magruder, JT; Suarez-Pierre, A; Ha, JS; Higgins, RS; Broderick, SR; Merlo, CA; Kim, BS; Bush, EL				Crawford, Todd C.; Lui, Cecillia; Magruder, J. Trent; Suarez-Pierre, Alejandro; Ha, Jinny S.; Higgins, Robert S.; Broderick, Stephen R.; Merlo, Christian A.; Kim, Bo S.; Bush, Errol L.			Traumatically Brain-Injured Donors and the Impact on Lung Transplantation Survival	ANNALS OF THORACIC SURGERY			English	Article; Proceedings Paper	54th Annual Meeting of the Society-of-Thoracic-Surgeons	JAN 27-31, 2018	Fort Lauderdale, FL	Soc Thorac Surg			DEATH; OUTCOMES; REGISTRY; CELLS	Background. Concern has been raised over inferior lung transplantation survival associated with traumatic brain injury (TBI) organ donors. Our purpose was to explore the relationship between TBI donors and lung transplantation survival in the lung allocation score (LAS) era. Methods. We queried the United Network for Organ Sharing Scientific Registry of Transplant Recipients and identified all adult (>= 18 years) lung transplantations performed from May 4, 2005, to December 31, 2015. Recipients were dichotomized based on donor cause of death, TBI versus non-TBI, propensity score across eight variables (final LAS, intensive care unit admission before transplantation, extracorporeal membrane oxygenation before transplantation, donor age 50 years or older, cytomegalovirus antibody recipientL/donorD, ischemia time, annual center transplantation volume, single versus double lung transplantation), and matched 1: 1 without replacement. Our primary outcomes were survival at 1, 3, and 5 years by Kaplan-Meier method. Results. A total of 17,610 patients underwent isolated lung transplantation over the study period at 75 different transplantation centers. TBI was the leading cause of death in the donor population: 47% of all donors. Propensity score matching generated 6,782 well-matched donor TBI versus non-TBI pairs (all covariate p > 0.2). Risk-adjusted survival was similar between recipients of TBI donors versus non-TBI donors at 1 year (86% versus 86%, log-rank p = 0.27), 3 years (68% versus 68%, log-rank p=0.47), and 5 years (55% versus 54%, log-rank p = 0.40). Conclusions. In the largest analysis of TBI donors and the impact on lung transplantation survival to date, we found similar survival out to 5 years in lung transplant recipients of TBI versus non-TBI donors, alleviating concerns over continued transplantation with this unique donor population. (C) 2018 by The Society of Thoracic Surgeons	Johns Hopkins Univ, Sch Med, Dept Surg, Div Thorac Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21287 USA		Bush, EL (corresponding author), Johns Hopkins Univ, Sch Med, Div Thorac Surg, 600 N Wolfe St,Blalock 240, Baltimore, MD 21287 USA.	errol.bush@jhu.edu		Bush, Errol/0000-0003-1251-8467; Suarez-Pierre, Alejandro/0000-0003-1821-6240			Aird WC, 2006, TRANSPLANTATION, V82, pS6, DOI 10.1097/01.tp.0000231345.23918.bd; Avlonitis VS, 2007, AM J TRANSPLANT, V7, P83, DOI 10.1111/j.1600-6143.2006.01593.x; Bittle GJ, 2013, J HEART LUNG TRANSPL, V32, P760, DOI 10.1016/j.healun.2013.04.012; Ciccone AM, 2002, J THORAC CARDIOV SUR, V123, P429, DOI 10.1067/mtc.2002.120732; Grimm JC, 2015, J HEART LUNG TRANSPL, V34, P1449, DOI 10.1016/j.healun.2015.07.001; Kemp CD, 2008, J TRAUMA, V64, P1573, DOI 10.1097/TA.0b013e318068fc2f; Moreno P, 2013, EUR J CARDIO-THORAC, V43, pE190, DOI 10.1093/ejcts/ezt033; Rostron AJ, 2008, TRANSPLANTATION, V85, P597, DOI 10.1097/TP.0b013e31816398dd; Singhal AK, 2009, TRANSPL P, V41, P3539, DOI 10.1016/j.transproceed.2009.06.192; Studer SM, 2004, EUR RESPIR J, V24, P674, DOI 10.1183/09031936.04.00065004; Treutiger CJ, 2003, J INTERN MED, V254, P375, DOI 10.1046/j.1365-2796.2003.01204.x; Valujskikh A, 2003, CURR OPIN IMMUNOL, V15, P493, DOI 10.1016/S0952-7915(03)00110-9; WALLER DA, 1995, J HEART LUNG TRANSPL, V14, P318; Wauters S, 2011, EUR J CARDIO-THORAC, V39, pE68, DOI 10.1016/j.ejcts.2010.11.049; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; Yusen RD, 2013, J HEART LUNG TRANSPL, V32, P965, DOI 10.1016/j.healun.2013.08.007	17	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	SEP	2018	106	3					842	847		10.1016/j.athoracsur.2018.03.075			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology; Respiratory System; Surgery	GQ9SZ	WOS:000442130600055	29730351	Bronze			2022-02-06	
J	Dolle, JP; Rodgers, JM; Browne, KD; Troxler, T; Gai, F; Smith, DH				Dolle, Jean-Pierre; Rodgers, Jeffrey M.; Browne, Kevin D.; Troxler, Thomas; Gai, Feng; Smith, Douglas H.			Newfound effect of N-acetylaspartate in preventing and reversing aggregation of amyloid-beta in vitro	NEUROBIOLOGY OF DISEASE			English	Article						N-Acetylaspartate; Amyloid beta; Aggregation inhibitor; Thioflavin-T; Fluorescence correlation spectroscopy; Dynamic light scattering; Transmission electron microscopy	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; FLUORESCENCE CORRELATION SPECTROSCOPY; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; THIOFLAVIN-T; HEAD-INJURY; PROTEIN DEPOSITION; FIBRIL FORMATION; MR SPECTROSCOPY	Although N-acetylaspartate (NAA) has long been recognized as the most abundant amino acid in neurons by far, its primary role has remained a mystery. Based on its unique tertiary structure, we explored the potential of NAA to modulate aggregation of amyloid-beta (A beta) peptide 1-42 via multiple corroborating aggregation assays along with electron microscopy. Thioflavin-T fluorescence assay demonstrated that at physiological concentrations, NAA substantially inhibited the initiation of A beta) fibril formation. In addition, NAA added after 25 min of A beta) aggregation was shown to break up preformed fibrils. Electron microscopy analysis confirmed the absence of mature fibrils following NAA treatment. Furthermore, fluorescence correlation spectroscopy and dynamic light scattering measurements confirmed significant reductions in A beta) fibril hydrodynamic radius following treatment with NAA. These results suggest that physiological levels of NAA could play an important role in controlling A beta) aggregation in vivo where they are both found in the same neuronal compartments.	[Dolle, Jean-Pierre; Browne, Kevin D.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Penn Ctr Brain Injury & Repair, 220 South 33rd St,283 Towne Bldg, Philadelphia, PA 19104 USA; [Rodgers, Jeffrey M.; Troxler, Thomas; Gai, Feng] Univ Penn, Ultrafast Opt Proc Lab, Dept Chem, Philadelphia, PA 19104 USA		Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, Penn Ctr Brain Injury & Repair, 3320 Smith Walk,Hayden Hall 105, Philadelphia, PA 19104 USA.	smithdou@pennmedicine.upenn.edu		Rodgers, Jeffrey M./0000-0003-1917-6041	Paul G. Allen Family Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS092398, NS038104, P41-GM104605]; PA Consortium on Traumatic Brain Injury [4100077083]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P41GM104605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126, R01NS092398, R01NS038104] Funding Source: NIH RePORTER	This work was supported by the Paul G. Allen Family Foundation, National Institutes of Health grants NS092398 (D.H.S), NS038104 (D.H.S), P41-GM104605 (F.G) and the PA Consortium on Traumatic Brain Injury 4100077083 (D.H.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hamdeh S, 2018, BRAIN PATHOL, V28, P451, DOI 10.1111/bpa.12532; Adalsteinsson E, 2000, LANCET, V355, P1696, DOI 10.1016/S0140-6736(00)02246-7; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Benedetti B, 2007, AM J NEURORADIOL, V28, P72; Bilgicer B, 2004, P NATL ACAD SCI USA, V101, P15324, DOI 10.1073/pnas.0403314101; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Brown M, 2018, J NEURORADIOLOGY, V45, P123, DOI 10.1016/j.neurad.2017.09.004; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cheng LL, 2002, MAGN RESON IMAGING, V20, P527, DOI 10.1016/S0730-725X(02)00512-X; Chowdhury P, 2007, J MOL BIOL, V369, P462, DOI 10.1016/j.jmb.2007.03.042; Chu B, 1991, LASER LIGHT SCATTERI; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Glodzik L, 2015, J ALZHEIMERS DIS, V43, P939, DOI 10.3233/JAD-140609; Grams AE, 2011, ACAD RADIOL, V18, P584, DOI 10.1016/j.acra.2010.12.010; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Inglese M, 2008, NEUROIMAGE, V41, P270, DOI 10.1016/j.neuroimage.2008.02.034; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Kantarci K, 2008, RADIOLOGY, V248, P210, DOI 10.1148/radiol.2481071590; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; Kennedy ME, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9704; KLUNK WE, 1992, NEUROLOGY, V42, P1578, DOI 10.1212/WNL.42.8.1578; Klunk WE, 2001, LIFE SCI, V69, P1471, DOI 10.1016/S0024-3205(01)01232-2; LAW RO, 1994, J EXP ZOOL, V268, P90, DOI 10.1002/jez.1402680204; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; LUYTEN PR, 1986, RADIOLOGY, V161, P795, DOI 10.1148/radiology.161.3.3786735; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Mittag JJ, 2014, BIOCHEM BIOPH RES CO, V448, P195, DOI 10.1016/j.bbrc.2014.04.088; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nedelska Z, 2017, NEUROLOGY, V89, P1391, DOI 10.1212/WNL.0000000000004421; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Paradis E, 1996, J NEUROSCI, V16, P7533; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Salomon AR, 1996, BIOCHEMISTRY-US, V35, P13568, DOI 10.1021/bi9617264; Sengupta P, 2003, BIOPHYS J, V84, P1977, DOI 10.1016/S0006-3495(03)75006-1; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Stancu IC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-51; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; TAYLOR DL, 1994, J NEUROCHEM, V62, P2349; Tomiyama T, 1996, J BIOL CHEM, V271, P6839, DOI 10.1074/jbc.271.12.6839; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Verma M, 2015, ANN INDIAN ACAD NEUR, V18, P138, DOI 10.4103/0972-2327.144284; Victor M. R., 2014, ADAMS VICTORS PRINCI; Watkins JC, 2000, BIOCHEM SOC T, V28, P297, DOI 10.1042/0300-5127:0280297; Wild JM, 1999, MAGN RESON MATER PHY, V8, P109; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhang A, 2009, BIOPHYS J, V96, P1091, DOI 10.1016/j.bpj.2008.10.022	77	5	5	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	SEP	2018	117						161	169		10.1016/j.nbd.2018.05.023			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO8ZO	WOS:000440392100012	29859874	Green Accepted			2022-02-06	
J	Dugue, R; Hassen, GW; Shulman, A; Goodman, JH; Michelson, H; Serrano, P; Chauhan, S; Ling, DSF				Dugue, Rachelle; Hassen, Getaw Worku; Shulman, Abraham; Goodman, Jeffrey H.; Michelson, Hillary; Serrano, Peter; Chauhan, Satendra; Ling, Douglas S. F.			Controlled cortical impact-induced neurodegeneration decreases after administration of the novel calpain-inhibitor Gabadur	BRAIN RESEARCH BULLETIN			English	Article						Calpain; Pregabalin; Traumatic brain injury; Leupeptin	TRAUMATIC BRAIN-INJURY; PHARMACOLOGICAL ANALYSIS; PREGABALIN; MDL-28170; EFFICACY; TARGET; PROTEOLYSIS; MECHANISMS; CASPASE; CALCIUM	One aspect of secondary injury in traumatic brain injury is the marked increase in intracellular calcium and resultant over-activation of the calcium-dependent neutral cysteine protease calpain. Gabadur is a novel protease inhibitor with calpain-inhibition properties formulated from the classic protease inhibitor leupeptin linked to a pregabalin carrier. This construction allows the entire compound to cross the blood-brain barrier after peripheral administration to better target the site of injury. In this study, a single intraperitoneal dose of Gabadur was administered immediately following controlled cortical impact injury in rats. Neocortical slices were examined at 48h post-injury via Fluoro-Jade B staining, revealing an improvement in cortical neurodegeneration in Gabadur treated rats. Levels of detrimental active calpain-2 measured via western blot were also decreased in rats receiving Gabadur. This data supports the benefit of targeted protease inhibition in the treatment of traumatic brain injury.	[Dugue, Rachelle; Goodman, Jeffrey H.; Michelson, Hillary; Ling, Douglas S. F.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA; [Hassen, Getaw Worku] New York Med Coll, Metropolitan Hosp Ctr, Emergency Med, Valhalla, NY 10595 USA; [Shulman, Abraham] Suny Downstate Med Ctr, Dept Otolaryngol, 450 Clarkson Ave Box 29, Brooklyn, NY 11203 USA; [Goodman, Jeffrey H.] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA; [Serrano, Peter] Hunter Coll, Dept Psychol, 695 Pk Ave, New York, NY 10065 USA; [Serrano, Peter] Gene Res Ctr, 695 Pk Ave, New York, NY 10065 USA; [Chauhan, Satendra] Peptides Int Inc, 11621 Electron Dr, Louisville, KY 40299 USA		Dugue, R (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	rad9068@nyp.org; getawh@yahoo.com; abe.shulman1@gmail.com; Jeffrey.goodman@downstate.edu; hillary.michelson@downstate.edu; serrano@genectr.hunter.cuny.edu; schauhan@pepnet.com; douglas.ling@downstate.edu	Goodman, Jeffrey/AAG-8734-2020	Chauhan, Satendra/0000-0001-8890-8563	New York State Institute for Basic Research; SigmaXi; Martha Entenmann Tinnitus Research Center, Inc.	The New York State Institute for Basic Research, SigmaXi Grants in Aid of Research, and the Martha Entenmann Tinnitus Research Center, Inc.	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Badalamente MA, 2000, MUSCLE NERVE, V23, P106, DOI 10.1002/(SICI)1097-4598(200001)23:1<106::AID-MUS14>3.3.CO;2-4; Bains M, 2013, J NEUROCHEM, V125, P125, DOI 10.1111/jnc.12118; Ben-Menachem E, 2004, EPILEPSIA, V45, P13, DOI 10.1111/j.0013-9580.2004.455003.x; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; CDC, 2013, TRAUM BRAIN INJ CONC; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Curcio M, 2016, PROG NEUROBIOL, V143, P1, DOI 10.1016/j.pneurobio.2016.06.001; Das A, 2008, CNS NEUROL DISORD-DR, V7, P313, DOI 10.2174/187152708784936699; Hassen GW, 2008, BRAIN RES, V1236, P206, DOI 10.1016/j.brainres.2008.07.124; Hassen GW, 2006, J NEUROIMMUNOL, V180, P135, DOI 10.1016/j.jneuroim.2006.08.005; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/neu.2013.2944, 10.1089/NEU.2013.2944]; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; Melrose HL, 2007, NEUROSCI LETT, V417, P187, DOI 10.1016/j.neulet.2007.02.068; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Stahl SM, 2013, TRENDS PHARMACOL SCI, V34, P332, DOI 10.1016/j.tips.2013.04.001; Stracher A, 1999, ANN NY ACAD SCI, V884, P52, DOI 10.1111/j.1749-6632.1999.tb08635.x; Stracher A., 2014, US Patent, Patent No. [8729024 B2, 8729024]; Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang J, 1999, NEUROREPORT, V10, P811, DOI 10.1097/00001756-199903170-00027; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang Y., 2017, J NEUROTRAUM, DOI DOI 10.1089/neu.2016.4953; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yoon JS, 2011, NEUROBIOL DIS, V41, P624, DOI 10.1016/j.nbd.2010.11.011	39	5	5	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2018	142						368	373		10.1016/j.brainresbull.2018.08.016			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY0PK	WOS:000448223400042	30149198				2022-02-06	
J	Goncalves-Pimentel, C; Moreno, GMM; Trindade, BS; Isaac, AR; Rodrigues, CG; Savariradjane, M; de Albuquerque, AV; Aguiar, JLD; Andrade-da-Costa, BLD				Goncalves-Pimentel, Catarina; Magalhaes Moreno, Giselle Machado; Trindade, Bruna Soares; Isaac, Alinny Rosendo; Rodrigues, Claudio Gabriel; Savariradjane, Mythili; de Albuquerque, Amanda Vasconcelos; de Andrade Aguiar, Jose Lamartine; da Silveira Andrade-da-Costa, Belmira Lara			Cellulose exopolysaccharide from sugarcane molasses as a suitable substrate for 2D and 3D neuron and astrocyte primary cultures	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; BACTERIAL CELLULOSE; ZOOGLOEA SP; STEM-CELLS; SCAFFOLDS; GROWTH; REGENERATION; BIOPOLYMER; BIOMATERIALS; DEPOSITION	Bacteria-synthesized polysaccharides have attracted interest for biomedical applications as promising biomaterials to be used as implants and scaffolds. The present study tested the hypothesis that cellulose exopolysaccharide (CEC) produced from sugarcane molasses of low cost and adequate purity would be suitable as a template for 2D and 3D neuron and/or astrocyte primary cultures, considering its low toxicity. CEC biocompatibility in these primary cultures was evaluated with respect to cell viability, adhesion, growth and cell function (calcium imaging). Polystyrene or MatrigelA (R) matrix were used as comparative controls. We demonstrated that the properties of this CEC in the 2D or 3D configurations are suitable for differentiation of cortical astrocytes and neurons in single or mixed cultures. No toxicity was detected in neurons that showed NMDA-induced Ca2+ influx. Unlike other polysaccharides of bacterial synthesis, the CEC was efficient as a support even in the absence of surface conjugation with extracellular matrix proteins, maintaining physiological characteristics of cultured neural cells. These observations open up the perspective for development of a novel 3D biofunctional scaffold produced from bacterial cellulose and obtained from renewable sources whose residues are not pollutants. Its low cost and possibility to be manufactured in scale are also suitable for potential applications in regenerative medicine. [GRAPHICS] .	[Goncalves-Pimentel, Catarina; Magalhaes Moreno, Giselle Machado; Trindade, Bruna Soares; Isaac, Alinny Rosendo; da Silveira Andrade-da-Costa, Belmira Lara] Univ Fed Pernambuco, Dept Fisiol & Farmacol, Ctr Biociencias, Recife, PE, Brazil; [Rodrigues, Claudio Gabriel] Univ Fed Pernambuco, Biofis & Radiobiol, Ctr Biociencias, Recife, PE, Brazil; [Savariradjane, Mythili] Univ Pierre & Marie Curie Paris VI, Inst Fer Moulin, INSERM, UMR 839, Paris, France; [de Albuquerque, Amanda Vasconcelos; de Andrade Aguiar, Jose Lamartine] Univ Fed Pernambuco, Dept Cirurgia, Ctr Ciencias Saude, Recife, PE, Brazil; [Goncalves-Pimentel, Catarina] Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal		Andrade-da-Costa, BLD (corresponding author), Univ Fed Pernambuco, Dept Fisiol & Farmacol, Ctr Biociencias, Recife, PE, Brazil.	belmira@gmail.com		Andrade-da-Costa, Belmira Lara da Silveira/0000-0002-3567-6436; Isaac, Alinny/0000-0003-3162-8258	Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PROCAD NF-2009]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPEFundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) [APQ 0036-2.07/11]; Instituto Nacional de Neurociencia Translacional (INCT) [573604/2008-8]; CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); FACEPE/CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [DCR 0079-2.07/10]; CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 5535/15-8]	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PROCAD NF-2009), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE (APQ 0036-2.07/11), Instituto Nacional de Neurociencia Translacional (INCT no. 573604/2008-8). We are also grateful to Prof. Vivaldo Moura Neto from Federal University of Rio de Janeiro and Dr. Patricia Gaspar, Ph.D., who stimulated and allowed the realization of some experiments at the Institut du Fer a Moulin, INSERM. CNPq provided scholarships for B. S. Trindade and A. R. Isaac. FACEPE/CNPq and CAPES provided fellowships to G. M. M. Moreno, C. Goncalves-Pimentel (DCR 0079-2.07/10) and B.L.S. Andrade-da-Costa (BEX 5535/15-8), respectively. The paper was revised by Sidney Pratt, Canadian, MAT (The Johns Hopkins University), RSAdip (TESOL, University of Cambridge).	Ai J, 2013, TISSUE ENG, V1, P15; Ali MY, 2014, SOFT MATTER, V10, P8829, DOI 10.1039/c4sm01602e; Silveira FCA, 2016, BRAZ J OTORHINOLAR, V82, P203, DOI 10.1016/j.bjorl.2015.03.015; Blunk T, 2003, BIOMATERIALS, V24, P4335, DOI 10.1016/S0142-9612(03)00336-3; Brini M, 2014, CELL MOL LIFE SCI, V71, P2787, DOI 10.1007/s00018-013-1550-7; Cavalcante AHM, 2006, BIOCHEM ENG J, V29, P258, DOI 10.1016/j.bej.2006.01.005; CAVALCANTI LUCIANA MARINS, 2017, Rev. Col. Bras. Cir., V44, P72, DOI 10.1590/0100-69912017001011; Clausen F, 2014, BRAIN RES, V1588, P37, DOI 10.1016/j.brainres.2014.08.043; de Barros-Marques SR, 2012, J VASC SURG, V55, P517, DOI 10.1016/j.jvs.2011.05.047; de Carvalho AM, 2012, INT BRAZ J UROL, V38, P544, DOI 10.1590/S1677-55382012000400015; Fabela- Sanchez O, 2008, TISSUE ENG CELL THER, V22; Flanagan KE, 2015, J BIOMED MATER RES B, V103, P485, DOI 10.1002/jbm.b.33217; Fragoso AS, 2014, J MATER SCI-MATER M, V25, P229, DOI 10.1007/s10856-013-5056-5; Geisel N, 2016, SMALL, V12, P5407, DOI 10.1002/smll.201601679; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gomes FCA, 1999, GLIA, V26, P97; Guerra Giulio D., 2011, International Journal of Carbohydrate Chemistry, DOI 10.1155/2011/303708; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003; Innala M, 2014, ARTIF CELL NANOMED B, V42, P302, DOI 10.3109/21691401.2013.821410; Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.10; Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409; Kowalska-Ludwicka K, 2013, ARCH MED SCI, V9, P527, DOI 10.5114/aoms.2013.33433; Lai YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045074; Li DD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00193; Little L, 2008, CHEM REV, V108, P1787, DOI 10.1021/cr078228t; Medeiros MD, 2013, ACTA CIR BRAS, V28, P233, DOI 10.1590/S0102-86502013000400001; Pinto FCM, 2016, CARBOHYD POLYM, V137, P556, DOI 10.1016/j.carbpol.2015.10.071; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller D, 2013, J BIOMAT SCI-POLYM E, V24, P1368, DOI 10.1080/09205063.2012.761058; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Paterson-Beedle M, 2000, CARBOHYD POLYM, V42, P375, DOI 10.1016/S0144-8617(99)00179-4; Pertile RAN, 2010, SEM ENG, V1, P11; Phillips JB, 2014, METHODS MOL BIOL, V1162, P113, DOI 10.1007/978-1-4939-0777-9_9; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Silveira RK, 2016, J MATER SCI-MATER M, V129, P1; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; de Lima FDT, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-016-5828-9; Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15; Vilar FD, 2016, INT BRAZ J UROL, V42, P1220, DOI [10.1590/s1677-5538.ibju.2016.0109, 10.1590/S1677-5538.IBJU.2016.0109]; Zamani F, 2014, J BIOMED MATER RES A, V102, P506, DOI 10.1002/jbm.a.34703	42	5	5	1	17	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4530	1573-4838		J MATER SCI-MATER M	J. Mater. Sci.-Mater. Med.	SEP	2018	29	9							139	10.1007/s10856-018-6147-0			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GQ8CK	WOS:000441977700006	30120571				2022-02-06	
J	Henry, MK; Wood, JN				Henry, M. Katherine; Wood, Joanne N.			Advanced Cervical Spine Imaging in Abusive Head Trauma: An Update on Recent Literature and Future Directions	ACADEMIC PEDIATRICS			English	Article						brain injuries; brain injuries; traumatic; child abuse; craniocerebral trauma; magnetic resonance imaging; shaken baby syndrome; spinal injuries	YOUNG-CHILDREN; INJURIES		[Henry, M. Katherine; Wood, Joanne N.] Childrens Hosp Philadelphia, Ctr Child Protect & Hlth, Philadelphia, PA 19104 USA; [Henry, M. Katherine; Wood, Joanne N.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA; [Wood, Joanne N.] Childrens Hosp Philadelphia, PolicyLab, Philadelphia, PA 19104 USA		Henry, MK (corresponding author), Childrens Hosp Philadelphia, 3401 Civ Ctr Blvd,Off 12NW93, Philadelphia, PA 19104 USA.	henrym2@email.chop.edu		Wood, Joanne/0000-0001-6431-8024			Baerg J, 2017, J PEDIATR SURG, V52, P816, DOI 10.1016/j.jpedsurg.2017.01.049; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; Governale LS, 2018, PEDIATR NEUROSURG, V53, P36, DOI 10.1159/000481511; Henry MK, 2021, PEDIATR EMERG CARE, V37, pE1, DOI 10.1097/PEC.0000000000001455; Henry MK, 2016, ACAD PEDIATR, V16, P684, DOI 10.1016/j.acap.2016.01.017; Jacob R, 2016, AM J NEURORADIOL, V37, P1944, DOI 10.3174/ajnr.A4817; Kadom N, 2014, PEDIATR RADIOL, V44, P839, DOI 10.1007/s00247-014-2874-7; Oh A, 2017, J NEUROSURG-PEDIATR, V20, P271, DOI 10.3171/2017.2.PEDS16644; Wu X, 2017, AJNR Am J Neuroradiol, V38, pE30, DOI 10.3174/ajnr.A5098	10	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1876-2859	1876-2867		ACAD PEDIATR	Acad. Pediatr.	SEP-OCT	2018	18	7					733	735		10.1016/j.acap.2018.05.008			3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GS3PQ	WOS:000443532400004	29859269				2022-02-06	
J	Hirschhorn, RM; Kerr, ZY; Wasserman, EB; Kay, MC; Clifton, DR; Dompier, TP; Yeargin, SW				Hirschhorn, Rebecca M.; Kerr, Zachary Y.; Wasserman, Erin B.; Kay, Melissa C.; Clifton, Daniel R.; Dompier, Thomas P.; Yeargin, Susan W.			Epidemiology of Injuries Requiring Emergency Transport Among Collegiate and High School Student-Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						incidents; prehospital care; sports; football; concussions; hockey; strains; fractures	ASSOCIATION POSITION STATEMENT; FOOTBALL PLAYERS; SPORTS INJURIES; CERVICAL-SPINE; SUDDEN-DEATH; TRAINERS; DEPARTMENTS; CONCUSSION; MANAGEMENT	Context: Data regarding the epidemiology of emergency-transport incidents (ETIs) of patients with sport-related injuries are lacking. Understanding the use of emergency services by athletic trainers can help improve emergency preparedness and prehospital care for injured student-athletes. Objective: To determine the frequencies and types of ETIs resulting from athletic participation. Design: Descriptive epidemiology study. Setting: Participating colleges and high schools during 2009-2010 to 2014-2015 and 2011-2012 to 2013-2014, respectively. Patients or Other Participants: Student-athletes in 23 high school and 25 intercollegiate sports. Main Outcome Measure(s): Data on injuries requiring emergency transport were collected by each team's athletic trainer via their respective online injury-tracking software. Athletic trainers also collected data on athlete-exposures (AEs). Emergency-transport incident frequencies and injury rates per 10000 AEs with 95% confidence intervals (Cls) were reported. For each ETI, the sport, body part, injury mechanism, and final diagnosis were recorded. Results: A total of 339 and 146 ETIs were reported in collegiate and high school players, respectively. Collegiate women's ice hockey had the highest ETI rate (1.28/10000 AEs; 95% CI = 0.71, 1.86). In high school, football had the highest rate at 0.80 per 10000 AEs (95% CI = 0.64, 0.97). Athletes with head or face injuries required the most transports in college (n = 71, 20.9%) and high school (n = 33, 22.6%) across all sports. Strains (n = 50, 14.7%) and fractures (n = 35, 24.0%) were the leading diagnoses for patients undergoing transport in college and high school, respectively. Conclusions: Athletic trainers should maintain a high level of emergency preparedness when working with sports that have high rates and numbers of ETIs. Athletes with injuries to the head/ face required the most frequent transport across competition levels. Athletic trainers should have the appropriate equipment and protocols in place to handle these patients. Future researchers should examine the differences between field and hospital diagnoses to help improve prehospital care and decrease the likelihood of unnecessary emergency transports.	[Hirschhorn, Rebecca M.; Yeargin, Susan W.] Univ South Carolina, Dept Exercise Sci, 1300 Wheat St,Room 213, Columbia, SC 29208 USA; [Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Wasserman, Erin B.] Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Kay, Melissa C.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA; [Clifton, Daniel R.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Dompier, Thomas P.] Lebanon Valley Coll, Annville, PA USA		Hirschhorn, RM (corresponding author), Univ South Carolina, Dept Exercise Sci, 1300 Wheat St,Room 213, Columbia, SC 29208 USA.	hirschhr@email.sc.edu	Hirschhorn, Rebecca/AAC-8952-2019	Hirschhorn, Rebecca/0000-0001-6305-7926; Wasserman, Erin/0000-0001-5957-5878; Clifton, Daniel/0000-0003-3857-124X	National Athletic Trainers' Association Research and Education Foundation (Carrollton, TX); Central Indiana Corporate Partnership Foundation (Indianapolis, IN); NCAA (Indianapolis, IN); BioCrossroads	Funding for this study was provided by the National Athletic Trainers' Association Research and Education Foundation (Carrollton, TX); BioCrossroads in partnership with the Central Indiana Corporate Partnership Foundation (Indianapolis, IN); and the NCAA (Indianapolis, IN). These sources had no role in designing or conducting the study; collecting, managing, analyzing, and interpreting the data; or preparing, reviewing, and approving the manuscript. The funding sources also had no role in the decision to submit the manuscript for publication. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the programs' sponsors. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP and NATION. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of athletes.	Ahn H, 2011, J NEUROTRAUM, V28, P1341, DOI 10.1089/neu.2009.1168; Andersen JC, 2002, J ATHL TRAINING, V37, P99; Belval LN, 2018, PREHOSP EMERG CARE, V22, P392, DOI 10.1080/10903127.2017.1392666; Billittier AJ, 1996, ACAD EMERG MED, V3, P1046; Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Casa DJ, 2012, CURR SPORT MED REP, V11, P115, DOI 10.1249/JSR.0b013e31825615cc; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Decoster LC, 2010, CLIN J SPORT MED, V20, P436, DOI 10.1097/JSM.0b013e3181fc0a54; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fletcher EN, 2014, J ATHL TRAINING, V49, P381, DOI 10.4085/1062-6050-49.3.09; Gaw CE, 2014, CLIN J SPORT MED, V24, P226, DOI 10.1097/JSM.0000000000000029; Gonzalez RP, 2013, AM SURGEON, V79, P1213; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Huffman EA, 2008, J ATHL TRAINING, V43, P624, DOI 10.4085/1062-6050-43.6.624; Johnson BK, 2017, CLIN J SPORT MED, V27, P388, DOI 10.1097/JSM.0000000000000351; Kay MC, 2017, J ATHL TRAINING, V52, P117, DOI 10.4085/1062-6050-52.1.01; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P19, DOI 10.1186/s40621-017-0116-9; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116664500; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2016, CATASTROPHIC SPORTS; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mazerolle SM, 2012, INT J ATHL THER TRAI, V17, P39, DOI 10.1123/ijatt.17.2.39; Meehan WP, 2013, PEDIATR EMERG CARE, V29, P624, DOI 10.1097/PEC.0b013e31828e9cea; Merkel DL, 2012, INT J SPORTS PHYS TH, V7, P691; Nalliah RP, 2014, PEDIATR EMERG CARE, V30, P511, DOI 10.1097/PEC.0000000000000180; Nelson NG, 2011, AM J PREV MED, V40, P54, DOI 10.1016/j.amepre.2010.09.031; Olympia RP, 2007, PEDIATR EMERG CARE, V23, P703, DOI 10.1097/PEC.0b013e318155adfc; Potter BW, 2006, ATHLET THER TODAY, V11, P18; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rehberg RS, 2007, SPORTS EMERGENCY CAR; Richards JR, 1999, ACAD EMERG MED, V6, P14, DOI 10.1111/j.1553-2712.1999.tb00088.x; Rifat Sami F, 2003, Curr Sports Med Rep, V2, P93; Swartz EE, 2009, J ATHL TRAINING, V44, P306, DOI 10.4085/1062-6050-44.3.306; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Vaillancourt C, 2009, ANN EMERG MED, V54, P663, DOI 10.1016/j.annemergmed.2009.03.008; Wham George, 2008, J S C Med Assoc, V104, P91; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	42	5	5	0	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2018	53	9					906	914		10.4085/1062-6050-340-17			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GY4NU	WOS:000448540500010	30284458	gold, Green Published			2022-02-06	
J	Mei, C; Anderson, V; Waugh, MC; Cahill, L; Morgan, AT				Mei, Cristina; Anderson, Vicki; Waugh, Mary-Clare; Cahill, Louise; Morgan, Angela T.		TBI Guideline Dev Grp	Evidence- and Consensus-Based Guidelines for the Management of Communication and Swallowing Disorders Following Pediatric Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; guideline; language; speech; swallowing; traumatic brain injury	PRAGMATIC LANGUAGE; DYSPHAGIA; CHILDREN; RECOVERY; REHABILITATION; ADOLESCENTS; OUTCOMES; SPEECH; SKILLS; PREDICTORS	Objective: Evidence-based management guidelines for communication and swallowing disorders following pediatric traumatic brain injury (TBI) are scarcely available, potentially resulting in suboptimal outcomes. To improve clinical care of this population, a multidisciplinary guideline development committee was formed to develop evidence-based recommendation (EBR) and consensus-based recommendation (CBR) for the management of speech, language, and swallowing disorders during the first year of recovery. Methods: A 3-round Delphi survey was completed by the committee to reach agreement (80% consensus) for the CBRs. Systematic review evidence guided development of EBRs, devised using the National Health and Medical Research Council statement form. Results: Altogether, 30 recommendations (5 EBRs and 25 CBRs) were developed to guide management of speech, language, and swallowing disorders, including prediction of these disorders; health team required, optimal timing of assessment; assessment tools; intervention strategies and commencement of treatment; and key information to support parents. Conclusion: The developed recommendations provide a basis for the systematic management of communication and swallowing disorders to be refined as new evidence emerges. Key recommendations include screening of children with moderate/severe TBI for these disorders acutely using specified measures. Patients with severe TBI and prolonged ventilation are a particular at-risk group and should be considered for early referral to speech-language pathology to support timely diagnosis and management. No evidence was identified to support an EBR for treatment, highlighting a key area for research.	[Mei, Cristina; Anderson, Vicki; Morgan, Angela T.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki; Morgan, Angela T.] Univ Melbourne, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Waugh, Mary-Clare] Childrens Hosp Westmead, Sydney, NSW, Australia; [Cahill, Louise] Lady Cilento Childrens Hosp, Brisbane, Qld, Australia		Morgan, AT (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, 50 Flemington Rd, Parkville, Vic 3052, Australia.; Morgan, AT (corresponding author), Univ Melbourne, Royal Childrens Hosp, 50 Flemington Rd, Parkville, Vic 3052, Australia.	angela.morgan@mcri.edu.au	Morgan, Angela/J-5235-2017	Morgan, Angela/0000-0003-1147-7405	Victorian Government's Operational Infrastructure Support Program; NHMRCNational Health and Medical Research Council of Australia [1105008]; NHMRC (Centre of Research Excellence in Brain Recovery)National Health and Medical Research Council of Australia [1023043]	The authors sincerely thank all members of the expert working committee (listed later) for their contribution, and Catherine King and Geraint Duggan for their guidance. Development of the guideline was supported by the Victorian Government's Operational Infrastructure Support Program and grants from the NHMRC (Centre of Research Excellence in Brain Recovery #1023043; Practitioner Fellowship awarded to AM #1105008).; Authors C.M., V.A., L.C., and A.M. are coauthors on studies included in the systematic review. The guideline was funded by grants from the NHMRC (Centre of Research Excellence in Brain Recovery #1023043; Practitioner Fellowship awarded to A.M. #1105008).	Access Economics , 2009, EC COST SPIN CORD IN; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Campbell TF, 2013, J SPEECH LANG HEAR R, V56, P1023, DOI 10.1044/1092-4388(2012/12-0077); Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Dayer A, 1998, Eur J Paediatr Neurol, V2, P109, DOI 10.1016/S1090-3798(98)80026-3; DeMatteo Carol, 2002, Physical & Occupational Therapy in Pediatrics, V22, P51, DOI 10.1300/J006v22n03_05; Devesa J, 2013, HORM BEHAV, V63, P331, DOI 10.1016/j.yhbeh.2012.02.022; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; ENDERBY P, 1990, BRIT J DISORD COMMUN, V25, P341; Fyrberg A, 2007, INT J REHABIL RES, V30, P153; Hainsworth D S, 1997, J Neurosci Nurs, V29, P156; Hillier S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-23; Huang CT, 2014, J HEAD TRAUMA REHAB, V29, pE31, DOI 10.1097/HTR.0000000000000032; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kriel RL, 1995, J NEUROL REHABIL, V9, P145; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Liegeois FJ, 2013, BRAIN LANG, V127, P388, DOI 10.1016/j.bandl.2013.05.003; Lundine JP, 2015, PEDIATR RADIOL, V45, P1323, DOI 10.1007/s00247-015-3314-z; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Morgan A, 2005, J MED SPEECH-LANG PA, V13, P109; Morgan A, 2004, J HEAD TRAUMA REHAB, V19, P226, DOI 10.1097/00001199-200405000-00004; Morgan A, 2004, BRAIN INJURY, V18, P359, DOI 10.1080/02699050310001617424; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Morgan A, 2002, J HEAD TRAUMA REHAB, V17, P220, DOI 10.1097/00001199-200206000-00004; Morgan A., 2017, CLIN PRACTICE GUIDEL; Morgan AT, 2010, CHILD CARE HLTH DEV, V36, P44, DOI 10.1111/j.1365-2214.2009.00961.x; Morgan A. T., 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD006279.PUB2; Morgan AT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009456.pub2; Morgan AT, 2013, BRAIN, V136, P646, DOI 10.1093/brain/aws355; Morgan AT, 2011, J EVAL CLIN PRACT, V17, P275, DOI 10.1111/j.1365-2753.2010.01436.x; Morgan AT, 2001, ASIA PACIFIC J SPEEC, V6, P9; Morse S, 1999, Pediatr Rehabil, V3, P139; National Health and Medical Research Council (NHMRC), 2009, LEV EV GRAD REC DEV; National Health and Medical Research Council (NHMRC), 2011, PROC REQ M 2011 NHMR; Pennington L, 2016, COCHRANE DB SYST REV, V7; Recla M, 2013, BRAIN INJURY, V27, P862, DOI 10.3109/02699052.2013.775499; Rowe LA, 1999, J HEAD TRAUMA REHAB, V14, P497, DOI 10.1097/00001199-199910000-00010; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Slattery J, 2012, DEV MED CHILD NEUROL, V54, P796, DOI 10.1111/j.1469-8749.2012.04318.x; Slomine B, 2008, J HEAD TRAUMA REHAB, V23, P286, DOI 10.1097/01.HTR.0000336841.53338.2f; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Trudeau N, 2000, INT J LANG COMM DIS, V35, P227; Turkstra L., 2005, J MED SPEECH-LANG PA, V13, P9; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Van Borsel J, 2001, CLIN LINGUIST PHONET, V15, P663; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	61	5	5	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					326	341		10.1097/HTR.0000000000000366			16	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500015	29385009				2022-02-06	
J	Oldenburg, C; Lundin, A; Edman, G; Deboussard, CN; Bartfai, A				Oldenburg, Christian; Lundin, Anders; Edman, Gunnar; Deboussard, Catharina Nygren; Bartfai, Aniko			Emotional reserve and prolonged post-concussive symptoms and disability: a Swedish prospective 1-year mild traumatic brain injury cohort study	BMJ OPEN			English	Article							PREINJURY PERSONALITY-TRAITS; COMA SCALE SCORE; HEAD-INJURY; POSTCONCUSSION SYNDROME; COGNITIVE RESERVE; DEPRESSION SCALE; HOSPITAL ANXIETY; SOCIOECONOMIC-STATUS; FOLLOW-UP; RESILIENCE	Objective Prolonged post-concussive symptoms (PCS) affect a significant minority of patients withmild traumatic brain injury (mTBI). The aetiology is multifactorial depending on preinjury as well as peri-injury and postinjury factors. In this study, we examine outcome from an emotional reserve perspective. Design Prospective cohort study. Setting Patients were recruited from three emergency departments in major university hospitals in Stockholm, Sweden. Follow-up data were collected in an outpatient setting at one of the recruiting hospitals. Participants 122 patients with a history of blunt head trauma (aged 15-65 years; admitted for mTBI within 24 hours after trauma (Glasgow Coma Scale score of 14-15, loss of consciousness <30 min and/or post-traumatic amnesia <24 hours). Exclusion criteria were other significant physical injury and other major neurological disorder, including previous significant head injury. Procedure Recruitment in three emergency departments. Initial assessments were made within 1 week after the injury. Patients were mailed the follow-up questionnaires 1 year postinjury. Outcome measures A psychiatric assessment was performed at 1 week post injury. The participants also completed a personality inventory, measures of psychological resilience, depression, anxiety and posttraumatic symptoms. One-year outcome was measured by the Rivermead Post Concussion Symptoms and the Rivermead Head Injury Follow-Up questionnaires. Results The psychiatric assessment revealed more symptoms of anxiety, depression and post-traumatic symptoms in the acute stage for patients who later developed PCS. After 1 year, 94 participants were still in the programme (male/female 57/37) and 12% matched the extended criteria for PCS (>= 3 symptoms and >= 2 disabilities). PCS patients reported more preinjury and concurrent psychiatric problems, lower level of functioning before the injury and experienced more stress. They showed higher somatic trait anxiety, embitterment, mistrust and lower level of psychological resilience than recovered participants. Conclusion Intrapersonal emotional reserve shape the emergence and persistence of PCS after mTBI.	[Oldenburg, Christian; Deboussard, Catharina Nygren; Bartfai, Aniko] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Rehabil Med, Stockholm, Sweden; [Lundin, Anders] Dizziness Ctr, Neuropsychiat Sect, Stockholm, Sweden; [Edman, Gunnar] Norrtalje Sjukhus, Tiohundra AB, Norrtalje, Sweden		Oldenburg, C (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Rehabil Med, Stockholm, Sweden.	christian.oldenburg@ki.se		Bartfai, Aniko/0000-0002-0815-2485; Oldenburg, Christian/0000-0003-4647-9136	Swedish insurance company AFA; Hjarnskadeforbundet Hjarnkraft, a Swedish organisation; Promobilia Foundation; Svenska Lakaresallskapet (The Swedish Medical Association)	This study was supported by grants from: The Swedish insurance company AFA, Hjarnskadeforbundet Hjarnkraft, a Swedish organisation for people with acquired brain injury, The Promobilia Foundation, Svenska Lakaresallskapet (The Swedish Medical Association).	American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; EYSENCK HJ, 1961, HDB ABNORMAL PSYCHOL; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Iverson GL, 2013, BRAIN INJURY MED PRI; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Ristner G, 2000, INJURY, V31, P751, DOI 10.1016/S0020-1383(00)00115-7; Rush BK, 2004, REHABIL PSYCHOL, V49, P275, DOI 10.1037/0090-5550.49.4.275; RUTHERFORD WH, 1977, LANCET, V1, P1; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SCHALLING D, 1987, ACTA PSYCHIAT SCAND, V76, P172, DOI 10.1111/j.1600-0447.1987.tb02881.x; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Weiss D, 1997, ASSESSING PSYCHOL TR, P399, DOI DOI 10.1037/T12199-000; Yuen KM, 2016, APPL NEUROPSYCH-ADUL, V23, P322, DOI 10.1080/23279095.2015.1057638; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	64	5	5	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	SEP	2018	8	7							e020884	10.1136/bmjopen-2017-020884			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV5YI	WOS:000446181900084	29982209	Green Published, gold			2022-02-06	
J	Sewry, N; Verhagen, E; Lambert, M; van Mechelen, W; Marsh, J; Readhead, C; Viljoen, W; Brown, J				Sewry, N.; Verhagen, E.; Lambert, M.; van Mechelen, W.; Marsh, J.; Readhead, C.; Viljoen, W.; Brown, J.			Trends in time-loss injuries during the 2011-2016 South African Rugby Youth Weeks	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						incidence; risk factors; rugby; South Africa	PREVENTION PROGRAM; MATCH INJURIES; UNION TOURNAMENTS; BODY-MASS; PLAYERS; BOKSMART; EPIDEMIOLOGY; CONCUSSION; SAFETY	Youth rugby is a popular sport in South Africa (SA) with a high injury incidence. The annual SA Rugby Youth Week tournaments attract the top age-group players in the country providing a sample of players for reliable injury surveillance. The aim of the study was to analyze the changes in time-loss injury rates at the SA Rugby Youth Week tournaments between 2011 and 2016, differences between age-groups, and to investigate associated injury risk factors. All confirmed time-loss injuries at the 4 age-group tournaments (under-13, under-16, and 2 under-18) from 2011 to 2016 were recorded. Injury incidence densities (HD) for years, tournaments, and injury risk factors were calculated and Poisson regression analyses were performed to determine differences. Time-loss injuries (n = 494) were reported over 24 240 exposure hours, with an overall HD of 20.4 (18.6-22.2) injuries per 1000 player hours. The year 2013 had a significantly lower HD compared to 2011. Injury risk decreased with increasing age; under-13 and under-16 had significantly higher HD compared to under-18 Craven Week. Tackling was the phase of play at highest risk, with an HD of 7.4 (6.3-8.5) injuries per 1000 player hours. Central/peripheral nervous system (CNS/PNS) and, therefore, the head/neck were the most commonly occurring injuries/location injured. In conclusion, within the SA Rugby tournament structure, the older players had a decreased rate of injury. The tackle event was still the phase of play with the highest injury incidence regardless of age. This increase in incidence is largely due to an increase in CNS/PNS injuries.	[Sewry, N.; Verhagen, E.; Lambert, M.; van Mechelen, W.; Marsh, J.; Readhead, C.; Viljoen, W.; Brown, J.] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Cape Town, South Africa; [Verhagen, E.; Lambert, M.; van Mechelen, W.; Brown, J.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam Collaborat Hlth & Safety Sports, Med Ctr,Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Verhagen, E.] Federat Univ Australia, ACRISP, Ballarat, Vic, Australia; [van Mechelen, W.] Univ Queensland, Fac Hlth & Behav Sci, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia; [van Mechelen, W.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin, Ireland; [Readhead, C.; Viljoen, W.] South African Rugby Union, Cape Town, South Africa		Sewry, N (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Cape Town, South Africa.	nicolasewry@hotmail.com	Verhagen, Evert/A-1502-2013	Verhagen, Evert/0000-0001-9227-8234; Sewry, Nicola/0000-0003-1022-4780; van Mechelen, Willem/0000-0001-7136-6382; Brown, James/0000-0002-7778-7783; Viljoen, Wayne/0000-0002-9432-6153	Vrije Universiteit Amsterdam/National Research Foundation South Africa through the Desmond Tutu Doctoral Scholarship; University of Cape Town; Zuid-Afrika Huis Study Foundation; Oppenheimer Memorial Trust	Vrije Universiteit Amsterdam/National Research Foundation South Africa through the Desmond Tutu Doctoral Scholarship; University of Cape Town; Zuid-Afrika Huis Study Foundation; Oppenheimer Memorial Trust	Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Brown JC, 2016, SCAND J MED SCI SPOR, V26, P221, DOI 10.1111/sms.12414; Brown JC, 2015, J SCI MED SPORT, V18, P394, DOI 10.1016/j.jsams.2014.06.015; Brown JC, 2015, INJURY PREV, V21, P173, DOI 10.1136/injuryprev-2014-041326; Brown JC, 2012, S AFR J SPORTS MED, V24, P49; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Burger N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005556; Cross M, 2017, BRIT J SPORT MED, V51, P309; Durandt J, 2018, J SPORT SCI, V36, P477, DOI 10.1080/02640414.2017.1317103; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2011, CLIN J SPORT MED, V21, P356, DOI 10.1097/JSM.0b013e31821f5085; Fuller CW, 2009, SAMJ S AFR MED J, V99, P232; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, BRIT J SPORT MED, V48, P1115, DOI 10.1136/bjsports-2013-092877; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; Meir RA, 2005, J STRENGTH COND RES, V19, P713; Nathan M, 1983, PRACTICE, V18, P15; Palmer-Green DS, 2013, AM J SPORT MED, V41, P749, DOI 10.1177/0363546512473818; Patricios J, 2014, CURR SPORT MED REP, V13, P142, DOI 10.1249/JSR.0000000000000049; Raftery M, 2014, BRIT J SPORT MED, V48, P79, DOI 10.1136/bjsports-2013-093051; ROUX CE, 1987, S AFR MED J, V71, P307; Sewry N, 2017, INJURY PREV, V23, P428, DOI 10.1136/injuryprev-2016-042188; Sewry N, 2017, SPORTS MED, V47, P1847, DOI 10.1007/s40279-017-0704-4; Union AR, 2008, KEY POINTS TACKL BAL, P18; Union NZR, 2007, TECHN KEY FACT TACKL, P12; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Rugby, 2014, YEAR REV 2014	35	5	5	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	SEP	2018	28	9					2066	2073		10.1111/sms.13087			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GQ5UB	WOS:000441756500011	29572956				2022-02-06	
J	Ulyanova, AV; Koch, PF; Cottone, C; Grovola, MR; Adam, CD; Browne, KD; Weber, MT; Russo, RJ; Gagnon, KG; Smith, DH; Chen, HI; Johnson, VE; Cullen, DK; Wolf, JA				Ulyanova, Alexandra V.; Koch, Paul F.; Cottone, Carlo; Grovola, Michael R.; Adam, Christopher D.; Browne, Kevin D.; Weber, Maura T.; Russo, Robin J.; Gagnon, Kimberly G.; Smith, Douglas H.; Chen, H. Isaac; Johnson, Victoria E.; Cullen, D. Kacy; Wolf, John A.			Electrophysiological Signature Reveals Laminar Structure of the Porcine Hippocampus	ENEURO			English	Article						Custom silicon probes; hippocampal cytoarchitecture; in vivo electrophysiology; pig	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; DENTATE AREA; MODEL; PIGS; IMMUNOREACTIVITY; IMPLANTATION; DISRUPTION; SUBICULUM; COGNITION	The hippocampus is integral to working and episodic memory and is a central region of interest in diseases affecting these processes. Pig models are widely used in translational research and may provide an excellent bridge between rodents and nonhuman primates for CNS disease models because of their gyrencephalic neuroanatomy and significant white matter composition. However, the laminar structure of the pig hippocampus has not been well characterized. Therefore, we histologically characterized the dorsal hippocampus of Yucatan miniature pigs and quantified the cytoarchitecture of the hippocampal layers. We then utilized stereotaxis combined with single-unit electrophysiological mapping to precisely place multichannel laminar silicon probes into the dorsal hippocampus without the need for image guidance. We used in vivo electrophysiological recordings of simultaneous laminar field potentials and single-unit activity in multiple layers of the dorsal hippocampus to physiologically identify and quantify these layers under anesthesia. Consistent with previous reports, we found the porcine hippocampus to have the expected archicortical laminar structure, with some anatomical and histological features comparable to the rodent and others to the primate hippocampus. Importantly, we found these distinct features to be reflected in the laminar electrophysiology. This characterization, as well as our electrophysiology-based methodology targeting the porcine hippocampal lamina combined with high-channel-count silicon probes, will allow for analysis of spike-field interactions during normal and disease states in both anesthetized and future awake behaving neurophysiology in this large animal.	[Ulyanova, Alexandra V.; Koch, Paul F.; Cottone, Carlo; Grovola, Michael R.; Adam, Christopher D.; Browne, Kevin D.; Weber, Maura T.; Russo, Robin J.; Gagnon, Kimberly G.; Smith, Douglas H.; Chen, H. Isaac; Johnson, Victoria E.; Cullen, D. Kacy; Wolf, John A.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Grovola, Michael R.; Adam, Christopher D.; Browne, Kevin D.; Chen, H. Isaac; Cullen, D. Kacy; Wolf, John A.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA		Wolf, JA (corresponding author), Perelman Sch Med, Dept Neurosurg, 172A Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.	wolfjo@pennmedicine.upenn.edu		Grovola, Michael/0000-0003-4125-9329; Adam, Christopher/0000-0002-6520-5301; Ulyanova, Alexandra/0000-0002-1319-5279; Russo, Robin/0000-0002-2208-073X	Department of Veterans AffairsUS Department of Veterans Affairs [IK2-RX001479, I01-RX001097]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R01-NS-101108-01, T32-NS043126]; CURE Foundation, Taking Flight Award; DoD ERP CDMRP [W81XWH-16-1-0675]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126, R01NS101108] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002705] Funding Source: NIH RePORTER	The Department of Veterans Affairs, IK2-RX001479, I01-RX001097. The National Institutes of Health, NINDS R01-NS-101108-01, T32-NS043126. CURE Foundation, Taking Flight Award. DoD ERP CDMRP, W81XWH-16-1-0675.	Asher L, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0402; Bjarkam CR, 2017, BRAIN STRUCT FUNCT, V222, P2093, DOI 10.1007/s00429-016-1327-5; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; Broom DM, 2009, ANIM BEHAV, V78, P1037, DOI 10.1016/j.anbehav.2009.07.027; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Chernyy N, 2008, IEEE ENG MED BIO, P2772, DOI 10.1109/IEMBS.2008.4649777; Conn PM, 2017, ANIMAL MODELS STUDY; Conrad MS, 2015, ANNU REV ANIM BIOSCI, V3, P245, DOI 10.1146/annurev-animal-022114-111049; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Ettrup KS, 2011, J NEUROSCI METH, V200, P41, DOI 10.1016/j.jneumeth.2011.06.011; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Fleming SA, 2017, BEHAV BRAIN RES, V321, P50, DOI 10.1016/j.bbr.2016.12.027; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Goodman S, 2002, NATURE, V417, P684, DOI 10.1038/417684a; Grimberg-Henrici CGE, 2016, ANIM COGN, V19, P271, DOI 10.1007/s10071-015-0932-7; Gross RE, 2006, MOVEMENT DISORD, V21, pS259, DOI 10.1002/mds.20960; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; HOLM IE, 1990, PROG BRAIN RES, V83, P85; HOLM IE, 1992, J COMP NEUROL, V322, P390, DOI 10.1002/cne.903220308; HOLM IE, 1993, J COMP NEUROL, V331, P310, DOI 10.1002/cne.903310303; HOLM IE, 1994, HIPPOCAMPUS, V4, P115, DOI 10.1002/hipo.450040112; Jang SS, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7969272; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lustig B, 2016, HIPPOCAMPUS, V26, P102, DOI 10.1002/hipo.22494; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARCILLOUX JC, 1989, BRAIN RES BULL, V22, P591, DOI 10.1016/0361-9230(89)90118-4; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Mitra PP, 2007, OBSERVED BRAIN DYNAM, P408; Mitzdorf U, 1985, PHYSL REV, V65; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; POCETA JS, 1981, ANAT RECORD, V200, P349, DOI 10.1002/ar.1092000315; Quester R, 1997, J NEUROSCI METH, V75, P81, DOI 10.1016/S0165-0270(97)00050-2; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rollin BE, 2006, THEOR MED BIOETH, V27, P285, DOI 10.1007/s11017-006-9007-8; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Saito T, 1998, J NEUROSCI METH, V80, P29, DOI 10.1016/S0165-0270(97)00183-0; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Schramke S, 2016, J NEUROSCI METH, V265, P34, DOI 10.1016/j.jneumeth.2015.11.013; Schuldenzucker V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185970; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Sorensen JC, 2011, PROG BRAIN RES, V194, P97, DOI 10.1016/B978-0-444-53815-4.00014-5; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; SZTEYN S, 1980, ANAT ANZEIGER, V147, P12; Van Gompel JJ, 2011, EPILEPSIA, V52, pE49, DOI 10.1111/j.1528-1167.2011.03096.x; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065	65	5	5	1	4	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2018	5	5							UNSP e0102-18.2018	10.1523/ENEURO.0102-18.2018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HF4VW	WOS:000454232900011	30229132	Green Published, gold, Green Submitted			2022-02-06	
J	Veeramuthu, V; Seow, P; Narayanan, V; Wong, JHD; Tan, LK; Hernowo, AT; Ramli, N				Veeramuthu, Vigneswaran; Seow, Pohchoo; Narayanan, Vairavan; Wong, Jeannie Hsiu Ding; Tan, Li Kuo; Hernowo, Aditya Tri; Ramli, Norlisah			Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI): An In Vivo Proton Magnetic Resonance Spectroscopy (1H-MRS) Study	ACADEMIC RADIOLOGY			English	Article						Neurometabolite; mild Traumatic Brain Injury (TBI); Magnetic Resonance Spectroscopy (MRS); N-acetylaspartate (NAA); Glasgow Coma Scale (GCS)	N-ACETYLASPARTATE; SEVERITY; DAMAGE	Rationale and Objectives: Magnetic resonance spectroscopy is a noninvasive imaging technique that allows for reliable assessment of microscopic changes in brain cytoarchitecture, neuronal injuries, and neurochemical changes resultant from traumatic insults. We aimed to evaluate the acute alteration of neurometabolites in complicated and uncomplicated mild traumatic brain injury (mTBI) patients in comparison to control subjects using proton magnetic resonance spectroscopy (1H magnetic resonance spectroscopy). Material and Methods: Forty-eight subjects (23 complicated mTBI [cmTBI] patients, 12 uncomplicated mTBI [umTBI] patients, and 13 controls) underwent magnetic resonance imaging scan with additional single voxel spectroscopy sequence. Magnetic resonance imaging scans for patients were done at an average of 10 hours (standard deviation 4.26) post injury. The single voxel spectroscopy adjacent to side of injury and noninjury regions were analysed to obtain absolute concentrations and ratio relative to creatine of the neurometabolites. One-way analysis of variance was performed to compare neurometabolite concentrations of the three groups, and a correlation study was done between the neurometabolite concentration and Glasgow Coma Scale. Results: Significant difference was found in ratio of N-acetylaspartate to creatine (NAA/Cr + PCr) (chi(2)(2) = 0.22, P < .05) between the groups. The sum of NAA and N-acetylaspartylglutamate (NAAG) also shows significant differences in both the absolute concentration (NAA + NAAG) and ratio to creatine (NAA + NAAG/Cr + PCr) between groups (chi(2)(2) = 4.03, P < .05 and (chi(2)(2) = 0.79, P < .05)), NAA values were lower in cmTBI and umTBI compared to control group. A moderate weak positive correlation were found between Glasgow Coma Scale with NM/Cr + PCr (rho = 0.36, P < .05 and NAA + NAAG/Cr + PCr (rho = 0.45, P < .05)), whereas a moderate correlation was seen with NAA + NAAG (rho = 0.38, P < .05). Conclusion: Neurometabolite alterations were already apparent at onset of both complicated and uncomplicated traumatic brain injury. The ratio of NAA and NAAG has potential to serve as a biomarker reflecting injury severity in a quantifiable manner as it discriminates between the complicated and uncomplicated cases of mTBI.	[Veeramuthu, Vigneswaran; Narayanan, Vairavan; Hernowo, Aditya Tri] Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Malaysia; [Veeramuthu, Vigneswaran] Gleneagles Medini Hosp, Brain & Cognit Recovery Ctr, Iskandar Puteri, Johor, Malaysia; [Veeramuthu, Vigneswaran] Univ Reading Malaysia, Dept Psychol, Persiaran Graduan Kota Ilmu, Educity, Johor, Malaysia; [Wong, Jeannie Hsiu Ding; Tan, Li Kuo; Ramli, Norlisah] Univ Malaya, Fac Med, Dept Biomed Imaging, Jalan Univ, Kuala Lumpur 50603, Wilayah Perseku, Malaysia; [Wong, Jeannie Hsiu Ding; Tan, Li Kuo; Ramli, Norlisah] Univ Malaya, Fac Med, Res Imaging Ctr, Kuala Lumpur, Malaysia		Ramli, N (corresponding author), Univ Malaya, Fac Med, Dept Biomed Imaging, Jalan Univ, Kuala Lumpur 50603, Wilayah Perseku, Malaysia.; Ramli, N (corresponding author), Univ Malaya, Fac Med, Res Imaging Ctr, Kuala Lumpur, Malaysia.	norlisahramli@gmail.com	Hernowo, Aditya T/M-9651-2015; Veeramuthu, Vigneswaran/F-2220-2015; Tan, Li Kuo/B-5494-2010; WONG, JEANNIE HSIU DING/B-8705-2010; NARAYANAN, VAIRAVAN/B-9191-2010; RAMLI, NORLISAH MOHD/G-5209-2010; Seow, Pohchoo/AAP-6940-2020	Hernowo, Aditya T/0000-0002-9212-6705; Veeramuthu, Vigneswaran/0000-0003-2052-0858; Tan, Li Kuo/0000-0002-6912-172X; WONG, JEANNIE HSIU DING/0000-0001-8080-1294; NARAYANAN, VAIRAVAN/0000-0002-1118-5042; RAMLI, NORLISAH MOHD/0000-0001-7497-8093; 	University of MalayaUniversiti Malaya [RG447-12HTM]; Bantuan Kecil Penyelidikan [BKP-BK045-2015]; Fundamental Research Grant Scheme [FP009-2016]	This study was made possible with financial assistance from the University of Malaya Research Grant (RG447-12HTM), Bantuan Kecil Penyelidikan (BKP-BK045-2015), and Fundamental Research Grant Scheme (FP009-2016). The authors gratefully acknowledge the essential contributions of the research staff of University of Malaya Research Imaging Centre (UMRIC).	Cavassila S, 2000, J MAGN RESON, V143, P311, DOI 10.1006/jmre.1999.2002; Dean PJA, 2013, NEUROREPORT, V24, P677, DOI 10.1097/WNR.0b013e3283637aa4; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Govindaraju V, 2004, AJNR AM J NEURORADIO, V25; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Long PM, 2013, J BIOL CHEM, V288, P26188, DOI 10.1074/jbc.M113.487553; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Provencher SW, 2011, LCMODEL LCMGUI USERS; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sidek S, 2016, EUR RADIOL, P1; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578	23	5	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	SEP	2018	25	9					1167	1177		10.1016/j.acra.2018.01.005			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	HF4DP	WOS:000454183700010	29449141	Green Accepted			2022-02-06	
J	Zhou, YT; Tong, DM; Wang, SD; Ye, S; Xu, BW; Yang, CX				Zhou, Ye-Ting; Tong, Dao-Ming; Wang, Shao-Dan; Ye, Song; Xu, Ben-Wen; Yang, Chen-Xi			Acute spontaneous intracerebral hemorrhage and traumatic brain injury are the most common causes of critical illness in the ICU and have high early mortality	BMC NEUROLOGY			English	Article						Critical illness; Causes; Incidence; Mortality; Epidemiology; Intracerebral hemorrhage; Head injury	INTENSIVE-CARE UNIT; PRESSURE; STATES	Background: Critical care covers multiple disciplines. However, the causes of critical illness in the ICU, particularly the most common causes, remain unclear. We aimed to investigate the incidence and the most common causes of critical illness and the corresponding early mortality rates in ICU patients. Methods: A retrospective cohort study was performed to examine critically ill patients (aged over 15 years) in the general ICU in Shuyang County in northern China (1/2014-12/2015). The incidences and causes of critical illnesses and their corresponding early mortality rates in the ICU were determined by an expert panel. Results: During the 2-year study period, 1,211,138 person-years (PY) and 1645 critically ill patients (mean age, 61.8 years) were documented. The median Glasgow Coma Scale (GCS) score was 6 (range, 3-15). The mean acute physiology and chronic health evaluation II (APACHE II) score was 21.2 +/- 6.8. The median length of the ICU stay was 4 days (range, 1-29 days). The most common causes of critical illness in the ICU were spontaneous intracerebral hemorrhage (SICH) (26%, 17.6/100,000 PY) and traumatic brain injury (TBI) (16.8%, 11.4/100,000 PY). During the first 7 days in the ICU, SICH was the most common cause of death (42.2%, 7.4/10,000 PY), followed by TBI (36.6%, 4.2/100,000 PY). Based on a logistic analysis, older patients had a significantly higher risk of death from TBI (risk ratio [RR], 1.7; 95% CI, 1.034-2.635), heart failure/cardiovascular crisis (RR, 0.2; 95% CI, 0.083-0.484), cerebral infarction (RR, 0.15; 95% CI, 0.050-0.486), or respiratory failure (RR, 035; 95% CI, 0.185-0.784) than younger patients. However, the risk of death from SICH in the two groups was similar. Conclusions: The most common causes of critical illness in the ICU were SICH and TBI, and both critical illnesses showed a higher risk of death during the first 7 days in the ICU.	[Zhou, Ye-Ting; Ye, Song; Xu, Ben-Wen; Yang, Chen-Xi] Xuzhou Med Univ, Affiliated Shuyang Hosp, Dept Surg, Xuzhou, Jiangsu, Peoples R China; [Tong, Dao-Ming] Xuzhou Med Univ, Affiliated Shuyang Hosp, Dept Neurol, Xuzhou, Jiangsu, Peoples R China; [Wang, Shao-Dan] Xuzhou Med Univ, Affiliated Shuyang Hosp, Dept Intens Care Med, Xuzhou, Jiangsu, Peoples R China		Tong, DM (corresponding author), Xuzhou Med Univ, Affiliated Shuyang Hosp, Dept Neurol, Xuzhou, Jiangsu, Peoples R China.	dmtong@xzhmu.edu.cn			Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [20160017]	This work is supported by a grant from the Medical Research Council, affiliated Shuyang People's Hospital, Xuzhou Medical University (Clinical Key Specialty Construction Project of Jiangsu Provence, 20160017).	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2013, STAT YB JIANGSU PROV, P1; Bral AL, 1994, JAMA-J AM MED ASSOC, V271, P226; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; BROOS PLO, 1993, ACTA CHIR BELG, P126; Cerro G, 2014, LANCET RESP MED, V2, P343, DOI 10.1016/S2213-2600(14)70042-6; Chan CL, 2014, J CLIN NEUROSCI, V21, P91, DOI 10.1016/j.jocn.2013.03.030; Chen Z., 2008, 3 CAUSE DEATH NETION, P8; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fogelholm R, 1997, STROKE, V28, P1396, DOI 10.1161/01.STR.28.7.1396; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Harrison DA, 2015, J NEUROTRAUM, V32, P1522, DOI 10.1089/neu.2014.3628; Hefny AF, 2013, AFR HEALTH SCI, V13, P731, DOI 10.4314/ahs.v13i3.30; Iwashyna TJ, 2016, CRITICAL CARE, V20, P1; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; Roman Mariana Isabel Vargas, 2005, Prehosp Emerg Care, V9, P344; Rosamond Wayne D, 2005, Prehosp Emerg Care, V9, P19, DOI 10.1080/10903120590891985; Sinuff T, 2004, CRIT CARE MED, V32, P1588, DOI 10.1097/01.CCM.0000130175.38521.9F; Sun Yanhua, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P925; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang J, 2016, STROKE, V11	23	5	10	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	AUG 27	2018	18								127	10.1186/s12883-018-1127-z			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GR8DJ	WOS:000442940100002	30149796	gold, Green Published			2022-02-06	
J	Hutchinson, EB; Schwerin, SC; Radomski, KL; Sadeghi, N; Komlosh, ME; Irfanoglu, MO; Juliano, SL; Pierpaoli, C				Hutchinson, Elizabeth B.; Schwerin, Susan C.; Radomski, Kryslaine L.; Sadeghi, Neda; Komlosh, Michel E.; Irfanoglu, M. O.; Juliano, Sharon L.; Pierpaoli, Carlo			Detection and Distinction of Mild Brain Injury Effects in a Ferret Model Using Diffusion Tensor MRI (DTI) and DTI-Driven Tensor-Based Morphometry (D-TBM)	FRONTIERS IN NEUROSCIENCE			English	Article						diffusion tensor MRI; ferret; controlled cortical impact; mild traumatic brain injury; tensor-based morphometry; white matter	TRAUMATIC AXONAL INJURY; COMMON DATA ELEMENTS; ANATOMICAL STRUCTURES; CEREBRAL-ISCHEMIA; MOUSE MODEL; ABNORMALITIES; REGISTRATION; TISSUES	Mild traumatic brain injury (mTBI) is highly prevalent but lacks both research tools with adequate sensitivity to detect cellular alterations that accompany mild injury and preclinical models that are able to robustly mimic hallmark features of human TBI. To address these related challenges, high-resolution diffusion tensor MRI (DTI) analysis was performed in a model of mild TBI in the ferret - a species that, unlike rodents, share with humans a gyrencephalic cortex and high white matter (WM) volume. A set of DTI image analysis tools were optimized and implemented to explore key features of DTI alterations in ex vivo adult male ferret brains (n = 26), evaluated 1 day to 16 weeks after mild controlled cortical impact (CCI). Using template-based ROI analysis, lesion overlay mapping and DTI-driven tensor-based morphometry (D-TBM) significant differences in DTI and morphometric values were found and their dependence on time after injury evaluated. These observations were also qualitatively compared with immunohistochemistry staining of neurons, astrocytes, and microglia in the same tissue. Focal DTI abnormalities including reduced cortical diffusivity were apparent in 12/13 injured brains with greatest lesion extent found acutely following CCI by ROI overlay maps and reduced WM FA in the chronic period was observed near to the CCI site (ANOVA for FA in focal WM: time after CCI p = 0.046, brain hemisphere p = 0.0012) often in regions without other prominent MRI abnormalities. Global abnormalities were also detected, especially for WM regions, which demonstrated reduced diffusivity (ANOVA for Trace: time after CCI p = 0.007) and atrophy that appeared to become more extensive and bilateral with longer time after injury (ANOVA for D-TBM Log of the Jacobian values: time after CCI p = 0.007). The findings of this study extend earlier work in rodent models especially by evaluation of focal WM abnormalities that are not influenced by partial volume effects in the ferret. There is also substantial overlap between DTI and morphometric findings in this model and those from human studies of mTBI implying that the combination of DTI tools with a human-similar model system can provide an advantageous and informative approach for mTBI research.	[Hutchinson, Elizabeth B.; Irfanoglu, M. O.; Pierpaoli, Carlo] Natl Inst Biomed Imaging & Bioengn, Sect Quantitat Med Imaging, NIH, Bethesda, MD 20892 USA; [Hutchinson, Elizabeth B.; Schwerin, Susan C.; Radomski, Kryslaine L.; Komlosh, Michel E.] Mil Med Inc, Henry M Jackson Fdn Adv, Bethesda, MD 20817 USA; [Schwerin, Susan C.; Radomski, Kryslaine L.; Juliano, Sharon L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Sadeghi, Neda; Komlosh, Michel E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Quantitat Imaging & Tissue Sci, NIH, Bethesda, MD USA		Hutchinson, EB (corresponding author), Natl Inst Biomed Imaging & Bioengn, Sect Quantitat Med Imaging, NIH, Bethesda, MD 20892 USA.; Hutchinson, EB (corresponding author), Mil Med Inc, Henry M Jackson Fdn Adv, Bethesda, MD 20817 USA.	elizabeth.hutchinson@nih.gov	Pierpaoli, Carlo/E-1672-2011; Juliano, Sharon/AAO-1030-2020	Pierpaoli, Carlo/0000-0001-8558-4428; Hutchinson, Elizabeth/0000-0002-3374-5469; Schwerin, Susan/0000-0001-5435-2448	Congressionally Directed Medical Research Programs (CDMRP)United States Department of Defense [W81XWH-13-2-0019, W81XWH-13-2-0018]; National Institute of Biomedical Imaging and Bioengineering, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [ZIAEB000089, ZIHEB000088] Funding Source: NIH RePORTER	This work was funded by the Congressionally Directed Medical Research Programs (CDMRP) (award numbers W81XWH-13-2-0019 and W81XWH-13-2-0018) and the Intramural Program of the National Institute of Biomedical Imaging and Bioengineering, NIH. The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) provided administrative support for these awards.	Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; CRAGG B, 1979, NEUROSCI LETT, V15, P301, DOI 10.1016/0304-3940(79)96130-5; Davatzikos C, 1996, J COMPUT ASSIST TOMO, V20, P88, DOI 10.1097/00004728-199601000-00017; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson E., 2014, P 45 ANN M SOC NEUR; Hutchinson EB, 2017, NEUROIMAGE, V152, P575, DOI 10.1016/j.neuroimage.2017.03.009; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Irfanoglu MO, 2016, NEUROIMAGE, V132, P439, DOI 10.1016/j.neuroimage.2016.02.066; Irfanoglu MO., 2017, P 25 ANN M ISMRM HON; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Korogod N, 2015, ELIFE, V4, DOI 10.7554/eLife.05793; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Nayak A., 2017, P ISMRM HON HI; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.3.CO;2-A; PIERPAOLI C, 1993, RADIOLOGY, V189, P439, DOI 10.1148/radiology.189.2.8210373; Pierpaoli C., 2010, P 19 ISMRM ANN M STO; Sadeghi N., 2016, DEFORMATION BASED MO; Schwerin SC, 2018, J NEUROSCI RES, V96, P556, DOI 10.1002/jnr.24218; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Ventura-Antunes L, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00003; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	50	5	5	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 17	2018	12								573	10.3389/fnins.2018.00573			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ7SH	WOS:000441945700001	30174584	Green Published, gold			2022-02-06	
J	McKenzie, DP; Downing, MG; Ponsford, JL				McKenzie, Dean P.; Downing, Marina G.; Ponsford, Jennie L.			Key Hospital Anxiety and Depression Scale (HADS) items associated with DSM-IV depressive and anxiety disorder 12-months post traumatic brain injury	JOURNAL OF AFFECTIVE DISORDERS			English	Article							LONGITUDINAL FOLLOW-UP; GULF-WAR; SCREENING INSTRUMENTS; RATING-SCALES; VALIDITY; PREVALENCE; DIAGNOSIS; ADOLESCENTS; PERFORMANCE; CURVES	Background: Anxiety and depression are common problems following traumatic brain injury (TBI), warranting routine screening. Self-report rating scales including the Hospital Anxiety and Depression Scale (HADS) are associated with depression and anxiety diagnoses in individuals with TBI. The relationship between individual HADS symptoms and structured clinical interview methods (SCID) requires further investigation, particularly in regard to identifying a small number of key items that can potentially be recognised by clinicians and carers of individuals with TBI. Methods: 138 individuals sustaining a complicated-mild to severe TBI completed the HADS, and the Structured Clinical Interview for DSM-IV, Research Version (SCID) at 12-months post-injury. The associations between individual HADS items, separately and in combination, as well as overall depression and anxiety subscale scores, and SCID-diagnosed depressive and anxiety disorders were analysed. Results: CART (Classification and Regression Tree) analysis found HADS depression item 2 "I still enjoy the things I used to enjoy" and a combination of two anxiety items, 3 "I get a sort of frightened feeling as if something awful is about to happen" and 5 "worrying thoughts go through my mind", performed similarly to total depression and anxiety subscales in terms of their association with depressive and anxiety disorders respectively, at 12-months post-injury. Limitations: Patients were predominantly injured in motor vehicle accidents and received comprehensive care within a no-fault accident compensation system and so may not be representative of the wider TBI population. Conclusions: Although validation is required, a small number of self-report items are highly associated with 12-month post-injury diagnoses.	[McKenzie, Dean P.; Downing, Marina G.; Ponsford, Jennie L.] Epworth HealthCare, Res & Dev, Richmond, Vic, Australia; [McKenzie, Dean P.; Downing, Marina G.; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia; [McKenzie, Dean P.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia		McKenzie, DP (corresponding author), Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia.	dean.mckenzie@monash.edu.au	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632	Transport Accident Commission (TAC)	The study was funded by the Transport Accident Commission (TAC). This publication is the work of the authors and Dr Dean McKenzie, Dr Marina Downing and Professor Jennie Ponsford will serve as guarantors for the contents of this paper. The funders had no role in the study design, collection analysis, conduct of the study nor in the writing and preparation of the manuscript or the decision to publish.	Altman DG, 2000, HEART, V83, P236, DOI 10.1136/heart.83.2.236; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Armitage P, 2002, STAT METHODS MED RES, V4th; Batterham PJ, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-75; Breiman L., 1984, CLASSIFICATION REGRE; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Bunevicius A, 2012, J PSYCHOSOM RES, V72, P22, DOI 10.1016/j.jpsychores.2011.10.006; Carter JV, 2016, SURGERY, V159, P1638, DOI 10.1016/j.surg.2015.12.029; Clarke DM, 2000, PSYCHOSOMATICS, V41, P418, DOI 10.1176/appi.psy.41.5.418; CLARKE DM, 1994, J PSYCHIAT RES, V28, P185, DOI 10.1016/0022-3956(94)90029-9; Clarke DM, 2003, J PSYCHOSOM RES, V54, P323, DOI 10.1016/S0022-3999(02)00410-5; Cumming G., 2016, INTRO NEW STAT ESTIM; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Exarchos TP, 2012, COMPUT BIOL MED, V42, P195, DOI 10.1016/j.compbiomed.2011.11.008; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Glover TA, 2007, J SCHOOL PSYCHOL, V45, P117, DOI 10.1016/j.jsp.2006.05.005; Green JG, 2010, INT J METH PSYCH RES, V19, P23, DOI 10.1002/mpr.314; Harrell FE Jr, 2017, REGRESSION MODELING; Hunt JC, 2017, J TRAUMA ACUTE CARE, V82, P93, DOI 10.1097/TA.0000000000001306; Izal M, 2010, PSYCHIAT RES, V178, P142, DOI 10.1016/j.psychres.2009.02.018; Judd LL, 2016, AM J PSYCHIAT, V173, P1140, DOI 10.1176/appi.ajp.2016.15111462; Lin XC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185287; Lu HY, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0187-x; McKenzie DP, 2015, J PSYCHOSOM RES, V79, P566, DOI 10.1016/j.jpsychores.2015.08.003; McKenzie DP, 2011, J AFFECT DISORDERS, V134, P151, DOI 10.1016/j.jad.2011.05.022; McKenzie DP, 2010, SOC PSYCH PSYCH EPID, V45, P843, DOI 10.1007/s00127-009-0134-1; McKenzie DP, 2004, PSYCHOL MED, V34, P1419, DOI 10.1017/S0033291704002818; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P286, DOI 10.1097/HTR.0000000000000277; Nguyen S., 2017, DISABIL REHABIL, P1; Palacios J, 2018, J PSYCHOSOM RES, V104, P1, DOI 10.1016/j.jpsychores.2017.10.015; Phan T, 2016, CHRON RESP DIS, V13, P220, DOI 10.1177/1479972316634604; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pourahmad S, 2016, METHOD INFORM MED, V55, P440, DOI 10.3414/ME15-01-0080; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schwarzbold ML, 2014, REV BRAS PSIQUIATR, V36, P206, DOI 10.1590/1516-4446-2013-1308; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Spitz G, 2016, J NEUROL NEUROSUR PS, V87, P173, DOI 10.1136/jnnp-2014-309479; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; Stott J, 2017, INT J GERIATR PSYCH, V32, P805, DOI 10.1002/gps.4530; Thombs BD, 2007, PSYCHOSOMATICS, V48, P185, DOI 10.1176/appi.psy.48.3.185; Thombs BD, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011913; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Witten IH, 2017, DATA MINING: PRACTICAL MACHINE LEARNING TOOLS AND TECHNIQUES, 4TH EDITION, pCP1; Wolfe R, 2002, CAN MED ASSOC J, V166, P65; Yokoi T, 2014, INT OPHTHALMOL, V34, P171, DOI 10.1007/s10792-013-9805-8; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	5	5	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	AUG 15	2018	236						164	171		10.1016/j.jad.2018.04.092			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	GH0ZJ	WOS:000433130600025	29738951				2022-02-06	
J	Gunawardhana, SM; Lunte, SM				Gunawardhana, Shamal M.; Lunte, Susan M.			Continuous monitoring of adenosine and its metabolites using microdialysis coupled to microchip electrophoresis with amperometric detection	ANALYTICAL METHODS			English	Article							TANDEM MASS-SPECTROMETRY; TRAUMATIC BRAIN-INJURY; TOTAL ANALYSIS SYSTEMS; ELECTROCHEMICAL DETECTION; CAPILLARY-ELECTROPHORESIS; IN-VIVO; PYRIMIDINE METABOLISM; CARBON ELECTRODE; HYPOXANTHINE; XANTHINE	Rapid monitoring of concentration changes of neurotransmitters and energy metabolites is important for understanding the biochemistry of neurological disease as well as for developing therapeutic options. This paper describes the development of a separation-based sensor using microchip electrophoresis (ME) with electrochemical (EC) detection coupled to microdialysis (MD) sampling for continuous on-line monitoring of adenosine and its downstream metabolites. The device was fabricated completely in PDMS. End-channel electrochemical detection was accomplished using a carbon fiber working electrode embedded in the PDMS. The separation conditions for adenosine, inosine, hypoxanthine, and guanosine were investigated using a ME-EC chip with a 5 cm long separation channel. The best resolution was achieved using a background electrolyte consisting of 35 mM sodium borate at pH 10, 15% dimethyl sulfoxide (DMSO), and 2 mM sodium dodecyl sulphate (SDS), and a field strength of 222 V cm(-1). Under these conditions, all four purines were separated in less than 85 s. Using a working electrode detection potential of 1.4 V vs. Ag/AgCl, the limits of detection were 25, 33, 10, and 25 M for adenosine, inosine, hypoxanthine, and guanosine, respectively. The ME-EC chip was then coupled to microdialysis sampling using a novel all-PDMS microdialysis-microchip interface that was reversibly sealed. This made alignment of the working electrode with the end of the separation channel much easier and more reproducible than could be obtained with previous MD-ME-EC systems. The integrated device was then used to monitor the enzymatic conversion of adenosine to inosine in vitro.	[Gunawardhana, Shamal M.; Lunte, Susan M.] Univ Kansas, Ralph N Adams Inst Bioanalyt Chem, Lawrence, KS 66045 USA; [Gunawardhana, Shamal M.; Lunte, Susan M.] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Lunte, Susan M.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA		Lunte, SM (corresponding author), Univ Kansas, Ralph N Adams Inst Bioanalyt Chem, Lawrence, KS 66045 USA.; Lunte, SM (corresponding author), Univ Kansas, Dept Chem, Lawrence, KS 66045 USA.; Lunte, SM (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA.	slunte@ku.edu	Lunte, Susan M/G-2263-2018; Gunawardhana, Shamal/AAG-5749-2020	Gunawardhana, Shamal/0000-0002-0800-9371	NIH COBREUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20 GM103638]; NSFNational Science Foundation (NSF) [1411993]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103638] Funding Source: NIH RePORTER	The authors thank NIH COBRE P20 GM103638 and NSF 1411993 grants for financial support. The authors would also like to thank Ryan Grigsby for help with microchip fabrication and Dr Rachel A. Saylor, Manjula B. Wijesinghe, and Kelci M. Schilly for helpful discussions. Lastly, we thank Nancy Harmony for her editorial assistance in the preparation of the manuscript.	Agui L, 2006, SENSOR ACTUAT B-CHEM, V113, P272, DOI 10.1016/j.snb.2005.03.001; BALLARIN M, 1991, ACTA PHYSIOL SCAND, V142, P97, DOI 10.1111/j.1748-1716.1991.tb09133.x; BARRACO RA, 1991, NEUROCHEM INT, V18, P243, DOI 10.1016/0197-0186(91)90191-F; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bergquist F, 1998, J NEUROCHEM, V70, P1532; Boison D, 2008, CURR OPIN PHARMACOL, V8, P2, DOI 10.1016/j.coph.2007.09.002; Burdett TC, 2013, BIOMED CHROMATOGR, V27, P122, DOI 10.1002/bmc.2760; Castro ER, 2015, J CHROMATOGR A, V1382, P66, DOI 10.1016/j.chroma.2014.11.034; Cavalheiro ETG, 1999, J PHARMACEUT BIOMED, V19, P217, DOI 10.1016/S0731-7085(98)00128-9; Cellar NA, 2005, ANAL CHEM, V77, P7067, DOI 10.1021/ac0510033; Compagnone D, 1997, ANAL CHIM ACTA, V340, P109, DOI 10.1016/S0003-2670(96)00451-5; CONWAY AC, 1981, J ELECTROANAL CHEM, V123, P243, DOI 10.1016/S0022-0728(81)80502-5; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; Dou P, 2009, J CHROMATOGR A, V1216, P7558, DOI 10.1016/j.chroma.2009.04.040; Gawron AJ, 2001, ELECTROPHORESIS, V22, P242, DOI 10.1002/1522-2683(200101)22:2<242::AID-ELPS242>3.0.CO;2-W; Goyal RN, 2006, ELECTROCHIM ACTA, V51, P5095, DOI 10.1016/j.electacta.2006.03.057; Goyal RN, 2002, J ELECTROANAL CHEM, V521, P72, DOI 10.1016/S0022-0728(02)00645-9; Gunasekara DB, 2016, RSC DETECT SCI SER, V6, P85; Hinzman JM, 2015, BIOSENS BIOELECTRON, V74, P512, DOI 10.1016/j.bios.2015.06.074; Huynh BH, 2004, ANAL CHEM, V76, P6440, DOI 10.1021/ac049365i; Jiang YQ, 2009, ANAL CHEM, V81, P6474, DOI 10.1021/ac901216n; Johnson AS, 2015, ANAL METHODS-UK, V7, P884, DOI 10.1039/c4ay02569e; Johnson AS, 2011, ELECTROPHORESIS, V32, P3121, DOI 10.1002/elps.201100433; Kapinos LE, 2011, CHEM-EUR J, V17, P8156, DOI 10.1002/chem.201003544; Karlinsey JM, 2012, ANAL CHIM ACTA, V725, P1, DOI 10.1016/j.aca.2012.02.052; Kerman K, 2008, ANAL LETT, V41, P2077, DOI 10.1080/00032710802208716; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; MANZ A, 1992, J CHROMATOGR, V593, P253, DOI 10.1016/0021-9673(92)80293-4; Mecker LC, 2008, ANAL CHEM, V80, P9257, DOI 10.1021/ac801614r; Micheli V, 2011, CURR TOP MED CHEM, V11, P923, DOI 10.2174/156802611795347645; Nandi P, 2010, ELECTROPHORESIS, V31, P1414, DOI 10.1002/elps.200900612; Nandi P, 2009, ANAL CHIM ACTA, V651, P1, DOI 10.1016/j.aca.2009.07.064; Nguyen MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087165; Nuchtavorn N, 2015, J PHARMACEUT BIOMED, V113, P72, DOI 10.1016/j.jpba.2015.03.002; Nyhan WL, 2005, MOL GENET METAB, V86, P25, DOI 10.1016/j.ymgme.2005.07.027; Oliveira-Brett AM, 2004, ANAL BIOCHEM, V332, P321, DOI 10.1016/j.ab.2004.06.021; Pajski ML, 2013, PURINERG SIGNAL, V9, P167, DOI 10.1007/s11302-012-9343-2; Patabadige DEW, 2016, ANAL CHEM, V88, P320, DOI 10.1021/acs.analchem.5b04310; Raj MA, 2013, ANAL CHIM ACTA, V771, P14, DOI 10.1016/j.aca.2013.02.017; Ross AE, 2014, J NEUROCHEM, V130, P50, DOI 10.1111/jnc.12711; Ross AE, 2012, ANALYST, V137, P3045, DOI 10.1039/c2an35297d; Saylor RA, 2018, ELECTROPHORESIS, V39, P462, DOI 10.1002/elps.201700211; Saylor RA, 2015, ELECTROPHORESIS, V36, P1912, DOI 10.1002/elps.201500150; Saylor RA, 2015, J CHROMATOGR A, V1382, P48, DOI 10.1016/j.chroma.2014.12.086; SCHWER C, 1991, ANAL CHEM, V63, P1801, DOI 10.1021/ac00017a026; Scott DE, 2015, ANALYST, V140, P3820, DOI [10.1039/c4an01928h, 10.1039/C4AN01928H]; Scott DE, 2013, CHEMPHYSCHEM, V14, P2288, DOI 10.1002/cphc.201300449; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Sonker M, 2017, ANAL CHIM ACTA, V986, P1, DOI 10.1016/j.aca.2017.07.043; Su WT, 2015, J CHROMATOGR A, V1377, P13, DOI 10.1016/j.chroma.2014.12.041; Swamy BEK, 2007, ANAL CHEM, V79, P744, DOI 10.1021/ac061820i; Tudos AJ, 2001, LAB CHIP, V1, P83, DOI 10.1039/b106958f; Wang M, 2008, ANAL CHEM, V80, P5607, DOI 10.1021/ac800622s; Wang X, 2015, J CHROMATOGR A, V1382, P98, DOI 10.1016/j.chroma.2014.10.039; Xia JF, 2009, J CHROMATOGR B, V877, P1930, DOI 10.1016/j.jchromb.2009.05.047; Zhu YX, 2001, J PHARMACEUT BIOMED, V26, P967, DOI 10.1016/S0731-7085(01)00450-2	57	5	5	0	31	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1759-9660	1759-9679		ANAL METHODS-UK	Anal. Methods	AUG 14	2018	10	30					3737	3744		10.1039/c8ay01041b			8	Chemistry, Analytical; Food Science & Technology; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Food Science & Technology; Spectroscopy	GQ3PT	WOS:000441579400004	31579297	Green Accepted, Green Submitted			2022-02-06	
J	Adatia, K; Geocadin, RG; Healy, R; Ziai, W; Ponce-Mejia, L; Anderson-White, M; Shah, D; Radzik, BR; Palmisano, C; Hogue, CW; Brown, C; Rivera-Lara, L				Adatia, Krishma; Geocadin, Romergryko G.; Healy, Ryan; Ziai, Wendy; Ponce-Mejia, Luciano; Anderson-White, Mirinda; Shah, Dhaval; Radzik, Batya R.; Palmisano, Caitlin; Hogue, Charles W.; Brown, Charles; Rivera-Lara, Lucia			Effect of Body Temperature on Cerebral Autoregulation in Acutely Comatose Neurocritically Ill Patients	CRITICAL CARE MEDICINE			English	Article						autoregulation; coma; hypothermia; neurocritical care; temperature	NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; LENGTH-OF-STAY; BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; CARDIAC-ARREST; CEREBROVASCULAR AUTOREGULATION; CARDIOPULMONARY-RESUSCITATION; INTRACEREBRAL HEMORRHAGE	Objectives: Impaired cerebral autoregulation following neurologic injury is a predictor of poor clinical outcome. We aimed to assess the relationship between body temperature and cerebral autoregulation in comatose patients. Design: Retrospective analysis of prospectively collected data. Setting: Neurocritical care unit of the Johns Hopkins Hospital. Patients: Eighty-five acutely comatose patients (Glasgow Coma Scale score of 8) admitted between 2013 and 2017. Interventions: None. Measurement and Main Results: Cerebral autoregulation was monitored using multimodal monitoring with near-infrared spectroscopy-derived cerebral oximetry index. Cerebral oximetry index was calculated as a Pearson correlation coefficient between low-frequency changes in regional cerebral oxygenation saturation and mean arterial pressure. Patients were initially analyzed together, then stratified by temperature pattern over the monitoring period: no change (< 1 degrees C difference between highest and lowest temperatures; n = 11), increasing ( 1 degrees C; n = 9), decreasing ( 1 degrees C; n = 9), and fluctuating ( 1 degrees C difference but no sustained direction of change; n = 56). Mixed random effects models with random intercept and multivariable logistic regression analysis were used to assess the association between hourly temperature and cerebral oximetry index, as well as between temperature and clinical outcomes. Cerebral oximetry index showed a positive linear relationship with temperature ( = 0.040.10; p = 0.29). In patients where a continual increase or decrease in temperature was seen during the monitoring period, every 1 degrees C change in temperature resulted in a cerebral oximetry index change in the same direction by 0.04 +/- 0.01 (p < 0.001) and 0.02 +/- 0.01 (p = 0.12), respectively, after adjusting for Paco(2), hemoglobin, mean arterial pressure, vasopressor and sedation use, and temperature probe location. There was no significant difference in mortality or poor outcome (modified Rankin Scale score of 4-6) between temperature pattern groups at discharge, 3, or 6 months. Conclusions: In acute coma patients, increasing body temperature is associated with worsening cerebral autoregulation as measured by cerebral oximetry index. More studies are needed to clarify the impact of increasing temperature on cerebral autoregulation in patients with acute brain injury.	[Adatia, Krishma] Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England; [Geocadin, Romergryko G.; Ziai, Wendy; Rivera-Lara, Lucia] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Geocadin, Romergryko G.; Healy, Ryan; Ziai, Wendy; Ponce-Mejia, Luciano; Anderson-White, Mirinda; Shah, Dhaval; Radzik, Batya R.; Palmisano, Caitlin; Hogue, Charles W.; Brown, Charles; Rivera-Lara, Lucia] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA		Adatia, K (corresponding author), Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England.	krishma.adatia@googlemail.com	Adatia, Krishma/AAQ-1340-2020; Rivera-Lara, Lucia/AAX-8233-2020	Adatia, Krishma/0000-0001-8877-071X; Rivera-Lara, Lucia/0000-0002-9053-2283	Headsense; MedtronicMedtronic; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Covidien/Medtronic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL092259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K76AG057020] Funding Source: NIH RePORTER	Dr. Ziai received funding from Headsense. Dr. Hogue received funding from Medtronic (advisory board; Medtronic makes near-infrared spectroscopy monitors), and he disclosed off-label product use of autoregulation monitoring. Drs. Hogue and Brown received support for article research from the National Institutes of Health. Dr. Brown's institution received funding from Medtronic. Dr. Rivera-Lara disclosed a grant from Covidien/Medtronic that provided equipment for monitoring. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Alderliesten T, 2014, NEUROIMAGE, V85, P255, DOI 10.1016/j.neuroimage.2013.07.015; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Bein B, 2006, EUR J ANAESTH, V23, P501, DOI 10.1017/S0265021506000366; Bohman LE, 2014, CURR OPIN CRIT CARE, V20, P182, DOI 10.1097/MCC.0000000000000070; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Cremer OL, 2004, ANESTHESIOLOGY, V100, P1101, DOI 10.1097/00000542-200405000-00011; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Erickson RS, 2007, AM J CRIT CARE, V16, P485; Fujita M, 2012, J NEUROTRAUM, V29, P1491, DOI 10.1089/neu.2011.2278; Geocadin RG, 2017, NEUROLOGY, V88, P2141, DOI 10.1212/WNL.0000000000003966; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; HEILBRUN MP, 1972, J NEUROSURG, V37, P36, DOI 10.3171/jns.1972.37.1.0036; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Lee JK, 2011, CRIT CARE MED, V39, P2337, DOI 10.1097/CCM.0b013e318223b910; Naidech AM, 2009, NEUROCRIT CARE, V10, P11, DOI 10.1007/s12028-008-9148-x; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Oeinck M, 2013, STROKE, V44, P2722, DOI 10.1161/STROKEAHA.113.001913; Ogoh S, 2014, ANESTH ANALG, V118, P823, DOI 10.1213/ANE.0000000000000145; Ono M, 2013, ANESTH ANALG, V116, P198, DOI 10.1213/ANE.0b013e318271fb10; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; Rivera-Lara L, 2017, NEUROCRIT CARE, V27, P362, DOI 10.1007/s12028-017-0421-8; Rivera-Lara L, 2017, ANESTHESIOLOGY, V126, P1187, DOI 10.1097/ALN.0000000000001625; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Schramm P, 2012, CRIT CARE, V16, DOI 10.1186/cc11665; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; Sundgreen C, 2001, STROKE, V32, P128, DOI 10.1161/01.STR.32.1.128; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Vretzakis G, 2014, J THORAC DIS, V6, pS60, DOI 10.3978/j.issn.2072-1439.2013.10.22; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	43	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2018	46	8					E733	E741		10.1097/CCM.0000000000003181			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM7RM	WOS:000438391400001	29727362	Green Accepted			2022-02-06	
J	Albanese, BJ; Macatee, RJ; Boffa, JW; Bryan, CJ; Zvolensky, MJ; Schmidt, NB				Albanese, Brian J.; Macatee, Richard J.; Boffa, Joseph W.; Bryan, Craig J.; Zvolensky, Michael J.; Schmidt, Norman B.			Interactive Effects of Traumatic Brain Injury and Anxiety Sensitivity on PTSD Symptoms: A Replication and Extension in Two Clinical Samples	COGNITIVE THERAPY AND RESEARCH			English	Article						Post-traumatic stress disorder (PTSD); Anxiety sensitivity; Traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; STATE WORRY QUESTIONNAIRE; COGNITIVE CONCERNS; GENDER-DIFFERENCES; MENTAL-HEALTH; SUICIDE RISK; INTERVENTION; ASSOCIATIONS; VALIDATION; DIMENSIONS	Traumatic brain injury is prevalent and linked with heightened risk for post-traumatic stress symptoms, yet little research has investigated the role of well-established cognitive-affective risk factors in explaining this association. The present study addressed this gap by evaluating if elevations in anxiety sensitivity global score and subscales (cognitive concerns, physical concerns, social concerns) potentiated the effects of traumatic brain injury history on post-traumatic stress symptoms in two clinical samples: trauma-exposed smokers (n = 256; study 1) and trauma-exposed treatment-seeking adults (n = 117; study 2). Both samples revealed a significant interaction such that traumatic brain injury was more strongly linked with post-traumatic stress symptoms among those with high anxiety sensitivity cognitive concerns. In addition, anxiety sensitivity cognitive concerns demonstrated a stronger relationship with post-traumatic stress symptoms among those with a traumatic brain injury history. Taken together, these results of both studies underscore the importance of anxiety sensitivity cognitive concerns in the association of traumatic brain injury and posttraumatic stress symptoms.	[Albanese, Brian J.; Macatee, Richard J.; Boffa, Joseph W.; Schmidt, Norman B.] Florida State Univ, Dept Psychol, 1107 W Call St, Tallahasssee, FL 32306 USA; [Bryan, Craig J.] Natl Ctr Vet Studies, Salt Lake City, UT USA; [Bryan, Craig J.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Zvolensky, Michael J.] Univ Houston, Dept Psychol, Houston, TX USA		Schmidt, NB (corresponding author), Florida State Univ, Dept Psychol, 1107 W Call St, Tallahasssee, FL 32306 USA.	schmidt@psy.fsu.edu	Schmidt, Norman B/C-6426-2015	Schmidt, Norman B/0000-0003-4125-9601	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH076629]; Military Suicide Research Consortium (MSRC); Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0181]; National Institute of Health Integrated Clinical Neuroscience Training for Translational Research [4T32MH093311-05]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH093311, R01MH076629] Funding Source: NIH RePORTER	Study 1 was funded in part by a Grant from the NIH (R01-MH076629). Study 2 was in part supported by the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-10-2-0181. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the MSRC or the Department of Defense. This work was also in part supported by the National Institute of Health Integrated Clinical Neuroscience Training for Translational Research (4T32MH093311-05). Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the National Institute of Health.	Albanese BJ, 2017, COGNITIVE THER RES, V41, P902, DOI 10.1007/s10608-017-9863-8; Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Allan NP, 2015, COGN BEHAV THERAPY, V44, P512, DOI 10.1080/16506073.2015.1075227; Asmundson Gordon J. G., 2008, Cognitive Behaviour Therapy, V37, P66, DOI 10.1080/16506070801969005; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bardeen JR, 2016, J PSYCHOPATHOL BEHAV, V38, P320, DOI 10.1007/s10862-015-9522-x; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boffa JW, 2016, BEHAV THER, V47, P367, DOI 10.1016/j.beth.2016.02.006; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Capron DW, 2017, J PSYCHIATR RES, V85, P75, DOI 10.1016/j.jpsychires.2016.11.003; Capron DW, 2016, BEHAV RES THER, V81, P47, DOI 10.1016/j.brat.2016.04.001; Chavarria J, 2015, J STUD ALCOHOL DRUGS, V76, P957, DOI 10.15288/jsad.2015.76.957; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Farris SG, 2015, PSYCHOL ASSESSMENT, V27, P1123, DOI 10.1037/pas0000112; Fergus TA, 2012, PERS INDIV DIFFER, V53, P213, DOI 10.1016/j.paid.2012.03.017; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Fresco DM, 2002, BEHAV RES THER, V40, P313, DOI 10.1016/S0005-7967(00)00113-3; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Hayes A.F., 2012, PROCESS VERSATILE CO; HAYS RD, 1994, J CONSULT CLIN PSYCH, V62, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jones CR, 2012, SOC PSYCHOL PERS SCI, V3, P556, DOI 10.1177/1948550611430166; Kraemer HC, 1997, ARCH GEN PSYCHIAT, V54, P337; Leyro TM, 2013, PSYCHOL ADDICT BEHAV, V27, P90, DOI 10.1037/a0029423; Marshall GN, 2010, J ABNORM PSYCHOL, V119, P143, DOI 10.1037/a0018009; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; McDermott MJ, 2009, J ANXIETY DISORD, V23, P591, DOI 10.1016/j.janxdis.2009.01.006; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Norr AM, 2016, PERS INDIV DIFFER, V90, P210, DOI 10.1016/j.paid.2015.11.014; Norr AM, 2015, J PSYCHIATR RES, V62, P101, DOI 10.1016/j.jpsychires.2015.01.014; Olatunji BO, 2009, PSYCHOL BULL, V135, P974, DOI 10.1037/a0017428; Raines AM, 2017, COGN BEHAV THERAPY, V46, P162, DOI 10.1080/16506073.2016.1244559; Reiss S., 1985, THEORETICAL ISSUES B, P107; Richardson JD, 2014, PSYCHIAT RES, V218, P118, DOI 10.1016/j.psychres.2014.04.008; Richey JA, 2012, BEHAV THER, V43, P285, DOI 10.1016/j.beth.2011.06.004; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scheftner W., 1984, 1753 W C PARKW CHIC; Schmidt NB, 2016, BEHAV RES THER, V77, P138, DOI 10.1016/j.brat.2015.12.011; Schmidt NB, 2014, J CONSULT CLIN PSYCH, V82, P1023, DOI 10.1037/a0036651; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2006, NEUROLOGY, V66, pA235; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stewart SH, 1997, J ANXIETY DISORD, V11, P179, DOI 10.1016/S0887-6185(97)00005-4; TAYLOR S, 2003, J COGN PSYCHOTHER, V17, P179, DOI DOI 10.1891/088983903780906147; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tucker P, 2000, J BEHAV HEALTH SER R, V27, P406, DOI 10.1007/BF02287822; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vujanovic Anka A., 2008, Cognitive Behaviour Therapy, V37, P76, DOI 10.1080/16506070801969039; Watson D, 2007, PSYCHOL ASSESSMENT, V19, P253, DOI 10.1037/1040-3590.19.3.253; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zvolensky MJ, 2016, PSYCHIAT RES, V243, P35, DOI 10.1016/j.psychres.2016.06.006	69	5	5	1	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0147-5916	1573-2819		COGNITIVE THER RES	Cogn. Ther. Res.	AUG	2018	42	4					510	523		10.1007/s10608-017-9883-4			14	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GI0CV	WOS:000434037900014	29881128	Green Accepted			2022-02-06	
J	Bardes, JM; Benjamin, E; Escalante, AA; Wu, JL; Demetriades, D				Bardes, James M.; Benjamin, Elizabeth; Escalante, Agustin Alvarez; Wu, Jinglan; Demetriades, Demetrios			Severe traumatic brain injuries in children: Does the type of trauma center matter?	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric; Traumatic brain injury; Trauma center designation	MORTALITY; PREDICTION; OUTCOMES	Background: Traumatic brain injury (TBI) is the leading cause of death among injured children. Depending on geographic location, and trauma resources, pediatric patients may be treated at pediatric (PTC), adult (ATC), or mixed trauma centers (MTC). The effect of the type of trauma center on outcomes in severe TBI is not known. Methods: NTDB study (2007-2014), level 1 trauma centers, patients <= 14 years with severe isolated TBI (head AIS >= 3 and extracranial AIS <= 2). Demographic, clinical and injury characteristics were abstracted. Logistic regression was used to compare outcomes between the three types of trauma centers. Results: 10,402 patients met inclusion criteria 4430 (42.6%) were admitted in PTC, 4044 (38.9%) in ATC and 1928 (18.5%) in MTC. Overall, 39.9% of patients had head AIS 3. 55.5% had AIS 4 and 4.6% AIS 5. Mortality was 3.2% (2.0% in PTC, 4.5% in ATC and 3.3% in MTC). On logistic regression, treatment at ATC was associated with significantly higher mortality than PTC (OR 1.55, p = 0.011). There was no significant difference between PTC and MTC (p = 0.394). There was no significant difference in mortality between the 3 types of trauma centers in the subgroups of patients with head AIS 3 or 5. However, patients with head AIS 4 treated at MTC had significantly lower mortality (OR 0.163, 95% CI 0.053-0.501, p = 0.002). Conclusion: Patients with isolated severe TBI treated at PTC have significantly better survival than patients treated at ATC, but not MTC. In the subgroup of patients with isolated TBI and a head AIS score of 4, patients treated at MTC have improved survival than those treated at PTC. (C) 2017 Elsevier Inc. All rights reserved.	[Bardes, James M.; Benjamin, Elizabeth; Escalante, Agustin Alvarez; Wu, Jinglan; Demetriades, Demetrios] Univ Southern Calif Los Angeles, Div Trauma & Crit Care, Los Angeles, CA USA		Bardes, JM (corresponding author), Los Angeles Cty Univ Southern Calif, Med Ctr, Div Trauma & Crit Care, 2051 Marengo St,IPT C5L100, Los Angeles, CA 90033 USA.	james.bardes@med.usc.edu; Elizabeth.benjamin@med.usc.edu; apa_320@usc.edu; doctorwu99@126.com; Demetrios.Demetriades@med.usc.edu	Benjamin, Elizabeth/AAD-2457-2020	Bardes, James/0000-0002-9361-6263			Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Dreyfus J, 2016, J PEDIATR SURG, V51, P1693, DOI 10.1016/j.jpedsurg.2016.04.005; Miyata S, 2017, J PEDIAT SURG; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Petrosyan M, 2009, J TRAUMA, V67, pS114, DOI 10.1097/TA.0b013e3181ad3251; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; U.S. GOV'T ACCOUNTABILITY OFFICE, 2017, GAO17243, P1; United States Department of the Army, 2006, COV REIMB GEN TESTS, P1; Webman RB, 2016, JAMA PEDIATR, V170, P780, DOI 10.1001/jamapediatrics.2016.0805	11	5	5	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	AUG	2018	53	8					1523	1525		10.1016/j.jpedsurg.2017.09.017			3	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GO0AC	WOS:000439577000012	29074134				2022-02-06	
J	Bosma, CM; Mansoor, N; Haller, CS				Bosma, Colin M.; Mansoor, Nashwa; Haller, Chiara S.			Association of Posttraumatic Stress Symptom Severity With Health-Related Quality of Life and Self-Reported Functioning Across 12 Months After Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Quality of life; Rehabilitation; Stress disorders, post-traumatic; Traumatic brain injury	EMOTION REGULATION DIFFICULTIES; SOCIAL SUPPORT; DISORDER; PTSD; SURVIVORS; SCALE; VETERANS; RECOVERY; ANXIETY; IRAQ	Objective: To investigate the relation between posttraumatic stress (PTS) symptom severity and health-related quality of life (HRQoL) after severe traumatic brain injury (TBI). Design: Longitudinal prospective multicenter, cohort study on severe TBI in Switzerland (2007-2011). Setting: Hospital, rehabilitation unit, and/or patient's living facility. Participants: Patients with severe TBI (N=109) were included in the analyses. Injury severity was determined using the Abbreviated Injury Score of the head region after clinical assessment and initial computed tomography scan. Interventions: Not applicable. Main Outcome Measures: HRQoL (Medical Outcomes Study 12-Item Short-Form Health Survey Physical and Mental Component Summaries) and self-reported emotional, cognitive, and interpersonal functioning (Patient Competency Rating Scale for Neurorehabilitation). Results: Multilevel models for patients >50 and <= 50 years of age revealed significant negative associations between PTS symptom severity and interpersonal functioning (P<.001 and P=.002), respectively. Among patients <= 50 years of age, PTS symptom severity was significantly associated with total functioning (P=.001) and emotional functioning (P<.001). Among all patients, PTS symptom severity was significantly associated with cognitive functioning (P<.001) and mental HRQoL (P=.01). Conclusions: Findings indicate that PTS symptoms after severe TBI are negatively associated with HRQoL and emotional, cognitive, and interpersonal functioning. (C) 2018 by the American Congress of Rehabilitation Medicine	[Bosma, Colin M.] Univ Maine, Dept Psychol, Orono, ME 04469 USA; [Bosma, Colin M.; Mansoor, Nashwa; Haller, Chiara S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Haller, Chiara S.] Massachusetts Mental Hlth Ctr, Div Publ Psychiat, Boston, MA 02115 USA		Haller, CS (corresponding author), Harvard Univ, 33 Kirkland St, Cambridge, MA 02138 USA.	haller@fas.harvard.edu		Bosma, Colin/0000-0002-4828-6023			Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Amstadter A, 2008, J ANXIETY DISORD, V22, P211, DOI 10.1016/j.janxdis.2007.02.004; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Association. AP, 2013, DIAGNOSTIC STAT MANU, V5; Bayen E, 2012, ANN PHYS REHABIL MED, V55, pe359; Beck J.G., 2010, INTERPERSONAL PROCES, P179, DOI [DOI 10.1037/12084-007, 10.1037/12084-007]; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryant RA, 2000, AM J PSYCHIAT, V12, P316; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Clapp JD, 2009, BEHAV RES THER, V47, P237, DOI 10.1016/j.brat.2008.12.006; Cloitre M, 2005, BEHAV THER, V36, P119, DOI 10.1016/S0005-7894(05)80060-7; Deb S, 1999, AM J PSYCHIAT, V156, P374; DiGangi JA, 2017, PROG NEURO-PSYCHOPH, V75, P63, DOI 10.1016/j.pnpbp.2017.01.004; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Donnelly JP, 2005, BRAIN INJURY, V19, P1077, DOI 10.1080/02699050500110728; Ehring T, 2010, BEHAV THER, V41, P587, DOI 10.1016/j.beth.2010.04.004; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fang SC, 2015, J WOMENS HEALTH, V24, P1038, DOI 10.1089/jwh.2014.5096; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Haller CS, 2017, J PERS, V85, P481, DOI 10.1111/jopy.12254; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Haller CS, 2017, QUAL LIFE RES, V26, P893, DOI 10.1007/s11136-016-1416-1; Haller CS, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14177; Haller CS, SEVERE TRAUMATIC BRA; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hill A, 2007, DATA ANAL USING REGR; Hodgson NF, 2000, CAN J SURG, V43, P130; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; Kool B, 2012, NEUROEPIDEMIOLOGY, V38, P179, DOI 10.1159/000337261; Lunney CA, 2007, J TRAUMA STRESS, V20, P955, DOI 10.1002/jts.20269; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; Phillips LH, 2008, J GERONTOL B-PSYCHOL, V63, pP138, DOI 10.1093/geronb/63.3.P138; Pielmaier L, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.8749; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Siegrist P., 2010, TRAUMA GEWALT, V4, P208; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; TEASDALE G, 1974, LANCET, V2, P81; Tull MT, 2007, BEHAV THER, V38, P303, DOI 10.1016/j.beth.2006.10.001; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	65	5	6	1	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2018	99	8					1576	1583		10.1016/j.apmr.2018.02.008			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GP0VE	WOS:000440528500018	29545000				2022-02-06	
J	Carrier-Toutant, F; Guay, S; Beaulieu, C; Leveille, E; Turcotte-Giroux, A; Papineau, SD; Brisson, B; D'Hondt, F; De Beaumont, L				Carrier-Toutant, Frederike; Guay, Samuel; Beaulieu, Christelle; Leveille, Edith; Turcotte-Giroux, Alexandre; Papineau, Samael D.; Brisson, Benoit; D'Hondt, Fabien; De Beaumont, Louis			Effects of Repeated Concussions and Sex on Early Processing of Emotional Facial Expressions as Revealed by Electrophysiology	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Event-related potentials; Long-term effects; EEG; EFE; Brain concussion; ERP; P1 N1; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; SPORTS-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; RECOGNITION; FACE; ATTENTION; ADULTS; ERP; DEPRESSION	Objectives: Concussions affect the processing of emotional stimuli. This study aimed to investigate how sex interacts with concussion effects on early event-related brain potentials (ERP) measures (P1, N1) of emotional facial expressions (EFE) processing in asymptomatic, multi-concussion athletes during an EFE identification task. Methods: Forty control athletes (20 females and 20 males) and 43 multi-concussed athletes (22 females and 21 males), recruited more than 3 months after their last concussion, were tested. Participants completed the Beck Depression Inventory II, the Beck Anxiety Inventory, the Post-Concussion Symptom Scale, and an Emotional Facial Expression Identification Task. Pictures of male and female faces expressing neutral, angry, and happy emotions were randomly presented and the emotion depicted had to be identified as fast as possible during EEG acquisition. Results: Relative to controls, concussed athletes of both sex exhibited a significant suppression of P1 amplitude recorded from the dominant right hemisphere while performing the emotional face expression identification task. The present study also highlighted a sex-specific suppression of the N1 component amplitude after concussion which affected male athletes. Conclusions: These findings suggest that repeated concussions alter the typical pattern of right-hemisphere response dominance to EFE in early stages of EFE processing and that the neurophysiological mechanisms underlying the processing of emotional stimuli are distinctively affected across sex.	[Carrier-Toutant, Frederike; Beaulieu, Christelle; Turcotte-Giroux, Alexandre; Papineau, Samael D.; Brisson, Benoit] Univ Quebec Trois Rivieres, Trois Rivieres, PQ, Canada; [Guay, Samuel; Leveille, Edith; De Beaumont, Louis] Hop Sacre Coeur Montreal, Res Ctr, 5400 Blvd,Gouin O, Montreal, PQ H4J 1C5, Canada; [Guay, Samuel] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Leveille, Edith] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [D'Hondt, Fabien] Univ Montreal, Ctr Hosp Univ St Justine, Ctr Rech, Montreal, PQ, Canada; [D'Hondt, Fabien] Univ Lille, Sci Cognit & Sci Affect, SCALab UMR CNRS 9193, Lille, France; [D'Hondt, Fabien] CHU Lille, Clin Psychiat, Lille, France; [De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ, Canada		De Beaumont, L (corresponding author), Hop Sacre Coeur Montreal, Res Ctr, 5400 Blvd,Gouin O, Montreal, PQ H4J 1C5, Canada.	louis.de.beaumont@umontreal.ca		Guay, Samuel/0000-0001-6990-839X; Guay, Stephane/0000-0001-9638-3242; Brisson, Benoit/0000-0002-3717-3365; D'Hondt, Fabien/0000-0001-5683-0490	UQTR Research Chair on the Neurobiology of traumatic brain injury	The authors declare no conflict of interests. This work was supported by the UQTR Research Chair on the Neurobiology of traumatic brain injury awarded to LDB.	Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1993, BECK ANXIETY INVENTO; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; BURKHART MA, 1993, ELECTROEN CLIN NEURO, V88, P42, DOI 10.1016/0168-5597(93)90027-M; Carton JS, 1999, J NONVERBAL BEHAV, V23, P91, DOI 10.1023/A:1021339410262; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; CICONE M, 1980, CORTEX, V16, P145, DOI 10.1016/S0010-9452(80)80029-3; D'Hondt F, 2017, COGN AFFECT BEHAV NE, V17, P124, DOI 10.3758/s13415-016-0467-7; Dai Q, 2011, CLIN NEUROPHYSIOL, V122, P52, DOI 10.1016/j.clinph.2010.05.025; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Demenescu LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015058; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; FARACE E, 2000, NEUROSURGICAL FOCUS, V0008, P00001, DOI [DOI 10.3171/F0C.2000.8.1.152, DOI 10.3171/foc.2000.8.1.152]; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hajcak G., 2012, OXFORD HDB EVENT REL; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Halit H, 2000, NEUROREPORT, V11, P1871, DOI 10.1097/00001756-200006260-00014; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Handy TC, 2005, EVENT RELATED POTENT; Hecht S, 2005, CLIN J SPORT MED, V15, P281, DOI DOI 10.1097/01.jsm.0000172669.85640.05; Heller W, 1998, CURR DIR PSYCHOL SCI, V7, P26, DOI 10.1111/1467-8721.ep11521823; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Holmes A, 2006, NEUROSCI LETT, V394, P48, DOI 10.1016/j.neulet.2005.10.002; Holmes A, 2005, COGNITIVE BRAIN RES, V25, P508, DOI 10.1016/j.cogbrainres.2005.08.003; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; KESTENBAUM R, 1992, J EXP CHILD PSYCHOL, V54, P1, DOI 10.1016/0022-0965(92)90014-W; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAURIAN S, 1991, INT J PSYCHOPHYSIOL, V10, P231, DOI 10.1016/0167-8760(91)90033-T; Leveille E., 2016, J INT NEUROPSYCH SOC, V22, P1; Luck S. J., 2011, OXFORD HDB EVENT REL; Luck S. J., 2005, INTRO EVENT RELATED, P45; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mainwaring L, 2012, J CLIN SPORT PSYCHOL, V6, P247, DOI 10.1123/jcsp.6.3.247; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Munte TF, 1998, NEUROSCI RES, V30, P25, DOI 10.1016/S0168-0102(97)00118-1; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Olivares EI, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/514361; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Proverbio AM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-44; Rigoulot S, 2012, NEUROPSYCHOLOGIA, V50, P2887, DOI 10.1016/j.neuropsychologia.2012.08.015; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Soo C., 2012, SOCIAL ANXIETY ITS T; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/00001756-200404090-00007; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; Utama NP, 2009, NEUROSCI RES, V64, P30, DOI 10.1016/j.neures.2009.01.009	71	5	5	1	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2018	24	7					673	683		10.1017/S1355617718000231			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	GR6FA	WOS:000442739900003	29729683	Bronze			2022-02-06	
J	Chau, A; Zhong, WT; Gordon, B; Krueger, F; Grafman, J				Chau, Aileen; Zhong, Wanting; Gordon, Barry; Krueger, Frank; Grafman, Jordan			Anterior insula lesions and alexithymia reduce the endorsements of everyday altruistic attitudes	NEUROPSYCHOLOGIA			English	Article						Altruistic attitudes; Alexithymia; Anterior insula; Voxel-based lesion-symptom mapping	PRO-SOCIAL ATTITUDES; INDIVIDUAL-DIFFERENCES; NEURAL RESPONSES; PERSPECTIVE-TAKING; PROSOCIAL BEHAVIOR; COGNITIVE EMPATHY; SCALE; IMPACT; MOTIVATIONS; CONCURRENT	Neuroimaging studies have reported a large network of brain regions involved in altruism. However, these studies are unable to determine if these regions are necessary for altruistic attitudes. Here, we examined the brain-basis of everyday altruistic attitudes ([Self-Report Altruism Scale]; e.g., helping a stranger with car troubles) and potential factors (i.e., alexithymia [Toronto Alexithymia Scale] such as empathic concern [Interpersonal Reactivity Index]) that may moderate this relationship. We carried out whole-brain voxel-based lesion-symptom mapping and region of interest analyses to study a large sample of patients (n = 130) with penetrating traumatic brain injuries. Our results showed that the effect of anterior insula (AI) lesions was moderated by alexithymia, but not empathic concern. The presence of AI lesions, as well as increased alexithymia, were associated with fewer endorsements of resource-costly altruistic attitudes. Empathic concern was positively correlated with endorsements of resource-costly altruistic attitudes. Taken together, our study provides direct evidence that the AI and alexithymia play crucial roles in everyday altruistic attitudes and reinforces the importance of the emotional experience in altruism.	[Chau, Aileen; Zhong, Wanting; Grafman, Jordan] Shirley Ryan AbilityLab, Think Speak Lab, Cognit Neurosci Lab, 355 East Erie St, Chicago, IL 60611 USA; [Zhong, Wanting; Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Zhong, Wanting; Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL 60208 USA; [Gordon, Barry] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gordon, Barry] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Krueger, Frank] Univ Mannheim, Dept Psychol, Mannheim, Germany; [Grafman, Jordan] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Cognit Neurol & Alzheimers Dis, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Psychiat, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Behav Sci & Psychol, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Neurol, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Dept Cognit Neurol & Alzheimers Dis, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Dept Psychiat, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Dept Behav Sci & Psychol, Evanston, IL 60208 USA		Chau, A; Grafman, J (corresponding author), Shirley Ryan AbilityLab, Think Speak Lab, Cognit Neurosci Lab, 355 East Erie St, Chicago, IL 60611 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Evanston, IL 60208 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Cognit Neurol & Alzheimers Dis, Chicago, IL 60611 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Psychiat, Chicago, IL 60611 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Behav Sci & Psychol, Chicago, IL 60611 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Neurol, Evanston, IL 60208 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Cognit Neurol & Alzheimers Dis, Evanston, IL 60208 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Psychiat, Evanston, IL 60208 USA.; Grafman, J (corresponding author), Northwestern Univ, Dept Behav Sci & Psychol, Evanston, IL 60208 USA.	achau@sralab.org; jgrafman@northwestern.edu		Zhong, Wanting/0000-0002-6025-1739	U.S. National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Therapeutic Cognitive Neuroscience Fund	This research was conducted at the National Institutes of Health Clinical Research Center and supported by U.S. National Institute of Neurological Disorders and Stroke Intramural Research Program. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the U.S. Government. This research was also partly supported by the Therapeutic Cognitive Neuroscience Fund (A.C., B.G., J.G.).	Afif AM, 2013, STEREOT FUNCT NEUROS, V91, P116; Ajzen I, 2001, ANNU REV PSYCHOL, V52, P27, DOI 10.1146/annurev.psych.52.1.27; Aknin LB, 2015, J EXP PSYCHOL GEN, V144, P788, DOI 10.1037/xge0000082; Aknin LB, 2013, J PERS SOC PSYCHOL, V104, P635, DOI 10.1037/a0031578; Allport G., 1935, HDB SOCIAL PSYCHOL, P789; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; BATSON CD, 1991, J PERS SOC PSYCHOL, V61, P413, DOI 10.1037/0022-3514.61.3.413; Beadle JN, 2013, ANN CLIN PSYCHIATRY, V25, P107; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bellucci G, 2017, HUM BRAIN MAPP, V38, P1233, DOI 10.1002/hbm.23451; Bernhardt BC, 2014, CEREB CORTEX, V24, P3258, DOI 10.1093/cercor/bht182; Bethlehem RAI, 2017, SOC NEUROSCI-UK, V12, P743, DOI 10.1080/17470919.2016.1249944; Bird G, 2013, T PSYCHIAT, V3, P2158; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Bockler A, 2016, SOC PSYCHOL PERS SCI, V7, P530, DOI 10.1177/1948550616639650; Boucher O, 2015, NEUROPSYCHOLOGIA, V71, P1, DOI 10.1016/j.neuropsychologia.2015.03.008; Campanella F, 2014, BRAIN, V137, P2532, DOI 10.1093/brain/awu183; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Cerliani L, 2012, HUM BRAIN MAPP, V33, P2005, DOI 10.1002/hbm.21338; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Cloutman LL, 2012, NEUROIMAGE, V59, P3514, DOI 10.1016/j.neuroimage.2011.11.016; Crivello F, 2002, HUM BRAIN MAPP, V16, P228, DOI 10.1002/hbm.10047; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; Duerden EG, 2013, NEUROIMAGE, V78, P159, DOI 10.1016/j.neuroimage.2013.04.014; Eisenberg N, 2014, DEV PSYCHOL, V50, P58, DOI 10.1037/a0032990; Feigin S, 2014, ANN NEUROSCI PSYCHOL, V1; FeldmanHall O, 2015, NEUROIMAGE, V105, P347, DOI 10.1016/j.neuroimage.2014.10.043; FeldmanHall O, 2013, CORTEX, V49, P899, DOI 10.1016/j.cortex.2012.10.015; Foulkes L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121018; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; Gu XS, 2012, BRAIN, V135, P2726, DOI 10.1093/brain/aws199; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hein G, 2016, SCIENCE, V351, P1074, DOI 10.1126/science.aac7992; Hein G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022759; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hogeveen J, 2016, NEUROPSYCHOLOGIA, V82, P142, DOI 10.1016/j.neuropsychologia.2016.01.021; Janoski T, 1998, SOCIOL FORUM, V13, P495, DOI 10.1023/A:1022131525828; Jonason PK, 2013, PERS INDIV DIFFER, V55, P532, DOI 10.1016/j.paid.2013.04.027; Jongen S, 2014, BEHAV BRAIN RES, V271, P129, DOI 10.1016/j.bbr.2014.05.069; Kahana E, 2013, J AGING HEALTH, V25, P159, DOI 10.1177/0898264312469665; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Kim S., 2015, ppcor: Partial and semi-partial (part) correlation (R package version 1.1); Kodumuri N, 2016, NEUROIMAGE-CLIN, V11, P41, DOI 10.1016/j.nicl.2016.01.007; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Kroll A, 2013, SOEP PAPERS MULTIDIS; Kvaal K, 2005, INT J GERIATR PSYCH, V20, P629, DOI 10.1002/gps.1330; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Lewis GB, 2002, PUBLIC ADMIN REV, V62, P395, DOI 10.1111/0033-3352.00193; Luminet O, 2004, COGNITION EMOTION, V18, P741, DOI 10.1080/02699930341000275; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Maner JK, 2002, PERS SOC PSYCHOL B, V28, P1601, DOI 10.1177/014616702237586; Marsh N, 2015, J NEUROSCI, V35, P15696, DOI 10.1523/JNEUROSCI.3199-15.2015; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Mathur VA, 2010, NEUROIMAGE, V51, P1468, DOI 10.1016/j.neuroimage.2010.03.025; Mattis JS, 2009, AM J COMMUN PSYCHOL, V43, P71, DOI 10.1007/s10464-008-9217-5; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Moll J, 2018, BRAIN, V141, P1558, DOI 10.1093/brain/awy064; Morelli SA, 2014, SOC COGN AFFECT NEUR, V9, P39, DOI 10.1093/scan/nss088; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Nilsson J, 2008, J BUS ETHICS, V83, P307, DOI 10.1007/s10551-007-9621-z; Patil I, 2017, NEUROANATOMICAL BASI; Patil I, 2014, J COGN PSYCHOL, V26, P597, DOI 10.1080/20445911.2014.929137; Patil I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00501; PEARCE PL, 1980, SOC PSYCHOL QUART, V43, P363, DOI 10.2307/3033956; Persson BN, 2016, J SOC PSYCHOL, V156, P610, DOI 10.1080/00224545.2016.1152212; R Core Team, 2016, R LANG ENV STAT COMP; Rameson LT, 2012, J COGNITIVE NEUROSCI, V24, P235, DOI 10.1162/jocn_a_00130; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Reker M, 2010, CORTEX, V46, P658, DOI 10.1016/j.cortex.2009.05.008; Revelle W., 2018, PSYCH PROCEDURES PER; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Safin V, 2015, BEHAV PROCESS, V116, P12, DOI 10.1016/j.beproc.2015.04.009; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Tusche A, 2016, J NEUROSCI, V36, P4719, DOI 10.1523/JNEUROSCI.3392-15.2016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valk SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700489; Wang XC, 2014, J NEURO-ONCOL, V117, P269, DOI 10.1007/s11060-014-1380-y; Weng HY, 2013, PSYCHOL SCI, V24, P1171, DOI 10.1177/0956797612469537; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Zanon M, 2014, NEUROIMAGE, V98, P134, DOI 10.1016/j.neuroimage.2014.04.053; ZUCKERMAN M, 1978, J PERS SOC PSYCHOL, V36, P498	92	5	5	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	AUG	2018	117						428	439		10.1016/j.neuropsychologia.2018.07.002			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	HA8LL	WOS:000450540800045	30033396				2022-02-06	
J	Dhillon, NK; Barmparas, G; Thomsen, GM; Patel, KA; Linaval, NT; Gillette, E; Margulies, DR; Ley, EJ				Dhillon, Navpreet K.; Barmparas, Galinos; Thomsen, Gretchen M.; Patel, Kavita A.; Linaval, Nikhil T.; Gillette, Emma; Margulies, Daniel R.; Ley, Eric J.			Nonoperative Management of Blunt Splenic Trauma in Patients with Traumatic Brain Injury: Feasibility and Outcomes	WORLD JOURNAL OF SURGERY			English	Article							HYPERTONIC SALINE; HEMORRHAGIC-SHOCK; SPLENECTOMY; COAGULOPATHY; ANGIOEMBOLIZATION; RESUSCITATION; EXPERIENCE; SYSTEM	Preventing secondary insult to the brain is imperative following traumatic brain injury (TBI). Although TBI does not preclude nonoperative management (NOM) of splenic injuries, development of hypotension in this setting may be detrimental and could therefore lead trauma surgeons to a lower threshold for operative intervention and a potentially higher risk of failure of NOM (FNOM). We hypothesized that the presence of a TBI in patients with blunt splenic injury would lead to a higher risk of FNOM. Patients with blunt splenic injury were selected from the National Trauma Data Bank research datasets from 2007 to 2011. TBI was defined as AIS head ae<yen> 3 and FNOM as patients who underwent a spleen-related operation after 2 h from admission. TBI patients were compared to those without head injury. The primary outcome was FNOM. Of 47,713 patients identified, 41,436 (86.8%) underwent a trial of NOM. FNOM was identical (10.6 vs. 10.8%, p = 0.601) among patients with and without TBI. TBI patients had lower adjusted odds for FNOM (AOR 0.66, p < 0.001), even among those with a high-grade splenic injury (AOR 0.68, p < 0.001). No difference in adjusted mortality was noted when comparing TBI patients with and without FNOM (AOR 1.01, p = 0.95). NOM of blunt splenic trauma in TBI patients has higher adjusted odds for success. This could be related to interventions targeting prevention of secondary brain injury. Further studies are required to identify those specific practices that lead to a higher success rate of NOM of splenic trauma in TBI patients.	[Dhillon, Navpreet K.; Barmparas, Galinos; Thomsen, Gretchen M.; Patel, Kavita A.; Linaval, Nikhil T.; Gillette, Emma; Margulies, Daniel R.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8635 West 3rd St,Suite 650 W, Los Angeles, CA 90048 USA		Barmparas, G (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8635 West 3rd St,Suite 650 W, Los Angeles, CA 90048 USA.	Navpreet.Dhillon@cshs.org; Galinos.Barmparas@cshs.org; Gretchen.Thomsen@cshs.org; Kavita.Patel@cshs.org; Nikhil.Linaval@cshs.org; Emma.Gillette@cshs.org; Daniel.Margulies@cshs.org; Eric.Ley@cshs.org	Barmparas, Galinos/L-6530-2019				Assalia A, 2001, SHOCK, V15, P307, DOI 10.1097/00024382-200115040-00010; Barmparas G, 2015, INT J SURG, V17, P10, DOI 10.1016/j.ijsu.2015.03.007; Bhullar IS, 2017, J TRAUMA ACUTE CARE, V82, P657, DOI 10.1097/TA.0000000000001366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coimbra R, 1996, J SURG RES, V64, P203, DOI 10.1006/jsre.1996.0329; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Demetriades D, 2012, J TRAUMA ACUTE CARE, V72, P229, DOI 10.1097/TA.0b013e31823fe0b6; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Gheju I, 2014, CHIRURGIA-BUCHAREST, V109, P433; Herbert JP, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070092; Huang Zhijun, 1998, Hunan Yike Daxue Xuebao, V23, P249; Jabbour G, 2017, MED SCI MONITOR, V23, P3383, DOI 10.12659/MSM.902438; Linnaus Maria E, 2017, J Trauma Acute Care Surg, V82, P672, DOI 10.1097/TA.0000000000001375; Liou DZ, 2016, NEUROCRIT CARE, V25, P145, DOI 10.1007/s12028-015-0223-9; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Motaharinia J, 2015, DARU, V23, DOI 10.1186/s40199-015-0130-9; Murphy EEK, 2015, J TRAUMA ACUTE CARE, V78, P930, DOI 10.1097/TA.0000000000000610; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Ogura T, 2015, J TRAUMA ACUTE CARE, V78, P132, DOI 10.1097/TA.0000000000000473; Salim A, 2008, J AM COLL SURGEONS, V207, P656, DOI 10.1016/j.jamcollsurg.2008.05.025; Stassen NA, 2012, J TRAUMA ACUTE CARE, V73, pS294, DOI 10.1097/TA.0b013e3182702afc; Teixeira PG, 2013, J TRAUMA ACUTE CARE, V75, P596, DOI 10.1097/TA.0b013e31829bb976; Tugnoli G, 2015, SURG TODAY, V45, P1210, DOI 10.1007/s00595-014-1084-0; Whalen EJ, 2014, MICROVASC RES, V91, P22, DOI 10.1016/j.mvr.2013.11.001; Whitaker-Lea WA, 2017, PHYS MED REH CLIN N, V28, P227, DOI 10.1016/j.pmr.2016.12.002	28	5	5	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	AUG	2018	42	8					2404	2411		10.1007/s00268-018-4494-0			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GM4NO	WOS:000438097800018	29387960				2022-02-06	
J	Kim, M; Ahn, JS; Park, W; Hong, SK; Jeon, SR; Roh, SW; Lee, S				Kim, Moinay; Ahn, Jae Sung; Park, Wonhyoung; Hong, Suk Kyung; Jeon, Sang Ryong; Roh, Sung Woo; Lee, Seungjoo			Diffuse axonal injury (DAI) in moderate to severe head injured patients: Pure DAI vs. non-pure DAI	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Brain injury; Diffuse axonal injury; Head injury; Head trauma; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; PROGNOSTIC VALUE; INTRAVENTRICULAR HEMORRHAGE; COMPUTED-TOMOGRAPHY; VEGETATIVE STATE; IMAGING FINDINGS; CORPUS-CALLOSUM; PRACTICAL SCALE; MRI; STEM	Objective: Diffuse axonal injury (DAI) is known to be associated with poor outcome. DAI often associates with other intracranial injuries but their distinct features have not been established. In this retrospective cohort study, we compared clinical outcomes between pure and non-pure DAI patients. Patients and Methods: Total of 1047 traumatic brain injury (TBI) patients visited our institute between 2011 and 2017. Age ranged between 15-85 years old and Glasgow coma scale (GCS) score less than 13 were included. DAI was diagnosed in 45 patients using CT and MRI and their clinical features and outcomes were compared depending on their associated cranial injury; 20 patients without evidence of associated injury (Pure DAI group) and other 25 patients with associated injury (Non-pure DAI group). DAI stage was adopted using Gentry, L.R. classification. Glasgow outcome scale (GOS) was measured at least 6 months after trauma to evaluate their functional outcome. Results: The mean age and follow-up period were 45.36 years and 15.09 months, respectively. There were no significant differences between pure and non-pure DAI groups regarding demographic data and clinical findings on their admission. Logistic regression model was used to examine the association between GOS and clinical factors. In this analysis, pure DAI was no significantly different to non-pure DAI (p = 0.607). However, DAI Stage, transfusion, and hypotension on admission were strongly related to poor outcome. Stage III showed sevenfold higher risk when compared to Stage I (p = 0.010). The risk was also high when Stage III was compare to Stage I and II (p = 0.002). Interestingly, no significant difference was observed between Stage I and II (p = 0.847). Conclusions: Unfavorable outcome was observed in 14 patients (31.11%) which was lower than we expected. Interestingly, non-pure DAI was no worse than pure DAI on their functional outcome. However, DAI Stage III was independently associated with poor outcome when compared to Stage I or I and II. Finally, we concluded that Stage II is clinically more related to Stage I, rather than Stage III.	[Kim, Moinay; Ahn, Jae Sung; Park, Wonhyoung; Jeon, Sang Ryong; Roh, Sung Woo; Lee, Seungjoo] Univ Ulsan, Asan Med Ctr, Dept Neurol Surg, Coll Med, 43gil Olymp Ro, Seoul 05505, South Korea; [Lee, Seungjoo] Univ Ulsan, Asan Med Ctr, Dept Neurosurg, Div Neurosurg Crit Care,Coll Med, Seoul 05505, South Korea; [Hong, Suk Kyung] Univ Ulsan, Asan Med Ctr, Dept Surg, Div Trauma & Surg Crit Care,Coll Med, Seoul 05505, South Korea		Lee, S (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Neurol Surg, Coll Med, 43gil Olymp Ro, Seoul 05505, South Korea.	rghree@amc.seoul.kr					Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1994, RADIOLOGY, V191, P1; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Henninger N., 2017, J TRAUMA ACUTE CARE; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Lee HS, 1990, J KOREAN NEUROSURG S, V19, P1101; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Park SJ, 2009, J KOREAN NEUROSURG S, V46, P205, DOI 10.3340/jkns.2009.46.3.205; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149	45	5	6	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2018	171						116	123		10.1016/j.clineuro.2018.06.011			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GO0YR	WOS:000439673100018	29909182				2022-02-06	
J	Mansur, A; Hauer, TM; Hussain, MW; Alatwi, MK; Tarazi, A; Khodadadi, M; Tator, CH				Mansur, Ann; Hauer, Tyler M.; Hussain, Mohammed Wasif; Alatwi, Mohammed K.; Tarazi, Apameh; Khodadadi, Mozhgan; Tator, Charles H.			A Nonliquid Crystal Display Screen Computer for Treatment of Photosensitivity and Computer Screen Intolerance in Post -Concussion Syndrome	JOURNAL OF NEUROTRAUMA			English	Article						computer screen intolerance; photosensitivity; post-concussion syndrome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CRITICAL FLICKER FREQUENCY; POSTCONCUSSION SYNDROME; RETROSPECTIVE ANALYSIS; CEREBRAL-CORTEX; COLORED GLASSES; HEAD-INJURY; SYMPTOMS; LIGHT; PHOTOPHOBIA	Liquid crystal display (LCD) screens refresh at a rate of 60 times per second, which can be perceived by concussed individuals who have photosensitivity, leading to computer intolerance. A non -LCD computer screen that refreshes at a much lower rate could relieve this photosensitivity and computer screen intolerance in patients with post -concussion syndrome (PCS). Twenty-nine patients with PCS, computer intolerance, and photosensitivity performed a reading task for a maximum of 30 min, with an LCD computer or a non -LCD device, and were given a comprehension test after completion of the reading task. The Sport Concussion Assessment Tool 3 was administered before and after each reading task. Symptom scores, amount of time spent reading, and performance on the comprehension tests were compared between the two devices. Patients also completed a self -report questionnaire of their subjective experience. The LCD screen computer produced significantly greater symptom exacerbation (median difference = 5, W = 315, p < 0.01) and a greater number of symptoms (median difference = 1, W = 148, p < 0.01) than the non -LCD screens. The non -LCD screen resulted in a longer symptom -free reading time (median = 48 sec, W =147, p < 0.01), but not a greater number of words read (median = 281, W = 148, p= 0.098). Females were more likely to have greater symptom exacerbation with the LCD screen (U = 14.0, p <0.01). No significant difference was found in performance on the comprehension test. Subjective reports showed that the non -LCD experience was more favorable, and most patients stated they would recommend this device for other patients with PCS. This study is the first to show the clinical utility of non -LCD screen computers in the management of photosensitivity and computer screen intolerance in patients with PCS. The non -LCD screen computer has the potential to facilitate return -to -work or return -to -school in concussed individuals.	[Mansur, Ann; Hauer, Tyler M.; Hussain, Mohammed Wasif; Alatwi, Mohammed K.; Tarazi, Apameh; Tator, Charles H.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Mansur, Ann; Hauer, Tyler M.; Hussain, Mohammed Wasif; Alatwi, Mohammed K.; Tarazi, Apameh; Khodadadi, Mozhgan; Tator, Charles H.] Canadian Concuss Ctr, Toronto, ON, Canada; [Tator, Charles H.] Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada		Tator, CH (corresponding author), Toronto Western Hosp, 399 Bathurst St,Room 4W-422, Toronto, ON M5T 1S8, Canada.	Charles.Tator@uhn.ca		Alatwi, Mohammed/0000-0002-0163-6698			[Anonymous], 2017, INSTR CONT PLATF; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Clark J, 2017, J ATHL TRAINING, V52, P725, DOI 10.4085/1062-6050-52.4.04; Davies LN., 2013, J OPTOM, V6, P134, DOI DOI 10.1016/J.0PT0M.2013.03.002; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Fimreite Vanessa, 2016, J Optom, V9, P231, DOI 10.1016/j.optom.2016.04.004; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Jackowski MM, 1996, NEUROREHABILITATION, V6, P193, DOI 10.3233/NRE-1996-6305; Katz BJ, 2016, SURV OPHTHALMOL, V61, P466, DOI 10.1016/j.survophthal.2016.02.001; Lynch JM, 2015, J ATHL TRAINING, V50, P270, DOI 10.4085/1062-6050-49.3.78; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Rabinowicz T, 2002, J NEUROPATH EXP NEUR, V61, P46, DOI 10.1093/jnen/61.1.46; Schrupp LE, 2009, OPTOMETRY, V80, P642, DOI 10.1016/j.optm.2009.04.097; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Takahashi Y, 2001, NEUROLOGY, V57, P1767, DOI 10.1212/WNL.57.10.1767; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Truong J. Q., 2017, J OPTOM, V11, P93; Truong JQ, 2016, MIL MED, V181, P1382, DOI 10.7205/MILMED-D-15-00587; Truong JQ, 2014, BRAIN INJURY, V28, P1283, DOI 10.3109/02699052.2014.915989; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wasserman E. B., 2016, AM J SPORTS MED, V44, P226; Wilkins AJ, 2002, CEPHALALGIA, V22, P711, DOI 10.1046/j.1468-2982.2002.00362.x; Wilkins AJ, 1999, SEIZURE-EUR J EPILEP, V8, P444, DOI 10.1053/seiz.1999.0337; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Yuhas PT, 2017, OPTOMETRY VISION SCI, V94, P108, DOI 10.1097/OPX.0000000000000934	37	5	5	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2018	35	16					1886	1894		10.1089/neu.2017.5539			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ2YY	WOS:000441527400007	30074876	Green Published, Bronze			2022-02-06	
J	Moskowitz, E; Melendez, CI; Dunn, J; Khan, AD; Gonzalez, R; Liebscher, S; Schroeppel, TJ				Moskowitz, Eliza; Melendez, Claudia I.; Dunn, Julie; Khan, Abid D.; Gonzalez, Richard; Liebscher, Sean; Schroeppel, Thomas J.			Long-Term Effects of Decompressive Craniectomy on Functional Outcomes after Traumatic Brain Injury: A Multicenter Study	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting and Postgraduate Course Program of the Southeastern-Surgical-Congress	FEB 10-13, 2018	Tampa, FL	SE Surg Congress			SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; FOLLOW-UP; SCALE; GUIDELINES; MANAGEMENT; DISABILITY; COMA	Decompressive craniectomy (DC) is a surgical modality sometimes used in the management of elevated intracranial pressure. Questions remain as to its long-term benefits in traumatic brain injury patients. The extended Glasgow Outcome Scale (eGOS) is a scoring system based on a structured interview that allows for consistent and reproducible measurement of long-term functional outcomes. The purpose of this study was to determine the eGOS score of post-craniectomy patients after discharge and stratify survivors based on outcome. A multicenter review of patients who underwent DC was performed. Survivors underwent a phone survey at which time the eGOS was calculated. Patients with an eGOS >= 5 were considered to have a good functional outcome. Fifty-four patients underwent DC. Age (OR 1.038; confidence interval 1.003-1.074) and Glasgow Coma Scale (OR 0677; confidence interval 0.527-0.870) were predictors of mortality. Patients who were available for follow-up (n = 13) had poor functional outcomes at discharge (eGOS = 3); however, this improved at the time of follow-up survey (eGOS = 5; P = 0.005). DC is a controversial operation with high mortality and uncertain benefit. Among our cohort, the eGOS score was significantly higher at follow-up survey than it was at discharge. Although the mortality was high, if patients survived to discharge, most had a good functional outcome at follow-up survey.	[Moskowitz, Eliza; Melendez, Claudia I.; Khan, Abid D.; Schroeppel, Thomas J.] Univ Colorado Hlth Mem Hosp, Dept Trauma & Acute Care Surg, Colorado Springs, CO 80909 USA; [Moskowitz, Eliza] Univ Colorado, Dept Surg, Sch Med, Aurora, CO USA; [Dunn, Julie] Univ Colorado, Hlth Med Ctr Rockies, Dept Trauma & Acute Care Surg, Loveland, CO USA; [Gonzalez, Richard; Liebscher, Sean] Loyola Univ, Sch Med, Dept Surg, Chicago, IL 60611 USA		Schroeppel, TJ (corresponding author), Univ Colorado Hlth Mem Hosp, Dept Surg, 1400 E Boulder St, Colorado Springs, CO 80909 USA.	thomas.schroeppel@uchealth.org		Khan, Abid/0000-0002-1533-4578; Schroeppel, Thomas/0000-0001-9164-5004			Alali AS, 2014, CRIT CARE MED, V42, P2235, DOI 10.1097/CCM.0000000000000500; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; Faul M, 2010, TRAUMATIC BRAIN INJU; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Graves JM, 2013, J SAFETY RES, V45, P133, DOI 10.1016/j.jsr.2012.11.001; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2016, INJURY, V47, P1886, DOI 10.1016/j.injury.2016.04.017; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Khan AD, 2017, AM SURGEON, V83, P836; Meier U, 2008, ACTA NEUROCHIR SUPPL, V102, P29, DOI 10.1007/978-3-211-85578-2_6; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Monro A., 1783, OBSERVATIONS STRUCTU; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Pape HC, 2006, INJURY, V37, P1197, DOI 10.1016/j.injury.2006.07.032; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zelle BA, 2013, J ORTHOP TRAUMA, V27, P177, DOI 10.1097/BOT.0b013e31825cf367	28	5	5	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2018	84	8					1314	1318					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	GS6SG	WOS:000443828300044	30185308				2022-02-06	
J	Osler, M; Mortensen, EL; Christensen, K; Christensen, GT				Osler, Merete; Mortensen, Erik L.; Christensen, Kaare; Christensen, Gunhild T.			A bidirectional association between cognitive ability in young adulthood and epilepsy: a population-based cohort study	INTERNATIONAL JOURNAL OF EPIDEMIOLOGY			English	Article						Cognitive ability; epilepsy; cohort study	EPIDEMIOLOGY; INTELLIGENCE; RISK; CHILDHOOD; CHILDREN; LIFE	Aim: To investigate the bidirectional association between cognitive ability in young adulthood and epilepsy. Methods: This cohort study included 1 159 076 men enrolled in the mandatory conscription board examination from the Danish Conscription Database (DCD; 658 465 men examined 1957-84), the Danish Defence Personnel Organization Database (DPOD; 216 509 men examined 1987-2005) and the Danish Conscription Registry (DCR; 284 102 men examined 2006-15). A supplementary analysis included 14 814 female volunteers. Cognitive ability was measured at conscription, and epilepsy was ascertained by physician diagnoses in the Danish National Patient Registries 1977-2016 [ using International Classification of Diseases (ICD) codes: ICD-8-345; ICD-10-G40-G41]. Differences in cognitive ability in relation to epilepsy status at the time of conscription (age 19) were calculated using linear regression. The risk of epilepsy associated with cognitive ability was estimated using Cox regression models, split at age at follow-up (40 and 60 years) and adjusted for year of birth, cerebrovascular disease, traumatic brain injury and education. Results: In all, 5097 (1.0%) men from the DPOD and DCR were diagnosed with epilepsy before conscription, and they had about 0.25 standard deviation (SD) lower cognitive scores than men without epilepsy. The largest difference in cognition was seen for those with the largest number of hospital contacts. A total of 22 364 (1.9%) men developed epilepsy, and cognitive ability was inversely associated with the risk of epilepsy. With the end of follow-up at age 40 years, the adjusted hazard ratio (HR) per SD increase was 0.75 (95% confidence interval =0.73-0.77). The association attenuated with increasing age at diagnosis. The findings were replicated in female conscripts. Conclusions: The cognitive impairment seen in adults with epilepsy seems to reflect combined effects of epileptic processes and lower premorbid cognitive ability.	[Osler, Merete; Christensen, Gunhild T.] Bispebjerg Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark; [Osler, Merete; Christensen, Gunhild T.] Frederiksberg Univ Hosp, Ctr Clin Res & Prevent, Frederiksberg, Denmark; [Osler, Merete; Mortensen, Erik L.; Christensen, Gunhild T.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Osler, Merete; Mortensen, Erik L.; Christensen, Kaare; Christensen, Gunhild T.] Univ Southern Denmark, Inst Publ Hlth, Danish Aging Res Ctr, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark		Osler, M (corresponding author), Hovedveien 5,Nordre Fasanvej 57, DK-2000 Frederiksberg, Denmark.	Merete.osler@regionh.dk	Osler, Merete/AAF-7885-2019; Christensen, Kaare/C-2360-2009	Christensen, Kaare/0000-0002-5429-5292; Okholm, Gunhild Tidemann/0000-0001-9729-708X	Danish Medical Research CouncilDanish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [09-063599, 09-069151]; Velux FoundationVelux Fonden [31205]; Jascha Foundation [6200]; Doctor Sofus Carl Emil Friis and Olga Doris Friis grant	The work was supported by the Danish Medical Research Council (grant number 09-063599 and 09-069151) and the Velux Foundation (grant number 31205), the Jascha Foundation (grant 6200) and Doctor Sofus Carl Emil Friis and Olga Doris Friis grant.	Abramovici S, 2016, HAND CLINIC, V138, P159, DOI 10.1016/B978-0-12-802973-2.00010-0; Baftiu A, 2016, EUR J CLIN PHARMACOL, V72, P1245, DOI 10.1007/s00228-016-2092-3; BOURGEOIS BFD, 1983, ANN NEUROL, V14, P438, DOI 10.1002/ana.410140407; Breuer LEM, 2016, NEUROSCI BIOBEHAV R, V64, P1, DOI 10.1016/j.neubiorev.2016.02.004; Camfield PR, 2014, PEDIATR NEUROL, V51, P17, DOI 10.1016/j.pediatrneurol.2014.02.020; Christensen GT, 2015, INT J EPIDEMIOL, V44, P432, DOI 10.1093/ije/dyu114; Christensen J, 2007, EPILEPSY RES, V76, P60, DOI 10.1016/j.eplepsyres.2007.06.012; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Deary IJ, 2007, J EPIDEMIOL COMMUN H, V61, P378, DOI 10.1136/jech.2005.039206; Dobson KG, 2017, CAN J CARDIOL, V33, P232, DOI 10.1016/j.cjca.2016.08.014; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Geerlings RPJ, 2015, EPILEPSY BEHAV, V51, P182, DOI 10.1016/j.yebeh.2015.07.035; Kee VR, 2012, PHARMACOEPIDEM DR S, V21, P183, DOI 10.1002/pds.2329; Kjeldsen MJ, 2001, EPILEPSY RES, V44, P167, DOI 10.1016/S0920-1211(01)00196-6; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; Nyberg J, 2014, BRAIN, V137, P1514, DOI 10.1093/brain/awu041; Osler M, 2007, INT J EPIDEMIOL, V36, P212, DOI 10.1093/ije/dyl261; Richards M, 2005, ANN NEUROL, V58, P617, DOI 10.1002/ana.20637; Singh A, 2016, NEUROL CLIN, V34, P837, DOI 10.1016/j.ncl.2016.06.015; St Germaine-Smith C, 2011, EPILEPSIA, V52, P2161, DOI 10.1111/j.1528-1167.2011.03292.x; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x	21	5	5	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0300-5771	1464-3685		INT J EPIDEMIOL	Int. J. Epidemiol.	AUG	2018	47	4					1151	1158		10.1093/ije/dyy018			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GT5OU	WOS:000444559900025	29452371				2022-02-06	
J	Pace, J; Parry, N; Vogt, K; Hilsden, R; Leeper, RR; Markova, Z; Priestap, F; Younan, J; Ball, I				Pace, Jacob; Parry, Neil; Vogt, Kelly; Hilsden, Rich; Leeper, R. Robert; Markova, Zarina; Priestap, Fran; Younan, Julia; Ball, Ian			A clinical prediction model for raised intracranial pressure in patients with traumatic brain injuries	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; severe head injury; intracranial hypertension; raised intracranial pressure; clinical prediction model	TOMOGRAPHIC SCAN CHARACTERISTICS; LINEAR RELATIONSHIP; LEVEL I; MORTALITY; IMPACT	BACKGROUND: Intracranial hypertension is believed to contribute to secondary brain insult in traumatically brain injured patients. Currently, the diagnosis of intracranial hypertension requires intracranial monitoring or advanced imaging. Unfortunately, prehospital transport times can be prolonged, delaying time to the initial radiographic assessment. The aim of this study was to identify clinical variables associated with raised intracranial pressure (ICP) prior to the completion of neuroimaging. METHODS: We performed a retrospective cohort study of head injured patients over a 3-year period. Patients were labeled as having increased ICP if they had a single reading of ICP greater than 20 mm Hg within 1 hour of ICP monitor insertion or computed tomography findings suggestive of raised ICP. Patient and clinical characteristics were analyzed using stepwise multivariable logistic regression with ICP as the dependent variable. RESULTS: Of 701 head injured patients identified, 580 patients met inclusion criteria. Mean age was 48.65 +/- 21 years, 73.3% were male. The mean Injury Severity Score was 22.71 +/- 12.38, and the mean Abbreviated Injury Scale for body region head was 3.34 +/- 1.06. Overall mortality was 14.7%. Only 46 (7.9%) patients had an ICP monitor inserted; however, a total of 107 (18%) patients met the definition of raised ICP. The mortality rate for patients with raised ICP was 50.4%. Independent predictors of raised ICP were as follows: age, older than 55 years (odds ratio [OR], 2.26; 95% confidence interval [CI], 1.35-3.76), pupillary fixation (OR, 5.76; 95% CI, 3.16-10.50), signs of significant head trauma (OR, 2.431; 95% CI, 1.39-4.26), and need for intubation (OR, 3.589; 95% CI, 2.10-6.14). CONCLUSION: This study identified four independent variables associated with raised ICP and incorporated these findings into a preliminary risk assessment scale that can be implemented at the bedside to identify patients at significant risk of raised ICP. Future work is needed to prospectively validate these findings prior to clinical implementation. Copyright (C) 2018 Wolters Kluwer Health, Inc. All rights reserved.	[Pace, Jacob] Western Univ, Div Emergency Med, London, ON, Canada; [Parry, Neil; Vogt, Kelly; Hilsden, Rich; Leeper, R. Robert] Western Univ, Dept Surg, London, ON, Canada; [Parry, Neil; Leeper, R. Robert; Ball, Ian] Western Univ, Dept Med, London, ON, Canada; [Pace, Jacob; Parry, Neil; Vogt, Kelly; Hilsden, Rich; Leeper, R. Robert; Ball, Ian] Western Univ, London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Markova, Zarina] Western Univ, Schulich Sch Med, London, ON, Canada; [Priestap, Fran; Ball, Ian] Western Univ, Div Crit Care Med, London, ON, Canada; [Ball, Ian] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada		Pace, J (corresponding author), Victoria Hosp, Trauma Program, 800 Commissioners Rd, East London, ON N6A 5W9, Canada.	Jacob.Pace@londonhospitals.ca					Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; [Anonymous], 2014, ONTARIO TRAUMA REGIS; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Ball IM, 2016, J CRIT CARE, V35, P206, DOI 10.1016/j.jcrc.2016.05.026; Bonds BW, 2015, J TRAUMA ACUTE CARE, V79, P85, DOI 10.1097/TA.0000000000000698; Carney N, 2016, J NEUROTRAUM, V17, P451; Chalkley D, 2011, EMERG MED J, V28, P305, DOI 10.1136/emj.2009.085613; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; Efron B., 1986, STAT SCI, V1, P54, DOI 10.1214/ss/1177013815; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Wang D, 2004, J TRAUMA, V56, P972; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Worster A, 2005, ANN EMERG MED, V45, P448, DOI 10.1016/j.annemergmed.2004.11.021	32	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2018	85	2					380	386		10.1097/TA.0000000000001965			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GR7AB	WOS:000442836600020	29787544				2022-02-06	
J	Sergeeva, EG; Espinosa-Garcia, C; Atif, F; Pardue, MT; Stein, DG				Sergeeva, Elena G.; Espinosa-Garcia, Claudia; Atif, Fahim; Pardue, Machelle T.; Stein, Donald G.			Neurosteroid allopregnanolone reduces ipsilateral visual cortex potentiation following unilateral optic nerve injury	EXPERIMENTAL NEUROLOGY			English	Article						Optic nerve crush; Mouse visual cortex; Neurosteroids; GABA(A) receptor; Stimulus-selective response potentiation	OCULAR-DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; TRAUMATIC BRAIN-INJURY; CROSS-MODAL PLASTICITY; MONOCULAR DEPRIVATION; PROGESTERONE TREATMENT; SYNAPTIC PLASTICITY; NEURONAL-ACTIVITY; TONIC INHIBITION; ADULT	In adult mice with unilateral optic nerve crush injury (ONC), we studied visual response plasticity in the visual cortex following stimulation with sinusoidal grating. We examined visually evoked potentials (VEP) in the primary visual cortex ipsilateral and contralateral to the crushed nerve. We found that unilateral ONC induces enhancement of visual response on the side ipsilateral to the injury that is evoked by visual stimulation to the intact eye. This enhancement was associated with supranormal spatial frequency thresholds in the intact eye when tested using optomotor response. To probe whether injury-induced disinhibition caused the potentiation, we treated animals with the neurosteroid allopregnanolone, a potent agonist of the GABAA receptor, one hour after crush and on post-injury days 3, 8, 13, and 18. Allopregnanolone diminished enhancement of the VEP and this effect was associated with the upregulated synthesis of the delta-subunit of the GABAA receptor. Our study shows a new aspect of experience-dependent plasticity following unilateral ONC. This hyper-activity in the ipsilateral visual cortex is prevented by upregulation of GABA inhibition with allopregnanolone. Our findings suggest the therapeutic potential of allopregnanolone for modulation of plasticity in certain eye and brain disorders and a possible role for disinhibition in ipsilateral hyper-activity following unilateral ONC.	[Sergeeva, Elena G.; Espinosa-Garcia, Claudia; Atif, Fahim; Stein, Donald G.] Emory Univ, Dept Emergency Med, 1365B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA; [Pardue, Machelle T.] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, 1670 Clairmont Rd, Decatur, GA 30033 USA; [Pardue, Machelle T.] Georgia Inst Technol, Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA		Sergeeva, EG; Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, 1365B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	elenagen.sergeeva@gmail.com; Dstei04@emory.edu	Stein, Donald/AAJ-5139-2020	Espinosa-Garcia, Claudia/0000-0002-9909-9092	Marcus Foundation; Allen and Company; Emory University Eye Center Core Facilities; Microscopy in Medicine Core (Emory School of Medicine, Division of Cardiology); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 EY006360]; Department of Veterans Affairs Rehabilitation R&D Service Merit AwardUS Department of Veterans Affairs [E0951-R]; Research Career Scientist AwardUS Department of Veterans Affairs [C9257]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY006360] Funding Source: NIH RePORTER	This work was funded by unrestricted gifts in support of research from The Marcus Foundation, and Allen and Company, and in part by the Emory University Eye Center Core Facilities and the Microscopy in Medicine Core (Emory School of Medicine, Division of Cardiology). National Institutes of Health (grant number P30 EY006360); the Department of Veterans Affairs Rehabilitation R&D Service Merit Award (E0951-R) and Research Career Scientist Award (C9257) to MTP.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Allen RS, 2016, RESTOR NEUROL NEUROS, V34, P947, DOI 10.3233/RNN-160672; Allen RS, 2015, INVEST OPHTH VIS SCI, V56, P2880, DOI 10.1167/iovs.14-16070; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Beston Brett R, 2010, Front Synaptic Neurosci, V2, P138, DOI 10.3389/fnsyn.2010.00138; Brinton RD, 2013, NAT REV ENDOCRINOL, V9, P241, DOI 10.1038/nrendo.2013.31; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carver CM, 2013, PSYCHOPHARMACOLOGY, V230, P151, DOI 10.1007/s00213-013-3276-5; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Coleman JE, 2010, J NEUROSCI, V30, P9670, DOI 10.1523/JNEUROSCI.1248-10.2010; Cooke SF, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2014.0021; Cooke SF, 2010, J NEUROSCI, V30, P16304, DOI 10.1523/JNEUROSCI.4333-10.2010; Cooper LN, 2012, NAT REV NEUROSCI, V13, P798, DOI 10.1038/nrn3353; Crowley T, 2016, BRAIN BEHAV IMMUN, V54, P260, DOI 10.1016/j.bbi.2016.02.001; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Disney A, 2001, J NEUROPHYSIOL, V86, P1052, DOI 10.1152/jn.2001.86.2.1052; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Epsztein J, 2006, J NEUROSCI, V26, P7082, DOI 10.1523/JNEUROSCI.1666-06.2006; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gavornik JP, 2014, LEARN MEMORY, V21, P527, DOI 10.1101/lm.034355.114; Gilbert CD, 2012, NEURON, V75, P250, DOI 10.1016/j.neuron.2012.06.030; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; HENDRY SHC, 1994, J NEUROSCI, V14, P2383; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Herd MB, 2007, PHARMACOL THERAPEUT, V116, P20, DOI 10.1016/j.pharmthera.2007.03.007; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; Irwin RW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00203; Ishikawa M, 2014, INVEST OPHTH VIS SCI, V55, P8531, DOI 10.1167/iovs.14-15624; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kaneko M, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0504; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kreutz MR, 2004, EUR J NEUROSCI, V19, P247, DOI 10.1111/j.1460-9568.2004.03087.x; Labombarda F, 2013, NEUROPHARMACOLOGY, V71, P46, DOI 10.1016/j.neuropharm.2013.03.010; Laing RJ, 2015, CEREB CORTEX, V25, P3314, DOI 10.1093/cercor/bhu128; Liu BH, 2016, NATURE, V538, P383, DOI 10.1038/nature19818; Macharadze T, 2012, CEREB CORTEX, V22, P1824, DOI 10.1093/cercor/bhr256; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nahmani M, 2005, J COMP NEUROL, V484, P458, DOI 10.1002/cne.20505; Nys J, 2015, J NEUROSCI, V35, P11174, DOI 10.1523/JNEUROSCI.3808-14.2015; Nys J, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00060; Peng HY, 2009, PAIN, V143, P12, DOI 10.1016/j.pain.2008.12.023; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Reddy DS, 2016, TRENDS PHARMACOL SCI, V37, P543, DOI 10.1016/j.tips.2016.04.003; Restani L, 2009, NEURON, V64, P707, DOI 10.1016/j.neuron.2009.10.019; Sabel BA, 1999, RESTOR NEUROL NEUROS, V15, P177; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; SAUTTER J, 1991, BRAIN RES, V565, P23, DOI 10.1016/0006-8993(91)91732-G; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schmidt S, 2012, NEUROBIOL AGING, V33, P1356, DOI 10.1016/j.neurobiolaging.2010.11.019; Shen H, 2005, NEUROPHARMACOLOGY, V49, P573, DOI 10.1016/j.neuropharm.2005.04.026; Smith GB, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00021; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tschetter WW, 2013, J NEUROSCI, V33, P5362, DOI 10.1523/JNEUROSCI.5229-12.2013; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Van Brussel L, 2011, CEREB CORTEX, V21, P2133, DOI 10.1093/cercor/bhq286; van Versendaal D, 2016, CELL MOL LIFE SCI, V73, P3677, DOI 10.1007/s00018-016-2264-4; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Vasconcelos N, 2011, P NATL ACAD SCI USA, V108, P15408, DOI 10.1073/pnas.1102780108; Walker MC., 2012, JASPERS BASIC MECH E; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	80	5	5	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2018	306						138	148		10.1016/j.expneurol.2018.05.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK7IQ	WOS:000436373600014	29729249	Green Accepted			2022-02-06	
J	Singh, S; Chouhan, RS; Bindra, A; Radhakrishna, N				Singh, Shalendra; Chouhan, Rajendra Singh; Bindra, Ashish; Radhakrishna, Nayani			Comparison of effect of dexmedetomidine and lidocaine on intracranial and systemic hemodynamic response to chest physiotherapy and tracheal suctioning in patients with severe traumatic brain injury	JOURNAL OF ANESTHESIA			English	Article						Dexmedetomidine; Lidocaine; Hemodynamic response; Tracheal suctioning; Head injury	CEREBRAL-BLOOD-FLOW; HEAD-INJURY; PRESSURE; SEDATION; HYPERTENSION; TRIAL; CARE	Chest physiotherapy and tracheal suction cause sympathetic stimulation and increase heart rate (HR), mean arterial pressure (MAP) and intracranial pressure (ICP) which may have deleterious effect in the head injured. We planned to compare the effect of intravenous dexmedetomidine and lidocaine on intracerebral and systemic hemodynamic response to chest physiotherapy (CP) and tracheal suctioning (TS) in patients with severe traumatic brain injury (sTBI). Prospective, randomized study in patients with sTBI, 18-60 years of age, undergoing mechanical ventilation and intraparenchymal ICP monitoring. Patients were randomized to receive either iv dexmedetomidine 0.5 mcg/kg (group I; n = 30) or iv lidocaine 2 mg/kg (group II; n = 30) over 10 min. After infusion of test drug, CP with vibrator and manual compression was performed for 2 min and TS was done over next 15-20 s. The hemodynamic response was recorded before, during and at interval of 1 min for 10 min after CP and TS. A 20% change in hemodynamic parameters was considered significant. The baseline hemodynamic (HR, MAP), intracranial (ICP, CPP) and respiratory (SPO2, AWP(peak)) parameters were normal and comparable in both the groups. After dexmedetomidine infusion, MAP and CPP decreased significantly from baseline value. In group II, there was no significant change in HR, MAP, ICP and CPP. At end of CP and TS, HR, MAP and CPP in group I was lower as compared to group II. During the 10-min observation period following CP and TS, MAP and CPP in group I remained significantly lower as compared to baseline and group II. There was no significant change in value of other measured parameters. Both dexmedetomidine and lidocaine were effective to blunt rise in HR, MAP and ICP in response to CP and TS in patients with sTBI. However, intravenous dexmedetomidine caused significant decrease in MAP and CPP as compared to the baseline and lidocaine.	[Singh, Shalendra; Chouhan, Rajendra Singh; Bindra, Ashish] All India Inst Med Sci, Dept Neuroanaesthesiol & Crit Care, New Delhi, India; [Radhakrishna, Nayani] Army Res & Referral Hosp, Dept Anaesthesia, Delhi, India		Bindra, A (corresponding author), All India Inst Med Sci, Dept Neuroanaesthesiol & Crit Care, New Delhi, India.	dr_ashi2208@yahoo.com	singh, shalendra/AAF-4604-2021; GARG, RAKESH/H-4591-2011	singh, shalendra/0000-0002-1112-3431; GARG, RAKESH/0000-0001-5842-8024; Bindra, Ashish/0000-0001-5685-2833			Brucia J J, 1992, J Neurosci Nurs, V24, P205; Caricato A, 2013, CRIT CARE, V17, DOI 10.1186/cc13097; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; de Cerqueira-Neto ML, 2010, ARQ NEURO-PSIQUIAT, V68, P567, DOI 10.1590/S0004-282X2010000400017; DONEGAN MF, 1980, ANESTHESIOLOGY, V52, P516, DOI 10.1097/00000542-198006000-00014; Erdman MJ, 2014, CRIT CARE MED, V42, P1696, DOI 10.1097/CCM.0000000000000328; Ferreira Lucas Lima, 2013, Rev. bras. ter. intensiva, V25, P327, DOI 10.5935/0103-507X.20130055; Gemma M, 2002, J NEUROSURG ANESTH, V14, P50, DOI 10.1097/00008506-200201000-00010; Grap MJ, 2014, HEART LUNG, V43, P6, DOI 10.1016/j.hrtlng.2013.10.012; Humble SS, 2016, BRAIN INJURY, V30, P1266, DOI 10.1080/02699052.2016.1187289; Kerr ME, 1999, CRIT CARE MED, V27, P2776, DOI 10.1097/00003246-199912000-00028; KERR ME, 1993, HEART LUNG, V22, P516; Leone M, 2004, ANESTH ANALG, V99, P1193, DOI 10.1213/01.ANE.0000132546.79769.91; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Mathieu A, 2013, J NEUROSURG ANESTH, V25, P8, DOI 10.1097/ANA.0b013e31826a75b1; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Puntillo KA, 2004, CRIT CARE MED, V32, P421, DOI 10.1097/01.CCM.0000108875.35298.D2; Rodrigues, 2013, J NEUROL RES, V3, P51; Schomer KJ, 2019, J INTENSIVE CARE MED, V34, P62, DOI 10.1177/0885066616689555; Spapen HD, 2017, J THORAC DIS, V9, pE44, DOI 10.21037/jtd.2017.01.32; Thiesen RA, 2005, ARQ NEURO-PSIQUIAT, V63, P110, DOI 10.1590/S0004-282X2005000100020; Venn RM, 2002, BRIT J ANAESTH, V88, P669, DOI 10.1093/bja/88.5.669; Wainwright S P, 1996, Intensive Crit Care Nurs, V12, P303, DOI 10.1016/S0964-3397(96)80801-9; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Zeiler FA, 2015, CRIT CARE RES PRACT, V2015, P12; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	27	5	6	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2018	32	4					518	523		10.1007/s00540-018-2505-9			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GO5ZF	WOS:000440112700006	29725828				2022-02-06	
J	Tang, QL; Zhang, C; Wu, X; Duan, WB; Weng, WJ; Feng, JF; Mao, Q; Chen, SB; Jiang, JY; Gao, GY				Tang, Qilin; Zhang, Chao; Wu, Xiang; Duan, Wenbin; Weng, Weiji; Feng, Junfeng; Mao, Qing; Chen, Shubin; Jiang, Jiyao; Gao, Guoyi			Comprehensive Proteomic Profiling of Patients' Tears Identifies Potential Biomarkers for the Traumatic Vegetative State	NEUROSCIENCE BULLETIN			English	Article						Trauma; Vegetative state; Tears; Proteomics; iTRAQ	MINIMALLY CONSCIOUS STATE; BRAIN-INJURY; DISORDERS; DIAGNOSIS; DISEASES	The vegetative state is a complex condition with unclear mechanisms and limited diagnostic, prognostic, and therapeutic methods. In this study, we aimed to explore the proteomic profile of tears from patients in a traumatic vegetative state and identify potential diagnostic markers using tears-a body fluid that can be collected non-invasively. Using iTRAQ quantitative proteomic technology, in the discovery phase, tear samples collected from 16 patients in a traumatic vegetative state and 16 normal individuals were analyzed. Among 1080 identified tear proteins, 57 were upregulated and 15 were downregulated in the patients compared to the controls. Bioinformatics analysis revealed that the differentially-expressed proteins were mainly involved in the wound response and immune response signaling pathways. Furthermore, we verified the levels of 7 differentially-expressed proteins in tears from 50 traumatic vegetative state patients and 50 normal controls (including the samples used in the discovery phase) using ELISA. The results showed that this 7-protein panel had a high discrimination ability for traumatic vegetative state (area under the curve = 0.999). In summary, the altered tear proteomic profile identified in this study provides a basis for potential tear protein markers for diagnosis and prognosis of the traumatic vegetative state and also provides novel insights into the mechanisms of traumatic vegetative state.	[Tang, Qilin; Zhang, Chao; Wu, Xiang; Weng, Weiji; Feng, Junfeng; Mao, Qing; Jiang, Jiyao; Gao, Guoyi] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China; [Tang, Qilin; Zhang, Chao; Wu, Xiang; Weng, Weiji; Feng, Junfeng; Mao, Qing; Jiang, Jiyao; Gao, Guoyi] Shanghai Head Trauma Inst, Shanghai 200127, Peoples R China; [Duan, Wenbin] Baoshan Peoples Hosp, Dept Neurosurg, Baoshan 678000, Peoples R China; [Chen, Shubin] Anda Hosp, Dept Neurol, Shanghai 201204, Peoples R China		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China.; Gao, GY (corresponding author), Shanghai Head Trauma Inst, Shanghai 200127, Peoples R China.	Gao3@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671198]; Grant of Shanghai Municipal Education Commission-Gaofeng Clinical Medicine [20152212]; Shanghai Shenkang Clinical Research Plan of the Shanghai Hospital Development Center [16CR3011A]	The work was supported by the National Natural Science Foundation of China (81671198), the Grant of Shanghai Municipal Education Commission-Gaofeng Clinical Medicine (20152212), and the Shanghai Shenkang Clinical Research Plan of the Shanghai Hospital Development Center (16CR3011A).	Bohm D, 2012, ONCOL REP, V28, P429, DOI 10.3892/or.2012.1849; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Chen J, 2016, CELL PHYSIOL BIOCHEM, V39, P2262, DOI 10.1159/000447919; Chen WQ, 2015, GENOM PROTEOM BIOINF, V13, P219, DOI 10.1016/j.gpb.2015.06.002; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Dartt DA, 2004, EXP EYE RES, V78, P337, DOI 10.1016/S0014-4835(03)00202-1; Denisin AK, 2012, ANALYST, V137, P5088, DOI 10.1039/c2an35821b; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fernandez-Espejo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095082; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Grada Ayman, 2016, Surg Technol Int, V29, P29; Guler A, 2015, J CLIN DIAGN RES, V9, pTD1, DOI 10.7860/JCDR/2015/10478.5396; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Guo YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36416; Hazell AS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00118; Hohenstein-Blaul NVU, 2013, EXP EYE RES, V117, P126, DOI 10.1016/j.exer.2013.07.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones SG, 2014, INT J LOW EXTR WOUND, V3, P201; Li AL, 2018, NEUROSCI BULL, V34, P85, DOI 10.1007/s12264-017-0142-1; Li DH, 2017, NEUROSCI BULL, V33, P292, DOI 10.1007/s12264-016-0095-9; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Marino S, 2009, FUNCT NEUROL, V24, P185; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2009, PROG BRAIN RES, V177, P249, DOI 10.1016/S0079-6123(09)17717-8; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Rathor MY, 2014, BANGLADESH J MED SCI, V13, P358, DOI 10.3329/bjms.v13i3.19159; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Thomas DR, 2013, CLIN GERIATR MED, V29, pXI, DOI 10.1016/j.cger.2013.02.001; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Zhou L, 2017, EXPERT REV PROTEOMIC, V14, P189, DOI 10.1080/14789450.2017.1285703; Zhou L, 2012, PROG RETIN EYE RES, V31, P527, DOI 10.1016/j.preteyeres.2012.06.002; Zhou L, 2012, J PROTEOMICS, V75, P3877, DOI 10.1016/j.jprot.2012.04.053; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	35	5	5	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	AUG	2018	34	4			SI		626	638		10.1007/s12264-018-0259-x			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO6NN	WOS:000440164500005	30019218	Green Published			2022-02-06	
J	Watson, EJR; Nenadlova, K; Clancy, OH; Farag, M; Nordin, NA; Nilsen, A; Mehmet, ART; Al-Hindawi, A; Mandalia, S; Williams, LM; Edginton, TL; Vizcaychipi, MP				Watson, Edward J. R.; Nenadlova, Klara; Clancy, Olivia H.; Farag, Mena; Nordin, Naz A.; Nilsen, Agnes; Mehmet, Ashley R. T.; Al-Hindawi, Ahmed; Mandalia, Sundhiya; Williams, Lisa M.; Edginton, Trudi L.; Vizcaychipi, Marcela P.			Perioperative Research into Memory (PRiMe): Cognitive impairment following a severe burn injury and critical care admission, part 1	BURNS			English	Article						Severe burns; Critical illness; Cognitive impairment; Mental health; Quality of Life	QUALITY-OF-LIFE; NEUROCOGNITIVE FUNCTION; CARDIOPULMONARY BYPASS; ELECTRICAL INJURY; NERVOUS-SYSTEM; DYSFUNCTION; BRAIN; INFLAMMATION; DEPRESSION; OUTCOMES	Introduction: An investigation into long-term cognitive impairment and Quality of Life (QoL) after severe burns. Methods: A proof of principle, cohort design, prospective, observational clinical study Patients with severe burns (>15% TBSA) admitted to Burns ICU for invasive ventilation were recruited for psychocognitive assessment with a convenience sample of age and sex-matched controls. Participants completed psychological and QoL questionnaires, the Cogstate((R)) electronic battery, Hopkins Verbal Learning, Verbal Fluency and Trail making tasks. Results: 15 patients (11M, 4F; 41 +/- 14 years; TBSA 38.4%+/- 18.5) and comparators (11M, 4F; 40 +/- 13 years) were recruited. Burns patients reported worse QoL (Neuro-QoL Short Form v2, patient 30.1 +/- 8.2, control 38.7 +/- 3.2, p=0.0004) and cognitive function (patient composite z-score 0.01, IQR -0.11 to 0.33, control 0.13, IQR 0.47-0.73, p=0.02). Compared to estimated premorbid FSIQ, patients dropped an equivalent of 8 IQ points (p = 0.002). Cognitive function negatively correlated with burn severity (rBaux score, p=0.04). QoL strongly correlated with depressive symptoms (Rho=-0.67, p=0.009) but not cognitive function. Conclusions: Severe burns injuries are associated with a significant, global, cognitive deficit. Patients also report worse QoL, depression and post-traumatic stress. Perceived QoL from cognitive impairment was more closely associated with depression than cognitive impairment. Crown Copyright (C) 2018 Published by Elsevier Ltd. All rights reserved	[Watson, Edward J. R.; Nenadlova, Klara; Clancy, Olivia H.; Farag, Mena; Nordin, Naz A.; Nilsen, Agnes; Mehmet, Ashley R. T.; Al-Hindawi, Ahmed; Mandalia, Sundhiya; Williams, Lisa M.; Vizcaychipi, Marcela P.] Chelsea & Westminster Hosp NHS Fdn Trust, Magill Dept Anaesthesia Pain Med & Intens Care, London, England; [Watson, Edward J. R.; Al-Hindawi, Ahmed; Mandalia, Sundhiya; Vizcaychipi, Marcela P.] Imperial Coll London, Fac Med, Dept Surg & Canc, London, England; [Nenadlova, Klara; Nilsen, Agnes; Mehmet, Ashley R. T.; Edginton, Trudi L.] Westminster Univ, Psychol Dept, London, England; [Nordin, Naz A.] West Hertfordshire Hosp NHS Trust, Watford Gen Hosp, Dept Anaesthesia, Watford, England; [Edginton, Trudi L.] City Univ London, Dept Psychol, London, England		Watson, EJR (corresponding author), Chelsea & Westminster Hosp NHS Fdn Trust, Magill Dept Anaesthesia Pain Med & Intens Care Me, 369 Fulham Rd, London SW10 9NH, England.	edward.watson@imperial.ac.uk	; Vizcaychipi, Marcela/H-5487-2011	Kierubinska Nilsen, Agnes Mathilde/0000-0001-5952-5395; Vizcaychipi, Marcela/0000-0001-7894-873X; Williams, Lisa/0000-0002-3243-1353; Watson, Edward J R/0000-0003-3379-7813; Mandalia, Sundhiya/0000-0003-2546-498X	CW Plus charity [556]; Chelsea and Westminster Hospital; Westminster University	We are grateful to all of our patients and comparator subjects for participation in this study, to the Katie Piper Foundation for helping to circulate our work for purposes of patient recruitment and to the C&W Plus charity for funding the materials and expenses for the study (reference number 556). Chelsea and Westminster Hospital provided funding for the research fellowships for AA, EJRW, MF, NAN and OHC, Westminster University funded the psychologists AM, AN and KN.	Aase DM, 2014, ARCH CLIN NEUROPSYCH, V29, P125, DOI 10.1093/arclin/act117; Ankri J, 2003, J CLIN EPIDEMIOL, V56, P1055, DOI 10.1016/S0895-4356(03)00175-6; BANKS WA, 1991, J PHARMACOL EXP THER, V259, P988; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beecher HK, 1943, ANN SURG, V117, P825, DOI 10.1097/00000658-194311760-00005; Bekker Alex Y, 2003, Best Pract Res Clin Anaesthesiol, V17, P259, DOI 10.1016/S1521-6896(03)00005-3; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Brusselaers N, 2005, INTENS CARE MED, V31, P1648, DOI 10.1007/s00134-005-2819-6; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cope O, 1943, ANN SURG, V117, P915, DOI 10.1097/00000658-194311760-00013; Dekkers AMM, 2010, COMMUNITY MENT HLT J, V46, P20, DOI 10.1007/s10597-009-9195-6; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Druery M, 2005, BURNS, V31, P692, DOI 10.1016/j.burns.2005.03.001; Duggan MC, 2017, J CRIT CARE, V37, P72, DOI 10.1016/j.jcrc.2016.08.023; Ehde DM, 2000, J BURN CARE REHABIL, V21, P105, DOI 10.1097/00004630-200021020-00005; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7794; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Girard T, 2013, CRIT CARE MED, V38, P1513, DOI [10.1097/CCM.0b013e3181e47be1.Delirium, DOI 10.1097/CCM.0B013E3181E47BE1.DELIRIUM]; Goehler LE, 2005, BRAIN BEHAV IMMUN, V19, P334, DOI 10.1016/j.bbi.2004.09.002; Goverman J, 2016, BURNS, V42, P1067, DOI 10.1016/j.burns.2016.01.018; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 2005, CURR OPIN CRIT CARE, V11, P369, DOI 10.1097/01.ccx.0000166399.88635.a5; Hough CL, 2012, CURR OPIN CRIT CARE, V18, P8, DOI 10.1097/MCC.0b013e32834f186d; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2003, ARCH CLIN NEUROPSYCH, V18, P688; Jackson PC, 2014, ANN SURG, V259, P979, DOI 10.1097/SLA.0b013e31829160ca; Jacobs AH, 2012, J CEREBR BLOOD F MET, V32, P1393, DOI 10.1038/jcbfm.2012.53; Jones C, 2006, INTENS CARE MED, V32, P923, DOI 10.1007/s00134-006-0112-y; Klepac N, 2008, EUR J NEUROL, V15, P128, DOI 10.1111/j.1468-1331.2007.02011.x; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Latenser BA, 2009, CRIT CARE MED, V37, P2819, DOI 10.1097/CCM.0b013e3181b3a08f; Li J, 2008, INT J RADIAT ONCOL, V71, P64, DOI 10.1016/j.ijrobp.2007.09.059; Lim WC, 2016, J CRIT CARE, V31, P183, DOI 10.1016/j.jcrc.2015.10.020; Lionelli GT, 2005, BURNS, V31, P958, DOI 10.1016/j.burns.2005.06.006; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Logsetty S, 2016, BURNS, V42, P738, DOI 10.1016/j.burns.2016.03.006; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mason SE, 2010, J ALZHEIMERS DIS, V22, pS67, DOI 10.3233/JAD-2010-101086; McPhail MJW, 2013, NEUROLOGY, V80, P1041, DOI 10.1212/WNL.0b013e31828726e1; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Morrison G, 2000, PSYCHOL MED, V30, P717, DOI 10.1017/S0033291799001920; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803; NEWMAN S, 1989, J PSYCHOSOM RES, V33, P227, DOI 10.1016/0022-3999(89)90050-0; Osler T, 2010, J TRAUMA, V68, P690, DOI 10.1097/TA.0b013e3181c453b3; Pan W, 2002, EXP NEUROL, V174, P193, DOI 10.1006/exnr.2002.7871; Pandharipande P, 2012, CRIT CARE, V40, P2022, DOI [10.1097/CCM.0b013e318250acc0.The, DOI 10.1097/CCM.0B013E318250ACC0.THE]; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Parra MA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-76; Patel RL, 1996, J THORAC CARDIOV SUR, V111, P1267, DOI 10.1016/S0022-5223(96)70230-1; Pavoni V, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-24; Persson J, 2012, CEREB CORTEX, V22, P2297, DOI 10.1093/cercor/bhr306; Phillips-Bute B, 2006, PSYCHOSOM MED, V68, P369, DOI 10.1097/01.psy.0000221272.77984.e2; PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393; Ramati A, 2009, J NEUROTRAUM, V26, P1815, DOI [10.1089/neu.2008.0867, 10.1089/neu.2008-0867]; Ramati A, 2009, GEN HOSP PSYCHIAT, V31, P360, DOI 10.1016/j.genhosppsych.2009.03.010; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Reginold W, 2013, DEMENT GERIATR COGN, V36, P67, DOI 10.1159/000350032; Schultzberg M, 2007, PHYSIOL BEHAV, V92, P121, DOI 10.1016/j.physbeh.2007.05.050; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; Singerman J, 2008, J BURN CARE RES, V29, P773, DOI 10.1097/BCR.0b013e318184815d; SMITH D, 1998, COGNITIVE NEUROPSYCH, V3, P71, DOI DOI 10.1080/135468098396251; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Teng E, 2012, AM J GERIAT PSYCHIAT, V20, P1016, DOI 10.1097/JGP.0b013e31826ce640; Wade CE, 2013, CYTOKINE, V61, P78, DOI 10.1016/j.cyto.2012.08.031; Ward H W, 1987, J Burn Care Rehabil, V8, P294, DOI 10.1097/00004630-198707000-00011; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wiechman SA, 2001, J BURN CARE REHABIL, V22, P417, DOI 10.1097/00004630-200111000-00012; Wolf SE, 2012, BURNS, V38, P1096, DOI 10.1016/j.burns.2012.10.002; Wolters AE, 2013, INTENS CARE MED, V39, P376, DOI 10.1007/s00134-012-2784-9; Wunder A, 2009, NEUROSCIENCE, V158, P1161, DOI 10.1016/j.neuroscience.2008.10.005; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Zhao JJ, 2017, NEUROPSYCHOL REHABIL, V27, P301, DOI 10.1080/09602011.2015.1078246	83	5	5	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179	1879-1409		BURNS	Burns	AUG	2018	44	5					1167	1178		10.1016/j.burns.2018.04.011			12	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Dermatology; Surgery	GL0PK	WOS:000436791900015	29752016	Green Accepted			2022-02-06	
J	Woolhouse, R; McKinlay, A; Grace, RC				Woolhouse, Rachel; McKinlay, Audrey; Grace, Randolph C.			Women in Prison With Traumatic Brain Injury: Prevalence, Mechanism, and Impact on Mental Health	INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY			English	Article						female offenders; brain injury; mental health; sleep problems	ANXIETY STRESS SCALES; SLEEP QUALITY INDEX; COPING STRATEGIES; EARLY-CHILDHOOD; DEPRESSION; GENDER; OUTCOMES; CRIME; ABUSE; RISK	Relatively little is known about the characteristics of female offenders. Here, we studied the prevalence of traumatic brain injury (TBI) and mental health issues in an exclusively female prison population in New Zealand. Participants (N = 38) were recruited from all security levels at Christchurch Women's Prison. Measures for depression, anxiety, and stress, sleep, and a history of TBI were administered; 94.7% (36/38) of participants presented with a history of TBI. Younger age at first injury was associated with an increased risk of mental health problems. The study concludes that TBI is highly prevalent among female offenders and may be linked to increased mental health problems. TBI should be considered as an important factor in offender pathways and treatment programs.	[Woolhouse, Rachel; McKinlay, Audrey; Grace, Randolph C.] Univ Canterbury, Christchurch, New Zealand; [McKinlay, Audrey] Univ Melbourne, Melbourne, Vic, Australia		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514			Achenbach TM, 2003, RATINGS RELATIONS DS; Albicini M, 2015, J CLIN EXP NEUROPSYC, V37, P776, DOI 10.1080/13803395.2015.1053843; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Andrews D. A., 2000, LEVEL SERVICE INVENT; [Anonymous], 1999, WECHSLER ABBREVIATED; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bennett S, 2005, AGGRESS VIOLENT BEH, V10, P263, DOI 10.1016/j.avb.2004.07.001; Bloom B., 2004, REV POLICY RES, V21, P31, DOI DOI 10.1111/J.1541-1338.2004.00056.X; Bloom B., 2003, GENDER RESPONSIVE ST; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Bureau of Justice Statistics, 2016, IMPR RAT SENT MAL PR; Bureau of Justice Statistics, 2016, IMPR RAT SENT FEM PR; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Covington S.S., 1998, FEMALE OFFENDERS CRI, VVol. 2, P113; Covington SS, 2002, HANDBOOK OF ADDICTION TREATMENT FOR WOMEN, P52; Covington SS, 2006, WOMEN THER, V29, P9, DOI 10.1300/J015v29n03_02; Craparo G, 2014, J SEX MED, V11, P1484, DOI 10.1111/jsm.12505; Daly K., 1994, GENDER CRIME PUNISHM; Department of Corrections, 2015, TRENDS OFF POP 2014; Elger BS, 2009, INT J LAW PSYCHIAT, V32, P74, DOI 10.1016/j.ijlp.2009.01.001; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Green BL, 2016, PSYCHOL TRAUMA-US, V8, P455, DOI 10.1037/tra0000113; Grennan S, 2007, PSYCHOL CRIME LAW, V13, P487, DOI 10.1080/10683160601060598; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Institute for Criminal Policy Research, 2017, WORLD PRIS BRIEF DAT; Kavanagh L, 2010, INT J LAW PSYCHIAT, V33, P20, DOI 10.1016/j.ijlp.2009.10.004; Kingi V., 2000, WOM CORR STAFF CLIEN; Knutson KL, 2006, SLEEP, V29, P1503, DOI 10.1093/sleep/29.11.1503; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay Audrey, 2016, Concussion, V1, pCNC25, DOI 10.2217/cnc-2016-0011; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Reisig MD, 2006, JUSTICE Q, V23, P384, DOI 10.1080/07418820600869152; Salisbury EJ, 2009, CRIM JUSTICE BEHAV, V36, P541, DOI 10.1177/0093854809334076; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Steffensmeier D, 1996, ANNU REV SOCIOL, V22, P459, DOI 10.1146/annurev.soc.22.1.459; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; van Vliet-Ruissen C, 2014, NEUROREHABILITATION, V34, P373, DOI 10.3233/NRE-131032; Van Voorhis P, 2010, CRIM JUSTICE BEHAV, V37, P261, DOI 10.1177/0093854809357442	47	5	5	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0306-624X	1552-6933		INT J OFFENDER THER	Int. J. Offender Ther. Comp. Criminol.	AUG	2018	62	10					3135	3150		10.1177/0306624X17726519			16	Criminology & Penology; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	GM9NS	WOS:000438577000014	28831827				2022-02-06	
J	Yun, BJ; Borczuk, P; Zachrison, KS; Goldstein, JN; Berlyand, Y; Raja, AS				Yun, Brian J.; Borczuk, Pierre; Zachrison, Kori S.; Goldstein, Joshua N.; Berlyand, Yosef; Raja, Ali S.			Utilization of head CT during injury visits to United States emergency departments: 2012-2015	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						CT scan; Head trauma; Intracranial hemorrhages; Traumatic brain hemorrhage; Traumatic subdural hematoma; Traumatic brain injuries; Traumatic subarachnoid hemorrhage; Brain concussion; Traumatic cerebral hemorrhage; Neurosurgery	COMPUTED-TOMOGRAPHY; TRENDS	Introduction: Studies have shown increasing utilization of head computed tomography (CT) imaging of emergency department (ED) patients presenting with an injury-related visit. Multiple initiatives, including the Choosing Wisely (TM) campaign and evidence-based clinical decision support based on validated decision rules, have targeted head CT use in patients with injuries. Therefore, we investigated national trends in the use of head CT during injury-related ED visits from 2012 to 2015. Methods: This was a secondary analysis of data from the annual United States (U.S.) National Hospital Ambulatory Medical Care Survey from 2012 to 2015. The study population was defined as injury-related ED visits, and we sought to determine the percentage in which a head CT was ordered and, secondarily, to determine both the diagnostic yield of clinically significant intracranial findings and hospital characteristics associated with increased head CT utilization. Results: Between 2012 and 2015, 12.25% (95% confidence interval [CI] 11.48-13.02%) of injury-related visits received at least one head CT. Overall head CT utilization showed an increased trend during the study period (2012: 11.7%, 2015: 13.23%, p = 0.09), but the results were not statistically significant. The diagnostic yield of head CT for a significant intracranial injury over the period of four years was 7.4% (9.68% in 2012 vs. 7.67% in 2015, p = 023). Conclusions: Head CT use along with diagnostic yield has remained stable from 2012 to 2015 among patients presenting to the ED for an injury-related visit. (C) 2018 Elsevier Inc. All rights reserved.	[Yun, Brian J.; Borczuk, Pierre; Zachrison, Kori S.; Goldstein, Joshua N.; Raja, Ali S.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Yun, Brian J.; Raja, Ali S.] Massachusetts Gen Hosp, Dept Emergency Med, CREDO, Boston, MA 02114 USA; [Yun, Brian J.; Borczuk, Pierre; Zachrison, Kori S.; Goldstein, Joshua N.; Berlyand, Yosef; Raja, Ali S.] Harvard Med Sch, Boston, MA USA		Yun, BJ (corresponding author), 55 Fruit St,0 Emerson Pl,Suite 3B, Boston, MA 02114 USA.	byun@mgh.harvard.edu	Zachrison, Kori/ABC-5938-2021; Raja, Ali S./AAE-5103-2019; Goldstein, Joshua N/H-8953-2016	Yun, Brian/0000-0002-3842-420X; Berlyand, Yosef/0000-0003-2313-8507	AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS024561] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08 HS024561] Funding Source: Medline		American College of Emergency Physicians, 2018, CHOOS WIS 10 THINGS; Boutis K, 2014, J EMERG MED, V47, P36, DOI 10.1016/j.jemermed.2014.01.030; Hussein W, 2015, ACAD EMERG MED, V22, P663, DOI 10.1111/acem.12684; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; McCaig LF, 2012, ANN EMERG MED, V60, P716, DOI 10.1016/j.annemergmed.2012.07.010; Menchine MD, 2009, ACAD EMERG MED, V16, P963, DOI 10.1111/j.1553-2712.2009.00521.x; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Raja AS, 2017, WEST J EMERG MED, V18, P454, DOI 10.5811/westjem.2017.1.32677	9	5	5	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	AUG	2018	36	8					1463	1466		10.1016/j.ajem.2018.05.018			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GN5MK	WOS:000439103800024	29779675	Green Accepted			2022-02-06	
J	Cheng, F; Xu, M; Liu, H; Wang, WM; Wang, ZM				Cheng, Feng; Xu, Min; Liu, Hua; Wang, Wenming; Wang, Zhimin			A Retrospective Study of Intracranial Pressure in Head-Injured Patients Undergoing Decompressive Craniectomy: A Comparison of Hypertonic Saline and Mannitol	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; intracranial pressure; decompressive craniectomy; hypertonic saline; mannitol	TRAUMATIC BRAIN-INJURY; 20-PERCENT MANNITOL; SODIUM-CHLORIDE; HYPERTENSION; EQUIOSMOLAR; MANAGEMENT; DEXTRAN; TRIAL	Objective: The impact of hypertonic saline (HTS) on the control of increased intracranial pressure (ICP) in head-injured patients undergoing decompressive craniectomy (DC) has yet to be established. The current retrospective study was conducted to compare the effect of HTS and mannitol on lowering the ICP burden of these patients. Methods: We reviewed data on patients who had sustained a traumatic brain injury (TBI) and were admitted to the First People's Hospital of Kunshan between January 1, 2012, and August 31, 2017. Patients who received only one type of hyperosmotic agent, 3% HTS or 20%mannitol, after DC were included. The daily ICP burden (h/day) and response to the hyperosmolar agent were used as primary outcome measures. The numbers of days in the intensive care unit and in the hospital, and the 2-weeks mortality rates were also compared between the groups. Results: The 30 patients who received 3% HTS only and the 30 who received 20% mannitol only were identified for approximate matching and additional data analyses. The demographic characteristics of the patients in the two groups were comparable, but the daily ICP burden was significantly lower in the HTS group than in the mannitol group (0.89 +/- 1.02 h/day vs. 2.11 +/- 2.95 h/day, respectively; P = 0.038). The slope of the reduction in ICP in response to a bolus dose at baseline was higher with HTS than with mannitol (P = 0.001). However, the between-group difference in the 2-weeks mortality rates was not statistically significant (2 [HTS] vs. 1 [mannitol]; P = 0.554). Conclusion: When used in equiosmolar doses, the reduction in the ICP of TBI patients achieved with 3% HTS was superior to that achieved with 20% mannitol after DC. However, this advantage did not seem to confer any additional benefit terms of short-term mortality.	[Cheng, Feng; Wang, Zhimin] Soochow Univ, Dept Neurosurg, Suzhou Kowloon Hosp, Suzhou, Peoples R China; [Cheng, Feng; Liu, Hua; Wang, Wenming] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China; [Xu, Min] Kunshan Hosp Tradit Chinese Med, Dept Neurosurg, Suzhou, Peoples R China		Wang, ZM (corresponding author), Soochow Univ, Dept Neurosurg, Suzhou Kowloon Hosp, Suzhou, Peoples R China.	wzm680104@qq.com			Clinical and basic researches of brain disease [KYC004]; Kunshan science and technology fund [KS1718, KS1644]	This study was supported by Clinical and basic researches of brain disease (KYC004), Kunshan science and technology fund (KS1718 and KS1644).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Celli P, 1997, Minerva Chir, V52, P1467; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jagannatha AT, 2016, J CLIN NEUROSCI, V27, P68, DOI 10.1016/j.jocn.2015.08.035; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kalita J, 2003, NEUROL INDIA, V51, P104; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Liu H. W., 2014, J CHIN URBAN FOR, V12, P10, DOI DOI 10.1016/j.enconman.2014.12.053; Liu H, 2016, ONCOTARGET, V7, P62657, DOI 10.18632/oncotarget.11632; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Schatzmann C, 1998, ACT NEUR S, V71, P31; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA	30	5	5	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 31	2018	9								631	10.3389/fneur.2018.00631			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO8NS	WOS:000440348100001	30131757	Green Published, gold			2022-02-06	
J	Chandrasekar, A; Heuvel, FO; Wepler, M; Rehman, R; Palmer, A; Catanese, A; Linkus, B; Ludolph, A; Boeckers, T; Huber-Lang, M; Radermacher, P; Roselli, F				Chandrasekar, Akila; Heuvel, Florian Olde; Wepler, Martin; Rehman, Rida; Palmer, Annette; Catanese, Alberto; Linkus, Birgit; Ludolph, Albert; Boeckers, Tobias; Huber-Lang, Markus; Radermacher, Peter; Roselli, Francesco			The Neuroprotective Effect of Ethanol Intoxication in Traumatic Brain Injury Is Associated with the Suppression of ErbB Signaling in Parvalbumin-Positive Interneurons	JOURNAL OF NEUROTRAUMA			English	Article						chemogenetics; ethanol intoxication; inhibitory interneurons; traumatic brain injury; tyrosine kinase receptors	NMDA RECEPTOR FUNCTION; BLOOD-ALCOHOL; SYNAPTIC PLASTICITY; COGNITIVE DEFICITS; UNITED-STATES; HEAD-INJURY; NEUREGULIN-1; EXPRESSION; EDEMA; MODEL	Ethanol intoxication (EI) is a frequent comorbidity of traumatic brain injury (TBI), but the impact of EI on TBI pathogenic cascades and prognosis is unclear. Although clinical evidence suggests that EI may have neuroprotective effects, experimental support is, to date, inconclusive. We aimed at elucidating the impact of EI on TBI-associated neurological deficits, signaling pathways, and pathogenic cascades in order to identify new modifiers of TBI pathophysiology. We have shown that ethanol administration (5 g/kg) before trauma enhances behavioral recovery in a weight-drop TBI model. Neuronal survival in the injured somatosensory cortex was also enhanced by EI. We have used phospho-receptor tyrosine kinase (RTK) arrays to screen the impact of ethanol on TBI-induced activation of RTK in somatosensory cortex, identifying ErbB2/ErbB3 among the RTKs activated by TBI and suppressed by ethanol. Phosphorylation of ErbB2/3/4 RTKs were upregulated in vGlut2(+) excitatory synapses in the injured cortex, including excitatory synapses located on parvalbumin (PV)-positive interneurons. Administration of selective ErbB inhibitors was able to recapitulate, to a significant extent, the neuroprotective effects of ethanol both in sensorimotor performance and structural integrity. Further, suppression of PV interneurons in somatosensory cortex before TBI, by engineered receptors with orthogonal pharmacology, could mimic the beneficial effects of ErbB inhibitors. Thus, we have shown that EI interferes with TBI-induced pathogenic cascades at multiple levels, with one prominent pathway, involving ErbB-dependent modulation of PV interneurons.	[Chandrasekar, Akila; Heuvel, Florian Olde; Rehman, Rida; Linkus, Birgit; Ludolph, Albert; Roselli, Francesco] Ulm Univ, Dept Neurol, Ulm, Germany; [Wepler, Martin; Radermacher, Peter] Ulm Univ, Inst Anesthesiol Pathophysiol & Proc Engn, Ulm, Germany; [Palmer, Annette; Huber-Lang, Markus] Ulm Univ, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Catanese, Alberto; Boeckers, Tobias; Roselli, Francesco] Ulm Univ, Dept Anat & Cell Biol, Ulm, Germany		Roselli, F (corresponding author), Ulm Univ, Dept Neurol, Dept Anat & Cell Biol, Ctr Biomed Res ZBMF, Helmholtzstr 81 R1-44, D-89081 Ulm, Germany.	francesco.roselli@uni-ulm.de	roselli, francesco/O-8847-2019; Rehman, Rida/AAR-4811-2020; Huber-Lang, Markus/AAJ-2209-2020; Catanese, Alberto/AAQ-9185-2021	roselli, francesco/0000-0001-9935-6899; Rehman, Rida/0000-0003-0518-5051; 	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); ERANET-NEURON initiative "External Insults to the Nervous System", MICRONET consortium; Baustein program of the Medical Faculty of Ulm University	This work has been supported by the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma." F.R. and R.R. are also supported by the ERANET-NEURON initiative "External Insults to the Nervous System" as part of the MICRONET consortium and by the Baustein program of the Medical Faculty of Ulm University.	Afshar M, 2016, INJURY, V47, P83, DOI 10.1016/j.injury.2015.10.063; Akimoto M, 2004, NEUROSCIENCE, V128, P155, DOI 10.1016/j.neuroscience.2004.06.031; Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Bean JC, 2014, J NEUROSCI, V34, P13549, DOI 10.1523/JNEUROSCI.2021-14.2014; Berry C, 2011, AM SURGEON, V77, P1416; Blasiole B, 2013, ANESTHESIOLOGY, V118, P649, DOI 10.1097/ALN.0b013e318280a42d; Boerboom A, 2016, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00038; Boucher BA, 1998, CLIN PHARMACOKINET, V35, P209, DOI 10.2165/00003088-199835030-00004; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Criswell HE, 2004, BRAIN RES, V1015, P107, DOI 10.1016/j.brainres.2004.04.050; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Flajolet M, 2008, NAT NEUROSCI, V11, P1402, DOI 10.1038/nn.2216; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Guan YF, 2015, NEUROSCIENCE, V307, P151, DOI 10.1016/j.neuroscience.2015.08.047; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Gupta VK, 2013, INT J MOL SCI, V14, P10122, DOI 10.3390/ijms140510122; Gurnik S, 2016, ACTA NEUROPATHOL, V131, P753, DOI 10.1007/s00401-016-1551-3; Hendry JM, 2016, ANN NEUROL, V80, P112, DOI 10.1002/ana.24688; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Hudachek SF, 2013, J PHARMACOKINET PHAR, V40, P157, DOI 10.1007/s10928-012-9295-8; Iwakura Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174780; Jacobi N, 2017, CANCERS, V9, DOI 10.3390/cancers9040033; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P403, DOI 10.1097/TA.0000000000000504; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Karunakaran S, 2016, NAT NEUROSCI, V19, P454, DOI 10.1038/nn.4231; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kedrin D, 2009, CLIN CANCER RES, V15, P3733, DOI 10.1158/1078-0432.CCR-08-2163; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Leo P, 2016, TRANSLATIONAL RES TR; Lu YS, 2014, NEURON, V84, P835, DOI 10.1016/j.neuron.2014.09.029; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Morikawa A, 2015, NEURO-ONCOLOGY, V17, P289, DOI 10.1093/neuonc/nou141; Neddens J, 2011, BIOL PSYCHIAT, V70, P636, DOI 10.1016/j.biopsych.2011.04.016; Nizamutdinov D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40112; Nolt MJ, 2011, J NEUROSCI, V31, P5353, DOI 10.1523/JNEUROSCI.0282-11.2011; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Polli JW, 2008, DRUG METAB DISPOS, V36, P695, DOI 10.1124/dmd.107.018374; Qiao LX, 2009, BIOORG MED CHEM LETT, V19, P6122, DOI 10.1016/j.bmcl.2009.09.010; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Roselli F, 2015, NEURON, V85, P901, DOI 10.1016/j.neuron.2014.12.063; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Schwarzkopf TM, 2013, EXP BIOL MED, V238, P84, DOI 10.1258/ebm.2012.012261; Sheffler-Collins SI, 2012, TRENDS NEUROSCI, V35, P293, DOI 10.1016/j.tins.2012.03.003; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Sun YJ, 2016, NEURON, V92, P160, DOI 10.1016/j.neuron.2016.08.033; Sysa-Shah P, 2016, CARDIOVASC RES, V109, P358, DOI 10.1093/cvr/cvv274; Tamura H, 2012, J NEUROSCI, V32, P12657, DOI 10.1523/JNEUROSCI.2542-12.2012; Tan GH, 2012, NAT NEUROSCI, V15, P258, DOI 10.1038/nn.3005; Thompson M, 2007, BRAIN RES, V1139, P95, DOI 10.1016/j.brainres.2006.11.047; Thundyil J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053528; Vaagenes IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120356; Vullhorst D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8222; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Wu WC, 2014, BRIT J NEUROSURG, V28, P739, DOI 10.3109/02688697.2014.915007; Wuchter J, 2012, J NEUROSCI, V32, P14821, DOI 10.1523/JNEUROSCI.1261-12.2012; Yin DM, 2013, J NEUROSCI, V33, P19295, DOI 10.1523/JNEUROSCI.2090-13.2013; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang H, 2017, NEUROBIOL DIS, V106, P171, DOI 10.1016/j.nbd.2017.07.001; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zimprich A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00125	90	5	5	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2718	2735		10.1089/neu.2017.5270		JUL 2018	18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000439629900001	29774782				2022-02-06	
J	DeDominicis, KE; Hwang, H; Cartagena, CM; Shear, DA; Boutte, AM				DeDominicis, Kristen E.; Hwang, Hye; Cartagena, Casandra M.; Shear, Deborah A.; Boutte, Angela M.			Cerebrospinal Fluid Biomarkers Are Associated With Glial Fibrillary Acidic Protein and alpha II-spectrin Breakdown Products in Brain Tissues Following Penetrating Ballistic-Like Brain Injury in Rats	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; biomarker; glial fibrillary acidic protein; alpha II-spectrin; breakdown product; penetrating ballistic-like brain injury; subacute; chronic	NEUROLOGICAL OUTCOME SCALE; LONG-TERM DISABILITY; UNITED-STATES; DECOMPRESSIVE CRANIECTOMY; TRANSFORMING RESEARCH; CLINICAL KNOWLEDGE; CALPAIN; MODEL; GFAP; ACCUMULATION	Treatments to improve outcomes following severe traumatic brain injury (TBI) are limited but may benefit from understanding subacute-chronic brain protein profiles and identifying biomarkers suitable for use in this time. Acute alterations in the well-known TBI biomarkers glial fibrillary acidic protein (GFAP), alpha II-spectrin, and their breakdown products (BDPs) have been well established, but little is known about the subacute-chronic post-injury profiles of these biomarkers. Thus, the current study was designed to determine the extended profile of these TBI-specific biomarkers both in brain tissue and cerebral spinal fluid (CSF). Protein abundance was evaluated in brain tissue samples taken from regions of interest and in CSF at 24 h, 3 days, 7 days, 1 month, and 3 months following severe TBI in rats. Results showed increased full length GFAP (GFAP-FL) and GFAP-BDPs starting at 24 h that remained significantly elevated in most brain regions out to 3 months post-injury. However, in CSF, neither GFAP-FL nor GFAP-BDPs were elevated as a consequence of injury. Regional-specific reduction in alpha II-spectrin was evident in brain tissue samples from 24 h through 3 months. In contrast, SBDP-145/150 was robustly elevated in most brain regions and in CSF from 24 h through 7 days. Correlation analyses revealed numerous significant relationships between proteins in CSF and brain tissue or neurological deficits. This work indicates that TBI results in chronic changes in brain protein levels of well-known TBI biomarkers GFAP, alpha II-spectrin, and their BDPs and that SBDP-145/150 may have utility as an acute-chronic biomarker.	[DeDominicis, Kristen E.; Hwang, Hye; Cartagena, Casandra M.; Shear, Deborah A.; Boutte, Angela M.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		DeDominicis, KE (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	kristen.dedominicis@gmail.com			U.S. Army Medical Research and Material Command's Combat Casualty Care Research Program	Portions of this work have previously been presented as posters at National Neurotrauma Symposia (55, 56). This research was funded by the U.S. Army Medical Research and Material Command's Combat Casualty Care Research Program.	Azuma M, 2008, SURV OPHTHALMOL, V53, P150, DOI 10.1016/j.survophthal.2007.12.006; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen SY, 2016, EXP THER MED, V11, P2049, DOI 10.3892/etm.2016.3153; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DeDominicis K, 2017, J NEUROTRAUM, V34, pA19; DeDominicis K, 2016, J NEUROTRAUM, V33, pA16; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; DVBIC. Defense and Veterans Brain Injury Center, 2018, DOD NUMB TRAUM BRAIN; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCauley SR, 2013, J NEUROTRAUM, V30, P1506, DOI 10.1089/neu.2013.2925; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Mountney A, 2016, J NEUROTRAUM, V33, P1492, DOI 10.1089/neu.2015.4139; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	56	5	7	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 4	2018	9								490	10.3389/fneur.2018.00490			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GL6PI	WOS:000437310200001	30022967	Green Published, gold			2022-02-06	
J	Amagasa, S; Matsui, H; Tsuji, S; Uematsu, S; Moriya, T; Kinoshita, K				Amagasa, Shunsuke; Matsui, Hikoro; Tsuji, Satoshi; Uematsu, Satoko; Moriya, Takashi; Kinoshita, Kosaku			Characteristics distinguishing abusive head trauma from accidental head trauma in infants with traumatic intracranial hemorrhage in Japan	ACUTE MEDICINE & SURGERY			English	Article						Abusive head trauma; diagnosis; infant; physical abuse; subdural hematoma	SHAKEN-BABY-SYNDROME; YOUNG-CHILDREN; BRAIN-INJURY; VALIDATION; AGE	Aim: To identify markers for detecting abusive head trauma (AHT) and its characteristics in the Japanese population. Methods: We retrospectively reviewed the clinical records of 166 infants with traumatic intracranial hemorrhage between 2002 and 2013 in three tertiary institutions in Japan. The infants were classified into AHT (57), suspected AHT (24), and accidental (85) group based on the defined criteria. We compared clinical presentations and computed tomography findings among these three groups and also compared age distribution of infants with AHT in our study to those in the USA. Results: Age distribution of AHT cases is significantly higher in our study than in the USA (P < 0.001). The rates of male sex, bruising, retinal hemorrhage, subdural hematoma, cerebral edema, and neurological sequelae were significantly higher, and those of skull fracture and scalp finding were significantly lower, in the AHT group than in the accidental group (P < 0.05). In the multivariable analysis of the infants with subdural hematoma, absence of skull fracture (odds ratio = 42.1; 95% confidence interval, 3.5-507.7, P = 0.003) was associated with AHT. Conclusions: The age range of AHT in Japan is significantly different from that of countries in Europe and North America because of familial and sociocultural situations. Absence of bruising, and rib or long bone fractures did not reduce the likelihood of AHT. Subdural hematoma without findings of an impact to the head strongly suggested AHT. Abusive head trauma is a global problem, however, diagnosis and defensive measures likely need to be tailored to accommodate cultural risk factors.	[Amagasa, Shunsuke; Matsui, Hikoro] Nagano Childrens Hosp, Dept Pediat Intens Care, Azumino City, Nagano, Japan; [Tsuji, Satoshi; Uematsu, Satoko] Natl Ctr Child & Dev, Div Pediat Emergency & Transport Serv, Tokyo, Japan; [Moriya, Takashi] Jichi Med Univ, Saitama Med Ctr, Dept Emergency & Crit Care Med, Saitama, Japan; [Kinoshita, Kosaku] Nihon Univ, Div Emergency & Crit Care Med, Dept Acute Med, Sch Med, Tokyo, Japan		Amagasa, S (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Emergency & Crit Care Med, Omiya Ku, 1-847 Amanuma Cho, Saitama, Saitama 3308503, Japan.	amagasa0828@gmail.com		Amagasa, Shunsuke/0000-0002-8371-1507			Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Cowley LE, 2015, PEDIATRICS, V136, P290, DOI 10.1542/peds.2014-3993; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Fujiwara T, 2008, J JPN PEDIAT SOC, V112, P704; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Fukumizu M, 2005, PEDIATRICS, V115, P217, DOI 10.1542/peds.2004-0815C; Hymel KP, 2014, PEDIATRICS, V134, pE1537, DOI 10.1542/peds.2014-1329; Karibe H, 2016, NEUROL MED-CHIR, V56, P264, DOI 10.2176/nmc.ra.2015-0308; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Latz S, 1999, ARCH PEDIAT ADOL MED, V153, P339; Lynoe N, 2017, ACTA PAEDIATR, V106, P1021, DOI 10.1111/apa.13760; Maehashi N, 2006, RES PREVENTION INTER, P375; Mizoguchi T, 2016, J JPN PEDIAT SOC, V120, P662; Nuno M, 2015, J NEUROSURG-PEDIATR, V16, P515, DOI 10.3171/2015.3.PEDS14544; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Shugerman RP, 1996, PEDIATRICS, V97, P664; Talvik I, 2008, ACTA PAEDIATR, V97, P782, DOI 10.1111/j.1651-2227.2008.00778.x; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Yanai Y, 2001, J JPN SOC PEDIAT PSY, V41, P373	25	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	JUL	2018	5	3					265	271		10.1002/ams2.341			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GL4EL	WOS:000437101600009	29988617	Green Published, gold			2022-02-06	
J	Cellina, M; Panzeri, M; Floridi, C; Martinenghi, CMA; Clesceri, G; Oliva, G				Cellina, Michaela; Panzeri, Marta; Floridi, Chiara; Martinenghi, Carlo Maria Andrea; Clesceri, Giulio; Oliva, Giancarlo			Overuse of computed tomography for minor head injury in young patients: an analysis of promoting factors	RADIOLOGIA MEDICA			English	Article						Minor head injury; Computed tomography; Head CT; Emergency department; Clinical decision rules; CT overuse	CUMULATIVE RADIATION-EXPOSURE; TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; EMERGENCY-DEPARTMENT; INTRACRANIAL INJURY; IONIZING-RADIATION; DECISION RULES; CT-SCAN; CANCER; MANAGEMENT	To assess the amount of computed tomography (CT) scans for minor head injury (MHI) performed in young patients in our emergency department (ED), not indicated by National Institute for Health and Clinical Excellence (NICE) and Canadian Computed Tomography Head Rules (CCHR), and to analyze factors contributing to unnecessary examinations. Secondary objectives were to calculate the effective dose, to establish the number of positive CT and to analyze which of the risk factors are correlated with positivity at CT; finally, to calculate sensitivity and specificity of NICE and CCHR in our population. We retrospectively evaluated 493 CT scans of patients aged 18-45 years, collecting the following parameters from ED medical records: patient demographics, risk factors indicating the need of brain imaging, trauma mechanism, specialty and seniority of the referring physician. For each CT, the effective dose and the negativity/positivity were assessed. 357/493 (72%) and 347/493 (70%) examinations were not in line with the CCHR and NICE guidelines, respectively. No statistically significant difference between physician specialty (p = 0.29 for CCHR; p = 0.24 for NICE), nor between physician seniority and the amount of inappropriate examinations (p = 0.93 for CCHR, p = 0.97 for NICE) was found but CT scans requested by ED physicians were less inappropriate [p = 0.28, odds ratio (OR) 0.562, CI (95%) 0.336-0.939]. There was no statistically significant correlation between patient age and over-referral (p = 0.74 for NICE, p = 0.93 for CCHR). According to NICE, low speed motor vehicle accident (p = 0.009), motor vehicle accident with high energy impact (p < 0.01) and domestic injuries (p = 0.002) were associated with a higher rate of unwarranted CT; according to CCHR only motor vehicle accident with high energy impact showed a significant correlation with unwarranted CT scan (p < 0.001, OR 44.650, CI 33.123-1469.854). 2% of CT was positive. Multivariate analysis demonstrated that factors significantly associated with CT scan positivity included signs of suspected skull fracture (p < 0.001, OR 20.430, CI 2.727-153.052) and motor vehicle accident with high energy impact (p < 0.001, OR 220.650, CI 33.123-1469.854). In our series, CCHR showed sensitivity of 100%, specificity of 74%; NICE showed sensitivity of 100%, specificity of 72%. We observed an important overuse of head CT scans in MHI; the main promoting factor for inappropriate was injury mechanism. 2% of head CT were positive, correlating with signs of suspected skull fracture and motor vehicle accident with high energy impact.	[Cellina, Michaela; Floridi, Chiara; Clesceri, Giulio; Oliva, Giancarlo] ASST Fatebenefratelli Sacco, Piazza Principessa Clotilde 3, I-20121 Milan, Italy; [Panzeri, Marta; Martinenghi, Carlo Maria Andrea] IRCCS San Raffaele Hosp, Via Olgettina 60, I-20132 Milan, Italy		Cellina, M (corresponding author), ASST Fatebenefratelli Sacco, Piazza Principessa Clotilde 3, I-20121 Milan, Italy.	michaela.cellina@asst-fbf-sacco.it	Cellina, Michaela/AAI-2011-2019	Cellina, Michaela/0000-0002-7401-1971; Floridi, Chiara/0000-0002-6863-9471; Martinenghi, Carlo/0000-0001-6391-8992			BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Fortin EM, 2016, EMERG RADIOL, V23, P597, DOI 10.1007/s10140-016-1424-z; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Giannitto C, 2018, RADIOL MED, V123, P185, DOI 10.1007/s11547-017-0819-6; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Griffey RT, 2009, AM J ROENTGENOL, V192, P887, DOI 10.2214/AJR.08.1351; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydon NB, 2013, J MED IMAG RADIAT ON, V57, P161, DOI 10.1111/1754-9485.12007; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jame SZB, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.13067; Khaji A, 2006, NEUROSCIENCES, V11, P248; Klang E, 2017, J AM COLL RADIOL, V14, P171, DOI 10.1016/j.jacr.2016.08.032; Lee J, 2013, EMERG RADIOL, V20, P219, DOI 10.1007/s10140-012-1098-0; Melnick ER, 2015, ACAD EMERG MED, V22, P1474, DOI 10.1111/acem.12824; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Sadegh R, 2016, EMERG RADIOL, V23, P9, DOI 10.1007/s10140-015-1349-y; Salerno S, 2016, RADIOL MED, V121, P144, DOI 10.1007/s11547-015-0584-3; Schueller G, 2015, RADIOL MED, V120, P641, DOI 10.1007/s11547-015-0500-x; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Vrijheid M, 2007, INT J EPIDEMIOL, V36, P1126, DOI 10.1093/ije/dym138; Wu SR, 2006, EMERG RADIOL, V13, P61, DOI 10.1007/s10140-006-0514-8	34	5	6	0	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0033-8362	1826-6983		RADIOL MED	Radiol. Med.	JUL	2018	123	7					507	514		10.1007/s11547-018-0871-x			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GJ2UU	WOS:000435130100004	29516354				2022-02-06	
J	Cohrs, G; Huhndorf, M; Niemczyk, N; Volz, LJ; Bernsmeier, A; Singhal, A; Larsen, N; Synowitz, M; Knerlich-Lukoschus, F				Cohrs, Gesa; Huhndorf, Monika; Niemczyk, Nils; Volz, Lukas J.; Bernsmeier, Alexander; Singhal, Ash; Larsen, Naomi; Synowitz, Michael; Knerlich-Lukoschus, Friederike			MRI in mild pediatric traumatic brain injury: diagnostic overkill or useful tool?	CHILDS NERVOUS SYSTEM			English	Article						Imaging; Children; Head injury; Alternative imaging	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CHILDREN; CT	Magnetic resonance imaging (MRI) is a sensitive imaging tool which lacks the burden of ionizing radiation. It is not established as primary diagnostic tool in traumatic brain injury (TBI). The purpose of this study was to evaluate the usefulness of MRI as initial imaging modality in the emergency management of mild pediatric TBI. Children (0-18 years, sub-divided in four age-groups) with mild TBI who received MRI in the emergency department were identified. Clinical characteristics and trauma mechanisms were evaluated retrospectively. Univariate and multivariate logistic regression analyses were used to identify clinical factors that might be indicative for trauma sequelae on MRI scans. An institutional case series of 569 patients (322 male/247 female; age < 18years; (GCS ae<yen> 13), who received MRI for mild TBI, was analyzed. Multi-sequence imaging (including T2, T2*, FLAIR, and diffusion-weighted sequences) was feasible without sedation in 96.8% of cases (sedation, 1.8%; general anesthesia, 1.4%). MRI revealed trauma-associated findings in 13% of all cases; incidental findings were detected in 4.7%. In our cohort, GCS deterioration, scalp hematoma, clinical signs of skull base fractures, and horseback riding accidents were related to structural trauma sequelae on MRI. MRI is a practical primary imaging tool for evaluating children with mild TBI in the emergency department. The presented analyses demonstrated that in our institution, MRI imaging is performed frequently in the emergency department. It resulted mostly in normal findings. This may reflect uneasiness of when to perform imaging in mild TBI and appears retrospectively as an "overdo." There are clinical factors that are more likely associated with MRI-positive findings. Their reliability has to be evaluated in prospective studies in order to formulate further decision rules of when to perform MRI imaging or not.	[Cohrs, Gesa; Niemczyk, Nils; Synowitz, Michael; Knerlich-Lukoschus, Friederike] Univ Med Ctr Schleswig Holstein UKSH, Dept Neurosurg, Campus Kiel,Arnold Heller Str 3,House 41, D-24105 Kiel, Germany; [Huhndorf, Monika; Larsen, Naomi] Univ Med Ctr Schleswig Holstein UKSH, Dept Neuroradiol, Campus Kiel,Arnold Heller Str 3,House 41, D-24105 Kiel, Germany; [Volz, Lukas J.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Bernsmeier, Alexander] Univ Med Ctr Schleswig Holstein UKSH, Dept Gen Visceral Thorac Transplantat & Pediat Su, Campus Kiel,Arnold Heller Str 3,House 41, D-24105 Kiel, Germany; [Singhal, Ash] Univ British Columbia, Div Pediat Neurosurg, Dept Surg, Vancouver, BC, Canada; [Singhal, Ash] BC Childrens Hosp, Vancouver, BC, Canada; [Knerlich-Lukoschus, Friederike] Asklepios Klin Sankt Augustin, Dept Pediat Neurosurg, Arnold Janssen Str 29, D-53757 St Augustin, Germany		Knerlich-Lukoschus, F (corresponding author), Univ Med Ctr Schleswig Holstein UKSH, Dept Neurosurg, Campus Kiel,Arnold Heller Str 3,House 41, D-24105 Kiel, Germany.; Knerlich-Lukoschus, F (corresponding author), Asklepios Klin Sankt Augustin, Dept Pediat Neurosurg, Arnold Janssen Str 29, D-53757 St Augustin, Germany.	f.knerlich@asklepios.com	Synowitz, Michael/G-2596-2012	Volz, Lukas J./0000-0002-0161-654X; Knerlich-Lukoschus, Friederike/0000-0003-4907-015X; Singhal, Ash/0000-0002-0061-9570			Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Malviya S, 2000, BRIT J ANAESTH, V84, P743, DOI 10.1093/oxfordjournals.bja.a013586; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Pal'a A, 2015, J CHILD NEUROL, V30, P1153, DOI 10.1177/0883073814554655; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wang XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111406; Young JY, 2016, EMERG RADIOL, V23, P325, DOI 10.1007/s10140-016-1392-3	17	5	6	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2018	34	7					1345	1352		10.1007/s00381-018-3771-4			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GJ0SN	WOS:000434964700012	29556697				2022-02-06	
J	Di, C; Zeng, Y; Mao, JY; Shen, ZJ; Gu, WZ				Di, Chong; Zeng, Yun; Mao, Jingyu; Shen, Zhengjie; Gu, Wenzhe			Dynamic changes and clinical significance of serum S100B protein and glial fibrillary acidic protein in patients with delayed encephalopathy after acute carbon monoxide poisoning	PAKISTAN JOURNAL OF MEDICAL SCIENCES			English	Article						S100B; Glial fibrillary acidic protein; Delayed encephalopathy; Acute carbon monoxide poisoning	HYPERBARIC-OXYGEN THERAPY; TRAUMATIC BRAIN-INJURY; COGNITIVE DYSFUNCTION; DAMAGE; EFFICACY; MARKERS	Objective: To study the dynamic changes and clinical significance of serum S100B protein and glial fibrillary acidic protein (GFAP) in patients with delayed encephalopathy after acute carbon monoxide poisoning (DEACMP). Methods: This study was conducted among DEACMP patients who were hospitalized from November 2014 to February 2016. Serum levels of S100B and GFAP in 66 DEACMP patients were measured by ELISA. Changes in patient states were examined dynamically using activities of daily living (ADL) scale, information-memory-concentration test (IMCT) and Hasegawa's dementia scale (HDS), and compared with those of 64 patients without DE after ACMP. Results: Serum S100B [(0.59 +/- 0.11) ng/ml] and GFAP [(227.67 +/- 12.43) ng/ml] levels of DEACMP group in acute phase were significantly higher than those of ACMP group [(0.48 +/- 0.10) ng/ml and (178.91 +/- 11.47) ng/ml] and DEACMP group in recovery phase [(0.49 +/- 0.12) ng/ml and (179.54 +/- 12.32) ng/ml] (all P<0.05). Serum S100B and GFAP levels of DEACMP group were significantly correlated in both acute and recovery phases (r=0.432 in acute phase, P=0.007; r=0.378 in recovery phase, P=0.034). ADL, HDS and IMCT scores of DEACMP group in acute phase were (45.12 +/- 3.12), (7.98 +/- 1.02) and (9.61 +/- 1.41) points respectively, which were significantly different from those of recovery phase [(33.25 +/- 3.09), (16.13 +/- 1.17) and (19.54 +/- 1.43) points respectively] (P<0.05). Conclusions: DEACMP was accompanied by secondary brain injury, for which glial activation may be important. Serum S100B and GFAP levels may be related to prognosis.	[Di, Chong] Xuzhou Med Univ, Affiliated Hosp, Emergency Ctr, Xuzhou 221006, Jiangsu, Peoples R China; [Zeng, Yun] Jiangsu Canc Hosp, Dept Med Oncol, Nanjing 210009, Jiangsu, Peoples R China; [Mao, Jingyu; Shen, Zhengjie] Zhangjiagang First Peoples Hosp, Med Oncol, Zhangjiagang 215600, Jiangsu, Peoples R China; [Gu, Wenzhe] Zhangjiagang Hosp Tradit Chinese Med, Depr Otorhinolaryngol, Zhangjiagang 215600, Jiangsu, Peoples R China; [Zeng, Yun; Mao, Jingyu] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Tradit Chines Med, Nanjing 210023, Jiangsu, Peoples R China		Di, C (corresponding author), Xuzhou Med Univ, Affiliated Hosp, Emergency Ctr, Xuzhou 221006, Jiangsu, Peoples R China.	dichongahxmu@163.com					Brvar M, 2004, RESUSCITATION, V61, P357, DOI 10.1016/j.resuscitation.2004.01.009; Chin W, 2016, UNDERSEA HYPERBAR M, V43, P29; Gahlot G, 2017, INDIAN J MEDNODENT A, V5, P24, DOI DOI 10.5958/2347-6206.2017.00005.X; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Kudo K, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-3; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Oh S, 2015, NEURAL REGEN RES, V10, P36, DOI 10.4103/1673-5374.150644; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Park EJ, 2014, MED HYPOTHESES, V83, P186, DOI 10.1016/j.mehy.2014.04.032; Rasmussen LS, 2002, ACTA ANAESTH SCAND, V46, P547, DOI 10.1034/j.1399-6576.2002.460512.x; Rodriguez-Osorio X, 2016, CEPHALALGIA, V36, P63; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Xiang W, 2017, ASIA PAC J CLIN TRIA, V2, P15, DOI [10.4103/2542-3932.198961, DOI 10.4103/2542-3932.198961]; Xiang WP, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.899499; Xiang WP, 2017, DRUG DES DEV THER, V11, P513, DOI 10.2147/DDDT.S126569; Zhao XZ, 1984, CHINESE J NEURPSYCHO, V17, P36	18	5	6	0	2	PROFESSIONAL MEDICAL PUBLICATIONS	SADDAR	PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO BOX 8766, SADDAR, KARACHI 00000, PAKISTAN	1682-024X			PAK J MED SCI	Pak. J. Med. Sci.	JUL-AUG	2018	34	4					945	949		10.12669/pjms.344.15363			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ8XS	WOS:000442047500032	30190758	Green Published, gold, Green Submitted			2022-02-06	
J	Hickey, K; Stabenfeldt, SE				Hickey, Kassondra; Stabenfeldt, Sarah E.			Using biomaterials to modulate chemotactic signaling for central nervous system repair	BIOMEDICAL MATERIALS			English	Article						chemotaxis; stroke; traumatic brain injury; spinal cord injury; drug delivery; central nervous system	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; NEURAL STEM-CELLS; MONOCYTE-CHEMOATTRACTANT PROTEIN-1; OLFACTORY-BULB NEUROGENESIS; FOCAL CEREBRAL-ISCHEMIA; GROWTH-FACTOR DELIVERY; MARROW STROMAL CELLS; FACTOR-I; NEUROTROPHIC FACTOR	Chemotaxis enables cellular communication and movement within the body. This review focuses on exploiting chemotaxis as a tool for repair of the central nervous system (CNS) damaged from injury and/or degenerative diseases. Chemokines and factors alone may initiate repair following CNS injury/disease, but exogenous administration may enhance repair and promote regeneration. This review will discuss critical chemotactic molecules and factors that may promote neural regeneration. Additionally, this review highlights how biomaterials can impact the presentation and delivery of chemokines and growth factors to alter the regenerative response.	[Hickey, Kassondra; Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	Sarah.Stabenfeldt@asu.edu		Hickey, Kassondra/0000-0002-3133-5714	NSFNational Science Foundation (NSF) [CBET 1454282]; NIH NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1DP2HD084067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [DP2HD084067] Funding Source: NIH RePORTER	The authors acknowledge Amanda Witten for assistance with graphic design. This work was supported by NSF CBET 1454282 (SES) and NIH NICHD 1DP2HD084067 (SES).	Addington CP, 2017, MATRIX BIOL, V60-61, P206, DOI 10.1016/j.matbio.2016.09.007; Addington CP, 2014, BIOMATERIALS, V35, P3263, DOI 10.1016/j.biomaterials.2013.12.102; Adelita T, 2017, STEM CELL RES, V22, P61, DOI 10.1016/j.scr.2017.05.013; Ardelt AA, 2013, EXP NEUROL, V248, P246, DOI 10.1016/j.expneurol.2013.06.017; Atterberry PN, 2015, BIOMACROMOLECULES, V16, P1582, DOI 10.1021/acs.biomac.5b00144; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004; BEHAR TN, 1994, BRAIN RES, V664, P155, DOI 10.1016/0006-8993(94)91966-6; Belmadani A, 2015, HIPPOCAMPUS, V25, P1224, DOI 10.1002/hipo.22428; Benslimane-Ahmim Z, 2017, CANCER LETT, V395, P11, DOI 10.1016/j.canlet.2017.02.032; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Bharadwaj VN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29988; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Cook DJ, 2017, J CEREBR BLOOD F MET, V37, P1030, DOI 10.1177/0271678X16649964; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6; DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021; Dong X, 2009, CURR NEUROPHARMACOL, V7, P269, DOI 10.2174/157015909790031157; Dutta D, 2017, BIOMATER SCI-UK, V5, P1640, DOI 10.1039/c7bm00489c; Dutta D, 2015, J MATER CHEM B, V3, P7963, DOI 10.1039/c5tb00935a; Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278; Enam SF, 2017, BIOMATERIALS, V142, P52, DOI 10.1016/j.biomaterials.2017.07.013; Faiz M, 2008, MOL CELL NEUROSCI, V38, P170, DOI 10.1016/j.mcn.2008.02.002; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Filippo TRM, 2013, STEM CELL RES, V11, P913, DOI 10.1016/j.scr.2013.06.003; Florio T, 2008, NEUROIMMUNE, V6, P243; Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016; Forstreuter F, 2002, J NEUROIMMUNOL, V132, P93, DOI 10.1016/S0165-5728(02)00315-6; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Lopez MAG, 2009, CELL SIGNAL, V21, P1748, DOI 10.1016/j.cellsig.2009.07.010; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Goncalves RM, 2012, EUR CELLS MATER, V23, P249, DOI 10.22203/eCM.v023a19; Gong XM, 2006, CELL BIOL INT, V30, P466, DOI 10.1016/j.cellbi.2006.01.007; Gordon RJ, 2007, NEUROSCIENCE, V146, P1704, DOI 10.1016/j.neuroscience.2007.03.011; Grade S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055039; Guaiquil VH, 2014, P NATL ACAD SCI USA, V111, P17272, DOI 10.1073/pnas.1407227111; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Guillemin GJ, 2003, GLIA, V41, P371, DOI 10.1002/glia.10175; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hartman NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015856; Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009; Iglesias P A, ENCY CELL BIOL, P4; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Khaing ZZ, 2016, J MATER CHEM B, V4, P7560, DOI 10.1039/c6tb01602b; Kim DH, 2015, BIOMATERIALS, V61, P115, DOI 10.1016/j.biomaterials.2015.05.025; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; Kranich S, 2009, NEUROCHEM INT, V55, P747, DOI 10.1016/j.neuint.2009.07.007; Leake A, 2000, NEUROSCI LETT, V291, P201, DOI 10.1016/S0304-3940(00)01418-X; Leber T, 1981, LANCET, V3539, P1446; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Lee YL, 2000, NEUROCHEM INT, V36, P417, DOI 10.1016/S0197-0186(99)00133-3; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Li H, 2016, ADV HEALTHC MATER, V5, P802, DOI 10.1002/adhm.201500810; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Lian D, 2016, J NEUROIMMUNOL, V294, P46, DOI 10.1016/j.jneuroim.2016.03.014; Lim TC, 2013, FASEB J, V27, P1023, DOI 10.1096/fj.12-221515; Liu KKY, 2009, J NEUROIMMUNOL, V215, P49, DOI 10.1016/j.jneuroim.2009.08.003; Liu YZ, 2017, LIFE SCI, V184, P87, DOI 10.1016/j.lfs.2017.06.012; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Maciejewski-Lenoir D, 1999, J IMMUNOL, V163, P1628; Mao WF, 2016, NEUROCHEM RES, V41, P1315, DOI 10.1007/s11064-016-1831-2; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Opatz J, 2009, MOL CELL NEUROSCI, V40, P293, DOI 10.1016/j.mcn.2008.11.002; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Parker J, 2016, BIOMACROMOLECULES, V17, P476, DOI 10.1021/acs.biomac.5b01366; Parlato M, 2014, RSC SOFT MATTER SER, V2, P1; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Popova T, 2015, BIOMATERIALS, V134, P13; Qin WJ, 2014, NEUROSCI LETT, V569, P80, DOI 10.1016/j.neulet.2014.03.052; Raja WK, 2010, INTEGR BIOL-UK, V2, P696, DOI 10.1039/c0ib00044b; Reiss K, 2002, NEUROSCIENCE, V115, P295, DOI 10.1016/S0306-4522(02)00307-X; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004; Skaat H, 2011, BIOCONJUGATE CHEM, V22, P2600, DOI 10.1021/bc200454k; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Stumm RK, 2003, J NEUROSCI, V23, P5123; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun JQ, 2010, BIOCHEM BIOPH RES CO, V394, P146, DOI 10.1016/j.bbrc.2010.02.132; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Teng LP, 2015, BIOMED PHARMACOTHER, V73, P29, DOI 10.1016/j.biopha.2015.05.009; Thakar D, 2017, BIOMATERIALS, V123, P24, DOI 10.1016/j.biomaterials.2017.01.022; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; Vulic K, 2014, BIOMACROMOLECULES, V15, P3867, DOI 10.1021/bm501084u; Wang H, 2006, EUR J NEUROSCI, V23, P1665, DOI 10.1111/j.1460-9568.2006.04682.x; Wang YN, 2011, BIOMATERIALS, V32, P4903, DOI 10.1016/j.biomaterials.2011.03.027; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Wang YQ, 2009, NEUROCHEM INT, V55, P629, DOI 10.1016/j.neuint.2009.06.007; Wang YF, 2011, J CONTROL RELEASE, V149, P225, DOI 10.1016/j.jconrel.2010.10.022; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Weiss JM, 1998, J IMMUNOL, V161, P6896; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Wu YB, 2009, J PHYS CHEM B, V113, P3512, DOI 10.1021/jp808145x; Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; Zamproni LN, 2017, INT J PHARMACEUT, V519, P323, DOI 10.1016/j.ijpharm.2017.01.036; Zendedel A, 2012, BRAIN RES, V1473, P214, DOI 10.1016/j.brainres.2012.07.037; Zhang LJ, 2016, NEUROSCIENCE, V337, P88, DOI 10.1016/j.neuroscience.2016.09.001; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zhu J, 2009, BRAIN RES, V1287, P173, DOI 10.1016/j.brainres.2009.06.068; Zimmermann N, 1999, J BIOL CHEM, V274, P12611, DOI 10.1074/jbc.274.18.12611	132	5	6	1	24	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-6041	1748-605X		BIOMED MATER	Biomed. Mater.	JUL	2018	13	4							044106	10.1088/1748-605X/aaad82			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GE2NY	WOS:000431053100001	29411713	Green Accepted			2022-02-06	
J	Lotan, E; Morley, C; Newman, J; Qian, M; Abu-Amara, D; Marmar, C; Lui, YW				Lotan, E.; Morley, C.; Newman, J.; Qian, M.; Abu-Amara, D.; Marmar, C.; Lui, Y. W.			Prevalence of Cerebral Microhemorrhage following Chronic Blast-Related Mild Traumatic Brain Injury in Military Service Members Using Susceptibility-Weighted MRI	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							WHITE-MATTER; SHELL SHOCK; MICROBLEEDS; HEMORRHAGE; DIFFUSE	BACKGROUND AND PURPOSE: Cerebral microhemorrhages are a known marker of mild traumatic brain injury. Blast-related mild traumatic brain injury relates to a propagating pressure wave, and there is evidence that the mechanism of injury in blast-related mild traumatic brain injury may be different from that in blunt head trauma. Two recent reports in mixed cohorts of blunt and blast-related traumatic brain injury in military personnel suggest that the prevalence of cerebral microhemorrhages is lower than in civilian head injury. In this study, we aimed to characterize the prevalence of cerebral microhemorrhages in military service members specifically with chronic blast-related mild traumatic brain injury. MATERIALS AND METHODS: Participants were prospectively recruited and underwent 3T MR imaging. Susceptibility-weighted images were assessed by 2 neuroradiologists independently for the presence of cerebral microhemorrhages. RESULTS: Our cohort included 146 veterans (132 men) who experienced remote blast-related mild traumatic brain injury (mean, 9.4 years; median, 9 years after injury). Twenty-one (14.4%) reported loss of consciousness for <30 minutes. Seventy-seven subjects (52.7%) had 1 episode of blast-related mild traumatic brain injury; 41 (28.1%) had 2 episodes; and 28 (19.2%) had >2 episodes. No cerebral microhemorrhages were identified in any subject, as opposed to the frequency of SWI-detectable cerebral microhemorrhages following blunt-related mild traumatic brain injury in the civilian population, which has been reported to be as high as 28% in the acute and subacute stages. CONCLUSIONS: Our results may reflect differences in pathophysiology and the mechanism of injury between blast- and blunt-related mild traumatic brain injury. Additionally, the chronicity of injury may play a role in the detection of cerebral microhemorrhages.	[Lotan, E.; Morley, C.; Lui, Y. W.] NYU, Langone Med Ctr, Steven & Alexandra Cohen Vet Ctr Posttraumat Stre, Dept Radiol, New York, NY USA; [Newman, J.; Qian, M.; Abu-Amara, D.; Marmar, C.] NYU, Langone Med Ctr, Steven & Alexandra Cohen Vet Ctr Posttraumat Stre, Dept Psychiat, New York, NY USA; [Lotan, E.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Lui, YW (corresponding author), 660 1st Ave,Room 336, New York, NY 10016 USA.	yvonne.lui@nyumc.org	Lotan, Eyal/AAV-9830-2021	Morley, Christopher/0000-0002-5810-6671	American Physicians Fellowship for Medicine in Israel; Dr. Pinchas Borenstein Talpiot Medical Leadership Program	Eyal Lotan is a recipient of Fellowship Grants from the American Physicians Fellowship for Medicine in Israel and from the Dr. Pinchas Borenstein Talpiot Medical Leadership Program 2013.	Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Daugherty AM, 2017, NEUROBIOL AGING, V59, P22, DOI 10.1016/j.neurobiolaging.2017.07.003; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Greenberg SM, 1996, NEUROLOGY, V46, P1751, DOI 10.1212/WNL.46.6.1751; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Kansagara D., 2013, COMPLICATIONS MILD T; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Roob G, 2000, CURR OPIN NEUROL, V13, P69, DOI 10.1097/00019052-200002000-00013; Roob G, 2000, STROKE, V31, P2665, DOI 10.1161/01.STR.31.11.2665; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shoamanesh A, 2011, CEREBROVASC DIS, V32, P528, DOI 10.1159/000331466; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; WechslerD, 2001, WECHSLER TEST ADULT; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	41	5	5	0	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JUL	2018	39	7					1222	1225		10.3174/ajnr.A5688			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GL6HD	WOS:000437283900011	29794235	Green Published, hybrid			2022-02-06	
J	Miranda, NA; Boris, JR; Kouvel, KM; Stiles, L				Miranda, Nicole A.; Boris, Jeffrey R.; Kouvel, Kristen M.; Stiles, Lauren			Activity and Exercise Intolerance After Concussion: Identification and Management of Postural Orthostatic Tachycardia Syndrome	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						lightheadedness; human movement system; mental fogginess; refractory dizziness; syncope	EHLERS-DANLOS-SYNDROME; TRAUMATIC BRAIN-INJURY; CELL-ACTIVATION-DISEASE; SYNDROME POTS; JOINT HYPERMOBILITY; INTERNATIONAL-CLASSIFICATION; VESTIBULAR REHABILITATION; CONSENSUS STATEMENT; PHYSICAL-THERAPY; BLOOD-VOLUME	Background and Purpose: Postural orthostatic tachycardia syndrome (POTS) is increasingly recognized as a complication affecting recovery from concussion. Individuals with POTS demonstrate refractory dizziness, lightheadedness, cognitive dysfunction, fatigue, headache, chronic pain, nausea and gastrointestinal dysmotility, activity and exercise intolerance, syncope, and tachycardia. Subtypes of POTS may include hypovolemia, hyperadrenergic states, autonomic neuropathy, and underlying autoimmunity, which may variably impact response to rehabilitation in varying ways. The subtle presentation of POTS postconcussion is often mistaken for underlying anxiety, conversion disorder, or lack of motivation for recovery. This article will present clinical features of POTS that may arise after concussion, and propose a role for physical therapists in the diagnosis and management of POTS during concussion recovery. Summary of Key Points: Data recorded and entered into a database during clinic visits from a large pediatric institution indicate that 11.4% of individuals diagnosed with POTS report onset of symptoms within 3 months of sustaining a concussion. Activation of the sympathetic nervous system can result in lightheadedness, shortness of breath, chest pain, tachycardia, palpitations on standing or with exertion, and activity and exercise intolerance. Identified comorbidities in people with POTS such as joint hypermobility and autoimmune disorders can further influence recovery. Recommendations for Clinical Practice: Physical therapists may identify signs and symptoms of POTS in a subset of individuals who remain refractory to typical interventions and who exhibit symptom exacerbation with orthostatic activity. Incorporation of an individualized POTS exercise program into current established concussion interventions may be useful, with emphasis on initial recumbent exercises and ongoing physical therapy assessment of exercise tolerance for dosing of activity intensity and duration. Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A211).	[Miranda, Nicole A.] Regis Univ, Phys Therapy Program, 3333 Regis Blvd, Denver, CO 80221 USA; [Miranda, Nicole A.] Marcus Inst Brain Hlth, Aurora, CO USA; [Boris, Jeffrey R.] Univ Penn, Philadelphia, PA 19104 USA; [Boris, Jeffrey R.] Univ Penn, Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA; [Boris, Jeffrey R.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kouvel, Kristen M.] Childrens Hosp Philadelphia, Phys Therapy Dept, Philadelphia, PA 19104 USA; [Stiles, Lauren] Dysauton Int, East Moriches, NY USA		Miranda, NA (corresponding author), Regis Univ, Phys Therapy Program, 3333 Regis Blvd, Denver, CO 80221 USA.	nicolemirandapt@gmail.com	Miranda, Nicole/ABB-1660-2020; Boris, Jeffrey/AAC-9942-2021; Boris, Jeffrey/L-5204-2019	Boris, Jeffrey/0000-0002-0428-7681			Afrin LB, 2016, ANN MED, V48, P190, DOI 10.3109/07853890.2016.1161231; Agarwal AK, 2007, POSTGRAD MED J, V83, P478, DOI 10.1136/pgmj.2006.055046; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Benarroch EE, 2012, MAYO CLIN PROC, V87, P1214, DOI 10.1016/j.mayocp.2012.08.013; Bhatia R, 2016, J PEDIATR-US, V173, P149, DOI 10.1016/j.jpeds.2016.02.035; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Blitshteyn S, 2015, LUPUS, V24, P1364, DOI 10.1177/0961203315587566; Boris JR, 2018, CARDIOL YOUNG, V28, P668, DOI 10.1017/S1047951117002888; Castori M, 2017, AM J MED GENET C, V175, P148, DOI 10.1002/ajmg.c.31539; Castori M, 2015, AM J MED GENET C, V169, P1, DOI 10.1002/ajmg.c.31432; Chelimsky G, 2015, J PEDIATR-US, V167, P120, DOI 10.1016/j.jpeds.2015.03.039; Conder RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00890; Dambinova SA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00172; Defense and Veteran Brain Injury Center and Defense Centers of Excellence Web site, 2014, DCOE CLIN REC PROGR; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Dysautonomia International Web site, 2017, EX DYS PAT CHOP MOD; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Engelbert RHH, 2017, AM J MED GENET C, V175, P158, DOI 10.1002/ajmg.c.31545; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fairbairn K, 2012, PHYS THER, V92, P310, DOI 10.2522/ptj.20090382; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Fu Q, 2011, HYPERTENSION, V58, P167, DOI 10.1161/HYPERTENSIONAHA.111.172262; Fu Q, 2010, HYPERTENSION, V56, P82, DOI 10.1161/HYPERTENSIONAHA.110.151787; Fu Q, 2010, J AM COLL CARDIOL, V55, P2858, DOI 10.1016/j.jacc.2010.02.043; Galbreath MM, 2011, CLIN AUTON RES, V21, P73, DOI 10.1007/s10286-010-0091-5; George SA, 2016, HEART RHYTHM, V13, P943, DOI 10.1016/j.hrthm.2015.12.012; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goodman B, 2015, NEUROLOGY S, V84, pP1; Goodman BP, 2013, NEUROLOGY S, V80; Goodman BP, 2019, AM J THER, V26, pE66, DOI 10.1097/MJT.0000000000000583; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Grigoriou E, 2015, CLIN ORTHOP RELAT R, V473, P722, DOI 10.1007/s11999-014-3898-x; Grubb BP, 2008, CIRCULATION, V117, P2814, DOI 10.1161/CIRCULATIONAHA.107.761643; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Heyer GL, 2013, HEADACHE, V53, P947, DOI 10.1111/head.12103; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Jennings S, 2014, J ALLER CL IMM-PRACT, V2, P70, DOI 10.1016/j.jaip.2013.09.004; Kanjwal K, 2011, CARDIOL J, V18, P527, DOI 10.5603/CJ.2011.0008; Khan AW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90183; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Kizilbash SJ, 2014, CURR PROB PEDIATR AD, V44, P108, DOI 10.1016/j.cppeds.2013.12.014; KLINE GM, 1987, MED SCI SPORT EXER, V19, P253; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Masuki S, 2007, J APPL PHYSIOL, V103, P1128, DOI 10.1152/japplphysiol.00175.2007; Masuki S, 2007, J APPL PHYSIOL, V102, P896, DOI 10.1152/japplphysiol.00927.2006; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Molderings GJ, 2016, N-S ARCH PHARMACOL, V389, P671, DOI 10.1007/s00210-016-1247-1; Pavlik D, 2016, JAAPA-J AM ACAD PHYS, V29, P17, DOI 10.1097/01.JAA.0000481398.76099.09; Penny HA, 2016, EUR J GASTROEN HEPAT, V28, P1383, DOI 10.1097/MEG.0000000000000740; Pianosi PT, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13040; Plash WB, 2013, CLIN SCI, V124, P109, DOI 10.1042/CS20120276; Raj Satish R, 2006, Indian Pacing Electrophysiol J, V6, P84; Raj SR, 2013, CIRCULATION, V127, P2336, DOI 10.1161/CIRCULATIONAHA.112.144501; Raj SR, 2005, CIRCULATION, V111, P1574, DOI 10.1161/01.CIR.0000160356.97313.5D; Rea NA, 2017, J NEUROL SCI, V377, P35, DOI 10.1016/j.jns.2017.03.032; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Richardson MV, 2017, PHYSIOTHER THEOR PR, V33, P670, DOI 10.1080/09593985.2017.1328719; Rombaut L, 2010, DISABIL REHABIL, V32, P1339, DOI 10.3109/09638280903514739; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Sheldon RS, 2015, HEART RHYTHM, V12, pE41, DOI 10.1016/j.hrthm.2015.03.029; Shibata S, 2012, J PHYSIOL-LONDON, V590, P3495, DOI 10.1113/jphysiol.2012.233858; Sletten DM, 2012, MAYO CLIN PROC, V87, P1196, DOI 10.1016/j.mayocp.2012.10.013; Smits-Engelsman B, 2011, J PEDIAT, V158; Stewart JM, 2004, J PEDIATR-US, V145, P725, DOI 10.1016/j.jpeds.2004.06.084; Stewart JM, 2007, AM J PHYSIOL-HEART C, V293, pH1908, DOI 10.1152/ajpheart.00439.2007; Thieben MJ, 2007, MAYO CLIN PROC, V82, P308; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Treister R, 2015, EUR J NEUROL, V22, P1124, DOI 10.1111/ene.12717; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200	78	5	5	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2018	42	3			SI		163	171		10.1097/NPT.0000000000000231			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	GL1OM	WOS:000436873100008	29864098	Green Published, hybrid			2022-02-06	
J	O'Neil-Pirozzi, TM; Ketchum, JM; Hammond, FM; Philippus, A; Weber, E; Dams-O'Connor, K				O'Neil-Pirozzi, Therese M.; Ketchum, Jessica M.; Hammond, Flora M.; Philippus, Angela; Weber, Erica; Dams-O'Connor, Kristen			Physical, Cognitive, and Psychosocial Characteristics Associated With Mortality in Chronic TBI Survivors: A National Institute on Disability, Independent Living, and Rehabilitation Research Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic health; death; longitudinal outcomes; traumatic brain injury	GLASGOW OUTCOME SCALE; LONG-TERM SURVIVAL; SEVERE HEAD-INJURY; RATING-SCALE; INPATIENT REHABILITATION; PARTICIPATION ASSESSMENT; LIFE EXPECTANCY; UNITED-STATES; DEATH; RECOVERY	Objective: To compare a group of individuals who died more than 1 year posttraumatic brain injury (TBI) with a matched group of survivors and to identify physical function, cognitive function, and/or psychosocial function variables associated with mortality. Design: Secondary analysis of data from a multicenter longitudinal cohort study. Setting: Acute inpatient rehabilitation facilities and community follow-up. Participants: Individuals 16 years and older with a primary diagnosis of TBI. Main Outcome Measures: Functional Independence Measure (FIM), Disability Rating Scale, Participation Assessment with Recombined Tools Objective, Extended Glasgow Outcome Scale, Satisfaction With Life Scale. Results: Individuals who died were distinguishable from their surviving counterparts. They demonstrated significantly poorer global functioning on all physical, cognitive, and psychosocial functioning variables at their most recent study follow-up visit prior to death. FIM Motor demonstrated the largest difference between survival groups, suggesting that independence in mobility may be particularly indicative of likelihood of longer-term survival. Conclusions: These findings may inform continued research to elucidate functional characteristics of individuals postchronic TBI prior to their death and to identify opportunities for prevention of accelerated death and interventions to improve health, longevity, and quality of life.	[O'Neil-Pirozzi, Therese M.] Northeastern Univ, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, 360 Huntington Ave,70 Forsyth Bldg Room 103, Boston, MA 02115 USA; [Ketchum, Jessica M.; Philippus, Angela] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Weber, Erica] Kessler Fdn, E Hanover, NJ USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, Dept Commun Sci & Disorders, 360 Huntington Ave,70 Forsyth Bldg Room 103, Boston, MA 02115 USA.	t.oneil-pirozzi@northeastern.edu	Ketchum, Jessica/AAE-8200-2020		National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [2012P002490]; Traumatic Brain Injury Model Systems National Data and Statistical Center [90DP0084-01-00]; Indiana University/Rehabilitation Hospital of Indiana TBI Model System [90DP0036-01-00]; Rocky Mountain Regional Brain Injury System [90DP0034-01-00]; Northern New Jersey Traumatic Brain Injury Model System [90DP0032]; New York TBI Model System [90DP0038-02-00]	This work was funded by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research to the Spaulding-Harvard TBI Model System (grant number 2012P002490), Traumatic Brain Injury Model Systems National Data and Statistical Center (grant number 90DP0084-01-00), Indiana University/Rehabilitation Hospital of Indiana TBI Model System (grant number 90DP0036-01-00), Rocky Mountain Regional Brain Injury System (grant number 90DP0034-01-00), Northern New Jersey Traumatic Brain Injury Model System (grant number 90DP0032), and New York TBI Model System (grant number 90DP0038-02-00).	Agarwal R, 2010, PREV CHRONIC DIS, V7; [Anonymous], 1997, GUID UN DAT SET MED; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Charrette AL, 2016, BRAIN INJURY, V30, P1213, DOI 10.1080/02699052.2016.1187766; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hirshson CI, 2013, NEUROREHABILITATION, V32, P225, DOI 10.3233/NRE-130840; Lakkireddy DR, 2004, AM J MED, V117, P492, DOI 10.1016/j.amjmed.2004.04.018; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nott MT, 2015, AUSTRALAS J AGEING, V34, pE1, DOI 10.1111/ajag.12151; O'Neil-Pirozzi TM, 2016, BRAIN INJURY, V30, P1617, DOI 10.1080/02699052.2016.1199906; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Pritt BS, 2005, ARCH PATHOL LAB MED, V129, P1476; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ravakhah K, 2006, SOUTH MED J, V99, P728, DOI 10.1097/01.smj.0000224337.77074.57; ROSSI JS, 1985, EDUC PSYCHOL MEAS, V45, P737, DOI 10.1177/0013164485454004; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Ulfarsson T, 2014, BRAIN INJURY, V28, P1675, DOI 10.3109/02699052.2014.947625; Vaaramo K, 2015, J NEUROTRAUM, V32, P1579, DOI 10.1089/neu.2014.3757; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wexelman BA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120288; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	48	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					237	245		10.1097/HTR.0000000000000365			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900010	29271788	Green Submitted			2022-02-06	
J	Ogunlade, J; Elia, C; Duong, J; Yanez, PJ; Dong, FL; Wacker, MR; Menoni, R; Goldenberg, T; Miulli, DE				Ogunlade, John; Elia, Chris; Duong, Jason; Yanez, Paulino J.; Dong, Fanglong; Wacker, Margaret R.; Menoni, Rosalinda; Goldenberg, Todd; Miulli, Dan E.			Severe Traumatic Brain Injury Requiring Surgical Decompression in the Young Adult: Factors Influencing Morbidity and Mortality - A Retrospective Analysis	CUREUS			English	Article						severe traumatic brain injury; traumatic brain injury; decompressive craniectomy; craniotomy; neurotrauma; glasgow outcome scale; glasgow coma scale	CRANIECTOMY; OUTCOMES; MEMORY	Introduction: Severe traumatic brain injury (TBI) is a leading cause of morbidity and mortality among young adults. The clinical outcome may also be difficult to predict. We aim to identify the factors predictive of favorable and unfavorable clinical outcomes for youthful patients with severe TBI who have the option of surgical craniotomy or surgical craniectomy. Methods: A retrospective review at a single Level II trauma center was conducted, identifying patients aged 18 to 30 years with isolated severe TBI with a mass-occupying lesion requiring emergent (< 6 hours from time of arrival) surgical decompression. Glasgow Coma Scale (GCS) score on arrival, type of surgery performed, mechanism of injury, length of hospital stay, Glasgow Outcome Score (GOS), mortality, and radiographic findings were recorded. A favorable outcome was a GOS of four or five at 30 days post operation, while an unfavorable outcome was GOS of 1 to 3. Results: Fifty patients were included in the final analysis. Closed head injuries (skull and dura intact), effacement of basal cisterns, disproportional midline shift (MLS), and GCS 3-5 on arrival all correlated with statistically significant higher rate of mortality and poor 30-day functional outcome. All mortalities (6/50 patients) were positive for each of these findings. Conclusions: Closed head injuries, the presenting GCS 3-5, the presence of MLS disproportional to the space occupying lesion (SOL), and effacement of basal cisterns on the initial computed tomography of the head all correlated with unfavorable 30-day outcome. Future prospective studies investigating a larger cohort may provide further insight into patients suffering from severe TBI.	[Ogunlade, John; Elia, Chris] Riverside Univ Hlth Syst, Neurosurg, Med Ctr, Riverside, CA 92555 USA; [Duong, Jason] Riverside Univ Hlth Syst Med Ctr, Neurosurg, Rancho Cucamonga, CA USA; [Yanez, Paulino J.] Harvard Univ, Clin Res, Boston, MA USA; [Dong, Fanglong] Western Univ Hlth Sci, Clin Res, Pomona, CA USA; [Wacker, Margaret R.] Arrowhead, Neurosurg, Moreno Valley, CA USA; [Menoni, Rosalinda] Arrowhead, Neurosurg, Colton, CA USA; [Goldenberg, Todd] Kaiser Permanente Fontana Med Ctr, Neurosurg, Fontana, CA USA; [Miulli, Dan E.] Riverside Univ Hlth Syst, Neurosurg, Med Ctr, Moreno Valley, CA USA		Ogunlade, J (corresponding author), Riverside Univ Hlth Syst, Neurosurg, Med Ctr, Riverside, CA 92555 USA.	j.ogunlade@ruhealth.org					BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Nguyen HS, 2016, WORLD NEUROSURG, V95, P85, DOI 10.1016/j.wneu.2016.07.067; Khan AD, 2017, AM SURGEON, V83, P836; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Olivecrona M, 2010, J NEUROSURG, V112, P1113, DOI 10.3171/2009.8.JNS09636; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sophie Su Y., 2016, TRANSLATIONAL RES TR; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Zaninotto AL, 2017, ACTA NEUROPSYCHIATR, V29, P35, DOI 10.1017/neu.2016.29; [No title captured]	20	5	6	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL	2018	10	7							e3042	10.7759/cureus.3042			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HB3HX	WOS:000450942900140	30258741	Green Submitted, gold, Green Published			2022-02-06	
J	Radomski, MV; Davidson, LF; Smith, L; Finkelstein, M; Cecchini, A; Heaton, KJ; McCulloch, K; Scherer, M; Weightman, MM				Radomski, Mary, V; Davidson, Leslie F.; Smith, Laurel; Finkelstein, Marsha; Cecchini, Amy; Heaton, Kristin J.; McCulloch, Karen; Scherer, Matthew; Weightman, Margaret M.			Toward Return to Duty Decision-Making After Military Mild Traumatic Brain Injury: Preliminary Validation of the Charge of Quarters Duty Test	MILITARY MEDICINE			English	Article							TASK-PERFORMANCE ASSESSMENT; EXECUTIVE FUNCTION; ECOLOGICAL VALIDITY; DUAL-TASK; RELIABILITY; MULTITASKING; REHABILITATION; CONCUSSION; VERSION; PEOPLE	Introduction: Determining duty-readiness after mild traumatic brain injury (mTBI) remains a priority of the United States Department of Defense as warfighters in both deployed and non-deployed settings continue to sustain these injuries in relatively large numbers. Warfighters with mTBI may experience unresolved sensorimotor, emotional, cognitive sequelae including problems with executive functions, a category of higher order cognitive processes that enable people to regulate goal-directed behavior. Persistent mTBI sequelae interfere with warfighters' proficiency in performing military duties and signal the need for graded return to activity and possibly rehabilitative services. Although significant strides have been carried out in recent years to enhance the identification and management of mTBI in garrison (EXORD 165-13) and deployed settings (EXORD 242-11; DoDI 6,490.11), the Department of Defense still lacks reliable, valid, and clinically feasible functional assessments to help inform duty-readiness decisions. Traditional functional assessments lack face validity for warfighters and may have ceiling effects, especially as related to executive functions. Performance-based multitasking assessments have been shown to be sensitive to executive dysfunction after acquired brain injury but no multitasking assessments have been validated in adults with mTBI. Existing multitasking assessments are not ecologically valid relative to military contexts. A multidisciplinary military-civilian team of researchers developed and evaluated a performance-based assessment called the Assessment of Military Multitasking Performance. One of the Assessment of Military Multitasking Performance multitasks, the Charge of Quarters Duty Test (CQDT), was designed to challenge the divided attention, foresight, and planning dimensions of executive functions. Here, we report on the preliminary validation results of the CQDT. Materials and methods: The team conducted a measurement development study at Fort Bragg, NC, enrolling 83 service members (33 with mTBI and 50 healthy controls). Discriminant validity was evaluated by comparing differences in CQDT sub-scores of warfighters with mTBI and healthy controls. Associations between CQDT sub-scores and neurocognitive measures known to be sensitive to mTBI were examined to explore convergent validity. The study was approved by the Womack Army Medical Center Institutional Review Board (Fort Bragg). Results: There were significant between-group differences in two of the four CQDT sub-scores (number of visits, p = 0.012; and performance accuracy, p = 0.020). Correlations between the CQDT sub-scores and some neurocognitive measures were statistically significant but weak, ranging from 0.287 (CQDT performance accuracy and NAB Numbers and Letters, Part D) to -0.421 (CQDT total number of visits and Automated Neuropsychological Assessment Metrics Tower Task). There were group differences in terms of participants' reading level, education, years in military, and stress symptoms; some of these characteristics may have influenced CQDT performance. Conclusions: The CQDT demonstrated initial evidence of discriminant validity. Further study is warranted to more formally evaluate convergent/divergent validity and ultimately how and whether this performance-based multitasking measure can inform readiness to return to duty after mTBI.	[Radomski, Mary, V; Finkelstein, Marsha; Weightman, Margaret M.] Courage Kenny Res Ctr, 800 E 28th St Chicago, Minneapolis, MN 55407 USA; [Davidson, Leslie F.; Heaton, Kristin J.] George Washington Univ, Clin Res & Leadership, Sch Med & Hlth Sci, 2100 Penn Suite 358 Ave, Washington, DC 20037 USA; [Smith, Laurel] US Army Res Inst Environm Med, Mil Performance Div, 10 Gen Greene Ave, Natick, MA 01760 USA; [Cecchini, Amy] Womack Army Med Ctr, Intrepid Spirit, 3908 Longst Rd Bldg 3-4303, Ft Bragg, NC 28310 USA; [McCulloch, Karen] Univ North Carolina Chapel Hill, Dept Allied Hlth, Div Phys Therapy, Sch Med, CB 7135, Chapel Hill, NC 27599 USA; [Scherer, Matthew] Med Res & Mat Command, Clin & Rehabil Med Res Program, 504 Scott St Bldg 722, Ft Detrick, MD 21702 USA		Radomski, MV (corresponding author), Courage Kenny Res Ctr, 800 E 28th St Chicago, Minneapolis, MN 55407 USA.				United States Army Medical Research Materiel Command [W81XWH-12-2-0070]	United States Army Medical Research Materiel Command (award number W81XWH-12-2-0070).	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Augustin A, 2010, DEV OPHTHALMOL, V47, P10, DOI 10.1159/000320071; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 1988, STAT POWER BEHAV SCI; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Department of Defense, 2012, 6490112012 DODI; Department of the Army, 2015, 165132015 HQDA EXORD; DVBIC  Defense and Veterans Brain Injury Center, 2015, DOD NUMB TRAUM BRAIN; Frisch S, 2012, J NEUROPSYCHOL, V6, P257, DOI 10.1111/j.1748-6653.2012.02026.x; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McCulloch KL, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932010-00002; MONTGOMERY GK, 1995, BRAIN INJURY, V9, P453, DOI 10.3109/02699059509008205; Morrison MT, 2015, AM J OCCUP THER, V69, P117, DOI 10.5014/ajot.2015.011528; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Schutz LE, 2009, AM J PHYS MED REHAB, V88, P419, DOI 10.1097/PHM.0b013e3181a0e2d3; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith LB, 2014, AM J OCCUP THER, V68, P439, DOI 10.5014/ajot.2014.012393; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Weathers F.W., 1993, 9 ANN C ISTSS; Weightman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169104; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wolf TJ, 2008, WORK, V31, P221; Wolf TJ, 2017, NEUROPSYCHOL REHABIL, V27, P707, DOI 10.1080/09602011.2015.1037771; Wolf TJ, 2011, OTJR-OCCUP PART HEAL, V31, pS23, DOI 10.3928/15394492-20101108-05	45	5	5	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL-AUG	2018	183	7-8					E214	E222		10.1093/milmed/usx045			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GL3EI	WOS:000437011100006	29365166	Bronze, Green Submitted			2022-02-06	
J	Russell-Giller, S; Toto, D; Heitzman, M; Naematullah, M; Shumko, J				Russell-Giller, Shira; Toto, Diana; Heitzman, Mike; Naematullah, Mustafa; Shumko, John			Correlating the King-Devick Test With Vestibular/Ocular Motor Screening in Adolescent Patients With Concussion: A Pilot Study	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						King-Devick test; vestibular/ocular motor screening; concussion	SPORTS-RELATED CONCUSSION; EYE-MOVEMENTS; YOUTH; ASSOCIATIONS; VISION; COMMON; VOMS; TOOL	Background: The King-Devick (K-D) test is a rapid number-naming task that has been well validated as a sensitive sideline performance measure for concussion detection. Patients with concussion take significantly longer to complete the K-D test than healthy controls. Previous research suggests that ocular motor deficits, specifically saccadic abnormalities, may be an underlying factor for the prolonged time. However, these findings have not been studied at length. Hypothesis: K-D testing time of concussed adolescents at the initial clinical concussion visit will positively correlate with vestibular/ocular motor screening (VOMS) total scores. Study Design: Case series. Level of Evidence: Level 3. Methods: A total of 71 patient charts were retrospectively analyzed between October 1, 2016, and January 31, 2017. Included charts consisted of patients between the ages of 10 and 18 years with a diagnosis of concussion and who had completed K-D testing and VOMS assessment at the initial physician visit. Univariate correlation between K-D testing time and the 7 VOMS items was assessed using Pearson correlation coefficients. Results: K-D testing time strongly correlated with all 7 VOMS items (r(69) = 0.325-0.585, P < 0.01). In a linear regression model that accounted for each VOMS item, the convergence (near point) item and the visual motion sensitivity item significantly predicted K-D testing time (beta = 0.387, t(63) = 2.81, P < 0.01 and beta = 0.375, t(63) = 2.35, P = 0.02, respectively). Additionally, 37.5% of the 24 patients with worsening symptoms after K-D testing freely reported increased visual problems. Conclusion: Our study suggests that prolonged K-D testing times in adolescents with concussion may be related to subtypes of vestibular/ocular motor impairment that extend beyond saccadic abnormalities.	[Russell-Giller, Shira] RWJBarnabas Hlth, Multiple Sclerosis Comprehens Care Ctr, Livingston, NJ USA; [Toto, Diana; Heitzman, Mike; Naematullah, Mustafa; Shumko, John] RWJBarnabas Hlth, Matthew J Morahan Hlth Assessment Ctr Athletes 3, Livingston, NJ USA		Russell-Giller, S (corresponding author), RWJBarnabas Hlth, Matthew J Morahan Hlth Assessment Ctr Athletes 3, Multiple Sclerosis Comprehens Care Ctr, 200 South Orange Ave, Livingston, NJ 07039 USA.; Russell-Giller, S (corresponding author), Barnabas Hlth Ambulatory Care Ctr, Ctr Hlth & Wellness, 200 South Orange Ave, Livingston, NJ 07039 USA.	shirarussell26@gmail.com					Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	23	5	5	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2018	10	4					334	339		10.1177/1941738118765450			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GM9ZN	WOS:000438616500007	29553882	Green Published			2022-02-06	
J	Sivanandapanicker, J; Nagar, M; Kutty, R; Sunilkumar, BS; Peethambaran, A; Rajmohan, BP; Asher, P; Shinihas, VP; Mohandas, K; Jain, S; Sharma, S				Sivanandapanicker, Jyothish; Nagar, Milesh; Kutty, Raja; Sunilkumar, B. S.; Peethambaran, Anilkumar; Rajmohan, B. P.; Asher, Prasanth; Shinihas, V. P.; Mohandas, K.; Jain, Sourabh; Sharma, Saurabh			Analysis and Clinical Importance of Skull Base Fractures in Adult Patients with Traumatic Brain Injury	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Cerebrospinal fluid leak; meningitis; road traffic accident; skull base fracture; traumatic brain injury	CEREBROSPINAL-FLUID LEAK; CLOSED HEAD-INJURY; PROPHYLACTIC ANTIBIOTICS; MAXILLOFACIAL TRAUMA; MANAGEMENT; CLASSIFICATION; NIGERIA; CT	Aims and Objectives: Basal skull fracture (BSF) is rare in head injury (HI) patients and occasionally goes unnoticed which may lead to cerebrospinal fluid (CSF) fistula. With changing trends in HI, there is a need to reassess incidence and pattern of BSF pattern, CSF leak, meningitis, and management protocol, especially in this part of the world where detailed literature is lacking. Subjects and Methods: We closely followed adult patients admitted with BSF in our institute between January 2013 and December 2014. Associated clinical features were recorded. In case of CSF leak, detailed CSF study was done and patients were managed accordingly. Patients with persistent CSF leak were managed surgically. Results: During the study period, 194 of 5041 HI patients had evidence of BSF (3.85%). BSF was most commonly associated with moderate-to-severe HI (73.19%). About 81.44% patients were male and 29.9% were <30 years. Most common cause was road traffic accident (84.54%). Isolated anterior cranial fossa (ACF) fracture was most common (50%). About 63.92% patients had raccoon eyes. Forty-three patients had CSF leak with CSF rhinorrhea being more common. Culture of only 5 patients suggested bacterial meningitis. CSF leak lasted for more than 10 days in 8 patients, of which 4 patients required surgical repair. Conclusions: BSF is rare in victims of HI. It is more common in young adult males. ACF fractures are most common in our setup. Clinical signs of BSF are supportive but not definitive; high resolution computed tomography head is gold standard to detect BSF. CSF leak is rare and most of the cases can be managed conservatively. Leak persisting more than 7-10 days has high risk of developing meningitis and likely to need surgical intervention.	[Sivanandapanicker, Jyothish; Nagar, Milesh; Kutty, Raja; Sunilkumar, B. S.; Peethambaran, Anilkumar; Rajmohan, B. P.; Asher, Prasanth; Shinihas, V. P.; Jain, Sourabh; Sharma, Saurabh] Govt Med Coll, Dept Neurosurg, Thiruvananthapuram 695011, Kerala, India; [Mohandas, K.] Govt Med Coll, Dept Gen Surg, Thiruvananthapuram, Kerala, India		Nagar, M (corresponding author), Govt Med Coll, Dept Neurosurg, Thiruvananthapuram 695011, Kerala, India.	millesh.kem@gmail.com		Sharma, Saurabh/0000-0003-3523-2947			Abiodun A, 2012, ANN AFR MED, V11, P131, DOI 10.4103/1596-3519.96860; Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Al Ahmed HE, 2004, ORAL SURG ORAL MED O, V98, P166, DOI 10.1016/j.tripleo.2004.01.020; Archer JB, 2016, J NEUROSURG, V124, P647, DOI 10.3171/2015.4.JNS1528; Baugnon KL, 2014, NEUROIMAG CLIN N AM, V24, P439, DOI 10.1016/j.nic.2014.03.001; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Brodie HA, 1997, AM J OTOL, V18, P188; Chavali KH, 2006, J INDIAN ACAD FORENS, V28, P12; CONFORTI PJ, 1993, J ORAL MAXIL SURG, V51, P298, DOI 10.1016/S0278-2391(10)80179-X; Connor SEJ, 2005, CLIN RADIOL, V60, P878, DOI 10.1016/j.crad.2005.04.003; DEMETRIADES D, 1992, INJURY, V23, P377, DOI 10.1016/0020-1383(92)90011-G; Emejulu J. K. C., 2008, East and Central African Journal of Surgery, V13, P86; Friedman J A, 2000, Neurosurg Focus, V9, pe1, DOI 10.3171/foc.2000.9.1.1; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Goh KYC, 1997, INJURY, V28, P353, DOI 10.1016/S0020-1383(97)00024-7; Guyer RA, 2015, ALLERGY RHINOL, V6, pE188, DOI 10.2500/ar.2015.6.0132; Hasheminia D, 2015, J MAXILLOFAC ORAL SU, V14, P258, DOI 10.1007/s12663-014-0630-z; La Fata V, 2008, AM J NEURORADIOL, V29, P536, DOI 10.3174/ajnr.A0885; LEECH PJ, 1973, LANCET, V1, P1013; Lewin W, 1964, Clin Neurosurg, V12, P237; LEWIN W, 1954, BRIT J SURG, V42, P1, DOI 10.1002/bjs.18004217102; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; Loew F, 1984, Adv Tech Stand Neurosurg, V11, P169; Mendizabal G R, 1992, Rev Laryngol Otol Rhinol (Bord), V113, P423; Nellis JC, 2014, LARYNGOSCOPE, V124, P8, DOI 10.1002/lary.23934; Olabinri EO, 2015, J NEUROSCI RURAL PRA, V6, P139, DOI 10.4103/0976-3147.153215; Parmar H, 2009, NEUROIMAG CLIN N AM, V19, P427, DOI 10.1016/j.nic.2009.06.011; Patel A, 2010, CRANIOMAX TRAUM REC, V3, P105, DOI 10.1055/s-0030-1254383; Patrascu E, 2017, ROM J RHINOL, V7, P143; Perheentupa U, 2014, J CRANIO MAXILL SURG, V42, P305, DOI 10.1016/j.jcms.2013.05.018; Phang SY, 2016, BRIT J NEUROSURG, V30, P596, DOI 10.1080/02688697.2016.1229746; Plaisier B, 2004, INTERNET J NEUROSURG, V2; Pretto Flores L, 2000, J Neurosurg Sci, V44, P77; Rafferty MA, 2006, CLIN OTOLARYNGOL, V31, P287, DOI 10.1111/j.1749-4486.2006.01267.x; Rao KVLN, 2010, INDIAN J NEUROTRAUM, V7, P171, DOI 10.1016/S0973-0508(10)80035-8; RATHORE MH, 1991, PEDIATR INFECT DIS J, V10, P87, DOI 10.1097/00006454-199102000-00001; Ratilal BO, 2015, COCHRANE DB SYST REV, V28; Rimmer J, 2014, J LARYNGOL OTOL, V128, P626, DOI 10.1017/S0022215114001431; Savastio G, 1991, Radiol Med, V82, P769; Wani AA, 2013, INDIAN J NEUROTRAUM, V10, P120, DOI 10.1016/j.ijnt.2013.05.009; World Health Organization, WORLD REPORT ROAD TR; World Health Organization, 2013, ROAD TRAFF INJ FACT; Yadav Yad Ram, 2016, Asian J Neurosurg, V11, P183, DOI 10.4103/1793-5482.145101; Yellinek S, 2016, J CLIN NEUROSCI, V25, P111, DOI 10.1016/j.jocn.2015.10.012	44	5	5	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL-SEP	2018	9	3					370	375		10.4103/jnrp.jnrp_38_18			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GN4KZ	WOS:000438993200015	30069094	Green Published, gold			2022-02-06	
J	Sheth, C; Prescot, A; Bueler, E; DiMuzio, J; Legarreta, M; Renshaw, PF; Yurgelun-Todd, D; McGlade, E				Sheth, Chandni; Prescot, Andrew; Bueler, Elliott; DiMuzio, Jennifer; Legarreta, Margaret; Renshaw, Perry F.; Yurgelun-Todd, Deborah; McGlade, Erin			Alterations in anterior cingulate cortex myoinositol and aggression in veterans with suicidal behavior: A proton magnetic resonance spectroscopy study	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Suicide; Veterans; Neurobiology; Anterior cingulate cortex; Endophenotype	TRAUMATIC BRAIN-INJURY; FRONTAL-CORTEX; HLA-DR; PREFRONTAL CORTEX; BIPOLAR DISORDER; RECEPTOR-BINDING; MR SPECTROSCOPY; INOSITOL LEVELS; RATING-SCALE; WHITE-MATTER	Studies investigating the neurochemical changes that correspond with suicidal behavior (SB) have not yielded conclusive results. Suicide correlates such as aggression have been used to explore risk factors for SB. Yet the neurobiological basis for the association between aggression and SB is unclear. Aggression and SB are both prevalent in veterans relative to civilian populations. The current study evaluated the relationship between brain chemistry in the anterior (ACC) and the posterior cingulate cortex (POC), as well as the relationship between aggression and SB in a veteran population using proton magnetic resonance spectroscopy (H-1-MRS). Single-voxel MRS data at 3 Tesla (T) were acquired from the ACC and POC voxels using a 2-dimensional J-resolved point spectroscopy sequence and quantified using the ProFit algorithm. Participants also completed a structured diagnostic interview and a clinical battery. Our results showed that the myoinositol (mI)/H2O ratio in the ACC and POC was significantly higher in veterans who reported SB when compared to veterans who did not. The two groups did not differ significantly with regard to other metabolites. Second, verbal aggression and SB measures positively correlated with mI/H2O in the ACC. Finally, verbal aggression mediated the relationship between mI/H2O in the ACC and SB.	[Sheth, Chandni; Renshaw, Perry F.; Yurgelun-Todd, Deborah; McGlade, Erin] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84108 USA; [Sheth, Chandni; Bueler, Elliott; DiMuzio, Jennifer; Legarreta, Margaret; Renshaw, Perry F.; Yurgelun-Todd, Deborah; McGlade, Erin] Univ Utah, Diagnost Neuroimaging, Salt Lake City, UT 84108 USA; [Prescot, Andrew] Univ Utah, Sch Med, Dept Radiol, Salt Lake City, UT 84108 USA; [Bueler, Elliott; DiMuzio, Jennifer; Legarreta, Margaret; Renshaw, Perry F.; Yurgelun-Todd, Deborah; McGlade, Erin] George E Wahlen Dept Vet Affairs Med Ctr, VA VISN Mental Illness Res Educ & Clin Ctr MIRREC, Salt Lake City, UT USA		Sheth, C (corresponding author), Univ Utah, Dept Psychiat, 383 Colorow Dr,Rm 325, Salt Lake City, UT 84108 USA.	Chandni.sheth@utah.edu	Renshaw, Perry/O-1384-2018; McGlade, Erin C/K-1157-2016	McGlade, Erin C/0000-0003-2234-1984; Legarreta, Margaret/0000-0003-1345-9390	Department of Veterans AffairsUS Department of Veterans Affairs; Military Suicide Research Consortium (MSRC); Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0178, 5I01CX000253-02]	This manuscript is based upon work supported by the Department of Veterans Affairs, but does not necessarily represent the views of the Department of Veterans Affairs or the United States Government. This presentation is based upon work supported with resources and the use of facilities at the VISN 19 MIRECC. This project is funded by the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under award no. W81XWH-10-2-0178; and through merit review 5I01CX000253-02.	ARORA RC, 1989, AM J PSYCHIAT, V146, P730; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Baca-Garcia E, 2011, J AFFECT DISORDERS, V134, P327, DOI 10.1016/j.jad.2011.06.026; Bittsansky M, 2012, GEN PHYSIOL BIOPHYS, V31, P101, DOI 10.4149/gpb_2012_007; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carballo JJ, 2008, ARCH SUICIDE RES, V12, P93, DOI 10.1080/13811110701857004; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; CDC, 2015, WEB BAS INJ STAT QUE; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Department of Veterans Affairs W. D, 2009, HLTH SERV RES DEV SE; Desmyter S, 2013, CNS NEUROL DISORD-DR, V12, P921, DOI 10.2174/18715273113129990093; Dickstein DP, 2008, PSYCHIAT RES-NEUROIM, V163, P30, DOI 10.1016/j.pscychresns.2007.11.006; Dwivedi Y, 2008, NEUROPSYCHOPHARMACOL, V33, P2324, DOI 10.1038/sj.npp.1301641; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Flanagan Julianne C, 2014, Ment Health Subst Use, V7, P315; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GEHRMANN J, 1993, J NEUROIMMUNOL, V48, P189, DOI 10.1016/0165-5728(93)90191-Z; Goldstein G, 2012, PSYCHIAT RES, V199, P37, DOI 10.1016/j.psychres.2012.03.029; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harvey BH, 2002, PROG NEURO-PSYCHOPH, V26, P21, DOI 10.1016/S0278-5846(01)00244-5; Hayes, 2018, INTRO MEDIATION MODE; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; Hochberg Y., 1995, J ROYAL STAT SOC B, V57, P289; Holmes SE, 2018, BIOL PSYCHIAT, V83, P61, DOI 10.1016/j.biopsych.2017.08.005; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Isometsa ET, 1998, BRIT J PSYCHIAT, V173, P531, DOI 10.1192/bjp.173.6.531; Jollant F, 2016, PROG NEUROPSYCHOPHAR; Jollant F, 2016, EUR NEUROPSYCHOPHARM, V26, P1255, DOI 10.1016/j.euroneuro.2016.06.005; Jollant F, 2013, PSYCHIAT RES, V210, P485, DOI 10.1016/j.psychres.2013.07.011; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kovacsics CE, 2009, ANNU REV PHARMACOL, V49, P175, DOI 10.1146/annurev.pharmtox.011008.145557; Li Jin, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P59; Lim TS, 2012, DEMENT GERIATR COGN, V33, P149, DOI 10.1159/000338177; Lo Vasco VR, 2015, J AFFECT DISORDERS, V174, P324, DOI [10.1016/J.jad.2014.12.006, 10.1016/j.jad.2014.12.006]; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; MANN JJ, 1986, ARCH GEN PSYCHIAT, V43, P954; Mathews DC, 2013, TRANSL NEUROSCI, V4, P203, DOI 10.2478/s13380-013-0120-7; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; McFall M, 1999, J TRAUMA STRESS, V12, P501, DOI 10.1023/A:1024771121189; Mick E, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087257, 10.1371/journal.pone.0094168]; Moore GJ, 1999, AM J PSYCHIAT, V156, P1902; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; O'Donnell T, 2000, BRAIN RES, V880, P84, DOI 10.1016/S0006-8993(00)02797-9; OGG RJ, 1994, J MAGN RESON SER B, V104, P1, DOI 10.1006/jmrb.1994.1048; Oquendo MA, 2006, BIOL PSYCHIAT, V59, P235, DOI 10.1016/j.biopsych.2005.06.037; Pacheco MA, 1996, BRAIN RES, V723, P37, DOI 10.1016/0006-8993(96)00207-7; Pawliczek CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078503; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Prescot AP, 2013, J MAGN RESON IMAGING, V37, P642, DOI 10.1002/jmri.23848; Prescot AP, 2012, NMR BIOMED, V25, P1245, DOI 10.1002/nbm.2795; Reynolds WM, 1998, J SCHOOL PSYCHOL, V36, P295, DOI 10.1016/S0022-4405(98)00010-7; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Rosell DR, 2010, BIOL PSYCHIAT, V67, P1154, DOI 10.1016/j.biopsych.2010.03.013; Rusch N, 2008, PSYCHIAT RES-NEUROIM, V164, P206, DOI 10.1016/j.pscychresns.2007.12.011; Schulte RF, 2006, NMR BIOMED, V19, P255, DOI 10.1002/nbm.1026; Shimon H, 1997, AM J PSYCHIAT, V154, P1148; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; STANLEY M, 1983, LANCET, V1, P214; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; Sterzer P, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.035.2009; Torres-Platas SG, 2011, NEUROPSYCHOPHARMACOL, V36, P2650, DOI 10.1038/npp.2011.154; ULVESTAD E, 1994, IMMUNOLOGY, V82, P535; van Heeringen K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00824; Veit R, 2010, NEUROIMAGE, V49, P3365, DOI 10.1016/j.neuroimage.2009.11.040; Wagner G, 2011, NEUROIMAGE, V54, P1607, DOI 10.1016/j.neuroimage.2010.08.082; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Zhang HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063477; Zhang XL, 2001, MAGNET RESON MED, V46, P443, DOI 10.1002/mrm.1212	78	5	5	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	JUN 30	2018	276						24	32		10.1016/j.pscychresns.2018.04.004			9	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	GG7VW	WOS:000432907500004	29723775				2022-02-06	
J	Dobbe, ASM; Stolmeijer, R; ter Maaten, JC; Ligtenberg, JJM				Dobbe, Anna S. M.; Stolmeijer, Renate; ter Maaten, Jan C.; Ligtenberg, Jack J. M.			Titration of oxygen therapy in critically ill emergency department patients: a feasibility study	BMC EMERGENCY MEDICINE			English	Article						Emergency medicine; Oxygen inhalation therapy; Hyperoxia; Normoxia; Hypoxia; Titration of oxygen therapy; Emergency department; Critically ill patients; Pulmonary disease; chronic obstructive; Prospective studies; Oxygen	TRAUMATIC BRAIN-INJURY; MULTICENTER COHORT; HYPEROXIA; MORTALITY; ILLNESS; TRIAL; LESS; CARE	Background: Liberal use of oxygen in an emergency situation is common. Today, most health care professionals do not adjust the amount of oxygen given when a saturation of 100% or a PaO2 which exceeds the normal range is reached-which may result in hyperoxia. There is increasing evidence for the toxic effects of hyperoxia. Therefore, it seems justified to aim for normoxia when giving oxygen. This study evaluates whether it is feasible to aim for normoxia when giving oxygen therapy to patients at the emergency department (ED). Methods: A prospective cohort study was performed at the ED of the University Medical Center Groningen (UMCG). A protocol was developed, aiming for normoxia. During a 14 week period all patients > 18 years arriving at the ED between 8 a.m. and 23 p.m. requiring oxygen therapy registered for cardiology, internal medicine, emergency medicine and pulmonology were included. Statistical analysis was performed using student independent t-test, Mann-Whitney U-test, Fisher's exact test or a Pearson's chi-squared test. Results: During the study period the study protocol was followed and normoxia was obtained after 1 h at the ED in 86,4% of the patients. Patients with COPD were more at risk for not being titrated to normal oxygen levels. Conclusions: We showed that it is feasible to titrate oxygen therapy to normoxia at the ED. The study results will be used for further research assessing the potential beneficial effects of normoxia compared to hyper-or hypoxia in ED patients and for the development of guidelines.	[Ligtenberg, Jack J. M.] Univ Med Ctr Groningen, Internal Med, Emergency Dept, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Dobbe, Anna S. M.] Univ Groningen, Fac Med, BSc Med, Groningen, Netherlands; [Stolmeijer, Renate] Univ Med Ctr Groningen, Emergency Dept, Emergency Phys, Groningen, Netherlands; [ter Maaten, Jan C.; Ligtenberg, Jack J. M.] Univ Med Ctr Groningen, Emergency Dept, Emergency Phys, Internist Acute Med, Groningen, Netherlands		Ligtenberg, JJM (corresponding author), Univ Med Ctr Groningen, Internal Med, Emergency Dept, Hanzepl 1, NL-9700 RB Groningen, Netherlands.; Ligtenberg, JJM (corresponding author), Univ Med Ctr Groningen, Emergency Dept, Emergency Phys, Internist Acute Med, Groningen, Netherlands.	j.j.m.ligtenberg@umcg.nl					Asher SR, 2013, J NEUROSURG ANESTH, V25, P168, DOI 10.1097/ANA.0b013e318283d350; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; de Graaff AE, 2011, INTENS CARE MED, V37, P46, DOI 10.1007/s00134-010-2025-z; Decalmer S, 2013, ANAESTHESIA, V68, P8, DOI 10.1111/anae.12088; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0996-4; Helmerhorst HJF, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0023-y; Mechem CC, 2016, PULSE OXIMETRY ADULT; Moon RE, 2015, CRIT CARE MED, V43, P1547, DOI 10.1097/CCM.0000000000001043; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; Stolmeijer R, 2014, EUR J EMERG MED, V21, P233, DOI 10.1097/MEJ.0b013e328361c6c7; Young P, 2014, RESUSCITATION, V85, P1686, DOI 10.1016/j.resuscitation.2014.09.011	16	5	5	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	JUN 26	2018	18								17	10.1186/s12873-018-0169-2			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GK9UP	WOS:000436602100001	29940886	Green Published, gold			2022-02-06	
J	Xu, H; Wang, XC; Chen, Z; Bai, GH; Yin, B; Wang, S; Sun, CZ; Gan, SQ; Wang, ZN; Cao, JL; Niu, X; Shao, MH; Gu, CH; Hu, LX; Ye, LM; Li, DD; Yan, ZH; Zhang, M; Bai, LJ				Xu, Hui; Wang, Xiaocui; Chen, Zhen; Bai, Guanghui; Yin, Bo; Wang, Shan; Sun, Chuanzhu; Gan, Shuoqiu; Wang, Zhuonan; Cao, Jieli; Niu, Xuan; Shao, Meihua; Gu, Chenghui; Hu, Liuxun; Ye, Limei; Li, Dandong; Yan, Zhihan; Zhang, Ming; Bai, Lijun			Longitudinal Changes of Caudate-Based Resting State Functional Connectivity in Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; caudate; dysfunction; longitudinal changes; a neuroimaging biomarker	BASAL GANGLIA; HUMAN STRIATUM; TASK-FORCE; NETWORKS; MEMORY; ORGANIZATION; DYSFUNCTION; DISRUPTION; CORTEX; IMPAIRMENT	Mild traumatic brain injury (mild TBI) is associated with dysfunctional brain network and accumulating evidence is pointing to the caudate as a vulnerable hub region. However, little is known about the longitudinal changes in the caudate-based resting-state functional connectivity following mild TBI. In the current study, 50 patients with mild TBI received resting-state functional magnetic resonance imaging as well as neuropsychological assessments within 7 days post-injury (acute phase) and 1 month later (subacute phase). Thirty-six age-and gender-matched healthy controls underwent the same protocol. The caudate was segmented into the dorsal and ventral sub-regions based on their related functionally distinct neural circuits and separate functional connectivity was investigated. Results indicated that patients with mild TBI at acute phase exhibited reduced left dorsal caudate-based functional connectivity with ventral lateral prefrontal cortex, dorsal anterior cingulate cortex, and inferior parietal lobule, which mainly distributed in the cognitive control network, and reduced right ventral caudate-based functional connectivity with the dorsal lateral prefrontal cortex, dorsal anterior cingulate cortex (dACC), and bilateral ventral anterior cingulate cortex (vACC), which mainly distributed in the executive network and emotional processing network. Furthermore, patients with mild TBI presented the reduced functional connectivity between the left dorsal caudate and the ventral lateral prefrontal cortex (vlPFC) compared with healthy controls at acute phase while this difference became no significance and return to the normal level following 1 month post-injury subacute phase. Similarly, the functional connectivity between the right ventral caudate and anterior cingulate cortex (both dorsal and ventral part) showed the reduced strength in patients compared with healthy controls only at the acute phase but presented no significant difference at subacute phase following mild TBI. Along the same line, patients with mild TBI presented the impaired performance on the information processing speed and more complaints on the pain impact index at acute phase compared with healthy controls but showed no significant difference at the follow-up 1 month post-injury subacute phase. The longitudinal changes of caudate-based dysfunction connectivity could serve as a neuroimaging biomarker following patients with mild TBI, with the evidence that the abnormal caudate-based functional connectivity at acute phase have returned to the normal level accompanying with the recovery of the neuropsychological syndromes following patients with mild TBI at subacute phase.	[Xu, Hui; Wang, Xiaocui; Chen, Zhen; Wang, Shan; Sun, Chuanzhu; Gan, Shuoqiu; Cao, Jieli; Bai, Lijun] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Minist Educ,Key Lab Biomed Informat Engn, Xian, Shaanxi, Peoples R China; [Xu, Hui; Wang, Zhuonan; Niu, Xuan; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian, Shaanxi, Peoples R China; [Bai, Guanghui; Shao, Meihua; Ye, Limei; Yan, Zhihan] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China; [Bai, Guanghui; Shao, Meihua; Ye, Limei; Yan, Zhihan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Yin, Bo; Gu, Chenghui; Hu, Liuxun; Li, Dandong] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Wenzhou, Peoples R China; [Yin, Bo; Gu, Chenghui; Hu, Liuxun; Li, Dandong] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China		Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Minist Educ,Key Lab Biomed Informat Engn, Xian, Shaanxi, Peoples R China.; Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian, Shaanxi, Peoples R China.	zhangming01@mail.xjtu.edu.cn; bailijun@xjtu.edu.cn	Niu, Xuan/AAD-7351-2022; Xu, Hui/AAB-9421-2020; Wang, Zhuonan/E-3691-2017; Bai, Lijun/C-5119-2015	Xu, Hui/0000-0003-4514-0413; Wang, Zhuonan/0000-0002-5745-4340; Bai, Lijun/0000-0001-8790-5424; Shao, Meihua/0000-0003-1203-9730	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571752, 81771914, 81571640]; Shanxi Nova Program [2014KJXX-34]; National key research and development plan of China [2016YFC0100300]; Zhejiang Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY15H090016]; Wenzhou Municipal Sci-Tech Bureau [Y20140577]	This research was supported by the National Natural Science Foundation of China under Grant Nos. 81571752, 81771914, 81571640, Shanxi Nova Program (2014KJXX-34) and National key research and development plan of China, 2016YFC0100300, the Zhejiang Natural Science Foundation (Grant no. LY15H090016), and Wenzhou Municipal Sci-Tech Bureau (Y20140577).	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang HQ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00091; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Jung WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106768; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Nakamura Y, 2017, BRAIN CONNECT, V7, P211, DOI 10.1089/brain.2016.0424; Nakano K, 2000, J NEUROL, V247, P1; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Robinson JL, 2012, NEUROIMAGE, V60, P117, DOI 10.1016/j.neuroimage.2011.12.010; Seger CA, 2005, J NEUROSCI, V25, P2941, DOI 10.1523/JNEUROSCI.3401-04.2005; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; SOSIN DM, 1991, BRAIN INJURY, V10, P47, DOI DOI 10.1080/026990596124719; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	56	5	5	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 19	2018	9								467	10.3389/fneur.2018.00467			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GK0TV	WOS:000435825700001	29973909	gold, Green Published			2022-02-06	
J	Whalen, AJ; Xiao, Y; Kadji, H; Dahlem, MA; Gluckman, BJ; Schiff, SJ				Whalen, Andrew J.; Xiao, Ying; Kadji, Herve; Dahlem, Markus A.; Gluckman, Bruce J.; Schiff, Steven J.			Control of Spreading Depression with Electrical Fields	SCIENTIFIC REPORTS			English	Article							EPILEPTIFORM ACTIVITY; CEREBRAL-CORTEX; HIPPOCAMPAL SLICES; CORTICAL DEPRESSION; STIMULATED AREAS; IN-VIVO; BRAIN; MIGRAINE; RAT; SUPPRESSION	Spreading depression or depolarization is a large-scale pathological brain phenomenon related to migraine, stroke, hemorrhage and traumatic brain injury. Once initiated, spreading depression propagates across gray matter extruding potassium and other active molecules, collapsing the resting membrane electro-chemical gradient of cells leading to spike inactivation and cellular swelling, and propagates independently of synaptic transmission. We demonstrate the modulation, suppression and prevention of spreading depression utilizing applied transcortical DC electric fields in brain slices, measured with intrinsic optical imagingand potassium dye epifluorescence. We experimentally observe a surface-positive electric field induced forcing of spreading depression propagation to locations in cortex deeper than the unmodulated propagation path, whereby further propagation is confined and arrested even after field termination. The opposite surface-negative electric field polarity produces an increase in propagation velocity and a confinement of the wave to more superficial layers of cortex than the unmodulated propagation path. These field polarities are of opposite sign to the polarity that blocks neuronal spiking and seizures, and are consistent with biophysical models of spreading depression. The results demonstrate the potential feasibility of electrical control and prevention of spreading depression.	[Whalen, Andrew J.; Schiff, Steven J.] Penn State Univ, Mech Engn, University Pk, PA 16802 USA; [Whalen, Andrew J.; Xiao, Ying; Kadji, Herve; Gluckman, Bruce J.; Schiff, Steven J.] Penn State Univ, Ctr Neural Engn, University Pk, PA 16802 USA; [Xiao, Ying; Kadji, Herve; Gluckman, Bruce J.; Schiff, Steven J.] Penn State Univ, Engn Sci & Mech, University Pk, PA 16802 USA; [Gluckman, Bruce J.; Schiff, Steven J.] Penn State Univ, Neurosurg, University Pk, PA 16802 USA; [Schiff, Steven J.] Penn State Univ, Phys, University Pk, PA 16802 USA; [Xiao, Ying] Univ Elect Sci & Technol China, Sch Med, Chengdu, Sichuan, Peoples R China; [Dahlem, Markus A.] Humboldt Univ, Phys, Berlin, Germany		Whalen, AJ (corresponding author), Penn State Univ, Mech Engn, University Pk, PA 16802 USA.; Whalen, AJ (corresponding author), Penn State Univ, Ctr Neural Engn, University Pk, PA 16802 USA.	andrew.john.whalen@gmail.com	Kadji, Herve/ABF-8010-2020; Whalen, Andrew/O-5043-2018	Whalen, Andrew/0000-0002-0782-9300; Gluckman, Bruce/0000-0001-7695-2225	US-German Collaborative Research in Computational Neuroscience program: NIH Grant [1R01EB014641, R01MH079502]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [BMBF 01GQ1001B]; NIH BRAIN Initiative [1R21EY026438]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R21EY026438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB014641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH079502] Funding Source: NIH RePORTER	We are grateful for the many helpful discussions with Koen Dijkstra, Stephan van Gils, and Stephen van Wert. Supported by US-German Collaborative Research in Computational Neuroscience program: NIH Grant 1R01EB014641 (A.J.W., B.J.G., S.J.S.), R01MH079502 (S.J.S., Y.X.), and Bundesministerium fur Bildung und Forschung, BMBF 01GQ1001B (M.A.D.), and NIH BRAIN Initiative 1R21EY026438 (H.K., S.J.S.).	Anderson TR, 2002, J NEUROPHYSIOL, V88, P2713, DOI 10.1152/jn.00321.2002; Antal A, 2011, CEPHALALGIA, V31, P820, DOI 10.1177/0333102411399349; Bikson M, 2001, J PHYSIOL-LONDON, V531, P181, DOI 10.1111/j.1469-7793.2001.0181j.x; Brighina Filippo, 2013, Handb Clin Neurol, V116, P585, DOI 10.1016/B978-0-444-53497-2.00047-4; BRINLEY FJ, 1960, J NEUROPHYSIOL, V23, P246, DOI 10.1152/jn.1960.23.3.246; Canals S, 2005, J NEUROPHYSIOL, V94, P943, DOI 10.1152/jn.01145.2004; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; DELUCA B, 1977, DEV PSYCHOBIOL, V10, P289, DOI 10.1002/dev.420100402; Dietz RM, 2008, J NEUROSCI, V28, P8014, DOI 10.1523/JNEUROSCI.0765-08.2008; Durand DM, 2001, P IEEE, V89, P1065, DOI 10.1109/5.939821; Francis JT, 2003, J NEUROSCI, V23, P7255; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P353, DOI 10.1113/jphysiol.1983.sp014539; Gluckman BJ, 1996, J NEUROPHYSIOL, V76, P4202, DOI 10.1152/jn.1996.76.6.4202; Gluckman BJ, 2001, J NEUROSCI, V21, P590, DOI 10.1523/JNEUROSCI.21-02-00590.2001; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P308, DOI 10.1152/jn.1956.19.4.308; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Huang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.18834; JEFFERYS JGR, 1981, J PHYSIOL-LONDON, V319, P143, DOI 10.1113/jphysiol.1981.sp013897; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; KOROLEVA VI, 1979, BRAIN RES, V173, P209, DOI 10.1016/0006-8993(79)90622-X; KOROLEVA VI, 1980, ELECTROEN CLIN NEURO, V48, P1, DOI 10.1016/0013-4694(80)90038-3; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Makarova J, 2008, EUR J NEUROSCI, V27, P444, DOI 10.1111/j.1460-9568.2008.06022.x; OCHS S, 1960, J NEUROPHYSIOL, V23, P432, DOI 10.1152/jn.1960.23.4.432; PURPURA DOMINICK P., 1966, BRAIN RES, V1, P403, DOI 10.1016/0006-8993(66)90132-6; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; REDDY MM, 1980, NEUROSCI LETT, V17, P243, DOI 10.1016/0304-3940(80)90030-0; Richardson KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028103; Richardson KA, 2003, EPILEPSIA, V44, P768, DOI 10.1046/j.1528-1157.2003.35402.x; Rushton WAH, 1927, J PHYSIOL-LONDON, V63, P357, DOI 10.1113/jphysiol.1927.sp002409; TERZUOLO CA, 1956, P NATL ACAD SCI USA, V42, P687, DOI 10.1073/pnas.42.9.687; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; TRANCHINA D, 1986, BIOPHYS J, V50, P1139, DOI 10.1016/S0006-3495(86)83558-5; Ullah G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004414; Voroslakos M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02928-3; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	42	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 8	2018	8								8769	10.1038/s41598-018-26986-1			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GI6VI	WOS:000434640800023	29884896	Green Published, gold, Green Submitted			2022-02-06	
J	Asan, Z				Asan, Ziya			Spinal Concussion in Adults: Transient Neuropraxia of Spinal Cord Exposed to Vertical Forces	WORLD NEUROSURGERY			English	Article						Neurologic deficit; SCIWORA; Spinal concussion; Spinal cord injury; Transient neurapraxia	CERVICAL-SPINE; NEURAPRAXIA; STENOSIS; SCIWORA	OBJECTIVE: The aim of the study is to discuss along with literature knowledge the post-traumatic clinical progression of cases with symptoms of transient spinal cord impact and cases of spinal concussion following exposure of the vertebral column to vertical forces. MATERIALS AND METHODS: A total of 43 cases, all falls from height, were diagnosed with spinal concussion. It was determined that the vertebral column had been exposed to the effects of vertical forces, and the spinal cord had been affected by vertical forces. In all cases, spinal magnetic resonance imaging and dynamic X-ray examinations were performed at the time of admission. Clinical symptoms of the cases were recorded by scoring based on the Torg Grading System. RESULTS: Cases were started on conservative treatment because radiologic symptoms that would explain the clinical symptoms could not be detected. Most frequently encountered were the neurologic symptoms related to the upper thoracic and lower cervical segments being affected. In 7 cases, urinary incontinence was also detected. Symptoms related to the spinal cord being affected were completely recovered in 1-3 days in all cases. CONCLUSION: As a result of the vertebral column being affected by vertical forces, the most frequently affected are the thoracic segments of the spinal cord. These cases show similarities to real spinal cord injury without radiographic abnormality cases when evaluated along with clinical and radiologic symptoms. Absolute differential diagnosis from real spinal cord injury without radiographic abnormality cases cannot be made until total neurologic recovery takes place.	[Asan, Ziya] Ahi Evran Univ, Fac Med, Dept Neurosurg, Kirsehir, Turkey		Asan, Z (corresponding author), Ahi Evran Univ, Fac Med, Dept Neurosurg, Kirsehir, Turkey.	ziyaasan@gmail.com					Andrews FJ, 2002, EMERG MED J, V19, P172, DOI 10.1136/emj.19.2.172; Dailey A, 2010, SPINE, V35, pS193, DOI 10.1097/BRS.0b013e3181f32db0; Dreizin D, 2015, AM J ROENTGENOL, V205, P853, DOI 10.2214/AJR.14.13374; Fischer I, 2016, NEURAL REGEN RES, V11, P58, DOI 10.4103/1673-5374.169634; Nagoshi N, 2017, SPINE J, V17, P291, DOI 10.1016/j.spinee.2016.09.013; Page S, 2004, SOUTH MED J, V97, P766, DOI 10.1097/00007611-200408000-00015; Proctor MR, 2002, CRIT CARE MED, V30, pS489, DOI 10.1097/00003246-200211001-00014; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; TORG JS, 1995, SPORTS MED, V20, P429, DOI 10.2165/00007256-199520060-00007; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017; TORG JS, 1995, CLIN ORTHOP RELAT R, P259; Yucesoy K, 2008, CLIN NEUROL NEUROSUR, V110, P429, DOI 10.1016/j.clineuro.2008.02.004; ZWIMPFER TJ, 1990, J NEUROSURG, V72, P894, DOI 10.3171/jns.1990.72.6.0894	15	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E1284	E1289		10.1016/j.wneu.2018.03.198			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600150	29626691				2022-02-06	
J	Asan, Z				Asan, Ziya			Spinal Cord Injury without Radiological Abnormality in Adults: Clinical and Radiological Discordance	WORLD NEUROSURGERY			English	Article						Adults; Magnetic resonance imaging; Spinal concussion; Spinal cord injury; SCIWORA	RADIOGRAPHIC ABNORMALITIES; SCIWORA	BACKGROUND: Patients with spinal cord injury without radiological abnormality (SCIWORA) show varying clinical prognostic courses independent of radiological findings. The fact that patients cannot be evaluated using a specific terminologic standard has led to the emergence of the real SCIWORA definition. In this study, clinical progressions of 11 patients diagnosed with SCIWORA were analyzed, and terminologic differences were discussed. METHODS: The clinical findings of 11 adults with a diagnosis of SCIWORA at the time of diagnosis and in the long term were analyzed according to the ASIA classification scheme. The presence of a correlation between radiological findings from the early and late periods and the clinical findings was investigated. High-dose methyl-prednisolone treatment was administered to all newly diagnosed patients in the early period, and the clinical response was observed. Clinical, prognostic, and radiological comparisons with SCIWORA cases reported in the literature were conducted. RESULTS: Seven patients received a diagnosis of cervical SCIWORA, and 4 patients had thoracal SCIWORA. Neuro-logic findings at the time of diagnosis and in the early and late periods vary independent of radiological findings. In the cases where significant neurologic recovery was not observed within the first 3 days, significant recovery also was not seen in the later period. In the cases where neurologic recovery was seen, improvements in sphincter function and sensory and motor deficits were observed. CONCLUSIONS: In patients diagnosed with SCIWORA, early neurologic response is the determining factor for prognosis. Clinical findings and prognosis demonstrate no correlation with radiological findings.	[Asan, Ziya] Ahi Evran Univ, Fac Med, Dept Neurosurg, Kirsehir, Turkey		Asan, Z (corresponding author), Ahi Evran Univ, Fac Med, Dept Neurosurg, Kirsehir, Turkey.	ziyaasan@gmail.com					Ajani AE, 1998, ANAESTH INTENS CARE, V26, P487, DOI 10.1177/0310057X9802600502; Andreoli Chiara, 2005, Radiol Med, V110, P636; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; DICKMAN CA, 1991, J SPINAL DISORD, V4, P296, DOI 10.1097/00002517-199109000-00006; Dreizin D, 2015, AM J ROENTGENOL, V205, P853, DOI 10.2214/AJR.14.13374; Gupta SK, 1999, SPINAL CORD, V37, P726, DOI 10.1038/sj.sc.3100900; Hoak SJ., 2001, J TRAUMA NURS, V8, P101; Kothari P, 2000, J BONE JOINT SURG BR, V82B, P1034, DOI 10.1302/0301-620X.82B7.10641; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Yucesoy K, 2008, CLIN NEUROL NEUROSUR, V110, P429, DOI 10.1016/j.clineuro.2008.02.004	12	5	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E1147	E1151		10.1016/j.wneu.2018.03.162			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600133	29614362				2022-02-06	
J	Becker, S; Frohlich, M; Kelm, J; Ludwig, O				Becker, Stephan; Froehlich, Michael; Kelm, Jens; Ludwig, Oliver			The Influence of Fatigued Core Muscles on Head Acceleration during Headers in Soccer	SPORTS			English	Article						heading; fatigue; concussion; soccer; acceleration; kinetics; repetitive head impacts; cumulative exposure	HIGH-SCHOOL; BALL; PERFORMANCE; CONCUSSIONS; FOOTBALL; FORCE; SPORT	The core muscles play a central role in stabilizing the head during headers in soccer. The objective of this study was to examine the influence of a fatigued core musculature on the acceleration of the head during jump headers and run headers. Acceleration of the head was measured in a pre-post-design in 68 soccer players (age: 21.5 +/- 3.8 years, height: 180.0 +/- 13.9 cm, weight: 76.9 +/- 8.1 kg). Data were recorded by means of a telemetric 3D acceleration sensor and with a pendulum header. The treatment encompassed two exercises each for the ventral, lateral, and dorsal muscle chains. The acceleration of the head between pre- and post-test was reduced by 0.3 G (p = 0.011) in jump headers and by 0.2 G (p = 0.067) in run headers. An additional analysis of all pretests showed an increased acceleration in run headers when compared to stand headers (p < 0.001) and jump headers (p < 0.001). No differences were found in the sub-group comparisons: semi-professional vs. recreational players, offensive vs. defensive players. Based on the results, we conclude that the acceleration of the head after fatiguing the core muscles does not increase, which stands in contrast to postulated expectations. More tests with accelerated soccer balls are required for a conclusive statement.	[Becker, Stephan; Froehlich, Michael; Ludwig, Oliver] Tech Univ Kaiserslautern, Dept Sport Sci, D-67663 Kaiserslautern, Germany; [Kelm, Jens] Chirurg Orthopad Zentrum, D-66557 Illingen, Germany		Becker, S (corresponding author), Tech Univ Kaiserslautern, Dept Sport Sci, D-67663 Kaiserslautern, Germany.	stephan.becker@sowi.uni-kl.de; michael.froehlich@sowi.uni-kl.de; jens.kelm@chirurgie-illingen.de; oliver.ludwig@sowi-uni-kl.de	Ludwig, Oliver/AAG-3410-2019	Ludwig, Oliver/0000-0002-9881-7355; Frohlich, Michael/0000-0003-1982-6374; Becker, Stephan/0000-0002-0115-7064			Babbs C F, 2001, ScientificWorldJournal, V1, P281; Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Becker S., 2016, DTSCH Z SPORTMEDIZIN, V67, P178; Becker S., 2013, BRIT J SPORT MED, V47, pe3, DOI [10.1136/bjsports-2013-092558.93, DOI 10.1136/BJSPORTS-2013-092558.93]; Becker S, 2017, SPORTS, V5, DOI 10.3390/sports5010010; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Borg G., 1998, BORGS PERCEIVED EXER; Busch D., 2016, LEISTUNGSSPORT, V46, P30; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Cohen J., 1988, STAT POWER ANAL BEHA; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Faul M, 2010, TRAUMATIC BRAIN INJU; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Granacher U, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-40; Granacher U, 2013, GERONTOLOGY, V59, P105, DOI 10.1159/000343152; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hohmann A., 2010, EINFUHRUNG TRAININGS; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Kerr H, 2004, BRIT J SPORT MED, V38, P650; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Mawdsley H.P., 1978, MOMENTUM, V3, P16; Mehnert Michael J, 2005, Pain Physician, V8, P391; Meyer T, 2018, SCI MED FOOTBALL, V2, P1, DOI 10.1080/24733938.2017.1416950; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Sarmento H, 2018, SPORTS MED, V48, P799, DOI 10.1007/s40279-017-0836-6; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Sunami S, 2008, FOOTBALL SCI, V5, P7; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Teymouri M, 2012, ARCH TRAUMA RES, V1, P44, DOI [10.5812/atr.5399, 10.5812/atr.5307]; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tschopp M., 2001, SWISS J SPORTS MED S, V49, P67; Wallace JL, 2014, J SCI MED SPORT, V17, P223, DOI 10.1016/j.jsams.2013.03.016; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	42	5	5	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2075-4663			SPORTS	Sports	JUN	2018	6	2							33	10.3390/sports6020033			11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	GK6GR	WOS:000436282300009	29910337	Green Published, gold, Green Submitted			2022-02-06	
J	Boutis, K; Gravel, J; Freedman, SB; Craig, W; Tang, K; DeMatteo, CA; Dubrovsky, AS; Beer, D; Burns, E; Sangha, G; Zemek, R				Boutis, Kathy; Gravel, Jocelyn; Freedman, Stephen B.; Craig, William; Tang, Ken; DeMatteo, Carol A.; Dubrovsky, Alexander Sasha; Beer, Darcy; Burns, Emma; Sangha, Gurinder; Zemek, Roger			THE DIAGNOSIS OF CONCUSSION IN PEDIATRIC EMERGENCY DEPARTMENTS: A PROSPECTIVE MULTICENTER STUDY	JOURNAL OF EMERGENCY MEDICINE			English	Article						concussion; diagnosis; pediatric	TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; SYMPTOMS; SPORT; CLASSIFICATION; SPECTRUM; ZURICH; RISK	Background: The accurate identification of children with a concussion by emergency physicians is important to initiate appropriate anticipatory guidance and management. Objectives: We compared the frequency of persistent concussion symptoms in children who were provided the diagnosis of concussion by an emergency physician versus those who met Berlin/Zurich international criteria for this diagnosis. We also determined the clinical variables independently associated with a physician-diagnosed concussion. Methods: This was a planned secondary analysis of a prospective, multicenter cohort study. Participants were 5-17 years of age and met the Zurich/Berlin International Consensus Statement criteria for concussion. Results: There were 2946 enrolled children. In those with physician-diagnosed concussion vs. no concussion, the frequency of persistent symptoms was 62.5% vs. 38.8% (p < 0.0001) at 1 week, 46.3% vs. 25.8% (p < 0.0001) at 2 weeks, and 33.0% vs. 23.0% (p < 0.0001) at 4 weeks. Of those meeting international criteria, 2340 (79.4%) were diagnosed with a concussion by an emergency physician and 12 variables were associated with this diagnosis. Five had an odds ratio (OR) > 1.5: older age (13-17 vs. 5-7 years, OR 2.9), longer time to presentation (>= 16 vs. < 16 h, OR 2.1), nausea (OR 1.7), sport mechanism (OR 1.7), and amnesia (OR 1.6). Conclusions: Relative to international criteria, the more selective assignment of concussion by emergency physicians was associated with a greater frequency of persistent concussion symptoms. In addition, while most children meeting international criteria for concussion were also provided this diagnosis for concussion by an emergency physician, the presence of 5 specific variables made this diagnosis more likely. (C) 2018 Elsevier Inc. All rights reserved.					Freedman, Stephen/H-9102-2012	Freedman, Stephen/0000-0003-2319-6192; Craig, William/0000-0002-4804-194X; Burns, Emma/0000-0001-8042-7124	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [126197, MRP119829]; Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team [TM1127047]	This study was supported by operating grant 126197 from the Canadian Institutes of Health Research, grant TM1127047 from the Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team, and planning grant MRP119829 from the Canadian Institutes of Health Research.	Babcock CL, 2011, 2011 CLINC TRANSL RE; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Concussion in Sports Group, 2013, BRIT J SPORT MED, V47, P263; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia G, 2006, ACUTE CONCUSSION EVA; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Huber PJ., 1967, BEHAV MAXIMUM LIKELI; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; R Core Team, R LANG ENV STAT COMP; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550corr1; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	33	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JUN	2018	54	6					757	764		10.1016/j.jemermed.2018.02.041			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GI6IJ	WOS:000434472600010	29685472				2022-02-06	
J	Ding, SS; Liu, YZ; Ma, CR; Zhang, JQ; Zhu, AW; Shi, GY				Ding, Shushu; Liu, Yingzi; Ma, Chunrong; Zhang, Junqi; Zhu, Anwei; Shi, Guoyue			Development of Glass-sealed Gold Nanoelectrodes for in vivo Detection of Dopamine in Rat Brain	ELECTROANALYSIS			English	Article						Dopamine; Glass-sealed Au nanoelectrode; Cluster-like gold nanostructure; Rat brain	SCAN CYCLIC VOLTAMMETRY; ELECTROCHEMICAL DETECTION; LIQUID-CHROMATOGRAPHY; MICRODIALYSIS PROBES; EXTRACELLULAR DOPAMINE; NUCLEUS-ACCUMBENS; MICROELECTRODES; FABRICATION; ELECTRODES; SENSITIVITY	In vivo monitoring of dopamine (DA) in cerebral nervous system with no traumatic brain injury is still a challenging work for reliably evaluating the role that DA plays in physical and cognitive functionality. In this work, to reduce the traumatic injury on the brain tissue, we develop a glass-sealed Au nanoelectrode (GSNE) with nanoscale physical dimention for cerebral DA detection. First, an Au microwire was sealed into the pre-thinned silica capillary. Then, the obtained Au/capillary assembly was pulled into two tips followed by polishing away the excess glass to expose the Au nanotip. The morphology of GSNE was characterized by scanning electron microscopy and transmission electron microscopy. The results showed that this nanoelectrode can be quickly fabricated with high reproducibility. By further electrodepositing cluster-like gold nanostructure on GSNE and modifying Nafion, amperometric detection of DA with high sensitivity and good selectivity were achieved on the Nafion-modified Au/GSNE. Moreover, the Nafion-modified Au/GSNE possessed advantages of easy tissue insertion and minimum tissue disturbance. Thus, the developed electrochemical nanosensor was successfully used for amperometrically monitoring DA level in the striatum of anesthetic rats.	[Ding, Shushu; Ma, Chunrong; Zhang, Junqi; Zhu, Anwei; Shi, Guoyue] East China Normal Univ, Sch Chem & Mol Engn, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Liu, Yingzi] East China Normal Univ, Inst Brain Funct Genom, 3663 Zhongshan Rd North, Shanghai 200062, Peoples R China		Zhu, AW; Shi, GY (corresponding author), East China Normal Univ, Sch Chem & Mol Engn, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	awzhu@chem.ecnu.edu.cn; gyshi@chem.ecnu.edu.cn	Zhu, Anwei/R-2784-2016	Zhu, Anwei/0000-0001-8574-7629	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21675053, 21405048, 21635003]; "Yang Fan" Project - Science and Technology Commission of Shanghai Municipality [14YF1404000]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016T90349, 2014M550225]	This work was supported by the National Natural Science Foundation of China (21675053, 21405048, 21635003), "Yang Fan" Project funded by Science and Technology Commission of Shanghai Municipality (14YF1404000), and China Postdoctoral Science Foundation (2016T90349, 2014M550225)	Ashton TD, 2015, CHEM SOC REV, V44, P4547, DOI 10.1039/c4cs00372a; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Chang JH, 2012, ANAL CHEM, V84, P5159, DOI 10.1021/ac300863r; Cheng H, 2007, ELECTROPHORESIS, V28, P1579, DOI 10.1002/elps.200600603; DIBBLE T, 1986, J PHYS CHEM-US, V90, P5275, DOI 10.1021/j100412a075; Ding SS, 2017, ACS SENSORS, V2, P394, DOI 10.1021/acssensors.6b00772; Dong H, 2017, ACS CHEM NEUROSCI, V8, P339, DOI 10.1021/acschemneuro.6b00296; Ferapontova EE, 2017, ELECTROCHIM ACTA, V245, P664, DOI 10.1016/j.electacta.2017.05.183; Gu H, 2015, ANAL CHEM, V87, P6088, DOI 10.1021/acs.analchem.5b00633; Hefco V, 2003, EUR J PHARMACOL, V475, P55, DOI 10.1016/S0014-2999(03)02115-0; Huang WH, 2001, ANAL CHEM, V73, P1048, DOI 10.1021/ac0008183; Hvman S. E., 2001, NAT REV NEUROSCI, V2, P695; Jackowska K, 2013, ANAL BIOANAL CHEM, V405, P3753, DOI 10.1007/s00216-012-6578-2; Jung MC, 2006, ANAL CHEM, V78, P1755, DOI 10.1021/ac051183g; Khan AS, 2003, TRAC-TREND ANAL CHEM, V22, P503, DOI 10.1016/S0165-9936(03)00908-7; Li YX, 2009, ANAL CHEM, V81, P5496, DOI 10.1021/ac900777n; Lin YQ, 2016, BIOSENS BIOELECTRON, V78, P274, DOI 10.1016/j.bios.2015.11.059; Liu YZ, 2015, BIOSENS BIOELECTRON, V63, P262, DOI 10.1016/j.bios.2014.07.040; Ma C, 2013, ANAL CHEM, V85, P9882, DOI 10.1021/ac402417w; McCreery RL, 2008, CHEM REV, V108, P2646, DOI 10.1021/cr068076m; NESTLER EJ, 1994, CELL, V79, P923, DOI 10.1016/0092-8674(94)90022-1; Ngo KT, 2017, ACS CHEM NEUROSCI, V8, P329, DOI 10.1021/acschemneuro.6b00383; Oh Y, 2016, ANAL CHEM, V88, P10962, DOI 10.1021/acs.analchem.6b02605; Park JH, 2013, J AM CHEM SOC, V135, P5258, DOI 10.1021/ja4000917; Robinson DL, 2003, CLIN CHEM, V49, P1763, DOI 10.1373/49.10.1763; Robinson DL, 2008, CHEM REV, V108, P2554, DOI 10.1021/cr068081q; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; Su S, 2013, PART PART SYST CHAR, V30, P326, DOI 10.1002/ppsc.201200076; SUGIYAMA K, 1994, J NEUROSCI METH, V53, P73, DOI 10.1016/0165-0270(94)90146-5; Szopa J, 2001, PHYTOCHEMISTRY, V58, P315, DOI 10.1016/S0031-9422(01)00232-1; Tamura K, 2012, J NEUROSCI METH, V211, P49, DOI 10.1016/j.jneumeth.2012.08.004; Taylor IM, 2017, BIOSENS BIOELECTRON, V89, P400, DOI 10.1016/j.bios.2016.05.084; Tsai TC, 2013, SENSOR ACTUAT B-CHEM, V181, P179, DOI 10.1016/j.snb.2013.01.081; Wang KQ, 2017, ANAL CHEM, V89, P8683, DOI 10.1021/acs.analchem.7b02814; Wang YX, 2012, J NEUROSCI METH, V208, P34, DOI 10.1016/j.jneumeth.2012.04.009; WIGHTMAN RM, 1988, ANAL CHEM, V60, pA769, DOI 10.1021/ac00164a001; Wightnnan M., 2003, ANAL CHEM, V75, p414A; Xiang L, 2014, ANAL CHEM, V86, P5017, DOI 10.1021/ac500622m; Yu YY, 2011, BIOELECTROCHEMISTRY, V81, P53, DOI 10.1016/j.bioelechem.2010.12.001; Zhang MN, 2012, ACCOUNTS CHEM RES, V45, P533, DOI 10.1021/ar200196h; Zhang Y, 2009, ELECTROCHIM ACTA, V55, P265, DOI 10.1016/j.electacta.2009.08.048; Zhang YY, 2015, RSC ADV, V5, P77248, DOI 10.1039/c5ra14777h; Zhao Y, 2012, BIOSENS BIOELECTRON, V35, P115, DOI 10.1016/j.bios.2012.02.030	44	5	6	7	48	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	JUN	2018	30	6					1041	1046		10.1002/elan.201700522			6	Chemistry, Analytical; Electrochemistry	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry	GJ3YP	WOS:000435271000009					2022-02-06	
J	Lee, S; Polimeni, JR; Price, CM; Edlow, BL; McNab, JA				Lee, Seul; Polimeni, Jonathan R.; Price, Collin M.; Edlow, Brian L.; McNab, Jennifer A.			Characterizing Signals Within Lesions and Mapping Brain Network Connectivity After Traumatic Axonal Injury: A 7 Tesla Resting-State FMRI Study	BRAIN CONNECTIVITY			English	Article						brain connectivity; coma; functional MRI; lesion analysis; resting-state; traumatic axonal injury	INDEPENDENT COMPONENT ANALYSIS; INDUCED B-0 FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; RECOVERY; SOFTWARE; MRI; VISUALIZATION; IMAGES; NOISE; FSL	Resting-state functional magnetic resonance imaging (RS-FMRI) has been widely used to map brain functional connectivity, but it is unclear how to probe connectivity within and around lesions. In this study, we characterize RS-FMRI signal time course properties and evaluate different seed placements within and around hemorrhagic traumatic axonal injury (hTAI) lesions. RS-FMRI was performed on a 7 Tesla scanner in a patient who recovered consciousness after traumatic coma and in three healthy controls. Eleven lesions in the patient were characterized in terms of (1) temporal signal-to-noise ratio (tSNR); (2) physiological noise, through comparison of noise regressors derived from the white matter (WM), cerebrospinal fluid (CSF), and gray matter (GM); and (3) seed-based functional connectivity. Temporal SNR at the center of the lesions was 38.3% and 74.1% lower compared with the same region in the contralesional hemisphere of the patient and in the ipsilesional hemispheres of the controls, respectively. Within the lesions, WM noise was more prominent than CSF and GM noise. Lesional seeds did not produce discernable networks, but seeds in the contralesional hemisphere revealed networks whose nodes appeared to be shifted or obscured due to overlapping or nearby lesions. Single-voxel seed analysis demonstrated that placing a seed within a lesion's periphery was necessary to identify networks associated with the lesion region. These findings provide evidence of resting-state network changes in the human brain after recovery from traumatic coma. Furthermore, we show that seed placement within a lesion's periphery or in the contralesional hemisphere may be necessary for network identification in patients with hTAI.	[Lee, Seul] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Lee, Seul; McNab, Jennifer A.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Polimeni, Jonathan R.; Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Polimeni, Jonathan R.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Price, Collin M.] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA		Lee, S (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	seul@stanford.edu	McNab, Jennifer/ABG-2746-2021; Polimeni, Jonathan R/P-1395-2014	Polimeni, Jonathan R/0000-0002-1348-1179; McNab, Jennifer/0000-0002-1763-0792	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23-NS094538, R01-NS095985, R01-EB019437, R01-MH111444]; Charles A. Dana Foundation; James S. McDonnell Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015891, R01EB019437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH111444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095985, K23NS094538] Funding Source: NIH RePORTER	We thank the patient for his participation and support of this work. The authors also thank Thomas Witzel for assistance with data acquisition, Michael D. Greicius for helping with data preprocessing and templates, and Gary Glover and Jingyuan Chen for helpful discussions. Support for this work was provided by the NIH: K23-NS094538, R01-NS095985, R01-EB019437, and R01-MH111444. Funding was also provided by the Charles A. Dana Foundation and the James S. McDonnell Foundation.	Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bodien YG, 2017, SEMIN NEUROL, V37, P485, DOI 10.1055/s-0037-1607310; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Caravasso CF, 2016, J NEUROTRAUM, V33, P1247, DOI 10.1089/neu.2015.4003; Chen S, 2008, BRAIN RES, V1239, P141, DOI 10.1016/j.brainres.2008.08.028; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; De Martino F, 2011, NEUROIMAGE, V57, P1031, DOI 10.1016/j.neuroimage.2011.05.008; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Edlow BL, 2016, NEUROCRIT CARE, V24, P342, DOI 10.1007/s12028-015-0216-8; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gold S, 1998, HUM BRAIN MAPP, V6, P73; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hayes SM, 2012, J NEUROSCI, V32, P14622, DOI 10.1523/JNEUROSCI.0700-12.2012; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keil B, 2010, P INT SOC MAGNETIC R, V18; Li J, 2017, EUR RADIOL, V27, P325, DOI 10.1007/s00330-016-4302-x; Madai VI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037631; McKeown MJ, 2003, CURR OPIN NEUROBIOL, V13, P620, DOI 10.1016/j.conb.2003.09.012; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Polimeni JR, 2016, MAGN RESON MED, V75, P665, DOI 10.1002/mrm.25628; Polimeni JR, 2013, P INT SOC MAG RESON, P2646; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Van de Moortele PF, 2002, MAGNET RESON MED, V47, P888, DOI 10.1002/mrm.10145; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van den Heuvel TLA, 2016, NEUROIMAGE-CLIN, V12, P241, DOI 10.1016/j.nicl.2016.07.002; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; van Gelderen P, 2007, MAGN RESON MED, V57, P362, DOI 10.1002/mrm.21136; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Zhang DY, 2009, NEUROSURGERY, V65, P226, DOI 10.1227/01.NEU.0000350868.95634.CA; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	51	5	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	JUN	2018	8	5					288	298		10.1089/brain.2017.0499			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP4WB	WOS:000440872000004	29665699	Green Published			2022-02-06	
J	Moring, JC; Peterson, AL; Kanzler, KE				Moring, John C.; Peterson, Alan L.; Kanzler, Kathryn E.			Tinnitus, Traumatic Brain Injury, and Posttraumatic Stress Disorder in the Military	INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE			English	Article						Tinnitus; Traumatic brain injury; Posttraumatic stress disorder; Mental health; Military; Veterans	ACTIVE-DUTY MILITARY; COMMITMENT THERAPY; PSYCHOMETRIC PROPERTIES; MENTAL-DISORDERS; PRIMARY-CARE; ACCEPTANCE; PTSD; VETERANS; PREVALENCE; MECHANISMS	Acoustic trauma is more prevalent in military settings, especially among individuals with combat-related military occupational specialties. Gunfire, improvised explosive devices, and mortar explosions are a few examples that may cause hearing degradation and tinnitus. It is possible that the same events that are associated with auditory problems can cause traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). This paper reviews the distinct and overlapping symptoms of tinnitus, TBI, and PTSD, and how these disorders interact to synergistically promote negative outcomes. Tinnitus may serve as a significant contributor to symptoms of TBI and PTSD. Therefore, tinnitus subtypes could be identified as physiologically or psychologically based, or both. Additional research is warranted to determine the common and unique symptoms and associated neurological pathways of tinnitus, TBI, and PTSD. Brief treatment recommendations are provided, including a multidisciplinary approach for the physical and psychological distress associated with tinnitus.	[Moring, John C.; Peterson, Alan L.; Kanzler, Kathryn E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7550 IH10 West,Suite 1325, San Antonio, TX 78229 USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, Off Res & Dev, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, 1 UTSA Circle, San Antonio, TX 78249 USA; [Kanzler, Kathryn E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, 7703 Foyd Curl Dr,MC 7794, San Antonio, TX 78229 USA; [Kanzler, Kathryn E.] ReACH Res Adv Community Hlth Ctr, 7411 John Smith,Suite 1050,MC 7768, San Antonio, TX 78229 USA		Moring, JC (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7550 IH10 West,Suite 1325, San Antonio, TX 78229 USA.	MoringJ@uthscsa.edu; PetersonA3@uthscsa.edu; Kanzler@uthscsa.edu	Kanzler, Kathryn/V-3732-2019	Kanzler, Kathryn/0000-0001-7253-7067; Moring, John/0000-0001-5810-3801			Alamgir H, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0082-5; Andersson G, 2005, TINNITUS MULTIDISCIP, VSecond; Andersson Gerhard, 2000, Scandinavian Journal of Behaviour Therapy, V29, P57; Andersson G, 2008, INT J AUDIOL, V47, pS106, DOI 10.1080/14992020802301670; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890425596; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Blount TH, 2014, COGN BEHAV PRACT, V21, P89, DOI 10.1016/j.cbpra.2013.05.004; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; BRINER W, 1995, PSYCHOL REP, V77, P27, DOI 10.2466/pr0.1995.77.1.27; Budd RJ, 1996, J PSYCHOSOM RES, V41, P327, DOI 10.1016/S0022-3999(96)00171-7; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Cicerone K, 2006, J COGNITIVE NEUROSCI, DOI [10.1162/jocn.2006.17.7.1212, DOI 10.1162/JOCN.2006.17.7.1212]; Cigrang J.A., 2005, PRAGMATIC CASE STUD, V1, P1, DOI [10.14713/pcsp.v1i2.857, DOI 10.14713/PCSP.V1I2.857]; Cigrang JA, 2015, J ANXIETY DISORD, V36, P110, DOI 10.1016/j.janxdis.2015.10.003; Cigrang JA, 2011, PSYCHOL SERV, V8, P104, DOI 10.1037/a0022740; Defense and Veterans Brain Injury Center, DOD NUMB TRAUM BRAIN; Department of Defense, 2012, DOD POL GUID MAN MIL; Department of Veterans Affairs, 2015, ANN BEN REP FISC YEA; Durch, 2005, NOISE MILITARY SERVI; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Fagelson MA, 2016, EAR HEARING, V37, P541, DOI 10.1097/AUD.0000000000000290; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Farb CR, 1999, SYNAPSE, DOI DOI 10.1002/(SICI)1098-2396(19990901)33:3<218::AIDSYN6>3.0.CO;2-146; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 1998, TREATING TRAUMA RAPE; Hayes S.C., 2011, ACCEPTANCE COMMITMEN; Hayes SC., 1999, ACCEPTANCE COMMITMEN; Hazell J., 1995, P 5 INT TINN SEM, V8, P51, DOI [10.3389/fneur.2017.00141, DOI 10.3389/FNEUR.2017.00141]; HAZELL JWP, 1990, J OTOLARYNGOL, V19, P1; Helfer Thomas M, 2011, MSMR, V18, P7; Henry JA, 2006, ACTA OTO-LARYNGOL, V126, P64, DOI 10.1080/03655230600895556; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Henry James A, 2008, Trends Amplif, V12, P188, DOI 10.1177/1084713808321184; Henry Jane L., 1998, Scandinavian Journal of Behaviour Therapy, V27, P156; Hesse G., 2006, TRENDS PSYCHOTHERAPY, P53; Hesser H, 2012, J CONSULT CLIN PSYCH, V80, P649, DOI 10.1037/a0027021; Hesser H, 2009, REHABIL PSYCHOL, V54, P381, DOI 10.1037/a0017565; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hinton DE, 2006, J TRAUMA STRESS, V19, P405, DOI 10.1002/jts.20115; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Husain FT, 2016, HEARING RES, V334, P37, DOI 10.1016/j.heares.2015.09.010; Institute of Medicine, 2014, LONG TERM EFF BLAST; Institute of Medicine, 2014, TREATM POSTTR STRESS; Jackson JL, 2006, CNS SPECTRUMS, V11, P212, DOI 10.1017/S1092852900014383; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Jastreboff Margaret M., 2002, Australian and New Zealand Journal of Audiology, V24, P74, DOI 10.1375/audi.24.2.74.31105; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kaldo V, 2008, BEHAV THER, V39, P348, DOI 10.1016/j.beth.2007.10.003; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; KIRSCH C A, 1989, Annals of Behavioral Medicine, V11, P58, DOI 10.1207/s15324796abm1102_3; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; LINDBERG P, 1989, BEHAV RES THER, V27, P593, DOI 10.1016/0005-7967(89)90143-5; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKenna L., 2000, TINNITUS HDB, P59; Meikle M. B, 1992, TINNITUS 91, P555; Moller AR, 2011, TEXTBOOK OF TINNITUS, P99, DOI 10.1007/978-1-60761-145-5_12; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Moring J, 2016, J CLIN PSYCHOL MED S, V23, P310, DOI 10.1007/s10880-015-9444-5; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Newman C W, 1998, J Am Acad Audiol, V9, P153; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pattyn T, 2016, HEARING RES, V333, P255, DOI 10.1016/j.heares.2015.08.014; Peterson A. L., 2011, TREATING PTSD MILITA, P42; Prins A, 2016, J GEN INTERN MED, DOI [10.1007/s11606-3703-5, DOI 10.1007/S11606-3703-5]; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Reiss S., 1985, THEORETICAL ISSUES B, P107; Resick P. A., 1993, COGNITIVE PROCESSING; Resick P. A., 2008, COGNITIVE PROCESSING; Resick PA, 2015, J CONSULT CLIN PSYCH, V83, P1058, DOI 10.1037/ccp0000016; Robinson Shannon K, 2008, Int Tinnitus J, V14, P119; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Soo C, 2011, BRAIN IMPAIR, V12, P54, DOI 10.1375/brim.12.1.54; Sood S. K., 1988, BRIT J AUDIOL, V22, P228; Stephens SDG, 1999, BRIT J AUDIOL, V33, P17, DOI 10.3109/03005364000000097; TEASDALE G, 1974, LANCET, V2, P81; Thompson BL, 2013, J CONTEMP PSYCHOTHER, V43, P133, DOI 10.1007/s10879-013-9233-0; Unterrainer Josef, 2003, Int Tinnitus J, V9, P130; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vernon J., 2000, TINNITUS HDB, P313; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Westin V, 2008, BEHAV RES THER, V46, P1259, DOI 10.1016/j.brat.2008.08.008; Westin VZ, 2011, BEHAV RES THER, V49, P737, DOI 10.1016/j.brat.2011.08.001; WILSON PH, 1991, J SPEECH HEAR RES, V34, P197, DOI 10.1044/jshr.3401.197; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Yong JSE, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0034-5; Yurgil KA, 2016, J HEAD TRAUMA REHAB, V31, P30, DOI 10.1097/HTR.0000000000000117; Zirke N, 2013, QUAL LIFE RES, V22, P2095, DOI 10.1007/s11136-012-0338-9; Zoger S., 2008, AUDIOL MED, V6, P62, DOI [10.1080/16513860801959092, DOI 10.1080/16513860801959092, DOI 10.1080/165138608019]; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	102	5	5	0	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1070-5503	1532-7558		INT J BEHAV MED	Int. J. Behav. Med.	JUN	2018	25	3					312	321		10.1007/s12529-017-9702-z			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GG0IV	WOS:000432362600005	29185182				2022-02-06	
J	Porath, JD; Meka, AP; Morrow, C; Iyengar, R; Shtull-Leber, E; Fagerlin, A; Meurer, WJ				Porath, Jonathan D.; Meka, Arjun P.; Morrow, Chelsea; Iyengar, Rahul; Shtull-Leber, Eytan; Fagerlin, Angela; Meurer, William J.			Patient Preferences for Diagnostic Testing in the Emergency Department: A Cross-sectional Study	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	National Annual Meeting of the Society-for-Academic-Emergency-Medicine	MAY 10-13, 2016	New Orleans, LA	Soc Acad Emergency Med			SHARED DECISION-MAKING	Background: Diagnostic testing is common during emergency department (ED) visits. Little is understood about patient preferences for such testing. We hypothesized that a patient's willingness to undergo diagnostic testing is influenced by the potential benefit, risk, and personal cost. Methods: We conducted a cross sectional survey among ED patients for diagnostic testing in two hypothetical scenarios: chest pain (CP) and mild traumatic brain injury (mTBI). Each scenario defined specific risks, benefits, and costs of testing. The odds of a participant desiring diagnostic testing were calculated using a series of nested multivariable logistic regression models. Results: Participants opted for diagnostic testing 68.2% of the time, including 69.7% of CP and 66.7% of all mTBI scenarios. In the CP scenario, 81% of participants desired free testing versus 59% when it was associated with a $100 copay (difference = 22%, 95% confidence interval [CI] = 16% to 28%). Similarly, in the mTBI scenario, 73% of adult participants desired free testing versus 56% when charged a $100 copayment (difference = 17%, 95% CI = 11% to 24%). Benefit and risk had mixed effects across the scenarios. In fully adjusted models, the association between cost and desire for testing persisted in the CP (odds ratio [OR] = 0.33, 95% CI = 0.23 to 0.47) and adult mTBI (OR = 0.47, 95% CI = 0.33 to 0.67) scenarios. Conclusions: In this ED-based study, patient preferences for diagnostic testing differed significantly across levels of risk, benefit, and cost of diagnostic testing. Cost was the strongest and most consistent factor associated with decreased desire for testing.	[Porath, Jonathan D.; Meka, Arjun P.; Morrow, Chelsea; Iyengar, Rahul] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Shtull-Leber, Eytan] Maricopa Integrated Hlth Syst, Dept Emergency Med, Phoenix, AZ USA; [Fagerlin, Angela] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Fagerlin, Angela] Dept Vet Affairs, Salt Lake City, UT USA; [Meurer, William J.] Univ Michigan Hlth Syst, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Meurer, William J.] Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48109 USA		Meurer, WJ (corresponding author), Univ Michigan Hlth Syst, Dept Emergency Med, Ann Arbor, MI 48109 USA.; Meurer, WJ (corresponding author), Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48109 USA.	wmeurer@umich.edu	Meurer, William J/A-7547-2010	Meurer, William J/0000-0002-1158-5302; Iyengar, Rahul/0000-0002-1178-1717	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T35HL007690-34]; University of Michigan Department of Emergency Medicine; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5TL1 TR000435]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000435] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T35HL007690] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health via grant 5T35HL007690-34 for salary support for JDP, CM, RI, and APM. In addition, ESL was supported via research funds from the University of Michigan Department of Emergency Medicine and the NIH via grant 5TL1 TR000435.	Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Baumann BM, 2011, ANN EMERG MED, V58, P1, DOI 10.1016/j.annemergmed.2010.10.018; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Elwyn G, 1999, BRIT MED J, V319, P753, DOI 10.1136/bmj.319.7212.753; Hawley ST, 2008, PATIENT EDUC COUNS, V73, P448, DOI 10.1016/j.pec.2008.07.023; Meka AP, 2017, ACAD EMERG MED, V24, P686, DOI 10.1111/acem.13148; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Polaris Julian J Z, 2014, BMC Res Notes, V7, P922, DOI 10.1186/1756-0500-7-922; Schapira MM, 2006, J HEALTH COMMUN, V11; Tevis Sarah E, 2014, J Hosp Adm, V3, P150	10	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUN	2018	25	6					627	633		10.1111/acem.13404			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	GJ0KP	WOS:000434943500002	29505177	Green Published, Green Accepted, Bronze			2022-02-06	
J	Shibahashi, K; Sugiyama, K; Okura, Y; Hoda, H; Hamabe, Y				Shibahashi, Keita; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hoda, Hidenori; Hamabe, Yuichi			Intraventricular Hemorrhage After Head Injury: A Multicenter, Retrospective, Cohort Study	WORLD NEUROSURGERY			English	Article						Head injury; Intraventricular hemorrhage; Mortality; Prognosis; Trauma	TRAUMATIC BRAIN-INJURY; CORPUS-CALLOSUM; PROGNOSIS; PREVALENCE; OUTCOMES; CHILDREN; SCORE	BACKGROUND: Data on traumatic intraventricular hemorrhage (IVH) are currently limited, and therefore, the condition is not fully understood. The aim of this study was to determine the epidemiology of traumatic IVH and its effects on outcome in patients with blunt head trauma. METHODS AND MATERIALS: Using a nationwide trauma registry-the Japan Trauma Data Bank, we identified patients who underwent head computed tomography (CT) after blunt head trauma and had intracranial injuries between 2004 and 2015. The endpoint was in-hospital mortality. We compared patients with IVH and without IVH and adjusted for potential confounders using a multivariate logistic regression model. RESULTS: A total of 236,698 patients were registered in the database. Of the 139,058 patients who underwent head CT after blunt trauma, 906 (0.7%) had traumatic IVH. Among the 53,618 patients who were eligible for analysis, 871 had IVH. Traumatic IVH was associated with the occurrence of traffic accidents that caused trauma and severe injuries. Mortality was significantly higher in patients with IVH than in those without IVH (33.5% vs. 18.5%; P < 0.001); however, the difference was not significant after adjusting for confounding factors, with an adjusted odds ratio of 1.13 (95% confidence interval: 0.91-1.40). CONCLUSIONS: Traumatic IVH is associated with a high mortality. However, the outcome in patients with traumatic IVH was worse than that in patients without IVH, which could be a result of factors associated with IVH rather than of IVH alone.	[Shibahashi, Keita; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hoda, Hidenori; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Sugiyama, Kazuhiro/0000-0003-4543-3064; Hoda, Hidenori/0000-0002-4283-4412			Abraszko RA, 1995, BRIT J NEUROSURG, V9, P769, DOI 10.1080/02688699550040747; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Flint AC, 2008, NEUROCRIT CARE, V8, P330, DOI 10.1007/s12028-008-9070-2; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; JAYAKUMAR PN, 1990, ACTA NEUROCHIR, V106, P48, DOI 10.1007/BF01809332; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kiymaz N, 2005, ADV THER, V22, P447, DOI 10.1007/BF02849864; KOBAYASHI S, 1985, CHILD NERV SYST, V1, P18, DOI 10.1007/BF00706725; Laleva M, 2016, ACTA NEUROCHIR, V158, P1465, DOI 10.1007/s00701-016-2854-9; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; Lichenstein R, 2012, ARCH PEDIAT ADOL MED, V166, P725, DOI 10.1001/archpediatrics.2011.1919; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; OLIFF M, 1978, J COMPUT ASSIST TOMO, V2, P625, DOI 10.1097/00004728-197811000-00020; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; ZUCCARELLO M, 1981, ACTA NEUROCHIR, V55, P283, DOI 10.1007/BF01808444	24	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E350	E355		10.1016/j.wneu.2018.02.183			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600039	29530690				2022-02-06	
J	Stephens, JA; Denckla, MB; McCambridge, T; Slomine, BS; Mahone, EM; Suskauer, SJ				Stephens, Jaclyn A.; Denckla, Martha B.; McCambridge, Teri; Slomine, Beth S.; Mahone, E. Mark; Suskauer, Stacy J.			Preliminary Use of the Physical and Neurological Examination of Subtle Signs for Detecting Subtle Motor Signs in Adolescents With Sport-Related Concussion	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injuries; Adolescent; Neurobehavioral Manifestations; Signs and Symptoms	EXTREMITY MUSCULOSKELETAL INJURY; NEUROCOGNITIVE ASSESSMENT; MILD; HEAD; RELIABILITY; RETURN; PLAY	Sensitive examination tools are needed to optimize evaluation after sports-related concussion. The Physical and Neurological Examination of Subtle Signs was preliminarily examined for sensitivity to motor changes in a pilot cohort of adolescents aged 13-17 yrs with sports-related concussion. A total of 15 adolescents (5 female adolescents) with sports-related concussion were evaluated up to three times: within 2 wks of injury, approximately 1 mo later (mean, 35 days between visits), and for those not recovered at the second visit, again after clinical recovery (mean, 70 days between the first and last visits for all participants). Comparison data were acquired from 20 age- and sex-matched healthy control athletes with no history of concussion who were evaluated twice (mean, 32 days apart). Main effects of group, time, and interaction effects were evaluated with an analysis of covariance, which controlled for socioeconomic status, times tested, and days between testing sessions. Adolescents with concussion had poorer Physical and Neurological Examination of Subtle Signs performance than controls did at all time points. Performance improved between visits within the concussion group, with no change within the control group. These findings suggest that the Physical and Neurological Examination of Subtle Signs merits additional study in larger cohorts and in combination with other markers of injury to facilitate an enhanced understanding of sports-related concussion and recovery.	[Stephens, Jaclyn A.; Denckla, Martha B.; Slomine, Beth S.; Mahone, E. Mark; Suskauer, Stacy J.] Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA; [Stephens, Jaclyn A.; Suskauer, Stacy J.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Denckla, Martha B.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Denckla, Martha B.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD USA; [McCambridge, Teri; Slomine, Beth S.; Suskauer, Stacy J.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Slomine, Beth S.; Mahone, E. Mark] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Stephens, Jaclyn A.] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Stephens, Jaclyn A.] Johns Hopkins, Baltimore, MD USA; [Stephens, Jaclyn A.] Colorado State Univ, Ft Collins, CO 80523 USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.				National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32HD007414, R21HD080378]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD080378, T32HD007414] Funding Source: NIH RePORTER	Supported by the National Institutes of Health (J.A. Stephens, 5T32HD007414; T. McCambridge and S.J. Suskauer, R21HD080378).	Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Larson JCG, 2007, DEV NEUROPSYCHOL, V32, P543; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Patankar V C, 2012, Indian J Psychiatry, V54, P159, DOI 10.4103/0019-5545.99540; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Rochefort C, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117695507; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Stephens J, 2017, J MOTOR BEHAV, V49, P20, DOI 10.1080/00222895.2016.1204267; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; VITIELLO B, 1989, J AM ACAD CHILD PSY, V28, P749, DOI 10.1097/00004583-198909000-00017; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020	25	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUN	2018	97	6					456	460		10.1097/PHM.0000000000000906			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GG3GG	WOS:000432579700016	29762156	Green Accepted			2022-02-06	
J	Kuno, M; Hirano, Y; Nakagawa, A; Asano, K; Oshima, F; Nagaoka, S; Matsumoto, K; Masuda, Y; Iyo, M; Shimizu, E				Kuno, Masaru; Hirano, Yoshiyuki; Nakagawa, Akiko; Asano, Kenichi; Oshima, Fumiyo; Nagaoka, Sawako; Matsumoto, Koji; Masuda, Yoshitada; Iyo, Masaomi; Shimizu, Eiji			White Matter Features Associated With Autistic Traits in Obsessive-Compulsive Disorder	FRONTIERS IN PSYCHIATRY			English	Article						obsessive-compulsive disorder; diffusion tensor imaging; white matter tracts; autism spectrum disorder; Autism-Spectrum Quotient; left uncinate fasciculus	TRAUMATIC BRAIN-INJURY; SPECTRUM QUOTIENT AQ; DIFFUSION TENSOR; WATER DIFFUSION; DSM-IV; ABNORMALITIES; OCD; TRACTOGRAPHY; BEHAVIORS; CHILDREN	Obsessive-compulsive disorder (OCD) is among the most debilitating psychiatric disorders. Comorbid autism spectrum disorder (ASD) or autistic traits may impair treatment response in OCD. To identify possible neurostructural deficits underlying autistic traits, we performed white matter tractography on diffusion tensor images (DTI) and assessed autistic trait severity using the Autism-Spectrum Quotient (AQ) in 33 OCD patients. Correlations between AQ and the DTI parameters, fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) were examined in major white matter tracts that were suggested to be altered in previous OCD studies. We found a negative correlation between AQ and FA and positive correlations between AQ and MD, AD and RD in the left uncinate fasciculus using age, Beck Depression Inventory, Yale-Brown Obsessive-Compulsive Scale, intelligence quotient and medication as covariates. However, we could not detect the significant results between AQ and all DTI parameters when adding gender as a covariate. In addition, in the ASD comorbid group, FA in the left uncinate fasciculus was significantly lower than in the non-ASD comorbid group and MD and RD were significantly higher than in the non-ASD group. These results did not survive correction for multiple comparisons. In ASD, the socio-emotional dysfunction is suggested to be related to the alteration of white matter microstructure in uncinate fasciculus. Our results suggest that variations in white matter features of the left uncinate fasciculus might be partly explained by autistic traits encountered in OCD patients.	[Kuno, Masaru; Hirano, Yoshiyuki; Nakagawa, Akiko; Asano, Kenichi; Oshima, Fumiyo; Nagaoka, Sawako; Shimizu, Eiji] Chiba Univ, Res Ctr Child Mental Dev, Chiba, Japan; [Matsumoto, Koji; Masuda, Yoshitada] Chiba Univ Hosp, Dept Radiol, Chiba, Japan; [Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan; [Shimizu, Eiji] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan		Hirano, Y (corresponding author), Chiba Univ, Res Ctr Child Mental Dev, Chiba, Japan.	hirano@chiba-u.jp	HIRANO, YOSHIYUKI/L-1234-2017	HIRANO, YOSHIYUKI/0000-0003-3844-3061; KUNO, Masaru/0000-0002-4153-280X; Oshima, Fumiyo/0000-0002-3050-4010	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP23591733, JP26461762, JP16H06280, JP16K04342, JP16K04344]; Mental Health Okamoto Memorial Foundation, Osaka, Japan	This work was supported by Grant-in-Aid from the JSPS KAKENHI Grant Numbers JP23591733, JP26461762, JP16H06280, JP16K04342, and JP16K04344, and the Mental Health Okamoto Memorial Foundation, Osaka, Japan the funding sources had no role in study design, interpretation, or decision to publish.	Acosta-Cabronero J, 2011, BRAIN, V134, P2025, DOI 10.1093/brain/awr119; Admon R, 2012, PSYCHIAT RES-NEUROIM, V203, P207, DOI 10.1016/j.pscychresns.2012.02.002; Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Ameis SH, 2016, AM J PSYCHIAT, V173, P1213, DOI 10.1176/appi.ajp.2016.15111435; Ameis SH, 2015, CORTEX, V62, P158, DOI 10.1016/j.cortex.2014.10.014; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Aoki Y, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-25; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Ayuso-Mateos J. L., 2000, GLOBAL BURDEN OBSESS; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bejerot S, 2007, AUTISM, V11, P101, DOI 10.1177/1362361307075699; Benedetti F, 2013, EUR NEUROPSYCHOPHARM, V23, P581, DOI 10.1016/j.euroneuro.2012.07.002; Bloch MH, 2008, AM J MED GENET B, V147B, P850, DOI 10.1002/ajmg.b.30699; Bolton PF, 1998, PSYCHOL MED, V28, P385, DOI 10.1017/S0033291797006004; Buxbaum JD, 2004, MOL PSYCHIATR, V9, P144, DOI 10.1038/sj.mp.4001465; Carlisi CO, 2017, BIOL PSYCHIAT, V82, P83, DOI 10.1016/j.biopsych.2016.10.006; Catapano F, 2006, J PSYCHIATR RES, V40, P502, DOI 10.1016/j.jpsychires.2005.04.010; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Ecker C, 2012, ARCH GEN PSYCHIAT, V69, P195, DOI 10.1001/archgenpsychiatry.2011.1251; Edelstyn NMJ, 2001, PSYCHOPATHOLOGY, V34, P299, DOI 10.1159/000049328; Elison JT, 2013, DEVELOPMENTAL SCI, V16, P186, DOI 10.1111/desc.12015; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Gotts SJ, 2012, BRAIN, V135, P2711, DOI 10.1093/brain/aws160; Grant JE, 2014, NEW ENGL J MED, V371, P646, DOI 10.1056/NEJMcp1402176; Hennig-Fast K, 2015, J PSYCHIATR RES, V68, P354, DOI 10.1016/j.jpsychires.2015.05.001; Hirstein W, 1997, P ROY SOC B-BIOL SCI, V264, P437, DOI 10.1098/rspb.1997.0062; Hollander E, 2003, PSYCHIAT RES, V117, P11, DOI 10.1016/S0165-1781(02)00304-9; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Jacob S, 2009, AUTISM RES, V2, P293, DOI 10.1002/aur.108; Jayarajan RN, 2012, DEPRESS ANXIETY, V29, P780, DOI 10.1002/da.21890; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kobayashi T, 2015, MAGN RESON MED SCI, V14, P329, DOI 10.2463/mrms.2014-0146; Koch K, 2014, J PSYCHIATR RES, V54, P26, DOI 10.1016/j.jpsychires.2014.03.006; Kumar A, 2010, CEREB CORTEX, V20, P2103, DOI 10.1093/cercor/bhp278; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Marcks BA, 2011, COMPR PSYCHIAT, V52, P670, DOI 10.1016/j.comppsych.2011.01.001; Meier SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141703; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Michael B, 2002, STRUCTURED CLIN INTE; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Molnar-Szakacs Istvan, 2009, Mcgill J Med, V12, P87; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pardini M, 2012, J AUTISM DEV DISORD, V42, P585, DOI 10.1007/s10803-011-1281-2; Piras F, 2015, CORTEX, V62, P89, DOI 10.1016/j.cortex.2013.01.016; Piras F, 2013, NEUROSCI BIOBEHAV R, V37, P2856, DOI 10.1016/j.neubiorev.2013.10.008; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Radua J, 2014, NEUROPSYCHOPHARMACOL, V39, P1547, DOI 10.1038/npp.2014.5; Samson AC, 2016, PSYCHIAT RES-NEUROIM, V255, P66, DOI 10.1016/j.pscychresns.2016.08.004; Saxena S, 1999, NEUROPSYCHOPHARMACOL, V21, P683, DOI 10.1016/S0893-133X(99)00082-2; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Solders SK, 2017, AUTISM RES, V10, P1606, DOI 10.1002/aur.1807; Storch EA, 2010, B MENNINGER CLIN, V74, P167, DOI 10.1521/bumc.2010.74.2.167; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wakabayashi A, 2007, J AUTISM DEV DISORD, V37, P491, DOI 10.1007/s10803-006-0181-3; Wakabayashi Akio, 2004, Shinrigaku Kenkyu, V75, P78; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D., 1981, WAIS R MANUAL WECHSL; Whitwell JL, 2010, NEUROLOGY, V74, P1279, DOI 10.1212/WNL.0b013e3181d9edde; Won E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10100-y; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Yoo SY, 2007, ACTA PSYCHIAT SCAND, V116, P211, DOI 10.1111/j.1600-0447.2007.01046.x; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zarei M, 2011, BIOL PSYCHIAT, V70, P1083, DOI 10.1016/j.biopsych.2011.06.032	78	5	6	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	MAY 29	2018	9								216	10.3389/fpsyt.2018.00216			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GH3WI	WOS:000433333000002	29896127	Green Published, gold			2022-02-06	
J	Badachhape, AA; Okamoto, RJ; Johnson, CL; Bayly, PV				Badachhape, Andrew A.; Okamoto, Ruth J.; Johnson, Curtis L.; Bayly, Philip, V			Relationships between scalp, brain, and skull motion estimated using magnetic resonance elastography	JOURNAL OF BIOMECHANICS			English	Article						Magnetic resonance elastography; Human brain tissue; In vivo; Traumatic brain injury	HEAD IMPACT SENSORS; VISCOELASTICITY; DEFORMATION; FOOTBALL	The objective of this study was to characterize the relationships between motion in the scalp, skull, and brain. In vivo estimates of motion transmission from the skull to the brain may illuminate the mechanics of traumatic brain injury. Because of challenges in directly sensing skull motion, it is useful to know how well motion of soft tissue of the head, i.e., the scalp, can approximate skull motion or predict brain tissue deformation. In this study, motion of the scalp and brain were measured using magnetic resonance elastography (MRE) and separated into components due to rigid-body displacement and dynamic deformation. Displacement estimates in the scalp were calculated using low motion-encoding gradient strength in order to reduce "phase wrapping" (an ambiguity in displacement estimates caused by the 2 pi-periodicity of MRE phase contrast). MRE estimates of scalp and brain motion were compared to skull motion estimated from three tri-axial accelerometers. Comparison of the relative amplitudes and phases of harmonic motion in the scalp, skull, and brain of six human subjects indicate that data from scalp-based sensors should be used with caution to estimate skull kinematics, but that fairly consistent relationships exist between scalp, skull, and brain motion. In addition, the measured amplitude and phase relationships of scalp, skull, and brain can be used to evaluate and improve mathematical models of head biomechanics. (C) 2018 Elsevier Ltd. All rights reserved.	[Badachhape, Andrew A.; Bayly, Philip, V] Washington Univ, Biomed Engn, Whitaker Hall Box 1097,1 Brookings Dr, St Louis, MO 63105 USA; [Okamoto, Ruth J.; Bayly, Philip, V] Washington Univ, Mech Engn & Mat Sci, St Louis, MO 63105 USA; [Johnson, Curtis L.] Univ Delaware, Biomed Engn, Newark, DE USA		Badachhape, AA (corresponding author), Washington Univ, Biomed Engn, Whitaker Hall Box 1097,1 Brookings Dr, St Louis, MO 63105 USA.	abadachhape@wustl.edu	Johnson, Curtis/U-8372-2019	Badachhape, Andrew/0000-0002-5857-9495; Okamoto, Ruth/0000-0002-3085-3878	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS055951]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	Financial support for this study was provided by National Institutes of Health (NIH) Grant R01 NS055951.	Atay S. M., 2008, J BIOMECH ENG, V22, P629, DOI [10.1016/j.bbi.2008.05.010, DOI 10.1016/J.BBI.2008.05.010]; Badachhape AA, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036146; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Genin J., 1995, DYNAMICS; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; GURDJIAN ES, 1970, J BIOMECH, V3, P239, DOI 10.1016/0021-9290(70)90025-4; Hiscox LV, 2016, PHYS MED BIOL, V61, pR401, DOI 10.1088/0031-9155/61/24/R401; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Johnson CL, 2016, HUM BRAIN MAPP, V37, P4221, DOI 10.1002/hbm.23314; Johnson CL, 2014, MAGN RESON MED, V71, P477, DOI 10.1002/mrm.25065; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Monea AG, 2012, J NEUROTRAUM, V29, P2305, DOI 10.1089/neu.2011.2271; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Scharnhorst K, 2001, ACTA APPL MATH, V69, P95, DOI 10.1023/A:1012692601098; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	25	5	5	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAY 17	2018	73						40	49		10.1016/j.jbiomech.2018.03.028			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	GG5XY	WOS:000432770400006	29580689	Green Accepted			2022-02-06	
J	Jackson, TC; Dixon, CE; Janesko-Feldman, K; Vagni, V; Kotermanski, SE; Jackson, EK; Kochanek, PM				Jackson, Travis C.; Dixon, C. Edward; Janesko-Feldman, Keri; Vagni, Vincent; Kotermanski, Shawn E.; Jackson, Edwin K.; Kochanek, Patrick M.			Acute Physiology and Neurologic Outcomes after Brain Injury in SCOP/PHLPP1 KO Mice	SCIENTIFIC REPORTS			English	Article							CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; HEMORRHAGIC-SHOCK; PROTEIN PHOSPHATASE; PERFUSION-PRESSURE; DELETION PROTECTS; AKT ACTIVITY; PHLPP1; ACTIVATION; KINASE	Suprachiasmatic nucleus circadian oscillatory protein (SCOP) (a.k.a. PHLPP1) regulates long-term memory consolidation in the brain. Using a mouse model of controlled cortical impact (CCI) we tested if (1) brain tissue levels of SCOP/PHLPP1 increase after a traumatic brain injury (TBI), and (2) if SCOP/PHLPP1 gene knockout (KO) mice have improved (or worse) neurologic outcomes. Blood chemistry (pH, pCO(2), pO(2), pSO(2), base excess, sodium bicarbonate, and osmolarity) and arterial pressure (MAP) differed in isoflurane anesthetized WT vs. KOs at baseline and up to 1 h post-injury. CCI injury increased cortical/hippocampal SCOP/PHLPP1 levels in WTs 7d and 14d post-injury. Injured KOs had higher brain tissue levels of phosphorylated AKT (pAKT) in cortex (14d post-injury), and higher levels of phosphorylated MEK (pMEK) in hippocampus (7d and 14d post-injury) and in cortex (7d post-injury). Consistent with an important role of SCOP/PHLPP1 on memory function, injured-KOs had near normal performance on the probe trial of the Morris water maze, whereas injured-WTs were impaired. CA1/CA3 hippocampal survival was lower in KOs vs. WTs 24 h post-injury but equivalent by 7d. No difference in 21d cortical lesion volume was detected. SCOP/PHLPP1 overexpression in cultured rat cortical neurons had no effect on 24 h cell death after a mechanical stretch-injury.	[Jackson, Travis C.; Dixon, C. Edward; Janesko-Feldman, Keri; Vagni, Vincent; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, John G Rangos Res Ctr, Sch Med,Childrens Hosp Pittsburgh,UPMC, 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA; [Jackson, Travis C.; Janesko-Feldman, Keri; Vagni, Vincent; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Scaife Hall,3550 Terrace St, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol, 811 Kaufmann Med Bldg,3471 Fifth Ave, Pittsburgh, PA USA; [Kotermanski, Shawn E.; Jackson, Edwin K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Bridgeside Point Bldg 1,100 Technol Dr, Pittsburgh, PA USA		Jackson, TC (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, John G Rangos Res Ctr, Sch Med,Childrens Hosp Pittsburgh,UPMC, 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA.; Jackson, TC (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Scaife Hall,3550 Terrace St, Pittsburgh, PA 15260 USA.	jacksontc@upmc.edu		Jackson, Edwin/0000-0002-8101-6009	American Heart Association grantAmerican Heart Association [14SDG20210000]; U.S. Army Grant [W81XWH-10-1-0623]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK079307] Funding Source: NIH RePORTER	The authors would like to thank Dr. Tianyan Gao for generously donating SCOP/PHLPP1 KO mice. This work was supported by an American Heart Association grant to Travis C. Jackson (14SDG20210000), and by a U.S. Army Grant to Patrick M. Kochanek (W81XWH-10-1-0623).	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Barnes T, 2018, CHEST, V154, P185, DOI 10.1016/j.chest.2017.11.010; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen B, 2013, J CEREBR BLOOD F MET, V33, P196, DOI 10.1038/jcbfm.2012.150; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; FORTUNE JB, 1995, J TRAUMA, V39, P463; Gao TY, 2005, FASEB J, V19, pA258; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Griesdale DEG, 2015, J CRIT CARE, V30, P111, DOI 10.1016/j.jcrc.2014.07.026; Hebert AE, 2002, LEARN MEMORY, V9, P156, DOI 10.1101/lm.48502; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Ito H, 2003, J CEREBR BLOOD F MET, V23, P665, DOI 10.1097/01.WCB.0000067721.64998.F5; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jackson TC, 2018, EXP NEUROL, V300, P232, DOI 10.1016/j.expneurol.2017.11.013; Jackson TC, 2017, NEUROSCIENCE, V361, P93, DOI 10.1016/j.neuroscience.2017.08.014; Jackson TC, 2015, SCI REP-UK, V5, DOI 10.1038/srep09377; Jackson TC, 2013, J PHARMACOL EXP THER, V347, P516, DOI 10.1124/jpet.113.206888; Jackson TC, 2010, J NEUROCHEM, V115, P941, DOI 10.1111/j.1471-4159.2010.06984.x; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Leon WC, 2010, LEARN MEMORY, V17, P297, DOI 10.1101/lm.1804410; Levenga J, 2017, ELIFE, V6, DOI 10.7554/eLife.30640; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Liu Y, 2016, LEARN MEMORY, V23, P399, DOI 10.1101/lm.042721.116; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; McNamara CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056576; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Moc C, 2015, CARDIOVASC RES, V105, P160, DOI 10.1093/cvr/cvu243; Patterson SJ, 2011, J IMMUNOL, V186, P5533, DOI 10.4049/jimmunol.1002126; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schwarzkopf TM, 2013, EXP BIOL MED, V238, P84, DOI 10.1258/ebm.2012.012261; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Shimizu K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12926; Smith AJ, 2016, ONCOTARGET, V7, P7801, DOI 10.18632/oncotarget.6848; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhao SF, 2014, NEUROL RES, V36, P483, DOI 10.1179/1743132814Y.0000000353; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	54	5	5	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 8	2018	8								7158	10.1038/s41598-018-25371-2			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF0MB	WOS:000431623800028	29739983	Green Published, gold			2022-02-06	
J	Esterhuizen, AI; Carvill, GL; Ramesar, RS; Kariuki, SM; Newton, CR; Poduri, A; Wilmshurst, JM				Esterhuizen, Alina I.; Carvill, Gemma L.; Ramesar, Rajkumar S.; Kariuki, Symon M.; Newton, Charles R.; Poduri, Annapurna; Wilmshurst, Jo M.			Clinical Application of Epilepsy Genetics in Africa: Is Now the Time?	FRONTIERS IN NEUROLOGY			English	Article						low; to middle-income countries; genetic testing; seizures; sub-Saharan Africa; genetic epilepsy; early-life epilepsy	ACTIVE CONVULSIVE EPILEPSY; SUB-SAHARAN AFRICA; ATAXIA TYPE 7; SOUTH-AFRICA; TUNISIAN FAMILIES; FEBRILE SEIZURES; ILAE COMMISSION; DRAVET SYNDROME; RISK-FACTORS; TASK-FORCE	Over 80% of people with epilepsy live in low-to middle-income countries where epilepsy is often undiagnosed and untreated due to limited resources and poor infrastructure. In Africa, the burden of epilepsy is exacerbated by increased risk factors such as central nervous system infections, perinatal insults, and traumatic brain injury. Despite the high incidence of these etiologies, the cause of epilepsy in over 60% of African children is unknown, suggesting a possible genetic origin. Large-scale genetic and genomic research in Europe and North America has revealed new genes and variants underlying disease in a range of epilepsy phenotypes. The relevance of this knowledge to patient care is especially evident among infants with early-onset epilepsies, where early genetic testing can confirm the diagnosis and direct treatment, potentially improving prognosis and quality of life. In Africa, however, genetic epilepsies are among the most under-investigated neurological disorders, and little knowledge currently exists on the genetics of epilepsy among African patients. The increased diversity on the continent may yield unique, important epilepsy-associated genotypes, currently absent from the North American or European diagnostic testing protocols. In this review, we propose that there is strong justification for developing the capacity to offer genetic testing for children with epilepsy in Africa, informed mostly by the existing counseling and interventional needs. Initial simple protocols involving well-recognized epilepsy genes will not only help patients but will give rise to further clinically relevant research, thus increasing knowledge and capacity.	[Esterhuizen, Alina I.; Ramesar, Rajkumar S.] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Pathol, Div Human Genet, Cape Town, South Africa; [Esterhuizen, Alina I.; Ramesar, Rajkumar S.] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Carvill, Gemma L.] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA; [Kariuki, Symon M.; Newton, Charles R.] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England; [Poduri, Annapurna] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Epilepsy Genet Program, Boston, MA USA; [Wilmshurst, Jo M.] Univ Cape Town, Sch Child & Adolescent Hlth, Cape Town, South Africa; [Wilmshurst, Jo M.] Red Cross War Mem Childrens Hosp, Paediat Neurol & Neurophysiol, Cape Town, South Africa		Wilmshurst, JM (corresponding author), Univ Cape Town, Sch Child & Adolescent Hlth, Cape Town, South Africa.; Wilmshurst, JM (corresponding author), Red Cross War Mem Childrens Hosp, Paediat Neurol & Neurophysiol, Cape Town, South Africa.	jo.wilmshurst@uct.ac.za	Yue, Yuhang/AAW-9279-2021; Newton, Charles RJC/B-7578-2014; Ramesar, Raj S/I-6941-2015	Newton, Charles RJC/0000-0002-6999-5507; Ramesar, Raj S/0000-0001-5688-1634; Kariuki, Symon/0000-0002-3934-5132; Wilmshurst, Jo/0000-0001-7328-1796	ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/N013751/1] Funding Source: UKRI		Allen AS, 2017, LANCET NEUROL, V16, P135, DOI 10.1016/S1474-4422(16)30359-3; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0; Balestrini S, 2018, NEUROSCI LETT, V667, P27, DOI 10.1016/j.neulet.2017.01.014; Belhedi N, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-93; Berg AT, 2017, JAMA PEDIATR, V171, P863, DOI 10.1001/jamapediatrics.2017.1743; Bistervels Ingrid M, 2016, Epilepsia Open, V1, P112, DOI 10.1002/epi4.12013; Buseh A, 2014, PUBLIC HEALTH GENOM, V17, P33, DOI 10.1159/000356013; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Dandara C, 2014, EXPERT OPIN DRUG MET, V10, P769, DOI 10.1517/17425255.2014.894020; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; Esmaeeli Nieh S, 2014, NEUROTHERAPEUTICS, V11, P796, DOI 10.1007/s13311-014-0301-2; Fendri-Kriaa N, 2011, EUR J NEUROL, V18, P695, DOI 10.1111/j.1468-1331.2010.03216.x; Fendri-Kriaa N, 2009, EUR J NEUROL, V16, P697, DOI 10.1111/j.1468-1331.2009.02570.x; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gebremedhin S, 2015, TWIN RES HUM GENET, V18, P100, DOI 10.1017/thg.2014.82; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Helbig I, 2016, MOL SYNDROMOL, V7, P172, DOI 10.1159/000448530; Kariuki Symon M, 2017, Epilepsia Open, V2, P8, DOI 10.1002/epi4.12035; Kariuki SM, 2014, EPILEPSIA, V55, P76, DOI 10.1111/epi.12392; Kim YO, 2013, DEV MED CHILD NEUROL, V55, P769, DOI 10.1111/dmcn.12197; Krause A, 2015, AM J MED GENET B, V168, P573, DOI 10.1002/ajmg.b.32332; Kurtz Z, 1998, BMJ-BRIT MED J, V316, P339, DOI 10.1136/bmj.316.7128.339; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Landoure Guida, 2014, North Afr Middle East Epilepsy J, V3, P5; Layouni S, 2010, EPILEPSY RES, V90, P33, DOI 10.1016/j.eplepsyres.2010.03.004; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Levira F, 2017, EPILEPSIA, V58, P6, DOI 10.1111/epi.13603; Lopez-Garcia Miguel A, 2014, Front Biosci (Elite Ed), V6, P377; Malherbe HL, 2015, SAMJ S AFR MED J, V105, P186, DOI 10.7196/SAMJ.9136; Margolis Russell L, 2005, Acta Neurol Taiwan, V14, P1; Marini C, 2012, EPILEPSIA, V53, P2111, DOI 10.1111/j.1528-1167.2012.03649.x; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Modell B., 2006, GLOBAL REPORT BIRTH; Mpye KL, 2017, GLOB HEALTH EPIDEM G, V2, DOI 10.1017/gheg.2016.21; Myers CT, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0214-7; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Olson H, 2014, ANN NEUROL, V75, P943, DOI 10.1002/ana.24178; Poduri A, 2014, NAT REV NEUROL, V10, P293, DOI 10.1038/nrneurol.2014.60; Rajman I, 2017, EBIOMEDICINE, V17, P67, DOI 10.1016/j.ebiom.2017.02.017; Richter LM, 2008, AIDS CARE, V20, P1019, DOI 10.1080/09540120701842738; Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Scheffer IE, 2014, NEUROPEDIATRICS, V45, P70, DOI 10.1055/s-0034-1371508; Smith DC, 2015, J NEUROL SCI, V354, P75, DOI 10.1016/j.jns.2015.04.053; Thomas RH, 2014, NAT REV NEUROL, V10, P283, DOI 10.1038/nrneurol.2014.62; Thomford NE, 2015, PHARMACEUTICALS-BASE, V8, P637, DOI 10.3390/ph8030637; Traore M, 2009, NEUROGENETICS, V10, P319, DOI 10.1007/s10048-009-0190-4; TSUBOI T, 1987, HUM GENET, V75, P7; Ughasoro MD, 2016, EPILEPSY RES, V125, P37, DOI 10.1016/j.eplepsyres.2016.05.006; Ughasoro MD, 2014, INT J TECHNOL ASSESS, V30, P469, DOI 10.1017/S0266462314000518; VERITY CM, 1992, BMJ-BRIT MED J, V305, P857, DOI 10.1136/bmj.305.6858.857; Vezyroglou K, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0407-4; Wagner RG, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1460-0; Wagner RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145300; Wagner RG, 2014, EPILEPSY RES, V108, P782, DOI 10.1016/j.eplepsyres.2014.01.004; Watson LM, 2016, SAMJ S AFR MED J, V106, pS107, DOI 10.7196/SAMJ.2016.v106i6.11010; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; Wilmshurst JM, 2015, EPILEPSIA, V56, P1185, DOI 10.1111/epi.13057; Wilmshurst JM, 2014, NAT REV NEUROL, V10, P249, DOI 10.1038/nrneurol.2014.58; Wilmshurst JM, 2014, SEMIN PEDIATR NEUROL, V21, P36, DOI 10.1016/j.spen.2014.01.005; Wilmshurst JM, 2013, J CHILD NEUROL, V28, P633, DOI 10.1177/0883073813482974; Woldeamanuel YW, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0480-6; Xu XJ, 2015, HUM MUTAT, V36, P861, DOI 10.1002/humu.22819; Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690	67	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 2	2018	9								276	10.3389/fneur.2018.00276			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE4RD	WOS:000431203500001	29770117	gold, Green Published			2022-02-06	
J	Heyer, GL; Young, JA; Fischer, AN				Heyer, Geoffrey L.; Young, Julie A.; Fischer, Anastasia N.			Lightheadedness After Concussion: Not All Dizziness is Vertigo	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						traumatic brain injury; mTBI; pediatric; adolescent; vertigo; dizziness; lightheadedness; orthostatic intolerance; postconcussion	HEAD-INJURY; SYMPTOMS; RECOVERY; OUTCOMES; SCALE; YOUTH	Objective: To characterize the presence and degree of postconcussion lightheadedness in relation to postconcussion vertigo and dizziness, and to determine whether lightheadedness influences overall symptom duration. Design: Prospective, cohort design. Setting: Nationwide Children's Hospital, Sports Concussion Clinic. Participants: Five hundred ten patients (9-19 years of age) within 30 days of concussion injury. Main Outcome Measures: Patient ratings (scale 0-6) of multiple postconcussion symptoms including lightheadedness, vertigo, and dizziness, reported from the day of clinic evaluation and recalled from the day of concussion. Results: Postconcussion lightheadedness occurred commonly relative to vertigo. Lightheadedness was recalled more than vertigo (70.8% vs 48.6%, P < 0.001) on concussion day and reported more than vertigo (47.1% vs 24.1%, P < 0.001) on the day of clinic evaluation. Principal component analysis demonstrated strong correlations among lightheadedness, vertigo, balance difficulties, difficulty concentrating, mental fogginess, and difficulty remembering, relative to other postconcussion symptoms. When present on the day of clinic evaluation, these highly correlated symptoms predicted prolonged concussion recovery [P = 0.028; Hazard Ratio (HR) = 1.2]. Female sex (P = 0.04; HR = 1.23), emotional symptoms recalled from the day of concussion (P= 0.007; HR = 1.23), and cephalalgic symptoms (P < 0.001; HR = 1.34) reported on the day of clinic evaluation also predicted prolonged concussion recovery. Conclusions: Not all postconcussion dizziness is vertigo. Postconcussion lightheadedness is common and, when present at the time of clinic evaluation, can influence concussion recovery. Clinical Relevance: Distinguishing postconcussion lightheadedness from vertigo may help to inform clinical treatment and concussion re search design. This study adds to the growing body of evidence that supports an association between concussion and autonomic dysfunction.	[Heyer, Geoffrey L.] Nationwide Childrens Hosp, Div Pediat Neurol, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA; [Heyer, Geoffrey L.; Fischer, Anastasia N.] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Young, Julie A.; Fischer, Anastasia N.] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH 43205 USA		Heyer, GL (corresponding author), Nationwide Childrens Hosp, Div Pediat Neurol, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Ohio State Univ, 700 Childrens Dr, Columbus, OH 43205 USA.	geoffrey.heyer@nationwidechildrens.org					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; DOBA N, 1974, CIRC RES, V34, P9, DOI 10.1161/01.RES.34.1.9; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Heyer GL, 2013, HEADACHE, V53, P947, DOI 10.1111/head.12103; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Jauregui-Renaud K, 2000, BRAIN RES BULL, V53, P17, DOI 10.1016/S0361-9230(00)00304-X; Joliffe I T, 1992, Stat Methods Med Res, V1, P69, DOI 10.1177/096228029200100105; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Radtke A, 2003, J VESTIBUL RES-EQUIL, V13, P25; Radtke A, 2000, LANCET, V356, P736, DOI 10.1016/S0140-6736(00)02635-0; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; YATES BJ, 1995, AM J PHYSIOL-REG I, V268, pR1381, DOI 10.1152/ajpregu.1995.268.6.R1381; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	34	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2018	28	3					272	277		10.1097/JSM.0000000000000445			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	GP1HS	WOS:000440566600006	28708707				2022-02-06	
J	Huebner, ARS; Cassedy, A; Brown, TM; Taylor, HG; Stancin, T; Kirkwood, MW; Wade, SL				Huebner, Andrea R. S.; Cassedy, Amy; Brown, Tanya M.; Taylor, H. Gerry; Stancin, Terry; Kirkwood, Michael W.; Wade, Shari L.			Use of Mental Health Services by Adolescents After Traumatic Brain Injury: A Secondary Analysis of a Randomized Controlled Trial	PM&R			English	Article							OF-CARE INDICATORS; PROBLEM-SOLVING THERAPY; LONG-TERM; EXECUTIVE DYSFUNCTION; BEHAVIORAL OUTCOMES; COMPLICATED MILD; EARLY-CHILDHOOD; YOUNG-CHILDREN; CLINICAL-TRIAL; REHABILITATION	Background: Mental health problems are common after pediatric traumatic brain injury (TBI). Many patients in need of mental health services do not receive them, but studies have not consistently used prospective and objective methods or followed samples for more than 1 year. Objective: To examine adolescents' use of mental health services after TBI. Design: Secondary analysis from multicenter prospective randomized controlled trial. Setting: Five level 1 U.S. trauma centers. Participants: Adolescents aged 12-17 years with moderate-to-severe TBI were recruited for a randomized clinical trial (n = 132 at baseline, 124 at 6 months, 113 at 12 months, and 101 at 18 months). Methods: Participants were randomly assigned to counselor-assisted problem-solving or Internet resource comparison. Follow-up assessments were completed at 6, 12, and 18 months after baseline. Generalized estimating equations with a logit link were used to examine use of mental health services. Treatment group and participant impairment were examined as predictors of use. Main Outcome Measurements: Mental health care use was measured with the Service Assessment for Children and Adolescents; daily functioning and clinical outcome with the Child and Adolescent Functional Assessment Scale; behavioral and emotional functioning with the Child Behavior Checklist; and executive dysfunction with the Behavior Rating Inventory of Executive Function. Results: Use of mental health services ranged from 22% to 31% in the 2 years post-TBI. Participants with impairments were about 3 times more likely than those without impairments to receive services (odds ratio 4.61; 95% confidence interval 2.61-8.14; P < .001). However, 50%-68% of patients identified as impaired had unmet mental health care needs. Conclusions: Less than one half of adolescents with behavioral health needs after TBI received mental health services. Future studies are needed to examine barriers associated with seeking services after TBI and psychoeducation as preventive care for this population.	[Huebner, Andrea R. S.; Brown, Tanya M.] Mayo Clin, Dept Psychiat & Psychol, 200 First St SW, Rochester, MN 55905 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Dept Psychiat, 3395 Scranton Rd, Cleveland, OH 44109 USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Huebner, ARS (corresponding author), Mayo Clin, Dept Psychiat & Psychol, 200 First St SW, Rochester, MN 55905 USA.	huebner.andrea@mayo.edu	Stancin, Terry/L-7993-2019		National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institutes of Health/Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	T.M.B. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN; Disclosures related to this publication: grant, National Institute of Mental Health (money to institution); H.G.T. Department of Pediatrics, Case Western Reserve University, Cleveland, OH; Disclosures related to this publication: grant, National Institutes of Health (money to institution); T.S. Department of Psychiatry, MetroHealth Medical Center and Case Western Reserve University, Cleveland, OH; Disclosures related to this publication: grant, National Institutes of Health/Patient-Centered Outcomes Research Institute (money to institution); S.L.W. Division of Physical Medicine and Rehabilitation, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH; Disclosures related to this publication: grant, National Institute of Mental Health (money to institution); support for travel to meetings for the study or other purposes, American Congress of Rehabilitation Medicine to present findings Disclosures outside this publication: consultancy, University of Oregon (money to institution); grants/grants pending, National Institute on Disability, Independent Living, and Rehabilitation Research (money to institution); This study was part of the CAPS clinical trial (NCT00409448), which is supported by the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Data Accountability Center, 2011, NUMB STUD AG 6 21 SE; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Diggle P., 2002, ANAL LONGITUDINAL DA; Ennis SK, 2014, J HEAD TRAUMA REHAB, V29, P208, DOI 10.1097/HTR.0b013e3182987dd4; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gioia G.A., 2000, BRIEF BEHAV RATING I; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Hoagwood K., 2000, J FAMILY STUD, V9, P315, DOI [DOI 10.1023/A:1026492423273, 10.1023/A:1026492423273]; Hodges K., 2003, CAFAS MANUAL TRAININ; Hodges K., 1996, J CHILD FAM STUD, V5, P445, DOI [10.1007/BF02233865, DOI 10.1007/BF02233865]; Horwitz SM, 2001, PSYCHIAT SERV, V52, P1088, DOI 10.1176/appi.ps.52.8.1088; Jaffe KM, 2008, J TRAUMA, V64, P819, DOI 10.1097/TA.0b013e318165f177; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kurowski BG, 2015, PEDIATRICS, V136, P782; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PM&R, V5, P1026, DOI 10.1016/j.pmrj.2013.08.589; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	41	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	MAY	2018	10	5					462	471		10.1016/j.pmrj.2017.10.004			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GG4NL	WOS:000432673300002	29097272	Green Accepted			2022-02-06	
J	Hunt, C; Michalak, A; Lefkimmiatis, C; Johnston, E; Macumber, L; Jocko, T; Ouchterlony, D				Hunt, Cindy; Michalak, Alicja; Lefkimmiatis, Chrissy; Johnston, Elaine; Macumber, Leila; Jocko, Tony; Ouchterlony, Donna			Exploring concussion awareness in hockey with a First Nations community in Canada	PUBLIC HEALTH NURSING			English	Article						American Indians; community health nursing; injury prevention; trauma	TRAUMATIC BRAIN-INJURY; KNOWLEDGE TRANSLATION; EDUCATION; ATTITUDES; PREVENTION; HEALTH; IMPACT; BEHAVIORS; AMERICAN; PROGRAMS	ObjectiveThe purpose of this pilot study was twofold: (1) to begin to understand concussion in youth hockey in a First Nations community in Canada and (2) to determine the impact of a novel concussion education workshop. DesignA one-group quasiexperimental time series study was undertaken. SampleA total of 41 participants consented, with 71% (n=29) completing data collection at all three study time points. Measurement and InterventionsTwo nurses one from the First Nations community and one from the tertiary care center collaborated to develop and deliver the intervention on concussion specifically general, hockey and symptom knowledge. The primary outcome was Total Knowledge Score (TKS), whereby correct responses to a self-reported questionnaire were summed and then converted to a percentage. ResultsThe TKS were similar across study time points; preworkshop 71.7%, postworkshop 71.8%, and 6-month follow-up 72%. ConclusionsNurses worked collaboratively with cultural experts from a First Nations community to integrate Indigenous ways of knowing into concussion awareness and safety for First Nations youth playing hockey.	[Hunt, Cindy; Michalak, Alicja; Lefkimmiatis, Chrissy; Ouchterlony, Donna] St Michaels Hosp, Head Injury Clin, Trauma & Neurosurg Program, North Bay, ON, Canada; [Johnston, Elaine] Serpent River First Nation, Cutler, ON, Canada; [Macumber, Leila] Serpent River First Nation, Kenabutch Hlth Ctr, Cutler, ON, Canada; [Jocko, Tony] Union Ontario Indians, North Bay, ON, Canada		Hunt, C (corresponding author), St Michaels Hosp, Head Injury Clin, Trauma & Neurosurg Program, North Bay, ON, Canada.; Hunt, C (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON, Canada.	huntci@smh.ca					[Anonymous], 1998, 1 NATIONS PRINCIPLES; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bartlett C., 2012, J ENVIRON STUD SCI, V2, P331, DOI [10.1007/s13412-012-0086-8, DOI 10.1007/S13412-012-0086-8]; Blackmer J, 1999, BRAIN INJURY, V13, P627; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; DesMeules M., 2006, HLTH AR RUR CAN ASS; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Estey E, 2008, CAN J NURS RES, V40, P24; Evans M., 2014, CONCUSSION MANAGEMEN; Fantus D, 2009, CAN J PUBLIC HEALTH, V100, P258, DOI 10.1007/BF03403943; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Hunt C., 2016, IDENTIFICATION HIDDE, V1, DOI 10. 2217/cnc-2016-0009; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kelly-Scott K., 2015, ABORIGINAL PEOPLES F; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Lynn RC, 2015, LANCET NEUROL, V14, P14, DOI 10.1016/S1474-4422(14)70308-4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Mrazik M, 2015, J HEAD TRAUMA REHAB, V30, P219, DOI 10.1097/HTR.0000000000000018; Ontario Neurotrauma Foundation ONF, 2013, GUID CONC PERS SYMPT; Parachute Canada, 2012, THINK 1 SMART HOCK; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Runyan CW, 2003, EPIDEMIOL REV, V25, P60, DOI 10.1093/epirev/mxg005; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Smylie J, 2016, SOC SCI MED, V150, P128, DOI 10.1016/j.socscimed.2015.12.019; Smylie J, 2009, HEALTH PROMOT PRACT, V10, P436, DOI 10.1177/1524839907307993; Tator Charles H, 2014, Neurosurgery, V75 Suppl 4, pS106, DOI 10.1227/NEU.0000000000000484; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039	38	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0737-1209	1525-1446		PUBLIC HEALTH NURS	Public Health Nurs.	MAY-JUN	2018	35	3					202	210		10.1111/phn.12407			9	Public, Environmental & Occupational Health; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Nursing	GF5TS	WOS:000432031300006	29667222				2022-02-06	
J	Johnson-Greene, D				Johnson-Greene, Doug			Clinical Neuropsychology in Integrated Rehabilitation Care Teams	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment; Cognition; Neuropsychologist; Rehabilitation; Integrated care team	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; PREDICTORS; CAPACITY; VALIDITY; STROKE; SCALE	Neuropsychologists have been an integral part of rehabilitation-oriented integrated care teams for some time and they provide care that is complimentary to other specialties, such as rehabilitation psychologists. Neuropsychologists are more likely than other specialties to offer objective cognitive data that includes consideration of emotional and behavioral features when assessing patients who have known or suspected brain injury or illness. Objective cognitive data is then often used for treatment and discharge planning as well as anticipating safety issues and impairment of functional skills. Unlike a consultative model, neuropsychologists in rehabilitation must work as part of a team of rehabilitation professionals and understand the contributions each specialty offers patients. This paper will highlight a number of issues pertaining to the practice of neuropsychology in rehabilitation settings including: (i) essential skills and duties, (ii) reimbursement, (iii) practice specifics, (iv) types of recommendations, (v) communication issues, (vi) impact of neuropsychological services, (vii) role satisfaction; (viii) advice for early career neuropsychologists, and (ix) a sample report.	[Johnson-Greene, Doug] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, 1120 NW 14th St,954, Miami, FL 33136 USA		Johnson-Greene, D (corresponding author), Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, 1120 NW 14th St,954, Miami, FL 33136 USA.	djgreene@med.miami.edu			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0046-02-00]	This paper was supported in part by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Grant #90DP0046-02-00	BARRY P, 1989, REHABIL PSYCHOL, V34, P83; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Benton AL, 1994, MULTILINGUAL APHASIA; Bishop C. L., 2003, CLIN NEUROPSYCHOL, V21, P371; Block CK, 2017, CLIN NEUROPSYCHOL, V31, P487, DOI 10.1080/13854046.2016.1267803; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Caplan B, 2008, NEUROREHABILITATION, V23, P395; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Furlan J., 2009, J NEUROTRAUM, V28, P1413; Grant M., 1992, AUDIT ALCOHOL USE DI; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; JENSEN MP, 1993, PAIN, V55, P195, DOI 10.1016/0304-3959(93)90148-I; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Lansing AE, 1999, ARCH CLIN NEUROPSYCH, V14, P481, DOI 10.1016/S0887-6177(98)00022-5; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; Marson DC, 1996, NEUROLOGY, V46, P666, DOI 10.1212/WNL.46.3.666; Novack TA., 2010, HDB REHABILITATION P, P165; Prigatano G. P., 2003, NEUROPSYCHOLOGY COST; Rasquin SMC, 2013, NEUROPSYCHOL REHABIL, V23, P811, DOI 10.1080/09602011.2013.821950; Robertson GJ., 2006, WIDE RANGE ACHIEVEME; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Soble JR, 2017, PHYS MED REH CLIN N, V28, P339, DOI 10.1016/j.pmr.2016.12.009; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; Wolf TJ, 2013, NEUROPSYCHOL REHABIL, V23, P256, DOI 10.1080/09602011.2012.748672; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	31	5	5	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2018	33	3			SI		310	318		10.1093/arclin/acx126			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GE3UE	WOS:000431137600008	29718076	Bronze			2022-02-06	
J	Kruithof, N; Traa, MJ; Karabatzakis, M; Polinder, S; de Vries, J; de Jongh, MAC				Kruithof, Nena; Traa, Marjan Johanna; Karabatzakis, Maria; Polinder, Suzanne; de Vries, Jolanda; de Jongh, Mariska Adriana Cornelia			Perceived Changes in Quality of Life in Trauma Patients: A Focus Group Study	JOURNAL OF TRAUMA NURSING			English	Article						Focus groups; Nonfatal outcome; QoL; Qualitative methods; Trauma	BRAIN-INJURY; PERSPECTIVES; CARE; EXPERIENCES; CAREGIVERS; SURVIVORS	Quality of life (QoL) following a physical trauma is still insufficiently known from a patient perspective. The aim of this study was to qualitatively report perceived changes in QoL after trauma. Focus groups were conducted. Patients admitted to the hospital were eligible for inclusion if they had a lower extremity trauma, severe injuries, or severe traumatic brain injury (TBI). Patients 75 years or older were invited. To analyze the perceived changes in QoL, open coding was used. Patients (n = 20, M = 55 years) reported comparable consequences. In the first month posttrauma, physical limitations, independency, pain, and anxiety predominated. Later, patients experienced problems with acceptance. The patients' feelings of the need to have control over their own situation, their own expectations, and a social network were related to QoL. Compared with the other patient groups, TBI patients reported more psychosocial consequences, and elderly patients reported more difficulties in performing (social) activities. Quality of health care was considered an important aspect in the patients' perceived QoL, and adequate aftercare was missed according to the patients. The impact of a trauma influences QoL in different health domains. Further improving the quality of aftercare may positively influence trauma patients' perceived QoL. These results indicated that TBI patients and elderly patients deserve specific attention regarding QoL.	[Kruithof, Nena; Karabatzakis, Maria; de Vries, Jolanda; de Jongh, Mariska Adriana Cornelia] Elisabeth TweeSteden Hosp, Dept Trauma TopCare, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands; [Traa, Marjan Johanna; de Vries, Jolanda] Elisabeth TweeSteden Hosp, Dept Med Psychol, Tilburg, Netherlands; [Traa, Marjan Johanna; de Vries, Jolanda] Tilburg Univ, Ctr Res Psychol Somat Dis, Dept Med & Clin Psychol, Tilburg, Netherlands; [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [de Jongh, Mariska Adriana Cornelia] Brabant Trauma Registry, Network Emergency Care Brabant, Tilburg, Netherlands		Kruithof, N (corresponding author), Elisabeth TweeSteden Hosp, Dept Trauma TopCare, Hilvarenbeekseweg 60, NL-5022 GC Tilburg, Netherlands.	n.kruithof@etz.nl		Karabatzakis, Maria/0000-0002-2438-3275	Netherlands Organisation for Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development [80-84200-98-14225]	This work was supported by The Netherlands Organisation for Health Research and Development (ZonMw) under Grant Number 80-84200-98-14225.	Arndt V, 2017, ACTA ONCOL, V56, P190, DOI 10.1080/0284186X.2016.1266089; Azar JM, 2017, J INTERPROF CARE, V31, P273, DOI 10.1080/13561820.2016.1248815; Baarda D. B., 2009, BASISBOEK KWALITATIE; Berden HJJ, 2015, LANDELIJKE TRAUMAREG; Boeije H., 2010, ANAL QUALITATIVE RES; Bruner-Canhoto L, 2016, J HEALTHC QUAL, V38, P255, DOI 10.1097/01.JHQ.0000462677.94393.a7; Crawford K, 2017, RES SOC ADMIN PHARM, V13, P1204, DOI 10.1016/j.sapharm.2016.11.013; Den Oudsten BL, 2011, DISABIL REHABIL, V33, P2490, DOI 10.3109/09638288.2011.575527; Gabbe BJ, 2014, INJURY, V45, P1445, DOI 10.1016/j.injury.2014.01.019; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Glaser B., 1967, DISCOVERY GROUNDED T; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Gustafsson M, 2002, J CLIN NURS, V11, P594, DOI 10.1046/j.1365-2702.2002.00657.x; Kenardy J, 2017, J AFFECT DISORDERS, V214, P8, DOI 10.1016/j.jad.2017.02.031; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levins SM, 2004, PHYS THER, V84, P496, DOI 10.1093/ptj/84.6.496; Luszczynska A, 2009, EUR PSYCHOL, V14, P51, DOI 10.1027/1016-9040.14.1.51; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Martin L, 2017, BURNS, V43, P459, DOI 10.1016/j.burns.2016.09.021; Mayer DK, 2017, LANCET ONCOL, V18, pE11, DOI 10.1016/S1470-2045(16)30573-3; Numminen S, 2016, FOLIA PHONIATR LOGO, V68, P86, DOI 10.1159/000449218; Sleney J, 2014, INJURY, V45, P312, DOI 10.1016/j.injury.2012.12.025; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; Walter E, 2015, J TRAUMA NURS, V22, P153, DOI 10.1097/JTN.0000000000000126; Wielenga-Boiten JE, 2015, J HEAD TRAUMA REHAB, V30, P424, DOI 10.1097/HTR.0000000000000128; World Health Organization, 2016, VIOL INJ PREV; Ziden L, 2010, DISABIL REHABIL, V32, P103, DOI 10.3109/09638280903009263	29	5	5	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	MAY-JUN	2018	25	3					177	186		10.1097/JTN.0000000000000364			10	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	GH9XI	WOS:000434023100006	29742630	Green Published			2022-02-06	
J	Lee, HJ; Kim, YJ; Seo, DW; Sohn, CH; Ryoo, SM; Ahn, S; Lee, YS; Kim, WY; Lim, KS				Lee, Hyung-Joo; Kim, Youn-Jung; Seo, Dong-Woo; Sohn, Chang Hwan; Ryoo, Seung Mok; Ahn, Shin; Lee, Yoon-Seon; Kim, Won Young; Lim, Kyoung Soo			Incidence of intracranial injury in orbital wall fracture patients not classified as traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Orbital wall fracture; Traumatic brain injury; Computed tomography; Facial injury; Decision rule	MINOR HEAD-INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENTS; EXTERNAL VALIDATION; FACIAL FRACTURES; RULE; DIAGNOSIS; MANAGEMENT; ADULTS	Objective: The detection of intracranial injury in patients with facial injury rather than traumatic brain injury (TBI) remains a challenge for emergency physicians. This study aimed to evaluate the incidence and risk factors of intracranial injury in patients with orbital wall fracture (OWF), who were classified with a chief complaint of facial injury rather than TBI. Methods: This retrospective case-control study enrolled adult OWF patients (age <= 18 years) who presented at the hospital between January 2004 and March 2016. Patients with definite TBI were excluded because non-contrast head computed tomography (CT) is recommended for such patients. Results: A total of 1220 patients with OWF were finally enrolled. CT of the head was performed on 677 patients, and the incidence of concomitant intracranial injury was found to be 9% (62/677). Patients with definite TBI were excluded. Symptoms raising a suspicion of TBI, such as loss of consciousness, alcohol intoxication, or vomiting, were present in 347 of the patients, with 44 of these patients (13%) showing a concomitant intracranial injury. Of the 330 patients without such symptoms, 18 (6%) demonstrated a concomitant intracranial injury. In OWF patients, superior wall fracture (odds ratio [OR], 4.15; 95% confidence interval [CI], 2.06-8.34; P < 0.001), associated frontal bone fracture (OR, 4.38; 95% CI, 2.08-9.23; P < 0.001), and older age (decades) (OR, 1.03; 95% CI, 1.01-1.04; P = 0.002) were independent risk factors for concomitant intracranial injury. Conclusions: Emergency physicians should maintain a high degree of suspicion of TBI, even when their primary concern is facial trauma with OWF. Head CT is recommended for OWF patients with a superior OWF, frontal bone fracture, or increased age. (C) 2018 Elsevier Ltd. All rights reserved.	[Lee, Hyung-Joo; Kim, Youn-Jung; Seo, Dong-Woo; Sohn, Chang Hwan; Ryoo, Seung Mok; Ahn, Shin; Lee, Yoon-Seon; Kim, Won Young; Lim, Kyoung Soo] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Emergency Med, 88 Olympic Ro,43 Gil, Seoul 05505, South Korea		Seo, DW (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Dept Emergency Med, 88 Olympic Ro,43 Gil, Seoul 05505, South Korea.	doctor.egun@gmail.com; yjkim.em@gmail.com; sdw@amc.seoul.kr; schwan97@gmail.com; chrisryoo@gmail.com; ans1023@gmail.com; ysdoc@amc.seoul.kr; wonpia73@naver.com; kslim@amc.seoul.kr		Seo, Dong-Woo/0000-0001-8104-0247; Kim, Won Young/0000-0002-6904-5966; Kim, Youn-Jung/0000-0003-1385-5836; Ryoo, Seung Mok/0000-0002-2436-3311			Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Donahue DJ, 1997, PEDIATR NEUROSURG, V26, P261, DOI 10.1159/000121201; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; HAUG RH, 1994, J ORAL MAXIL SURG, V52, P729, DOI 10.1016/0278-2391(94)90488-X; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hogg NJV, 2000, J TRAUMA, V49, P425, DOI 10.1097/00005373-200009000-00007; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kanzaria HK, 2015, ACAD EMERG MED, V22, P390, DOI 10.1111/acem.12625; Kim Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19548; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Puljula J, 2012, INJURY, V43, P2100, DOI 10.1016/j.injury.2012.04.010; Rosengren David, 2004, Emerg Med Australas, V16, P195, DOI 10.1111/j.1742-6723.2004.00563.x; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shin SY, 2015, J KOREAN MED SCI, V30, P7, DOI 10.3346/jkms.2015.30.1.7; Shin SY, 2014, HEALTHC INFORM RES, V20, P109, DOI 10.4258/hir.2014.20.2.109; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511	29	5	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2018	49	5					963	968		10.1016/j.injury.2018.02.025			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	GG0LO	WOS:000432370300014	29503015				2022-02-06	
J	McCully, KS				McCully, Kilmer S.			Communication: Loss of the Thioretinaco Ozonide Oxygen Adenosine Triphosphate Complex from Mitochondria Produces Mitochondrial Dysfunction and Carcinogenesis	ANNALS OF CLINICAL AND LABORATORY SCIENCE			English	Article						aging; catecholamines; dementia; dopamine quinone; electrophilic carcinogens; glyphosate; homocysteine; ionizing radiation; melatonin; mitochondrial dysfunction; mitochondrial permeability transition pore; oncogenic viruses; thioretinaco ozonide; traumatic brain injury	2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; HOMOCYSTEINE THIOLACTONE METABOLISM; PERMEABILITY TRANSITION PORE; CYSTATHIONINE BETA-SYNTHASE; RAT-BRAIN MITOCHONDRIA; CHEMICAL PATHOLOGY; OXIDATIVE-PHOSPHORYLATION; MELATONIN; ATHEROSCLEROSIS; PATHOGENESIS	The active site of oxidative phosphorylation and adenosine triphosphate (ATP) biosynthesis is proposed to consist of thioretinaco, a complex of two molecules of thioretinamide with cobalamin, oxidized to the disulfonium derivative, thioretinaco ozonide, and complexed with oxygen, nicotinamide adenine dinucleotide, inorganic phosphate and ATP. Reduction of the active site complex by electrons from mitochondrial electron transport complexes releases ATP from binding to the active site, producing nicotinamide riboside and hydroperoxide and generating a membrane potential from proton transport to the active site. Opening of the mitochondrial permeability transition pore from decreased mitochondrial melatonin leads to loss of the active site complex from mitochondrial membranes, as observed in aging and dementia. Loss of the active site complex from mitochondria also results from opening of the permeability transition pore and from decomposition of the disulfonium active site by electrophilic carcinogens, oncogenic viruses and microbes which cause depletion of adenosyl methionine because of increased biosynthesis of polyamines, and by free radical oxygen species generated by ionizing radiation, and by catecholamines. Thus the loss of thioretinaco ozonide from mitochondria produces the impaired oxidative phosphorylation, oxidative stress, calcium influx, apoptosis, aerobic glycolysis, and mitochondrial dysfunction that are observed in chemical carcinogenesis, microbial carcinogenesis, traumatic brain injury, aging and dementia.	[McCully, Kilmer S.] Boston Vet Affairs Med Ctr, Pathol & Lab Med Serv, 1400 Vet Foreign Wars Pkwy, West Roxbury, MA 02132 USA; [McCully, Kilmer S.] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA		McCully, KS (corresponding author), Boston Vet Affairs Med Ctr, Pathol & Lab Med Serv, 1400 Vet Foreign Wars Pkwy, West Roxbury, MA 02132 USA.; McCully, KS (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA.	kilmer.mccully@va.gov					Abu-Lubad M, 2014, J IMMUNOL, V193, P2941, DOI 10.4049/jimmunol.1400377; Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; Andreotti G, 2018, JNCI-J NATL CANCER I, V110, P509, DOI 10.1093/jnci/djx233; Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; Baburina Y, 2017, BBA-BIOMEMBRANES, V1859, P94, DOI 10.1016/j.bbamem.2016.11.003; Baburina Y, 2015, NEUROCHEM INT, V90, P46, DOI 10.1016/j.neuint.2015.07.012; Baydas G, 2005, NEUROSCIENCE, V135, P879, DOI 10.1016/j.neuroscience.2005.05.048; Berman SB, 1999, J NEUROCHEM, V73, P1127, DOI 10.1046/j.1471-4159.1999.0731127.x; Carballal S, 2008, BIOCHEMISTRY-US, V47, P3194, DOI 10.1021/bi700912k; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; GAULL G, 1972, PEDIATR RES, V6, P538, DOI 10.1203/00006450-197206000-00002; Gross L., 1961, ONCOGENIC VIRUSES; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hatefi M, 2017, WORLD NEUROSURG, V97, P70, DOI 10.1016/j.wneu.2016.09.080; HAUSEN HZ, 1991, SCIENCE, V254, P1167, DOI 10.1126/science.1659743; HOPFER SM, 1984, ANN CLIN LAB SCI, V14, P355; Izem-Meziane M, 2012, AM J PHYSIOL-HEART C, V302, pH665, DOI 10.1152/ajpheart.00467.2011; Kazimir Michal, 2002, Research Communications in Molecular Pathology and Pharmacology, V111, P179; Kim J, 2009, ONCOL REP, V21, P1449, DOI 10.3892/or_00000373; Krestinina O, 2015, NEUROCHEM INT, V80, P41, DOI 10.1016/j.neuint.2014.09.008; LAPIN V, 1981, J NEURAL TRANSM, V52, P123, DOI 10.1007/BF01253104; Leach JK, 2001, CANCER RES, V61, P3894; McCully KS, 2018, ANN CLIN LAB SCI, V48, P126; McCully KS, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00324; McCully KS, 2016, ANN CLIN LAB SCI, V46, P701; McCully KS, 2016, J ALZHEIMERS DIS, V54, P1283, DOI 10.3233/JAD-160549; McCully KS, 2016, COMPR PHYSIOL, V6, P471, DOI 10.1002/cphy.c150021; McCully KS, 2015, ANN CLIN LAB SCI, V45, P222; McCully KS, 2011, ANN CLIN LAB SCI, V41, P301; MCCULLY KS, 1989, P SOC EXP BIOL MED, V191, P346; MCCULLY KS, 1987, CARCINOGENESIS, V8, P1559, DOI 10.1093/carcin/8.10.1559; MCCULLY KS, 1994, ANN CLIN LAB SCI, V24, P27; MCCULLY KS, 1976, CANCER RES, V36, P3198; MCCULLY KS, 1994, ANN CLIN LAB SCI, V24, P134; MILLER EC, 1981, CANCER-AM CANCER SOC, V47, P2327, DOI 10.1002/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO;2-Z; Paul R, 2015, LIFE SCI, V139, P97, DOI 10.1016/j.lfs.2015.07.031; PULLMAN A, 1962, NATURE, V196, P228, DOI 10.1038/196228a0; Rahmani A, 2016, WORLD NEUROSURG, V87, P507, DOI 10.1016/j.wneu.2015.09.016; Samsel A, 2013, ENTROPY-SWITZ, V15, P1416, DOI 10.3390/e15041416; SHAH PN, 1984, CANCER RES, V44, P3403; SMITH TJ, 1991, BIOCHIM BIOPHYS ACTA, V1075, P119, DOI 10.1016/0304-4165(91)90240-H; STANBERRY LR, 1983, ENDOCRINOLOGY, V113, P469, DOI 10.1210/endo-113-2-469; Vacek JC, 2018, J CELL PHYSIOL, V233, P3080, DOI 10.1002/jcp.26145; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	45	5	5	0	2	ASSOC CLINICAL SCIENTISTS	MIDDLEBURY	PO BOX 1287, MIDDLEBURY, VT 05753 USA	0091-7370	1550-8080		ANN CLIN LAB SCI	Ann. Clin. Lab. Sci.	MAY-JUN	2018	48	3					386	393					8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	GM2ML	WOS:000437920300021	29970446				2022-02-06	
J	Purkayastha, S; Maffuid, K; Zhu, XJ; Zhang, R; Raven, PB				Purkayastha, Sushmita; Maffuid, Kaitlyn; Zhu, Xiaojie; Zhang, Rong; Raven, Peter B.			The influence of the carotid baroreflex on dynamic regulation of cerebral blood flow and cerebral tissue oxygenation in humans at rest and during exercise	EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY			English	Article						Cerebral blood vessels; Cerebral tissue oxygenation; Dynamic exercise; Power spectral density; Sympathetic activity; Transfer function gain	NEAR-INFRARED SPECTROSCOPY; SYMPATHETIC-NERVOUS-SYSTEM; AUTONOMIC NEURAL-CONTROL; TRAUMATIC BRAIN-INJURY; ACUTE HYPOTENSION; PRESSURE; AUTOREGULATION; CIRCULATION; METABOLISM; PRAZOSIN	This preliminary study tested the hypothesis that the carotid baroreflex (CBR) mediated sympathoexcitation regulates cerebral blood flow (CBF) at rest and during dynamic exercise. In seven healthy subjects (26 +/- 1 years), oscillatory neck pressure (NP) stimuli of + 40 mmHg were applied to the carotid baroreceptors at a pre-determined frequency of 0.1 Hz at rest, low (10 +/- 1W), and heavy (30 +/- 3W) exercise workloads (WLs) without (control) and with alpha - 1 adrenoreceptor blockade (prazosin). Spectral power analysis of the mean arterial blood pressure (MAP), mean middle cerebral artery blood velocity (MCAV), and cerebral tissue oxygenation index (ScO2) in the low-frequency range (0.07-0.20 Hz) was estimated to examine NP stimuli responses. From rest to heavy exercise, WLs resulted in a greater than three-fold increase in MCAV power (42 +/- 23.8-145.2 +/- 78, p < 0.01) and an almost three-fold increase in ScO2 power (0.51 +/- 0.3-1.53 +/- 0.8, p = 0.01), even though there were no changes in MAP power (from 24.5 +/- 21 to 22.9 +/- 11.9) with NP stimuli. With prazosin, the overall MAP (p = 0.0017), MCAV (p = 0.019), and ScO2 (p = 0.049) power was blunted regardless of the exercise conditions. Prazosin blockade resulted in increases in the Tf gain index between MAP and MCAV compared to the control (p = 0.03). CBR-mediated changes in sympathetic activity contribute to dynamic regulation of the cerebral vasculature and CBF at rest and during dynamic exercise in humans.	[Purkayastha, Sushmita; Maffuid, Kaitlyn] Southern Methodist Univ, Simmons Sch Educ & Human Dev, Dept Appl Physiol & Wellness, 3101 Univ Blvd,Rm 118 A, Dallas, TX 75205 USA; [Zhu, Xiaojie] Southern Methodist Univ, Dept Stat, Dallas, TX USA; [Zhang, Rong] Texas Hlth Presbyterian Hosp, inst Exercise & Environm Med, Dallas, TX USA; [Zhang, Rong] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Raven, Peter B.] Univ North Texas, Hlth Sci Ctr, Inst Cardiovasc & Metab Dis, Ft Worth, TX USA		Purkayastha, S (corresponding author), Southern Methodist Univ, Simmons Sch Educ & Human Dev, Dept Appl Physiol & Wellness, 3101 Univ Blvd,Rm 118 A, Dallas, TX 75205 USA.	spurkayastha@smu.edu	Purkaysastha, Sushmita/Y-8908-2019		Cardiovascular Research Institute; Department of Integrative Physiology at the University of North Texas Health Science Center at Fort Worth, TX	This study was supported in part by funds provided by the Cardiovascular Research Institute and the Department of Integrative Physiology at the University of North Texas Health Science Center at Fort Worth, TX. The authors also wish to thank the subjects for volunteering to undertake the study.	Astrand P, 1986, TXB PHYSL; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Brassard P, 2010, J APPL PHYSIOL, V108, P1472, DOI 10.1152/japplphysiol.01206.2009; Davis SL, 2006, J APPL PHYSIOL, V100, P221, DOI 10.1152/japplphysiol.00867.2005; EDWARDS AD, 1993, J APPL PHYSIOL, V75, P1884, DOI 10.1152/jappl.1993.75.4.1884; FITCH W, 1975, CIRC RES, V37, P550, DOI 10.1161/01.RES.37.5.550; Fuke S, 2009, RESPIROLOGY, V14, P436, DOI 10.1111/j.1440-1843.2008.01442.x; Gierthmuhlen J, 2010, J NEUROL, V257, P1798, DOI 10.1007/s00415-010-5613-5; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; Heistad DD., 1983, HDB PHYSL CARDIOVASC, P137; Hilz MJ, 2013, STROKE, V44, P1062, DOI 10.1161/STROKEAHA.111.680256; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; INOUE M, 1991, J CEREBR BLOOD F MET, V11, P242, DOI 10.1038/jcbfm.1991.56; JAILLON P, 1980, CLIN PHARMACOKINET, V5, P365, DOI 10.2165/00003088-198005040-00004; Kohl HW, 1996, MED SCI SPORT EXER, V28, P601, DOI 10.1097/00005768-199605000-00011; Lee RH, 2017, AM J PHYSIOL-HEART C, V312, pH182, DOI 10.1152/ajpheart.00482.2016; LEVINE BD, 1994, CIRCULATION, V90, P298, DOI 10.1161/01.CIR.90.1.298; MACDOUGALL JD, 1985, J APPL PHYSIOL, V58, P785, DOI 10.1152/jappl.1985.58.3.785; MITCHELL JH, 1990, MED SCI SPORT EXER, V22, P141; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Ogoh S, 2003, J PHYSIOL-LONDON, V550, P317, DOI 10.1113/jphysiol.2003.041517; Ogoh S, 2002, J PHYSIOL-LONDON, V540, P707, DOI 10.1113/jphysiol.2001.013259; Ogoh S, 2008, STROKE, V39, P1979, DOI 10.1161/STROKEAHA.107.510008; Ogoh S, 2010, J PHYSIOL-LONDON, V588, P365, DOI 10.1113/jphysiol.2009.180844; PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; PAWELCZYK JA, 1989, AM J PHYSIOL, V257, pH1389, DOI 10.1152/ajpheart.1989.257.5.H1389; Querry RG, 2001, AM J PHYSIOL-HEART C, V280, pH2390, DOI 10.1152/ajpheart.2001.280.5.H2390; RAPELA CE, 1967, CIRC RES, V21, P559, DOI 10.1161/01.RES.21.4.559; ROWELL LB, 1990, J APPL PHYSIOL, V69, P407, DOI 10.1152/jappl.1990.69.2.407; Scherjon SA, 2014, EXP PHYSIOL, V98, P451; Secher NH, 2008, J APPL PHYSIOL, V104, P306, DOI 10.1152/japplphysiol.00853.2007; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Sykora M, 2009, STROKE, V40, pE678, DOI 10.1161/STROKEAHA.109.565838; THOMPSON PD, 1989, AM J MED, V86, P104, DOI 10.1016/0002-9343(89)90143-5; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; Verbree J, 2017, J CEREBR BLOOD F MET, V37, P2921, DOI 10.1177/0271678X16679419; WHIPP BJ, 1989, RESP PHYSIOL, V76, P357, DOI 10.1016/0034-5687(89)90076-5; Wray DW, 2004, J PHYSIOL-LONDON, V559, P675, DOI 10.1113/jphysiol.2004.066183; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	43	5	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1439-6319	1439-6327		EUR J APPL PHYSIOL	Eur. J. Appl. Physiol.	MAY	2018	118	5					959	969		10.1007/s00421-018-3831-1			11	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	GG4YJ	WOS:000432701900009	29497836				2022-02-06	
J	Ramos, SDS; Oddy, M; Liddement, J; Fortescue, D				Ramos, Sara D. S.; Oddy, Michael; Liddement, James; Fortescue, Deborah			Brain Injury and Offending: The Development and Field Testing of a Linkworker Intervention	INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY			English	Article						traumatic brain injury; acquired brain injury; prisoners; rehabilitation	VIOLENT CRIMINAL BEHAVIOR; FEMALE PRISON-INMATES; HEAD-INJURY; COGNITIVE REHABILITATION; SALIVARY CORTISOL; SEXUAL-ABUSE; RISK-TAKING; POPULATION; PREVALENCE; PERSONALITY	Evidence suggests that traumatic brain injury (TBI) is more prevalent amongst offender populations than in the general population, and that it can lead to aggressive behaviour while in custody and impair engagement with offender rehabilitation programmes. The aim of this study was to develop, implement, and evaluate a brain injury Linkworker approach designed to support prisoners who report a significant TBI or multiple mild TBIs. Three clinical case examples are reported to illustrate the conceptual foundations of the approach and to demonstrate the feasibility of the service. Early results showed that engagement with a Linkworker led to effective identification of key areas of intervention and resulted in better integration for prisoners while in custody and in enhancement of the outcomes of offender rehabilitation. These initial findings provide justification for wider implementation and systematic evaluation of the efficacy of this model of service.	[Ramos, Sara D. S.] Disabil Trust, 32 Market Pl, Burgess Hill RH15 9NP, W Sussex, England; [Oddy, Michael; Liddement, James; Fortescue, Deborah] Disabil Trust Fdn, Burgess Hill, W Sussex, England		Ramos, SDS (corresponding author), Disabil Trust, 32 Market Pl, Burgess Hill RH15 9NP, W Sussex, England.	sara.dasilvaramos@thedtgroup.org					Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Brewer-Smyth K, 2008, NURS RES, V57, P166, DOI 10.1097/01.NNR.0000319501.97864.d5; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Evans JJ, 2009, REHABILITATION EXECU, P59; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel M, 2008, SOC PSYCH PSYCH EPID, V43, P319, DOI 10.1007/s00127-007-0295-8; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Howard P., 2009, RES SUMMARY, P1; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; McCrea M., 2008, MILD TRAUMATIC BRAIN; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McMillan TM., 2017, NEUROBEHAVIOURAL DIS; Mouridsen SE, 2008, INT J OFFENDER THER, V52, P196, DOI 10.1177/0306624X07302056; O'Sullivan M, 2015, AGGRESS VIOLENT BEH, V25, P54, DOI 10.1016/j.avb.2015.07.006; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Turner Cathy, 2003, Inj Control Saf Promot, V10, P123, DOI 10.1076/icsp.10.3.123.14560; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Williams H., 2012, REPAIRING SHATTERED; Williams W. H., 2016, BRAIN INJURY CUSTODY; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; Young SJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-32	39	5	5	1	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0306-624X	1552-6933		INT J OFFENDER THER	Int. J. Offender Ther. Comp. Criminol.	MAY	2018	62	7					1854	1868		10.1177/0306624X17708351			15	Criminology & Penology; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	GD2LO	WOS:000430331300006	28511571				2022-02-06	
J	Rhine, T; Cassedy, A; Yeates, KO; Taylor, HG; Kirkwood, MW; Wade, SL				Rhine, Tara; Cassedy, Amy; Yeates, Keith Owen; Taylor, Hudson Gerry; Kirkwood, Michael W.; Wade, Shari L.			Investigating the Connection Between Traumatic Brain Injury and Posttraumatic Stress Symptoms in Adolescents	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; patient outcome assessment; posttraumatic stress disorder; traumatic brain injuries	CHILDRENS DEPRESSION INVENTORY; QUALITY-OF-LIFE; BEHAVIOR PROBLEMS; DISORDER; MILD; HEALTH; IMPACT; PREDICTORS; SEVERITY; RISK	Objective: To identify potentially modifiable individual and social-environmental correlates of posttraumatic stress symptoms (PTSS) among adolescents hospitalized for traumatic brain injury (TBI). Setting: Four pediatric hospitals and 1 general hospital in the United States. Participants: Children ages 11 to 18 years, hospitalized for moderate-severe TBI within the past 18 months. Design: Retrospective cross-sectional analysis. Main Measures: The University of California at Los Angeles (UCLA) Post-traumatic Stress Disorder (PTSD) Reaction Index and the Youth Self-Report (YSR) PTSD subscale. Results: Of 147 adolescents enrolled, 65 (44%) had severe TBI, with an average time since injury of 5.8 4 months. Of the 104 who completed the UCLA-PTSD Reaction Index, 22 (21%) reported PTSS and 9 (8%) met clinical criteria for PTSD. Of the 143 who completed the YSR-PTSD subscale, 23 (16%) reported PTSS and 6 (4%) met clinical criteria for PTSD. In multivariable analyses, having a negative approach to problem solving and depressive symptoms were both associated (P < .001) with higher levels of PTSS based on the UCLA-PTSD Reaction Index ( = 0.41 and = 0.33, respectively) and the YSR-PTSD subscale ( = 0.33 and = 0.40, respectively). Conclusion: Targeting negative aspects of problem solving in youths after brain injury may mitigate PTSS.	[Rhine, Tara] Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Dept Pediat, Cincinnati, OH 45229 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Calgary, AB, Canada; [Taylor, Hudson Gerry] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA		Rhine, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Dept Pediat, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER	This publication was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant number H133B090010).	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Allgaier AK, 2012, J PSYCHOSOM RES, V73, P369, DOI 10.1016/j.jpsychores.2012.08.016; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bang YR, 2015, PSYCHIAT INVEST, V12, P23, DOI 10.4306/pi.2015.12.1.23; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bonfield CM, 2015, ATTENTION DEFICIT HY, P283; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Derogatis LR, 1994, PSYCHOL TESTS SCREEN; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Kenardy J, 2012, J CLIN CHILD ADOLESC, V41, P5, DOI 10.1080/15374416.2012.632348; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Moos RH, 1994, LIFE STRESSORS SOCIA; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Roussos A, 2005, AM J PSYCHIAT, V162, P530, DOI 10.1176/appi.ajp.162.3.530; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Strand VC, 2005, TRAUMA VIOLENCE ABUS, V6, P55, DOI 10.1177/1524838004272559; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; WOLFE VV, 1989, BEHAV THER, V20, P215, DOI 10.1016/S0005-7894(89)80070-X; You DS, 2015, J CLIN CHILD ADOLESC, P1; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	34	5	5	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					210	218		10.1097/HTR.0000000000000319			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500126	28520669				2022-02-06	
J	Presneill, J; Gantner, D; Nichol, A; McArthur, C; Forbes, A; Kasza, J; Trapani, T; Murray, L; Bernard, S; Cameron, P; Capellier, G; Huet, O; Newby, L; Rashford, S; Rosenfeld, JV; Smith, T; Stephenson, M; Varma, D; Vallance, S; Walker, T; Webb, S; Cooper, DJ				Presneill, Jeffrey; Gantner, Dashiell; Nichol, Alistair; McArthur, Colin; Forbes, Andrew; Kasza, Jessica; Trapani, Tony; Murray, Lynnette; Bernard, Stephen; Cameron, Peter; Capellier, Gilles; Huet, Olivier; Newby, Lynette; Rashford, Stephen; Rosenfeld, Jeffrey V.; Smith, Tony; Stephenson, Michael; Varma, Dinesh; Vallance, Shirley; Walker, Tony; Webb, Steve; Cooper, D. James		POLAR Investigators; ANZICS Clinical Trials Grp	Statistical analysis plan for the POLAR-RCT: The Prophylactic hypOthermia trial to Lessen trAumatic bRain injury-Randomised Controlled Trial	TRIALS			English	Article						Traumatic brain injury; Cooling; Hypothermia; Outcome; Critical care; Randomised controlled trials	HEAD-INJURY; THERAPEUTIC HYPOTHERMIA; FLUID RESUSCITATION; PROTOCOL; SALINE; MODEL; EXPLANATION; OUTCOMES; ALBUMIN; SCALES	Background: The Prophylactic hypOthermia to Lessen trAumatic bRain injury-Randomised Controlled Trial (POLAR-RCT) will evaluate whether early and sustained prophylactic hypothermia delivered to patients with severe traumatic brain injury improves patient-centred outcomes. Methods: The POLAR-RCT is a multicentre, randomised, parallel group, phase III trial of early, prophylactic cooling in critically ill patients with severe traumatic brain injury, conducted in Australia, New Zealand, France, Switzerland, Saudi Arabia and Qatar. A total of 511 patients aged 18-60 years have been enrolled with severe acute traumatic brain injury. The trial intervention of early and sustained prophylactic hypothermia to 33 degrees C for 72 h will be compared to standard normothermia maintained at a core temperature of 37 degrees C. The primary outcome is the proportion of favourable neurological outcomes, comprising good recovery or moderate disability, observed at six months following randomisation utilising a midpoint dichotomisation of the Extended Glasgow Outcome Scale (GOSE). Secondary outcomes, also assessed at six months following randomisation, include the probability of an equal or greater GOSE level, mortality, the proportions of patients with haemorrhage or infection, as well as assessment of quality of life and health economic outcomes. The planned sample size will allow 80% power to detect a 30% relative risk increase from 50% to 65% (equivalent to a 15% absolute risk increase) in favourable neurological outcome at a two-sided alpha of 0.05. Discussion: Consistent with international guidelines, a detailed and prospective analysis plan has been developed for the POLAR-RCT. This plan specifies the statistical models for evaluation of primary and secondary outcomes, as well as defining covariates for adjusted analyses and methods for exploratory analyses. Application of this statistical analysis plan to the forthcoming POLAR-RCT trial will facilitate unbiased analyses of these important clinical data.	[Presneill, Jeffrey; Gantner, Dashiell; Nichol, Alistair; McArthur, Colin; Forbes, Andrew; Kasza, Jessica; Trapani, Tony; Murray, Lynnette; Huet, Olivier; Stephenson, Michael; Vallance, Shirley; Webb, Steve; Cooper, D. James] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia; [Gantner, Dashiell; Nichol, Alistair; Trapani, Tony; Bernard, Stephen; Vallance, Shirley; Cooper, D. James] The Alfred, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] St Vincents Univ Hosp, Dept Anaesthesia & Intens Care Med, Dublin, Ireland; [Nichol, Alistair] Univ Coll, Sch Med & Med Sci, Dublin, Ireland; [Cameron, Peter] Monash Univ, The Alfred, Ctr Excellence Traumat Brain Injury Res, Melbourne, Vic, Australia; [Presneill, Jeffrey] Royal Melbourne Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Cameron, Peter] Hamad Med Corp, Emergency Med, Doha, Qatar; [Smith, Tony] St John New Zealand, Auckland, New Zealand; [Varma, Dinesh] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.; Varma, Dinesh] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Webb, Steve] Royal Perth Hosp, Intens Care Unit, Perth, WA, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Bernard, Stephen; Stephenson, Michael; Walker, Tony] Ambulance Victoria, Melbourne, Vic, Australia; [McArthur, Colin; Newby, Lynette; Smith, Tony] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Capellier, Gilles] CHRU Jean Minjoz, Reanimat Med, Besancon, France; [Capellier, Gilles] Univ Franche Comte, 1 Rue Claude Goudimel, F-25030 Besancon, France; [Rashford, Stephen] Queensland Ambulance Serv, Brisbane, Qld, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, Dept Surg, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Cameron, Peter] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Cameron, Peter] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Presneill, Jeffrey] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Huet, Olivier] CHRU Brest, Hop La Cavale Blanche, Dept Anaesthesia & Intens Care Med, Brest, France; [Huet, Olivier] Univ Bretagne Occidental, UFR Med & Sci Sante, Brest, France		Cooper, DJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.; Cooper, DJ (corresponding author), The Alfred, Dept Intens Care, Melbourne, Vic, Australia.	Jamie.Cooper@monash.edu	/AAB-3060-2019; Cooper, D. James/G-7961-2013	Cooper, D. James/0000-0002-5872-9051; Nichol, Alistair/0000-0002-4689-1238; Cameron, Peter/0000-0002-1443-557X; Forbes, Andrew/0000-0003-4269-914X	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [545901]; Victorian Transport Accident Commission [D162]	Funding for this investigator-initiated research is sourced in Australia from the National Health and Medical Research Council (Project Grant ID 545901) and the Victorian Transport Accident Commission (formerly Victorian Neurotrauma Initiative; Project Grant ID D162). Trial design, data collection and analyses will be undertaken independent of the funding bodies. The POLAR-RCT trial is co-ordinated by the Australian and New Zealand Intensive Care-Research Centre, Monash University, Melbourne and endorsed by the Australian and New Zealand Intensive Care Society Clinical Trials Group. POLAR-RCT is managed in France by the Centre Hospitalier Regional Universitaire (CHRU) Besancon. The members of the Management Committee are listed in Additional file 6. The POLAR-RCT trial sites, principal investigator(s) and research coordinator(s) are listed in Additional file 7.	Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2012, CRIT CARE MED, V40, P747, DOI 10.1097/CCM.0b013e3182377038; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Cooper DJ, 2016, NEW ENGL J MED, V374, P1384, DOI 10.1056/NEJMc1600339; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; Cytel Inc, 2016, E 6 4; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Finfer S, 2004, NEW ENGL J MED, V350, P2247; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hernan MA, 2017, NEW ENGL J MED, V377, P1391, DOI 10.1056/NEJMsm1605385; Imbens GW, 2015, CAUSAL INFERENCE FOR STATISTICS, SOCIAL, AND BIOMEDICAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1017/CBO9781139025751; Jennison C., 2000, GROUP SEQUENTIAL MET; Kovalchik SA, 2013, STAT MED, V32, P808, DOI 10.1002/sim.5553; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Lin JY, 2008, J AM STAT ASSOC, V103, P462, DOI 10.1198/016214507000000374; Marschner IC, 2012, BIOSTATISTICS, V13, P179, DOI 10.1093/biostatistics/kxr030; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; Nichol AD, 2011, LANCET NEUROL, V10, P405, DOI 10.1016/S1474-4422(11)70085-0; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; SAS Institute Inc, 2017, SAS SOFTW; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Spritzler John, 2008, Int J Biostat, V4, P1, DOI 10.2202/1557-4679.1068; Stata Corporation, 2010, STAT REL 11 1; Stata Corporation, 2016, STAT STAT SOFTW REL; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Vittinghoff E, 2012, STAT BIOL HLTH, p[XX, 512]; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	41	5	8	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	APR 27	2018	19								259	10.1186/s13063-018-2610-y			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GE6SV	WOS:000431360300006	29703266	Green Published, gold			2022-02-06	
J	Prang, KH; Newnam, S; Berecki-Gisolf, J				Prang, Khic-Houy; Newnam, Sharon; Berecki-Gisolf, Janneke			"That's what you do for people you love": A qualitative study of social support and recovery from a musculoskeletal injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; FAMILY-MEMBERS; SELF-MANAGEMENT; OUTCOMES; HEALTH; EXPERIENCES; DISABILITY; DISORDERS; COMMUNITY	Background Social support has been identified as a significant factor in facilitating better health outcomes following injury. However, research has primarily focused on the role of social support from the perspective of the person experiencing an injury. Limited research has examined the experiences of the family members and friends of a person with injury. This study aims to explore the perceptions and experiences of social support and recovery following a transport-related musculoskeletal injury (MSI) in a population of injured persons and their family members and friends. Methods This study was conducted using a phenomenological qualitative research design. In-depth semi-structured interviews were conducted with ten persons with MSI, recruited via the Transport Accident Commission (TAC) in Victoria, Australia. Seven family members and friends were also interviewed. The data was analysed using constant comparative method and thematic analysis. Results Several themes were identified including: (1) key sources and types of support received, (2) relationship development and (3) challenges of providing and receiving support. Participants with MSI reported stories about how the social network provided emotional and tangible support. Family members and friends confirmed the supportive acts provided to the participants with MSI. Positive iterative changes in relationships were reported by the participants with MSI. Participants with MSI, their family members and friends described several difficulties including loss of independence, feeling like a burden, and the impact of caring on health and well-being. Conclusions The role of social support is complex given the multitude of people involved in the recovery process. The findings of this study suggest that persons with MSI may benefit from support groups and maintenance of existing support networks. Furthermore, family members and friends engaged in the recovery process may benefit from support in this role.	[Prang, Khic-Houy; Newnam, Sharon; Berecki-Gisolf, Janneke] Monash Univ, Accid Res Ctr, Melbourne, Vic, Australia; [Prang, Khic-Houy] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia		Prang, KH (corresponding author), Monash Univ, Accid Res Ctr, Melbourne, Vic, Australia.; Prang, KH (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia.	khic-houy.prang@unimelb.edu.au			Transport Accident Commission (TAC); Worksafe Victoria (WSV) via the Institute for Safety, Compensation and Recovery Research (ISCRR)	This research was supported by a scholarship from the Transport Accident Commission (TAC) and Worksafe Victoria (WSV) via the Institute for Safety, Compensation and Recovery Research (ISCRR). Views expressed are those of the authors and not the funding agencies.	Artiga Samantha, 2018, SOCIAL EPIDEMIOLOGY; Asfaw A, 2015, AM J IND MED, V58, P1205, DOI 10.1002/ajim.22500; Baltov P, 2008, DISABIL REHABIL, V30, P1947, DOI 10.1080/09638280701791245; Barak A, 2008, COMPUT HUM BEHAV, V24, P1867, DOI 10.1016/j.chb.2008.02.004; Berecki-Gisolf J, 2013, ACCIDENT ANAL PREV, V51, P129, DOI 10.1016/j.aap.2012.11.010; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Buitenhuis J, 2003, SPINE, V28, P896, DOI 10.1097/00007632-200305010-00011; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; Coronas Ramon, 2008, Depress Anxiety, V25, pE16, DOI 10.1002/da.20324; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Crotty MM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0897-x; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; Dickson A, 2010, PSYCHOL HEALTH, V25, P1101, DOI 10.1080/08870440903038949; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Heaney CA, 2008, HLTH BEHAV HLTH ED T; Hogan BE, 2002, CLIN PSYCHOL REV, V22, P381, DOI 10.1016/S0272-7358(01)00102-7; Holeva V, 2001, BEHAV THER, V32, P65, DOI 10.1016/S0005-7894(01)80044-7; Hours M, 2010, ACCIDENT ANAL PREV, V42, P412, DOI 10.1016/j.aap.2009.09.002; Isaksson G, 2008, SCAND J OCCUP THER, V15, P236, DOI 10.1080/11038120802194265; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kreuter M, 2000, SPINAL CORD, V38, P2, DOI 10.1038/sj.sc.3100933; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Muller R, 2013, INT J REHABIL RES, V36, P236, DOI 10.1097/MRR.0b013e32835dd5ff; Murgatroyd D, 2015, BMC PUBLIC HEALTH, V15, P1; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Newnam S, 2014, PUBLIC HEALTH, V128, P587, DOI 10.1016/j.puhe.2014.04.004; Nijs J, 2011, CLIN RHEUMATOL, V30, P927, DOI 10.1007/s10067-011-1712-7; Ogilvie R, 2015, INJURY, V46, P1834, DOI 10.1016/j.injury.2015.03.030; Ogilvie R, 2015, INJURY, V46, P1841, DOI 10.1016/j.injury.2015.05.036; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Prang K-H, 2015, HEALTH QUAL LIFE OUT, V13, P1; Rosenbloom BN, 2013, J PAIN RES, V6, P39, DOI 10.2147/JPR.S38878; Sleney J, 2014, INJURY, V45, P312, DOI 10.1016/j.injury.2012.12.025; Spiegel DA, 2008, J BONE JOINT SURG AM, V90A, P915, DOI 10.2106/JBJS.G.00637; Urquhart DM, 2006, ANZ J SURG, V76, P600, DOI 10.1111/j.1445-2197.2006.03785.x; World Health Organization, 2013, GLOB STAT REP ROAD S	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196337	10.1371/journal.pone.0196337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	WOS:000430802400084	29694438	gold, Green Published, Green Submitted			2022-02-06	
J	Woods, DL; Wyma, JM; Herron, TJ; Yund, EW; Reed, B				Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William; Reed, Bruce			The Dyad-Adaptive Paced Auditory Serial Addition Test (DA-PASAT): Normative data and the effects of repeated testing, simulated malingering, and traumatic brain injury	PLOS ONE			English	Article							INFORMATION-PROCESSING CAPACITY; TEST ADJUSTING-PSAT; MINOR HEAD-INJURY; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL ASSESSMENT; CLINICAL NEUROPSYCHOLOGISTS; COMPUTERIZED MEASURES; COGNITIVE FATIGUE; SPEED DEFICITS; UNITED-STATES	The Paced Auditory Serial Addition Test (PASAT) is widely used to evaluate processing speed and executive function in patients with multiple sclerosis, traumatic brain injury, and other neurological disorders. In the PASAT, subjects listen to sequences of digits while continuously reporting the sum of the last two digits presented. Four different stimulus onset asynchronies (SOAs) are usually tested, with difficulty increasing as SOAs are reduced. Ceiling effects are common at long SOAs, while the digit delivery rate often exceeds the subject's processing capacity at short SOAs, causing some subjects to stop performing altogether. In addition, subjects may adopt an "alternate answer" strategy at short SOAs, which reduces the test's demands on working-memory and processing speed. Consequently, studies have shown that the number of dyads (consecutive correct answers) is a more sensitive measure of PASAT performance than the overall number of correct sums. Here, we describe a 2.5-minute computerized test, the Dyad-Adaptive PASAT (DA-PASAT), where SOAs are adjusted with a 2:1 staircase, decreasing after each pair of correct responses and increasing after misses. Processing capacity is reflected in the minimum SOA (minSOA) achieved in 54 trials. Experiment 1 gathered normative data in two large populations: 1617 subjects in New Zealand ranging in age from 18 to 65 years, and 214 Californians ranging in age from 18 to 82 years. Minimum SOAs were influenced by age, education, and daily hours of computer-use. Minimum SOA z-scores, calculated after factoring out the influence of these factors, were virtually identical in the two control groups, as were response times (RTs) and dyad ratios (the proportion of hits occurring in dyads). Experiment 2 measured the test-retest reliability of the DA-PASAT in 44 young subjects who underwent three test sessions at weekly intervals. High intraclass correlation coefficients (ICCs) were found for minSOAs (0.87), response times (0.76), and dyad ratios (0.87). Performance improved across test sessions for all measures. Experiment 3 investigated the effects of simulated malingering in 50 subjects: 42% of simulated malingerers produced abnormal (p<0.05) minSOA z-scores. Simulated malingerers with abnormal scores were distinguished with 87% sensitivity and 69% specificity from control subjects with abnormal scores by excessive differences between training performance and the actual test. Experiment 4 investigated patients with traumatic brain injury (TBI): patients with mild TBI performed within the normal range while patients with severe TBI showed deficits. The DA-PASAT reduces the time and stress of PASAT assessment while gathering sensitive measures of dyad processing that reveal the effects of aging, malingering, and traumatic brain injury on performance.	[Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Woods, David L.; Reed, Bruce] Univ Calif Davis, Dept Neurol, Sacramento, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Woods, David L.] NeuroBehav Syst Inc, Berkeley, CA 94704 USA; [Reed, Bruce] Alzheimers Dis Ctr, Davis, CA USA		Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.; Woods, DL (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95616 USA.; Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.; Woods, DL (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA.; Woods, DL (corresponding author), NeuroBehav Syst Inc, Berkeley, CA 94704 USA.	dlwoods@ucdavis.edu		Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X; Yund, E./0000-0002-6833-0052	VA Research and Development Grants [CX000583, CX001000]; National Institute of Environmental Health SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES014038]; Neurobehavioral Systems (NBS), Inc.	This research was supported by a VA Research and Development Grants grant CX000583 and CX001000 to DLW and by R01ES014038 from the National Institute of Environmental Health Sciences to Michael Bates. Neurobehavioral Systems (NBS), Inc. provided salary support for authors DLW and JMW, but NBS did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The content is solely the responsibility of the authors and does not necessarily represent the official views of Department of Veterans Affairs or the U.S. Government.	Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Baird BJ, 2007, APPL NEUROPSYCHOL, V14, P88, DOI 10.1080/09084280701319912; Balzano J, 2006, ARCH CLIN NEUROPSYCH, V21, P819, DOI 10.1016/j.acn.2006.09.002; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Bryant D, 2004, REHABIL PSYCHOL, V49, P114, DOI 10.1037/0090-5550.49.2.114; Chronicle EP, 1998, NEUROPSYCHOL REHABIL, V8, P273; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Coo H, 2005, MULT SCLER J, V11, P85, DOI 10.1191/1352458505ms1124oa; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P255, DOI 10.1080/713755575; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Drake A, 2009, MULTIPLE SCLEROSIS; DYCHE GM, 1991, PERCEPT MOTOR SKILL, V72, P563, DOI 10.2466/PMS.72.2.563-572; Fisher JS, 2001, MULTIPLE SCLEROSIS F; Fisk JD, 2001, J INT NEUROPSYCH SOC, V7, P363, DOI 10.1017/S1355617701733103; Gonzalez R, 2006, ASSESSMENT, V13, P381, DOI 10.1177/1073191106286567; Gonzalez R, 2006, CLIN NEUROPSYCHOL, V20, P396, DOI 10.1080/13854040590967559; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; Lapshin H, 2013, MULT SCLER J, V19, P1905, DOI 10.1177/1352458513488841; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levitt H., 1971, J ACOUST SOC AM S, V49, DOI [10.1076/jcen.25.4.571.13876, DOI 10.1076/JCEN.25.4.571.13876]; Lopez-Gongora M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0296-2; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; McCaffrey RJ, 2001, ARCH CLIN NEUROPSYCH, V16, P9, DOI 10.1016/S0887-6177(99)00055-4; McNally RJ, 2012, J TRAUMA STRESS, V25, P454, DOI 10.1002/jts.21713; Morrow SA, 2013, CAN J NEUROL SCI, V40, P842, DOI 10.1017/S0317167100015997; Ozakbas S, 2016, CLIN NEUROL NEUROSUR, V140, P97, DOI 10.1016/j.clineuro.2015.11.014; Patton J.H., 1991, CLIN NEUROPSYCHOL, V5, P33, DOI [10.1080/13854049108401840, DOI 10.1080/13854049108401840]; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reed BR, 2014, NEUROTOXICOL TERATOL, V42, P68, DOI 10.1016/j.ntt.2014.02.002; Rosti E, 2006, MULT SCLER J, V12, P586, DOI 10.1177/1352458506070624; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Sandry J, 2016, J INT NEUROPSYCH SOC, V22, P375, DOI 10.1017/S1355617715001307; Sherman EMS, 1997, CLIN NEUROPSYCHOL, V11, P34, DOI 10.1080/13854049708407027; Snyder PJ, 2001, BRAIN COGNITION, V46, P279, DOI 10.1016/S0278-2626(01)80084-1; Snyder PJ, 2001, NEUROPSYCHOLOGY, V15, P617, DOI 10.1037//0894-4105.15.4.617; Solari A, 2007, MULT SCLER J, V13, P1020, DOI 10.1177/1352458507077619; Sonder JM, 2013, MULT SCLER J; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spreen O, 1991, COMPENDIUM NEUROPSYC; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tombaugh TN, 2004, J CLIN EXP NEUROPSYC, V26, P257, DOI 10.1076/jcen.26.2.257.28080; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P753, DOI 10.1016/j.acn.2006.08.009; Cores EV, 2015, APPL NEUROPSYCH-ADUL, V22, P241, DOI 10.1080/23279095.2014.910214; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanotti S, 2016, APPL NEUROPSYCHOL, P1; Walker LAS, 2012, J NEUROL SCI, V316, P86, DOI 10.1016/j.jns.2012.01.021; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wiens AN, 1997, J CLIN EXP NEUROPSYC, V19, P473, DOI 10.1080/01688639708403737; Wingenfeld SA, 1999, CLIN NEUROPSYCHOL, V13, P268, DOI 10.1076/clin.13.3.268.1736; Woods DL, 2017, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00654; Woods DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166439; Woods DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153952; Woods DL, 2016, MEMORY, V24, P1142, DOI 10.1080/09658211.2015.1076849; Woods DL, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00690; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149	86	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0178148	10.1371/journal.pone.0178148			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD6SO	WOS:000430638900001	29677192	Green Published, Green Submitted, gold			2022-02-06	
J	Bai, W; Li, P; Ning, YL; Peng, Y; Xiong, RP; Yang, N; Chen, X; Zhou, YG				Bai, Wei; Li, Ping; Ning, Ya-Lei; Peng, Yan; Xiong, Ren-Ping; Yang, Nan; Chen, Xing; Zhou, Yuan-Guo			Adenosine A(2A) receptor inhibition restores the normal transport of endothelial glutamate transporters in the brain	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Membrane proteins; Adenosine A(2A) receptor; Glutamate transporters; G-protein-coupled receptors	CORTICAL IMPACT MODEL; OXIDATIVE STRESS; IN-VITRO; INJURY; BARRIER; NA,K-ATPASE; EXPRESSION; ISCHEMIA; INFLAMMATION; DYSFUNCTION	Excitatory amino acid transporters (EAATs) on cerebral vascular endothelial cells play an important role in maintaining glutamate homeostasis in the brain. The dysfunction of endothelial EAATs is an important reason for the dramatically elevated brain glutamate levels after brain injury, such as traumatic brain injury (TBI). The adenosine A(2A) receptor (A(2A)R) plays an important role in regulating the brain glutamate level after brain injury; however, researchers have not clearly determined whether this role was related to its ability to regulate endothelial EAATs. Activation of A(2A)R in vitro not only decreased the PKA- and glutamate level-dependent strengthening of the interaction between NKA-alpha 1 and the FXYD1 subunit and the subsequent decrease in the activity of Na+/K+-ATPases (NKAs) but also enhanced its interaction with EAATs and ultimately aggravated the reverse transport function of endothelial EAATs under oxygen glucose deprivation (OGD) conditions. Conversely, inhibition of A(2A)R restored the normal transport of EAAT. Moreover, A(2A)R inhibition increased NKA activity and decreased its interaction with EAATs in isolated brain capillaries after TBI, further confirming its role in endothelial EAATs in vivo. Based on our results, A(2A)R played an important role in regulating endothelial EAAT function, and strategies that restore the normal transport of endothelial EAATs through the inhibition of A(2A)R might serve as an effective treatment for brain injury. (C) 2018 Elsevier Inc. All rights reserved.	[Zhou, Yuan-Guo] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China; [Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China		Zhou, YG (corresponding author), Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burn & Combined Injury, Ctr Mol Biol, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.; Zhou, YG (corresponding author), Third Mil Med Univ, Daping Hosp, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.	ygzhou@tmmu.edu.cn	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171022]	This work was supported by grants from the National Natural Science Foundation of China (No. 31171022).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bai W, 2017, FRONT MOL NEUROSCI, V10, DOI [10.3389/fnmol.2017.00443, 10.3389/fnmol.2017.00400]; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banine F, 2011, J NEUROSCI RES, V89, P840, DOI 10.1002/jnr.22608; Bauer DE, 2012, NEUROCHEM INT, V61, P566, DOI 10.1016/j.neuint.2012.01.013; BEGLEY DJ, 1994, J CHROMATOGR B, V657, P185, DOI 10.1016/0378-4347(94)80085-5; Benarroch EE, 2011, NEUROLOGY, V77, P281, DOI [10.1212/WNL.0b013e31822550e2, 10.1212/WNL.0b013e3182074c2f]; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Chang CT, 2007, NEPHROL DIAL TRANSPL, V22, P722, DOI 10.1093/ndt/gfl668; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Ciriacks CM, 2006, NEUROSCI LETT, V393, P200, DOI 10.1016/j.neulet.2005.09.080; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROCHEM, V113, P1536, DOI 10.1111/j.1471-4159.2010.06716.x; DALLAIRE L, 1991, BIOCHEM J, V276, P745, DOI 10.1042/bj2760745; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Duan SM, 1999, J NEUROSCI, V19, P10193; Fairman WA, 1999, AM J PHYSIOL-RENAL, V277, pF481, DOI 10.1152/ajprenal.1999.277.4.F481; HASENAUER J, 1993, J BIOL CHEM, V268, P3289; Kangwantas K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0495-9; Leite MR, 2011, EXP GERONTOL, V46, P309, DOI 10.1016/j.exger.2010.11.034; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Matos M, 2013, J NEUROSCI, V33, P18492, DOI 10.1523/JNEUROSCI.1828-13.2013; Matos M, 2012, GLIA, V60, P702, DOI 10.1002/glia.22290; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; ZLOKOVIC BV, 1993, J BIOL CHEM, V268, P8019	35	5	6	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 15	2018	498	4					795	802		10.1016/j.bbrc.2018.03.060			8	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	GC9ZT	WOS:000430158200015	29526759				2022-02-06	
J	Rosas-Hernandez, H; Cuevas, E; Escudero-Lourdes, C; Lantz, SM; Sturdivant, NM; Imam, SZ; Sarkar, S; Slikker, W; Paule, MG; Balachandran, K; Ali, SF				Rosas-Hernandez, Hector; Cuevas, Elvis; Escudero-Lourdes, Claudia; Lantz, Susan M.; Sturdivant, Nasya M.; Imam, Syed Z.; Sarkar, Sumit; Slikker, William, Jr.; Paule, Merle G.; Balachandran, Kartik; Ali, Syed F.			Characterization of uniaxial high-speed stretch as an in vitro model of mild traumatic brain injury on the blood-brain barrier	NEUROSCIENCE LETTERS			English	Article						High-speed stretch; Traumatic brain injury; Blood-brain barrier; Tight junctions; Cell death	PERMEABILITY; TBI	Traumatic brain injury (TBI) occurs when external mechanical forces induce brain damage as result of impact, penetration or rapid acceleration/deceleration that causes deformation of brain tissue. Depending on its severity, TBI can be classified as mild, moderate or severe and can lead to blood-brain barrier (BBB) dysfunction. In the present study, we evaluated the effects of uniaxial high-speed stretch (HSS) at 0, 5, 10 and 15% on a pure culture of primary rat brain endothelial cells as an in vitro model of TBI to the BBB. LDH release, viability and apoptosis analysis, expression of tight junction proteins and endothelial permeability were evaluated 24 h after a single stretch episode. HSS slightly increased cell death and apoptosis at 10 and 15%, while LDH release was increased only at 15% stretch. Occludin expression was increased at 10% stretch, while claudin-5 expression was increased at 5% stretch, which also decreased the endothelial permeability. In summary, 15% HSS induced low levels of cell death, consistent with mild TBI and very low percentages of HSS (5%) enhanced the BBB properties, promoting the formation of a stronger barrier. These data support the use of 15% HSS as valuable tool in the study of mild TBI to the BBB in vitro.	[Rosas-Hernandez, Hector; Cuevas, Elvis; Lantz, Susan M.; Imam, Syed Z.; Sarkar, Sumit; Slikker, William, Jr.; Paule, Merle G.; Ali, Syed F.] Natl Ctr Toxicol Res, Div Neurotoxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA; [Escudero-Lourdes, Claudia] Univ Autonoma San Luis Potosi, Colonia Univ, Fac Ciencias Quim, Av Manuel Nava 6, San Luis Potosi 78240, Mexico; [Sturdivant, Nasya M.; Balachandran, Kartik] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA		Balachandran, K (corresponding author), Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.; Ali, SF (corresponding author), US FDA, Neurochem Lab, Div Neurotoxicol, Natl Ctr Toxicol,Res, Jefferson, AR 72079 USA.	kbalacha@uark.edu; Syed.Ali@fda.hhs.gov	Rosas-Hernandez, Hector/AAU-1294-2020	Rosas-Hernandez, Hector/0000-0002-2736-8302; Burks, Susan/0000-0002-4459-8126	National Science FoundationNational Science Foundation (NSF) [CMMI-1404716]	This research was supported in part by an appointment (H. R-H.) to the Research Participation Program at the National Center for Toxicological Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. NCTR Protocol E.7584.11. This work was also supported in part by the National Science Foundation under grant No. CMMI-1404716.	Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; [Anonymous], 2015, CAC REPORT TO CONGRE; Bailey ZS, 2020, J NEUROTRAUM, V37, P1452, DOI 10.1089/neu.2016.4644; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Berrout J, 2012, BRAIN RES, V1436, P1, DOI 10.1016/j.brainres.2011.11.044; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Liu XM, 2013, AM J PHYSIOL-HEART C, V304, pH1634, DOI 10.1152/ajpheart.00872.2012; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Partyka PP, 2017, BIOMATERIALS, V115, P30, DOI 10.1016/j.biomaterials.2016.11.012; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rayamajhi Manira, 2013, Methods Mol Biol, V1040, P85, DOI 10.1007/978-1-62703-523-1_7; Rosas-Hernandez H., 2018, HDB DEV NEUROTOXICOL, P229, DOI DOI 10.1016/C2015-0-04830-4; Rosas-Hernandez H, 2018, MOL NEUROBIOL, V55, P258, DOI 10.1007/s12035-017-0738-5; Rosas-Hernandez H, 2018, METHODS MOL BIOL, V1727, P315, DOI 10.1007/978-1-4939-7571-6_23; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Song MJ, 2016, CELL MOL BIOENG, V9, P65, DOI 10.1007/s12195-015-0405-8; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Suzuki N, 1997, BIOCHEM BIOPH RES CO, V239, P372, DOI 10.1006/bbrc.1997.7364; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491	38	5	5	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 13	2018	672						123	129		10.1016/j.neulet.2018.02.019			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GD5DD	WOS:000430524300021	29458086				2022-02-06	
J	Li, MZ; Ouyang, JY; Zhang, Y; Cheng, BCY; Zhan, Y; Yang, L; Zou, HY; Zhao, H				Li, Manzhong; Ouyang, Junyao; Zhang, Yi; Cheng, Brian Chi Yan; Zhan, Yu; Yang, Le; Zou, Haiyan; Zhao, Hui			Effects of total saponins from Trillium tschonoskii rhizome on grey and white matter injury evaluated by quantitative multiparametric MRI in a rat model of ischemic stroke	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Ischemic stroke; Middle cerebral artery occlusion; Trillium tschonoskii rhizome; Total saponins; Grey matter; White matter; Magnetic resonance imaging	FOCAL CEREBRAL-ISCHEMIA; IN-VIVO; ALZHEIMERS-DISEASE; STEROIDAL SAPONINS; ARTERY OCCLUSION; MOUSE MODEL; BLOOD-FLOW; DIFFUSION; BRAIN; CYTOTOXICITY	Ethnopharmacological relevance: Trillium tschonoskii rhizome (TTR), a medicinal herb, has been traditionally used to treat traumatic brain injury and headache in China. Although the potential neuroprotective efficacy of TTR has gained increasing interest, the pharmacological mechanism remains unclear. Steroid saponins are the main bioactive components of the herb. Aim of the study: To investigate the protective and repair-promoting effects of the total saponins from TTR (TSTT) on grey and white matter damages in a rat model of middle cerebral artery occlusion (MCAO) using magnetic resonance imaging (MRI) assay. Materials and methods: Ischemic stroke was induced by MCAO. TSTT and Ginaton (positive control) were administered orally to rats 6 h after stroke and daily thereafter. After 15 days of treatment, the survival rate of each group was calculated. We then conducted neurological deficit scores and beam walking test to access the neurological function after ischemic stroke. Subsequently, T2-weighted imaging (T2WI) and T2 relaxometry mapping were performed to measure infarct volume and grey and white matter integrity, respectively. Moreover, diffusion tensor imaging (DTI) was carried out to evaluate the grey and white matter microstructural damage. Additionally, arterial spin labelling (ASL) - cerebral blood flow (CBF) and magnetic resonance angiography (MRA) images provided dynamic information about vascular hemodynamic dysfunction after ischemic stroke. Finally, haematoxylin and eosin (HE) staining was carried out to evaluate the stroke-induced pathological changes in the brain. Results: The survival rate and neurological behavioural outcomes (Bederson scores and beam walking tests) were markedly ameliorated by TSTT (65 mg/kg) treatment within 15 days after ischemic stroke. Moreover, T2WI and T2 relaxometry mapping showed that TSTT (65 mg/kg) significantly reduced infarct volume and attenuated grey and white matter injury, respectively, which was confirmed by histopathological evaluation of brain tissue. The results obtained from DTI showed that TSTT (65 mg/kg) not only significantly alleviated axonal damage and demyelination, but also promoted axonal remodelling and re-myelination. In addition, TSTT treatment also enhanced vascular signal density and increased CBF in rats after MCAO. Conclusion: Our results suggested the potential protective and repair-promoting effects of TSTT on grey and white matter from damage induced by ischemia. This study provides a modern pharmacological basis for the application of TSTT in managing ischemic stroke.	[Li, Manzhong; Ouyang, Junyao; Zhan, Yu; Yang, Le; Zou, Haiyan; Zhao, Hui] Capital Med Univ, Sch Tradit Chinese Med, Beijing 100069, Peoples R China; [Li, Manzhong; Ouyang, Junyao; Zhan, Yu; Yang, Le; Zou, Haiyan; Zhao, Hui] Beijing Key Lab TCM Collateral Dis Theory Res, Beijing 100069, Peoples R China; [Zhang, Yi] Beijing Univ Chinese Med, Dept Pharmacol, Beijing 100102, Peoples R China; [Cheng, Brian Chi Yan] Hong Kong Polytech Univ, Coll Profess & Continuing Educ, Hong Kong, Hong Kong, Peoples R China		Zou, HY; Zhao, H (corresponding author), Capital Med Univ, Sch Tradit Chinese Med, Beijing 100069, Peoples R China.	bwzhy@sina.com; zhaohuishouyi@sina.com			Scientific Research Common Program of Beijing Municipal Commission of EducationBeijing Municipal Commission of Education [KM201510025011]	This work was supported by the Scientific Research Common Program of Beijing Municipal Commission of Education (KM201510025011).	Aung Wint Yan, 2013, Imaging Med, V5, P427; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Besselmann M, 2001, NMR BIOMED, V14, P289, DOI 10.1002/nbm.705; Chan KC, 2009, INT J DEV NEUROSCI, V27, P607, DOI 10.1016/j.ijdevneu.2009.05.012; Chen TY, 2011, CRIT CARE MED, V39, P1130, DOI 10.1097/CCM.0b013e31820a9442; Cheng ZG, 2014, INT J MOL MED, V34, P957, DOI 10.3892/ijmm.2014.1873; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Farr TD, 2010, J CEREBR BLOOD F MET, V30, P703, DOI 10.1038/jcbfm.2010.5; Feeney D M, 1987, Brain Inj, V1, P27, DOI 10.3109/02699058709034441; Fellgiebel A, 2004, DEMENT GERIATR COGN, V18, P101, DOI 10.1159/000077817; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Gong GH, 2011, PHYTOMEDICINE, V18, P458, DOI 10.1016/j.phymed.2010.08.015; Granziera C, 2007, Open Neuroimag J, V1, P10, DOI 10.2174/1874440000701010010; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Harsan LA, 2010, NMR BIOMED, V23, P884, DOI 10.1002/nbm.1496; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Kantarci K, 2011, CURR MED IMAGING, V7, P28, DOI 10.2174/157340511794653432; Kara F, 2012, NEUROIMAGE, V60, P958, DOI 10.1016/j.neuroimage.2011.12.055; Khan KM, 2016, PHYTOTHER RES, V30, P1716, DOI 10.1002/ptr.5672; Koundal S, 2015, NEUROSCIENCE, V289, P106, DOI 10.1016/j.neuroscience.2014.12.049; Kubo K, 2009, BRAIN RES, V1279, P139, DOI 10.1016/j.brainres.2009.04.045; Kujoth GC, 2016, TURK NEUROSURG, V26, P500, DOI 10.5137/1019-5149.JTN.15192-15.1; Lan R., 2013, EVID-BASED COMPL ALT, V2013, P697; Lee JH, 2003, BRAIN RES, V994, P91, DOI 10.1016/j.brainres.2003.09.021; Li J. W., 1995, TRADITIONAL CHINESE; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Liu Z, 2013, J ETHNOPHARMACOL, V149, P422, DOI 10.1016/j.jep.2013.06.033; lmai H., 2001, STROKE, V32, P2149; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Man SL, 2010, J CHROMATOGR B, V878, P2943, DOI 10.1016/j.jchromb.2010.08.033; McCracken E, 2002, J CEREBR BLOOD F MET, V22, P1090, DOI 10.1097/00004647-200209000-00006; Niibo T, 2013, STROKE, V44, P2601, DOI 10.1161/STROKEAHA.113.002097; Pitkonen M, 2012, BRAIN RES, V1445, P103, DOI 10.1016/j.brainres.2012.01.043; Qiao M, 2004, NEUROSCI LETT, V368, P332, DOI 10.1016/j.neulet.2004.07.065; Rosenzweig S, 2015, BRAIN RES, V1623, P123, DOI 10.1016/j.brainres.2015.02.019; State Administration of Traditional Chinese Medicine, 2004, CHIN MAT MED ED BOAR; Tang YN, 2015, J ETHNOPHARMACOL, V165, P127, DOI 10.1016/j.jep.2015.02.017; Tao XF, 2015, FREE RADICAL BIO MED, V84, P103, DOI 10.1016/j.freeradbiomed.2015.03.003; Wang Y, 2013, PHARM BIOL, V51, P1321, DOI 10.3109/13880209.2013.790065; Wang YF, 2006, BRIT J PHARMACOL, V148, P147, DOI 10.1038/sj.bjp.0706720; Wei JC, 2012, BIOCHEM SYST ECOL, V44, P112, DOI 10.1016/j.bse.2012.04.016; Wideroe M, 2012, EUR J NEUROSCI, V36, P2006, DOI 10.1111/j.1460-9568.2012.08114.x; Winship IR, 2014, J CEREBR BLOOD F MET, V34, P61, DOI 10.1038/jcbfm.2013.162; Yang ds, 2009, TUJIA MED; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Zerbi V, 2013, NEUROBIOL AGING, V34, P1440, DOI 10.1016/j.neurobiolaging.2012.11.017; Zhan YH, 1994, RESOURCES MED PLANTS; Zhang J, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1184-z; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	49	5	7	2	33	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	APR 6	2018	215						199	209		10.1016/j.jep.2018.01.006			11	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	FY9UX	WOS:000427213500021	29309860				2022-02-06	
J	Andresen, M; Donnelly, J; Aries, M; Juhler, M; Menon, D; Hutchinson, PJA; Smielewski, P				Andresen, Morten; Donnelly, Joseph; Aries, Marcel; Juhler, Marianne; Menon, David; Hutchinson, P. J. A.; Smielewski, Peter			Further Controversies About Brain Tissue Oxygenation Pressure-Reactivity After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						ICP; PRx; ORx; Tissue oxygenation; CPPopt; Cerebral perfusion pressure; Cerebral autoregulation	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; CEREBROVASCULAR AUTOREGULATION; SUBARACHNOID HEMORRHAGE; VASOMOTOR REACTIVITY; SENSOR; FLOW	Background Continuous monitoring of cerebral autoregulation is considered clinically useful due to its ability to warn against brain ischemic insults, which may translate to a relationship with adverse outcome. It is typically performed using the pressure reactivity index (PRx) based on mean arterial pressure and intracranial pressure. A new ORx index based on brain tissue oxygenation and cerebral perfusion pressure (CPP) has been proposed that similarly allows for evaluation of cerebrovascular reactivity. Conflicting results exist concerning its clinical utility. Methods Retrospective analysis was performed in 85 patients with traumatic brain injury (TBI). ORx was calculated using three time windows of 5, 20, and 60 min. Correlation coefficients and individual "optimal CPP'' (CPPopt) were calculated using both PRx and ORx, and relation to patient outcome investigated. Results Correlation coefficients for all comparisons between PRx and ORx indicated poor association between these indices (range from -0.04 to 0.07). PRx was significantly lower in patients with good outcome (p = 0.01), while none of the ORx indices proved to be significantly different in the two outcome groups. Higher mortality related to average CPP < CPPopt was found regardless of which index was used to calculate CPPopt. Conclusion In the TBI setting, ORx does not appear to correlate with vascular pressure reactivity as assessed with PRx. Its potential use for individualizing CPP thresholds remains unclear.	[Andresen, Morten; Donnelly, Joseph; Aries, Marcel; Hutchinson, P. J. A.; Smielewski, Peter] Cambridge Univ Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Andresen, Morten; Juhler, Marianne] Copenhagen Univ Hosp, Clin Neurosurg, Rigshosp, Copenhagen, Denmark; [Aries, Marcel] Univ Groningen, Dept Neurol, Groningen, Netherlands; [Menon, David] Cambridge Univ Hosp, Div Anesthesiol, Cambridge, England		Andresen, M (corresponding author), Cambridge Univ Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England.; Andresen, M (corresponding author), Copenhagen Univ Hosp, Clin Neurosurg, Rigshosp, Copenhagen, Denmark.	andresen@gmail.com	Donnelly, Joseph/E-9235-2018; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Andresen, Morten/0000-0002-3802-6033	NIHR Research Professorship; NIHR BRC; GlaxoSmithKline LtdGlaxoSmithKline; Pfizer LtdPfizer; NeuroTrauma Sciences Inc; Pressura Ltd; Lantmannen AS-Faktor AB; Glide Pharma; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish	Dr. Andresen has nothing to disclose. Dr. Donnelly has nothing to disclose. Dr. Aries has nothing to disclose. Dr. Juhler has nothing to disclose. Dr. Menon reports grants and non-financial support from GlaxoSmithKline Ltd, personal fees and other from Pfizer Ltd, personal fees from NeuroTrauma Sciences Inc, personal fees from Pressura Ltd, other from Fortuna Fix, personal fees from Lantmannen AS-Faktor AB, personal fees from Glide Pharma, other from Calico Inc, outside the submitted work. Dr. Hutchinson is an unpaid member of the board of directors of Technicam Ltd. that produces the cranial access device used in the study. Dr. Hutchinson is supported by a NIHR Research Professorship and the NIHR BRC. Dr. Smielewski has a financial interest in part of the licensing fees for the data collection and analysis software ICM+ (Cambridge Enterprise Ltd, UK) that has been used in this study.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dengl M, 2012, Acta Neurochir Suppl, V114, P165, DOI 10.1007/978-3-7091-0956-4_31; Dengler J, 2013, NEUROCRIT CARE, V19, P74, DOI 10.1007/s12028-012-9686-0; Grozinger G, 2012, NEUROCRIT CARE, V17, P271, DOI 10.1007/s12028-012-9714-0; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang E.W., 2013, OPEN CRIT CARE MED J, V6, P1, DOI [10.2174/1874828701306010001, DOI 10.2174/1874828701306010001]; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Purins K, 2010, ACTA NEUROCHIR, V152, P681, DOI 10.1007/s00701-009-0532-x; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002	22	5	5	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2018	28	2					162	168		10.1007/s12028-017-0438-z			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GF5GM	WOS:000431994700005	28819737				2022-02-06	
J	Atlan, LS; Smith, C; Margulies, SS				Atlan, Lorre S.; Smith, Colin; Margulies, Susan S.			Improved prediction of direction-dependent, acute axonal injury in piglets	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						rotational; kinematics; biomechanics; brain trauma; pediatric	TRAUMATIC BRAIN-INJURY; ROTATIONAL HEAD-INJURY; MODEL PREDICTIONS; DEFORMATION; MORTALITY; SEVERITY; WHIPLASH; SYSTEM; COMA; PIGS	To guide development of safety equipment that reduces sports-related head injuries, we sought to enhance predictive relationships between head movement and acute axonal injury severity. The severity of traumatic brain injury (TBI) is influenced by the magnitude and direction of head kinematics. Previous studies have demonstrated correlation between rotational head kinematics and symptom severity in the adult. More recent studies have demonstrated brain injury age-and direction-dependence, relating head kinematics to white matter tract-oriented strains. We have recently developed and assessed novel rotational head kinematic parameters as predictors of white matter damage in the female immature piglet. We show that many previously published rotational kinematic injury predictor metrics poorly predict acute axonal pathology induced by rapid, non-impact head rotations and that inclusion of cerebral moments of inertia (MOI) in rotational head injury metrics refines prediction of diffuse axonal injury following rapid head rotations for two immature age groups. Rotational Work (RotWork) was the best significant predictor of traumatic axonal injury in both newborn and pre-adolescent piglets following head rotations in the axial, coronal, and sagittal planes. An improvement over current metrics, we find that RotWork, which incorporates head rotation rate, direction, and brain shape, significantly enhanced acute traumatic axonal injury prediction. For similar injury extent, the RotWork threshold is lower for the newborn piglet than the pre-adolescent.	[Atlan, Lorre S.; Margulies, Susan S.] Univ Penn, Bioengn, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Ctr Clin Brain Sci, Acad Dept Neuropathol, Edinburgh, Midlothian, Scotland		Margulies, SS (corresponding author), Univ Penn, Bioengn, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu		Margulies, Susan/0000-0002-3615-7902; Smith, Colin/0000-0002-4507-5132	US Department of Transportation-National Highway Transportation and Safety Administration [DTNH 22-07-H-00088]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R01 NS39679]; American Heart AssociationAmerican Heart Association; University of Pennsylvania Fontaine Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097549, R01NS039679, U01NS069545] Funding Source: NIH RePORTER	Research was supported by funds from the US Department of Transportation-National Highway Transportation and Safety Administration, grant number: DTNH 22-07-H-00088); the National Institutes of Health, grant number: NINDS R01 NS39679; and the American Heart Association. The University of Pennsylvania Fontaine Society supported Lorre Atlan.	[Anonymous], 2006, PERC DISTR TBI REL D; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Diamond IR, 2009, J PEDIATR SURG, V44, P981, DOI 10.1016/j.jpedsurg.2009.01.039; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Duhaime A. C., 1998, PATHOPHYSIOLOGY, V5, P236, DOI DOI 10.1016/50928-4680(98)81216-9; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M., 2010, BLUE BOOK PDF; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gawryszewski VP, 2007, SAO PAULO MED J, V125, P139, DOI 10.1590/S1516-31802007000300003; Gennarelli T. A., 1985, DIRECTIONAL DEPENDEN; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kypri K, 2000, J PAEDIATR CHILD H, V36, P431, DOI 10.1046/j.1440-1754.2000.00559.x; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Loyd Andre M, 2010, Stapp Car Crash J, V54, P167; Maltese M.R., 2012, THESIS, P1; Maltese MR, 2016, COMPUT METHOD BIOMEC, V19, P1618, DOI 10.1080/10255842.2016.1176153; Maltese MR, 2012, TRAUMATIC BRAIN INJU; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Newman J A, 2000, Stapp Car Crash J, V44, P215; Ommaya A.K., 1970, SAE TECHNICAL PAPERS; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; Ommaya AK, 1967, SAE TECHNICAL PAPER, DOI http://dx.doi.org/10.4271/670906; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Takahashi, 2015, SAE TECHNICAL PAPER; Takhounts e.g., 2011, P 22 ENH SAF VEH C W; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Wang Sheng-Yong, 2003, Inj Control Saf Promot, V10, P83, DOI 10.1076/icsp.10.1.83.14105; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Winkelstein BA, 2013, Orthopaedic Biomechanics, P1; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Zhao W., 2015, 2015 IRCOBI C P LYON	48	5	5	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		536	544		10.1002/jnr.24108			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV2DK	WOS:000424374300006	28833411	Green Submitted, Green Accepted			2022-02-06	
J	Borniger, JC; Ungerleider, K; Zhang, N; Karelina, K; Magalang, UJ; Weil, ZM				Borniger, Jeremy C.; Ungerleider, Kyra; Zhang, Ning; Karelina, Kate; Magalang, Ulysses J.; Weil, Zachary M.			Repetitive Brain Injury of Juvenile Mice Impairs Environmental Enrichment-Induced Modulation of REM Sleep in Adulthood	NEUROSCIENCE			English	Article						mild traumatic brain injury; REM sleep; non-REM sleep; environmental enrichment; orexin; neurodegeneration	VISUAL-CORTEX SYNAPSES; PARADOXICAL SLEEP; SPATIAL MEMORY; DENTATE GYRUS; RAT-BRAIN; OUTCOMES; NEURONS; PLASTICITY; CONSEQUENCES; WAKEFULNESS	Traumatic brain injuries (TBIs) are a common and costly ongoing public health concern. Injuries that occur during childhood development can have particularly profound and long-lasting effects. One common consequence and potential mediator of negative outcomes of TBI is sleep disruption which occurs in a substantial proportion of TBI patients. These individuals report greater incidences of insomnia and sleep fragmentation combined with a greater overall sleep requirement meaning that many patients are chronically sleep-deprived. We sought to develop an animal model of developmental TBI-induced sleep dysfunction. Specifically, we tested the hypothesis that early (postnatal day 21), repeated closed head injuries in Swiss-Webster mice, would impair basal and homeostatic sleep responses in adulthood. Further, we asked whether environmental enrichment (EE), a manipulation that improves functional recovery following TBI and has been shown to alter sleep physiology, would prevent TBI-induced sleep dysfunction and alter sleep-modulatory peptide expression. In contrast to our hypothesis, the mild, repeated head injury that we used did not significantly alter basal or homeostatic sleep responses in mice housed in standard laboratory conditions. Sham-injured mice housed in enriched environments exhibited enhanced rapid eye movement (REM) sleep and expression of the REM-promoting peptide pro-melanin-concentrating hormone, an effect that was not apparent in TBI mice housed in enriched environments. Thus, TBI blocked the REM-enhancing effects of EE. This work has important implications for the management and rehabilitation of the TBI patient population. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Borniger, Jeremy C.; Ungerleider, Kyra; Zhang, Ning; Karelina, Kate; Weil, Zachary M.] Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Dept Neurosci,Behav Neuroendocrinol Grp,Neurosci, Columbus, OH 43210 USA; [Magalang, Ulysses J.] Ohio State Univ, Wexner Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Borniger, Jeremy C.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA		Weil, ZM (corresponding author), 460 W 12th Ave 618 Biomed Res Tower, Columbus, OH 43201 USA.	zachary.weil@osumc.edu	Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809; Ungerleider, Kyra/0000-0002-2871-0325	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045758]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS104177] Funding Source: NIH RePORTER	We acknowledge The Ohio State University Laboratory Animal Resource (ULAR) personnel for providing excellent care to the animals used in these studies. We also wish to thank Dr. Randy Nelson for use of the telemetry equipment and other generous support. Additional support for this research was provided by the National Institutes of Health (NS045758). JCB, KU, UJM and ZMW designed the study; all authors were actively involved in acquisition of data; JCB, KU, KK, and ZMW analyzed/interpreted data; JCB, KU, KK, and ZMW drafted the manuscript; JCB, KK, and ZMW provided critical revision of the manuscript.	Baumann CR, 2008, J NEUROL, V255, P42; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Billiard M, 2013, SLEEP MED, V14, P462, DOI 10.1016/j.sleep.2013.01.009; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Blunden S, 2005, J PEDIATR-US, V146, P780, DOI 10.1016/j.jpeds.2005.01.043; BLUNDEN SL, 2005, SLEEP S, V28, pA84; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Borniger JC, 2015, BRAIN BEHAV IMMUN, V47, P218, DOI 10.1016/j.bbi.2014.11.001; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Buschert J, 2016, PROG NEURO-PSYCHOPH, V67, P10, DOI 10.1016/j.pnpbp.2016.01.005; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; GUTWEIN BM, 1980, BRAIN RES BULL, V5, P9, DOI 10.1016/0361-9230(80)90276-2; Guzman-Marin R, 2003, J PHYSIOL-LONDON, V549, P563, DOI 10.1113/jphysiol.2003.041665; HENDERSO.ND, 1970, SCIENCE, V169, P768, DOI 10.1126/science.169.3947.776; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Karelina K, 2017, BRAIN BEHAV IMMUN, V60, P304, DOI 10.1016/j.bbi.2016.11.009; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KIYONO S, 1981, PHYSIOL BEHAV, V26, P391, DOI 10.1016/0031-9384(81)90164-5; Kong JM, 2002, J NEUROSCI, V22, P5581; Lancel M, 2003, EUR J NEUROSCI, V17, P2171, DOI 10.1046/j.1460-9568.2003.02658.x; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Leproult R, 1997, SLEEP, V20, P865; Maria NSS, 2017, J NEUROTRAUM, V34, P1692, DOI 10.1089/neu.2016.4747; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; MIRMIRAN M, 1983, DEV BRAIN RES, V7, P102, DOI 10.1016/0165-3806(83)90086-X; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Oyanedel CN, 2015, BRAIN BEHAV IMMUN, V50, P178, DOI 10.1016/j.bbi.2015.07.001; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PRESSE F, 1992, ENDOCRINOLOGY, V131, P1241, DOI 10.1210/en.131.3.1241; ROSENZWEIG MR, 1972, SCI AM, V226, P22, DOI 10.1038/scientificamerican0272-22; ROSENZWEIG MR, 1972, J COMP PHYSIOL PSYCH, V80, P304, DOI 10.1037/h0032978; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sale A, 2014, PHYSIOL REV, V94, P189, DOI 10.1152/physrev.00036.2012; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schreiber S, 2014, BEHAV BRAIN RES, V271, P59, DOI 10.1016/j.bbr.2014.05.060; SIREVAAG AM, 1985, DEV BRAIN RES, V19, P215, DOI 10.1016/0165-3806(85)90193-2; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Steininger TL, 2004, J CHEM NEUROANAT, V27, P165, DOI 10.1016/j.jchemneu.2004.02.007; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; TAGNEY J, 1973, BRAIN RES, V53, P353, DOI 10.1016/0006-8993(73)90220-5; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Veasey SC, 2000, SLEEP, V23, P1025; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Viola-Saltzman M, 2016, NEUROPSYCH DIS TREAT, V12, P339, DOI 10.2147/NDT.S69105; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404	66	5	5	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 1	2018	375						74	83		10.1016/j.neuroscience.2018.01.064			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY6TV	WOS:000426996600007	29432885	Green Accepted			2022-02-06	
J	Devulapalli, KK; Talbott, JF; Narvid, J; Gean, A; Rehani, B; Manley, G; Uzelac, A; Yuh, E; Huang, MC				Devulapalli, K. K.; Talbott, J. F.; Narvid, J.; Gean, A.; Rehani, B.; Manley, G.; Uzelac, A.; Yuh, E.; Huang, M. C.			Utility of Repeat Head CT in Patients with Blunt Traumatic Brain Injury Presenting with Small Isolated Falcine or Tentorial Subdural Hematomas	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MANAGEMENT	BACKGROUND AND PURPOSE: In blunt traumatic brain injury with isolated falcotentorial subdural hematoma not amenable to neurosurgical intervention, the routinely performed, nonvalidated practice of serial head CT scans frequently necessitates increased hospital resources and exposure to ionizing radiation. The study goal was to evaluate clinical and imaging features of isolated falcotentorial subdural hematoma at presentation and short-term follow-up. MATERIALS AND METHODS: We performed a retrospective analysis of patients presenting to a level 1 trauma center from January 2013 to March 2015 undergoing initial and short-term follow-up CT with initial findings positive for isolated subdural hematoma along the falx and/or tentorium. Patients with penetrating trauma, other sites of intracranial hemorrhage, or depressed skull fractures were excluded. Patient sex, age, Glasgow Coma Scale score, and anticoagulation history were obtained through review of the electronic medical records. RESULTS: Eighty patients met the inclusion criteria (53 males; 27 females; median age, 61 years). Of subdural hematomas, 57.1% were falcine, 33.8% were tentorial, and 9.1% were mixed. The mean initial Glasgow Coma Scale score was 14.2 (range, 6-15). Isolated falcotentorial subdural hematomas were small (mean, 2.8 mm; range, 1-8 mm) without mass effect and significant change on follow-up CT (mean, 2.7 mm; range, 0-8 mm; P = .06), with an average follow-up time of 10.3 hours (range, 3.9-192 hours). All repeat CTs demonstrated no change or decreased size of the initial subdural hematoma. No new intracranial hemorrhages were seen on follow-up CT. CONCLUSIONS: Isolated falcotentorial subdural hematomas in blunt traumatic brain injury average 2.8 mm in thickness and do not increase in size on short-term follow-up CT. Present data suggest that repeat CT in patients with mild traumatic brain injury with isolated falcotentorial subdural hematoma may not be necessary.	[Devulapalli, K. K.; Talbott, J. F.; Narvid, J.; Gean, A.; Rehani, B.; Uzelac, A.; Yuh, E.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 400 Parnassus Ave, San Francisco, CA 94110 USA; [Devulapalli, K. K.; Talbott, J. F.; Narvid, J.; Gean, A.; Rehani, B.; Uzelac, A.; Yuh, E.] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Manley, G.; Huang, M. C.] Zuckerberg San Francisco Gen Hosp, Dept Neurol Surg, San Francisco, CA USA; [Talbott, J. F.; Manley, G.; Yuh, E.; Huang, M. C.] Brain & Spinal Injury Ctr, Dept Neurol Surg, San Francisco, CA USA		Talbott, JF (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 400 Parnassus Ave, San Francisco, CA 94110 USA.	Jason.talbott@ucsf.edu		talbott, jason/0000-0003-3943-5530; Rehani, Bhavya/0000-0001-5785-0071			Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; BARTELS RHMA, 1995, NEUROSURGERY, V36, P1210, DOI 10.1227/00006123-199506000-00026; Howard BM, 2017, J NEUROTRAUM, V34, P128, DOI 10.1089/neu.2015.4270; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; McKhann GM, 1996, NEUROTRAUMA, P103; Meyer Scott H., 1996, P1443; Sweis RT, 2015, J EMERG MED, V49, P679, DOI 10.1016/j.jemermed.2015.06.055; Takeuchi S, 2012, TURK NEUROSURG, V22, P305, DOI 10.5137/1019-5149.JTN.5178-11.2; VAZ R, 1991, ACTA NEUROCHIR, V111, P128, DOI 10.1007/BF01400500; Wang YH, 2014, TURK NEUROSURG, V24, P228, DOI 10.5137/1019-5149.JTN.8377-13.0; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254	13	5	5	0	4	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2018	39	4					654	657		10.3174/ajnr.A5557			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GC4HL	WOS:000429745500008	29496726	Green Published, hybrid			2022-02-06	
J	Hart, T; Whyte, J; Watanabe, T; Chervoneva, I				Hart, Tessa; Whyte, John; Watanabe, Thomas; Chervoneva, Inna			Effects of dextroamphetamine in subacute traumatic brain injury: A randomized, placebo-controlled pilot study	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						psychostimulants; traumatic brain injury recovery; clinical trials	COGNITIVE FAILURES QUESTIONNAIRE; ATTENTION RATING-SCALE; CONTROLLED-TRIAL; DOUBLE-BLIND; REHABILITATION; METHYLPHENIDATE; AMPHETAMINE; CROSSOVER; RECOVERY; DEFICITS	Psychostimulants that affect neurotransmitters implicated in cognitive function and neural plasticity have potential to enhance the rate and extent of recovery after traumatic brain injury (TBI). Ten milligrams dextroamphetamine (DEX) or an identical placebo was administered daily for 3 weeks to 32 participants with moderate to severe TBI, engaged in inpatient rehabilitation, at a mean of 2 months post injury. A variety of outcome measures assessing cognitive function and overall functional status was administered at weekly intervals, to examine effect sizes that may inform a larger trial, and to evaluate safety. Results indicated trivial-to-small effect sizes for DEX-placebo differences, with the largest effects seen on speed of information processing (more improvement with DEX) and agitation (exacerbation with DEX). Examination of adverse events and vital signs suggested safety of DEX, but the pattern of results did not suggest accelerated recovery due to the drug. Future trials of DEX in this population need to consider the impact of floor effects of commonly used measures of cognitive and physical function, and the heterogeneity of TBI. Although the small sample precludes definitive conclusions, these findings are not encouraging with regard to clinical trials of DEX in subacute TBI.	[Hart, Tessa; Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Watanabe, Thomas] MossRehab Hosp, Drucker Brain Injury Ctr, Elkins Pk, PA USA; [Chervoneva, Inna] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Div Biostat, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA		Hart, T (corresponding author), MRRI, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A070040, 90DP0037]	This research was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, grant numbers: H133A070040 and 90DP0037.	BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Fleminger S., 2006, COCHRANE DB SYST REV, V3; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; GRANGER CV, 1986, GUIDE USE UNIFORM DA; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hornstein A, 1996, BRAIN INJURY, V10, P145, DOI 10.1080/026990596124647; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Martinsson L, 2007, COCHRANE DB SYST REV, V1; McCaffrey RJ, 2000, PRACTITIONERS GUIDE; MCNAIR DM, 1981, EDITS MANUAL PROFILE; MEADOR KJ, 1991, NEUROLOGY, V41, P1537, DOI 10.1212/WNL.41.10.1537; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schuster C, 2011, NEUROREHAB NEURAL RE, V25, P749, DOI 10.1177/1545968311405674; Smith A., 1982, SYMBOL DIGIT MODALIT; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Wagle AC, 1999, COMPR PSYCHIAT, V40, P478, DOI 10.1016/S0010-440X(99)90093-7; Walker-Batson D, 2016, PROG NEURO-PSYCHOPH, V64, P225, DOI 10.1016/j.pnpbp.2015.04.002; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2003, ARCH PHYS MED REHAB, V84, P268, DOI 10.1053/apmr.2003.50108; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; [No title captured]	29	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		702	710		10.1002/jnr.24102			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV2DK	WOS:000424374300020	28653428				2022-02-06	
J	Hartmann, A; Kegelmeyer, D; Kloos, A				Hartmann, Annie; Kegelmeyer, Deb; Kloos, Anne			Use of an Errorless Learning Approach in a Person With Concomitant Traumatic Spinal Cord Injury and Brain Injury: A Case Report	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						errorless learning; implicit learning; spinal cord injury; traumatic brain injury	CLINICALLY IMPORTANT DIFFERENCE; CLOSED-HEAD-INJURY; REHABILITATION; MEMORY; DEMENTIA; INTERVENTION; ORIENTATION; VALIDITY; OUTCOMES; AMNESIA	Individuals with concomitant spinal cord injury and traumatic brain injury have cognitive deficits that may limit the ability to learn novel motor tasks necessary for functional independence. Errorless learning has been shown to improve cognitive task performance in persons with brain injury but little is known about its usefulness for improving novel motor task learning. Case Description: A 44-year-old man with traumatic spinal cord and brain injuries from a motor vehicle accident was admitted to an inpatient rehabilitation hospital. His spinal cord injury was classified as T4 American Spinal Injury Association Impairment Scale (AIS) A, and his cognitive status was level IV on the Ranchos Los Amigos Scale. Initially, the patient required maximal assistance from 2 clinicians to complete a slide board transfer, propelled his wheelchair 25 ft with minimal assistance, and scored 9/56 on the Function in Sitting Test. Intervention: The therapist applied traditional motor-learning approaches during the first 37 days of the patient's inpatient rehabilitation facility stay without meaningful gains in functional mobility. A subsequent change to errorless learning was made for the following 32 days until discharge. Outcomes: After use of errorless learning, the patient performed novel mobility-related tasks of slide board transfers with minimal assistance and wheelchair propulsion without physical assistance up to 150 ft; the Function in Sitting Test score improved to 18/56. His sensorimotor system progressed to an AIS classification of AIS B, while his cognition emerged to a level V on the Ranchos Los Amigos Scale. Discussion: Errorless learning may have facilitated acquisition of novel transfer and mobility skills in this individual with dual diagnoses. This approach may have value for patients with neurologic conditions who have both motor and cognitive impairment. Video Abstract available for more insights from the authors (see Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A201).	[Hartmann, Annie; Kegelmeyer, Deb; Kloos, Anne] Ohio State Univ, Div Phys Therapy, Columbus, OH 43210 USA		Hartmann, A (corresponding author), Ohio State Univ, Coll Med, Div Phys Therapy, 453West 10th Ave,Atwell Hall 516, Columbus, OH 43210 USA.	kloos.4@osu.edu	Kloos, Anne/E-3403-2011	Kloos, Anne/0000-0002-9169-6589			American Spinal Injury Association, INT STAND NEUR CLASS; Batchelor-Murphy MK, 2017, J AM GERIATR SOC, V65, pE89, DOI 10.1111/jgs.14728; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bernardi NF, 2015, J NEUROSCI, V35, P14316, DOI 10.1523/JNEUROSCI.1344-15.2015; Bertens D, 2015, J INT NEUROPSYCH SOC, V21, P639, DOI 10.1017/S1355617715000764; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Caffo AO, 2014, DEV NEUROREHABIL, V17, P200, DOI 10.3109/17518423.2012.749951; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Cohen M, 2010, NEUROPSYCHOL REHABIL, V20, P355, DOI 10.1080/09602010903309401; Dalhousie University, 2012, FAC MED WHEELCH SKIL; Dechamps A, 2011, AM J ALZHEIMERS DIS, V26, P273, DOI 10.1177/1533317511404394; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Giesbrecht EM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-350; Gorman SL, 2014, ARCH PHYS MED REHAB, V95, P2304, DOI 10.1016/j.apmr.2014.07.415; Hagen C, 1992, RANCHO AMIGOSREVISED; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Middleton EL, 2012, NEUROPSYCHOL REHABIL, V22, P138, DOI 10.1080/09602011.2011.639619; Middleton JM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0600-7; Muratori LM, 2013, J HAND THER, V26, P94, DOI 10.1016/j.jht.2012.12.007; Nissley HM, 2002, NEUROPSYCHOLOGY, V16, P111, DOI 10.1037//0894-4105.16.1.111; Nott Melissa T, 2014, Top Spinal Cord Inj Rehabil, V20, P225, DOI 10.1310/sci2003-225; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Pitel AL, 2006, BRAIN INJURY, V20, P1099, DOI 10.1080/02699050600909961; Samuel Merritt University, FUNCT SITT TEST; Shumway-Cook A, 2007, MOTOR CONTROL TRANSL, P21; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Uniform Data System for Medical Rehabilitation, 1999, FIM SYST	33	5	5	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	APR	2018	42	2					102	109		10.1097/NPT.0000000000000218			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN8YW	WOS:000439465600008	29547485				2022-02-06	
J	Ianieri, G; Marvulli, R; Gallo, GA; Fiore, P; Megna, M				Ianieri, Giancarlo; Marvulli, Riccardo; Gallo, Giulia Alessia; Fiore, Pietro; Megna, Marisa			"Appropriate Treatment" and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units	TOXINS			English	Article						spasticity; botulinum toxin type A; appropriate treatment; Therapeutic Index	TOXIN TYPE-A; BOTULINUM NEUROTOXIN; GASTROCNEMIUS-MUSCLE; AMERICAN-ACADEMY; LIMB SPASTICITY; STROKE; SAFETY; EFFICACY; SUBCOMMITTEE; NEUROLOGY	Many neurological diseases (ischemic and hemorrhagic stroke, multiple sclerosis, infant cerebral palsy, spinal cord injuries, traumatic brain injury, and other cerebrovascular disorders) may cause muscle spasticity. Different therapeutic strategies have been proposed for the treatment of spasticity. One of the major treatments for tone modulation is botulinum toxin type A (BTX-A), performed in addition to other rehabilitation strategies based on individualized multidisciplinary programs aimed at achieving certain goals for each patient. Therapeutic plans must be precisely defined as they must balance the reduction of spastic hypertonia and retention of residual motor function. To perform and optimize the treatment, an accurate clinical and instrumental evaluation of spasticity is needed to determine how this symptom is invalidating and to choose the best doses, muscles and times of injection in each patient. We introduce an appropriate treatment and no standard or high dosage treatment concept based on our retrospective observational study on 120 patients lasting two years, according to the larger Therapeutic Index and Therapeutic Window of Incobotulinumtoxin A doses from 100 to 1000 units. We studied the efficiency and safety of this drug considering the clinical spasticity significance for specialist physicians and patients.	[Ianieri, Giancarlo; Marvulli, Riccardo; Gallo, Giulia Alessia; Fiore, Pietro; Megna, Marisa] Univ Bari Aldo Moro, Dept Basic Sci Neurosci & Sense Organs, G Cesare Pl 11, I-70125 Bari, Italy		Ianieri, G (corresponding author), Univ Bari Aldo Moro, Dept Basic Sci Neurosci & Sense Organs, G Cesare Pl 11, I-70125 Bari, Italy.	igc@neurol.uniba.it; ricmarv81@hotmail.it; giulia.gallo1985@gmail.com; p_fiore@hotmail.it; marisa.megna@uniba.it	Megna, Marisa/ABE-8907-2020	, Riccardo/0000-0002-3617-7452; Megna, Marisa/0000-0002-8486-103X			Bensmail Djamel, 2014, J Med Econ, V17, P618, DOI 10.3111/13696998.2014.925462; Demetrios M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009689.pub2; Dressler D, 2012, EUR J NEUROL, V19, P385, DOI 10.1111/j.1468-1331.2011.03559.x; Dressler D, 2015, J NEURAL TRANSM, V122, P327, DOI 10.1007/s00702-014-1252-9; Fabbri M, 2016, NEUROTOX RES, V29, P105, DOI 10.1007/s12640-015-9565-5; Fleuren JFM, 2010, J NEUROL NEUROSUR PS, V81, P46, DOI 10.1136/jnnp.2009.177071; Gao F, 2009, ARCH PHYS MED REHAB, V90, P819, DOI 10.1016/j.apmr.2008.11.004; Gerrard P, 2013, ARCH PHYS MED REHAB, V94, P1521, DOI 10.1016/j.apmr.2013.02.019; Hefter H, 2012, INT J REHABIL RES, V35, P227, DOI 10.1097/MRR.0b013e328353e3d4; Heidari M, 2011, IRAN REHABIL J, V9, P26; Ianieri G, 2009, Int J Immunopathol Pharmacol, V22, P21; Jarocka E, 2012, PHYSIOL MEAS, V33, P65, DOI 10.1088/0967-3334/33/1/65; Jost WH, 2014, J NEUROL SCI, V337, P86, DOI 10.1016/j.jns.2013.11.022; Kocabas H, 2010, EUR J PHYS REHAB MED, V46, P5; Lo WLA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4294028; Marvulli R., 2016, CLIN IMMUNOL ENDOCR, V3, P62, DOI [10.2174/2212707003666160728143344, DOI 10.2174/2212707003666160728143344]; Marvulli R., 2016, CLIN IMMUNOL ENDOCR, V3, P73, DOI DOI 10.2174/2212707003666160810143854; Merz Pharma UK Ltd, XEOMIN 100 U SUMM PR; Merz Pharmaceuticals LLC, XEOMIN US PRESCR INF; Munari D., 2016, EUR J PHYS REHABIL M; Park SK, 2015, J PHYS THER SCI, V27, P2891, DOI [10.1589/jpts.27.2891, 10.1589/jpts.28.2289]; Picelli A, 2016, EUR J PHYS REHAB MED, V52, P759; Picelli A, 2014, ARCH PHYS MED REHAB, V95, P1564, DOI 10.1016/j.apmr.2014.04.011; Reiffel JA, 2001, CURR OPIN CARDIOL, V16, P23, DOI 10.1097/00001573-200101000-00004; Reiffel JA, 2000, AM J CARDIOL, V85, p46D; Royal College of Physicians British Society of Rehabilitation Medicine, SPAST AD MAN US BOT; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2016, NEUROLOGY, V86, P1818, DOI 10.1212/WNL.0000000000002560; Synnot A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008929.pub2; Tamargo J, 2015, EUR J CLIN PHARMACOL, V71, P549, DOI 10.1007/s00228-015-1832-0; Van Deun B, 2018, J GERIATR PHYS THER, V41, P194, DOI 10.1519/JPT.0000000000000119; Velozo CA, 2012, ARCH PHYS MED REHAB, V93, pS154, DOI 10.1016/j.apmr.2012.06.001; von Werder SCFA, 2016, J ELECTROMYOGR KINES, V28, P67, DOI 10.1016/j.jelekin.2016.03.004; Wissel J, 2017, NEUROLOGY, V88, P1321, DOI 10.1212/WNL.0000000000003789	34	5	5	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2072-6651			TOXINS	Toxins	APR	2018	10	4							140	10.3390/toxins10040140			12	Food Science & Technology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology; Toxicology	GJ3HU	WOS:000435183700011	29597251	gold, Green Published			2022-02-06	
J	Kumar, RG; Wang, ZS; Kesinger, MR; Newman, M; Huynh, TT; Niemeier, JP; Sperry, JL; Wagner, AK				Kumar, Raj G.; Wang, Zhensheng; Kesinger, Matthew R.; Newman, Mark; Huynh, Toan T.; Niemeier, Janet P.; Sperry, Jason L.; Wagner, Amy K.			Probabilistic Matching of Deidentified Data From a Trauma Registry and a Traumatic Brain Injury Model System Center: A Follow-up Validation Study	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Probabilistic Linkage; TBI; Trauma; Rehabilitation; Trauma Registry; TBI Model Systems	LINKAGE	In a previous study, individuals from a single Traumatic Brain Injury Model Systems and trauma center were matched using a novel probabilistic matching algorithm. The Traumatic Brain Injury Model Systems is a multicenter prospective cohort study containing more than 14,000 participants with traumatic brain injury, following them from inpatient rehabilitation to the community over the remainder of their lifetime. The National Trauma Databank is the largest aggregation of trauma data in the United States, including more than 6 million records. Linking these two databases offers a broad range of opportunities to explore research questions not otherwise possible. Our objective was to refine and validate the previous protocol at another independent center. An algorithm generation and validation data set were created, and potential matches were blocked by age, sex, and year of injury; total probabilistic weight was calculated based on of 12 common data fields. Validity metrics were calculated using a minimum probabilistic weight of 3. The positive predictive value was 98.2% and 97.4% and sensitivity was 74.1% and 76.3%, in the algorithm generation and validation set, respectively. These metrics were similar to the previous study. Future work will apply the refined probabilistic matching algorithm to the Traumatic Brain Injury Model Systems and the National Trauma Databank to generate a merged data set for clinical traumatic brain injury research use.	[Kumar, Raj G.; Wang, Zhensheng; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA; [Kumar, Raj G.; Wang, Zhensheng] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Newman, Mark; Niemeier, Janet P.] Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA; [Huynh, Toan T.] Carolinas Healthcare, Acute Care Trauma Surg, Charlotte, NC USA; [Kesinger, Matthew R.; Sperry, Jason L.] Univ Pittsburgh, Dept Trauma, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093032] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD089075] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23 GM093032] Funding Source: Medline		Kesinger MR, 2017, AM J PHYS MED REHAB, V96, P17, DOI 10.1097/PHM.0000000000000513; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Mason CA, 2008, BIRTH DEFECTS RES A, V82, P812, DOI 10.1002/bdra.20510; Sayers A, 2016, INT J EPIDEMIOL, V45, P954, DOI 10.1093/ije/dyv322	4	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	APR	2018	97	4					236	241		10.1097/PHM.0000000000000838			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GA1MM	WOS:000428080300008	29557888	Green Accepted			2022-02-06	
J	Naseri, H; Johansson, H; Brolin, K				Naseri, Hosein; Johansson, Hakan; Brolin, Karin			A Nonlinear Viscoelastic Model for Adipose Tissue Representing Tissue Response at a Wide Range of Strain Rates and High Strain Levels	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						biomechanics; a nonlinear viscoelastic model; adipose tissue; traumatic injury	BRAIN-TISSUE; CONSTITUTIVE MODEL; BEHAVIOR; INJURY; CRASHES; SHEAR; OBESITY; RISK	Finite element human body models (FEHBMs) are nowadays commonly used to simulate pre- and in-crash occupant response in order to develop advanced safety systems. In this study, a biofidelic model for adipose tissue is developed for this application. It is a nonlinear viscoelastic model based on the Reese et al.'s formulation. The model is formulated in a large strain framework and applied for finite element (FE) simulation of two types of experiments: rheological experiments and ramped-displacement experiments. The adipose tissue behavior in both experiments is represented well by this model. It indicates the capability of the model to be used in large deformation and wide range of strain rates for application in human body models.	[Naseri, Hosein; Johansson, Hakan; Brolin, Karin] Chalmers Univ Technol, Mech & Maritime Sci, SE-41296 Gothenburg, Sweden		Naseri, H (corresponding author), Chalmers Univ Technol, Mech & Maritime Sci, SE-41296 Gothenburg, Sweden.	hosein.naseri@chalmers.se; Hakan.Johansson@chalmers.se; brolin@chalmers.se	; /A-4801-2016	, Hosein/0000-0002-8577-4739; /0000-0002-7207-8486; /0000-0002-9173-2498	Swedish Research Council (VR) within the area of Applied Mechanics [621-2013-3909]	Swedish Research Council (VR) within the area of Applied Mechanics (Contract No. 621-2013-3909).	Bathe ICJ, 2006, FINITE ELEMENT PROCE; Bathe K.-J., 1975, International Journal for Numerical Methods in Engineering, V9, P353, DOI 10.1002/nme.1620090207; Bathe KJ, 2005, COMPUT STRUCT, V83, P2513, DOI 10.1016/j.compstruc.2005.08.001; Bathe KJ, 2012, COMPUT STRUCT, V98-99, P1, DOI 10.1016/j.compstruc.2012.01.009; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Bonet J, 1997, NONLINEAR CONTINUUM; Brands Dave W A, 2002, Stapp Car Crash J, V46, P103; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Cavanaugh J. M., 1986, 861878 SAE; Comley K, 2012, INT J IMPACT ENG, V46, P1, DOI 10.1016/j.ijimpeng.2011.12.009; Comley K, 2010, INT J SOLIDS STRUCT, V47, P2982, DOI 10.1016/j.ijsolstr.2010.07.001; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Davila-Velderrain J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00160; Desapriya E, 2014, ASIA-PAC J PUBLIC HE, V26, P447, DOI 10.1177/1010539511430720; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Foster Craig D, 2006, Stapp Car Crash J, V50, P27; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Geerligs M, 2010, J BIOMECH, V43, P1153, DOI 10.1016/j.jbiomech.2009.11.037; Geerligs M, 2008, BIORHEOLOGY, V45, P677, DOI 10.3233/BIR-2008-0517; Gefen A, 2007, J BIOMECH ENG-T ASME, V129, P924, DOI 10.1115/1.2800830; Hardy W N, 2001, Stapp Car Crash J, V45, P1; Hardy W. N., 2015, ACCIDENTAL INJURY, P373; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hrapko M, 2009, INT J CRASHWORTHINES, V14, P245, DOI 10.1080/13588260802440290; Iwamoto M., 2002, INT RES COUNC BIOM I, P31; Jehle D, 2012, AM J EMERG MED, V30, P191, DOI 10.1016/j.ajem.2010.10.017; Mendoza-Vazquez M, 2015, ACCIDENT ANAL PREV, V85, P73, DOI 10.1016/j.aap.2015.08.003; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; MILLER MA, 1989, J TRAUMA, V29, P1571, DOI 10.1097/00005373-198911000-00019; Naseri H., 2016, 29 NORD SEM COMP MEC, P4; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Nusholtz G. S., 1985, 851737 SAE; Pipkin A. C., 2012, LECT VISCOELASTICITY, V7, pNew York; Reese S, 1998, INT J SOLIDS STRUCT, V35, P3455, DOI 10.1016/S0020-7683(97)00217-5; Rouhana S. W, 2002, ACCIDENTAL INJURY BI, P405; Ruan Jesse S, 2005, Stapp Car Crash J, V49, P343; Shi XN, 2015, COMPUT METHOD BIOMEC, V18, P1280, DOI 10.1080/10255842.2014.900544; Sommer G, 2013, ACTA BIOMATER, V9, P9036, DOI 10.1016/j.actbio.2013.06.011; Svensson M., 2015, 24 INT TECHN C ENH S; Tanner R. I, 2000, ENG RHEOLOGY, V52; Tiwary G., 2016, TRANSPORT PLAN TECHN, P362; Viano D. C, 1989, 892432 SAE	43	5	5	1	4	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	APR	2018	140	4							041009	10.1115/1.4038200			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FY1GV	WOS:000426560800009	29049689				2022-02-06	
J	O'Brien, NF; Maa, T; Moore-Clingenpeel, M; Rosenberg, N; Yeates, KO				O'Brien, Nicole Fortier; Maa, Tensing; Moore-Clingenpeel, Melissa; Rosenberg, Nathan; Yeates, Keith Owen			Relationships between cerebral flow velocities and neurodevelopmental outcomes in children with moderate to severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Hypoperfusion; Hyperemia; Vasospasm; Cerebral blood flow velocities; Neurologic outcomes; Neurodevelopmental outcomes; Cognitive outcomes; Trauma; Traumatic brain injury	TRANSCRANIAL DOPPLER ULTRASOUND; BLOOD-FLOW; HEAD-INJURY; CEREBROVASCULAR RESPONSE; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; CRITICALLY-ILL; AGE; ADOLESCENTS; THRESHOLDS	This study aimed to determine relationships between cerebral blood flow and neurodevelopmental outcomes in children with moderate to severe traumatic brain injury (TBI). Children with TBI, a Glasgow Coma Score of 8-12, and abnormal brain imaging were enrolled prospectively. Cerebral blood flow velocity (CBFV) was assessed within 24 h of trauma and daily thereafter through death, discharge, or hospital day 8, whichever came first. Twelve months from injury, participants completed neurodevelopmental testing. Sixty-nine patients were enrolled. Low flow velocities (< 2 SD below age/gender normal) were found in 6% (n = 4). No patient with a single low CBFV measurement had a good neurologic outcome (Pediatric Glasgow Outcome Scale (GOS-E Peds) <= 4)). Normal flow velocities (+/- 2 SD around age/gender normal) were seen in 43% of participants (n = 30). High flow velocities (> 2 SD above age and gender normal with a Lindegaard ratio (LR) < 3) were identified in 23% of children (n = 16), and vasospasm (> 2 SD above age/gender normal with LR >= 3) was identified in 28% (n = 19). Children with good outcomes based on GOS-E Peds scoring were more likely to have had normal flow velocity than other flow patterns. No other differences in neurodevelopmental outcomes were noted. Individual patient responses to TBI in terms of CBFV alterations were heterogeneous. Low flow was uniformly associated with a poor outcome. Patients with good outcomes were more likely to have normal flow. This suggests CBFV may serve as a prognostic indicator in children with TBI. Future studies are needed to determine if aberrant CBFVs are also a therapeutic target.	[O'Brien, Nicole Fortier; Maa, Tensing] Ohio State Univ, Nationwide Childrens Hosp, Div Crit Care Med, 700 Childrens Dr, Columbus, OH 43205 USA; [Moore-Clingenpeel, Melissa] Nationwide Childrens Hosp, Res Inst, Biostat Core, 700 Childrens Dr, Columbus, OH 43205 USA; [Rosenberg, Nathan] Ohio State Univ, Nationwide Childrens Hosp, Div Phys Med & Rehabil, 700 Childrens Dr, Columbus, OH 43205 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Alberta Childrens Hosp,Res Inst, 2500 Univ Dr NW,AD254, Calgary, AB T2N 1N4, Canada		O'Brien, NF (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Div Crit Care Med, 700 Childrens Dr, Columbus, OH 43205 USA.	nicole.obrien@nationwidechildrens.org; tensing.maa@nationwidechildrens.org; Melissa.Moore-Clingenpeel@nationwidechildrens.org; Nathan.Rosenberg@nationwidechildrens.org; kyeates@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Maa, Tensing/J-9791-2012; Moore-Clingenpeel, Melissa/K-7232-2019	Maa, Tensing/0000-0001-6104-8401; Yeates, Keith/0000-0001-7680-2892			AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson NM, 2016, PEDIATR CRIT CARE ME, V17, P444, DOI 10.1097/PCC.0000000000000709; Finkelstein E., 2006, INCIDENCE EC BURDEN; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Merkel S I, 1997, Pediatr Nurs, V23, P293; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Sorond FA, 2010, J ULTRAS MED, V29, P1017, DOI 10.7863/jum.2010.29.7.1017; Voepel-Lewis T, 2010, AM J CRIT CARE, V19, P55, DOI 10.4037/ajcc2010624	26	5	5	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2018	34	4					663	672		10.1007/s00381-017-3693-6			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FZ6HC	WOS:000427697700014	29264705				2022-02-06	
J	Quatman-Yates, C; Bonnette, S; Gupta, R; Hugentobler, JA; Wade, SL; Glauser, TA; Ittenbach, RF; Paterno, MV; Riley, MA				Quatman-Yates, Catherine; Bonnette, Scott; Gupta, Resmi; Hugentobler, Jason A.; Wade, Shari L.; Glauser, Tracy A.; Ittenbach, Richard F.; Paterno, Mark, V; Riley, Michael A.			Spatial and temporal analysis center of pressure displacement during adolescence: Clinical implications of developmental changes	HUMAN MOVEMENT SCIENCE			English	Article						Postural control; Center of pressure displacement; Adolescence; Development; Spatial and temporal analysis	POSTURAL CONTROL; CEREBRAL CONCUSSION; PARKINSONS-DISEASE; CHILDREN; VARIABILITY; BALANCE; MATURATION; COMPLEXITY; PERSPECTIVE; STABILITY	This study aimed to provide insight into the development of postural control abilities in youth. A total of 276 typically developing adolescents (155 males, 121 females) with a mean age of 13.23 years (range of 7.11-18.80) were recruited for participation. Subjects performed two-minute quiet standing trials in bipedal stance on a force plate. Center of pressure (COP) trajectories were quantified using Sample Entropy (SampEn) in the anterior-posterior direction (SampEn-AP), SampEn in the medial-lateral direction (SampEn-ML), and Path Length (PL) measures. Three separate linear regression analyses were conducted to predict the relationship between age and each of the response variables after adjusting for individuals' physical characteristics. Linear regression models showed an inverse relationship between age and entropy measures after adjusting for body mass index. Results indicated that chronological age was predictive of entropy and path length patterns. Specifically, older adolescents exhibited center of pressure displacement (smaller path length) and less complex, more regular center of pressure displacement patterns (lower SampEn-AP and SampEn-ML values) compared to the younger children. These findings support prior studies suggesting that developmental changes in postural control abilities may continue throughout adolescence and into adulthood.	[Quatman-Yates, Catherine; Hugentobler, Jason A.; Paterno, Mark, V] Cincinnati Childrens Hosp, Div Occupat & Phys Therapy, Cincinnati, OH USA; [Quatman-Yates, Catherine; Bonnette, Scott; Paterno, Mark, V] Cincinnati Childrens Hosp, Div Sports Med, Cincinnati, OH USA; [Quatman-Yates, Catherine] Ohio State Univ, Dept Phys Therapy, Columbus, OH 43210 USA; [Bonnette, Scott; Riley, Michael A.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Bonnette, Scott; Riley, Michael A.] Univ Cincinnati, Ctr Act & Percept, Cincinnati, OH 45221 USA; [Gupta, Resmi; Ittenbach, Richard F.] Cincinnati Childrens Hosp, Div Biostat & Epidemiol, Cincinnati, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp, Div Phys Med & Rehabil, Cincinnati, OH USA; [Glauser, Tracy A.] Cincinnati Childrens Hosp, Div Neurol, Cincinnati, OH USA		Quatman-Yates, C (corresponding author), Ohio State Univ, Dept Phys Therapy, Columbus, OH 43210 USA.	catherine.quatman@osumc.edu	Quatman-Yates, Catherine/U-9580-2019; Quatman-Yates, Catherine/AAK-4507-2021		Ohio Physical Therapy Association; Cincinnati Children's Hospital; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [KL2 TR001426-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001426] Funding Source: NIH RePORTER	Sources of funding supporting the project included: The Ohio Physical Therapy Association's Research Grant, Cincinnati Children's Hospital Research in Patient Services PS2 Grant, and The National Institutes of Health KL2 TR001426-01.	Barozzi S, 2014, EUR ARCH OTO-RHINO-L, V271, P2069, DOI 10.1007/s00405-014-2930-9; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chesnokov YV, 2008, ARTIF INTELL MED, V43, P151, DOI 10.1016/j.artmed.2008.03.009; Cumberworth VL, 2007, J LARYNGOL OTOL, V121, P449, DOI 10.1017/S0022215106004051; Deffeyes JE, 2011, INFANT BEHAV DEV, V34, P81, DOI 10.1016/j.infbeh.2010.10.001; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; Gouleme N, 2014, INT J DEV NEUROSCI, V38, P169, DOI 10.1016/j.ijdevneu.2014.08.011; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; HYTONEN M, 1993, ACTA OTO-LARYNGOL, V113, P119, DOI 10.3109/00016489309135778; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Quatman-Yates CC, 2013, INT J SPORTS PHYS TH, V8, P741; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Schlenstedt C, 2016, PARKINSONISM RELAT D, V24, P107, DOI 10.1016/j.parkreldis.2015.12.011; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Wolff DR, 1998, J ORTHOPAED RES, V16, P271, DOI 10.1002/jor.1100160215	27	5	5	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	APR	2018	58						148	154		10.1016/j.humov.2018.02.002			7	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	GD6KT	WOS:000430618600015	29438912	Green Accepted			2022-02-06	
J	Rao, AJ; Lin, AL; Hilliard, C; Fu, R; Lennox, T; Barbosa, RR; Rowell, SE				Rao, Abigail J.; Lin, Amber Laurie; Hilliard, Cole; Fu, Rongwei; Lennox, Tori; Barbosa, Ronald R.; Rowell, Susan E.			Blood Ethanol Levels Are Not Related to Coagulation Changes, as Measured by Thromboelastography, in Traumatic Brain Injury Patients	WORLD NEUROSURGERY			English	Article						Alcohol; Coagulation; Coagulopathy; Ethanol; Hemorrhage; Thromboelastography; Traumatic brain injury	HEAD-INJURY; ALCOHOL; COAGULOPATHY; THROMBELASTOGRAPHY; INTOXICATION; ASSOCIATION; PROGRESSION; MORTALITY; RISK	BACKGROUND: Brain injury is a leading cause of death and disability in trauma patients. Ethanol (EtOH) use near the time of injury may contribute to worse outcomes in these patients by exacerbating coagulopathy. There are limited data regarding the effects of EtOH on coagulation and progression of traumatic intracranial hemorrhage (TICH). METHODS: We performed a retrospective analysis of a prospective observational study of 168 trauma patients with TBI at an urban level 1 trauma center. Thromboelastography (TEG) was performed on admission and over the subsequent 48 hours. Demographic, physiologic, and outcomes data were collected. Computed tomography imaging of the head performed within the first 48 hours of admission was analyzed for progression of TICH. RESULTS: Thirty-six percent of patients (n = 61) had positive blood EtOH on admission (median EtOH level = 198 mg/dL [range, 16-376 mg/dL]). EtOH-positive patients were less severely injured than EtOH-negative patients (P = 0.01). Other admission demographic and physiologic variables were similar between groups. There were no significant differences in TEG values between EtOH-positive and EtOH-negative patients on admission or during the subsequent 48 hours. There were no differences in radiographic progression of hemorrhage, the need for neurosurgical procedure, or mortality between EtOH-positive and EtOH-negative patients. CONCLUSIONS: EtOH use near the time of traumatic injury was not associated with alterations in coagulation, as measured by traditional coagulation tests or by TEG, in patients with TICH. Furthermore, a positive blood alcohol at admission was not associated with increased mortality or need for neurosurgical procedure these patients.	[Rao, Abigail J.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Lin, Amber Laurie; Fu, Rongwei] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Lin, Amber Laurie; Fu, Rongwei] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy Res Emergency Med, Portland, OR 97201 USA; [Hilliard, Cole; Lennox, Tori; Rowell, Susan E.] Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Surg, Portland, OR 97201 USA; [Barbosa, Ronald R.] Legacy Emanuel Hosp & Hlth Ctr, Trauma Serv, Portland, OR USA; [Rao, Abigail J.] Univ Calif Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; [Rao, Abigail J.] Greater Los Angeles Vet Adm Hosp, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; [Lennox, Tori] Univ Washington, Div Cardiothorac Surg, 1959 NE Pacific St, Seattle, WA 98195 USA		Rowell, SE (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Surg, Portland, OR 97201 USA.	rowells@ohsu.edu	Rowell, Susan/S-7480-2019		NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12 HL108974] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER		Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Berry C, 2011, AM SURGEON, V77, P1416; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Crews FT, 1998, PHARMACOL BIOCHEM BE, V59, P981, DOI 10.1016/S0091-3057(97)00538-8; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Howard BM, 2014, J TRAUMA ACUTE CARE, V77, P865, DOI 10.1097/TA.0000000000000357; Hu TT, 2016, BIOL RES NURS, V18, P5, DOI 10.1177/1099800415577634; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Reikvam H, 2009, TRANSFUS APHER SCI, V40, P119, DOI 10.1016/j.transci.2009.01.019; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Spoerke N, 2010, J TRAUMA, V68, P1106, DOI 10.1097/TA.0b013e3181d86860; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	25	5	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2018	112						E216	E222		10.1016/j.wneu.2018.01.025			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8FH	WOS:000432932700026	29330077	Green Accepted			2022-02-06	
J	Sabo, T; Supnet, C; Purkayastha, S				Sabo, Tonia; Supnet, Charlene; Purkayastha, Sushmita			Secondary intracranial hypertension (pseudotumor cerebri) presenting as post-traumatic headache in mild traumatic brain injury: a case series	CHILDS NERVOUS SYSTEM			English	Article						Idiopathic intracranial hypertension; Post-traumatic headache; Acetazolamide; Intracranial pressure; Pseudotumor cerebri; Concussion	ACETAZOLAMIDE; TOPIRAMATE; MANAGEMENT; MIGRAINE	Cerebral edema peaks 36-72 h after moderate traumatic brain injury but thought to be uncommon after mild traumatic brain injury. Post-traumatic headache can develop 48-72 h post-injury, perhaps reflecting the developing cerebral edema. Pseudotumor cerebri can result from various causes, including cerebral edema, and is characterized by increased intracranial pressure, headache, visual, and other common symptoms. Our objective was to report a phenotypically identifiable post-traumatic headache subtype. This case series of six pediatric patients with post-traumatic pseudotumor cerebri was assessed at 48-120 h post-primary injury with new or a change in symptoms such as headache, vision, auditory, balance, and cognition. Clinical findings included slight fever, neck/head pain, papilledema or cranial nerve deficit (6th), and lack of coordination. Elevated cerebral spinal fluid pressure was documented by lumbar puncture, with no infection. Symptoms improved with treatment specific to post-traumatic headache subtype (lumbar puncture, topiramate, or acetazolamide). Recognition of specific post-traumatic headache subtypes after mild traumatic brain injury will expedite treatment intervention to lower intracranial pressure and resolve symptoms.	[Sabo, Tonia] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Sabo, Tonia] Childrens Hlth Childrens Med Ctr, 2350 North Stemmons Freeway, Dallas, TX 75235 USA; [Sabo, Tonia; Supnet, Charlene] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Purkayastha, Sushmita] Southern Methodist Univ, Dept Appl Physiol & Wellness, 3101 Univ Blvd, Dallas, TX 75205 USA		Sabo, T (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Sabo, T (corresponding author), Childrens Hlth Childrens Med Ctr, 2350 North Stemmons Freeway, Dallas, TX 75235 USA.; Sabo, T; Supnet, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Purkayastha, S (corresponding author), Southern Methodist Univ, Dept Appl Physiol & Wellness, 3101 Univ Blvd, Dallas, TX 75205 USA.	tonia.sabo@utsouthwestern.edu; charlene.supnet@utsouthwestern.edu; spurkayastha@smu.edu	Purkaysastha, Sushmita/Y-8908-2019	Sabo, Tonia/0000-0002-7293-4764; Supnet, Charlene/0000-0001-6917-770X			Aylward SC, 2016, PEDIATR NEUROL, V61, P76, DOI 10.1016/j.pediatrneurol.2016.04.007; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Faul M, 2010, TRAUMATIC BRAIN INJU; Galetta SL, 2013, NEUROLOGY, V81, P1112, DOI 10.1212/WNL.0b013e3182a55ff7; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Ivkovic M, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0004-z; Karadas O, 2014, TURK NEUROSURG, V24, P704, DOI 10.5137/1019-5149.JTN.9059-13.1; Kruschitz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072002; Krymchantowski AV, 2011, HEADACHE, V51, P554, DOI 10.1111/j.1526-4610.2011.01868.x; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Markey KA, 2016, LANCET NEUROL, V15, P78, DOI 10.1016/S1474-4422(15)00298-7; Piovesan EJ, 2002, ARQ NEURO-PSIQUIAT, V60, P453, DOI 10.1590/S0004-282X2002000300021; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Shah LM, 2013, AM J ROENTGENOL, V200, P400, DOI 10.2214/AJR.12.8611; Silberstein SD, 2001, WOLFF S HEADACHE AND; Stiebel-Kalish H, 2013, MED HYPOTHESES, V81, P1059, DOI 10.1016/j.mehy.2013.10.002; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Wall M, 2014, JAMA-J AM MED ASSOC, V311, P1641, DOI 10.1001/jama.2014.3312; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003	22	5	5	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2018	34	4					681	690		10.1007/s00381-017-3681-x			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FZ6HC	WOS:000427697700016	29230542				2022-02-06	
J	Tan, DW; Lim, AME; Ong, DY; Peng, LL; Chan, YH; Ibrahim, I; Sen Kuan, W				Tan, Desmond Wei; Lim, Annabelle Mei En; Ong, Daniel Yuxuan; Peng, Li Lee; Chan, Yiong Huak; Ibrahim, Irwani; Sen Kuan, Win			Computed tomography of the head for adult patients with minor head injury: are clinical decision rules a necessary evil?	SINGAPORE MEDICAL JOURNAL			English	Article						decision support techniques; guideline adherence; head injuries	TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; MILD; MANAGEMENT; PHYSICIANS; PERFORMANCE; SUPPORT	INTRODUCTION This study aimed to evaluate compliance with and performance of the Canadian Computed Tomography Head Rule (CCHR), and its applicability to the Singapore adult population with minor head injury. METHODS We conducted a retrospective study over six months of consecutive patients who presented to the adult emergency department (ED) with minor head injury. Data on predictor variables indicated in the CCHR was collected and compliance with the CCHR was assessed by comparing the recommendations for head computed tomography (CT) to its actual usage. RESULTS In total, 349 patients satisfied the inclusion criteria. Common mechanisms of injury were falls (59.3%), motor vehicle crashes (16.9%) and assault (12.0%). 249 (71.3%) patients underwent head CT, yielding 42 (12.0%) clinically significant findings. 1 (0.3%) patient required neurosurgical intervention. According to the CCHR, head CT was recommended for 209 (59.9%) patients. Compliance with the CCHR was 71.3%. Among the noncompliant group, head CT was overperformed for 20.1% and underperformed for 8.6% of patients. Multivariate logistic regression analysis revealed that absence of retrograde amnesia (odds ratio [OR] 4.1, 95% confidence interval [CI] 1.8-9.7) was associated with noncompliance to the CCHR. Factors associated with underperformance were absence of motor vehicle crashes as a mechanism of injury (OR 6.6, 95% CI 1.2-36.3) and absence of headache (OR 10.8, 95% CI 1.3-87.4). CONCLUSION Compliance with the CCHR for adult patients with minor head injury remains low in the ED. A qualitative review of physicians' practices and patients' preferences may be carried out to evaluate reasons for noncompliance.	[Tan, Desmond Wei; Lim, Annabelle Mei En] Natl Univ Singapore, Minist Hlth Holdings, Singapore, Singapore; [Ong, Daniel Yuxuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Peng, Li Lee; Ibrahim, Irwani; Sen Kuan, Win] Natl Univ Singapore Hosp, Emergency Med Dept, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore; [Peng, Li Lee; Ibrahim, Irwani; Sen Kuan, Win] Natl Univ Singapore, Dept Surg, Yong Loo Lin Sch Med, Singapore, Singapore; [Chan, Yiong Huak] Natl Univ Singapore, Biostat Unit, Yong Loo Lin Sch Med, Singapore, Singapore		Sen Kuan, W (corresponding author), Natl Univ Singapore Hosp, Emergency Med Dept, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.	win_sen_kuan@nuhs.edu.sg	Kuan, Win Sen/I-7684-2018	Kuan, Win Sen/0000-0002-2134-7842; Ibrahim, Irwani/0000-0001-6831-8742; Ong, Daniel/0000-0002-6666-5772			American College of Emergency Physicians, CHOOS WIS 5 THINGS P; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Curran JA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-25; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Klement W, 2012, ARTIF INTELL MED, V54, P163, DOI 10.1016/j.artmed.2011.11.005; Korley FK, 2013, ACAD EMERG MED, V20, P463, DOI 10.1111/acem.12136; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lo WS, 2016, HONG KONG J EMERG ME, V23, P25, DOI 10.1177/102490791602300103; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Quaas J, 2014, INJURY, V45, P1503, DOI 10.1016/j.injury.2014.05.012; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Rosengren David, 2004, Emerg Med Australas, V16, P195, DOI 10.1111/j.1742-6723.2004.00563.x; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609	22	5	5	0	0	SINGAPORE MEDICAL ASSOC	SINGAPORE	2985 JALAN BUKIT MERAH, #02-2C, SMF BUILDING, SINGAPORE, SINGAPORE	0037-5675			SINGAP MED J	Singap. Med. J.	APR	2018	59	4					199	204		10.11622/smedj.2017046			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GE4JH	WOS:000431181200007	28540393	Green Published, Bronze			2022-02-06	
J	Thibaudeau, E; Cellard, C; Legendre, M; Villeneuve, K; Achim, AM				Thibaudeau, Elisabeth; Cellard, Caroline; Legendre, Maxime; Villeneuve, Karele; Achim, Amelie M.			Reliability of two social cognition tests: The combined stories test and the social knowledge test	PSYCHIATRY RESEARCH			English	Article						Psychometric properties; Test-retest reliability; Inter-rater reliability	TRAUMATIC BRAIN-INJURY; BIPOLAR DISORDER; 1ST-EPISODE PSYCHOSIS; SCHIZOPHRENIA; MIND; METAANALYSIS; NEUROCOGNITION; PERCEPTION; DEFICITS; DOMAINS	Deficits in social cognition are common in psychiatric disorders. Validated social cognition measures with good psychometric properties are necessary to assess and target social cognitive deficits. Two recent social cognition tests, the Combined Stories Test (COST) and the Social Knowledge Test (SKT), respectively assess theory of mind and social knowledge. Previous studies have shown good psychometric properties for these tests, but the test-retest reliability has never been documented. The aim of this study was to evaluate the test-retest reliability and the inter-rater reliability of the COST and the SKT. The COST and the SKT were administered twice to a group of forty-two healthy adults, with a delay of approximately four weeks between the assessments. Excellent test-retest reliability was observed for the COST, and a good test-retest reliability was observed for the SKT. There was no evidence of practice effect. Furthermore, an excellent inter-rater reliability was observed for both tests. This study shows a good reliability of the COST and the SKT that adds to the good validity previously reported for these two tests. These good psychometrics properties thus support that the COST and the SKT are adequate measures for the assessment of social cognition.	[Thibaudeau, Elisabeth; Cellard, Caroline; Legendre, Maxime; Villeneuve, Karele; Achim, Amelie M.] CERVO Brain Res Ctr, 2601 Chemin Canardiere, Quebec City, PQ G1J 2G3, Canada; [Thibaudeau, Elisabeth; Cellard, Caroline; Legendre, Maxime; Villeneuve, Karele] Univ Laval, Ecole Psychol, Pavillon Felix Antoine Savard,2325 Allee Biblioth, Quebec City, PQ G1V 0A6, Canada; [Achim, Amelie M.] Univ Laval, Dept Psychiat & Neurosci, Pavillon Ferdinand Vandry,1050 Ave Med, Quebec City, PQ G1V 0A6, Canada		Achim, AM (corresponding author), 2601 Canardiere F-4561-4, Quebec City, PQ G1J 2G3, Canada.	elisabeth.thibaudeau.2@ulaval.ca; Caroline.Cellard@psy.ulaval.ca; maxime.legendre.1@ulaval.ca; karele.villeneuve.1@ulaval.ca; amelie.achim@fmed.ulaval.ca		Legendre, Maxime/0000-0003-2755-716X	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [435556- 2013]; Fonds de Recherche du Quebec en Sante (FRQS); FRQS	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) [grant number #435556- 2013, 2013]. AMA is supported by a salary grant from Fonds de Recherche du Quebec en Sante (FRQS) and ET is supported by a studentship also from FRQS. The funding sources were not involved in any step of this study, from the design to the writing of the manuscript.	Abdel-Hamid M, 2009, PSYCHIAT RES, V165, P19, DOI 10.1016/j.psychres.2007.10.021; Achim AM, 2013, PSYCHOL ASSESSMENT, V25, P117, DOI 10.1037/a0029137; Achim AM, 2013, SCHIZOPHR RES, V145, P75, DOI 10.1016/j.schres.2013.01.012; Achim AM, 2012, PSYCHIAT RES, V196, P207, DOI 10.1016/j.psychres.2011.10.011; Addington J, 2006, BRIT J PSYCHIAT, V189, P373, DOI 10.1192/bjp.bp.105.021022; Banziger T, 2011, J NONVERBAL BEHAV, V35, P189, DOI 10.1007/s10919-011-0108-3; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; Bell M, 2009, SCHIZOPHRENIA BULL, V35, P738, DOI 10.1093/schbul/sbm169; Bell MD, 2010, SCHIZOPHR RES, V122, P164, DOI 10.1016/j.schres.2010.03.024; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bora E, 2016, PSYCHOL MED, V46, P253, DOI 10.1017/S0033291715001993; Bora E, 2011, ACTA PSYCHIAT SCAND, V123, P165, DOI 10.1111/j.1600-0447.2010.01638.x; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Chung YS, 2014, SCHIZOPHRENIA BULL, V40, P602, DOI 10.1093/schbul/sbt048; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; CORRIGAN PW, 1995, SCHIZOPHR RES, V16, P137, DOI 10.1016/0920-9964(94)00072-G; Deltour J.J., 2005, ECHELLE VOCABULAIRE; Fernandez-Gonzalo S, 2014, J NERV MENT DIS, V202, P576, DOI 10.1097/NMD.0000000000000164; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Green MF, 2015, NAT REV NEUROSCI, V16, P620, DOI 10.1038/nrn4005; Grove TB, 2016, PSYCHIAT RES, V243, P198, DOI 10.1016/j.psychres.2016.06.031; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Lahera G, 2012, J NERV MENT DIS, V200, P135, DOI 10.1097/NMD.0b013e3182438eae; Lajoie M.-.P., 2014, 36 C SOC QUEB RECH P; Lavoie MA, 2016, CORTEX, V81, P176, DOI 10.1016/j.cortex.2016.04.017; Lavoie MA, 2014, PSYCHIAT RES, V220, P118, DOI 10.1016/j.psychres.2014.07.055; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Pickup GJ, 2008, PSYCHOPATHOLOGY, V41, P206, DOI 10.1159/000125554; Pinkham A. E., 2017, SCHIZOPHR B, DOI [10.1093/schbul/sbx140, DOI 10.1093/SCHBUL/SBX140]; Pinkham AE, 2016, SCHIZOPHRENIA BULL, V42, P494, DOI 10.1093/schbul/sbv056; Pinkham AE, 2014, J CLIN PSYCHIAT, V75, P14, DOI 10.4088/JCP.13065su1.04; Pinkham AE, 2014, SCHIZOPHRENIA BULL, V40, P813, DOI 10.1093/schbul/sbt081; Ritchie SJ, 2015, DEV PSYCHOL, V51, P573, DOI 10.1037/a0038981; Samame C, 2015, J AFFECT DISORDERS, V173, P146, DOI 10.1016/j.jad.2014.10.055; Savla GN, 2013, SCHIZOPHRENIA BULL, V39, P979, DOI 10.1093/schbul/sbs080; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Schaefer J, 2013, SCHIZOPHR RES, V150, P42, DOI 10.1016/j.schres.2013.07.009; Sergi MJ, 2009, PSYCHIAT RES, V166, P54, DOI 10.1016/j.psychres.2008.03.010; Tousignant B., 2016, NEUROPSYCHOL REHABIL, P1, DOI DOI 10.1080/09602011.2016.1158114."; Ziv I, 2011, COGN NEUROPSYCHIATRY, V16, P71, DOI 10.1080/13546805.2010.492693	47	5	5	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	APR	2018	262						63	69		10.1016/j.psychres.2018.01.026			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GD6VN	WOS:000430646700010	29407571				2022-02-06	
J	Tomczyk, CP; Mormile, M; Wittenberg, MS; Langdon, JL; Hunt, TN				Tomczyk, Christopher P.; Mormile, Megan; Wittenberg, Megan S.; Langdon, Jody L.; Hunt, Tamerah N.			An Examination of Adolescent Athletes and Nonathletes on Baseline Neuropsychological Test Scores	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; youths; sports	HIGH-SCHOOL; CONCUSSION-ASSESSMENT; REACTION-TIME; SPORT; IMPACT; COLLEGIATE; EPIDEMIOLOGY; PERFORMANCE; MANAGEMENT; STATEMENT	Context: An estimated 15.3 million adolescent students are enrolled in US high schools, with approximately 7.8 million participating in athletics. Researchers have examined various demographics in high school athletes; however, athletic participation may play a larger role in test performance than previously thought. Currently, investigations of concussion assessment may rely on uninjured athletes as controls. However, due to the intense nature of athletics, this may not be an appropriate practice. Objective: To examine differences between athletes and nonathletes using a common computerized neuropsychological test. Design: Retrospective cross-sectional study. Setting: High schools from a school district in Columbus, Ohio. Patients or Other Participants: A total of 662 adolescent high school students (athletes: n = 383, female n = 18; nonathletes: n = 279, female n = 193). Main Outcome Measure(s): Participants were administered a computerized neuropsychological test battery (Immediate Post-Concussion Assessment and Cognitive Test [ImPACT]) during baseline concussion assessment. Differences between groups were established for output composite scores. Results: Differences were found between athletes and nonathletes in composite reaction time (F-1,F-522 = 14.855, P < .001) and total symptom score (F-1,F-427 = 33.770, P < .001). Nonathletes reported more symptoms, whereas athletes had faster reaction times. No differences were present in composite verbal memory, composite visual memory, composite visual motor speed, or composite impulse control (P > .05). Conclusions: Symptom reporting and reaction time differed between high school athletes and nonathletes. Participation in extracurricular activities may lead to cognitive differences in adolescents that can influence performance on the Immediate Post-Concussion Assessment and Cognitive Test battery. Researchers should account for these differences in baseline performance when making concussion diagnostic and management decisions.	[Tomczyk, Christopher P.; Mormile, Megan; Wittenberg, Megan S.; Langdon, Jody L.; Hunt, Tamerah N.] Georgia Southern Univ, Dept Hlth Sci & Kinesiol, POB 8076, Statesboro, GA 30460 USA		Tomczyk, CP (corresponding author), Georgia Southern Univ, Dept Hlth Sci & Kinesiol, POB 8076, Statesboro, GA 30460 USA.	cptom101@gmail.com	Langdon, Jody/AAY-4638-2021	Tomczyk, Christopher/0000-0003-3790-2385	National Operating Committee on Standards for Athletic Equipment (NOCSAE)	This study was supported by the National Operating Committee on Standards for Athletic Equipment (NOCSAE).	[Anonymous], NAT EL SEC ENR PROJ; Balkó Štefan, 2016, Rev. bras. cineantropom. desempenho hum., V18, P391, DOI 10.5007/1980-0037.2016v18n4p391; Benes FM, 2001, DEV COGN NEUROSCI, P79; BREWER BW, 1993, INT J SPORT PSYCHOL, V24, P237; Brisswalter J, 1997, PERCEPT MOTOR SKILL, V85, P1019, DOI 10.2466/pms.1997.85.3.1019; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bruzi Alessandro Teodoro, 2013, Rev. Bras. Ciênc. Esporte, V35, P469; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Dege F, 2011, EUR J DEV PSYCHOL, V8, P608, DOI 10.1080/17405629.2011.590668; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guest A, 2003, SOCIOL EDUC, V76, P89, DOI 10.2307/3090271; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jensen AR, 2006, CLOCKING MIND MENTAL; Kilgour AR, 2000, MEM COGNITION, V28, P700, DOI 10.3758/BF03198404; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; National Federation of State High School Associations, 2015, 2015 2016 HIGH SCH A; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Rammsayer T. H., 2003, PSYCHOL MUSIC, V31, P123, DOI [10.1177/0305735603031002290, DOI 10.1177/0305735603031002290]; RYAN ED, 1966, PERCEPT MOTOR SKILL, V22, P383, DOI 10.2466/pms.1966.22.2.383; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Seidman L J, 1998, Harv Ment Health Lett, V14, P4; TWEIT AH, 1963, RES QUART, V34, P508, DOI 10.1080/10671188.1963.10613264; Ursache A, 2016, PSYCHOPHYSIOLOGY, V53, P71, DOI 10.1111/psyp.12547; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Verburgh L, 2016, J SPORT SCI, V34, P1782, DOI 10.1080/02640414.2015.1137344; Verma S, 2011, INDIAN J PHYSIOTHER, V5, P126; Williams LRT, 2000, PERCEPT MOTOR SKILL, V91, P131, DOI 10.2466/PMS.91.5.131-142	41	5	5	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2018	53	4					404	409		10.4085/1062-6050-84-17			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GG7KB	WOS:000432875800009	29543036	Green Published, gold			2022-02-06	
J	Yang, GS; Zhou, XY; An, XF; Liu, XJ; Zhang, YJ; Yu, D				Yang, Guo-Shuai; Zhou, Xiao-Yan; An, Xue-Fang; Liu, Xuan-Jun; Zhang, Yan-Jun; Yu, Dan			mTOR is involved in stroke-induced seizures and the anti-seizure effect of mild hypothermia	MOLECULAR MEDICINE REPORTS			English	Article						mammalian target of rapamycin; stroke; seizures; mild hypothermia; solute carrier family 2 facilitated glucose transporter member 1	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; POSTISCHEMIC SEIZURES; EPILEPSY; DYSFUNCTION; INHIBITION; METABOLISM; MICE	Stroke is considered an underlying etiology of the development of seizures. Stroke leads to glucose and oxygen deficiency in neurons, resulting in brain dysfunction and injury. Mild hypothermia is a therapeutic strategy to inhibit stroke-induced seizures, which may be associated with the regulation of energy metabolism of the brain. Mammalian target of rapamycin (mTOR) signaling and solute carrier family 2, facilitated glucose transporter member (GLUT)-1 are critical for energy metabolism. Furthermore, mTOR overactivation and GLUT-1 deficiency are associated with genetically acquired seizures. It has been hypothesized that mTOR and GLUT-1 may additionally be involved in seizures elicited by stroke. The present study established global cerebral ischemia (GCI) models of rats. Convulsive seizure behaviors frequently occurred during the first and the second days following GCI, which were accompanied with seizure discharge reflected in the EEG monitor. Expression of phosphor (p)-mTOR and GLUT-1 were upregulated in the cerebral cortex and hippocampus, as evidenced by immunohistochemistry and western blot analyses. Mild hypothermia and/or rapamycin (mTOR inhibitor) treatments reduced the number of epileptic attacks, seizure severity scores and seizure discharges, thereby alleviating seizures induced by GCI. Mild hypothermia and/or rapamycin treatments reduced phosphorylation levels of mTOR and the downstream effecter p70S6 in neurons, and the amount of GLUT-1 in the cytomembrane of neurons. The present study revealed that mTOR is involved in stroke-induced seizures and the anti-seizure effect of mild hypothermia. The role of GLUT-1 in stroke-elicited seizures appears to be different from the role in seizures induced by other reasons. Further studies are necessary in order to elucidate the exact function of GLUT-1 in stroke-elicited seizures.	[Yang, Guo-Shuai; Zhou, Xiao-Yan; An, Xue-Fang; Liu, Xuan-Jun; Zhang, Yan-Jun; Yu, Dan] Cent S Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Neurol, Haikou 570208, Hainan, Peoples R China		Yang, GS (corresponding author), Cent S Univ, Xiangya Sch Med, Affiliated Haikou Hosp, Dept Neurol, Haikou 570208, Hainan, Peoples R China.	ygs_hk@163.com			Key Program of Science and Technology Planning of Haikou [2014-73]; Hainan Provincial Natural Science Foundation [20158272]	The present study was supported by the Key Program of Science and Technology Planning of Haikou (grant no. 2014-73) and Hainan Provincial Natural Science Foundation (grant no. 20158272).	Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bakhsheshi MF, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.035006; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Cao L, 2015, CELL PHYSIOL BIOCHEM, V35, P1633, DOI 10.1159/000373977; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute to Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; de Assis TMR, 2015, ARQ NEURO-PSIQUIAT, V73, P510, DOI 10.1590/0004-282X20150043; Demel HR, 2015, AM J CANCER RES, V5, P1649; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Feng JZ, 2017, J TRAUMA ACUTE CARE, V83, P296, DOI 10.1097/TA.0000000000001522; Fu L, 2016, BRAIN RES, V1650, P103, DOI 10.1016/j.brainres.2016.08.035; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Harbert MJ, 2011, J CHILD NEUROL, V26, P1126, DOI 10.1177/0883073811408092; Inglis DJ, 2014, CANCER BIOL THER, V15, P1552, DOI 10.4161/15384047.2014.956605; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jiang XY, 2008, AM J PATHOL, V172, P1748, DOI 10.2353/ajpath.2008.070958; KAWAI K, 1992, J CEREBR BLOOD F MET, V12, P238, DOI 10.1038/jcbfm.1992.34; LaSarge CL, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00018, 10.3389/fnmol.2014.00018]; Lei ZG, 2016, EPILEPSY RES, V124, P40, DOI 10.1016/j.eplepsyres.2016.05.008; Liemburg-Apers DC, 2016, J CELL SCI, V129, P4411, DOI 10.1242/jcs.194480; Liu FD, 2012, AGE, V34, P157, DOI 10.1007/s11357-011-9214-8; Luo M, 2014, EXP THER MED, V8, P1219, DOI 10.3892/etm.2014.1884; Marin-Valencia I, 2012, NEUROBIOL DIS, V48, P92, DOI 10.1016/j.nbd.2012.04.011; Pascual JM, 2008, NEUROLOGIST, V14, pS2, DOI 10.1097/01.nrl.0000340787.30542.41; Procaccianti G, 2012, NEUROEPIDEMIOLOGY, V39, P45, DOI 10.1159/000338374; Robertson Charlene Mt, 2006, Paediatr Child Health, V11, P278; Stefanidou M, 2017, SEIZURE-EUR J EPILEP, V47, P105, DOI 10.1016/j.seizure.2017.03.009; Ullner PM, 2009, NEUROBIOL DIS, V36, P60, DOI 10.1016/j.nbd.2009.06.014; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Wong M, 2012, FUTUR NEUROL, V7, P537, DOI 10.2217/FNL.12.45; Wu CP, 2015, EXP NEUROL, V271, P1, DOI 10.1016/j.expneurol.2015.04.018	32	5	6	1	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2018	17	4					5821	5829		10.3892/mmr.2018.8629			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GA9PA	WOS:000428672100121	29484389	Green Published, Green Submitted, hybrid			2022-02-06	
J	Maneshi, MM; Sachs, F; Hua, SZ				Maneshi, Mohammad M.; Sachs, Frederick; Hua, Susan Z.			Heterogeneous Cytoskeletal Force Distribution Delineates the Onset Ca2+ Influx Under Fluid Shear Stress in Astrocytes	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						astrocytes; cytoskeletal forces; traumatic brain injury (TBI); fluid shear stress; FRET; mechanosensitive ion channel (MSC)	TRAUMATIC BRAIN-INJURY; IN-VIVO; MICROCHIP ELECTROPHORESIS; NMDA RECEPTOR; ACTIN STRESS; CELLS; RESPONSES; CULTURES; MECHANOTRANSDUCTION; FLUORESCENCE	Mechanical perturbations increase intracellular Ca2+ in cells, but the coupling of mechanical forces to the Ca2+ influx is not well understood. We used a microfluidic chamber driven with a high-speed pressure servo to generate defined fluid shear stress to cultured astrocytes, and simultaneously measured cytoskeletal forces using a force sensitive actinin optical sensor and intracellular Ca2+. Fluid shear generated non-uniform forces in actinin that critically depended on the stimulus rise time emphasizing the presence of viscoelasticity in the activating sequence. A short (ms) shear pulse with fast rise time (2 ms) produced an immediate increase in actinin tension at the upstream end of the cell with minimal changes at the downstream end. The onset of Ca2+ rise began at highly strained areas. In contrast to stimulus steps, slow ramp stimuli produced uniform forces throughout the cells and only a small Ca2+ response. The heterogeneity of force distribution is exaggerated in cells having fewer stress fibers and lower pre-tension in actinin. Disruption of cytoskeleton with cytochalasin-D (Cyt-D) eliminated force gradients, and in those cells Ca2+ elevation started from the soma. Thus, Ca2+ influx with a mechanical stimulus depends on local stress within the cell and that is time dependent due to viscoelastic mechanics.	[Maneshi, Mohammad M.; Sachs, Frederick; Hua, Susan Z.] Suny Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA; [Maneshi, Mohammad M.; Hua, Susan Z.] Suny Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA		Hua, SZ (corresponding author), Suny Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.; Hua, SZ (corresponding author), Suny Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA.	zhua@buffalo.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS085517, HL054887]; National Science FoundationNational Science Foundation (NSF) [CMMI-1537239]	This work was supported by National Institutes of Health grant (NS085517, HL054887) and National Science Foundation (CMMI-1537239).	Akinlaja J, 1998, BIOPHYS J, V75, P247, DOI 10.1016/S0006-3495(98)77511-3; Besch SR, 2002, PFLUG ARCH EUR J PHY, V445, P161, DOI 10.1007/s00424-002-0903-0; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Butler PJ, 2001, FASEB J, V15, P216, DOI 10.1096/fj.01-0434fje; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; De Carlo RM, 2015, ANAL BIOANAL CHEM, V407, P1217, DOI 10.1007/s00216-014-8339-x; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Fresta CG, 2017, ANAL METHODS-UK, V9, P402, DOI [10.1039/c6ay03009b, 10.1039/C6AY03009B]; Guo J, 2014, P NATL ACAD SCI USA, V111, pE5252, DOI 10.1073/pnas.1411683111; Haidekker MA, 2001, CHEM BIOL, V8, P123, DOI 10.1016/S1074-5521(00)90061-9; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kanemaru K, 2014, CELL REP, V8, P311, DOI 10.1016/j.celrep.2014.05.056; LANGAN TJ, 1995, GLIA, V14, P174, DOI 10.1002/glia.440140303; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Li L, 2016, ANAL CHEM, V88, P930, DOI 10.1021/acs.analchem.5b03664; Lind BL, 2013, P NATL ACAD SCI USA, V110, pE4678, DOI 10.1073/pnas.1310065110; Maneshi MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep39610; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Meng FJ, 2012, J CELL SCI, V125, P743, DOI 10.1242/jcs.093104; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Parri HR, 2003, NEUROSCIENCE, V120, P979, DOI 10.1016/S0306-4522(03)00379-8; Rahimzadeh J, 2011, AM J PHYSIOL-CELL PH, V301, pC646, DOI 10.1152/ajpcell.00099.2011; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Sachs F, 2015, J GEN PHYSIOL, V145, P373, DOI 10.1085/jgp.201411297; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Tseng CY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061912; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0	35	5	5	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	MAR 16	2018	12								69	10.3389/fncel.2018.00069			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FZ5KO	WOS:000427631400001	29615869	Green Published, gold			2022-02-06	
J	Bandte, A; Fritzsche, FS; Emami, P; Kammler, G; Puschel, K; Krajewski, K				Bandte, Angela; Fritzsche, Friederike-Sophie; Emami, Pedram; Kammler, Getrud; Pueschel, Klaus; Krajewski, Kara			Sport-Related Traumatic Brain Injury with and without Helmets in Children	WORLD NEUROSURGERY			English	Article						Bicycling; Children; Helmets; Horseback riding; Soccer; Sports injuries; Traumatic brain injury	EQUESTRIAN INJURIES; ACCIDENTS; PATTERNS; HEMATOMA; SAFETY	BACKGROUND: Soccer, bicycling, and horseback riding are sports most commonly associated with traumatic brain injury (TBI) in Germany. The latter 2 sports activities are commonly practiced with helmets, and data on helmet use and usefulness vary widely. METHODS: On Ethics Committee approval, a retrospective analysis was performed for patients age 5-17 between January 2009 and August 2014 based on a diagnosis of TBI, using the electronic patient file for 2 university hospital locations. Descriptive data analysis and multivariate and univariate logistic regression were used to calculate odds ratios (ORs). RESULTS: A total of 380 children were identified, including 162 females (42.6%) and 218 males (57.4%), with a mean age of 11.9 +/- 3.8 years. Activities included bicycling (n = [64), horseback riding (n = 19), and soccer (n = 16). Helmet use was documented in 26 patients (14 cyclists, 12 riders), and nonuse was documented in 20 (all cyclists). Compared with not wearing a helmet, wearing a helmet was associated with a trend toward lower odds of loss of consciousness (OR, 0.7; 95% confidence interval [CI], 0.18-2.52). A cohort of 251 patients with nonesports-related TBI (NSTBI) served as a control group for further analyses. Compared with the NSTBI group, the odds of amnesia were 2.9 times greater (95% CI, 1.1-21.6) in the patients with a riding-related TBI and 4.8 times greater (95% CI, 0.3-239) in those with a cycling-related TBI, and the odds of epidural hematoma were 2.2 times greater (95% CI, 0.4-12.3) in those with a cycling-related TBI and 4.9 times greater (95% CI, 0.5-50.4) greater in those with a soccer-related TBI. CONCLUSIONS: We gained important epidemiologic data on pediatric TBI in our region. Despite the descriptive nature of the data, a trend toward reduced odds of loss of consciousness was seen in the helmet wearers. Nevertheless, serious injury can occur despite helmet use.	[Bandte, Angela; Pueschel, Klaus] Univ Med Ctr Hamburg Eppendorf, Dept Forens Pathol, Hamburg, Germany; [Fritzsche, Friederike-Sophie; Emami, Pedram; Kammler, Getrud; Krajewski, Kara] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany		Krajewski, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	k.krajewski@uke.de	Krajewski, Kara/ABH-2587-2020				Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Bambach MR, 2013, ACCIDENT ANAL PREV, V53, P78, DOI 10.1016/j.aap.2013.01.005; Bruzzone E, 2000, AM J SPORT MED, V28, P901, DOI 10.1177/03635465000280062201; Centers for Disease Control and Prevention, 2011, INJ PREV CONTR FY 20; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; Cuenca AG, 2009, J PEDIATR SURG, V44, P148, DOI 10.1016/j.jpedsurg.2008.10.025; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; Dekker R, 2004, DISABIL REHABIL, V26, P91, DOI 10.1080/09638280310001629688; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Feddermann N., CONCUSSIONS USUALLY; Hasler Rebecca M, 2011, J Trauma Manag Outcomes, V5, P4, DOI 10.1186/1752-2897-5-4; Hessler C, 2010, SPORTVERLETZ SPORTSC, V24, P154, DOI 10.1055/s-0029-1245442; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lutfi R, 2009, PEDIATR EMERG CARE, V25, P582, DOI 10.1097/PEC.0b013e3181b4f5f7; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 2000, MED J AUSTRALIA, V172, P217, DOI 10.5694/j.1326-5377.2000.tb123912.x; McNally DS, 2013, ACCIDENT ANAL PREV, V59, P469, DOI 10.1016/j.aap.2013.07.022; Moss PS, 2002, EMERG MED J, V19, P412, DOI 10.1136/emj.19.5.412; Olds K, 2015, J FORENSIC LEG MED, V34, P99, DOI 10.1016/j.jflm.2015.05.018; Puschel V, 2012, SPORTVERLETZ SPORTSC, V26, P159, DOI 10.1055/s-0032-1313006; Raschka V C, 1995, Sportverletz Sportschaden, V9, P24; Smartt P, 2009, J SCI MED SPORT, V12, P376, DOI 10.1016/j.jsams.2008.04.001; Teisch LF, 2015, PEDIATR SURG INT, V31, P1021, DOI 10.1007/s00383-015-3756-2; Weber J, 1999, SPORTVERLETZ SPORTSC, V13, P30, DOI 10.1055/s-2007-993311; Zuckerman SL, 2015, WORLD NEUROSURG, V83, P1098, DOI 10.1016/j.wneu.2014.12.030	27	5	5	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2018	111						E434	E439		10.1016/j.wneu.2017.12.094			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	GG7WI	WOS:000432908700054	29277588				2022-02-06	
J	Curran-Sills, G; Abedin, T				Curran-Sills, Gwynn; Abedin, Tasnima			Risk factors associated with injury and concussion in sanctioned amateur and professional mixed martial arts bouts in Calgary, Alberta	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article								Background There is limited literature that examines risk factors for injury and mild traumatic brain injury (mTBI) in mixed martial arts (MMA). An examination of previously unstudied bout and athlete characteristics that may pose health risks while partaking in this sport is warranted. Hypothesis/purpose To determine the incidence of injury and concussion, along with the identification of risk factors that contribute to injury and mTBI in amateur and professional MMA bouts in Calgary, Alberta. Study design A retrospective cohort study with case-control design. Methods Calgary amateur and professional MMA records were examined from 1 January 2010 to 31 December 2015. Descriptive statistics were used to describe the incidence of injury and concussion, along with univariate and multivariable logistic regression to identify risk factors for injury and mTBI. Results The injury rate per 100 athlete exposure (AE), the injury rate per 100 min of exposure and the concussion rate per 100 AE were 23.6 (95% CI 20.5 to 27.0), 4.1 (95% CI 3.48 to 4.70) and 14.7 (95% CI 11.8 to 17.2), respectively. The most common location of injury was the head and mTBI was the most common type of injury. Athletes whose bout was finished by a knockout/technical knockout, corner stoppage, draw, no contest or physician, and those whose country of origin was non-Canadian, were more likely to sustain an injury. No risk factors for concussion were shown to be significant. Conclusion Engaging in MMA exposes athletes to inherent risk and several recommendations are proposed to reduce these risks. Future prospective investigations are necessary to better delineate the findings in this study.	[Curran-Sills, Gwynn; Abedin, Tasnima] Univ Calgary, Family Med & Primary Care Res Off, Calgary, AB, Canada		Curran-Sills, G (corresponding author), Univ Calgary, Family Med & Primary Care Res Off, Calgary, AB, Canada.	gwynn.curran.sills@utoronto.ca					American Medical Association, H470965 AM MED ASS; [Anonymous], FORBES; Australian Medical Association, MIX MART ARTS MUST B; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; Bledsoe GH, 2006, J SPORT SCI MED, V5, P136; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Canadian Medical Association, MIX MART ARTS MMA BA; Curran-Sills G, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0119-2; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; ESTWANIK J J, 1984, Physician and Sportsmedicine, V12, P123; Frey A, 2004, J TRAUMATOLOGIE SPOR, V21, P100, DOI DOI 10.1016/S0762-915X(04)97390-1; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Lystad RP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518492; Lystad RP, 2009, J SCI MED SPORT, V12, P614, DOI 10.1016/j.jsams.2008.09.013; McClain R, 2014, CLIN J SPORT MED, V24, P497, DOI 10.1097/JSM.0000000000000078; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mixed Martial Arts Inc, OFF MMA FIGHT DAT; MMA Payout, BUSS MMA; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Scoggin James F 3rd, 2010, Am J Orthop (Belle Mead NJ), V39, P247; White C, 2007, BMJ-BRIT MED J, V335; White C, 2007, BRIT MED J, V335, P469, DOI 10.1136/bmj.39328.486100.DB; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	28	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000348	10.1136/bmjsem-2018-000348			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200057	30018788	Green Published, gold			2022-02-06	
J	Fletcher, JJ; Wilson, TJ; Rajajee, V; Davidson, SB; Walsh, JC				Fletcher, Jeffrey J.; Wilson, Thomas J.; Rajajee, Venkatakrishna; Davidson, Scott B.; Walsh, Jon C.			Changes in Therapeutic Intensity Level Following Airway Pressure Release Ventilation in Severe Traumatic Brain Injury	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						brain injuries; intracranial pressure; positive pressure respiration; cerebral perfusion pressure; mechanical ventilation	END-EXPIRATORY PRESSURE; ACUTE LUNG INJURY; INTRACRANIAL-PRESSURE; TIDAL VOLUME; HEAD-INJURY; PEEP	Purpose: Airway pressure release ventilation (APRV) utilizes high levels of airway pressure coupled with brief expiratory release to facilitate open lung ventilation. The aim of our study was to evaluate the effects of APRV-induced elevated airway pressure mean in patients with severe traumatic brain injury. Materials and Methods: This was a retrospective cohort study at a 424-bed Level I trauma center. Linear mixed effects models were developed to assess the difference in therapeutic intensity level (TIL), intracranial pressure (ICP), and cerebral perfusion pressure (CPP) over time following the application of APRV. Results: The study included 21 epochs of APRV in 21 patients. In the 6-hour epoch following the application of APRV, the TIL was significantly increased (P = .002) and the ICP significantly decreased (P = .041) compared to that before 6 hours. There was no significant change in CPP (P = .42) over time. The baseline static compliance and time interaction was not significant for TIL ((2) = 0.2 [df 1], P = .655), CPP ((2) = 0 [df 1], P = 1), or ICP ((2) = 0.1 [df 1], P = .752). Conclusions: Application of APRV in patients with severe traumatic brain injury was associated with significantly, but not clinically meaningful, increased TIL and decreased ICP. No significant change in CPP was observed. No difference was observed based on the baseline pulmonary static compliance.	[Fletcher, Jeffrey J.; Wilson, Thomas J.; Rajajee, Venkatakrishna] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Fletcher, Jeffrey J.] Bronson Methodist Hosp, Bronson Neurosci Ctr, Kalamazoo, MI USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Davidson, Scott B.; Walsh, Jon C.] Bronson Methodist Hosp, Trauma Burn & Surg Crit Care Program, Kalamazoo, MI USA		Fletcher, JJ (corresponding author), Univ Michigan, Bronson Methodist Hosp, Dept Neurosurg, Bronson Neurosci Ctr, 601 John St M-124, Kalamazoo, MI 49007 USA.	jeffletc@med.umich.edu					Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BURCHIEL KJ, 1981, NEUROSURGERY, V8, P443, DOI 10.1227/00006123-198104000-00007; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; COOPER KR, 1985, J NEUROSURG, V63, P552, DOI 10.3171/jns.1985.63.4.0552; Daoud EG, 2012, RESP CARE, V57, P282, DOI 10.4187/respcare.01238; FROST EAM, 1977, J NEUROSURG, V47, P195, DOI 10.3171/jns.1977.47.2.0195; Gonzalez M, 2010, INTENS CARE MED, V36, P817, DOI 10.1007/s00134-010-1837-1; Habashi Nader M, 2005, Crit Care Med, V33, pS228, DOI 10.1097/01.CCM.0000155920.11893.37; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Koutsoukou A, 2006, INTENS CARE MED, V32, P1947, DOI 10.1007/s00134-006-0406-0; Lowe GJ, 2006, CURR OPIN CRIT CARE, V12, P3, DOI 10.1097/01.ccx.0000198055.29600.4b; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Marik PE, 2012, NEUROCRIT CARE, V17, P219, DOI 10.1007/s12028-012-9739-4; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Maung AA, 2011, CRIT CARE CLIN, V27, P501, DOI 10.1016/j.ccc.2011.05.003; Maxwell RA, 2010, J TRAUMA, V69, P501, DOI 10.1097/TA.0b013e3181e75961; Moore F, 2002, J TRAUMA, V53, P492; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Myers TR, 2007, RESP CARE, V52, P452; Seder DB, 2012, NEUROCRIT CARE, V17, P4, DOI 10.1007/s12028-012-9753-6; Stevens RD, 2008, NEUROL CLIN, V26, P543, DOI 10.1016/j.ncl.2008.03.014; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457	28	5	5	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	MAR	2018	33	3					196	202		10.1177/0885066616669315			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU9XG	WOS:000424209900007	27651443				2022-02-06	
J	Forsyth, R; Young, D; Kelly, G; Davis, K; Dunford, C; Golightly, A; Marshall, L; Wales, L				Forsyth, Rob; Young, David; Kelly, Gemma; Davis, Kathy; Dunford, Carolyn; Golightly, Andrew; Marshall, Lindsay; Wales, Lorna			Paediatric Rehabilitation Ingredients Measure: a new tool for identifying paediatric neurorehabilitation content	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; STROKE REHABILITATION	AimTo develop an instrument (Paediatric Rehabilitation Ingredients Measure [PRISM]) for quantitative estimation of contents of interdisciplinary neurorehabilitation for use in studies of relationships between rehabilitation treatment delivered and severity-adjusted outcomes after acquired brain injury (ABI). MethodThe measure was developed using an ingredients-mediators-outcomes model consistent with the International Classification of Functioning, Disability and Health, a literature review, and other current initiatives in the development of rehabilitation treatment taxonomies, with item codevelopment in workshops with rehabilitation professionals. Interrater reliability was assessed in inpatient and residential paediatric rehabilitation settings. ResultsAlthough sometimes an initially unfamiliar perspective on rehabilitation practice, PRISM's acceptability amongst professionals was excellent. Internal consistency of scores was sometimes an issue for users unfamiliar with the tool; however, this improved with practice and interrater reliability (assessed by Kendall's W) was good. The tool was felt to have particular value in facilitating interdisciplinary communication and working. Modifications to the design of the tool have improved internal consistency. InterpretationPRISM supports identification of the active ingredients' of an interdisciplinary rehabilitation package and facilitates interdisciplinary communication. It also has potential as a research tool examining relationships between rehabilitation delivered and severity-adjusted outcomes observed after paediatric ABI.	[Forsyth, Rob] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Forsyth, Rob] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Young, David] Cambridge Univ Hosp NHS Fdn Trust, Paediat Physiotherapy, Cambridge, England; [Kelly, Gemma; Davis, Kathy; Dunford, Carolyn; Wales, Lorna] Childrens Trust, Harrison Res Ctr, Tadworth, England; [Golightly, Andrew] Newcastle Univ, Math & Stat, Newcastle Upon Tyne, Tyne & Wear, England; [Marshall, Lindsay] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne, Tyne & Wear, England		Forsyth, R (corresponding author), Newcastle Univ, Inst Neurosci, Royal Victoria Infirm, Sir James Spence Bldg, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	rob.forsyth@newcastle.ac.uk	Forsyth, Rob/H-9193-2019; Forsyth, Rob J/I-9226-2012	Forsyth, Rob/0000-0002-5657-4180; Forsyth, Rob J/0000-0002-5657-4180; wales, lorna/0000-0003-3987-5341; Golightly, Andrew/0000-0001-6730-1279	National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-DG-0613-10002]	We are grateful to the rehabilitation professionals who took part in the PRISM development workshops and who participated in the interrater reliability exercises. We thank Niina Kolehmainen and John Whyte for helpful discussions. This paper reports independent research funded by the National Institute for Health Research Programme Grants for Applied Research Programme Development Grant scheme (RP-DG-0613-10002). The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the UK Department of Health. The funder played no role in study design, data collection, data analysis, manuscript preparation, or publication decisions. The authors have stated that they had no interests that might be perceived as posing a conflict or bias.	Czaja SJ, 2003, PSYCHOL AGING, V18, P385, DOI 10.1037/0882-7974.18.3.385; DeJong G, 2006, ARCH PHYS MED REHAB, V87, P595, DOI 10.1016/j.apmr.2006.02.009; Fauconnier J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1458; Forsyth R, 2015, DEV MED CHILD NEUROL, V57, P16, DOI 10.1111/dmcn.12575; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Gassaway J, 2005, ARCH PHYS MED REHAB, V86, pS16, DOI 10.1016/j.apmr.2005.08.114; Hart T, 2016, ARCH PHYS MED REHAB, V97, P2045, DOI 10.1016/j.apmr.2016.07.012; Ishizaka Alessio, 2012, Pesqui. Oper., V32, P87; Kendall MG, 1939, ANN MATH STAT, V10, P275, DOI 10.1214/aoms/1177732186; Knoester H, 2008, INTENS CARE MED, V34, P1076, DOI 10.1007/s00134-008-1061-4; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Putman K, 2006, DISABIL REHABIL, V28, P1417, DOI 10.1080/09638280600638216; Putman K, 2009, TOP STROKE REHABIL, V16, P20, DOI 10.1310/tsr1601-20; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Turner-Stokes L, 2012, DISABIL REHABIL, V34, P715, DOI 10.3109/09638288.2011.615880; Turner-Stokes L, 2009, CLIN REHABIL, V23, P922, DOI 10.1177/0269215509337447; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	19	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	MAR	2018	60	3					299	305		10.1111/dmcn.13648			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	FW9BA	WOS:000425629500020	29266225	Green Submitted, Bronze			2022-02-06	
J	Grabyan, JM; Morgan, EE; Cameron, MV; Villalobos, J; Grant, I; Woods, SP				Grabyan, Jonathan M.; Morgan, Erin E.; Cameron, Marizela V.; Villalobos, Javier; Grant, Igor; Woods, Steven Paul		HIV Neurobehavioral Res Program	Deficient Emotion Processing is Associated with Everyday Functioning Capacity in HIV-associated Neurocognitive Disorder	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Social cognition; Emotion; Theory of mind; Everyday functioning; Social functioning	FACIAL AFFECT RECOGNITION; HUMAN-IMMUNODEFICIENCY-VIRUS; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL IMPAIRMENT; SOCIAL COGNITION; ANTIRETROVIRAL THERAPY; PARKINSONS-DISEASE; SKILLS ASSESSMENT; INFECTION; SCHIZOPHRENIA	Objective: Emotion processing has received little research focus in HIV, but emerging evidence suggests that abilities such as facial affect discrimination may be features of HIV-associated neurocognitive disorder (HAND). The present study hypothesized that individuals with HAND would evidence an emotion processing deficit relative to cognitively unimpaired individuals with HIV and seronegative comparison participants on a task assessing these abilities. Moreover, it was expected that this deficit would be significantly associated with social aspects of everyday functioning. Method: To explore these hypotheses, 37 HIV+ individuals with HAND, 46 HIV+ without HAND, and 38 HIV-seronegative comparison participants were administered the CogState Social Emotional Cognition Task (SECT) and the UCSD Performance-based Skills Assessment-Brief (UPSA-B). Results: Results revealed that the HAND group was more likely to have impaired accuracy and slower reaction time relative to the comparison groups on the SECT task. In fact, individuals with HAND were almost 10 times more likely to be impaired on emotion processing accuracy than HIV+without HAND. Among individuals with HIV, accuracy (but not reaction time) was independently related to a functional capacity measure tapping social ability, but not to a similar measure without a social component (UPSA-B Communication and Finances subscales, respectively). Conclusions: These results suggest that disruption of emotion processing may be an important feature of HAND that has clinical value as an independent predictor of real-world activities that involve social components. Future research should prospectively investigate this relationship, which may inform of intervention strategies for improving everyday functioning.	[Grabyan, Jonathan M.; Woods, Steven Paul] Univ Houston, Dept Psychol, Houston, TX USA; [Morgan, Erin E.; Cameron, Marizela V.; Villalobos, Javier; Grant, Igor; Woods, Steven Paul] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Morgan, EE (corresponding author), Univ Calif San Diego, HIV Neurobehav Res Program, 220 Dickinson St,Suite B,MC 8231, San Diego, CA 92103 USA.	eemorgan@ucsd.edu			National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [L30-DA032120, P50-DA026306]; National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21-MH098607, R01-MH073419, U24-MH100928, P30-MH62512]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U24MH100928, P30MH062512] Funding Source: NIH RePORTER	This research was supported by the following funding institutes and awards: National Institute of Mental Health (NIMH): R21-MH098607, R01-MH073419, U24-MH100928, and P30-MH62512. National Institute on Drug Abuse (NIDA): L30-DA032120 and P50-DA026306. The San Diego HIV Neurobehavioral Research Program [HNRP] group is affiliated with the University of California, San Diego; the Naval Hospital, San Diego; and the Veterans Affairs San Diego Healthcare System, and includes: Director: Igor Grant, M.D.; Co-Directors: J. Hampton Atkinson, M.D.; Ronald J. Ellis, M.D., Ph.D.; and J. Allen McCutchan, M.D.; Center Manager: Thomas D. Marcotte, Ph.D.; Jennifer Marquie-Beck, M.P.H.; Melanie Sherman; Neuromedical Component: Ronald J. Ellis, M.D., Ph.D. (P.I.); J. Allen McCutchan, M.D.; Scott Letendre, M.D.; Edmund Capparelli, Pharm.D.; Rachel Schrier, Ph.D.; Debra Rosario, M.P.H.; Neurobehavioral Component: Robert K. Heaton, Ph.D. (P.I.); Mariana Cherner, Ph.D.; Jennifer E. Iudicello, Ph.D.; David J. Moore, Ph.D.; Erin E. Morgan, Ph.D.; Matthew Dawson; Neuroimaging Component: Terry Jernigan, Ph.D. (P.I.); Christine Fennema-Notestine, Ph.D.; Sarah L. Archibald, M.A.; John Hesselink, M.D.; Jacopo Annese, Ph.D.; Michael J. Taylor, Ph.D.; Neurobiology Component: Eliezer Masliah, M.D. (P.I.); Cristian Achim, M.D., Ph.D.; Ian Everall, FRCPsych., FRCPath., Ph.D. (Consultant); Neurovirology Component: Douglas Richman, M.D., (P.I.); David M. Smith, M.D.; International Component: J. Allen McCutchan, M.D., (P.I.); Developmental Component: Cristian Achim, M.D., Ph.D.; (P.I.), Stuart Lipton, M.D., Ph.D.; Participant Accrual and Retention Unit: J. Hampton Atkinson, M.D. (P.I.); Data Management Unit: Anthony C. Gamst, Ph.D. (P.I.); Clint Cushman (Data Systems Manager); Statistics Unit: Ian Abramson, Ph.D. (P.I.); Florin Vaida, Ph.D.; Reena Deutsch, Ph.D.; Anya Umlauf, M.S.	Addington J, 2006, SCHIZOPHR RES, V85, P142, DOI 10.1016/j.schres.2006.03.028; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ances BM, 2012, JAIDS-J ACQ IMM DEF, V59, P469, DOI 10.1097/QAI.0b013e318249db17; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Baldonero Eleonora, 2013, BMC Psychol, V1, P3, DOI 10.1186/2050-7283-1-3; Bechara A., 1994, IOWA GAMBLING TASK; Becker JT, 2011, BRAIN IMAGING BEHAV, V5, P77, DOI 10.1007/s11682-011-9113-8; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R.H., 1996, BRIEF VISUOSPATIAL M; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Blackstone K, 2012, J INT NEUROPSYCH SOC, V18, P79, DOI 10.1017/S135561771100141X; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Clark US, 2015, NEUROPSYCHOLOGIA, V70, P263, DOI 10.1016/j.neuropsychologia.2015.03.003; Clark US, 2010, J INT NEUROPSYCH SOC, V16, P1127, DOI 10.1017/S1355617710001037; Darwin C, 1965, EXPRESSION EMOTIONS, V526; Dawes S, 2008, J CLIN EXP NEUROPSYC, V30, P613, DOI 10.1080/13803390701565225; Delis DC., 2001, DELIS KAPLAN EXECUTI; Ekman P., 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI [DOI 10.1037/0022-3514.53.4.712, 10.1177/2F0022022196271003]; Ellis RJ, 2009, NEUROPSYCHOL REV, V19, P144, DOI 10.1007/s11065-009-9094-1; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; FRIDLUND AJ, 1991, BIOL PSYCHOL, V32, P3, DOI 10.1016/0301-0511(91)90003-Y; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Gonzalez-Baeza A, 2014, J INT AIDS SOC, V17, P114, DOI 10.7448/IAS.17.4.19664; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Heilman KJ, 2013, BIOL PSYCHOL, V94, P143, DOI 10.1016/j.biopsycho.2013.06.003; Hinkin CH, 2002, NEUROLOGY, V59, P1944, DOI 10.1212/01.WNL.0000038347.48137.67; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Jacks A, 2015, AIDS, V29, P1711, DOI 10.1097/QAD.0000000000000700; Klove H., 1963, GROOVED PEGBOARD; Kuper M, 2011, J NEUROL, V258, P1066, DOI 10.1007/s00415-010-5883-y; Lane TA, 2012, NEUROPSYCHOLOGY, V26, P713, DOI 10.1037/a0029964; Lysaker PH, 2012, J NERV MENT DIS, V200, P130, DOI 10.1097/NMD.0b013e3182439533; Maki PM, 2009, NEUROLOGY, V72, P1661, DOI 10.1212/WNL.0b013e3181a55f65; Marcotte TD, 1999, J INT NEUROPSYCH SOC, V5, P579, DOI 10.1017/S1355617799577011; Mausbach BT, 2007, SCHIZOPHRENIA BULL, V33, P1364, DOI 10.1093/schbul/sbm014; Mausbach BT, 2010, BIPOLAR DISORD, V12, P45, DOI 10.1111/j.1399-5618.2009.00787.x; Mitchell RLC, 2015, NEUROPSYCHOLOGIA, V70, P1, DOI 10.1016/j.neuropsychologia.2015.02.018; Morgan EE, 2015, AIDS BEHAV, V19, P166, DOI 10.1007/s10461-014-0851-7; Narme P, 2013, NEUROPSYCHOLOGY, V27, P182, DOI 10.1037/a0031522; Pan YJ, 2009, COMPR PSYCHIAT, V50, P443, DOI 10.1016/j.comppsych.2008.11.003; Parsons TD, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-11; Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870; Pietrzak RH, 2009, J CLIN EXP NEUROPSYC, V31, P848, DOI 10.1080/13803390802592458; Poletti M, 2013, PSYCHIAT CLIN NEUROS, V67, P273, DOI 10.1111/pcn.12045; Poole JH, 2000, J INT NEUROPSYCH SOC, V6, P649, DOI 10.1017/S135561770066602X; Reitan R, 1985, HALSTEAD REITAN NEUR; Van Gorp WG, 1999, J INT NEUROPSYCH SOC, V5, P534, DOI 10.1017/S1355617799566071; Weschler D., 1997, WESCHLER ADULT INTEL; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; World Health Organization, 1998, COMP INT DIAGN INT V; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203	58	5	5	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2018	33	2					184	193		10.1093/arclin/acx058			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY4QD	WOS:000426808700005	28655206	Bronze, Green Published			2022-02-06	
J	Jia, JM; Chen, FF; Wu, YF				Jia, Jinming; Chen, Feifei; Wu, Yunfei			Recombinant PEP-1-SOD1 improves functional recovery after neural stem cell transplantation in rats with traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						aquaporin-4; neural stem cells; superoxide dismutase; traumatic brain injury	SPINAL-CORD-INJURY; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; EDEMA; MODEL; EXPRESSION; PROTEIN; DIFFERENTIATION; AMELIORATION	The transplantation of neural stem cells (NSCs) has been demonstrated as a potential treatment strategy for traumatic brain injury (TBI). Cu, Zn-superoxide dismutase (SOD1) is an important antioxidant enzyme that detoxifies intracellular reactive oxygen species, thereby protecting cells from oxidative damage. PEP-1, a peptide carrier, is able to deliver full-length native peptides or proteins into cells. Therefore, the current study investigated the effect of the transplantation of NSCs in combination with PEP-1-SOD1 for the treatment of experimental TBI in rats. Initially, the effect of PEP-1-SOD1 on the proliferation of NSCs was evaluated by MTT assay. PEP-1-SOD1 (0.5, 2.5 and 4.5 mu M) significantly increased the proliferation rates of NSCs at 24, 48 and 72 h in a dose-dependent manner. PEP-1-SOD1 also promoted the differentiation of NSCs in vitro. The in vivo experiment showed that PEP-1-SOD1 in combination with NSC transplantation significantly improved the functional recovery of rats following TBI compared with NSC transplantation alone. A significant increase in brain aquaporin-4 (AQP4) mRNA and protein expression levels was observed 4 days post-TBI in PEP-1-SOD1, NSCs and PEP-1-SOD1 + NSCs groups compared with the saline group. The PEP-1-SOD1 + NSCs group showed a further increase of AQP4 mRNA and protein expression levels compared with the NSCs and PEP-1-SOD1 groups. In conclusion, the current data suggests that PEP-1-SOD1 may promote the proliferation and differentiation of NSCs, and thereby improve the functional recovery of TBI model rats following NSCs transplantation through upregulating the expression of AQP4.	[Jia, Jinming] Putian Hanjiang Hosp, Dept Crit Care Med, 183 DingPu Rd, Putian 351100, Fujian, Peoples R China; [Chen, Feifei] Third Peoples Hosp Changzhou, Dept Emergency, Changzhou 213001, Jiangsu, Peoples R China; [Wu, Yunfei] Third Peoples Hosp Changzhou, Dept Pathol, Changzhou 213001, Jiangsu, Peoples R China		Jia, JM (corresponding author), Putian Hanjiang Hosp, Dept Crit Care Med, 183 DingPu Rd, Putian 351100, Fujian, Peoples R China.	jjmdoctor@126.com					Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Cho JH, 2008, NEUROCHEM INT, V52, P659, DOI 10.1016/j.neuint.2007.08.013; Crumrine R Christian, 2012, Exp Transl Stroke Med, V4, P10, DOI 10.1186/2040-7378-4-10; Crumrine R Christian, 2011, Exp Transl Stroke Med, V3, P10, DOI 10.1186/2040-7378-3-10; Cui T, 2015, CELL BIOCHEM BIOPHYS, V71, P595, DOI 10.1007/s12013-014-0239-3; Dasuri K, 2013, FREE RADICAL BIO MED, V62, P170, DOI 10.1016/j.freeradbiomed.2012.09.016; Ding ZY, 2013, CELL BIOCHEM BIOPHYS, V67, P615, DOI 10.1007/s12013-013-9549-0; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kabeer FA, 2013, J INTEGR MED-JIM, V11, P269, DOI 10.3736/jintegrmed2013040; Li YJ, 2015, ONCOL REP, V33, P693, DOI 10.3892/or.2014.3629; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Marmarou A, 2003, ACT NEUR S, V86, P7; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mutinati M, 2014, REPROD DOMEST ANIM, V49, P7, DOI 10.1111/rda.12230; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Peluffo H, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-12; Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; Ryu HH, 2009, J VET SCI, V10, P273, DOI 10.4142/jvs.2009.10.4.273; Sakata H, 2012, STROKE, V43, P2423, DOI 10.1161/STROKEAHA.112.656900; Sun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073581; Takemura S, 2006, J NEUROSURG, V104, P129, DOI 10.3171/jns.2006.104.1.129; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Wakai T, 2014, J CEREBR BLOOD F MET, V34, P441, DOI 10.1038/jcbfm.2013.215; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Xiong Z, 2014, STEM CELL RES, V12, P387, DOI 10.1016/j.scr.2013.11.003; Yao ZG, 2015, INT J CLIN EXP MED, V8, P404; Yune TY, 2008, FREE RADICAL BIO MED, V45, P1190, DOI 10.1016/j.freeradbiomed.2008.07.016; Zhao JJ, 2012, NEURAL REGEN RES, V7, P741, DOI 10.3969/j.issn.1673-5374.2012.10.004	36	5	6	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAR	2018	15	3					2929	2935		10.3892/etm.2018.5781			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FZ6XI	WOS:000427743500104	29599832	Green Submitted, Green Published, gold			2022-02-06	
J	Jones, KM; Barker-Collo, S; Parmar, P; Starkey, N; Theadom, A; Ameratunga, S; Feigin, VL				Jones, Kelly M.; Barker-Collo, Suzanne; Parmar, Priya; Starkey, Nicola; Theadom, Alice; Ameratunga, Shanthi; Feigin, Valery L.		BIONIC Study Grp	Trajectories in health recovery in the 12 months following a mild traumatic brain injury in children: findings from the BIONIC Study	JOURNAL OF PRIMARY HEALTH CARE			English	Article						Health research; paediatrics; population health; carers	QUALITY-OF-LIFE; OUTCOMES; RELIABILITY; VALIDITY	INTRODUCTION: There is growing consensus that adverse child outcomes may be evident in the early recovery phase following mild traumatic brain injury (TBI). However, controversy remains around the nature of children's longer-term recovery. AIM: To examine child cognitive, behavioural and quality-of-life outcomes over 12 months following mild injury, and to identify prognostic factors associated with outcomes. METHODS: A prospective sample of 222 children (aged 2-15 years at injury) with mild TBI was assessed using a cognitive testing battery and parent-report questionnaires at <= 14 days, 1, 6 and/or 12-months post-injury. RESULTS: Parents reported significant improvements in their child's behavioural adjustment between baseline and 6 months (P = 0.003), with further improvements at 12 months following injury (P = 0.001). Cognitive recovery and quality-of-life improvements were more gradual with minimal changes in the first month (P > 0.05), but significant improvements by 12-months post-injury (P = 0.03, P = 0.02, respectively). Time since injury, male gender, living rurally and parent anxiety were associated with extent of recovery beyond the acute period. CONCLUSIONS: Children's recovery from mild TBI continues beyond the initial 6 months following injury. Health-care providers need to be vigilant about the varying trajectories in children's recovery from TBI. On-going monitoring of children following injury will enable timely and proactive responses to persistent difficulties, with a view to minimising longer-term adverse consequences.	[Jones, Kelly M.; Parmar, Priya; Theadom, Alice; BIONIC Study Grp] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Tamaki Campus, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Fac Arts & Social Sci, Hamilton, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand		Jones, KM (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Sch Publ Hlth & Psychosocial Studies, Fac Hlth & Environm Studies, AUT North Shore Campus,AA254,90 Akoranga Dr, Auckland 1142, New Zealand.	kelly.jones@aut.ac.nz	Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019; Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A]	The authors would like to acknowledge the children and their families, researchers and community-based, health-care providers involved in this study. Funding was provided by the Health Research Council of New Zealand (grant number 09/063A). The funders had no role in the study design, data collection and analysis, preparation of the manuscript or the decision to submit for publication.	Anderson VA, 2000, BRAIN INJURY, V14, P679; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brown FL, 2014, J CHILD PSYCHOL PSYC, V55, P1172, DOI 10.1111/jcpp.12227; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gualtieri C Thomas, 2006, J Atten Disord, V9, P534, DOI 10.1177/1087054705283758; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Gualtieri CT, 2006, J CHILD ADOL PSYCHOP, V16, P147, DOI 10.1089/cap.2006.16.147; Khairy SA, 2016, EGYPT PEDIATR ASSO, V64, P53, DOI 10.1016/j.epag.2016.05.001; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Masarik AS, 2017, CURR OPIN PSYCHOL, V13, P85, DOI 10.1016/j.copsyc.2016.05.008; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Olsson KA, 2011, BRAIN INJURY, V27, DOI [10.1097/NEN.0b013e3181a9d503, DOI 10.1097/NEN.0B013E3181A9D503]; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Pink B.N., 2006, AUSTR NZ STANDARD CL; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Reynolds C. R., 1998, BEHAV ASSESSMENT SYS; Reynolds CR., 1992, BEHAV ASSESSMENT SYS; RICHTERS JE, 1992, PSYCHOL BULL, V112, P485, DOI 10.1037/0033-2909.112.3.485; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Statistics New Zealand, 2006, URB RUR MIGR TABL 1; Team RDC, 2008, R FDN STAT COMP; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	37	5	5	0	2	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	1172-6164	1172-6156		J PRIM HEALTH CARE	J. Prim. Health Care	MAR	2018	10	1					81	89		10.1071/HC17038			9	Primary Health Care	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GB0AS	WOS:000428705600015	30068456	Green Published, gold, Green Submitted			2022-02-06	
J	Kolecki, R; Dammavalam, V; Bin Zahid, A; Hubbard, M; Choudhry, O; Reyes, M; Han, B; Wang, T; Papas, PV; Adem, A; North, E; Gilbertson, DT; Kondziolka, D; Huang, JH; Huang, PP; Samadani, U				Kolecki, Radek; Dammavalam, Vikalpa; Bin Zahid, Abdullah; Hubbard, Molly; Choudhry, Osamah; Reyes, Marleen; Han, ByoungJun; Wang, Tom; Papas, Paraskevi Vivian; Adem, Aylin; North, Emily; Gilbertson, David T.; Kondziolka, Douglas; Huang, Jason H.; Huang, Paul P.; Samadani, Uzma			Elevated intracranial pressure and reversible eye-tracking changes detected while viewing a film clip	JOURNAL OF NEUROSURGERY			English	Article						cranial nerves; neurocritical care; intracranial pressure; eye movement; diagnostic technique	TRAUMATIC BRAIN-INJURY; HEAD-DOWN TILT; DECOMPRESSIVE CRANIECTOMY; HYPERTENSION; HYDROCEPHALUS; MICROGRAVITY; TRIAL	OBJECTIVE The precise threshold differentiating normal and elevated intracranial pressure (ICP) is variable among individuals. In the context of several pathophysiological conditions, elevated ICP leads to abnormalities in global cerebral functioning and impacts the function of cranial nerves (CNs), either or both of which may contribute to ocular dysmotility. The purpose of this study was to assess the impact of elevated ICP on eye-tracking performed while patients were watching a short film clip. METHODS Awake patients requiring placement of an ICP monitor for clinical purposes underwent eye tracking while watching a 220-second continuously playing video moving around the perimeter of a viewing monitor. Pupil position was recorded at 500 Hz and metrics associated with each eye individually and both eyes together were calculated. Linear regression with generalized estimating equations was performed to test the association of eye-tracking metrics with changes in ICP. RESULTS Eye tracking was performed at ICP levels ranging from -3 to 30 mm Hg in 23 patients (12 women, 11 men, mean age 46.8 years) on 55 separate occasions. Eye-tracking measures correlating with CN function linearly decreased with increasing ICP (p < 0.001). Measures for CN VI were most prominently affected. The area under the curve (AUC) for eye-tracking metrics to discriminate between ICP < 12 and >= 12 mm Hg was 0.798. To discriminate an ICP < 15 from >= 15 mm Hg the AUC was 0.833, and to discriminate ICP < 20 from >= 20 mm Hg the AUC was 0.889. CONCLUSIONS Increasingly elevated ICP was associated with increasingly abnormal eye tracking detected while patients were watching a short film clip. These results suggest that eye tracking may be used as a noninvasive, automatable means to quantitate the physiological impact of elevated ICP, which has clinical application for assessment of shunt malfunction, pseudotumor cerebri, concussion, and prevention of second-impact syndrome.	[Kolecki, Radek; Choudhry, Osamah; Reyes, Marleen; Han, ByoungJun; Wang, Tom; Papas, Paraskevi Vivian; Adem, Aylin; North, Emily; Kondziolka, Douglas; Huang, Paul P.] NYU, Sch Med, Dept Neurosurg, New York, NY USA; [Dammavalam, Vikalpa; Bin Zahid, Abdullah; Hubbard, Molly; Gilbertson, David T.; Samadani, Uzma] Hennepin Cty Med Ctr, Dept Neurosurg, 701 Pk Ave S,PL 610, Minneapolis, MN 55415 USA; [Dammavalam, Vikalpa; Bin Zahid, Abdullah; Hubbard, Molly; Gilbertson, David T.; Samadani, Uzma] Univ Minnesota, 701 Pk Ave S,PL 610, Minneapolis, MN 55415 USA; [Huang, Jason H.] Scott & White Healthcare, Temple, TX USA		Samadani, U (corresponding author), Hennepin Cty Med Ctr, Dept Neurosurg, 701 Pk Ave S,PL 610, Minneapolis, MN 55415 USA.; Samadani, U (corresponding author), Univ Minnesota, 701 Pk Ave S,PL 610, Minneapolis, MN 55415 USA.	uzma.samadani@hcmed.org	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168; Choudhry, Osamah/0000-0002-2790-2894; Papas, Paraskevi/0000-0001-9209-7740; Huang, Paul/0000-0003-0563-921X	National Space and Biomedical Research Institute SMARTCAP (Space Medical and Related Technologies Commercialization Assistance Program)	This work was supported by a grant from the National Space and Biomedical Research Institute SMARTCAP (Space Medical and Related Technologies Commercialization Assistance Program).	Akinsola F B, 2011, Nig Q J Hosp Med, V21, P252; Akinsola FB, 2008, J NEUROTRAUM, V25, P276; Andresen M, 2015, ACTA NEUROCHIR, V157, P109, DOI 10.1007/s00701-014-2250-2; Andresen M, 2014, J NEUROSURG, V121, P797, DOI 10.3171/2014.2.JNS132209; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aring E, 2007, STRABISMUS, V15, P79, DOI 10.1080/09273970701405305; Berdahl JP, 2012, MED HYPOTHESES, V79, P719, DOI 10.1016/j.mehy.2012.08.009; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CORBETT JJ, 1986, SEMIN NEUROL, V6, P111, DOI 10.1055/s-2008-1041454; Farahvar A, 2011, J NEUROSURG, V115, P191, DOI 10.3171/2011.4.JNS101116a; Gotoh Taro Miyahara, 2003, Biol Sci Space, V17, P204; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Haines D.E., 2013, FUNDAMENTAL NEUROSCI; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lang E W, 1995, New Horiz, V3, P400; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Macias BR, 2015, AEROSP MED HUM PERF, V86, P3, DOI 10.3357/AMHP.4044.2015; Passi N, 2013, AM J NEURORADIOL, V34, P919, DOI 10.3174/ajnr.A3022; Romner B, 2013, NAT REV NEUROL, V9, P185, DOI 10.1038/nrneurol.2013.37; Saindane AM, 2013, AM J ROENTGENOL, V201, P412, DOI 10.2214/AJR.12.9638; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Samadani U, 2015, J NEUROSURG, V122, P707, DOI 10.3171/2014.10.JNS14762; SHALLAT RF, 1973, J NEUROSURG, V38, P717, DOI 10.3171/jns.1973.38.6.0717; Steffen H, 1996, OPHTHALMOLOGY, V103, P1229, DOI 10.1016/S0161-6420(96)30518-6; Stevens SA, 2005, AVIAT SPACE ENVIR MD, V76, P329; Taibbi G, 2013, SURV OPHTHALMOL, V58, P155, DOI 10.1016/j.survophthal.2012.04.002; Wilson MH, 2011, HIGH ALT MED BIOL, V12, P379, DOI 10.1089/ham.2011.1026; Yri HM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004376; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	35	5	5	1	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2018	128	3					811	818		10.3171/2016.12.JNS161265			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX7WD	WOS:000426301400019	28574312	Bronze			2022-02-06	
J	Levack, W; Tomori, K; Takahashi, K; Sherrington, AJ				Levack, William; Tomori, Kounosuke; Takahashi, Kayoko; Sherrington, Aidan J.			Development of an English-language version of a Japanese iPad application to facilitate collaborative goal setting in rehabilitation: a Delphi study and field test	BMJ OPEN			English	Article							PROOF-OF-CONCEPT; TABLET TECHNOLOGY; DECISION-MAKING; STROKE; APHASIA; PEOPLE; APPS; PARTICIPATION; PROGRAM; SCORE	Objective This study aimed to investigate the content of an English-language version of a Japanese iPad application designed to facilitate shared decision-making around goal setting in rehabilitation: Aid for Decision making in Occupational Choice English (ADOC-E). Design Phase 1: Delphi methods to reach consensus with an international group of expert occupational therapists on the text and images in ADOC-E. Phase 2: Testing correct recognition (unprompted and prompted) of images in ADOC-E by health service users in inpatient rehabilitation and residential care. Setting Phase 1: International, online. Phase 2: Three healthcare services in New Zealand (1) a residential rehabilitation service for traumatic brain injury, (2) a nursing home for frail older adults and (3) an inpatient rehabilitation ward in a public hospital. Participants Phase 1: Fourteen experienced occupational therapists from New Zealand (4), Australia (4), UK (2) and USA (4). Phase 2: Twenty-four rehabilitation and residential care service users (10 men, 14 women; 20-95 years; Mini-Mental State Exam scores 13-30). Results Four Delphi rounds were required to reach consensus with the experienced occupational therapists on the content of ADOC-E, ending with 100 items covering daily activities that people do artd social roles they participate in. Ninety-five per cent (95/1 00) of ADOC-E items could each be correctly identified by over 80 % of service user participants with either unprompted or prompted recognition. Conclusion While a few of the more abstract concepts in ADOC-E (related to complex social roles) were less likely to be correctly recognised by all participants, the text and images ADOC-E were deemed to befit for purpose overall and ready for future clinical testing.	[Levack, William] Univ Otago, Dept Med, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Tomori, Kounosuke] Tokyo Univ Technol, Sch Hlth Sci, Dept Occupat Therapy, Yokosuka, Kanagawa, Japan; [Takahashi, Kayoko] Kitasato Univ, Sch Allied Hlth Sci, Dept Occupat Therapy, Tokyo, Japan; [Sherrington, Aidan J.] Univ Otago, Teaching & Res Unit, Dept Med Rehabil, Dunedin, New Zealand		Levack, W (corresponding author), Univ Otago, Dept Med, Rehabil Teaching & Res Unit, Wellington, New Zealand.	william.levack@otago.ac.nz	Tomori, Kounosuke/AAN-3565-2020; Levack, William Mark Magnus/F-9607-2018	Levack, William Mark Magnus/0000-0001-6631-908X; Tomori, Kounosuke/0000-0003-0695-4385	University of Otago Research Committee; Kakenhi Grant from the Japanese Society for the Promotion of Science [15K01425]	No funding was involved in phase 1. Funding for data collection in phase 2 of this study was provided by the University of Otago Research Committee. ADOC research in Japan is supported by Kakenhi Grant from the Japanese Society for the Promotion of Science (Grant number: 15K01425).	Akins Ralitsa B, 2005, BMC Med Res Methodol, V5, P37, DOI 10.1186/1471-2288-5-37; Baker SM, 2001, PHYS THER, V81, P1118, DOI 10.1093/ptj/81.5.1118; Barnard RA, 2010, QUAL HEALTH RES, V20, P239, DOI 10.1177/1049732309358327; Berg K, 2017, DISABIL REHABIL, V39, P1122, DOI 10.1080/09638288.2016.1185167; Blair J, 2011, PUBLIC OPIN QUART, V75, P636, DOI 10.1093/poq/nfr035; Bradshaw J, 2013, TIZARD LEARN DISABIL, V18, P31, DOI 10.1108/13595471311295996; Conneeley A. L., 2004, BR J OCCUP THER, V67, P248, DOI DOI 10.1177/030802260406700603; Des Roches CA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01015; Fizzotti G, 2015, STUD HEALTH TECHNOL, V210, P479, DOI 10.3233/978-1-61499-512-8-479; HAAS J, 1993, AM J PHYS MED REHAB, V72, P228, DOI 10.1097/00002060-199308000-00011; Hill D. A., 2013, J APPL REHABIL COUS, V44, P28; Kizony R, 2016, J NEUROL PHYS THER, V40, P31, DOI 10.1097/NPT.0000000000000110; Kurland J, 2014, SEMIN SPEECH LANG, V35, P51, DOI 10.1055/s-0033-1362991; Leng FY, 2014, DEMENTIA-LONDON, V13, P265, DOI 10.1177/1471301213494514; Levack W., 2012, INTERPROFESSIONAL RE, P79; Levack WMM, 2006, DISABIL REHABIL, V28, P741, DOI 10.1080/09638280500265961; Levack WMM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009727.pub2; Levack WMM, 2011, PATIENT EDUC COUNS, V85, P206, DOI 10.1016/j.pec.2011.01.011; Levack WMM, 2015, REHABILITATION GOAL, P67; McNaughton D, 2013, AUGMENT ALTERN COMM, V29, P107, DOI 10.3109/07434618.2013.784930; Mednick Z, 2017, CAN J OPHTHALMOL, V52, P13, DOI 10.1016/j.jcjo.2016.05.015; Nijhuis BJG, 2008, CLIN REHABIL, V22, P348, DOI 10.1177/0269215507083055; Ohno K, 2017, BRIT J OCCUP THER, V80, P310, DOI 10.1177/0308022617692602; Playford ED, 2000, CLIN REHABIL, V14, P491, DOI 10.1191/0269215500cr343oa; Ramsberger G, 2014, SEMIN SPEECH LANG, V35, P17, DOI 10.1055/s-0033-1362992; Rand D, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0796-9; Rohde A, 2012, APHASIOLOGY, V26, P1298, DOI 10.1080/02687038.2012.706799; Saposnik G, 2014, INT J STROKE, V9, P956, DOI 10.1111/ijs.12328; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tomori K, 2015, DISABIL REHABIL-ASSI, V10, P126, DOI 10.3109/17483107.2013.871074; Tomori K, 2013, DISABIL REHABIL, V35, P113, DOI 10.3109/09638288.2012.689919; Tomori K, 2012, OCCUP THER INT, V19, P88, DOI 10.1002/oti.325; White JH, 2015, DISABIL REHABIL, V37, P593, DOI 10.3109/09638288.2014.935876; Yan F, 2011, LECT NOTES COMPUT SC, V6944, P129, DOI 10.1007/978-3-642-23834-5_12	34	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAR	2018	8	3							e018908	10.1136/bmjopen-2017-018908			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH7YZ	WOS:000433881200075	29500204	gold, Green Published			2022-02-06	
J	Little, JR; Pavliscsak, HH; Cooper, MR; Goldstein, LA; Fonda, SJ				Little, Jeanette R.; Pavliscsak, Holly H.; Cooper, Mabel R.; Goldstein, Lois A.; Fonda, Stephanie J.			Does Mobile Care ('mCare') Improve Quality of Life and Treatment Satisfaction Among Service Members Rehabilitating in the Community? Results from a 36-Wk, Randomized Controlled Trial	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; BEING SCHEDULE GWB; PSYCHOMETRIC CHARACTERISTICS; PHONE; INTERVENTION; FEASIBILITY; MANAGEMENT; REMINDERS; MHEALTH; THERAPY	Introduction: Research has shown that mobile phones can help with management of numerous health problems. As an adjunct to care management provided to injured service members rehabilitating in their communities, particularly those with mild traumatic brain injury (mTBI), post-traumatic stress (PTS), and/or behavioral health problems, the Army developed a mobile phone application called "mCare." This study examined whether service members who received mCare had higher well-being, were more satisfied with their care, and viewed mCare as a valuable part of their care management as compared with their counterparts who received standard care management alone, and whether those with mTBI, PTS, and/or behavioral health problems benefited differently from mCare. Materials and Methods: In-processing service members at four community-based warrior transition units were recruited for participation in a 36-wk, randomized, controlled trial and allocated to receive standard care management plus mCare (n = 95) or standard care management alone (n = 87). Participants in the mCare group received daily questionnaires, tips, and appointment reminders. All participants were asked to complete the General Well-being Schedule (GWS) at baseline, 12, 24, and 36 wk, and the Case Management Quality Questionnaire (CMQQ) at 12, 24, and 36 wk. All participants and care managers were approached to complete interviews about the usability/likeability of mCare or standard care management. The analyses tested for group differences in completion of the intervention, graphed means for the GWS and CMQQ by group/subgroup, and statistically compared the longitudinal trends in these outcomes using mixed models in which group, time, and group*time were included as regression variables. The analyses also tallied interview responses and identified thematic quotes. The study protocol was reviewed and approved by the Walter Reed National Military Medical Center's Institutional Review Board. Results: Estimated rate of change in GWS scores was -2.2 (standard error = 1.0; t = -2.1; p = 0.0382). Estimated rate of change in CMQQ scores was -0.8 (standard error = 0.5; t = -1.52; p = 0.1299). Neither change was meaningful. Rates of change in the GWS and CMQQ scores did not differ by group or by behavioral health, mTBI, and PTS subgroups within the groups. The interviews found that 83% of mCare participants liked the communication with their care managers versus 73% of standard care management participants. Participants in both the mCare group and the care managers said that they liked the application's appointment tracking and reminders. Care managers thought mCare was particularly useful for people with mTBI, PTS, and cognitive problems. Conclusion: mCare did not result in differences in general well-being and satisfaction with care management among service members rehabilitating in their communities, some with mTBI, PTS, and/or behavioral health problems. But participants and care managers who used mCare said that they found it useful. Study limitations included the diversity of clinical issues of the participants, greater missing data among mCare participants, and the high baseline quality of care management in the settings observed. The fact that patients and care managers liked mCare, apart from no changes in outcomes, is important because health care is increasingly adopting mobile solutions.	[Little, Jeanette R.; Pavliscsak, Holly H.; Cooper, Mabel R.; Goldstein, Lois A.; Fonda, Stephanie J.] Mobile Hlth Innovat Ctr, Telemed & Adv Technol Res Ctr, Bldg 38711, Ft Gordon, GA 30905 USA		Little, JR (corresponding author), Mobile Hlth Innovat Ctr, Telemed & Adv Technol Res Ctr, Bldg 38711, Ft Gordon, GA 30905 USA.				Office of Force Health Protection	This study was funded by the Office of Force Health Protection and managed by the Mobile Health Innovation Center (MHIC), an intramural laboratory of the Telemedicine and Advanced Technology Research Center (TATRC), United States Army Medical Research and Material Command (USAMRMC).	[Anonymous], 2016, ECONOMIST; Ashoorkhani M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1638-0; Asklund I, 2017, NEUROUROL URODYNAM, V36, P1369, DOI 10.1002/nau.23116; Baron JS, 2017, J TELEMED TELECARE, V23, P503, DOI 10.1177/1357633X16655911; Bell Amanda M, 2012, J Diabetes Sci Technol, V6, P310; Berrouiguet S, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5066; Bigna JJR, 2014, LANCET INFECT DIS, V14, P600, DOI 10.1016/S1473-3099(14)70741-8; Brinker TJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-014288; Davey DJ, 2016, JAIDS-J ACQ IMM DEF, V73, pE23, DOI 10.1097/QAI.0000000000001115; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fazio A F, 1977, Vital Health Stat 2, P1; Hadjistavropoulos Heather D, 2003, Care Manag J, V4, P8, DOI 10.1891/cmaj.4.1.8.57475; Husain N, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116669613; Juengst SB, 2015, BRAIN INJURY, V29, P1351, DOI 10.3109/02699052.2015.1045031; Kahn JR, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5800; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Little JR, 2017, J MOB TECHNOL MED; McDowell I, 1996, J Health Serv Res Policy, V1, P238; Morland LA, 2016, MIL MED, V181, P990, DOI 10.7205/MILMED-D-15-00293; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pavliscsak H, 2016, J AM MED INFORM ASSN, V23, P110, DOI 10.1093/jamia/ocv121; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Poropatich RK, 2014, TELEMED E-HEALTH, V20, P563, DOI 10.1089/tmj.2013.0226; Poston WSC, 1998, WOMEN HEALTH, V27, P51, DOI 10.1300/J013v27n03_04; Sander L, 2016, JMIR MENT HEALTH, V3, DOI 10.2196/mental.6061; Shany T, 2017, J TELEMED TELECARE, V23, P650, DOI 10.1177/1357633X16659410; Stephani V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3226-3; Taylor JE, 2003, QUAL LIFE RES, V12, P31, DOI 10.1023/A:1022052804109; Thakkar J, 2016, EUR J PREV CARDIOL, V23, P1894, DOI 10.1177/2047487316664190	30	5	5	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183	3-4					E148	E156		10.1093/milmed/usx035			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF9BF	WOS:000432270400009	29514344	hybrid			2022-02-06	
J	McCredie, VA; Shrestha, GS; Acharya, S; Bellini, A; Singh, JM; Hemphill, JC; Goffi, A				McCredie, Victoria A.; Shrestha, Gentle S.; Acharya, Subhash; Bellini, Antonio; Singh, Jeffrey M.; Hemphill, J. Claude, III; Goffi, Alberto			Evaluating the effectiveness of the Emergency Neurological Life Support educational framework in low-income countries	INTERNATIONAL HEALTH			English	Article						Educational course; Knowledge assessment; Low-income countries; Neurocritical care; Neurological emergencies	CONTINUING MEDICAL-EDUCATION; TRAUMATIC BRAIN-INJURY; CARE; PERFORMANCE	Background: The Emergency Neurological Life Support (ENLS) is an educational initiative designed to improve the acute management of neurological injuries. However, the applicability of the course in low-income countries in unknown. We evaluated the impact of the course on knowledge, decision-making skills and preparedness to manage neurological emergencies in a resource-limited country. Methods: A prospective cohort study design was implemented for the first ENLS course held in Asia. Knowledge and decision-making skills for neurological emergencies were assessed at baseline, post-course and at 6 months following course completion. To determine perceived knowledge and preparedness, data were collected using surveys administered immediately post-course and 6 months later. Results: A total of 34 acute care physicians from across Nepal attended the course. Knowledge and decision-making skills significantly improved following the course (p=0.0008). Knowledge and decision-making skills remained significantly improved after 6 months, compared with before the course (p=0.02), with no significant loss of skills immediately following the course to the 6-month follow-up (p=0.16). At 6 months, the willingness to participate in continuing medical education activities remained evident, with 77% (10/13) of participants reporting a change in their clinical practice and decision-making, with the repeated use of ENLS protocols as the main driver of change. Conclusions: Using the ENLS framework, neurocritical care education can be delivered in low-income countries to improve knowledge uptake, with evidence of knowledge retention up to 6 months.	[McCredie, Victoria A.; Singh, Jeffrey M.; Goffi, Alberto] Univ Toronto, Dept Med, Interdept Div Crit Care Med, Toronto, ON, Canada; [McCredie, Victoria A.; Singh, Jeffrey M.; Goffi, Alberto] Univ Hlth Network, Dept Med, Div Crit Care Med, Toronto, ON, Canada; [Shrestha, Gentle S.; Acharya, Subhash] Tribhuvan Univ Teaching Hosp, Dept Anesthesiol, Kathmandu, Nepal; [Bellini, Antonio] Barking Havering & Redbridge Univ Hosp NHS Trust, Dept Anesthesia, Queens Hosp, London, England; [Hemphill, J. Claude, III] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Neurol, San Francisco, CA USA		McCredie, VA (corresponding author), Univ Hlth Network, Toronto Western Hosp, Dept Crit Care Med, 2nd Floor McLaughlin Rm 411-Q,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	Victoria.McCredie@uhn.ca	Hemphill, Claude/AAY-5630-2021; Goffi, Alberto/X-1053-2019; Demchuk, Andrew M/E-1103-2012; Goffi, Alberto/AAE-2817-2020	Hemphill, Claude/0000-0003-4019-7525; Demchuk, Andrew M/0000-0002-4930-7789; Goffi, Alberto/0000-0002-9658-3903; Singh, Jeffrey/0000-0003-3499-574X			Aryal D, 2015, AM J RESP CRIT CARE, V192, P781, DOI 10.1164/rccm.201507-1346ED; Bennett NL, 2000, ACAD MED, V75, P1167, DOI 10.1097/00001888-200012000-00007; Bliss LA, 2012, J AM COLL SURGEONS, V215, P766, DOI 10.1016/j.jamcollsurg.2012.07.015; Braksick SA, 2017, NEUROCRIT CARE, V26, P96, DOI 10.1007/s12028-016-0293-3; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanitites Research Council of Canada, 2010, TRIC POL STAT ETH CO, P135; Chin JH, 2014, NEUROLOGY, V83, P349, DOI 10.1212/WNL.0000000000000610; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Goffi A, 2015, NEUROCRIT CARE S1, V23, P1; Grant J, 1999, J CONTIN EDUC HEALTH, V19, P214; Howe KL, 2013, WORLD NEUROSURG, V80, pE171, DOI [10.1016/j.wneu.2013.07.003, 10.1016/j.wneu.2013.02.087]; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI [10.1007/s00134-009-1738-3, 10.1097/CCM.0b013e3181cb0cdc]; Miller CM, 2015, NEUROCRIT CARE, V23, pS1, DOI 10.1007/s12028-015-0170-5; Pandey Sanjay, 2012, Indian J Public Health, V56, P227, DOI 10.4103/0019-557X.104253; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shrestha GS, 2016, CURR OPIN CRIT CARE, V22, P100, DOI 10.1097/MCC.0000000000000285; Smith WS, 2012, NEUROCRIT CARE, V17, P1, DOI 10.1007/s12028-012-9741-x; Streiner DL., 2008, HLTH MEASUREMENT SCA; van den Broek JM, 2015, CRIT CARE MED, V43, P1731, DOI 10.1097/CCM.0000000000000980; Weiss CH, 2011, AM J RESP CRIT CARE, V184, P680, DOI 10.1164/rccm.201101-0037OC	22	5	5	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1876-3413	1876-3405		INT HEALTH	Int. Health	MAR	2018	10	2					116	124		10.1093/inthealth/ihy003			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FZ9LM	WOS:000427932800009	29506188	Green Published, Green Submitted, hybrid			2022-02-06	
J	Richards, JE; Scalea, TM; Mazzeffi, MA; Rock, P; Galvagno, SM				Richards, Justin E.; Scalea, Thomas M.; Mazzeffi, Michael A.; Rock, Peter; Galvagno, Samuel M.			Does Lactate Affect the Association of Early Hyperglycemia and Multiple Organ Failure in Severely Injured Blunt Trauma Patients?	ANESTHESIA AND ANALGESIA			English	Article							CRITICALLY-ILL PATIENTS; GLUCOSE CONTROL; ADMISSION HYPERGLYCEMIA; PROGNOSTIC INDICATOR; MAJOR TRAUMA; BRAIN-INJURY; MORTALITY; OUTCOMES; POSTINJURY; CRANIOTOMY	BACKGROUND: Early hyperglycemia is associated with multiple organ failure (MOF) after traumatic injury; however, few studies have considered the contribution of depth of clinical shock. We hypothesize that when considered simultaneously, glucose and lactate are associated with MOF in severely injured blunt trauma patients. METHODS: We performed a retrospective investigation at a single tertiary care trauma center. Inclusion criteria were patient age 18 years, injury severity score (ISS) >15, blunt mechanism of injury, and an intensive care unit length of stay >48 hours. Patients with a history of diabetes or who did not survive the initial 48 hours were excluded. Demographics, injury severity, and physiologic data were recorded. Blood glucose and lactate values were collected from admission through the initial 24 hours of hospitalization. Multiple metrics of glucose and lactate were calculated: the first glucose (Gluc(adm), mg/dL) and lactate (Lac(adm), mmol/L) at hospital admission, the mean initial 24-hour glucose (Gluc(24hMean), mg/dL) and lactate (Lac(24hMean), mmol/L), and the time-weighted initial 24-hour glucose (Gluc(24hTW)) and lactate (Lac(24hTW)). These metrics were divided into quartiles. The primary outcome was MOF. Separate Cox proportional hazard models were generated to assess the association of each individual glucose and lactate metric on MOF, after controlling for ISS, admission shock index, and disposition to the operating room after hospital admission. We assessed the interaction between glucose and lactate metrics in the multivariable models. Results are reported as hazard ratios (HRs) for an increase in the quartile level of glucose and lactate measurements, with 95% confidence intervals (CIs). RESULTS: A total of 507 severely injured blunt trauma patients were evaluated. MOF occurred in 46 of 507 (9.1%) patients and was associated with a greater median ISS (33.5, interquartile range [IQR]: 22-41 vs 27, IQR: 21-34; P < .001) and a greater median admission shock index (0.82, IQR: 0.68-1.1 vs 0.73, IQR: 0.60-0.91; P = .02). Patients who were transferred to the operating room after the initial trauma resuscitation were also more likely to develop MOF (20 of 119, 14.4% vs 26 of 369, 7.1%; P = .01). Three separate Cox proportional regression models demonstrated the following HR for an increase in the individual glucose metric quartile and MOF, while controlling for confounding variables: Gluc(adm) HR: 1.35, 95% CI, 1.02-1.80; Gluc(24hMean) HR: 1.63, 95% CI, 1.14-2.32; Gluc(24hTW) HR: 1.14, 95% CI, 0.86-1.50. Three separate Cox proportional hazards models also demonstrated the following HR for each individual lactate metric quartile while controlling for the same confounders, with MOF again representing the dependent variable: Lac(adm) HR: 1.94, 95% CI, 1.38-2.96; Lac(24hMean) HR: 1.68, 95% CI, 1.22-2.31; Lac(24hTW) HR: 1.49, 95% CI, 1.10-2.02. When metrics of both glucose and lactate were entered into the same model only lactate remained significantly associated with MOF: Lac(adm) HR: 1.86, 95% CI, 1.29-2.69, Lac(24hMean) HR: 1.54, 95% CI, 1.11-2.12, and Lac(24hTW) HR: 1.48, 95% CI, 1.08-2.01. There was no significant interaction between lactate and glucose variables in relation to the primary outcome. CONCLUSIONS: When glucose and lactate are considered simultaneously, only lactate remained significantly associated with MOF in severely injured blunt trauma patients.	[Richards, Justin E.; Mazzeffi, Michael A.; Rock, Peter; Galvagno, Samuel M.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Richards, Justin E.; Galvagno, Samuel M.] R Adams Cowley Shock Trauma Ctr, Div Trauma Anesthesiol, 22 S Greene St,T1R77, Baltimore, MD 21201 USA; [Richards, Justin E.; Scalea, Thomas M.] R Adams Cowley Shock Trauma Ctr, Program Trauma, 22 S Greene St,T1R77, Baltimore, MD 21201 USA; [Scalea, Thomas M.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA		Richards, JE (corresponding author), R Adams Cowley Shock Trauma Ctr, Div Trauma Anesthesiol, 22 S Greene St,T1R77, Baltimore, MD 21201 USA.; Richards, JE (corresponding author), R Adams Cowley Shock Trauma Ctr, Program Trauma, 22 S Greene St,T1R77, Baltimore, MD 21201 USA.	justin.richards@som.umaryland.edu	Mazzeffi, Michael/AAI-8178-2020				ABRAMSON D, 1993, J TRAUMA, V35, P584, DOI 10.1097/00005373-199310000-00014; Badawi O, 2012, CRIT CARE MED, V40, P3180, DOI 10.1097/CCM.0b013e3182656ae5; Bhattacharjee S, 2014, J NEUROSURG ANESTH, V26, P313, DOI 10.1097/ANA.0000000000000057; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Duane TM, 2008, J TRAUMA, V64, P1184, DOI 10.1097/TA.0b013e31816c5c95; Duane TM, 2006, AM SURGEON, V72, P613; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Frisch A, 2010, DIABETES CARE, V33, P1783, DOI 10.2337/dc10-0304; Green JP, 2012, ACAD EMERG MED, V19, P1268, DOI 10.1111/acem.12015; Guyette F, 2011, J TRAUMA, V70, P782, DOI 10.1097/TA.0b013e318210f5c9; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Hutchings L, 2017, J TRAUMA ACUTE CARE, V82, P534, DOI 10.1097/TA.0000000000001328; Jackson RS, 2012, J AM COLL SURGEONS, V214, P68, DOI 10.1016/j.jamcollsurg.2011.09.016; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Kaukonen KM, 2014, CRIT CARE MED, V42, P1379, DOI 10.1097/CCM.0000000000000214; Kerby JD, 2012, ANN SURG, V256, P446, DOI 10.1097/SLA.0b013e3182654549; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; Mowery Nathan T, 2009, J Intensive Care Med, V24, P242, DOI 10.1177/0885066609335663; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12851; Paladino L, 2010, J TRAUMA, V69, P41, DOI 10.1097/TA.0b013e3181c9f0cb; Pecha T, 2011, ANESTH ANALG, V113, P336, DOI 10.1213/ANE.0b013e31821d3dde; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Scalea TM, 2007, ANN SURG, V246, P605, DOI 10.1097/SLA.0b013e318155a789; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Sperry JL, 2007, J TRAUMA, V63, P487, DOI 10.1097/TA.0b013e31812e51fc; Sperry JL, 2009, J TRAUMA, V66, P1076, DOI 10.1097/TA.0b013e31817db0de; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vandromme MJ, 2010, J AM COLL SURGEONS, V210, P861, DOI 10.1016/j.jamcollsurg.2010.01.012; Vogelzang M, 2004, CRIT CARE, V8, pR122, DOI 10.1186/cc2840; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72	36	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	MAR	2018	126	3					904	910		10.1213/ANE.0000000000002626			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	FW5GI	WOS:000425343900025	29283920				2022-02-06	
J	Rodriguez, A; Smielewski, P; Rosenthal, E; Moberg, D				Rodriguez, Anna; Smielewski, Peter; Rosenthal, Eric; Moberg, Dick			Medical Device Connectivity Challenges Outline the Technical Requirements and Standards For Promoting Big Data Research and Personalized Medicine in Neurocritical Care	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				TRAUMATIC BRAIN-INJURY	Brain injuries are complicated medical problems and their management requires data from disparate sources to extract actionable information. In neurocritical care, interoperability is lacking despite the perceived benefits. Several efforts have been underway, but none have been widely adopted, underscoring the difficulty of achieving this goal. We have identified the current pain points of data collection and integration based on the experience with two large multi-site clinical studies: Transforming Research And Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) in the United States and Collaborative European Neuro Trauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) in Europe. The variability of measurements across sites remains a barrier to uniform data collection. We found a need for annotation standards and for a standardized archive format for high-resolution data. Overall, the hidden cost for successful data collection was initially underestimated. Although the use of bedside data integration solutions, such as the Moberg's Component Neuromonitoring System (Moberg Research, Inc., Ambler, PA, USA) or ICM+ software (Cambridge Enterprise, Cambridge, UK), facilitated the homogenous collection of synchronized data, there remain issues that need to be addressed by the neurocritical care community. To this end, we have organized a Working Group on Neurocritical Care Informatics, whose next step is to create an overarching informatics framework that takes advantage of the collected information to answer scientific questions and to accelerate the translation of trial results to actions benefitting military medicine.	[Rodriguez, Anna; Moberg, Dick] Moberg Res Inc, 224 South Maple St, Ambler, PA 19002 USA; [Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Brain Phys Lab, Div Neurosurg, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0QQ, England; [Rosenthal, Eric] Massachusetts Gen Hosp, Dept Neurol, Lunder Neurosci ICU 6, 55 Fruit St, Boston, MA 02114 USA		Rodriguez, A (corresponding author), Moberg Res Inc, 224 South Maple St, Ambler, PA 19002 USA.		PAN, ZEQIANG/X-6341-2018; Rosenthal, Eric Scott/A-2085-2017	Rosenthal, Eric Scott/0000-0003-3900-356X	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-C-0055]	This study was supported in part by the U.S. Army Medical Research and Materiel Command under contract no. W81XWH-09-C-0055.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Cabeleira M, 16 INT S INT PRESS N; Citerio G, 2015, CURR OPIN CRIT CARE, V21, P113, DOI 10.1097/MCC.0000000000000179; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Defense and Veterans Brain Injury Center, DOD NUMB TRAUM BRAIN; Faul M, 2010, TRAUMATIC BRAIN INJU; Feyen BFE, 2012, MINERVA ANESTESIOL, V78, P949; Lazaridis C, 2016, ACTA NEUROCHIR SUPPL, V122, P117, DOI 10.1007/978-3-319-22533-3_23; Le Roux P, 2014, NEUROCRIT CARE, V21; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Moberg RS, 2013, MONITORING NEUROCRIT, P391; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Olson DM, 2012, NEUROCRIT CARE, V16, P55, DOI 10.1007/s12028-011-9613-9; Ristic A, 2015, J NEUROANAESTH CRIT, V2, P97; Rodriguez A, 2015, IPROC, V1, pe12; Stead M, 2016, J CLIN NEUROPHYSIOL, V33, P403, DOI 10.1097/WNP.0000000000000257; Vespa P, 2014, NEUROCRIT CARE, V21, P270, DOI 10.1007/s12028-014-0049-x; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	19	5	5	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			99	104		10.1093/milmed/usx146			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GC0JM	WOS:000429463600014	29635618	Bronze			2022-02-06	
J	Sato, R; Kuriyama, A; Nasu, M; Gima, S; Iwanaga, W; Takada, T; Kitahara, Y; Fukui, H; Yonemori, T; Yagi, M				Sato, Ryota; Kuriyama, Akira; Nasu, Michitaka; Gima, Shinnji; Iwanaga, Wataru; Takada, Tadaaki; Kitahara, Yusuke; Fukui, Hideto; Yonemori, Terutake; Yagi, Masaharu			Impact of rapid response car system on ECMO in out-of-hospital cardiac arrest: A retrospective cohort study	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Cardiac arrest; Extracorporeal circulation; Extracorporeal membrane oxygenation; Cardiopulmonary resuscitation; Out-of-hospital cardiac arrest	EXTRACORPOREAL CARDIOPULMONARY-RESUSCITATION; EMERGENCY MEDICAL-SERVICES; FAVORABLE NEUROLOGICAL OUTCOMES; TRAUMATIC BRAIN-INJURY; LIFE-SUPPORT; SURVIVAL; MORTALITY; ANESTHESIOLOGIST; ASSOCIATION; PHYSICIANS	Introduction: Extracorporeal life support (ECLS) has been reported to be more effective than conventional cardiopulmonary resuscitation (CPR). In ECLS, a shorter time from arrival to implantation of extracorporeal membrane oxygenation (ECMO; door-to-ECMO) time was predicted to be associated with better survival rates. This study aimed to examine the impact of the physician-based emergency medical services (P-EMS) using a rapid response car (RRC) on door-to-ECMO time in patients with out-of-hospital cardiac arrest (OHCA). Methods: In this retrospective cohort study, adult patients with OHCA who were admitted to a Japanese tertiary care hospital from April 2012 to December 2016 and underwent venoarterial ECMO were included. Patients were either transferred by emergency medical service (EMS only group) or RRC (RRC group). Primary outcome was door-to-ECMO time. Wilcoxon rank-sum test was used to compare the outcome between the two groups. Results: A total of 34 patients were included in this study, and outcome data were available for all patients. The door-to-ECMO time was significantly shorter in the RRC group than in the EMS only group (median, 23 min vs. 36 min; P = 0.006). Additionally, the RRC was also associated with earlier successful intubation and intravenous adrenaline administration. Conclusion: The physician-based RRC system was associated with a shorter door-to-ECMO time and successful advanced procedures in prehospital settings. Combination of the RRC system with ECLS may lead to better outcomes in patients with OHCA. (c) 2017 Elsevier Inc. All rights reserved.	[Sato, Ryota; Nasu, Michitaka; Gima, Shinnji; Iwanaga, Wataru; Kitahara, Yusuke; Fukui, Hideto; Yonemori, Terutake; Yagi, Masaharu] Urasoe Gen Hosp, Dept Emergency & Crit Care Med, Okinawa, Japan; [Sato, Ryota] Univ Hawaii Manoa, John A Burns Sch Med, Dept Internal Med, Honolulu, HI 96822 USA; [Kuriyama, Akira] Kurashiki Cent Hosp, Emergency & Crit Care Ctr, Okayama, Japan; [Takada, Tadaaki] Tokushima Red Cross Hosp, Dept Emergency Med, Tokushima, Japan		Sato, R (corresponding author), 4-16-1 Iso, Urasoe City, Okinawa 9012131, Japan.	st051035@gmail.com					ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; Ausserer J, 2017, INJURY, V48, P20, DOI 10.1016/j.injury.2016.09.005; Bottiger BW, 1999, HEART, V82, P674, DOI 10.1136/hrt.82.6.674; Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7; Ewy GA, 2015, RESUSCITATION, V96, P180, DOI 10.1016/j.resuscitation.2015.08.011; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Franschman G, 2013, INJURY, V44, P1232, DOI 10.1016/j.injury.2013.06.002; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; Gries A, 2006, ANAESTHESIST, V55, P1080, DOI 10.1007/s00101-006-1051-2; Hajbaghery MA, 2005, RESUSCITATION, V66, P317, DOI 10.1016/j.resuscitation.2005.04.004; Han SJ, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-015-0212-2; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kruger AJ, 2013, ACTA ANAESTH SCAND, V57, P1175, DOI 10.1111/aas.12181; Leick J, 2013, CLIN RES CARDIOL, V102, P661, DOI 10.1007/s00392-013-0580-3; Maekawa K, 2013, CRIT CARE MED, V41, P1186, DOI 10.1097/CCM.0b013e31827ca4c8; Mikkelsen S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006167; Morimura N, 2011, RESUSCITATION, V82, P10, DOI 10.1016/j.resuscitation.2010.08.032; Nielsen K, 2011, RESUSCITATION, V82, P1410, DOI 10.1016/j.resuscitation.2011.05.027; Osterwalder JJ, 2003, J TRAUMA, V55, P355, DOI 10.1097/01.TA.0000034231.94460.1F; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Sakamoto T, 2014, RESUSCITATION, V85, P762, DOI 10.1016/j.resuscitation.2014.01.031; Shih CL, 2007, RESUSCITATION, V72, P394, DOI 10.1016/j.resuscitation.2006.07.020; Shin TG, 2011, CRIT CARE MED, V39, P1, DOI 10.1097/CCM.0b013e3181feb339; Tanaka H, 2016, AM J EMERG MED, V34, P2284, DOI 10.1016/j.ajem.2016.08.026; Timmermann A, 2008, CURR OPIN ANESTHESIO, V21, P222, DOI 10.1097/ACO.0b013e3282f5f4f7; Ueta H, 2017, AM J EMERG MED, V35, P676, DOI 10.1016/j.ajem.2016.12.066	26	5	5	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAR	2018	36	3					442	445		10.1016/j.ajem.2017.08.055			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GA3LR	WOS:000428231100019	28863949				2022-02-06	
J	Saunders, RN; Adams, NS; Chapman, AJ; Davis, AT; Koehler, TJ; Durling, LT; Iskander, GA; Girotto, JA				Saunders, Rachel N.; Adams, Nicholas S.; Chapman, Alistair J.; Davis, Alan T.; Koehler, Tracy J.; Durling, Luke T.; Iskander, Gaby A.; Girotto, John A.			The impact of the repeal of Michigan's universal helmet law on traumatic brain injury: A statewide analysis	AMERICAN JOURNAL OF SURGERY			English	Article						Helmet; Helmet law; Mortality; Motorcycle; Traumatic brain injury	HEAD-INJURY; DEATHS	Background: In April of 2012, Michigan repealed its 35-year-old universal motorcycle helmet law in favor of a partial helmet law, which permits motorcyclists older than 21 years old with sufficient insurance and experience to drive un-helmeted. We evaluated the clinical impact of the repeal. Methods: The Michigan Trauma Quality Improvement Program's trauma database was queried for motorcycle crash patients between 1/1/09-4/12/12 and between 4/13/12-12/31/14. Results: There were 1970 patients in the pre-repeal analysis and 2673 patients in the post-repeal analysis. Following the repeal, patients were more likely to be un-helmeted (p < 0.001) and to have a traumatic brain injury (p < 0.001). Patients were also more likely to require neurosurgical interventions (relative risk 1.4, p = 0.011). Conclusion: Following the repeal of the universal helmet law, there has been a significant increase in traumatic brain injuries and neurosurgical interventions. This analysis highlights another detrimental impact of the repeal of the universal helmet law. (c) 2017 Elsevier Inc. All rights reserved.	[Saunders, Rachel N.] Michigan State Univ, Spectrum Hlth, Gen Surg Residency, 221 Michigan NE,Suite 402, Grand Rapids, MI 49503 USA; [Adams, Nicholas S.] Michigan State Univ, Spectrum Hlth, Plast Surg Residency, 221 Michigan NE,Suite 402, Grand Rapids, MI 49503 USA; [Chapman, Alistair J.; Durling, Luke T.; Iskander, Gaby A.] Michigan State Univ, Spectrum Hlth Hosp, Coll Human Med, Acute Care Surg, 221 Michigan NE,Suite 402, Grand Rapids, MI 49503 USA; [Davis, Alan T.; Koehler, Tracy J.] Grand Rapids Med Educ Partners, 945 Ottawa Ave NE, Grand Rapids, MI 49503 USA; [Girotto, John A.] Michigan State Univ, Spectrum Hlth Helen DeVos Childrens Hosp, Coll Human Med, Pediat Plast & Craniofacial Surg, 426 Michigan St NE,Suite 304, Grand Rapids, MI 49503 USA		Saunders, RN (corresponding author), Michigan State Univ, Spectrum Hlth, Gen Surg Residency, 221 Michigan NE,Suite 402, Grand Rapids, MI 49503 USA.	rachel.saunders@spectrumhealth.org		Saunders, Rachel/0000-0001-7560-8895			Bledsoe GH, 2002, J TRAUMA, V53, P1078, DOI 10.1097/00005373-200212000-00009; Carter PM, 2017, AM J PUBLIC HEALTH, V107, P166, DOI 10.2105/AJPH.2016.303525; Chapman AJ, 2014, AM J SURG, V207, P352, DOI 10.1016/j.amjsurg.2013.12.001; Croce MA, 2009, ANN SURG, V250, P390, DOI 10.1097/SLA.0b013e3181b365a2; Hothem Z, 2016, AM J SURG, P1; Houston DJ, 2008, ACCIDENT ANAL PREV, V40, P200, DOI 10.1016/j.aap.2007.05.005; KELLY P, 1991, ANN EMERG MED, V20, P852, DOI 10.1016/S0196-0644(05)81426-X; Mertz KJ, 2008, AM J PUBLIC HEALTH, V98, P1464, DOI 10.2105/AJPH.2007.123299; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; Striker RH, 2016, AM J SURG, V211, P529, DOI 10.1016/j.amjsurg.2015.11.004; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631	11	5	5	0	7	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	MAR	2018	215	3					424	427		10.1016/j.amjsurg.2017.09.033			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	FZ4LV	WOS:000427564600024	29126593				2022-02-06	
J	Shin, S; Lee, HJ; Shin, J; Lee, S				Shin, Somi; Lee, Hui Jai; Shin, Jongwhan; Lee, Sejong			Predictors of abnormal brain computed tomography findings in patients with acute altered mental status in the emergency department	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Unconsciousness; Tomography; X-Ray computed; Diagnosis; Risk factors	C-REACTIVE PROTEIN; MINOR HEAD-INJURY; NEW-ORLEANS CRITERIA; RULE; PROGNOSIS; RISK	Objective Brain computed tomography (CT) is commonly performed to diagnose acute altered mental status (AMS), a critically important symptom in many serious diseases. However, negative CT results are common, which result in unnecessary CT use. Therefore, this study aimed to determine the clinical factors associated with positive CT findings. Methods Patients with acute AMS selected from an emergency department-based registry were retrospectively evaluated. Patients with non-traumatic and noncommunicable diseases on initial presentation and with Glasgow Comal Scale scores of <15 were included in the study. Results Among the 367 brain CT results of patients with AMS during the study period, 14.6 (39.8%) were positive. In a multivariate analysis, the presence of focal neurologic deficit (odds ratio [OR], 132.6; 9586 confidence interval [CI], 37.8 to 464.6), C-reactive protein level <2 mg/dL (OR, 3.9; 95% CI, 1.4 to 10.6), and Glasgow Coma I Scale score <9 (OR, 2.4; 95% CI, 1.2 to 4.8) were significantly associated with positive brain CT results. Conclusion The presence of focal neurologic deficit, initial Glasgow Comal Scale score of <9, and initial C-reactive protein levels of <2 mg/dL can facilitate the selection of brain CT to diagnose patients with acute AMS in the emergency department	[Shin, Somi; Lee, Hui Jai; Shin, Jongwhan; Lee, Sejong] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Emergency Med, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea		Lee, HJ (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Emergency Med, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea.	emdrlee@snu.ac.kr	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085; Lee, Se Jong/0000-0001-6628-5967	SNU EM Research Grant	This study is supported by a grant from the SNU EM Research Grant.	[Anonymous], 1999, ANN EMERG MED, V33, P251; Di Napoli M, 2005, STROKE, V36, P1316, DOI 10.1161/01.STR.0000165929.78756.ed; Di Napoli M, 2012, NEUROLOGY, V79, P690, DOI 10.1212/WNL.0b013e318264e3be; Han JH, 2013, CLIN GERIATR MED, V29, P101, DOI 10.1016/j.cger.2012.09.005; Hardy JE, 2008, EMERG MED AUSTRALAS, V20, P420, DOI 10.1111/j.1742-6723.2008.01118.x; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Kanich W, 2002, AM J EMERG MED, V20, P613, DOI 10.1053/ajem.2002.35464; Lee J, 2013, EMERG RADIOL, V20, P219, DOI 10.1007/s10140-012-1098-0; Lee J, 2010, ANN EMERG MED, V56, P591, DOI 10.1016/j.annemergmed.2010.05.027; Leong LB, 2010, EUR J EMERG MED, V17, P219, DOI 10.1097/MEJ.0b013e328331dde5; Nouh A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00030; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Patel MM, 2002, AM J EMERG MED, V20, P212, DOI 10.1053/ajem.2002.32632; Sierra R, 2004, INTENS CARE MED, V30, P2038, DOI 10.1007/s00134-004-2434-y; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973	18	5	5	0	2	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	MAR	2018	5	1					1	6		10.15441/ceem.16.163			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GL9PF	WOS:000437667100001	29618186	Green Submitted, hybrid, Green Published			2022-02-06	
J	Stenberg, J; Godbolt, AK; Moller, MC				Stenberg, Jonas; Godbolt, Alison K.; Moller, Marika C.			THE VALUE OF INCORPORATING PERSONALLY RELEVANT STIMULI INTO CONSCIOUSNESS ASSESSMENT WITH THE COMA RECOVERY SCALE - REVISED: A PILOT STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						consciousness disorders; minimally consciousness state; vegetative state; unresponsive wakefulness syndrome; personally relevant stimuli	TRAUMATIC BRAIN-INJURY; VISUAL PURSUIT; PROLONGED DISORDERS; DIAGNOSTIC UTILITY; STATES; WAKEFULNESS; PREVALENCE; BEHAVIOR; OUTCOMES; MIRROR	Objective: To explore whether the use of personally relevant stimuli, for some tasks in the Coma Recovery Scale - Revised (CRS-R), generates more responses in patients with prolonged disorders of consciousness compared with neutral stimuli. Design: Multiple single-case design. Subjects: Three patients with prolonged disorders of consciousness recruited from an inpatient department at a regional brain injury rehabilitation clinic in Stockholm, Sweden. Methods: Patients were repeatedly assessed with the CRS-R, Randomization tests (bootstrapping) were used to compare the number of responses generated by personally relevant and neutral stimuli on 5 items in the CRS-R. Results: Compared with neutral stimuli, photographs of relatives generated significantly more visual fixations, A mirror generated visual pursuit to a significantly greater extent than other self-relevant stimuli. On other items, no significant differences between neutral and personally relevant stimuli were seen. Conclusion: Personally relevant visual stimuli may minimize the risk of missing visual fixation, compare with the neutral stimuli used in the current gold standard behavioural assessment measure (CRS-R). However, due to the single-subject design this conclusion is tentative and more research is needed.	[Stenberg, Jonas; Godbolt, Alison K.; Moller, Marika C.] Danderyd Hosp, Dept Rehabil Med, Stockholm, Sweden; [Godbolt, Alison K.; Moller, Marika C.] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Rehabil Med, Stockholm, Sweden		Stenberg, J (corresponding author), Danderyds Sjukhus AB, Rehabil Med Univ Kliniken, SE-18220 Danderyd, Sweden.	jonas.stenberg@ntnu.no	Moller, Marika/S-5427-2019; Stenberg, Jonas/AAN-4552-2021; MAller, Marika C/N-8782-2016	Moller, Marika/0000-0001-8700-5186; Stenberg, Jonas/0000-0002-5769-7959; MAller, Marika C/0000-0001-8700-5186			Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bayne T, 2016, TRENDS COGN SCI, V20, P405, DOI 10.1016/j.tics.2016.03.009; Bodien Yelena G, 2016, Open Neuroimag J, V10, P23, DOI 10.2174/1874440001610010023; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cheng LJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-27; Cruse D, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0798-1; Di HB, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-147; Di Stefano C, 2012, BRAIN INJURY, V26, P1250, DOI 10.3109/02699052.2012.667588; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Godbolt AK, 2012, BRAIN INJURY, V26, P188, DOI 10.3109/02699052.2011.648708; Hauger SL, 2017, J HEAD TRAUMA REHAB, V32, P185, DOI 10.1097/HTR.0000000000000267; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee Y, 2012, NEUROIMAGE, V61, P1287, DOI 10.1016/j.neuroimage.2012.02.073; Lovstad M, 2014, J HEAD TRAUMA REHAB, V29, pE31, DOI 10.1097/HTR.0000000000000017; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Pisa FE, 2014, J HEAD TRAUMA REHAB, V29, pE23, DOI 10.1097/HTR.0b013e3182a4469f; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Todman J. B., 2001, SINGLE CASE SMALL N; Trojano L, 2013, J NEUROL, V260, P306, DOI 10.1007/s00415-012-6717-x; Trojano L, 2012, J NEUROL, V259, P1888, DOI 10.1007/s00415-012-6435-4; van Erp WS, 2014, EUR J NEUROL, V21, P1361, DOI 10.1111/ene.12483; Vanhaudenhuyse A, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.121624; Wannez S, 2017, J NEUROL, V264, P928, DOI 10.1007/s00415-017-8469-0	31	5	5	0	0	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAR	2018	50	3					253	260		10.2340/16501977-2309			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GF3NY	WOS:000431864100004	29313873	gold, Green Published, Green Submitted			2022-02-06	
J	Domowicz, M; Wadlington, NL; Henry, JG; Diaz, K; Munoz, MJ; Schwartz, NB				Domowicz, Miriam; Wadlington, Natasha L.; Henry, Judith G.; Diaz, Kasandra; Munoz, Miranda J.; Schwartz, Nancy B.			Glial cell responses in a murine multifactorial perinatal brain injury model	BRAIN RESEARCH			English	Article						Perinatal brain injury; Astrocyte precursors; Oligodendrocytes precursors; Neural stem cells; Inflammation; Lipopolysaccharide	DEVELOPING RAT-BRAIN; WHITE-MATTER INJURY; NEURAL STEM-CELLS; PREMATURE-INFANTS; DEVELOPMENTAL NEUROPATHOLOGY; ASTROCYTE DEVELOPMENT; CEREBRAL-PALSY; HEAD-INJURY; IN-VIVO; MICE	The impact of traumatic brain injury during the perinatal period, which coincides with glial cell (astrocyte and oligodendrocyte) maturation was assessed to determine whether a second insult, e.g., increased inflammation due to remote bacterial exposure, exacerbates the initial injury's effects, possibly eliciting longer-term brain damage. Thus, a murine multifactorial injury model incorporating both mechanisms consisting of perinatal penetrating traumatic brain injury, with or without intraperitoneal injection of lipopolysaccharide (LPS), an analog of remote pathogen exposure has been developed. Four days after injury, gene expression changes for different cell markers were assessed using mRNA in situ hybridization (ISH) and qPCR. Astrocytic marker mRNA levels increased in the stab-alone and stab-plus-LPS treated animals indicating reactive gliosis. Activated microglial/macrophage marker levels, increased in the ipsilateral sides of stab and stab-plus LPS animals by P10, but the differences resolved by P15. Ectopic expression of glial precursor and neural stem cell markers within the cortical injury site was observed by ISH, suggesting that existing precursors and neural stem cells migrate into the injured areas to replace the cells lost in the injury process. Furthermore, single exposure to LPS concomitant with acute stab injury affected the oligodendrocyte population in both the injured and contralateral uninjured side, indicating that after compromise of the blood-brain barrier integrity, oligodendrocytes become even more susceptible to inflammatory injury. This multifactorial approach should lead to a better understanding of the pathogenic sequelae observed as a consequence of perinatal brain insult/injury, caused by combinations of trauma, intrauterine infection, hypoxia and/or ischemia in humans. (C) 2017 Elsevier B.V. All rights reserved.	[Domowicz, Miriam; Wadlington, Natasha L.; Henry, Judith G.; Diaz, Kasandra; Munoz, Miranda J.; Schwartz, Nancy B.] Univ Chicago, Dept Pediat, Biol Sci Div, Chicago, IL 60637 USA; [Schwartz, Nancy B.] Univ Chicago, Dept Biochem & Mol Biol, Biol Sci Div, 920 E 58Th St, Chicago, IL 60637 USA		Domowicz, M (corresponding author), Univ Chicago, Med Ctr, Dept Pediat, 5841 S Maryland Ave,MC 5058, Chicago, IL 60637 USA.	mdxx@uchicago.edu		Munoz, Miranda/0000-0002-3782-6530; Domowicz, Miriam/0000-0001-7860-4427; Wadlington, Natasha/0000-0002-4380-7838	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [NICHD: P01 HD09402, P30 HD054275]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD009402] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD054275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM066522] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Child Health and Human Development (NICHD: P01 HD09402; P30 HD054275). We thank Jim Mensch for helpful comments during manuscript preparation.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Arsenault D, 2014, BRAIN BEHAV IMMUN, V38, P77, DOI 10.1016/j.bbi.2013.12.016; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Bingham D, 2013, J NEUROIMMUNOL, V256, P28, DOI 10.1016/j.jneuroim.2012.12.009; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bloch JR, 2005, JOGNN-J OBST GYN NEO, V34, P358, DOI 10.1177/0884217505276255; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Cardoso FL, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0299-3; Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; de Beer MC, 2003, J LIPID RES, V44, P674, DOI 10.1194/jlr.M200444-JLR200; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Domowicz MS, 2011, BRAIN RES, V1389, P35, DOI 10.1016/j.brainres.2011.03.006; Dornowicz MS, 2008, DEV BIOL, V315, P114, DOI 10.1016/j.ydbio.2007.12.014; Fleiss B, 2015, DEV MED CHILD NEUROL, V57, P17, DOI 10.1111/dmcn.12723; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Girard S, 2009, NEUROSCIENCE, V158, P673, DOI 10.1016/j.neuroscience.2008.10.032; Girard S, 2012, BRAIN BEHAV IMMUN, V26, P1331, DOI 10.1016/j.bbi.2012.09.001; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Guo ZB, 2013, BRAIN RES, V1532, P14, DOI 10.1016/j.brainres.2013.08.003; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawson MA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-54; Lea PM, 2001, MENT RETARD DEV D R, V7, P235, DOI 10.1002/mrdd.1033; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Mallard C, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/102153; Marin-Padilla M, 1999, J NEUROPATH EXP NEUR, V58, P407, DOI 10.1097/00005072-199905000-00001; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; McAdams RM, 2017, DEV NEUROSCI-BASEL, V39, P124, DOI 10.1159/000470903; McAdams RM, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/561494; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; Mckillop WM, 2013, GLIA, V61, P164, DOI 10.1002/glia.22424; Melville JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00079; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moretti R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00040; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; Rodricks CL, 2008, INT J DEV NEUROSCI, V26, P113, DOI 10.1016/j.ijdevneu.2007.08.006; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sewell MD, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5474; Stubbs D, 2009, CEREB CORTEX, V19, pI32, DOI 10.1093/cercor/bhp040; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Titomanlio L, 2015, PEDIATR NEUROL, V52, P566, DOI 10.1016/j.pediatrneurol.2015.01.016; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Walker AK, 2013, NEUROPSYCHOPHARMACOL, V38, P1609, DOI 10.1038/npp.2013.71; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Yager J. Y., 2015, NEUROMETHODS; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001	64	5	5	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 15	2018	1681						52	63		10.1016/j.brainres.2017.12.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FW1QP	WOS:000425074800007	29274879	Green Accepted			2022-02-06	
J	Kwan, V; Vo, M; Noel, M; Yeates, K				Kwan, Vivian; Vo, Mai .; Noel, Melanie; Yeates, Keith			A Scoping Review of Pain in Children after Traumatic Brain Injury: Is There More Than Headache?	JOURNAL OF NEUROTRAUMA			English	Article						pain assessment; pediatrics; traumatic brain injury	FUNCTIONAL ABDOMINAL-PAIN; SPORTS-RELATED CONCUSSION; PEDIATRIC PAIN; SELF-REPORT; POSTTRAUMATIC HEADACHES; ADOLESCENTS; IMPACT; INTENSITY; SYMPTOMS; VALIDITY	Headache is a common source of pain in children after traumatic brain injury (TBI); however, relatively little is known about nonheadache pain in this pediatric population. The present review seeks to map the extant literature to determine the prevalence, characteristics, and impact of nonheadache pain in children post-TBI of all severities. We found that of 109 studies published on pain in children after a TBI, 95 (87%) were focused exclusively on headache pain and only 14 (13%) reported on nonheadache pain or overall pain, with half (n=7) in the form of case studies. Overall, the level of evidence was low, with only three level 1 high-quality prospective studies. In one study, over half (57.1%) of adolescents who experienced persistent pain post-TBI reported pain in multiple body sites (e.g., back, lower limb, and neck).(1) For each additional noncephalic pain site, the risk for developing chronic migraine is also increased. Nevertheless, pain in body regions other than the head is often not assessed systematically in pediatric TBI research. Findings of the current review suggest that pain assessment in children post-TBI needs improvement, given that pain is linked to worse recovery, poorer quality of life, and can be long-lasting. More rigorous examination of nonheadache pain and its role in impeding recovery in children post-TBI is imperative and has the potential to improve the care and management of children with TBI. We conclude with recommendations for pain assessment, discuss gaps in the literature, and highlight directions for future research.	[Kwan, Vivian; Noel, Melanie; Yeates, Keith] Univ Calgary, Calgary, AB, Canada; [Vo, Mai .] Univ Alberta, Edmonton, AB, Canada		Kwan, V (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr,Northwest, Calgary, AB T2N 1N4, Canada.	Vivian.kwan2@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Vo, Mai/0000-0003-3816-7124	Robert and Irene Ward Chair in Pediatric Brain Injury - Alberta Children's Hospital Foundation; University of Calgary Integrated Concussion Research Program; Alberta Children's Hospital Research Institute; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Vi Riddell Pediatric Pain Initiative of the Alberta Children's Hospital Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD076885] Funding Source: NIH RePORTER	The authors thank Dr. Alix Hayden for her help with developing and adapting the search strategy. V.K. is supported by funding from the University of Calgary Integrated Concussion Research Program and the Alberta Children's Hospital Research Institute. K.O.Y. is supported by the Robert and Irene Ward Chair in Pediatric Brain Injury, funded by the Alberta Children's Hospital Foundation, as well as by a Foundation Grant from the Canadian Institutes of Health Research. M.N. is supported by the Vi Riddell Pediatric Pain Initiative of the Alberta Children's Hospital Research Institute.	ABUSAAD HH, 1990, PAIN, V43, P249, DOI 10.1016/0304-3959(90)91079-X; Andersson HI, 1996, SCAND J RHEUMATOL, V25, P146, DOI 10.3109/03009749609080005; Asmundson GJG, 2012, PAIN RES MANAG, V17, P397, DOI 10.1155/2012/908061; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bakoula C, 2006, ACTA PAEDIATR, V95, P947, DOI 10.1080/08035250600684453; Batailler P, 2014, ACCIDENT ANAL PREV, V71, P267, DOI 10.1016/j.aap.2014.06.001; Brown EA, 2014, J PEDIATR PSYCHOL, V39, P512, DOI 10.1093/jpepsy/jsu014; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chambers CT, 1998, PAIN, V78, P27, DOI 10.1016/S0304-3959(98)00112-2; Chambers CT, 1999, PAIN, V83, P25, DOI 10.1016/S0304-3959(99)00086-X; Cohen LL, 2008, J PEDIATR PSYCHOL, V33, P939, DOI 10.1093/jpepsy/jsm103; Demyttenaere S, 2001, CLIN J PAIN, V17, P173, DOI 10.1097/00002508-200106000-00010; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2015, CURR SPORT MED REP, V14, P20, DOI 10.1249/JSR.0000000000000108; Forgeron PA, 2013, PAIN RES MANAG, V18, pE115, DOI 10.1155/2013/120632; Gioia G., 2008, J INT NEUROPSYCH SOC, V14, P1; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Groenewald CB, 2014, J PAIN, V15, P925, DOI 10.1016/j.jpain.2014.06.002; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Hechler T, 2011, EUR J PAIN, V15, pe1; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Howick J CI, 2011, 2011 OXFORD CEBM LEV; Hunfeld JAM, 2001, J PEDIATR PSYCHOL, V26, P145, DOI 10.1093/jpepsy/26.3.145; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kwan V., THESIS; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; Lawler KA, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199612000-00005; Lim LW, 2007, J CRANIOFAC SURG, V18, P674, DOI 10.1097/scs.0b013e31803ffacc; Logan SM, 2001, J ATHL TRAINING, V36, P433; Malviya S, 2006, PEDIATR ANESTH, V16, P258, DOI 10.1111/j.1460-9592.2005.01773.x; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Nader K., 1996, CLIN ADM PTSD SCALE, pVT; Nampiaparampil D., 2011, J BEHAV BRAIN SCI, V1, P81, DOI DOI 10.4236/jbbs.2011.13011; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P100; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Palermo TA, 2004, PAIN, V107, P213, DOI 10.1016/j.pain.2003.10.005; Palermo TM, 2000, J DEV BEHAV PEDIATR, V21, P58, DOI 10.1097/00004703-200002000-00007; Pardini D., 2004, BRIT J SPORT MED, V38, P11; Perquin CW, 2000, PAIN, V87, P51, DOI 10.1016/S0304-3959(00)00269-4; Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44; RICHARDSON GM, 1983, HEADACHE, V23, P184, DOI 10.1111/j.1526-4610.1983.hed2304184.x; Roden-Foreman K, 2017, J ORTHOP TRAUMA, V31, pE275, DOI 10.1097/BOT.0000000000000884; Scher AI, 2017, NEUROLOGY, V89, P461, DOI 10.1212/WNL.0000000000004177; Shelby GD, 2013, PEDIATRICS, V132, P475, DOI 10.1542/peds.2012-2191; Stinson JN, 2006, PAIN, V125, P143, DOI 10.1016/j.pain.2006.05.006; Tham SW, 2013, J PAIN, V14, P1242, DOI 10.1016/j.jpain.2013.05.007; Uhl RL, 2013, J AM ACAD ORTHOP SUR, V21, P624, DOI 10.5435/JAAOS-21-10-624; Valovich McLeod TC, 2010, ATHL TRAIN SPORTS HL, V2, P219; Varni JW, 2010, J PAIN, V11, P1109, DOI 10.1016/j.jpain.2010.02.005; VARNI JW, 1987, PAIN, V28, P27, DOI 10.1016/0304-3959(87)91056-6; von Baeyer Carl L, 2006, Pain Res Manag, V11, P157; von Baeyer CL, 2007, PAIN, V127, P140, DOI 10.1016/j.pain.2006.08.014; von Baeyer CL, 2017, J PAIN, V18, P1017, DOI 10.1016/j.jpain.2017.03.005; von Baeyer CL, 2009, PAIN RES MANAG, V14, P39, DOI 10.1155/2009/259759; Walker LS, 2012, PAIN, V153, P1798, DOI 10.1016/j.pain.2012.03.026; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007	61	5	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	7					877	888		10.1089/neu.2017.5281		FEB 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GC0NF	WOS:000424836800001	29207908	Green Published			2022-02-06	
J	Mikkelsen, MLG; Ambrus, R; Rasmussen, R; Miles, JE; Poulsen, HH; Moltke, FB; Eriksen, T				Mikkelsen, Mai Louise Grandsgaard; Ambrus, Rikard; Rasmussen, Rune; Miles, James Edward; Poulsen, Helle Harding; Moltke, Finn Borgbjerg; Eriksen, Thomas			The influence of norepinephrine and phenylephrine on cerebral perfusion and oxygenation during propofol-remifentanil and propofol-remifentanil-dexmedetomidine anaesthesia in piglets	ACTA VETERINARIA SCANDINAVICA			English	Article						Cerebral oxygenation; Cerebral perfusion; Dexmedetomidine; Laser speckle contrast imaging; Licox; NIRS; Norepinephrine; Phenylephrine; Propofol; Remifentanil; Vasopressor	NEAR-INFRARED SPECTROSCOPY; TOTAL INTRAVENOUS ANESTHESIA; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW VELOCITY; CARBON-DIOXIDE; AUTOREGULATION; SATURATION; HYPOTENSION; ISOFLURANE; PRESSURE	Background: Vasopressors are frequently used to increase blood pressure in order to ensure sufficient cerebral perfusion and oxygenation (CPO) during hypotensive periods in anaesthetized patients. Efficacy depends both on the vasopressor and anaesthetic protocol used. Propofol-remifentanil total intravenous anaesthesia (TIVA) is common in human anaesthesia, and dexmedetomidine is increasingly used as adjuvant to facilitate better haemodynamic stability and analgesia. Little is known of its interaction with vasopressors and subsequent effects on CPO. This study investigates the CPO response to infusions of norepinephrine and phenylephrine in piglets during propofol-remifentanil and propofol-remifentanil-dexmedetomidine anaesthesia. Sixteen healthy female piglets (25-34 kg) were randomly allocated into a two-arm parallel group design with either normal blood pressure (NBP) or induced low blood pressure (LBP). Anaesthesia was induced with propofol without premedication and maintained with propofol-remifentanil TIVA, and finally supplemented with continuous infusion of dexmedetomidine. Norepinephrine and phenylephrine were infused in consecutive intervention periods before and after addition of dexmedetomidine. Cerebral perfusion measured by laser speckle contrast imaging was related to cerebral oxygenation as measured by an intracerebral Licox probe (partial pressure of oxygen) and transcranial near infrared spectroscopy technology (NIRS) (cerebral oxygen saturation). Results: During propofol-remifentanil anaesthesia, increases in blood pressure by norepinephrine and phenylephrine did not change cerebral perfusion significantly, but cerebral partial pressure of oxygen (Licox) increased following vasopressors in both groups and increases following norepinephrine were significant (NBP: P = 0.04, LBP: P = 0.02). In contrast, cerebral oxygen saturation (NIRS) fell significantly in NBP following phenylephrine (P = 0.003), and following both norepinephrine (P = 0.02) and phenylephrine (P = 0.002) in LBP. Blood pressure increase by both norepinephrine and phenylephrine during propofol- remifentanil-dexmedetomidine anaesthesia was not followed by significant changes in cerebral perfusion. Licox measures increased significantly following both vasopressors in both groups, whereas the decreases in NIRS measures were only significant in the NBP group. Conclusions: Cerebral partial pressure of oxygen measured by Licox increased significantly in concert with the vasopressor induced increases in blood pressure in healthy piglets with both normal and low blood pressure. Cerebral oxygenation assessed by intracerebral Licox and transcranial NIRS showed opposing results to vasopressor infusions. Keywords: Cerebral oxygenation, Cerebral perfusion, Dexmedetomidine, Laser speckle contrast imaging, Licox, NIRS,	[Mikkelsen, Mai Louise Grandsgaard; Miles, James Edward; Poulsen, Helle Harding; Eriksen, Thomas] Univ Copenhagen, Dept Vet Clin Sci, 16 Dyrlaegevej, DK-1870 Frederiksberg C, Denmark; [Ambrus, Rikard] Univ Copenhagen, Rigshosp, Dept Surg Gastroenterol C, 9 Blegdamsvej, DK-2100 Copenhagen O, Denmark; [Rasmussen, Rune] Univ Copenhagen, Rigshosp, Dept Neurosurg, Neurosci Ctr, 9 Blegdamsvej, DK-2100 Copenhagen O, Denmark; [Moltke, Finn Borgbjerg] Univ Copenhagen, Rigshosp, Dept Neuroanaesthesia, 9 Blegdamsvej, DK-2100 Copenhagen O, Denmark; [Moltke, Finn Borgbjerg] Univ Copenhagen, Dept Anaesthesia, Bispebjerg Hosp, 23 Bispebjerg Bakke, DK-2400 Copenhagen NV, Denmark; [Moltke, Finn Borgbjerg] Univ Copenhagen, Frederiksberg Hosp, 23 Bispebjerg Bakke, DK-2400 Copenhagen NV, Denmark		Mikkelsen, MLG (corresponding author), Univ Copenhagen, Dept Vet Clin Sci, 16 Dyrlaegevej, DK-1870 Frederiksberg C, Denmark.	mailo@sund.ku.dk		Mikkelsen, Mai Louise Grandsgaard/0000-0002-3175-9496; Miles, James/0000-0002-4377-1572; Eriksen, Thomas/0000-0001-5774-1166; Poulsen, Helle Harding/0000-0001-9000-9030	University of Copenhagen	This study was funded by a PhD scholarship granted by the University of Copenhagen.	Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; ASADA Y, 1992, AM J PHYSIOL, V263, pH1907; Asano Y, 1997, AM J PHYSIOL-HEART C, V272, pH2547, DOI 10.1152/ajpheart.1997.272.6.H2547; Bekker A, 2005, NEUROSURGERY, V57, P1, DOI 10.1227/01.NEU.0000163476.42034.A1; Brassard P, 2009, BRIT J ANAESTH, V102, P800, DOI 10.1093/bja/aep065; BRESLOW MJ, 1987, AM J PHYSIOL, V252, pH291, DOI 10.1152/ajpheart.1987.252.2.H291; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Chang EH, 2012, LARYNGOSCOPE, V122, P1898, DOI 10.1002/lary.23392; Cole CD, 2007, NEUROSURGERY, V61, P369, DOI 10.1227/01.neu.0000303996.74526.30; Conrad MS, 2015, ANNU REV ANIM BIOSCI, V3, P245, DOI 10.1146/annurev-animal-022114-111049; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Conti A, 2006, BRIT J ANAESTH, V97, P333, DOI 10.1093/bja/ael169; Dagal A, 2011, CORE TOPICS NEUROANA, P147; Dagal A, 2009, CURR OPIN ANESTHESIO, V22, P547, DOI 10.1097/ACO.0b013e32833020be; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; Drummond JC, 2008, ANESTHESIOLOGY, V108, P225, DOI 10.1097/01.anes.0000299576.00302.4c; Ducrocq N, 2012, ANESTHESIOLOGY, V116, P1083, DOI 10.1097/ALN.0b013e31824f9669; Eikaas H, 2009, CURR OPIN ANESTHESIO, V22, P725, DOI 10.1097/ACO.0b013e3283310f6b; Engelhard K, 2006, CURR OPIN ANESTHESIO, V19, P504, DOI 10.1097/01.aco.0000245275.76916.87; Farag E, 2011, OCHSNER J, V11, P57; Flaherty D, 2013, IN PRACTICE, V35, P565, DOI 10.1136/inp.f6613; Flaherty D, 2013, IN PRACTICE, V35, P513, DOI 10.1136/inp.f5826; Friess SH, 2015, J NEUROTRAUM, V32, P237, DOI 10.1089/neu.2014.3468; Hahn GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063069; HARADA J, 1991, J NEUROSURG, V75, P103, DOI 10.3171/jns.1991.75.1.0103; HEISTAD DD, 1974, ANESTHESIOLOGY, V41, P139, DOI 10.1097/00000542-197408000-00005; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Ito H, 2005, ANN NUCL MED, V19, P65, DOI 10.1007/BF03027383; KARLSSON BR, 1990, ANESTH ANALG, V71, P125; Keong NC, 2011, CORE TOPICS NEUROANA, P1; Krejci V, 2006, CRIT CARE MED, V34, P1456, DOI 10.1097/01.CCM.0000215834.48023.57; Kroppenstedt SN, 2002, ACTA NEUROCHIR S, V81, P37; Lagerkranser M, 1997, J NEUROSURG ANESTH, V9, P188, DOI 10.1097/00008506-199704000-00015; LAGERKRANSER M, 1989, ACTA ANAESTH SCAND, V33, P15, DOI 10.1111/j.1399-6576.1989.tb02852.x; Lauder GR, 2015, PEDIATR ANESTH, V25, P52, DOI 10.1111/pan.12553; Lee WA, 2008, J VASC SURG, V48, P494, DOI 10.1016/j.jvs.2008.03.003; Lucas SJE, 2010, HYPERTENSION, V55, P698, DOI 10.1161/HYPERTENSIONAHA.109.146290; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Mahmoud M, 2015, BRIT J ANAESTH, V115, P171, DOI 10.1093/bja/aev226; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Meng L, 2012, BRIT J ANAESTH, V108, P815, DOI 10.1093/bja/aes023; Meng L, 2011, BRIT J ANAESTH, V107, P209, DOI 10.1093/bja/aer150; MESSICK JM, 1985, ANESTH ANALG, V64, P143; Mikkelsen MLG, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0293-0; Miller RD., 2010, MILLERS ANESTHESIA; Moerman AT, 2015, ANESTHESIOLOGY, V123, P327, DOI 10.1097/ALN.0000000000000715; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Murrell JC, 2005, VET ANAESTH ANALG, V32, P117, DOI 10.1111/j.1467-2995.2005.00233.x; Nathanson M, 2011, NEUROANAESTHESIA; Nissen P, 2010, NEUROCRIT CARE, V12, P17, DOI 10.1007/s12028-009-9313-x; Ogoh S, 2014, ANESTH ANALG, V118, P823, DOI 10.1213/ANE.0000000000000145; Ogoh S, 2011, CLIN PHYSIOL FUNCT I, V31, P445, DOI 10.1111/j.1475-097X.2011.01040.x; Overgaard CB, 2008, CIRCULATION, V118, P1047, DOI 10.1161/CIRCULATIONAHA.107.728840; Peng K, 2014, J CLIN NEUROSCI, V21, P1951, DOI 10.1016/j.jocn.2014.02.023; Poterman M, 2015, EUR J ANAESTH, V32, P571, DOI 10.1097/EJA.0000000000000247; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Prielipp RC, 2002, ANESTH ANALG, V95, P1052, DOI 10.1097/00000539-200210000-00048; Pro.medicin. Dansk Laegemiddel Information A/ S Copenhagen, 2016, MET SAD PHEN; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; Rozet I, 2008, CURR OPIN ANESTHESIO, V21, P537, DOI 10.1097/ACO.0b013e32830edafd; Sano H, 2010, EXP ANIM TOKYO, V59, P199, DOI 10.1538/expanim.59.199; Silva A, 2014, VET ANAESTH ANALG, V41, P153, DOI 10.1111/vaa.12091; Soeding PF, 2013, BRIT J ANAESTH, V111, P229, DOI 10.1093/bja/aet024; Sorensen H, 2012, ANESTHESIOLOGY, V117, P263, DOI 10.1097/ALN.0b013e3182605afe; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Tranquilli WJ, 2007, LUMB JONES VET ANEST; Tsaousi GG, 2016, CLIN NEUROPHARMACOL, V39, P144, DOI 10.1097/WNF.0000000000000151; Uilenreef JJ, 2008, VET ANAESTH ANALG, V35, P1, DOI 10.1111/j.1467-2995.2007.00344.x; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Xanthos T, 2007, J AM ASSOC LAB ANIM, V46, P21; ZORNOW MH, 1993, J CEREBR BLOOD F MET, V13, P350, DOI 10.1038/jcbfm.1993.45; ZORNOW MH, 1990, ANESTH ANALG, V70, P624	74	5	5	2	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0044-605X	1751-0147		ACTA VET SCAND	Acta Vet. Scand.	FEB 8	2018	60								8	10.1186/s13028-018-0362-z			10	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	FV7HN	WOS:000424754300001	29422100	gold, Green Published			2022-02-06	
J	Andre, EA; Forcelli, PA; Pak, DTS				Andre, Emily A.; Forcelli, Patrick A.; Pak, Daniel T. S.			What goes up must come down: homeostatic synaptic plasticity strategies in neurological disease	FUTURE NEUROLOGY			English	Article						Alzheimer's disease; antiseizure drugs; CA3; dentate gyrus; epilepsy; homeostatic synaptic plasticity; kappa opioid receptors; mossy fiber; Plk2; synaptoporin	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; AMYLOID-BETA; IN-VIVO; MOUSE MODEL; A-BETA; HIPPOCAMPAL HYPERACTIVITY; COGNITIVE IMPAIRMENT; OPTOGENETIC CONTROL	Brain activity levels are tightly regulated to minimize imbalances in activity state. Deviations from the normal range of activity are deleterious and often associated with neurological disorders. To maintain optimal levels of activity, regulatory mechanisms termed homeostatic synaptic plasticity establish desired 'set points' for neural activity, monitor the network for deviations from the set point and initiate compensatory responses to return activity to the appropriate level that permits physiological function [1,2]. We speculate that impaired homeostatic control may contribute to the etiology of various neurological disorders including epilepsy and Alzheimer's disease, two disorders that exhibit hyperexcitability as a key feature during pathogenesis. Here, we will focus on recent progress in developing homeostatic regulation of neural activity as a therapeutic tool.	[Andre, Emily A.; Forcelli, Patrick A.; Pak, Daniel T. S.] Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Washington, DC 20057 USA		Pak, DTS (corresponding author), Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Washington, DC 20057 USA.	Daniel.Pak@georgetown.edu		Andre, Emily/0000-0002-9679-7514; Forcelli, Patrick/0000-0003-1763-060X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097762, R03AG052730, RF1AG056603]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG056603, R03AG052730] Funding Source: NIH RePORTER	The authors have received grants from the NIH (R01NS097762 to PAF; R03AG052730 and RF1AG056603 to DTSP). The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Chan JX, 2015, EPILEPSIA, V56, pe73, DOI 10.1111/epi.12993; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Doheny HC, 1999, EPILEPSY RES, V34, P161, DOI 10.1016/S0920-1211(98)00104-1; Evers DM, 2010, NAT NEUROSCI, V13, P1199, DOI 10.1038/nn.2624; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2012, ANN NEUROL, V71, P157, DOI 10.1002/ana.22621; Forcelli PA, 2017, J NEUROSCI RES, V95, P2345, DOI 10.1002/jnr.24135; Friedman D, 2012, CNS NEUROSCI THER, V18, P285, DOI 10.1111/j.1755-5949.2011.00251.x; GALL C, 1988, J NEUROSCI, V8, P1852; Jang SS, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7969272; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Krook-Magnuson E, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0005-14.2014; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Kros L, 2015, ANN NEUROL, V77, P1027, DOI 10.1002/ana.24399; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lam AD, 2017, NAT MED, V23, P678, DOI 10.1038/nm.4330; Larner AJ, 2010, NEUROMOL MED, V12, P71, DOI 10.1007/s12017-009-8076-z; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lazarevic V, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00221; Lee KJ, 2013, NEURON, V77, P99, DOI 10.1016/j.neuron.2012.10.033; Lee KJ, 2011, NEURON, V69, P957, DOI 10.1016/j.neuron.2011.02.004; Lee Y, 2017, NEUROPHARMACOLOGY, V117, P387, DOI 10.1016/j.neuropharm.2017.02.027; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Musaeus CS, 2017, J ALZHEIMERS DIS, V58, P1065, DOI 10.3233/JAD-160742; Nicastro N, 2016, EPILEPTIC DISORD, V18, P1, DOI 10.1684/epd.2016.0808; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Overk CR, 2014, BIOCHEM PHARMACOL, V88, P508, DOI 10.1016/j.bcp.2014.01.015; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; POST RM, 1975, LIFE SCI, V17, P943, DOI 10.1016/0024-3205(75)90447-6; Puzzo D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.020; Queenan BN, 2018, EPILEPSIA, V59, P106, DOI 10.1111/epi.13941; Queenan BN, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/718203; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; SCHEFF SW, 1993, ANN NEUROL, V33, P190, DOI 10.1002/ana.410330209; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Stargardt A, 2015, NEUROBIOL AGING, V36, P1, DOI 10.1016/j.neurobiolaging.2014.08.014; Sun H, 2013, P NATL ACAD SCI USA, V110, P5199, DOI 10.1073/pnas.1208010110; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; TORTELLA FC, 1981, EUR J PHARMACOL, V76, P121, DOI 10.1016/0014-2999(81)90493-3; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Xiao R, 2016, CURR TOP MED CHEM, V16, P565, DOI 10.2174/1568026615666150813144603	66	5	5	0	7	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1479-6708	1748-6971		FUTUR NEUROL	Futur. Neurol.	FEB	2018	13	1					13	22		10.2217/fnl-2017-0028			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FS9TV	WOS:000422762800003	29379396	Green Published			2022-02-06	
J	Gincberg, G; Shohami, E; Lazarovici, P; Elchalal, U				Gincberg, Galit; Shohami, Esther; Lazarovici, Philip; Elchalal, Uriel			Human Umbilical Cord Blood CD45(+) Pan-Hematopoietic Cells Induced a Neurotherapeutic Effect in Mice with Traumatic Brain Injury: Immunophenotyping, Comparison of Maternal and Neonatal Parameters, and Immunomodulation	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						CD45(+) pan-hematopoietic cells; Vaginal and cesarean deliveries; Neurotherapeutic effect; Transplantation; Traumatic brain injury; Umbilical cord blood	MESENCHYMAL STEM-CELLS; BONE-MARROW; TRANSPLANTATION; COLLECTION; UNITS; THERAPY; BANKING; WEIGHT; PREDICTORS; VARIABLES	Human umbilical cord blood (HUCB) transplantation has become an alternative cell therapy for hematological and oncological malignancies in the clinic and is considered for neurological disorders. The heterogeneity in the content of the different stem and progenitor cells composing HUCB mononuclear cells (MNC) may influence their engraftment and neurotherapeutic effect. We hypothesized that CD45 pan-hematopoietic marker expression is heterogeneous in MNC, and therefore, CD45(+) subpopulation enrichment for neurotherapy may provide a tool to overcome cellular variance in different HUCB units. We employed an immunomagnetic separation method to isolate and characterize HUCB CD45(+) pan-hematopoietic subpopulation and to investigate whether the vaginal or cesarean deliveries influence their neurotherapeutic effect in a traumatic brain injury (TBI) mouse model. Adult C57BL/6J male mice were subjected to moderate TBI and intravenously xenotransplanted with 1 x 10(6) CD45(+) cells derived from either vaginal or cesarean HUCB units. A large heterogeneity in the expression of CD45 marker in MNC, both in vaginal and cesarean HUCB units, was found, regardless of the number of live births. A higher expression of hematopoietic markers was found in the CD45(+) subpopulation while low expressional levels of typical mesenchymal markers were detected. Neurotherapeutic effects, evaluated with an established neurological severity score and novel object recognition test, indicated improved functional motor and memory recovery and found independent of delivery type. Cytokine analysis in extracts of TBI brain cortices indicated an acute immunomodulatory effect by HUCB CD45(+) subpopulation upon xenotransplantation. These results may provide insights to CD45 marker as a predictor of HUCB units' quality for neurotherapy in TBI.	[Gincberg, Galit; Shohami, Esther; Lazarovici, Philip] Hebrew Univ Jerusalem, Sch Pharm Inst Drug Res, Fac Med, Jerusalem, Israel; [Elchalal, Uriel] Hadassah Hebrew Univ, Dept Obstet & Gynecol, Med Ctr, Jerusalem, Israel		Elchalal, U (corresponding author), Hadassah Hebrew Univ, Dept Obstet & Gynecol, Med Ctr, Jerusalem, Israel.	uriel@hadassah.org.il	Lazarovici, Philip/S-5261-2018	Lazarovici, Philip/0000-0003-3650-4721	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; David R. Bloom Center for Pharmacy; Dr. Adolf and Klara Bretler Center for Research in Molecular Pharmacology and Therapeutics at the Hebrew University of Jerusalem, Israel	ES was partly supported by a grant from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. PL holds the Jacob Gitlin Chair in Physiology and is affiliated with and supported by the David R. Bloom Center for Pharmacy and the Dr. Adolf and Klara Bretler Center for Research in Molecular Pharmacology and Therapeutics at the Hebrew University of Jerusalem, Israel. The funding sources had no involvement in the conduction, data collection, and analysis and preparation of the article.	Arien-Zakay H, 2014, J NEUROTRAUM, V31, P1405, DOI 10.1089/neu.2013.3270; Arien-Zakay H, 2010, BEST PRACT RES CL HA, V23, P291, DOI 10.1016/j.beha.2010.04.001; Arien-Zakay H, 2010, INT J MOL SCI, V11, P3513, DOI 10.3390/ijms11093513; Askari S, 2005, TRANSFUSION, V45, P189, DOI 10.1111/j.1537-2995.2004.04117.x; Ballen KK, 2001, BONE MARROW TRANSPL, V27, P7, DOI 10.1038/sj.bmt.1702729; BEKSAC M, 2016, FRONT MED, V3, P9210, DOI DOI 10.3389/FMED.2016; Bonab MAM, 2004, TRANSFUSION, V44, P690, DOI 10.1111/j.1537-2995.2004.03227.x; Chandra T, 2012, J PEDIAT HEMATOL ONC, V34, P184, DOI 10.1097/MPH.0b013e318249adb6; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elchalal U, 2000, AM J OBSTET GYNECOL, V182, P227, DOI 10.1016/S0002-9378(00)70517-5; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Frandberg S, 2015, TRANSFUSION, V55, P1283, DOI 10.1111/trf.13013; Gluckman E, 2000, EXP HEMATOL, V28, P1197, DOI 10.1016/S0301-472X(00)00540-3; Gluckman E, 2009, HAEMATOL-HEMATOL J, V94, P451, DOI 10.3324/haematol.2009.005694; Grisaru D, 1999, AM J OBSTET GYNECOL, V180, P1240, DOI 10.1016/S0002-9378(99)70623-X; Jones J, 2003, AM J OBSTET GYNECOL, V188, P503, DOI 10.1067/mob.2003.19; Jung G, 2008, CYTOM PART A, V73A, P16, DOI 10.1002/cyto.a.20490; Kang M, 2015, STEM CELLS DEV, V24, P2259, DOI 10.1089/scd.2015.0074; Kuchma MD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/418752; LEONARD CH, 1994, PEDIATRICS, V93, P611; Lim FTH, 2000, AM J OBSTET GYNECOL, V183, P1144, DOI 10.1067/mob.2000.108848; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Nakagawa R, 2004, TRANSFUSION, V44, P262, DOI 10.1111/j.1537-2995.2004.00645.x; Rizk M., 2017, BIOL BLOOD MARROW TR; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Solves P, 2006, GYNECOL OBSTET INVES, V61, P34, DOI 10.1159/000088340; Solves P, 2003, ACTA OBSTET GYN SCAN, V82, P439; Sparrow RL, 2002, TRANSFUSION, V42, P210, DOI 10.1046/j.1537-2995.2002.00028.x; Tamburini A, 2006, TRANSPL P, V38, P1171, DOI 10.1016/j.transproceed.2006.03.051; Tse WW, 2008, BONE MARROW TRANSPL, V41, P465, DOI 10.1038/sj.bmt.1705994; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yang HY, 2011, TRANSFUSION, V51, P284, DOI 10.1111/j.1537-2995.2010.02826.x; Yang WZ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-65; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhu H, 2016, CELL TRANSPLANT, V25, P1925, DOI 10.3727/096368916X691411	40	5	5	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2018	64	2					185	199		10.1007/s12031-017-1008-8			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FX4OZ	WOS:000426059000004	29249007				2022-02-06	
J	Jang, SH; Kim, SH; Seo, JP				Jang, Sung Ho; Kim, Seong Ho; Seo, Jeong Pyo			Recovery of an injured corticofugal tract from the supplementary motor area in a patient with traumatic brain injury A case report	MEDICINE			English	Article						corticofugal tract; diffusion tensor tractography; limb-kinetic apraxia; traumatic brain injury	LIMB-KINETIC APRAXIA; STROKE PATIENT; TRACTOGRAPHY; INTEGRITY; LEVODOPA; INFARCT; FIBERS	Rationale: We report on a patient with traumatic brain injury who showed motor recovery concurrent with recovery of injured corticofugal tracts (CFTs), diagnosed by diffusion tensor tractography (DTT). Patientconcerns: Four weeks after onset, when the patient started rehabilitation, he showed severe weakness of both upper and lower extremities [Motricity Index (MI, full score: 100/100): 9/30]. Diagnoses: A 29-year-old male patient underwent conservative management for traumatic hemorrhages in both frontal lobes and right thalamus resulting from a car accident. Interventions: The patient participated in a comprehensive rehabilitative management program, including movement therapy, dopaminergic drugs for improvement of apraxia (pramipexole: 2.5mg, amantadine: 300mg, ropinirole: 0.75 mg, and levodopa: 500mg), and neuromuscular electrical stimulation therapy of the right elbow extensors, finger extensors, both knee extensors, and ankle dorsiflexors. Outcomes: After 2 months' intensive rehabilitation, his motor weakness rapidly recovered to the point that he was able to move all 4 extremities against some resistance (MI: 75/75). The right supplementary motor area (SMA)-CFT showed narrowing and partial tearing in the upper portion on 1-month DTT, and became thicker on 3-month DTT. Compared to the 12 normal control subjects, the fractional anisotropy (FA) values of the right corticospinal tract and both dorsal premotor cortex-CFT were more than 1 standard deviation lower than those of normal control subjects on both 1- and 3-month DTTs. Lessons: Although the tract volume of the right SMA-CFT was more than 1 standard deviation lower than normal control subjects on 1-month DTT, it increased to within 1 standard deviation on 3-month DTT. Recovery of the injured SMA-CFT concurrent with motor recovery was demonstrated in a patient with traumatic brain injury.	[Jang, Sung Ho; Seo, Jeong Pyo] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu, South Korea		Seo, JP (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	raphael0905@hanmail.net					Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Hong JH, 2012, NEUROREHABILITATION, V30, P255, DOI 10.3233/NRE-2012-0753; Jang SH, 2016, ACTA NEUROL BELG, V116, P467, DOI 10.1007/s13760-016-0600-y; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE115, DOI 10.1097/PHM.0000000000000474; Jang SH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001838; Jang SH, 2013, NEUROREHABILITATION, V33, P195, DOI 10.3233/NRE-130945; Lee KC, 2004, PHARMACOTHERAPY, V24, P401, DOI 10.1592/phco.24.4.401.33174; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Medical research council, 1976, 45 MED RES COUNC; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Perkins J., 2002, ATLAS NEUROANATOMY N; Schulz R, 2015, NEUROIMAGE-CLIN, V7, P82, DOI 10.1016/j.nicl.2014.11.006; Schulz R, 2012, STROKE, V43, P2248, DOI 10.1161/STROKEAHA.112.662619; Seo JP, 2013, AM J NEURORADIOL, V34, P1359, DOI 10.3174/ajnr.A3389; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Yamada S, 2004, NEUROLOGY, V62, P830, DOI 10.1212/01.WNL.0000113751.19247.84	20	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	FEB	2018	97	7							e9063	10.1097/MD.0000000000009063			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA1ZQ	WOS:000428116700005	29443731	gold, Green Published			2022-02-06	
J	Kokanovic, R; Stone, M				Kokanovic, Renata; Stone, Meredith			Listening to what cannot be said: Broken narratives and the lived body	ARTS AND HUMANITIES IN HIGHER EDUCATION			English	Article						Narrative; broken narratives; embodiment; lived body; illness; biographical disruption; trauma; mental illness	ILLNESS NARRATIVES; SELF; NEUROTRAUMA; TALK	The core of this special issue of Arts and Humanities in Higher Education emerged from the Broken Narratives and the Lived Body conference held in 2016. The Broken Narrative' essays included in this issue open up a critical space for understanding and theorising illness narratives that defy a conventional cognitive ordering of the self as a bounded spatial and temporal entity. Here, we discuss how narratives might be ''broken' by discourse, trauma, ''ill' lived bodies and experiences that exceed linguistic representation. We trouble distinctions between coherent and incoherent narratives, attending to what gaps, silences and ''nonsenses' can convey about embodied illness experiences. Ultimately, we suggest that ''breaks' are in fact a continuation of embodied narration. This is shown in the ''Art and Trauma' forum of essays, which reveal how narrative silences can ''infect' other embodied subjects and be transformed, achieving musical or visual representation that allow us to apprehend the ''constitutive outside' of narratives of illness or trauma.	[Kokanovic, Renata; Stone, Meredith] RMIT Univ, Sch Global Urban & Social Studies GUSS, Melbourne, Vic, Australia		Kokanovic, R (corresponding author), RMIT Univ, 124 La Trobe St, Melbourne, Vic 3000, Australia.	renata.kokanovic@rmit.edu.au		Kokanovic, Renata/0000-0002-4308-3403	Monash Arts Faculty	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The conference Broken Narratives and the Lived Body was supported by the Monash Arts Faculty.	Avrahami E, 2003, LIT MED, V22, P164, DOI 10.1353/lm.2003.0013; Bamberg M, 2011, THEOR PSYCHOL, V21, P3, DOI 10.1177/0959354309355852; Blackman L., 2008, BODY KEY CONCEPTS; Blackman L, 2010, BODY SOC, V16, P163, DOI 10.1177/1357034X09354356; Bond E, 2012, DISRUPTED NARRATIVES; Brockmeier J., 1993, COLLEGIUM BUDAPEST D, V4; Brockmeier J, 2008, ROUT STUD HLTH SOC W, V2, P16; Bruner Jerome S., 1990, ACTS MEANING; Bury M, 2001, SOCIOL HEALTH ILL, V23, P263, DOI 10.1111/1467-9566.00252; Butler J, 2001, GIVING ACCOUNT ONESE; Butler Judith., 1993, BODIES MATTER DISCUR; Carel H., 2013, ILLNESS CRY FLESH; Charmaz, 2002, QUALITATIVE INQUIRY, V8, P302, DOI [DOI 10.1177/107780040200800307, 10.1177/107780040200800307]; Cho G.M., 2008, HAUNTING KOREAN DIAS; Foucault M., 1973, MADNESS CIVILISATION; Foucault M., 2003, BIRTH CLIN ARCHAEOLO; Frank A. W., 1991, WILL BODY REFLECTION; Frank Arthur, 1995, WOUNDED STORY TELLER; Grosz Elizabeth, 1994, VOLATILE BODIES CORP, P3; Hurley, 1978, WILL KNOWLEDGE HIST, VI; Hurwitz B., 2004, NARRATIVE RES HLTH I; Hyden L.-C, 2013, DOING NARRATIVE RES, P126; Hyden LC, 2008, ROUT STUD HLTH SOC W, V2, P1; Hyden LC, 2008, ROUT STUD HLTH SOC W, V2, P36; Hyv?rinen, 2010, NARRATIVE COHERENCE; Karpinski Eva, 2015, A B AUTOBIOGRAPHY ST, V30, P199, DOI [10.1080/08989575.2015.1088714, DOI 10.1080/08989575.2015.1088714]; Lacan J, 1995, ESCRITS A SELECTION; Lillrank A, 2002, CULT MED PSYCHIAT, V26, P111, DOI 10.1023/A:1015285013489; Massumi B, 2003, 21 C MAGAZINE; Mattingly Cheryl, 2000, NARRATIVE CULTURAL C; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; Medved MI, 2008, ROUT STUD HLTH SOC W, V2, P54; Merleau-Ponty M., 2012, PHENOMENOLOGY PERCEP; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; RICOEUR PAUL, 1984, TIME NARRATIVE, V1; Shapiro J, 2011, MED HUMANIT, V37, P68, DOI 10.1136/jmh.2011.007328; Stone M, 2016, SOC SCI MED, V163, P98, DOI 10.1016/j.socscimed.2016.06.040; Williams Simon J, 1998, LIVED BODY SOCIOLOGI	38	5	5	3	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1474-0222	1741-265X		ARTS HUM HIGH EDUC	Arts Hum. High. Educ.	FEB	2018	17	1			SI		20	31		10.1177/1474022217732871			12	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	FS5YZ	WOS:000419876400002					2022-02-06	
J	Kollia, B; Basch, CH; Mouser, C; Deleon, AJ				Kollia, Betty; Basch, Corey H.; Mouser, Christina; Deleon, Aurea J.			Assessment of Information on Concussion Available to Adolescents on Social Media	INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE			English	Article						Adolescents; concussion; social media; YouTube	CHRONIC TRAUMATIC ENCEPHALOPATHY; NATIONAL-FOOTBALL-LEAGUE; BRAIN-INJURY; ONLINE; PLAYER	Background: Considering how many people obtain information about their health online, the aim of this study was to describe the content of the currently most widely viewed YouTube videos related to concussions and to test the hypothesis that consumer videos would be anecdotal, while other sources would be more informational. Methods: The term "concussion" was used to search for videos with 100,000 or more views on YouTube that were posted in English or Spanish. Descriptive information about each video was recorded, as was information on whether certain content was conveyed during the video. The main outcome measures are sources of upload and content of videos. Results: Consumer videos accounted for 48% of the videos, television based accounted for 50% of the videos, and internet based accounted for only 2% of the videos. None of the videos viewed fell into the professional category. Television based videos were viewed significantly more than consumer or internet based videos. Consumer and television based videos were equally anecdotal. Many of the videos focused on adolescents and were related to sports injuries. The majority of the videos (70.4%) addressed concussion causes, with 48% stating sports. Few videos discussed symptoms of concussion and prevention. Conclusions: The potential for widespread misinformation necessitates caution when obtaining information on concussion on a freely accessible and editable medium, such as YouTube.	[Kollia, Betty] William Paterson Univ, Dept Commun Disorders & Sci, Univ Hall, Wayne, NJ 07470 USA; [Basch, Corey H.; Deleon, Aurea J.] William Paterson Univ, Dept Publ Hlth, Wayne, NJ 07470 USA; [Mouser, Christina] William Paterson Univ, Dept Math, Wayne, NJ 07470 USA		Kollia, B (corresponding author), William Paterson Univ, Dept Commun Disorders & Sci, Univ Hall, Wayne, NJ 07470 USA.	kolliaB@wpunj.edu					Ahmed OH, 2016, PHYS THER SPORT, V21, P82, DOI 10.1016/j.ptsp.2016.03.001; Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; American Speech-Language-Hearing Association, TRAUM INJ AD; [Anonymous], TRAUM BRAIN INJ CONC; Basch CH, 2016, INT J ADOLESC MED HL; Basch CH, 2017, INT J ADOLESC MED HL; Basch Corey H, 2017, J Prev Med Public Health, V50, P133, DOI 10.3961/jpmph.16.107; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Department of Education of the State of New Jersey, NEW JERS STUD LEARN; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Faul M, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fullwood MD, 2016, INT J ADOLESC MED HL; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Harrison D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164123; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Knight E, 2015, INTERACT J MED RES, V4, P52, DOI 10.2196/ijmr.3835; Korngold C, 2013, J AM ACAD PSYCHIATRY, V41, P430; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Peter L., 2015, CONCUSSION; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	29	5	5	1	3	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	2008-7802	2008-8213		INT J PREVENTIVE MED	Int. J. Preventive Med.	FEB	2018	9								19	10.4103/ijpvm.IJPVM_265_17			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FZ0XY	WOS:000427300000009	29541434	Green Published, gold, Green Submitted			2022-02-06	
J	Schmidt, AE; Gore, E; Henrichs, KF; Conley, G; Dorsey, C; Bjugstad, KB; Refaai, MA; Blumberg, N; Cholette, JM				Schmidt, Amy E.; Gore, Emily; Henrichs, Kelly F.; Conley, Grace; Dorsey, Charles; Bjugstad, Kimberly B.; Refaai, Majed A.; Blumberg, Neil; Cholette, Jill M.			Oxidation Reduction Potential (ORP) is Predictive of Complications Following Pediatric Cardiac Surgery	PEDIATRIC CARDIOLOGY			English	Article						Blood; Red blood cells; Oxidation reduction potential; Cardiac surgery; Pediatrics; Complications	TRAUMATIC BRAIN-INJURY; BLOOD-CELL PROCESSOR; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; ANTIINFLAMMATORY RESPONSE; PLASMA-LEVELS; REDOX STATUS; SEPSIS; STRESS; EXPRESSION	Oxidation reduction potential (ORP) or Redox is the ratio of activity between oxidizers and reducers. Oxidative stress (OS) can cause cellular injury and death, and is important in the regulation of immune response to injury or disease. In the present study, we investigated changes in the redox system as a function of cardiopulmonary bypass (CPB) in pediatric patients. 664 plasma samples were collected from 162 pediatric patients having cardiac surgery of various CPB times. Lower ORP values at 12 h post-CPB were associated with poor survival rate (mean +/- SD 167 +/- 20 vs. 138 +/- 19, p = 0.005) and higher rate of thrombotic complications (153 +/- 21 vs. 168 +/- 20, p < 0.008). Similarly, patients who developed infections had lower ORP values at 6 h (149 +/- 19 vs. 160 +/- 22, p = 0.02) and 12 h (156 +/- 17 vs. 168 +/- 21, p = 0.004) post-CPB. Patients that developed any post-operative complication also had lower 6 h (149 +/- 17 vs. 161 +/- 23, p = 0.002) and 12 h (157 +/- 18 vs. 170 +/- 21, p = 0.0007) post-CPB ORP values. Free hemoglobin and IL-6, IL-10, and CRP were not associated with ORP levels. However, higher haptoglobin levels preoperatively were protective against decreases in ORP. Decreased ORP is a marker for poor outcome and predictive of post-operative thrombosis, infection, and other complications in critically ill pediatric cardiac surgery patients. These results suggest that redox imbalance and OS may contribute to the risk of complications and poor outcome in pediatric CBP patients. Haptoglobin may be a marker for increased resilience to OS in this population.	[Schmidt, Amy E.; Gore, Emily; Henrichs, Kelly F.; Conley, Grace; Refaai, Majed A.; Blumberg, Neil] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, 601 Elmwood Ave,Box 608, Rochester, NY 14642 USA; [Cholette, Jill M.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Dorsey, Charles; Bjugstad, Kimberly B.] Aytu Biosci, Englewood, CO USA		Schmidt, AE (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, 601 Elmwood Ave,Box 608, Rochester, NY 14642 USA.	Amy_Schmidt@urmc.rochester.edu		Bjugstad, Kimberly/0000-0002-0473-5413; Gore, Emily/0000-0001-7157-259X	Aytu Bioscience	This study was funded by a grant from Aytu Bioscience.	Allen ML, 2006, CRIT CARE MED, V34, P2658, DOI 10.1097/01.CCM.0000240243.28129.36; Bar-Or D, 2015, REDOX REP, V20, P193, DOI 10.1179/1351000215Y.0000000005; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Bilgin YM, 2010, CRIT CARE MED, V38, P546, DOI 10.1097/CCM.0b013e3181c0de7b; Bjugstad KB, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6974257; Cholette JM, 2012, PEDIATR CRIT CARE ME, V13, P290, DOI 10.1097/PCC.0b013e31822f173c; Cowley HC, 1996, CRIT CARE MED, V24, P1179, DOI 10.1097/00003246-199607000-00019; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9; Eggum R, 2008, ANN THORAC SURG, V85, P611, DOI 10.1016/j.athoracsur.2007.10.062; Gando S, 2000, SURG TODAY, V30, P689, DOI 10.1007/s005950050041; Gessler P, 2004, SHOCK, V22, P513, DOI 10.1097/01.shk.0000145939.54838.51; Gessler P, 2003, J THORAC CARDIOV SUR, V126, P718, DOI 10.1016/S0022-5223(03)00685-8; Giannoudis PV, 2000, INTENS CARE MED, V26, P1076, DOI 10.1007/s001340051320; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; Hatherill M, 2000, CRIT CARE MED, V28, P2591, DOI 10.1097/00003246-200007000-00068; Hess JR, 2010, TRANSFUS APHER SCI, V43, P51, DOI 10.1016/j.transci.2010.05.009; Hietbrink F, 2006, World J Emerg Surg, V1, P15, DOI 10.1186/1749-7922-1-15; Hirai Shinji, 2003, Ann Thorac Cardiovasc Surg, V9, P365; Holmes JH, 2002, INFLAMM RES, V51, P579, DOI 10.1007/PL00012432; KALMIN ND, 1982, TRANSFUSION, V22, P125, DOI 10.1046/j.1537-2995.1982.22282177118.x; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Madhok AB, 2006, PEDIATR CARDIOL, V27, P408, DOI 10.1007/s00246-006-0934-y; Mokart D, 2002, BRIT J SURG, V89, P1450, DOI 10.1046/j.1365-2168.2002.02218.x; Rael LT, 2015, ELECTROANAL, V27, P2567, DOI 10.1002/elan.201500178; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI 10.1089/neu.2008-0816; Schroeder VA, 2003, CIRCULATION, V107, P2823, DOI 10.1161/01.CIR.0000070955.55636.25; Scudellari M, 2015, NATURE, V528, P322, DOI 10.1038/528322a; Seekamp A, 1998, J TRAUMA, V44, P874, DOI 10.1097/00005373-199805000-00022; Spanidis Y, 2016, EXP THER MED, V11, P895, DOI 10.3892/etm.2016.2968; Spanidis Y, 2015, IN VIVO, V29, P595; Stapley R, 2012, BIOCHEM J, V446, P499, DOI 10.1042/BJ20120675; SULLIVAN JS, 1992, J PEDIATR-US, V120, P510, DOI 10.1016/S0022-3476(05)82476-X; VESILIND GW, 1988, TRANSFUSION, V28, P46, DOI 10.1046/j.1537-2995.1988.28188127952.x; Watson JD, 2014, LANCET, V383, P841, DOI 10.1016/S0140-6736(13)62365-X; Yalcin O, 2014, TRANSFUSION, V54, P1015, DOI 10.1111/trf.12361; Zhi LZ, 2014, J CRIT CARE, V29, P1063, DOI 10.1016/j.jcrc.2014.06.013	38	5	6	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	FEB	2018	39	2					299	306		10.1007/s00246-017-1755-x			8	Cardiac & Cardiovascular Systems; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Pediatrics	FV0UQ	WOS:000424275400011	29090352				2022-02-06	
J	Van Voorhees, EE; Moore, DA; Kimbrel, NA; Dedert, EA; Dillon, KH; Elbogen, EB; Calhoun, PS				Van Voorhees, Elizabeth E.; Moore, Daniel A.; Kimbrel, Nathan A.; Dedert, Eric A.; Dillon, Kirsten H.; Elbogen, Eric B.; Calhoun, Patrick S.			Association of Posttraumatic Stress Disorder and Traumatic Brain Injury With Aggressive Driving in Iraq and Afghanistan Combat Veterans	REHABILITATION PSYCHOLOGY			English	Article						military; aggression; Operation Enduring Freedom/Operation Iraqi Freedom; road rage	HYPERAROUSAL SYMPTOMS; ENDURING FREEDOM; US VETERANS; PTSD; IMPULSIVITY; PREVALENCE; SOLDIERS; BEHAVIOR; ANGER; PERFORMANCE	Purpose: Aggressive driving contributes to the high rates of postdeployment motor vehicle-related injury and death observed among veterans, and veterans cite problems with anger, aggressive driving, and road rage as being among their most pressing driving-related concerns. Both posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) have been associated with driving-related deficits in treatment-seeking samples of veterans, but the relative contribution of each of these conditions to problems with aggressive driving in the broader population of combat veterans is unclear. Method: chi(2) and logistic regression analyses were used to examine the relative association of PTSD, TBI, and co-occurring PTSD and TBI to self-reported problems with road rage in a sample of 1,102 veterans living in the mid-Atlantic region of the United States who had served in Afghanistan or Iraq. Results: Results indicate that controlling for relevant demographic variables, PTSD without TBI (odds ratio = 3.44, p < .001), and PTSD with co-occurring TBI (odds ratio = 4.71, p < .001) were associated with an increased risk of road rage, but TBI without PTSD was not. Conclusions: Our findings suggest that PTSD, with or without comorbid TBI, may be associated with an increased risk of aggressive driving in veterans. Clinical implications for treating problems with road rage are discussed, including use of interventions targeting hostile interpretation bias and training in emotional and physiological arousal regulation skills.	[Van Voorhees, Elizabeth E.; Moore, Daniel A.; Kimbrel, Nathan A.; Dedert, Eric A.; Elbogen, Eric B.; Calhoun, Patrick S.] Durham Vet Affairs Med Ctr, 508 Fulton St, Durham, NC 27705 USA; [Van Voorhees, Elizabeth E.; Moore, Daniel A.; Kimbrel, Nathan A.; Dedert, Eric A.; Elbogen, Eric B.; Calhoun, Patrick S.] Vet Affairs Midatlantic Mental Illness Res Educ &, Durham, NC USA; [Van Voorhees, Elizabeth E.; Moore, Daniel A.; Kimbrel, Nathan A.; Dedert, Eric A.; Dillon, Kirsten H.; Elbogen, Eric B.; Calhoun, Patrick S.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Moore, Daniel A.] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA		Van Voorhees, EE (corresponding author), Durham Vet Affairs Med Ctr, 508 Fulton St, Durham, NC 27705 USA.	e.vanv@duke.edu			Department of Veterans Affairs' (VA) Mid-Atlantic Mental Illness Research, Education and Clinical Center of the VA Office of Mental Health Services; VA Veterans Integrated Service Network 6 Mid-Atlantic Health Care Network; Research and Development and Mental Health Services of the Durham VA Medical Center; Rehabilitation Research and Development of the VA Office of Research and Development [5IK2RX001298]; Clinical Science Research and Development Service of the VA Office of Research and Development [IK2CX000525, IK2CX000718]; Veterans AffairsUS Department of Veterans Affairs [IK2CX000718, IK2RX001298, IK2CX000525] Funding Source: NIH RePORTER	This project was supported in part by the Department of Veterans Affairs' (VA) Mid-Atlantic Mental Illness Research, Education and Clinical Center of the VA Office of Mental Health Services, the VA Veterans Integrated Service Network 6 Mid-Atlantic Health Care Network, and the Research and Development and Mental Health Services of the Durham VA Medical Center. Elizabeth E. Van Voorhees was supported by Career Development Awards (5IK2RX001298) from the Rehabilitation Research and Development of the VA Office of Research and Development. Nathan A. Kimbrel and Eric A. Dedert were supported by Career Development Awards (IK2CX000525 and IK2CX000718, respectively) from the Clinical Science Research and Development Service of the VA Office of Research and Development.	Amick MM, 2013, J REHABIL RES DEV, V50, P463, DOI 10.1682/JRRD.2012.06.0108; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; CMS Alliance to Modernize Health Care, 2015, IND ASS HLTH CAR DEL, V1; Contractor AA, 2016, J NERV MENT DIS, V204, P20, DOI 10.1097/NMD.0000000000000417; Crawford EF, 2015, J TRAUMA STRESS, V28, P118, DOI 10.1002/jts.21993; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; Hannold EM, 2013, J REHABIL RES DEV, V50, P1315, DOI 10.1682/JRRD.2013.04.0084; Hawkins KA, 2013, BEHAV THER, V44, P479, DOI 10.1016/j.beth.2013.04.005; Heinz AJ, 2015, J SUBST ABUSE TREAT, V50, P59, DOI 10.1016/j.jsat.2014.10.014; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoggatt KJ, 2015, TRAFFIC INJ PREV, V16, P17, DOI 10.1080/15389588.2014.896994; Hwang EJ, 2014, AM J OCCUP THER, V68, P386, DOI 10.5014/ajot.2014.011668; Ilie G, 2015, ACCIDENT ANAL PREV, V81, P1, DOI 10.1016/j.aap.2015.04.021; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Kachadourian LK, 2013, J TRAUMA STRESS, V26, P580, DOI 10.1002/jts.21850; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Krahl PL, 2010, AM J PREV MED, V38, pS189, DOI 10.1016/j.amepre.2009.10.024; Kuhn E, 2010, J TRAUMA STRESS, V23, P399, DOI 10.1002/jts.20536; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2010, NEUROREHABILITATION, V26, P271, DOI 10.3233/NRE-2010-0562; Lincoln Andrew E, 2006, Traffic Inj Prev, V7, P31, DOI 10.1080/15389580500412028; Miles SR, 2016, J INTERPERS VIOLENCE, V31, P1795, DOI 10.1177/0886260515570746; Pavic L, 2003, EUR ARCH PSY CLIN N, V253, P80, DOI 10.1007/s00406-003-0411-z; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schry AR, 2015, PSYCHOSOMATICS, V56, P674, DOI 10.1016/j.psym.2015.07.010; Strom T, 2013, J TRAUMA STRESS, V26, P405, DOI 10.1002/jts.21808; Strom TQ, 2012, MIL MED, V177, P390, DOI 10.7205/MILMED-D-11-00133; Taft CT, 2015, J TRAUMA STRESS, V28, P314, DOI 10.1002/jts.22017; Teten AL, 2010, J INTERPERS VIOLENCE, V25, P1612, DOI 10.1177/0886260509354583; United States Automobile Association, 2012, RET WARR DRIV SAF RE; Wickens CM, 2008, ACCIDENT ANAL PREV, V40, P1223, DOI 10.1016/j.aap.2008.01.006; Woodall KA, 2014, AM J PREV MED, V46, P350, DOI 10.1016/j.amepre.2013.11.015; Zhang TR, 2016, ACCIDENT ANAL PREV, V90, P50, DOI 10.1016/j.aap.2016.02.009	40	5	5	1	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2018	63	1					160	166		10.1037/rep0000178			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FZ6YK	WOS:000427746300017	29553791	Green Accepted			2022-02-06	
J	Wang, HW; Zhou, Y; Liu, J; Ou, L; Han, JD; Xiang, LB				Wang, Hongwei; Zhou, Yue; Liu, Jun; Ou, Lan; Han, Jianda; Xiang, Liangbi			Traumatic skull fractures in children and adolescents: A retrospective observational study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Child; Adolescent; Traumatic skull fractures; Traumatic brain injury; Epidemiology	BRAIN-INJURY; HEAD-INJURIES; OUTCOMES; EPIDEMIOLOGY; ASSOCIATION; NECESSITY; NEED	Objective: To investigate the epidemiological features of child and adolescent (<= 18 years old) patients managed for traumatic skull fractures (TSKFs) and associated traumatic brain injury (TBI). Design: 393 Patients who were children and adolescent who had TSKFs admitted to our university affiliated hospitals between January 2003 and December 2010. The incidence and patterns were summarized with respect to different age group, admission time and etiology. Setting: Two university-affiliated hospitals from January 2003 to May 2010. Results: The most common etiologies were motor vehicle collisions (MVCs) (166, 42.2%) and high fall (101, 25.7%). The most common skull fracture sites were parietal fractures (n = 111, 28.2%) and basilar skull fracture (n = 111, 28.2%). A total of 300 (76.3%) patients suffered TBI and 23 (5.9%) patients suffered OCI. The most common intracranial hemorrhage was epidural hemorrhage (n = 94, 23.9%). The frequencies of emergency admission, medical insurance and associated injuries were 56.2% (n = 221), 22.4% (n = 88) and 37.2% (n = 146). The frequencies of TBI and associated injuries were significantly increased from 53.45% to 76.3% and from 6.9% to 41.6% with age, respectively. Conclusions: MVCs were the most common etiologies. Parietal and basilar skull fractures, epidural hemorrhages were the most common fracture sites and intracranial hemorrhage. (C) 2017 Elsevier Ltd. All rights reserved.	[Wang, Hongwei; Liu, Jun; Xiang, Liangbi] Chinese PLA, Shenyang Mil Area Command, Gen Hosp, Dept Orthoped, Shenyang 110016, Liaoning, Peoples R China; [Wang, Hongwei; Han, Jianda] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Liaoning, Peoples R China; [Wang, Hongwei] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Hubei, Peoples R China; [Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing 400037, Peoples R China; [Ou, Lan] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing 400038, Peoples R China		Wang, HW (corresponding author), Chinese PLA, Shenyang Mil Area Command, Gen Hosp, Dept Orthoped, Shenyang 110016, Liaoning, Peoples R China.	cplawhw@163.com			Foundation of the State Key Laboratory of Robotics [2017-O01]; Foundation of the State Key Laboratory of Materials Processing and Die & Mould Technology [P2018-011]; State Key Laboratory of CADCG [A1718]; Liaoning Province Doctor Startup Fund [201601389]	This work was supported by the Foundation of the State Key Laboratory of Robotics (2017-O01), the Foundation of the State Key Laboratory of Materials Processing and Die & Mould Technology (P2018-011), the Open Project Program of the State Key Laboratory of CAD&CG (A1718) and the Liaoning Province Doctor Startup Fund (201601389).	Alhelali I, 2015, J TRAUMA ACUTE CARE, V78, P1155, DOI 10.1097/TA.0000000000000662; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Blackwood BP, 2016, J PEDIATR SURG, V51, P654, DOI 10.1016/j.jpedsurg.2015.08.064; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carson HJ, 2009, J FORENSIC LEG MED, V16, P115, DOI 10.1016/j.jflm.2008.08.013; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; Chattopadhyay Saurabh, 2010, J Inj Violence Res, V2, P99, DOI 10.5249/jivr.v2i2.46; Erlichman DB, 2010, PEDIATR RADIOL, V40, P1375, DOI 10.1007/s00247-010-1555-4; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Hentzen AS, 2015, AM J SURG, V210, P322, DOI 10.1016/j.amjsurg.2014.11.011; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; McCutcheon BA, 2013, OTOLARYNG HEAD NECK, V149, P931, DOI 10.1177/0194599813508539; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Menon Anand, 2008, J Forensic Leg Med, V15, P75, DOI 10.1016/j.jflm.2007.06.001; Munoz-Sanchez MA, 2009, BRAIN INJURY, V23, P39, DOI 10.1080/02699050802590346; Parri N, 2013, J EMERG MED, V44, P135, DOI 10.1016/j.jemermed.2012.02.038; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Reuveni-Salzman A, 2016, CHILD NERV SYST, V32, P1669, DOI 10.1007/s00381-016-3175-2; Saadat S, 2011, ULUS TRAVMA ACIL CER, V17, P149, DOI 10.5505/tjtes.2011.26043; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Solomon S, 2009, HEADACHE, V49, P1112, DOI 10.1111/j.1526-4610.2009.01462.x; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Tunik MG, 2016, ANN EMERG MED, V68, P431, DOI 10.1016/j.annemergmed.2016.04.058; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Yavuz MS, 2003, AM J FOREN MED PATH, V24, P339, DOI 10.1097/01.paf.0000103011.14578.c3	31	5	5	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	FEB	2018	49	2					219	225		10.1016/j.injury.2017.11.039			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FX9TX	WOS:000426451500011	29203200				2022-02-06	
J	Zhou, MG; Wang, P; Yang, ZF; Wu, HD; Huang, ZT				Zhou, Minggen; Wang, Peng; Yang, Zhengfei; Wu, Haidong; Huang, Zitong			Spontaneous hypothermia ameliorated inflammation and neurologic deficit in rat cardiac arrest models following resuscitation	MOLECULAR MEDICINE REPORTS			English	Article						cardiac arrest; return of spontaneous circulation; inflammasome; NACHT; LRR and PYD domains-containing protein 3; spontaneous hypothermia; neurologic deficit	TRAUMATIC BRAIN-INJURY; NLRP3 INFLAMMASOME; CARDIOPULMONARY-RESUSCITATION; MOLECULAR MECHANISMS; ACTIVATION; ADMISSION; APOPTOSIS; MICE; EXPRESSION; SURVIVAL	Cardiac arrest (CA) is a leading cause of mortality worldwide. The majority of the associated mortalities are caused by post-CA syndrome, which includes symptoms, such as neurologic damage, myocardial dysfunction and systemic inflammation. Following CA, return of spontaneous circulation (ROSC) leads to a brain reperfusion injury, which subsequently causes adverse neurologic outcomes or mortality. Therefore, investigating the underlying mechanisms of ROSC-induced neurologic deficits and establishing potential treatments is critical to prevent and treat post-CA syndrome. In the current study, CA rat models were established by asphyxia. Following ROSC, the temperature was controlled to achieve hypothermia. The general neurologic status was assessed using the neurologic deficit scale. Changes in the concentrations of interleukin (IL)-18 and IL-1 were measured with ELISA and the dynamic change in NACHT, LRR and PYD domains-containing protein 3 inflammasome components was determined by western blot analysis and immunohistochemistry. Neuronal death and apoptosis were measured via TUNEL assays. In the CA rat models, increasing the duration of CA before cardiopulmonary resuscitation was found to aggravate the neural deficit and increase the incidence of inflammation. Following ROSC, the expression level of the inflammasome components was observed to increase in CA rat models, which was accompanied by increased secretion of IL-18 and IL-1, indicating the promotion of inflammation. In addition, the study identified the beneficial role of spontaneous hypothermia in ameliorating the ROSC-induced inflammation and neurologic deficit in CA rat models, including the downregulation of inflammasome components and attenuating neuronal apoptosis. The present study contributes to the understanding of underlying mechanisms in CA-evoked inflammation and the subsequent neurologic damage following ROSC. A novel potential therapeutic strategy that may increase survival times and the quality of life for patients suffering from post-CA syndrome is proposed in the present study.	[Zhou, Minggen] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Intens Care Unit, Guangzhou 510120, Guangdong, Peoples R China; [Zhou, Minggen; Wang, Peng; Yang, Zhengfei; Wu, Haidong; Huang, Zitong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Inst Cardiopulmonary Cerebral Resuscitat, Guangzhou 510120, Guangdong, Peoples R China; [Wang, Peng; Yang, Zhengfei; Wu, Haidong; Huang, Zitong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Emergency Med, 107 Yanjiang Xi Lu, Guangzhou 510120, Guangdong, Peoples R China		Yang, ZF; Huang, ZT (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Emergency Med, 107 Yanjiang Xi Lu, Guangzhou 510120, Guangdong, Peoples R China.	yangzhengfei@vip.163.com; zithuang@163.com		Zhou, Minggen/0000-0002-4574-9299	project of Leading Talents in the Pearl River Talent Plan of Guangdong Province [81000-42020004]	The current study was supported by a research grant from project of Leading Talents in the Pearl River Talent Plan of Guangdong Province (grant no. 81000-42020004).	Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Callaway CW, 2008, CRIT CARE MED, V36, P2607, DOI 10.1097/CCM.0b013e318184443b; D'Cruz BJ, 2005, BRAIN RES, V1064, P108, DOI 10.1016/j.brainres.2005.09.052; Ding L, 2014, CELL BIOCHEM BIOPHYS, V70, P1519, DOI 10.1007/s12013-014-0087-1; Drabek T, 2014, RESUSCITATION, V85, P284, DOI 10.1016/j.resuscitation.2013.10.015; Gong P, 2013, J CEREBR BLOOD F MET, V33, P928, DOI 10.1038/jcbfm.2013.33; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; Hua W, 2009, J AM COLL CARDIOL, V54, P1110, DOI 10.1016/j.jacc.2009.06.016; Jia XF, 2008, RESUSCITATION, V76, P431, DOI 10.1016/j.resuscitation.2007.08.014; JOHNSON EM, 1995, J NEUROTRAUM, V12, P843, DOI 10.1089/neu.1995.12.843; Kida K, 2014, ANESTHESIOLOGY, V120, P880, DOI 10.1097/ALN.0000000000000149; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Lu J, 2014, WORLD J EMERG MED, V5, P298, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.010; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Mizushima H, 2002, J COMP NEUROL, V448, P203, DOI 10.1002/cne.10262; Neumar RW, 2000, ANN EMERG MED, V36, P483, DOI 10.1067/mem.2000.110995; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rubiano AM, 2013, INJURY, V44, P1219, DOI 10.1016/j.injury.2012.11.026; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vijlbrief DC, 2012, NEONATOLOGY, V102, P243, DOI 10.1159/000339117; Wang HE, 2005, RESUSCITATION, V67, P69, DOI 10.1016/j.resuscitation.2005.05.008; Wiklund L, 2013, ACTA ANAESTH SCAND, V57, P1073, DOI 10.1111/aas.12106; Xu YJ, 2016, BRAIN BEHAV IMMUN, V56, P175, DOI 10.1016/j.bbi.2016.02.022; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5	31	5	5	0	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	FEB	2018	17	2					2127	2136		10.3892/mmr.2017.8113			10	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FT5WP	WOS:000423224300007	29207113	Green Published, Green Submitted, hybrid			2022-02-06	
J	Beste, C; Muckschel, M; Paucke, M; Ziemssen, T				Beste, Christian; Mueckschel, Moritz; Paucke, Madlen; Ziemssen, Tjalf			Dual-Tasking in Multiple Sclerosis - Implications for a Cognitive Screening Instrument	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						multiple sclerosis; dual task; executive function; behavior; psychological refractory period	PSYCHOLOGICAL REFRACTORY PERIOD; LATERAL PREFRONTAL CORTEX; CLOSED-HEAD INJURY; PROCESSING SPEED; MULTICOMPONENT BEHAVIOR; EXECUTIVE FUNCTIONS; PARKINSONS-DISEASE; CENTRAL BOTTLENECK; PERFORMANCE; WALKING	The monitoring of cognitive functions is central to the assessment and consecutive management of multiple sclerosis (MS). Though, especially cognitive processes that are central to everyday behavior like dual-tasking are often neglected. We examined dual-task performance using a psychological-refractory period (PRP) task in N = 21 patients and healthy controls and conducted standard neuropsychological tests. In dual-tasking, MS patients committed more erroneous responses when dual-tasking was difficult. In easier conditions, performance of MS patients did not differ to controls. Interestingly, the response times were generally not affected by the difficulty of the dual task, showing that the deficits observed do not reflect simple motor deficits or deficits in information processing speed but point out deficits in executive control functions and response selection in particular. Effect sizes were considerably large with d similar to 0.80 in mild affected patients and the achieved power was above 99%. There are cognitive control and dual tasking deficits in MS that are not attributable to simple motor speed deficits. Scaling of the difficulty of dual-tasking makes the test applied suitable for a wide variety of MS-patients and may complement neuropsychological assessments in clinical care and research setting.	[Beste, Christian; Mueckschel, Moritz] Tech Univ Dresden, Dept Child & Adolescent Psychiat, Cognit Neurophysiol, Fac Med, Dresden, Germany; [Mueckschel, Moritz; Paucke, Madlen; Ziemssen, Tjalf] Tech Univ Dresden, Dept Neurol, Multiple Sclerosis Ctr, Fac Med,Ctr Clin Neurosci, Dresden, Germany		Beste, C (corresponding author), Tech Univ Dresden, Dept Child & Adolescent Psychiat, Cognit Neurophysiol, Fac Med, Dresden, Germany.	christian.beste@uniklinikum-dresden.de	Ziemssen, Tjalf/J-2017-2019	Ziemssen, Tjalf/0000-0001-8799-8202	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [BE4045/10-2]; Roland Ernst Foundation; Hertie Foundation	This work was supported by a Grant from the Deutsche Forschungsgemeinschaft (DFG) BE4045/10-2 to CB and by Grant from Roland Ernst Foundation and the Hertie Foundation.	Allai G, 2014, NEUROPHYSIOL CLIN, V44, P87, DOI 10.1016/j.neucli.2013.10.136; Amato MP, 2013, J NEUROL, V260, P1452, DOI 10.1007/s00415-012-6678-0; Amato MP, 2010, NEUROL SCI, V31, P211, DOI 10.1007/s10072-010-0376-4; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; BEATTY WW, 1989, BRAIN COGNITION, V11, P73, DOI 10.1016/0278-2626(89)90006-7; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Beste C, 2013, BEHAV BRAIN RES, V252, P260, DOI 10.1016/j.bbr.2013.06.013; Beste C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01797; Beste C, 2012, NEUROIMAGE, V62, P137, DOI 10.1016/j.neuroimage.2012.05.019; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Bier B, 2017, EXP AGING RES, V43, P161, DOI 10.1080/0361073X.2017.1276377; Bonzano L, 2011, NEUROIMAGE, V57, P495, DOI 10.1016/j.neuroimage.2011.04.037; Bonzano L, 2009, NEUROIMAGE, V44, P9, DOI 10.1016/j.neuroimage.2008.08.015; Butchard-MacDonald E, 2018, J INT NEUROPSYCH SOC, V24, P247, DOI 10.1017/S1355617717000947; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Chmielewski WX, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00193; Dell'Acqua R, 2003, EXP BRAIN RES, V152, P29, DOI 10.1007/s00221-003-1512-7; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Denney DR, 2011, ARCH CLIN NEUROPSYCH, V26, P110, DOI 10.1093/arclin/acq104; Denney DR, 2009, J INT NEUROPSYCH SOC, V15, P451, DOI 10.1017/S1355617709090730; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dippel G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7587; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Downer MB, 2016, HUM MOVEMENT SCI, V49, P124, DOI 10.1016/j.humov.2016.06.010; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Foong J, 1999, J NEUROPSYCH CLIN N, V11, P45, DOI 10.1176/jnp.11.1.45; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Gohil K, 2017, HUM BRAIN MAPP, V38, P4933, DOI 10.1002/hbm.23705; Gohil K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09485; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Guimaraes Joana, 2012, Front Neurol, V3, P74, DOI 10.3389/fneur.2012.00074; Hamilton F, 2009, MULT SCLER J, V15, P1215, DOI 10.1177/1352458509106712; Hesselmann G, 2011, NEUROIMAGE, V56, P1608, DOI 10.1016/j.neuroimage.2011.03.017; Holtzer R, 2014, J GERONTOL A-BIOL, V69, P980, DOI 10.1093/gerona/glt180; Holtzer R, 2014, AGE, V36, P373, DOI 10.1007/s11357-013-9570-7; Janczyk M, 2014, COGNITION, V132, P30, DOI 10.1016/j.cognition.2014.03.001; Krause I, 2013, MULT SCLER J, V19, P1792, DOI 10.1177/1352458513485655; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Learmonth YC, 2017, ARCH PHYS MED REHAB, V98, P1229, DOI 10.1016/j.apmr.2016.07.018; Leone C, 2015, MULT SCLER J, V21, P123, DOI 10.1177/1352458514547408; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; LITVAN I, 1988, ARCH NEUROL-CHICAGO, V45, P607, DOI 10.1001/archneur.1988.00520300025012; Marois R, 2006, PSYCHOL RES-PSYCH FO, V70, P436, DOI 10.1007/s00426-005-0022-6; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Miller J, 2006, PSYCHOL RES-PSYCH FO, V70, P484, DOI 10.1007/s00426-005-0011-9; Mitolo M, 2015, J NEUROL SCI, V354, P1, DOI 10.1016/j.jns.2015.05.004; Monticone M, 2014, GAIT POSTURE, V40, P715, DOI 10.1016/j.gaitpost.2014.06.015; Muckschel M, 2016, ACTA NEUROL SCAND, V134, P55, DOI 10.1111/ane.12656; Nieuwhof F, 2017, BRAIN, V140, P1384, DOI 10.1093/brain/awx042; Pacheco R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00117; PASHLER H, 1984, J EXP PSYCHOL HUMAN, V10, P358, DOI 10.1037/0096-1523.10.3.358; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Preston J, 2013, BRIT J OCCUP THER, V76, P225, DOI 10.4276/030802213X13679275042726; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rocca MA, 2015, LANCET NEUROL, V14, P302, DOI 10.1016/S1474-4422(14)70250-9; Rocca MA, 2009, HUM BRAIN MAPP, V30, P2844, DOI 10.1002/hbm.20712; Salazar RD, 2017, NEUROPSYCHOLOGY, V31, P613, DOI 10.1037/neu0000331; Schulz S, 2012, NEUROPHARMACOLOGY, V62, P1028, DOI 10.1016/j.neuropharm.2011.10.012; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stelzel C, 2008, J COGNITIVE NEUROSCI, V20, P613, DOI 10.1162/jocn.2008.20053; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stock AK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04828-w; Stock AK, 2014, J NEUROSCI, V34, P5335, DOI 10.1523/JNEUROSCI.5140-13.2014; Szameitat AJ, 2006, PSYCHOL RES-PSYCH FO, V70, P541, DOI 10.1007/s00426-005-0015-5; Van Selst M, 1999, J EXP PSYCHOL HUMAN, V25, P1268, DOI 10.1037/0096-1523.25.5.1268; VanSelst M, 1997, COGNITIVE PSYCHOL, V33, P266, DOI 10.1006/cogp.1997.0662; Vaportzis E, 2015, J NEUROL, V262, P268, DOI 10.1007/s00415-014-7563-9; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Verhaeghen P, 2011, CURR DIR PSYCHOL SCI, V20, P174, DOI 10.1177/0963721411408772; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wajda DA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/720856; Welford AT, 1952, B J PSYCHOL-GEN SECT, V43, P2, DOI 10.1111/j.2044-8295.1952.tb00322.x; Wu CX, 2008, PSYCHOL REV, V115, P913, DOI 10.1037/a0013123; Yildiz A, 2015, BRAIN STRUCT FUNCT, V220, P3131, DOI 10.1007/s00429-014-0847-0; Yildiz A, 2014, PSYCHONEUROENDOCRINO, V42, P178, DOI 10.1016/j.psyneuen.2014.01.022; Yildiz A, 2013, BEHAV BRAIN RES, V250, P304, DOI 10.1016/j.bbr.2013.05.010	79	5	5	0	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JAN 31	2018	12								24	10.3389/fnhum.2018.00024			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FU2WC	WOS:000423709700001	29445335	gold, Green Published			2022-02-06	
J	Skrifvars, MB; French, C; Bailey, M; Presneill, J; Nichol, A; Little, L; Durantea, J; Huet, O; Haddad, S; Arabi, Y; McArthur, C; Cooper, DJ; Bellomo, R				Skrifvars, Markus B.; French, Craig; Bailey, Michael; Presneill, Jeffrey; Nichol, Alistair; Little, Lorraine; Durantea, Jacques; Huet, Olivier; Haddad, Samir; Arabi, Yaseen; McArthur, Colin; Cooper, D. James; Bellomo, Rinaldo		EPO-TBI Investigators & ANZICS	Cause and Timing of Death and Subgroup Differential Effects of Erythropoietin in the EPO-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical management of central nervous system injury; head trauma; human studies; traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; CLASSIFICATION-SYSTEM; PROGESTERONE; MORTALITY; EPIDEMIOLOGY; TOMOGRAPHY; VALIDATION; WITHDRAWAL	The EPO-TBI study randomized 606 patients with moderate or severe traumatic brain injury (TBI) to be treated with weekly epoetin alfa (EPO) or placebo. Six month mortality was lower in EPO treated patients in an analysis adjusting for TBI severity. Knowledge of possible differential effects by TBI injury subtype and acute neurosurgical treatment as well as timing and cause of death (COD) will facilitate the design of future interventional TBI trials. We defined COD as cerebral (brain death, cerebral death with withdrawal, or death during maximal care) and non-cerebral (death following withdrawal or during maximal care, which had a non-cerebral cause). The study included 305 patients treated with EPO and 297 treated with placebo, with COD recorded in 77 (99%) out of 78 non-survivors. Median time to death in patients dying of cerebral COD was 8 days (interquartile range [IQR] 5-16) compared with 29 days (IQR 7-56) (p = 0.01) for non-cerebral COD. When assessing subgroups by admission CT scan injury findings, we found no significant differential effects of EPO compared with placebo. However, EPO appeared more effective in patients with an injury type not requiring a neurosurgical operation prior to intensive care unit (ICU) admission (odds ratio [OR] 0.29, 95% confidence interval [CI] 0.14-0.61, p = 0.001, p for interaction = 0.003) and in this subgroup, fewer patients died of cerebral causes in the EPO than in the placebo group (5% compared with 14%, p = 0.03). In conclusion, most TBI deaths were from cerebral causes that occurred during the first 2 weeks, and were related to withdrawal of care. EPO appeared to specifically reduce cerebral deaths in the important subgroup of patients with a diffuse type of injury not requiring a neurosurgical intervention prior to randomization.	[Skrifvars, Markus B.; Bailey, Michael; Presneill, Jeffrey; Nichol, Alistair; Little, Lorraine; Cooper, D. James; Bellomo, Rinaldo] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Skrifvars, Markus B.] Univ Helsinki, Dept Anaesthesiol Intens Care & Pain Med, Div Intens Care, Helsinki, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Helsinki, Finland; [French, Craig] Western Hlth, Dept Intens Care, Melbourne, Vic, Australia; [French, Craig] Univ Melbourne, North West Acad Ctr, Melbourne, Vic, Australia; [Presneill, Jeffrey] Royal Melbourne Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Nichol, Alistair] St Vincents Univ Hosp, Dublin, Ireland; [Nichol, Alistair; Cooper, D. James] The Alfred, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Durantea, Jacques] Univ Paris Sud, Hop Univ Paris Sud, AP HP, Dept Anesthesie Reanimat,Hop Bicetre, Paris, France; [Huet, Olivier] CHU La Cavale Blanche, Dept Anaesthesiol & Intens Care Med, Brest, France; [Haddad, Samir; Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Haddad, Samir; Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [McArthur, Colin] Auckland City Hosp, Auckland, New Zealand; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia		Skrifvars, MB (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, 55 Commercial Rd, Melbourne, Vic 3004, Australia.	markus.skrifvars@monash.edu	Cooper, D. James/G-7961-2013; Arabi, Yaseen/ABF-3316-2020; Bailey, Michael J/A-4499-2012; French, Craig/ABF-5087-2020	Cooper, D. James/0000-0002-5872-9051; Arabi, Yaseen/0000-0001-5735-6241; Bailey, Michael J/0000-0002-5551-1401; French, Craig/0000-0003-1363-9711; Nichol, Alistair/0000-0002-4689-1238	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [545902]; Transport Accident Commission of Victoria [D162]; Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Svenska Kulturfonden; Health Research Board of Ireland	EPO-TBI was supported by grants from the National Health and Medical Research Council of Australia (grant 545902) and the Transport Accident Commission of Victoria (grant D162). Markus Skrifvars has received personal research funding from Medicinska Understodsforeningen Liv och Halsa, Finska Lakaresallskapet, and Svenska Kulturfonden. Alistair Nichol has received support from the Health Research Board of Ireland.	Andrews PJD, 2017, CRIT CARE MED, V45, P883, DOI 10.1097/CCM.0000000000002376; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chu HL, 2014, LAB INVEST, V94, P1042, DOI 10.1038/labinvest.2014.84; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Moore L, 2017, ANN SURG, V265, P212, DOI 10.1097/SLA.0000000000001614; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Ridgeon E, 2016, CRIT CARE RESUSC, V18, P50; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Skolnick BE, 2015, NEW ENGL J MED, V372, P1767, DOI 10.1056/NEJMc1503138; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xydakis MS, 2015, NEW ENGL J MED, V372, P1765, DOI 10.1056/NEJMc1503138	31	5	5	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					333	340		10.1089/neu.2017.5135			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000422918000014	29020866	Green Accepted			2022-02-06	
J	Mathiasen, R; Hogrefe, C; Harland, K; Peterson, A; Smoot, MK				Mathiasen, Ross; Hogrefe, Christopher; Harland, Kari; Peterson, Andrew; Smoot, M. Kyle			Longitudinal Improvement in Balance Error Scoring System Scores among NCAA Division-I Football Athletes	JOURNAL OF NEUROTRAUMA			English	Article						athletes; balance; BESS; concussion; football	POSTURAL STABILITY; PERFORMANCE; CONCUSSION	The Balance Error Scoring System (BESS) is a commonly used concussion assessment tool. Recent studies have questioned the stability and reliability of baseline BESS scores. The purpose of this longitudinal prospective cohort study is to examine differences in yearly baseline BESS scores in athletes participating on an NCAA Division-I football team. NCAA Division-I freshman football athletes were videotaped performing the BESS test at matriculation and after 1 year of participation in the football program. Twenty-three athletes were enrolled in year 1 of the study, and 25 athletes were enrolled in year 2. Those athletes enrolled in year 1 were again videotaped after year 2 of the study. The paired t-test was used to assess for change in score over time for the firm surface, foam surface, and the cumulative BESS score. Additionally, inter- and intrarater reliability values were calculated. Cumulative errors on the BESS significantly decreased from a mean of 20.3 at baseline to 16.8 after 1 year of participation. The mean number of errors following the second year of participation was 15.0. Inter-rater reliability for the cumulative score ranged from 0.65 to 0.75. Intrarater reliability was 0.81. After 1 year of participation, there is a statistically and clinically significant improvement in BESS scores in an NCAA Division-I football program. Although additional improvement in BESS scores was noted after a second year of participation, it did not reach statistical significance. Football athletes should undergo baseline BESS testing at least yearly if the BESS is to be optimally useful as a diagnostic test for concussion.	[Mathiasen, Ross] Univ Nebraska Med Ctr, Dept Emergency Med, 981150 Nebraska Med Ctr, Omaha, NE 68198 USA; [Mathiasen, Ross] Univ Nebraska Med Ctr, Dept Orthopaed Surg, 981150 Nebraska Med Ctr, Omaha, NE 68198 USA; [Hogrefe, Christopher] Northwestern Univ, Dept Med, Dept Emergency Med, Feinberg Sch Med,Dept Orthopaed Surg Sports Med, Chicago, IL 60611 USA; [Harland, Kari] Univ Iowa Hosp & Clin, Dept Emergency Med, Iowa City, IA 52242 USA; [Peterson, Andrew] Univ Iowa Hosp & Clin, Dept Pediat, Dept Orthopaed & Rehabil, Iowa City, IA 52242 USA; [Smoot, M. Kyle] Univ Kentucky, Dept Orthopaed & Sports Med, Lexington, KY USA		Mathiasen, R (corresponding author), Univ Nebraska Med Ctr, Dept Emergency Med, 981150 Nebraska Med Ctr, Omaha, NE 68198 USA.; Mathiasen, R (corresponding author), Univ Nebraska Med Ctr, Dept Orthopaed Surg, 981150 Nebraska Med Ctr, Omaha, NE 68198 USA.	remathia@unmc.edu		Peterson, Andrew/0000-0003-4555-7366; Hogrefe, Christopher/0000-0002-2069-9563			Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	14	5	5	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2018	35	4					691	694		10.1089/neu.2017.5072		JAN 2018	4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FV3OH	WOS:000419867000001	29149800				2022-02-06	
J	Alderman, N; Williams, C; Wood, RL				Alderman, Nick; Williams, Claire; Wood, Rodger Ll.			When normal scores don't equate to independence: Recalibrating ratings of neurobehavioural disability from the 'St Andrew's - Swansea Neurobehavioural Outcome Scale' to reflect context-dependent support	BRAIN INJURY			English	Article						Head injury; traumatic brain injury; assessment; neurobehavioural; rehabilitation	TRAUMATIC BRAIN-INJURY; CHALLENGING BEHAVIOR; OVERT AGGRESSION; REHABILITATION; VERSION; VALIDATION; VALIDITY	Primary objective: Context is critical to the interpretation of measurement instruments that capture acquired brain injury (ABI) outcomes. Ratings reflect behaviours and abilities observed in a particular setting; it cannot be assumed that results are generalizable beyond these. This study explored the utility of a method to convey the impact of context-dependent support given on ratings of neurobehavioural disability (NBD) using the St Andrews-Swansea Neurobehavioural Outcome Scale (SASNOS). Methods and procedures: A supplementary SASNOS scoring system was developed using a mixed-methods approach. Dependency ratings were used to recalibrate standardised SASNOS scores to reflect support received. To aid interpretation, an expert panel reviewed SASNOS ratings for 50 ABI cases participating in residential neurobehavioural rehabilitation programmes. An end-user survey was undertaken to explore some of its psychometric properties. Finally, a representative case study was employed to illustrate its clinical utility. Main outcomes: The expert panel identified three dependency profiles: (1) Normal/Independent; (2) Normal/Dependent; and (3) Abnormal/Review. Survey results supported face and construct validity of the supplementary system; the case study demonstrated benefits of discriminating between dependency profiles. Conclusions: The supplementary scoring system enables SASNOS to convey the impact of support received on ratings of NBD, solidifying its usefulness for measuring outcomes in rehabilitation.	[Alderman, Nick] Elysium Neurol, Badby Pk, Daventry, Northants, England; [Alderman, Nick; Williams, Claire] Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Swansea, W Glam, Wales; [Wood, Rodger Ll.] Swansea Univ, Coll Med, Neuropsychol Clin, Swansea, W Glam, Wales		Alderman, N (corresponding author), Elysium Neurol, Neurobehav Rehabil Serv, Badby Pk, Daventry NN11 4NH, Northants, England.	nick.alderman@elysiumhealthcare.co.uk		Alderman, Nick/0000-0002-8523-4142			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Alderman N, 2015, UK ACQ BRAIN INJ FOR; Alderman N, 2017, INT HDB NEUROPSYCHOL; Alderman N, TXB TRAUMAT IN PRESS; Alderman N, 2017, ARCH CLIN NEUROPSYCH, V32, P951, DOI 10.1093/arclin/acx026; Alderman N, 2013, NEUROREHABILITATION, V32, P761, DOI 10.3233/NRE-130900; Alderman N, 2011, BRAIN INJURY, V25, P83, DOI 10.3109/02699052.2010.532849; BURKE WH, 1988, INT J REHABIL RES, V11, P235, DOI 10.1097/00004356-198809000-00003; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Swan L, 2004, BRAIN INJURY, V18, P143, DOI 10.1080/02699050310001596923; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tate RL, 2010, COMPENDIUM TESTS SCA; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600; Turner-Stokes L, 2012, DISABIL REHABIL, V34, P715, DOI 10.3109/09638288.2011.615880; Turner-Stokes L, 2009, CLIN REHABIL, V23, P922, DOI 10.1177/0269215509337447; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood R, OXFORD TXB IN PRESS; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1; YOUNGSON HA, 1994, BRAIN INJURY, V8, P23, DOI 10.3109/02699059409150956	23	5	5	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					218	229		10.1080/02699052.2017.1406989			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600008	29190147	Green Accepted			2022-02-06	
J	Bin Zahid, A; Hubbard, ME; Dammavalam, VM; Balser, DY; Pierre, G; Kim, A; Kolecki, R; Mehmood, T; Wall, SP; Frangos, SG; Huang, PP; Tupper, DE; Barr, W; Samadani, U				Bin Zahid, Abdullah; Hubbard, Molly E.; Dammavalam, Vikalpa M.; Balser, David Y.; Pierre, Gritz; Kim, Amie; Kolecki, Radek; Mehmood, Talha; Wall, Stephen P.; Frangos, Spiros G.; Huang, Paul P.; Tupper, David E.; Barr, William; Samadani, Uzma			Assessment of acute head injury in an emergency department population using sport concussion assessment tool-3rd edition	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Brain concussion; diagnosis; emergency treatment; classification; humans; mild traumatic brain injury; diagnosis; neuropsychological Tests; statistics and numerical data	TRAUMATIC-BRAIN-INJURY; STANDARDIZED ASSESSMENT; POSTCONCUSSION SYNDROME; TEST-PERFORMANCE; SAC; SCAT2	Sport Concussion Assessment Tool version 3 (SCAT-3) is one of the most widely researched concussion assessment tools in athletes. Here normative data for SCAT3 in nonathletes are presented. The SCAT3 was administered to 98 nonathlete healthy controls, as well as 118 participants with head-injury and 46 participants with other body trauma (OI) presenting to the ED. Reference values were derived and classifier functions were built to assess the accuracy of SCAT3. The control population had a mean of 2.30 (SD=3.62) symptoms, 4.38 (SD=8.73) symptom severity score (SSS), and 26.02 (SD=2.52) standardized assessment of concussion score (SAC). Participants were more likely to be diagnosed with a concussion (from among healthy controls) if the SSS>7; or SSS7 and SAC 22 (sensitivity=96%, specificity=77%). Identification of head injury patients from among both, healthy controls and body trauma was possible using rule SSS>7 and headache or pressure in head present, or SSS7 and SAC22 (sensitivity=87%, specificity=80%). In this current study, the SCAT-3 provided high sensitivity to discriminate acute symptoms of TBI in the ED setting. Individuals with a SSS>7 and headache or pressure in head, or SSS7 but with a SAC22 within 48-hours of an injury should undergo further testing.	[Bin Zahid, Abdullah; Hubbard, Molly E.; Dammavalam, Vikalpa M.; Balser, David Y.; Samadani, Uzma] Hennepin Cty Med Ctr, Div Neurosurg, Minneapolis, MN 55415 USA; [Bin Zahid, Abdullah; Dammavalam, Vikalpa M.; Balser, David Y.; Samadani, Uzma] Minneapolis VA Hlth Care Syst, Div Neurosurg, Minneapolis, MN USA; [Bin Zahid, Abdullah; Hubbard, Molly E.; Samadani, Uzma] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Pierre, Gritz; Huang, Paul P.] NYU, Dept Neurosurg, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Kim, Amie; Mehmood, Talha] Westchester Med Ctr, Dept Surg, Valhallah, NY USA; [Kolecki, Radek] Oculogica Inc, New York, NY USA; [Wall, Stephen P.] NYU, Sch Med, Ronald O Perelman Dept Emergency Med, New York, NY USA; [Frangos, Spiros G.] NYU, Dept Surg, Sch Med, New York, NY 10016 USA; [Huang, Paul P.] Bellevue Hosp Ctr, Dept Neurosurg, New York, NY 10016 USA; [Tupper, David E.] Hennepin Cty Med Ctr, Neuropsychol Sect G8, Minneapolis, MN 55415 USA; [Barr, William] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Barr, William] NYU, Sch Med, Dept Psychiat, New York, NY USA		Bin Zahid, A (corresponding author), Hennepin Cty Med Ctr, 701 Pk Ave S PL-662, Minneapolis, MN 55415 USA.	Abdullah.binzahid@hcmed.org		Frangos, Spiros/0000-0003-2860-8969; Huang, Paul/0000-0003-0563-921X; Wall, Stephen/0000-0003-3965-5074	ASRF grant from New York University School of Medicine; NSBRI grant from NASA; Steve and Alexandra Cohen Veterans Foundation for Traumatic brain injury and post-traumatic stress disorder	This work was supported by an ASRF grant from New York University School of Medicine and a NSBRI grant from NASA. U. Samadani was also partly supported by the Steve and Alexandra Cohen Veterans Foundation for Traumatic brain injury and post-traumatic stress disorder.	Alfano MS, 2000, J CLIN PSYCHOL, V56, P975, DOI 10.1002/1097-4679(200007)56:7<975::AID-JCLP13>3.0.CO;2-Z; Allen RM, 2000, J CLIN PSYCHOL, V56, P969, DOI 10.1002/1097-4679(200007)56:7<969::AID-JCLP12>3.0.CO;2-R; Ansbacher H L, 1943, Science, V98, P218, DOI 10.1126/science.98.2540.218; Atzema C, 2004, ANN EMERG MED, V44, P47, DOI 10.1016/j.annemergmed.2004.02.032; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2016, RAT TBI REL EM DEP V; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Maroon JC, 2012, PHYSICIAN SPORTSMED, V40, P73, DOI 10.3810/psm.2012.11.1990; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; O'Neil B, 2014, MIL MED, V179, P1250, DOI 10.7205/MILMED-D-13-00585; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Zottoli TM, 2015, CLIN NEUROPSYCHOL, V29, P678, DOI 10.1080/13854046.2015.1062562	24	5	5	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	2					110	119		10.1080/23279095.2016.1248765			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FT9MO	WOS:000423476400002	27854143				2022-02-06	
J	Broers, MC; Niermeijer, JMF; Kotsopoulos, IAW; Lingsma, HF; Bruinenberg, JFM; Catsman-Berrevoets, CE				Broers, Merel C.; Niermeijer, Jikke-Mien F.; Kotsopoulos, Irene A. W.; Lingsma, Hester F.; Bruinenberg, Jos F. M.; Catsman-Berrevoets, Coriene E.			Evaluation of management and guideline adherence in children with mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; minor head trauma; brain computed tomography; hospital admission; guideline compliance	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; SCANDINAVIAN GUIDELINES; IDENTIFYING CHILDREN; PEDIATRIC-PATIENTS; NICE GUIDELINES; DECISION RULE; CT; RISK; PHYSICIANS	Aim: To evaluate the management and guideline adherence in children with mild traumatic brain injury (MTBI) in emergency departments (ED) in the Netherlands.Methods: A multicentre cohort study was conducted, including children younger than 18years with MTBI who presented within 24hours after trauma in the ED of hospitals in the southwest region of the Netherlands, in 2014. Primary outcome measures for management were percentages of performed computed tomography (CT) scans and hospital admissions. Guideline adherence was defined as percentages of correctly following the guideline. Secondary outcome measures were differences in management and guideline adherence between hospitals.Results: About 563 patients were analysed. Hospital admission was the most frequently performed management type (49.2% hospital admission vs. 30.9% CT). In only 49.7% of patients, the guideline was followed correctly. A substantial overuse of hospital admission (35%) and underuse of CT (40.1%) were found. Percentages of hospital admission and CT varied between 39.4-55.6% and 23.3-44.1%, respectively, across hospitals. Percentages of correctly following the guideline varied between 39.2-64.9% across hospitals.Conclusion: These findings suggest that physicians in the participating hospitals prefer hospital admission of children with MTBI instead of CT despite the current recommendations of the national MTBI guideline in the Netherlands.	[Broers, Merel C.; Catsman-Berrevoets, Coriene E.] Erasmus Univ Hosp, Sophia Childrens Hosp, Dept Paediat Neurol, Rotterdam, Netherlands; [Niermeijer, Jikke-Mien F.] Elisabeth TweeSteden Hosp, Dept Neurol, Tilburg, Netherlands; [Kotsopoulos, Irene A. W.] Amphia Hosp, Dept Neurol, Breda, Netherlands; [Lingsma, Hester F.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Bruinenberg, Jos F. M.] Elisabeth TweeSteden Hosp, Dept Paediat, Tilburg, Netherlands		Catsman-Berrevoets, CE (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Paediat Neurol, Wijtemaweg 80, NL-3015 CN Rotterdam, Netherlands.	c.catsman@erasmusmc.nl					Aitken ME, 1998, ARCH PEDIAT ADOL MED, V152, P1176; [Anonymous], 2007, NEUR DIS PUBL HLTH C, P164; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Bainbridge J, 2012, BRIT J RADIOL, V85, P183, DOI 10.1259/bjr/56169980; Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Chen JX, 2014, OTOLARYNG HEAD NECK, V151, P554, DOI 10.1177/0194599814542588; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Fundaro C, 2012, CHILD NERV SYST, V28, P1063, DOI 10.1007/s00381-012-1717-9; Ghosh R, 2012, EMERG MED J, V29, P197, DOI 10.1136/emj.2009.085639; Goldberg J, 2011, J PEDIATR SURG, V46, P1777, DOI 10.1016/j.jpedsurg.2011.02.052; Harris A, 2006, INT J CLIN PRACT, V60, P1120, DOI 10.1111/j.1742-1241.2006.01016.x; Hebb MO, 2007, CAN J SURG, V50, P187; Heskestad B, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-32; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Klement W, 2012, ARTIF INTELL MED, V54, P163, DOI 10.1016/j.artmed.2011.11.005; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Linscott LL, 2013, AM J NEURORADIOL, V34, P1252, DOI 10.3174/ajnr.A3366; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; (NVN), 2010, NVVN CBO RICHTL OPV; Palchak MJ, 2009, PEDIATR EMERG CARE, V25, P61, DOI 10.1097/PEC.0b013e318196e9c0; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Strand IH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-62; Tilma IS, 2015, NED TIJDSCHR GENEES, V159, pA8405; van den Brand Crispijn L, 2014, Ned Tijdschr Geneeskd, V158, pA6973; Velasco, PROJECT PROPOSAL EVA; Willis AP, 2008, CLIN RADIOL, V63, P165, DOI 10.1016/j.crad.2007.05.027; Zhu HP, 2014, INT J ENV RES PUB HE, V11, P3493, DOI 10.3390/ijerph110403493; Zorg, 2012, RKV RICTLIJN RICHTLI	41	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		1028	1039		10.1080/02699052.2018.1469047			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400010	29775090	Green Published			2022-02-06	
J	Chiu, HY; Li, W; Lin, JH; Su, YK; Lin, EY; Tsai, PS				Chiu, Hsiao-Yean; Li, Wei; Lin, Jiann-Her; Su, Yu-Kai; Lin, En-Yuan; Tsai, Pei-Shan			Measurement properties of the Chinese version of the Mental Fatigue Scale for patients with traumatic brain injury	BRAIN INJURY			English	Article						Mental fatigue; traumatic brain injury; item response theory; validation	DEPRESSION OUTCOME SCALE; ITEM RESPONSE THEORY; MULTIPLE-SCLEROSIS; IMPACT; RELIABILITY; MILD; QUESTIONNAIRE; SYMPTOMS; VALIDITY	Objectives: To translate the Mental Fatigue Scale into a Chinese version (CMFS), to develop a more valid and precise CMFS by using an item response theory-based model, and to examine the reliability and validity of the CMFS.Methods: One hundred and fifty adults having traumatic brain injury for at least 6months were included. Each participant completed a battery of questionnaires (i.e. the Chinese version of the Chalder Fatigue Scale [ChCFS], Chinese version of the Clinically Useful Depression Outcome Scale [CUDOS-Chinese], and CMFS). Two-parameter graded response models were used to evaluate the location and discrimination performance of the CMFS. The reliability and validity of the CMFS were also evaluated.Results: One item investigating increased sleep at night' (item 14) was removed because it had a low discrimination value (0.86) and provided less information. The internal consistency and test-retest reliability of the 13-item CMFS were high (0.92 and 0.96, respectively). The CMFS score was positively correlated with the ChCFS and the CUDOS-Chinese scores (r=0.77 and 0.80, respectively).Conclusion: The CMFS provides reliable and valid information on mental fatigue for future research and clinical practice involving patients with traumatic brain injury.	[Chiu, Hsiao-Yean; Tsai, Pei-Shan] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Li, Wei] Taipei Med Univ, Dept Neurosurg, Taipei Municipal Wanfang Hosp, Taipei, Taiwan; [Lin, Jiann-Her; Lin, En-Yuan] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Su, Yu-Kai] Taipei Med Univ, Dept Neurosurg, Shuang Ho Hosp, New Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan		Tsai, PS (corresponding author), 250 Wu Hsing St, Taipei 110, Taiwan.	ptsai@tmu.edu.tw			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 103-2314-B-038-068-MY2]	This study was supported by a grant to H.Y. Chiu [grant number MOST 103-2314-B-038-068-MY2] by the Ministry of Science and Technology, Taiwan.	Baker, 2001, BASICS ITEM RESPONSE; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cai L, 2011, IRTPRO FLEXIBLE MULT; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chen WH, 1997, J EDUC BEHAV STAT, V22, P265, DOI 10.3102/10769986022003265; Dinno A, 2009, STATA J, V9, P291, DOI 10.1177/1536867X0900900207; Edelen MO, 2007, QUAL LIFE RES, V16, P5, DOI 10.1007/s11136-007-9198-0; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; FISK JD, 1994, CAN J NEUROL SCI, V21, P9, DOI 10.1017/S0317167100048691; Hambleton RK, 2011, HDB POLYTOMOUS ITEM; Hambleton RK., 1991, FUNDAMENTALS ITEM RE; Hemker BT, 1996, PSYCHOMETRIKA, V61, P679, DOI 10.1007/BF02294042; Hsu LF, 2014, INT J NURS STUD, V51, P1595, DOI 10.1016/j.ijnurstu.2014.05.004; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Johansson B, 2012, BRAIN INJURY FUNCTIO; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Ledesma R.D., 2007, PRACTICAL ASSESSMENT, V12, P1, DOI 10.12691/ajams-6-3-1; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Morriss RK, 1998, J PSYCHOSOM RES, V45, P411, DOI 10.1016/S0022-3999(98)00022-1; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Orlando M, 2000, APPL PSYCH MEAS, V24, P48; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Thorpe GL, 2012, PSYCHOL FAC SCHOLARS, V20, P1; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wong WS, 2010, J PSYCHOSOM RES, V68, P89, DOI 10.1016/j.jpsychores.2009.05.008; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Zimmerman M, 2008, COMPR PSYCHIAT, V49, P131, DOI 10.1016/j.comppsych.2007.10.006	42	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					652	664		10.1080/02699052.2018.1432893			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200017	29461861				2022-02-06	
J	Delorenzo, A; St Clair, T; Andrew, E; Bernard, S; Smith, K				Delorenzo, Ashleigh; St Clair, Toby; Andrew, Emily; Bernard, Stephen; Smith, Karen			Prehospital Rapid Sequence Intubation by Intensive Care Flight Paramedics	PREHOSPITAL EMERGENCY CARE			English	Article						prehospital; intubation; emergency medical services	EMERGENCY MEDICAL-SERVICE; TRAUMATIC BRAIN-INJURY; ADVERSE EVENTS; REGISTRY; QUALITY	Objective: Rapid sequence intubation (RSI) is an advanced airway procedure for critically ill or injured patients. Paramedic-performed RSI in the prehospital setting remains controversial, as unsuccessful or poorly conducted RSI is known to result in significant complications. In Victoria, intensive care flight paramedics (ICFPs) have a broad scope of practice including RSI in both the adult and pediatric population. We sought to describe the success rates and characteristics of patients undergoing RSI by ICFPs in Victoria, Australia. Methods: A retrospective data review was conducted of adult ( 16 years) patients who underwent RSI by an ICFP between January 1, 2011, and December 31, 2016. Data were sourced from the Ambulance Victoria data warehouse. Results: A total of 795 cases were included in analyses, with a mean age of 45 (standard deviation = 19.6) years. The majority of cases involved trauma (71.7%), and most patients were male (70.1%). Neurological pathologies were the most common clinical indication for RSI (68.3%). The first pass success rate of intubation was 89.4%, and the overall success rate was 99.4%. Of the 5 failed intubations (0.6%), all patients were safely returned to spontaneous respiration. Two patients were returned via bag/valve/mask (BVM) support alone, two with BVM and oropharyngeal airway, and one via supraglottic airway. No surgical airways were required. Overall, we observed transient cases of hypotension (5.2%), hypoxemia (1.3%), or both (0.1%) in 6.6% of cases during the RSI procedure. Conclusion: A very high RSI procedural success rate was observed across the study period. This supports the growing recognition that appropriately trained paramedics can perform RSI safely in the prehospital environment.	[Delorenzo, Ashleigh; St Clair, Toby; Smith, Karen] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Clayton, Vic, Australia; [Delorenzo, Ashleigh; St Clair, Toby; Andrew, Emily; Bernard, Stephen; Smith, Karen] Ambulance Victoria, Intens Care Unit, Doncaster, Vic, Australia; [Andrew, Emily; Bernard, Stephen; Smith, Karen] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia; Alfred Hosp, Melbourne, Vic, Australia		Delorenzo, A (corresponding author), Ambulance Victoria, 375 Manningham Rd, Doncaster, Vic 3108, Australia.	ashleigh.delorenzo@ambulance.vic.gov.au		StClair, Toby/0000-0002-3398-1242; Smith, Karen/0000-0002-9057-0685			Andrew E, 2015, PREHOSP EMERG CARE, V19, P416, DOI 10.3109/10903127.2014.995846; Bernard SA, 2015, EMERG MED J, V32, P60, DOI 10.1136/emermed-2013-202930; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bukur M, 2011, J SURG RES, V170, pE117, DOI 10.1016/j.jss.2011.04.005; Burns Brian, 2016, Air Med J, V35, P28, DOI 10.1016/j.amj.2015.10.002; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Cox S, 2013, AUST HEALTH REV, V37, P54, DOI 10.1071/AH11161; Crewdson K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1603-7; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Delorenzo Ashleigh J, 2017, Air Med J, V36, P173, DOI 10.1016/j.amj.2017.02.008; Fouche PF, 2017, ANN EMERG MED, V70, P449, DOI 10.1016/j.annemergmed.2017.03.026; Fouche PF, 2017, PREHOSP EMERG CARE, V21, P700, DOI 10.1080/10903127.2017.1325952; Gunning M, 2013, SAMJ, S. Afr. med. j., V103, P632, DOI 10.7196/samj.6656; Harris T, 2011, EMERG MED J, V28, P225, DOI 10.1136/emj.2009.088302; Lah K, 2010, SIGNA VITAE, V5, P34, DOI 10.22514/SV51.042010.5; Lockey DJ, 2017, ANAESTHESIA, V72, P379, DOI 10.1111/anae.13779; Nakstad AR, 2011, AM J EMERG MED, V29, P639, DOI 10.1016/j.ajem.2010.01.013; Natt BS, 2016, BRIT J ANAESTH, V117, P60, DOI 10.1093/bja/aew061; Nehme Z, 2015, CIRC-CARDIOVASC QUAL, V8, P56, DOI 10.1161/CIRCOUTCOMES.114.001185; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Perkins ZB, 2013, INJURY, V44, P618, DOI 10.1016/j.injury.2012.03.019; Sobuwa Simpiwe, 2013, S Afr Med J, V103, P644, DOI 10.7196/samj.7035; Tuma M, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/135986	24	5	5	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care		2018	22	5					595	601		10.1080/10903127.2018.1426666			7	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	GS7UH	WOS:000443909100008	29405803				2022-02-06	
J	Dorer, CL; Manktelow, AE; Allanson, J; Sahakian, BJ; Pickard, JD; Bateman, A; Menon, DK; Stamatakis, EA				Dorer, Charlie L.; Manktelow, Anne E.; Allanson, Judith; Sahakian, Barbara J.; Pickard, John D.; Bateman, Andrew; Menon, David K.; Stamatakis, Emmanuel A.			Methylphenidate-mediated motor control network enhancement in patients with traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; methylphenidate; functional MRI; functional connectivity; structural connectivity	DIFFUSE AXONAL INJURY; HEMISPHERIC-ASYMMETRY REDUCTION; SELF-INITIATED MOVEMENTS; WORKING-MEMORY; ACTIVATION BALANCE; LONGITUDINAL FMRI; HUMAN CEREBELLUM; HAROLD MODEL; OLDER-ADULTS; TBI PATIENTS	Primary Objective: To investigate functional improvement late (>6months) after traumatic brain injury (TBI). To this end, we conducted a double-blind, placebo-controlled experimental medicine study to test the hypothesis that a widely used cognitive enhancer would benefit patients with TBI.Research Design: We focused on motor control function using a sequential finger opposition fMRI paradigm in both patients and age-matched controls.Methods and Procedures: Patients' fMRI and DTI scans were obtained after randomised administration of methylphenidate or placebo. Controls were scanned without intervention. To assess differences in motor speed, we compared reaction times from the baseline condition of a sustained attention task.Main Outcomes and Results: Patients' reaction times correlated with wide-spread motor-related white matter abnormalities. Administration of methylphenidate resulted in faster reaction times in patients, which were not significantly different from those achieved by controls. This was also reflected in the fMRI findings in that patients on methylphenidate activated the left inferior frontal gyrus significantly more than when on placebo. Furthermore, stronger functional connections between pre-/post-central cortices and cerebellum were noted for patients on methylphenidate.Conclusions: Our findings suggest that residual functionality in patients with TBI may be enhanced by a single dose of methylphenidate.	[Dorer, Charlie L.; Manktelow, Anne E.; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England; [Allanson, Judith] Cambridge Univ Hosp NHS Fdn, Dept Neurosci, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Pickard, John D.] Univ Cambridge, Acad Neurosurg Unit, Cambridge, England; [Bateman, Andrew] Oliver Zangwill Ctr, Ely, England		Stamatakis, EA (corresponding author), Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England.	eas46@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Evelyn Trust [06/20]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G0600986, G9439390] Funding Source: UKRI	This work was supported by the Evelyn Trust [06/20].	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Berlingeri M, 2013, EXP BRAIN RES, V224, P393, DOI 10.1007/s00221-012-3319-x; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Calautti C, 2010, J NEUROL NEUROSUR PS, V81, P788, DOI 10.1136/jnnp.2009.190512; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Cui SZ, 2000, NEUROREPORT, V11, P3849, DOI 10.1097/00001756-200011270-00049; Faraone SV, 2004, J CLIN PSYCHOPHARM, V24, P24, DOI 10.1097/01.jcp.0000108984.11879.95; Frey SH, 2011, NEUROREHAB NEURAL RE, V25, p6S, DOI 10.1177/1545968311410940; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hoffstaedter F, 2013, CEREB CORTEX, V23, P520, DOI 10.1093/cercor/bhr391; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kim DG, 2009, NEUROREHABILITATION, V25, P117, DOI 10.3233/NRE-2009-0506; Kuypers HGJM, 1981, HDB PHYSL; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; Meadows L, 2009, BOBATH CONCEPT THEOR; Moreno-Lopez L, 2017, EUR NEUROPSYCHOPHARM, V27, P159, DOI 10.1016/j.euroneuro.2016.12.002; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rausch M, 1998, NEUROREPORT, V9, P2865, DOI 10.1097/00001756-199808240-00034; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; SAHAKIAN B, 1989, BRIT J PSYCHIAT, V154, P797, DOI 10.1192/bjp.154.6.797; Sakai K, 2000, J NEUROSCI, V20, P2691; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Tardy J, 2006, NEUROIMAGE, V33, P913, DOI 10.1016/j.neuroimage.2006.07.014; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaillancourt DE, 2006, J NEUROPHYSIOL, V95, P922, DOI 10.1152/jn.00718.2005; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Wiese H, 2006, NEUROIMAGE, V30, P1292, DOI 10.1016/j.neuroimage.2005.11.012; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Zimmermann KM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00555	53	5	5	2	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		1040	1049		10.1080/02699052.2018.1469166			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400011	29738277	Green Submitted			2022-02-06	
J	Doser, K; Poulsen, I; Wuensch, A; Norup, A				Doser, Karoline; Poulsen, Ingrid; Wuensch, Alexander; Norup, Anne			Psychological outcome after severe traumatic brain injury in adolescents and young adults: The chronic phase	BRAIN INJURY			English	Article						psychological outcome; TBI; young adults; adolescents; chronic phase	PSYCHIATRIC-DISORDERS; PRACTICAL SCALE; FAMILY NEEDS; AGGRESSION; SURVIVORS; INDIVIDUALS; AGREEMENT; CHILDREN; RECOVERY; IMPACT	Objectives. Young individuals surviving severe traumatic brain injury (TBI) frequently experience a wide range of cognitive, emotional and behavioural consequences. This cross-sectional follow-up study investigated psychological outcome of young survivors in the chronic phase, and whether psychological outcome was associated with improvement of functional abilities during sub-acute admission. Methods. Patients, who acquired a severe TBI during adolescence or early adulthood (n = 36) and received early intensive rehabilitation, were contacted for follow-up assessment concerning psychological outcome and completed the Adult Self Report 18-59 (ASR18-59). Demographic data, functional outcomes and severity measures were obtained from the local database. Results. The participants had a mean age of 24.1 years (SD = 4.1) at follow-up, and the mean time since injury was 72.1 months (SD = 44.2). Results showed significantly higher scores compared with the normative reference population in relation to the subscales withdrawal/isolation (p = 0.013), attention problems (p = 0.008) and intrusive behaviour (p = 0.046). Pearson correlation analyses showed that young survivors experiencing more functional improvement during inpatient rehabilitation had fewer psychological problems during the chronic phase in the subscales: withdrawal/isolation, rule breaking, intrusive behaviour and total problems. Conclusion. Young patients reported psychological problems in several areas during the chronic phase of injury, which may hinder complete reintegration and participation in society. Larger functional improvement during sub-acute rehabilitation seemed to be associated with less psychological problems in the chronic phase.	[Doser, Karoline] Danish Canc Soc, Res Ctr, Survivorship Unit, Strandboulevarden 49, DK-2100 Copenhagen, Denmark; [Doser, Karoline] Catholic Univ Appl Sci, Dept Clin Pedag & Therapeut Studies, Freiburg, Germany; [Doser, Karoline; Poulsen, Ingrid] Copenhagen Univ Hosp, RUBRIC Rigshosp, Res Unit Brain Injury Rehabil Copenhagen, Dept Neurorehabilitat,Traumat Brain Injury, Copenhagen, Denmark; [Wuensch, Alexander] Univ Freiburg, Fac Med, Med Ctr, Dept Psychosomat Med & Psychotherapy, Freiburg, Germany; [Norup, Anne] Copenhagen Univ Hosp, Rigshosp, Natl Study Young Brain Injury Survivors, Dept Neurol, Glostrup, Denmark		Doser, K (corresponding author), Danish Canc Soc, Res Ctr, Survivorship Unit, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	kdoser@cancer.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Norup, Anne/0000-0002-5598-6116; Doser, Karoline Bianca/0000-0002-2746-3326			Achenbach TM., 2003, MANUAL ASEBA ADULT F; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Eren S, 2014, SOCIAL CARE NEURODIS, V5, P135, DOI [10.1108/SCN-06-2013-0022, DOI 10.1108/SCN-06-2013-0022]; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Greve KW, 2001, BRAIN INJURY, V15, P255; Hagen C., 1972, LEVELS COGNITIVE FUN; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2014, ARCH PHYS MED REHAB, V95, P2103, DOI 10.1016/j.apmr.2014.07.001; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Ivanova MY, 2015, J PSYCHOPATHOL BEHAV, V37, P171, DOI 10.1007/s10862-014-9448-8; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Preedy V., 2010, HDB DIS BURDENS QUAL; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; TEASDALE G, 1974, LANCET, V2, P81; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P1	34	5	5	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					64	71		10.1080/02699052.2017.1363408			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300006	29156990				2022-02-06	
J	Dunham, CM; Malik, RJ; Huang, GS; Kohli, CM; Brocker, BP; Ugokwe, KT				Dunham, C. Michael; Malik, Rema J.; Huang, Gregory S.; Kohli, Chander M.; Brocker, Brian P.; Ugokwe, Kene T.			Hypertonic saline administration and complex traumatic brain injury outcomes: a retrospective study	INTERNATIONAL JOURNAL OF BURNS AND TRAUMA			English	Article						Saline solution; hypertonic; intracranial pressure; brain injuries; traumatic	INTRACRANIAL HYPERTENSIVE EPISODES; HYPEROSMOLAR THERAPY; SODIUM LACTATE; MIDLINE SHIFT; HEAD-INJURY; BONE FLAP; MANNITOL; MANAGEMENT; DECISION; REMOVE	Although hypertonic saline (HTS) decreases intracranial pressure (ICP) with traumatic brain injury (TBI), its effects on survival and post-discharge neurologic function are less certain. We assessed the impact of HTS administration on TBI outcomes and hypothesized that favorable outcomes would be associated with larger amounts of 3% saline. This is a retrospective study of consecutive-patients with the following criteria: blunt trauma, age 18-70 years, intracranial hemorrhage, Glasgow Coma Scale score (GCS) 3-12, and mechanical ventilation >= 5 days. The need for craniotomy or craniectomy denoted surgical decompression patients. Amounts of HTS were during the first-5 trauma center days. Traits for the 112 patients during 2012-2016 were as follows: GCS, 6.8 +/- 3.2; subdural hematoma, 71.4%; cerebral contusion, 31.3%, ICP device, 47.3%; surgical decompression, 51.8%; ventilator days, 14.8 +/- 6.7; trauma center mortality, 13.4%; and no commands at 3 months 35.5%. In surgically decompressed patients, trauma center mortality was greater with <= 8.0 mEq/kg sodium (38.9%) than with > 8.0 mEq/kg (7.5%; P = 0.0037). In surgically decompressed patients, following commands at 3 months was greater with >= 1400 mEq sodium (76.9%) than with < 1400 mEq (50.0%; P = 0.0489). For trauma center surviving non-decompression patients with no ICP device, those following commands at 3 months received more sodium (513 +/- 784 mEq) than individuals not following commands (82 +/- 144 mEq; P = 0.0142). For patients with a GCS 5-8, following commands at 3 months was greater with >= 1350 mEq sodium (92.3%) than with < 1350 mEq (60.0%; P = 0.0214). In patients with subdural hematoma or cerebral contusion, following commands at 3 months was greater with >= 1400 mEq sodium (84.2%) than with < 1400 mEq (61.8%; P = 0.0333). Patients with ICP > 20 mmHg for <= 10 hours (mean hours 2.0) received more sodium (16.5 +/- 11.5 mEq/kg) when compared to ICP elevation for >= 11 hours (mean hours 34) (9.4 +/- 6.3 mEq/kg, P = 0.0139). These observations demonstrate that hypertonic saline administration in patients with complex traumatic brain injury is associated with 1) mitigation of intracranial hypertension, 2) trauma center survival, and 3) following commands at 3 months post-injury.	[Dunham, C. Michael; Huang, Gregory S.] St Elizabeth Youngstown Hosp, Gen Surg Serv, Trauma Crit Care, Level 1 Trauma Ctr,1044 Belmont Ave, Youngstown, OH 44501 USA; [Malik, Rema J.] St Elizabeth Youngstown Hosp, Dept Surg, Level 1 Trauma Ctr,1044 Belmont Ave, Youngstown, OH 44501 USA; [Kohli, Chander M.; Brocker, Brian P.; Ugokwe, Kene T.] St Elizabeth Youngstown Hosp, Dept Neurosurg, Level 1 Trauma Ctr,1044 Belmont Ave, Youngstown, OH 44501 USA		Dunham, CM (corresponding author), St Elizabeth Youngstown Hosp, Gen Surg Serv, Trauma Crit Care, Level 1 Trauma Ctr,1044 Belmont Ave, Youngstown, OH 44501 USA.	dunham.michael@sbcglobal.net		Huang, Gregory/0000-0001-6355-6012; Dunham, C. Michael/0000-0002-7842-9750			Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Carney N, GUIDELINES MANAGEMEN, P1; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Dean AG, EPI INFO OPENEPI EPI, P103; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; Graffelman J, 2013, STAT APPL GENET MOL, V12, P433, DOI 10.1515/sagmb-2012-0039; Nguyen HS, 2016, WORLD NEUROSURG, V95, P85, DOI 10.1016/j.wneu.2016.07.067; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Hwang JTG, 2001, STAT SINICA, V11, P807; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kahle KT, 2013, J CLIN NEUROSCI, V20, P30, DOI 10.1016/j.jocn.2012.10.004; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kolmodin L, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-35; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Magder LS, 2003, J CLIN EPIDEMIOL, V56, P956, DOI 10.1016/S0895-4356(03)00153-7; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Roquilly A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018035; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; SCHULGEN G, 1994, AM J EPIDEMIOL, V140, P172, DOI 10.1093/oxfordjournals.aje.a117227; Shao LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117314; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Tan SKR, 2016, CAN J ANESTH, V63, P664, DOI 10.1007/s12630-016-0633-y; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Toth A, 2015, J NEUROTRAUM, V32, P1307, DOI 10.1089/neu.2014.3696; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wang K, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0006-8; Wang XF, 2014, TURK NEUROSURG, V24, P351, DOI 10.5137/1019-5149.JTN.8302-13.1; Wells DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11678; Yamamura H, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0271-y; Young RJ, 2002, NEUROIMAG CLIN N AM, V12, P189, DOI 10.1016/S1052-5149(02)00003-5; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	51	5	5	1	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2160-2026			INT J BURNS TRAUMA	Int. J. Burns Trauma		2018	8	3					40	53					14	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GN8PY	WOS:000439431100001	30042863				2022-02-06	
J	Dyck, ACF; Ivanco, TL				Dyck, Allison C. F.; Ivanco, Tammy L.			BDNF expression increases without changes in play behavior following concussion in juvenile rats (Rattus Norvegicus)	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Brain Derived Neurotrophic Factor; development; mild traumatic brain injury; pediatric injury; social play	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; MOTOR CORTEX; HIPPOCAMPUS; MODULATION; PLASTICITY; NEURONS; RODENTS; DAMAGE	Purpose: Young children have a high risk of concussion or mild traumatic brain injury (mTBI). Children often appear healthy soon after mTBI, but some have pervasive cognitive and/or motor impairments. Understanding underlying mechanisms recruited after concussion may help for return to play protocols and mitigating what might be lifelong impairments. Methods: We investigated molecular and behavioral changes in a rat model of childhood concussion. Rats received an injury or sham procedure at an age approximately equivalent to the human period of early childhood. Social play was analyzed for behavioral differences. Tissue from the right motor cortex (impacted), left motor cortex, and medial prefrontal cortex were analyzed for brain derived neurotrophic factor (BDNF) protein. Results: Play behavior was not significantly different between conditions. BDNF levels were much higher in both the right and left motor cortices of the mTBI group compared to medial prefrontal cortex, which is relatively remote from the impact site, within the mTBI group and all tissue collected from the sham group. Conclusions: There is ongoing plastic change at the cellular level in both the impacted area and the well-connected contralateral area after a concussion, suggesting compensatory mechanisms after injury are still at play.	[Dyck, Allison C. F.; Ivanco, Tammy L.] Univ Manitoba, Dept Psychol, Winnipeg, MB, Canada; [Ivanco, Tammy L.] Childrens Hosp Res Fdn Manitoba, Winnipeg, MB, Canada		Ivanco, TL (corresponding author), Univ Manitoba, P415 Duff Roblin,190 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.	Tammy.Ivanco@umanitoba.ca					Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Edut S, 2014, J MOL NEUROSCI, V54, P684, DOI 10.1007/s12031-014-0399-z; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Himmler BT, 2013, JOVE-J VIS EXP, DOI 10.3791/4288; Kamitakahara H, 2007, BEHAV NEUROSCI, V121, P164, DOI 10.1037/0735-7044.121.1.164; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Kolb B, 2012, DEV PSYCHOBIOL, V54, P311, DOI 10.1002/dev.20515; Madathil SK, 2017, J TRAUMA ACUTE CARE, V83, pS16, DOI 10.1097/TA.0000000000001471; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Pellis SM, 2006, BEHAV NEUROSCI, V120, P72, DOI 10.1037/0735-7044.120.1.72; Pellis SM, 1997, DEV PSYCHOBIOL, V31, P193; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sulejczak D, 2007, J NEUROTRAUM, V24, P1362, DOI 10.1089/neu.2006.0261; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945	23	5	5	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2018	21	7			SI		475	479		10.1080/17518423.2018.1460878			5	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	GR1HR	WOS:000442284100007	29648487				2022-02-06	
J	Fu, CJ; Wang, Q; Zhai, XF; Gao, JM				Fu, Chuanjing; Wang, Qi; Zhai, Xiaofu; Gao, Juemin			Sinomenine reduces neuronal cell apoptosis in mice after traumatic brain injury via its effect on mitochondrial pathway	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						sinomenine; traumatic brain injury; apoptosis; mitochondria	H2O2-INDUCED OXIDATIVE STRESS; NEURAL APOPTOSIS; ISCHEMIC-STROKE; NEUROPROTECTION; DEATH; MODEL; RATS	Background: Sinomenine (SIN) has been shown to have protective effects against brain damage following traumatic brain injury (TBI). However, the mechanisms and its role in these effects remain unclear. This study was conducted to investigate the potential mechanisms of the protective effects of SIN. Methods: The weight-drop model of TBI in Institute of Cancer Research (ICR) mice were treated with SIN or a vehicle via intraperitoneal administration 30 min after TBI. All mice were euthanized 24 h after TBI and after neurological scoring, a series of tests were performed, including brain water content and neuronal cell death in the cerebral cortex. Results: The level of cytochrome c (Cyt c), malondialdehyde (MDA), glutathione peroxidase (GPx) and superoxide dismutase 1 (SOD) were restored to some degree following the SIN treatment. The SIN treatment significantly decreased caspase-3 expression and reduced the number of positive cells by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay and improved the survival of neuronal cells. Additionally, the pretreatment levels of MDA were restored, while Bax translocation to mitochondria and Cyt c release into the cytosol were reduced by the SIN treatment. Conclusion: SIN protected neuronal cells by protecting them against apoptosis via mechanisms that involve the mitochondria following TBI.	[Fu, Chuanjing; Gao, Juemin] Jiangsu Hosp Tradit Chinese Med, Dept Neurosurg, 155 Hanzhong Rd, Nanjing, Jiangsu, Peoples R China; [Wang, Qi] Fourth Peoples Hosp Huaian, Dept Radiol, Huaian, Peoples R China; [Zhai, Xiaofu] Xuzhou Med Coll, Peoples Hosp Huaian 2, Dept Neurosurg, Huaian, Peoples R China		Gao, JM (corresponding author), Jiangsu Hosp Tradit Chinese Med, Dept Neurosurg, 155 Hanzhong Rd, Nanjing, Jiangsu, Peoples R China.	szjuemingao@126.com					Abe H, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/9358092; Arredondo F, 2010, FREE RADICAL BIO MED, V49, P738, DOI 10.1016/j.freeradbiomed.2010.05.020; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bigler ED, 2017, NEUROLOGY, V88, P1490, DOI 10.1212/WNL.0000000000003852; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Franco JL, 2007, CHEM RES TOXICOL, V20, P1919, DOI 10.1021/tx7002323; Gao YY, 2017, AM J TRANSL RES, V9, P887; Gao YG, 2016, MOL MED REP, V14, P5481, DOI 10.3892/mmr.2016.5936; Ghosh A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057735, 10.1371/journal.pone.0082529]; Huang L, 2017, PROCEEDINGS OF 2017 8TH INTERNATIONAL CONFERENCE ON MECHANICAL AND INTELLIGENT MANUFACTURING TECHNOLOGIES (ICMIMT), P125, DOI 10.1109/ICMIMT.2017.7917449; Jiang YM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091945; Karuppagounder SS, 2013, NEUROSCIENCE, V236, P136, DOI 10.1016/j.neuroscience.2013.01.032; Li XM, 2016, ADV ENG SOFTW, V93, P1, DOI 10.1016/j.advengsoft.2015.11.003; Lu Y, 2017, ONCOL LETT, V14, P3947, DOI 10.3892/ol.2017.6708; Panickar KS, 2011, NEUROSCIENCE, V183, P1, DOI 10.1016/j.neuroscience.2011.03.064; Qiu J, 2016, INT IMMUNOPHARMACOL, V40, P492, DOI 10.1016/j.intimp.2016.09.024; Qiu J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0739-8; Rao SQ, 2017, PURINERG SIGNAL, V13, P237, DOI 10.1007/s11302-017-9560-9; Tian X, 2016, NEUROL RES, V38, P1079, DOI 10.1080/01616412.2016.1245030; Ulbrich F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165182; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wan JZ, 2016, CAN J PHYSIOL PHARM, V94, P919, DOI 10.1139/cjpp-2015-0262; Wang JW, 2017, ANN CLIN LAB SCI, V47, P10; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Waseem M, 2016, PROTOPLASMA, V253, P417, DOI 10.1007/s00709-015-0821-6; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yang HF, 2017, MICROB PATHOGENESIS, V110, P573, DOI 10.1016/j.micpath.2017.07.044; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Zhai XF, 2016, NEUROIMMUNOMODULAT, V23, P179, DOI 10.1159/000448716; Zwemer E, CLIN PEDIAT PHILA	33	5	6	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2018	12						77	84		10.2147/DDDT.S154391			8	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FS8BK	WOS:000422634300001	29379271	Green Submitted, Green Published, gold			2022-02-06	
J	Gamboa, OL; Yuen, KSL; von Wegner, F; Behrens, M; Steinmetz, H				Gamboa, Olga Lucia; Yuen, Kenneth Sung Lai; von Wegner, Frederic; Behrens, Marion; Steinmetz, Helmuth			The challenge of forgetting: Neurobiological mechanisms of auditory directed forgetting	HUMAN BRAIN MAPPING			English	Article						auditory directed forgetting; memory; response inhibition; intentional forgetting; attention	POSTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; MEMORY RETRIEVAL; INHIBITORY CONTROL; UNWANTED MEMORIES; EMOTIONAL CONTEXT; NEURAL MECHANISMS; EPISODIC MEMORY; DEFAULT NETWORK; FMRI	Directed forgetting (DF) is considered an adaptive mechanism to cope with unwanted memories. Understanding it is crucial to develop treatments for disorders in which thought control is an issue. With an item-method DF paradigm in an auditory form, the underlying neurocognitive processes that support auditory DF were investigated. Subjects were asked to perform multi-modal encoding of word-stimuli before knowing whether to remember or forget each word. Using functional magnetic resonance imaging, we found that DF is subserved by a right frontal-parietal-cingulate network. Both qualitative and quantitative analyses of the activation of this network show converging evidence suggesting that DF is a complex process in which active inhibition, attentional switching, and working memory are needed to manipulate both unwanted and preferred items. These results indicate that DF is a complex inhibitory mechanism which requires the crucial involvement of brain areas outside prefrontal regions to operate over attentional and working memory processes. Hum Brain Mapp 39:249-263, 2018. (c) 2017 Wiley Periodicals, Inc.	[Gamboa, Olga Lucia; von Wegner, Frederic; Steinmetz, Helmuth] Goethe Univ, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany; [Gamboa, Olga Lucia; von Wegner, Frederic; Steinmetz, Helmuth] Goethe Univ, Brain Imaging Ctr, Schleusenweg 2-16, D-60528 Frankfurt, Germany; [Yuen, Kenneth Sung Lai] Johannes Gutenberg Univ Mainz, Med Ctr, Focus Program Translat Neurosci, Neuroimaging Ctr Mainz NIC, D-55131 Mainz, Germany; [von Wegner, Frederic] Goethe Univ, Epilepsy Ctr Rhein Main, Frankfurt, Germany; [Behrens, Marion] Johannes Gutenberg Univ Mainz, Inst Microanat & Neurobiol, Dept Neurol, Med Ctr, Mainz, Germany		Gamboa, OL (corresponding author), Goethe Univ, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.; Gamboa, OL (corresponding author), Goethe Univ, Brain Imaging Ctr, Schleusenweg 2-16, D-60528 Frankfurt, Germany.; Yuen, KSL (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Focus Program Translat Neurosci, Neuroimaging Ctr Mainz NIC, D-55131 Mainz, Germany.	olgalucia.gamboa@kgu.de; k.yuen@uni-mainz.de		Gamboa, Olga Lucia/0000-0001-6846-5320; von Wegner, Frederic/0000-0002-6779-9959			Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anderson MC, 2014, TRENDS COGN SCI, V18, P279, DOI 10.1016/j.tics.2014.03.002; Bastin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029905; Benoit RG, 2012, NEURON, V76, P450, DOI 10.1016/j.neuron.2012.07.025; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Cano ME, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00133; CAPITANI E, 1992, CORTEX, V28, P315, DOI 10.1016/S0010-9452(13)80143-8; Conway MA, 2003, CORTEX, V39, P667, DOI 10.1016/S0010-9452(08)70859-1; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Depue BE, 2016, CEREB CORTEX, V26, P1634, DOI 10.1093/cercor/bhu324; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Depue BE, 2012, NEUROSCI BIOBEHAV R, V36, P1382, DOI 10.1016/j.neubiorev.2012.02.012; Erk S, 2005, NEUROIMAGE, V26, P829, DOI 10.1016/j.neuroimage.2005.02.045; Erk S, 2003, NEUROIMAGE, V18, P439, DOI 10.1016/S1053-8119(02)00015-0; Fawcett JM, 2008, MEM COGNITION, V36, P1168, DOI 10.3758/MC.36.6.1168; Freud S., 2008, GEN PSYCHOL THEORY P; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gamboa OL, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00432; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gerlach KD, 2011, NEUROIMAGE, V55, P1816, DOI 10.1016/j.neuroimage.2011.01.030; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Hardt O, 2013, TRENDS COGN SCI, V17, P111, DOI 10.1016/j.tics.2013.01.001; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Iidaka T, 2006, CEREB CORTEX, V16, P1349, DOI 10.1093/cercor/bhl040; Japee S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00023; Kim C, 2012, BRAIN RES, V1469, P92, DOI 10.1016/j.brainres.2012.06.013; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kim H, 2010, NEUROIMAGE, V49, P1045, DOI 10.1016/j.neuroimage.2009.07.058; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laufs H, 2007, BRAIN, V130, DOI 10.1093/brain/awm084; Lee YS, 2012, Q J EXP PSYCHOL, V65, P1110, DOI 10.1080/17470218.2011.644303; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Leitman DI, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2010.00019, 10.3389/fnhum.2011.00096]; Maddock RF, 2001, NEUROSCIENCE, V104, P667, DOI 10.1016/S0306-4522(01)00108-7; Makino Y, 2004, NEUROIMAGE, V23, P525, DOI 10.1016/j.neuroimage.2004.06.026; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Nowicka A, 2011, CEREB CORTEX, V21, P539, DOI 10.1093/cercor/bhq117; Nowicka A, 2009, PSYCHOPHYSIOLOGY, V46, P1108, DOI 10.1111/j.1469-8986.2009.00839.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Quak M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00197; Schirmer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009080; Tsivilis D, 2008, NAT NEUROSCI, V11, P834, DOI 10.1038/nn.2149; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Wimber M, 2008, J NEUROSCI, V28, P13419, DOI 10.1523/JNEUROSCI.1916-08.2008; Wylie GR, 2008, CEREB CORTEX, V18, P670, DOI 10.1093/cercor/bhm101; Yang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064030; Yang TL, 2016, INT J PSYCHOPHYSIOL, V100, P44, DOI 10.1016/j.ijpsycho.2015.09.007; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Zacks Rose T., 1994, P241; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143	60	5	7	1	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JAN	2018	39	1					249	263		10.1002/hbm.23840			15	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FP0IF	WOS:000417282000017	29080232	Green Published			2022-02-06	
J	Glang, A; Todis, B; Ettel, D; Wade, SL; Yeates, KO				Glang, Ann; Todis, Bonnie; Ettel, Debbie; Wade, Shari L.; Yeates, Keith Owen			Results from a randomized trial evaluating a hospital-school transition support model for students hospitalized with traumatic brain injury	BRAIN INJURY			English	Article						Education; brain injuries; *rehabilitation; disabled children; *education; child; programme development; programme evaluation; surveys and questionnaires; schools; hospitals; school health services	BUILDING STATEWIDE INFRASTRUCTURE; PSYCHIATRIC-DISORDERS; CLINICAL-TRIAL; CHILDREN; REHABILITATION; ADOLESCENTS; CONCUSSION; OUTCOMES; REENTRY; TBI	Objective: To evaluate the utility of the STEP model, a systematic hospital-school transition protocol for children hospitalized for TBI.Setting: Five children's hospitals in Colorado, Ohio, and Oregon.Participants: Hundred families of children with mild, complicated mild, moderate, or severe TBI.Design: Randomized controlled trial (RCT); participants were randomized while hospitalized to the STEP (a standardized hospital-school transition protocol for children treated for TBI) or usual care condition.Main Measures: Questionnaire about child's special education eligibility status, support services, and academic accommodations; Achenbach Child Behaviour Checklist (CBCL); Behaviour Rating Inventory of Executive Function (BRIEF); Child and Adolescent Scale of Participation (CASP); Child and Adolescent Scales of Environment (CASE)Results: There were no significant effects, indicating that STEP participants did not differ from usual care participants on any study outcome at one month post-discharge or at one-year follow-up.Conclusion: The lack of significant findings in this study does not imply that effective hospital-to-school transition programming is unnecessary. Rather, the findings raise important questions regarding timing and dosage/intensity of intervention, appropriate measurement of outcomes, and fidelity of programme delivery. The study highlights difficulties involved in the conduct of community-based RCTs in the paediatric TBI population.	[Glang, Ann; Todis, Bonnie] Univ Oregon, Ctr Brain Injury Res & Training, 1600 Millrace,Suite 202, Eugene, OR 97403 USA; [Ettel, Debbie] Springfield Sch Dist, Springfield, OR USA; [Wade, Shari L.] Cincinnati Childrens Hosp, Div Phys Med & Rehabil, Cincinnati, OH USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada		Glang, A (corresponding author), Univ Oregon, Ctr Brain Injury Res & Training, 1600 Millrace,Suite 202, Eugene, OR 97403 USA.	aglang@uoregon.edu	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Glang, Ann/0000-0002-3057-1977	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A060075]	This work was supported by the National Institute on Disability and Rehabilitation Research (now National Institute on Disability, Independent Living, and Rehabilitation Research) [grant number H133A060075].	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; ACHENBACH TM, 1980, J AM ACAD CHILD PSY, V19, P395, DOI 10.1016/S0002-7138(09)61061-X; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Bedell G., 2013, DEV NEUROREHABIL, V18, P375; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Epstein MH, 1993, J EMOT BEHAV DISORD, V1, P127; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Faul M, 2010, TRAUMATIC BRAIN INJU; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Glang A, 1999, MAKING IEP PROCESS W; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greene NH, 2014, ARCH PHYS MED REHAB, V10, P180; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hartman LR, 2015, BRAIN INJURY, V29, P1387, DOI 10.3109/02699052.2015.1071431; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Katz E R, 1992, Child Health Care, V21, P69, DOI 10.1207/s15326888chc2102_1; Katz ER, 1989, J PSYCHOSOC ONCOL, V6, P123, DOI DOI 10.1300/J077V06N03; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kollins SH, 2011, GUIDE ASSESSMENT SCA; KRAUS JF, 1987, PEDIATRICS, V79, P501; Lei H, 2012, ANNU REV CLIN PSYCHO, V8, P21, DOI 10.1146/annurev-clinpsy-032511-143152; Lipsey M.W., 2001, PRACTICAL META ANAL; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Odom SL, 2005, EXCEPT CHILDREN, V71, P137, DOI 10.1177/001440290507100201; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Raghunathan T.E., 2002, IVEWARE IMPUTATION V; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; RUBIN DB, 1987, J AM STAT ASSOC, V82, P543, DOI 10.2307/2289460; SAS Institute Inc, 2011, SAS STAT R 9 2 US GU; Savage RC, 2001, NEUROREHABILITATION, V16, P49; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Shaw SR, 2008, PSYCHOL SCHOOLS, V45, P74, DOI 10.1002/pits.20280; Slavin R. E., 2013, ED WEEK, V32, P24; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stuart J. L., 1996, TEACHING EXCEPTIONAL, V28, P58, DOI DOI 10.1177/004005999602800212; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; Todis B, 1997, CHILDREN ACQUIRED BR; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Turri MG, 2016, ASSESS EFF INTERV; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; West SG, 2008, AM J PUBLIC HEALTH, V98, P1359, DOI 10.2105/AJPH.2007.124446; Winter AC, 2014, OPEN ACCESS J CLIN T, V6, P101, DOI 10.2147/OAJCT.S39758; Worchel-Prevatt FF, 1998, J SCHOOL PSYCHOL, V36, P261, DOI 10.1016/S0022-4405(98)00012-0; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P25, DOI 10.1097/00001199-199512000-00006; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	74	5	5	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					608	616		10.1080/02699052.2018.1433329			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200012	29388885				2022-02-06	
J	Hickey, L; Anderson, V; Hearps, S; Jordan, B				Hickey, Lyndal; Anderson, Vicki; Hearps, Stephen; Jordan, Brigid			Family appraisal of paediatric acquired brain injury: a social work clinical intervention trial	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Acquired brain injury; social work; child; family intervention; grief; trauma	PROBLEM-SOLVING INTERVENTION; HEAD-INJURY; CHILD; ADOLESCENTS; ADAPTATION; PARENTS; PROGRAM; ILLNESS; GRIEF; TBI	Objective: To compare the efficacy of a new intervention 'Family Forward' with 'Usual Care' social work practice in optimising family appraisal of a child's acquired brain injury to ensure better adaptation during the inpatient rehabilitation phase of care and early transition home.Research Design: Single site, prospective, sequential comparison group design. Methods and Procedures: Families were recruited on admission to an inpatient rehabilitation service based at a tertiary paediatric hospital. The 'Usual Care' group (n=22; 29 parents) recruitment, intervention and data collection were completed first (Phase 1), followed by the 'Family Forward' group (n=25; 43 parents) (Phase 2). Parents/caregivers completed measures: (Impact of Event Scale- Revised: IES-R; Parents Experience of Childhood Illness and Brief Illness Perception Questionnaire: Brief IPQ) at the time of their child's inpatient rehabilitation admission, inpatient rehabilitation discharge, and 6 weeks post-discharge. Main Outcomes and Results: There were more children with traumatic brain injuries in the Family Forward group (n=13) than Usual Care (n=6) and the Family Forward group had a longer hospital admission (days, M=56.4, SD=46.1 vs. M=37.5, SD=16.4, p=0.019). No significant group differences were found for family appraisal outcomes at any of the three time-points. Both groups reported reductions in trauma and grief responses, emotional experiences and perceptions of their child's injury at post-intervention and follow-up. Both groups continued to have depleted emotional resources (PECI scale) at 6 weeks post-discharge. Conclusions: The study contributes important insights into family appraisal experience in the early stages following paediatric acquired brain injury. In this context, Family Forward' needs to incorporate interventions that support and promote ongoing family appraisal as issues related to their child's injury arise over time. Future research is needed to focus on whether the Family Forward approach does sustain family system adaptation (a key aim informing the design of the intervention) over the longer term.	[Hickey, Lyndal; Anderson, Vicki; Jordan, Brigid] Royal Childrens Hosp, 50 Flemington Rd, Melbourne, Vic 3052, Australia; [Hickey, Lyndal; Anderson, Vicki; Jordan, Brigid] Univ Melbourne, Melbourne, Vic, Australia; [Hickey, Lyndal; Anderson, Vicki; Hearps, Stephen; Jordan, Brigid] Murdoch Childrens Res Inst, Melbourne, Vic, Australia		Hickey, L (corresponding author), Royal Childrens Hosp, 50 Flemington Rd, Melbourne, Vic 3052, Australia.	lyndal.hickey@mcri.edu.au	Hickey, Lyndal/AAY-9024-2020; Hearps, Stephen/L-6853-2016	Hearps, Stephen/0000-0003-2984-1172; Hickey, Lyndal/0000-0001-6418-4935			Anderson V., 2010, PEDIAT TRAUMATIC BRA; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Benn KM, 2004, BRAIN INJURY, V18, P239, DOI 10.1080/02699050310001617343; Bonner MJ, 2006, J PEDIATR PSYCHOL, V31, P310, DOI 10.1093/jpepsy/jsj034; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Collings C, 2008, BRIT J SOC WORK, V38, P1499, DOI 10.1093/bjsw/bcm055; Conoley JC, 1996, J LEARN DISABIL-US, V29, P662, DOI 10.1177/002221949602900610; Eren S, 2006, BRAIN IMPAIR, V7, P61; FOLKMAN S, 1988, SOC SCI MED, V26, P309, DOI 10.1016/0277-9536(88)90395-4; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Hickey L, 2016, J SOC WORK DISABIL R, V15, P179, DOI 10.1080/1536710X.2016.1220884; Jacobson L, 2013, FAM J, V21, P417, DOI 10.1177/1066480713488530; Jantz P, 2015, CONT SCH PSYCHOL, V19, P218; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; KOSCIULEK JF, 1993, J REHABIL, V59, P40; McCubbin M., 1993, FAMILIES HLTH ILLNES, P21, DOI 10.4135/9781452274720.n8; Miller L, 2001, FAMILY THERAPY AND MENTAL HEALTH, P311; Narad ME, 2017, J PEDIATR PSYCHOL, V42, P304, DOI 10.1093/jpepsy/jsw079; Perlesz A., 1999, AUSTR NZ J FAMILY TH, V20, P11, DOI DOI 10.1111/J.0814-723X.1999.00089.X; Roscigno CI, 2013, SOC SCI MED, V90, P32, DOI 10.1016/j.socscimed.2013.04.017; SPINA S, 2005, BRAIN IMPAIR, V6, P33, DOI DOI 10.1375/BRIM.6.1.33.65478; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Woolf C, 2016, J CLIN PSYCHOL MED S, V23, P53, DOI 10.1007/s10880-015-9430-y; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Zittle K. M., 2002, J HUMAN BEHAV SOCIAL, V5, P19, DOI [10.1300/j137v05n01_02, DOI 10.1300/J137V05N01_02]	31	5	5	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2018	21	7			SI		457	464		10.1080/17518423.2018.1434697			8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	GR1HR	WOS:000442284100005	29420102				2022-02-06	
J	Ho, MY; Tseng, WL; Xiao, F				Ho, Meng-Yin; Tseng, Wei-Lung; Xiao, Furen			Estimation of the Craniectomy Surface Area by Using Postoperative Images	INTERNATIONAL JOURNAL OF BIOMEDICAL IMAGING			English	Article							TRAUMATIC BRAIN-INJURY; ABC/2 ESTIMATION TECHNIQUE; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL HYPERTENSION; HEMICRANIECTOMY; MANAGEMENT; SIZE	Decompressive craniectomy (DC) is a neurosurgical procedure performed to relieve the intracranial pressure engendered by brain swelling. However, no easy and accurate method exists for determining the craniectomy surface area. In this study, we implemented and compared three methods of estimating the craniectomy surface area for evaluating the decompressive effort. We collected 118 sets of preoperative and postoperative brain computed tomography images from patients who underwent craniectomy procedures between April 2009 and April 2011. The surface area associated with each craniectomy was estimated using the marching cube and quasi-Monte Carlo methods. The surface area was also estimated using a simple AC method, in which the area is calculated by multiplying the craniectomy length (A) by its height (C). The estimated surface area ranged from 9.46 to 205.32 cm(2), with a median of 134.80 cm(2). The root-mean-square deviation (RMSD) between the marching cube and quasi-Monte Carlo methods was 7.53 cm(2). Furthermore, the RMSD was 14.45 cm(2) between the marching cube and AC methods and 12.70 cm(2) between the quasi-Monte Carlo and AC methods. Paired t-tests indicated no statistically significant difference between these methods. The marching cube and quasi-Monte Carlo methods yield similar results. The results calculated using the AC method are also clinically acceptable for estimating the DC surface area. Our results can facilitate additional studies on the association of decompressive effort with the effect of craniectomy.	[Ho, Meng-Yin; Xiao, Furen] Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Tseng, Wei-Lung] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Tseng, Wei-Lung] Fu Jen Catholic Univ Hosp, Dept Neurosurg, New Taipei, Taiwan		Xiao, F (corresponding author), Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei, Taiwan.	xfuren@gmail.com		Xiao, Furen/0000-0001-9683-3979	Taiwan Ministry of Science and Technology [101-2314-B-002-039, 106-2314-B002-082]	This work was supported by Taiwan Ministry of Science and Technology (Grant nos. 101-2314-B-002-039 and 106-2314-B002-082).	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Chung J, 2011, NEUROLOGIST, V17, P11, DOI 10.1097/NRL.0b013e3181f4ec88; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Curry WT, 2005, NEUROSURGERY, V56, P681, DOI 10.1227/01.NEU.0000156604.41886.62; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Erbil HY, 1997, J PHYS CHEM B, V101, P6867, DOI 10.1021/jp970328n; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Gough B., 2009, GNU SCI LIB REFERENC, V3rd; Harris J., 1998, HDB MATH COMPUTATION; Huh JS, 2007, J KOREAN NEUROSURG S, V42, P331, DOI 10.3340/jkns.2007.42.4.331; Huttner HB, 2006, STROKE, V37, P404, DOI 10.1161/01.STR.0000198806.67472.5c; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Liu YS, 2010, PATTERN RECOGN, V43, P3900, DOI 10.1016/j.patcog.2010.06.002; Lorensen W.E., 1987, COMPUT GRAPHICS-US, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Saleev, 1979, USSR COMP MATH MATH, V19, P252, DOI DOI 10.1016/0041-5553(79)90085-5; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schroeder W. J., 2004, VISUALIZATION TOOLKI; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Team RC, 2012, R LANG ENV STAT COMP; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wirtz C.R., 1997, NEUROSURG FOCUS, V2, pE7; Wong ST, 2003, J NEUROSCI METH, V123, P1, DOI 10.1016/S0165-0270(02)00318-7; Xiao FR, 2012, CLIN NEUROL NEUROSUR, V114, P205, DOI 10.1016/j.clineuro.2011.10.003; Yoo TS, 2002, STUD HEALTH TECHNOL, V85, P586	35	5	5	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-4188	1687-4196		INT J BIOMED IMAGING	Int. J. Biomed. Imaging		2018	2018								5237693	10.1155/2018/5237693			8	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	GK0RQ	WOS:000435819600001	29971096	gold, Green Submitted, Green Published			2022-02-06	
J	Egea-Guerrero, JJ; Rodriguez-Rodriguez, A; Gordillo-Escobar, E; Fernandez-Delgado, E; Martinez-Roldan, A; Roldan-Reina, A; Duran-Martinez, P; de Vega-Rios, E; Freire-Aragon, MD; Vilches-Arenas, A; Murillo-Cabezas, F; Quintana-Diaz, M				Jose Egea-Guerrero, Juan; Rodriguez-Rodriguez, Ana; Gordillo-Escobar, Elena; Fernandez-Delgado, Esperanza; Martinez-Roldan, Angela; Roldan-Reina, Alvaro; Duran-Martinez, Pilar; de Vega-Rios, Enrique; Dolores Freire-Aragon, Maria; Vilches-Arenas, Angel; Murillo-Cabezas, Francisco; Quintana-Diaz, Manuel			IMPACT Score for Traumatic Brain Injury: Validation of the Prognostic Tool in a Spanish Cohort	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						external validation; outcome; prognostic tool; traumatic brain injury	NEURON-SPECIFIC ENOLASE; HEAD-INJURY; CLINICAL-TRIALS; S100B PROTEIN; INTERNATIONAL MISSION; EXTERNAL VALIDATION; MODEL; PREDICTION; MORTALITY; ACCURACY	Background: The aim of this work was to validate the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials in TBI) model in a Spanish cohort of patients with moderate-severe TBI (traumatic brain injury). Setting: Two level I neurotrauma centers. Participants: Patients admitted to these hospitals between 2011 and 2014 with a diagnosis of TBI and a Glasgow Coma Scale score of 12 or less. Design: Prospective observational study. Main Measures: We collected prospectively the clinical variables included in the IMPACT models. Outcome evaluation was prospectively done at 6-month follow-up according to the Glasgow Outcome Scale. Results: A total of 290 patients were included in the study. Forty-seven patients (16.2%) died within 6 months post-TBI, and 74 patients (25.5%) had an unfavorable outcome. The Hosmer-Lemeshow test revealed that there was no difference between observed and predicted outcomes; hence, the 3 models displayed adequate calibration for predicting 6-month mortality or unfavorable outcome. The receiver operating characteristic curve indicated that the 3 models (Core, Extended, and Lab) could accurately discriminate between favorable and unfavorable outcomes, as well as between survival and mortality (P < .001). Conclusion: The IMPACT model validates prediction of 6-month outcomes in a Spanish population of moderate-severe TBI. IMPACT Lab model is the one that presents a higher discriminative capacity. These results encourage the implementation of the IMPACTmodel as a prognostic tool in the management of patients with TBI.	[Jose Egea-Guerrero, Juan; Gordillo-Escobar, Elena; Fernandez-Delgado, Esperanza; Martinez-Roldan, Angela; Roldan-Reina, Alvaro; Duran-Martinez, Pilar; Dolores Freire-Aragon, Maria; Murillo-Cabezas, Francisco] Univ Seville, Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, IBIS,CSIC, Seville, Spain; [Rodriguez-Rodriguez, Ana] Univ Seville, Virgen del Rocio Univ Hosp, Emergency Dept, IBIS,CSIC, Avda Manuel Siurot S-N, Seville 41013, Spain; [de Vega-Rios, Enrique] La Princesa Univ Hosp, Internal Med, Madrid, Spain; [Vilches-Arenas, Angel] Univ Seville, Dept Prevent Med & Publ Hlth, Virgen Macarena Univ Hosp, Seville, Spain; [Quintana-Diaz, Manuel] Univ Hosp La Paz, Emergency Dept, Madrid, Spain		Rodriguez-Rodriguez, A (corresponding author), Univ Seville, Virgen del Rocio Univ Hosp, Emergency Dept, IBIS,CSIC, Avda Manuel Siurot S-N, Seville 41013, Spain.	rodriguezana13m@gmail.com	Vilches-Arenas, Angel/C-1167-2015; Murillo-Cabezas, Francisco/AAO-3348-2021; Egea-Guerrero, Juan Jose JJ/P-5080-2014; Quintana-Diaz, Manuel/M-2313-2017	Vilches-Arenas, Angel/0000-0003-2197-3760; Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Quintana-Diaz, Manuel/0000-0003-4852-4148			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHAMPION HR, 1995, J TRAUMA, V38, P94, DOI 10.1097/00005373-199501000-00024; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P395, DOI 10.1016/j.medin.2015.11.003; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P327, DOI 10.1016/j.medin.2015.07.011; Edwards P, 2005, LANCET, V365, P1957; Egea-Guerrero JJ, 2014, MED INTENSIVA, V38, P502, DOI 10.1016/j.medin.2014.06.003; Egea-Guerrero JJ, 2014, MED INTENSIVA, V38, P218, DOI 10.1016/j.medin.2013.03.015; Egea-Guerrero JJ, 2013, TRANSPL P, V45, P3569, DOI 10.1016/j.transproceed.2013.10.021; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Gordillo-Escobar E, 2016, MED INTENSIVA, V40, P105, DOI 10.1016/j.medin.2015.11.008; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meynaar IA, 2003, INTENS CARE MED, V29, P189, DOI 10.1007/s00134-002-1573-2; Morrison Gavin, 2013, Pathophysiology, V20, P49, DOI 10.1016/j.pathophys.2012.02.006; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181	42	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					46	52		10.1097/HTR.0000000000000292			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300013	28195955				2022-02-06	
S	Katz, PS; Molina, PE		Tharakan, B		Katz, Paige S.; Molina, Patricia E.			A Lateral Fluid Percussion Injury Model for Studying Traumatic Brain Injury in Rats	TRAUMATIC AND ISCHEMIC INJURY: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Fluid percussion injury; Lateral; Craniotomy	PATHOPHYSIOLOGY	Traumatic brain injury (TBI) diagnoses have increased in frequency during the past decade, becoming a silent epidemic. The pathophysiology of TBI involves pathophysiological processes affecting the brain, induced by traumatic biomechanical forces resulting in temporary impairment of neurological function. Preclinical models have been generated to recapitulate the mechanical, neuroinflammatory, and behavioral outcomes observed in the clinical setting. The lateral fluid percussion (LFP) model is the most extensively used and well-characterized model of nonpenetrating and nonischemic TBI. The model is reproducible and can be adjusted to produce a mild to moderate and severe injury, as reflected by mortality and return of reflexes, by adjusting the amount of force applied. The histopathological changes achieved with this model reproduce that seen in human TBI including focal contusion in the cortex, with accompanying intraparenchymal punctate hemorrhage, followed by inflammation and neuronal degeneration. This chapter describes the LFP model, which produces a mixed model of focal and diffuse brain injury that progresses over time affecting predominantly the cortical parenchyma.	[Katz, Paige S.; Molina, Patricia E.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, New Orleans, LA 70112 USA		Katz, PS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, New Orleans, LA 70112 USA.		Molina, Patricia E./AAK-9814-2021	Molina, Patricia E./0000-0002-3598-384X			DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Ling GSF, 2001, TRAUMATIC BRAIN INJU; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	14	5	5	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-7526-6; 978-1-4939-7524-2	METHODS MOL BIOL	Methods Mol. Biol.		2018	1717						27	36		10.1007/978-1-4939-7526-6_3	10.1007/978-1-4939-7526-6		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Research & Experimental Medicine	BK3CS	WOS:000434764100004	29468581				2022-02-06	
J	Lambregts, SAM; Van Markus-Doornbosch, F; Catsman-Berrevoets, CE; Berger, MAM; De Kloet, AJ; Hilberink, SR; Roebroeck, ME				Lambregts, Suzanne A. M.; Van Markus-Doornbosch, Frederike; Catsman-Berrevoets, Coriene E.; Berger, Monique A. M.; De Kloet, Arend J.; Hilberink, Sander R.; Roebroeck, Marij E.			Neurological outcome in children and youth with acquired brain injury 2-year post-injury	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Acquired brain injury; adolescents; children; neurological outcome; participation; traumatic brain injury	ARTERIAL ISCHEMIC-STROKE; COGNITIVE RESERVE; CHILDHOOD; SCHOOL; SCALE; RECOVERY; MOTOR; TERM; TBI; REHABILITATION	Objective: To determine neurological outcome in children and youth with acquired brain injury (ABI) and explore associated factors. Design: Cross-sectional study, two-years post-injury. Patients: Hospital-based sample (n=112) aged 6-22 years. Methods: Neurological outcome and participation were assessed with a multidimensional neurological examination and the Child and Adolescent Scale of Participation. Logistic regression analyses were used to explore the relationships. Results: Both sensorimotor and cognitive deficits were found in 30-31%, language deficits and behavioural deficits in 10-17%. Non-traumatic injury had a negative impact on neurological outcome, specifically regarding sensorimotor and language deficits. Lower education level showed a significantly poorer neurological outcome. High levels of age-expected participation were reported, with a significant relation between deficits and participation restrictions, especially at school. Conclusion: One out of three have a poor neurological outcome, related to type of injury and lower level of education. The amount of deficits is associated with participation restrictions.	[Lambregts, Suzanne A. M.; Hilberink, Sander R.; Roebroeck, Marij E.] Erasmus MC Univ Med Ctr, Dept Rehabil Med, Rotterdam, Netherlands; [Lambregts, Suzanne A. M.] Revant Rehabil Ctr, Dept Pediat Rehabil, Breda, Netherlands; [Van Markus-Doornbosch, Frederike; De Kloet, Arend J.] Sophia Rehabil Ctr, Dept Pediat & Youth Rehabil, The Hague, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus MC Univ Med Ctr, Dept Pediat Neurol, Rotterdam, Netherlands; [Berger, Monique A. M.; De Kloet, Arend J.] The Hague Univ Appl Sci, Expert Grp Rehabil, Dept Acquired Brain Injury Rehabil, The Hague, Netherlands; [Roebroeck, Marij E.] Rijndam Rehabil Inst, Dept Rehabil Med, Rotterdam, Netherlands		Lambregts, SAM (corresponding author), Revant Rehabil Ctr, Brabantlaan 1, NL-4817 JW Breda, Netherlands.	s.lambregts@revant.nl					Aarsen FK, 2006, CANCER-AM CANCER SOC, V106, P396, DOI 10.1002/cncr.21612; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bulder MMM, 2011, CEREBROVASC DIS, V32, P463, DOI 10.1159/000332087; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; (CBO) DIfHI, 2010, MAN PAT MILD TRAUM H; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Dahl E, 2013, J REHABIL MED, V45, P729, DOI 10.2340/16501977-1188; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, BRAIN INJURY, P1; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P554, DOI 10.1136/adc.2009.161083; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lo W, 2014, J CHILD NEUROL, V29, P1524, DOI 10.1177/0883073813503186; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Murphy LK, 2017, DEV MED CHILD NEUROL, V59, P1146, DOI 10.1111/dmcn.13547; Organization WH, 2007, INT CLASS FUNCT DIS; Pericall MTL, 2014, DEV MED CHILD NEUROL, V56, P19, DOI 10.1111/dmcn.12237; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	48	5	5	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2018	21	7			SI		465	474		10.1080/17518423.2018.1460770			10	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	GR1HR	WOS:000442284100006	29652209				2022-02-06	
J	Li, CX; Zhang, XD				Li, Chun-Xia; Zhang, Xiaodong			Evaluation of prolonged administration of isoflurane on cerebral blood flow and default mode network in macaque monkeys anesthetized with different maintenance doses	NEUROSCIENCE LETTERS			English	Article						Anesthesia; CBF; Non-human primate; Pseudo continuous arterial-spin-labeling (pCASL); Functional MRI; Default mode network (DMN); Dosage effect	RESTING-STATE CONNECTIVITY; TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; NONHUMAN-PRIMATES; INHALATIONAL ANESTHESIA; ANIMAL-MODELS; HUMANS; STROKE; SEVOFLURANE; HALOTHANE	Object Isoflurane is a commonly used volatile anesthetic agent in clinical anesthesia and biomedical research. Prior study suggested the cerebral blood flow (CBF) and default mode network (DMN) could be changed after prolonged administration of isoflurane. The normal maintenance doses of isoflurane may vary from light (similar to 0.75%) to deep (similar to 1.5 or 2%) anesthesia. However, it is not clear how the duration effects are affected by the altered doses. The present study is aimed to examine if the duration effects are affected when isoflurane concentration is altered within normal maintenance doses. Materials and methods: Adult rhesus monkeys (n = 5, 8-12 years old, 8-10 kg) were anesthetized and maintained at isoflurane levels 0.89 +/- 0.03%, 1.05 +/- 0.12%, or 1.19 +/- 0.08%. CBF and DMN of monkeys were examined using arterial spin-labeling perfusion and resting state functional MRI techniques. Results: the functional connectivity (FC) in the dominant DMN (posterior cingulate cortex (PCC) to anterior cingulated cortex (ACC) or media prefrontal cortex (MPFC)) decreased substantially and similarly during 4-h administration of isoflurane at any given maintenance dosage. CBF changes varied with isoflurane dosage. At the low dose (similar to 0.89%), CBF decreased in most brain regions. In contrast, no obvious changes was seen in those regions (except for the subcortex) when higher doses of isoflurane were applied. Conclusion: FC in DMN was reduced substantially during prolonged administration of isoflurane. The FC reduction was not varying significantly with maintenance doses of isoflurane but the duration effect on CBF was dose-dependent. Such duration effects of isoflurane administration on DMN and CBF should be considered in the interpretation of the outcome in related neuroimaging studies of anesthetized subjects.	[Li, Chun-Xia; Zhang, Xiaodong] Emory Univ, Yerkes Natl Primate Res Ctr, Yerkes Imaging Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Zhang, Xiaodong] Emory Univ, Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, Atlanta, GA 30329 USA		Zhang, XD (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Yerkes Imaging Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA.	xzhang8@emory.edu			National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P51RR000165]; Office of Research Infrastructure Programs [OD P51OD011132]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P51OD011132] Funding Source: NIH RePORTER	The authors are grateful to Sudeep Patel, Ruth Connelly, and Doty Kempf (DVM) for assistance in data acquisition and animal handling. The project was funded by the National Center for Research Resources (P51RR000165) and is currently supported by the Office of Research Infrastructure Programs (OD P51OD011132).	Biswal Bharat B., 2009, V489, P255, DOI 10.1007/978-1-59745-543-5_12; Bomberg H, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2065-0; Capitanio JP, 2008, LANCET, V371, P1126, DOI 10.1016/S0140-6736(08)60489-4; Chan AW, 2015, DIS MARKERS, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0122335; DETRE JA, 1994, NMR BIOMED, V7, P75, DOI 10.1002/nbm.1940070112; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ferron JF, 2009, J NEUROSCI, V29, P9850, DOI 10.1523/JNEUROSCI.5176-08.2009; Hamilton C., 2017, BRAIN STRUCT FUNCT; HANSEN TD, 1989, J CEREBR BLOOD F MET, V9, P323, DOI 10.1038/jcbfm.1989.50; Hirano Y, 2011, J NEUROSCI, V31, P1440, DOI 10.1523/JNEUROSCI.3986-10.2011; Hutchison RM, 2015, NEUROIMAGE, V116, P10, DOI 10.1016/j.neuroimage.2015.04.068; Hutchison RM, 2014, HUM BRAIN MAPP, V35, P5754, DOI 10.1002/hbm.22583; Iida H, 1998, ANESTHESIOLOGY, V89, P954, DOI 10.1097/00000542-199810000-00020; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Keilholz SD, 2013, BRAIN CONNECT, V3, P31, DOI 10.1089/brain.2012.0115; Khalili-Mahani N, 2014, HUM BRAIN MAPP, V35, P929, DOI 10.1002/hbm.22224; Kuroda Y, 1997, ANESTHESIOLOGY, V87, P527, DOI 10.1097/00000542-199709000-00011; Kuroda Y, 1996, ANESTHESIOLOGY, V84, P555, DOI 10.1097/00000542-199603000-00010; KURODA Y, 2000, J ANESTH, V14, P124; Lauzon M. L., 2006, NEUROIMAGE CLIN N AM, V16; Lenz C, 1999, ANESTHESIOLOGY, V91, P1720, DOI 10.1097/00000542-199912000-00025; Li CX, 2017, BRAIN CONNECT, V7, P98, DOI 10.1089/brain.2016.0445; Li CX, 2014, MAGN RESON IMAGING, V32, P956, DOI 10.1016/j.mri.2014.04.019; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Li ZH, 2017, HUM BRAIN MAPP, V38, P4098, DOI 10.1002/hbm.23651; Li ZH, 2008, BRAIN IMAGING BEHAV, V2, P39, DOI 10.1007/s11682-007-9013-0; Liang ZF, 2012, J NEUROSCI, V32, P10183, DOI 10.1523/JNEUROSCI.1020-12.2012; Liu X, 2013, BRAIN TOPOGR, V26, P363, DOI 10.1007/s10548-012-0267-5; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Ma YC, 2017, BRAIN CONNECT, V7, P1, DOI 10.1089/brain.2016.0464; MCPHERSON RW, 1994, ANESTHESIOLOGY, V80, P1320, DOI 10.1097/00000542-199406000-00020; Almeida SRM, 2017, J NEUROIMAGING, V27, P65, DOI 10.1111/jon.12362; Meng YG, 2016, NEUROBIOL LEARN MEM, V134, P31, DOI 10.1016/j.nlm.2016.04.003; Nael K, 2013, STROKE, V44, P3090, DOI 10.1161/STROKEAHA.113.002377; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; REINSTRUP P, 1995, ANESTHESIOLOGY, V82, P359, DOI 10.1097/00000542-199502000-00006; Saleem K.S., 2007, COMBINED MRI HISTOLO; Sander-Kiesling A, 2002, PAEDIATR ANAESTH, V12, P429, DOI 10.1046/j.1460-9592.2002.00862.x; Shalbaf R, 2015, COGN NEURODYNAMICS, V9, P41, DOI 10.1007/s11571-014-9295-z; Shen Q, 2008, NMR BIOMED, V21, P839, DOI 10.1002/nbm.1264; Silva AC, 2011, METHODS MOL BIOL, V711, P281, DOI 10.1007/978-1-61737-992-5_14; Silva Afonso C., 2009, V489, P277, DOI 10.1007/978-1-59745-543-5_13; Sim J, 2016, EXP NEUROBIOL, V25, P130, DOI 10.5607/en.2016.25.3.130; Stamatakis EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014224; Tak S, 2015, BRAIN CONNECT, V5, P137, DOI 10.1089/brain.2014.0299; Tremoleda JL, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-44; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; VANAKEN H, 1986, ANESTH ANALG, V65, P565; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2010, J NEUROPHYSIOL, V103, P793, DOI 10.1152/jn.00546.2009; Wang K, 2011, NMR BIOMED, V24, P61, DOI 10.1002/nbm.1556; Wang SL, 2015, J NEUROL SCI, V357, P28, DOI 10.1016/j.jns.2015.06.055; Wang Z, 2013, NEURON, V78, P1116, DOI 10.1016/j.neuron.2013.04.023; Wu TL, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.591; Zhang X., 2013, J CLIN CELL IMMUNOL; Zhang XD, 2016, QUANT IMAG MED SURG, V6, P573, DOI 10.21037/qims.2016.10.05; Zhang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117290; Zhang XL, 2014, QUANT IMAGING MED SU, V4, P1, DOI [10.3978/j.issn.2223-4292.2014.03.01, 10.3978/j.issn.2223-4292.2014.04.06]; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063	61	5	5	0	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 1	2018	662						402	408		10.1016/j.neulet.2017.10.034			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR0BS	WOS:000418726700066	29055725	Green Accepted, Bronze			2022-02-06	
J	Mangas, A; Heredia, M; Riolobos, A; de la Fuente, A; Criado, JM; Yajeya, J; Geffard, M; Covenas, R				Mangas, Arturo; Heredia, Margarita; Riolobos, Adelaida; de la Fuente, Antonio; Maria Criado, Jose; Yajeya, Javier; Geffard, Michel; Covenas, Rafael			Overexpression of kynurenic acid and 3-hydroxyanthranilic acid after rat traumatic brain injury	EUROPEAN JOURNAL OF HISTOCHEMISTRY			English	Article						3-OH-anthranilic acid; astrocyte; glia; immunohistochemistry; kynurenic acid; neurotoxicity; trauma	QUINOLINIC ACID; MISMATCH NEGATIVITY; PATHWAY; TRYPTOPHAN; ASTROCYTES; HEALTH; NEUROPROTECTION; COMBINATION; METABOLITES; ANTAGONISTS	Using an immunohistochemical technique, we have studied the distribution of kynuneric acid (KYNA) and 3-hydroxyanthranilic acid (3-HAA) in a rat brain injury model (trauma). The study was carried out inducing a cerebral ablation of the frontal motor cortex. Two mouse monoclonal specific antibodies previously developed by our group directed against KYNA and 3-HAA were used. In control animals (shamoperated), the expression of both KYNA and 3-HAA was not observed. In animals in which the ablation was performed, the highest number of immunoreactive cells containing KYNA or 3-HAA was observed in the region surrounding the lesion and the number of these cells decreased moving away from the lesion. KYNA and 3-HAA were also observed in the white matter (ipsilateral side) located close to the injured region and in some cells placed in the white matter of the contralateral side. The distribution of KYNA and 3-HAA perfectly matched with the peripheral injured regions. The results found were identical independently of the perfusion date of animals (17, 30 or 54 days after brain injury). For the first time, the presence of KYNA and 3-HAA has been described in a rat trauma model. Moreover, by using a double immunocytochemistry protocol, it has been demonstrated that both metabolites were located in astrocytes. The findings observed suggestthat, in cerebral trauma, KYNA and 3-HAA are involved in tissue damage and that these compounds could act, respectively, as a neuroprotector and a neurotoxic. This means that, in trauma, a counterbalance occurs and that a regulation of the indoleamine 2,3 dioxygenase (IDO) pathway could be required after a brain injury in order to decrease the deleterious effects of ending metabolites (the neurotoxic picolinic acid). Moreover, the localization of KYNA and 3-HAA in the contralateral side of the lesion suggests that the IDO pathway is also involved in the sprouting and pathfinding that follows a traumatic brain injury.	[Mangas, Arturo; Geffard, Michel] Gemacbio, St Jean Dillac, France; [Mangas, Arturo; Covenas, Rafael] Univ Salamanca, INCYL, Lab Neuroanat Peptiderg Syst, Salamanca, Spain; [Heredia, Margarita; Riolobos, Adelaida; de la Fuente, Antonio; Maria Criado, Jose; Yajeya, Javier] Univ Salamanca, Sch Med, Dept Physiol, Salamanca, Spain		Mangas, A (corresponding author), Univ Salamanca, INCYL, Lab Neuroanat Peptiderg Syst, Lab 14, C Pintor Fernando Gallego 1, Salamanca 37007, Spain.	mangasam@usal.es	Covenas, Rafael/ABA-4723-2020; Criado, Jose M/B-2579-2017	Mangas, Arturo/0000-0001-5448-4176; Covenas, Rafael/0000-0001-5677-8266; Criado, Jose M/0000-0002-3457-9896; Heredia, Margarita/0000-0003-4610-1037	Gemacbio S.A. Laboratories (Saint Jean d'Illac, France); IDRPHT (Talence, France); "Programa XI: Financiacion de Unidades de Excelencia de la Universidad de Salamanca" (Salamanca, Spain)	This work has been supported by Gemacbio S.A. Laboratories (Saint Jean d'Illac, France), IDRPHT (Talence, France) and by the "Programa XI: Financiacion de Unidades de Excelencia de la Universidad de Salamanca" (Salamanca, Spain). The authors wish to thank Javier Blanco for technical assistance.	Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Barresi MJF, 2010, DEV DYNAM, V239, P2603, DOI 10.1002/dvdy.22393; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; Blizzard CA, 2009, BRAIN RES, V1300, P24, DOI 10.1016/j.brainres.2009.08.059; Bohar Z, 2015, INT J MOL SCI, V16, P9772, DOI 10.3390/ijms16059772; Braidy N, 2009, INT J TRYPTOPHAN RES, V2, P61; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Chen YQ, 2010, NEUROTOX RES, V18, P132, DOI 10.1007/s12640-009-9129-7; Covenas R, 2017, FOLIA HISTOCHEM CYTO, V55, P177, DOI 10.5603/FHC.a2017.0023; DYKENS JA, 1987, BIOCHEM PHARMACOL, V36, P211, DOI 10.1016/0006-2952(87)90691-5; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Garrison AM, 2018, PSYCHONEUROENDOCRINO, V94, P1, DOI 10.1016/j.psyneuen.2018.04.019; Gellert L, 2011, EUR J PHARMACOL, V667, P182, DOI 10.1016/j.ejphar.2011.05.069; Gold AB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-17; Goldstein LE, 2000, BIOCHEMISTRY-US, V39, P7266, DOI 10.1021/bi992997s; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Heredia M, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/6125901; Heredia M, 2013, BEHAV BRAIN RES, V247, P48, DOI 10.1016/j.bbr.2013.03.012; Jha MK, 2018, PROG NEUROBIOL, V162, P37, DOI 10.1016/j.pneurobio.2017.12.003; Kim SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07394-3; Klauser P, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0266-8; Koola MM, 2018, SCHIZOPHR RES, V193, P459, DOI 10.1016/j.schres.2017.07.005; Koola MM, 2018, PRIM CARE COMPANION, V20; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lim CK, 2017, PROG NEUROBIOL, V155, P76, DOI 10.1016/j.pneurobio.2015.12.009; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075561; Sanchez ML, 2018, FOLIA HISTOCHEM CYTO, V56, P49, DOI 10.5603/FHC.a2018.0003; Lopez YP, 2016, J CHEM NEUROANAT, V71, P6, DOI 10.1016/j.jchemneu.2015.10.010; Lovelace MD, 2017, NEUROPHARMACOLOGY, V112, P373, DOI 10.1016/j.neuropharm.2016.03.024; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mangas A, 2017, ANN ANAT, V211, P33, DOI 10.1016/j.aanat.2017.01.002; Mangas A, 2016, EUR J HISTOCHEM, V60, P247, DOI 10.4081/ejh.2016.2709; Mangas A, 2017, EUR J HISTOCHEM, V61, P112, DOI 10.4081/ejh.2017.2790; Mangas A, 2013, NEUROL RES, V35, P903, DOI 10.1179/1743132813Y.0000000233; Marcet Paul, 2017, Neuroimmunol Neuroinflamm, V4, P82, DOI 10.20517/2347-8659.2017.07; Marcos P, 1997, BRAIN RES PROTOC, V2, P1, DOI 10.1016/S1385-299X(97)00018-4; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Morita T, 2001, ANN CLIN BIOCHEM, V38, P242, DOI 10.1258/0004563011900461; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; O'Farrell K, 2017, EUR J PHARMACOL, V810, P163, DOI 10.1016/j.ejphar.2017.07.008; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Perez-de la Cruz V, 2012, J NEUROCHEM, V120, P1026, DOI 10.1111/j.1471-4159.2012.07653.x; Perez-De La Cruz Veronica, 2007, CNS & Neurological Disorders-Drug Targets, V6, P398; QUAGLIARIELLO E, 1964, BIOCHEM J, V91, P137, DOI 10.1042/bj0910137; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sas K, 2018, MOLECULES, V23, DOI 10.3390/molecules23010191; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Suma T, 2008, NEUROL RES, V30, P420, DOI 10.1179/016164107X251745; Sun HY, 2015, NEURAL REGEN RES, V10, P618, DOI 10.4103/1673-5374.155437; Sundaram G, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0204-5; Tatro JB, 2006, ENDOCRINOLOGY, V147, P1122, DOI 10.1210/en.2005-1573; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628	59	5	5	1	2	PAGEPRESS PUBL	PAVIA	MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY	1121-760X	2038-8306		EUR J HISTOCHEM	Eur. J. Histochem.		2018	62	4					278	284	2985	10.4081/ejh.2018.2985			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	HG7JP	WOS:000455167400003	30426733	gold, Green Published, Green Submitted			2022-02-06	
J	Marchesseault, ER; Nguyen, D; Spahr, L; Beals, C; Razak, B; Rosene, JM				Marchesseault, Erin Renee; Nguyen, Daniel; Spahr, Lee; Beals, Caroline; Razak, Brian; Rosene, John M.			Head impacts and cognitive performance in men's lacrosse	PHYSICIAN AND SPORTSMEDICINE			English	Article						Lacrosse; impact; cognition; subconcussive; concussion	WORKING-MEMORY; INJURY; CONCUSSION; ATTENTION; FOOTBALL; SPORT	Objectives: The purpose of this investigation was to record head impacts and assess cognitive function throughout a NCAA Division III men's lacrosse season. Methods: Fifteen NCAA Div III men's lacrosse players (age=21.11.5years; height=1797.00cm; weight=80.74 +/- 8.00kg) wore Smart Impact Monitors (SIM) (Triax Technologies, Inc., Norwalk, CT) within headbands, in 28 practices and 9 home games of one season. The SIM devices communicated with the Triax Technologies SKYi, which confirmed activated SIMs and obtained data of linear acceleration, rotational acceleration, rotational velocity, direction, and location of each head impact. A minimum threshold of 15g of force was set for head impacts to register with the SIMs. The Comprehensive Trail Making Test and Stroop Color and Word Test were administered at preseason, midseason, and postseason to assess cognitive function performance. Results: There was no significant difference found between all measures of frequency and magnitude of head impacts between games and practices. There was also no significant difference for peak linear acceleration of head impacts between different positions and no significant difference between the magnitude of force and the location of impact on the head. There was a significant increase in CTMT performance from preseason to midseason, from midseason to postseason, and preseason to postseason. There was no significant difference in Stroop test performance throughout the season. Conclusion: Subconcussive head impacts in men's lacrosse appear to occur at the same magnitude in practices and games, and do not appear to be position dependent, nor head location dependent. Men's lacrosse athletes' cognitive function as measured by the CTMT, can improve, while cognitive function as measured by the Stroop test remained unchanged.	[Marchesseault, Erin Renee; Nguyen, Daniel; Spahr, Lee; Razak, Brian; Rosene, John M.] Univ New England, Exercise & Sport Performance, 11 Hills Beach Rd, Biddeford, ME 04005 USA; [Beals, Caroline] Univ New England, Hlth Wellness & Occupat Studies, Biddeford, ME 04005 USA		Rosene, JM (corresponding author), Univ New England, Exercise & Sport Performance, 11 Hills Beach Rd, Biddeford, ME 04005 USA.	jrosene@une.edu		Nguyen, Daniel/0000-0002-9268-0300			Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; Borges A, 2017, INT J SPORTS PHYS TH, V12, P381; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Buck KK, 2008, J CLIN EXP NEUROPSYC, V30, P312, DOI 10.1080/13803390701390483; Chueh T, 2017, PEER J; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Dux PE, 2009, NEURON, V63, P127, DOI 10.1016/j.neuron.2009.06.005; Gatzia DE, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00739; Golden CJ., 2002, STROOP COLOR WORD TE; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Gutowski AE, 2011, STRENGTH COND J, V33, P16, DOI 10.1519/SSC.0b013e318208cb04; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Karton C, 2016, HOSHIZAKI TB MEASURE; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Kyllonen P.C., 2003, INT J TEST, V3, P233, DOI [https://doi.org/10.1207/S15327574IJT0303_3, DOI 10.1207/S15327574IJT0303_3]; Lupyan G, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00553; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Melnik A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04757-8; Miyashita T, 2016, ATHLETIC TRAINING SP, V8, P202, DOI DOI 10.3928/19425864-20160503-01; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; Reynolds BB, 2016, AM J SPORTS MED, V44, P1; Reynolds CR, 2002, CTMT COMPREHENSIVE T; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Sinclair KL, 2013, J CLIN EXP NEUROPSYC, V35, P210, DOI 10.1080/13803395.2012.762340; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Veneri G, 2014, EUR J NEUROSCI, V40, P2833, DOI 10.1111/ejn.12639; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Zuckerman SL, 2015, AM J SPORTS MED, V20, P1	32	5	5	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2018	46	3					324	330		10.1080/00913847.2018.1470888			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	GS7WR	WOS:000443915700010	29733264				2022-02-06	
J	Marsh, NV				Marsh, Nigel V.			Cognitive functioning following traumatic brain injury: The first 5 years	NEUROREHABILITATION			English	Article						Cognition; head injury; outcome; longitudinal design; neuropsychological assessment; long-term follow-up	VERBAL FLUENCY; HEAD-INJURY; RECOVERY; PERFORMANCE; MODERATE; DECLINE; MEMORY; INTELLIGENCE; IMPAIRMENT; ADULTS	OBJECTIVE: This study reports the results from a 5-year longitudinal investigation of the prevalence and severity of cognitive deficits following significant (i.e., ventilation required for > 24 hours) traumatic brain injury. The changes in performance, either improvement or decline, across five domains of cognitive functioning are described. METHOD: A group of 56 adults was assessed at approximately 6 months, 1 year, and 5 years following injury. RESULTS: Impairment was evident on all measures but prevalence and rate of improvement varied. Overall, by 5 years post-injury over 85% of patients were not impaired on measures of general intelligence, simple attention, and visual perception. However, 28% of patients continued to show some degree of impairment on complex attention and verbal fluency, and performance on verbal memory remained impaired for 60% of patients. There was also evidence for deterioration in complex attention and verbal memory between 1 year and 5 years. ANOVAs showed that improvement occurred on most measures between 6 months and 1 year, but there was both improvement and decline on some measures between 1 year and 5 years. CONCLUSIONS: The findings show that there is considerable heterogeneity in cognitive outcome following TBI, with some deterioration evident over the long term.	[Marsh, Nigel V.] Sunway Univ, Dept Psychol, 5 Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia		Marsh, NV (corresponding author), Sunway Univ, Dept Psychol, 5 Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia.	nigelm@sunway.edu.my	Marsh, Nigel V./F-5433-2019; Marsh, Nigel/ABA-3609-2021	Marsh, Nigel V./0000-0002-4060-6432; Marsh, Nigel/0000-0002-4060-6432	Neurological Foundation of New Zealand [NF 98/17PG]	This study was supported by grant number NF 98/17PG from the Neurological Foundation of New Zealand.	BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; BROOKER BH, 1986, J CLIN PSYCHOL, V42, P982, DOI 10.1002/1097-4679(198611)42:6<982::AID-JCLP2270420624>3.0.CO;2-G; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cohen J., 2013, STAT POWER ANAL BEHA; Griffen J., 2014, HDB NEUROPSYCHOLOGY, P25; Havill JH, 1998, NEW ZEAL MED J, V111, P161; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; JENNETT B, 1975, LANCET, V1, P480; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; Marsh NV, 2005, J CLIN EXP NEUROPSYC, V27, P352, DOI 10.1080/13803390490515685; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKenna K, 2006, BRAIN INJURY, V20, P507, DOI 10.1080/02699050600664368; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Nelson H.E., 1982, NATL ADULT READING T; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schmidt M., 1996, REY AUDITORY VERBAL; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TEASDALE G, 1974, LANCET, V2, P81; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whiteside Douglas M, 2016, Appl Neuropsychol Adult, V23, P29, DOI 10.1080/23279095.2015.1004574	40	5	5	0	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	4					377	386		10.3233/NRE-182457			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM5XL	WOS:000459548500003	30400114				2022-02-06	
J	Matsangas, P; Mysliwiec, V				Matsangas, Panagiotis; Mysliwiec, Vincent			The utility of the Pittsburgh Sleep Quality Index in US military personnel	MILITARY PSYCHOLOGY			English	Article						Military personnel; sleep disorders; insomnia; service-related illnesses	TEST-RETEST RELIABILITY; REPORT QIDS-SR; DEPRESSIVE SYMPTOMATOLOGY; PSYCHOMETRIC EVALUATION; QUICK INVENTORY; INSOMNIA; APNEA; QUESTIONNAIRE; DISORDERS; DISTURBANCE	Sleep disturbances are endemic in military personnel with nonclinical populations averaging 6 hours of sleep. The Pittsburgh Sleep Quality Index (PSQI), however, has not been validated in this population. It is thus unknown if the PSQI can differentiate clinically significant sleep disorders from sleep disturbances resulting from military duties with restricted sleep periods. After a clinical evaluation and polysomnogram, participants (N = 148) were classified as having insomnia only, obstructive sleep apnea (OSA) only, comorbid insomnia and OSA (CIO), service-related illnesses only (SRI-; pain, depression, posttraumatic stress disorder, traumatic brain injury), and controls. Military personnel in the insomnia only, and the CIO groups had higher PSQI scores (13.5 +/- 2.8 and 14.7 +/- 3.5, respectively) compared to the controls (8.9 +/- 3.9). A cut-off score of >= 10 was optimal (90% sensitivity and 69% specificity) for determining clinically significant insomnia (>= 12 for CIO; 84% sensitivity, 77% specificity). In military personnel, a PSQI score >5 is not necessarily indicative of a clinically significant sleep disorder. The use of elevated cut-off PSQI scores are likely better suited to differentiate military personnel who require further clinical evaluation versus a more conservative sleep improvement protocol.	[Matsangas, Panagiotis] Naval Postgrad Sch, Dept Operat Res, Monterey, CA 93943 USA; [Mysliwiec, Vincent] JBSA, San Antonio Mil Med Ctr, Dept Sleep Med, Lackland AFB, TX USA		Matsangas, P (corresponding author), Naval Postgrad Sch, 1411 Cunningham Rd, Monterey, CA 93943 USA.	pmatsang@nps.edu	Matsangas, Panagiotis/L-1154-2015	Matsangas, Panagiotis/0000-0002-9829-4347			Alsaadi SM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-196; American Academy of Sleep Medicine, 2013, INT CLASS SLEEP DIS; American Congress of Rehabilitation Medicine, 2016, DEF MILD TRAUM BRIN; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; BUYSSE DJ, 1991, SLEEP, V14, P331; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; GENTILI A, 1995, J AM GERIATR SOC, V43, P1317, DOI 10.1111/j.1532-5415.1995.tb07415.x; Iber C., 2007, AASM MANUAL SCORING, P7; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Liu Y, 2016, MMWR-MORBID MORTAL W, V65, P137, DOI 10.15585/mmwr.mm6506a1; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Miller N. L., 2012, OXFORD HDB MILITARY, P262; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mysliwiec Vincent, 2016, US Army Med Dep J, P128; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Scarlata S, 2013, J MED SCREEN, V20, P220, DOI 10.1177/0969141313511591; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Shattuck N.L., 2014, NPSOR14004; Shattuck NL, 2016, ERGONOMICS, V59, P657, DOI 10.1080/00140139.2015.1073794; Shattuck NL, 2015, NPSOR15006; Sinnott C, 2005, DIABETES CARE, V28, P1534, DOI 10.2337/diacare.28.6.1534; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Troxel WM, 2015, SLEEP MILITARY PROMO; Ulmer CS, 2015, J CLIN SLEEP MED, V11, P995, DOI 10.5664/jcsm.5012; Weathers F.W., 1993, 9 ANN C ISTSS; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	38	5	5	2	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.		2018	30	4					360	369		10.1080/08995605.2018.1478547			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	GQ8IA	WOS:000441994900007					2022-02-06	
J	Mc Fie, S; Abrahams, S; Patricios, J; Suter, J; Posthumus, M; September, AV				Mc Fie, Sarah; Abrahams, Shameemah; Patricios, Jon; Suter, Jason; Posthumus, Michael; September, Alison V.			Inflammatory and apoptotic signalling pathways and concussion severity: a genetic association study	JOURNAL OF SPORTS SCIENCES			English	Article						Concussion; genetics; interleukin; neuroinflammation; rugby	TRAUMATIC BRAIN-INJURY; INTERLEUKIN-1 RECEPTOR ANTAGONIST; WHITE-MATTER INTEGRITY; FOCAL CEREBRAL-ISCHEMIA; APOE EPSILON-4 ALLELE; NITRIC-OXIDE; RISK-FACTORS; CELL-DEATH; POLYMORPHISM; SPORT	The objective was to investigate the relationship between IL-1B rs16944, IL-6 rs1800795, and CASP8 rs3834129 genetic polymorphisms and concussion severity. Rugby players from high school, senior amateur, and professional teams completed a concussion severity questionnaire and donated a DNA sample. Participants (n = 163) were split into symptom severity groups around the median number and duration of symptoms. The frequency of participants with high symptom counts (more than five symptoms) increased across the IL-1B (C/C: 35%; C/T: 51%; T/T: 56%; P = 0.047) and the IL-6 (C/C: 31%; C/G: 44%; G/G: 58%; P = 0.027) genotypes. The C-C inferred interleukin allele construct frequency, created from combining the IL-1B and IL-6 genotype data, was lower in participants reporting a high symptom count (18%), compared to those with a low symptom count (fewer than six symptoms, 36%, P = 0.002). Similarly, the C-C inferred interleukin allele construct frequency was lower in those reporting prolonged symptom duration (more than one week, 16%), as opposed to short symptom duration (less than one week, 34%, P = 0.015). This study provides evidence of novel inflammatory pathway genetic associations with concussion severity, which supports the hypothesis implicating neuroinflammation in the development of concussion symptoms.	[Mc Fie, Sarah; Abrahams, Shameemah; Posthumus, Michael; September, Alison V.] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, 1 Boundary Rd, ZA-7700 Cape Town, South Africa; [Patricios, Jon] Morningside Sports Med Clin, Johannesburg, South Africa; [Patricios, Jon] Univ Pretoria, Sect Sports Med, Pretoria, South Africa; [Patricios, Jon] Univ Witwatersrand, Dept Emergency Med, Johannesburg, South Africa; [Suter, Jason] Sports Sci Sports & Exercise Med Clin, Cape Town, South Africa		September, AV (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, 1 Boundary Rd, ZA-7700 Cape Town, South Africa.	Alison.September@uct.ac.za		Patricios, Jon/0000-0002-6829-4098; Abrahams, Shameemah/0000-0002-1120-678X; September, Alison V/0000-0003-0950-286X	National Research Foundation [90942, 93416:2015, 85534:2015]; National Research Foundation; University of Cape Town	The National Research Foundation funded the study (A.V.S., grant number 90942), (M.P., grant numbers 93416:2015, 85534:2015). The National Research Foundation and the University of Cape Town funded S.A. and S.M.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Almolda B, 2014, GLIA, V62, P1142, DOI 10.1002/glia.22668; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Belanger M, 2011, J NEUROCHEM, V116, P564, DOI 10.1111/j.1471-4159.2010.07135.x; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Frost B, 2015, TRENDS CELL BIOL, V25, P46, DOI 10.1016/j.tcb.2014.07.005; Gaudino M, 2003, CIRCULATION, V108, P195, DOI 10.1161/01.cir.0000087441.48566.0d; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Hulkkonen J, 2001, RHEUMATOLOGY, V40, P656, DOI 10.1093/rheumatology/40.6.656; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; LEE SC, 1993, J NEUROIMMUNOL, V46, P19, DOI 10.1016/0165-5728(93)90229-R; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Libra M, 2006, J CLIN PATHOL, V59, P211, DOI 10.1136/jcp.2004.025452; Little J, 2009, EUR J CLIN INVEST, V39, P247, DOI 10.1111/j.1365-2362.2009.02125.x; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Madura SA, 2016, BRAIN INJURY, V30, P908, DOI 10.3109/02699052.2016.1146958; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mccrea M., 2014, JAMA-J AM MED ASSOC, V290, P2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt J, 2015, BRAIN INJURY, V29, P1674, DOI 10.3109/02699052.2015.1075252; McDevitt JK, 2011, BRAIN INJURY, V25, P1108, DOI 10.3109/02699052.2011.607790; Merritt V., 2016, ARCH CLIN NEUROPSYCH, V31, P628; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; NORRIS JG, 1994, J IMMUNOL, V152, P841; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Persson J, 2006, NEUROLOGY, V66, P1029, DOI 10.1212/01.wnl.0000204180.25361.48; R Core Team R, 2013, R LANG ENV STAT COMP; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; RINK A, 1995, AM J PATHOL, V147, P1575; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; September AV, 2011, BRIT J SPORT MED, V45, P1040, DOI 10.1136/bjsm.2010.076760; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Terrell Thomas, 2013, BRIT J SPORT MED, V47, pE1, DOI DOI 10.1136/BJSPORTS-2012-092101.31; Thomas D. C., 2001, CANCER EPIDEM BIOMAR, V11, P505; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Warnes G, 2006, GENETICS POPULATION; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yang S., 2013, SHOCK, V27, P417; Zhai PP, 2015, NEUROPHARMACOLOGY, V95, P1, DOI 10.1016/j.neuropharm.2015.02.026; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	77	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2018	36	19					2226	2234		10.1080/02640414.2018.1448570			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GL7BD	WOS:000437349100010	29509495				2022-02-06	
J	McKinlay, A; Albicini, M; Than, M				McKinlay, A.; Albicini, M.; Than, M.			Preinjury characteristics of children with mild traumatic brain injury: Is "other injury" an appropriate comparison group"?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; preschool; school age; preinjury; concussion	DEFICIT HYPERACTIVITY DISORDER; OLD-DAYS BIAS; RISK-FACTORS; HEAD-INJURY; BIRTH COHORT; ADOLESCENTS; PRESCHOOL; SYMPTOMS; PREVALENCE; BEHAVIOR	Background: Mild traumatic brain injury (mTBI) has been associated with ongoing problems in children and young people. However, there remains to be considerable debate regarding whether outcomes are a result of brain impairment, or simply reflect preinjury characteristics of the child or family. To reliably assess outcomes, an appropriate control group is required. Aims: This study aimed to identify the preinjury characteristics of children with mTBI, and to examine whether an other injury to the head group is an appropriate comparison to control for preinjury characteristics of children with mTBI. Method: Parents of 290 children admitted to the emergency department with either a diagnosis of mTBI (n=186, M=6.44years) or a superficial injury to the head (SIH) (n=104, M=5.40years) were assessed. Parents completed three questionnaires examining behavioral problems (Clinical Assessment of Behavior), parental stress (Parenting Stress Index), and background variables (e.g., medical issues, socioeconomic factors). Results: A series of chi-square analyses and multivariate analysis of variance tests revealed no differences for behavior, parental stress, and other preexisting problems between children with mTBI and those with SIH. Conclusions: Children who experience a mTBI event present similarly to individuals with a SIH, and SIH is an appropriate comparison group to examine the outcomes of childhood mTBI, as it may help minimize any confounding effects of preexisting issues associated with mTBI.	[McKinlay, A.; Albicini, M.] Univ Melbourne, Sch Psychol Sci, Clayton Campus, Melbourne, Vic 3800, Australia; [McKinlay, A.; Albicini, M.] Univ Canterbury, Dept Psychol, Christchurch, New Zealand; [Than, M.] Christchurch Hosp, Emergency Dept, Christchurch, New Zealand		McKinlay, A (corresponding author), Univ Melbourne, Sch Psychol Sci, Clayton Campus, Melbourne, Vic 3800, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514	Health Research Council/Accident Compensation Corporation of New Zealand	A. McKinlay was supported by a postdoctoral fellowship from the Health Research Council/Accident Compensation Corporation of New Zealand;	Abidin, 1995, PARENTING STRESS IND; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Asarnow R, 1995, TRAUMATIC BRAIN INJU, P117; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; Bracken B., 2006, CLIN ASSESSMENT BEHA; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Demellweek Colin, 2002, Pediatr Rehabil, V5, P81, DOI 10.1080/136384902320807194; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Halldorsson JG, 2012, BRAIN INJURY, V26, P1, DOI 10.3109/02699052.2011.635359; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; Lange R. T., 2010, ARCH CLIN NEUROPSYCH, V26, P127; Liao CC, 2012, J TRAUMA ACUTE CARE, V73, P1327, DOI 10.1097/TA.0b013e31826fc87f; Love PF, 2009, J TRAUMA, V67, pS12, DOI 10.1097/TA.0b013e3181ac7f22; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A., 2010, INJURY PREVENTION, P5; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Wazana A, 1997, CAN J PSYCHIAT, V42, P602, DOI 10.1177/070674379704200606; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899	34	5	5	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	3					285	291		10.1080/13803395.2017.1342771			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FV7WV	WOS:000424797100006	28659005				2022-02-06	
J	Odgaard, L; Kothari, M				Odgaard, Lene; Kothari, Mohit			Prevalence and association of oral candidiasis with dysphagia in individuals with acquired brain injury	BRAIN INJURY			English	Article						Oral thrush; stroke; traumatic brain injury; oral health; oral hygiene	REHABILITATION; PLAQUE	Objective: To describe the prevalence of oral candidiasis (OC) in individuals with acquired brain injury (ABI) and to evaluate the association of OC with improvement in dysphagia. Design: Longitudinal observational study. Methods: Individuals with ABI admitted to rehabilitation were recruited over a one-year period (n = 206 (59% with dysphagia)). OC-data were collected by clinical examinations and verified by cultivation/microscopy in every 3 weeks during first 10 weeks of admission. Dysphagia improvement was defined by: 1) first positive change in food consistency, 2) initiation of at least soft food consistency. Individuals with/without OC were compared using multivariable Cox proportional hazards regression. Results: The overall OC prevalence in all individuals, in individuals with dysphagia and in individuals not treated with antifungal agents were 32.5%, 43.4% and 29.7%, respectively. The OC prevalence was 24.8% at one week after admission and reduced to 10.1% ten weeks after admission. Adjusted hazard ratios for improvement in dysphagia were 0.64-0.77 in OC compared to without OC, though not statistically significant. Conclusion: Prevalence of OC was high at admission but reduced during rehabilitation. Though non-significant, the negative trend between OC and improvement in dysphagia suggest that OC may delay rehabilitation of dysphagia.	Aarhus Univ, Hammel Neurorehabil Ctr, Res Unit, Hammel, Denmark; Aarhus Univ, Univ Res Clin, Hammel, Denmark		Kothari, M (corresponding author), Hammel Neurorehabil Ctr, Voldbyvej 15, DK-8450 Hammel, Denmark.; Kothari, M (corresponding author), Univ Res Clin, Voldbyvej 15, DK-8450 Hammel, Denmark.	mohkot@rm.dk	Kothari, Mohit/Q-3847-2019; Odgaard, Lene/AAF-1909-2020	Kothari, Mohit/0000-0002-8191-9769; Odgaard, Lene/0000-0002-9830-3282			Aizen E, 2004, ISRAEL MED ASSOC J, V6, P342; Ansigt KA, 2005, MUND SVAELG UNDERSOG, P169; Arai Koji, 2003, Gerodontology, V20, P78, DOI 10.1111/j.1741-2358.2003.00078.x; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; Deng ZY, 2010, OTOLARYNG HEAD NECK, V143, P242, DOI 10.1016/j.otohns.2010.02.003; Dickinson H, 2001, CLIN EFFECTIVENESS N, V5, P104, DOI DOI 10.1054/CEIN.2001.0221; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Hansen TS, 2010, DISABIL REHABIL, V32, P1447, DOI 10.3109/09638280903556482; Kaushik N, 2015, PRIMARY CARE, V42, P501, DOI 10.1016/j.pop.2015.08.004; Kothari M, 2017, ANN OTO RHINOL LARYN, V126, P199, DOI 10.1177/0003489416683192; Kothari M, 2017, OR SURG OR MED OR PA, V123, P205, DOI 10.1016/j.oooo.2016.10.024; Kothari M, 2016, BRAIN INJURY, V30, P1103, DOI 10.3109/02699052.2016.1167244; Lalla RV, 2010, SUPPORT CARE CANCER, V18, P985, DOI 10.1007/s00520-010-0892-z; Nikawa H, 1998, J DENT, V26, P299, DOI 10.1016/S0300-5712(97)00026-2; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Poisson P, 2016, GERODONTOLOGY, V33, P161, DOI 10.1111/ger.12123; Sroussi HY, 2007, ORAL DIS, V13, P324, DOI 10.1111/j.1601-0825.2006.01289.x; Stenberg M, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/680308	18	5	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					247	251		10.1080/02699052.2017.1407960			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600011	29182379				2022-02-06	
J	Ostberg, A; Virta, J; Rinne, JO; Oikonen, V; Luoto, P; Nagren, K; Arponen, E; Tenovuo, O				Ostberg, Anna; Virta, Jere; Rinne, Juha O.; Oikonen, Vesa; Luoto, Pauliina; Nagren, Kjell; Arponen, Eveliina; Tenovuo, Olli			Brain Cholinergic Function and Response to Rivastigmine in Patients With Chronic Sequels of Traumatic Brain Injury: A PET Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acetylcholine; acetylcholinesterase inhibitors; cognitive impairment; positron emission tomography; traumatic brain injury	CORTICAL ACETYLCHOLINESTERASE ACTIVITY; POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; HEAD-INJURY; NUCLEUS BASALIS; DONEPEZIL; INHIBITION; IMPAIRMENT; PATHOLOGY; MEYNERT	Objective: To investigate quantitative positron emission tomography (PET) findings and to study whether the cholinergic function differs between respondents to cholinergic medication versus nonrespondents. Setting: Outpatient clinic and university PET imaging center. Participants: We studied 17 subjects for more than 1 year after at least moderate traumatic brain injury. Ten of the subjects were respondents and 7 nonrespondents to cholinergic medication. Design: Cholinergic function was assessed with [methyl-C-11] N-methylpiperidyl-4-acetate-PET (C-11-MP4A-PET), which reflects the activity of the acetylcholinesterase (AChE) enzyme. The subjects were PET scanned twice: without medication and after a 4-week treatment with rivastigmine 1.5 mg twice a day. Measures: Regional cerebral AChE activity was measured with PET. Results: At baseline Statistical Parametric Mapping analyses showed significantly lower AChE activity in respondents bilaterally in the frontal cortex as compared with nonrespondents. Region of interest (ROI) analysis revealed that the difference was most pronounced in the lateral frontal cortex (-9.4%, P =.034) and anterior cingulate (-6.0%, P =.049). After rivastigmine treatment, AChE activity was notably lower throughout the cortex in both respondents and nonrespondents, without significant differences between them. Conclusion: Our study suggests that frontal cholinergic dysfunction is associated with the clinical response to cholinergic stimulation in patients with traumatic brain injury.	[Ostberg, Anna; Rinne, Juha O.; Tenovuo, Olli] Turku Univ Hosp, Div Clin Neurosci, Turku 20521, Finland; [Virta, Jere; Rinne, Juha O.; Oikonen, Vesa; Luoto, Pauliina; Arponen, Eveliina] Turku Univ Hosp, Turku Positron Emission Tomog Ctr, Turku, Finland; [Nagren, Kjell] Odense Univ Hosp, Dept Nucl Med, PET & Cyclotron Unit, Odense, Denmark		Ostberg, A (corresponding author), Turku Univ Hosp, Div Clin Neurosci, Turku 20521, Finland.	anna.ostberg@tyks.fi	Nagren, Kjell/AAE-7039-2019; Kumar, Rishabh/P-4667-2017	Nagren, Kjell/0000-0001-5182-8199; Oikonen, Vesa/0000-0002-1947-0219	Sigrid Juselius FoundationSigrid Juselius Foundation; Turku University Hospital clinical grants; Finnish doctoral association Duodecim; OrionCorp.	This study was financially supported by grants from the Sigrid Juselius Foundation and from Turku University Hospital clinical grants. Author Ostberg has received a grant from the Finnish doctoral association Duodecim. Author Virta is involved in contact research with Orion-Pharma Ltd, Bayer Schering Pharma Ltd, and Turku Imanet Oy. Author Tenovuo has received speaker fees from OrionCorp. Author Rinne serves as a consultant for Clinical Research Services Turku (CRST) Ltd.	[Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Azuar C, 2014, NEUROIMAGE, V84, P1053, DOI 10.1016/j.neuroimage.2013.09.031; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Bohnen NI, 2005, J NEUROL NEUROSUR PS, V76, P315, DOI 10.1136/jnnp.2004.038729; Hong JH, 2012, J HEAD TRAUMA REHAB, V27, P172, DOI 10.1097/HTR.0b013e318217192d; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iyo M, 1997, LANCET, V349, P1805, DOI 10.1016/S0140-6736(96)09124-6; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaasinen V, 2002, J CLIN PSYCHOPHARM, V22, P615, DOI 10.1097/00004714-200212000-00012; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Kuhl DE, 2000, ANN NEUROL, V48, P391, DOI 10.1002/1531-8249(200009)48:3<391::AID-ANA17>3.0.CO;2-H; Kuhl DE, 1999, NEUROLOGY, V52, P691, DOI 10.1212/WNL.52.4.691; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Polinsky RJ, 1998, CLIN THER, V20, P634, DOI 10.1016/S0149-2918(98)80127-6; Poole NA, 2008, BRAIN INJURY, V22, P519, DOI 10.1080/02699050802132495; Rinne JO, 2003, J NEUROL NEUROSUR PS, V74, P113, DOI 10.1136/jnnp.74.1.113; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	34	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					25	32		10.1097/HTR.0000000000000279			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300011	28060207				2022-02-06	
J	Payne, L; Hawley, L; Ketchum, JM; Philippus, A; Eagye, CB; Morey, C; Gerber, D; Harrison-Felix, C; Diener, E				Payne, Lisa; Hawley, Lenore; Ketchum, Jessica M.; Philippus, Angela; Eagye, C. B.; Morey, Clare; Gerber, Don; Harrison-Felix, Cynthia; Diener, Ed			Psychological well-being in individuals living in the community with traumatic brain injury	BRAIN INJURY			English	Article						TBI; psychological well-being; productivity	QUALITY-OF-LIFE; SATISFACTION; WORK; RELIABILITY; DEPRESSION; VALIDITY; RETURN; SCALE	Background: Well-being and quality of life issues remain a long-term problem for many individuals with traumatic brain injury (TBI). Meaningful activity is key to developing life satisfaction and a sense of contribution to society, yet individuals with TBI are often unable to return to competitive employment.Objective: To describe the self-reported psychological well-being of a cohort of unemployed individuals living in the community at least 1 year post TBI with low life satisfaction.Methods: Seventy-four unemployed individuals with low life satisfaction at least 1 year post TBI were administered measures of psychological well-being and cognitive functioning.Results: This cohort of 74 participants demonstrated cognitive impairment and elevated levels of emotional distress. Significant bivariate relationships were noted among nearly all measures of well-being, and associations were in the directions as expected. Individuals reported low life satisfaction and well-being. Two newer measures of well-being correlated with established measures used with this population.Conclusions: Individuals with TBI living in the community who are not employed but who seek to be productive reported low life satisfaction and well-being. This study highlights the need for interventions aimed at increasing productivity and meaning in life for individuals with TBI, and a broader understanding of psychological health after TBI.	[Payne, Lisa; Hawley, Lenore; Ketchum, Jessica M.; Philippus, Angela; Eagye, C. B.; Morey, Clare; Gerber, Don; Harrison-Felix, Cynthia] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica M.; Eagye, C. B.; Harrison-Felix, Cynthia] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Harrison-Felix, Cynthia] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO 80202 USA; [Diener, Ed] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Diener, Ed] Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA		Payne, L (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	CMorey@CraigHospital.org	Ketchum, Jessica/AAE-8200-2020	Philippus, Angela/0000-0001-7427-8660	National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, Department of Health and Human Services [90DP0034]	This study was funded under a Traumatic Brain Injury Model Systems Center grant from the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, Department of Health and Human Services grant number 90DP0034.	[Anonymous], 2002, SAS SYST VERS 9 4; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Cantor N., 1999, WELL BEING FDN HEDON, P230; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2010, SOC INDIC RES, V97, P143, DOI 10.1007/s11205-009-9493-y; Ditchman N, 2017, REHABIL PSYCHOL, V62, P130, DOI 10.1037/rep0000139; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fuhrer MJ, 2000, DISABIL REHABIL, V22, P481, DOI 10.1080/096382800413961; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Green P., 2004, MED SYMPTOM VALIDITY; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Kahneman D., 2012, THINKING FAST SLOW; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Law BMF, 2009, THESCIENTIFICWORLDJO, V9, P855, DOI 10.1100/tsw.2009.32; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Mortera MK, 2017, ARCH PHYS MED REHABI; Musick MA, 2003, SOC SCI MED, V56, P259, DOI 10.1016/S0277-9536(02)00025-4; National Institute of Neurological Disorders and Stroke, 2012, NINDS COMM DAT EL TR; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reitan R, 1986, TRAIL MAKING TEST; Rice RW, 1980, BASIC APPL SOC PSYCH, V1, P37, DOI 10.1207/s15324834basp0101_4; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Schmidt M, 2010, REY AUDITORY VERBAL; Silva AJ, 2013, SOC INDIC RES, V110, P469, DOI 10.1007/s11205-011-9938-y; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; The Psychological Corporation, 1997, WAIS 3 WMS 2 TECHN M; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2017, TRAUM BRAIN INJ MOD; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2012, FORM 2 ANN REP, P2012; United States Department of Labor, 2016, VOL US 2015; University of Wisconsin; Center for Demography of Health and Aging, 2008, DOC SCAL WISC LONG S; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Winkler D, 2005, J OCCUP SCI, V12, P69, DOI 10.1080/14427591.2005.9686550; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	44	5	5	3	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		980	985		10.1080/02699052.2018.1468573			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400004	29708442	Green Accepted			2022-02-06	
J	Pirracchio, R; Yue, JK; Manley, GT; van der Laan, MJ; Hubbard, AE; Gordon, WA; Lingsma, HF; Maas, AIR; Mukherjee, P; Okonkwo, DO; Schnyer, DM; Valadka, AB; Yuh, EL				Pirracchio, Romain; Yue, John K.; Manley, Geoffrey T.; van der Laan, Mark J.; Hubbard, Alan E.; Gordon, Wayne A.; Lingsma, Hester F.; Maas, Andrew I. R.; Mukherjee, Pratik; Okonkwo, David O.; Schnyer, David M.; Valadka, Alex B.; Yuh, Esther L.		TRACK-TBI Investigators	Collaborative targeted maximum likelihood estimation for variable importance measure: Illustration for functional outcome prediction in mild traumatic brain injuries	STATISTICAL METHODS IN MEDICAL RESEARCH			English	Article						Variable importance measure; causal inference; high-dimensional data; semi-parametric; collaborative targeted maximum likelihood; positivity	HEAD-INJURY; CLASSIFICATION; GENE	Standard statistical practice used for determining the relative importance of competing causes of disease typically relies on ad hoc methods, often byproducts of machine learning procedures (stepwise regression, random forest, etc.). Causal inference framework and data-adaptive methods may help to tailor parameters to match the clinical question and free one from arbitrary modeling assumptions. Our focus is on implementations of such semiparametric methods for a variable importance measure (VIM). We propose a fully automated procedure for VIM based on collaborative targeted maximum likelihood estimation (cTMLE), a method that optimizes the estimate of an association in the presence of potentially numerous competing causes. We applied the approach to data collected from traumatic brain injury patients, specifically a prospective, observational study including three US Level-1 trauma centers. The primary outcome was a disability score (Glasgow Outcome Scale - Extended (GOSE)) collected three months post-injury. We identified clinically important predictors among a set of risk factors using a variable importance analysis based on targeted maximum likelihood estimators (TMLE) and on cTMLE. Via a parametric bootstrap, we demonstrate that the latter procedure has the potential for robust automated estimation of variable importance measures based upon machine-learning algorithms. The cTMLE estimator was associated with substantially less positivity bias as compared to TMLE and larger coverage of the 95% CI. This study confirms the power of an automated cTMLE procedure that can target model selection via machine learning to estimate VIMs in complicated, high-dimensional data.	[Pirracchio, Romain] UCSF, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, 1001 Potrero Ave, San Francisco, CA 94110 USA; [Yue, John K.; Manley, Geoffrey T.] Brain & Spinal Injury Ctr, San Francisco, CA USA; [Yue, John K.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [van der Laan, Mark J.; Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Dept Biostat, Berkeley, CA 94720 USA		Pirracchio, R (corresponding author), UCSF, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, 1001 Potrero Ave, San Francisco, CA 94110 USA.	romainpirracchio@yahoo.fr	Yue, John K/P-1348-2015; Maas, Andrew IR/C-5584-2013; Schnyer, David/ABD-6372-2021	Yue, John K/0000-0001-9694-7722; Maas, Andrew IR/0000-0003-1612-1264; Schnyer, David/0000-0002-7472-2853	Fulbright Foundation; Assistance Publique - Hopitaux de Paris (APHP); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RC2 NS069409, NS069409-02S1]; DOD USAMRAAUnited States Department of Defense [W81XWH-13-1-0441]; One Mind; Patient-Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [ME-1306-02735]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090, RC2NS069409] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: RP received funding from the Fulbright Foundation and the Assistance Publique - Hopitaux de Paris (APHP). NIH RC2 NS069409, NS069409-02S1, DOD USAMRAA W81XWH-13-1-0441, and One Mind (to G.T.M.). In addition, this work was partially supported through a Patient-Centered Outcomes Research Institute (PCORI) Pilot Project Program Award (ME-1306-02735).	American Psychiatric Association and American Psychiatric Association and others, 2000, DIAGN STAT MAN TEXT; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chambaz A, 2012, ELECTRON J STAT, V6, P1059, DOI 10.1214/12-EJS703; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Dudoit S., 2005, STAT METHODOL, V2, P131, DOI [10.1016/j.stamet.2005.02.003, DOI 10.1016/J.STAMET.2005.02.003]; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Green PE, 1978, J MARK RES JMR, V15; Gruber S., 2010, INT J BIOSTAT, V6; Gruber S, 2012, J STAT SOFTW, V51, P1; Hubbard A, 2013, J TRAUMA ACUTE CARE, V75, pS53, DOI 10.1097/TA.0b013e3182914553; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Laan MJ van der, 2006, INT J BIOSTAT, V2, P1557; Lawford BR, 2006, EUR PSYCHIAT, V21, P180, DOI 10.1016/j.eurpsy.2005.01.006; LeDell E, PACKAGE CVAUC; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; Pearl J., 2009, CAUSALITY, P486; Petersen ML, 2012, STAT METHODS MED RES, V21, P31, DOI 10.1177/0962280210386207; Polley E., 2014, SUPERLEARNER SUPER L; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ripley B.D, 2002, MODERN APPL STAT S, DOI DOI 10.1007/978-0-387-21706-2; Ripley BD, 2008, PATTERN RECOGNITION; Robins JM, 2000, P AM STAT ASS SECTIO, P6; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Rosenblum M, 2010, INT J BIOSTAT, V6, P1557; Savitz J, 2013, INT J NEUROPSYCHOPH, V16, P2095, DOI 10.1017/S146114571300045X; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tuglus C, 2008, TARGETED METHODS BIO; van der Laan M.J., 2003, UC BERKELEY DIVISION, V130, P1; van der Laan MJ, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1241; van der Laan MJ, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1211; VANDERLAAN MJ, 2007, STAT APPL GENET MOL, V6; Wang H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-312; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	38	5	5	5	15	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0962-2802	1477-0334		STAT METHODS MED RES	Stat. Methods Med. Res.	JAN	2018	27	1					286	297		10.1177/0962280215627335			12	Health Care Sciences & Services; Mathematical & Computational Biology; Medical Informatics; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Mathematical & Computational Biology; Medical Informatics; Mathematics	FS5YF	WOS:000419874400020	27363429	Green Accepted			2022-02-06	
J	Portnova, GV; Atanov, MS				Portnova, Galina, V; Atanov, Michael S.			Nonlinear EEG parameters of emotional perception in patients with moderate traumatic brain injury, coma, stroke and schizophrenia	AIMS NEUROSCIENCE			English	Article						EEG; fractal dimension; EEG envelope; Hjorth; schizophrenia; stroke; coma; traumatic brain injury	ELECTROENCEPHALOGRAPHIC MEASURE; FRACTAL DIMENSION; DEPRESSION; SYMPTOMS; ENTROPY; MEG	Objective: The aim of this study was to determine the EEG changes induced by emotional non-verbal sounds using nonlinear signals' features and also to examine the subjective emotional response in patients with different neurological and psychiatric disorders. Methods: 141 subjects participated in our study: patients after moderate TBI, patients in acute coma, patients after stroke, patients with schizophrenia and controls. 7 types of emotionally charged stimuli were presented. Non-comatose participants were asked to assess the levels of experienced emotions. We analyzed fractal dimension, signal's envelope parameters and Hjorth mobility and complexity. Results: The Hjorth parameters were negatively correlated with irritation. The fractal dimension was positively correlated with arousal and empathy levels. The only presentation of laughter to post-stroke patients induced the reaction similar to the control group. Conclusions: The results showed that the investigated nonlinear features of resting state EEG are quite group-specific and also specific to the emotional state. Significance: The investigated features could serve to diagnose emotional impairments.	[Portnova, Galina, V; Atanov, Michael S.] RAS, Inst Higher Nervous Act & Neurophysiol, 5A Butlerova St, Moscow 117485, Russia; [Portnova, Galina, V] Pushkin State Russian Language Inst, Moscow, Russia		Portnova, GV (corresponding author), RAS, Inst Higher Nervous Act & Neurophysiol, 5A Butlerova St, Moscow 117485, Russia.; Portnova, GV (corresponding author), Pushkin State Russian Language Inst, Moscow, Russia.	caviter@list.ru	Atanov, Michael/I-2126-2016	Atanov, Michael/0000-0002-0666-6247	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [16-04-00092]; Russian Academy of ScienceRussian Academy of Sciences	The research was supported by the grant #16-04-00092 of the Russian Foundation for Basic Research and by Russian Academy of Science.	Al-Qazzaz NK, 2016, SENSORS AND ELECTRONIC INSTRUMENTATION ADVANCES (SEIA), P92; Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Bornas X, 2013, INT J PSYCHOL, V48, P695, DOI 10.1080/00207594.2012.671945; Bruhn J, 2000, ANESTHESIOLOGY, V92, P715, DOI 10.1097/00000542-200003000-00016; Cheng M, 2017, INT J WAVELETS MULTI, V15, DOI 10.1142/S0219691317500424; Chu WL, 2017, ANN GEN PSYCHIATR, V16, DOI 10.1186/s12991-017-0157-z; Duan RN, 2013, I IEEE EMBS C NEUR E, P81, DOI 10.1109/NER.2013.6695876; EKMAN P, 1985, J PERS SOC PSYCHOL, V49, P1416, DOI 10.1037/0022-3514.49.5.1416; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; Fuss F. K., 2016, APPL MATH, V7, P355, DOI [10.4236/am.2016.74033, DOI 10.4236/am.2016.74033, DOI 10.4236/AM.2016.74033]; Galina P., 2014, OPEN J MODERN NEUROS, V4, P81, DOI DOI 10.4236/ojmn.2014.42017; Georgiev S., 2009, INT J BIOAUTOMATION, V12, P70; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; Gomez C, 2009, MED ENG PHYS, V31, P306, DOI 10.1016/j.medengphy.2008.06.010; Hamida STB, 2015, 2015 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY (ISSPIT), P548, DOI 10.1109/ISSPIT.2015.7394397; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Hinkley LBN, 2011, BIOL PSYCHIAT, V70, P1134, DOI 10.1016/j.biopsych.2011.06.029; HJORTH B, 1970, ELECTROEN CLIN NEURO, V29, P306, DOI 10.1016/0013-4694(70)90143-4; IRAGUI VJ, 1983, J NEUROL NEUROSUR PS, V46, P632, DOI 10.1136/jnnp.46.7.632; KOUKKOU M, 1993, BIOL PSYCHIAT, V33, P397, DOI 10.1016/0006-3223(93)90167-C; Kring AM, 2010, CURR DIR PSYCHOL SCI, V19, P255, DOI 10.1177/0963721410377599; KTONAS PY, 1980, SIGNAL PROCESS, V2, P373, DOI 10.1016/0165-1684(80)90079-1; Liu YS, 2011, LECT NOTES COMPUT SC, V6670, P256, DOI 10.1007/978-3-642-22336-5_13; Mehmood RM., 2015, IJBSBT, V7, P23, DOI 10.14257/ijbsbt.2015.7.3.03; Mohammadi MR, 2016, BIOMED ENG LETT, V6, P66, DOI 10.1007/s13534-016-0218-2; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Pezard L, 1996, BIOL PSYCHIAT, V39, P991, DOI 10.1016/0006-3223(95)00307-X; Pohjasvaara T, 2001, EUR J NEUROL, V8, P315, DOI 10.1046/j.1468-1331.2001.00182.x; Portnova GV, 2018, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00654; Sohn H, 2010, CLIN NEUROPHYSIOL, V121, P1863, DOI 10.1016/j.clinph.2010.04.007; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Sutter R., 2012, EPILEPTOLOGIE, V29, P201; Takahashi T, 2013, PROG NEURO-PSYCHOPH, V45, P258, DOI 10.1016/j.pnpbp.2012.05.001; Takehara T, 2013, COGNITION EMOTION, V27, P577, DOI 10.1080/02699931.2012.725655; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Unterlohner, 2013, THESIS; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Zappasodi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100199	39	5	5	0	2	AMER INST MATHEMATICAL SCIENCES-AIMS	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	2373-8006	2373-7972		AIMS NEUROSCI	AIMS Neurosci.		2018	5	4					221	235		10.3934/Neuroscience.2018.4.221			15	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HI6BS	WOS:000456538800002	32341963	Green Published, gold			2022-02-06	
J	Post, A; Kendall, M; Cournoyer, J; Karton, C; Oeur, RA; Dawson, L; Hoshizaki, TB				Post, Andrew; Kendall, Marshall; Cournoyer, Janie; Karton, Clara; Oeur, R. Anna; Dawson, Lauren; Hoshizaki, T. Blaine			Brain tissue analysis of impacts to American football helmets	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						American football; concussion; biomechanics; brain injury; mTBI	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; HEAD IMPACTS; ANGULAR ACCELERATION; CONCUSSION; INJURY; SIMULATIONS; PREDICTORS; MAGNITUDE; FREQUENCY	Concussion in American football is a prevalent concern. Research has been conducted examining frequencies, location, and thresholds for concussion from impacts. Little work has been done examining how impact location may affect risk of concussive injury. The purpose of this research was to examine how impact site on the helmet and type of impact, affects the risk of concussive injury as quantified using finite element modelling of the human head and brain. A linear impactor was used to impact a helmeted Hybrid III headform in several locations and using centric and non-centric impact vectors. The resulting dynamic response was used as input for the Wayne State Brain Injury Model to determine the risk of concussive injury by utilizing maximum principal strain as the predictive variable. The results demonstrated that impacts that occur primarily to the side of the head resulted in higher magnitudes of strain in the grey and white matter, as well as the brain stem. Finally, commonly worn American football helmets were used in this research and significant risk of injury was incurred for all impacts. These results suggest that improvements in American football helmets are warranted, in particular for impacts to the side of the helmet.	[Post, Andrew; Kendall, Marshall; Cournoyer, Janie; Karton, Clara; Oeur, R. Anna; Dawson, Lauren; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Post, Andrew] St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada		Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.; Post, A (corresponding author), St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552	National Operating Committee on Standards for Athletic Equipment [ND 001]	This work was supported by National Operating Committee on Standards for Athletic Equipment [grant number ND 001].	Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark MD, 2018, RADIOL, DOI 10/1148/radiol.2017170539; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T.A., 1987, 872197 SAE, P49; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2001, BRIT J SPORT MED, V35, P146, DOI 10.1136/bjsm.35.3.146; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller RT, 1998, P 42 STAPP CAR CRASH; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2015, P I MECH ENG P-J SPO, V229, P17, DOI 10.1177/1754337114551444; Post A, 2014, P I MECH ENG P-J SPO, V228, P276, DOI 10.1177/1754337114527742; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Taghdiri F, 2018, J NEUROTRAUM, V35, P1; Tartaglia MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00030; Trosseille X., 1992, P 36 STAPP CAR CRASH; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang J, 2009, 53 AAAM ANN C ANN AD; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	49	5	5	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2018	21	3					264	277		10.1080/10255842.2018.1445229			14	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	GB2GJ	WOS:000428869300008	29502453				2022-02-06	
J	Privman, M; Guz, N; Katz, E				Privman, Marina; Guz, Nataliia; Katz, Evgeny			Enzyme-Logic Digital Biosensors for Biomedical Applications	INTERNATIONAL JOURNAL OF UNCONVENTIONAL COMPUTING			English	Article							TRAUMATIC BRAIN-INJURY; SERUM AMYLASE; LACTATE-DEHYDROGENASE; IMPROVED SEPARATION; RADIATION-EXPOSURE; MOLECULAR MARKERS; OXIDATIVE STRESS; OUTPUT SIGNALS; BIOMARKERS; FILTER	The article overviews novel biosensor/bioassay applications based on enzyme-logic systems. The binary (YES/NO) responses generated by the systems in response to various combinations of biomarkers allow rapid processing of biomolecular signals being particularly useful for end-users and on-filed applications.	[Guz, Nataliia; Katz, Evgeny] Clarkson Univ, Dept Chem & Biomol Sci, Potsdam, NY 13699 USA; [Privman, Marina] SUNY, Empire State Coll, POB 908, Ft Drum, NY 13602 USA		Katz, E (corresponding author), Clarkson Univ, Dept Chem & Biomol Sci, Potsdam, NY 13699 USA.	ekatz@clarkson.edu					Akleyev AV, 2010, RADIAT ENVIRON BIOPH, V49, P281, DOI 10.1007/s00411-010-0269-1; Alexander GA, 2007, RADIAT MEAS, V42, P972, DOI 10.1016/j.radmeas.2007.05.035; Bailly N, 2017, MED SCI SPORT EXER, V49, P1, DOI 10.1249/MSS.0000000000001078; Bakshi S, 2013, J PHYS CHEM B, V117, P9857, DOI 10.1021/jp4058675; BARRETT A, 1982, BRIT MED J, V285, P170, DOI 10.1136/bmj.285.6336.170; BECCIOLINI A, 1994, EUR J NUCL MED, V21, P1121; BECCIOLINI A, 1987, ACTA ONCOL, V26, P139, DOI 10.3109/02841868709091753; Beninson D., 1986, BIOL DOSIMETRY CHROM; Berger RP, 2006, CLIN PEDIATR EMERG M, V7, P186, DOI 10.1016/j.cpem.2006.06.001; Bhasale A, 1998, FAM PRACT, V15, P308, DOI 10.1093/fampra/15.4.308; Blakely WF, 2007, RADIAT MEAS, V42, P1164, DOI 10.1016/j.radmeas.2007.05.013; Blakely WF, 2005, HEALTH PHYS, V89, P494, DOI 10.1097/01.HP.0000175913.36594.a4; BLOOR CM, 1974, RADIAT RES, V57, P311, DOI 10.2307/3573837; Bocharova V, 2011, TALANTA, V85, P800, DOI 10.1016/j.talanta.2011.03.034; Borisov SM, 2008, CHEM REV, V108, P423, DOI 10.1021/cr068105t; Bower JE, 2009, CLIN CANCER RES, V15, P5534, DOI 10.1158/1078-0432.CCR-08-2584; Calude C. S., 2009, COMPUTER SCI, V5715; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; CHEN IW, 1973, RADIAT RES, V54, P141, DOI 10.2307/3573872; CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Crowther J. R., 2010, ELISA GUIDEBOOK; de Silva AP, 2007, NAT NANOTECHNOL, V2, P399, DOI 10.1038/nnano.2007.188; Donnelly EH, 2010, SOUTH MED J, V103, P541, DOI 10.1097/SMJ.0b013e3181ddd571; Ehrenkranz JRL, 2002, EPIDEMIOLOGY, V13, pS15, DOI 10.1097/00001648-200205001-00003; Freitas AD, 2015, ABCD-ARQ BRAS CIR DI, V28, P163, DOI 10.1590/S0102-67202015000300004; Fu L, 2004, ADV COLLOID INTERFAC, V111, P133, DOI 10.1016/j.cis.2004.09.004; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Gusev I., 2001, MED MANAGEMENT RAD A; Haffty BG, 2003, ONCOGENE, V22, P5915, DOI 10.1038/sj.onc.1206704; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Halamek J, 2012, J PHYS CHEM B, V116, P4457, DOI 10.1021/jp300447w; Halamek J, 2011, ANAL CHEM, V83, P8383, DOI 10.1021/ac202139m; Halamek J, 2010, MOL BIOSYST, V6, P2554, DOI 10.1039/c0mb00153h; Halamek J, 2010, ANALYST, V135, P2249, DOI 10.1039/c0an00270d; Halamkova L, 2012, ANALYST, V137, P1768, DOI 10.1039/c2an00014h; Hara R, 2004, CHEST, V125, P340, DOI 10.1378/chest.125.1.340; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Horneck G, 2006, ADV SPACE RES, V37, P100, DOI 10.1016/j.asr.2005.06.077; Horneck G, 2003, ADV SPACE RES-SERIES, V31, P87, DOI 10.1016/S0273-1177(02)00662-2; Horneck G., 1992, INT J RAD APPL INS D, V20, P185; HORVATH M, 1980, STRAHLENTHER ONKOL, V156, P244; Jack CIA, 1996, INT J RADIAT ONCOL, V34, P149, DOI 10.1016/0360-3016(95)00209-X; Jeffery J., 1980, DEHYDROGENASES REQUI; Katz, 2012, MOL SUPRAMOLECULAR I; Katz E, 2012, BIOMOLECULAR INFORM; Katz E., ENZYME BASED COMPUTI; Katz E, 2012, ANAL CHEM, V84, P5463, DOI 10.1021/ac3007076; Katz E, 2010, CHEM SOC REV, V39, P1835, DOI 10.1039/b806038j; Khalili H, 2011, CLIN GASTROENT-SER, P47, DOI 10.1007/978-1-60761-866-9_3; Koushanpour A, 2017, ELECTROANAL, V29, P950, DOI 10.1002/elan.201600706; Koushanpour A, 2017, ELECTROANAL, V29, P1602, DOI 10.1002/elan.201700126; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; Kumar V, 2011, ANALYST, V136, P5151, DOI 10.1039/c1an15726d; Lakstein D, 2003, J TRAUMA, V54, pS221, DOI 10.1097/01.TA.0000047227.33395.49; Laverde Sabogal C. E., 2014, COLOMBIAN J ANESTHES, V42, P60; Lee SY, 2010, J NEUROL, V257, P1708, DOI 10.1007/s00415-010-5608-2; LEECH D, 1994, CHEM SOC REV, V23, P205, DOI 10.1039/cs9942300205; Li ZJ, 2011, CHEM COMMUN, V47, P3060, DOI 10.1039/c0cc05037g; Lusczek E. R., 2011, J BIOANAL BIOMED, V3, P38, DOI DOI 10.4172/1948-593X.1000041; Mailloux S, 2014, BIOMATER SCI-UK, V2, P184, DOI 10.1039/c3bm60197h; Margulies D, 2009, J AM CHEM SOC, V131, P9142, DOI 10.1021/ja900848t; May EE, 2008, IEEE SENS J, V8, P1011, DOI 10.1109/JSEN.2008.923945; Melnikov D, 2010, J PHYS CHEM B, V114, P12166, DOI 10.1021/jp105912e; Menard C, 2006, CANCER RES, V66, P1844, DOI 10.1158/0008-5472.CAN-05-3466; MICHAELI D, 1979, J ROY SOC MED, V72, P370; Okunieff P, 2008, CANCER METAST REV, V27, P363, DOI 10.1007/s10555-008-9138-7; OLERUD JE, 1976, ARCH INTERN MED, V136, P692, DOI 10.1001/archinte.136.6.692; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Park SangHyun, 2010, Research Journal of Pharmaceutical Biological and Chemical Sciences, V1, P165; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; Privman M, 2011, ACS APPL MATER INTER, V3, P1620, DOI 10.1021/am200165m; Privman V, 2008, J PHYS CHEM B, V112, P11777, DOI 10.1021/jp802673q; Privman V, 2014, J PHYS CHEM B, V118, P12435, DOI 10.1021/jp508224y; Privman V, 2013, J PHYS CHEM B, V117, P14928, DOI 10.1021/jp408973g; Privman V, 2011, ISR J CHEM, V51, P118, DOI 10.1002/ijch.201000066; Privman V, 2010, J PHYS CHEM B, V114, P14103, DOI 10.1021/jp108693m; Renneberg R., 2008, SERIES ADV BIOCH ENG; RIGNAULT DP, 1992, WORLD J SURG, V16, P940, DOI 10.1007/BF02066996; Ronkainen NJ, 2010, CHEM SOC REV, V39, P1747, DOI 10.1039/b714449k; ROSENBERG J, 1961, ANN SURG, V154, P611, DOI 10.1097/00000658-196110000-00011; Sassolas A, 2008, CHEM REV, V108, P109, DOI 10.1021/cr0684467; Schena M., 2002, MICROARRAY ANAL; Schneider J, 1999, AM J IND MED, V36, P602, DOI 10.1002/(SICI)1097-0274(199912)36:6<602::AID-AJIM2>3.0.CO;2-M; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SPRULES SD, 1995, ANAL CHIM ACTA, V304, P17, DOI 10.1016/0003-2670(94)00565-4; Steinem C., 2010, SERIES SPRINGER SERI; Stephan Guenter, 2007, P341, DOI 10.1007/978-3-540-71414-9_22; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Swartz HM, 2010, HEALTH PHYS, V98, P95, DOI 10.1097/HP.0b013e3181b8cffd; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tan KK, 2009, INJURY, V40, P978, DOI 10.1016/j.injury.2009.02.023; Vaidya V. S., 2010, MED DRUG DISCOVERY E; van Emon JM, 2006, IMMUNOASSAY OTHER BI; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; von Maltzahn G, 2007, J AM CHEM SOC, V129, P6064, DOI 10.1021/ja070461l; Wang J, 2008, CHEM REV, V108, P814, DOI 10.1021/cr068123a; Wang J, 2011, ISR J CHEM, V51, P141, DOI 10.1002/ijch.201000069; Wang J, 2010, ANAL BIOANAL CHEM, V398, P1591, DOI 10.1007/s00216-010-3746-0; Warsinke A, 2009, ANAL BIOANAL CHEM, V393, P1393, DOI 10.1007/s00216-008-2572-0; Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44; Wickremesekera JK, 2001, INT J RADIAT ONCOL, V49, P1015, DOI 10.1016/S0360-3016(00)01420-6; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E; Wilson M, 2003, J EMERG MED, V24, P413, DOI 10.1016/S0736-4679(03)00042-8; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Zauner KP, 2005, CRIT REV SOLID STATE, V30, P33, DOI 10.1080/10408430590918387; Zavalov O, 2012, J PHYS CHEM B, V116, P9683, DOI 10.1021/jp305183d; Zhou JA, 2011, TALANTA, V83, P955, DOI 10.1016/j.talanta.2010.10.057; Zhou ND, 2011, ANAL CHIM ACTA, V703, P94, DOI 10.1016/j.aca.2011.07.023; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; Zourob M, 2010, RECOGNITION RECEPTORS IN BIOSENSORS, P415, DOI 10.1007/978-1-4419-0919-0_11	114	5	5	0	0	OLD CITY PUBLISHING INC	PHILADELPHIA	628 NORTH 2ND ST, PHILADELPHIA, PA 19123 USA	1548-7199	1548-7202		INT J UNCONV COMPUT	Int. J. Unconv. Comput.		2018	13	6					435	476					42	Computer Science, Theory & Methods	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	HJ3UL	WOS:000457099100002					2022-02-06	
J	Raynowska, J; Rizzo, JR; Rucker, JC; Dai, WW; Birkemeier, J; Hershowitz, J; Selesnick, I; Balcer, LJ; Galetta, SL; Hudson, T				Raynowska, Jenelle; Rizzo, John-Ross; Rucker, Janet C.; Dai, Weiwei; Birkemeier, Joel; Hershowitz, Julian; Selesnick, Ivan; Balcer, Laura J.; Galetta, Steven L.; Hudson, Todd			Validity of low-resolution eye-tracking to assess eye movements during a rapid number naming task: performance of the eyetribe eye tracker	BRAIN INJURY			English	Article						Concussion; eye movements; eye movement measurements; king-devick; rapid number naming; saccades; video oculography	KING-DEVICK; CONCUSSION	Objective: To evaluate the performance of the EyeTribe compared to the EyeLink for eye movement recordings during a rapid number naming test in healthy control participants. Background: With the increasing accessibility of portable, economical, video-based eye trackers such as the EyeTribe, there is growing interest in these devices for eye movement recordings, particularly in the domain of sports-related concussion. However, prior to implementation there is a primary need to establish the validity of these devices. One current limitation of portable eye trackers is their sampling rate (30-60 samples per second, or Hz), which is typically well below the benchmarks achieved by their research-grade counterparts (e.g., the EyeLink, which samples at 500-2000 Hz). Methods: We compared video-oculographic measurements made using the EyeTribe with those of the EyeLink during a digitized rapid number naming task (the King-Devick test) in a convenience sample of 30 controls. Results: EyeTribe had loss of signal during recording, and failed to reproduce the typical shape of saccadic main sequence relationships. In addition, EyeTribe data yielded significantly fewer detectable saccades and displayed greater variance of inter-saccadic intervals than the EyeLink system. Conclusion: Caution is advised prior to implementation of low-resolution eye trackers for objective saccade assessment and sideline concussion screening.	[Raynowska, Jenelle; Rizzo, John-Ross; Rucker, Janet C.; Dai, Weiwei; Balcer, Laura J.; Galetta, Steven L.; Hudson, Todd] NYU, Sch Med, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA; [Dai, Weiwei; Selesnick, Ivan] NYU, Tandon Sch Engn, Dept Elect & Comp Engn, New York, NY 10016 USA; [Rizzo, John-Ross; Birkemeier, Joel; Hershowitz, Julian; Hudson, Todd] NYU, Sch Med, Dept Phys Med & Rehabil, 240 East 38th St,20th Floor, New York, NY 10016 USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Balcer, Laura J.; Galetta, Steven L.] NYU, Sch Med, Dept Ophthalmol, New York, NY 10016 USA		Hudson, T (corresponding author), NYU, Sch Med, Dept Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA.; Hudson, T (corresponding author), NYU, Sch Med, Dept Phys Med & Rehabil, 240 East 38th St,20th Floor, New York, NY 10016 USA.	teh9@columbia.edu		Rucker, Janet/0000-0002-0397-0999; Rizzo, John-Ross/0000-0002-4084-0085	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NCMRR [5K12HDOO1097]; Empire Clinical Research Investigator Program (ECRIP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001445] Funding Source: NIH RePORTER	This work was supported by the NICHD and NCMRR [5K12HDOO1097]; Empire Clinical Research Investigator Program (ECRIP);	[Anonymous], 2016, SENSOMOTORIC INSTR R; [Anonymous], 2015, TOBII PRO X2; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Dai WW, 2016, IEEE SIG PROC MED; Dalmaijer E, 2014, PEERJ PREPRINTS, V2, P585, DOI 10.7287/peerj.preprints.585v1; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Kimmel DL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00049; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Leigh RJ, 2015, NEUROLOGY EYE MOVEME; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCamy MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128428; Niehorster DC, 2018, BEHAV RES METHODS, V50, P213, DOI 10.3758/s13428-017-0863-0; Ooms K, 2015, J EYE MOVEMENT RES, V8, DOI 10.16910/jemr.8.1.5; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Samadani U, 2015, CONCUSSION, V1, pCNC3; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; van der Geest JN, 2002, J NEUROSCI METH, V114, P185, DOI 10.1016/S0165-0270(01)00527-1; Wierts R, 2008, IEEE T BIO-MED ENG, V55, P2840, DOI 10.1109/TBME.2008.925290	25	5	5	2	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					200	208		10.1080/02699052.2017.1374469			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600006	29211506	Green Accepted			2022-02-06	
J	Rigon, A; Reber, J; Patel, NN; Duff, MC				Rigon, Arianna; Reber, Justin; Patel, Nirav N.; Duff, Melissa C.			Convergent thinking and traumatic brain injury: an investigation of performance on the remote associate test	BRAIN INJURY			English	Article						Creativity; convergent thinking; memory; Remote Associate Test; creative thinking	LATENT-VARIABLE ANALYSIS; CREATIVE-THINKING; WORKING-MEMORY; DIVERGENT; VALIDITY	Objective: While deficits in several cognitive domains following moderate-to-severe traumatic brain injury (TBI) have been well documented, little is known about the impact of TBI on creativity. In the current study, our goal is to determine whether convergent problem solving, which contributes to creative thinking, is impaired following TBI.Methods: We administered a test of convergent problem solving, the Remote Associate Task (RAT), as well as a battery of neuropsychological tests, to 29 individuals with TBI and 20 healthy comparisons.Results: A mixed-effect regression analysis revealed that individuals with TBI were significantly less likely to produce a correct response, although on average they attempted to respond to the same number of items. Moreover, we found that the TBI (but not the comparison) group's performance on the RAT was significantly and positively associated with verbal learning and memory, providing further evidence supporting the association between declarative memory and creative convergent thinking.Conclusion: In summary, our findings reveal that convergent thinking can be compromised by moderate-to-severe TBI, furthering our understanding of the higher-level cognitive sequelae of TBI.	[Rigon, Arianna; Patel, Nirav N.; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, 10328 Med Ctr East,South Tower, Nashville, TN 37232 USA; [Reber, Justin] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA		Rigon, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, 10328 Med Ctr East,South Tower, Nashville, TN 37232 USA.	arianna.rigon@vanderbilt.edu	Reber, Justin/J-1005-2019	Reber, Justin/0000-0002-4489-569X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM108540] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM108540] Funding Source: Medline		Bates D, 2016, PACKAGE LME4 R PROJE; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Duff MC, 2013, HIPPOCAMPUS, V23, P1143, DOI 10.1002/hipo.22208; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Jaarsveld S, 2012, INTELLIGENCE, V40, P172, DOI 10.1016/j.intell.2012.01.002; Lee CS, 2014, PSYCHOL AESTHET CREA, V8, P446, DOI 10.1037/a0036773; Lee CS, 2013, INTELLIGENCE, V41, P306, DOI 10.1016/j.intell.2013.04.008; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MEDNICK MT, 1963, J CONSULT PSYCHOL, V27, P265, DOI 10.1037/h0042429; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; RUNCO MA, 1988, J YOUTH ADOLESCENCE, V17, P211, DOI 10.1007/BF01538162; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Simonov P V, 1997, Neurosci Behav Physiol, V27, P585, DOI 10.1007/BF02463907; TAFT R, 1966, PSYCHOL REP, V19, P1313, DOI 10.2466/pr0.1966.19.3f.1313; TORRANCE EP, 1972, J CREATIVE BEHAV, V6, P236, DOI 10.1002/j.2162-6057.1972.tb00936.x; Warren DE, 2016, HIPPOCAMPUS, V26, P835, DOI 10.1002/hipo.22591	26	5	5	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	9					1110	1114		10.1080/02699052.2018.1483031			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL0ZJ	WOS:000436823600007	29883201	Green Accepted			2022-02-06	
J	Robinson, DM; Bazzi, MS; Millis, SR; Bitar, AA				Robinson, David M.; Bazzi, Moussa S.; Millis, Scott R.; Bitar, Ali A.			Predictors of readmission to acute care during inpatient rehabilitation for non-traumatic spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; Quality measures; Outcome assessment; Rehabilitation; Patient readmission	TRAUMATIC BRAIN-INJURY; FUNCTIONAL OUTCOMES; RISK-FACTORS; EPIDEMIOLOGY; LESIONS; REHOSPITALIZATION; FREQUENCY; ETIOLOGY; REASONS; RETURN	Objectives: To investigate the frequency of and reasons for readmissions to acute care (RTAC) during inpatient rehabilitation (IPR) after non-traumatic spinal cord injury (NT-SCI). To develop a predictive model for RTAC using identified risk factors. Design: Retrospective case-control. Setting: Academic IPR hospital. Participants: Individuals with NT-SCI admitted to an academic SCI rehabilitation unit from January 2014-December 2015. Interventions: Not applicable. Main Outcome Measures: Readmissions to acute care services from IPR. Results: Thirty-seven participants (20%) experienced a RTAC for a total of 39 episodes. Thirty-five experienced 1 RTAC, while two had 2. The most common medical reasons for RTAC were infection (27%), neurological (27%), and noninfectious respiratory (16%). Multivariable logistic regression was used to develop a model to predict RTAC. Paraplegia was associated with 3.2 times increase in the odds of RTAC (P = 0.03). For every unit increase in FIM-Motor, there was a 5% reduction in the odds of RTAC (P = 0.03) Body mass index less than 30 decreased odds of RTAC by 61% (P = 0.004). Conclusion: RTACs were associated with body mass index greater than 30, decreased FIM-Motor subscore on admission, and paraplegia. Physiatrists caring for the non-traumatic SCI patient need be more circumspect of individuals with these parameters to potentially prevent the problems necessitating acute care transfer.	[Robinson, David M.] Wayne State Univ, Sch Med, Detroit, MI USA; [Bazzi, Moussa S.; Millis, Scott R.; Bitar, Ali A.] Rehabil Inst Michigan, Dept Phys Med & Rehabil, Detroit, MI USA		Robinson, DM (corresponding author), 5420 Wessex Ct Apt 106, Dearborn, MI 48126 USA.	darobins@med.wayne.edu		Robinson, David/0000-0003-4481-1246			Asher A, 2014, PM&R, V6, P808, DOI 10.1016/j.pmrj.2014.01.009; Battaglino RA, 2012, CURR OSTEOPOROS REP, V10, P278, DOI 10.1007/s11914-012-0117-0; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; Catz A, 2004, SPINE, V29, P2278, DOI 10.1097/01.brs.0000142008.49907.c7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YY, 2011, ARCH PHYS MED REHAB, V92, P391, DOI 10.1016/j.apmr.2010.06.030; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Epstein Nancy E, 2014, Surg Neurol Int, V5, pS66, DOI 10.4103/2152-7806.130674; Fu JB, 2014, PM&R, V6, P629, DOI 10.1016/j.pmrj.2013.12.009; Fu JB, 2013, AM J PHYS MED REHAB, V92, P215, DOI 10.1097/PHM.0b013e3182744151; Fu JB, 2017, RETURN PRIMARY ACUTE; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS98, DOI 10.1016/j.apmr.2012.11.051; Hammond FM, 2015, ARCH PHYS MED REHAB, V96; Horwitz LI, 2015, MEASURE UPDATES SPEC; Kennedy P, 2013, SPINAL CORD, V51, P579, DOI 10.1038/sc.2013.27; Mahmoudi E, 2014, ARCH PHYS MED REHAB, V95, P2158, DOI 10.1016/j.apmr.2014.07.399; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P619, DOI 10.1016/S0003-9993(99)90162-4; Medicare Program, 2014, FED REGISTER, V79, P45871; Middleton J, 2007, ARCH PHYS MED REHAB, V88, P1643, DOI 10.1016/j.apmr.2007.09.001; National Spinal Cord Injury Statistical Center, 2017, FACTS FIG GLANC; New PW, 2008, SPINAL CORD, V46, P406, DOI 10.1038/sj.sc.3102152; New PW, 2014, SPINAL CORD, V52, P97, DOI 10.1038/sc.2012.165; New PW, 2016, ARCH PHYS MED REHAB, V97, P380, DOI 10.1016/j.apmr.2015.10.107; New PW, 2015, ARCH PHYS MED REHAB, V96, P1080, DOI 10.1016/j.apmr.2015.02.016; New PW, 2005, ARCH PHYS MED REHAB, V86, P250, DOI 10.1016/j.apmr.2004.04.028; Prasad D, 2005, LANCET ONCOL, V6, P15, DOI 10.1016/S1470-2045(04)01709-7; Pretz CR, 2017, ARCH PHYS MED REHAB, V98, P997, DOI 10.1016/j.apmr.2016.12.012; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schneider JC, 2012, J TRAUMA ACUTE CARE, V73, P1596, DOI 10.1097/TA.0b013e318270d73d; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Scivoletto G, 2011, SPINAL CORD, V49, P391, DOI 10.1038/sc.2010.85; Slocum C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142180; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; van der Putten JMF, 2001, NEUROREHAB NEURAL RE, V15, P99, DOI 10.1177/154596830101500203	36	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.		2018	41	4					444	449		10.1080/10790268.2018.1426235			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GJ8MJ	WOS:000435643600009	29355465	Green Published			2022-02-06	
J	Ross, DE; Seabaugh, J; Cooper, L; Seabaugh, J				Ross, David E.; Seabaugh, John; Cooper, Leah; Seabaugh, Jan			NeuroQuant (R) and NeuroGage (R) reveal effects of traumatic brain injury on brain volume	BRAIN INJURY			English	Article						NeuroQuant; NeuroGage; traumatic brain injury; MRI	OBSTRUCTIVE SLEEP-APNEA; HIPPOCAMPAL ATROPHY; MODERATE; MRI; CONNECTIVITY; METAANALYSIS; IMPULSIVITY; DEPRESSION; SYMPTOMS; PATIENT	This report describes the case of a 58-year-old man with moderate traumatic brain injury (TBI) and pre-accident brain disorders who had multiple persistent neuropsychiatric symptoms. NeuroQuant (R) 2.0 and NeuroGage (R) 2.0 MRI brain volume analyses were used during the chronic stage of injury (>1year after injury) to help understand the effects of the TBI on his brain volume. NeuroQuant (R) showed widespread cross-sectional atrophy, especially in the frontal and temporal lobes, consistent with encephalomalacia seen on the MRIs. Several of his clinical symptoms were consistent with the volume abnormalities. NeuroGage (R) longitudinal analyses of volume change from the time 1 to time 2 magnetic resonance imaging showed abnormally rapid atrophy and ventricular enlargement. The high rates of volume change were much more consistent with the relatively recent effects of TBI than with effects of the much more chronic pre-accident brain disorders.	[Ross, David E.; Seabaugh, John; Cooper, Leah; Seabaugh, Jan] Virginia Inst Neuropsychiat, 364 Browns Hill Court, Midlothian, VA 23114 USA; [Ross, David E.; Seabaugh, John; Cooper, Leah; Seabaugh, Jan] NeuroGage LLC, Midlothian, VA USA; [Ross, David E.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Cooper, Leah] Virginia Polytech Inst & State Univ, Neurosci, Blacksburg, VA 24061 USA		Ross, DE (corresponding author), Virginia Inst Neuropsychiat, 364 Browns Hill Court, Midlothian, VA 23114 USA.	dross@vaneuropsychiatry.org					Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Bigler E.D., 2011, TXB TRAUMATIC BRAIN, P73, DOI DOI 10.1177/1753193410381840; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Cui ZX, 2016, HUM BRAIN MAPP, V37, P1443, DOI 10.1002/hbm.23112; Depping MS, 2016, PROG NEURO-PSYCHOPH, V71, P97, DOI 10.1016/j.pnpbp.2016.06.005; Ebert D, 1996, BIOL PSYCHIAT, V39, P1044, DOI 10.1016/0006-3223(95)00320-7; Ersche KD, 2011, BRAIN, V134, P2013, DOI 10.1093/brain/awr138; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Han KM, 2016, J AFFECT DISORDERS, V194, P21, DOI 10.1016/j.jad.2016.01.019; Izquierdo A, 2017, J NEUROSCI, V37, P10529, DOI 10.1523/JNEUROSCI.1678-17.2017; Kaag AM, 2014, DRUG ALCOHOL DEPEN, V144, P210, DOI 10.1016/j.drugalcdep.2014.09.016; Kaufman DM, 2013, CLIN NEUROLOGY PSYCH; Kril JJ, 1999, PROG NEUROBIOL, V58, P381, DOI 10.1016/S0301-0082(98)00091-4; Kumar R, 2014, NEUROIMAGE-CLIN, V4, P383, DOI 10.1016/j.nicl.2014.01.009; Matsumura Hideaki, 2016, Surg Neurol Int, V7, pS752; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Muller UJ, 2015, EUR ARCH PSY CLIN N, V265, P647, DOI 10.1007/s00406-015-0617-x; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Richlan F, 2013, HUM BRAIN MAPP, V34, P3055, DOI 10.1002/hbm.22127; Ross DE, 2016, NEUROIMAGE, V127, P510, DOI 10.1016/j.neuroimage.2015.11.019; Ross DE, 2015, J NEUROPSYCH CLIN N, V27, P147, DOI 10.1176/appi.neuropsych.13040088; Ross DE, 2014, NEUROIMAGE, V102, P565, DOI 10.1016/j.neuroimage.2014.07.043; Ross DE, 2013, PSYCHOL INJ LAW, V6, P75, DOI 10.1007/s12207-012-9140-9; Ross DE, 2013, BRAIN INJURY, V27, P634, DOI 10.3109/02699052.2013.767939; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2012, J NEUROPSYCH CLIN N, V24, pE33, DOI 10.1176/appi.neuropsych.11020044; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ross DE, 2013, J NEUROPSYCHIATRY CL, V25, P1, DOI DOI 10.1176/appi.neuropsych.12120401; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Terpstra AR, 2017, NEUROREHAB NEURAL RE, V31, P1063, DOI 10.1177/1545968317736817; Wang JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161956; Wang LB, 2016, ADDICT BIOL, V21, P646, DOI 10.1111/adb.12228; Weng HH, 2014, SLEEP, V37, P167, DOI 10.5665/sleep.3330; Ye M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133775; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	37	5	5	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1437	1441		10.1080/02699052.2018.1489980			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000017	29953249				2022-02-06	
S	Rowson, B; Tyson, A; Rowson, S; Duma, S		Hainline, B; Stern, RA		Rowson, Bethany; Tyson, Abigail; Rowson, Steven; Duma, Stefan			Measuring head impacts: accelerometers and other sensors	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							INTRACRANIAL-PRESSURE; INSTRUMENTED MOUTHGUARD; LABORATORY EVALUATION; ACCELERATION; FOOTBALL; SYSTEM; VALIDATION; CONCUSSION; KINEMATICS; EXPOSURE	Understanding the biomechanics of head injuries is essential for the development of preventive strategies and protective equipment design. However, there are many challenges associated with determining the forces that cause injury. Acceleration of the skull is often measured because it is relatively easy to quantify and relates to severity of impact, but it is difficult to relate those measurements to the type and extent of injury that occurs. Experimental work in the laboratory has used either human cadavers or volunteers. Cadavers can be instrumented with high-grade sensors that are tightly coupled to the skull for accurate measurements, but they cannot exhibit a functional response to determine a threshold for brain injury. Volunteers can also be instrumented with high-grade sensors in controlled laboratory experiments, but any head accelerations they experience must be well below an injurious level. Athletes participating in contact sports present a unique opportunity to collect biomechanical data from populations that have increased exposure to head impacts and a higher risk of head injury than the general population. Recent advances in sensor technology have allowed for more accurate measurements from instrumented athletes during play, but it is challenging to tightly couple the instrumentation to the skull to provide meaningful measurements. Because of the challenges associated with on-field measurements, it is important to consider the type of sensor used and its accuracy in the field when evaluating head impact data from athletes.	[Rowson, Bethany; Tyson, Abigail; Rowson, Steven; Duma, Stefan] Virginia Tech, Inst Crit Technol & Appl Sci, Blacksburg, VA USA		Duma, S (corresponding author), Virginia Tech, 410H Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	duma@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	National Collegiate Athletic Association-Department of Defense Grand Alliance research program [R01NS094410]	Some of the research reported in this publication was supported by R01NS094410. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support for data presented was provided by the National Collegiate Athletic Association-Department of Defense Grand Alliance research program.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Anderson B.E., 2015, INT J INSTRUM TECHNO, V1, P282, DOI [10.1504/IJIT.2015.075925, DOI 10.1504/IJIT.2015.075925]; Arbogast KB, 2009, STAPP CAR CRASH JO, V53, P329; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Becker E, 1975, EXPERIMENTALLY VALID; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Clarke TD, 1971, HUMAN HEAD LINEAR AN; Cobb BR, 2017, P I MECH ENG P; Cobb BR, 2014, P I MECH ENG P; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Ewing CL, 1973, TORQUE VERSUS ANGULA; Foreman S, 2014, MECH CONCUSSION SPOR; Foster J.K., 1977, P 21 STAPP CAR CRASH; Funk J. R., 2009, VALIDATION APPL METH; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Hanlon E, 2010, J APPL BIOMECH, V26, P424, DOI 10.1123/jab.26.4.424; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hodgson V, 1972, HEAD MODEL IMPACT; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Lamond L. C., 2016, DIFFERENCES HEAD ACC; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McKendry G, 2017, VALIDATION I1 BIOMET; Mertz HJ, 1985, SAE TECHNICAL PAPER; Mertz HJ, 2015, ACCIDENTAL INJURY; Mertz HJ, 1967, INVESTIGATION KINEMA; Mertz L, 2013, IEEE PULSE, V4, P18, DOI 10.1109/MPUL.2012.2228809; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morrison M., 2015, J BIOSENS BIOELECTRO, V6, P1; Morrison W. E., 1983, CALIBRATION UTILIZAT; Myers B., 2009, SHOCK, V1, P54; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Nevins D, 2016, PROCEDIA ENGINEER, V147, P186, DOI 10.1016/j.proeng.2016.06.211; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; REID SE, 1971, SURG GYNECOL OBSTETR, V133, P929; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Trosseille X, 1992, DEV AFEMOF HUMAN HEA; Ward CC., 1977, INTRACRANIAL PRESSUR; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	71	5	5	0	3	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						235	243		10.1016/B978-0-444-63954-7.00023-9			9	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100025	30482351				2022-02-06	
S	Sajja, VS; Arun, P; Van Albert, SA; Long, JB		Srivastava, AK; Cox, CS		Sajja, Venkatasivasai Sujith; Arun, Peethambaram; Van Albert, Stephen A.; Long, Joseph B.			Rodent Model of Primary Blast-Induced Traumatic Brain Injury: Guidelines to Blast Methodology	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Blast; Primary blast; Characterization; Blast simulator; Guidelines; Traumatic brain injury	EXPOSURE; ABNORMALITIES; NEUROSCIENCE; MECHANISM; NEURONS	Neuropsychological symptoms in warfighters after exposures to blast have triggered considerable research interest in the pathophysiological manifestations of blast-induced traumatic brain injury (bTBI). Preclinical research models of blast are attractive tools to understand the prognosis of behavioral changes, identify relevant biomarkers and characterize the neurobiological underpinnings of blast injury. However, the lack of standardization among preclinical bTBI studies has led to numerous inconsistencies in the data. Inadequate characterization of blast simulators, incomplete understanding and interpretation of blast physics, improper use of animal restraining techniques, and misapplication of biomechanical loading conditions in animal research have led to laboratory results that all-too-often bear little resemblance and relevance to injuries sustained by warfighters. Another major challenge for the bTBI research community is inadequate reporting of methodological conditions such as total pressure, static pressure, positive pressure duration, negative pressure duration, and impulse, to name a few, which has also contributed to ambiguous and sometimes conflicting research outcomes. This report focuses on the requirements for standardization of rodent experimental blast exposure conditions, blast simulator characterization, and guidelines on the dissemination of blast injury research methodology.	[Sajja, Venkatasivasai Sujith; Arun, Peethambaram; Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA; [Van Albert, Stephen A.] Walter Reed Army Inst Res, Geneva Fdn, Silver Spring, MD USA		Sajja, VS (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.		Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501			Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; ADAMS RW, 1951, AM J SURG, V82, P219, DOI 10.1016/0002-9610(51)90346-7; Alphonse Vanessa D, 2014, Biomed Sci Instrum, V50, P248; Arun P, 2015, NEUROSCI LETT, V609, P152, DOI 10.1016/j.neulet.2015.10.036; BEAL SL, 1989, J TRAUMA, V29, P1346, DOI 10.1097/00005373-198910000-00009; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Center for Disease Control, 2013, EXPL BLAST INJ PRIM; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Connolly M, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0080-7; Dewey JM, 2016, MEASUREMENT PHYS PRO, P53; DoD Worldwide Numbers for TBI, 2017, DVBIC STAT; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; FEARNLEY GR, 1945, BMJ-BRIT MED J, V1, P474, DOI 10.1136/bmj.1.4396.474; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; HENRY GA, 1945, LARYNGOSCOPE, V55, P663; HOGE CW, 2008, JAMA-J AM MED ASSOC, V358, P453; Hubbard WB, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5175249; Igra O, 2016, SHOCK TUBES EXPT MET, P3; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; McGraw CM, 2017, AM J MED GENET C, V175, P368, DOI 10.1002/ajmg.c.31570; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Miyazaki H, 2015, ACTA NEUROCHIR, V157, P2111, DOI 10.1007/s00701-015-2613-3; Morrissey E J, 1944, Cal West Med, V61, P196; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Ritzel DV, 2018, SHOCK WAVES, V28, P101, DOI 10.1007/s00193-017-0768-y; Rodriguez O, 2016, J NEUROTRAUM, V33, P662, DOI 10.1089/neu.2015.4002; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VS, 2017, MIL HLTH SYST RES S; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Toklu HZ, 2015, J CEREBR BLOOD F MET, V35, P1950, DOI 10.1038/jcbfm.2015.151; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h	47	5	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						123	138		10.1007/978-1-4939-8564-7_8	10.1007/978-1-4939-8564-7		16	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100010					2022-02-06	
J	Sarac, N; Sarac, B; Pedroza, A; Borchers, J				Sarac, Nikolas; Sarac, Benjamin; Pedroza, Angela; Borchers, James			Epidemiology of mental health conditions in incoming division I collegiate athletes	PHYSICIAN AND SPORTSMEDICINE			English	Article						Psychology; sports; brain concussion; sports medicine; orthopedics; athletics; epidemiology; mental disorders	MAJOR DEPRESSIVE DISORDER; ANXIETY DISORDERS; PHYSICAL-EXERCISE; SYMPTOMS; PREVALENCE; CONCUSSION; INJURY; PAIN; MECHANISMS; PARTICIPATION	Objectives: The purpose of this study is to examine the epidemiology of mental health conditions in incoming American Division I collegiate athletes. Methods: Pre-participation physical questionnaires from 1118 incoming student athletes at a Division I Institution were collected retrospectively from 2011-2017. Data collected included lifetime history of any mental health condition, musculoskeletal injuries, concussions, and post-concussion depression. History of any mental health condition was evaluated by gender and sport played. It was also evaluated in comparison to musculoskeletal injuries and concussions. Results: The lifetime prevalence of any mental health condition was 14.0% for all athletes, 14.2% for male athletes, and 13.6% for female athletes. Individual sports reported a greater prevalence (17.2%) than did team sports (11.8%) (p = 0.010). The prevalence was also higher in contact sports (16.4%) than in non-contact sports (12.5%), although this difference was not statistically significant (p = 0.072). There was a significant association between mental health condition and all four major groups of injuries examined: upper extremity (p = 0.043), lower extremity (p = 0.007), axial skeletal (p < 0.001), and concussions (p = 0.039). Post-concussion depression occurred in 2.0% of all athletes reporting a concussion. Conclusion: The lifetime prevalence of mental health conditions in this population (14.0%) is far less than estimates in the general population. This observation may be due to a combination of factors including exercise/athletic participation mitigating depressive symptoms, competitive selection, and underreporting. History of a mental health condition may be associated with injury, although causation cannot be determined.	[Sarac, Nikolas; Sarac, Benjamin] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Pedroza, Angela; Borchers, James] Ohio State Univ, Dept Sports Med, Columbus, OH 43210 USA		Sarac, N (corresponding author), 99 W Hubbard Ave, Columbus, OH 43215 USA.	nikolas.sarac@osumc.edu			Ohio State University College of Medicine Bennett Research Scholarship	This work was supported in part by The Ohio State University College of Medicine Bennett Research Scholarship.	Auerbach RP, 2016, PSYCHOL MED, V46, P2955, DOI 10.1017/S0033291716001665; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Bar KJ, 2013, EUR ARCH PSY CLIN N, V263, pS205, DOI 10.1007/s00406-013-0458-4; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; BrawmanMintzer O, 1997, J CLIN PSYCHIAT, V58, P16; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Corruble E, 2000, PSYCHOPATHOLOGY, V33, P307, DOI 10.1159/000029163; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Gerrits MMJG, 2015, J PSYCHOSOM RES, V78, P64, DOI 10.1016/j.jpsychores.2014.10.011; Gulliver A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01209; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Halperin JM, 2011, NEUROSCI BIOBEHAV R, V35, P621, DOI 10.1016/j.neubiorev.2010.07.006; Helmerhorst GTT, 2014, J BONE JOINT SURG AM, V96A, P495, DOI 10.2106/JBJS.L.01406; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-091287; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Keyes CLM, 2012, J AM COLL HEALTH, V60, P126, DOI 10.1080/07448481.2011.608393; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; Lin CH, 2014, J AFFECT DISORDERS, V166, P173, DOI 10.1016/j.jad.2014.03.039; Mahoney JW, 2014, J SPORT EXERCISE PSY, V36, P281, DOI 10.1123/jsep.2013-0260; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Mann BJ, 2007, AM J SPORT MED, V35, P2140, DOI 10.1177/0363546507304140; Morgan W, 1985, SELECTED PSYCHOL FAC; National Institute of Mental Health, STATISTICS; Nekovarova T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00099; Nicholl BI, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0350-4; Nixdorf I, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00893; PETRUZZELLO SJ, 1991, SPORTS MED, V11, P143, DOI 10.2165/00007256-199111030-00002; Rice SM, 2016, SPORTS MED, V46, P1333, DOI 10.1007/s40279-016-0492-2; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Sabiston CM, 2016, J SPORT EXERCISE PSY, V38, P105, DOI 10.1123/jsep.2015-0175; Saeed SA, 2010, AM FAM PHYSICIAN, V81, P981; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Scully D, 1998, BRIT J SPORT MED, V32, P111, DOI 10.1136/bjsm.32.2.111; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1002, DOI 10.2174/1871527313666140612102841; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; World Health Organization DoMHaSD, GEND DISP MENT HLTH; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	48	5	5	1	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2018	46	2					242	248		10.1080/00913847.2018.1427412			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	GG3AA	WOS:000432562800012	29322858				2022-02-06	
J	Schwarz, KA; Pfister, R; Buchel, C				Schwarz, Katharina A.; Pfister, Roland; Buechel, Christian			The being a patient effect: negative expectations based on group labeling and corresponding treatment affect patient performance	PSYCHOLOGY HEALTH & MEDICINE			English	Article						Clinical research; expectations; stereotypes; patients	TRAUMATIC BRAIN-INJURY; STEREOTYPE THREAT; DIAGNOSIS THREAT; HEAD-INJURY; COGNITIVE PERFORMANCE; MENTAL ROTATION; MECHANISMS; PLACEBO; POPULATION; BELIEFS	Patient studies provide insights into mechanisms underlying diseases and thus represent a cornerstone of clinical research. In this study, we report evidence that differences between patients and controls might partly be based on expectations generated by the patients' knowledge of being invited and treated as a patient: the Being a Patient effect (BP effect). This finding extends previous neuropsychological reports on diagnosis threat. Participants with mild allergies were addressed either as patients or control subjects in a clinical study. We measured the impact of this group labeling and corresponding instructions on pain perception and cognitive performance. Our results provide evidence that the BP effect can indeed affect physiological and cognitive measures in clinical settings. Importantly, these effects can lead to systematic overestimation of genuine disease effects and should be taken into account when disease effects are investigated. Finally, we propose strategies to avoid or minimize this critical confound.	[Schwarz, Katharina A.; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Schwarz, Katharina A.; Pfister, Roland] Univ Wurzburg, Dept Psychol, Wurzburg, Germany		Schwarz, KA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.; Schwarz, KA (corresponding author), Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	katharina.schwarz@uni-wuerzburg.de	Pfister, Roland/D-6594-2011; Schwarz, Katharina/AAQ-1427-2021	Pfister, Roland/0000-0002-4429-1052; Schwarz, Katharina/0000-0001-8714-790X	ERCEuropean Research Council (ERC)European Commission [ERC-2010-AdG_20100407]; DFGGerman Research Foundation (DFG)European Commission [FOR 1328, SFB 936]	KAS and CB are supported by the ERC [ERC-2010-AdG_20100407]. CB is also supported by the DFG [Research group FOR 1328], [SFB 936]. The sponsors had no role in the design and conduct of the study.	Bandura A., 1997, SELF EFFICACY EXERCI; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Blaine H, 2013, J NEUROTRAUM, V30, P1405, DOI 10.1089/neu.2013.2865; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; Canonica GW, 2008, WORLD ALLERGY ORGAN, V1, P138, DOI 10.1097/WOX.0b013e3181865faf; Cole JC, 2006, J PSYCHOPHARMACOL, V20, P518, DOI 10.1177/0269881105058572; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; CORNBLATT BA, 1989, PSYCHIAT RES, V29, P65, DOI 10.1016/0165-1781(89)90188-1; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kit KA, 2014, J INT NEUROPSYCH SOC, V20, P157, DOI 10.1017/S1355617713001264; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pajares F, 1996, REV EDUC RES, V66, P543, DOI 10.2307/1170653; Peters M, 2008, BRAIN COGNITION, V66, P260, DOI 10.1016/j.bandc.2007.09.003; Pfister R, 2013, ADV COGN PSYCHOL, V9, P74, DOI [10.2478/v10053-008-0133-x, 10.5709/acp-0133-x]; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Schwarz KA, 2016, TRENDS COGN SCI, V20, P469, DOI 10.1016/j.tics.2016.04.001; Schwarz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122051; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; TSUANG MT, 1979, ARCH GEN PSYCHIAT, V36, P1302	27	5	5	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1354-8506	1465-3966		PSYCHOL HEALTH MED	Psychol. Health Med.		2018	23	1					99	105		10.1080/13548506.2017.1332375			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FN1ME	WOS:000415752700010	28537088				2022-02-06	
J	Shahaf, DB; Bar, S; Leiba, R; Dvir, V; Shavit, I				Shahaf, Dana Baron; Bar, Sapir; Leiba, Ronit; Dvir, Vered; Shavit, Itai			Unscheduled adolescents return to the emergency department following acute concussion	BRAIN INJURY			English	Article						Concussion; head injury; adolescent	TRAUMATIC BRAIN-INJURY; PREVALENCE	Objective: Emergency department (ED) visits due to concussion have increased over recent years. We aimed to identify variables associated with unscheduled adolescents return to the ED.Methods: A retrospective cohort study was conducted. All children aged 11 to 18years who were admitted to the ED due to concussion between 2011 and 2016 were included. Multivariable logistic regression was performed to identify predictors of ED return.Results: Overall, 616 adolescents were admitted to the ED due to concussion. Within the first week from discharge, 37/616 (6%) patients returned unscheduled to the ED, 21 (3.4%) during the first 48hours and 16 (2.6%) during the following 3-7days. Age, gender, ethnicity, diagnosis of concussion on first visit and length-of-stay in the ED were not associated with unscheduled ED returns. Variables that were independently associated with increased odds for an unscheduled ED return included two or more symptoms of concussion [odds ratio (OR): 2.81; 95% confidence interval (CI): (1.16-6.82)], bicycle or motor vehicle accident (OR: 3.48; 95% CI: 1.29-9.4), and performance of CT scan on first visit (OR: 2.47; 95% CI: 1.12-5.48).Conclusions: The findings suggest that certain variables on the first ED visit can predict an unscheduled return visit in adolescents.Abbreviations: Emergency department (ED); Length of stay (LOS); computerised tomography (CT)	[Shahaf, Dana Baron; Dvir, Vered] Rambam Hlth Care Campus, Dept Anesthesiol, Haifa, Israel; [Bar, Sapir] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Leiba, Ronit] Rambam Hlth Care Campus, Qual Care Unit, Haifa, Israel; [Shavit, Itai] Rambam Hlth Care Campus, Emergency Dept, Ruth Childrens Hosp, Haifa, Israel		Shavit, I (corresponding author), Hof Hacarmel Reg Council, POB 274, IL-3080500 Kibutz Maayan Tzvi, Israel.	itai@pem-database.org					Akenroye AT, 2014, J HOSP MED, V9, P779, DOI 10.1002/jhm.2273; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Graham R, 2013, SPORTS RELATED CONCU; Israel Ministry of Health, 2014, APPR PED MIN HEAD IN; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; LERMAN B, 1987, Journal of Emergency Medicine, V5, P359, DOI 10.1016/0736-4679(87)90138-7; Rosen B, 2015, HEALT SYST TRANSIT, V17, P1; Sannuel N, 2015, BRAIN INJURY, V29, P946, DOI 10.3109/02699052.2015.1017005; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	17	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	3					331	334		10.1080/02699052.2018.1425914			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FU3PV	WOS:000423764700007	29341786				2022-02-06	
S	Shanks, S; Leisman, G		Pokorski, M		Shanks, Steven; Leisman, Gerry			Perspective on Broad-Acting Clinical Physiological Effects of Photobiomodulation	REHABILITATION SCIENCE IN CONTEXT	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Cold laser; Laser therapy; Lipolysis; Neurodegeneration; Onychomycosis; Pain; Photobiomodulation; Photobiostimulation; Stroke	LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; LIGHT THERAPY; 2-PHOTON ABSORPTION; NEUROPATHIC PAIN; ISCHEMIC-STROKE; HUMAN BLOOD; C-OXIDASE; RAT MODEL; IN-VITRO	Research into photobiomodulation reveals beneficial effects of light therapy for a rapidly expanding list of medical conditions and illnesses. Although it has become more widely accepted by the mainstream medicine, the effects and mechanisms of action appear to be poorly understood. The therapeutic benefits of photobiomodulation using low-energy red lasers extend far beyond superficial applications, with a well-described physics allowing an understanding of how red lasers of certain optimum intensities may cross the cranium. We now have a model for explaining potential therapeusis for applications in functional neurology that include stroke, traumatic brain injury, and neurodegenerative conditions in addition to the currently approved functions in lipolysis, in onychomycosis treatment, and in pain management.	[Shanks, Steven] Erchonia Corp, Melbourne, FL USA; [Leisman, Gerry] Univ Haifa, Fac Hlth Sci, Haifa, Israel; [Leisman, Gerry] Natl Inst Brain & Rehabil Sci, Nazareth, Israel		Leisman, G (corresponding author), Univ Haifa, Fac Hlth Sci, Haifa, Israel.; Leisman, G (corresponding author), Natl Inst Brain & Rehabil Sci, Nazareth, Israel.	g.leisman@alumni.manchester.ac.uk	Leisman, Gerry/U-3267-2019	Leisman, Gerry/0000-0002-9975-7331			Adamskaya N, 2011, INJURY, V42, P917, DOI 10.1016/j.injury.2010.03.023; Anders JJ, 2015, PHOTOMED LASER SURG, V33, P183, DOI 10.1089/pho.2015.9848; ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297; Aragona S E, 2017, J Biol Regul Homeost Agents, V31, P213; Arany PR, 2016, J DENT RES, V95, P977, DOI 10.1177/0022034516648939; Avci P, 2014, LASER SURG MED, V46, P144, DOI 10.1002/lsm.22170; Avci P, 2013, SEMIN CUTAN MED SURG, V32, P41; Avram MM, 2009, LASER SURG MED, V41, P703, DOI 10.1002/lsm.20864; Basso Fernanda G., 2011, Braz. Dent. J., V22, P502, DOI 10.1590/S0103-64402011000600011; Berman Marvin H, 2017, J Neurol Neurosci, V8, DOI 10.21767/2171-6625.1000176; Biermann K, 2010, PROSTATE, V70, P1196, DOI 10.1002/pros.21154; Bjordal JM, 2011, SUPPORT CARE CANCER, V19, P1069, DOI 10.1007/s00520-011-1202-0; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; Burger E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003541; Burks SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024730; Carney C, 2013, J AM ACAD DERMATOL, V69, P578, DOI 10.1016/j.jaad.2013.04.054; Carroll J, 2015, J ORTHOP RHEUMATOL, V2, DOI [10.15406/mojor.2015.02.00068, DOI 10.15406/MOJOR.2015.02.00068]; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; de Oliveira VLC, 2017, LASER MED SCI, V32, P87, DOI 10.1007/s10103-016-2089-2; Cerdeira CD, 2016, J BIOPHOTONICS, V9, P1180, DOI 10.1002/jbio.201600035; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; de Lima FM, 2014, J LASERS MED SCI, V5, P63; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Farivar S, 2014, J LASERS MED SCI, V5, P58; Gross Anita R, 2013, Open Orthop J, V7, P396, DOI 10.2174/1874325001307010396; Grover F, 2017, PHOTOMED LASER SURG, V35, P136, DOI 10.1089/pho.2015.4036; Prianti ACG, 2014, LASER MED SCI, V29, P1397, DOI 10.1007/s10103-014-1543-2; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hanczyc P, 2012, DALTON T, V41, P3123, DOI 10.1039/c2dt12264b; HARRIS SE, 1990, PHYS REV LETT, V64, P1107, DOI 10.1103/PhysRevLett.64.1107; Hawkins DH, 2006, LASER SURG MED, V38, P74, DOI 10.1002/lsm.20271; Heidari M, 2017, J PHOTOCH PHOTOBIO B, V172, P109, DOI 10.1016/j.jphotobiol.2017.05.022; Helou J, 2016, MYCOSES, V59, P7, DOI 10.1111/myc.12425; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holanda VM, 2017, LASER SURG MED, V49, P516, DOI 10.1002/lsm.22628; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hsieh YL, 2014, PHOTOMED LASER SURG, V32, P669, DOI 10.1089/pho.2014.3821; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Huang ZY, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0882-0; Ip D, 2015, J PAIN RES, V8, P247, DOI 10.2147/JPR.S84376; Jackson RF, 2013, LASER SURG MED, V45, P141, DOI 10.1002/lsm.22119; Jackson RF, 2012, LASER SURG MED, V44, P211, DOI 10.1002/lsm.22007; Jackson RF, 2009, LASER SURG MED, V41, P799, DOI 10.1002/lsm.20855; Jacskon RF, 2010, AM J COSMETIC SURG, V27, P177; Janzadeh A, 2016, LASER MED SCI, V31, P1863, DOI 10.1007/s10103-016-2062-0; KARU TI, 1995, DOKL AKAD NAUK+, V342, P693; Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; Kuffler DP, 2016, REGEN MED, V11, P107, DOI 10.2217/rme.15.82; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Litscher D, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/575798; Lu S, 2016, ANN DERMATOL, V28, P406, DOI 10.5021/ad.2016.28.3.406; Luo Y, 2000, J PHYS CHEM A, V104, P4718, DOI 10.1021/jp9938031; Maksimovich IV, 2016, BRAIN, V5; Martins DF, 2016, NEUROSCIENCE, V324, P485, DOI 10.1016/j.neuroscience.2016.03.035; Maver-Biscanin M, 2005, PHOTOMED LASER SURG, V23, P328, DOI 10.1089/pho.2005.23.328; McRae E, 2013, LASER SURG MED, V45, P1, DOI 10.1002/lsm.22113; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; MESTER E, 1971, Radiobiologia Radiotherapia, V12, P377; Mi XQ, 2004, PHOTOMED LASER SURG, V22, P477, DOI 10.1089/pho.2004.22.477; Mi XQ, 2004, J PHOTOCH PHOTOBIO B, V74, P7, DOI 10.1016/j.jphotobiol.2004.01.003; Moges H, 2011, LASER SURG MED, V43, P901, DOI 10.1002/lsm.21117; Moon SH, 2014, J COSMET LASER THER, V16, P165, DOI 10.3109/14764172.2014.910082; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Moro C, 2014, J NEUROSURG, V120, P670, DOI 10.3171/2013.9.JNS13423; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Neira R, 2002, PLAST RECONSTR SURG, V110, P912, DOI 10.1097/01.PRS.0000019876.96703.AE; Nenoff P, 2014, J DTSCH DERMATOL GES, V12, P33, DOI 10.1111/ddg.12251; Nestor Mark S, 2012, J Clin Aesthet Dermatol, V5, P42; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Noguchi Hiromitsu, 2013, Med Mycol J, V54, P333, DOI 10.3314/mmj.54.333; Olesiak-Banska J, 2012, CHEM PHYS, V404, P33, DOI 10.1016/j.chemphys.2012.02.001; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Paasch U, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.018001; Paasch U, 2013, INT J HYPERTHER, V29, P544, DOI 10.3109/02656736.2013.823672; Pereira FC, 2017, LASER SURG MED, V49, P844, DOI 10.1002/lsm.22696; Perez-Moreno J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2834198; de Sousa MVP, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.015003; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Roche GC, 2016, FUNCT NEUROL REHABIL, V6, P97; Roche GC, 2017, PHOTOMED LASER SURG, V35, P142, DOI 10.1089/pho.2016.4172; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Rushdi TA, 2010, EJCTA, V4, P95; Salehpour F, 2017, REV NEUROSCIENCE, V28, P441, DOI 10.1515/revneuro-2016-0087; Santana-Blank L, 2016, PHOTOMED LASER SURG, V34, P93, DOI 10.1089/pho.2015.4015; Scherman M, 2012, OPT EXPRESS, V20, P4346, DOI 10.1364/OE.20.004346; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Scwingel AR, 2012, PHOTOMED LASER SURG, V30, P429, DOI 10.1089/pho.2012.3225; Seyedmousavi S, 2014, PHOTOMED LASER SURG, V32, P322, DOI 10.1089/pho.2012.3387; Shaw VE, 2010, J COMP NEUROL, V518, P25, DOI 10.1002/cne.22207; Solarte E, 2003, P SOC PHOTO-OPT INS, V4829, P994, DOI 10.1117/12.527513; Solmaz H, 2017, LASER MED SCI, V32, P903, DOI 10.1007/s10103-017-2191-0; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Suarez DP, 2014, AM J COSMET SURG, V31, P34; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Takahashi Hiroshi, 2012, Laser Ther, V21, P193, DOI 10.5978/islsm.12-OR-10; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Thornfeldt Carl R, 2016, J Clin Aesthet Dermatol, V9, P31; Wang LN, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/630361; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30540; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Yadav A, 2017, PHOTODERMATOL PHOTO, V33, P4, DOI 10.1111/phpp.12282; Zang Kerry, 2017, J Clin Aesthet Dermatol, V10, P24; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	112	5	6	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-95708-1; 978-3-319-95707-4	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2018	1096						41	52		10.1007/5584_2018_188	10.1007/978-3-319-95708-1		12	Biology; Medicine, Research & Experimental; Neurosciences	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine; Neurosciences & Neurology	BL9PH	WOS:000457990600005	29572678				2022-02-06	
J	Silva, MA; Belanger, HG; Dams-O'Connor, K; Tang, XY; McKenzie-Hartman, T; Nakase-Richardson, R				Silva, Marc A.; Belanger, Heather G.; Dams-O'Connor, Kristen; Tang, Xinyu; McKenzie-Hartman, Tamara; Nakase-Richardson, Risa			Prevalence and predictors of tobacco smoking in veterans and service members following traumatic brain injury rehabilitation: a VA TBIMS study	BRAIN INJURY			English	Article						Brain Injuries; Traumatic; tobacco smoking; military personnel; veterans	DISABILITY RATING-SCALE; FUNCTIONAL INDEPENDENCE MEASURE; RANDOMIZED CONTROLLED-TRIAL; CURRENT CIGARETTE-SMOKING; LONG-TERM CONSEQUENCES; PRACTICAL SCALE; US VETERANS; HEAD-INJURY; ALCOHOL-USE; CESSATION	Objective: To identify prevalence and predictors of tobacco smoking among veterans and military service members (V/SM) with traumatic brain injury (TBI) admitted for rehabilitation.Methods: Participants were drawn from the VA TBI Model Systems multicentre longitudinal research study. Tobacco smoking was assessed both preinjury and at 1- or 2-year post-TBI follow-up for 336 participants.Results: Smoking prevalence was 32% preinjury and 28% at follow-up. Most participants had a stable smoking pattern but 12% of preinjury non-smokers became smokers at follow-up. Preinjury smoking was the strongest predictor of post-TBI smoking. Higher cognitive function also predicted smoking at follow-up. In univariate analyses, smoking was predicted by lower education, preinjury mental health (MH) history, selected TBI severity metrics, and higher functional status at rehabilitation hospital discharge (Disability Rating Scale [DRS] and motor subscale of the Functional Independence Measure [FIM]).Conclusion: Study findings may help clinicians and administrators recognize who is at high risk for smoking following TBI, to plan for in-hospital and postdischarge screening and interventions.	[Silva, Marc A.; Belanger, Heather G.; Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBSS, Tampa, FL 33612 USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Silva, Marc A.; Belanger, Heather G.; McKenzie-Hartman, Tamara; Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr DVBIC Tampa, Tampa, FL USA; [Silva, Marc A.; Belanger, Heather G.; Nakase-Richardson, Risa] Ctr Innovat Disabil & Rehabil Res CINDRR, Hlth Serv Res & Dev Serv HSR, Tampa, FL USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Dams-O'Connor, Kristen] Brain Injury Res Ctr Mt Sinai, New York, NY USA; [Tang, Xinyu] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL USA		Silva, MA (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd 116B, Tampa, FL 33612 USA.	marc.silva1@va.gov	Silva, Marc A./J-1874-2019	Silva, Marc A./0000-0002-3879-6054	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services, National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR); VHA Central Office VA TBI Model System Program of Research; General Dynamics Information Technology (GDIT)/General Dynamics Health Solutions (GDHS) from the Defense and Veterans Brain Injury Center (DVBIC), Defense Health Agency (DHA) [W91YTZ-13-C-0015]; U.S. Department of Defense Congressionally Directed Medical Research Programs	The VA Polytrauma Rehabilitation Center Traumatic Brain Injury Model Systems is a funded collaboration between the Department of Veterans Affairs and the Department of Health and Human Services, National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Information Technology (GDIT)/General Dynamics Health Solutions (GDHS) [W91YTZ-13-C-0015] from the Defense and Veterans Brain Injury Center (DVBIC), Defense Health Agency (DHA), and U.S. Department of Defense Congressionally Directed Medical Research Programs. This research was conducted with resources and the use of facilities at the James A. Haley Veterans' Hospital.	Ames Genevieve M, 2002, Prev Sci, V3, P135, DOI 10.1023/A:1015435401380; Bastian LA, 2016, GERONTOLOGIST, V56, pS102, DOI 10.1093/geront/gnv664; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Brown DW, 2010, J GEN INTERN MED, V25, P147, DOI 10.1007/s11606-009-1160-0; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Cypel YS, 2016, PUBLIC HEALTH REP, V131, P714, DOI 10.1177/0033354916664864; Department of Veterans Affairs, 2012, 2011 SURV VET ENR HL; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Duffy SA, 2010, PREV MED, V50, P285, DOI 10.1016/j.ypmed.2010.01.012; Duffy SA, 2008, APPL NURS RES, V21, P199, DOI 10.1016/j.apnr.2006.11.002; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Durazzo TC, 2010, INT J ENV RES PUB HE, V7, P3760, DOI 10.3390/ijerph7103760; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gfroerer J, 2013, MMWR-MORBID MORTAL W, V62, P81; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Institute of Medicine, 2009, COMB TOB MIL VET POP; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Masel B., 2014, UNDERSTANDING TRAUMA, P28; McFall M, 2010, JAMA-J AM MED ASSOC, V304, P2485, DOI 10.1001/jama.2010.1769; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ostberg A, 2014, BRAIN INJURY, V28, P155, DOI 10.3109/02699052.2013.860468; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reed MB, 2007, ADDICT BEHAV, V32, P449, DOI 10.1016/j.addbeh.2006.05.016; Rigotti NA, 2008, ARCH INTERN MED, V168, P1950, DOI 10.1001/archinte.168.18.1950; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; TEASDALE G, 1974, LANCET, V2, P81; U.S. Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; US Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE	42	5	5	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		994	999		10.1080/02699052.2018.1468576			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400006	29708447				2022-02-06	
J	Smith, ME; Eskandari, R				Smith, Michael E.; Eskandari, Ramin			A novel technology to model pressure-induced cellular injuries in the brain	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Hydrocephalus; Traumatic brain injury; Pressure injury; 3D model; Engineered neural tissue	INTRACEREBRAL HEMORRHAGE; HYDROCEPHALUS; RECOVERY; NEURONS; SURGERY; SYSTEM	Background: Elevated intracranial pressure (ICP) accompanying a number of neurological emergencies is poorly understood, and lacks a model to determine cellular pathophysiology. This limits our ability to identify cellular and molecular biomarkers associated with the pathological progression from physiologic to pathologic ICP. New method: We developed an ex vivo model of pressure-induced brain injury, which combines 3D neural cell cultures and a newly developed Pressure Controlled Cell Culture Incubator ((PCI)-I-3). Human astrocytes and neurons maintained in 3D peptide-conjugated alginate hydrogels were subjected to pressures that mimic both physiologic and pathologic levels of ICP for up to 48 h to evaluate the earliest impacts of isolated pressure on cellular viability and quantify early indicators of pressure-induced cellular injury. Results: Compared to control cell cultures grown under physiologic pressure, sustained pathologic pressure exposure increased the release of intracellular ATP in a cell-specific manner. Eighteen hours of sustained pressure resulted in increased ATP release from neurons but not astrocytes. Comparison with existing methods: Cell culture incubators maintain cultures at normal atmospheric pressure. Based on multiple literature searches, we are not aware of any other cell culture incubator systems that modify the pressure at which primary CNS cells are maintained. Conclusion: This model simulates the clinical features of elevated ICP encountered in patients with hydrocephalus, and provides a first estimate of the pathological signaling encountered during the earliest perid of progression in neonatal hydrocephalus. This model should provide a means to better understand the pathological biomarkers associated with the earliest stages of elevated ICP. (C) 2017 Elsevier B.V. All rights reserved.	[Smith, Michael E.; Eskandari, Ramin] Med Univ South Carolina, Dept Neurosurg, Charleston, SC 29425 USA; [Eskandari, Ramin] Med Univ South Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA		Eskandari, R (corresponding author), Dept Neurosurg, 96 Jonathan Luas St,301 CSB,MSC 606, Charleston, SC 29425 USA.	eskandar@musc.edu			Department of Neurosurgey; MUSC Neuroscience Institute	We would like to acknowledge financial support from the Department of Neurosurgey, and MUSC Neuroscience Institute Pilot Project funding.	Aojula A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0033-2; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barbiro-Michaely E, 2003, NEUROL RES, V25, P42, DOI 10.1179/016164103101201102; Chavez-Valdez R, 2016, INT J DEV NEUROSCI, V48, P58, DOI 10.1016/j.ijdevneu.2015.11.007; Cotte J, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; Dengler J, 2016, CEREBROVASC DIS, V41, P187, DOI 10.1159/000443485; Harris C, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0023-9; Hertz-Pannier L, 2002, BRAIN, V125, P361, DOI 10.1093/brain/awf020; Huber KBG, 2016, CURR PHARM DESIGN, V22, P2072, DOI 10.2174/1381612822666160127113631; Kestle JRW, 2016, J NEUROSURG-PEDIATR, V17, P391, DOI 10.3171/2015.8.PEDS15253; Morgan T, 2008, ACTA NEUROCHIR SUPPL, V105, P147; Nalayanda DD, 2013, INTEGR BIOL-UK, V5, P1141, DOI 10.1039/c3ib40037a; Ortega E, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0566-7; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; ROBERTSON JS, 1973, BMJ-BRIT MED J, V2, P289, DOI 10.1136/bmj.2.5861.289; Rodrigues RJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00148; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Siddique MS, 2000, BRIT MED BULL, V56, P444, DOI 10.1258/0007142001903085; STRANDGAS, 1973, BMJ-BRIT MED J, V1, P507, DOI DOI 10.1007/S00134-016-4249-Z; VENES JL, 1979, CHILD BRAIN, V5, P45; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115; Yoneshige A., 2016, MOL NEUROBIOL; Zakhvataev VE, 2016, MED HYPOTHESES, V90, P57, DOI 10.1016/j.mehy.2016.03.008; Zhao YL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4706915	26	5	5	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 1	2018	293						247	253		10.1016/j.jneumeth.2017.10.004			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FQ2TP	WOS:000418211200028	28993205				2022-02-06	
J	Stockbridge, MD; Doran, A; King, K; Newman, RS				Stockbridge, Melissa D.; Doran, Anthony; King, Kristin; Newman, Rochelle S.			The effects of concussion on rapid picture naming in children	BRAIN INJURY			English	Article						Brain injury; language	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; SPORTS-RELATED CONCUSSION; WORD RETRIEVAL; PHONOTACTIC PROBABILITY; LEXICAL FACTORS; MILD; RECOVERY; IMPACT; PLASTICITY	Primary Objective: The purpose of this investigation was to examine children's accuracy and speed when asked to name rapidly images following a concussion. The authors predicted that children with a recent concussion would not differ in accuracy from peers, but would be slower.Research Design: Children with and without a recent concussion were compared on their accuracy and speed of naming objects, and speed was correlated with time since injury.Methods and Procedures: Fifty-eight participants, aged 10-22years, 32 within one month of concussion and 26 age-matched participants with no history of concussion, rapidly viewed and verbally named 107 illustrations of common objects, and sensitive measures of response time were recorded.Main Outcomes and Results: Groups did not differ in rate of accuracy, but children with recent injury responded significantly more slowly. A trajectory of recovery was calculated, providing qualified evidence for a longer timeline of recovery than the typical two-week period.Conclusions: These findings affirm the presence of this naming latency effect in children, explore the duration of this effect over the course of recovery, and add nuance to inconsistently reported chronic naming deficits following concussion, informing recommendations for return to full academic and recreational participation.	[Stockbridge, Melissa D.; Newman, Rochelle S.] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA; [Doran, Anthony] HeadFirst Sports Injury & Concuss Care, Waugh Chapel, MD USA; [King, Kristin] Passy Muir Inc, Irvine, CA USA		Stockbridge, MD (corresponding author), Univ Maryland, Language Dev & Percept Labs, Dept Hearing & Speech Sci, 0100 Samuel J LeFrak Hall,7251 Preinkert Dr, College Pk, MD 20742 USA.	mdstock@umd.edu	Stockbridge, Melissa/AAP-7382-2020; Newman, Rochelle/AAA-3185-2019	Stockbridge, Melissa/0000-0001-9069-1236; Newman, Rochelle/0000-0002-1626-4241			Allensworth E.M., 2005, ON TRACK INDICATOR P; ARAM DM, 1994, NEUROPSYCHOLOGIA, V32, P85, DOI 10.1016/0028-3932(94)90071-X; Asarnow R, 1995, TRAUMATIC BRAIN INJU, P117; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cochran W. G., 1957, EXPT DESIGNS, V2nd; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Forsythe A, 2017, BEHAV RES METHODS, V49, P1484, DOI 10.3758/s13428-016-0808-z; Fratantoni JM, 2017, J NEUROTRAUM, V34, P1017, DOI 10.1089/neu.2016.4651; Ganguly K, 2013, NEURON, V80, P729, DOI 10.1016/j.neuron.2013.10.028; German DI, 2004, J SPEECH LANG HEAR R, V47, P624, DOI 10.1044/1092-4388(2004/048); Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gottfried MA, 2010, AM EDUC RES J, V47, P434, DOI 10.3102/0002831209350494; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hough MS, 2008, APHASIOLOGY, V22, P644, DOI 10.1080/02687030701541024; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; JUSCZYK PW, 1994, J MEM LANG, V33, P630, DOI 10.1006/jmla.1994.1030; Kieffer MJ, 2014, J SCHOOL PSYCHOL, V52, P549, DOI 10.1016/j.jsp.2014.09.002; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Newman RS, 2018, COMMUN DISORD Q, V39, P356, DOI 10.1177/1525740117712205; Newman RS, 2002, LANG SPEECH, V45, P285, DOI 10.1177/00238309020450030401; Nusbaum H. C., 1984, RES SPEECH PERCEPTIO, V10, P357; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; PLUNKETT Kim, 1998, RETHINKING INNATENES; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ratner NB, 2009, J FLUENCY DISORD, V34, P225, DOI 10.1016/j.jfludis.2009.09.005; Rogers JM, 2015, BRAIN INJURY, V29, P343, DOI 10.3109/02699052.2014.976273; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Storkel H, 2004, J SPEECH LANG HEAR R, V47, P1454, DOI 10.1044/1092-4388(2004/108); Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vitevitch MS, 2004, BEHAV RES METH INS C, V36, P481, DOI 10.3758/BF03195594; Vitevitch MS, 2002, J EXP PSYCHOL HUMAN, V28, P270, DOI 10.1037//0096-1523.28.2.270; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	85	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					506	514		10.1080/02699052.2018.1429660			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400015	29388844				2022-02-06	
J	Stubbs, E; Togher, L; Kenny, B; Fromm, D; Forbes, M; MacWhinney, B; McDonald, S; Tate, R; Turkstra, L; Power, E				Stubbs, Elin; Togher, Leanne; Kenny, Belinda; Fromm, Davida; Forbes, Margaret; MacWhinney, Brian; McDonald, Skye; Tate, Robyn; Turkstra, Lyn; Power, Emma			Procedural discourse performance in adults with severe traumatic brain injury at 3 and 6 months post injury	BRAIN INJURY			English	Article						Linguistic productivity; macrostructure; communication; recovery; follow-up; discourse	CLOSED-HEAD-INJURY; TROBE COMMUNICATION QUESTIONNAIRE; NARRATIVE DISCOURSE; FOLLOW-UP; VERBAL IMPAIRMENT; DEFICITS; EPIDEMIOLOGY; RECOVERY; COHESION; LANGUAGE	Background: There is limited research on communicative recovery during the early stages after a severe traumatic brain injury (TBI) in adults. Methods and procedures: In the current study 43 people with severe TBI described a simple procedure at 3 and 6 months post injury and this was compared to the description provided by 37 healthy speakers. Linguistic productivity and the presence of macrostructural discourse elements were analysed. Main outcomes and results: No change occurred in productivity in the TBI group between the two time points. There was increased use of relevant information (macrostructure) over time for the TBI group, reflecting improvement. People with TBI differed from controls in speech rate and in two out of three macrostructural categories at both time points, indicating difficulties even after 12 weeks of recovery. Conclusions: Overall, the quality, rather than the quantity of discourse was disordered for participants with TBI. Findings indicate that procedural discourse is sensitive to discourse deficits of people with TBI and can be used to map recovery during the sub-acute phase.	[Stubbs, Elin] Karolinska Inst, Discipline Speech Pathol, Stockholm, Sweden; [Togher, Leanne; Kenny, Belinda; Power, Emma] Univ Sydney, Discipline Speech Pathol, Sydney, NSW, Australia; [Fromm, Davida; Forbes, Margaret; MacWhinney, Brian] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Togher, Leanne; Kenny, Belinda; McDonald, Skye; Tate, Robyn; Power, Emma] NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Fac Med, Sydney, NSW, Australia; [Turkstra, Lyn] Univ Wisconsin, Dept Commun Disorders, Madison, WI USA		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Cumberland Campus, Sydney, NSW 2141, Australia.	Leanne.togher@sydney.edu.au	Turkstra, Lyn/ABC-5831-2021; Togher, Leanne/AAC-7083-2019; McDonald, Skye/G-4118-2014; Power, Emma/A-9263-2015	McDonald, Skye/0000-0003-0723-6094; Turkstra, Lyn/0000-0002-6948-6921; Power, Emma/0000-0002-2638-0406; Togher, Leanne/0000-0002-4518-6748			[Anonymous], 2007, APHASIABANK REPETITI; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; COPPENS P, 1995, BRAIN INJURY, V9, P195, DOI 10.3109/02699059509008192; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Eggins S, 1994, INTRO SYSTEMIC FUNCT, P25; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Ellis C, 2005, J REHABIL RES DEV, V42, P737, DOI 10.1682/JRRD.2005.02.0026; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Enderby P., 2008, FRENCHAY DYSARTHRIA; Field AP., 2013, DISCOVERING STAT USI, P40; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HUNT KW, 1970, MONOGR SOC RES CHILD, V35, P1; Joyce H., 1992, WORKPLACE TEXTS LANG, P53; Kaplan E., 2001, BOSTON NAMING TEST; Kertesz A., 1982, W APHASIA BATTERY WA; Kertesz A., 2006, W APHASIA BATTERY RE; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McDonlad S, 2013, SOCIAL COMMUNICATION, P26; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Naugle RI, 1990, TRAUMATIC BRAIN INJU, P69; NSW Department of School Education, 1989, BRIEF INTR GENR; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Shadden B., 1998, ANAL DISCOURSE COMMU, P9; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson CK, NW ASSESSMENT UNPUB; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; ULATOWSKA HK, 1983, BRAIN LANG, V18, P315, DOI 10.1016/0093-934X(83)90023-8; WHO, 1992, INT STAT CLASS DIS R; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	52	5	5	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					167	181		10.1080/02699052.2017.1291989			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600003	29281420				2022-02-06	
J	Sullivan, EG; Guernon, A; Blabas, B; Herrold, AA; Pape, TLB				Sullivan, Emily Galassi; Guernon, Ann; Blabas, Brett; Herrold, Amy A.; Pape, Theresa L. -B.			Familiar auditory sensory training in chronic traumatic brain injury: a case study	DISABILITY AND REHABILITATION			English	Article						Brain injury; vegetative state; comatose; minimally conscious; unresponsive wakefulness syndrome; familiar voice stimulation; passive sensory stimulation	PERSISTENT VEGETATIVE STATE; MINIMALLY CONSCIOUS STATE; EVOKED POTENTIALS; HEAD-INJURY; DISORDERS; RECOVERY; COMA; SCALE; REHABILITATION; OUTCOMES	Purpose: The evaluation and treatment for patients with prolonged periods of seriously impaired consciousness following traumatic brain injury (TBI), such as a vegetative or minimally conscious state, poses considerable challenges, particularly in the chronic phases of recovery. Method: This blinded crossover study explored the effects of familiar auditory sensory training (FAST) compared with a sham stimulation in a patient seven years post severe TBI. Baseline data were collected over 4 weeks to account for variability in status with neurobehavioral measures, including the Disorders of Consciousness scale (DOCS), Coma Near Coma scale (CNC), and Consciousness Screening Algorithm. Pre-stimulation neurophysiological assessments were completed as well, namely Brainstem Auditory Evoked Potentials (BAEP) and Somatosensory Evoked Potentials (SSEP). Results: Results revealed that a significant improvement in the DOCS neurobehavioral findings after FAST, which was not maintained during the sham. BAEP findings also improved with maintenance of these improvements following sham stimulation as evidenced by repeat testing. Conclusions: The results emphasize the importance for continued evaluation and treatment of individuals in chronic states of seriously impaired consciousness with a variety of tools. Further study of auditory stimulation as a passive treatment paradigm for this population is warranted.	[Sullivan, Emily Galassi] Edward Hines Jr Hosp, Phys Med & Rehabil Serv, Hines, IL USA; [Guernon, Ann] Marianjoy Rehabil Hosp, Northwestern Med, Dept Res, Wheaton, IL USA; [Guernon, Ann; Blabas, Brett; Herrold, Amy A.; Pape, Theresa L. -B.] Edward Hines Jr VA Hosp Hines IL, Res Serv, Hines, IL USA; [Herrold, Amy A.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Pape, Theresa L. -B.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Sullivan, EG (corresponding author), 1812 S Fairview Ave,Pk Ridge, Park Ridge, IL 60068 USA.	Emily.Sullivan1@va.gov		Bender Pape, Theresa/0000-0001-7738-5963	VA Office of Research and Development, Rehabilitation Research and Development Service (RRD Grant) [4951]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER	This project was funded, in part, by VA Office of Research and Development, Rehabilitation Research and Development Service (RR&D Grant # 4951).	Abbate Carlo, 2014, Front Hum Neurosci, V8, P616, DOI 10.3389/fnhum.2014.00616; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Carlson K, 2009, ASSESSMENT TREATMENT; Chiappa Keith H., 1997, P199; Claassen J, 2001, CRIT CARE MED, V29, P494, DOI 10.1097/00003246-200103000-00005; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199708000-00003; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Klingshirn H, 2015, J REHABIL MED, V47, P577, DOI 10.2340/16501977-1983; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lew HL, 2004, AM J PHYS MED REHAB, V83, P210, DOI 10.1097/01.PHM.0000113402.85460.59; Lotze M, 2011, J REHABIL MED, V43, P230, DOI 10.2340/16501977-0653; Mallinson T, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000184; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Moritz CH, 2001, MAGN RESON IMAGING, V19, P1129, DOI 10.1016/S0730-725X(01)00432-5; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Pape TLB, 2014, ARCH PHYS MED REHAB, V95, P1672, DOI 10.1016/j.apmr.2014.04.015; Pape TLB, 2012, J REHABIL RES DEV, V49, P1137, DOI 10.1682/JRRD.2011.08.0154; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Passmore Steven R, 2014, J Can Chiropr Assoc, V58, P170; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schnakers C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00297; SCHWENDER D, 1994, ANESTHESIOLOGY, V80, P493, DOI 10.1097/00000542-199403000-00004; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sun J, 2015, EUR REV MED PHARMACO, V19, P1209; von Kriegstein K, 2003, COGNITIVE BRAIN RES, V17, P48, DOI 10.1016/S0926-6410(03)00079-X; Walker AJ, 2010, AUST PSYCHOL, V45, P112, DOI 10.1080/00050060903428210; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020	37	5	5	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	8					945	951		10.1080/09638288.2016.1277403			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FY5YB	WOS:000426913400010	28102097				2022-02-06	
J	Sullivan, L; Molcho, M				Sullivan, Lindsay; Molcho, Michal			What do coaches want to know about sports-related concussion? A needs assessment study	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Coaches; Concussion; Concussion education; GAA; Mild traumatic brain injury; Needs assessment	CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL PLAYERS; US COLLEGIATE SPORT; HIGH-SCHOOL; RECURRENT CONCUSSION; GAELIC FOOTBALL; NCAA CONCUSSION; HEAD-INJURY; EDUCATION; KNOWLEDGE	Purpose: This study aims to identify the concussion-related training and education needs of Gaelic Athletic Association (GAA) coaches in Ireland, as well as the preferred method of concussion education delivery. Methods: We used a self-report questionnaire to collect data from a convenience sample of 108 GAA coaches in Ireland. Data were captured on (1) informational needs and desires, (2) preferred methods of delivery, and (3) concussion practices and procedures. Questionnaires were completed electronically from June 3rd-September 29th, 2015. Results: Coaches indicated that they were most interested in receiving information about the (1) signs and symptoms of concussion, (2) assessment of concussion, and (3) return-to-play guidelines. Over two-thirds of participants indicated that in-person training would be the most effective mode of delivery of concussion education for this population. Additionally, only 10% coaches reported that before the start of the season they talked to their athletes about concussion management and safety, and this was more common among coaches who reported being formally educated about concussion. Conclusion: Our findings reveal a disconnect between the concussion education needs and the education that is currently provided to GAA coaches, in terms of content and delivery modality. Our results suggest a need for a multifaceted approach to concussion education, tailored to the needs and learning preferences of the target population. (C) 2018 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport.	[Sullivan, Lindsay] NUI Galway, Sch Hlth Sci, Discipline Hlth Promot, Galway, Ireland; [Molcho, Michal] NUI Galway, Sch Arts Social Sci & Celt Studies, Childrens Studies Programme, Galway, Ireland		Sullivan, L (corresponding author), NUI Galway, Sch Hlth Sci, Discipline Hlth Promot, Galway, Ireland.	l.sullivan2@nuigalway.ie			Irish Research CouncilIrish Research Council for Science, Engineering and Technology [GOIPG/2014/914]	This work was supported by the Irish Research Council (Grant No. GOIPG/2014/914).	Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Blake C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005059; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chrisman SP, 2013, J AM COLL SURGEONS, V216, pe55; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cromwell F, 2000, BRIT J SPORT MED, V34, P104, DOI 10.1136/bjsm.34.2.104; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kroshus E, 2016, CLIN J SPORT MED, V26, P391, DOI 10.1097/JSM.0000000000000272; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Murphy JC, 2012, AM J SPORT MED, V40, P2113, DOI 10.1177/0363546512455315; Newton JD, 2014, J SCI MED SPORT, V17, P469, DOI 10.1016/j.jsams.2013.10.240; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Reilly T, 2001, J SPORT SCI, V19, P181, DOI 10.1080/026404101750095277; Roe M, 2016, J ATHL TRAINING, V51, P303, DOI 10.4085/1062-6050-51.4.07; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Sullivan L, 2016, INT J ADOLESC MED HL, V29, DOI [10.1515/ijamh-2015-0084., DOI 10.1515/IJAMH-2015-0084]; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Wilson F, 2007, BRIT J SPORT MED, V41, P317, DOI 10.1136/bjsm.2006.033167	50	5	5	1	5	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	JAN	2018	7	1					102	108		10.1016/j.jshs.2017.05.003			7	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	FX2XL	WOS:000425929600015	30356480	gold, Green Published			2022-02-06	
J	Sun, L; Xu, YW; Han, J; Xiao, C; Cao, SS; Liang, H; Cheng, Y				Sun, Li; Xu, Yan-Wei; Han, Jing; Xiao, Chen; Cao, Shan-Shan; Liang, Hao; Cheng, Yan			Hydroxysafflor Yellow A Shows Protection against PPAR gamma Inactivation in Nitrosative Neurons	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							TRAUMATIC BRAIN-INJURY; NITROTYROSINE FORMATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ISCHEMIC BRAIN; J(2) PROTECTS; UP-REGULATION; CELL-DEATH; RAT-BRAIN	Peroxynitrite-mediated nitrosative stress in the brain has been associated with various neurodegenerative disorders. Recent evidence highlights peroxisome proliferator-activated receptor gamma (PPAR gamma) as a critical neuroprotective factor in neurodegenerative diseases. Here, we observed the effect of the herb hydroxysafflor yellow A (HSYA) during nitrosative stress in neurons and investigated the mechanism based on PPAR gamma protection. We found that a single exposure of primary neurons to peroxynitrite donor SIN-1 caused neuronal injury, which was accompanied by the increase of PPAR gamma nitration status and lack of activation of the receptor, as measured by PPAR gamma DNA-binding activity, by agonist (15d-PGJ2 or rosiglitazone) stimulation. The crucial role of PPAR gamma in neuronal defense against nitrosative stress was verified by showing that pretreatment with 15d-PGJ2 or rosiglitazone attenuated SIN-1-induced neuronal injury but pretreatment with GW9662, a PPAR gamma antagonist, aggravated SIN-1-induced neuronal injury. The addition of HSYA not only inhibited SIN1-induced neuronal damage but prevented PPAR gamma nitrative modification and resumed PPAR gamma activity stimulated by either 15d-PGJ2 or rosiglitazone. Furthermore, HSYA also showed the ability to rescue the neuroprotective effect of 15d-PGJ2 or rosiglitazone when the agonists were coincubated with SIN-1. Finally, in vivo experiments demonstrated that the administration of HSYA also efficiently blocked PPAR gamma nitration and loss of activity in the SIN-1-injected hippocampus and reversed the increased neuronal susceptibility which was supported by the inhibition of Bcl-2 protein downregulation induced by SIN-1. The results suggest that HSYA protects neurons from nitrosative stress through keeping PPAR gamma as a functional receptor, allowing a more effective activation of this neuroprotective factor by the endogenous or exogenous agonist. Our findings provide new clues in understanding the role of the neuroprotective potential of the herbal HSYA.	[Sun, Li; Xu, Yan-Wei; Han, Jing; Xiao, Chen; Cao, Shan-Shan; Liang, Hao; Cheng, Yan] Tianjin Med Univ, Minist Educ & Tianjin City, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Gen Hosp,Tianjin Neurol Inst, Tianjin 300052, Peoples R China		Sun, L (corresponding author), Tianjin Med Univ, Minist Educ & Tianjin City, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Gen Hosp,Tianjin Neurol Inst, Tianjin 300052, Peoples R China.	lisun@tmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571201, 81401023, 81601039]; Tianjin Municipal Science and Technology Commission [13ZCZDSY01900, 14JCZDJC35400]; Tianjin Municipal Education Commission [131]	This work was supported by the National Natural Science Foundation of China (nos. 81571201, 81401023, and 81601039), Tianjin Municipal Science and Technology Commission (nos. 13ZCZDSY01900 and 14JCZDJC35400), and Tianjin Municipal Education Commission (no. 131 creative talents team training project of 2016 year).	Bentes ALA, 2011, MOLECULES, V16, P1749, DOI 10.3390/molecules16021749; Bernardo A, 2006, NEUROBIOL DIS, V22, P25, DOI 10.1016/j.nbd.2005.09.012; Bian K, 2003, P NATL ACAD SCI USA, V100, P5712, DOI 10.1073/pnas.0931291100; Bie XD, 2010, J ASIAN NAT PROD RES, V12, P239, DOI 10.1080/10286020903510636; Butts BD, 2004, INT J ONCOL, V24, P1305; Choi RJ, 2016, J ETHNOPHARMACOL, V190, P219, DOI 10.1016/j.jep.2016.06.013; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Guo Y, 2014, BIOMED CHROMATOGR, V28, P1090, DOI 10.1002/bmc.3124; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Han B, 2010, NEUROCHEM RES, V35, P107, DOI 10.1007/s11064-009-0035-4; Jiang JS, 2010, ORG LETT, V12, P1196, DOI 10.1021/ol902971w; Kaji T, 2002, NITRIC OXIDE-BIOL CH, V6, P125, DOI 10.1006/niox.2001.0389; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Lim SY, 2004, J BIOL CHEM, V279, P46263, DOI 10.1074/jbc.M406555200; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Marshall KA, 1999, FREE RADICAL BIO MED, V27, P515, DOI 10.1016/S0891-5849(99)00094-5; Martin HL, 2012, EXP NEUROL, V235, P528, DOI 10.1016/j.expneurol.2012.02.017; Matata BM, 2002, J BIOL CHEM, V277, P2330, DOI 10.1074/jbc.M106393200; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Puttfarcken PS, 1996, EXP NEUROL, V138, P73, DOI 10.1006/exnr.1996.0048; Qian Y, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0598-3; Qin HD, 2015, CELL MOL NEUROBIOL, V35, P303, DOI 10.1007/s10571-014-0125-y; Saeki M, 2000, NEUROSCI RES, V38, P213, DOI 10.1016/S0168-0102(00)00138-3; Shibuya A, 2002, FEBS LETT, V525, P43, DOI 10.1016/S0014-5793(02)03059-4; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Sun L, 2015, J LIPID RES, V56, P502, DOI 10.1194/jlr.M053058; Sun L, 2013, NITRIC OXIDE-BIOL CH, V35, P144, DOI 10.1016/j.niox.2013.10.002; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Takizawa S, 2002, J CEREBR BLOOD F MET, V22, P50, DOI 10.1097/00004647-200201000-00006; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Tian JW, 2008, PHARMACOLOGY, V82, P121, DOI 10.1159/000141653; Tohgi H, 1999, NEUROSCI LETT, V269, P52, DOI 10.1016/S0304-3940(99)00406-1; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Zhang YJ, 2006, FASEB J, V20, P1431, DOI 10.1096/fj.05-5223com; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009; Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061	40	5	6	1	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2018	2018								9101740	10.1155/2018/9101740			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GY4XL	WOS:000448571300001	30410641	Green Published, gold			2022-02-06	
J	Sutiono, AB; Faried, A; McAllister, S; Ganefianty, A; Sarjono, K; Arifin, MZ; Derrett, S				Sutiono, Agung Budi; Faried, Ahmad; McAllister, Susan; Ganefianty, Amelia; Sarjono, Kalih; Arifin, Muhammad Zafrullah; Derrett, Sarah			The Bandung neurosurgery patient outcomes project, Indonesia (Part II): Patient pathways and feasibility and acceptability of telephone follow-up	INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT			English	Article						health-care pathways; Indonesia; neurosurgery; telephone follow-up	TRAUMATIC BRAIN-INJURY; TELEREHABILITATION; INTERVENTION; TRIAL; CARE	IntroductionSupport of neurosurgery patients following discharge from hospital is important. Currently, little is known about patients' in low- and middle-income countries before and after their hospital treatment. This companion paper reports patients' pathways before and after hospital admission and the feasibility of following up this ill-patient population by telephone. MethodsEligible patients were aged 18years admitted to the Neurosurgery Department in Dr. Hasan Sadikin Hospitala regional referral hospital in Bandung City, Indonesia. Clinical data were collected on admission by clinicians. In-person interviews were undertaken with a clinical research nurse 1 to 2days pre-discharge, and telephone follow-up interviews at 1, 2, and 3months post-discharge. Information was also collected on pathways prior to admission and following discharge. The number of contact attempts for each patient interview was documented, as was the overall acceptability of undertaking a telephone interview. ResultsOf 178 patients discharged from hospital, 12 later died. Of the remaining 166 patients, 95% were able to be followed up to 3months. Two-thirds of patients had been referred from another hospital. Patients came from, and were discharged to, locations throughout the West Java region. At the 1-month interview, 84% participants reported that they had had a follow-up consultation with a health professionalmostly with a neurosurgeon. ConclusionThis study has shown that, with a neurosurgery nurse delegated to the role, it is feasible to conduct follow-up telephone interviews with patients after discharge from a neurosurgery ward and that in fact such follow-up was appreciated by patients.	[Sutiono, Agung Budi; Faried, Ahmad; Ganefianty, Amelia; Sarjono, Kalih; Arifin, Muhammad Zafrullah] Univ Padjadjaran, Dr Hasan Sadikin Hosp, Fac Med, Dept Neurosurg, Bandung, Indonesia; [McAllister, Susan] Univ Otago, Dept Prevent & Social Med, Ctr Int Hlth, Dunedin 9054, New Zealand; [Derrett, Sarah] Univ Otago, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand		McAllister, S (corresponding author), Univ Otago, Dept Prevent & Social Med, Ctr Int Hlth, Dunedin 9054, New Zealand.	sue.mcallister@otago.ac.nz	Ganefianty, Amelia/M-5339-2019	McAllister, Susan/0000-0001-7881-6622; Ganefianty, Amelia/0000-0003-3303-1519; Derrett, Sarah/0000-0003-2867-0498	EuroQol Research Foundation [2015170]	EuroQol Research Foundation, Grant/Award Number: EQ Project 2015170.	Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Hailey D, 2011, J TELEMED TELECARE, V17, P281, DOI 10.1258/jtt.2011.101208; Kairy D, 2009, DISABIL REHABIL, V31, P427, DOI 10.1080/09638280802062553; McAllister S, 2018, INT J HEALTH PLAN M, V33, pE57, DOI 10.1002/hpm.2408; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Sankaranarayanan R, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-3; StataCorp, 2013, STAT STAT SOFTW REL; Winters JM, 2002, ANNU REV BIOMED ENG, V4, P287, DOI 10.1146/annurev.bioeng.4.112801.121923; World Health Organization, 2015, IND WHO STAT PROF	11	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0749-6753	1099-1751		INT J HEALTH PLAN M	Int. J. Health Plan. Manag.	JAN-MAR	2018	33	1					E49	E56		10.1002/hpm.2406			8	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	GA5AT	WOS:000428345200008	28252219				2022-02-06	
J	Wang, KY; Yang, HP; Wang, WL; Han, Z				Wang, Keyi; Yang, Haipeng; Wang, Wanli; Han, Zhuang			FORCE CONFIGURATION OF A RIGID-FLEXIBLE GAIT REHABILITATION ROBOT	INTERNATIONAL JOURNAL OF ROBOTICS & AUTOMATION			English	Article						Rehabilitation robots; rigid-flexible coupled robots; gait correction; wires-driven force; force configuration	DESIGN	A rigid-flexible coupled robot configuration designed to understand the functional requirements of gait correction training for lower limb rehabilitation robots was proposed. By matching the trajectory of normal human gait, the input for the robot was obtained, the gait correction training pattern was analysed, and a planning strategy for the rigid chain was suggested. By considering the vibration problems of the wire-drive unit, which were caused by an unreasonable configuration of the drive force of the wires, the reason for the concussion existing in the system was analysed by building a mathematic model of the system. Several types of allocation plans were presented. All of these measures were employed to optimize the drive characteristics of the wires. A simulation of the tension on the wires was performed using MATLAB software, and a rope tension allocation plan that satisfied the requirements for the rope unit stability was developed. In addition, the validity of the allocation plan was visually verified by a figure with a spatial curved surface about the driven tension of the wires. The wire tension configuration method, which has important significance for configuring the wire drive force in paralleled robots, was researched in this paper.	[Wang, Keyi; Yang, Haipeng; Wang, Wanli; Han, Zhuang] Harbin Engn Univ, Coll Mech & Elect Engn, Harbin 150001, Heilongjiang, Peoples R China		Wang, KY (corresponding author), Harbin Engn Univ, Coll Mech & Elect Engn, Harbin 150001, Heilongjiang, Peoples R China.	wangkeyi@hrbeu.edu.cn; yanghaipeng@hrbeu.edu.cn; wangwanli@hrbeu.edu.cn; hanzhuang@hrbeu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51405095]; Postdoctoral Scientific Research Fund of Heilongjiang [LBH-Q15030]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [HEUCF180701]	This project is supported by National Natural Science Foundation of China (51405095); supported by Postdoctoral Scientific Research Fund of Heilongjiang (LBH-Q15030); supported by Fundamental Research Funds for the Central Universities (HEUCF180701).	Colombo G, 2000, J REHABIL RES DEV, V37, P693; Hiller M, 2005, MECH MACH THEORY, V40, P429, DOI 10.1016/j.mechmachtheory.2004.08.002; HOMMA K, 2004, P 2004 IEEE RSJ INT, P1668; HUANG J, 2007, J CHINA U MINING TEC, V17, P179, DOI DOI 10.1016/S1006-1266(07)60067-4; Li L., 2007, ERGONOMICS, V13, P36; Simon AM, 2007, J BIOMECH, V40, P1286, DOI 10.1016/j.jbiomech.2006.05.021; Varziri MS, 2007, MECH MACH THEORY, V42, P960, DOI 10.1016/j.mechmachtheory.2006.07.007; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; Wang K.Y., 2011, J HARBIN ENG U, V3, P1112; Wang KY, 2015, ADV MECH ENG, V7, DOI 10.1155/2014/298434; Wang KY, 2013, INT J ROBOT AUTOM, V28, P311, DOI 10.2316/Journal.206.2013.4.206-3621; Wang Q., 2011, THESIS; Ye X.Q., 2010, CHINESE J REHABILITA, V5, P781; Zhang Lixun, 2012, Robot, V34, P217, DOI 10.3724/SP.J.1218.2012.00217; [张立勋 Zhang Lixun], 2011, [哈尔滨工程大学学报, Journal of Harbin Engineering University], V32, P1179; 侯来永, 2007, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V22, P155	16	5	5	8	31	ACTA PRESS	CALGARY	2509 DIEPPE AVE SW, BLDG B6, STE 101, CALGARY, AB T3E 7J9, CANADA	0826-8185	1925-7090		INT J ROBOT AUTOM	Int. J. Robot. Autom.		2018	33	6					577	583		10.2316/Journal.206.2018.6.206-4709			7	Automation & Control Systems; Robotics	Science Citation Index Expanded (SCI-EXPANDED)	Automation & Control Systems; Robotics	HE7FZ	WOS:000453597000002					2022-02-06	
J	Weng, SW; Chen, TL; Yeh, CC; Lane, HL; Liao, CC; Shih, CC				Weng, Shu-Wen; Chen, Ta-Liang; Yeh, Chun-Chieh; Lane, Hsin-Long; Liao, Chien-Chang; Shih, Chun-Chuan			The effects of Bu Yang Huan Wu Tang on post-stroke epilepsy: a nationwide matched study	CLINICAL EPIDEMIOLOGY			English	Article						stroke; epilepsy; Bu Yang Huan Wu Tang; long-term risk	TRADITIONAL CHINESE MEDICINE; INSURANCE RESEARCH DATABASE; TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; ASTRAGALUS-MEMBRANACEUS; OUTCOMES; RISK; MORTALITY; HEMORRHAGE; DECOCTION	Objective: To compare the long-term risk of epilepsy in stroke patients who use Bu Yang Huan Wu Tang (BYHWT) and those who do not. Methods:In the Taiwanese national insurance claims data, we identified newly diagnosed stroke patients receiving inpatient care in the years 2000-2004. Using propensity score-matched pairs to balance the baseline characteristics, we selected eligible stroke patients who did (n=8,971) and did not (n=8,971) receive BYHWT. These two groups were followed up until the end of 2009 to track the occurrence of epilepsy. We used Cox proportional hazard models to calculate the adjusted HRs and 95% CIs for post-stroke epilepsy during the follow-up period according to BYHWT use. Results: Compared with the control group, stroke patients with BYHWT had a reduced risk of epilepsy during the 5-9 years of the follow-up period (HR 0.69, 95% CI 0.61-0.77). The association between BYHWT and reduced post-stroke epilepsy was significant in various subgroups of stroke patients. There was a dose-dependent decrease in the frequency of epilepsy with increasing quantities of BYHWT use from 1 package (HR 0.77, 95% CI 0.66-0.90) to >= 6 packages (HR 0.52, 95% CI 0.42-0.65). Conclusion: Stroke patients who received BYHWT therapy had a reduced long-term risk of epilepsy, and the beneficial effect could be observed in various subgroups. However, future clinical trials will be necessary to corroborate the present findings and identify the biochemical mechanism involved.	[Weng, Shu-Wen] Minist Hlth & Welf, Taichung Hosp, Dept Chinese Med, Taichung, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Dept Anesthesiol, Coll Med, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Lane, Hsin-Long; Shih, Chun-Chuan] I Shou Univ, Sch Chinese Med Postbaccalaureate, 8 Yida Rd, Kaohsiung 824, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Shih, Chun-Chuan] Taipei Med Univ, Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan		Shih, CC (corresponding author), I Shou Univ, Sch Chinese Med Postbaccalaureate, 8 Yida Rd, Kaohsiung 824, Taiwan.	hwathai@seed.net.tw			Taiwan's Ministry of Science and Technology [MOST106-2314-B-038-036-MY3, MOST106-2320-B-214-003]	This study was supported in part by Taiwan's Ministry of Science and Technology (MOST106-2314-B-038-036-MY3, MOST106-2320-B-214-003).	[Anonymous], 2003, ALTERN MED REV, V8, P72; [Anonymous], 2003, ALT MED REV, V8, P72; [Anonymous], 2018, ASTR; Arntz RM, 2015, STROKE, V46, P2309, DOI 10.1161/STROKEAHA.115.010115; Bain D, 2015, INT J RECENT RES LIF, V2, P8; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Beghi E, 2011, NEUROLOGY, V77, P1785, DOI 10.1212/WNL.0b013e3182364878; Bensky D., 2004, CHINESE HERBAL MED M, V3rd; Chang CC, 2016, J ETHNOPHARMACOL, V186, P311, DOI 10.1016/j.jep.2016.04.018; Chang CC, 2016, J ETHNOPHARMACOL, V177, P46, DOI 10.1016/j.jep.2015.11.028; Chang HM, 1986, PHARM APPL CHINESE M; Chen CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/708452; Chen J, 2004, CHINESE MED HERBOLOG; Chen ZJ, 2018, FOOD CHEM TOXICOL, V119, P309, DOI 10.1016/j.fct.2018.02.050; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chu S, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7272694; Deng L, 2018, EUR J PHARMACOL, V825, P119, DOI 10.1016/j.ejphar.2018.02.011; European Medicines Agency, 2018, ASS REP ANG SIN OL D; European Medicines Agency, 2018, ASS REP PAEON LACT P; Fu J, 2014, PHYTOTHER RES, V28, P1275, DOI 10.1002/ptr.5188; Graham NSN, 2013, STROKE, V44, P605, DOI 10.1161/STROKEAHA.111.000220; Hao CZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/630124; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Huang CW, 2014, NEUROLOGY, V82, P768, DOI 10.1212/WNL.0000000000000166; Hung IL, 2015, AM J CHINESE MED, V43, P1365, DOI 10.1142/S0192415X15500779; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Jennes F, 2004, HERB TOXICITIES DRUG; Kao TK, 2013, EXP NEUROL, V247, P188, DOI 10.1016/j.expneurol.2013.04.010; Koh PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054217; Li JH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/506783; Li X., 2002, CHINESE MATERIA MED; Liao CC, 2014, BRIT J SURG, V101, P1616, DOI 10.1002/bjs.9639; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liao CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/387164; Lin MY, 2016, ONCOL LETT, V12, P904, DOI 10.3892/ol.2016.4698; Liu CH, 2016, J ETHNOPHARMACOL, V194, P954, DOI 10.1016/j.jep.2016.10.058; Liu L, 2012, J ETHNOPHARMACOL, V139, P381, DOI 10.1016/j.jep.2011.11.016; Luengo-Fernandez R, 2009, STROKE, V40, pE18, DOI 10.1161/STROKEAHA.108.529776; Luo L, 2017, EVID BASED COMPLEMEN, V2017; Marcus A, 2005, FDN INTEGRATIVE MUSC; Mehta A, 2018, WORLD NEUROSURG, V112, pE385, DOI 10.1016/j.wneu.2018.01.052; Mu Q, 2018, WORLD NEUROSURG, V112, pe385; Okuda S, 2012, J STROKE CEREBROVASC, V21, P583, DOI 10.1016/j.jstrokecerebrovasdis.2011.01.006; Pan R, 2017, BMC COMPLEMENT ALTER, V17, P173; Park SU, 2014, COMPLEMENT THER CLIN, V20, P37, DOI 10.1016/j.ctcp.2013.10.007; Pitkanen A, 2016, LANCET NEUROL, V15, P185, DOI 10.1016/S1474-4422(15)00248-3; Qian XL, 2015, J ALTERN COMPLEM MED, V21, P748, DOI 10.1089/acm.2015.0084; Schroder S, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/423713; Shao AW, 2014, INT J MED SCI, V11, P1073, DOI 10.7150/ijms.9282; Shigematsu K, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0297-1; Shih CC, 2017, BMJ OPEN, V7, pe013638; Shih CC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001572; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Tanaka T, 2017, NEUROCHEM INT, V107, P219, DOI 10.1016/j.neuint.2017.02.002; Wang HW, 2011, J ETHNOPHARMACOL, V138, P22, DOI 10.1016/j.jep.2011.06.033; Wang HL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8424326; Wang LS, 2013, J PHARMACEUT BIOMED, V86, P143, DOI 10.1016/j.jpba.2013.07.046; Wei RL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/138484; Wu YC, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-32; Yang CB, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-23; Yang J, 2018, INTRO CHINESE MATERI; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Yeh YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004115	65	5	5	1	9	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1349			CLIN EPIDEMIOL	Clin. Epidemiol.		2018	10						1839	1850		10.2147/CLEP.S175677			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	HE1LF	WOS:000453032000001	30573993	Green Published, gold			2022-02-06	
J	Woytowicz, EJ; Sours, C; Gullapalli, RP; Rosenberg, J; Westlake, KP				Woytowicz, Elizabeth J.; Sours, Chandler; Gullapalli, Rao P.; Rosenberg, Joseph; Westlake, Kelly P.			Modulation of working memory load distinguishes individuals with and without balance impairments following mild traumatic brain injury	BRAIN INJURY			English	Article						Attention; balance; cognition; functional connectivity; traumatic brain injury	SHORT-TERM-MEMORY; STABILITY FOLLOWING CONCUSSION; POSTERIOR PARIETAL CORTEX; DEFAULT MODE; ATTENTION; GAIT; ROBUST; REHABILITATION; CONNECTIVITY; INFERENCE	Objectives: Balance and gait deficits can persist after mild traumatic brain injury (TBI), yet an understanding of the underlying neural mechanism remains limited. The purpose of this study was to investigate differences in attention network modulation in patients with and without balance impairments 2-8 weeks following mild TBI. Methods: Using functional magnetic resonance imaging, we compared activity and functional connectivity of cognitive brain regions of the default mode, central-executive and salience networks during a 2-back working memory task in participants with mild TBI and balance impairments (n = 7, age 47 +/- 15 years) or no balance impairments (n = 7, age 47 +/- 15 years). Results: We first identified greater activation in the lateral occipital cortex in the balance impaired group. Second, we observed stronger connectivity of left pre-supplementary motor cortex in the balance impaired group during the working memory task, which was related to decreased activation of regions within the salience and central executive networks and greater suppression of the default mode network. Conclusions: Results suggest a link between impaired balance and modulation of cognitive resources in patients in mTBI. Findings also highlight the potential importance of moving beyond traditional balance assessments towards an integrative assessment of cognition and balance in this population.	[Woytowicz, Elizabeth J.; Rosenberg, Joseph; Westlake, Kelly P.] Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, 100 Penn St AHB,Suite 205C, Baltimore, MD 21201 USA; [Sours, Chandler; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA		Westlake, KP (corresponding author), Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, 100 Penn St AHB,Suite 205C, Baltimore, MD 21201 USA.	kwestlake@som.umaryland.edu	Woytowicz, Elizabeth/M-1564-2019; Westlake, Kelly/AAK-1223-2021	Westlake, Kelly/0000-0003-3799-5710	Department of DefenseUnited States Department of Defense [W81XWH-08-1-0725, W81XWH-12-1-0098]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105503] Funding Source: NIH RePORTER	This research was supported by the Department of Defense award #W81XWH-08-1-0725 and #W81XWH-12-1-0098.	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franchignoni F, 2010, J REHABIL MED, V42, P323, DOI 10.2340/16501977-0537; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Glascher J, 2007, J NEUROSCI, V27, P4366, DOI 10.1523/JNEUROSCI.3310-06.2007; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2005, 11 ANN M ORG HUM BRA, V17, P176; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maki BE, 2001, NEUROREPORT, V12, P3583, DOI 10.1097/00001756-200111160-00042; Matsuyoshi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038623; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McDowd Joan M, 2007, J Neurol Phys Ther, V31, P98; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Powell JM, 2002, ARCH PHYS MED REHAB, V83, P1235, DOI 10.1053/apmr.2002.34556; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Siu KC, 2009, BRAIN RES, V1248, P59, DOI 10.1016/j.brainres.2008.10.078; Smith S.M., 2009, NEUROIMAGE, V47, pS148; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smolders C, 2010, HUM MOVEMENT SCI, V29, P809, DOI 10.1016/j.humov.2009.07.009; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Watanabe T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2388; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Westlake KP, 2016, GAIT POSTURE, V45, P51, DOI 10.1016/j.gaitpost.2016.01.007; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Xu Y., 2008, J COGNITIVE NEUROSCI, V21, P511; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	60	5	5	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					191	199		10.1080/02699052.2017.1403045			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600005	29182372	Green Accepted			2022-02-06	
J	Xu, JY; Shi, J; Zhang, JM; Zhang, Y				Xu, Jinyu; Shi, Jun; Zhang, Jiaming; Zhang, Yun			Vorinostat: a histone deacetylases (HDAC) inhibitor ameliorates traumatic brain injury by inducing iNOS/Nrf2/ARE pathway	FOLIA NEUROPATHOLOGICA			English	Article						vorinostat; traumatic brain injury; apoptosis; oxidative stress and inflammation	OXIDATIVE STRESS	The present investigation evaluates the protective effect of vorinostat on neuronal cells in the traumatic brain injury (TBI) and also postulates the possible mechanism of its action. Marmarou's weight-drop model was used to induce the TBI. Further, animals were treated with vorinostat 100 mg/kg intraperitoneally 30 min before the TBI induction. Neurological score and brain water content were determined in all the groups and thereafter oxidative stress parameters and adenosine triphosphate (ATP) content were determined in the neuronal tissues of TBI mice. Western blot assay and reverse transcription polymerase chain reaction (RT-PCR) was performed for the determination of the expression of several proteins in the neuronal tissues. Moreover, immunohistochemical staining and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was also done on the neuronal tissues of TBI mice. Data of the study reveal that treatment with vorinostat significantly reduces the altered level of grip test scores and water content in the brain of traumatic injured mice. Moreover, the altered level of oxidative stress parameters, translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) and ATP content was attenuated by treating TBI mice with vorinostat. Also treatment with vorinostat ameliorates the altered expression of p-Akt, NF-kappa B, iNOS and caspase by the western blot assay in the neuronal tissue of TBI mice and mRNA level of HO-1 and NQO-1 significantly enhanced in vorinostat compared to the negative control group. Furthermore, the TUNEL assay also reveals that the apoptosis of neuronal cells was significantly (p < 0.01) reduced in the vorinostat-treated group compared to the negative control group. The present study concludes that vorinostat protects the neuronal injury in TBI mice by reducing the altered level of oxidative stress and inflammatory response.	[Xu, Jinyu; Shi, Jun; Zhang, Jiaming; Zhang, Yun] Wuxi Peoples Hosp, Dept Emergency, 299 Qingyang Rd, Wuxi 214000, Peoples R China		Xu, JY; Zhang, Y (corresponding author), Wuxi Peoples Hosp, Dept Emergency, 299 Qingyang Rd, Wuxi 214000, Peoples R China.	JoeMozellevo@yahoo.com; yppqp4e@163.com					Bassett SA, 2014, NUTRIENTS, V6, P4273, DOI 10.3390/nu6104273; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Jeong YH, 2016, BIOMOL THER, V24, P581, DOI 10.4062/biomolther.2016.141; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Lohman RJ, 2016, J PHARMACOL EXP THER, V356, P387, DOI 10.1124/jpet.115.229328; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; McElvaney NG, 2016, ANN AM THORAC SOC, V13, pS191, DOI 10.1513/AnnalsATS.201504-245KV; Nita Malgorzata, 2016, Oxid Med Cell Longev, V2016, P3164734, DOI 10.1155/2016/3164734; Pettke A, 2016, ANTI-CANCER DRUG, V27, P1001, DOI 10.1097/CAD.0000000000000418; Popescu C, 2015, J Med Life, V8, P272; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Toklu HZ, 2015, BRAIN NEUROTRAUMA MO; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003	18	5	5	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1641-4640	1509-572X		FOLIA NEUROPATHOL	Folia Neuropathol.		2018	56	3					179	186		10.5114/fn.2018.78697			8	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GW1SB	WOS:000446659900004	30509039	gold			2022-02-06	
J	Zhang, HM; Chen, W; Liu, RN; Zhao, Y				Zhang, Hong-Mei; Chen, Wei; Liu, Rui-Ning; Zhao, Yan			Notch inhibitor can attenuate apparent diffusion coefficient and improve neurological function through downregulating NOX2-ROS in severe traumatic brain injury	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						traumatic brain injury; secondary brain injury; apparent diffusion coefficient; Notch; cerebral blood flow	CEREBRAL-BLOOD-FLOW; NADPH OXIDASE 2; VASOGENIC EDEMA; SUBARACHNOID HEMORRHAGE; LUXURY-PERFUSION; PATHWAY; STRESS; ROS; POPULATION; CONTEXT	Introduction: Secondary brain injury is a major factor that affects the prognosis and outcome of traumatic brain injury (TBI) patients. Secondary brain edema is considered to be an initiating factor in secondary brain injury after TBI. A previous study has indicated that Notch signaling activation contributes to neuron death in mice affected by stroke; however, its role in neuronal oxidation stress for brain edema after TBI is not well established. Apparent diffusion coefficient (ADC) values can represent the brain edema after TBI. Methods: We established a rat model of acute craniocerebral injury, using functional MRI to evaluate the ADC and cerebral blood flow values. The present study was designed to determine the effect of Notch inhibitor DAPT upon oxidation stress for brain edema after Till. Rats were randomly distributed into five groups, control group, severe TBI group, severe TBI + vehicle group, severe TBI+ DAPT group, and severe TBI + DPI group. All rats were sacrificed at 24 hours after TBI. Results: Our data indicated that Notch signaling inhibitor DAPT significantly reduced the ADC values and improved the neurological function after TBI. In addition, DAPT decreased NOX2 levels and the ROS levels. Furthermore, DPI can decrease NOX2 levels and ROS levels. Conclusion: This study indicated that DAPT Notch signal inhibitors can inhibit NOX2-ROS generation, reduce the ADC values, relieve cerebral edema, and improve nerve function.	[Zhang, Hong-Mei; Liu, Rui-Ning; Zhao, Yan] Wuhan Univ, Zhongnan Hosp, Emergency Ctr, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China; [Zhang, Hong-Mei] Jinan Univ, Shenzhen Peoples Hosp, Med Coll 2, Emergency Dept, Shenzhen 518020, Guangdong, Peoples R China; [Chen, Wei] Hubei Univ Med, Dept Intens Care Unit, Taihe Hosp, Shiyan 442000, Hubei, Peoples R China		Zhao, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Emergency Ctr, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China.	doctoryanzhao@163.com			Emergency Diagnostic and Therapeutic Center of Central China	This study was financially supported by the Emergency Diagnostic and Therapeutic Center of Central China. The authors would like to thank the Core Facilities for Medical Imaging of Capital Medical University (Beijing, People's Republic of China) for the technical assistance in fMRI imaging.	Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Cai WX, 2014, CELL IMMUNOL, V287, P129, DOI 10.1016/j.cellimm.2013.12.009; Chandran R, 2017, J CEREB BLOOD FLOW M; Chen JW, 2016, ACTA NEUROCHIR SUPPL, V121, P279, DOI 10.1007/978-3-319-18497-5_48; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Dalla Sega FV, 2017, BIOFACTORS, V43, P475, DOI 10.1002/biof.1359; Eve DJ, 2016, NEUROPSYCH DIS TREAT, V12, P2689, DOI 10.2147/NDT.S110126; Fazio C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.408; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2014, J VET DIAGN INVEST, V26, P470, DOI 10.1177/1040638714530127; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Kimberly WT, 2014, NEUROCRIT CARE, V20, P193, DOI 10.1007/s12028-013-9917-z; Kurita D, 2003, ACT NEUR S, V86, P41; LANGFITT TW, 1982, CLIN NEUR, V29, P353; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Martin M, 2017, NEUROCRIT CARE, V26, P87, DOI 10.1007/s12028-016-0291-5; Mathieu Patricia, 2013, Biomol Concepts, V4, P465, DOI 10.1515/bmc-2013-0006; Murakami K, 2016, BRAIN RES, V1633, P73, DOI 10.1016/j.brainres.2015.12.016; Polacheck WJ, 2017, NATURE, V552, P258, DOI 10.1038/nature24998; Sharma VK, 2011, CIRCULATION, V123, pE243, DOI 10.1161/CIRCULATIONAHA.110.972000; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Wei XE, 2014, NEUROL SCI, V35, P295, DOI 10.1007/s10072-013-1514-6; Weimer JM, 2017, AM J NEURORADIOL, V38, P928, DOI 10.3174/ajnr.A5181; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Zhang HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193037; Zhang L, 2017, FREE RADICAL RES, V51, P316, DOI 10.1080/10715762.2017.1311015; Zhu YF, 2017, AM J TRANSL RES, V9, P3422	34	5	7	1	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2018	12						3847	3854		10.2147/DDDT.S174037			8	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HA5OA	WOS:000450321700002	30510400	Green Published, Green Submitted, gold			2022-02-06	
J	Zhang, J; Knight, R; Wang, YS; Sawyer, TW; Martyniuk, CJ; Langlois, VS				Zhang, Jing; Knight, Rosalinda; Wang, Yushan; Sawyer, Thomas W.; Martyniuk, Christopher J.; Langlois, Valerie S.			Comprehensive assessment of shockwave intensity: Transcriptomic biomarker discovery for primary blast-induced mild traumatic brain injury using the mammalian hair follicle	BRAIN INJURY			English	Article						Microarray; pathway analysis; high-throughput gene expression profile; neurotrauma	DNA-DAMAGE RESPONSE; GENE SET ENRICHMENT; EXPRESSION; PROTEIN; BARRIER; BLOOD; LEADS; RATS	Objective: Primary blast-induced mild traumatic brain injury (mTBI) is an injury experienced during modern warfare due to exposure to the pressure waves produced by the detonation of explosives. With virtually no apparent physical damage or symptoms presented, there is a need for more objective and accessible mTBI biomarkers posing minimal invasiveness risk. Methods: We measured the transcriptomic sensitivity of the hair follicles in relation to the severity of primary blast-derived TBI. An Advanced Blast Simulator system was used to expose male rats to single pulse shock waves (intensities ranging from 15 to 30 psi) in a head-only fashion. Gene differential expression (DE) and gene set (GS) analyses were conducted in the rat whisker hair follicles and the whole blood samples. Results: While shared cellular function, themes were found across the exposure groups, some gene sets under such themes were unique to the exposure conditions. Intensity-specific pathway enrichment patterns within shared GS themes were also identified. Furthermore, while exhibited shared pathways, the blood transcriptome showed substantially fewer enriched gene sets compared with the hair follicles across all exposure conditions. Conclusions: Accordingly, we demonstrate the potential of mammalian hair follicles serving as an additional source for biomarker discovery and for diagnosing mTBI with high accessibility.	[Zhang, Jing; Langlois, Valerie S.] Royal Mil Coll Canada, Chem & Chem Engn Dept, Kingston, ON, Canada; [Knight, Rosalinda; Martyniuk, Christopher J.] Univ New Brunswick, Fredericton, NB, Canada; [Knight, Rosalinda; Martyniuk, Christopher J.] Canadian River Inst, Fredericton, NB, Canada; [Wang, Yushan; Sawyer, Thomas W.] Suffield Res Ctr, Def Res & Dev Canada, Medicine Hat, AB, Canada; [Martyniuk, Christopher J.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA; [Martyniuk, Christopher J.] Dept Physiol Sci, Gainesville, FL USA		Langlois, VS (corresponding author), Royal Mil Coll Canada, Ecotoxicogen & Endocrine Disrupt, Stn Forces, POB 17 000, Kingston, ON K7K 7B4, Canada.; Langlois, VS (corresponding author), Royal Mil Coll Canada, Chem & Chem Engn Dept, Stn Forces, POB 17 000, Kingston, ON K7K 7B4, Canada.	valerie.langlois@rmc.ca	Zhang, Jing/F-4468-2017	Zhang, Jing/0000-0002-6076-7321; Langlois, Valerie S./0000-0003-4031-6838; Martyniuk, Christopher J./0000-0003-0921-4796	Defence Research and Development Canada (DRDC) Technology Investment Fund (TIF)	This research was supported by the Defence Research and Development Canada (DRDC) Technology Investment Fund (TIF) to VSL (PI), CJM, and YW.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Cheng CW, 2016, MOL CARCINOGEN, V55, P499, DOI 10.1002/mc.22297; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Gill RM, 2013, MOL CELL BIOL, V33, P498, DOI 10.1128/MCB.00276-12; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kumar Parvathy R, 2014, J Tradit Complement Med, V4, P89, DOI 10.4103/2225-4110.130374; Lafleur MA, 2013, TOXICOL PATHOL, V41, P235, DOI 10.1177/0192623312470764; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nowsheen S., 2012, Experimental Oncology, V34, P243; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; R Core Team, 2018, R LANGUAGE ENV STAT; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104518	28	5	5	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					123	134		10.1080/02699052.2017.1342000			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300014	29157017				2022-02-06	
J	Nasretdinov, A; Lotfullina, N; Vinokurova, D; Lebedeva, J; Burkhanova, G; Chernova, K; Zakharov, A; Khazipov, R				Nasretdinov, Azat; Lotfullina, Nailya; Vinokurova, Daria; Lebedeva, Julia; Burkhanova, Gulshat; Chernova, Kseniya; Zakharov, Andrey; Khazipov, Roustem			Direct Current Coupled Recordings of Cortical Spreading Depression Using Silicone Probes	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						electroencephalography; DC recordings; silicone probes; spreading depression; epilepsy; migraine; traumatic brain injury; brain ischemia	CURRENT SOURCE-DENSITY; ACTIVITY TRANSIENTS; DEPOLARIZATION; PROPAGATION; OSCILLATIONS; MECHANISMS; ISCHEMIA; MIGRAINE; STROKE; K+	Electrophysiological assessment of infraslow (<0.1 Hz) brain activities such as cortical spreading depression (SD), which occurs in a number of pathologies including migraine, epilepsy, traumatic brain injury (TBI) and brain ischemia requires direct current (DC) coupled recordings of local field potentials (LFPs). Here, we describe how DC-coupled recordings can be performed using high-density iridium electrode arrays (silicone probes). We found that the DC voltage offset of the silicone probe is large and often exceeds the amplifier input range. Introduction of an offset compensation chain at the signal ground efficiently minimized the DC offsets. Silicone probe DC-coupled recordings across layers of the rat visual and barrel cortices revealed that epipial application of KCl, dura incision or pinprick TBI induced SD which preferentially propagated through the supragranular layers and further spread to the granular and infragranular layers attaining maximal amplitudes of similar to-30 mV in the infragranular layers. SD at the superficial cortical layers was nearly two-fold longer than at the deep cortical layers. Continuous epipial KCl evoked multiple recurrent SDs which always started in the supragranular layers but often failed to propagate through the deeper cortical layers. Intracortical KCl injection into the infragranular layers evoked SD which also started in the supragranular layers and spread to the granular and infragranular layers, further indicating that the supragranular layers are particularly prone to SD. Thus, DC-coupled recordings with silicone probes after offset compensation can be successfully used to explore the spatial-temporal dynamics of SD and other slow brain activities.	[Nasretdinov, Azat; Lotfullina, Nailya; Vinokurova, Daria; Lebedeva, Julia; Burkhanova, Gulshat; Chernova, Kseniya; Zakharov, Andrey; Khazipov, Roustem] Kazan Fed Univ, Dept Human & Anim Physiol, Lab Neurobiol, Kazan, Russia; [Khazipov, Roustem] Aix Marseille Univ, Inst Neurobiol Mediterranee INMED, INSERM, UMR901, Marseille, France		Khazipov, R (corresponding author), Kazan Fed Univ, Dept Human & Anim Physiol, Lab Neurobiol, Kazan, Russia.; Khazipov, R (corresponding author), Aix Marseille Univ, Inst Neurobiol Mediterranee INMED, INSERM, UMR901, Marseille, France.	roustem.khazipov@inserm.fr	Vinokurova, Daria/F-4832-2015; Burkhanova, Gulshat F/Y-2459-2018; Khazipov, Roustem/M-1834-2016; Zakharov, Andrey V/J-8151-2014; Lebedeva, Julia/O-2041-2013; Chernova, Kseniya/B-8115-2019; Andrey, Zakharov/AAO-7384-2021	Burkhanova, Gulshat F/0000-0002-7936-2906; Khazipov, Roustem/0000-0002-6763-2841; Zakharov, Andrey V/0000-0002-6175-9796; Lebedeva, Julia/0000-0002-3874-9549; Chernova, Kseniya/0000-0002-7044-9669; Andrey, Zakharov/0000-0002-6175-9796; Nasretdinov, Azat/0000-0003-0010-4419	Russian Science Foundation (RSF)Russian Science Foundation (RSF) [17-15-01271]	This work was supported by Russian Science Foundation (RSF) (17-15-01271) and performed within the framework of the Program of Competitive Growth of Kazan University. We thank Drs. A. Sirota, M. Minlebaev and reviewers for their helpful and critical comments.	Akhmetshina D, 2016, J NEUROSCI, V36, P9922, DOI 10.1523/JNEUROSCI.1781-16.2016; Guedes RCA, 2017, BRAIN RES, V1672, P29, DOI 10.1016/j.brainres.2017.07.011; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Bragin A, 1997, J NEUROSCI, V17, P2567; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canals S, 2005, J NEUROPHYSIOL, V94, P943, DOI 10.1152/jn.01145.2004; Colonnese MT, 2010, J NEUROSCI, V30, P4325, DOI 10.1523/JNEUROSCI.4995-09.2010; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1857, DOI 10.1177/0271678X16653135; HERRERAS O, 1993, BRAIN RES, V610, P283, DOI 10.1016/0006-8993(93)91412-L; HERRERAS O, 1993, BRAIN RES, V610, P276, DOI 10.1016/0006-8993(93)91411-K; HERRERAS O, 1994, J NEUROSCI, V14, P7087; Joshi I, 2001, J NEUROPHYSIOL, V85, P414, DOI 10.1152/jn.2001.85.1.414; Kaufmann D, 2017, J CEREBR BLOOD F MET, V37, P1748, DOI 10.1177/0271678X16659496; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00161; Leao AAP, 1944, J NEUROPHYSIOL, V7, P391, DOI 10.1152/jn.1944.7.6.391; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Makarova J, 2008, EUR J NEUROSCI, V27, P444, DOI 10.1111/j.1460-9568.2008.06022.x; Minlebaev M, 2011, SCIENCE, V334, P226, DOI 10.1126/science.1210574; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; RICHTER F, 1993, NEUROSCI LETT, V152, P65, DOI 10.1016/0304-3940(93)90484-3; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Tallgren P, 2005, CLIN NEUROPHYSIOL, V116, P799, DOI 10.1016/j.clinph.2004.10.001; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Vanhatalo S, 2005, CLIN EEG NEUROSCI, V36, P311, DOI 10.1177/155005940503600411; WADMAN WJ, 1992, BRAIN RES, V570, P85, DOI 10.1016/0006-8993(92)90567-S	34	5	5	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	DEC 21	2017	11								408	10.3389/fncel.2017.00408			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ9WH	WOS:000418711900001	29311836	Green Published, gold			2022-02-06	
J	Hifumi, T; Kuroda, Y; Kawakita, K; Yamashita, S; Oda, Y; Dohi, K; Maekawa, T				Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya; Yamashita, Susumu; Oda, Yasutaka; Dohi, Kenji; Maekawa, Tsuyoshi		Brain Hypothermia B-HYPO Stu	Therapeutic hypothermia in patients with coagulopathy following severe traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Coagulopathy; Therapeutic hypothermia; Traumatic brain injury; Targeted temperature management; Fibrinogen degradation products	RANDOMIZED CONTROLLED-TRIAL; FEVER CONTROL; COAGULATION; HYPOPERFUSION; METAANALYSIS; MULTICENTER; PARAMETERS; RISK; CARE	Background: Coagulopathy in traumatic brain injury (TBI) has been associated with poor neurological outcomes and higher in-hospital mortality. In general principle of trauma management, hypothermia should be prevented as it directly worsens coagulopathy. Therefore, we examined the safety of mild therapeutic hypothermia (MTH) in patients with coagulopathy following severe TBI. Methods: We re-evaluated the brain hypothermia (B-HYPO) study data based on coagulopathy and compared the Glasgow Outcome Scale scores and survival rates at 6 months using per protocol analyses. Coagulopathy was defined as an activated partial thromboplastin time (APTT) > 60 s and/or fibrin/fibrinogen degradation product levels (FDP) > 90 mu g/mL on admission. Baseline characteristics, coagulation parameters, and outcomes were compared between the control and MTH groups with or without coagulopathy. Results: In patients with coagulopathy, 12 patients were allocated to the control group (35.5-37.0 degrees C) and 20 patients to the MTH group (32-34 degrees C). In patients without coagulopathy, 28 were allocated to the control group and 59 patients were allocated to the MTH group. In patients with coagulopathy, favorable neurological outcomes and survival rates were comparable between the control and MTH groups (33.3% vs. 35.0%, P = 1.00; 50.0% vs. 60.0%, P = 0.72) with no difference in complication rates. On admission, no significant differences in APTT or FDP levels were observed between the two groups; however, APTT was significantly prolonged in the MTH group compared to the control group on day 3. Discussion: Based on our study, MTH did not seem to negatively affect the outcomes in patients with coagulopathy following severe TBI on admission; therefore, the present study indicates that MTH may be applicable even in patients with severe TBI and coagulopathy. Conclusions: Our study suggests that in comparison to control, MTH does not worsen the outcome of patients with coagulopathy following severe TBI.	[Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya] Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan; [Yamashita, Susumu] Tokuyama Cent Hosp, Dept Emergency Med, 1-1 Kouda, Shunan, Yamaguchi 7458522, Japan; [Oda, Yasutaka] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan; [Dohi, Kenji] Showa Univ, Sch Med, Dept Emergency Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428666, Japan; [Maekawa, Tsuyoshi] Yamaguchi Prefectural Grand Med Ctr, 77 Osaki, Boufu, Yamaguchi 7478511, Japan; [Hifumi, Toru] Dept Emergency Disaster & Crit Care Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan		Hifumi, T (corresponding author), Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.; Hifumi, T (corresponding author), Dept Emergency Disaster & Crit Care Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hifumitoru@gmail.com		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Health, Labour and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labour and Welfare (H-14-shinkin-005, H-15-shinkin-001, and H-16-shinkin-001) and by the Japanese Human Science Association, 2002-2004.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cariou A, 2017, ANAESTH CRIT CARE PA; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chhabra G, 2010, NEUROL INDIA, V58, P756, DOI 10.4103/0028-3886.72175; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Endo A, 2016, CRIT CARE MED, V44, pE797, DOI 10.1097/CCM.0000000000001731; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; POLLER L, 1980, SCAND J HAEMATOL, V25, P49; Sawamura A, 2009, THROMB RES, V124, P706, DOI 10.1016/j.thromres.2009.06.036; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Sawamura A, 2009, CLIN APPL THROMB-HEM, V15, P561, DOI 10.1177/1076029608323497; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tokutomi T, 2004, NEUROCRIT CARE, V1, P171, DOI 10.1385/NCC:1:2:171; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825	29	5	5	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	DEC 20	2017	25								120	10.1186/s13049-017-0465-y			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FQ9KF	WOS:000418680300001	29262829	Green Published, gold			2022-02-06	
J	Kesavan, C; Bajwa, NM; Watt, H; Mohan, S				Kesavan, Chandrasekhar; Bajwa, Nikita M.; Watt, Heather; Mohan, Subburaman			Experimental repetitive mild traumatic brain injury induces deficits in trabecular bone microarchitecture and strength in mice	BONE RESEARCH			English	Article							GROWTH-HORMONE; MOUSE MODEL; SUBARACHNOID HEMORRHAGE; PITUITARY-FUNCTION; NEGATIVE IMPACT; INBRED STRAINS; PARIS-TBI; IGF-I; HYPOPITUITARISM; INSUFFICIENCY	To evaluate the long-term consequence of repetitive mild traumatic brain injury (mTBI)on bone, mTBI was induced in 10-week-old female C57BL/6J mice using a weight drop model, once per day for 4 consecutive days at different drop heights (0.5, 1 and 1.5m) and the skeletal phenotype was evaluated at different time points after the impact. In vivo micro-CT (mu-CT) analysis of the tibial metaphysis at 2, 8 and 12 weeks after the impact revealed a 5%-32% reduction in trabecular bone mass. Histomorphometric analyses showed a reduced bone formation rate in the secondary spongiosa of 1.5m impacted mice at 12 weeks post impact. Apparent modulus (bone strength), was reduced by 30% (P < 0.05) at the proximal tibial metaphysis in the 1.5m drop height group at 2 and 8 weeks post impact. Ex vivo mu-CT analysis of the fifth lumbar vertebra revealed a significant reduction in trabecular bone mass at 12 weeks of age in all three drop height groups. Serum levels of osteocalcin were decreased by 22%, 15%, and 19% in the 0.5, 1.0 and 1.5m drop height groups, respectively, at 2 weeks post impact. Serum IGF-I levels were reduced by 18%-32% in mTBI mice compared to contro1 mice at 2 weeks post impact. Serum osteocalcin and IGF-I levels correlated with trabecular BV/TV (r(2)=0.14 and 0.16, P < 0.05). In conclusion, repetitive mTBI exerts significant negative effects on the trabecular bone microarchitecture and bone mechanical properties by influencing osteoblast function via reduced endocrine IGF-I actions.	[Kesavan, Chandrasekhar; Bajwa, Nikita M.; Watt, Heather; Mohan, Subburaman] VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Kesavan, Chandrasekhar; Mohan, Subburaman] Dept Med, Loma Linda, CA 92357 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Orthoped Surg, Loma Linda, CA 92350 USA		Mohan, S (corresponding author), VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA.; Mohan, S (corresponding author), Dept Med, Loma Linda, CA 92357 USA.; Mohan, S (corresponding author), Loma Linda Univ, Dept Orthoped Surg, Loma Linda, CA 92350 USA.	Subburaman.mohan@va.gov			Veterans Administration BLR&D merit review grant [1-101-BX-002717]	The research work was performed at facilities provided by the Department of Veterans Affairs. This study was supported by funding from a Veterans Administration BLR&D merit review grant 1-101-BX-002717 to Dr Subburaman Mohan. We thank Nancy Lowen for technical assistance and Dr Donna Strong for proof reading the manuscript.	Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Boehncke S, 2011, CEREBROVASC DIS, V31, P163, DOI 10.1159/000321738; Center of Disease Control and Prevention, INJ PREV CONTR TRAUM; Cheng SH, 2016, ENDOCRINOLOGY, V157, P127, DOI 10.1210/en.2015-1473; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DONAHUE LR, 1993, J ENDOCRINOL, V136, P91, DOI 10.1677/joe.0.1360091; Gajda M, 2000, FOLIA HISTOCHEM CYTO, V38, P103; Garcia-Castellano J M, 2000, Iowa Orthop J, V20, P49; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; Grassel S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0485-1; Hari Kumar K V S, 2016, Indian J Endocrinol Metab, V20, P772; Heffner MA, 2014, J MUSCULOSKEL NEURON, V14, P1; Ibrahim M, 2016, FOLIA BIOL-PRAGUE, V62, P175; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Karaca Z, 2016, PROG MOL BIOL TRANSL, V138, P167, DOI 10.1016/bs.pmbts.2015.10.010; Kasukawa Y, 2003, ENDOCRINOLOGY, V144, P3950, DOI 10.1210/en.2002-0123; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kesavan C, 2006, BONE, V39, P634, DOI 10.1016/j.bone.2006.03.005; Kristensen E, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/294965; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Li X, 2001, CALCIFIED TISSUE INT, V68, P365, DOI 10.1007/s00223-001-0004-7; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mohan S, 2015, PHYSIOL GENOMICS, V47, P33, DOI 10.1152/physiolgenomics.00107.2014; Mormando M, 2016, CLIN ENDOCRINOL, V85, P717, DOI 10.1111/cen.13161; Nemes O, 2015, HORM-INT J ENDOCRINO, V14, P383, DOI 10.14310/horm.2002.1564; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; van Varsseveld NC, 2016, PITUITARY, V19, P381, DOI 10.1007/s11102-016-0716-3; VANRIETBERGEN B, 1995, J BIOMECH, V28, P69; VOGELSANG GB, 1990, HEMATOL ONCOL CLIN N, V4, P625, DOI 10.1016/S0889-8588(18)30482-9; Wergedal JE, 2005, BONE, V36, P111, DOI 10.1016/j.bone.2004.09.012; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu HR, 2014, J REHABIL RES DEV, V51, P1427, DOI 10.1682/JRRD.2014.04.0095; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735; Yu HR, 2013, STRESS, V16, P564, DOI 10.3109/10253890.2013.806908	44	5	5	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-4700	2095-6231		BONE RES	Bone Res.	DEC 19	2017	5								17042	10.1038/boneres.2017.42			10	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FR5BN	WOS:000419081000001	29263937	gold, Green Published			2022-02-06	
J	Vavilala, MS; Lujan, SB; Qiu, Q; Bell, MJ; Ballarini, NM; Guadagnoli, N; Depetris, MA; Faguaga, GA; Baggio, GM; Busso, LO; Garcia, ME; Carrillo, ORG; Medici, PL; Saenz, SS; Vanella, EE; Farr, CK; Petroni, GJ				Vavilala, Monica S.; Lujan, Silvia B.; Qiu, Qian; Bell, Michael J.; Ballarini, Nicolas M.; Guadagnoli, Nahuel; Alejandra Depetris, Maria; Faguaga, Gabriela A.; Baggio, Gloria M.; Busso, Leonardo O.; Garcia, Mirta E.; Gonzalez Carrillo, Osvaldo R.; Medici, Paula L.; Saenz, Silvia S.; Vanella, Elida E.; Farr, Carly K.; Petroni, Gustavo J.			Intensive care treatments associated with favorable discharge outcomes in Argentine children with severe traumatic brain injury: For the South American Guideline Adherence Group	PLOS ONE			English	Article							PERFORMANCE CATEGORY; PRESSURE	Objective Little is known about the critical care management of children with traumatic brain injury (TBI) in low middle income countries. We aimed to identify indicators of intensive care unit (ICU) treatments associated with favorable outcomes in Argentine children with severe TBI. Methods We conducted a secondary analysis of data from patients previously enrolled in a prospective seven center study of children with severe TBI who were admitted to an ICU in one of the seven study centers. Severe TBI was defined by head AIS >= 3, head CT with traumatic lesion, and admission GCS < 9. Seven indicators of best practice TBI care were examined. The primary outcome was discharge Pediatric Cerebral Performance Category Scale [PCPC] and Pediatric Overall Performance category Scale [POPC]. We also examined variation in ICU care and in- patient mortality. Results Of the 117 children, 67% were male and 7.5 (4.3) years on average, 92% had isolated TBI. Hypotension (54%) was more common than hypoxia (28%) and clinical or radiographic signs of high intracranial pressure (ICP) were observed in 92%. Yet, ICP monitoring occurred in 60% and hyperosmolar therapy was used in only 36%. Adherence to indicators of best TBI practice ranged from 55.6% to 83.7% across the seven centers and adherence was associated with favorable discharge PCPC (aRR 0.98; 95% CI [0.96, 0.99]), and POPC (aRR 0.98; 95% CI [0.96, 0.99]). Compared to patients whose adherence rates were below 65%, patients whose adherence rates were higher between 75%- 100% had better discharge PCPC (aRR 0.28; 95% CI [0.10, 0.83]) and POPC (aRR 0.32; 95% CI [0.15, 0.73]. Two indicators were associated with favorable discharge PCPC: Avoidance of hypoxia (aRR 0.46; 95% CI [0.23, 0.93]), and Nutrition started in 72 hours (aRR 0.45; 95% CI [0.21, 0.99]). Avoiding hypoxia was also associated with favorable discharge POPC (aRR 0.47; 95% CI [0.22, 0.99]). Conclusion There is variation in Argentine ICU practice in the care of children with severe TBI. Second insults are common and hyperosmolar therapy use is uncommon. Adherence to best practice TBI care by avoiding hypoxia and providing timely nutrition were associated with significantly favorable discharge outcomes. Implementing strategies that prevent hypoxia and facilitate early nutrition in the ICUs are urgently needed to improve pediatric TBI outcomes.	[Vavilala, Monica S.; Qiu, Qian; Farr, Carly K.] Univ Washington, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Lujan, Silvia B.; Ballarini, Nicolas M.; Guadagnoli, Nahuel; Alejandra Depetris, Maria; Petroni, Gustavo J.] Ctr Informat & Invest Clin, Rosario, Santa Fe, Argentina; [Lujan, Silvia B.; Petroni, Gustavo J.] Hosp Emergencias Dr Clemente Alvarez, Rosario, Santa Fe, Argentina; [Bell, Michael J.] Childrens Natl Hosp, Crit Care Med, Pediat, Washington, DC USA; [Faguaga, Gabriela A.; Baggio, Gloria M.] Hosp Ninos Victor J Vilela, Rosario, Santa Fe, Argentina; [Busso, Leonardo O.] Hosp El Cruce Ezpeleta Oeste, Buenos Aires, DF, Argentina; [Garcia, Mirta E.] Hosp Ninos Sor Maria Ludovica, La Plata, Buenos Aires, Argentina; [Gonzalez Carrillo, Osvaldo R.] Hosp Ninos Dr Orlando Alassia, Santa Fe, Santa Fe, Argentina; [Medici, Paula L.] Hosp Interzonal Especializado Materno Infantil Dr, Mar Del Plata, Buenos Aires, Argentina; [Saenz, Silvia S.] Hosp Ninos Santisima Trinidad, Cordoba, Argentina; [Vanella, Elida E.] Hosp Pediat Dr Humberto Notti, Mendoza, Argentina		Vavilala, MS (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pain Med, Seattle, WA 98195 USA.	vavilala@uw.edu		Ballarini, Nicolas/0000-0002-3432-8931			Bureau of Statistics and Information, 2016, BUR STAT INF VIT STA; Carney NA, 2016, PEDIATR CRIT CARE ME, V17, P658, DOI 10.1097/PCC.0000000000000772; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Doshi H, 2015, PLOS ONE, V10; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Graves JM, 2016, PEDIATR CRIT CARE ME, V17, P438, DOI 10.1097/PCC.0000000000000698; Hardcastle N, 2014, PEDIATR ANESTH, V24, P703, DOI 10.1111/pan.12415; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; National Institute of Neurological Disorders and Stroke, 2017, TRAUM BRAIN INJ NIND; Nenadovic V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094942; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Vavilala MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166478; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	21	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2017	12	12							e0189296	10.1371/journal.pone.0189296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FQ2KG	WOS:000418184700027	29244842	Green Published, Green Submitted, gold			2022-02-06	
J	Dollman, AK; Figaji, AA; Schrieff-Elson, LE				Dollman, Aimee K.; Figaji, Anthony A.; Schrieff-Elson, Leigh E.			Academic and Behavioral Outcomes in School-Age South African Children Following Severe Traumatic Brain Injury	FRONTIERS IN NEUROANATOMY			English	Article						pediatric; traumatic brain injury; academic; behavior; outcome; developing countries	PEDIATRIC HEAD-INJURY; EXECUTIVE FUNCTION; RATING INVENTORY; RECOVERY; REHABILITATION; TBI; EPIDEMIOLOGY; ADOLESCENTS; PERFORMANCE; ATTENTION	Background: Children who have sustained severe traumatic brain injuries (TBIs) demonstrate a range of post-injury neurocognitive and behavioral sequelae, which may have adverse effects on their academic and behavioral outcomes and interfere with school re-entry, educational progress, and quality of life. These post-TBI sequelae are exacerbated within the context of a resource-poor country like South Africa (SA) where the education system is in a somewhat precarious state especially for those from disadvantaged backgrounds. Objectives: To describe behavioral and academic outcomes of a group of school-aged SA children following severe TBI. Methods: The sample included 27 school-age children who were admitted to the Red Cross War Memorial Children's Hospital (RXH), SA, between 2006 and 2011 for closed severe TBI and who received intracranial monitoring. We collected behavioral data using the Child Behavior Checklist (CBCL) and the Behavior Rating Inventory of Executive Function (BRIEF) and academic information sourced from the BRIEF, CBCL, medical folders, and caregivers. Analyses include descriptive statistics and bivariate correlation matrices. Results: The descriptive results show that (1) more than half of the participants experienced clinically-significant behavioral problems across the CBCL scales, (2) the working memory BRIEF subscale appeared to be the most problematic subdomain, (3) two thirds of the sample were receiving some form of, or were in the process of being placed in, special needs education, (4) there was a three-fold increase in the use of special education services from pre- to post-injury, and (5) more than half (n = 16) of the sample repeated at least one grade after returning to school post-injury. Correlation analyses results suggest that children with increased externalizing behavioral problems and executive dysfunction are more likely to repeat a grade post-injury; and that children with executive dysfunction post-TBI are more likely to require some form of special educational services. Conclusion: While there is a vast amount of literature on pediatric TBI (pTBI) academic and behavioral outcomes, little literature exists on the pTBI population from the developing world and SA specifically. This is important to address given unique challenges that face the country and its educational system, and its implications for the management and care of children post-TBI.	[Dollman, Aimee K.; Schrieff-Elson, Leigh E.] Univ Cape Town, Dept Psychol, Appl Cognit Sci & Expt Neuropsychol Team, Cape Town, South Africa; [Figaji, Anthony A.] Univ Cape Town, Sch Child & Adolescent Hlth, Red Cross War Mem Childrens Hosp, Div Neurosurg,Dept Surg, Cape Town, South Africa		Schrieff-Elson, LE (corresponding author), Univ Cape Town, Dept Psychol, Appl Cognit Sci & Expt Neuropsychol Team, Cape Town, South Africa.	leigh.schrieff-elson@uct.ac.za	Schrieff, Leigh/AAQ-5577-2020	Schrieff, Leigh/0000-0003-0192-4830; Figaji, Anthony/0000-0002-3357-6490	National Research Foundation; Victor Nell-SACNA Endowment for the Study of Neuropsychology in South Africa; KW Johnston Bequest; UCT Research Scholarship; Ernst and Ethel Ericksen Trust	This research was supported through funds obtained from the following sources: National Research Foundation, Victor Nell-SACNA Endowment for the Study of Neuropsychology in South Africa, KW Johnston Bequest, UCT Research Scholarship, and the Ernst and Ethel Ericksen Trust.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alexander T, 2009, S AFR J SURG, V47, P120; Amollo R., 2008, ESR REV, V9, P15; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson V, 2010, PEDIAT TRAUMATIC BRA, DOI DOI 10.1017/CB09780511676383; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; [Anonymous], 2017, ECONOMIST; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chomba M. J., 2014, DISAB STUD Q, V34, P1; Ciccia AH, 2015, INT J LANG COMM DIS, V50, P436, DOI 10.1111/1460-6984.12153; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; *DEP ED, 2001, 6 DEP ED; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Donders J, 2000, J HEAD TRAUMA REHAB, V15, P792, DOI 10.1097/00001199-200004000-00004; Donohue Dana, 2014, S. Afr. j. educ., V34, P01; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Du Plessis E., 2001, THESIS; Engelbrecht P, 2006, EUR J PSYCHOL EDUC, V21, P253, DOI 10.1007/BF03173414; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Field A., 2017, DISCOVERING STAT USI, V5th; Figaji AA, 2017, CHILD NERV SYST, V33, P1649, DOI 10.1007/s00381-017-3582-z; Flanagan SR, 2008, ARCH PHYS MED REHAB, V89, pS9, DOI 10.1016/j.apmr.2007.12.010; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gontkovsky ST, 2006, BRAIN INJURY, V20, P701, DOI 10.1080/02699050600744103; Haaring G. J., 2011, CHILD SAFE NEWS CAPE; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hooft Van't, 2010, PEDIAT TRAUMATIC BRA, P1; Huizinga M, 2011, CHILD NEUROPSYCHOL, V17, P51, DOI 10.1080/09297049.2010.509715; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Jerome E, 2017, SAMJ S AFR MED J, V107, P621, DOI [10.7196/SAMJ.2017.v107i7.10562, 10.7196/samj.2017.v107i7.10562]; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kumar R, 2009, CHILD NERV SYST, V25, P813, DOI 10.1007/s00381-009-0820-z; Legotlo M. W., 2014, CHALLENGES ISSUES FA, P167; Letgotlo M. W., 2014, CHALLENGES ISSUES FA; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin K, 2004, DISABIL REHABIL, V26, P306, DOI 10.1080/0963828032000174089; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Mayfield J, 2005, PREV SCH FAIL, V49, P17, DOI 10.3200/PSFL.49.4.17-22; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Naidoo Dinesh, 2013, SAMJ, S. Afr. med. j., V103, P613, DOI 10.7196/samj.7325; Nelson JR, 2004, EXCEPT CHILDREN, V71, P59, DOI 10.1177/001440290407100104; Palin FL, 2009, AIDS BEHAV, V13, P1241, DOI 10.1007/s10461-008-9447-4; Penn C, 2009, INT J AUDIOL, V48, P135, DOI 10.1080/14992020802635309; Pillay J, 2009, S AFR J EDUC, V29, P491, DOI 10.15700/saje.v29n4a293; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Qian Y, 2010, CLIN NEUROPSYCHOL, V24, P793, DOI 10.1080/13854041003749342; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Sa T., 2019, EMERGEN MED, DOI [10.4172/2165-7548.1000229, DOI 10.4172/2165-7548.1000229]; SACE, 2016, STAT SPEC NEEDS ED S; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Schrieff-Elson LE, 2017, CHILD NERV SYST, V33, P1775, DOI 10.1007/s00381-017-3527-6; Schrieff-Elson LE, 2015, CHILD NERV SYST, V31, P2257, DOI 10.1007/s00381-015-2892-2; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shields N, 2008, CHILD ABUSE NEGLECT, V32, P589, DOI 10.1016/j.chiabu.2007.07.010; Soudien Crain, 2006, DISABILITY SOCIAL CH, P149; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Taylor H. G., 2010, PEDIAT TRAUMATIC BRA, P1; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; United Nations Educational Scientific and Cultural Organization (UNESCO), 1990, ON BILL ILL CHALL OU; WHO, 2001, B WORLD HEALTH ORGAN, V79, P373, DOI DOI 10.1111/DDG.13528; World Health Organization, 2011, WORLD HLTH STAT 2011; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates K. O., 2009, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Zillmer E., 2008, PRINCIPLES NEUROPSYC	94	5	5	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5129			FRONT NEUROANAT	Front. Neuroanat.	DEC 13	2017	11								121	10.3389/fnana.2017.00121			14	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anatomy & Morphology; Neurosciences & Neurology	FP7HF	WOS:000417802500001	29326559	Green Published, gold			2022-02-06	
J	Bin Tan, L; Tse, KM; Tan, YH; Bin Sapingi, MA; Tan, VBC; Lee, HP				Bin Tan, Long; Tse, Kwong Ming; Tan, Yuan Hong; Bin Sapingi, Mohamad Ali; Tan, Vincent Beng Chye; Lee, Heow Pueh			Face shield design against blast-induced head injuries	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						aerogel; coupled-Eulerian-Lagrangian (CEL); fluid-structure-interaction (FSI); head model; helmet; traumatic brain injury (TBI)	HELMETS; POLYUREA; IMPACT	Blast-induced traumatic brain injury has been on the rise in recent years because of the increasing use of improvised explosive devices in conflict zones. Our study investigates the response of a helmeted human head subjected to a blast of 1atm peak overpressure, for cases with and without a standard polycarbonate (PC) face shield and for face shields comprising of composite PC and aerogel materials and with lateral edge extension. The novel introduction of aerogel into the laminate face shield is explored and its wave-structure interaction mechanics and performance in blast mitigation is analysed. Our numerical results show that the face shield prevented direct exposure of the blast wave to the face and help delays the transmission of the blast to reduce the intracranial pressures (ICPs) at the parietal lobe. However, the blast wave can diffract and enter the midface region at the bottom and side edges of the face shield, resulting in traumatic brain injury. This suggests that the bottom and sides of the face shield are important regions to focus on to reduce wave ingress. The laminated PC/aerogel/PC face shield yielded higher peak positive and negative ICPs at the frontal lobe, than the original PC one. For the occipital and temporal brain regions, the laminated face shield performed better than the original. The composite face shield with extended edges reduced ICP at the temporal lobe but increases ICP significantly at the parietal lobe, which suggests that a greater coverage may not lead to better mitigating effects.	[Bin Tan, Long; Tan, Yuan Hong; Bin Sapingi, Mohamad Ali; Tan, Vincent Beng Chye; Lee, Heow Pueh] Natl Univ Singapore, Dept Mech Engn, 21 Lower Kent Ridge Rd, Singapore 119077, Singapore; [Tse, Kwong Ming] Univ Melbourne, Dept Mech Engn, Parkville, Vic 3010, Australia		Bin Tan, L (corresponding author), Natl Univ Singapore, Dept Mech Engn, 21 Lower Kent Ridge Rd, Singapore 119077, Singapore.; Tse, KM (corresponding author), Univ Melbourne, Dept Mech Engn, Parkville, Vic 3010, Australia.	mpetl@nus.edu.sg; tsekm.research@yahoo.com	Lee, Heow Pueh/I-7834-2014; Tse, Kwong Ming/D-8669-2011	Lee, Heow Pueh/0000-0002-4380-3888; Tse, Kwong Ming/0000-0002-8170-0775; Tan, Long Bin/0000-0002-3897-7365			[Anonymous], 2012, TOP GEN EXPECTS IED; [Anonymous], 2013, POLYCARBONATE TECHNI; [Anonymous], 2013, WHAT IS AEROGEL; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Corwin F., 2011, CHARACTERIZATION BLA; Courtney E.D.S., 2012, J BATTLEF TECHNOL, V15, P19, DOI [10.3316/INFORMIT.504179178509386, DOI 10.3316/INFORMIT.504179178509386]; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Ganpule S, 2010, 16 US NAT C THEOR AP, P1; Gibson PW, 1994, BLAST OVERPRESSURE S, P24; Global Security Organization, EXPLOSIVES; Grujicic A, 2012, J MATER ENG PERFORM, V21, P1562, DOI 10.1007/s11665-011-0065-3; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P297, DOI 10.1108/15736101211269122; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Huang, 2011, WICOM 2011 23 25 SEP, P1; Hyde DW, 1991, CONWEP CONVENTIONAL; Jason AM, 2010, FACIAL PROTECTIVE DE; Jenson D, 2015, COMPOS STRUCT, V121, P211, DOI 10.1016/j.compstruct.2014.08.028; Krysl P, 2012, J COMPUT NONLIN DYN, V7, DOI 10.1115/1.4006143; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Lee HP, 2010, COMPUT METHOD BIOMEC, V13, P537, DOI 10.1080/10255840903337848; Lee HP, 2010, COMPUTER METHODS BIO, V13, P537; Lockhart PA, 2010, PRIMARY BLAST INJURY; Miller S, 2014, EXPLOSIVES ENG EXPLO; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Murray C, 2015, J CHEM HEALTH SAF, V22, P18, DOI 10.1016/j.jchas.2014.11.004; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; National Academies and the Department of Homeland Security, IED ATT IMPR EXPL DE; Nyein M.K., 2010, P NATL ACAD SCI; OKIE S, 2005, THE NEW ENGLAND JOUR, V352, P2043; Parmenter KE, 1998, J NON-CRYST SOLIDS, V223, P179, DOI 10.1016/S0022-3093(97)00430-4; Prospector, 2015, POL PC TYP PROP GEN; RICHMOND DR, 1968, ANN NY ACAD SCI, V152, P103, DOI 10.1111/j.1749-6632.1968.tb11970.x; Sarvghad-Moghaddam H, 2016, INT J NUMERICAL METH; Sarvghad-Moghaddam H., 2014, 17 US NAT C THEOR AP; Sarvghad-Moghaddam H, 2017, COMPUT METHOD BIOMEC, V20, P16, DOI 10.1080/10255842.2016.1193597; SARVGHADMOGHADD. H, 2015, COMPUTER METHODS IN, V18, P1846; Sharma S, 2011, OH STAT U INJ BIOM S; Simmonds KE, 2009, SENSOR SYSTEMS MEASU, P1; Stewart C., 2006, EMERG MED PRACT, V8, P1; Tan LB, 2012, PERFORMANCE EVALUATI; Tan LB, 2014, INT J NUMER METH BIO, V30, P1476, DOI 10.1002/cnm.2668; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; The Frontier, 2011, AER THEIR HIST STRUC; Tomlinson S., 2015, INCREDIBLE FOOTAGE S; Ward CC, 1980, 24 STAPP CAR CRASH C, P347; Woignier T, 2015, GELS-BASEL, V1, P256, DOI 10.3390/gels1020256; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Zhang L, 2009, ANN REPORT PREPARED	52	5	5	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	DEC	2017	33	12							e2884	10.1002/cnm.2884			17	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	FO8CK	WOS:000417109700004	28329435	Green Published			2022-02-06	
J	Chandee, T; Lyons, VH; Vavilala, MS; Krishnamoorthy, V; Chaikittisilpa, N; Watanitanon, A; Lele, AV				Chandee, Theerada; Lyons, Vivian H.; Vavilala, Monica S.; Krishnamoorthy, Vijay; Chaikittisilpa, Nophanan; Watanitanon, Arraya; Lele, Abhijit V.			Critical Care Resource Utilization and Outcomes of Children With Moderate Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; intracranial pressure; moderate; pediatric; traumatic brain injury	DISCHARGE DISPOSITION; UNITED-STATES; HEAD-INJURY; EPIDEMIOLOGY; MORTALITY; CENTERS; PRESSURE; ADULTS; MILD	Objectives: To characterize admission patterns, critical care resource utilization, and outcomes in moderate pediatric traumatic brain injury. Design: Retrospective cohort study. Setting: National Trauma Data Bank. Patients: Children under 18 years old with a diagnosis of moderate traumatic brain injury (admission Glasgow Coma Scale score of 9-13) in the National Trauma Data Bank between 2007 and 2014. Measurement and Main Results: We examined clinical characteristics, critical care resource utilization, and discharge outcomes. Poor outcomes were defined as discharge to hospice, skilled nursing facility, long-term acute care, or death. We examined 20,010 patient records. Patients were 9 years old (interquartile range, 2-15 yr), male (64%) with isolated traumatic brain injury (81%), Glasgow Coma Scale score of 12, head Abbreviated Injury Scale score of 3, and Injury Severity Score of 10. Majority (34%) were admitted to nontrauma hospitals. Critical care utilization was 58.7% including 11.5% mechanical ventilation and 3.2% intracranial pressure monitoring. Compared to patients with Glasgow Coma Scale score of 13, admission Glasgow Coma Scale score of 9 was associated with greater critical care resource utilization, such as ICU admission (72% vs 50%), intracranial pressure monitoring (7% vs 1.8%), mechanical ventilation (21% vs 6%), and intracranial surgery (10% vs 5%). Most patients (70%) were discharged to home, but up to one third had poor outcomes. Older age group had a higher risk of poor outcomes (10-14 yr; adjusted relative risk, 1.32; 95% CI, 1.13-1.54; 15-17 yr; adjusted relative risk, 2.39; 95% CI, 2.12-2.70). Poor outcomes occurred with lower Glasgow Coma Scale (Glasgow Coma Scale score of 9 vs Glasgow Coma Scale score of 13: adjusted relative risk, 2.89; 95% CI, 2.47-3.38), higher Injury Severity Score (Injury Severity Score of 16 vs Injury Severity Score of < 9: adjusted relative risk, 8.10; 95% CI 6.27-10.45), and polytrauma (adjusted relative risk, 1.40; 95% CI, 1.22-1.61). Conclusions: Critical care resources are used in more than half of all moderate pediatric traumatic brain injury, and many receive care at nontrauma hospitals. Up to one third of moderate pediatric traumatic brain injury have poor outcomes, risk factors for which include age greater than 10 years, lower admission Glasgow Coma Scale, higher Injury Severity Score, and polytrauma. There is urgent need to optimize triage, care, and outcomes in this vulnerable population.	[Chandee, Theerada; Vavilala, Monica S.; Krishnamoorthy, Vijay; Chaikittisilpa, Nophanan; Watanitanon, Arraya; Lele, Abhijit V.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Chandee, Theerada; Lyons, Vivian H.; Vavilala, Monica S.; Krishnamoorthy, Vijay; Chaikittisilpa, Nophanan; Watanitanon, Arraya] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Lyons, Vivian H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Lele, AV (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	abhijit2@uw.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH/National Institute of Neurological Disorders and Stroke Acute Hypertension After Intracerebral Hemorrhage-II clinical trial; Edge therapeutics and Aqueduct Critical Care	Drs. Vavilala and Lele received support for article research from the National Institutes of Health (NIH). Dr. Lele's institution received funding from the NIH/National Institute of Neurological Disorders and Stroke Acute Hypertension After Intracerebral Hemorrhage-II clinical trial, and he received funding from Edge therapeutics and Aqueduct Critical Care. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Brewer LE, 2017, ENVIRON INT, V102, P30, DOI 10.1016/j.envint.2016.12.005; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; COLOHAN ART, 1992, J NEUROTRAUM, V9, pS259; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Gross BW, 2017, J TRAUMA ACUTE CARE, V82, P368, DOI 10.1097/TA.0000000000001291; Guilliams K, 2016, J CHILD NEUROL, V31, P35, DOI 10.1177/0883073814562626; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Kannan N, 2016, PEDIATR EMERG CARE; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kernic MA, 2013, J NEUROTRAUM, V30, P1129, DOI 10.1089/neu.2012.2716; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Mills B, 2015, J NEUROTRAUM, V32, P841, DOI 10.1089/neu.2014.3733; Nnadi MON, 2014, J PEDIATR NEUROSCI, V9, P237, DOI 10.4103/1817-1745.147577; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Steiner Emanuel, 2016, J Trauma Manag Outcomes, V10, P5, DOI 10.1186/s13032-016-0035-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Vaghani Gaurang, 2013, J Pediatr Neurosci, V8, P104, DOI 10.4103/1817-1745.117836; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	40	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	DEC	2017	18	12					1166	1174		10.1097/PCC.0000000000001350			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	FO7ZX	WOS:000417101200017	28945629				2022-02-06	
J	Cohen-Zimerman, S; Chau, A; Krueger, F; Gordon, B; Grafman, J				Cohen-Zimerman, Shira; Chau, Aileen; Krueger, Frank; Gordon, Barry; Grafman, Jordan			Machiavellian tendencies increase following damage to the left dorsolateral prefrontal cortex	NEUROPSYCHOLOGIA			English	Article						Machiavellianism; Dorsolateral prefrontal cortex; Lesion study; Traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PENETRATING HEAD-INJURY; EMOTIONAL INTELLIGENCE; DARK TRIAD; DECISION-MAKING; COMBAT VETERANS; NEURAL BASIS; BRAIN; DEFICITS; LESIONS	Machiavellianism a personality trait that is characterized by a tendency to distrust, deceive and exploit others has been the focus of growing attention in psychological research. Neuroimaging studies of Machiavellianism highlight the influence of the dorsolateral prefrontal cortex (dlPFC) on Machiavellianism tendencies. However, knowledge regarding the causal role of the left and right dlPFC on Machiavellianism is still obscure. Here, we measured general Machiavellian tendencies, as well as two subscales (i.e., Machiavellian Views and Machiavellian Tactics) in a large sample of brain-injured patients (N = 129) and non-brain-injured control participants (N = 37) to determine whether Machiavellianism tendencies can be altered by brain damage. We analyzed Machiavellianism tendencies as a function of lesion location, with patients separated into four groups based on dlPFC damage: left dlPFC damage, right dlPFC damage, non-dlPFC damage, and healthy controls. We found that left dlPFC damage increased Machiavellianism in general, and Machiavellian perspective (views) in particular, but did not modulate behavior (tactics). Critically, left dlPFC damage predicted higher levels of Machiavellianism after controlling for general and emotional intelligence, linguistic abilities, empathy and psychopathology. These findings establish a causal role of the left dlPFC in modulating Machiavellian views, and indicate that one can hold Machiavellian views without necessarily endorsing Machiavellian tactics.	[Cohen-Zimerman, Shira; Chau, Aileen; Grafman, Jordan] Shirley Ryan AbilityLab, Cognit Neurosci Lab, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Gordon, Barry] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gordon, Barry] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Cohen-Zimerman, S (corresponding author), Shirley Ryan AbilityLab, Cognit Neurosci Lab, Chicago, IL 60611 USA.	scohenzime@sralab.org; jgrafman@northwestern.edu	Cohen-Zimerman, Shira/X-8330-2019	Cohen-Zimerman, Shira/0000-0001-6098-2550	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Therapeutic Cognitive Neuroscience Fund (Johns Hopkins University); Julius Frankel Foundation; Smart Family Foundation of New York	We are grateful to all of the Vietnam veterans and caregivers for their participation in the study. We thank The National Naval Medical Center and the National Institute of Neurological Disorders and Stroke for providing their facilities and supporting this research. We thank Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, G. Tasick, S. Bonifant, M. Tierney, L. Glass, L. Yozawitz, C. Noury, V. Tsen, and A. Leopold for testing participants and organizing the study. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government. JG, AC, and BG were supported by the Therapeutic Cognitive Neuroscience Fund (Johns Hopkins University and BG). JG was also supported by the Julius Frankel Foundation and the Smart Family Foundation of New York.	Ali F, 2010, PERS INDIV DIFFER, V49, P169, DOI 10.1016/j.paid.2010.03.027; Ali F, 2009, PERS INDIV DIFFER, V47, P758, DOI 10.1016/j.paid.2009.06.016; Austin EJ, 2007, PERS INDIV DIFFER, V43, P179, DOI 10.1016/j.paid.2006.11.019; Barbey AK, 2014, SOC COGN AFFECT NEUR, V9, P265, DOI 10.1093/scan/nss124; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bereczkei T, 2015, BRAIN COGNITION, V98, P53, DOI 10.1016/j.bandc.2015.05.006; Bereczkei T, 2013, BRAIN COGNITION, V82, P108, DOI 10.1016/j.bandc.2013.02.012; Brewer G, 2017, PERS INDIV DIFFER, V106, P226, DOI 10.1016/j.paid.2016.11.001; Carre JR, 2017, REV GEN PSYCHOL, V21, P23, DOI 10.1037/gpr0000093; Caruso D. R, 2002, MAYER SALOVEY CARUSO; CHRISTIE Richard, 1970, STUDIES MACHIAVELLIA; Cristofori I., 2017, NEUROPSYCHOLOGIA; Delis DC., 2001, DELIS KAPLAN EXECUTI; Driscoll DM, 2012, COGN BEHAV NEUROL, V25, P160, DOI 10.1097/WNN.0b013e318280cf4e; Goodgiass H, 1983, BOSTON NAMING TEST; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Grafman J, 2005, CURR ISS THINK REASO, P181; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Gunnthorsdottir A, 2002, J ECON PSYCHOL, V23, P49, DOI 10.1016/S0167-4870(01)00067-8; Hogeveen J, 2016, TRENDS NEUROSCI, V39, P694, DOI 10.1016/j.tins.2016.08.007; Hogeveen J, 2016, NEUROPSYCHOLOGIA, V82, P142, DOI 10.1016/j.neuropsychologia.2016.01.021; Hoyle R.H., 2009, HDB INDIVIDUAL DIFFE, P93; IRLE E, 1987, BRAIN RES REV, V12, P307, DOI 10.1016/0165-0173(87)90003-8; Jonason PK, 2013, PERS INDIV DIFFER, V55, P532, DOI 10.1016/j.paid.2013.04.027; Jones DN, 2017, J PERS SOC PSYCHOL, V113, P329, DOI 10.1037/pspp0000139; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kaller CP, 2011, CEREB CORTEX, V21, P307, DOI 10.1093/cercor/bhq096; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Kessler SR, 2010, J APPL SOC PSYCHOL, V40, P1868, DOI 10.1111/j.1559-1816.2010.00643.x; Knutson KM, 2015, J NEUROPSYCH CLIN N, V27, P193, DOI 10.1176/appi.neuropsych.14060126; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Lang A, 2015, PERS INDIV DIFFER, V77, P81, DOI 10.1016/j.paid.2014.12.054; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Marcus D.K., 2016, DARK SIDE PERSONALIT, DOI DOI 10.1037/14854-005; McDonald V, 2017, HUM BRAIN MAPP, V38, P656, DOI 10.1002/hbm.23406; McIlwain D., 2003, INDIVIDUAL DIFFERENC, P39; Mehrabian A, 1996, MANUAL BALANCED EMOT; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monaghan C, 2016, PERS INDIV DIFFER, V94, P72, DOI 10.1016/j.paid.2016.01.002; Neria AL, 2016, PERS INDIV DIFFER, V101, P264, DOI 10.1016/j.paid.2016.05.054; Paal T, 2007, PERS INDIV DIFFER, V43, P541, DOI 10.1016/j.paid.2006.12.021; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Satpute AB, 2014, CEREB CORTEX, V24, P1269, DOI 10.1093/cercor/bhs408; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Verbeke W. J., 2011, J NEUROSCI PSYCHOL E, V4, P205, DOI DOI 10.1037/A0025802; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilson DS, 1996, PSYCHOL BULL, V119, P285, DOI 10.1037/0033-2909.119.2.285; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012	61	5	5	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	DEC	2017	107						68	75		10.1016/j.neuropsychologia.2017.11.007			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	FR3SK	WOS:000418986600008	29126929				2022-02-06	
J	Esquenazi, A; Lee, S; Mayer, N; Garreta, R; Patel, A; Elovic, E; Koelbel, S; Francisco, G; Reuter, I				Esquenazi, Alberto; Lee, Stella; Mayer, Nathaniel; Garreta, Roser; Patel, Atul; Elovic, Elie; Koelbel, Stephen; Francisco, Gerard; Reuter, Iris		PROS World Grp	Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Botulinum Toxin; Muscle Overactivity; Stroke; Traumatic Brain Injury	BOTULINUM-TOXIN-A; ADULT SPASTICITY; LIMB SPASTICITY; PAIN INTENSITY; DOUBLE-BLIND; TRIAL; ONABOTULINUMTOXINA; EFFICACY	Objective The aim of the study was to report physician experience-based real-world treatment patterns with botulinum toxin type A in patients with stroke and traumatic brain injury. Design A prospective, multicenter, international observational registry design was used. Results Six hundred twenty-seven participants with stroke and 132 participants with traumatic brain injury were assessed and treated by 17 more experienced physicians and 12 less experienced physicians. Due to the limited usage of abobotulinumtoxinA Dysport and incobotulinumtoxinA Xeomin, data were reported on onabotulinumtoxinA BOTOX only. Based on physician experience, onabotulinumtoxinA doses were statistically different with larger mean doses injected by more experienced physicians in the upper limb (59.9 [39.0], P = 0.001) and in the lower limb (101.8 [69.2], P < 0.001). Treated deformities significantly differed for both upper limb and lower limb (P < 0.001). More experienced physicians showed a larger mean change in Ashworth Scale scores from baseline for the equinovarus/equinus foot and stiff knee (P = 0.001 and 0.03). Less experienced physicians showed a larger mean change in Ashworth Scale scores from baseline for the adducted thigh (P = 0.05). Less experienced physicians had statistically significant larger change in hand pain scores for clenched fist deformity treatment at follow-up compared with more experienced physicians (P = 0.01). Physician experience demonstrated a significant difference on patients reported satisfaction toward their secondary goal with higher scores for more experienced physician (P = 0.04). Conclusions This international registry provides clinical nuances of treatment based on physician clinical experience in a robust sample size.	[Esquenazi, Alberto; Lee, Stella; Mayer, Nathaniel] MossRehab Gait & Mot Anal Lab, Elkins Pk, PA USA; [Garreta, Roser] Mutua Terrassa Univ Hosp, Cataluna, Spain; [Patel, Atul] Kansas City Bone & Joint Clin, Overland Pk, KS USA; [Elovic, Elie] Phys Med & Rehabil, Reno, NV USA; [Koelbel, Stephen] Braintree Rehabil Hosp, Braintree, MA USA; [Francisco, Gerard] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Francisco, Gerard] TIRR Mem Hermann, Houston, TX 77030 USA; [Reuter, Iris] Justus Liebig Univ Giessen, Giessen, Hesse, Germany		Esquenazi, A (corresponding author), MossRehab Gait Lab, 60 Township Line Rd, Elkins Pk, PA 19027 USA.				Allergan, Inc.AbbVieAllergan	The study was funded by an unrestricted researcher initiated grant from Allergan, Inc.	ASHWORTH B, 1964, PRACTITIONER, V192, P540; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; DUNNE JW, 1995, J NEUROL NEUROSUR PS, V58, P232, DOI 10.1136/jnnp.58.2.232; Esquenazi A, 2004, Eura Medicophys, V40, P111; Esquenazi A, 2004, AM J PHYS MED REHAB, V83, pS19, DOI 10.1097/01.PHM.0000141127.63160.3E; Esquenazi A, 2013, TOXICON, V67, P115, DOI 10.1016/j.toxicon.2012.11.025; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P729, DOI 10.1097/PHM.0b013e31824fa9ca; Farrar JT, 2010, ANESTHESIOLOGY, V112, P1464, DOI 10.1097/ALN.0b013e3181de0e6d; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Francisco GE, 2002, AM J PHYS MED REHAB, V81, P355, DOI 10.1097/00002060-200205000-00007; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; Jankovic J, 2015, J NEUROL SCI, V349, P84, DOI 10.1016/j.jns.2014.12.030; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Lance JW, 1980, SPASTICITY DISORDERE; Lipitz-Snyderman A, 2016, JAMA INTERN MED, V176, P1541, DOI 10.1001/jamainternmed.2016.4426; Manack A, 2012, EPIDEMIOLOGY CURRENT; Mancini F, 2005, NEUROL SCI, V26, P26, DOI 10.1007/s10072-005-0378-9; Mayer N H, 2004, Eura Medicophys, V40, P85; Mayer Nathaniel H, 2003, Phys Med Rehabil Clin N Am, V14, P855, DOI 10.1016/S1047-9651(03)00093-7; Mayer NH, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P821; Murray C, 2011, GLOBAL BURDEN DIS IN; Olver J, 2010, EUR J NEUROL, V17, P57, DOI 10.1111/j.1468-1331.2010.03128.x; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Popescu I, 2016, MED CARE, V54, P780, DOI 10.1097/MLR.0000000000000561; Schramm A, 2014, J NEURAL TRANSM, V121, P521, DOI 10.1007/s00702-013-1145-3; Sheean G, 2006, DRUG SAFETY, V29, P31, DOI 10.2165/00002018-200629010-00003; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Wissel J, 2000, J PAIN SYMPTOM MANAG, V20, P44, DOI 10.1016/S0885-3924(00)00146-9; Wissel J, 2011, NERVENARZT, V82, P481, DOI 10.1007/s00115-010-3172-8; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303; Yablon SA, 2011, MOVEMENT DISORD, V26, P209, DOI 10.1002/mds.23426	32	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2017	96	12					881	888		10.1097/PHM.0000000000000781			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FN1MD	WOS:000415752600013	28657917	Green Published			2022-02-06	
J	Ginath, S; Elyashiv, O; Weiner, E; Sagiv, R; Bar, J; Menczer, J; Kovo, M; Condrea, A				Ginath, Shimon; Elyashiv, Osnat; Weiner, Eran; Sagiv, Ron; Bar, Jacob; Menczer, Joseph; Kovo, Michal; Condrea, Alexander			The optimal angle of the mediolateral episiotomy at crowning of the head during labor	INTERNATIONAL UROGYNECOLOGY JOURNAL			English	Article; Proceedings Paper	38th Annual Meeting of the International-Urogynaecology-Association (IUGA)	MAY 28-JUN 01, 2013	Dublin, IRELAND	Int Urogynaecol Assoc		Mediolateral episiotomy; Incision angle; Crowning	ANAL-SPHINCTER INJURY; RISK-FACTORS; INCISION ANGLE	The aim of the mediolateral episiotomy incision is to increase the diameter of the soft tissue of the vaginal outlet to facilitate birth and to prevent vaginal tears. Episiotomy angles that are too narrow and close to the midline increase the risk of obstetric anal sphincter injuries. In order to determine the optimal angle of the episiotomy, we assessed the changes in the angles of episiotomy lines marked during the first stage of labor and measured at the time of crowning of the head. Incision lines for mediolateral episiotomy were marked on the perineal skin at angles of 30A degrees, 45A degrees, and 60A degrees from the midline during the first stage of labor in women with a singleton pregnancy. The angles of the marked lines were measured at crowning of the head. Mediolateral episiotomy was performed only for obstetric indications. The study included 102 women with a singleton pregnancy. Of these women, 50 were primiparous and 52 were multiparous. All angles marked during the first stage of labor increased significantly (by more than 30A degrees) at crowning of the head. Similar changes were observed in primiparous and multiparous women. The angle of the mediolateral episiotomy line was significantly greater at crowning of the head than when marked during the first stage of labor. To achieve the desired episiotomy angle, it is important to take into consideration the changes in mediolateral episiotomy angles that occur during labor.	[Ginath, Shimon; Elyashiv, Osnat; Weiner, Eran; Sagiv, Ron; Bar, Jacob; Menczer, Joseph; Kovo, Michal; Condrea, Alexander] Edith Wolfson Med Ctr, Dept Obstet & Gynecol, Holon, Israel; [Ginath, Shimon; Elyashiv, Osnat; Weiner, Eran; Sagiv, Ron; Bar, Jacob; Menczer, Joseph; Kovo, Michal; Condrea, Alexander] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Ginath, Shimon] E Wolfson Med Ctr, Dept Gynecol & Obstet, HaLochamim 62,POB 5, IL-58100 Holon, Israel		Ginath, S (corresponding author), Edith Wolfson Med Ctr, Dept Obstet & Gynecol, Holon, Israel.; Ginath, S (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.; Ginath, S (corresponding author), E Wolfson Med Ctr, Dept Gynecol & Obstet, HaLochamim 62,POB 5, IL-58100 Holon, Israel.	ginath@gmail.com	Kovo, Michal/AAW-9252-2021				Andrews V, 2006, BIRTH-ISS PERINAT C, V33, P117, DOI 10.1111/j.0730-7659.2006.00088.x; Andrews V, 2005, BJOG-INT J OBSTET GY, V112, P1156, DOI 10.1111/j.1471-0528.2005.00645.x; Carroli G, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000081.pub2, DOI 10.1002/14651858.CD000081.PUB2]; COATS PM, 1980, BRIT J OBSTET GYNAEC, V87, P408, DOI 10.1111/j.1471-0528.1980.tb04569.x; DeLancey JOL, 2008, INT J GYNECOL OBSTET, V103, P3, DOI 10.1016/j.ijgo.2008.06.004; Eogan M, 2006, BJOG-INT J OBSTET GY, V113, P190, DOI 10.1111/j.1471-0528.2005.00835.x; Fraser D.M., 2009, MYLES TXB MIDWIVES; Gabbe SG, 2012, OBSTET NORMAL PROBLE; Gurol-Urganci I, 2013, BJOG-INT J OBSTET GY, V120, P1516, DOI 10.1111/1471-0528.12363; Jha S, 2016, INT UROGYNECOL J, V27, P849, DOI 10.1007/s00192-015-2893-4; Kalis V, 2008, INT J GYNECOL OBSTET, V100, P188, DOI 10.1016/j.ijgo.2007.07.022; Kalis V, 2012, BJOG-INT J OBSTET GY, V119, P522, DOI 10.1111/j.1471-0528.2011.03268.x; Kalis V, 2008, INT J GYNECOL OBSTET, V103, P5, DOI 10.1016/j.ijgo.2008.05.026; Kalis V, 2011, INT J GYNECOL OBSTET, V112, P220, DOI 10.1016/j.ijgo.2010.09.015; Kapoor DS, 2015, INT UROGYNECOL J, V26, P1725, DOI 10.1007/s00192-015-2747-0; Kettle Chris, 2011, BMJ Clin Evid, V2011; Revicky V, 2010, EUR J OBSTET GYN R B, V150, P142, DOI 10.1016/j.ejogrb.2010.03.002; Sagi-Dain L, 2015, INT UROGYNECOL J, V26, P1213, DOI 10.1007/s00192-015-2680-2; Stedenfeldt M, 2012, BJOG-INT J OBSTET GY, V119, P724, DOI 10.1111/j.1471-0528.2012.03293.x; Tincello DG, 2003, BJOG-INT J OBSTET GY, V110, P1041, DOI 10.1016/S1470-0328(03)03930-2; Twidale E, 2013, AUST NZ J OBSTET GYN, V53, P17, DOI 10.1111/j.1479-828X.2012.01483.x; van Dillen J, 2010, INT J GYNECOL OBSTET, V108, P97, DOI 10.1016/j.ijgo.2009.08.021; Wong MW, 2014, EUR J OBSTET GYN R B, V174, P46, DOI 10.1016/j.ejogrb.2013.12.002; Zafran N, 2012, ARCH GYNECOL OBSTET, V286, P591, DOI 10.1007/s00404-012-2333-3	24	5	6	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-3462	1433-3023		INT UROGYNECOL J	Int. Urogynecol. J.	DEC	2017	28	12					1795	1799		10.1007/s00192-017-3349-9			5	Obstetrics & Gynecology; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Obstetrics & Gynecology; Urology & Nephrology	FO0DX	WOS:000416414100004	28477150				2022-02-06	
J	Gomez, D; Byrne, JP; Alali, AS; Xiong, W; Hoeft, C; Neal, M; Subacius, H; Nathens, AB				Gomez, David; Byrne, James P.; Alali, Aziz S.; Xiong, Wei; Hoeft, Chris; Neal, Melanie; Subacius, Harris; Nathens, Avery B.			Inclusion of Highest Glasgow Coma Scale Motor Component Score in Mortality Risk Adjustment for Benchmarking of Trauma Center Performance	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							PREDICTION MODELS; BRAIN-INJURY; HEAD-INJURY	BACKGROUND: The Glasgow Coma Scale (GCS) is the most widely used measure of traumatic brain injury (TBI) severity. Currently, the arrival GCS motor component (mGCS) score is used in risk-adjustment models for external benchmarking of mortality. However, there is evidence that the highest mGCS score in the first 24 hours after injury might be a better predictor of death. Our objective was to evaluate the impact of including the highest mGCS score on the performance of risk-adjustment models and subsequent external benchmarking results. STUDY DESIGN: Data were derived from the Trauma Quality Improvement Program analytic dataset (January 2014 through March 2015) and were limited to the severe TBI cohort (16 years or older, isolated head injury, GCS <= 8). Risk-adjustment models were created that varied in the mGCS covariates only (initial score, highest score, or both initial and highest mGCS scores). Model performance and fit, as well as external benchmarking results, were compared. RESULTS: There were 6,553 patients with severe TBI across 231 trauma centers included. Initial and highest mGCS scores were different in 47% of patients (n = 3,097). Model performance and fit improved when both initial and highest mGCS scores were included, as evidenced by improved C-statistic, Akaike Information Criterion, and adjusted R-squared values. Three-quarters of centers changed their adjusted odds ratio decile, 2.6% of centers changed outlier status, and 45% of centers exhibited a >= 0.5-SD change in the odds ratio of death after including highest mGCS score in the model. CONCLUSIONS: This study supports the concept that additional clinical information has the potential to not only improve the performance of current risk-adjustment models, but can also have a meaningful impact on external benchmarking strategies. Highest mGCS score is a good potential candidate for inclusion in additional models. (C) 2017 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)	[Gomez, David; Byrne, James P.; Nathens, Avery B.] Univ Toronto, St Michaels Hosp, Div Gen Surg, Dept Surg, Toronto, ON, Canada; [Alali, Aziz S.] Univ Toronto, St Michaels Hosp, Interdept Div Crit Care, Toronto, ON, Canada; [Gomez, David] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Byrne, James P.; Alali, Aziz S.; Xiong, Wei; Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Hoeft, Chris; Neal, Melanie; Subacius, Harris; Nathens, Avery B.] Amer Coll Surg, Trauma Qual Improvement Program, Chicago, IL USA		Gomez, D (corresponding author), St Michaels Hosp, 30 Bond St,Donnelly Wing,Room 3-074B, Toronto, ON M4N 3M5, Canada.	David.gomezjaramillo@mail.utoronto.ca		Gomez, David/0000-0002-0926-2547; Byrne, James/0000-0002-3760-8509			American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; American College of Surgeons Committee on Trauma, 2015, NAT TRAUM DAT STAND; Byrne JP, 2015, J TRAUMA ACUTE CARE, V79, P850, DOI 10.1097/TA.0000000000000843; Gerds TA, 2008, BIOMETRICAL J, V50, P457, DOI 10.1002/bimj.200810443; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hattori N, 2003, J NUCL MED, V44, P1709; Hosmer DW, 1997, STAT MED, V16, P965; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MRC Crash Trial Collaborators, 2008, BMJ-BRIT MED J, V336, P423; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	14	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	DEC	2017	225	6					755	762		10.1016/j.jamcollsurg.2017.08.020			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FO1AD	WOS:000416487600010	28912029				2022-02-06	
J	Jorgensen, JK; Thoreson, AR; Stuart, MB; Loyd, A; Smith, AM; Twardowski, C; Gaz, DV; Hollman, JH; Krause, DA; An, KN; Stuart, MJ				Jorgensen, Janelle K.; Thoreson, Andrew R.; Stuart, Michael B.; Loyd, Andre; Smith, Aynsley M.; Twardowski, Casey; Gaz, Daniel V.; Hollman, John H.; Krause, David A.; An, Kai Nan; Stuart, Michael J.			Interpreting oblique impact data from an accelerometer-instrumented ice hockey helmet	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Concussion; dynamics; helmet; ice hockey; impact	TRAUMATIC BRAIN-INJURY; HEAD ACCELERATION; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; CONCUSSION; FOOTBALL; SYSTEM; VALIDATION; SPORT; EPIDEMIOLOGY	The purpose of this study was to assess the correlations of acceleration measurements between an instrumented hockey helmet and the Hybrid III headform and to determine whether collision with a broad surface affects the correlations between these data. A CCM Vector hockey helmet, instrumented with the Head Impact Telemetry System, was fitted onto an instrumented Hybrid III headform and dropped onto an inclined plate to simulate impacts in hockey. The helmet and headform were dropped from 0.15, 0.30, and 0.60m at different orientations to create impacts to the vertex, occipital, right, left, and forehead surfaces. Peak linear and rotational acceleration magnitudes and head injury criteria were assessed for each system. Correlations were assessed with the Pearson correlation coefficient, and linear regression models were generated. Relative error was assessed, and results were compared with the Wilcoxon signed rank test. Peak acceleration magnitudes generally had strong mathematical correlations, although a 1:1 linear relationship for rotational acceleration data was not observed. Differences between helmet and head peak acceleration magnitudes were significant. The linear relationship varied according to the impact direction. Instrumented helmet and head data demonstrated a strong mathematical correlation, but measures of linear acceleration generally had better 1:1 agreement than rotational acceleration measures. There is some dependence in the relationship between the helmet and head data on the impact direction, with vertex strikes showing the weakest correlation. Although data generated from the helmet may be useful for interpreting head accelerations experienced by on-ice players, additional analysis of the time-series data should be performed to understand its full utility.	[Jorgensen, Janelle K.; Stuart, Michael B.; Smith, Aynsley M.; Twardowski, Casey; Gaz, Daniel V.; Stuart, Michael J.] Mayo Clin, Ctr Sports Med, Rochester, MN USA; [Thoreson, Andrew R.; Loyd, Andre; An, Kai Nan] Mayo Clin, Div Orthoped Res, Rochester, MN USA; [Hollman, John H.; Krause, David A.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Stuart, Michael J.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA		Stuart, MJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	stuart.michael@mayo.edu	Hollman, John H./AAG-9301-2019	Hollman, John/0000-0003-4690-223X	USA Hockey Foundation; Johannson-Gund Endowment; Mayo Clinic Sports Medicine Center Discretionary Committee; Mayo Clinic-Karolinska Institute Collaborative Travel Award; Mayo Rehabilitation Research Training Grant [T32-HD-07447]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work received financial support from the USA Hockey Foundation, the Johannson-Gund Endowment, the Mayo Clinic Sports Medicine Center Discretionary Committee, and the Mayo Clinic-Karolinska Institute Collaborative Travel Award. Dr Loyd was sponsored by T32-HD-07447 Mayo Rehabilitation Research Training Grant.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; [Anonymous], 2011, TRAUMATIC BRAIN INJU; [Anonymous], F1045991999 ASTM; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bishop PJ, 2009, AM SOC TEST MATER, V1516, P3, DOI 10.1520/JAI101900; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Chu JJ, 2006, J BIOMECH S1, V39, pS534; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Cubos J, RELATIONSHIP RISK FA, V6, P260; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gwin JT, 2009, SITU MEASURES HEAD I, V6; Hanlon E, 2010, J APPL BIOMECH, V26, P424, DOI 10.1123/jab.26.4.424; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McPherson M, 2009, ANAL HEAD IMPACT PRO, V6; Mertz H. J, 1985, 851245 SAE; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Rousseau P., 2009, J ASTM INT, V6, P1; SMITH AM, 1999, POWER PLAY MENTAL TO; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Smith AM, 2011, AM J PHYS MED REHAB, V90, P694, DOI 10.1097/PHM.0b013e318224736b; Williamson IJS, 2009, AM SOC TEST MATER, V1516, P211, DOI 10.1520/JAI101851; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	35	5	5	2	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	DEC	2017	231	4					307	316		10.1177/1754337117700549			10	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	FO1VW	WOS:000416557100007					2022-02-06	
J	Khokhar, B; Simoni-Wastila, L; Slejko, JF; Perfetto, E; Zhan, M; Smith, GS				Khokhar, Bilal; Simoni-Wastila, Linda; Slejko, Julia F.; Perfetto, Eleanor; Zhan, Min; Smith, Gordon S.			In-Hospital Mortality Following Traumatic Brain Injury Among Older Medicare Beneficiaries, Comparing Statin Users With Nonusers	JOURNAL OF PHARMACY TECHNOLOGY			English	Article						trauma medicine; cardiovascular drugs; trauma; geriatrics; pharmacoepidemiology	UNITED-STATES; SURVIVAL; THERAPY; SURVEILLANCE; STRATEGIES; ADULTS; RISK; BIAS	Background: Traumatic brain injury (TBI) is a significant public health concern for older adults. Small-scale human studies have suggested pre-TBI statin use is associated with decreased in-hospital mortality following TBI, highlighting the need for large-scale translational research. Objective: To investigate the relationship between pre-TBI statin use and in-hospital mortality following TBI. Methods: A retrospective study of Medicare beneficiaries 65 and older hospitalized with a TBI during 2006 to 2010 was conducted to assess the impact of pre-TBI statin use on in-hospital mortality following TBI. Exposure of interest included atorvastatin, fluvastatin, lovastatin, pravastatin, rosuvastatin, and simvastatin. Beneficiaries were classified as current, recent, past, and nonusers of statins prior to TBI. The outcome of interest was in-hospital mortality. Logistic regression was used to obtain odds ratios (ORs) and 95% confidence intervals (CIs) comparing current, recent, and prior statin use to nonuse. Results: Most statin users were classified as current users (90%). Current atorvastatin (OR = 0.88; 95% = CI 0.82, 0.96), simvastatin (OR = 0.84; 95% CI = 0.79, 0.91), and rosuvastatin (OR = 0.79; 95% CI = 0.67, 0.94) use were associated with a significant decrease in the risk of in-hospital mortality following TBI. Conclusions: In addition to being the most used statins, current use of atorvastatin, rosuvastatin, and simvastatin was associated with a significant decrease in in-hospital mortality following TBI among older adults. Future research must include clinical trials to help exclude the possibility of a healthy user effect in order to better understand the impact of statin use on in-hospital mortality following TBI.	[Khokhar, Bilal] Def & Vet Brain Injury Ctr, Gen Dynam Hlth Solut, 1335 East West Highway, Silver Spring, MD 20910 USA; [Simoni-Wastila, Linda; Slejko, Julia F.; Perfetto, Eleanor; Zhan, Min; Smith, Gordon S.] Univ Maryland, Baltimore, MD 21201 USA; [Perfetto, Eleanor] Natl Hlth Council, Washington, DC USA; [Smith, Gordon S.] West Virginia Univ, Morgantown, WV 26506 USA		Khokhar, B (corresponding author), Def & Vet Brain Injury Ctr, Gen Dynam Hlth Solut, 1335 East West Highway, Silver Spring, MD 20910 USA.	Bilal.khokhar@gdit.com	Slejko, Julia/M-9335-2019	Smith, Gordon/0000-0002-2911-3071	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AG000262-14, R01AA18707]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018707] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr Khokhar was supported by National Institutes of Health Grant T32AG000262-14 (Magaziner, PI) and Dr Smith by National Institutes of Health Grant R01AA18707.	Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Centers for Disease Control and Prevention, 2001, RAT TBI REL HOSP AG; Centers for Disease Control and Prevention, TBI GET FACTS; Chong PH, 2001, AM J MED, V111, P390, DOI 10.1016/S0002-9343(01)00870-1; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Efron DT, 2008, J TRAUMA, V64, P66, DOI 10.1097/TA.0b013e31815b842a; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Khokhar B, 2017, J HEAD TRAUMA REHAB, V32, pE42, DOI 10.1097/HTR.0000000000000231; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Neilson SJ, 2016, BRAIN INJURY, V30, P993, DOI 10.3109/02699052.2016.1147599; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; Orlando Alessandro, 2013, J Clin Med Res, V5, P168, DOI 10.4021/jocmr1333w; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409; Radosevich JJ, 2013, BRAIN INJURY, V27, P1492, DOI 10.3109/02699052.2013.823658; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Shrank WH, 2011, J GEN INTERN MED, V26, P546, DOI 10.1007/s11606-010-1609-1; Tawakol A, 2013, J AM COLL CARDIOL, V62, P909, DOI 10.1016/j.jacc.2013.04.066; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; van Rein N, 2016, AM J EPIDEMIOL, V183, P930, DOI 10.1093/aje/kwv255; Zhou Q, 2009, CURR PHARM DESIGN, V15, P467, DOI 10.2174/138161209787315684	30	5	5	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	8755-1225	1549-4810		J PHARM TECHNOL	J. Pharm. Technol.	DEC	2017	33	6					225	236		10.1177/8755122517735656			12	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	FL0OL	WOS:000413910600003	29607441	Green Accepted, Green Published			2022-02-06	
J	Madhukar, A; Chen, Y; Ostoja-Starzewski, M				Madhukar, Amit; Chen, Ying; Ostoja-Starzewski, Martin			Effect of cerebrospinal fluid modeling on spherically convergent shear waves during blunt head trauma	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						blunt head trauma; cerebrospinal fluid; constitutive laws; human brain; MRI; shear wave	MECHANICAL-PROPERTIES; BRAIN; INJURY; CONCUSSION; FOOTBALL; IMPACTS; MOTION; SCALP	The MRI-based computational model, previously validated by tagged MRI and harmonic phase imaging analysis technique on in vivo human brain deformation, is used to study transient wave dynamics during blunt head trauma. Three different constitutive models are used for the cerebrospinal fluid: incompressible solid elastic, viscoelastic, and fluid-like elastic using an equation of state model. Three impact cases are simulated, which indicate that the blunt impacts give rise not only to a fast pressure wave but also to a slow, and potentially much more damaging, shear (distortional) wave that converges spherically towards the brain center. The wave amplification due to spherical geometry is balanced by damping due to tissues' viscoelasticity and the heterogeneous brain structure, suggesting a stochastic competition of these 2 opposite effects. It is observed that this convergent shear wave is dependent on the constitutive property of the cerebrospinal fluid, whereas the peak pressure is not as significantly affected.	[Madhukar, Amit] Univ Illinois, Dept Mech Sci & Engn, Champaign, IL USA; [Chen, Ying; Ostoja-Starzewski, Martin] Univ Illinois, Dept Mech Sci & Engn, Champaign, IL 61801 USA; [Chen, Ying; Ostoja-Starzewski, Martin] Univ Illinois, Beckman Inst, Champaign, IL 61801 USA		Ostoja-Starzewski, M (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Champaign, IL 61801 USA.; Ostoja-Starzewski, M (corresponding author), Univ Illinois, Beckman Inst, Champaign, IL 61801 USA.	martinos@illinois.edu	Ostoja-Starzewski, Martin/C-9963-2012	Ostoja-Starzewski, Martin/0000-0002-3493-363X	NSFNational Science Foundation (NSF) [CMMI-1462749]; NCSA/IACAT	NSF, Grant/Award Number: CMMI-1462749; NCSA/IACAT Fellows; Illinois Distinguished Fellows	Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen Y.F., 2011, INT J NUMER ANAL MOD, V03, P1; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; ESTES MS, 1970, P 4 ASME BIOM C; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; HOFMAN MA, 1991, J HIRNFORSCH, V32, P103; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Joldes GR, 2016, COMPUTATIONAL BIOMEC, P177; Joumaa H, 2013, EUR PHYS J-SPEC TOP, V222, P1951, DOI 10.1140/epjst/e2013-01976-x; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miller K, 2011, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-1-4419-9997-9; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1968, J BIOMECH; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Ostoja-Starzewski M, 2012, ACTA MECH, V223, P1777, DOI 10.1007/s00707-012-0658-4; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Tabacu S, 2015, COMPUT METHOD BIOMEC, V18, P769, DOI 10.1080/10255842.2013.847092; THOMAS LM, 1966, J NEUROL NEUROSUR PS, V29, P404, DOI 10.1136/jnnp.29.5.404; Watanabe DY, 2008, HEN TRANSJAPAN SOC M, V74, P611; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	42	5	5	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	DEC	2017	33	12							e2881	10.1002/cnm.2881			11	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	FO8CK	WOS:000417109700002	28294580				2022-02-06	
J	Makhoba, MA; du Toit-Prinsloo, L				Makhoba, Musa Aubrey; du Toit-Prinsloo, Lorraine			Self-inflicted explosive death by intra-oral detonation of a firecracker: a case report	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Article						Blast injury; Fireworks; Intra-cranial injuries; Intra-oral injuries; Suicide	FIREWORKS	Self-inflicted explosive deaths due to detonation of fireworks are rare. In this case report, a peculiar case of an elderly male who discharged a firecracker inside his mouth, resulting in fatal blast induced craniofacial injuries, is described. There is paucity of published data describing fireworks-related suicidal and/or non-suicidal deaths. Even scantier data is present specifically describing fireworks-related blast induced neurotrauma and the mechanism(s) of injury involved in such cases. This case report emphasizes the severe damage that a commercially available explosive, the so-called "Gorilla Bomb", can cause, and raises questions about the relative ease of its acquisition.	[Makhoba, Musa Aubrey; du Toit-Prinsloo, Lorraine] Univ Pretoria, Dept Forens Med, Private Bag X323, ZA-0007 Arcadia, South Africa		Makhoba, MA (corresponding author), Univ Pretoria, Dept Forens Med, Private Bag X323, ZA-0007 Arcadia, South Africa.	aubrey.makhoba@up.ac.za	du Toit-Prinsloo, Lorraine/V-4482-2019	du Toit-Prinsloo, Lorraine/0000-0003-1974-9313			Blanco-Pampin JM, 2001, J FORENSIC SCI, V46, P402; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Elsayed NM, 2010, EXPLOSION BLAST RELA, P400; Farooqui JM, 2016, MED SCI LAW, V56, P233, DOI 10.1177/0025802415588991; Kunz SN, 2011, FORENSIC SCI INT, V210, pE4, DOI 10.1016/j.forsciint.2011.04.013; Stedman TL, 1995, STEDMAN MED DICT HLT, P2029; Temple RK, 2007, GENIUS CHINA 3 000 Y, P256; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zhao Y, 2015, CHIN J TRAUMATOL, V18, P201, DOI 10.1016/j.cjtee.2015.10.002; Zwirner J, 2017, INT J LEGAL MED	10	5	6	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X	1556-2891		FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.	DEC	2017	13	4					459	463		10.1007/s12024-017-9910-5			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	FN0DP	WOS:000415647300012	28871369	Green Submitted			2022-02-06	
J	Summers, Z; Teague, WJ; Hutson, JM; Palmer, CS; Jowett, HE; King, SK				Summers, Zara; Teague, Warwick J.; Hutson, John M.; Palmer, Cameron S.; Jowett, Helen E.; King, Sebastian K.			The spectrum of pediatric injuries sustained in snow sports	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	50th Annual Meeting of the Pacific-Association-of-Pediatric-Surgeons (PAPS)	MAY 28-JUN 01, 2017	Seattle, WA	Pacif Assoc Pediat Surg		Snow sports; Skiing; Snowboarding; Injuries; Children; Helmets	HELMET USE; HEAD-INJURIES; SNOWBOARDING INJURIES; SKIERS; CHILDREN; RISK; SEVERITY; PATTERNS; WEAR	Background: Snow sports are popular among children but carry the potential for significant injury. Head injuries are less common than fractures and sprains but may be fatal. Helmets are recommended for all snow sports, and yet their effectiveness remains unknown. We aimed to evaluate the spectrum of injuries sustained at three large alpine resorts and to assess the effect of helmet usage on injury severity. Methods: We performed a retrospective analysis of prospectively collected pediatric trauma data (2005-2015) from the three largest alpine resorts in our state. Data were analyzed using Spearman's correlation, chi-square, and odds ratio. Results: A total of 6299 incidents were reviewed. Skiers accounted for 3821 (60.7%) patients, while snowboarders accounted for 2422 (38.5%) patients. More than half (53.5%) of the injuries were related to falls, predominantly affecting knees in skiers and wrists in snowboarders. Overall, helmet usage decreased with age (p < 0.001), though helmet uptake was positively associated with higher level of ability in both skiers and snowboarders (p < 0.001). Concussions in both skiers and snowboarders were inversely correlated with the rates of helmet usage (p < 0.05). Conclusion: Helmet usage was associated with reduced rates of concussion. However, helmet usage decreased with age. We advocate for promotion of helmet usage, using mandatory guidelines, across all pediatric age groups. (c) 2017 Elsevier Inc. All rights reserved.	[Summers, Zara; Teague, Warwick J.; Hutson, John M.; King, Sebastian K.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Summers, Zara; Teague, Warwick J.; Hutson, John M.; King, Sebastian K.] Murdoch Childrens Res Inst, F Douglas Stephens Surg Res Grp, Melbourne, Vic, Australia; [Teague, Warwick J.; King, Sebastian K.] Royal Childrens Hosp, Dept Paediat Surg, Melbourne, Vic 3052, Australia; [Teague, Warwick J.; Palmer, Cameron S.; Jowett, Helen E.] Royal Childrens Hosp, Trauma Serv, Melbourne, Vic, Australia; [Hutson, John M.] Royal Childrens Hosp, Dept Urol, Melbourne, Vic, Australia; [Palmer, Cameron S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [King, Sebastian K.] Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Melbourne, Vic, Australia		King, SK (corresponding author), Royal Childrens Hosp, Dept Paediat Surg, Melbourne, Vic 3052, Australia.	sebastian.king@rch.org.au	Teague, Warwick J/AAY-7260-2020	Teague, Warwick J/0000-0003-4747-6025	Murdoch Children's Research Institute; Royal Australasian College of Surgeons; Royal Children's Hospital Foundation	Associate Professor Sebastian King is the grateful recipient of a Career Development Award (Murdoch Children's Research Institute) and Senior Lecturer Fellowship (Royal Australasian College of Surgeons). His position as an Academic Pediatric Surgeon is generously supported by The Royal Children's Hospital Foundation. Associate Professor Warwick Teague's position as an Academic Pediatric Surgeon and Director of Trauma Services is generously supported by The Royal Children's Hospital Foundation.	Andersen PA, 2004, INJURY PREV, V10, P358, DOI 10.1136/ip.2004.005967; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Byrd D., 2013, NATL SKI ASS AM 2013; Chaze B, 2009, PHYS MED REH CLIN N, V20, P287, DOI 10.1016/j.pmr.2008.10.016; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Fenerty L, 2013, J TRAUMA ACUTE CARE, V74, P895, DOI 10.1097/TA.0b013e31827e19ca; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Fukuda O, 2007, NEUROL MED-CHIR, V47, P491, DOI 10.2176/nmc.47.491; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Graves JM, 2013, INJURY PREV, V19, P399, DOI 10.1136/injuryprev-2012-040727; Hackam DJ, 1999, J PEDIATR SURG, V34, P65, DOI 10.1016/S0022-3468(99)90230-0; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; Hagel B, 2005, MED SPORT SCI, V48, P74, DOI 10.1159/000084284; Hagel BE, 2010, AM J EPIDEMIOL, V171, P1134, DOI 10.1093/aje/kwq039; Hoshizaki B, 2012, J NEUROSURG-PEDIATR, V9, P133, DOI 10.3171/2011.11.PEDS11299; Macnab A J, 1998, Paediatr Child Health, V3, P321; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Macpherson A, 2008, COCHRANE DB SYST REV, V3, P16; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Peterson Andrew R, 2010, WMJ, V109, P28; Pigozzi F, 1997, ORTHOPEDICS, V20, P505; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Russell K, 2007, CLIN J SPORT MED, V17, P145, DOI 10.1097/JSM.0b013e31803f901b; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sutherland AG, 1996, INJURY, V27, P423, DOI 10.1016/0020-1383(96)00026-5; Xiang H, 2004, INJURY PREV, V10, P99, DOI 10.1136/ip.2003.004655; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	30	5	5	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	DEC	2017	52	12					2038	2041		10.1016/j.jpedsurg.2017.08.038			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Surgery	FP5EA	WOS:000417641500031	28958714				2022-02-06	
J	Wainwright, C; McClure, J; McDowall, J				Wainwright, Charlotte; McClure, John; McDowall, John			Misconceptions about Stroke: Causal Attributions for Stroke-Related Symptoms Reflect the Age of the Survivor	BRAIN IMPAIRMENT			English	Article						stroke; age; young stroke survivors; invisible disorders; attributions; rehabilitation; stigma; misconceptions	QUALITY-OF-LIFE; APHASIA TREATMENT; FAMILY-MEMBERS; SOCIAL SUPPORT; POSTSTROKE; DEPRESSION; PEOPLE; RECOVERY; REHABILITATION; COMMUNICATION	With visible disabilities, observers tend to overgeneralise from the disability. In contrast, with invisible disabilities such as traumatic brain injury and stroke, observers often fail to allow for challenges resulting from the disability. Persons who have suffered a stroke claim that people misunderstand their symptoms and stigmatise them as a result of these symptoms. This misunderstanding, which happens particularly with young survivors of stroke, may reflect people's causal attributions for symptoms that follow a stroke. Using a scenario design, this crosssectional study examined whether people attribute ambiguous symptoms that may result from stroke to other causes (the stroke survivor's personality and age) and whether these attributions reflect the age of the stroke survivor. Participants (N = 120) read scenarios describing a male who was aged either 22, 72, or whose age was unstated and who showed four symptom changes: fatigue, depression, irritability and reduced friendships. For each symptom change, participants rated three causal attributions: the person's age, his personality and stroke. The age of the person in the scenario affected attributions; when the person in the scenario was 22, participants attributed his symptoms significantly more to his personality than to his age or stroke, whereas when he was 72, participants attributed his symptoms more to his age than to his personality or stroke and when his age was unstated, they attributed his symptoms equally to age, stroke and personality. Because misattributions for stroke symptoms hinder rehabilitation, therapy can target people's misattributions to enhance rehabilitation for survivors of stroke.	[Wainwright, Charlotte; McClure, John; McDowall, John] Victoria Univ Wellington, Sch Psychol, POB 600, Wellington, New Zealand		McClure, J (corresponding author), Victoria Univ Wellington, Sch Psychol, POB 600, Wellington, New Zealand.	john.mcclure@vuw.ac.nz	McClure, John/O-9060-2015	McClure, John/0000-0002-9261-4995; McDowall, John/0000-0001-6778-0134			[Anonymous], 2014, NAT STROK AUD REH SE; Babbitt EM, 2011, APHASIOLOGY, V25, P727, DOI 10.1080/02687038.2010.537347; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brock K, 2009, DISABIL REHABIL, V31, P880, DOI 10.1080/09638280802356179; Brown K, 2013, INT J SPEECH-LANG PA, V15, P165, DOI 10.3109/17549507.2012.692814; Brown K, 2010, APHASIOLOGY, V24, P1267, DOI 10.1080/02687031003755429; Brumfitt SM, 1999, BRIT J CLIN PSYCHOL, V38, P387, DOI 10.1348/014466599162980; Ch'ng AM, 2008, J HEALTH PSYCHOL, V13, P1136, DOI 10.1177/1359105308095967; Chapey R., 2000, ASHA LEADER, V5, P4, DOI [10.1044/leader.FTR.05032000.4, DOI 10.1044/LEADER.FTR.05032000.4]; Chapey R., 2008, LANGUAGE INTERVENTIO, V5th, P279; Code C, 2003, NEUROPSYCHOL REHABIL, V13, P379, DOI 10.1080/09602010244000255; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Cruice M, 2006, TOP STROKE REHABIL, V13, P14, DOI 10.1310/4JW5-7VG8-G6X3-1QVJ; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grant JS, 2001, REHABIL PSYCHOL, V46, P44, DOI 10.1037/0090-5550.46.1.44; Grawburg M, 2013, DISABIL REHABIL, V35, P1324, DOI 10.3109/09638288.2012.735341; Grohn B, 2014, APHASIOLOGY, V28, P1405, DOI 10.1080/02687038.2014.935118; Grohn B, 2012, INT J SPEECH-LANG PA, V14, P390, DOI 10.3109/17549507.2012.692813; Hallowell B., 2008, LANGUAGE INTERVENTIO; Hilari K, 2010, CLIN REHABIL, V24, P181, DOI 10.1177/0269215509346090; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Howe T, 2012, INT J LANG COMM DIS, V47, P511, DOI 10.1111/j.1460-6984.2012.00159.x; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kang HJ, 2013, J AFFECT DISORDERS, V147, P186, DOI 10.1016/j.jad.2012.10.035; Kauhanen ML, 2000, CEREBROVASC DIS, V10, P455, DOI 10.1159/000016107; Kimbarow ML, 2007, TOP LANG DISORD, V27, P318, DOI 10.1097/01.TLD.0000299886.16617.25; Kirkevold M, 2012, INT J NURS STUD, V49, P386, DOI 10.1016/j.ijnurstu.2011.10.006; Kneebone II, 2016, DISABIL REHABIL, V38, P1836, DOI 10.3109/09638288.2015.1107764; Kutlubaev MA, 2014, INT J STROKE, V9, P1026, DOI 10.1111/ijs.12356; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; Natterlund BS, 2010, SCAND J OCCUP THER, V17, P117, DOI 10.3109/11038120902814416; Northcott S, 2015, FOLIA PHONIATR LOGO, V67, P156, DOI 10.1159/000439217; Parr S., 1997, TALKING APHASIA LIVI; Paul D.R., 2005, QUALITY COMMUNICATIO; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Plano Clark, 2018, DESIGNING CONDUCTING; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; Sarno MT, 1997, APHASIOLOGY, V11, P665, DOI 10.1080/02687039708249414; Sekhon JK, 2015, INT J SPEECH-LANG PA, V17, P252, DOI 10.3109/17549507.2015.1024170; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shadden BB, 2005, APHASIOLOGY, V19, P211, DOI 10.1080/02687930444000697; Simmons-Mackie N, 2011, TOP LANG DISORD, V31, P336, DOI 10.1097/TLD.0b013e318234ea9f; Thomas SA, 2008, STROKE, V39, P1240, DOI 10.1161/STROKEAHA.107.498279; Thomas SA, 2013, CLIN REHABIL, V27, P398, DOI 10.1177/0269215512462227; WADE DT, 1986, J NEUROL NEUROSUR PS, V49, P11, DOI 10.1136/jnnp.49.1.11; Whyte J, 2009, ARCH PHYS MED REHAB, V90, pS3, DOI 10.1016/j.apmr.2009.07.008; Zemva N, 1999, APHASIOLOGY, V13, P219, DOI 10.1080/026870399402190; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	5	5	1	16	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2017	18	3					299	309		10.1017/BrImp.2017.13			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	FS0YI	WOS:000419499900007					2022-02-06	
J	Wong, DN; Wang, QJ; Stolwyk, R; Ponsford, J				Wong, Dana; Wang, Qiao Jerry; Stolwyk, Renerus; Ponsford, Jennie			Do Smartphones have the Potential to Support Cognition and Independence Following Stroke?	BRAIN IMPAIRMENT			English	Article						smartphones; stroke; assistive technology; cognitive rehabilitation; memory aids	TRAUMATIC BRAIN-INJURY; INVISIBLE DISABILITY; CAUSAL ATTRIBUTIONS; CASE-FATALITY; REHABILITATION; DEPRESSION; SURVIVORS; MISCONCEPTIONS; KNOWLEDGE; INTERVENTION	Management of cognitive difficulties is a significant unmet need for individuals with stroke. Incorporating multiple functions, including memory aids and communication tools, smartphones have potential to improve everyday cognitive function and independence in daily activities post-stroke. We aimed to investigate patterns of smartphone use, facilitators and barriers to use, and relationships between smartphone use and daily functioning. Twenty-nine participants with stroke and 29 comparison participants with no history of neurological conditions completed measures of smartphone use, objective and subjective cognitive function, mood and community integration. Themajority of participants used smartphones, though the proportion of users was lower in the stroke group (62%) than the comparison group (86%). Older participants were less likely to use smartphones. Using apps that support memory was a main benefit of smartphone use post-stroke. In the stroke group, frequent users of memory apps had significantly fewer motor symptoms (d = 1.20), and higher productivity (d = 0.84). Stroke survivors identified difficulty learning how to use smartphones, but only one participant had assistance with this from a clinician. These results suggest that smartphones have potential as assistive technology post-stroke, however, support in using them is essential, particularly for older individuals with motor dysfunction.	[Wong, Dana; Wang, Qiao Jerry; Stolwyk, Renerus; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Wong, Dana; Wang, Qiao Jerry; Stolwyk, Renerus; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Wong, Dana; Stolwyk, Renerus; Ponsford, Jennie] Monash Univ, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Wong, DN (corresponding author), Monash Univ, Sch Psychol Sci, 18 Innovat Walk, Clayton, Vic 3800, Australia.	dana.wong@monash.edu		Wong, Dana/0000-0001-9619-1929			ANDERSON CS, 1995, STROKE, V26, P843, DOI 10.1161/01.STR.26.5.843; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Burton CAC, 2013, INT J STROKE, V8, P545, DOI 10.1111/j.1747-4949.2012.00906.x; Carod-Artal FJ, 2010, FUTUR NEUROL, V5, P569, DOI 10.2217/FNL.10.27; Carod-Artal FJ, 2009, J NEUROL SCI, V284, P63, DOI 10.1016/j.jns.2009.04.008; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Clark MS, 1998, DISABIL REHABIL, V20, P90, DOI 10.3109/09638289809166061; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Dam H, 2001, ACTA PSYCHIAT SCAND, V103, P287, DOI 10.1034/j.1600-0447.2001.103004287.x; Davis CG, 2013, REHABIL PSYCHOL, V58, P287, DOI 10.1037/a0033400; Davis NA, 2005, ETHICS, V116, P153, DOI 10.1086/453151; Duncan F, 2014, J PSYCHOSOM RES, V77, P368, DOI 10.1016/j.jpsychores.2014.06.013; Dunn DS, 2008, REHABIL PSYCHOL, V53, P254, DOI 10.1037/a0012962; Dunn DS, 2005, REHABIL PSYCHOL, V50, P183, DOI 10.1037/0090-5550.50.2.183; Dyall L, 2008, SOC POLICY J NZ, P178; Eagly AH, 2000, DEVELOPMENTAL SOCIAL PSYCHOLOGY OF GENDER, P123; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; FISKE ST, 1982, J EXP SOC PSYCHOL, V18, P105, DOI 10.1016/0022-1031(82)90046-4; Foster L, 2013, BRAIN INJURY, V27, P485, DOI 10.3109/02699052.2012.750747; Gallagher J., 2017, INFORM STROKE SURVIV; Garcia SF, 2015, ARCH PHYS MED REHAB, V96, P596, DOI 10.1016/j.apmr.2014.06.019; Gibb BE, 2006, J CLIN CHILD ADOLESC, V35, P264, DOI 10.1207/s15374424jccp3502_10; Goffman E., 1963, STIGMA NOTES MANAGEM; GOUVIER WD, 1991, REHABIL PSYCHOL, V36, P121, DOI 10.1037/0090-5550.36.2.121; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; Groppo E, 2012, NEUROL SCI, V33, P53, DOI 10.1007/s10072-011-0654-9; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Irwin LG, 2014, ARCH CLIN NEUROPSYCH, V29, P194, DOI 10.1093/arclin/act118; Joachim G, 2000, J ADV NURS, V32, P243, DOI 10.1046/j.1365-2648.2000.01466.x; Jones SP, 2010, AGE AGEING, V39, P11, DOI 10.1093/ageing/afp196; Kim Jong S, 2005, J Clin Neurol, V1, P1, DOI 10.3988/jcn.2005.1.1.1; Knapp P., 2010, ACUTE STROKE NURSING, P205, DOI DOI 10.1002/9781444318838; Krahn T.M., 2015, HDB NEUROETHICS, P1501, DOI [10.1007/978-94-007-4707-4_126, DOI 10.1007/978-94-007-4707-4_126]; Lawrence Maggie, 2010, Br J Nurs, V19, P241; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Lingsom S, 2008, SCAND J DISABIL RES, V10, P2, DOI 10.1080/15017410701391567; Maaijwee NAMM, 2014, NAT REV NEUROL, V10, P612, DOI 10.1038/nrneurol.2014.183; Mackenzie A, 2007, DISABIL REHABIL, V29, P111, DOI 10.1080/09638280600731599; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Mayo NE, 2015, CLIN REHABIL, V29, P1198, DOI 10.1177/0269215514565396; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; McClure J, 2011, J HEAD TRAUMA REHAB, V26, P392, DOI 10.1097/HTR.0b013e3181f8fd34; McClure J, 2009, BRAIN IMPAIR, V10, P180, DOI 10.1375/brim.10.2.180; Morris R, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/534812; Murray CD, 2004, DISABIL REHABIL, V26, P808, DOI 10.1080/09638280410001696746; Paranthaman R, 2006, INT REV PSYCHIATR, V18, P453, DOI 10.1080/09540260600935462; Pontes-Neto OM, 2008, STROKE, V39, P292, DOI 10.1161/STROKEAHA.107.493908; RAVAUD JF, 1992, SOC SCI MED, V35, P951, DOI 10.1016/0277-9536(92)90234-H; Rodgers H, 1999, STROKE, V30, P2585, DOI 10.1161/01.STR.30.12.2585; Roding J, 2003, DISABIL REHABIL, V25, P867, DOI 10.1080/0963828031000122276; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Smith GC, 2012, REHABIL PSYCHOL, V57, P196, DOI 10.1037/a0029587; SNYDER ML, 1979, J PERS SOC PSYCHOL, V37, P2297, DOI 10.1037/0022-3514.37.12.2297; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Stone SD, 2005, DISABIL REHABIL, V27, P293, DOI 10.1080/09638280400008990; Sullivan Karen, 2005, Top Stroke Rehabil, V12, P72; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P205; Turner-Stokes L, 2002, CLIN REHABIL, V16, P231, DOI 10.1191/0269215502cr487oa; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Tyrrell P. J., 2005, THERAPY, V2, P865, DOI DOI 10.2217/14750708.2.6.865; WELLWOOD I, 1994, AGE AGEING, V23, P293, DOI 10.1093/ageing/23.4.293; Wolfenden B, 2012, BRAIN IMPAIR, V13, P203, DOI 10.1017/BrImp.2012.16; Wu SM, 2015, STROKE, V46, P893, DOI 10.1161/STROKEAHA.114.006647	69	5	5	2	18	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2017	18	3					310	320		10.1017/BrImp.2017.10			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	FS0YI	WOS:000419499900008					2022-02-06	
J	Zemrak, WR; Smith, KE; Rolfe, SS; May, T; Trowbridge, RL; Hayes, TL; Grindlinger, GA; Seder, DB				Zemrak, Wesley R.; Smith, Kathryn E.; Rolfe, Stephen S.; May, Teresa; Trowbridge, Robert L.; Hayes, Timothy L.; Grindlinger, Gene A.; Seder, David B.			Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0	NEUROCRITICAL CARE			English	Article						Warfarin; Prothrombin complex concentrate; Intracranial hemorrhage; Reversal	TRAUMATIC BRAIN-INJURY; VITAMIN-K ANTAGONISTS; FRESH-FROZEN PLASMA; ACUTE INTRACEREBRAL HEMORRHAGE; ANTICOAGULANT-THERAPY; ORAL ANTICOAGULATION; HEMATOMA GROWTH; REVERSAL; SAFETY; COAGULOPATHY	Prothrombin complex concentrates (PCCs) have become the first-line therapy for warfarin reversal in the setting of central nervous system (CNS) hemorrhage. Randomized, controlled studies comparing agents for warfarin reversal excluded patients with international normalized ratio (INR) < 2, yet INR values of 1.6-1.9 are also associated with poor outcomes. We retrospectively reviewed our use of a low-dose (15 units/kg) strategy of 4-factor PCC (4F-PCC) on warfarin reversal (INR 1.6-1.9) in the setting of both traumatic and spontaneous intracranial bleeding. A total of 21/134 (15.7%) patients with either spontaneous or traumatic intracranial hemorrhage presented with an INR value of 1.6-1.9. Nine patients (43%) presented with traumatic bleeding and 12 (57%) with spontaneous bleeding. The median (IQR) presenting INR was 1.8 (1.7, 1.9) which decreased to 1.3 (1.2, 1.3) following the administration of low-dose 4F-PCC (median dose = 1062 units; 15.2 units/kg). A total of 19/20 (95%) patients achieved a goal INR value of ae<currency>1.5 on the first check following dosing and 17/20 (85%) achieved an INR value ae<currency>1.3. One patient did not have follow-up INR testing due to withdrawal of life support. No patient experienced hematoma expansion within 48 h of 4F-PCC, and there were no thromboembolic events within 72 h of administration. The administration of low dose (15 units/kg) of 4F-PCC for urgent warfarin reversal in the setting of CNS hemorrhage was effective in correcting the INR in patients presenting with INR values of 1.6-1.9. Further assessment of low-dose PCC for urgent reversal of modest INR elevation is warranted.	[Zemrak, Wesley R.; Smith, Kathryn E.; Rolfe, Stephen S.] Maine Med Ctr, Dept Pharm, 22 Bramhall St, Portland, ME 04102 USA; [May, Teresa; Seder, David B.] Maine Med Ctr, Div Neurocrit Care, Portland, ME 04102 USA; [Trowbridge, Robert L.] Maine Med Ctr, Dept Med, Portland, ME 04102 USA; [Hayes, Timothy L.] Maine Med Ctr, Dept Pathol, Portland, ME 04102 USA; [Grindlinger, Gene A.] Maine Med Ctr, Div Surg Crit Care, Portland, ME 04102 USA		Zemrak, WR (corresponding author), Maine Med Ctr, Dept Pharm, 22 Bramhall St, Portland, ME 04102 USA.	zemraw@mmc.org	Trowbridge, Robert/U-8278-2019; Seder, David B./M-4829-2019	Trowbridge, Robert/0000-0002-0460-2733; Seder, David/0000-0002-9717-1038			Abdoellakhan RA, 2017, NEUROCRIT CARE, V26, P64, DOI 10.1007/s12028-016-0248-8; Cucchiara B, 2008, STROKE, V39, P2993, DOI 10.1161/STROKEAHA.108.520668; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Flaherty ML, 2008, NEUROLOGY, V71, P1084, DOI 10.1212/01.wnl.0000326895.58992.27; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Frontera JA, 2014, NEUROCRIT CARE, V21, P397, DOI 10.1007/s12028-014-9972-0; Gulati G, 2011, ARCH PATHOL LAB MED, V135, P490, DOI 10.1043/2009-0474-OA.1; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Huynh TK, 2014, PHARMACOTHERAPY, V34, P260, DOI 10.1002/phar.1384; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Kalina M, 2008, AM SURGEON, V74, P858; Khan M, 2017, J NEUROIMAGING, V27, P144, DOI 10.1111/jon.12370; Khorsand N, 2011, TRANSFUSION MED, V21, P116, DOI 10.1111/j.1365-3148.2010.01050.x; Khorsand N, 2012, HAEMATOL-HEMATOL J, V97, P1501, DOI 10.3324/haematol.2012.063701; Koster A, 2014, A A CASE REP, V2, P89, DOI 10.1097/ACC.0b013e3182a070e9; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Kuwashiro T, 2011, CEREBROVASC DIS, V31, P170, DOI 10.1159/000321766; Majeed A, 2014, THROMB HAEMOSTASIS, V111, P233, DOI 10.1160/TH13-07-0536; Mayer SA, 2005, STROKE, V36, P74, DOI 10.1161/01.STR.0000149628.80251.b8; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Milling TJ, 2016, ANN EMERG MED, V67, P96, DOI 10.1016/j.annemergmed.2015.04.036; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rivosecchi RM, 2016, NEUROCRIT CARE, V25, P359, DOI 10.1007/s12028-016-0271-9; Safaoui MN, 2009, AM J SURG, V197, P785, DOI 10.1016/j.amjsurg.2008.04.003; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Steiner T, 2016, LANCET NEUROL, V15, P566, DOI 10.1016/S1474-4422(16)00110-1; Varga C, 2013, TRANSFUSION, V53, P1451, DOI 10.1111/j.1537-2995.2012.03924.x; Warren O, 2009, ANN EMERG MED, V53, P758, DOI 10.1016/j.annemergmed.2008.12.027; Williams TM, 2008, J TRAUMA, V65, P772, DOI 10.1097/TA.0b013e3181877ff7; Yanamadala V, 2014, J CLIN NEUROSCI, V21, P1881, DOI 10.1016/j.jocn.2014.05.001; Yasaka M, 2005, THROMB RES, V115, P455, DOI 10.1016/j.thromres.2004.09.002; Zemrak WR, 2016, AM J EMERG MED, V34, DOI 10.1016/j.ajem.2015.12.069	34	5	5	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2017	27	3					334	340		10.1007/s12028-017-0422-7			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN7DT	WOS:000416179300005	28660341				2022-02-06	
J	Zhang, YJ; Liu, SL; Yue, W; Shi, ZH; Guan, YL; Li, MZ; Ji, Y; Li, X				Zhang, Yajing; Liu, Shuling; Yue, Wei; Shi, Zhihong; Guan, Yalin; Li, Mingzi; Ji, Yong; Li, Xin			Association of apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients	MEDICINE			English	Article						apolipoprotein E; ischemic stroke; NIHSS; outcome	TRAUMATIC BRAIN-INJURY; APOE GENOTYPE; E POLYMORPHISM; CEREBROVASCULAR-DISEASE; ALZHEIMERS-DISEASE; TYPE-4 ALLELE; E ISOFORMS; RISK; METAANALYSIS; CLASSIFICATION	The aim of this study was to study the ability of the genotype to predict impairment and disability in hospitalized ischemic stroke (IS) patients after hospital discharge and 6 months after the onset of stroke symptoms. A total of 786 patients with a first IS were enrolled. Apolipoprotein E (ApoE) polymorphism was examined using polymerase chain reaction. Stroke subtype was classified using the Oxfordshire Community Stroke Project classification scheme and the Trial of Org 10172 in Acute Stroke Treatment criteria. Impairment as assessed using the National Institutes of Health Stroke Scale (NIHSS), and disability as measured using the modified Rankin Scale (mRS), were compared against the ApoE genotype. There was no significant association between the type of ApoE allele present and the stroke subtype. On multivariate regression analysis, the apolipoprotein E*E4 allele genotype did not predict poor outcome at discharge and or at 6 months after stroke onset. A higher NIHSS score on admission, older age, and higher fasting glucose levels did predict poor outcome at hospital discharge. Higher glucose levels and higher NIHSS scores on admission were independent risk factors predicting poor neurologic status at 6 months after stroke onset. The presence of the apolipoprotein E*E4 and apolipoprotein E*E2 genotypes, although related to cholesterol and triglyceride levels, do not affect recovery during rehabilitation. A higher NIHSS score on admission and a higher fasting glucose level predict poor neurologic status, both at hospital discharge and 6 months after onset.	[Zhang, Yajing; Li, Xin] Tianjin Med Univ, Hosp 2, Dept Neurol, 23 Pingjiang Rd, Tianjin 300211, Peoples R China; [Zhang, Yajing; Liu, Shuling; Yue, Wei; Shi, Zhihong; Guan, Yalin; Ji, Yong] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Zhang, Yajing; Liu, Shuling; Yue, Wei; Shi, Zhihong; Guan, Yalin; Ji, Yong] Tianjin Huanhu Hosp, Tianjin Key Lab Cerebrovasc Dis & Neurodegenerat, Tianjin, Peoples R China; [Liu, Shuling; Li, Mingzi] Peking Univ, Sch Nursing, Beijing, Peoples R China		Li, X (corresponding author), Tianjin Med Univ, Hosp 2, Dept Neurol, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.; Ji, Y (corresponding author), Tianjin Huanhu Hosp, Tianjin Key Lab Cerebrovasc Dis & Neurodegenerat, Dept Neurol, 6 Jizhao Rd, Tianjin 300350, Peoples R China.	jiyongusa@sina.com; hhyyfirst@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571057]	This study was financially supported by the National Natural Science Foundation of China (funding number: 81571057).	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Anthopoulos PG, 2010, MOL GENET METAB, V100, P283, DOI 10.1016/j.ymgme.2010.03.008; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Boumendjel S, 2013, ANN BIOL CLIN-PARIS, V71, P21, DOI 10.1684/abc.2012.0783; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Dieckmann M, 2013, J BONE MINER RES, V28, P236, DOI 10.1002/jbmr.1757; Drory VE, 2001, J NEUROL SCI, V190, P17, DOI 10.1016/S0022-510X(01)00569-X; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Folsom AR, 2001, AM J CARDIOL, V88, P112, DOI 10.1016/S0002-9149(01)01603-4; Frank A, 2002, J NEUROL SCI, V203, P173, DOI 10.1016/S0022-510X(02)00286-1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gu L, 2013, EXP THER MED, V5, P853, DOI 10.3892/etm.2012.866; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Ji Y, 2013, DEMENT GERIATR COGN, V36, P163, DOI 10.1159/000350872; Kantarci OH, 2004, NEUROLOGY, V62, P811, DOI 10.1212/01.WNL.0000113721.83287.83; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kumar A, 2016, ANN NEUROSCI, V23, P113, DOI 10.1159/000443568; Lampl Y, 2010, CLIN NEUROPHARMACOL, V33, P129, DOI 10.1097/WNF.0b013e3181d47863; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; McCarron MO, 2000, ARCH NEUROL-CHICAGO, V57, P1480, DOI 10.1001/archneur.57.10.1480; Moulard B, 1996, J NEUROL SCI, V139, P34, DOI 10.1016/0022-510X(96)00085-8; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Ring H, 1997, ARCH PHYS MED REHAB, V78, P630, DOI 10.1016/S0003-9993(97)90429-9; Roth EJ, 1998, ARCH PHYS MED REHAB, V79, P329, DOI 10.1016/S0003-9993(98)90015-6; Schmidt S, 2002, AM J HUM GENET, V70, P708, DOI 10.1086/339269; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tan CE, 2003, ATHEROSCLEROSIS, V170, P253, DOI 10.1016/S0021-9150(03)00232-6; Tonk M, 2007, J NEUROL SCI, V257, P273, DOI 10.1016/j.jns.2007.01.037; Tuttolomondo A, 2008, INT J CARDIOL, V125, P391, DOI 10.1016/j.ijcard.2007.03.109; Tuttolomondo A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003186; Tuttolomondo A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000813; Tuttolomondo A, 2011, INT J CARDIOL, V151, P318, DOI 10.1016/j.ijcard.2010.06.005; Tziomalos K, 2015, ATHEROSCLEROSIS, V243, P65, DOI 10.1016/j.atherosclerosis.2015.08.043; Wang QY, 2013, J NEURAL TRANSM, V120, P1479, DOI 10.1007/s00702-013-1019-8; Xu T, 2014, BIOMED ENVIRON SCI, V27, P106, DOI 10.3967/bes2014.023	46	5	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2017	96	50							e8964	10.1097/MD.0000000000008964			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT2QG	WOS:000422990500040	29390290	gold, Green Published			2022-02-06	
J	Pineda-Rodriguez, B; Toscano-Tejeida, D; Garcia-Vences, E; Rodriguez-Barrera, R; Flores-Romero, A; Castellanos-Canales, D; Ospina, GG; Castillo-Carvajal, L; Melendez-Herrera, E; Ibarra, A				Pineda-Rodriguez, Beatriz; Toscano-Tejeida, Diana; Garcia-Vences, Elisa; Rodriguez-Barrera, Roxana; Flores-Romero, Adrian; Castellanos-Canales, Daniela; Gutierrez Ospina, Gabriel; Castillo-Carvajal, Laura; Melendez-Herrera, Esperanza; Ibarra, Antonio			Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury	PLOS ONE			English	Article							REGULATORY T-CELLS; TRAUMATIC BRAIN-INJURY; MYELIN BASIC-PROTEIN; ADULT NEUROGENESIS; NEUROPATHIC PAIN; NKT CELLS; IN-VIVO; METHYLPREDNISOLONE; NEUROINFLAMMATION; PATHOPHYSIOLOGY	The inflammatory response is probably one of the main destructive events occurring after spinal cord injury (SCI). Its progression depends mostly on the autoimmune response developed against neural constituents. Therefore, modulation or inhibition of this self-reactive reaction could help to reduce tissue destruction. Anterior chamber associated immune deviation (ACAID) is a phenomenon that induces immune-tolerance to antigens injected into the eye A s anterior chamber, provoking the reduction of such immune response. In the light of this notion, induction of ACAID to neural constituents could be used as a potential prophylactic therapy to promote neuroprotection. In order to evaluate this approach, three experiments were performed. In the first one, the capability to induce ACAID of the spinal cord extract (SCE) and the myelin basic protein (MBP) was evaluated. Using the delayed type hypersensibility assay (DTH) we demonstrated that both, SCE and MBP were capable of inducing ACAID. In the second experiment we evaluated the effect of SCE-induced ACAID on neurological and morphological recovery after SCI. In the results, there was a significant improvement of motor recovery, nociceptive hypersensitivity and motoneuron survival in rats with SCE-induced ACAID. Moreover, ACAID also up-regulated the expression of genes encoding for anti-inflammatory cytokines and FoxP3 but down-regulated those for pro-inflamatory cytokines. Finally, in the third experiment, the effect of a more simple and practical strategy was evaluated: MBP-induced ACAID, we also found significant neurological and morphological outcomes. In the present study we demonstrate that the induction of ACAID against neural antigens in rats, promotes neuroprotection after SCI.	[Pineda-Rodriguez, Beatriz; Toscano-Tejeida, Diana; Garcia-Vences, Elisa; Rodriguez-Barrera, Roxana; Flores-Romero, Adrian; Castellanos-Canales, Daniela; Castillo-Carvajal, Laura; Ibarra, Antonio] Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud CICSA, Campus Norte,Ave Univ Anahuac 46, Anahuac, Huixquilucan Es, Mexico; [Gutierrez Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Ciudad De Mexico, Mexico; [Melendez-Herrera, Esperanza] Univ Michoacana, Inst Invest Recursos Nat, Dept Zool, Lab Ecofisiol Anim, Morelia, Michoacan, Mexico; [Ibarra, Antonio] Proyecto CAMINA AC, Ciudad De Mexico, Mexico		Ibarra, A (corresponding author), Univ Anahuac Mexico, Fac Ciencias Salud, Ctr Invest Ciencias Salud CICSA, Campus Norte,Ave Univ Anahuac 46, Anahuac, Huixquilucan Es, Mexico.; Ibarra, A (corresponding author), Proyecto CAMINA AC, Ciudad De Mexico, Mexico.	jose.ibarra@anahuac.mx		Castillo Carvajal, Laura Catalina/0000-0002-1531-2504; garcia vences, edna elisa/0000-0001-7588-3846	National Council of Science and Technology (CONACyT)Consejo Nacional de Ciencia y Tecnologia (CONACyT) [178544]; nonprofit foundation Proyecto Camina AC	This work was supported by the National Council of Science and Technology (CONACyT; Grant 178544; https://www.conacyt.gob.mx). Al is the author who received the funding. The nonprofit foundation Proyecto Camina AC provided financial support in the form of research materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0625-4; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bhowmick S, 2011, INT IMMUNOL, V23, P119, DOI 10.1093/intimm/dxq461; Chamberlain JD, 2015, INJURY EPIDEMIOLOGY, V2, P1, DOI DOI 10.1186/S40621-014-0032-1; Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006/exnr.1999.7065; Crowley MG, 2017, J NEUROSURG SCI, V61, P291, DOI 10.23736/S0390-5616.16.03921-7; Cui Y, 2009, INVEST OPHTH VIS SCI, V50, P5811, DOI 10.1167/iovs.09-3389; Farooq SM, 2013, CNS NEUROSCI THER, V19, P503, DOI 10.1111/cns.12087; Faunce DE, 2002, J IMMUNOL, V169, P31, DOI 10.4049/jimmunol.169.1.31; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Garcia E, 2012, J NEUROSCI RES, V90, P656, DOI 10.1002/jnr.22771; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Ibarra A, 2013, NEUROSCI LETT, V554, P59, DOI 10.1016/j.neulet.2013.08.048; Ibarra A, 2003, BRAIN RES, V979, P165, DOI 10.1016/S0006-8993(03)02898-1; Ibarra A, 2010, NEUROSCI LETT, V476, P62, DOI 10.1016/j.neulet.2010.04.003; Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002; KAPLAN HJ, 1975, TRANSPLANTATION, V19, P302, DOI 10.1097/00007890-197504000-00005; KARTHIGASAN J, 1992, J MOL NEUROSCI, V3, P185, DOI 10.1007/BF03380137; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Legos JJ, 2001, NEUROSURGERY, V49, P1427, DOI 10.1097/00006123-200112000-00022; Lin CY, 2012, J NEUROTRAUM, V29, P589, DOI 10.1089/neu.2011.2059; London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Martinon S, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0267-6; Meng H, 2015, DRUG RES, V65, P437, DOI 10.1055/s-0034-1389949; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Nakamura T, 2003, J IMMUNOL, V171, P1266, DOI 10.4049/jimmunol.171.3.1266; Nawaz S, 2013, GLIA, V61, P1364, DOI 10.1002/glia.22520; Neal JM, 2015, REGION ANESTH PAIN M, V40, P506, DOI 10.1097/AAP.0000000000000297; Niederkorn Jerry Y, 2007, Chem Immunol Allergy, V92, P27, DOI 10.1159/000099251; Niederkorn JY, 2009, EXPERT REV CLIN IMMU, V5, P137, DOI 10.1586/1744666X.5.2.137; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Pais R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043182; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Rodriguez-Barrera R, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-016-0331-2; Saganova K, 2009, CELL MOL NEUROBIOL, V29, P1045, DOI 10.1007/s10571-009-9395-1; Stonesifer C, 2017, PROG NEUROBIOL, V158, P94, DOI 10.1016/j.pneurobio.2017.07.004; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; Teng YD, 1998, EUR J NEUROSCI, V10, P798, DOI 10.1046/j.1460-9568.1998.00100.x; Toscano-Tejeida D, 2016, MED HYPOTHESES, V88, P38, DOI 10.1016/j.mehy.2016.01.006; Wang YF, 2003, OCUL IMMUNOL INFLAMM, V11, P39, DOI 10.1076/ocii.11.1.39.15578; Zajarias-Fainsod D, 2012, EUR SPINE J, V21, P964, DOI 10.1007/s00586-011-2060-7; Zhang HN, 2008, IMMUNOLOGY, V124, P304, DOI 10.1111/j.1365-2567.2007.02769.x; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004	46	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188506	10.1371/journal.pone.0188506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	WOS:000416841900065	29190648	gold, Green Published, Green Submitted			2022-02-06	
J	Ozkunt, O; Sariyilmaz, K; Gemalmaz, HC; Gurgen, SG; Yener, U; Dikici, F				Ozkunt, Okan; Sariyilmaz, Kerim; Gemalmaz, Halil Can; Gurgen, Seren Gulsen; Yener, Ulas; Dikici, Fatih			Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone	JOURNAL OF ORTHOPAEDIC SURGERY			English	Article						animal study; erythropoietin; GFAP; methylprednisolone; paraplegia; PDGF; spinal cord injury	TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR; RECEPTOR-BETA; ASTROCYTES; RATS; EXPRESSION; NEUROPROTECTION; ACTIVATION; PROTECT; BARRIER	Background: Investigation of the expression of platelet-derived growth factor (PDGF)-beta and glial fibrillary acidic protein (GFAP) in rats with spinal cord injury as a marker of neurologic recovery between groups treated with erythropoietin (EPO) and methylprednisolone (MP). Methods: Thirty adult female rats were randomly divided into three even groups. A laminectomy was applied to thoracic ninth vertebra and contusion injury was induced by extradural application of an aneurysm clip. Group 1 rats received one-time intrathecal administration of normal saline, group 2 rats received MP, and group 3 rats received EPO. Motor neurological function was evaluated by the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale. Thirty days after the surgery, T8-10 segments of the spinal cords were extracted and the immunohistochemical assay revealed the number of PDGF-beta- and GFAP-positive cells. Results: Evaluation of the last control animal showed that BBB score in the EPO group showed an increase from 1 to 12 (p < 0.05). The immunohistochemical assay revealed that the number of PDGF-beta- and GFAP-positive cells was significantly higher in EPO group (p = 0.000) when compared to MP and control groups. After studying the effect of PDGF-beta expression on the locomotor function, we determined that PDGF-beta expression and locomotor function after a spinal injury has a strong relationship (p < 0.05). Conclusion: EPO seems to better increase the expression of PDGF-beta, thus produce better results in locomotor functions when compared to MP.	[Ozkunt, Okan; Sariyilmaz, Kerim; Gemalmaz, Halil Can; Dikici, Fatih] Acibadem Univ, Atakent Hosp, Dept Orthoped & Traumatol, TR-34303 Istanbul, Turkey; [Gurgen, Seren Gulsen] Celal Bayar Univ, Sch Vocat Hlth Serv, Dept Histol & Embryol, Yunusemre, Manisa, Turkey; [Yener, Ulas] Acibadem Univ, Atakent Hosp, Dept Neurosurg, Istanbul, Turkey		Ozkunt, O (corresponding author), Acibadem Univ, Atakent Hosp, Dept Orthoped & Traumatol, TR-34303 Istanbul, Turkey.	drdeto@gmail.com	Yener, Ulas/ABE-2075-2020; Sariyilmaz, Kerim/W-9304-2018; Gurgen, Seren Gulsen/AAT-2326-2021; gemalmaz, halil can/D-5948-2015	Yener, Ulas/0000-0001-6663-1081; Sariyilmaz, Kerim/0000-0002-8680-1428; gemalmaz, halil can/0000-0002-5741-199X			Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cabezas R, 2016, MED CHEM, V12, P204, DOI 10.2174/1573406411666151019120444; Chen J, 2005, EUR J NEUROSCI, V22, P1895, DOI 10.1111/j.1460-9568.2005.04348.x; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; D'Andrea RJ, 2000, EXP HEMATOL, V28, P231, DOI 10.1016/S0301-472X(99)00159-9; Dalla Costa D, 2015, NEUROL SCI, V36, P1567, DOI 10.1007/s10072-015-2182-5; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gordh T, 2006, PAIN, V124, P211, DOI 10.1016/j.pain.2006.05.020; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; HALL ED, 1982, SURG NEUROL, V18, P320, DOI 10.1016/0090-3019(82)90140-9; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Hong ZH, 2011, EXP THER MED, V2, P837, DOI 10.3892/etm.2011.285; Ishii Y, 2006, J NEUROCHEM, V98, P588, DOI 10.1111/j.1471-4159.2006.03922.x; Janmaat ML, 2010, BLOOD, V115, P1453, DOI 10.1182/blood-2009-07-230870; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Makihara N, 2015, EXP NEUROL, V264, P127, DOI 10.1016/j.expneurol.2014.12.007; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Vega-Avelaira D, 2007, BRAIN BEHAV IMMUN, V21, P617, DOI 10.1016/j.bbi.2006.10.007; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; Wu QH, 2010, CHINESE MED J-PEKING, V123, P1577, DOI 10.3760/cma.j.issn.0366-6999.2010.12.018; Zhang KH, 2004, NEUROSCIENCE, V128, P375, DOI 10.1016/j.neuroscience.2004.07.008	27	5	5	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2309-4990			J ORTHOP SURG-HONG K	J. Orthop. Surg.	NOV 9	2017	25	3								10.1177/2309499017739481			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	FM5DJ	WOS:000415050200001	29121822	gold			2022-02-06	
J	Clarencon, F; Bardinet, E; Martinerie, J; Pelbarg, V; Champfleur, NMD; Gupta, R; Tollard, E; Soto-Ares, G; Ibarrola, D; Schmitt, E; Tourdias, T; Degos, V; Yelnik, J; Dormont, D; Puybasset, L; Galanaud, D				Clarencon, Frederic; Bardinet, Eric; Martinerie, Jacques; Pelbarg, Vincent; Champfleur, Nicolas Menjot dDe; Gupta, Rajiv; Tollard, Eleonore; Soto-Ares, Gustavo; Ibarrola, Danielle; Schmitt, Emmanuelle; Tourdias, Thomas; Degos, Vincent; Yelnik, Jerome; Dormont, Didier; Puybasset, Louis; Galanaud, Damien		Neuro Imaging Coma Emergence	Lesions in deep gray nuclei after severe traumatic brain injury predict neurologic outcome	PLOS ONE			English	Article							VEGETATIVE STATE; AXONAL INJURY; PROGNOSTIC VALUE; BASAL GANGLIA; HEAD-INJURY; CORPUS-CALLOSUM; WHITE-MATTER; MRI; STEM; NEUROPATHOLOGY	Purpose This study evaluates the correlation between injuries to deep gray matter nuclei, as quanti-tated by lesions in these nuclei on MR T2 Fast Spin Echo (T2 FSE) images, with 6-month neurological outcome after severe traumatic brain injury (TBI). Materials and methods Ninety-five patients (80 males, mean age = 36.7y) with severe TBI were prospectively enrolled. All patients underwent a MR scan within the 45 days after the trauma that included a T2 FSE acquisition. A 3D deformable atlas of the deep gray matter was registered to this sequence; deep gray matter lesions (DGML) were evaluated using a semi-quantitative classification scheme. The 6-month outcome was dichotomized into unfavorable (death, vegetative or minimally conscious state) or favorable (minimal or no neurologic deficit) outcome. Results Sixty-six percent of the patients (63/95) had both satisfactory registration of the 3D atlas on T2 FSE and available clinical follow-up. Patients without DGML had an 89% chance (P = 0.0016) of favorable outcome while those with bilateral DGML had an 80% risk of unfavorable outcome (P = 0.00008). Multivariate analysis based on DGML accurately classified patients with unfavorable neurological outcome in 90.5% of the cases. Conclusion Lesions in deep gray matter nuclei may predict long-term outcome after severe TBI with high sensitivity and specificity.	[Clarencon, Frederic; Dormont, Didier; Galanaud, Damien] Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France; [Clarencon, Frederic; Degos, Vincent; Dormont, Didier; Puybasset, Louis; Galanaud, Damien] Paris VI Univ Pierre & Marie Curie, Paris, France; [Bardinet, Eric; Martinerie, Jacques] CNRS, UMR 7225, Inst Cerveau & Moelle Epiniere ICM, Paris, France; [Pelbarg, Vincent] Brain & Spine Inst ICM, IHU A ICM, Bioinformat & Biostat Plateform, Paris, France; [Champfleur, Nicolas Menjot dDe] Guy de Chauliac Univ Hosp, Dept Neuroradiol, Montpellier, France; [Gupta, Rajiv] Massachusetts Gen Hosp, Dept Neuroradiol, Boston, MA 02114 USA; [Tollard, Eleonore] Rouen Univ Hosp, Dept Neuroradiol, Rouen, France; [Soto-Ares, Gustavo] Roger Salengro Hosp, Dept Neuroradiol, Lille, France; [Ibarrola, Danielle] Pierre Wertheimer Neurol & Neurosurg Hosp, CERMEP, Bron, France; [Schmitt, Emmanuelle] Nancy Univ Hosp, Dept Neuroradiol, Nancy, France; [Tourdias, Thomas] Bordeaux Univ Hosp, Dept Neuroradiol, Bordeaux, France; [Degos, Vincent; Puybasset, Louis] Paris VI Univ, Pitie Salpetriere Hosp, Neurosurg Intens Care Unit, Paris, France; [Yelnik, Jerome] Paris VI Univ, Pitie Salpetriere Hosp, INSERM, U679, Paris, France		Clarencon, F (corresponding author), Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France.; Clarencon, F (corresponding author), Paris VI Univ Pierre & Marie Curie, Paris, France.	fredclare5@msn.com	Tourdias, Thomas/K-1209-2019	Tourdias, Thomas/0000-0002-7151-6325; YELNIK, Jerome/0000-0003-4814-708X	Projet Hospitalier de Recherche Clinique (PHRC) [P051061]	This work has been funded by the Projet Hospitalier de Recherche Clinique (PHRC) #P051061.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Comoglu S, 2001, Australas Radiol, V45, P357, DOI 10.1046/j.1440-1673.2001.00937.x; de la Cueva L, 2006, Rev Esp Med Nucl, V25, P89, DOI 10.1157/13086250; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Hopkins RO, 2006, BRAIN INJURY, V20, P273, DOI 10.1080/02699050500488181; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; Masuzawa H, 1997, NEUROL SURG TOKYO, V25, P689; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Patrick PD, 2007, BRAIN INJURY, V21, P63, DOI 10.1080/02699050601111401; Rosi J, 2017, J CLIN NEUROSCI, V42, P122, DOI 10.1016/j.jocn.2017.03.012; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Shakir A, 2016, J NEUROIMAGING, V26, P103, DOI 10.1111/jon.12286; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Su E, 2016, FRONTIERS NEUROSCIEN; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Vapnik V. N., 1998, STAT LEARNING THEORY; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Xu WW, 2016, WORLD NEUROSURG, V94, P167, DOI 10.1016/j.wneu.2016.06.123; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Yuan L, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150129	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186641	10.1371/journal.pone.0186641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	WOS:000414340200019	29095850	Green Submitted, gold, Green Published			2022-02-06	
J	Ajdari, A; Boyle, LN; Kannan, N; Rowhani-Rahbar, A; Wang, J; Mink, R; Ries, B; Wainwright, M; Groner, JI; Bell, MJ; Giza, C; Zatzick, DF; Ellenbogen, RG; Mitchell, PH; Rivara, FP; Vavilala, MS				Ajdari, Ali; Boyle, Linda Ng; Kannan, Nithya; Rowhani-Rahbar, Ali; Wang, Jin; Mink, Richard; Ries, Benjamin; Wainwright, Mark; Groner, Jonathan I.; Bell, Michael J.; Giza, Chris; Zatzick, Douglas F.; Ellenbogen, Richard G.; Mitchell, Pamela H.; Rivara, Frederick P.; Vavilala, Monica S.			Examining Emergency Department Treatment Processes in Severe Pediatric Traumatic Brain Injury	JOURNAL FOR HEALTHCARE QUALITY			English	Article						TBI; regression analysis; pediatrics; non-value-added time; healthcare	COMMON OUTCOMES; CARE	Background: In the treatment of pediatric traumatic brain injury (TBI), timely treatment of patients can affect the outcome. Our objectives were to examine the treatment process of acute pediatric TBI and the impact of non-value-added time (NVAT) on patient outcomes. Methods: Data for 136 pediatric trauma patients (age, 18 years) with severe TBI from 2 trauma centers in the United States were collected. A process flow and value stream map identified NVATs and their sources in the treatment process. Cluster and regression analysis were used to examine the relationship between NVAT, as a percentage of the patient's length of stay (LOS), and the patient outcome, measured by their corresponding Glasgow outcome scale. Results: There were 14 distinct sources of NVAT identified. A regression analysis showed that increased NVAT was associated with less favorable outcomes (relative ratio = 1.015, confidence interval = [1.002-1.029]). Specifically, 1% increase in the NVAT-to-LOS ratio was associated with a 1.5% increase in the chance of a less favorable outcome (i.e., death or vegetative state). Conclusion: The NVAT has a significant impact on the outcome of pediatric TBI, and every minute spent on performing non-value-added processes can lead to an increase in the likelihood of less favorable outcomes.	[Ajdari, Ali] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Boyle, Linda Ng] Univ Washington, Coll Engn, Seattle, WA 98195 USA; [Kannan, Nithya] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Rowhani-Rahbar, Ali] Univ Washington, Sch Publ Hlth, Epidemiol, Seattle, WA 98195 USA; [Wang, Jin] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Mink, Richard] Univ Calif Los Angeles, David Geffen Sch Med, Pediat, Los Angeles, CA 90095 USA; [Ries, Benjamin] Coursera Inc, Mountain View, CA USA; [Ries, Benjamin] Human Factors & Stat Modeling Lab, Seattle, WA USA; [Wainwright, Mark] Northwestern Univ, Feinberg Sch Med, Pediat & Neurol, Chicago, IL 60611 USA; [Wainwright, Mark] Northwestern Univ, Feinberg Sch Med, Founders Board Chair Neurocrit Care, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Clin Surg, Columbus, OH 43210 USA; [Groner, Jonathan I.] Nationwide Childrens Hosp Columbus, Columbus, OH USA; [Bell, Michael J.] Univ Pittsburgh, Crit Care Med Pediat & Neurol Surg, Pittsburgh, PA 15260 USA; [Giza, Chris] David Geffen Sch Med, Pediat Neurol & Neurosurg, Los Angeles, CA USA; [Giza, Chris] Mattel Childrens Hosp, Los Angeles, CA USA; [Giza, Chris] UCLA, Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Zatzick, Douglas F.] Univ Washington, Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Neurol Surg, Seattle, WA 98195 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Mitchell, Pamela H.] Univ Washington, Hlth Serv, Seattle, WA 98195 USA; [Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Epidemiol, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, HIPRC, Seattle, WA 98195 USA		Boyle, LN (corresponding author), Univ Washington, Coll Engn, Seattle, WA 98195 USA.	linda@uw.edu	Ajdari, Ali/S-7013-2019	Rowhani-Rahbar, Ali/0000-0002-2705-4485	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R01 NS072308-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	This research was supported by funding by an NIH grant (NINDS R01 NS072308-05).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Akaike H., 1973, P 2 INT S INF THEOR, V1973, P267, DOI 10.1007/978-1-4612-1694-0; Backhaus S, 2011, ENCY CLIN NEUROPSYCH, P1890; Berkhin P, 2006, GROUPING MULTIDIMENSIONAL DATA: RECENT ADVANCES IN CLUSTERING, P25; Dickson EW, 2009, J EMERG MED, V37, P177, DOI 10.1016/j.jemermed.2007.11.108; DONABEDIAN A, DEFINITION QUALITY A, V1; Granacher RP, 2004, TRAUMATIC BRAIN INJU; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Ikuma, 2013, IIE T HEALTHCARE SYS, V3, P240, DOI DOI 10.1080/19488300.2013.857371; Jallo JI, 2011, NEUROTRAUMA CRITICAL; James B, 2008, COST POOR QUALITY WA; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lotfi-Sadigh S, 2015, ANAL RES CLIN MED, V3, P57; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Moody L, 2012, P 2012 S HUM FACT ER; Newcomer SR, 2011, AM J MANAG CARE, V17, pE324; Ries BS, 2013, P HUM FACT ERG SOC A, V57, P1536; Sharma S, 2013, ACCESS NEUROSURGICAL; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Storfjell JL, 2009, J NURS ADMIN, V39, P38, DOI 10.1097/NNA.0b013e31818e9cd4; Sutherland ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036631; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wilson JM, 2003, EUR J OPER RES, V149, P430, DOI 10.1016/S0377-2217(02)00769-5; Young TP, 2008, QUAL SAF HEALTH CARE, V17, P382, DOI 10.1136/qshc.2006.020131; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	26	5	5	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1062-2551	1945-1474		J HEALTHC QUAL	J. Healthc. Qual.	NOV-DEC	2017	39	6					334	344		10.1097/JHQ.0000000000000052			11	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	FU5OS	WOS:000423903500003	28166114	Green Accepted			2022-02-06	
J	Buttner, MM; Godfrey, KM; Floto, E; Pittman, J; Lindamer, L; Afari, N				Buttner, Melissa M.; Godfrey, Kathryn M.; Floto, Elizabeth; Pittman, James; Lindamer, Laurie; Afari, Niloofar			Combat exposure and pain in male and female Afghanistan and Iraq veterans: The role of mediators and moderators	PSYCHIATRY RESEARCH			English	Article						Combat exposure; Pain intensity; Somatic pain; Mediators; Moderated mediation; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; PHYSICAL HEALTH; RESILIENCE CONSTRUCT; DEPRESSION SEVERITY; GENDER-DIFFERENCES; OEF/OIF VETERANS; MILITARY SERVICE; WOMEN VETERANS	Veterans experience physical health problems associated with disability and poor quality of life following combat exposure (CE). Understanding the CE-physical health relationship, specifically pain intensity and somatic pain, may inform etiological models and interventions. This study examined the CE-pain relationship, associated mediators, and gender as a Jnoderator. 2381 veterans at the VA San Diego Healthcare System completed paper or electronic self-report measures of pain intensity and somatic pain. Analyses examined associations of pain with CE and posttraumatic stress disorder (PTSD), depression, and resilience as mediators of the CE pain association. Moderated mediation models explored gender as a moderator of significant mediated pathways. Controlling for age, veterans with CE had significantly higher pain intensity and somatic pain, and PTSD and depression scores significantly mediated the CE-pain relationships. Gender significantly moderated the CE pain intensity association through depression scores such that the indirect effect was stronger for female veterans relative to male veterans. CE is associated with pain intensity and somatic pain, with greater levels of PTSD and depression mediating the CE-pain link and gender moderating the depression mediated CE-pain association. Future studies should examine gender differences and mediators in the CE-pain relationships using longitudinal designs to inform etiological models and targeted pain interventions.	[Buttner, Melissa M.; Godfrey, Kathryn M.; Floto, Elizabeth; Pittman, James; Lindamer, Laurie; Afari, Niloofar] VA San Diego Healthcare Syst, VA Ctr Excellence Stress & Mental Hlth CESAMH, San Diego, CA USA; [Buttner, Melissa M.; Lindamer, Laurie; Afari, Niloofar] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Godfrey, Kathryn M.] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA		Afari, N (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,0737, La Jolla, CA 92093 USA.	nafari@ucsd.edu		Floto, Elizabeth/0000-0002-8238-0793	Department of Veterans Affairs (VA) Center of Excellence for Stress and Mental Health (CESAMH); VA Center for Innovation	This project was supported by Department of Veterans Affairs (VA) Center of Excellence for Stress and Mental Health (CESAMH) and funding for data collection was provided by the VA Center for Innovation. None of the authors have any conflicts of interest to declare. The views expressed in this paper are those of the authors and do not reflect the official policy or position of the Department of Veterans Affairs or any of the institutions with which the authors are affiliated. We thank Matthew Morgan and Ryan Wong for their support and diligent work on this project.	Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Cleeland CS, 2003, CLIN J PAIN, V19, P298, DOI 10.1097/00002508-200309000-00003; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Driscoll MA, 2015, PAIN MED, V16, P1101, DOI 10.1111/pme.12744; Eisen SV, 2014, AM J PREV MED, V47, P754, DOI 10.1016/j.amepre.2014.07.049; Forbes D, 2013, PSYCHIAT RES, V206, P33, DOI 10.1016/j.psychres.2012.09.037; Gibbons RD, 2013, J CLIN PSYCHIAT, V74, P669, DOI 10.4088/JCP.12m08338; Green KT, 2010, J CLIN PSYCHIAT, V71, P823, DOI 10.4088/JCP.09m05780blu; Haskell SG, 2006, J WOMENS HEALTH, V15, P862, DOI 10.1089/jwh.2006.15.862; Hayes, 2018, INTRO MEDIATION MODE; Hoge CW, 2007, INT J EPIDEMIOL, V36, P327, DOI 10.1093/ije/dym013; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kelly UA, 2011, RES NURS HEALTH, V34, P457, DOI 10.1002/nur.20453; Kerns RD, 2011, ANNU REV CLIN PSYCHO, V7, P411, DOI 10.1146/annurev-clinpsy-090310-120430; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2011, J PAIN, V12, P964, DOI 10.1016/j.jpain.2011.03.003; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Maia A, 2011, ANXIETY STRESS COPIN, V24, P309, DOI 10.1080/10615806.2010.521238; Nillni YI, 2014, HEALTH PSYCHOL, V33, P1281, DOI 10.1037/hea0000084; Polusny MA, 2014, J PSYCHIATR RES, V49, P1, DOI 10.1016/j.jpsychires.2013.09.016; Post Deployment Health Group, 2013, VA HEALTHC UT OEF OI; Quartana PJ, 2015, J PSYCHOSOM RES, V78, P478, DOI 10.1016/j.jpsychores.2014.11.017; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; Rytwinski NK, 2014, J HEALTH PSYCHOL, V19, P509, DOI 10.1177/1359105312474913; Sadler AG, 2004, J WOMENS HEALTH, V13, P799, DOI 10.1089/jwh.2004.13.799; Seery MD, 2010, PAIN, V150, P507, DOI 10.1016/j.pain.2010.06.007; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; U. S. Department of Veterans Affairs National Center for PTSD, US PTSD CHECKL DSM 4; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Youssef NA, 2013, ARCH SUICIDE RES, V17, P106, DOI 10.1080/13811118.2013.776445	41	5	6	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	NOV	2017	257						7	13		10.1016/j.psychres.2017.07.001			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FK3KZ	WOS:000413385300002	28709118				2022-02-06	
J	Carlozzi, NE; Goodnight, S; Umlauf, A; Heaton, RK; Heinemann, AW; Schalet, BD; Gershon, RC; Tulsky, DS				Carlozzi, Noelle E.; Goodnight, Siera; Umlauf, Anya; Heaton, Robert K.; Heinemann, Allen W.; Schalet, Benjamin D.; Gershon, Richard C.; Tulsky, David S.			Motor-Free Composites From the National Institutes of Health Toolbox Cognition Battery (NIHTB-CB) for People With Disabilities	REHABILITATION PSYCHOLOGY			English	Article						cognition; NIHTB; spinal cord injury; traumatic brain injury; stroke	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; EXECUTIVE FUNCTION; PROCESSING SPEED; WORKING-MEMORY; RELIABILITY; VALIDATION; VALIDITY; STROKE; SCORES	Purpose/Objective: The National Institutes of Health Toolbox Cognition Battery (NIHTB-CB) includes a group of brief measures (i.e., 30 min) designed to assess language, processing speed, working memory, episodic memory, and executive functioning. These subtests can be combined to create composite scores that reflect fluid and crystallized cognition, as well as overall cognition. The battery is of limited utility with individuals who have impaired upper extremity motor functioning. This manuscript examines the accuracy of the Oral Symbol Digit Modalities Test as a substitute for the Pattern Comparison Processing Speed Test for computing motor-free composite scores. Research Method/Design: Individuals with spinal cord injury (SCI; n = 188), traumatic brain injury (TBI; n = 159), or stroke (n = 180) completed the NIHTB-CB. We used the Oral Symbol Digit Modalities Test to create a Motor-Free Pattern Comparison score; this was used to create revised, Motor-Free Composite scores for Fluid Cognition and Overall Cognition. Results: Although there were statistically significant overall differences between the two Fluid and Overall Cognition composite scores for some of the clinical groups (scores based on the motor-free approach were significantly higher than the original score), these differences were small and partly because of overclassification of impaired processing speed in participants with motor impairment. There was good to substantial agreement with regard to "impairment" classification between the two sets of Original and Motor-Free composite scores. Conclusions/Implications: Although the Motor-Free scores are not a perfect match for the Original Composite scores, they provide a reliable and valid way to examine overall and fluid cognition in individuals with upper extremity motor impairments.	[Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Umlauf, Anya; Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Chicago, IL USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA; [Schalet, Benjamin D.; Gershon, Richard C.] Northwestern Univ, Dept Med Social Sci, Dept Prevent Med, Feinberg Sch Med, Evanston, IL 60208 USA; [Schalet, Benjamin D.; Gershon, Richard C.] Northwestern Univ, Inst Hlth Serv Res & Policy Studies, Feinberg Sch Med, Evanston, IL 60208 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509	NIDILRR RRTC on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; Federal funds from Blueprint for Neuroscience Research, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHS-N-260-2006-00007-C]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER	This study was supported by the NIDILRR RRTC on Improving Measurement of Medical Rehabilitation Outcomes (Award H133B090024, PI: Allen W. Heinemann). This project was also supported in part with Federal funds from the Blueprint for Neuroscience Research, National Institutes of Health, under Contract HHS-N-260-2006-00007-C.	American Spinal Injury Association International Medical Society of Paraplegia, 2002, INT STAND NEUR FUNCT; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Brennan R., 2004, LINKING EQUIVALENT G; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carlozzi N. E., REHABILITAT IN PRESS; Carlozzi N. E., ARCH CLIN N IN PRESS; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Choi SW, 2014, PSYCHOL ASSESSMENT, V26, P513, DOI 10.1037/a0035768; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen M. L., REHABILITAT IN PRESS; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Dikmen SS, 2014, J INT NEUROPSYCH SOC, V20, P611, DOI 10.1017/S1355617714000460; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Enderby P, 1996, DISABIL REHABIL, V18, P238, DOI 10.3109/09638289609166307; Enderby P M, 1987, Int Rehabil Med, V8, P166; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Gontkovsky ST, 2006, INT J NEUROSCI, V116, P1317, DOI 10.1080/00207450500516537; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Koh CL, 2011, ARCH CLIN NEUROPSYCH, V26, P356, DOI 10.1093/arclin/acr029; Kolen M., 2014, TEST EQUATING SCALIN, V3rd Edn; Magasi S., REHABILITAT IN PRESS; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Noonan VK, 2012, QUAL LIFE RES, V21, P1123, DOI 10.1007/s11136-011-0040-3; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Salter K, 2006, BRAIN INJURY, V20, P559, DOI 10.1080/02699050600744087; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; Tulsky D. S., REHABILITATION PSYCH; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	39	5	5	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					464	473		10.1037/rep0000185			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400007	29265867	Green Accepted, Bronze			2022-02-06	
J	Deryugina, AV; Shumilova, AV; Filippenko, ES; Galkina, YV; Simutis, IS; Boyarinov, GA				Deryugina, A. V.; Shumilova, A. V.; Filippenko, E. S.; Galkina, Ya. V.; Simutis, I. S.; Boyarinov, G. A.			Functional and Biochemical Parameters of Erythrocytes during Mexicor Treatment in Posttraumatic Period after Experimental Blood Loss and Combined Traumatic Brain Injury	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						traumatic brain injury; blood loss; Mexicor		Mexicor treatment (8 mg/kg body weight per day) during the posttraumatic period after concomitant traumatic brain injury and acute blood loss in rats increased electrophoretic mobility and concentration of 2,3-diphosphoglycerate, and reduced malondialdehyde content in erythrocytes. These changes improved hemodynamics and oxygen-transporting function of the blood. The most pronounced effects of Mexicor were observed at the early stages of posttraumatic period.	[Deryugina, A. V.; Shumilova, A. V.; Filippenko, E. S.; Galkina, Ya. V.] NI Lobachevsky Natl Res Nizhny Novgorod State Uni, Dept Biochem & Physiol, Nizhnii Novgorod, Russia; [Simutis, I. S.] Municipal Clin Hosp 40, Dept Anesthesiol & Reanimatol, Nizhnii Novgorod, Russia; [Boyarinov, G. A.] Nizhny Novgorod State Med Acad, Fac Continuing Med Educ, Dept Anesthesiol & Reanimatol, Nizhnii Novgorod, Russia		Deryugina, AV (corresponding author), NI Lobachevsky Natl Res Nizhny Novgorod State Uni, Dept Biochem & Physiol, Nizhnii Novgorod, Russia.	derugina69@yandex.ru	Deryugina, Anna/E-7522-2019; Polozova, Anastasia/AAS-3655-2020	Polozova, Anastasia/0000-0003-1255-9760; Deryugina, Anna/0000-0001-8812-8559			[Боровкова Наталья Валерьевна Borovkova N.V.], 2013, [Общая реаниматология, Obshchaya reanimatologiya], VIX, P18; Boyarinov G. A., 2015, MEDIAL, V16, P31; [Дамулин И.В. Damulin I.V.], 2009, [Неврологический журнал, Nevrologicheskii zhurnal], V14, P38; Egorov IV, 2008, POLIKLINIKA, P24; Fraerman AP, 2010, SOVREM TEHNOL MED, P113; Kochin OV, 2008, UKR NEIROKHIRURG ZH, V2, P10; [Крылов В.Н. Krylov V.N.], 2014, [Биомедицина, Biomeditsina], V1, P37; Krylov VN, 2015, BIOPHYSICS-USSR, V60, P79, DOI DOI 10.1134/S0006350915010170; Mikhin VP, 2011, RUSS J CARDIOL, P37; [Мороз В.В. Moroz V.V.], 2012, [Общая реаниматология, Obshchaya reanimatologiya], VVIII, P52; Nasrullayev MN., 2013, VESTN SOVREMEN KLIN, V6, P94; Nikonov VV, 2013, ZH NEVROL PSIKHIATR, V113, P32; [Симутис Ионас Стасио Simutis Ionas Stasio], 2014, [Общая реаниматология, Obshchaya reanimatologiya], VX, P52, DOI 10.15360/1813-9779-2014-3-50-58; Trofimov AO, 2015, REGIONAR KROVOOBR MI, V14, P4; Zakharov GA, 2014, VESTN TAMBOSCK GOS U, V19, P738	15	5	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	NOV	2017	164	1					26	29		10.1007/s10517-017-3918-4			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FM9TA	WOS:000415613100007	29119396				2022-02-06	
J	Fehr, AE; Scicluna, VM; Pentz, RD; Haggins, AN; Dickert, NW				Fehr, Alexandra E.; Scicluna, Victoria M.; Pentz, Rebecca D.; Haggins, Adrianne N.; Dickert, Neal W.			Patient and Surrogate Views of Community Consultation for Emergency Research	ACADEMIC EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; INFORMED-CONSENT; PATIENTS EXPERIENCES; EXCEPTION; IMPLEMENTATION; PROGESTERONE; ENROLLMENT	ObjectivePretrial community consultation (CC) is required for emergency research conducted under an exception from informed consent (EFIC) in the United States. CC remains controversial and challenging, and minimal data exist regarding the views of individuals enrolled in EFIC trials on this process. It is important to know whether participants perceive CC to be meaningful and, if so, whom they believe should be consulted. MethodsWe conducted a secondary analysis of data from two studies interviewing patients and surrogates of two recent EFIC trials (PEER-RAMPART and PEER-ProTECT). These interviews included similar open- and closed-ended questions regarding participants' views of the importance of CC, the rationale for their responses, and their views regarding which populations should be included in consultation efforts. A template analytic strategy was used for qualitative analysis of textual data, and descriptive statistics were tabulated to characterize demographic data and instances of major themes. ResultsNinety percent of participants perceived CC to be valuable. Participants' reasons for finding CC valuable clustered in two categories: 1) as a method of informing the public about the trial to be conducted and 2) as a way of obtaining input and feedback from the community. Participants cited the medical community (43%) and individuals with a connection to the study condition (41%) as the most important groups to involve in consultation efforts; only 5% suggested consulting the general public in the area where the research will be conducted. ConclusionParticipants in EFIC trials and their decision makers generally valued CC as a method of informing and seeking input from the community. Participants felt that the most appropriate groups to consult were the medical community and individuals with connections to the condition under study. Consultation efforts focused on these two groups, rather than the general public, may be more efficient and more meaningful to individuals involved in EFIC trials. These findings also reinforce the importance of the distinction between public disclosure and CC.	[Fehr, Alexandra E.; Scicluna, Victoria M.; Dickert, Neal W.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Pentz, Rebecca D.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA USA; [Dickert, Neal W.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Haggins, Adrianne N.] Univ Michigan, Sch Med, Dept Emergency Med, North Campus Res Ctr, Ann Arbor, MI USA		Dickert, NW (corresponding author), Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA.; Dickert, NW (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	njr@emory.edu			Greenwall Foundation; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL095358-01A1]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5U01NS062778]; National Institute of Neurological Disorders and Stroke, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R03NS066378-01, 5U01NS056975-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL095358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS062778, R03NS066378] Funding Source: NIH RePORTER	PEER-ProTECT: Supported, by the Greenwall Foundation and the National Heart, Lung, and Blood Institute (F32HL095358-01A1). The parent trial was supported by the National Institute for Neurological Disorders and Stroke (5U01NS062778). Study sponsors played no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the article; or decision to submit the article for publication.; PEER RAMPART: The PEER Study (1R03NS066378-01) and the RAMPART study (5U01NS056975-02) were funded by the National Institute of Neurological Disorders and Stroke, National Institutes of Health. NINDS played no role in the design of the study, interpretation of data, or development of the manuscript.	Dickert NW, 2015, CRIT CARE MED, V43, P603, DOI 10.1097/CCM.0000000000000747; Dickert NW, 2013, RESUSCITATION, V84, P1416, DOI 10.1016/j.resuscitation.2013.04.006; Fehr AE, 2015, ANN EMERG MED, V65, P162, DOI 10.1016/j.annemergmed.2014.06.023; Fordyce CB, 2017, CLIN TRIALS, V14, P88, DOI 10.1177/1740774516676084; Halperin H, 2007, CIRCULATION, V116, P1855, DOI 10.1161/CIRCULATIONAHA.107.186661; Mosesso VN, 2004, RESUSCITATION, V61, P29, DOI 10.1016/j.resuscitation.2003.11.016; Office of Good Clinical Practice, 2011, GUID I REV BOARDS CL; Silbergleit R, 2012, ACAD EMERG MED, V19, P448, DOI 10.1111/j.1553-2712.2012.01328.x; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	9	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	NOV	2017	24	11					1410	1414		10.1111/acem.13265			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FM4IA	WOS:000414977200012	28756646	Green Published			2022-02-06	
J	Hixson, KM; Allen, AN; Williams, AS; McLeod, TCV				Hixson, Krista M.; Allen, Alex N.; Williams, Andrew S.; McLeod, Tamara C. Valovich			Is State Anxiety, Trait Anxiety, or Anxiety Sensitivity a Clinical Predictor of Symptoms in Those Presenting With Mild Traumatic Brain Injury or Concussion?	JOURNAL OF SPORT REHABILITATION			English	Article						risk factor; return-to-play; post-concussion; patient-reported outcome measure; psychology	MINOR HEAD-INJURY	Clinical Scenario: Mild traumatic brain injury, or concussion, has been associated with physical, cognitive, and emotional sequelae. Little is understood in regard to many characteristics, such as anxiety, and their effect on post-concussion symptoms. Clinical Question: Is state anxiety, trait anxiety, or anxiety sensitivity a clinical predictor of symptoms in those presenting with mild traumatic brain injury or concussion? Summary of Key Findings: A literature search returned 3 possible studies; 3 studies met inclusion criteria and included. One study reported in athletes that greater social support was associated with decreased state-anxiety, lower state anxiety post-concussion was associated with increased social support, and that those with greater social support may experience reduced anxiety, regardless of injury type sustained. One study reported baseline trait anxiety in athletes was not significantly associated with post-concussion state anxiety, but that symptoms of depression at baseline was the strongest predictor for post-concussion state anxiety. Three studies reported that state and trait anxiety are not related to increased post-concussion symptom scores. One study reported that greater anxiety sensitivity is related to higher reported post-concussion symptom scores, which may manifest as somatic symptoms following concussion, and revealed that anxiety sensitivity may be a risk factor symptom development. Clinical Bottom Line: There is low-level to moderate evidence to support that anxiety sensitivity is linked to post-concussion symptoms. State and trait anxiety do not appear to be related to post-concussion symptoms alone. Post-concussion state anxiety may occur if post-concussion symptoms of depression are present or if baseline symptoms of depression are present. Better social support may improve state anxiety post-concussion. Strength of Recommendation: There is grade B evidence to support that state and trait anxiety are not risk factors for post-concussion symptom development. There is grade C evidence to support anxiety sensitivity as a risk factor for developing post-concussion symptoms.	[Hixson, Krista M.; Allen, Alex N.; Williams, Andrew S.; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA		Hixson, KM (corresponding author), AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA.	khixson@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; NCAA Sport Science Institute and the NCAA, 2016, MENT HLTH BEST PRACT; Neal TL, 2015, J ATHL TRAINING, V50, P231, DOI 10.4085/1062-6050-50.3.03; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	9	5	5	0	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	NOV	2017	26	6					588	594		10.1123/jsr.2016-0122			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FP4AA	WOS:000417557900015	28182530				2022-02-06	
J	Irvine, A; Babul, S; Goldman, RD				Irvine, Andrew; Babul, Shelina; Goldman, Ran D.			Return to learn after concussion in children	CANADIAN FAMILY PHYSICIAN			English	Article							SPORTS; REST	Question Despite recent interest in the pathophysiology and management of concussion in children, as well as the ongoing concern about return to activity, advice regarding the type and length of cognitive rest has been inconsistent. What should I recommend to the children and adolescents in my clinic regarding cognitive rest following mild concussion? Answer Strict cognitive rest is not needed in those with mild concussion. Evidence suggests a decrease in usual activity to a level that allows children to remain asymptomatic, followed by a gradual return to learning, is appropriate. It is clear that either too little or too much activity is disadvantageous to recovery and can worsen outcomes.				rgoldman@cw.bc.ca		Babul, Shelina/0000-0002-0227-2574; Goldman, Ran D./0000-0001-8318-5415			[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2017, BRIT J SPORT MED, V51, P859; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Halstead ME, 2017, BRIT J SPORT MED, V51, P147, DOI 10.1136/bjsports-2016-096674; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Olympia RP, 2016, CLIN J SPORT MED, V26, P115, DOI 10.1097/JSM.0000000000000208; Rajabali F., 2012, BURDEN CONCUSSION BR; Taubman B, 2016, J CHILD NEUROL, V31, P1555, DOI 10.1177/0883073816664835; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Varner CE, 2017, ACAD EMERG MED, V24, P75, DOI 10.1111/acem.13073	18	5	5	0	1	COLL FAMILY PHYSICIANS CANADA	MISSISSAUGA	2630 SKYMARK AVE, MISSISSAUGA, ONTARIO L4W 5A4, CANADA	0008-350X	1715-5258		CAN FAM PHYSICIAN	Can. Fam. Phys.	NOV	2017	63	11					859	862					3	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO3JT	WOS:000416725800017	29138156				2022-02-06	
J	Kalra, ID; Watanabe, TK				Kalra, Inder D.; Watanabe, Thomas K.			Mood Stabilizers for Traumatic Brain Injury-Related Agitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							ALCOHOL-WITHDRAWAL SYNDROME; PHARMACOLOGICAL MANAGEMENT; INPATIENT REHABILITATION; AGGRESSIVE BEHAVIORS; VALPROIC ACID; HEAD-INJURY; LITHIUM; CARBAMAZEPINE; DISORDERS; SCALE		[Kalra, Inder D.] Einstein Healthcare Network, Dept Psychiat, Elkins Pk, PA USA; [Watanabe, Thomas K.] Temple Univ, Sch Med, Drucker Brain Injury Ctr, MossRehab Elkins Pk,Einstein Healthcare Network, Philadelphia, PA 19122 USA; [Watanabe, Thomas K.] Temple Univ, Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19122 USA		Kalra, ID (corresponding author), MossRehab, Elkins Pk, PA 19027 USA.	kalraind@einstein.edu					Ambrosio AF, 2002, NEUROCHEM RES, V27, P121, DOI 10.1023/A:1014814924965; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; Barrons R, 2010, J CLIN PHARM THER, V35, P153, DOI 10.1111/j.1365-2710.2009.01098.x; Bellus SB, 1996, BRAIN INJURY, V10, P849, DOI 10.1080/026990596123954; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; Brown KM, 2013, THER ADV PSYCHOPHARM, V3, P163, DOI 10.1177/2045125312471963; Chatham-Showalter PE, 1995, J NEUROPSYCHIATRY CL, V8, P96; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Gill D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009183.pub2; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; Goodyear-Smith F, 2009, CLIN J PAIN, V25, P528, DOI 10.1097/AJP.0b013e318197d4cc; Hammond CJ, 2015, CNS DRUGS, V29, P293, DOI 10.1007/s40263-015-0240-4; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; PELLOCK JM, 1987, EPILEPSIA, V28, pS64, DOI 10.1111/j.1528-1157.1987.tb05780.x; Sher Y, 2015, PSYCHOSOMATICS, V56, P615, DOI 10.1016/j.psym.2015.09.008; Showalter PEC, 2000, J NEUROPSYCH CLIN N, V12, P395; Silver Jonathan M., 1994, P313; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Wiffen PJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001133.pub3; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	34	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					E61	E64		10.1097/HTR.0000000000000359			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100009	29095772				2022-02-06	
J	Kim, H; Lee, HS; Ahn, SY; Park, SC; Huh, W				Kim, Han; Lee, Heui Seung; Ahn, Sung Yeol; Park, Sung Chun; Huh, Won			Factors Associated Postoperative Hydrocephalus in Patients with Traumatic Acute Subdural Hemorrhage	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain injuries, Traumatic; Hematoma, Subdural; Craniectomy; Hydrocephalus; Intraventricular hemorrhage	DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; POSTTRAUMATIC HYDROCEPHALUS; BRAIN-INJURY; HYGROMA	Objective : Postoperative hydrocephalus is a common complication following craniectomy in patients with traumatic brain injury, and affects patients' long-term outcomes. This study aimed to verify the risk factors associated with the development of hydrocephalus after craniectomy in patients with acute traumatic subdural hemorrhage (tSDH). Methods : Patients with acute traumatic SDH who had received a craniectomy between December 2005 and January 2016 were retrospectively assessed by reviewing the coexistence of other types of hemorrahges, measurable variables on computed tomography (CT) scans, and the development of hydrocephalus during the follow-up period. Results : Data from a total of 63 patients who underwent unilateral craniectomy were analyzed. Postoperative hydrocephalus was identified in 34 patients (54%) via brain CT scans. Preoperative intraventricular hemorrhage (IVH) was associated with the development of hydrocephalus. Furthermore, the thickness of SDH (p=0.006) and the extent of midline shift before craniectomy (p=0.001) were significantly larger in patients with postoperative hydrocephalus. Indeed, multivariate analyses showed that the thickness of SDH (p=0.019), the extent of midline shift (p<0.001) and the coexistence of IVH (p=0.012) were significant risk factors for the development of postoperative hydrocephalus. However, the distance from the midline to the craniectomy margin was not an associated risk factor for postoperative hydrocephalus. Conclusion : In patients with acute traumatic SDH with coexisting IVH, a large amount of SDH, and a larger midline shift, close follow-up is necessary for the early prediction of postoperative hydrocephalus. Furthermore, craniectomy margin need not be limited in acute traumatic SDH patients for the reason of postoperative hydrocephalus.	[Kim, Han; Lee, Heui Seung; Ahn, Sung Yeol; Park, Sung Chun; Huh, Won] Myongji Hosp, Dept Neurosurg, 55 Hwasu Ro 14Beon Gil, Goyang 10475, South Korea		Lee, HS (corresponding author), Myongji Hosp, Dept Neurosurg, 55 Hwasu Ro 14Beon Gil, Goyang 10475, South Korea.	antanatia@gmail.com					CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; FOROGLOU G, 1972, Acta Radiologica Diagnosis, V13, P524; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vedantam A, 2017, J NEUROSURG; Wang QP, 2016, NEUROSCIENCES, V21, P10, DOI 10.17712/nsj.2016.1.20150543; Wani AA, 2013, PEDIATR NEUROSURG, V49, P287, DOI 10.1159/000363701; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yuan Q, 2015, BRAIN INJURY, V29, P971, DOI 10.3109/02699052.2015.1004760	18	5	9	2	7	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2017	60	6					730	737		10.3340/jkns.2017.0210			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FS9WW	WOS:000422771000016	29142634	gold, Green Published			2022-02-06	
J	Kurowski, BG; Treble-Barna, A; Zang, HY; Zhang, NH; Martin, LJ; Yeates, KO; Taylor, HG; Wade, SL				Kurowski, Brad G.; Treble-Barna, Amery; Zang, Huaiyu; Zhang, Nanhua; Martin, Lisa J.; Yeates, Keith Owen; Taylor, H. Gerry; Wade, Shari L.			Catechol-O-Methyltransferase Genotypes and Parenting Influence on Long-Term Executive Functioning After Moderate to Severe Early Childhood Traumatic Brain Injury: An Exploratory Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior; cognitive function; genetic factors; pediatric brain injury; traumatic brain injury	JUVENILE-OFFENDERS; HEALTH; PREVALENCE; SYSTEM	Objectives: To examine catechol-O-methyltransferase (COMT) rs4680 genotypes as moderators of the effects of parenting style on postinjury changes in parent behavior ratings of executive dysfunction following moderate to severe early childhood traumatic brain injury. Setting: Research was conducted in an outpatient setting. Participants: Participants included children admitted to hospital with moderate to severe traumatic brain injury (n = 55) or orthopedic injuries (n = 70) between ages 3 and 7 years. Design: Prospective cohort followed over 7 years postinjury. Main Measures: Parenting Practices Questionnaire and the Behavior Rating Inventory of Executive Functioning obtained at baseline, 6, 12, and 18 months, and 3.5 and 6.8 years postinjury. DNA was collected from saliva samples, purified using the Oragene (DNA Genotek, Ottawa, Ontario, Canada) OG-500 self-collection tubes, and analyzed using TaqMan (Applied Biosystems, Thermo Fisher Scientific, Waltham, Massachusetts) assay protocols to identify the COMT rs4680 polymorphism. Results: Linear mixed models revealed a significant genotype x parenting style x time interaction (F = 5.72, P =.02), which suggested that the adverse effects of authoritarian parenting on postinjury development of executive functioning were buffered by the presence of the COMT AA genotype (lower enzyme activity, higher dopamine levels). There were no significant associations of executive functioning with the interaction between genotype and authoritative or permissive parenting ratings. Conclusion: The lower activity COMT rs4680 genotype may buffer the negative effect of authoritarian parenting on long-term executive functioning following injury in early childhood. The findings provide preliminary evidence for associations of parenting style with executive dysfunction in children and for a complex interplay of genetic and environmental factors as contributors to decreases in these problems after traumatic injuries in children. Further investigation is warranted to understand the interplay among genetic and environmental factors related to recovery after traumatic brain injury in children.	[Kurowski, Brad G.; Treble-Barna, Amery; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Kurowski, Brad G.; Treble-Barna, Amery; Zang, Huaiyu; Zhang, Nanhua; Martin, Lisa J.; Wade, Shari L.] Univ Cincinnati, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Rainbow Child Dev Ctr, Cleveland, OH 44106 USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Martin, Lisa/E-2425-2016; Zang, Huaiyu/AAY-6603-2021; Yeates, Keith/AAJ-4223-2020	Martin, Lisa/0000-0001-8702-9946; Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	Rehabilitation Medicine Scientist Training Program (RMSTP) [K-12 HD001097-16]; National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683-01A1, R01 HD42729]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683, K12HD001097, R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	This study was funded in part by the Rehabilitation Medicine Scientist Training Program (RMSTP) K-12 HD001097-16, National Institute for Child Health and Human Development K23HD074683-01A1, R01 HD42729, and grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other supporting agencies.	Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Elbogen EB, 2015, J HEAD TRAUMA REHAB, V30, pE3, DOI 10.1097/HTR.0000000000000083; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Gordon W.A., 1999, BRAIN INJURY SCREENI; Gordon WA, 2009, CEREBRUM 2009 EMERGI, P57; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux D, 1998, BRAIN INJURY, V12, P667; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	22	5	5	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					404	412		10.1097/HTR.0000000000000281			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100096	28060209	Green Accepted			2022-02-06	
J	Langelier, DM; Kline, GA; Debert, CT				Langelier, David M.; Kline, Gregory A.; Debert, Chantel T.			Neuroendocrine Dysfunction in a Young Athlete With Concussion: A Case Report	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport concussion; hypopituitarism; growth hormone deficiency; head trauma; neuroendocrine dysfunction	TRAUMATIC BRAIN-INJURY; DEFICIENCY	An 18-year-old female ringette and basketball player presented to our sport concussion clinic 27 months after concussion with fatigue, headache, exercise intolerance, polyuria, nocturia, and difficulties concentrating. Her history was remarkable for 4 previous concussions. Her neurologic examination was normal. Neuroendocrine screen including thyroid function, morning cortisol, glucose, and insulin-like growth factor-1 (screening test for growth hormone deficiency) were normal. Further testing for growth hormone deficiency with an insulin hypoglycemia test revealed severe growth hormone deficiency. Urine and serum electrolytes were borderline normal, suggesting partial diabetes insipidus. Treatments with growth hormone replacement lead to complete recovery. This case highlights the importance of maintaining a high index of suspicion for neuroendocrine abnormalities in athletes with persistent symptoms after sport concussion. Symptoms can be nonspecific and go undiagnosed for years, but appropriate recognition and treatment can restore function.	[Langelier, David M.; Debert, Chantel T.] Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, Foothills Med Ctr, Calgary, AB, Canada; [Kline, Gregory A.] Univ Calgary, Div Endocrinol, Dept Internal Med, Calgary, AB, Canada		Debert, CT (corresponding author), Dept Clin Neurosci, Div Phys Med & Rehabil, 1403-29 St NW, Calgary, AB T2N 2T9, Canada.	chantel.debert@gmail.com	MUI, HOI LING/I-3220-2018	Langelier, David/0000-0002-9863-5084; Debert, Chantel/0000-0002-2704-0438			Abe S, 2009, J PAEDIATR CHILD H, V45, P636, DOI 10.1111/j.1440-1754.2009.01586.x; Dubourg J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11182; Foley CM, 2012, SPORTS HEALTH, V4, P139, DOI 10.1177/1941738111434275; Gardner CJ, 2015, EUR J ENDOCRINOL, V172, P371, DOI 10.1530/EJE-14-0654; Guaraldi F, 2015, J CLIN MED, V4, P1025, DOI 10.3390/jcm4051025; Ives JC, 2007, J ATHL TRAINING, V42, P431; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814	10	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2017	27	6					E78	E79		10.1097/JSM.0000000000000408			2	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	FN2KO	WOS:000415821300002	28114247				2022-02-06	
J	Martindale, SL; Farrell-Carnahan, LV; Ulmer, CS; Kimbrel, NA; McDonald, SD; Rowland, JA				Martindale, Sarah L.; Farrell-Carnahan, Leah V.; Ulmer, Christi S.; Kimbrel, Nathan A.; McDonald, Scott D.; Rowland, Jared A.		VA Mid-Atlantic MIRECC Registry Wo	Sleep Quality in Returning Veterans: The Influence of Mild Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; veteran; sleep; posttraumatic stress disorder; combat exposure	POSTTRAUMATIC-STRESS-DISORDER; ENDURING FREEDOM; COMBAT EXPOSURE; HEALTH SYMPTOMS; IRAQI FREEDOM; INSOMNIA; DISTURBANCES; DIFFICULTIES; ASSOCIATIONS; DEPRIVATION	Objective: Sleep disturbance is a key behavioral health concern among Iraq and Afghanistan era veterans and is a frequent complaint among veterans with a history of mild traumatic brain injury (mTBI). Currently, it is unclear whether sleep disturbance is a core sequelae of mTBI or if it may be related to other behavioral health conditions that are commonly present in postdeployment veterans. The purpose of this study was to determine if history of mTBI is associated with poor sleep quality beyond combat exposure and behavioral health concerns, including posttraumatic stress disorder (PTSD), mood disorders, anxiety disorders, and substance use disorders. Research Method: Participants included 527 veterans who deployed after September 11, 2001, in support of the wars in Iraq and Afghanistan. Participants completed the Structured Clinical Interview for DSM-IV Disorders, Combat Exposure Scale, a structured clinical TBI interview, and the Pittsburgh Sleep Quality Index. Results: Deployment-related mTBI was associated with poor sleep quality independent of combat exposure, PTSD, mood disorders, anxiety disorders, and substance use disorders (B = 1.84, p = .001) an average of 6 years after the injury event. No interaction effects between deployment-related mTBI and combat exposure, PTSD, mood disorders, anxiety disorders, or substance use disorders on sleep quality were detected. Conclusions: Veterans with a history of mTBI sustained during deployment reported significantly poorer sleep quality than veterans without history of mTBI, even when considering combat exposure and behavioral health issues. Clinicians should consider mTBI as a potential contributor to sleep problems, even years after an injury event.	[Martindale, Sarah L.] WG Hefner Vet Affairs Med Ctr, Midatlantic Mental Illness Res Educ & Clin Ctr MA, Salisbury, NC USA; [Martindale, Sarah L.; Rowland, Jared A.] WG Hefner Vet Affairs Med Ctr, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Psychiat & Behav Med, Winston Salem, NC USA; [Farrell-Carnahan, Leah V.; McDonald, Scott D.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Farrell-Carnahan, Leah V.; McDonald, Scott D.] Virginia Commonwealth Univ Hlth Syst, Dept Phys Med & Rehabil, Richmond, VA USA; [Ulmer, Christi S.] Durham Vet Affairs Med Ctr, Hlth Serv Res Dev, Durham, NC USA; [Ulmer, Christi S.; Kimbrel, Nathan A.] Duke Univ, Dept Psychiat & Behav Sci, Med Ctr, Durham, NC 27706 USA; [Kimbrel, Nathan A.; VA Mid-Atlantic MIRECC Registry Wo] Durham Vet Affairs Med Ctr, Durham, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat & Psychiat & Behav Med, Winston Salem, NC USA		Martindale, SL (corresponding author), WG Hefner VAMC, Mental Hlth & Behav Sci, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Sarah.Martindale-Supak@va.gov	Rowland, Jared A./AAN-3030-2021; Martindale, Sarah L/O-8553-2018	Rowland, Jared A./0000-0002-3655-3411; Martindale, Sarah L/0000-0002-0059-3454	Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and TreatmentUS Department of Veterans Affairs; W. G. Hefner Veterans Affairs Medical Center; Durham Veterans Affairs Medical Center; Hunter Holmes McGuire Veterans Affairs Medical Center; Mid-Atlantic Mental Illness Research, Education, and Clinical Center (VISN 6 MIRECC) of the Department of Veterans Affairs Office of Mental Health Services; Department of Veterans Affairs Office of Research and DevelopmentUS Department of Veterans Affairs; Department of Veterans Affairs Health Services Research and Development Career Development AwardUS Department of Veterans Affairs [CDA 09-218]; Department of Veterans Affairs Clinical Science Research and Development Career Development Award [IK2CX000525, IK2CX000718]; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [IK2CX000718, 1IK2RX000703-01, 1IK2RX000908]	This research was supported by the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness, Research, and Treatment, the W. G. Hefner Veterans Affairs Medical Center, Durham Veterans Affairs Medical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, and the Mid-Atlantic Mental Illness Research, Education, and Clinical Center (VISN 6 MIRECC) of the Department of Veterans Affairs Office of Mental Health Services, and the Department of Veterans Affairs Office of Research and Development. The Mid-Atlantic MIRECC Registry Workgroup contributors for this paper include: Mira Brancu, Jean C. Beckham, Patrick S. Calhoun, Eric Dedert, Eric B. Elbogen, John A. Fairbank, Kimberly T. Green, Robin A. Hurley, Jason D. Kilts, Angela Kirby, Christine E. Marx, Gregory McCarthy, Marinell Miller-Mumford, Scott D. Moore, Rajendra A. Morey, Jennifer C. Naylor, Treven C. Pickett, Jennifer J. Runnals, Cindy Swinkels, Steven T. Szabo, Katherine H. Taber, Larry A. Tupler, Elizabeth E. Van Voorhees, Richard D. Weiner, Ruth E. Yoash-Gantz, Ulmer is funded by a Department of Veterans Affairs Health Services Research and Development Career Development Award (CDA 09-218). Kimbrel is funded by a Department of Veterans Affairs Clinical Science Research and Development Career Development Award (IK2CX000525). McDonald is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1IK2RX000703-01). Dedert is funded by a Department of Veterans Affairs Clinical Science Research and Development Career Development Award (IK2CX000718). Naylor is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1IK2RX000908). Van Voorhees is funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1K2RX001298).	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Baumann CR, 2016, SLEEP MED CLIN, V11, P19, DOI 10.1016/j.jsmc.2015.10.004; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Defense and Veterans Brain Injury Center, 2015, DOD NUMB TRAUM BRAIN; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Faul M, 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; First M.B., 1996, STRUCTURED CLIN INTE; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kahn-Greene ET, 2007, SLEEP MED, V8, P215, DOI 10.1016/j.sleep.2006.08.007; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lind MJ, 2017, J CLIN SLEEP MED, V13, P291, DOI 10.5664/jcsm.6466; LUND M, 1984, J CLIN PSYCHOL, V40, P1323, DOI 10.1002/1097-4679(198411)40:6<1323::AID-JCLP2270400607>3.0.CO;2-I; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Schell T.L., 2011, NEEDS ASSESSMENT NEW; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Troxel WM, 2015, SLEEP MILITARY PROMO; Ulmer CS, 2015, J CLIN SLEEP MED, V11, P995, DOI 10.5664/jcsm.5012; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Waters F, 2011, J INT NEUROPSYCH SOC, V17, P571, DOI 10.1017/S1355617711000610	44	5	5	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					563	570		10.1037/rep0000159			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400017	28703617	Bronze			2022-02-06	
J	Mas, MF; Mathews, A; Gilbert-Baffoe, E				Mas, Manuel F.; Mathews, Amy; Gilbert-Baffoe, Ekua			Rehabilitation Needs of the Elder with Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Elderly; Cognitive rehabilitation; Preventive medicine	LONG-TERM RECOVERY; INPATIENT REHABILITATION; OLDER-ADULTS; COMMUNITY INTEGRATION; COGNITIVE IMPAIRMENT; FOLLOW-UP; POSTTRAUMATIC HYDROCEPHALUS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; RISK-FACTORS	The incidence of traumatic brain injury (TBI) in older adults is increasing. As the expected life expectancy increases, there is a heightened need for comprehensive rehabilitation for this population. Elderly patients with TBI benefit from rehabilitation interventions at all stages of injury and can achieve functional gains during acute inpatient rehabilitation. Clinicians should be vigilant of unique characteristics of this population during inpatient rehabilitation, including vulnerability to polypharmacy, posttraumatic hydrocephalus, neuropsychiatric sequelae, sleep disturbances, and sensory deficits. Long-term care should include fall prevention, assessment of cognitive deficits, aerobic activity, community reintegration, and caretaker support. Life expectancy is reduced after TBI.	[Mas, Manuel F.] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, McGovern Med Sch, TIRR Mem Hermann, 1333 Moursund St, Houston, TX 77030 USA; [Mathews, Amy; Gilbert-Baffoe, Ekua] Baylor Coll Med, Dept Phys Med & Rehabil, 7200 Cambridge St,Suite 10C, Houston, TX 77030 USA		Mas, MF (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, McGovern Med Sch, TIRR Mem Hermann, 1333 Moursund St, Houston, TX 77030 USA.	manuel.mas@uth.tmc.edu					Albrecht JS, 2017, J HEAD TRAUMA REHAB, P1; [Anonymous], 1996, J NEUROL SCI, V144, P218; Arciniegas DB, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1215; Arciniegas DB, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1227; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Cosano G, 2016, BRAIN INJURY, V30, P353, DOI 10.3109/02699052.2015.1118767; Crane PK, 2016, JAMA NEUROL, V98104, P7; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Eum RS, 2017, J HEAD TRAUMA REHAB, V32, P158, DOI 10.1097/HTR.0000000000000246; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Frewen J, 2014, J AM GERIATR SOC, V62, P117, DOI 10.1111/jgs.12592; Frieden T.R., 2015, CDC NIH REP C, P1, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; GARCIA CA, 1984, J AM GERIATR SOC, V32, P339, DOI 10.1111/j.1532-5415.1984.tb02036.x; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Graven C, 2016, STROKE, V47, P2820, DOI 10.1161/STROKEAHA.116.013081; Greiss C, 2016, J TRAUMA ACUTE CARE, V80, P70, DOI 10.1097/TA.0000000000000890; Guyot LL, 2000, NEUROL RES, V22, P25; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hartog LC, 2016, ARCH PHYS MED REHABI; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Hoyert DL., 1935, NCHS DATA BRIEF, V2012, P1; Husson N, 2014, J NUTR HEALTH AGING, V18, P87, DOI 10.1007/s12603-013-0337-8; Jordan D, 1997, JAMA NEUROL, V278, P136; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kose Eiji, 2016, J Aging Res, V2016, P7957825, DOI 10.1155/2016/7957825; Levine J, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P420; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Luck-Sikorski C, 2017, INT PSYCHOGERIATR, V29, P389, DOI 10.1017/S1041610216001885; LYNESS JM, 1995, J AM GERIATR SOC, V43, P216, DOI 10.1111/j.1532-5415.1995.tb07325.x; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Morris T, 2016, RESTOR NEUROL NEUROS, V34, P977, DOI 10.3233/RNN-160687; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murphy MP, 2014, REHABIL NURS, V39, P113, DOI 10.1002/rnj.89; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Oishi E, 2016, INTERNAL MED, V55, P1947, DOI 10.2169/internalmedicine.55.4524; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Pisa FE, 2015, BRAIN INJURY, V29, P508, DOI 10.3109/02699052.2014.992474; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Rothenhausler HB, 2000, J CLIN PSYCHIAT, V61, P750, DOI 10.4088/JCP.v61n1007; Salat DH, 1999, ARCH NEUROL-CHICAGO, V56, P338, DOI 10.1001/archneur.56.3.338; Saum KU, 2017, J AM GERIATR SOC, V65, pE27, DOI 10.1111/jgs.14718; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Senathi-Raja D, 2009, J REHABIL MED, V41, P666, DOI 10.2340/16501977-0396; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shahab S, 2017, ARCH PHYS MED REHAB, V98, P500, DOI 10.1016/j.apmr.2016.07.014; Swift CG, 2014, CLIN MED, V14, P658, DOI 10.7861/clinmedicine.14-6-658; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vollmer DG, 1991, J NEUROSURG S, V75, P37; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	91	5	6	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2017	28	4					829	+		10.1016/j.pmr.2017.06.014			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FM4XB	WOS:000415031000018	29031347				2022-02-06	
J	McKinlay, A; Corrigan, JD; Bogner, JA; Horwood, LJ				McKinlay, Audrey; Corrigan, John D.; Bogner, Jennifer A.; Horwood, L. John			Obtaining a History of Childhood Traumatic Brain Injury Using the Ohio State University TBI Identification Method to Elicit Adult Recall	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cohort; head injury; longitudinal; memory; recall	SUBSTANCE-ABUSE; BIRTH COHORT; RELIABILITY; VALIDITY; PRESCHOOL; CHILDREN	Objective: To investigate the concordance between medically documented childhood traumatic brain injury (TBI) and recall of same by adults aged 35 years. Participants: A total of 962 birth cohort members from the Christchurch Health and Development Study available at the 35-year follow-up. Main Measures: Childhood TBI information prospectively collected yearly over ages 0 to 15 years as part of the Christchurch Health and Development Study. At age 35 years, cohort members were administered the Ohio State University TBI Identification Method (OSU TBI-ID) to elicit recall of TBIs with loss of consciousness (LOC). Results: Ninety-four individuals reported 116 TBI events. Twenty-five TBI events resulting in LOC, 17 (68%) were recalled (true positives) and 8 (32%) were not recalled (false negatives). LOC was incorrectly recalled for 56 events (false positives), but 868 individuals correctly recalled no TBI event (no LOC). A further 35 events were (correctly) recalled for which a TBI had been recorded but no LOC (true negatives; 91.8%). Implications: We evaluated the utility of the OSU TBI-ID to identify adult recall of childhood TBI with LOC occurring 19 to 35 years earlier. Most of the cohort accurately reported whether or not they had experienced a medically attended TBI with LOC, indicating that a positive result from the OSU TBI-ID provides useful screening information.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Corrigan, John D.; Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Horwood, L. John] Univ Otago, Christchurch Hlth & Dev Study, Christchurch, New Zealand		McKinlay, A (corresponding author), Univ Melbourne, Psychol Clin, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au	Corrigan, John D./E-2921-2011	McKinlay, Audrey/0000-0001-9846-8514; Horwood, L./0000-0003-4881-1956			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bruce D, 2000, PSYCHOL SCI, V11, P360, DOI 10.1111/1467-9280.00271; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; HOWE ML, 1994, CONSCIOUS COGN, V3, P327, DOI 10.1006/ccog.1994.1019; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590	14	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					E24	E28		10.1097/HTR.0000000000000284			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100003	28060210	Green Submitted			2022-02-06	
J	Nitsch, KP; Casaletto, KB; Carlozzi, NE; Tulsky, DS; Heinemann, AW; Heaton, RK				Nitsch, Kristian P.; Casaletto, Kaitlin B.; Carlozzi, Noelle E.; Tulsky, David S.; Heinemann, Allen W.; Heaton, Robert K.			Uncorrected Versus Demographically-Corrected Scores on the NIH Toolbox Cognition Battery in Persons With Traumatic Brain Injury and Stroke	REHABILITATION PSYCHOLOGY			English	Article						NIHTB-CB; traumatic brain injury; stroke; cognition; statistical data analysis	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; MEASURING EPISODIC MEMORY; PROCESSING SPEED TEST; VERBAL-LEARNING TEST; CLASSIFICATION ACCURACY; NORMATIVE STANDARDS; EXECUTIVE FUNCTION; AFRICAN-AMERICAN; WORKING-MEMORY; SORTING TEST	Objective: The association between demographic characteristics and neurocognitive performance is well established; however, clinicians may have difficulty selecting when to use uncorrected versus demographically corrected scores. We compared these score types in individuals with traumatic brain injury (TBI) and stroke, on the National Institutes of Health Toolbox-Cognition Battery (NIHTB-CB). Research Method: Adults with TBI and stroke were demographically matched to controls, and completed the NIHTB-CB. Published "corrected scores" are adjusted for age, education, sex, and race/ethnicity; "uncorrected scores" were created using census data to represent the average adult in the U.S. population. Results: Effect sizes for the TBI and stroke groups versus controls were larger using corrected scores compared with uncorrected scores for the fluid composite (uncorrected to corrected effect sizes: TBI: d = 0.66, p < .001 to 0.83, p < .001; stroke d = 0.97, p < .001 to 1.10, p < .001). For the crystallized composite, effect sizes for the TBI and stroke groups versus controls were smaller and nonsignificant using corrected scores (uncorrected to corrected effect sizes: TBI d = 0.23, p = .03 to 0.20, p = .06; stroke d = 0.40, p = .001 to 0.17, p = .09). In the injury groups, demographic characteristics accounted for up to 33% of variance in uncorrected scores (p < .001), but <5% of variance in corrected scores (p > .06). Conclusions: Corrected scores were more sensitive to neurocognitive impairments in the brain-injured groups. Corrected scores have the advantage of controlling for variance associated with premorbid factors rather than changes in neurological functioning; are more helpful in characterizing acquired neurocognitive changes; and can aid in the interpretation of test performance.	[Nitsch, Kristian P.] IIT, Dept Psychol, Chicago, IL 60616 USA; [Nitsch, Kristian P.; Heinemann, Allen W.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, 446 East Ontario St,Room 970, Chicago, IL 60611 USA; [Casaletto, Kaitlin B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Tulsky, David S.] Univ Delaware, Ctr Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Tulsky, David S.] Kessler Fdn, Res Ctr, W Orange, NJ USA; [Heinemann, Allen W.] Northwestern Univ, Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA; [Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA		Nitsch, KP (corresponding author), Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, 446 East Ontario St,Room 970, Chicago, IL 60611 USA.	knitsch@ric.org	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30 MH062512] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER		Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P34, DOI 10.1111/mono.12033; Beaumont JL, 2013, NEUROLOGY, V80, pS87, DOI 10.1212/WNL.0b013e3182872e70; Blake TM, 2009, CLIN NEUROPSYCHOL, V23, P373, DOI 10.1080/13854040802279691; Byrd DA, 2004, J INT NEUROPSYCH SOC, V10, P401, DOI 10.1017/S1355617704103081; Carlozzi NE, 2015, ARCH CLIN NEUROPSYCH, V30, P359, DOI 10.1093/arclin/acv031; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Carlozzi NE, 2013, MONOGR SOC RES CHILD, V78, P88, DOI 10.1111/mono.12036; Carvalho JO, 2015, J GERONTOL B-PSYCHOL, V70, P545, DOI 10.1093/geronb/gbu086; Casaletto KB, 2016, J INT NEUROPSYCH SOC, V22, P364, DOI 10.1017/S135561771500137X; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Cattell R.B., 1971, ABILITIES THEIR STRU; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Dikmen SS, 2014, J INT NEUROPSYCH SOC, V20, P611, DOI 10.1017/S1355617714000460; Gasquoine PG, 2009, NEUROPSYCHOL REV, V19, P250, DOI 10.1007/s11065-009-9090-5; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Heaton R. K., 2004, REVISED COMPREHENSIV; Heaton RK, 2009, NEUROPSYCHOLOGICAL A, P127; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Lenze EJ, 2004, INT J GERIATR PSYCH, V19, P472, DOI 10.1002/gps.1116; Manly JJ, 2006, MED CARE, V44, pS10, DOI 10.1097/01.mlr.0000245427.22788.be; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; MCFIE J, 1975, ASSESSMENT ORGANIC I; Mungas D, 2005, NEUROPSYCHOLOGY, V19, P466, DOI 10.1037/0894-4105.19.4.466; Mungas D, 2009, PSYCHOL AGING, V24, P116, DOI 10.1037/a0013421; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; O'Connell ME, 2011, J CLIN EXP NEUROPSYC, V33, P422, DOI 10.1080/13803395.2010.532114; O'Connell ME, 2010, ARCH CLIN NEUROPSYCH, V25, P126, DOI 10.1093/arclin/acp111; Poynter L, 2013, INT J CLIN PRACT, V67, P811, DOI 10.1111/ijcp.12161; Psychological Corporation, 2001, MAN WECHSL TEST AD R; Rabadi MH, 2008, ARCH PHYS MED REHAB, V89, P441, DOI 10.1016/j.apmr.2007.11.014; Reitan R M, 1997, Appl Neuropsychol, V4, P16, DOI 10.1207/s15324826an0401_3; Reitan RM, 2005, APPL NEUROPSYCHOL, V12, P181, DOI 10.1207/s15324826an1204_1; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Sliwinski M, 1997, J Int Neuropsychol Soc, V3, P317; Sliwinski M., 2003, OPTIMIZING COGNITIVE; Strong CAH, 2005, J CLIN EXP NEUROPSYC, V27, P746, DOI 10.1081/13803390490919155; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; TEASDALE G, 1974, LANCET, V2, P81; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wechsler D., 1958, MEASUREMENT APPRAISA, V4; WECHSLER D, 1935, RANGE HUMAN CAPACITI; Wechsler D, 1952, RANGE HUMAN CAPACITI; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, MONOGR SOC RES CHILD, V78, P1, DOI 10.1111/mono.12031; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022	58	5	5	0	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					485	495		10.1037/rep0000122			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400009	29265869	Green Accepted			2022-02-06	
J	Panzer, S; Covaliov, L; Augat, P; Peschel, O				Panzer, Stephanie; Covaliov, Lidia; Augat, Peter; Peschel, Oliver			Traumatic brain injury: Comparison between autopsy and antemortem CT	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Autopsy; Virtual autopsy; Computed tomography; Ante-mortem computed tomography; Traumatic brain injury	POSTMORTEM COMPUTED-TOMOGRAPHY; ACUTE SUBDURAL-HEMATOMA; DIFFUSE AXONAL INJURY; VIRTUAL AUTOPSY; HEMORRHAGE; REDISTRIBUTION; RADIOLOGY; VIRTOPSY	Purpose: The aim of this study was to compare pathological findings after traumatic brain injury between autopsy and ante-mortem computed tomography (CT). A second aim was to identify changes in these findings between the primary posttraumatic CT and the last follow-up CT before death. Methods: Through the collaboration between clinical radiology and forensic medicine, 45 patients with traumatic brain injury were investigated. These patients had undergone ante-mortem CT as well as autopsy. During autopsy, the brain was cut in fronto-parallel slices directly after removal without additional fixation or subsequent histology. Typical findings of traumatic brain injury were compared between autopsy and radiology. Additionally, these findings were compared between the primary CT and the last follow-up CT before death. Results: The comparison between autopsy and radiology revealed a high specificity (>= 80%) in most of the findings. Sensitivity and positive predictive value were high (>= 80%) in almost half of the findings. Sixteen patients had undergone craniotomy with subsequent follow-up CT. Thirteen conservatively treated patients had undergone a follow-up CT. Comparison between the primary CT and the last ante-mortem CT revealed marked changes in the presence and absence of findings, especially in patients with severe traumatic brain injury requiring decompression craniotomy. Conclusion: The main pathological findings of traumatic brain injury were comparable between clinical ante-mortem CT examinations and autopsy. Comparison between the primary CT after trauma and the last ante-mortem CT revealed marked changes in the findings, especially in patients with severe traumatic brain injury. Hence, clinically routine ante-mortem CT should be included in the process of autopsy interpretation. (C) 2017 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Panzer, Stephanie] Trauma Ctr Murnau, Dept Radiol, Prof Kuntscher Str 8, D-82418 Murnau, Germany; [Panzer, Stephanie; Augat, Peter] Med Univ Salzburg, Inst Biomech, Trauma Ctr Murnau & Paracelsus, Prof Kuntscher Str 8, D-82418 Murnau, Germany; [Covaliov, Lidia; Peschel, Oliver] Ludwig Maximilians Univ Munchen, Inst Legal Med, Nussbaumstr 26, D-80336 Munich, Germany		Panzer, S (corresponding author), Trauma Ctr Murnau, Dept Radiol, Prof Kuntscher Str 8, D-82418 Murnau, Germany.	stephanie.panzer@bgu-murnau.de	Augat, Peter/A-2051-2011	Augat, Peter/0000-0003-4805-2128			Baglivo M, 2013, J FORENSIC RADIOL IM; Berger N, 2015, EUR J RADIOL, V84, P643, DOI 10.1016/j.ejrad.2014.12.014; Berger N, 2015, FORENSIC SCI MED PAT, V11, P40, DOI 10.1007/s12024-014-9642-8; Berger N, 2013, J FORENSIC RADIOL IM, V1, P137, DOI 10.1016/j.jofri.2013.05.012; Bolliger SA, 2008, EUR RADIOL, V18, P273, DOI 10.1007/s00330-007-0737-4; Cepeda S, 2015, J NEUROTRAUMA, V21; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Christe A, 2010, LEGAL MED, V12, P215, DOI 10.1016/j.legalmed.2010.05.005; Dirnhofer R, 2006, RADIOGRAPHICS, V26, P1305, DOI 10.1148/rg.265065001; Flach PM, 2014, FORENSIC SCI MED PAT, V10, P583, DOI 10.1007/s12024-014-9555-6; FLACH PM, 2014, AJR, V202, P325; Geyer LL, 2013, ACTA RADIOL, V54, P592, DOI 10.1177/0284185113475443; Huber-Wagner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068880; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Liu B, 2013, CLIN NEUROL NEUROSUR, V115, P2310, DOI 10.1016/j.clineuro.2013.06.022; Makino Y, 2015, FORENSIC SCI INT, V249, P107, DOI 10.1016/j.forsciint.2015.01.022; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Osborn A. G., 2004, DIAGNOSTIC IMAGING B, V1st; Palmiere C, 2012, FORENSIC SCI INT, V222, P33, DOI 10.1016/j.forsciint.2012.04.031; Pappu S, 2016, J NEUROIMAGING, V26, P37, DOI 10.1111/jon.12289; Park Jae-Young, 2013, J Med Case Rep, V7, P67, DOI 10.1186/1752-1947-7-67; Peschel O, 2013, FORENSIC SCI INT, V233, P45, DOI 10.1016/j.forsciint.2013.08.012; Qureshi Adnan I, 2015, J Vasc Interv Neurol, V8, P42; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Thali MJ, 2010, BROGDONS FORENSIC RA; Wada D, 2013, CRIT CARE, V17, DOI 10.1186/cc12861; Watanabe A, 2010, NEUROL MED-CHIR, V50, P924, DOI 10.2176/nmc.50.924	32	5	5	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	NOV	2017	52						62	69		10.1016/j.jflm.2017.08.007			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FM9PB	WOS:000415602200011	28866283				2022-02-06	
J	Rochkind, S				Rochkind, Shimon			Photobiomodulation in Neuroscience: A Summary of Personal Experience	PHOTOMEDICINE AND LASER SURGERY			English	Article						nerve cells; muscle cells; peripheral nerve; brain; spinal cord; injury; transplantation; photobiomodulation	POWER LASER IRRADIATION; PERIPHERAL-NERVE INJURY; CREATINE-KINASE ACTIVITY; HE-NE-LASER; SPINAL-CORD; MUSCLE RESPONSE; TRAUMATIC PARAPLEGIA; SCIATIC-NERVE; IN-VITRO; 780 NM	Objective: This review summarizes personal experience with laser photobiomodulation and its potentials for the treatment of peripheral and central nerve system injuries. Methods and Results: Laser photobiomodulation was shown to induce nerve cell activation, have a positive effect on metabolism of the nerve cells, and to stimulate nerve sprouting processes. Studies investigating the effects of laser photobiomodulation on injured peripheral nerves in rats reported immediate protective effects which increase the functional activity of the nerve, decrease or prevent scar tissue formation at the injured site, prevent or decrease degeneration in corresponding motor neurons of the spinal cord, and significantly increase axonal growth and myelinization. A direct application of laser on the spinal cord had a positive impact on the corresponding injured peripheral nerve and promoted recovery. A 780-nm laser phototherapy was applied following peripheral nerve reconstruction using a guiding nerve tube. Results showed myelinated axons crossing through the nerve tube and the continuation of axonal sprouting through the tube toward the distal part of the nerve. In a double-blind, placebo-controlled randomized pilot clinical trial in patients with incomplete stable long-term peripheral nerve injury (PNI), 780-nm laser irradiation progressively improved peripheral nerve function and led to substantial functional recovery. Muscle atrophy represents a major challenge in restorative medicine. Laser phototherapy was shown to increase biochemical activity and improve morphological recovery in muscle and, thus, could have a direct therapeutic application, especially during progressive muscle atrophy resulting from PNI. The effectiveness of composite implants of cultured embryonal nerve cells and the role of laser irradiation on regeneration and repair of the completely transected rat spinal cord were examined. Results suggested that laser photobiomodulation treatment accelerates the axonal growth. Conclusions: The significance of the performed experimental and clinical studies is in the provision of new laser technology in field of cell therapy and its therapeutic value for peripheral nerve and spinal cord injuries. Additional well-designed clinical studies are needed to evaluate the effectiveness and role of laser photobiomodulation treatment in a clinical setting.	[Rochkind, Shimon] Tel Aviv Univ, Div Peripheral Nerve Reconstruct, Res Ctr Nerve Reconstruct, Dept Neurosurg,Tel Aviv Sourasky Med Ctr, 6 Weizmann St, IL-6423906 Tel Aviv, Israel		Rochkind, S (corresponding author), Tel Aviv Univ, Div Peripheral Nerve Reconstruct, Res Ctr Nerve Reconstruct, Dept Neurosurg,Tel Aviv Sourasky Med Ctr, 6 Weizmann St, IL-6423906 Tel Aviv, Israel.	rochkind@zahav.net.il	Rochkind, Shimon/AAO-6447-2020	Rochkind, Shimon/0000-0002-9590-9764			Aguayo AJ, 1985, BIRTH DEFECTS, V19, P327; ANDERS JJ, 1993, LASER SURG MED, V13, P72, DOI 10.1002/lsm.1900130113; Byrnes KR, 2005, LASER SURG MED, V37, P161, DOI 10.1002/lsm.20202; Carraro U, 2005, ARTIF ORGANS, V29, P187, DOI 10.1111/j.1525-1594.2005.29032.x; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899; Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305; Gigo-Benato D, 2004, LASER MED SCI, V19, P57, DOI 10.1007/s10103-004-0300-3; Mandelbaum-Livnat MM, 2016, PHOTOMED LASER SURG, V34, P638, DOI 10.1089/pho.2016.4095; Meijs MFL, 2004, J NEUROTRAUM, V21, P1415, DOI 10.1089/neu.2004.21.1415; NISSAN M, 1988, MED BIOL ENG COMPUT, V26, P448, DOI 10.1007/BF02442309; REIER PJ, 1985, NEUROPATH APPL NEURO, V11, P81, DOI 10.1111/j.1365-2990.1985.tb00007.x; ROCHKIND S, 1987, LASER SURG MED, V7, P441, DOI 10.1002/lsm.1900070512; Rochkind S, 2006, EUR SPINE J, V15, P234, DOI 10.1007/s00586-005-0981-8; ROCHKIND S, 1988, ACTA NEUROCHIR, V94, P74, DOI 10.1007/BF01406620; ROCHKIND S, 1992, LASER MED SCI, V7, P143, DOI 10.1007/BF02594064; Rochkind S, 2002, NEUROL RES, V24, P355, DOI 10.1179/016164102101200131; Rochkind S, 2001, LASER SURG MED, V28, P216, DOI 10.1002/lsm.1041; ROCHKIND S, 1990, SPINE, V15, P6, DOI 10.1097/00007632-199001000-00003; ROCHKIND S, 1987, NEUROSURGERY, V20, P843, DOI 10.1227/00006123-198706000-00004; Rochkind S, 1978, MORPHOGEN REGEN, V83, P25; Rochkind S, 2009, LASER THER, V18, P27; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P436, DOI 10.1089/pho.2007.2093; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P137, DOI 10.1089/pho.2007.2076; Rochkind S, 2017, J RECONSTR MICROSURG, V33, P352, DOI 10.1055/s-0037-1598619; Rochkind S, 2013, PHOTOMED LASER SURG, V31, P499, DOI 10.1089/pho.2013.3537; Rochkind S, 2013, INT REV NEUROBIOL, V109, P99, DOI 10.1016/B978-0-12-420045-6.00004-3; Rochkind S, 2009, INT REV NEUROBIOL, V87, P445, DOI 10.1016/S0074-7742(09)87025-6; Rochkind S, 2009, LASER SURG MED, V41, P277, DOI 10.1002/lsm.20757; Rochkind S, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E8; Roisen FJ, 2001, BRAIN RES, V890, P11, DOI 10.1016/S0006-8993(00)03016-X; Ruitenberg MJ, 2005, BRAIN, V128, P839, DOI 10.1093/brain/awh424; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Shamir MH, 2001, J RECONSTR MICROSURG, V17, P133, DOI 10.1055/s-2001-12702; Shin DH, 2003, NEUROSCI LETT, V344, P71, DOI 10.1016/S0304-3940(03)00354-9; Simunovic Z, 2003, LASERS MED SURG DENT, P277; Snyder SK, 2002, LASER SURG MED, V31, P216, DOI 10.1002/lsm.10098; Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041; VANBREUGEL HHFI, 1993, J NEUROCYTOL, V22, P185, DOI 10.1007/BF01246357; Wollman Y, 1996, NEUROL RES, V18, P467; Wollman Y, 1998, NEUROL RES, V20, P470; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069	42	5	7	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1549-5418	1557-8550		PHOTOMED LASER SURG	Photomed. Laser Surg.	NOV	2017	35	11			SI		604	615		10.1089/pho.2017.4381			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FL9RK	WOS:000414594700005	29099679				2022-02-06	
J	Xu, ZY; Li, YC; Wang, ZG; Cai, HQ				Xu, Zhenyu; Li, Yuchan; Wang, Zhigang; Cai, Haiqing			Open reduction combined with CORA-based osteotomy of the ulna in the treatment of missed Bado type I Monteggia injury A retrospective study of 5 cases	MEDICINE			English	Article						monteggia injury; radial head dislocation; ulnar osteotomy	RADIAL HEAD DISLOCATION; FRACTURE-DISLOCATIONS; EXTERNAL FIXATION; ANTERIOR DISLOCATION; SURGICAL-TREATMENT; CLOSED REDUCTION; CHILDREN; MANAGEMENT; LESIONS	Open reduction combined with ulnar osteotomy is the most common approach to treating missed Monteggia injuries. The osteotomy is usually performed at the proximal ulna to ensure better healing and fewer complications. The purpose of this study is to present a center of rotation angulation (CORA)-based osteotomy of the ulna for treating Bado type I Monteggia injuries. We retrospectively reviewed the cases of patients who were treated with open reduction combined with a CORA-based ulnar osteotomy between February 2014 and December 2016. Each patient provided his or her internal control, and paired data of the involved and uninvolved sides were analyzed to evaluate forearm rotation function. Five patients (3 male, 2 female) with median age 5.7 years (range, 3.4-6.8 years) were operated on by the senior author in our hospital. The median interval between the original injury and the corrective surgery was 3 months (range, 1-4 months). In a median follow-up of 10 months (range, 6-17 months), all patients obtained stable reduction of the radial head and uneventful healing of the ulnar osteotomy. All patients had pain-free elbows with no neurological or vascular complications and no implant breakage. Patients showed excellent outcomes evaluated using the Broberg and Morrey index. Open reduction with a CORA-based osteotomy of the ulna for the treatment of missed Bado type I Monteggia injury with an obvious ulnar bowing deformity resulted in stable reduction of the radial head and excellent forearm function.	[Xu, Zhenyu; Li, Yuchan; Wang, Zhigang; Cai, Haiqing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat Orthoped, Shanghai, Peoples R China		Li, YC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, 1678 Dongfang Rd, Shanghai 200127, Peoples R China.	karinelyc@hotmail.com					Aversano F, 2011, J ORTHOP TRAUMA, V25, pE38, DOI 10.1097/BOT.0b013e3181dc245d; Bado J L, 1967, Clin Orthop Relat Res, V50, P71; BEST TN, 1994, J PEDIATR ORTHOPED, V14, P193, DOI 10.1097/01241398-199403000-00012; Bhaskar A, 2013, CURR ORTHOP PRACT, V24, P49, DOI 10.1097/BCO.0b013e31827ddc42; Bor N, 2015, J PEDIATR ORTHOPED, V35, P7, DOI 10.1097/BPO.0000000000000203; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Datta T, 2014, J CLIN DIAGN RES, V8, pLC1, DOI 10.7860/JCDR/2014/9891.4409; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Delpont M, 2014, ORTHOP TRAUMATOL-SUR, V100, P803, DOI 10.1016/j.otsr.2014.06.022; Devnani AS, 1997, INJURY, V28, P131, DOI 10.1016/S0020-1383(96)00160-X; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; Eygendaal D, 2007, STRATEG TRAUMA LIMB, V2, P31, DOI 10.1007/s11751-007-0013-9; Goyal T, 2015, J PEDIATR ORTHOP B, V24, P191, DOI 10.1097/BPB.0000000000000147; Hasler CC, 2005, J BONE JOINT SURG BR, V87B, P88, DOI 10.1302/0301-620X.87B1.14669; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639, DOI 10.1302/0301-620X.69B4.3611173; HURST LC, 1983, J PEDIATR ORTHOPED, V3, P227, DOI 10.1097/01241398-198305000-00015; Inoue G, 1998, ACTA ORTHOP SCAND, V69, P73, DOI 10.3109/17453679809002361; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; Lu XM, 2013, J PEDIATR ORTHOPED, V33, P398, DOI 10.1097/BPO.0b013e3182812762; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; Paley D., 2002, PRINCIPLES DEFORMITY, P99, DOI [10.1007/978-3-642-59373-4_5, DOI 10.1007/978-3-642-59373-4_5]; Rahbek O, 2011, J CHILD ORTHOP, V5, P449, DOI 10.1007/s11832-011-0372-0; Ray R, 2014, J PEDIATR ORTHOP B, V23, P472, DOI 10.1097/BPB.0000000000000062; Soubeyrand M, 2011, J HAND SURG-EUR VOL, V36E, P447, DOI 10.1177/1753193410396976; Wallace AL, 1997, J BONE JOINT SURG BR, V79B, P422, DOI 10.1302/0301-620X.79B3.7142; Wang MN, 2006, J ORTHOP TRAUMA, V20, P1, DOI 10.1097/01.bot.0000189881.75421.92	28	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2017	96	47							e8609	10.1097/MD.0000000000008609			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP5FP	WOS:000417645700023	29381932	gold, Green Published			2022-02-06	
J	Yousuf, S; Brat, DJ; Shu, HK; Wang, Y; Stein, DG; Atif, F				Yousuf, Seema; Brat, Daniel J.; Shu, Hui-Kuo; Wang, Ya; Stein, Donald G.; Atif, Fahim			Progesterone improves neurocognitive outcomes following therapeutic cranial irradiation in mice	HORMONES AND BEHAVIOR			English	Article						Brain; Cognitive deficit; Ionizing radiation; Neurotoxicity; Progesterone	TRAUMATIC BRAIN-INJURY; LONG-TERM OUTCOMES; HIPPOCAMPAL NEUROGENESIS; GAMMA-IRRADIATION; OXIDATIVE STRESS; ISCHEMIC-STROKE; COGNITIVE DYSFUNCTION; ADULT NEUROGENESIS; RADIATION-THERAPY; GENE-EXPRESSION	Despite improved therapeutic methods, CNS toxicity resulting from cancer treatment remains a major cause of post-treatment morbidity. More than half of adult patients with cranial irradiation for brain cancer develop neurobehavioral/cognitive deficits that severely impact quality of life. We examined the neuroprotective effects of the neurosteroid progesterone (PROG) against ionizing radiation (IR)-induced neurobehavioral/cognitive deficits in mice. Male C57/BL mice were exposed to one of two fractionated dose regimens of IR (3 Gy x 3 or 3 Gy x 5). PROG (16 mg/kg; 0.16 mg/g) was given as a pre-, concurrent or post-IR treatment for 14 days. Mice were tested for short- and long-term effects of IR and PROG on neurobehavioral/cognitive function on days 10 and 30 after IR treatment. We evaluated both hippocampus-dependent and -independent memory functions. Locomotor activity, elevated plus maze, novel object recognition and Morris water maze tests revealed behavioral deficits following IR. PROG treatment produced improvement in behavioral performance at both time points in the mice given IR. Western blot analysis of hippocampal and cortical tissue showed that IR at both doses induced astrocytic activation (glial fibrillary acidic protein), reactive macrophages/microglia (CD68) and apoptosis (cleaved caspase-3) and PROG treatment inhibited these markers of brain injury. There was no significant difference in the degree of deficit in any test between the two dose regimens of IR at either time point. These findings could be important in the context of patients with brain tumors who may undergo radiotherapy and eventually develop cognitive deficits.	[Yousuf, Seema; Stein, Donald G.; Atif, Fahim] Brain Res Lab, Dept Emergency Med, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA; [Brat, Daniel J.] Emory Univ Hosp, Dept Pathol, Room H183,1364 Clifton Rd NE, Atlanta, GA 30322 USA; [Shu, Hui-Kuo; Wang, Ya] Emory Univ, Sch Med, Dept Radiat Oncol, 1365 C Clifton Rd NE, Atlanta, GA 30322 USA		Atif, F (corresponding author), Brain Res Lab, Dept Emergency Med, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	syousu2@emory.edu; dbrat@emory.edu; hgshu@emory.edu; ywang94@wmory.edu; dstei04@emory.edu; fatif@emory.edu	Stein, Donald/AAJ-5139-2020	Shu, Hui-Kuo/0000-0002-4060-0874	Allen and Company; Marcus Foundation; Laney Graduate School of Arts and Sciences at Emory University	This research was supported in part by unrestricted gifts from Allen and Company and The Marcus Foundation, and by the Laney Graduate School of Arts and Sciences at Emory University.	Acevedo SF, 2008, RADIAT RES, V170, P422, DOI 10.1667/RR1494.1; Achanta P, 2007, NEUROSCI LETT, V418, P143, DOI 10.1016/j.neulet.2007.03.029; Acharya MM, 2015, CANCER RES, V75, P676, DOI 10.1158/0008-5472.CAN-14-2237; Akiyama K, 2001, NEUROL MED-CHIR, V41, P590, DOI 10.2176/nmc.41.590; Arbo BD, 2016, PROG NEUROBIOL, V144, P27, DOI 10.1016/j.pneurobio.2016.03.010; Atif F, 2016, NEUROPHARMACOLOGY, V107, P317, DOI 10.1016/j.neuropharm.2016.03.052; Atif F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131441; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Balentova S, 2015, INT J MOL SCI, V16, P27796, DOI 10.3390/ijms161126068; Balentova S, 2013, ACTA HISTOCHEM, V115, P308, DOI 10.1016/j.acthis.2012.09.001; Balentova S, 2013, GEN PHYSIOL BIOPHYS, V32, P91, DOI 10.4149/gpb_2013009; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Ben Abdallah NMB, 2013, BEHAV BRAIN RES, V252, P275, DOI 10.1016/j.bbr.2013.05.034; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bovi JA, 2012, CURR ONCOL REP, V14, P55, DOI 10.1007/s11912-011-0208-6; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Cekic M., 2012, RESTOR NEUROL NEUROS, V28, P1; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; D'Antonio C, 2014, THER ADV MED ONCOL, V6, P101, DOI 10.1177/1758834014521110; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Diep CH, 2013, CELL CYCLE, V12, P1433, DOI 10.4161/cc.24550; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Frye CA, 2010, BEHAV PHARMACOL, V21, P530, DOI 10.1097/FBP.0b013e32833e0a23; German-Castelan L, 2016, ARCH MED RES, V47, P419, DOI 10.1016/j.arcmed.2016.10.002; Grimm SL, 2016, J MOL BIOL, V428, P3831, DOI 10.1016/j.jmb.2016.06.020; Gutierrez-Rodriguez A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1295087; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Huang TT, 2012, SEMIN CELL DEV BIOL, V23, P738, DOI 10.1016/j.semcdb.2012.04.003; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jabbour SK, 2010, J GASTROINTEST ONCOL, V1, P102, DOI 10.3978/j.issn.2078-6891.2010.013; Jenrow KA, 2013, RADIAT RES, V179, P549, DOI 10.1667/RR3026.1; Jin XM, 2016, J BIOCHEM, V159, P491, DOI 10.1093/jb/mvw009; Kalm M, 2009, RADIAT RES, V171, P66, DOI 10.1667/RR1269.1; Kempf SJ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-57; Kim S, 2011, NEUROSCI LETT, V498, P47, DOI 10.1016/j.neulet.2011.04.059; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Kumar M, 2013, EXP NEUROL, V248, P360, DOI 10.1016/j.expneurol.2013.06.005; Lee TC, 2012, RADIAT RES, V178, P46, DOI 10.1667/RR2731.1; Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346; Lei BL, 2016, NEUROENDOCRINOLOGY, V103, P665, DOI 10.1159/000442204; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Marin A, 2015, REP PRACT ONCOL RADI, V20, P12, DOI 10.1016/j.rpor.2014.08.004; McTyre Emory, 2013, Surg Neurol Int, V4, pS236, DOI 10.4103/2152-7806.111301; Melcangi RC, 2016, NEUROSCI BIOBEHAV R, V67, P25, DOI 10.1016/j.neubiorev.2015.09.023; Moravan MJ, 2011, RADIAT RES, V176, P459, DOI 10.1667/RR2587.1; Murphy ES, 2016, PEDIATR BLOOD CANCER, V63, P398, DOI 10.1002/pbc.25831; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Paris JJ, 2014, HORM BEHAV, V65, P445, DOI 10.1016/j.yhbeh.2014.04.001; Petersen SL, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00164; Robison LL, 2005, CANCER-AM CANCER SOC, V104, P2557, DOI 10.1002/cncr.21249; Roughton K, 2012, EUR J NEUROSCI, V36, P2763, DOI 10.1111/j.1460-9568.2012.08197.x; Sasaki R, 2000, NEUROSCI LETT, V279, P57, DOI 10.1016/S0304-3940(99)00910-6; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Si DW, 2014, BEHAV BRAIN RES, V264, P135, DOI 10.1016/j.bbr.2014.01.049; Silasi G, 2004, BIOCHEM BIOPH RES CO, V325, P1223, DOI 10.1016/j.bbrc.2004.10.166; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Slowik A, 2015, J STEROID BIOCHEM, V153, P135, DOI 10.1016/j.jsbmb.2015.02.013; Son Y, 2015, NEUROBIOL LEARN MEM, V121, P12, DOI 10.1016/j.nlm.2015.03.002; Stein DG, 2017, HORMONES, BRAIN AND BEHAVIOR, VOL 5: DEVELOPMENT OF HORMONE-BEHAVIOR RELATIONSHIPS, 3RD EDITION, P411, DOI 10.1016/B978-0-12-803592-4.00110-3; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stranahan AM, 2011, NEUROSCI LETT, V495, P60, DOI 10.1016/j.neulet.2011.03.037; Tang HL, 2015, BRAIN INJURY, V29, P1165, DOI 10.3109/02699052.2015.1035330; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Villasana L, 2013, RADIAT RES, V179, P493, DOI 10.1667/RR3210.1; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wilson CM, 2009, INT J RADIAT ONCOL, V74, P934, DOI 10.1016/j.ijrobp.2009.02.035; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu NYY, 2017, CELL REP, V18, P2557, DOI 10.1016/j.celrep.2017.02.049; Xu PF, 2015, BRAIN BEHAV IMMUN, V50, P87, DOI 10.1016/j.bbi.2015.06.020; Yan D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011397; Yousuf S, 2016, HORM BEHAV, V84, P29, DOI 10.1016/j.yhbeh.2016.06.002; Yousuf S, 2015, RESTOR NEUROL NEUROS, V33, P251, DOI 10.3233/RNN-140450; Yousuf S, 2014, PSYCHOPHARMACOLOGY, V231, P3313, DOI 10.1007/s00213-014-3556-8; Zamora-Sanchez CJ, 2017, STEROIDS, V119, P36, DOI 10.1016/j.steroids.2017.01.004; Zhou H, 2011, AM J NEURORADIOL, V32, P1795, DOI 10.3174/ajnr.A2643	83	5	7	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0018-506X	1095-6867		HORM BEHAV	Horm. Behav.	NOV	2017	96						21	30		10.1016/j.yhbeh.2017.08.004			10	Behavioral Sciences; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Endocrinology & Metabolism	FQ4FM	WOS:000418313100006	28866326				2022-02-06	
J	Zuo, HH; Li, YP; Cui, YH; An, Y				Zuo, Hanheng; Li, Yinping; Cui, Yinghua; An, Yi			Cardioprotective effect of Malva sylvestris L. in myocardial ischemic/reprefused rats	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Cytokines; Malva sylvestris L.; Myocardial ischemia; Oxidative stress	TRAUMATIC BRAIN-INJURY; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA; REPERFUSION; ATHEROSCLEROSIS; NEUROPROTECTION; INFARCTION; RELEVANCE; COUMARIN; RADICALS	Purpose: The present investigation evaluated the cardioprotective effect of Malva sylvestris L. (MS) on myocardial ischemic/reperfusion (MI/R) in rats. Methods: All animals were divided into four groups: the sham operated group, ischemia/reperfusion group (MI/R), and the MS (250 and 500 mg/kg) treated groups, who received MS 250 and 500 mg/kg intragastrically for 15 consecutive days, respectively. At the end of the protocol, concentrations of aspartate transaminase (AST), creatine kinase-MB fraction (CK-MB) and lactate dehydrogenase (LDH) were estimated in serum and the concentrations of other parameters, such as C-reactive protein, macrophage inflammatory protein 1 alpha (MIP-1 alpha), and nitric oxide (NO) were also estimated in the blood. Tissue homogenate concentrations of inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-alpha), interlukin-1 beta (IL-1 beta), IL-10 and IL-6 as well as oxidative stress parameters, such as lipid peroxidation, catalase, and superoxide dismutase were estimated in MI/R rats. Result: Significant decreases (p < 0.01) in AST, LDH, and CK-MB levels were observed in the MS-treated group compared with those in the MI/R group. C-reactive protein and MIP-1 alpha levels decreased in the MS-treated group compared with those in the MI/R group. Plasma NO level was significantly enhanced in the MS-treated group than in the MI/R group. Moreover, treatment with MS significantly reduced TNF-alpha, IL-1 beta, and IL-6 levels and increased IL-10 levels in the MS group compared with the MI/R group. Treatment with MS also attenuated the altered oxidative stress parameters in MI/R rats. Conclusion: The present results indicate the cardioprotective effects of MS of reducing oxidative stress and the inflammatory response in MI/R rats.	[Zuo, Hanheng] Qingdao Univ, Med Coll, Cardiovasc Div, Qingdao 266021, Shandong, Peoples R China; [Li, Yinping; Cui, Yinghua] Jining Med Univ, Affiliated Hosp, Cardiac Care Unit, Jining 272029, Shandong, Peoples R China; [An, Yi] Qingdao Univ, Affiliated Hosp, Cardiovasc Div, Qingdao 222071, Shandong, Peoples R China		An, Y (corresponding author), Qingdao Univ, Affiliated Hosp, Cardiovasc Div, Qingdao 222071, Shandong, Peoples R China.	anyi3446@hotmail.com			Affiliated Hospital of Qingdao University, China	All authors are grateful to The Affiliated Hospital of Qingdao University, China for providing funding for this study.	Aedin C., 2013, CIRCULATION, V127, P188; Aeibi H, 1974, METHOD ENZYMAT AN, V2, P673, DOI DOI 10.1016/B978-0-12-091302-2.50032-3; Ben Saad A, 2017, BIOMED PHARMACOTHER, V86, P127, DOI 10.1016/j.biopha.2016.12.004; Brouwer MA, 2002, CIRCULATION, V106, P659, DOI 10.1161/01.CIR.0000024408.81821.32; Cheng Cui-lin, 2006, Journal of Forestry Research (Harbin), V17, P83, DOI 10.1007/s11676-006-0020-6; Daemen MARC, 1999, TRANSPLANTATION, V67, P792, DOI 10.1097/00007890-199903270-00003; DOWNEY JM, 1991, FREE RADICAL RES COM, V12-3, P703, DOI 10.3109/10715769109145850; Esteves PF, 2009, LAT AM J PHARM, V28, P454; Fan TM, 2008, MOL IMMUNOL, V45, P2937, DOI 10.1016/j.molimm.2008.01.019; FORSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788, DOI 10.1073/pnas.88.5.1788; GODIN DV, 1989, CAN J CARDIOL, V5, P365; GROSS GJ, 1986, AM J PHYSIOL, V250, pH372, DOI 10.1152/ajpheart.1986.250.3.H372; Gurevitch J, 1997, J AM COLL CARDIOL, V30, P1554, DOI 10.1016/S0735-1097(97)00328-8; HANSEN PR, 1995, EUR HEART J, V16, P734, DOI 10.1093/oxfordjournals.eurheartj.a060991; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Hua L., 2012, PLOS ONE, V7; HUGHES BP, 1962, CLIN CHIM ACTA, V7, P597, DOI 10.1016/0009-8981(62)90137-7; KLONER RA, 1989, CIRCULATION, V80, P1115, DOI 10.1161/01.CIR.80.5.1115; Lakoski SG, 2008, ATHEROSCLEROSIS, V197, P443, DOI 10.1016/j.atherosclerosis.2007.06.033; Laursen BE, 2006, CARDIOVASC DRUG REV, V24, P247, DOI 10.1111/j.1527-3466.2006.00247.x; LEDWOZYW A, 1986, CLIN CHIM ACTA, V155, P275, DOI 10.1016/0009-8981(86)90247-0; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Min JY, 2011, NEUROSCI LETT, V500, P157, DOI 10.1016/j.neulet.2011.05.048; Misra H.P., 1979, J BIOL CHEM, V2457, P3170; Prudente AS, 2013, FOOD CHEM TOXICOL, V58, P324, DOI 10.1016/j.fct.2013.04.042; Reichenbach Gustavo, 2005, Curr Drug Targets Cardiovasc Haematol Disord, V5, P65; Shukla SK, 2014, J MED FOOD, V17, P244, DOI 10.1089/jmf.2013.2795; Song H, 2016, NEUROSCI LETT, V622, P95, DOI 10.1016/j.neulet.2016.04.048; TAKEMURA G, 1992, CIRC RES, V71, P96, DOI 10.1161/01.RES.71.1.96; Wang C, 2012, J NEUROCHEM, V121, P1007, DOI 10.1111/j.1471-4159.2012.07744.x; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yousefi K, 2013, INDIAN J EXP BIOL, V51, P653	32	5	5	1	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	NOV	2017	95						679	684		10.1016/j.biopha.2017.08.111			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	FP6OC	WOS:000417744400079	28886527				2022-02-06	
J	Chen, YJ; Liang, CM; Tai, MC; Chang, YH; Lin, TY; Chung, CH; Lin, FH; Tsao, CH; Chien, WC				Chen, Ying-Jen; Liang, Chang-Min; Tai, Ming-Cheng; Chang, Yun-Hsiang; Lin, Tzu-Yu; Chung, Chi-Hsiang; Lin, Fu-Huang; Tsao, Chang-Huei; Chien, Wu-Chien			Longitudinal relationship between traumatic brain injury and the risk of incident optic neuropathy: A 10-year follow-up nationally representative taiwan survey	ONCOTARGET			English	Article						traumatic brain injury; optic neuropathy; national health insurance research database	OBSTRUCTIVE SLEEP-APNEA; HEPATOCELLULAR-CARCINOMA; HEAD TRAUMA; NERVE; DAMAGE; CONSEQUENCES; SURVEILLANCE; POPULATIONS; MECHANISMS	Accumulating evidences had shown that traumatic brain injury was associated with visual impairment or vision loss. However, there were a limited number of empirical studies regarding the longitudinal relationship between traumatic brain injury and incident optic neuropathy. We studied a cohort from the Taiwanese National Health Insurance data comprising 553918 participants with traumatic brain injury and optic neuropathy-free in the case group and 1107836 individuals without traumatic brain injury in the control group from 1st January 2000. After the index date until the end of 2010, Cox proportional hazards analysis was used to compare the risk of incident optic neuropathy. During the follow-up period, case group was more likely to develop incident optic neuropathy (0.24%) than the control group (0.11%). Multivariate Cox regression analysis demonstrated that the case group had a 3-fold increased risk of optic neuropathy (HR = 3.017, 95% CI= 2.767-3.289, p < 0.001). After stratification by demographic information, traumatic brain injury remained a significant factor for incident optic neuropathy. Our study provided evidence of the increased risk of incident optic neuropathy after traumatic brain injury during a 10-year follow-up period. Patients with traumatic brain injury required periodic and thorough eye examinations for incident optic neuropathy to prevent potentially irreversible vision loss.	[Chen, Ying-Jen; Liang, Chang-Min; Tai, Ming-Cheng; Chang, Yun-Hsiang] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan; [Chen, Ying-Jen] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Tzu-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Ophthalmol, New Taipei, Taiwan; [Chung, Chi-Hsiang; Lin, Fu-Huang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang; Lin, Fu-Huang; Tsao, Chang-Huei; Chien, Wu-Chien] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan		Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chien, WC (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan.	chienwu@mail.ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021		Tri-Service General Hospital Research Foundation [TSGH-C102-155, TSGH-C106-002]	This study was funded by a grant from Tri-Service General Hospital Research Foundation (TSGH-C102-155 and TSGH-C106-002).	ANDERSON RL, 1982, OPHTHALMOLOGY, V89, P445; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Biousse V, 2016, LANCET NEUROL, V15, P1355, DOI 10.1016/S1474-4422(16)30237-X; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; BROOKS AMV, 1984, BRIT J OPHTHALMOL, V68, P838, DOI 10.1136/bjo.68.11.838; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Carta A, 2003, J NEUROL NEUROSUR PS, V74, P246, DOI 10.1136/jnnp.74.2.246; Chou PI, 1996, NEURO-OPHTHALMOLOGY, V16, P325, DOI 10.3109/01658109609044636; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; Ford RL, 2012, J AAPOS, V16, P413, DOI 10.1016/j.jaapos.2012.04.009; Fraser CL, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0465-5; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; GOSSMAN MD, 1992, CLIN PLAST SURG, V19, P71; Hathiram BT, 2010, INDIAN J OTOLARYNGOL, V62, P229, DOI 10.1007/s12070-010-0072-y; Jang SH, 2015, J NEURO-OPHTHALMOL, V35, P270, DOI 10.1097/WNO.0000000000000249; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; Lee V, 2010, EYE, V24, P240, DOI 10.1038/eye.2009.79; Levin LA, 2007, CAN J OPHTHALMOL, V42, P403, DOI 10.3129/i07-046; Lin HC, 2015, QJM-INT J MED, V108, P959, DOI 10.1093/qjmed/hcv079; Liu CY HY, 2006, INT J HEALTHC MANAG, V4, P22; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Odebode TO, 2005, EYE, V19, P561, DOI 10.1038/sj.eye.6701566; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P841; Sen N., 2017, NEUROCHEM INT; Shangkuan WC, 2017, INCREASED LONG TERM; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sturm V, 2010, ACTA OPHTHALMOL, V88, P486, DOI 10.1111/j.1755-3768.2008.01444.x; Tsan YT, 2012, J CLIN ONCOL, V30, P623, DOI 10.1200/JCO.2011.36.0917; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Walsh F, 1969, CLIN NEUROOPHTHALMOL; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004	37	5	5	0	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	OCT 17	2017	8	49					86924	86933		10.18632/oncotarget.21008			10	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	FJ9FN	WOS:000413077800192	29156847	Green Published, Green Submitted, gold			2022-02-06	
J	Ahmed, Z				Ahmed, Zaghloul			Effects of cathodal trans-spinal direct current stimulation on lower urinary tract function in normal and spinal cord injury mice with overactive bladder	JOURNAL OF NEURAL ENGINEERING			English	Article						bladder; spinal cord injury; trans-spinal direct current stimulation; sphincter	EXTERNAL URETHRAL SPHINCTER; ELECTRICAL-STIMULATION; MOTOR CORTEX; ANESTHETIZED RATS; AFFERENT-FIBERS; PUDENDAL NERVE; NEURAL-CONTROL; CAT; NEUROMODULATION; MICTURITION	Objective. Lower urinary tract (LUT) dysfunction is a monumental problem affecting quality of life following neurotrauma, such as spinal cord injury (SCI). Proper function of the bladder and its associated structures depends on coordinated activity of the neuronal circuitry in the spinal cord and brain. Disconnection between the spinal and brain centers controlling the LUT causes fundamental changes in the mechanisms involved in the micturition and storage reflexes. We investigated the effects of cathodal trans-spinal direct current stimulation (c-tsDCS) of the lumbosacral spine on bladder and external urinary sphincter (EUS) functions. Approach. We used cystometry and electromyography (EMG), in mice with and without SCI. Main results. c-tsDCS caused initiation of the micturition reflex in urethane-anesthetized normal mice with depressed micturition reflexes. This effect was associated with normalized EUS-EMG activity. Moreover, in urethane-anesthetized normal mice with expressed micturition reflexes, c-tsDCS increased the firing frequency, amplitude, and duration of EUS-EMG activity. These effects were associated with increased maximum intravesical pressure (P-max) and intercontraction interval (ICI). In conscious normal animals, c-tsDCS caused significant increases in P-max, ICI, threshold pressure (P-thres), baseline pressure (P-base), and number and amplitude of non-voiding contractions (NVCnumb and P-im, respectively). In conscious mice with severe contusive SCI and overactive bladder, c-tsDCS increased P-max, ICI, and P-thres, but decreased P-base, NVCnumb, and P-im. c-tsDCS reduced the detrusor-overactivity/cystometry ratio, which is a measure of bladder overactivity associated with renal deterioration. Significance. These results indicate that c-tsDCS induces robust modulation of the lumbosacral spinal-cord circuitry that controls the LUT.	[Ahmed, Zaghloul] Coll Staten Isl New York, Dept Phys Therapy, Staten Isl, NY 10314 USA; [Ahmed, Zaghloul] Coll Staten Isl New York, Sch Hlth Sci, Staten Isl, NY 10314 USA; [Ahmed, Zaghloul] Coll Staten Isl New York, Ctr Dev Neurosci, Staten Isl, NY 10314 USA; [Ahmed, Zaghloul] CUNY, Biol Dept, Grad Ctr New York, New York, NY 10016 USA		Ahmed, Z (corresponding author), Coll Staten Isl New York, Dept Phys Therapy, Staten Isl, NY 10314 USA.; Ahmed, Z (corresponding author), Coll Staten Isl New York, Sch Hlth Sci, Staten Isl, NY 10314 USA.; Ahmed, Z (corresponding author), Coll Staten Isl New York, Ctr Dev Neurosci, Staten Isl, NY 10314 USA.; Ahmed, Z (corresponding author), CUNY, Biol Dept, Grad Ctr New York, New York, NY 10016 USA.	zaghloul.ahmed@csi.cuny.edu	Ahmed, zaghloul/AAV-8812-2021		New York Department of Health [C30836GG]	This work was funded by a grant from New York Department of Health contract # C30836GG.	Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; Ahmed Z, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12157; Ahmed Z, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12696; Ahmed Z, 2014, J NEUROSCI, V34, P1701, DOI 10.1523/JNEUROSCI.4445-13.2014; Ahmed Z, 2013, J NEUROSCI, V33, P14949, DOI 10.1523/JNEUROSCI.2793-13.2013; Ahmed Z, 2013, J NEUROSCI, V33, P4935, DOI 10.1523/JNEUROSCI.4930-12.2013; Ahmed Z, 2012, J APPL PHYSIOL, V112, P1576, DOI 10.1152/japplphysiol.00967.2011; Ahmed Z, 2011, J APPL PHYSIOL, V110, P1414, DOI 10.1152/japplphysiol.01390.2010; Biering-Sorensen F, 2008, SPINAL CORD, V46, P325, DOI 10.1038/sj.sc.3102145; Blok BFM, 1998, NEUROSCI LETT, V249, P68, DOI 10.1016/S0304-3940(98)00382-6; Bolzoni F, 2015, J PHYSIOL-LONDON, V593, P947, DOI 10.1113/jphysiol.2014.285940; Buschges A, 1998, CURR OPIN NEUROBIOL, V8, P733, DOI 10.1016/S0959-4388(98)80115-3; CARDENAS DD, 1995, ARCH PHYS MED REHAB, V76, P272, DOI 10.1016/S0003-9993(95)80615-6; Chen SC, 2013, NEUROUROL URODYNAM, V32, P293, DOI 10.1002/nau.22280; Cheng CL, 1999, AM J PHYSIOL-REG I, V277, pR786, DOI 10.1152/ajpregu.1999.277.3.R786; CHENG CL, 1995, BRAIN RES, V678, P40, DOI 10.1016/0006-8993(95)00212-9; Crook J, 2016, NEUROSCIENCE, V313, P73, DOI 10.1016/j.neuroscience.2015.11.027; de Groat W C, 1997, Adv Neurol, V72, P347; de Groat WC, 2006, PROG BRAIN RES, V152, P59, DOI 10.1016/S0079-6123(05)52005-3; de Groat WC, 2001, SCAND J UROL NEPHROL, V35, P35, DOI 10.1080/003655901750174872; de Groat WC, 2012, EXP NEUROL, V235, P123, DOI 10.1016/j.expneurol.2011.05.003; DEGROAT WC, 1990, J AUTONOM NERV SYST, V30, pS71, DOI 10.1016/0165-1838(90)90105-R; DEGROAT WC, 1995, PARAPLEGIA, V33, P493, DOI 10.1038/sc.1995.109; ECCLES JC, 1962, J PHYSIOL-LONDON, V162, P138, DOI 10.1113/jphysiol.1962.sp006920; Elmelund M, 2016, NEUROUROL URODYN; Evans JP, 1936, J PHYSIOL-LONDON, V86, P396, DOI 10.1113/jphysiol.1936.sp003375; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Gad PN, 2016, EXP NEUROL, V285, P182, DOI 10.1016/j.expneurol.2016.06.034; Gad PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108184; Gaunt RA, 2006, PROG BRAIN RES, V152, P163, DOI 10.1016/S0079-6123(05)52011-9; GROAT WCD, 1976, J PHYSIOL-LONDON, V259, P223, DOI 10.1113/jphysiol.1976.sp011463; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HOLSTEGE G, 1986, J COMP NEUROL, V250, P449, DOI 10.1002/cne.902500404; Jiang HH, 2013, AM J PHYSIOL-RENAL, V304, pF239, DOI 10.1152/ajprenal.00235.2012; Kadekawa K, 2016, AM J PHYSIOL-REG I, V310, pR752, DOI 10.1152/ajpregu.00450.2015; KRUSE MN, 1993, AM J PHYSIOL, V264, pR1157, DOI 10.1152/ajpregu.1993.264.6.R1157; KRUSE MN, 1995, J AUTONOM NERV SYST, V54, P215, DOI 10.1016/0165-1838(95)00011-L; MACKEL R, 1979, J PHYSIOL-LONDON, V294, P105, DOI 10.1113/jphysiol.1979.sp012918; Marson L, 1997, J COMP NEUROL, V389, P584; McCreery D, 2004, IEEE T NEUR SYS REH, V12, P195, DOI 10.1109/TNSRE.2004.827223; Pannek J, 2011, J SPINAL CORD MED, V34, P11, DOI 10.1179/107902610X12886261091839; Powell CR, 2016, CURR BLADDER DYSFUNC, V11, P379, DOI 10.1007/s11884-016-0388-x; Priori A, 2014, J PHYSIOL-LONDON, V592, P3345, DOI 10.1113/jphysiol.2013.270280; Samaddar S, 2017, J APPL PHYSIOL, V122, P339, DOI 10.1152/japplphysiol.00834.2016; Seth A, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-24; Shaker H, 2000, BJU INT, V85, P905, DOI 10.1046/j.1464-410x.2000.00559.x; Song WG, 2016, EXP NEUROL, V277, P46, DOI 10.1016/j.expneurol.2015.12.008; Song WG, 2015, J NEUROPHYSIOL, V113, P2801, DOI 10.1152/jn.00784.2014; Thor KB, 2010, AM J PHYSIOL-REG I, V299, pR416, DOI 10.1152/ajpregu.00111.2010; THOR KB, 1989, J COMP NEUROL, V288, P263, DOI 10.1002/cne.902880206; VanderHorst VGJM, 1996, J COMP NEUROL, V376, P361, DOI 10.1002/(SICI)1096-9861(19961216)376:3<361::AID-CNE2>3.0.CO;2-0; Wieraszko A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2823735; Woock JP, 2011, AM J PHYSIOL-REG I, V300, pR398, DOI 10.1152/ajpregu.00154.2010; YOSHIYAMA M, 1994, EUR J PHARMACOL, V264, P417, DOI 10.1016/0014-2999(94)00505-2	54	5	6	0	5	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	OCT	2017	14	5							056002	10.1088/1741-2552/aa76f2			13	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	FD1GM	WOS:000407285500002	28776505				2022-02-06	
J	Arieff, AI; Gabbai, R; Goldfine, ID				Arieff, Allen I.; Gabbai, Ramin; Goldfine, Ira D.			Cerebral Salt-Wasting Syndrome: Diagnosis by Urine Sodium Excretion	AMERICAN JOURNAL OF THE MEDICAL SCIENCES			English	Article						Cerebral salt wasting; Urine sodium; Traumatic brain injury; Hyponatremic encephalopathy; Syndrome of inappropriate secretion of antidiuretic hormone	TRAUMATIC BRAIN-INJURY; HYPONATREMIA; FOOTBALL	Background: Cerebral salt-wasting syndrome (CSWS) was initially described over 60 years ago in hyponatremic patients with a cerebral lesion. However, the diagnostic criteria for CSWS have not been fully established. Thus, when hyponatremia is observed in patients with CSWS, they may be misdiagnosed as having the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Thus, it is critical to differentiate between these 2 conditions because their treatments are diametrically opposed. Materials and Methods: We carried out a retrospective study of 45 patients with CSWS and compared them to 60 normonatremic control patients, and 28 patients with SIADH. All patients had their 24-hour urine volumes and sodium (Na) excretion measured. Resuls: In patients with CSWS, urinary Na excretion was 394 +/- 369 mmol/24 hours and urinary volume was 2,603 996 mL/24 hours; both values significantly greater than in controls (P < 0.01). By contrast, in patients with SIADH, the urine Na excretion was only 51 +/- 25 mmol/24 hours and urine volume was 745 +/- 298 mL/24 hours; values significantly lower than in patients with CSWS (P < 0.01). Conclusions: CSWS was diagnosed in patients with cerebral lesion who had (1) symptomatic hyponatremia, (2) urine Na excretion 2 standard deviations above controls and (3) increased urine volume. Patients with SIADH also had symptomatic hyponatremia but, in contrast to patients with CSWS, they had decreased Na excretion and urine volume. Thus urine Na excretion and volume are very important for diagnosing the cause of hyponatremia in patients with cerebral lesions.	[Arieff, Allen I.; Goldfine, Ira D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Gabbai, Ramin] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA		Arieff, AI (corresponding author), 2 Roanoke St, San Francisco, CA 94131 USA.	a.arieff@comcast.net			Veterans AdministrationUS Department of Veterans Affairs	This work was funded by the Veterans Administration.	ALMUFTI H, 1984, AM J MED, V77, P740, DOI 10.1016/0002-9343(84)90377-2; ASHRAF N, 1981, AM J MED, V70, P1163, DOI 10.1016/0002-9343(81)90822-6; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; COGAN MC, 1978, AM J MED, V64, P500, DOI 10.1016/0002-9343(78)90237-1; CORT JH, 1954, LANCET, V1, P752; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoorn EJ, 2006, NEPHROL DIAL TRANSPL, V21, P70, DOI 10.1093/ndt/gfi082; Klein MJ, 2009, PHYS MED REHAB, V5, P1; Maesaka JK, 2009, KIDNEY INT, V76, P934, DOI 10.1038/ki.2009.263; Oh JY, 2015, FRONT PEDIATR, V2, P1; OSTER JR, 1983, ARCH INTERN MED, V143, P2187, DOI 10.1001/archinte.143.11.2187; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; WENIG BL, 1987, LARYNGOSCOPE, V97, P467; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011	17	5	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9629	1538-2990		AM J MED SCI	Am. J. Med. Sci.	OCT	2017	354	4					350	354		10.1016/j.amjms.2017.05.007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM9XM	WOS:000415626100005	29078838				2022-02-06	
J	Boyd, LR; Borawski, J; Lairet, J; Limkakeng, AT				Boyd, L. Renee; Borawski, J.; Lairet, J.; Limkakeng, A. T., Jr.			Critical Care Air Transport Team severe traumatic brain injury short-term outcomes during flight for Operation Iraqi Freedom/Operation Enduring Freedom between 1 June 2007 and 31 August 2010	JOURNAL OF THE ROYAL ARMY MEDICAL CORPS			English	Article								Introduction Our understanding of the expertise and equipment required to air transport injured soldiers with severe traumatic brain injuries (TBIs) continue to evolve. Methods We conducted a retrospective chart review of characteristics, interventions required and short-term outcomes of patients with severe TBI managed by the US Air Force Critical Care Air Transport Teams (CCATTs) deployed in support of Operation Iraqi Freedom and Operation Enduring Freedom between 1 June 2007 and 31 August 2010. Patients were cared for based on guidelines given by the Brain Trauma Foundation and the Joint Theater Trauma System by non-neurosurgeon physicians with dedicated neurocritical care training. We report basic characteristics, injuries, interventions required and complications during transport. Results Intracranial haemorrhage was the most common diagnosis in this cohort. Most injuries were weapon related. During this study, there were no reported in-flight deaths. The majority of patients were mechanically ventilated. There were 45 patients who required at least one vasopressor to maintain adequate tissue perfusion, including four patients who required three or more. Some patients required intracranial pressure (ICP) management, treatment of diabetes insipidus and/or seizure prophylaxis medications. Conclusions Air transport personnel must be prepared to provide standard critical care but also care specific to TBIs, including ICP control and management of diabetes insipidus. Although these patients and their potential complications are traditionally managed by neurosur-geons, those providers without neurosurgical backgrounds can be provided this training to help fill a wartime need. This study provides data for the future development of air transport guidelines for validating and clearing flight surgeons.	[Boyd, L. Renee; Limkakeng, A. T., Jr.] Duke Univ, Med Ctr, Emergency Med, DUMC BOX 3096,2301 Erwin Rd, Durham, NC 27710 USA; [Borawski, J.] Emory Univ, Sch Med, Emergency Med, Atlanta, GA USA		Borawski, J (corresponding author), Duke Univ, Med Ctr, Emergency Med, DUMC BOX 3096,2301 Erwin Rd, Durham, NC 27710 USA.	joseph.borawski@duke.edu	Lairet, Julio/AAE-8406-2021	Limkakeng, Alexander T./0000-0002-9822-5595			[Anonymous], 2010, GUIDELINES MANAGEMEN; Barnes SL, 2008, J TRAUMA, V64, pS129, DOI 10.1097/TA.0b013e318160a5b4; Beekley AC, 2007, SURG CLIN N AM, V87, P157, DOI 10.1016/j.suc.2006.09.008; Beninati W, 2009, CHEST, V136; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Grissom Thomas E, 2005, Crit Care Med, V33, pS13, DOI 10.1097/01.CCM.0000151063.85112.5A; Johannigman JA, 2007, J TRAUMA, V62, pS35, DOI 10.1097/TA.0b013e31806540f3; Mason PE, 2006, ANN EMERG MED, V48, pS104; Richardson MW, 2007, J TRAUMA, V62, pS64, DOI 10.1097/TA.0b013e318065adf3; Schmelz Joseph O, 2003, Crit Care Nurs Clin North Am, V15, P171, DOI 10.1016/S0899-5885(02)00056-4; Topley DK, 2003, MIL MED, V168, P822, DOI 10.1093/milmed/168.10.822; U. S. Army Institute of Surgical Research, 2012, JOINT THEAT TRAUM SY	12	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0035-8665	2052-0468		J ROY ARMY MED CORPS	J. R. Army Med. Corps	OCT	2017	163	5					342	346		10.1136/jramc-2016-000743			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR9MV	WOS:000419398700009	28385926				2022-02-06	
J	Frank, RM; Romeo, AA; Bush-Joseph, CA; Bach, BR				Frank, Rachel M.; Romeo, Anthony A.; Bush-Joseph, Charles A.; Bach, Bernard R., Jr.			INJURIES TO THE FEMALE ATHLETE IN 2017 Part I: General Considerations, Concussions, Stress Fractures, and the Female Athlete Triad	JBJS REVIEWS			English	Article							SPORTS-RELATED CONCUSSION; HIGH-SCHOOL SPORTS; STATES HIGH-SCHOOL; UNITED-STATES; GENDER-DIFFERENCES; SEX-DIFFERENCES; OVERUSE INJURIES; EATING-DISORDERS; RISK-FACTORS; BASE-LINE	Youth female athletes are more likely to sustain overuse injuries compared with traumatic injuries, and youth male patients are more likely to present following a traumatic injury compared with an overuse injury. Among high-school athletes, although boys' football tends to have the overall highest rate of injuries requiring a surgical procedure, among directly comparable sports (soccer, basketball, and baseball or softball), girls generally have a significantly higher rate of injury requiring a surgical procedure, with the knee being the most commonly injured anatomical location. In sports with similar playing rules, specifically basketball and soccer, the reported incidence of concussion is higher in female athletes compared with male athletes. The incidence of lower-extremity stress fractures is substantially higher in female athletes, female military personnel, and female runners compared with male athletes, male military personnel, and male runners. In 2007, the description of the female athlete triad was modified by the American College of Sports Medicine to focus more on the underlying metabolic features of the syndrome, and has more recently been described as the combination of low-energy availability, with or without disordered eating; menstrual dysfunction; and low bone mineral density.	[Romeo, Anthony A.; Bush-Joseph, Charles A.; Bach, Bernard R., Jr.] Rush Univ, Med Ctr, Dept Orthopaed Surg, Chicago, IL 60612 USA; [Frank, Rachel M.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA		Frank, RM (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO 80045 USA.	rmfrank3@gmail.com					ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Barrack MT, 2014, AM J SPORT MED, V42, P949, DOI 10.1177/0363546513520295; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Bessem BB, 2017, J SCI MED SPORT, V20, P213, DOI 10.1016/j.jsams.2016.06.010; Brook EM, 2016, PHYSICIAN SPORTSMED, V44, P20, DOI 10.1080/00913847.2016.1142834; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Chen YT, 2013, CURR REV MUSCULOSKE, V6, P173, DOI 10.1007/s12178-013-9167-x; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; De Souza MJ, 2014, CLIN J SPORT MED, V24, P96, DOI 10.1097/JSM.0000000000000085; Dick RW, 2009, BRIT J SPORT MED, V43, P146; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Epstein Y, 2015, J STRENGTH COND RES, V29, pS107, DOI 10.1519/JSC.0000000000001079; Erickson BJ, 2015, AM J SPORTS MED, V43, P1770, DOI DOI 10.1177/0363546515580304.A; Field AE, 2011, ARCH PEDIAT ADOL MED, V165, P723, DOI 10.1001/archpediatrics.2011.34; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hansen M, 2016, ADV EXP MED BIOL, V920, P139, DOI 10.1007/978-3-319-33943-6_13; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hill JL, 2004, J STRENGTH COND RES, V18, P426, DOI 10.1519/00124278-200408000-00006; Ivkovic A, 2007, CROAT MED J, V48, P767, DOI 10.3325/cmj.2007.6.767; Joy E, 2016, BRIT J SPORT MED, V50, P154, DOI 10.1136/bjsports-2015-095735; Kong PL, 2015, J PSYCHOL, V149, P141, DOI 10.1080/00223980.2013.846291; Kumar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053365; Ladd AL, 2014, CLIN ORTHOP RELAT R, V472, P1681, DOI 10.1007/s11999-014-3606-x; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lopiano DA, 2000, CLIN SPORT MED, V19, P163, DOI 10.1016/S0278-5919(05)70196-4; Mandic S, 2010, PHYSICIAN SPORTSMED, V38, P156, DOI 10.3810/psm.2010.06.1794; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall SW, 2007, J ATHL TRAINING, V42, P286; Matzkin E, 2015, CURR SPORT MED REP, V23, P424; Miller BF, 2007, J APPL PHYSIOL, V102, P541, DOI 10.1152/japplphysiol.00797.2006; Miller BF, 2006, AM J PHYSIOL-ENDOC M, V290, pE163, DOI 10.1152/ajpendo.00300.2005; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; Nattiv A, 2013, AM J SPORT MED, V41, P1930, DOI 10.1177/0363546513490645; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Powell JW, 2000, AM J SPORT MED, V28, P385, DOI 10.1177/03635465000280031801; Rechel JA, 2011, J TRAUMA, V71, P982, DOI 10.1097/TA.0b013e318230e716; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Remvig L, 2007, J RHEUMATOL, V34, P804; Rojas IL, 2009, AM J SPORT MED, V37, P558, DOI 10.1177/0363546508328105; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; Schroeder AN, 2015, J PEDIATR-US, V166, P600, DOI 10.1016/j.jpeds.2014.09.037; Sonneville KR, 2012, ARCH PEDIAT ADOL MED, V166, P595, DOI 10.1001/archpediatrics.2012.5; Stone S, 2016, SPORTS HEALTH; Stracciolini A, 2014, AM J SPORT MED, V42, P965, DOI 10.1177/0363546514522393; SUNDGOTBORGEN J, 1994, MED SCI SPORT EXER, V26, P414; Sutton KM, 2013, J AM ACAD ORTHOP SUR, V21, P41, DOI 10.5435/JAAOS-21-01-41; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8; Templeton Kimberly J, 2008, Instr Course Lect, V57, P539; Tenforde AS, 2017, AM J SPORT MED, V45, P302, DOI 10.1177/0363546516676262; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; VanHeest Jaci L, 2007, Curr Sports Med Rep, V6, P190, DOI 10.1007/s11932-007-0027-6; Vincent HK, 2015, SPORTS HEALTH, V7, P448, DOI 10.1177/1941738114552990; Wentz L, 2012, INT J SPORT NUTR EXE, V22, P374, DOI 10.1123/ijsnem.22.5.374; Wentz L, 2011, MIL MED, V176, P420, DOI 10.7205/MILMED-D-10-00322; Werner SL, 2006, AM J SPORT MED, V34, P597, DOI 10.1177/0363546505281796; Werner SL, 2005, AM J SPORT MED, V33, P552, DOI 10.1177/0363546504269253; Wolf JM, 2015, J AM ACAD ORTHOP SUR, V23, P339, DOI 10.5435/JAAOS-D-14-00020; Wright AA, 2015, BRIT J SPORT MED, V49, P1517, DOI 10.1136/bjsports-2015-094828; Yang JZ, 2012, J ATHL TRAINING, V47, P198; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	66	5	5	3	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2329-9185			JBJS REV	JBJS Rev.	OCT	2017	5	10							e4	10.2106/JBJS.RVW.17.00017			9	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	FQ6QU	WOS:000418489900004	29028750				2022-02-06	
J	Intan-Shameha, AR; Divers, TJ; Morrow, JK; Graves, A; Olsen, E; Johnson, AL; Mohammed, HO				Intan-Shameha, A. R.; Divers, Thomas J.; Morrow, Jennifer K.; Graves, Amy; Olsen, Emil; Johnson, Amy L.; Mohammed, Hussni O.			Phosphorylated neurofilament H (pNF-H) as a potential diagnostic marker for neurological disorders in horses	RESEARCH IN VETERINARY SCIENCE			English	Article						Biomarker; Serum; CSF; Phosphorylated neurofilament; Neurological disorders; Horse	PROTOZOAL MYELOENCEPHALITIS EPM; TRAUMATIC BRAIN-INJURY; SUBUNIT NF-H; MULTIPLE-SCLEROSIS; PROGNOSTIC BIOMARKER; SARCOCYSTIS-NEURONA; AXONAL INJURY; BLOOD; PHOSPHOFORMS; DEGENERATION	The current study aimed at the investigating the potential use of phosphorylated neurofilament H (pNF-H) as a diagnostic biomarker for neurologic disorders in the horse. Paired serum and cerebrospinal fluid (CSF) samples (n = 88) and serum only (n = 30) were obtained from horses diagnosed with neurologic disorders and clinically healthy horses as control. The neurologic horses consisted of equine protozoal myeloencephalitis (EPM) (38 cases) and cervical vertebral malformation (CVM) (23 cases). Levels of pNF-H were determined using an ELISA. The correlation between CSF and serum concentrations of pNF-H was evaluated using Spearman's Rank test and the significance of the difference among the groups was assessed using a nonparametric test. Horses had higher pNF-H levels in the CSF than serum. Horses afflicted with EPM had significantly higher serum pNF-H levels in comparison to controls or CVM cases. The correlation between CSF and serum pNF-H levels was poor in both the whole study population and among subgroups of horses included in the study. There was significant association between the likelihood of EPM and the concentrations of pNF-H in either the serum or CSF. These data suggest that pNF-H could be detected in serum and CSF samples from neurologic and control horses. This study demonstrated that pNF-H levels in serum and CSF have the potential to provide objective information to help in the early diagnosis of horses afflicted with neurologic disorders.	[Divers, Thomas J.; Olsen, Emil; Mohammed, Hussni O.] Cornell Univ, Coll Vet Med, S1 070 Schurman Hall, Ithaca, NY 14853 USA; [Morrow, Jennifer K.; Graves, Amy] Equine Diagnost Solut LLC, Lexington, KY 40511 USA; [Johnson, Amy L.] Univ Penn, Sch Vet Med, Kennett Sq, PA 19348 USA; [Intan-Shameha, A. R.] Univ Putra Malaysia, Dept Vet Preclin Sci, Fac Vet Med, Serdang 43400, Selangor, Malaysia		Mohammed, HO (corresponding author), Cornell Univ, Coll Vet Med, S1 070 Schurman Hall, Ithaca, NY 14853 USA.	hom1@cornell.edu		Abdul Razak, Intan Shameha/0000-0001-6787-3621; Olsen, Emil/0000-0001-5809-3324	Jack Lowe Foundation at the College of Veterinary Medicine, Cornell University; Ministry of Higher Education, MalaysiaMinistry of Education, Malaysia	The research is partially funded by grants from the Jack Lowe Foundation at the College of Veterinary Medicine, Cornell University and from the Ministry of Higher Education, Malaysia supported the visit of Dr. Intan to Cornell.	Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Baldwin SA, 1996, GLIA, V16, P266; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Boylan KB, 2013, J NEUROL NEUROSUR PS, V84, P467, DOI 10.1136/jnnp-2012-303768; Claridge HAH, 2010, EQUINE VET J, V42, P726, DOI 10.1111/j.2042-3306.2010.00114.x; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dubey JP, 2001, VET PARASITOL, V95, P89, DOI 10.1016/S0304-4017(00)00384-8; Furr M, 2002, J VET INTERN MED, V16, P618, DOI 10.1892/0891-6640(2002)016&lt;0618:CDOEPM&gt;2.3.CO;2; Gresle MM, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/315406; NEWCOMBE J, 1986, J NEUROCHEM, V47, P1713, DOI 10.1111/j.1471-4159.1986.tb13079.x; Nishida H, 2014, VET SURG, V43, P289, DOI 10.1111/j.1532-950X.2014.12144.x; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; Petzold A, 2010, J IMMUNOL METHODS, V352, P23, DOI 10.1016/j.jim.2009.09.014; Reed SM, 2013, J VET INTERN MED, V27, P1193, DOI 10.1111/jvim.12158; Ringger NC, 2011, J VET INTERN MED, V25, P132, DOI 10.1111/j.1939-1676.2010.0645.x; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Stratford CH, 2013, EQUINE VET J, V45, P254, DOI 10.1111/j.2042-3306.2012.00603.x; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	24	5	5	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0034-5288	1532-2661		RES VET SCI	Res. Vet. Sci.	OCT	2017	114						401	405		10.1016/j.rvsc.2017.07.020			5	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	FM3CL	WOS:000414881800060	28750210	Green Accepted			2022-02-06	
J	Lim, SW; Nyam, TTE; Ho, CH; Shiue, YL; Wang, JJ; Chio, CC; Kuo, JR				Lim, Sher-Wei; Nyam, Tee-Tau Eric; Ho, Chung-Han; Shiue, Yow-Ling; Wang, Jhi-Joung; Chio, Chung-Ching; Kuo, Jinn-Rung			Increased Risk of Anxiety or Depression After Traumatic Spinal Cord Injury in Patients with Preexisting Hyperlipidemia: A Population-Based Study	WORLD NEUROSURGERY			English	Article						Anxiety; Depression; Hyperlipidemia; Population database; Spinal cord injury	BRAIN-INJURY; HEALTH; DISORDERS; NEUROINFLAMMATION; SYMPTOMS; WOMEN; COMORBIDITIES; ATORVASTATIN; ASSOCIATION; PREVALENCE	OBJECTIVE: Anxiety or depression (AD) is a common complication after traumatic spinal cord injury (tSCI). This study sought to investigate the role of preexisting hyperlipidemia in new-onset AD after tSCI using a longitudinal population database. METHODS: This retrospective cohort study used Longitudinal Health Insurance Database data from January 1997 to December 2011. The case and comparison groups were individuals who experienced tSCI and who did and did not have preexisting hyperlipidemia, respectively. Kaplan-Meier curves were plotted, and log-rank test was used to compare the differences between these 2 groups. A Cox regression model was used to estimate the relative risk of AD. RESULTS: A total of 26,892 adult patients were enrolled in this study. After 1: 3 matching with age and gender, it showed 1) tSCI patients with preexisting hyperlipidemia have a 1.32-fold adjusted hazard ratio (HR) compared with those without hyperlipidemia (P < 0.05); 2) The Kaplan-Meier plot in tSCI patients with hyperlipidemia were more likely to develop the new-onset AD than those without hyperlipidemia during the follow-up period (P = 0.0003); and 3) the stratified analysis showed the risk of AD among patients with tSCI aged 18-34 years (HR, 3.2; 95% confidence interval (CI) 1.2-8.9), male patients (HR, 1.3; 95% CI 1.1-1.6), and higher Charlson's comorbidity index (CCI) score (CCI > 2; HR, 1.9; 95% CI 1.2-2.9), and those with a history of stroke (HR, 1.7; 95% CI 1.0-2.7). CONCLUSIONS: Preexisting hyperlipidemia is an independent predictor of new-onset AD in patients with tSCI, especially in those who are younger, male, have a higher CCI score, and have stroke.	[Lim, Sher-Wei; Shiue, Yow-Ling] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Lim, Sher-Wei; Nyam, Tee-Tau Eric; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Chiali, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Chiali, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Chiali, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Chiali, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477	Chi-Mei Medical Center [CMFHR10638]	This work was supported by Chi-Mei Medical Center grant number CMFHR10638.	Al-Owesie RM, 2012, NEUROSCIENCES, V17, P145; [Anonymous], 2008, J Spinal Cord Med, V31, P357; Bahorik AL, 2016, J AFFECT DISORDERS, V206, P169, DOI 10.1016/j.jad.2016.07.039; Bromberger JT, 2013, MENOPAUSE, V20, P488, DOI [10.1097/gme.0b013e3182730599, 10.1097/GME.0b013e3182730599]; Broomfield NM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0198-8; Byeon H, 2015, PEERJ, V3, DOI 10.7717/peerj.1288; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Chang HY, 2002, CHINESE J PHYSIOL, V45, P187; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chu LW, 2015, ACS CHEM NEUROSCI, V6, P889, DOI 10.1021/acschemneuro.5b00032; Craig A, 2015, ARCH PHYS MED REHAB, V96, P1426, DOI 10.1016/j.apmr.2015.02.027; Cui YL, 2014, CHINESE MED J-PEKING, V127, P2623, DOI 10.3760/cma.j.issn.0366-6999.20132684; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Doud AN, 2015, CLIN ORTHOP RELAT R, V473, P297, DOI 10.1007/s11999-014-3870-9; Esmaillzadeh A, 2010, ANN NUTR METAB, V57, P77, DOI 10.1159/000318588; Gibson-Smith D, 2016, J AFFECT DISORDERS, V198, P222, DOI 10.1016/j.jad.2016.03.032; HANCOCK KM, 1993, PARAPLEGIA, V31, P349, DOI 10.1038/sc.1993.59; Ho CH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005269; JOHANSSON R, 2013, PEERJ, V1, DOI DOI https://doi.org/10.7717/peerj.98; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P267; Kilic SA, 2013, SPINAL CORD, V51, P553, DOI 10.1038/sc.2013.25; Lerma A, 2017, PSYCHOL PSYCHOTHER-T, V90, P105, DOI 10.1111/papt.12098; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Lim SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169623; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Limampai P, 2017, INT J NEUROSCI, P1; Llaneza P, 2012, MATURITAS, V71, P120, DOI 10.1016/j.maturitas.2011.11.017; Maaijwee NAMM, 2016, EUR J NEUROL, V23, P1262, DOI 10.1111/ene.13009; Margolis JM, 2014, ARCH PHYS MED REHAB, V95, P2279, DOI 10.1016/j.apmr.2014.07.416; Migliorini C, 2008, AUST NZ J PSYCHIAT, V42, P309, DOI 10.1080/00048670801886080; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Pakpour AH, 2016, SPINAL CORD, V54, P1053, DOI 10.1038/sc.2016.7; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Sakakibara BM, 2009, SPINAL CORD, V47, P841, DOI 10.1038/sc.2009.93; Salmans S, 1997, DEPRESSION QUESTIONS; Schmieder RE, 2013, J HYPERTENS, V31, P610, DOI 10.1097/HJH.0b013e32835d6e53; Scott KM, 2009, PSYCHOL MED, V39, P33, DOI 10.1017/S0033291708003188; Shear MK, 1997, SEMIN REPROD ENDOCR, V15, P69, DOI 10.1055/s-2008-1067969; Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013; Song SE, 2016, TUBERC RESPIR DIS, V79, P289, DOI 10.4046/trd.2016.79.4.289; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; SUN X, 2016, J NEUROINFLAMMATION, V13; Tran J, 2016, SPINAL CORD, V54, P640, DOI 10.1038/sc.2016.66; Tully PJ, 2013, PSYCHOL HEALTH MED, V18, P627, DOI 10.1080/13548506.2012.749355; VANREEDT DAK, 2013, PSYCHONEUROENDOCRINO, V38, P209, DOI DOI 10.1016/J.PSYNEUEN.2012.05.017; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Wee HY, 2016, J CLIN PSYCHIAT, V77, P505, DOI 10.4088/JCP.14m09749	49	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2017	106						402	408		10.1016/J.WNEU.2017.06.182			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FN2UP	WOS:000415850400050	28711537				2022-02-06	
J	Lunardi, LW; Zimmer, ER; dos Santos, SC; Merzoni, J; Portela, LV; Stefani, MA				Lunardi, Luciano Werle; Zimmer, Eduardo R.; dos Santos, Samir C.; Merzoni, Joice; Portela, Luis V.; Stefani, Marco Antonio			Cell Index in the Diagnosis of External Ventricular Drain-Related Infections	WORLD NEUROSURGERY			English	Article						Cerebral hemorrhage; Cerebral ventriculitis; Craniocerebral trauma; Diagnosis; Meningitis; Ventriculostomy	BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID; CARE PATIENTS; MANAGEMENT	BACKGROUND: The use of an external ventricular drain is required for the treatment of many diseases, such as traumatic brain injury and subarachnoid hemorrhage (SAH). Meningitis and ventriculitis are frequent complications arising from the use of external ventricular drain therapy. This study aimed to determine the sensitivity, specificity, and cutoff point for cell index (CI) in patients with traumatic brain injury, SAH, and hemorrhagic stroke. METHODS: Our study population consisted of patients with different underlying diseases and few culture-positive cerebrospinal fluid samples. The diagnosis of infection was based on Centers of Disease Control and Prevention criteria. RESULTS: Overall CI analysis showed an area under the curve (AUC) of 0.982. The cutoff of 2.9 for overall CI provided a sensitivity of 95% and a specificity of 92.9%. In patients with SAH, the AUC was 1.0 for a CI of 2.8; furthermore, sensitivity and specificity were 100%. The relative variation of the CI was also assessed. This analysis revealed an AUC of 0.882, and a 4.33-fold increase was found be indicative of infection (P = 0.002), findings similar to those in the literature. In addition, a heatmap analysis demonstrated that the CI is unlikely to return to normal in patients with meningitis, even after treatment. CONCLUSIONS: Therefore, CI is valuable for the diagnosis of infection, but was inadequate for monitoring treatment. We hope to use the new cutoff point proposed by this study in our institution to improve patient clinical outcome.	[Lunardi, Luciano Werle] Hosp Cristo Redentor, Serv Controle Infeccao, Porto Alegre, RS, Brazil; [Zimmer, Eduardo R.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Zimmer, Eduardo R.] Brain Inst BraIns Rio Grande Sul, Porto Alegre, RS, Brazil; [dos Santos, Samir C.] Hosp Cristo Redentor, Neurosurg Dept, Porto Alegre, RS, Brazil; [Merzoni, Joice] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Portela, Luis V.] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Stefani, Marco Antonio] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil		Lunardi, LW (corresponding author), Hosp Cristo Redentor, Serv Controle Infeccao, Porto Alegre, RS, Brazil.	lwlunardi@gmail.com	Portela, Luis V/I-3410-2014; STEFANI, MARCO ANTONIO/C-3993-2013; Zimmer, Eduardo R Rigon/I-2932-2015	STEFANI, MARCO ANTONIO/0000-0002-4728-8764; Zimmer, Eduardo R Rigon/0000-0002-5349-0053; Portela, Luis Valmor/0000-0001-6113-8466			[Anonymous], 2011, SURG IMPL PROSTH NAT; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; Beer R, 2010, CURR OPIN CRIT CARE, V16, P117, DOI 10.1097/MCC.0b013e328338cb5f; Beer R, 2009, NEUROCRIT CARE, V10, P363, DOI 10.1007/s12028-008-9155-y; Camacho EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050708; Centers for Disease Control and Prevention, 2013, CDC NHSN SURV DEF SP; Chatzi M, 2014, CRIT CARE MED, V42, P66, DOI 10.1097/CCM.0b013e31829a70a5; dos Santos SC, 2017, WORLD NEUROSURG, V99, P580, DOI 10.1016/j.wneu.2016.12.071; Flint AC, 2013, NEUROSURGERY, V72, P993, DOI 10.1227/NEU.0b013e31828e8dfd; Humphreys H, 2015, J HOSP INFECT, V89, P281, DOI 10.1016/j.jhin.2014.12.019; Maskin LP, 2013, CLIN NEUROL NEUROSUR, V115, P1820, DOI 10.1016/j.clineuro.2013.05.034; Pfausler B, 2004, J ANTIMICROB CHEMOTH, V53, P848, DOI 10.1093/jac/dkh158; Tunkel AR, 2017, CLIN INFECT DIS, V64, P701, DOI 10.1093/cid/cix152; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573	14	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2017	106						504	508		10.1016/j.wneu.2017.07.012			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN2UP	WOS:000415850400064	28711541				2022-02-06	
J	Naiyer, N; Chounthirath, T; Smith, GA				Naiyer, Nada; Chounthirath, Thiphalak; Smith, Gary A.			Pediatric Cheerleading Injuries Treated in Emergency Departments in the United States	CLINICAL PEDIATRICS			English	Article						National Electronic Injury Surveillance System; sports; trauma; injury; children	EPIDEMIOLOGY; CHILDREN; SAFETY	This study investigates the epidemiology of cheerleading injuries to children in the United States. Data were analyzed from the National Electronic Injury Surveillance System for children 5 through 18 years of age treated in US emergency departments for cheerleading injuries from 1990 through 2012. An estimated 497095 children ages 5 to 18 years were treated in US emergency departments for a cheerleading injury during the 23-year study period, averaging 21613 injured children per year. From 1990 to 2012, the annual cheerleading injury rate increased significantly by 189.1%; and from 2001 to 2012, the annual rate of cheerleading-related concussion/closed head injury increased significantly by 290.9%. Falls were the most common mechanism of injury (29.4%) and were more likely to lead to hospitalization (relative risk = 2.47; 95% confidence interval = 1.67-3.68) compared with other injury mechanisms. The rising number and rate of pediatric cheerleading injuries underscore the need for increased efforts to prevent these injuries.	[Naiyer, Nada; Chounthirath, Thiphalak; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org					American Association of Cheerleading Coaches and Administrators, 2016 17 AACCA SCH CH; American Association of Cheerleading Coaches and Administrators, AACCA REL CHEERL RUL; American Medical Association, 2014 ANN M BOARD TRU; [Anonymous], SENATE GEN ASSEMBLY; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Campbell J, PREVENTING CHEERLEAD; Currie DW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2447; Jacobson B, 2008, SPORTS AM RECREATION, V12; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; Jacobson NA, 2012, J TRAUMA ACUTE CARE, V72, P521, DOI 10.1097/TA.0b013e31823f5fe3; LaBella CR, 2012, PEDIATRICS, V130, P966, DOI 10.1542/peds.2012-2480; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Mueller FO, 2009, J ATHL TRAINING, V44, P565, DOI 10.4085/1062-6050-44.6.565; National Conference of State Legislatures, TRAUM BRAIN INJ LEG; National Football League, CONC LEG STAT; Ortega HW, 2004, CLIN PEDIATR, V43, P251, DOI 10.1177/000992280404300306; Pollard KA, 2011, CLIN PEDIATR, V50, P844, DOI 10.1177/0009922811406262; Potteiger JA, 2010, J STRENGTH COND RES, V24, P1755, DOI 10.1519/JSC.0b013e3181e06cfb; Randazzo C, 2010, PEDIATRICS, V126, P727, DOI 10.1542/peds.2009-2497; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Schroeder T., NEISS SAMPLE DESIGN; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2011, AM J EMERG MED, V29, P1003, DOI 10.1016/j.ajem.2010.05.014; Shields BJ, 2009, J ATHL TRAINING, V44, P595, DOI 10.4085/1062-6050-44.6.595; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567; Singh S, 2008, PEDIATRICS, V121, pE954, DOI 10.1542/peds.2007-0767; US Census Bureau, NC EST2011 ALLDATA M; US Census Bureau, US EST00INT ALLDATA; US Census Bureau, US EST90INT 07 INT E; US Consumer Product Safety Commission, PUBL PLAYGR SAF HDB; Yard EE, 2007, J SCI MED SPORT, V10, P219, DOI 10.1016/j.jsams.2006.06.016	36	5	6	1	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	OCT	2017	56	11					985	992		10.1177/0009922817702938			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FG1EQ	WOS:000409537600001	28403661				2022-02-06	
J	Prangley, A; Aggerholm, M; Cinelli, M				Prangley, Alyssa; Aggerholm, Mathew; Cinelli, Michael			Improvements in balance control in individuals with PCS detected following vestibular training: A case study	GAIT & POSTURE			English	Article						Concussion; Balance; Post-concussion syndrome; Brain injury	SYSTEM; CONCUSSIONS	Concussed individuals have been found to experience balance deficits in the anterior-posterior (AP) direction as indicated by greater Center of Pressure (COP) displacement and velocity. One possible reason for this change in balance control could be due to damage to the lateral vestibulospinal tract which sends signals to control posterior muscles, specifically ankle extensors leading to compensatory torques about the ankle. The purpose of the study was to quantify balance assessments in individuals experiencing persistent post-concussion symptoms (PCS) to determine balance control changes following a vestibular training intervention. Participants (N = 6, > 26 days symptomatic), were tested during their first appointment with a registered physiotherapist (PT) and during each follow up appointment. Participants were prescribed balance, visual, and neck strengthening exercises by the PT that were to be completed daily between bi-weekly appointments. Balance assessments were quantified using a Nintendo Wii board to record ground reaction forces. Participants completed 4 balance assessments: 1) Romberg stance eyes open (REO); 2) Romberg stance eyes closed (REC); 3) single leg stance eyes open (SEO); and 4) single leg stance eyes closed (SEC). The balance assessments were conducted on both a firm and compliant surfaces. Significant improvements in balance control were noted in ML/AP displacement and velocity of COP for both SEC and Foam REC conditions, with additional improvements in AP velocity of COP for Foam REC and in ML displacement of COP during Foam SEC. Overall, findings indicate that objectively quantifying balance changes for individuals experiencing persistent PCS allows for a more sensitive measure of balance and detects changes unrecognizable to the naked eye.	[Prangley, Alyssa; Aggerholm, Mathew; Cinelli, Michael] Wilfrid Laurier Univ, Dept Kinesiol & Phys Ed, Waterloo, ON, Canada		Cinelli, M (corresponding author), Dept Kinesiol & Phys Ed, 75 Univ Ave W, Waterloo, ON N2L 3C5, Canada.	mcinelli@wlu.ca	Cinelli, Michael/ABE-7625-2020	Cinelli, Michael/0000-0002-5802-2590			[Anonymous], 1995, GAIT POSTURE; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026	10	5	5	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	OCT	2017	58						229	231		10.1016/j.gaitpost.2017.08.006			3	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	FM7EH	WOS:000415234200039	28822327				2022-02-06	
J	Raeissadat, SA; Shahraeeni, S; Sedighipour, L; Vahdatpour, B				Raeissadat, S. A.; Shahraeeni, S.; Sedighipour, L.; Vahdatpour, B.			Randomized controlled trial of local progesterone vs corticosteroid injection for carpal tunnel syndrome	ACTA NEUROLOGICA SCANDINAVICA			English	Article						carpal tunnel syndrome; corticosteroid; hydroxyprogesterone	TRAUMATIC BRAIN-INJURY; LASER THERAPY; NEUROPROTECTION; PREVALENCE; RECEPTORS; SYMPTOMS; ESTROGEN	ObjectivesA number of studies have demonstrated the neuroprotective effects of progesterone and its influence on the recovery after neural injury. Few studies investigated the efficacy of local progesterone in carpal tunnel syndrome. The objective of this study was to compare the long-term effects of progesterone vs corticosteroid local injections in patients with mild and moderate carpal tunnel syndrome. MethodsIn this randomized clinical trial, 78 patients with carpal tunnel syndrome were assigned to two groups. Patients were treated with a single local injection of triamcinolone acetonide in one group and single local injection of hydroxy progesterone in the other group. Variables including pain (based on visual analogue scale), symptom severity, and functional status (based on Bostone/Levine symptom severity and functional status scale) and nerve conduction study were evaluated before and 6months after the treatments. ResultsAll outcome measures including pain and electrophysiologic findings, improved in both groups and there were no meaningful differences between two groups regarding mentioned variables except for functional outcome, which was significantly better in progesterone compared with corticosteroid group at 6-month follow-up (P=.04). ConclusionsThe efficacy of progesterone local injection in mild and moderate CTS is equal and somehow superior to corticosteroid injection for relieving symptoms and improving functional and electrophysiologic findings at long-term follow-up.	[Raeissadat, S. A.; Shahraeeni, S.; Sedighipour, L.] Shahid Beheshti Univ Med Sci, Phys Med & Rehabil Res Ctr, Clin Res Dev Ctr, Shahid Modarres Hosp, Tehran, Iran		Shahraeeni, S (corresponding author), Shahid Beheshti Univ Med Sci, Phys Med & Rehabil Res Ctr, Tehran, Iran.	dr.shahraeeni@gmail.com	Vahdatpour, babak/C-7540-2018; Raeissadat, Seyed ahmad/AAN-6791-2021; raeissadat, ahmad/AAV-6187-2020	Raeissadat, Seyed Ahmad/0000-0003-1512-0921			Bahrami MH, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0752-6; Benson LS, 2006, ARTHROSCOPY, V22, P919, DOI 10.1016/j.arthro.2006.05.008; Bonfiglioli R, 2007, INT ARCH OCC ENV HEA, V80, P248, DOI 10.1007/s00420-006-0129-0; Chen Y, 2016, NEURAL REGEN RES, V11, P1180, DOI 10.4103/1673-5374.187063; CONFINOCOHEN R, 1991, BRIT MED J, V303, P1514, DOI 10.1136/bmj.303.6816.1514; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Dumitru D., 2002, ELECTRODIAGNOSTIC ME, V2, P1058; Ginanneschi F, 2012, J MOL NEUROSCI, V47, P59, DOI 10.1007/s12031-011-9679-z; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Huisstede BM, 2010, ARCH PHYS MED REHAB, V91, P981, DOI 10.1016/j.apmr.2010.03.022; Karadas O, 2011, AM J PHYS MED REHAB, V90, P287, DOI 10.1097/PHM.0b013e31820639ec; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Marshall S, 2007, COCHRANE DB SYST REV, V18, P1; Milani P, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-11; Mohammadi Azam, 2016, J Menopausal Med, V22, P80, DOI 10.6118/jmm.2016.22.2.80; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Padua L, 2016, LANCET NEUROL, V15, P1271; Peters-Veluthamaningal C, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-54; Piazzini D, 2007, CLIN REHABIL, V21, P299, DOI 10.1177/0269215507077294; Raeissadat A, 2010, J LASERS MED SCI, V1, P24; Raeissadat SA, 2014, J LASERS MED SCI, V5, P39; Rayegani SM, 2013, J LASERS MED SCI, V4, P182; Ren YM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004857; Rezazadeh A., 2014, KOOMESH J, V15, P138; Roglio I, 2008, NEUROSCIENCE, V155, P673, DOI 10.1016/j.neuroscience.2008.06.034; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Salaffi F, 2005, CLIN EXP RHEUMATOL, V23, P819; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Sitruk-Ware R, 2013, CLIMACTERIC, V16, P69, DOI 10.3109/13697137.2013.802556; Toesca A, 2008, CELL BIOL INT, V32, P75, DOI 10.1016/j.cellbi.2007.08.014; Werner RA, 2005, ARCH PHYS MED REHAB, V86, P1, DOI 10.1016/j.apmr.2004.05.013; Werner RA, 2011, MUSCLE NERVE, V44, P597, DOI 10.1002/mus.22208	33	5	5	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	OCT	2017	136	4					365	371		10.1111/ane.12739			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FF6OW	WOS:000409134100012	28229457				2022-02-06	
J	Schrieff-Elson, LE; Steenkamp, N; Hendricks, MI; Thomas, KGF; Rohlwink, UK				Schrieff-Elson, L. E.; Steenkamp, N.; Hendricks, M. I.; Thomas, K. G. F.; Rohlwink, U. K.			Local and global challenges in pediatric traumatic brain injury outcome and rehabilitation assessment	CHILDS NERVOUS SYSTEM			English	Article						Brain injuries; Traumatic; Pediatric; Neuropsychology; Rehabilitation; Outcome assessment	RANDOMIZED CONTROLLED-TRIAL; OF-THE-LITERATURE; TERM NEUROPSYCHOLOGICAL OUTCOMES; CROSS-CULTURAL NEUROPSYCHOLOGY; CHILDHOOD HEAD-INJURY; EFNS TASK-FORCE; COGNITIVE REHABILITATION; SOCIOECONOMIC-STATUS; SOUTH-AFRICA; ATTENTIONAL PROCESSES	Traumatic brain injury (TBI) is a major public health problem associated with high morbidity and mortality rates in children in both high- and low- and middle-income countries. Predicting outcome after pediatric TBI is challenging given the wide range of injury and non-injury-related factors which may have an impact. Some of these factors are relevant globally (like heterogeneity in patient and injury-related factors and research methodology) and others are more specific to local contexts (like sociodemographic and cultural factors). The assessment of rehabilitation outcomes post-TBI are similarly challenging given the various methodological limitations, disparities in access to rehabilitation, and limited awareness of deficits, which are encountered globally, as well as the lack of services in the local settings. In this article, we discuss these global and local challenges to outcome and rehabilitation assessment following pediatric TBI.	[Schrieff-Elson, L. E.; Steenkamp, N.; Hendricks, M. I.; Thomas, K. G. F.] Univ Cape Town, Dept Psychol, ACSENT Lab, Cape Town, South Africa; [Rohlwink, U. K.] Univ Cape Town, Dept Surg, Div Neurosurg, Cape Town, South Africa		Schrieff-Elson, LE (corresponding author), Univ Cape Town, Dept Psychol, ACSENT Lab, Cape Town, South Africa.	leigh.schrieff-elson@uct.ac.za	Rohlwink, Ursula/AAE-2513-2020; Rohlwink, Ursula Karin/U-8917-2019; Thomas, Kevin Garth Flusk/AAA-8655-2020; Schrieff, Leigh/AAQ-5577-2020	Rohlwink, Ursula Karin/0000-0002-4469-4935; Thomas, Kevin Garth Flusk/0000-0002-0807-6101; Schrieff, Leigh/0000-0003-0192-4830; Steenkamp, nina/0000-0003-1491-1596			Abdullah Jafri Malin, 2005, Asian J Surg, V28, P163, DOI 10.1016/S1015-9584(09)60334-1; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Ardila A, 2005, NEUROPSYCHOL REV, V15, P185, DOI 10.1007/s11065-005-9180-y; Ardila A., 1994, NEUROPSYCHOLOGICAL E, DOI [10.1007/978-1-4899-1453-8, DOI 10.1007/978-1-4899-1453-8]; Ardila A, 2013, INT HDB CROSS CULTUR, P23; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bangirana P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-96; Boroditsky L, 2011, SCI AM, V304, P62, DOI 10.1038/scientificamerican0211-62; Boroditsky Lera, 2009, DOES OUR LANGUAGE SH; Boyd RN, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0381-6; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Butler RW, 1998, MED PEDIATR ONCOL, P75; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carstairs JR, 2006, AUST PSYCHOL, V41, P48, DOI 10.1080/00050060500391878; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; CAVE J, 2009, NEW VOICES PSYCHOL, V5, P29; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Crowe M, 2013, J GERONTOL A-BIOL, V68, P198, DOI 10.1093/gerona/gls122; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Eslinger PJ, 1999, DEV NEUROPSYCHOL, V15, P157, DOI 10.1080/87565649909540744; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Ferraro, 2015, MINORITY CROSS CULTU; Ferrett H. L., 2011, THESIS; Ferrett HL, 2014, METAB BRAIN DIS, V29, P395, DOI 10.1007/s11011-014-9495-6; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Flanagan SR, 2008, ARCH PHYS MED REHAB, V89, pS9, DOI 10.1016/j.apmr.2007.12.010; Foxcroft C, 2005, INTRO PSYCHOL ASSESS; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gontkovsky ST, 2006, BRAIN INJURY, V20, P701, DOI 10.1080/02699050600744103; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Greenfield PM, 1997, AM PSYCHOL, V52, P1115, DOI 10.1037/0003-066X.52.10.1115; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hlatky R., 2003, NEUROSURG FOCUS, V14, P1; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs DM, 1997, J CLIN EXP NEUROPSYC, V19, P331, DOI 10.1080/01688639708403862; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Kendall D, 2015, S AFR J COMMUN DISOR, V62, DOI [10.4102/sajcd.v62i1.111, 10.4102/SAJCD.V62I1.111]; Kerns K A, 1998, Pediatr Rehabil, V2, P77; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kishiyama MM, 2009, J COGNITIVE NEUROSCI, V21, P1106, DOI 10.1162/jocn.2009.21101; Knowles J, 2010, THESIS; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Levin K, 2004, DISABIL REHABIL, V26, P306, DOI 10.1080/0963828032000174089; Levin Karen, 2006, Pediatr Rehabil, V9, P285, DOI 10.1080/13638490500293358; Lexell J, 2007, J HEAD TRAUMA REHAB, V22, P229, DOI 10.1097/01.HTR.0000281838.00344.03; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Manly JJ, 2008, NEUROPSYCHOL REV, V18, P179, DOI 10.1007/s11065-008-9068-8; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; Maroon JC, 2012, PHYSICIAN SPORTSMED, V40, P73, DOI 10.3810/psm.2012.11.1990; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Mbakile-Mahlanza L, 2015, NEUROPSYCHOL REHABIL, V25, P936, DOI 10.1080/09602011.2014.999000; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Nell V, 1999, CROSS CULTURAL NEURO; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Nxumalo N, 2011, J PUBLIC HEALTH POL, V32, pS124, DOI 10.1057/jphp.2011.26; Nyein K, 2007, J HEAD TRAUMA REHAB, V22, P239, DOI 10.1097/01.HTR.0000281840.85096.1f; Olness K, 2003, J DEV BEHAV PEDIATR, V24, P120, DOI 10.1097/00004703-200304000-00009; Olson K, 2015, APPL NEUROPSYCH-CHIL, V4, P166, DOI 10.1080/21622965.2013.830258; Pedraza O, 2008, NEUROPSYCHOL REV, V18, P184, DOI 10.1007/s11065-008-9067-9; Penkman Louise, 2004, Pediatr Rehabil, V7, P111, DOI 10.1080/13638490310001649417; Prabhu S, 2004, SURG MANAGEMENT TRAU, P5145; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Robbins RN, 2013, CLIN NEUROPSYCHOL, V27, P437, DOI 10.1080/13854046.2012.759627; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sanson-Fisher RW, 2007, AM J PREV MED, V33, P155, DOI 10.1016/j.amepre.2007.04.007; Sarsour K, 2011, J INT NEUROPSYCH SOC, V17, P120, DOI 10.1017/S1355617710001335; Semple PL, 1998, S AFR MED J, V88, P440; Skuy M, 2001, PERS INDIV DIFFER, V30, P1413, DOI 10.1016/S0191-8869(00)00123-9; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Uzzell B., 2013, INT HDB CROSS CULTUR; Van Wyhe K, 2009, THESIS; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	122	5	5	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1775	1784		10.1007/s00381-017-3527-6			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900022	29149382				2022-02-06	
J	Shah, SA; Mohamadpour, M; Askin, G; Nakase-Richardson, R; Stokic, DS; Sherer, M; Yablon, SA; Schiff, ND				Shah, Sudhin A.; Mohamadpour, Maliheh; Askin, Gulce; Nakase-Richardson, Risa; Stokic, Dobrivoje S.; Sherer, Mark; Yablon, Stuart A.; Schiff, Nicholas D.			Focal Electroencephalographic Changes Index Post-Traumatic Confusion and Outcome	JOURNAL OF NEUROTRAUMA			English	Article						cognitive outcomes; delirium; delta alpha ratio; EEG; post-traumatic confusional state	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; EEG ALPHA POWER; HEAD-INJURY; AMNESIA; COMA; CONSCIOUSNESS; RECOVERY; DELIRIUM; RHYTHMS	While the duration and severity of post-traumatic confusional state (PTCS) after traumatic brain injury have well-established implications for long-term outcomes, little is known about the underlying pathophysiology and their role in functional outcomes. Here, we analyzed the delta-to-alpha frequency band power ratios (DAR) from localized scalp areas derived from standard resting electroencephalographic (EEG) data recorded during eyes closed state in 49 patients diagnosed with PTCS. Higher global, occipital, parietal, and temporal DARs were significantly associated with the severity of PTCS, as assessed by the Confusion Assessment Protocol (CAP) observed on the same day, after controlling for injury severity. Also, occipital DARs were positively associated with both the CAP disorientation score 2, and the CAP symptom fluctuation score 4, after controlling for injury severity (n=35). Posterior DARs were significantly associated with Functional Independence Measure-cognitive subscale average score at 1 (n=45), 2 (n=42), and 5 (n=34) year(s) post-injury. The associations at 1 (temporal left) and 2 (parietal left) years survive after controlling for an injury severity index. Our finding that posterior DAR is a marker of PTCS and functional recovery post-injury, likely reflects functional de-afferentation of the posterior medial complex (PMC) in PTCS. Altered function of the PMC is proposed as a unifying physiological mechanism underlying both acute and chronic confusional states. We discuss the relationship of these findings to electrophysiological markers associated with disorders of consciousness.	[Shah, Sudhin A.] Blythedale Childrens Hosp, TBI DOC Res Program, Weill Cornell Med, Feil Family Brain & Mind Res Inst, 1300 York Ave,F610, New York, NY 10065 USA; [Mohamadpour, Maliheh] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Askin, Gulce] Weill Cornell Med, Div Biostat & Epidemiol, Dept Healthcare Policy & Res, New York, NY USA; [Nakase-Richardson, Risa] Univ S Florida, Polytrauma TBI Rehabil, James A Haley Vet Hosp, Tampa, FL USA; [Stokic, Dobrivoje S.; Yablon, Stuart A.] Methodist Rehabil Ctr, Jackson, MS USA; [Sherer, Mark] Univ Texas Houston, Baylor Coll Med, Med Sch, Houston, TX USA; [Schiff, Nicholas D.] Weill Cornell Med, Feil Family Brain Mind Res Inst, Lab Cognit Neuromodulat, New York, NY USA		Shah, SA (corresponding author), Blythedale Childrens Hosp, TBI DOC Res Program, Weill Cornell Med, Feil Family Brain & Mind Res Inst, 1300 York Ave,F610, New York, NY 10065 USA.	sut2006@med.cornell.edu	Mohamadpour, Maliheh/I-8041-2019	Stokic, Dobrivoje/0000-0002-1891-5730	VHA Central Office VA TBI; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015]; US Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); Administration for Community Living / National Institute on Disability, Independent Living, and Rehabilitation [90DP0028-02-01, H133A020514]; Wilson Research Foundation, Jackson, MS; Jerold B. Katz Foundation	Portions of this work were sponsored by VHA Central Office VA TBI Model System Program of Research, Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), Administration for Community Living / National Institute on Disability, Independent Living, and Rehabilitation Research grants 90DP0028-02-01 and H133A020514, Wilson Research Foundation, Jackson, MS and the Jerold B. Katz Foundation. The authors also thank Nicholas David W. Smith for assistance with manuscript preparation. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position or any other federal agency, policy or decision unless so designated by other official documentation.	Aggleton JP, 2010, NEUROPSYCHOLOGIA, V48, P2328, DOI 10.1016/j.neuropsychologia.2009.09.030; Babiloni C, 2009, HUM BRAIN MAPP, V30, P1431, DOI 10.1002/hbm.20612; Beridze M, 2010, Georgian Med News, P28; BOGOUSSLAVSKY J, 1988, J NEUROL NEUROSUR PS, V51, P116, DOI 10.1136/jnnp.51.1.116; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; DASILVA FHL, 1977, NEUROSCI LETT, V6, P237, DOI 10.1016/0304-3940(77)90024-6; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Fuhrer M.J., 1987, REHABILITATION OUTCO; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; HAKKINEN VK, 1988, INT J CLIN MONIT COM, V5, P97, DOI 10.1007/BF02919650; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jacobson S, 2000, Semin Clin Neuropsychiatry, V5, P86; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; KOPONEN H, 1989, J NEUROL NEUROSUR PS, V52, P980, DOI 10.1136/jnnp.52.8.980; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Larson CL, 1998, PSYCHOPHYSIOLOGY, V35, P162, DOI 10.1017/S0048577298001620; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leon-Carrion J, 2009, CLIN NEUROPHYSIOL, V120, P1039, DOI 10.1016/j.clinph.2009.01.021; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; MESULAM MM, 1976, J NEUROL NEUROSUR PS, V39, P84, DOI 10.1136/jnnp.39.1.84; Mitra P, 2007, OBSERVED BRAIN DYNAM; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Mullally W J, 1989, N J Med, V86, P541; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Nunez P. L., 2006, ELECT FIELDS BRAIN N; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Romano J, 1944, ARCH NEURO PSYCHIATR, V51, P356, DOI 10.1001/archneurpsyc.1944.02290280054003; Sadato N, 1998, NEUROREPORT, V9, P893, DOI 10.1097/00001756-199803300-00024; Schiff ND, 2012, ANN NEUROL, V72, P305, DOI 10.1002/ana.23671; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	58	5	5	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2691	2699		10.1089/neu.2016.4911			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700003	28462682				2022-02-06	
J	Singh, N; Singhal, A				Singh, Navneet; Singhal, Ash			Challenges in minor TBI and indications for head CT in pediatric TBI-an update	CHILDS NERVOUS SYSTEM			English	Article						Pediatric head trauma; Glasgow Coma Score (GCS); Traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; 2ND IMPACT SYNDROME; COMPUTED-TOMOGRAPHY; CHILDREN; CONCUSSION; MANAGEMENT; PATHOPHYSIOLOGY; HEMORRHAGE; GUIDELINES; RISKS	Pediatric head trauma is one of the commonest presentations to emergency departments. Over 90% of such head injuries are considered mild, but still present risk acute clinical deterioration and longer term morbidity. Identifying which children are at risk of clinically important brain injuries remains challenging and much of the data on minor head injuries is based on the adult population. Children, however, are different, both anatomically and in terms of mechanism of injury, to adults and, even within the pediatric group, there are differences with age and stage of development. CT scans have added to the repertoire of clinicians in the assessment of pediatric head injury population, but judicious use is required given radiation exposure, malignancy risk, and resource constraints. Guidelines and head injury rules have been developed, for adults and children, to support decision-making in the emergency department though whether their use is applicable to all population groups is debatable. Further challenges in mild pediatric head trauma also include appropriate recommendations for school attendance and physical activity after discharge. Concern remains for second-impact syndrome and, in the longer term, for post-concussive syndrome and further research in both is still needed. Furthermore, the development of clinical decision rules raises further questions on the purpose of admitting children with minor head injuries and answering this question may aid the evolution of clinical decision guidelines. The next generation of catheter with homogeneous flow patterns based on parametric designs may represent a step forward for the treatment of hydrocephalus, by possibly broadening their lifespan.	[Singh, Navneet; Singhal, Ash] British Columbia Childrens Hosp, Div Pediat Neurosurg, 4480 Oak St,Room K3-159, Vancouver, BC V6H 3V4, Canada		Singhal, A (corresponding author), British Columbia Childrens Hosp, Div Pediat Neurosurg, 4480 Oak St,Room K3-159, Vancouver, BC V6H 3V4, Canada.	asinghal@cw.bc.ca		Singhal, Ash/0000-0002-0061-9570			Babl FE, 2017, LANCET; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Bey T, 2009, WEST J EMERG MED, V10, P6; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Erlichman DB, 2010, PEDIATR RADIOL, V40, P1375, DOI 10.1007/s00247-010-1555-4; Farrell CA, 2013, PAED CHILD HEALT-CAN, V18, P253, DOI 10.1093/pch/18.5.253; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gordon Kevin E, 2006, Semin Pediatr Neurol, V13, P243, DOI 10.1016/j.spen.2006.09.005; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lloyd DA, 2005, ANN ROY COLL SURG, V87, P323, DOI 10.1308/003588405X51191; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Mower WR, 2017, LANCET; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Reed MJ, 2005, ARCH DIS CHILD, V90, P859, DOI 10.1136/adc.2004.053603; Roberts RM, 2017, BRAIN INJURY, P1; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Sookplung P, 2009, CURR OPIN ANESTHESIO, V22, P572, DOI 10.1097/ACO.0b013e3283303884; Squier W, 2012, CHILD NERV SYST, V28, P2005, DOI 10.1007/s00381-012-1870-1; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	40	5	5	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1677	1681		10.1007/s00381-017-3535-6			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900010	29149393				2022-02-06	
J	Valier, ARS; Bacon, CEW; Bay, RC; Molzen, E; Lam, KC; McLeod, TCV				Valier, Alison R. Snyder; Bacon, Cailee E. Welch; Bay, R. Curtis; Molzen, Eileen; Lam, Kenneth C.; McLeod, Tamara C. Valovich			Reference Values for the Pediatric Quality of Life Inventory and the Multidimensional Fatigue Scale in Adolescent Athletes by Sport and Sex	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						patient-reported outcome measures; health-related; whole person; sport-related injury; normative; patient-oriented evidence	GENERIC CORE SCALES; BASE-LINE; PHYSICAL-ACTIVITY; OUTCOME MEASURES; YOUTH SPORT; HEALTH; CONCUSSION; VALIDITY; PATIENT; RELIABILITY	Background: Effective use of patient-rated outcome measures to facilitate optimal patient care requires an understanding of the reference values of these measures within the population of interest. Little is known about reference values for commonly used patient-rated outcome measures in adolescent athletes. Purpose: To determine reference values for the Pediatric Quality of Life Inventory (PedsQL) and the Multidimensional Fatigue Scale (MFS) in adolescent athletes by sport and sex. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A convenience sample of interscholastic adolescent athletes from 9 sports was used. Participants completed the PedsQL and MFS during one testing session at the start of their sport season. Data were stratified by sport and sex. Dependent variables included the total PedsQL score and the 5 PedsQL subscale scores: physical functioning, psychosocial functioning, emotional functioning, social functioning, and school functioning. Dependent variables for the MFS included 3 subscale scores: general functioning, sleep functioning, and cognitive functioning. Summary statistics were reported for total and subscale scores by sport and sex. Results: Among 3574 males and 1329 female adolescent athletes, the PedsQL scores (100 possible points) generally indicated high levels of health regardless of sport played. Mean PedsQL total and subscales scores ranged from 82.6 to 95.7 for males and 83.9 to 95.2 for females. Mean MFS subscale scores (100 possible points) ranged from 74.2 to 90.9 for males and 72.8 to 87.4 for females. Conclusion: Healthy male and female adolescent athletes reported relatively high levels of health on the PedsQL subscales and total scores regardless of sport; no mean scores were lower than 82.6 points for males or 83.9 points for females. On the MFS, males and females tended to report low effect of general and cognitive fatigue regardless of sport; mean scores were higher than 83.5 points for males and 83.8 points for females. Clinically, athletes who score below the reference values for their sport have poorer health status than average adolescent athletes participating in that sport. Scores below reference values may warrant consideration of early intervention or treatment.	[Valier, Alison R. Snyder; Molzen, Eileen] AT Still Univ, Mesa, AZ USA; [Valier, Alison R. Snyder; Bacon, Cailee E. Welch; Lam, Kenneth C.; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA; [Valier, Alison R. Snyder; Bacon, Cailee E. Welch; Bay, R. Curtis; Lam, Kenneth C.; McLeod, Tamara C. Valovich] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ USA; [Valier, Alison R. Snyder; Bacon, Cailee E. Welch; McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ USA		Valier, ARS (corresponding author), AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA.	arsnyder@atsu.edu	Lam, Kenny/ABB-9733-2020; Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Lam, Kenneth/0000-0002-2185-0990	National Athletic Trainers' Association Research and Education Foundation; National Operating Committee on Standards for Athletic Equipment	One or more of the authors has declared the following potential conflict of interest or source of funding: The National Athletic Trainers' Association Research and Education Foundation and the National Operating Committee on Standards for Athletic Equipment provided funding for this research investigation.	Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Brand S, 2009, J HEALTH PSYCHOL, V14, P1144, DOI 10.1177/1359105309342602; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Committee on Quality of Health Care in America Institute of Medicine, 2001, CROSSING QUALITY CHA; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gould D., 2009, Journal of Intercollegiate Sport, V2, P16; Guagliano JM, 2015, J SCI MED SPORT, V18, P412, DOI 10.1016/j.jsams.2015.01.014; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Hunsaker FG, 2002, J BONE JOINT SURG AM, V84A, P208, DOI 10.2106/00004623-200202000-00007; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lam KC, 2013, J ATHL TRAINING, V48, P233, DOI 10.4085/1062-6050-48.2.12; Lyman S, 2001, MED SCI SPORT EXER, V33, P1803, DOI 10.1097/00005768-200111000-00002; Mayfield R, 2013, ATHLETIC TRAINING SP, V5, P265, DOI DOI 10.3928/19425864-20131017-01; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; McLeod TCV, 2009, J ATHL TRAINING, V44, P603, DOI 10.4085/1062-6050-44.6.603; Michener LA, 2011, J SPORT REHABIL, V20, P37, DOI 10.1123/jsr.20.1.37; National Federation of State High School Associations, 2013 2014 HIGH SCH A; Olsen SJ, 2006, AM J SPORT MED, V34, P905, DOI 10.1177/0363546505284188; Roberts RE, 2008, J ADOLESCENT HEALTH, V42, P294, DOI 10.1016/j.jadohealth.2007.09.016; Sauers EL, 2011, J SPORT REHABIL, V20, P100, DOI 10.1123/jsr.20.1.100; Simon JE, 2014, AM J SPORT MED, V42, P423, DOI 10.1177/0363546513510393; Snyder AR, 2007, ATHLET THER TODAY, V12, P12, DOI 10.1123/att.12.6.12; Snyder AR, 2010, J SPORT REHABIL, V19, P237, DOI 10.1123/jsr.19.3.237; Tanabe T, 2010, ATHL TRAIN SPORTS HL, V2, P106, DOI [10.3928/19425864-20100301-01, DOI 10.3928/19425864-20100301-01]; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Valier AR, 2016, ARCH PHYS MED REHAB, V97, P1202, DOI 10.1016/j.apmr.2015.11.015; Valier ARS, 2013, J SPORT REHABIL, V22, P248, DOI 10.1123/jsr.22.4.248; Valier AR, 2015, ATHL TRAIN ED J, V10, P91, DOI [DOI 10.4085/100191, 10.4085/100191]; Valovich TC, 2008, J ATHL TRAINING, V43, P437, DOI 10.4085/1062-6050-43.4.437; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a; Youngstedt S., 2005, EXERCISE HLTH MENTAL, P159; [No title captured], DOI DOI 10.1111/AJPS.12001	41	5	5	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	OCT	2017	45	12					2723	2729		10.1177/0363546517714471			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	FJ1NL	WOS:000412484500004	28708425				2022-02-06	
J	Wirth, P; Yu, WL; Kimball, AL; Liao, J; Berkner, P; Glenn, MJ				Wirth, Peter; Yu, Waylin; Kimball, Amanda L.; Liao, Jennifer; Berkner, Paul; Glenn, Melissa J.			New method to induce mild traumatic brain injury in rodents produces differential outcomes in female and male Sprague Dawley rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Adult hippocampal neurogenesis; Biological sex differences; Behavioral inhibition; Spatial cognition; BDNF	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SEX-DIFFERENCES; CONCUSSION SYMPTOMS; ENCEPHALOPATHY; ACCELERATION; CONSEQUENCES; IMPAIRMENT; ANESTHESIA; PLASTICITY; PSYCHOSIS	Background: Mild traumatic brain injuries (mTBI) are an increasing health concern due to persistent behavioral and neurological effects. To better understand these effects, researchers frequently rely on animal injury models. Existing models, however, may not adequately reproduce the mechanism of injury as it occurs in humans. New method: Our new model for inducing mTBI in rodents entails acceleration of the animal toward a stationary impact zone to produce rapid rotational movement of the head. The aim of the present experiment was to characterize the effects of this injury in female and male rats on behavior, cognition, and neural plasticity. Results: mTBI produced the most widespread effects in females: they were more active during recovery within minutes of mTBI and more active in the center of the open field 4 days after mTBI. Spatial learning deficits in the water maze were mild but persistent and accompanied by reduced numbers of immature neurons in the hippocampus along with reductions in sera levels of the neurotrophin, BDNF. By contrast, male mTBI rats mainly exhibited mild spatial learning deficits, with no other observed effects. Comparison with existing methods: Our model induced effects on behavior and biology in rats that aligned with existing models. However, new patterns were observed, particularly when comparing females and males. Conclusions: Taken together, these findings confirm the validity of this model and point to key differences between females and males in symptom severity and type. Additionally, our model adds a novel injury mechanism that complements existing rodent models. (C) 2017 Elsevier B.V. All rights reserved.	[Yu, Waylin; Kimball, Amanda L.; Glenn, Melissa J.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Wirth, Peter; Kimball, Amanda L.] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Wirth, Peter; Liao, Jennifer; Berkner, Paul; Glenn, Melissa J.] Colby Coll, Maine Concuss Management Initiat, Waterville, ME 04901 USA; [Wirth, Peter] 3120 R St,Unit 206, Washington, DC 20007 USA; [Yu, Waylin] 5023 Thurston Bowles Bldg,104 Manning Dr, Chapel Hill, NC 27599 USA; [Kimball, Amanda L.] 5550 Mayflower Hill Dr, Waterville, ME 04901 USA; [Liao, Jennifer] 44 Binney St, Boston, MA 02115 USA; [Berkner, Paul] 4460 Mayflower Hill Dr, Waterville, ME 04901 USA		Glenn, MJ (corresponding author), 5550 Mayflower Hill Dr, Waterville, ME 04901 USA.	pjw61@georgetown.edu; wayliny@gmail.com; akimball@colby.edu; jliao3@pennstatehealth.psu.edu; paul.berkner@colby.edu; mjglenn@colby.edu		Yu, Waylin/0000-0001-5489-3260	National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5P20RR016463-12]; National Institute of General Medical Sciences from the National Institutes of HealthGeneral Electric [8P20GM103423-12]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103423] Funding Source: NIH RePORTER	The authors would like to thank Edward Yeterian, Bruce Maxwell, and Joseph Atkins for their feedback and assistance on aspects of apparatus development, Amelia Chambers for assisting with data collection, and Stephanie Desrochers and Sarah Steimel for their editorial assistance. This work was supported by funding to MJG from the National Center for Research Resources (5P20RR016463-12) and the National Institute of General Medical Sciences (8P20GM103423-12) from the National Institutes of Health.	Andine P, 1999, J PHARMACOL EXP THER, V290, P1393; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; BLIZARD DA, 1975, PHYSIOL BEHAV, V14, P601, DOI 10.1016/0031-9384(75)90188-2; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Gray JA, 1982, NEUROPSYCHOLOGY ANXI; Gray JA., 2000, NEUROPSYCHOLOGY ANXI; Ibrahim S., 2016, SCI REP, P6; Keppel G., 2004, DESIGN ANAL RES HDB, V4th ed.; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Konrad KN, 2000, BRAIN INJURY, V14, P859; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Manahan-Vaughan D, 2008, HIPPOCAMPUS, V18, P125, DOI 10.1002/hipo.20367; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCall N, 2015, PHARMACOL BIOCHEM BE, V132, P125, DOI 10.1016/j.pbb.2015.03.004; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mouton PR, 2002, J MICROSC-OXFORD, V206, P54, DOI 10.1046/j.1365-2818.2002.01006.x; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Myles PS, 2001, BRIT MED J, V322, P710, DOI 10.1136/bmj.322.7288.710; National Center for Injury Prevention and Control, 2014, REP C TRAUM BRAIN IN; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9	50	5	5	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 1	2017	290						133	144		10.1016/j.jneumeth.2017.07.030			12	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FI2NQ	WOS:000411776000015	28780369	Green Accepted			2022-02-06	
J	Liang, T; Chen, QW; Li, Q; Li, RW; Tang, J; Hu, R; Zhong, J; Ge, HF; Liu, X; Hua, F				Liang, Tan; Chen, Qianwei; Li, Qiang; Li, Rongwei; Tang, Jun; Hu, Rong; Zhong, Jun; Ge, Hongfei; Liu, Xin; Hua, Feng			5-HT1a activation in PO/AH area induces therapeutic hypothermia in a rat model of intracerebral hemorrhage	ONCOTARGET			English	Article						intracerebral hemorrhage; therapeutic hypothermia; 8-OH-DPAT; 5-HT1a; PO/AH area	TRAUMATIC BRAIN-INJURY; PHARMACOLOGICALLY INDUCED HYPOTHERMIA; RANDOMIZED CONTROLLED-TRIAL; ACUTE ISCHEMIC-STROKE; RECEPTOR AGONISTS; CEREBRAL-ISCHEMIA; HEAD-INJURY; SEROTONIN; NORMOTHERMIA; MECHANISMS	Therapeutic hypothermia is widely applied as a neuroprotective measure on intracerebral hemorrhage (ICH). However, several clinical trials regarding physical hypothermia encountered successive failures because of its side-effects in recent years. Increasing evidences indicate that chemical hypothermia that targets hypothalamic 5-HT1a has potential to down-regulate temperature set point without major side-effects. Thus, this study examined the efficacy and safety of 5-HT1a stimulation in PO/AH area for treating ICH rats. First, the relationship between head temperature and clinical outcomes was investigated in ICH patients and rat models, respectively. Second, the expression and distribution of 5-HT1a receptor in PO/AH area was explored by using whole-cell patch and confocal microscopy. In the meantime, the whole-cell patch was subsequently applied to investigate the involvement of 5-HT1a receptors in temperature regulation. Third, we compared the efficacy between traditional PH and 5-HT1a activation-induced hypothermia for ICH rats. Our data showed that more severe perihematomal edema (PHE) and neurological deficits was associated with increased head temperature following ICH. 5-HT1a receptor was located on warm-sensitive neurons in PO/AH area and 8-OH-DPAT (5-HT1a receptor agonist) significantly enhanced the firing rate of warm-sensitive neurons. 8-OH-DPAT treatment provided a steadier reduction in brain temperature without a withdrawal rebound, which also exhibited a superior neuroprotective effect on ICH-induced neurological dysfunction, white matter injury and BBB damage compared with physical hypothermia. These findings suggest that chemical hypothermia targeting 5-HT1a receptor in PO/AH area could act as a novel therapeutic manner against ICH, which may provide a breakthrough for therapeutic hypothermia.	[Liang, Tan; Chen, Qianwei; Li, Qiang; Li, Rongwei; Tang, Jun; Hu, Rong; Zhong, Jun; Ge, Hongfei; Liu, Xin; Hua, Feng] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China		Hua, F (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China.	fenghua8888@yeah.net			Natural Basic Research Program of China (973 program)National Basic Research Program of China [2014CB541606]; National Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81601026/H0906]; Medical technology innovation program of Southwest hospital [SWH2016JSYB-06]	This study was supported by the Natural Basic Research Program of China (973 program 2014CB541606), the National Science Foundation of China (NSFC No 81601026/H0906) and Medical technology innovation program of Southwest hospital (NO. SWH2016JSYB-06).	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Bortolozzi A, 2012, MOL PSYCHIATR, V17, P612, DOI 10.1038/mp.2011.92; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; D'Ambrosio R, 2013, ANN NEUROL, V73, P199, DOI 10.1002/ana.23764; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kiyatkin EA, 2009, NEUROSCIENCE, V161, P926, DOI 10.1016/j.neuroscience.2009.04.004; Leslie M, 2015, SCIENCE, V349, P18, DOI [10.1126/science.349.6243.18, 10.1126/science.347.6217.18]; Li RW, 2016, SCI REP-UK, V6, DOI 10.1038/srep35923; Lin MT, 1998, AM J PHYSIOL-REG I, V274, pR1260, DOI 10.1152/ajpregu.1998.274.5.R1260; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Meng FX, 2012, EXP PHYSIOL, V97, P730, DOI 10.1113/expphysiol.2011.064204; Mortensen JK, 2014, STROKE, V45, P2121, DOI 10.1161/STROKEAHA.114.005302; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Muzzi M, 2012, J CEREBR BLOOD F MET, V32, P978, DOI 10.1038/jcbfm.2012.36; Narayan RK, 2001, NEW ENGL J MED, V344, P602, DOI 10.1056/NEJM200102223440810; Nikolov RP, 2011, AMINO ACIDS, V40, P1441, DOI 10.1007/s00726-010-0754-5; Oddo M, 2010, NEUROCRIT CARE, V12, P10, DOI 10.1007/s12028-009-9280-2; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rincon F, 2012, TRANSL STROKE RES, V3, pS10, DOI 10.1007/s12975-012-0175-8; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Serviddio G, 2008, GUT, V57, P957, DOI 10.1136/gut.2007.147496; Shirakawa H, 2008, BIOCHEM BIOPH RES CO, V377, P1211, DOI 10.1016/j.bbrc.2008.10.152; Staykov D, 2012, NERVENARZT, V83, P1569, DOI 10.1007/s00115-012-3531-8; Su YY, 2016, STROKE, V47, P457, DOI 10.1161/STROKEAHA.115.009789; Suzuki N, 2012, BRAIN RES, V1430, P93, DOI 10.1016/j.brainres.2011.10.044; Tang Y, 2012, NEUROSCIENCE, V219, P10, DOI 10.1016/j.neuroscience.2012.05.063; Tomte O, 2011, CRIT CARE MED, V39, P443, DOI 10.1097/CCM.0b013e318206b80f; Torup L, 2000, EUR J PHARMACOL, V395, P137, DOI 10.1016/S0014-2999(00)00175-8; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Xie BH, 2012, TRANSL STROKE RES, V3, pS174, DOI 10.1007/s12975-012-0164-y; Zhang MJ, 2013, CNS NEUROL DISORD-DR, V12, P371, DOI 10.2174/1871527311312030010; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	43	5	5	1	5	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	SEP 26	2017	8	43					73613	73626		10.18632/oncotarget.20280			14	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	FI2HT	WOS:000411760400023	29088731	Green Published, Green Submitted, gold			2022-02-06	
J	Zens, TJ; Danobeitia, JS; Chlebeck, PJ; Zitur, LJ; Odorico, S; Brunner, K; Coonen, J; Capuano, S; D'Alessandrol, AM; Matkowskyj, K; Zhong, WX; Torrealba, J; Fernandez, L				Zens, Tiffany J.; Danobeitia, Juan S.; Chlebeck, Peter J.; Zitur, Laura J.; Odorico, Scott; Brunner, Kevin; Coonen, Jennifer; Capuano, Saverio; D'Alessandrol, Anthony M.; Matkowskyj, Kristina; Zhong, Weixiong; Torrealba, Jose; Fernandez, Luis			Guidelines for the management of a brain death donor in the rhesus macaque: A translational transplant model	PLOS ONE			English	Article							DECEASED ORGAN DONORS; CARE MEDICINE/AMERICAN COLLEGE; CHEST PHYSICIANS/ASSOCIATION; ICU SOCIETY; PRETREATMENT; PROCUREMENT; KIDNEY; INFLAMMATION; DOPAMINE	Introduction The development of a translatable brain death animal model has significant potential to advance not only transplant research, but also the understanding of the pathophysiologic changes that occur in brain death and severe traumatic brain injury. The aim of this paper is to describe a rhesus macaque model of brain death designed to simulate the average time and medical management described in the human literature. Methods Following approval by the Institutional Animal Care and Use Committee, a brain death model was developed. Non-human primates were monitored and maintained for 20 hours after brain death induction. Vasoactive agents and fluid boluses were administered to maintain hemodynamic stability. Endocrine derangements, particularly diabetes insipidus, were aggressively managed. Results A total of 9 rhesus macaque animals were included in the study. The expected hemodynamic instability of brain death in a rostral to caudal fashion was documented in terms of blood pressure and heart rate changes. During the maintenance phase of brain death, the animal's temperature and hemodynamics were maintained with goals of mean arterial pressure greater than 60mmHg and heart rate within 20 beats per minute of baseline. Resuscitation protocols are described so that future investigators may reproduce this model. Conclusion We have developed a reproducible large animal primate model of brain death which simulates clinical scenarios and treatment. Our model offers the opportunity for researchers to have translational model to test the efficacy of therapeutic strategies prior to human clinical trials.	[Zens, Tiffany J.; Danobeitia, Juan S.; Chlebeck, Peter J.; Zitur, Laura J.; Odorico, Scott; D'Alessandrol, Anthony M.; Fernandez, Luis] Univ Wisconsin, Dept Surg, Div Transplantat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brunner, Kevin; Coonen, Jennifer; Capuano, Saverio] Univ Wisconsin, Wisconsin Primate Res Ctr, Madison, WI USA; [Matkowskyj, Kristina; Zhong, Weixiong] Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Torrealba, Jose] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA		Fernandez, L (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	luisf@surgery.wisc.edu	Danobeitia, Juan/AAC-5327-2020	Danobeitia, Juan/0000-0003-1641-3822; ZITUR, LAURA/0000-0002-1238-2726	National Institutes of Health NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1-R01-A1110617-01A1]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AI125231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32AI125231, R01AI110617] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health NIH #1-R01-A1110617-01A1 (PI: Luis Fernandez) and an NIH training grant NIH #T32 AI125231 is funding Dr. Danobeitia's postdoctoral research fellowship in the lab.; This work was supported by National Institutes of Health NIH #1-R01-AI110617-01A1 (PI: LAF) and NIH # T32 AI125231 training grant. We would also like to acknowledge the National Primate Center at the University of Wisconsin for the excellent technical support on the care of our animals and Alpha Genesis for the kind support on providing animals and resources for our research.	Amatschek S, 2012, J HEPATOL, V56, P1305, DOI 10.1016/j.jhep.2012.01.020; Blasco V, 2007, CRIT CARE, V11, DOI 10.1186/cc6120; Blasi-Ibanez A, 2009, ANESTHESIOLOGY, V110, P333, DOI 10.1097/ALN.0b013e318194ca8a; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Chen L, 2016, TRANSPL P, V48, P205, DOI 10.1016/j.transproceed.2016.01.007; Danobeitia JS, 2015, CELL TRANSPLANT, V24, P1863, DOI 10.3727/096368914X681045; Floerchinger B, 2012, TRANSPLANT REV-ORLAN, V26, P54, DOI 10.1016/j.trre.2011.10.001; Frontera JA, 2010, NEUROCRIT CARE, V12, P103, DOI 10.1007/s12028-009-9292-y; Goarin JP, 1996, ANESTH ANALG, V83, P41, DOI 10.1097/00000539-199607000-00008; Herodin F, 2005, EUR CYTOKINE NETW, V16, P104; Hoeger S, 2007, TRANSPL INT, V20, P790, DOI 10.1111/j.1432-2277.2007.00510.x; Kolkert JLP, 2007, LAB ANIM-UK, V41, P363, DOI 10.1258/002367707781282848; Kotloff RM, 2015, CRIT CARE MED, V43, P1291, DOI 10.1097/CCM.0000000000000958; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; Marasco S, 2013, TRANSPL P, V45, P33, DOI 10.1016/j.transproceed.2012.08.008; Marques RG, 2004, TRANSPL P, V36, P1048, DOI 10.1016/j.transproceed.2004.04.043; Minambres E, 2010, NEPHROL DIAL TRANSPL, V25, P2352, DOI 10.1093/ndt/gfq054; Muller E, 2015, TRANSPLANTATION, V99, P1743, DOI 10.1097/TP.0000000000000896; Niemann CU, 2015, NEW ENGL J MED, V373, P2687, DOI 10.1056/NEJMc1511744; Nijboer WN, 2010, CRIT CARE MED, V38, P1155, DOI 10.1097/CCM.0b013e3181cf6e78; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Plurad DS, 2012, AM J SURG, V204, P856, DOI 10.1016/j.amjsurg.2012.05.011; Remuzzi G, 1999, J AM SOC NEPHROL, V10, P2591; Spindler RS, 2015, TRANSPLANTATION, V99, P935, DOI 10.1097/TP.0000000000000577; Uno Y, 2015, DRUG METAB PHARMACOK, V30, P130, DOI 10.1016/j.dmpk.2014.10.002; Uno Y, 2011, DRUG METAB REV, V43, P346, DOI 10.3109/03602532.2010.549492; Valenza F, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/2197-425X-2-12; Westphal GA, 2016, CLIN TRANSPLANT, V30, P138, DOI 10.1111/ctr.12667; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; Wood KE, 2007, CURR OPIN ANESTHESIO, V20, P97, DOI 10.1097/ACO.0b013e3280895ac8; Youn TS, 2014, CRIT CARE CLIN, V30, P813, DOI 10.1016/j.ccc.2014.06.010; Yuan QP, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-52; Zhang SJ, 2014, EXP CLIN TRANSPLANT, V12, P469, DOI 10.6002/ect.2013.0229	33	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0182552	10.1371/journal.pone.0182552			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH4XT	WOS:000411166600002	28926566	Green Published, gold, Green Submitted			2022-02-06	
J	Fisher, A; Bellon, M; Lawn, S; Lennon, S				Fisher, Alinka; Bellon, Michelle; Lawn, Sharon; Lennon, Sheila			Identifying Current Practices and Supports in Behaviour Management Following ABI in South Australian Community Settings: A Delphi Study	BRAIN IMPAIRMENT			English	Article						behaviour; family; community; acquired brain injury; services	TRAUMATIC BRAIN-INJURY; CHALLENGING BEHAVIOR; YOUNG-CHILDREN; CAREGIVER BURDEN; DWELLING ADULTS; TBI; INDIVIDUALS; MULTICENTER; AGGRESSION; EXPERIENCE	Objectives: To consider the strategies currently used by family care givers to manage challenging behaviour in the community following ABI, and to identify what supports are available that support family care givers in addressing this issue. Research design: Delphi study. Methods: Service providers (n = 8) and family care givers (n = 3) completed a three-round Delphi process with the aim of reaching consensus (75% agreement) regarding research objectives. Round 1 consisted of an open-ended questionnaire in which items were identified; these items were then rated in Round 2 and 3 using a Likert scale. Statistical aggregation then allowed for quantitative analysis. Results: The findings suggest a number of behaviour management approaches are being used by family care givers, including basic antecedent strategies, agreeing with the person's demands, and medication. Consensus was reached that only two services in SA provide specific support to family care givers regarding behaviour management in the community: Families4Families Inc. (a peer support network) and Private Specialists (e.g., [neuro] psychologists and [neuro] psychiatrists). Conclusions: Findings emphasise the need for more specialised services specific to educating and supporting family care givers in the management of challenging behaviours following ABI. These services should be accessible, centralised, and easy for family care givers to navigate.	[Fisher, Alinka; Bellon, Michelle] Flinders Univ S Australia, Sch Hlth Sci, Dept Disabil & Community Inclus, Adelaide, SA, Australia; [Lawn, Sharon] Flinders Univ S Australia, Sch Hlth Sci, Dept Psychiat, Adelaide, SA, Australia; [Lennon, Sheila] Flinders Univ S Australia, Sch Hlth Sci, Repatriat Gen Hosp, Adelaide, SA, Australia		Fisher, A (corresponding author), Flinders Univ S Australia, Sch Hlth Sci, Dept Disabil & Community Inclus, Adelaide, SA, Australia.	Alinka.Fisher@flinders.edu.au	; Lawn, Sharon/E-1171-2015	Fisher, Alinka/0000-0003-0147-5051; Lennon, Sheila/0000-0001-5434-0893; Bellon, Michelle/0000-0003-2551-1846; Lawn, Sharon/0000-0002-5464-8887			AIHW, 2007, AUSTR I HLTH WELF, V55, P1; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Allen Michael H, 2003, J Psychiatr Pract, V9, P16, DOI 10.1097/00131746-200301000-00004; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Arco L, 2009, BRAIN IMPAIR, V10, P307, DOI 10.1375/brim.10.3.307; Borgmeier C, 2015, INDIVIDUAL POSITIVE, P145; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; British Society of Rehabilitation Medicine, 2003, NAT GUID REH FOLL AC; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; Carnevale GJ, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199602000-00005; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Currier GW, 2000, PSYCHIATR SERV, V51, P717, DOI 10.1176/appi.ps.51.6.717; Damasio A., 1994, DESCARTES ERROR EMOT; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Denscombe M., 2010, GOOD RES GUIDE SMALL, V4th; Department of Health, 2012, ACQ BRAIN INJ MOD RE; Disability SA, 2016, OFF SEN PRACT RESTR; Disability Services, 2013, AD SPEC SERV INT POS; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Families4Families Inc, 2011, FAMILIES4FAMILIES AB; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Fink A., 1985, CONDUCT SURVEYS STEP; Fisher A, 2015, BRAIN INJURY, V29, P661, DOI 10.3109/02699052.2015.1004751; Fleming J, 2012, SCAND J OCCUP THER, V19, P184, DOI 10.3109/11038128.2011.611531; Fleminger S., 2008, COCHRANE DB SYST REV, V4, P1; Forsyth R., 2002, CURRENT PAEDIAT, V12, P275; Gelber DA, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P3, DOI 10.1201/9781439849828-c1; Green J., 2014, QUALITATIVE METHODS, V3rd ed; Iqbal S, 2009, PSYCHOLOGIST, V22, P598; Jacobs HE, 1995, BEHAV ANAL GUIDELINE; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Keeney S., 2011, DELPHI TECHNIQUE NUR; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Littlefield L, 2012, GOVT FUNDED CLIN NEU; Manchester D, 1997, BRAIN INJURY, V11, P271; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDermott GL, 2014, BRAIN INJURY, V28, P81, DOI 10.3109/02699052.2013.857790; Munce SEP, 2014, BRAIN INJURY, V28, P1042, DOI 10.3109/02699052.2014.890744; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; NZGG, 2006, EV BAS BEST PRACT GU; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rolls E. T., 2002, FUNCTIONS ORBITOGRON, P354; Rowe G, 1999, INT J FORECASTING, V15, P353, DOI 10.1016/S0169-2070(99)00018-7; SA Health, 2015, BRAIN INJ REH SERV; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sander AM, 2000, J INT NEUROPSYCH SOC, V6, P649; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Saout V., 2011, Annals of Physical and Rehabilitation Medicine, V54, P259, DOI 10.1016/j.rehab.2011.04.003; Schlund MW, 2002, BRAIN INJURY, V16, P527, DOI 10.1080/02699050110113679; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Skulmoski GJ, 2007, J INF TECHNOL EDUC-R, V6, P1; Stewart I, 2010, BRAIN INJURY, V24, P1616, DOI 10.3109/02699052.2010.523050; Tam S, 2015, BRIEF BIOINFORM, V16, P950, DOI 10.1093/bib/bbv019; Willis TJ, 2003, J HEAD TRAUMA REHAB, V18, P75, DOI 10.1097/00001199-200301000-00008; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Wood RL, 2011, J HEAD TRAUMA REHAB, V26, P202, DOI 10.1097/HTR.0b013e318217b46d; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	82	5	5	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2017	18	2			SI		211	225		10.1017/BrImp.2016.36			15	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	FD5GN	WOS:000407559000004					2022-02-06	
J	Gaither, JB; Chikani, V; Stolz, U; Viscusi, C; Denninghoff, K; Barnhart, B; Mullins, T; Rice, AD; Mhayamaguru, M; Smith, JJ; Keim, SM; Bobrow, BJ; Spaite, DW				Gaither, Joshua B.; Chikani, Vatsal; Stolz, Uwe; Viscusi, Chad; Denninghoff, Kurt; Barnhart, Bruce; Mullins, Terry; Rice, Amber D.; Mhayamaguru, Moses; Smith, Jennifer J.; Keim, Samuel M.; Bobrow, Bentley J.; Spaite, Daniel W.			Body Temperature after EMS Transport: Association with Traumatic Brain Injury Outcomes	PREHOSPITAL EMERGENCY CARE			English	Article						hyperthermia; traumatic brain injury; hypothermia; mortality; cost	SEVERE HEAD-INJURY; RAPID-SEQUENCE INTUBATION; DATA-BANK; HYPERTHERMIA; HYPOTHERMIA; SEVERITY; IMPACT; HYPERVENTILATION; EPIDEMIOLOGY; GUIDELINES	Introduction: Low body temperatures following prehospital transport are associated with poor outcomes in patients with traumatic brain injury (TBI). However, a minimal amount is known about potential associations across a range of temperatures obtained immediately after prehospital transport. Furthermore, a minimal amount is known about the influence of body temperature on non-mortality outcomes. The purpose of this study was to assess the correlation between temperatures obtained immediately following prehospital transport and TBI outcomes across the entire range of temperatures. Methods: This retrospective observational study included all moderate/severe TBI cases (CDC Barell Matrix Type 1) in the pre-implementation cohort of the Excellence in Prehospital Injury Care (EPIC) TBI Study (NIH/NINDS: 1R01NS071049). Cases were compared across four cohorts of initial trauma center temperature (ITCT): <35.0 degrees C [Very Low Temperature (VLT)]; 35.0-35.9 degrees C [Low Temperature (LT)]; 36.0-37.9 degrees C [Normal Temperature (NT)]; and 38.0 degrees C [Elevated Temperature (ET)]. Multivariable analysis was performed adjusting for injury severity score, age, sex, race, ethnicity, blunt/penetrating trauma, and payment source. Adjusted odds ratios (aORs) with 95% confidence intervals (CI) for mortality were calculated. To evaluate non-mortality outcomes, deaths were excluded and the adjusted median increase in hospital length of stay (LOS), ICU LOS and total hospital charges were calculated for each ITCT group and compared to the NT group. Results: 22,925 cases were identified and cases with interfacility transfer (7361, 32%), no EMS transport (1213, 5%), missing ITCT (2083, 9%), or missing demographic data (391, 2%) were excluded. Within this study cohort the aORs for death (compared to the NT group) were 2.41 (CI: 1.83-3.17) for VLT, 1.62 (CI: 1.37-1.93) for LT, and 1.86 (CI: 1.52-3.00) for ET. Similarly, trauma center (TC) LOS, ICU LOS, and total TC charges increased in all temperature groups when compared to NT. Conclusion: In this large, statewide study of major TBI, both ETs and LTs immediately following prehospital transport were independently associated with higher mortality and with increased TC LOS, ICU LOS, and total TC charges. Further study is needed to identify the causes of abnormal body temperature during the prehospital interval and if in-field measures to prevent temperature variations might improve outcomes.	[Gaither, Joshua B.; Chikani, Vatsal; Stolz, Uwe; Viscusi, Chad; Denninghoff, Kurt; Barnhart, Bruce; Rice, Amber D.; Mhayamaguru, Moses; Smith, Jennifer J.; Keim, Samuel M.; Bobrow, Bentley J.; Spaite, Daniel W.] Univ Arizona, Coll Med, Arizona Emergency Med Res Ctr, Tucson, AZ USA; [Gaither, Joshua B.; Viscusi, Chad; Denninghoff, Kurt; Barnhart, Bruce; Rice, Amber D.; Mhayamaguru, Moses; Smith, Jennifer J.; Keim, Samuel M.; Bobrow, Bentley J.; Spaite, Daniel W.] Univ Arizona, Coll Med, Dept Emergency Med, 1501 N Campbell Ave,POB 245057, Tucson, AZ 85724 USA; [Chikani, Vatsal; Mullins, Terry; Bobrow, Bentley J.] Arizona Dept Hlth Serv, Bur Emergency Med Serv, Phoenix, AZ USA		Gaither, JB (corresponding author), Univ Arizona, Coll Med, Dept Emergency Med, 1501 N Campbell Ave,POB 245057, Tucson, AZ 85724 USA.	JGaither@aemrc.arizona.edu		Chikani, Vatsal/0000-0003-0904-7887	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071049]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071049] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS071049.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Axelrod YK, 2008, NEUROL CLIN, V26, P585, DOI 10.1016/j.ncl.2008.02.005; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090956; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Childs Charmaine, 2010, Front Neurol, V1, P146, DOI 10.3389/fneur.2010.00146; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Dukes SF, 2013, MIL MED, V178, P11, DOI 10.7205/MILMED-D-12-00177; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gaither JB, 2015, J EMERG MED, V49, P375, DOI 10.1016/j.jemermed.2015.01.038; Gaither JB, 2012, ANN EMERG MED, V60, P732, DOI 10.1016/j.annemergmed.2012.06.017; Hermstad Erik, 2010, J Emerg Trauma Shock, V3, P66, DOI 10.4103/0974-2700.58660; Ireland S, 2011, RESUSCITATION, V82, P300, DOI 10.1016/j.resuscitation.2010.10.016; JONES TS, 1982, JAMA-J AM MED ASSOC, V247, P3327, DOI 10.1001/jama.247.24.3327; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; Keim SM, 2002, ANN AGR ENV MED, V9, P1; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; McSwain NE, 2004, J TRAUMA, V57, P8; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Saxena M, 2014, COCHRANE DB SYST REV, V8; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Spaite DW, 2014, ACAD EMERG MED, V21, P818, DOI 10.1111/acem.12411; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Strachan R D, 1989, Brain Inj, V3, P51, DOI 10.3109/02699058909008073; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wade CE, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-35; WEISEND MP, 1994, J NEUROSURG, V80, P120, DOI 10.3171/jns.1994.80.1.0120; Zheng DN, 2014, NEUROEPIDEMIOLOGY, V42, P169, DOI 10.1159/000358304	46	5	5	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	SEP-OCT	2017	21	5					575	582		10.1080/10903127.2017.1308609			8	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	FH1YU	WOS:000410936500006	28481163	Green Accepted			2022-02-06	
J	Hassan, WMNW; Nasir, YM; Zaini, RHM; Shukeri, WFWM				Hassan, Wan Mohd Nazaruddin Wan; Nasir, Yusnizah Mohd; Zaini, Rhendra Hardy Mohamad; Shukeri, Wan Fadzlina Wan Muhd			Target-controlled Infusion Propofol Versus Sevoflurane Anaesthesia for Emergency Traumatic Brain Surgery: Comparison of the Outcomes	MALAYSIAN JOURNAL OF MEDICAL SCIENCES			English	Article						traumatic brain injury; infusion; propofol; Glasgow Outcome Scale	INTRACRANIAL SURGERY; INTRAVENOUS ANESTHESIA; BALANCED ANESTHESIA; CRANIOTOMY; DESFLURANE; INJURY	Background: The choice of anaesthetic techniques is important for the outcome of traumatic brain injury (TBI) emergency surgery. The objective of this study was to compare patient outcomes for target-controlled infusion (TCI) of propofol and sevoflurane anaesthesia. Methods: A total of 110 severe TBI patients, aged 18-60, who underwent emergency brain surgery were randomised into Group T (TCI) (n = 55) and Group S (sevoflurane) (n = 55). Anaesthesia was maintained in Group T with propofol target plasma concentration of 3-6 ae g/mL and in Group S with minimum alveolar concentration (MAC) of sevoflurane 1.0-1.5. Both groups received TCI remifentanil 2-8 ng/mL for analgesia. After the surgery, patients were managed in the intensive care unit and were followed up until discharge for the outcome parameters. Results: Demographic characteristics were comparable in both groups. Differences in Glasgow Outcome Scale (GOS) score at discharge were not significant between Group T and Group S (P = 0.25): the percentages of mortality (GOS 1) [27.3% versus 16.4%], vegetative and severe disability (GOS 2-3) [29.1% versus 41.8%] and good outcome (GOS 4-5) [43.6% versus 41.8%] were comparable in both groups. There were no significant differences in other outcome parameters. Conclusion: TCI propofol and sevoflurane anaesthesia were comparable in the outcomes of TBI patients after emergency surgery.	[Hassan, Wan Mohd Nazaruddin Wan; Nasir, Yusnizah Mohd; Zaini, Rhendra Hardy Mohamad; Shukeri, Wan Fadzlina Wan Muhd] Univ Sains Malaysia, Sch Med Sci, Dept Anaesthesiol, Jalan Sultanah Zainab II, Kubang Kerian 16150, Kelantan, Malaysia		Hassan, WMNW (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Anaesthesiol, Jalan Sultanah Zainab II, Kubang Kerian 16150, Kelantan, Malaysia.	drnaza_anaest@yahoo.co.uk	Shukeri, Wan Fadzlina Wan Muhd/T-8037-2019; Hassan, Wan Mohd Nazaruddin Wan/F-1124-2019	Hassan, Nazaruddin/0000-0002-3771-0327	Universiti Sains MalaysiaUniversiti Sains Malaysia [304/PPSP/61312033]	This study was supported by a short-term grant from Universiti Sains Malaysia (Account no: 304/PPSP/61312033).	Bastola P, 2015, INDIAN J ANAESTH, V59, P287, DOI 10.4103/0019-5049.156868; Bedforth NM, 2000, ANESTH ANALG, V91, P152, DOI 10.1097/00000539-200007000-00028; Citerio G, 2012, EUR J ANAESTH, V29, P371, DOI 10.1097/EJA.0b013e32835422db; Grathwohl KW, 2008, ANESTHESIOLOGY, V109, P44, DOI 10.1097/ALN.0b013e31817c02e3; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kerr Zachary Y, 2014, N C Med J, V75, P8; Liao R, 2010, EUR J ANAESTH, V27, P369, DOI 10.1097/EJA.0b013e32832edc70; Magni G, 2005, J NEUROSURG ANESTH, V17, P134, DOI 10.1097/01.ana.0000167447.33969.16; Magni G, 2007, J NEUROSURG ANESTH, V19, P229, DOI 10.1097/ANA.0b013e31806e5f5a; RAVUSSIN P, 1995, ANAESTHESIST, V44, P405, DOI 10.1007/s001010050168; Sabariah F J, 2008, Med J Malaysia, V63 Suppl C, P45; Schwender D, 1998, ANAESTHESIST, V47, pS37, DOI 10.1007/PL00002496; Sharda Priya, 2014, Asian J Neurosurg, V9, P203, DOI 10.4103/1793-5482.146605; Sneyd JR, 2005, BRIT J ANAESTH, V94, P778, DOI 10.1093/bja/aei141; Tay EL, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0590-1; Valencia L, 2014, Ann Fr Anesth Reanim, V33, pe59, DOI 10.1016/j.annfar.2013.12.020; Weninger B, 2004, ANASTH INTENSIV NOTF, V39, P212, DOI 10.1055/s-2004-814363	17	5	5	0	3	UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES	KELANTAN	HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA	1394-195X	2180-4303		MALAYS J MED SCI	Malays. J. Med. Sci.	SEP-OCT	2017	24	5					73	82		10.21315/mjms2017.24.5.8			10	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FP1JA	WOS:000417367100008	29386974	Green Published, gold			2022-02-06	
J	Hoonakker, M; Doignon-Camus, N; Marques-Carneiro, JE; Bonnefond, A				Hoonakker, Marc; Doignon-Camus, Nadege; Marques-Carneiro, Jose Eduardo; Bonnefond, Anne			Sustained attention ability in schizophrenia: Investigation of conflict monitoring mechanisms	CLINICAL NEUROPHYSIOLOGY			English	Article						Schizophrenia; Sustained attention; Conflict detection; Conflict resolution; Time-on-task; Event-related potentials	TRAUMATIC BRAIN-INJURY; CONTINUOUS PERFORMANCE-TEST; GO/NO-GO TASK; RESPONSE-INHIBITION; BIPOLAR DISORDER; NEUROCOGNITIVE DEFICITS; SELECTIVE ATTENTION; ANTERIOR CINGULATE; SUBSTANTIA-NIGRA; HEALTHY CONTROLS	Objective: The main goal of the current study was to assess, with a time-on-task approach, sustained attention ability in schizophrenia, and to investigate conflict monitoring underlying this ability.& para;& para;Methods: Behavioral and event-related potentials data (N2 and P3a amplitudes) were recorded in a long-lasting sustained attention Go/NoGo task (sustained attention to response task, SART), over a period of 30 min, in 29 patients with schizophrenia and 29 pair-matched healthy subjects.& para;& para;Results: Our results revealed spared sustained attention ability in patients throughout the task. Impairment of conflict detection (N2) in patients was particularly significant at the end of the task. Furthermore, both schizophrenia and healthy subjects exhibited a decline in conflict detection from the beginning to the middle of the task. Whereas controls' conflict detection recovered in the last part of the task, patients' did not, suggesting a deficit in recovery processes reflecting a lack of additional resources sustained attention Go/NoGo task. Conflict resolution (P3a) was preserved throughout the task in both groups.& para;& para;Conclusions: Conflict monitoring processes are increasingly impaired in schizophrenia during a long-lasting sustained attention Go/NoGo task.& para;& para;Significance: This impairment at the end of the task may rely on deficit in recovery processes, rather than a deficit in conflict detection per se in schizophrenia. (C) 2017 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Hoonakker, Marc; Marques-Carneiro, Jose Eduardo; Bonnefond, Anne] Univ Hosp Strasbourg, Dept Psychiat, INSERM, U1114, 1 Pl Hop, F-67000 Strasbourg, France; [Doignon-Camus, Nadege] Univ Lorraine, Univ Haute Alsace, Univ Strasbourg, LISEC EA 2310, Nancy, France		Hoonakker, M (corresponding author), Univ Hosp Strasbourg, Dept Psychiat, INSERM, U1114, 1 Pl Hop, F-67091 Strasbourg, France.	marc.hoonakker@etu.unistra.fr		Marques-Carneiro, Jose Eduardo/0000-0003-1131-178X	MESR grant	We wish to thank the individuals with schizophrenia and healthy subjects who participated in this work. In addition, we thank the staff of the unit 1114 of the French National Institute for Health and Medical Research (INSERM). This research was supported by MESR grant allocated to first author.	Addington J, 1997, SCHIZOPHR RES, V23, P197, DOI 10.1016/S0920-9964(96)00105-3; American Psychiatric Association, 2004, DIAGN STAT MAN MENT; Araki T, 2016, PSYCHIAT CLIN NEUROS, V70, P278, DOI 10.1111/pcn.12389; Bates AT, 2002, CLIN NEUROPHYSIOL, V113, P1454, DOI 10.1016/S1388-2457(02)00154-2; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beste C, 2010, NEUROPSYCHOLOGIA, V48, P366, DOI 10.1016/j.neuropsychologia.2009.09.023; Birkett P, 2007, SCHIZOPHR RES, V95, P76, DOI 10.1016/j.schres.2007.05.030; Bleuler E., 1950, DEMENTIA PRAECOX GRO; Bonnefond A, 2010, BEHAV BRAIN RES, V211, P185, DOI 10.1016/j.bbr.2010.03.030; Buchanan RW, 1997, AM J PSYCHIAT, V154, P363; Buzzell GA, 2014, NEUROSCI LETT, V563, P61, DOI 10.1016/j.neulet.2014.01.030; Chan RCK, 2009, COGN BEHAV NEUROL, V22, P180, DOI 10.1097/WNN.0b013e3181b7ef84; Chan RCK, 2004, CLIN NEUROPSYCHOL, V18, P114, DOI 10.1080/13854040490507208; Chan WY, 2009, ANN ACAD MED SINGAP, V38, P388; Chun J, 2013, SCHIZOPHR RES, V151, P175, DOI 10.1016/j.schres.2013.10.020; Daffner KR, 2000, J COGNITIVE NEUROSCI, V12, P393, DOI 10.1162/089892900562219; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Demeter E, 2013, SCHIZOPHR RES, V144, P136, DOI 10.1016/j.schres.2013.01.003; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2005, NEUROIMAGE, V27, P587, DOI 10.1016/j.neuroimage.2005.05.044; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Donohoe G, 2005, J NERV MENT DIS, V193, P803, DOI 10.1097/01.nmd.0000190587.01950.72; Donohoe Gary, 2006, Cogn Neuropsychiatry, V11, P13, DOI 10.1080/13546800444000155; Egeland J, 2003, ACTA PSYCHIAT SCAND, V108, P276, DOI 10.1034/j.1600-0447.2003.00146.x; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fleck DE, 2001, SCHIZOPHR RES, V52, P251, DOI 10.1016/S0920-9964(01)00170-0; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 1996, AM J PSYCHIAT, V153, P321; Hahn B, 2012, J ABNORM PSYCHOL, V121, P641, DOI 10.1037/a0028492; HART S G, 1988, P139; Jabs BE, 2001, NEUROPSYCHOBIOLOGY, V44, P183, DOI 10.1159/000054940; Jones LA, 2001, SCHIZOPHR RES, V48, P263, DOI 10.1016/S0920-9964(00)00136-5; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kiehl KA, 2000, BIOL PSYCHIAT, V48, P210, DOI 10.1016/S0006-3223(00)00834-9; Kraepelin E., 1971, DEMENTIA PRAECOX PAR; Kraepelin E., 1919, DEMENTIA PRAECOX PAR; Kurtz MM, 2001, SCHIZOPHR RES, V48, P307, DOI 10.1016/S0920-9964(00)00060-8; LIDDLE PF, 1992, BRIT J PSYCHIAT, V160, P179, DOI 10.1192/bjp.160.2.179; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Mar CM, 1996, BRIT J PSYCHIAT, V169, P781, DOI 10.1192/bjp.169.6.781; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Matthews G., 1999, PERS PSYCHOL EUR, V7, P335, DOI DOI 10.1177/154193120404801107; McNeely HE, 2003, J ABNORM PSYCHOL, V112, P679, DOI 10.1037/0021-843X.112.4.679; Minzenberg MJ, 2014, PSYCHIAT RES-NEUROIM, V221, P114, DOI 10.1016/j.pscychresns.2013.11.003; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P160, DOI 10.1093/schbul/10.2.160; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; O'Grada C, 2009, SCHIZOPHR RES, V107, P319, DOI 10.1016/j.schres.2008.07.013; Parasuraman R, 1998, ATTENTIVE BRAIN, P221; Perez VB, 2012, J ABNORM PSYCHOL, V121, P372, DOI 10.1037/a0025487; Phillips RC, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00502; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polli FE, 2006, SCHIZOPHR RES, V82, P191, DOI 10.1016/j.schres.2005.10.003; Raven J. C., 1998, ADV PROGR MATRICES; Rentrop M, 2011, SCHIZOPHR RES, V131, P206, DOI 10.1016/j.schres.2011.06.020; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rund BR, 1998, SCAND J PSYCHOL, V39, P101, DOI 10.1111/1467-9450.00062; Sanz JC, 2012, COGN BEHAV NEUROL, V25, P63, DOI 10.1097/WNN.0b013e318255feaf; SHAKOW D, 1962, ARCH GEN PSYCHIAT, V6, P1; Smallwood J, 2003, CONSCIOUS COGN, V12, P169, DOI 10.1016/S1053-8100(02)00003-X; Sponheim SR, 2006, BIOL PSYCHIAT, V60, P242, DOI 10.1016/j.biopsych.2005.11.017; Staub B, 2015, NEUROPSYCHOLOGIA, V75, P607, DOI 10.1016/j.neuropsychologia.2015.07.021; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Wagenmakers EJ, 2007, PSYCHOL REV, V114, P830, DOI 10.1037/0033-295X.114.3.830; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weisbrod M, 2000, BIOL PSYCHIAT, V47, P51, DOI 10.1016/S0006-3223(99)00218-8; Weschsler D, 1997, WECHSLER ADULT INTEL; Williams MR, 2014, EUR ARCH PSY CLIN N, V264, P285, DOI 10.1007/s00406-013-0479-z; Wing VC, 2011, PSYCHIAT RES, V188, P320, DOI 10.1016/j.psychres.2011.05.037; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	73	5	5	3	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	SEP	2017	128	9					1599	1607		10.1016/j.clinph.2017.06.036			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FN1IW	WOS:000415742000010	28715711				2022-02-06	
J	Jodoin, M; Rouleau, DM; Gosselin, N; Benoit, B; Leduc, S; Laflamme, Y; Larson-Dupuis, C; De Beaumont, L				Jodoin, Marianne; Rouleau, Dominique M.; Gosselin, Nadia; Benoit, Benoit; Leduc, Stephane; Laflamme, Yves; Larson-Dupuis, Camille; De Beaumont, Louis			Comorbid mild traumatic brain injury increases pain symptoms in patients suffering from an isolated limb fracture	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Mild traumatic brain injury; Orthopaedic monotrauma; Pain	DISTAL RADIUS FRACTURE; COHORT	Objectives: This study seeks to evaluate the effects of a mild traumatic brain injury (mTBI) on pain in patients with an isolated limb fracture (ILF) when compared to a matched cohort group with no mTBI (control group). Patients and methods: All subjects included in this observational study suffered from an ILF. Groups were matched according to the type of injury, sex, age, and time since the accident. Main outcome measurements were: Standardized semi-structured interviews at follow-up of a Level I Trauma Center, and a questionnaire on fracture-related pain symptoms. Factors susceptible to influence the perception of pain, such as age, sex, severity of post-concussive symptoms, and worker compensation were also assessed. Results: A total of 68 subjects (36 females; 45 years old) with an ILF were selected, 34 with a comorbid mTBI and 34 without (24/34 with an upper limb fracture per group, 71% of total sample). Patients with mTBI and an ILF reported significantly higher pain scores at the time of assessment (mean: 49 days, SD: 34.9), compared to the control group (p < 0.0001; mean difference 2.8, 95% confidence interval 1.8-4.0). Correlational analyses show no significant association between the level of pain and factors such as age, sex, severity of post-concussive symptoms, and worker compensation. Conclusions: Results suggest that mTBI exacerbate perception of pain in the acute phase when occurring with an ILF, and were not explained by age, sex, post-concussive symptoms, or worker compensation. Rather, it appears possible that neurological sequelae induced by mTBI may interfere with the normal recovery of pain following trauma. (C) 2017 Elsevier Ltd. All rights reserved.	[Jodoin, Marianne; Rouleau, Dominique M.; Gosselin, Nadia; Benoit, Benoit; Leduc, Stephane; Laflamme, Yves; Larson-Dupuis, Camille; De Beaumont, Louis] Montreal Sacred Heart Hosp, Res Ctr, Montreal, PQ, Canada; [Jodoin, Marianne; Gosselin, Nadia; Larson-Dupuis, Camille] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Rouleau, Dominique M.; Benoit, Benoit; Leduc, Stephane; Laflamme, Yves; De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ, Canada		De Beaumont, L (corresponding author), 5400 Gouin Ouest,Suite E-1340, Montreal, PQ, Canada.	louis.de.beaumont@umontreal.ca			Fonds de la Recherche du Quebec en sante	Financial support from Fonds de la Recherche du Quebec en sante awarded to LDB.	Albrecht E, 2013, BRIT J ANAESTH, V110, P96, DOI 10.1093/bja/aes355; Archer KR, 2012, J TRAUMA ACUTE CARE, V72, P1068, DOI 10.1097/TA.0b013e3182452df5; Carr DB, 1999, LANCET, V353, P2051, DOI 10.1016/S0140-6736(99)03313-9; Centers for Disease C, 2011, NAT HOSP AMB MED CAR; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Helmerhorst GTT, 2014, J BONE JOINT SURG AM, V96A, P495, DOI 10.2106/JBJS.L.01406; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Jodoin M, 2016, INJURY, V47, P1835, DOI 10.1016/j.injury.2016.05.036; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; MacDermid JC, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-24; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mehta SP, 2015, J ORTHOP SPORT PHYS, V45, P119, DOI 10.2519/jospt.2015.5129; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Moseley GL, 2014, J PAIN, V15, P16, DOI 10.1016/j.jpain.2013.08.009; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ootes Daan, 2012, Hand (N Y), V7, P18, DOI 10.1007/s11552-011-9383-z; Pergolizzi JV, 2014, PAIN MANAG NURS, V15, P380, DOI 10.1016/j.pmn.2012.07.004; Platts-Mills TF, ANN EMERGENCY MED; Pollak AN, 2013, BONE JOINT BURDEN; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Vijayan R., 2011, MANAGING ACUTE PAIN	28	5	6	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2017	48	9					1927	1931		10.1016/j.injury.2017.06.025			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FE2LA	WOS:000408046600013	28693815				2022-02-06	
J	Kroshus, E; Gillard, D; Haarbauer-Krupa, J; Goldman, RE; Bickham, DS				Kroshus, E.; Gillard, D.; Haarbauer-Krupa, J.; Goldman, R. E.; Bickham, D. S.			Talking with young children about concussions: an exploratory study	CHILD CARE HEALTH AND DEVELOPMENT			English	Article						brain injury; children; concussion; parents; sport	TRAUMATIC BRAIN-INJURY; RISK-TAKING; SPORT; KNOWLEDGE; SOCIALIZATION; COGNITIONS; ATTITUDES; BEHAVIOR; PARENTS; HEALTH	BackgroundConcussion education for children early in their participation in organized sport may help shape lasting attitudes about concussion safety. However, existing programming and research focus on older ages. MethodsQualitative interviews about concussions were conducted with twenty children between the ages of six and eight. Structural, descriptive and pattern coding were used to organize the transcribed interviews and identify emergent themes. ResultsEighteen of the participants indicated that they had heard of the word concussion, with 12 describing the injury as related to the brain or head. The most frequently described mechanisms of injury were impacts to the head or falls, and symptoms tended to be somatic, such as generalized pain. The most frequently endorsed strategy to avoid sustaining a concussion was to follow the rules.' Multiple participants referenced parents as an informal source of information about concussions. ConclusionsWhile most participants demonstrated some awareness about concussions, there were clear knowledge gaps that can be addressed with developmentally appropriate concussion education programming. Consistent with their developmental stage, interventions targeted at children in this age range may be most successful if they use basic logic, concrete ideas, provide rules to be followed and engage parents in dissemination.	[Kroshus, E.] Univ Washington, Dept Pediat, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98195 USA; [Gillard, D.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Haarbauer-Krupa, J.] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Goldman, R. E.] Brown Univ, Alpert Med Sch, Ctr Primary Care & Prevent, Dept Family Med, Pawtucket, RI USA; [Bickham, D. S.] Boston Childrens Hosp, Ctr Media & Child Hlth, Boston, MA USA		Kroshus, E (corresponding author), Univ Washington, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Dept Pediat,Harborview Injury Prevent & Res Ctr, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu		Goldman, Roberta/0000-0001-7801-0530	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1 TR001443] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001443] Funding Source: NIH RePORTER		Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Andrews R., 2011, INT J SPORTS ETHICS, V1, P31; Auerbach C., 2003, QUALITATIVE DATA INT; Bandura A., 1977, SOCIAL LEARNING THEO; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Cain K., 2008, CHILDRENS COMPREHENS; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cook S, 1999, BEHAV THER, V30, P5, DOI 10.1016/S0005-7894(99)80042-2; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DiFiori JP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093299; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Fenton LT, 2010, RES Q EXERCISE SPORT, V81, P212; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lamb ME, 2007, CHILD ABUSE NEGLECT, V31, P1201, DOI 10.1016/j.chiabu.2007.03.021; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lin A. C., 2015, SPORTS HLTH MULTIDIS; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mercy J., 2003, AM J HLTH ED, V34, pS6, DOI [10.1080/19325037.2003.10603586, DOI 10.1080/19325037.2003.10603586]; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Morrongiello BA, 2008, INJURY PREV, V14, P176, DOI 10.1136/ip.2007.016782; Morrongiello BA, 2005, J APPL DEV PSYCHOL, V26, P347, DOI 10.1016/j.appdev.2005.02.003; Morrongiello BA, 2004, J APPL DEV PSYCHOL, V25, P303, DOI 10.1016/j.appdev.2004.04.003; Morrongiello BA, 2014, J APPL DEV PSYCHOL, V35, P254, DOI 10.1016/j.appdev.2014.02.001; Myant KA, 2005, J HEALTH PSYCHOL, V10, P805, DOI 10.1177/1359105305057315; Namey E., 2008, HDB TEAM BASED QUALI, V2, P137; PERRIN EC, 1981, PEDIATRICS, V67, P841; PIAGET J, 1964, J RES SCI TEACH, V2, P176, DOI 10.1002/tea.3660020306; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Saldana J, 2015, CODING MANUAL QUALIT; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Tinsley B. J., 1995, HDB PARENTING, V4, P187; TINSLEY BJ, 1992, CHILD DEV, V63, P1043, DOI 10.2307/1131518; White SA, 2004, SCAND J MED SCI SPOR, V14, P57, DOI 10.1111/j.1600-0838.2003.00314.x; Yin H Shonna, 2009, Pediatrics, V124 Suppl 3, pS289, DOI 10.1542/peds.2009-1162E	47	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1862	1365-2214		CHILD CARE HLTH DEV	Child Care Health Dev.	SEP	2017	43	5					758	767		10.1111/cch.12433			10	Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics	FD1AC	WOS:000407268800014	28019016	Green Accepted			2022-02-06	
J	Kroshus, E; Chrisman, SPD; Rivara, FP				Kroshus, Emily; Chrisman, Sara P. D.; Rivara, Frederick P.			Parent Beliefs about Chronic Traumatic Encephalopathy: Implications for Ethical Communication by Healthcare Providers	JOURNAL OF LAW MEDICINE & ETHICS			English	Article							SPORTS-RELATED CONCUSSION	The objective of this study was to assess the beliefs of parents of youth soccer players about Chronic Traumatic Encephalopathy (CTE), concussion, and retirement from sport decisions and compare them to those of concussion-specialized clinicians. An electronic survey was completed by parents of youth club soccer players (n=247/1600, 15.4% response rate) and concussion-specialized clinicians (n=18/47, 38.3% response rate) located in a large U.S. urban center. Parents believed more strongly in the causal relationship between concussions and CTE, and between CTE and harm than did clinicians. Parents who themselves had participated in sport at a high level had more conservative beliefs than other parents about the number of concussions after which an athlete should retire from contact or collision sport. Results are discussed in the context of ethical risk communication between clinicians and parents. This includes the importance of communicating information about CTE to parents and youth athletes in an understandable way so that they can make informed choices about contact and collision sport participation. Further research is encouraged to evaluate approaches of communicating evidence about CTE to a diverse population of families of youth athletes.	[Kroshus, Emily; Chrisman, Sara P. D.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily; Chrisman, Sara P. D.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98105 USA; [Rivara, Frederick P.] Acad Affairs Univ Washington, Dept Pediat, Washington, DC USA; [Rivara, Frederick P.] Seattle Childrens Hosp Guild Assoc Endowed, Seattle, WA USA; [Rivara, Frederick P.] Pediat Hlth Outcomes Res, Seattle, WA USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Kroshus, E (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98105 USA.			Chrisman, Sara/0000-0001-5373-7223			Bailes Julian E, 2015, Neurosurgery, V62 Suppl 1, P15, DOI 10.1227/NEU.0000000000000811; Bandura A, 1986, SOCIAL FDN THOUGHT A; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dargis Manohla, NY TIMES; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Keirns CC, 2009, JAMA-J AM MED ASSOC, V302, P1805, DOI 10.1001/jama.2009.1550; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Love S, 2015, AM J SPORT MED, V43, P1260, DOI 10.1177/0363546514535187; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Murphy ST, 2013, J COMMUN, V63, P116, DOI 10.1111/jcom.12007; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961	18	5	5	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	SEP	2017	45	3					421	430		10.1177/1073110517737542			10	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	FK1DP	WOS:000413220700016					2022-02-06	
J	Ozcan, O; Eroglu, M; Boya, H; Kaya, Y				Ozcan, Ozal; Eroglu, Mehmet; Boya, Hakan; Kaya, Yilmaz			Proximal tibiofibular joint pain versus peroneal nerve dysfunction: clinical results of closed-wedge high tibial osteotomy performed with proximal tibiofibular joint disruption	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Closed-wedge high tibial osteotomy; Proximal tibiofibular joint; Pain; Tenderness; Peroneal nerve injury	LATERAL KNEE PAIN; OSTEOARTHRITIS; COMPLICATIONS; SLOPE	Closed-wedge high tibial osteotomy (CW-HTO) requires shortening of the fibula or the fibular head or disruption of the proximal tibiofibular joint (PTFJ). However, no study has evaluated the proximal tibiofibular joint after the osteotomy. The aim of this study was to investigate the fate of the PTFJ after CW-HTO applied with using PTFJ disruption method. This prospective study included 22 knees of 20 patients who underwent CW-HTO. The mean age of the patients was 50 +/- 4 years, and the mean follow-up period was 27.5 +/- 14.3 months (12-46 months). The grade of gonarthrosis (Ahlback's classification), tibiofemoral alignment and tibial slope angles were measured on radiographs pre- and post-operatively. During the surgery, the PTFJ capsule was released meticulously so as not to injure the peroneal nerve. Tenderness over the PTFJ was recorded preoperatively and at the last follow-up. No patient had tenderness or pain over PTFJ preoperatively. On the follow-up examinations, tenderness with compression was detected in nine knees with dorsiflexion, in ten with plantar flexion and in nine with neutral position of the ankle, respectively. None of the patients had peroneal nerve injury (including hypesthesia and mild weakness) post-operatively. However, while 11 knees were pain free in all positions of the ankle, seven knees had tenderness over PTFJ both in dorsiflexion and in plantar flexion. CW-HTO using PTFJ disruption provides good clinical results in terms of medial knee pain and corrects the alignment sufficiently while avoiding peroneal nerve injury. However, the results of this study indicated that this technique might result in painful PTFJs. Thus, the surgeon should consider a possibly painful PTFJ, which can be a cause of chronic lateral knee pain when performing this technique. III.	[Ozcan, Ozal; Eroglu, Mehmet] Afyon Kocatepe Univ, Sch Med, Dept Orthopaed & Traumatol, Afyon, Turkey; [Boya, Hakan] Baskent Univ, Zubeyde Hanim Practice & Res Ctr, Dept Orthopaed & Traumatol, Izmir, Turkey; [Kaya, Yilmaz] Usak State Hosp, Dept Orthopaed & Traumatol, Usak, Turkey		Eroglu, M (corresponding author), Afyon Kocatepe Univ, Sch Med, Dept Orthopaed & Traumatol, Afyon, Turkey.	meroglufb@gmail.com	Boya, Hakan/W-7391-2019	Boya, Hakan/0000-0001-6110-4004			Amendola A, 2010, INT ORTHOP, V34, P155, DOI 10.1007/s00264-009-0889-8; Atrey A, 2012, BONE JOINT RES, V1, P205, DOI 10.1302/2046-3758.19.2000084; Aydogdu S, 2000, KNEE SURG SPORT TR A, V8, P305, DOI 10.1007/s001670000138; Aydogdu S, 1996, Acta Orthop Belg, V62, P156; Bozkurt M, 2004, KNEE, V11, P307, DOI 10.1016/j.knee.2003.08.006; Bozkurt M, 2003, CLIN ORTHOP RELAT R, P136, DOI 10.1097/01.blo.0000030167.56585.2f; Dowd GSE, 2006, KNEE, V13, P87, DOI 10.1016/j.knee.2005.08.002; Ducat A, 2012, ORTHOP TRAUMATOL-SUR, V98, P68, DOI 10.1016/j.otsr.2011.08.013; Efe T, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-46; El-Azab H, 2010, AM J SPORT MED, V38, P323, DOI 10.1177/0363546509348050; Hohmann E, 2006, KNEE SURG SPORT TR A, V14, P454, DOI 10.1007/s00167-005-0700-3; Horst PK, 2010, KNEE SURG SPORT TR A, V18, P1452, DOI 10.1007/s00167-010-1049-9; Kurosaka H, 2000, INT ORTHOP, V24, P227, DOI 10.1007/s002640000151; OGDEN JA, 1974, CLIN ORTHOP RELAT R, P186; Ozel O, 2017, KNEE SURG SPORT TR A, V25, P314, DOI 10.1007/s00167-015-3571-2; Oztuna V, 2003, KNEE, V10, P347, DOI 10.1016/S0968-0160(03)00004-8; Ramanoudjame M, 2012, ORTHOP TRAUMATOL-SUR, V98, P863, DOI 10.1016/j.otsr.2012.09.010; SEMONIAN RH, 1995, J ORTHOP SPORT PHYS, V21, P248, DOI 10.2519/jospt.1995.21.5.248; Smith TO, 2011, KNEE, V18, P361, DOI 10.1016/j.knee.2010.10.001; Tunggal JAW, 2010, INT ORTHOP, V34, P255, DOI 10.1007/s00264-009-0819-9; van Egmond N, 2016, KNEE SURG SPORT TR A, V24, P34, DOI 10.1007/s00167-014-3303-z; WOOTTON JR, 1995, ANN ROY COLL SURG, V77, P31; Zeng C, 2016, KNEE SURG SPORT TR A, V24, P830, DOI 10.1007/s00167-014-3382-x	23	5	5	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	SEP	2017	25	9					2936	2941		10.1007/s00167-016-4066-5			6	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	FE7SM	WOS:000408407200038	26971107				2022-02-06	
J	Rush, GA; Rush, GA; Sbravati, N; Prabhu, R; Williams, LN; DuBien, JL; Horstemeyer, MF				Rush, G. Alston; Rush, Gus A., III; Sbravati, Nathanael; Prabhu, R.; Williams, Lakiesha N.; DuBien, Janice L.; Horstemeyer, M. F.			Comparison of shell-facemask responses in American football helmets during NOCSAE drop tests	SPORTS ENGINEERING			English	Article						Mild Traumatic Brain Injury; Head Injury Criterion; Gadd Severity Index; National Operating Committee on Standards for Athletic Equipment; Football helmet testing	HIGH-SCHOOL FOOTBALL; IMPACTS	This study compares drop tower tests of four commonly used football helmets, under the National Operating Committee on Standards for Athletic Equipment (NOCSAE) football helmet standard, to show that the tests need modification to include the facemask. In our study, the need for a more robust systematic approach to football helmet testing procedures is emphasized by comparing the Head Injury Criterion (HIC), the Gadd Severity Index (SI), and peak acceleration values for different helmets at different locations on the helmet under modified NOCSAE standard drop tower tests. Drop tests were performed on four modern football helmets at eight impact locations (front, front boss, side, rear, rear boss, top, front top, and front top boss), two different impact velocities (5.46 and 4.88 m/s), and two helmet configurations ("with facemasks" and "without facemasks"). Statistically significant differences (p < 0.05) were found in 41% of the comparisons between "with facemasks" and "without facemasks". Addition of the facemask resulted in an increased HIC, SI, and peak acceleration response measures in 62% of these cases. For example, the stiffening boundary conditions arising from the attached facemask can decrease the helmet performance by up to 50% depending on the impact location when considering the peak acceleration (p < 0.001) as a metric. In terms of location, the top and front top impacts gave the largest HIC, SI, and peak acceleration values. In summary, these comparative drop test results revealed that the current NOCSAE test methods need improvement by attaching the facemasks to helmets and by including two new helmet impact locations (front top and front top boss). The modified NOCSAE football helmet standard test gives a more accurate representation of a helmet's performance and its ability to mitigate on-field impact.	[Rush, G. Alston; Rush, Gus A., III] Rush Sports Med, POB 2147, Meridian, MS 39302 USA; [Rush, G. Alston; Sbravati, Nathanael; Prabhu, R.; Williams, Lakiesha N.] Mississippi State Univ, Agr & Biol Engn, Box 9632, Mississippi State, MS 39762 USA; [Rush, G. Alston; Horstemeyer, M. F.] Mississippi State Univ, Ctr Adv Vehicular Syst, Box 5405, Mississippi State, MS 39762 USA; [DuBien, Janice L.] Mississippi State Univ, Math & Stat, Box 9715, Mississippi State, MS 39762 USA		Rush, GA (corresponding author), Rush Sports Med, POB 2147, Meridian, MS 39302 USA.; Rush, GA (corresponding author), Mississippi State Univ, Agr & Biol Engn, Box 9632, Mississippi State, MS 39762 USA.	alstonrush@gmail.com; gusarush@gmail.com; Nate.sbravati@gmail.com; rprabhu@abe.msstate.edu; lwilliams@abe.msstate.edu; dubien@math.msstate.edu; mfhorst@cavs.msstate.edu	Prabhu, Raj/M-7188-2017	Prabhu, Raj/0000-0002-6073-4802	Center for Advanced Vehicular Systems (CAVS) at Mississippi State University; Rush Sports Medicine	The authors would like to thank the Center for Advanced Vehicular Systems (CAVS) at Mississippi State University for supporting this work. G. Alston Rush would also like to thank Rush Sports Medicine for their support.	Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beusenberg MC., 2000, P INT RES C BIOM IMP; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Gadd CW, 1966, SAE TECHNICAL PAPERS; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gurdjian E. S., 1963, P 7 STRAPP CAR CRASH; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hodgson V. R., 1970, SAE TECHNICAL PAPERS; Langlois JA, 2006, EPIDEMIOLOGY IMPACT; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Newman J A, 2000, Stapp Car Crash J, V44, P215; NOCSAE, 2012, ND04111M12 NOCSAE; NOCSAE, 2013, NOCSAE NEWS; NOCSAE, 2011, 00211M11A NOCSAE; NOCSAE, 2011, ND08711M11 NOCSAE; NOCSAE, 2013, NOCSAE STAND PROC; Patrick L. M., 1963, 7 STRAPP CAR CRASH C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prevention C. f. D. C. a., 2011, MORBIDITY MORTALITY, V60; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schutt, 2009, ION 4D FAC ATT INSTR; Schutt, 2009, SCHUTT HELM FITT INS; Versace J, 1971, SAE TECHNICAL PAPERS; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Xenith, 2011, X2 PLAYERS MANUAL	27	5	5	0	6	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	SEP	2017	20	3					199	211		10.1007/s12283-017-0233-2			13	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	FE1FY	WOS:000407965000003					2022-02-06	
J	Letsinger, J; Rommel, C; Hirschi, R; Nirula, R; Hawryluk, GWJ				Letsinger, Joshua; Rommel, Casey; Hirschi, Ryan; Nirula, Raminder; Hawryluk, Gregory W. J.			The aggressiveness of neurotrauma practitioners and the influence of the IMPACT prognostic calculator	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; EXTERNAL VALIDATION; OUTCOME PREDICTION; HEAD-INJURY; INTERNATIONAL MISSION; CLINICAL-TRIALS; MODELS; MODERATE; CRASH; MORTALITY	Published guidelines have helped to standardize the care of patients with traumatic brain injury; however, there remains substantial variation in the decision to pursue or withhold aggressive care. The International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) prognostic calculator offers the opportunity to study and decrease variability in physician aggressiveness. The authors wish to understand how IMPACT's prognostic calculations currently influence patient care and to better understand physician aggressiveness. The authors conducted an anonymous international, multidisciplinary survey of practitioners who provide care to patients with traumatic brain injury. Questions were designed to determine current use rates of the IMPACT prognostic calculator and thresholds of age and risk for death or poor outcome that might cause practitioners to consider withholding aggressive care. Correlations between physician aggressiveness, putative predictors of aggressiveness, and demographics were examined. One hundred fifty-four responses were received, half of which were from physicians who were familiar with the IMPACT calculator. The most frequent use of the calculator was to improve communication with patients and their families. On average, respondents indicated that in patients older than 76 years or those with a >85% chance of death or poor outcome it might be reasonable to pursue non-aggressive care. These thresholds were robust and were not influenced by provider or institutional characteristics. This study demonstrates the need to educate physicians about the IMPACT prognostic calculator. The consensus values for age and prognosis identified in our study may be explored in future studies aimed at reducing variability in physician aggressiveness and should not serve as a basis for withdrawing care.	[Letsinger, Joshua; Hawryluk, Gregory W. J.] Univ Utah, Dept Surg, Clin Neurosci Ctr, Salt Lake City, UT 84112 USA; [Rommel, Casey] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Hirschi, Ryan] Univ Utah, Sch Med, Salt Lake City, UT USA; [Nirula, Raminder] Univ Utah, Dept Surg, Salt Lake City, UT USA		Hawryluk, GWJ (corresponding author), Univ Utah, Dept Surg, Clin Neurosci Ctr, Salt Lake City, UT 84112 USA.	gregory.hawryluk@hsc.utah.edu	Rommel, Casey/N-9261-2019	Rommel, Casey/0000-0001-7757-9573; Hawryluk, Gregory/0000-0002-5604-7057	National Institutes of Health, United States National Library of Medicine [T15LM007124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T35HL007744] Funding Source: NIH RePORTER	CR is funded as a pre-doctoral trainee via the National Institutes of Health, United States National Library of Medicine, Grant Number T15LM007124. CR has received the University of Utah, Richard A. Fay and Carol M. Fay Endowed Graduate Fellowship for the Department of Biomedical Informatics in Honor of Homer R. Warner, M.D., Ph.D. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this work.	Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; Baltazar GA, 2015, AM SURGEON, V81, pE61; Bazzazi A, 2014, ULUS TRAVMA ACIL CER, V20, P236, DOI 10.5505/tjtes.2014.57089; Brandner S, 2015, J NEUROSURG ANESTH, V27, P26, DOI 10.1097/ANA.0000000000000083; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Butler E, 1923, Cal State J Med, V21, P295; Carney N, 2016, NEUROSURGERY; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gao L, 2015, FRONT BIOSCI-LANDMRK, V20, P763, DOI 10.2741/4335; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V128, P761, DOI 10.1016/B978-0-444-63521-1.00047-9; Iorio-Morin C, 2016, CLIN NEUROL NEUROSUR, V142, P48, DOI 10.1016/j.clineuro.2016.01.021; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kirschen MP, 2015, SEMIN PEDIATR NEUROL, V22, P187, DOI 10.1016/j.spen.2015.05.004; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Liedes H, 2016, STUD HEALTH TECHNOL, V224, P175, DOI 10.3233/978-1-61499-653-8-175; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu J, 2013, J NEUROTRAUM, V30, P1925, DOI 10.1089/neu.2013.2891; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Mikola A, 2015, IEEE ENG MED BIO, P1532, DOI 10.1109/EMBC.2015.7318663; Moore NA, 2013, BRIT J NEUROSURG, V27, P340, DOI 10.3109/02688697.2012.754402; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Pourahmad S, 2016, METHOD INFORM MED, V55, P440, DOI 10.3414/ME15-01-0080; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Ramesh VG, 2013, J NEUROSURG, V119, P1351, DOI 10.3171/2013.4.JNS13875; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762	59	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183552	10.1371/journal.pone.0183552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	WOS:000408355800063	28832674	Green Published, gold, Green Submitted			2022-02-06	
J	Por, ED; Sandoval, ML; Thomas-Benson, C; Burke, TA; Brackley, AD; Jeske, NA; Cleland, JM; Lund, BJ				Por, Elaine D.; Sandoval, Melody L.; Thomas-Benson, Chiquita; Burke, Teresa A.; Brackley, Allison Doyle; Jeske, Nathaniel A.; Cleland, Jeffery M.; Lund, Brian J.			Repeat low-level blast exposure increases transient receptor potential vanilloid 1 (TRPV1) and endothelin-1 (ET-1) expression in the trigeminal ganglion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PRIMARY AFFERENT NEURONS; INDUCED OCULAR TRAUMA; GENE-RELATED PEPTIDE; PAIN-LIKE BEHAVIOR; THERMAL HYPERALGESIA; PROSTATE-CANCER; PROTEIN-KINASE; A-RECEPTOR; CA2+-DEPENDENT DESENSITIZATION	Blast-associated sensory and cognitive trauma sustained by military service members is an area of extensively studied research. Recent studies in our laboratory have revealed that low-level blast exposure increased expression of transient receptor potential vanilloid 1 (TRPV1) and endothelin-1 (ET-1), proteins well characterized for their role in mediating pain transmission, in the cornea. Determining the functional consequences of these alterations in protein expression is critical to understanding blast-related sensory trauma. Thus, the purpose of this study was to examine TRPV1 and ET-1 expression in ocular associated sensory tissues following primary and tertiary blast. A rodent model of blast injury was used in which anesthetized animals, unrestrained or restrained, received a single or repeat blast (73.8 +/- 5.5 kPa) from a compressed air shock tube once or daily for five consecutive days, respectively. Behavioral and functional analyses were conducted to assess blast effects on nocifensive behavior and TRPV1 activity. Immunohistochemistry and Western Blot were also performed with trigeminal ganglia (TG) to determine TRPV1, ET-1 and glial fibrillary associated protein (GFAP) expression following blast. Increased TRPV1, ET-1 and GFAP were detected in the TG of animals exposed to repeat blast. Increased nocifensive responses were also observed in animals exposed to repeat, tertiary blast as compared to single blast and control. Moreover, decreased TRPV1 desensitization was observed in TG neurons exposed to repeat blast. Repeat, tertiary blast resulted in increased TRPV1, ET-1 and GFAP expression in the TG, enhanced nociception and decreased TRPV1 desensitization.	[Por, Elaine D.; Sandoval, Melody L.; Thomas-Benson, Chiquita; Burke, Teresa A.; Cleland, Jeffery M.; Lund, Brian J.] US Army Inst Surg Res, Ocular Trauma, Houston, TX 78234 USA; [Brackley, Allison Doyle; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA		Por, ED (corresponding author), US Army Inst Surg Res, Ocular Trauma, Houston, TX 78234 USA.	elaine.d.por.mil@mail.mil		Brackley, Allison/0000-0002-9552-3159; Por, Elaine/0000-0001-8025-5713	U.S. Army Military Operational Medicine Research Program (MOMRP); Clinical Rehabilitative Medicine Research Program (CRMRP); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [F31DE025551] Funding Source: NIH RePORTER	This work was supported by U.S. Army Military Operational Medicine Research Program (MOMRP) and Clinical Rehabilitative Medicine Research Program (CRMRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the U.S. Army Military Operational Medicine Research Program (MOMRP) and the Clinical Rehabilitative Medicine Research Program (CRMRP). We would like to thank Josianne Babineaux and Shenouda Zarif for expert technical assistance and Andre Akers and Peter Edsall for assistance with illustrations, ocular imaging and operation of the USAISR shock tube.	Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bates BD, 2010, PAIN, V149, P522, DOI 10.1016/j.pain.2010.03.024; Cady RJ, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-94; Capo-Aponte JE, 2015, J REHABIL RES DEV, V52, P273, DOI 10.1682/JRRD.2014.09.0204; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Chichorro JG, 2009, NEUROPEPTIDES, V43, P133, DOI 10.1016/j.npep.2008.12.001; Chichorro JG, 2010, BRAIN RES, V1345, P73, DOI 10.1016/j.brainres.2010.04.075; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Cornelison LE, 2016, NEUROSCIENCE, V339, P491, DOI 10.1016/j.neuroscience.2016.10.013; Czikora A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078184; DAHLOF B, 1990, J HYPERTENS, V8, P811, DOI 10.1097/00004872-199009000-00004; Davar G, 1998, NEUROREPORT, V9, P2279, DOI 10.1097/00001756-199807130-00025; Del Fiacco M, 2015, J NEUROL NEUROSUR PS, V86, P393, DOI 10.1136/jnnp-2014-308813; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Farazifard R, 2005, BRAIN RES PROTOC, V16, P44, DOI 10.1016/j.brainresprot.2005.10.003; FERREIRA SH, 1989, J CARDIOVASC PHARM, V13, pS220, DOI 10.1097/00005344-198900135-00065; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Gokin AP, 2001, J NEUROSCI, V21, P5358, DOI 10.1523/JNEUROSCI.21-14-05358.2001; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kawamata T, 2008, NEUROSCIENCE, V154, P1067, DOI 10.1016/j.neuroscience.2008.04.010; Kawamata T, 2009, NEUROREPORT, V20, P233, DOI 10.1097/WNR.0b013e32831befa5; Knotkova H, 2008, CLIN J PAIN, V24, P142, DOI 10.1097/AJP.0b013e318158ed9e; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kopetz ES, 2002, INVEST NEW DRUG, V20, P173, DOI 10.1023/A:1015630513908; Lassiter LK, 2003, SEMIN ONCOL, V30, P678, DOI 10.1016/S0093-7754(03)00353-1; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Menendez L, 2003, N-S ARCH PHARMACOL, V367, P28, DOI 10.1007/s00210-002-0655-6; Mergler S, 2014, OPHTHALMIC RES, V52, P151, DOI 10.1159/000365334; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Motta EM, 2009, NEUROSCI LETT, V457, P146, DOI 10.1016/j.neulet.2009.03.055; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Nelson JB, 2003, J UROLOGY, V170, pS65, DOI 10.1097/01.ju.0000096372.07687.86; Okamoto K, 2009, NEUROSCIENCE, V160, P858, DOI 10.1016/j.neuroscience.2009.03.003; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; Plant TD, 2006, EXP BIOL MED, V231, P1161; Por ED, 2016, CURR EYE RES, V41, P1294, DOI 10.3109/02713683.2015.1122812; Raffa RB, 1996, J PHARMACOL EXP THER, V278, P1; Rigoni M, 2003, BRIT J PHARMACOL, V138, P977, DOI 10.1038/sj.bjp.0705110; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schicho R, 2005, BRAIN RES, V1039, P108, DOI 10.1016/j.brainres.2005.01.050; Schlereth T, 2016, NEUROPEPTIDES, V59, P57, DOI 10.1016/j.npep.2016.06.001; Schmidt BL, 2007, EUR J PAIN, V11, P406, DOI 10.1016/j.ejpain.2006.05.007; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Silberstein SD, 2015, J NEUROL NEUROSUR PS, V86, P361, DOI 10.1136/jnnp-2014-309295; St Onge Paul, 2011, US Army Med Dep J, P97; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Stratton KJ, 2014, J PAIN, V15, P1023, DOI 10.1016/j.jpain.2014.07.002; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Tang HB, 2004, EUR J PHARMACOL, V498, P37, DOI 10.1016/j.ejphar.2004.07.076; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Yamamoto H, 2006, NEUROSCIENCE, V137, P949, DOI 10.1016/j.neuroscience.2005.09.036; Yamamoto T, 2013, J DENT RES, V92, P335, DOI 10.1177/0022034513478428; Yang YX, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.340.5470; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	68	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182102	10.1371/journal.pone.0182102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	WOS:000407396200030	28797041	Green Published, gold, Green Submitted			2022-02-06	
J	Hehar, H; Ma, I; Mychasiuk, R				Hehar, Harleen; Ma, Irene; Mychasiuk, Richelle			Intergenerational Transmission of Paternal Epigenetic Marks: Mechanisms Influencing Susceptibility to Post-Concussion Symptomology in a Rodent Model	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-FAT DIET; TELOMERE LENGTH; GENE-EXPRESSION; ALZHEIMERS-DISEASE; STRESS EXPOSURE; PRENATAL STRESS; AGE; OBESITY; OXYTOCIN	Epigenetic transmission of phenotypic variance has been linked to paternal experiences prior to conception and during perinatal development. Previous reports indicate that paternal experiences increase phenotypic heterogeneity and may contribute to offspring susceptibility to post-concussive symptomology. This study sought to determine if epigenetic tags, specifically DNA methylation of promoter regions, are transmitted from rodent fathers to their sons. Using MethyLight, promoter methylation of specific genes involved in recovery from concussion and brain plasticity were analyzed in sperm and brain tissue. Promoter methylation in sperm differed based on paternal experience. Differences in methylation were often identified in both the sperm and brain tissue obtained from their sons, demonstrating transmission of epigenetic tags. For certain genes, methylation in the sperm was altered following a concussion suggesting that a history of brain injury may influence paternal transmission of traits. As telomere length is paternally inherited and linked to neurological health, this study examined paternally derived differences in telomere length, in both sperm and brain. Telomere length was consistent between fathers and their sons, and between brain and sperm, with the exception of the older fathers. Older fathers exhibited increased sperm telomere length, which was not evident in sperm or brain of their sons.	[Hehar, Harleen; Ma, Irene; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada		Mychasiuk, R (corresponding author), Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.	rmmychas@ucalgary.ca			Alberta Children's Hospital Research Institute; Integrated Concussion Research Project	The authors would like to thank the Alberta Children's Hospital Research Institute and the Integrated Concussion Research Project for their financial support.	Abel EL, 2004, ADDICT BIOL, V9, P127, DOI 10.1080/13556210410001716980; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Bales K., 2011, FRONTIERS PSYCHIAT, V2; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Binder NK, 2015, REPRODUCTION, V149, P435, DOI 10.1530/REP-14-0676; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2004, CARCINOGENESIS, V25, P1083, DOI 10.1093/carcin/bgh185; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Casas E, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00330; Cassidy A., 2010, AM J CLIN NUTR; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P1; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cohen P, 2004, J NUTR, V134, p2455S, DOI 10.1093/jn/134.9.2455S; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Crean A., 2014, TRENDS ECOL EVOL, V29, P1; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Derauf C, 2009, SEMIN CELL DEV BIOL, V20, P441, DOI 10.1016/j.semcdb.2009.03.001; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Entringer S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003580; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson-Smith AC, 2011, CELL METAB, V13, P115, DOI 10.1016/j.cmet.2011.01.011; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Glover V, 2012, PHYSIOL BEHAV, V106, P736, DOI 10.1016/j.physbeh.2012.02.011; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Harris RBS, 2000, ANNU REV NUTR, V20, P45, DOI 10.1146/annurev.nutr.20.1.45; Hehar H., 2015, NONGENET INHERITANCE, V2, P23; Hehar H, 2016, NEUROSCIENCE, V332, P61, DOI 10.1016/j.neuroscience.2016.06.039; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kent L, 2005, MOL PSYCHIATR, V10, P939, DOI 10.1038/sj.mp.4001696; Kimura M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040037; LAUREYS G, 1988, GENOMICS, V3, P224, DOI 10.1016/0888-7543(88)90083-3; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Lundstrom S, 2010, J CHILD PSYCHOL PSYC, V51, P850, DOI 10.1111/j.1469-7610.2010.02223.x; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Mattson MP, 2000, EXP GERONTOL, V35, P489, DOI 10.1016/S0531-5565(00)00115-7; MCKELVIE PA, 1992, J NEUROPATH EXP NEUR, V51, P464, DOI 10.1097/00005072-199207000-00009; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Muhammad A, 2012, SYNAPSE, V66, P950, DOI 10.1002/syn.21589; Mychasiuk R, 2011, NEUROSCIENCE, V180, P105, DOI 10.1016/j.neuroscience.2011.02.026; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; O'Malley D, 2007, MOL CELL NEUROSCI, V35, P559, DOI 10.1016/j.mcn.2007.05.001; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Paul L, 2011, J NUTR BIOCHEM, V22, P895, DOI 10.1016/j.jnutbio.2010.12.001; Perkeybile AM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00191; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Rodgers AB, 2015, P NATL ACAD SCI USA, V112, P13699, DOI 10.1073/pnas.1508347112; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Van den Hove DLA, 2013, EUR NEUROPSYCHOPHARM, V23, P1226, DOI 10.1016/j.euroneuro.2012.09.011; Vera E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053760; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	89	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 2	2017	7								7171	10.1038/s41598-017-07784-7			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4NO	WOS:000406816700001	28769086	Green Published, gold			2022-02-06	
J	Anto-Ocrah, M; Jones, CMC; Diacovo, D; Bazarian, JJ				Anto-Ocrah, Martina; Jones, Courtney Marie Cora; Diacovo, Danielle; Bazarian, Jeffrey J.			Blood-Based Biomarkers for the Identification of Sports-Related Concussion	NEUROLOGIC CLINICS			English	Article						Sports-related concussion; Traumatic brain injury; Concussion; Biomarkers	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; ICE HOCKEY PLAYERS; HIGH-SCHOOL; BARRIER PERMEABILITY; SERUM CONCENTRATIONS; BIOCHEMICAL MARKERS; CEREBROSPINAL-FLUID; S-100B PROTEIN; SOCCER PLAYERS	Sports-related concussions (SRCs) are common among athletes in the United States. Most athletes who sustain an SRC recover within 7 to 10 days; however, many athletes who sustain the injury do not recover as expected and experience prolonged, persistent symptoms. In this document, the authors provide an overview of the empirical evidence related to the use of blood-based brain biomarkers in the athlete population for diagnosis of SRCs, prognosis of recovery and return to play guidelines, and indications of neurodegeneration. The authors also provide a summary of research challenges, gaps in the literature, and future directions for research.	[Anto-Ocrah, Martina; Jones, Courtney Marie Cora; Diacovo, Danielle; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA; [Anto-Ocrah, Martina; Jones, Courtney Marie Cora; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Neurol, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Neurosurg, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Phys Med & Rehabil, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA		Anto-Ocrah, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Emergency Med, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA.	Martina_Anto-Ocrah@URMC.Rochester.edu		Anto-Ocrah, Martina/0000-0002-0368-2575			Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Belson K, 2016, NY TIMES; Bouvier D, 2016, SPORTS MED; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dietrich MO, 2003, CAN J APPL PHYSIOL, V28, P710, DOI 10.1139/h03-054; Ding QX, 2006, EUR J NEUROSCI, V24, P1265, DOI 10.1111/j.1460-9568.2006.05026.x; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Michetti F, 2011, CLIN BIOCHEM, V44, P245, DOI 10.1016/j.clinbiochem.2010.10.007; Mussack T, 2003, EUR J MED RES, V8, P457; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Nierwinska K, 2008, J HUM KINET, V19, P83, DOI 10.2478/v10078-008-0006-x; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Saur L, 2014, BRAIN STRUCT FUNCT, V219, P293, DOI 10.1007/s00429-012-0500-8; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schulte S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0050-x; Schulte S, 2013, EUR J APPL PHYSIOL, V113, P811, DOI 10.1007/s00421-012-2503-9; Shahim P, 2016, J NEUROTRAUMA; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; SHARMA HS, 1991, NEUROSCI RES, V10, P211; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Spiropoulos A, 2010, CLIN CHEM LAB MED, V48, P199, DOI 10.1515/CCLM.2010.034; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; TBI D.C.o.E.f.P.H, 2010, PORT FIELD BAS DEV E; Watson P, 2005, AM J PHYSIOL-REG I, V288, pR1689, DOI 10.1152/ajpregu.00676.2004; Watson P, 2006, MED SCI SPORT EXER, V38, P2118, DOI 10.1249/01.mss.0000235356.31932.0a; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; [No title captured]	69	5	5	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					473	+		10.1016/j.ncl.2017.03.008			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OI	WOS:000406819500007	28673410				2022-02-06	
J	Beidler, E; Donnellan, MB; Covassin, T; Phelps, AL; Kontos, AP				Beidler, Erica; Donnellan, M. Brent; Covassin, Tracey; Phelps, Amy L.; Kontos, Anthony P.			The Association Between Personality Traits and Sport-Related Concussion History in Collegiate Student-Athletes	SPORT EXERCISE AND PERFORMANCE PSYCHOLOGY			English	Article						sport-related concussion; personality traits; Big Five Inventory	EPIDEMIOLOGY; BEHAVIORS; SYMPTOMS	Cross-sectional survey data were used to test whether personality traits were associated with a self-reported history of diagnosed sport-related concussions (SRC) and undiagnosed SRCs. A total of 1,398 of 2,055 (68%) collegiate student-athletes from four National Collegiate Athletic Association (NCAA) institutions voluntarily completed a one-time survey during their preparticipation physical examinations or a team meeting. Previously diagnosed SRCs and undiagnosed SRCs were measured with self-reports. The personality traits of neuroticism, extraversion, openness, agreeableness, and conscientiousness were captured via the 44-item Big Five Inventory. After exclusions, responses from 1,246 collegiate student-athletes (n = 702 males; n = 544 females; n = 727 SRC high-risk sport participants; and n = 518 SRC low-risk sport participants) were included for the final analyses. SRC history responses were grouped into 0, 1, and 2+ for diagnosed and undiagnosed. Nominal logistic regression models that included personality traits, demographics, and sport information were used for the primary analyses. No personality traits were found to be significantly related to 0, 1, or 2+ diagnosed SRCs. Agreeableness (p <= .01) was the only personality trait that was significantly associated with self-reporting 2+ undiagnosed SRCs compared with 0. One possible explanation is that broad personality traits may not be important risk factors for SRCs. Future studies should investigate specific individual differences that could be related to SRCs, such as risk-taking propensities and thrill-seeking tendencies. Likewise, future studies should use prospective designs to provide some constraints on inferences about the direction of the associations.	[Beidler, Erica] Duquesne Univ, Dept Athlet Training, 600 Forbes Ave,118 Hlth Sci Bldg, Pittsburgh, PA 15282 USA; [Donnellan, M. Brent] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Phelps, Amy L.] Duquesne Univ, Econ & Stat Div, Pittsburgh, PA 15282 USA; [Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Concuss Program, Pittsburgh, PA 15260 USA		Beidler, E (corresponding author), Duquesne Univ, Dept Athlet Training, 600 Forbes Ave,118 Hlth Sci Bldg, Pittsburgh, PA 15282 USA.	johnsone1@duq.edu		Kontos, Anthony/0000-0002-3749-4310	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]	This research was supported in part by a grant to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to Anthony P. Kontos.	Allen MS, 2013, INT REV SPORT EXER P, V6, P184, DOI 10.1080/1750984X.2013.769614; Caspi A, 1997, J PERS SOC PSYCHOL, V73, P1052, DOI 10.1037/0022-3514.73.5.1052; Egan S, 2003, PERS INDIV DIFFER, V34, P1491, DOI 10.1016/S0191-8869(02)00130-7; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gleason KA, 2004, AGGRESSIVE BEHAV, V30, P43, DOI 10.1002/ab.20002; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; John OP., 1999, HDB PERSONALITY THEO, P102; John P., 2008, HDB PERSONALITY THEO, V3, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McAdams DP, 2006, AM PSYCHOL, V61, P204, DOI 10.1037/0003-066X.61.3.204; MCCRAE RR, 1994, EUR J PERSONALITY, V8, P251, DOI 10.1002/per.2410080404; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Merritt VC, 2015, DEV NEUROPSYCHOL, V40, P45, DOI 10.1080/87565641.2014.979928; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rush BK, 2004, REHABIL PSYCHOL, V49, P275, DOI 10.1037/0090-5550.49.4.275; SHER KJ, 1999, PSYCHOL THEORIES DRI, P00054; Tok S, 2011, SOC BEHAV PERSONAL, V39, P1105, DOI 10.2224/sbp.2011.39.8.1105; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	23	5	5	1	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	2157-3905	2157-3913		SPORT EXERC PERFORM	Sport Exerc. Perform. Psychol.	AUG	2017	6	3					252	261		10.1037/spy0000107			10	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	FD8RW	WOS:000407792800005		Bronze			2022-02-06	
J	Hua, Y; Wang, YG; Gu, LX				Hua, Yi; Wang, Yugang; Gu, Linxia			Primary blast waves induced brain dynamics influenced by head orientations	BIOMEDICAL ENGINEERING LETTERS			English	Article						Blast wave; Head orientation; Traumatic brain injury; Finite element modeling; Stress transfer	FINITE-ELEMENT; INJURY; IMPACT; STRAIN	There is controversy regarding the directional dependence of head responses subjected to blast loading. The goal of this work is to characterize the role of head orientation in the mechanics of blast wave-head interactions as well as the load transmitting to the brain. A three-dimensional human head model with anatomical details was reconstructed from computed tomography images. Three different head orientations with respect to the oncoming blast wave, i.e., front-on with head facing blast, back-on with head facing away from blast, and side-on with right side exposed to blast, were considered. The reflected pressure at the blast wave-head interface positively correlated with the skull curvature. It is evidenced by the maximum reflected pressure occurring at the eye socket with the largest curvature on the skull. The reflected pressure pattern along with the local skull areas could further influence the intracranial pressure distributions within the brain. We did find out that the maximum coup pressure of 1.031 MPa in the side-on case as well as the maximum contrecoup pressure of -0.124 MPa in the back-on case. Moreover, the maximum principal strain (MPS) was also monitored due to its indication to diffuse brain injury. It was observed that the peak MPS located in the frontal cortex region regardless of the head orientation. However, the local peak MPS within each individual function region of the brain depended on the head orientation. The detailed interactions between blast wave and head orientations provided insights for evaluating the brain dynamics, as well as biomechanical factors leading to traumatic brain injury.	[Hua, Yi; Gu, Linxia] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Wang, Yugang] China JiLiang Univ, Hangzhou 310018, Zhejiang, Peoples R China; [Gu, Linxia] Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA		Gu, LX (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.; Gu, LX (corresponding author), Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.	lgu2@unl.edu	gu, linxia/A-5645-2013; Lang, Steven/AAE-8102-2021	gu, linxia/0000-0003-2637-0299; Lang, Steven/0000-0003-1669-9146			Akula P, 2015, BIOMED ENG LETT, V5, P281, DOI 10.1007/s13534-015-0204-0; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Gennarelli TA, SAE TECHNICAL PAPER; Hodgson VR, SAE TECHNICAL PAPER; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Hua Y, 2014, COMPOS PART B-ENG, V56, P456, DOI 10.1016/j.compositesb.2013.08.070; Kleinschmit NN, 2011, THESIS; KUIJPERS AHWM, 1995, J NEUROTRAUM, V12, P715, DOI 10.1089/neu.1995.12.715; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Mao HJ, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031765; Mao HJ, 2011, J NEUROTRAUM, V28, P2263, DOI 10.1089/neu.2010.1600; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	22	5	5	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2093-9868	2093-985X		BIOMED ENG LETT	Biomed. Eng. Lett.	AUG	2017	7	3			SI		253	259		10.1007/s13534-017-0027-2			7	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	GV8WZ	WOS:000446432700010	30603173	Green Published			2022-02-06	
J	Kelly, K; Erdal, K				Kelly, Kiersten; Erdal, Kristi			Diagnostic terminology, athlete status, and history of concussion affect return to play expectations and anticipated symptoms following mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Concussion; Diagnostic terminology; Injury expectations; Mild traumatic brain injury; Return to play	HEAD-INJURY; POSTCONCUSSION SYNDROME; COGNITIVE PERFORMANCE; ILLNESS PERCEPTIONS; THREAT; SPORT; RECOMMENDATIONS; ASSOCIATION; MANAGEMENT; SEQUELAE	Mild traumatic brain injury (mTBI) and concussion are terms often used interchangeably. However, mTBI is frequently seen as representing a broader injury that encompasses the construct of concussion, which often conveys transience or decreased severity. The present study examined the influence of varying diagnostic terminology on acute injury expectations in an undergraduate population (N=105). Participants were presented with an mTBI vignette and were randomly assigned to one of two conditions in which the term mTBI or concussion was used to describe the injury. There were no significant differences between the two conditions on anxiety, symptomatology, timeline, or consequence scales. However, participants in the mTBI group allocated more days to return to play than participants in the concussion group, suggesting that terminology has an effect on perceptions of the severity of the injury. Varsity athletes allocated fewer days to return to play than nonathletes. Individuals with a history of concussion, both athletes and nonathletes, indicated fewer days to return to play, but greater symptomatology than individuals with no history of concussion. Clinicians should consider the influence of diagnostic terminology, athletic background, and history of concussion on perceptions of the severity of an injury because expectations can influence injury outcomes and compliance in a recovery process.	[Kelly, Kiersten; Erdal, Kristi] Colorado Coll, Dept Psychol, 14 E Cache La Poudre St, Colorado Springs, CO 80903 USA		Erdal, K (corresponding author), Colorado Coll, Dept Psychol, 14 E Cache La Poudre St, Colorado Springs, CO 80903 USA.	kerdal@coloradocollege.edu			Cornelia Sabine Endowed Fund for Psychology at Colorado College	This project was supported by the Cornelia Sabine Endowed Fund for Psychology at Colorado College.	Bachmann LM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-50; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2016, MAN RET ACT INF HLTH; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Edmed SL, 2015, BRAIN INJURY, V29, P623, DOI 10.3109/02699052.2014.998709; Edmed SL, 2014, J CLIN EXP NEUROPSYC, V36, P221, DOI 10.1080/13803395.2013.877124; Evans SC, 2015, INT J CLIN HLTH PSYC, V15, P160, DOI 10.1016/j.ijchp.2014.12.001; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; IBM, 2011, STAT PACK SOC SCI WI; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kempe CB, 2013, CLIN NEUROPSYCHOL, V27, P762, DOI 10.1080/13854046.2013.795245; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; National Collegiate Athletic Association, 2013, 2013 2014 NCAA SPORT; Raugust J, 2013, PM&R, V5, pS129, DOI DOI 10.1016/j.pmrj.2013.08.003; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan KA, 2014, J HEAD TRAUMA REHAB, V29, P54, DOI 10.1097/HTR.0b013e31828c708a; Sullivan KA, 2013, BRAIN INJURY, V27, P19, DOI 10.3109/02699052.2012.698360; Trontel HG, 2013, J CLIN EXP NEUROPSYC, V35, P960, DOI 10.1080/13803395.2013.844770; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1992, ICD 10 CLASSIFICATIO	36	5	5	0	28	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	2017	39	6					587	595		10.1080/13803395.2016.1250870			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ES7QM	WOS:000399745400007	27841084				2022-02-06	
J	McCrea, MA; Asken, B; Nelson, LD				McCrea, Michael A.; Asken, Breton; Nelson, Lindsay D.			Neuropsychological Screening of Sport-Related Concussion	NEUROLOGIC CLINICS			English	Article						Concussion; Mild traumatic brain injury; Neuropsychological testing; Sports injuries	TRAUMATIC BRAIN-INJURY; POSITION STATEMENT CONCUSSION; 4TH INTERNATIONAL-CONFERENCE; AMERICAN MEDICAL SOCIETY; HIGH-SCHOOL; NORMATIVE DATA; COGNITIVE ASSESSMENT; CONSENSUS STATEMENT; FOOTBALL PLAYERS; TEST-PERFORMANCE	Neuropsychological assessment is a key component of the multidimensional approach recommended by international consensus guidelines for evaluation of athletes affected by sport-related concussion (SRC). Over the past 2 decades, a number of conventional and computerized neuropsychological test batteries have been developed for the assessment of SRC. Standardized neurocognitive assessment tools are now commonly used across the continuum of concussion care, ranging from the sports sideline to critical care setting and the outpatient concussion clinic. We provide a brief, high-level overview of current approaches to best practice in neuropsychological assessment of SRC.	[McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Asken, Breton] Univ Florida, Dept Clin & Hlth Psychol, 1225 Ctr Dr,Room 3151, Gainesville, FL 32611 USA		McCrea, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mmccrea@mcw.edu		Asken, Breton/0000-0001-8419-142X			Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Barth Jeffrey T, 2010, HDB SPORT NEUROPSYCH, P75; Barth JT, 2003, ARCH CLIN NEUROPSYCH, V18, P551, DOI 10.1016/S0887-6177(02)00146-4; Barth JT, 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Echemendia RJ, 2011, CLIN NEUROPSYCHOL, V25, P1289, DOI 10.1080/13854046.2011.618466; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Putukian M, 2003, CLIN SPORT MED, V22, P617, DOI 10.1016/S0278-5919(02)00100-X; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; SMITH AM, 1990, SPORTS MED, V9, P352, DOI 10.2165/00007256-199009060-00004; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Webbe FM, 2015, BRAIN INJURY, V29, P129, DOI 10.3109/02699052.2014.937746	61	5	5	1	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					487	+		10.1016/j.ncl.2017.03.005			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FC4OI	WOS:000406819500008	28673411				2022-02-06	
J	Podell, K; Presley, C; Derman, H				Podell, Kenneth; Presley, Chase; Derman, Howard			Sideline Sports Concussion Assessment	NEUROLOGIC CLINICS			English	Article						Concussion; Sideline assessment; SCAT; Assessment	SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTERNATIONAL-CONFERENCE; STANDARDIZED ASSESSMENT; CONSENSUS STATEMENT; POSITION STATEMENT; ASSESSMENT-TOOL; SYMPTOMS; COLLEGIATE	The sideline assessment of concussions is a complex multisystem assessment to detect whether an athlete shows signs or symptoms of concussion and should be removed from practice or competition to prevent greater neurologic compromise. Sideline concussion assessments are challenging given some of the environmental conditions, substitution rules of some sports, the possibility of athletes underreporting symptoms, and the difficulties of defining a concussion. The SCAT is the standard of care and is augmented with other procedures to enhance sensitivity and specificity. Serial assessments acutely are important to detect any evolving neurologic emergencies. This article provides a detailed review of the procedures in performing a sideline concussion assessment.	[Podell, Kenneth; Derman, Howard] Houston Methodist Hosp, Houston Methodist Concuss Ctr, Weill Cornell Med Coll, Dept Neurol, 6560 Fannin St,Suite 1840, Houston, TX 77030 USA; [Presley, Chase] Houston Methodist Hosp, Houston Methodist Concuss Ctr, Dept Neurol, 6560 Fannin St,Suite 1840, Houston, TX 77030 USA		Podell, K (corresponding author), Houston Methodist Hosp, Houston Methodist Concuss Ctr, Weill Cornell Med Coll, Dept Neurol, 6560 Fannin St,Suite 1840, Houston, TX 77030 USA.	kpodell@houstonmethodist.org					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Anderson S, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0575-7; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Galetta K. M., 2015, CONCUSSION, V1, pCNC8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hsu AC, 2012, MED SCI SPORT EXER, V44, P178, DOI 10.1249/MSS.0b013e318275044f; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Kutcher JS, 2011, NEUROLOGY, V76, P1450, DOI 10.1212/WNL.0b013e31821a4527; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; Mayo Clinic, 2016, KING DEV TEST ASS MA; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nelson LD, 2016, CLIN J SPORT MED; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Swartz EE, 2009, PHYSICIAN SPORTSMED, V37, P20, DOI 10.3810/psm.2009.12.1738; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Vrentas J, 2014, NFLS EYE SKY SEES EV; Whyno S, 2016, DALY NHL ADDING MORE; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	68	5	5	1	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					435	+		10.1016/j.ncl.2017.03.003			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FC4OI	WOS:000406819500005	28673408				2022-02-06	
J	Shen, J; Chen, B; Zheng, GR; Qiu, SZ; Yin, HM; Mao, W; Wang, HX; Gao, JB				Shen, Jia; Chen, Bin; Zheng, Guan-Rong; Qiu, Shen-Zhong; Yin, Huai-Ming; Mao, Wei; Wang, Hong-Xiang; Gao, Jian-Bo			Detection of high serum concentration of CXC chemokine ligand-12 in acute intracerebral hemorrhage	CLINICA CHIMICA ACTA			English	Article						Intracerebral hemorrhage; CXC chemokine ligand-12; Mortality; Severity; Functional outcome; Prognosis	TRAUMATIC BRAIN-INJURY; SDF-1 EXPRESSION; OUTCOMES; LEVEL; RECEPTORS; MORTALITY; CARCINOMA; CALCIUM; HEALTH; GROWTH	Background: CXC chemokine ligand-12 (CXCL12), a member of the CXC chemokine subfamily, is involved in both focal angiogenesis and inflammatory reactions. We examined serum CXCL12 concentration in intracerebral hemorrhage (ICH) patients and its correlation to stroke severity and outcome. Methods: The study was carried out on 105 ICH patients on 105 healthy controls. Serum samples were at admission obtained to measure CXCL12 concentrations. The National Institutes of Health Stroke Scale (NIHSS) and hematoma volume were recorded to assess stroke severity. Results: As compared to the controls, CXCL12 concentrations were significantly increased in the patients. Also, non-survivors within 6 months and patients with an unfavorable outcome (modified Rankin Scale score > 2) at 6 months had higher CXCL12 concentrations than other remaining ones. CXCL12 concentrations had positive correlation with NIHSS scores and hematoma volume. Serum CXCL12 significantly discriminated patients at risk of 6-month mortality and 6-month unfavorable outcome under receiver operating characteristic curve. Moreover, serum CXCL12 was independently associated with the mortality, overall survival and unfavorable outcome. Conclusions: Serum CXCL12 concentrations are enhanced after ICH and CXCL12 in serum has the potential to reflect severity and prognosis following hemorrhagic stroke.	[Shen, Jia; Chen, Bin; Zheng, Guan-Rong; Qiu, Shen-Zhong; Yin, Huai-Ming; Mao, Wei] First Peoples Hosp Fuyang Dist Hangzhou, Dept Neurosurg, 429 Beihuan Rd, Hangzhou 311400, Zhejiang, Peoples R China; [Wang, Hong-Xiang] First Peoples Hosp Fuyang Dist Hangzhou, Dept Neurol, 429 Beihuan Rd, Hangzhou 311400, Zhejiang, Peoples R China; [Gao, Jian-Bo] First Peoples Hosp Fuyang Dist Hangzhou, Dept Emergency Med, 429 Beihuan Rd, Hangzhou 311400, Zhejiang, Peoples R China		Qiu, SZ (corresponding author), First Peoples Hosp Fuyang Dist Hangzhou, Dept Neurosurg, 429 Beihuan Rd, Hangzhou 311400, Zhejiang, Peoples R China.	weiaanggg@163.com					Aguilar MI, 2010, SEMIN NEUROL, V30, P555, DOI 10.1055/s-0030-1268865; Bakhshayesh B, 2014, IRAN J NEUROL, V13, P231; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Castan L, 2017, ALLERGY, V72, P682, DOI 10.1111/all.13089; Chan S, 2014, CRIT CARE CLIN, V30, P699, DOI 10.1016/j.ccc.2014.06.003; Chen TJ, 2016, CLIN CHIM ACTA, V454, P6, DOI 10.1016/j.cca.2015.12.033; Cheng X, 2017, MOL NEUROBIOL, V54, P895, DOI 10.1007/s12035-015-9645-9; Cheung C. M., 2008, Hong Kong Medical Journal, V14, P367; Cho BS, 2017, KOREAN J INTERN MED, V32, P248, DOI 10.3904/kjim.2016.244; da Silva JM, 2016, ORAL ONCOL, V56, P8, DOI 10.1016/j.oraloncology.2016.02.016; Dong XQ, 2015, CLIN CHIM ACTA, V450, P349, DOI 10.1016/j.cca.2015.09.013; Du Q, 2014, CLIN CHIM ACTA, V437, P141, DOI 10.1016/j.cca.2014.07.014; Du Q, 2013, PEPTIDES, V45, P35, DOI 10.1016/j.peptides.2013.04.017; Duan XX, 2015, NEUROL SCI, V36, P2227, DOI 10.1007/s10072-015-2341-8; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Khorramdelazad H, 2016, J NEUROIMMUNOL, V290, P70, DOI 10.1016/j.jneuroim.2015.11.021; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Li BY, 2015, J INTERF CYTOK RES, V35, P23, DOI 10.1089/jir.2014.0004; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Li X, 2015, INT SURG, V100, P1220, DOI 10.9738/INTSURG-D-14-00086.1; Lin XF, 2016, ACTA NEUROL SCAND, V133, P192, DOI 10.1111/ane.12445; LoPresti MA, 2014, J NEUROL SCI, V345, P3, DOI 10.1016/j.jns.2014.06.057; Luo X, 2016, REV NEUROSCIENCE, V27, P83, DOI 10.1515/revneuro-2015-0016; Mao WF, 2014, INT J NEUROSCI, V124, P281, DOI 10.3109/00207454.2013.838236; Morotti A, 2016, JAMA NEUROL, V73, P1285, DOI 10.1001/jamaneurol.2016.2252; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Pan DS, 2016, J NEUROL SCI, V362, P53, DOI 10.1016/j.jns.2016.01.024; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Provencio JJ, 2013, NEUROSURG CLIN N AM, V24, P349, DOI 10.1016/j.nec.2013.03.002; Qidwai T, 2016, IMMUNOL LETT, V176, P128, DOI 10.1016/j.imlet.2016.05.018; Schutt RC, 2012, STROKE, V43, P3382, DOI 10.1161/STROKEAHA.112.660878; Semaan A, 2017, VIRCHOWS ARCH, V470, P185, DOI 10.1007/s00428-016-2051-5; Shin JH, 2014, BBA-GENE REGUL MECH, V1839, P826, DOI 10.1016/j.bbagrm.2014.06.019; Wang Y, 2016, CURR MOL MED, V16, P738, DOI 10.2174/1566524016666160829153453; Yao Y, 2012, TRANSL STROKE RES, V3, pS70, DOI 10.1007/s12975-012-0155-z; You SJ, 2016, J STROKE CEREBROVASC, V25, P914, DOI 10.1016/j.jstrokecerebrovasdis.2015.12.023; Yu DG, 2016, ANN CLIN LAB SCI, V46, P508; Zhu L, 2015, INT J CLIN EXP MED, V8, P21257	39	5	6	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG	2017	471						55	61		10.1016/j.cca.2017.05.022			7	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FD2ZK	WOS:000407403100009	28526531				2022-02-06	
J	Sokhal, N; Rath, GP; Chaturvedi, A; Singh, M; Dash, HH				Sokhal, Navdeep; Rath, Girija Prasad; Chaturvedi, Arvind; Singh, Manmohan; Dash, Hari Hara			Comparison of 20% mannitol and 3% hypertonic saline on intracranial pressure and systemic hemodynamics	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Mannitol; Hypertonic saline; Intraoperative brain relaxation; Intracranial pressure; Systemic hemodynamics	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; CARDIAC-OUTPUT; SODIUM-CHLORIDE; BLOOD-VISCOSITY; HYPERTENSION; RESUSCITATION; RELAXATION; CRANIOTOMY; TRIAL	Mannitol and hypertonic saline (HS) are most commonly used hyperosmotic agents for intraoperative brain relaxation. We compared the changes in ICP and systemic hemodynamics after infusion of equiosmolar solutions of both agents in patients undergoing craniotomy for supratentorial tumors. Forty enrolled adults underwent a standard anesthetic induction. Apart from routine monitoring parameters, subdural ICP with Codmann catheter and cardiac indices by Vigileo monitor, were recorded. The patients were randomized to receive equiosmolar solutions of either 20% mannitol (5 ml/kg) or 3% HS (5.35 ml/kg) for brain relaxation. The time of placement of ICP catheter was marked as To and baseline ICP and systemic hemodynamic variables were noted; it was followed by recording of the same parameters every 5 min till 45 min (Study Period). After the completion of study period, brain relaxation score as assessed by the neurosurgeon was recorded. Arterial blood gas (ABG) was analysed every 30 min starting from To upto one and half hours (T90), and values of various parameters were recorded. Data was analysed using appropriate statistical methods. Both mannitol and HS significantly reduced the ICP; the values were comparable in between the two groups at most of the times. The brain relaxation score was comparable in both the groups. Urine output was significantly higher with mannitol. The perioperative complications, overall hospital stay, and Glasgow outcome score at discharge were comparable in between the two groups. To conclude, both mannitol and hypertonic saline in equiosmolar concentrations produced comparable effects on ICP reduction, brain relaxation, and systemic hemodynamics. (C) 2017 Elsevier Ltd. All rights reserved.	[Sokhal, Navdeep; Rath, Girija Prasad; Chaturvedi, Arvind] AIIMS, Dept Neuroanaesthesiol & Crit Care, New Delhi, India; [Singh, Manmohan] AIIMS, Dept Neurosurg, New Delhi, India; [Dash, Hari Hara] Fortis Hosp, Dept Anaesthesiol & Pain Management, Gurgaon, India		Rath, GP (corresponding author), AIIMS, Dept Neuroanaesthesiol & Crit Care, Neurosci Ctr, New Delhi 110029, India.	girijarath@yahoo.co.in	Rath, Girija Prasad/J-4046-2019	Rath, Girija Prasad/0000-0002-3985-8202			[Anonymous], 2000, J NEUROTRAUMA, V17, P463; ATALLAH MM, 1995, J CLIN ANESTH, V7, P182, DOI 10.1016/0952-8180(94)00050-E; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; Berl T, 2000, PATHOPHYSIOLOGY WATE, P866; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Chatterjee N, 2012, J NEUROSURG ANESTH, V24, P25, DOI 10.1097/ANA.0b013e3182338b11; De Vivo P, 2001, Minerva Anestesiol, V67, P603; FINDLAY SR, 1981, J CLIN INVEST, V67, P1604, DOI 10.1172/JCI110195; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Gemma M, 1997, J NEUROSURG ANESTH, V9, P329, DOI 10.1097/00008506-199710000-00007; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Himmelseher S, 2007, CURR OPIN ANESTHESIO, V20, P414, DOI 10.1097/ACO.0b013e3282eff9ea; Hirota Kiichi, 2005, J Anesth, V19, P75, DOI 10.1007/s00540-004-0270-4; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KOFKE WA, 1993, J NEUROSURG ANESTH, V5, P1; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; MAKOFF DL, 1970, AM J PHYSIOL, V218, P1201, DOI 10.1152/ajplegacy.1970.218.4.1201; MOON PF, 1995, CRIT CARE MED, V23, P323, DOI 10.1097/00003246-199502000-00019; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Palma L, 2006, J Neurosurg Sci, V50, P63; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Sabharwal N, 2009, J NEUROSURG ANESTH, V21, P248, DOI 10.1097/ANA.0b013e3181a6aebf; Sankar T, 2008, J NEUROSURG, V108, P1010, DOI 10.3171/JNS/2008/108/5/1010; SCHMIDSCHONBEIN H, 1969, CIRC RES, V25, P131, DOI 10.1161/01.RES.25.2.131; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; TODD MM, 1993, ANESTHESIOLOGY, V78, P1005, DOI 10.1097/00000542-199306000-00002; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Wu CT, 2010, ANESTH ANALG, V110, P903, DOI 10.1213/ANE.0b013e3181cb3f8b	35	5	6	1	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2017	42						148	154		10.1016/j.jocn.2017.03.016			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA6EJ	WOS:000405535800032	28342705				2022-02-06	
J	Wulffeld, S; Rasmussen, LS; Bech, BH; Steinmetz, J				Wulffeld, S.; Rasmussen, L. S.; Bech, B. Hojlund; Steinmetz, J.			The effect of CT scanners in the trauma room - an observational study	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							TOTAL-BODY CT; RADIOLOGY; PATIENT; TIME	BackgroundA CT scanner incorporated in the trauma resuscitation bay may benefit trauma patients by fastening work-up times; however, evidence in the area is still sparse. We assessed if time from admission to first CT scan was lower after incorporation of a CT scanner in the resuscitation bay. MethodsWe included trauma patients admitted in two 1-year periods, before and after a major rebuilding of the trauma room. Beforehand, one CT scanner was located in an adjacent room. After the rebuilding, two mobile CT scanners were placed in the resuscitation bays, where a moving gantry was combined with a trauma resuscitation table. Subgroup analyses were performed on severely injured and patients with traumatic brain injury. ResultsWe included 784 patients before and 742 patients after the reconstruction. Case-mix differed between study periods as there was a higher proportion of severe injuries, traumatic brain injury and penetrating trauma in the after period. We found a minor increase in time to CT in the after period (20 vs. 21 min, P = 0.008). In a multivariate regression analysis adjusted for differences in case-mix and with time to CT as outcome, period was an insignificant explanatory variable [ (before vs. after): 0.96 min 95% CI: 0.9-1.02, P = 0.3]. In both subgroups, we found no significant difference in time to CT. ConclusionWe found no reduction in time to CT scan, when comparing a period with mobile CT scanners incorporated in the resuscitation bay to an earlier period with a CT scanner next to the trauma room.	[Wulffeld, S.; Rasmussen, L. S.; Steinmetz, J.] Univ Copenhagen, Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Copenhagen, Denmark; [Bech, B. Hojlund] Univ Copenhagen, Dept Diagnost Radiol, Rigshosp, Copenhagen, Denmark; [Steinmetz, J.] Univ Copenhagen, Trauma Ctr, Rigshosp, Ctr Head & Orthopaed, Copenhagen, Denmark		Wulffeld, S (corresponding author), Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, 4231,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	sandrawulffeld@gmail.com	Steinmetz, Jacob/AAY-6076-2020; Steinmetz, Jacob/O-6014-2017	Steinmetz, Jacob/0000-0001-9620-8911; Steinmetz, Jacob/0000-0001-9620-8911; Rasmussen, Lars/0000-0002-7480-3004; Wulffeld, Sandra/0000-0003-4278-5005	TrygFonden	The TrygFonden funded this study. The foundation has not been involved in the study design, writing of the manuscript or the decision to submit the manuscript for publication.	Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Chakraverty S, 2014, BRIT J ANAESTH, V113, P250, DOI 10.1093/bja/aeu203; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Frellesen C, 2015, EUR J RADIOL, V84, P117, DOI 10.1016/j.ejrad.2014.10.013; Gross T, 2010, BRIT J SURG, V97, P118, DOI 10.1002/bjs.6842; Harvey JJ, 2013, CLIN RADIOL, V68, P871, DOI 10.1016/j.crad.2013.01.006; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Huber-Wagner S, 2014, INJURY, V45, pS76, DOI 10.1016/j.injury.2014.08.022; Huber-Wagner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068880; Jin PHPFK, 2008, J TRAUMA, V64, P1320, DOI 10.1097/TA.0b013e318059b9ae; Lee KL, 2009, INJURY, V40, P873, DOI 10.1016/j.injury.2008.12.001; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; Saltzherr TP, 2012, BRIT J SURG, V99, P105, DOI 10.1002/bjs.7705; Sierink JC, 2016, LANCET, V388, P673, DOI 10.1016/S0140-6736(16)30932-1; Subcommittee A, 2013, J TRAUMA ACUTE CARE, V74, P1363; Wada D, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-52; Wurmb TE, 2016, LANCET, V388, P636, DOI 10.1016/S0140-6736(16)30933-3; Wutzler S, 2016, J THORAC DIS, V8, P3040, DOI 10.21037/jtd.2016.11.15	18	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	AUG	2017	61	7					832	840		10.1111/aas.12927			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EZ8MU	WOS:000404981100016	28635146				2022-02-06	
J	Lam, PK; Wang, KKW; Lo, AWI; Tong, CSW; Ching, DWC; Wong, K; Yang, ZH; Kong, T; Lo, KKY; Choy, RKW; Lai, PBS; Wong, GKC; Poon, WS				Lam, Ping K.; Wang, Kevin K. W.; Lo, Anthony W. I.; Tong, Cindy S. W.; Ching, Don W. C.; Wong, Kenneth; Yang, Zhihui; Kong, Themis; Lo, Kin K. Y.; Choy, Richard K. W.; Lai, Paul B. S.; Wong, George K. C.; Poon, Wai S.			Interactome and reciprocal activation of pathways in topical mesenchymal stem cells and the recipient cerebral cortex following traumatic brain injury	SCIENTIFIC REPORTS			English	Article							MARROW STROMAL CELLS; MECHANISMS; THERAPIES; EFFICACY	In this study, GFP-MSCs were topically applied to the surface of cerebral cortex within 1 hour of experimental TBI. No treatment was given to the control group. Three days after topical application, the MSCs homed to the injured parenchyma and improved the neurological function. Topical MSCs triggered earlier astrocytosis and reactive microglia. TBI penumbra and hippocampus had higher cellular proliferation. Apoptosis was suppressed at hippocampus at 1 week and reduced neuronal damaged was found in the penumbral at day 14 apoptosis. Proteolytic neuronal injury biomarkers (alphaII-spectrin breakdown products, SBDPs) and glial cell injury biomarker, glial fibrillary acidic protein (GFAP)-breakdown product (GBDPs) in injured cortex were also attenuated by MSCs. In the penumbra, six genes related to axongenesis (Erbb2); growth factors (Artn, Ptn); cytokine (IL3); cell cycle (Hdac4); and notch signaling (Hes1) were up-regulated three days after MSC transplant. Transcriptome analysis demonstrated that 7,943 genes were differentially expressed and 94 signaling pathways were activated in the topical MSCs transplanted onto the cortex of brain injured rats with TBI. In conclusion, topical application offers a direct and efficient delivery of MSCs to the brain.	[Lam, Ping K.; Tong, Cindy S. W.; Ching, Don W. C.; Kong, Themis; Lo, Kin K. Y.; Lai, Paul B. S.; Wong, George K. C.; Poon, Wai S.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Lam, Ping K.; Tong, Cindy S. W.; Kong, Themis; Lo, Kin K. Y.; Lai, Paul B. S.; Wong, George K. C.; Poon, Wai S.] Chinese Univ Hong Kong, Chow Tai Fook Cheng Yu Tung Surg Stem Cell Res Ct, Hong Kong, Hong Kong, Peoples R China; [Lo, Anthony W. I.; Ching, Don W. C.] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Wong, Kenneth; Choy, Richard K. W.] Chinese Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Yang, Zhihui] Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA		Poon, WS (corresponding author), Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.; Poon, WS (corresponding author), Chinese Univ Hong Kong, Chow Tai Fook Cheng Yu Tung Surg Stem Cell Res Ct, Hong Kong, Hong Kong, Peoples R China.	wspoon@surgery.cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Lai, Paul BS/K-8556-2015; Wong, George Kwok Chu/L-4344-2016; Lo, Anthony/G-5414-2015	Lai, Paul BS/0000-0002-9469-6728; Lo, Anthony/0000-0002-9388-310X; Wang, Kevin/0000-0002-9343-6473	U.S. Department of Defense (US Army Medical Research & Material Command) [W81XWH-10-1-0930]	This study is in part supported by U.S. Department of Defense Grant (US Army Medical Research & Material Command under award # W81XWH-10-1-0930) to KKWW. The opinions, interpretation, conclusions and recommendations are those of authors and are not necessarily endorsed by the DoD. And in conducting research using animals, the investigators adhere to the laws of the USA and regulations of the Department of Agriculture.	Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Lam PK, 2013, J CLIN NEUROSCI, V20, P300, DOI 10.1016/j.jocn.2012.03.028; Lam PK, 2011, TRANSPLANTATION, V92, pE9, DOI 10.1097/TP.0b013e318221d3b7; Lam PK, 1999, ANN PLAS SURG, V43, P523, DOI 10.1097/00000637-199911000-00010; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahood A., 2003, NEUROSURGERY, V53, P697, DOI [10.1227/01.NEU.0000079333.61863.AA, DOI 10.1227/01.NEU.0000079333.61863.AA]; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mendick R., TELEGRAPH; Momin EN, 2010, CURR STEM CELL RES T, V5, P326; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003	28	5	5	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 10	2017	7								5017	10.1038/s41598-017-01772-7			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA1EA	WOS:000405180900090	28694468	Green Published, gold			2022-02-06	
J	Wu, X; Zhang, C; Feng, JF; Mao, Q; Gao, GY; Jiang, JY				Wu, Xiang; Zhang, Chao; Feng, Junfeng; Mao, Qing; Gao, Guoyi; Jiang, Jiyao			Right median nerve electrical stimulation for acute traumatic coma (the Asia Coma Electrical Stimulation trial): study protocol for a randomised controlled trial	TRIALS			English	Article						Traumatic brain injury; Comatose patient; Right median nerve electrical stimulation	RETICULAR ACTIVATING SYSTEM; BRAIN-INJURED PATIENTS; UNRESPONSIVENESS SCORE; VEGETATIVE STATE; FULL OUTLINE; CONSCIOUSNESS; SCALE; DISORDERS; AROUSAL; MANAGEMENT	Background: Traumatic brain injury (TBI) has become the most common cause of death and disability in persons between 15 and 30 years of age, and about 10-15% of patients affected by TBI will end up in a coma. Coma caused by TBI presents a significant challenge to neuroscientists. Right median nerve electrical stimulation has been reported as a simple, inexpensive, non-invasive technique to speed recovery and improve outcomes for traumatic comatose patients. Methods/design: This multicentre, prospective, randomised (1:1) controlled trial aims to demonstrate the efficacy and safety of electrical right median nerve stimulation (RMNS) in both accelerating emergence from coma and promoting long-term outcomes. This trial aims to enrol 380 TBI comatose patients to partake in either an electrical stimulation group or a non-stimulation group. Patients assigned to the stimulation group will receive RMNS in addition to standard treatment at an amplitude of 15-20 mA with a pulse width of 300 mu s at 40 Hz ON for 20 s and OFF for 40 s. The electrical treatment will last for 8 h per day for 2 weeks. The primary endpoint will be the percentage of patients regaining consciousness 6 months after injury. The secondary endpoints will be Extended Glasgow Outcome Scale, Coma Recovery Scale-Revised and Disability Rating Scale scores at 28 days, 3 months and 6 months after injury; Glasgow Coma Scale, Glasgow Coma Scale Motor Part and Full Outline of Unresponsiveness scale scores on day 1 and day 7 after enrolment and 28 days, 3 months and 6 months after injury; duration of unconsciousness and mechanical ventilation; length of intensive care unit and hospital stays; and incidence of adverse events. Discussion: Right median nerve electrical stimulation has been used as a safe, inexpensive, non-invasive therapy for neuroresuscitation of coma patients for more than two decades, yet no trial has robustly proven the efficacy and safety of this treatment. The Asia Coma Electrical Stimulation (ACES) trial has the following novel features compared with other major RMNS trials: (1) the ACES trial is an Asian multicentre randomised controlled trial; (2) RMNS therapy starts at an early stage 7-14 days after the injury; and (3) various assessment scales are used to evaluate the condition of patients. We hope the ACES trial will lead to optimal use of right median nerve electrical treatment.	[Wu, Xiang; Zhang, Chao; Feng, Junfeng; Mao, Qing; Gao, Guoyi; Jiang, Jiyao] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China.	guoyigao@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671198]	This trial is funded by National Natural Science Foundation of China (Grant No. 81671198).	Bernat JL, 2010, NEUROLOGY, V75, P206, DOI 10.1212/WNL.0b013e3181e8e960; Buitrago MM, 2004, EXP BRAIN RES, V158, P336, DOI 10.1007/s00221-004-1906-1; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; Cooper E B Jr, 1973, Surg Forum, V24, P477; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Cooper EB, 2003, ACT NEUR S, V87, P7; Cooper EB, 1988, P AM INP OUTP SYST A; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; Cruse D, 2014, NEUROCRIT CARE, V21, P238, DOI 10.1007/s12028-014-9982-y; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Feng Z, 2015, NEURAL REGEN RES, V10, P594, DOI 10.4103/1673-5374.155433; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, J HEAD TRAUMA REHAB, V19, P254, DOI 10.1097/00001199-200405000-00006; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Jang SH, 2015, AM J NEURORADIOL, V36, P667, DOI 10.3174/ajnr.A4203; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; KOKAIA Z, 1994, NEUROREPORT, V5, P1241, DOI 10.1097/00001756-199406020-00021; Kramer AA, 2012, CRIT CARE MED, V40, P2671, DOI 10.1097/CCM.0b013e318258fd88; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; Lei J, 2015, J NEUROTRAUM, V32, P1584, DOI 10.1089/neu.2014.3768; Lemaire JJ, 2014, ANN FR ANESTH, V33, P88, DOI 10.1016/j.annfar.2013.11.007; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Oyama Hirofumi, 2011, No Shinkei Geka, V39, P465; Padilla R, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.021022; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Peri CV, 2001, BRAIN INJURY, V15, P903, DOI 10.1080/02699050110065709; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Tsubokawa T, 1990, Brain Inj, V4, P315; Wang F, 2016, NEUROL SCI, V37, P693, DOI 10.1007/s10072-015-2460-2; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	40	5	11	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUL 10	2017	18								311	10.1186/s13063-017-2045-x			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FA0SO	WOS:000405145900002	28693604	Green Published, gold			2022-02-06	
J	Ahl, R; Barmparas, G; Riddez, L; Ley, EJ; Wallin, G; Ljungqvist, O; Mohseni, S				Ahl, Rebecka; Barmparas, Galinos; Riddez, Louis; Ley, Eric J.; Wallin, Goran; Ljungqvist, Olle; Mohseni, Shahin			Does Beta-Blockade Reduce the Risk of Depression in Patients with Isolated Severe Extracranial Injuries?	WORLD JOURNAL OF SURGERY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PROPRANOLOL; REACTIVATION; MEMORY	Background Approximately half of trauma patients develop post-traumatic depression. It is suggested that beta-blockade impairs trauma memory recollection, reducing depressive symptoms. This study investigates the effect of early beta-blockade on depression following severe traumatic injuries in patients without significant brain injury. Methods Patients were identified by retrospectively reviewing the trauma registry at an urban university hospital between 2007 and 2011. Severe extracranial injuries were defined as extracranial injuries with Abbreviated Injury Scale score >= 3, intracranial Abbreviated Injury Scale score <3 and an Injury Severity Score >= 16. In-hospital deaths and patients prescribed antidepressant therapy <= 1 year prior to admission were excluded. Patients were stratified into groups based on pre-admission beta-blocker status. The primary outcome was post-traumatic depression, defined as receiving antidepressants <= 1 year following trauma. Results Five hundred and ninety-six patients met the inclusion criteria with 11.4% prescribed pre-admission beta-blockade. Patients receiving beta-blockers were significantly older (57 +/- 18 vs. 42 +/- 17 years, p < 0.001) with lower Glasgow Coma Scale score (12 +/- 3 vs. 14 +/- 2, p < 0.001). The beta-blocked cohort spent significantly longer in hospital (21 +/- 20 vs. 15 +/- 17 days, p < 0.01) and intensive care (4 +/- 7 vs. 3 +/- 5 days, p = 0.01). A forward logistic regression model was applied and predicted lack of beta-blockade to be associated with increased risk of depression (OR 2.7, 95% CI 1.1-7.2, p = 0.04). After adjusting for group differences, patients lacking beta-blockers demonstrated an increased risk of depression (AOR 3.3, 95% CI 1.2-8.6, p = 0.02). Conclusions Pre-admission beta-blockade is associated with a significantly reduced risk of depression following severe traumatic injury. Further investigation is needed to determine the beneficial effects of beta-blockade in these instances.	[Ahl, Rebecka; Wallin, Goran; Ljungqvist, Olle; Mohseni, Shahin] Univ Orebro, Sch Med Sci, Fakultetsgatan 1, S-70281 Orebro, Sweden; [Wallin, Goran; Ljungqvist, Olle; Mohseni, Shahin] Orebro Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-70185 Orebro, Sweden; [Barmparas, Galinos; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Acute Care Surg & Surg Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA; [Ahl, Rebecka; Riddez, Louis; Mohseni, Shahin] Karolinska Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-17176 Stockholm, Sweden		Mohseni, S (corresponding author), Univ Orebro, Sch Med Sci, Fakultetsgatan 1, S-70281 Orebro, Sweden.; Mohseni, S (corresponding author), Orebro Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-70185 Orebro, Sweden.; Mohseni, S (corresponding author), Karolinska Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-17176 Stockholm, Sweden.	rebecka.ahl@karolinska.se; gbarmparas@gmail.com; Louis.riddez@karolinska.se; Eric.Ley@cshs.org; goran.wallin@orebroll.se; olle.ljugqvist@ki.se; mohsenishahin@yahoo.com	Barmparas, Galinos/L-6530-2019; Ahl, Rebecka/AAG-4162-2020	Ahl, Rebecka/0000-0001-7930-3845			Battes LC, 2012, J AFFECT DISORDERS, V136, P751, DOI 10.1016/j.jad.2011.09.047; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Brunet A, 2014, CAN J PSYCHIAT, V59, P228, DOI 10.1177/070674371405900408; Christianson S. A., 1992, HDB EMOTION MEMORY C; Cooney RE, 2010, COGN AFFECT BEHAV NE, V10, P470, DOI 10.3758/CABN.10.4.470; Davydow DS, 2009, INTENS CARE MED, V35, P796, DOI 10.1007/s00134-009-1396-5; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Hoge EA, 2012, CNS NEUROSCI THER, V18, P21, DOI 10.1111/j.1755-5949.2010.00227.x; Huang CQ, 2010, AGEING RES REV, V9, P131, DOI 10.1016/j.arr.2009.05.005; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Lindgren ME, 2013, PSYCHO-ONCOLOGY, V22, P1889, DOI 10.1002/pon.3233; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Poundja J, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.15470; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Spring JD, 2015, PSYCHOPHYSIOLOGY, V52, P407, DOI 10.1111/psyp.12326; Stein MB, 2007, J TRAUMA STRESS, V20, P923, DOI 10.1002/jts.20270; Terzioglu B, 2013, NEUROCHEM RES, V38, P1726, DOI 10.1007/s11064-013-1076-2; Whale R, 2010, J PSYCHOPHARMACOL, V24, P513, DOI 10.1177/0269881108097714; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; Wood NE, 2015, PSYCHIAT RES, V225, P31, DOI 10.1016/j.psychres.2014.09.005	23	5	5	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUL	2017	41	7					1801	1806		10.1007/s00268-017-3935-5			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EX2KY	WOS:000403056400020	28265730	Green Published			2022-02-06	
J	Burton, JM; Morozova, OM				Burton, Justin M.; Morozova, Olga M.			Calming the Storm: Dysautonomia for the Pediatrician	CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE			English	Article							TRAUMATIC BRAIN-INJURY; PAROXYSMAL SYMPATHETIC HYPERACTIVITY; AUTONOMIC DYSFUNCTION; DIENCEPHALIC SEIZURES; HEAD-INJURY; MANAGEMENT; BROMOCRIPTINE; SCALE	Dysautonomia is a potentially life-threatening syndrome seen in many different types of brain injuries. It involves paroxysmal sympathetic hyperactivity and typically includes a constellation of symptoms, including: tachycardia, tachypnea, hyperthermia, hypertension, diaphoresis, hypertonia, and/or decerebrate or decorticate posturing. It is a clinical diagnosis of exclusion. A multimodal treatment approach is necessary including environmental modifications along with pharmacotherapy. Early management can help prevent comorbidities including secondary brain injury while also improving patient outcomes. This discussion serves as an overview of dysautonomia with a focus on management in the pediatric population including an example of a clinical algorithm and a review of the commonly used medications.	[Burton, Justin M.; Morozova, Olga M.] Childrens Natl Hlth Syst, Div Pediat Rehabil Med, Washington, DC 20010 USA		Burton, JM (corresponding author), Childrens Natl Hlth Syst, Div Pediat Rehabil Med, Washington, DC 20010 USA.			Burton, Justin/0000-0002-5876-6629			Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Hamilton BB, 1990, REHABILITATION UNIFO; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Lambert V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014497; Lemke DM, 2007, CRIT CARE NURSE, V27, P30; Lemke Denise M, 2004, J Neurosci Nurs, V36, P4; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; McClymont S, DYSAUTONOMIA LEARNIN; Mehta NM, 2008, JPEN-PARENTER ENTER, V32, P281, DOI 10.1177/0148607108316196; Penfield W, 1954, EPILEPSY FUNCTIONAL, P412; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Pozzi M, 2017, J HEAD TRAUMA REHAB, V32, P117, DOI 10.1097/HTR.0000000000000255; Pozzi M, 2014, J NEUROTRAUM, V31, P1897, DOI 10.1089/neu.2014.3540; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; Ryan JB, 2003, J HEART LUNG TRANSPL, V22, P922, DOI 10.1016/S1053-2498(02)00558-2; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	36	5	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1538-5442	1538-3199		CURR PROB PEDIATR AD	Curr. Probl. Pediatr. Adolesc. Health Care	JUL	2017	47	7					145	150		10.1016/j.cppeds.2017.06.009			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FE4KQ	WOS:000408183200003	28716515				2022-02-06	
J	Hack, D; Huff, JS; Curley, K; Naunheim, R; Dastidar, SG; Prichep, LS				Hack, Dallas; Huff, J. Stephen; Curley, Kenneth; Naunheim, Roseanne; Dastidar, Samanwoy Ghosh; Prichep, Leslie S.			Increased prognostic accuracy of TBI when a brain electrical activity biomarker is added to loss of consciousness (LOC)	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic brain injury TBI; EEG; Loss of consciousness LOC; Traumatic amnesia	HEAD-INJURY; CLASSIFICATION	Background: Extremely high accuracy for predicting CT+ traumatic brain injury (TBI) using a quantitative EEG (QEEG) based multivariate classification algorithm was demonstrated in an independent validation trial, in Emergency Department (ED) patients, using an easy to use handheld device. This study compares the predictive power using that algorithm(which includes LOC and amnesia), to the predictive power of LOC alone or LOC plus traumatic amnesia. Participants: ED patients 18-85 years presenting within 72 h of closed head injury, with GSC 12-15, were study candidates. 680 patients with known absence or presence of LOC were enrolled (145 CT+ and 535 CT - patients). Methods: 5-10 min of eyes closed EEG was acquired using the Ahead 300 handheld device, from frontal and frontotemporal regions. The same classification algorithm methodology was used for both the EEG based and the LOC based algorithms. Predictive power was evaluated using area under the ROC curve (AUC) and odds ratios. Results: The QEEG based classification algorithm demonstrated significant improvement in predictive power compared with LOC alone, both in improved AUC (83% improvement) and odds ratio (increase from 4.65 to 16.22). Adding RGA and/or PTA to LOC was not improved over LOC alone. Conclusions: Rapid triage of TBI relies on strong initial predictors. Addition of an electrophysiological based marker was shown to outperform report of LOC alone or LOC plus amnesia, in determining risk of an intracranial bleed. In addition, ease of use at point-of-care, non-invasive, and rapid result using such technology suggests significant value added to standard clinical prediction. (C) 2017 Elsevier Inc. All rights reserved.	[Hack, Dallas] Brain Hlth, Sevierville, TN USA; [Huff, J. Stephen] Univ Virginia Hlth Syst, Charlottesville, VA USA; [Curley, Kenneth] Iatrikos Res & Dev Strategies LLC, Tampa, FL USA; [Curley, Kenneth] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Naunheim, Roseanne] Washington Univ, Barnes Jewish Med Ctr, St Louis, MO USA; [Dastidar, Samanwoy Ghosh; Prichep, Leslie S.] BrainScope Co, Bethesda, MD USA; [Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, 1115 Broadway,Room 1082, New York, NY 10010 USA		Prichep, LS (corresponding author), NYU, Sch Med, Dept Psychiat, 1115 Broadway,Room 1082, New York, NY 10010 USA.	leslie.prichep@nyumc.org			U.S. ArmyUnited States Department of Defense [W81XWH-14-C-1405]; BrainScope Company, Inc.	The data used in this study was collected under support in part by a research contract from the U.S. Army, contract # W81XWH-14-C-1405, entitled, "Validation of Point-of-Care TBI Detection System for Head Injured Patients,"<SUP>2</SUP> and by research grants from BrainScope Company, Inc. to the clinical sites. The authors wish to acknowledge the contributions of the research staff at the clinical sites for their efforts toward conducting of this study and the patients who volunteered to participate.	DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; Hanley D, 2016, ACAD EMERG MED; Hanley D, 2016, ACAD EMERG IN PRESS; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757	15	5	5	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2017	35	7					949	952		10.1016/j.ajem.2017.01.060			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FA2TI	WOS:000405293300002	28258840				2022-02-06	
J	Klein, TA; Graves, JM; Graham, JY				Klein, Tracy A.; Graves, Janessa M.; Graham, Jasmine Y.			Driving After Adolescent Concussion: Advice From Nurse Practitioners in the Absence of Standardized Recommendations	JOURNAL OF PEDIATRIC HEALTH CARE			English	Article						Adolescent; concussion; driving; nurse practitioner; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FITNESS-TO-DRIVE; NEUROCOGNITIVE IMPAIRMENT; SLEEP DISTURBANCES; YOUNG-ADULTS; SPORT; BEHAVIOR; INFORMATION; DISORDERS; STATEMENT	Introduction: Nurse practitioners (NPs) are authorized to manage concussion recovery. Common adolescent activities, like driving, are omitted from guidelines. We investigated NP driving guidance and its clinical basis for restriction or limitation following adolescent concussion. Method: NPs completed a web-based questionnaire after viewing a scripted video scenario of an adolescent describing symptoms of concussion occurring 72 hours prior. Driving recommendations were collected using an open-ended query, then coded and categorized by type, characteristic, and basis. Results: 1,051 (20%) responded to the question of interest. The majority (93.8%) provided driving recommendations: 32.6% based on time, 49.8% based on symptoms, and 28.5% based on health care utilization. 5.3% mentioned fatigue and sleep symptoms. 1% advised use of a standardized assessment tool. Discussion: Symptomatology, examination, and time were key factors in clinical decision-making for post-concussion driving, rather than use of standardized tools. Persistent symptoms that can impact driving, such as sleep and visual disturbances, may warrant consideration.	[Klein, Tracy A.] Washington State Univ, Coll Nursing Vancouver, Vancouver, WA USA; [Graves, Janessa M.] Washington State Univ, Coll Nursing Spokane, Spokane, WA USA; [Graham, Jasmine Y.] Univ Washington, HIPRC, Seattle, WA 98195 USA		Klein, TA (corresponding author), Washington State Univ, Coll Nursing, 14204 NE Salmon Creek Ave, Vancouver, WA 98686 USA.	takein@wsu.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634; Klein, Tracy/0000-0002-6618-3538; Hu, Jasmine/0000-0002-7259-0332	Washington State University New Faculty Seed Grant; American Nurses Foundation/Western Institute of Nursing Grant	This study was funded by the Washington State University New Faculty Seed Grant and the American Nurses Foundation/Western Institute of Nursing Grant.	American Academy of Neurology, 2013, SUMM EV BAS GUID CLI; American Occupational Therapy Association, 2016, FIND DRIV SPEC; Association for Driver Rehabilitation Specialists, 2016, DIR SERV; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Baker A, 2015, AUST OCCUP THER J, V62, P50, DOI 10.1111/1440-1630.12172; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Centers for Disease Control and Prevention, HEADS SCH FACT SHEET; Children's Hospital of Philadelphia, DRIV CONC; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Foss RD, 2015, J ADOLESCENT HEALTH, V57, pS1, DOI 10.1016/j.jadohealth.2015.04.024; Garner AA, 2015, SLEEP MED, V16, P796, DOI 10.1016/j.sleep.2015.03.003; Giola G, 2006, ACUTE CONCUSSION EVA; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kansagara D., 2014, 05225 VA ESP DEP VET; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kingery KM, 2015, J ABNORM CHILD PSYCH, V43, P1175, DOI 10.1007/s10802-014-9954-x; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Martiniuk ALC, 2013, JAMA PEDIATR, V167, P647, DOI 10.1001/jamapediatrics.2013.1429; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McManus B, 2015, TRAFFIC INJ PREV, V16, P818, DOI 10.1080/15389588.2015.1027339; Ontario Neurological Foundation, 2013, GUID MILD TRAUM BRAI, V2nd; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rike PO, 2014, BRAIN INJURY, V28, P1687, DOI 10.3109/02699052.2014.947632; Ross P, 2016, DISABIL REHABIL, V38, P994, DOI 10.3109/09638288.2015.1074293; Schmidt AT, 2015, COGN BEHAV NEUROL, V28, P53, DOI 10.1097/WNN.0000000000000056; Shults RA, 2015, MMWR-MORBID MORTAL W, V64, P313; Shultzman S, 2016, PATIENT INFORM HEAD; Starkey NJ, 2016, TRANSPORT RES F-TRAF, V38, P127, DOI 10.1016/j.trf.2016.01.013; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Verma A, 2007, J CLIN SLEEP MED, V3, P357	44	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5245	1532-656X		J PEDIATR HEALTH CAR	J. Pediatr. Health Care	JUL-AUG	2017	31	4					441	451		10.1016/j.pedhc.2016.11.004			11	Health Policy & Services; Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing; Pediatrics	FC6GB	WOS:000406937300012	27955874				2022-02-06	
J	Lobo, MA; Kagan, SH; Corrigan, JD				Lobo, Michele A.; Kagan, Sarah H.; Corrigan, John D.			Research Design Options for Intervention Studies	PEDIATRIC PHYSICAL THERAPY			English	Article						observational research; qualitative research; research designs; single-case research	TRAUMATIC BRAIN-INJURY; QUALITATIVE RESEARCH; RANDOMIZATION; METHODOLOGY; OUTCOMES; PATIENT; ISSUES; TESTS	Purpose: To review research designs for rehabilitation. Summary of Key Points: Single-case, observational, and qualitative designs are highlighted in terms of recent advances and ability to answer important scientific questions about rehabilitation. Statement of Conclusions: Single-case, observational, and qualitative designs can be conducted in a systematic and rigorous manner that provides important information that cannot be acquired using more common designs, such as randomized controlled trials. These less commonly used designs may be more feasible and effective in answering many research questions in the field of rehabilitation. Recommendations for Clinical Practice: Researchers should consider these designs when selecting the optimal design to answer their research questions. We should improve education about the advantages and disadvantages of existing research designs to enable more critical analysis of the scientific literature we read and review to avoid undervaluing studies not within more commonly used categories.	[Lobo, Michele A.] Univ Delaware, Biomech & Movement Sci Program, Dept Phys Therapy, Newark, DE 19713 USA; [Kagan, Sarah H.] Univ Penn, Sch Nursing, Dept Biobehav Hlth Sci, Philadelphia, PA 19104 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Lobo, MA (corresponding author), Univ Delaware, Phys Therapy Dept, 540 S Coll Ave,Room 210K, Newark, DE 19713 USA.	malobo@udel.edu	Lobo, Michele/AAB-5968-2021	Lobo, Michele A./0000-0003-2892-7687	Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development (NICHD) [1R21HD076092-01A1]; Traumatic Brain Injury Model System Centers grant from the National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) [90DP0040-01-00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD076092] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000040] Funding Source: NIH RePORTER	Dr Lobo's contribution to this article was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) (1R21HD076092-01A1, Lobo, PI). Dr Corrigan's contribution was supported by a Traumatic Brain Injury Model System Centers grant from the National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR) to The Ohio State University (grant no. 90DP0040-01-00).	Baxter P, 2008, QUAL REP, V13, P544; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bulte I, 2008, BEHAV RES METHODS, V40, P467, DOI 10.3758/BRM.40.2.467; Bulte I, 2009, BEHAV RES METHODS, V41, P477, DOI 10.3758/BRM.41.2.477; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Creswell JW, 2007, COUNS PSYCHOL, V35, P236, DOI 10.1177/0011000006287390; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1284, DOI 10.1016/j.apmr.2009.02.009; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Effgen SK, 2016, PEDIATR PHYS THER, V28, P47, DOI 10.1097/PEP.0000000000000197; Gage NA, 2014, J SPEC EDUC, V48, P3, DOI 10.1177/0022466912443894; Garattini S, 2016, EUR J INTERN MED, V32, P13, DOI 10.1016/j.ejim.2016.03.020; Goodwin WL, 1996, UNDERSTANDING QUANTI; Graham JE, 2012, ARCH PHYS MED REHAB, V93, pS111, DOI 10.1016/j.apmr.2011.12.017; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS245, DOI 10.1016/j.apmr.2014.06.024; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS173, DOI 10.1016/j.apmr.2015.03.027; Jewell D. V., 2015, GUIDE EVIDENCE BASED; Kratochwill TR, 2010, PSYCHOL METHODS, V15, P124, DOI 10.1037/a0017736; Kratochwill TR., 2014, SINGLE CASE INTERVEN; Levin JR, 2012, J SCHOOL PSYCHOL, V50, P599, DOI 10.1016/j.jsp.2012.05.001; Onghena P., 2005, ENCY STAT BEHAV SCI, V4, P1850, DOI DOI 10.1002/0470013192; Parker RI, 2007, BEHAV THER, V38, P95, DOI 10.1016/j.beth.2006.05.002; Ponterotto JG, 2005, J COUNS PSYCHOL, V52, P126, DOI 10.1037/0022-0167.52.2.126; Ramasamy R., 2013, SINGLE SUBJECT RES A; Sim J, 1998, J ADV NURS, V28, P345, DOI 10.1046/j.1365-2648.1998.00692.x; Tate RL, 2016, PHYS THER, V96, P932, DOI 10.1037/arc0000026.supp; Tate RL, 2014, NEUROPSYCHOL REHABIL, V24, P315, DOI 10.1080/09602011.2013.875043; TBI Model Systems National Data and Statistical Center, TRAUM BRAIN INJ MOD; Trainor AA, 2014, REM SPEC EDUC, V35, P267, DOI 10.1177/0741932514528100; Whiteneck GG, 2013, ARCH PHYS MED REHAB, V94, pS67, DOI 10.1016/j.apmr.2012.12.022	31	5	5	4	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-5669	1538-005X		PEDIATR PHYS THER	Pediatr. Phys. Ther.	JUL	2017	29	3		S			S57	S63		10.1097/PEP.0000000000000380			7	Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Rehabilitation	EZ7LX	WOS:000404907300008	28654478	Green Accepted			2022-02-06	
J	Madathil, SK; Deng-Bryant, Y; Wilfred, BS; Leung, LY; Gilsdorf, JS; Shear, DA				Madathil, Sindhu K.; Deng-Bryant, Ying; Wilfred, Bernard S.; Leung, Lai Yee; Gilsdorf, Janice S.; Shear, Deborah A.			Alterations in brain-derived neurotrophic factor and insulin-like growth factor-1 protein levels after penetrating ballistic-like brain injury in rats	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Brain-derived neurotrophic factor; traumatic brain injury; insulin-like growth factor-1; penetrating ballistic-like brain injury	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN; MESSENGER-RNA; REGIONAL CHANGES; CEREBRAL-CORTEX; BDNF; EXPRESSION; HIPPOCAMPUS; MODEL; RECEPTORS	BACKGROUND: Brain-derived neurotrophic factor (BDNF) and insulin-like growth factor-1 (IGF-1) are essential for neuroplasticity and neuronal survival. Despite the importance of these endogenous factors in mediating posttraumatic recovery, little is known about their response after penetrating type traumatic brain injury. The objective of this study was to quantify the expression levels BDNF and IGF-1, two well-known neuroplasticity mediators, after penetrating ballistic-like brain injury (PBBI). METHODS: Rats were randomly assigned to receive unilateral sham or PBBI injuries. Using enzyme-linked immunosorbent assay and immunohistochemistry, we performed a comprehensive evaluation of BDNF and IGF-1 expression at acute (1 hour, 6 hours, 1 day) and subacute (2, 3, 7, and 14 days) timepoints after injury. RESULTS: BDNF and IGF-1 expression was transiently upregulated in both cortex and hippocampus after PBBI. Although BDNF levels increased at acute timepoints, IGF-1 expression peaked at 3 days in cortical homogenates. Although there was loss of staining in cells bordering the cavity, increased BDNF and IGF-1 immunoreactivity was observed in scattered neurons away from the contusion site. Glial upregulation of both growth factors was observed at early timepoints in the hippocampus. CONCLUSION: Our findings demonstrate that PBBI results in a brief upregulation of BDNF and IGF-1 during early posttraumatic period, providing critical information for interventions aiming to enhance neuronal survival and brain plasticity. (Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.)	[Madathil, Sindhu K.; Deng-Bryant, Ying; Wilfred, Bernard S.; Leung, Lai Yee; Gilsdorf, Janice S.; Shear, Deborah A.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Madathil, SK (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	sindhu.kizhakkemadathil.ctr@mail.mil	Madathil, Sindhu K/E-9407-2012; Wilfred, Bernard Srambical/AAC-8221-2020	Wilfred, Bernard Srambical/0000-0002-0674-0187	Combat Casualty Care Research ProgramUnited States Department of Defense [H_026_2014]	This research is funded by Combat Casualty Care Research Program (H_026_2014). We thank Ms. Trisha Lala and Ms. Xiaofang Yang for their technical expertise.	Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; ANDERSSON IK, 1988, ACTA PHYSIOL SCAND, V132, P167, DOI 10.1111/j.1748-1716.1988.tb08314.x; Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; BARTLETT WP, 1991, DEV BIOL, V147, P239, DOI 10.1016/S0012-1606(05)80021-1; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bosco A, 1999, J NEUROSCI RES, V57, P759, DOI 10.1002/(SICI)1097-4547(19990915)57:6<759::AID-JNR1>3.0.CO;2-Y; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Conte V., 2003, EUR J TRAUMA, V7, P335; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Galvin KA, 2003, NEUROSCIENCE, V118, P1023, DOI 10.1016/S0306-4522(03)00066-6; Gao X, 2009, J NEUROTRAUM, V26, P1325, DOI [10.1089/neu.2008.0744, 10.1089/neu.2008-0744]; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hwang IK, 2004, NEUROCHEM INT, V45, P149, DOI 10.1016/j.neuint.2003.10.006; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Nordqvist ACS, 1996, MOL BRAIN RES, V38, P285; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tsiperson V, 2015, ASN NEURO, V7, DOI 10.1177/1759091414566878; Van Wyck D.W., 2015, J NEUROL NEUROPHYSIO, V6; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C	44	5	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2017	83			1			S16	S24		10.1097/TA.0000000000001471			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EY3XA	WOS:000403907300004	28628600				2022-02-06	
J	Song, SJ; Kong, XY; Acosta, S; Sava, V; Borlongan, CV; Sanchez-Ramos, J				Song, Shijie; Kong, Xiaoyuan; Acosta, Sandra; Sava, Vasyl; Borlongan, Cesar V.; Sanchez-Ramos, Juan			Effects of an Inhibitor of Monocyte Recruitment on Recovery from Traumatic Brain Injury in Mice Treated with Granulocyte Colony-Stimulating Factor	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						granulocyte-colony stimulating factor; monocyte chemotactic protein-1; radial arm water maze; bone marrow transplantation; hippocampal neurogenesis	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REVERSES COGNITIVE IMPAIRMENT; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; CHEMOATTRACTANT PROTEIN-1; MULTIPLE-SCLEROSIS; BONE-MARROW; G-CSF; EXPRESSION; MCP-1	Administration of the hematopoietic growth factor granulocyte-colony stimulating Factor (G-CSF) has been reported to enhance recovery from controlled cortical impact (CCI) in rodent models. G-CSF exerts actions in both the periphery (stimulation of hematopoiesis) and in the brain, where it serves as a neurotrophic factor, promoting neuronal survival and stimulating neural stem/progenitor cell proliferation in the hippocampus. In order to distinguish the direct CNS actions of G-CSF from its peripheral actions, experiments were designed to block the recruitment of peripheral monocytes to the site of the lesion produced by CCI. The selective C-C motif receptor 2 (CCR2) antagonist (RS504303) was co-administered with G-CSF for three days after CCI in a chimeric mouse previously transplanted with GFP-expressing (GFP+) blood stem-progenitor cells. Results: The drug significantly impaired infiltration of GFP+ bone marrow-derived cells to the frontal cortex and striatum without impeding recovery performance and hippocampal neurogenesis in the behavioral test, the Radial Arm Water Maze (RAWM). Administration of the CCR2 antagonist alone, without G-CSF, was effective in promoting recovery in RAWM. These results support the hypothesis that the direct action of G-CSF on neural cells, independent of its hematopoietic effects, is primarily responsible for enhanced recovery from CCI. In addition, this study confirms the importance of CCR2 and its ligand, monocyte chemotactic protein-1 (MCP-1), in mediating the inflammatory response following CCI.	[Song, Shijie; Kong, Xiaoyuan; Sava, Vasyl; Sanchez-Ramos, Juan] James A Haley VAH, Res Serv, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Song, Shijie; Sava, Vasyl; Sanchez-Ramos, Juan] Univ S Florida, Dept Neurol, 13220 Laurel Dr, Tampa, FL 33612 USA; [Kong, Xiaoyuan; Acosta, Sandra; Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, 12901 Bruce B,Downs Blvd, Tampa, FL 33612 USA		Song, SJ; Sanchez-Ramos, J (corresponding author), James A Haley VAH, Res Serv, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.; Song, SJ; Sanchez-Ramos, J (corresponding author), Univ S Florida, Dept Neurol, 13220 Laurel Dr, Tampa, FL 33612 USA.	ssong@health.usf.edu; xkong@health.usf.edu; sacosta@health.usf.edu; vsava@health.usf.edu; cborlong@health.usf.edu; jsramos@health.usf.edu	Sanchez-Ramos, Juan/O-7870-2014; Sanchez-Ramos, Juan/A-1188-2009	Sanchez-Ramos, Juan/0000-0002-3391-7857	Veterans Administration Merit Review GrantUS Department of Veterans Affairs; Helen Ellis Research Endowment Funds	Supported by Veterans Administration Merit Review Grant to Shijie Song and by the Helen Ellis Research Endowment Funds to Juan Sanchez-Ramos. The contents of this publication do not represent the views of the Department of Veterans Affairs or the United States Government.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Amanda P., 2013, J ALZHEIMERS DIS PAR, V3, P121; Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Berman JW, 1996, J IMMUNOL, V156, P3017; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; Galasso JM, 2000, EXP NEUROL, V165, P295, DOI 10.1006/exnr.2000.7466; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Umehara F, 1996, ACTA NEUROPATHOL, V91, P343, DOI 10.1007/s004010050435; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	27	5	5	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUL	2017	18	7							1418	10.3390/ijms18071418			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	FF2SJ	WOS:000408746800089	28671601	gold, Green Submitted, Green Published			2022-02-06	
J	Wang, SL; Gu, XH; Paudyal, R; Wei, L; Dix, TA; Yu, SP; Zhang, XD				Wang, Silun; Gu, Xiaohuan; Paudyal, Ramesh; Wei, Ling; Dix, Thomas A.; Yu, Shan P.; Zhang, Xiaodong			Longitudinal MRI evaluation of neuroprotective effects of pharmacologically induced hypothermia in experimental ischemic stroke	MAGNETIC RESONANCE IMAGING			English	Article						HPI201; Drug-induced hypothermia; MRI; Ischemic stroke; Logarithm pattern	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; WEIGHTED MRI; DIFFUSION; TEMPERATURE; MODEL; MICE; NEUREGULIN-1	Pharmacologically induced hypothermia (PIH) shows promising neuroprotective effects after stroke insult. However, the dynamic evolution of stroke infarct during the hypothermic therapy has not been understood very well. In the present study, MRI was utilized to longitudinally characterize the infarct evolution in a mouse model of ischemic stroke treated by PIH using the neurotensin agonist HPI201. Adult male C57BL/6 mice underwent permanent occlusion of the right middle cerebra artery (MCA). Each animal received a vehicle or HPI201 intraperitoneal injection. The temporal changes of stroke lesion were examined using T2-weighted imaging and diffusion-weighted imaging (DWI) in the acute phase (1 - 3h) and 24 h post stroke. Significantly reduced infarct and edema volumes were observed in PIH treated stroke mice, in agreement with TTC staining findings. Also, the TUNEL staining results indicated apoptotic cells were widely distributed among the ischemic cortex in control group but limited in PIH treated mice. Dramatically reduced growth rate of infarction was seen in PIH treated stroke mice. These results demonstrate HPI201 has strong neuroprotection effects during acute stroke. In particular, MRI with the numerical modelling of temporal infarct evolution could provide a unique means to examine and predict the dynamic response of the PIH treatment on infarct evolution. (C) 2017 Elsevier Inc. All rights reserved.	[Wang, Silun; Paudyal, Ramesh; Zhang, Xiaodong] Emory Univ, Yerkes Imaging Ctr, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Gu, Xiaohuan; Wei, Ling; Yu, Shan P.] Emory Univ, Sch Med, Dept Anesthesiol, 101 Woodruff Circle,WMR Bldg Suite 621, Atlanta, GA 30322 USA; [Paudyal, Ramesh] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA; [Dix, Thomas A.] Med Univ South Carolina, Dept Drug Discovery Biomed Sci, Charleston, SC 29425 USA; [Dix, Thomas A.] JT Pharmaceut Inc, Mt Pleasant, SC 29464 USA; [Yu, Shan P.] Atlanta VA Med Ctr, Ctr Visual & Neurocognit Rehabil, Decatur, GA 30033 USA; [Zhang, Xiaodong] Emory Univ, Div Neuropharmacol & Neurol Dis, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA		Zhang, XD (corresponding author), Emory Univ, Yerkes Imaging Ctr, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA.; Yu, SP (corresponding author), Emory Univ, Sch Med, Dept Anesthesiol, 101 Woodruff Circle,WMR Bldg Suite 621, Atlanta, GA 30322 USA.	spyu@emory.edu; xzhang8@emory.edu			NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P51RR000165]; Office of Research Infrastructure Programs of NIH [OD P510D011132]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS085568, R44NS90629]; VA Merit grant [RX000666]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS090629, R01NS085568] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P51OD011132] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000666] Funding Source: NIH RePORTER	The authors thank Ruth Connelly, Paul Chen, and Doty Kempf (DVM) for animal handling. This project was supported in part by NCRR (P51RR000165) and currently by the Office of Research Infrastructure Programs of NIH (OD P510D011132). It is also supported by NIH grants NS085568, R44NS90629, and a VA Merit grant RX000666.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bang OY, 2009, J CLIN NEUROL, V5, P107, DOI 10.3988/jcn.2009.5.3.107; Barber PA, 1998, NEUROLOGY, V51, P418, DOI 10.1212/WNL.51.2.418; Bardutzky J, 2005, STROKE, V36, P2000, DOI 10.1161/01.STR.0000177486.85508.4d; Ching SN, 2012, P NATL ACAD SCI USA, V109, P3095, DOI 10.1073/pnas.1121461109; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Daniele Ornella, 2002, J Stroke Cerebrovasc Dis, V11, P28, DOI 10.1053/jscd.2002.123972; Dehkharghani S, 2015, AM J NEURORADIOL, V36, P1128, DOI 10.3174/ajnr.A4241; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Ding GL, 2015, STROKE, V46, P507, DOI 10.1161/STROKEAHA.114.007538; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hacke W, 2004, LANCET, V363, P768; Hadden MK, 2005, NEUROPHARMACOLOGY, V49, P1149, DOI 10.1016/j.neuropharm.2005.06.010; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang M. Q, 2016, BRAIN PATHOL; Lansberg MG, 2001, ARCH NEUROL-CHICAGO, V58, P613, DOI 10.1001/archneur.58.4.613; LAPTOOK AR, 1995, STROKE, V26, P1240, DOI 10.1161/01.STR.26.7.1240; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; Lee JH, 2016, NEUROBIOL DIS, V96, P248, DOI 10.1016/j.nbd.2016.09.013; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Li YG, 2007, BRAIN RES, V1184, P277, DOI 10.1016/j.brainres.2007.09.037; Liu YR, 2007, STROKE, V38, P138, DOI 10.1161/01.STR.0000252127.07428.9c; Lutsep HL, 1997, ANN NEUROL, V41, P574, DOI 10.1002/ana.410410505; Macleod MR, 2010, INT J STROKE, V5, P489, DOI 10.1111/j.1747-4949.2010.00520.x; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; Mandeville ET, 2016, TRANSL STROKE RES; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; Musizza B, 2010, SENSORS-BASEL, V10, P10896, DOI 10.3390/s101210896; Nagel Simon, 2008, Expert Rev Neurother, V8, P1255, DOI 10.1586/14737175.8.8.1255; NORDSTROM CH, 1978, ACTA ANAESTH SCAND, V22, P7, DOI 10.1111/j.1399-6576.1978.tb01272.x; OTIS AB, 1957, AM J PHYSIOL, V188, P355, DOI 10.1152/ajplegacy.1957.188.2.355; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Schwab S, 1997, NEUROLOGY, V48, P762, DOI 10.1212/WNL.48.3.762; Schwab S, 1998, ACT NEUR S, V71, P131; Shen Q, 2003, J CEREBR BLOOD F MET, V23, P1479, DOI 10.1097/01.WCB.0000100064.36077.03; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tagaya M, 1997, STROKE, V28, P1245, DOI 10.1161/01.STR.28.6.1245; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Wang M, 2015, MAGN RESON MED; Wang SL, 2015, J NEUROL SCI, V357, P28, DOI 10.1016/j.jns.2015.06.055; Wang YL, 2009, ADV MATER RES-SWITZ, V79-82, P3, DOI 10.4028/www.scientific.net/AMR.79-82.3; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027; Yanagawa Y, 2002, RESUSCITATION, V53, P93, DOI 10.1016/S0300-9572(01)00499-3; Zhang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117290; Zhang XL, 2014, QUANT IMAGING MED SU, V4, P1, DOI [10.3978/j.issn.2223-4292.2014.03.01, 10.3978/j.issn.2223-4292.2014.04.06]; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	51	5	6	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JUL	2017	40						24	30		10.1016/j.mri.2017.03.011			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	EX6XU	WOS:000403386200004	28377304	Green Accepted			2022-02-06	
J	Weber, RA; Chan, CH; Nie, XJ; Maggioncalda, E; Valiulis, G; Lauer, A; Hui, ES; Jensen, JH; Adkins, DL				Weber, Rachel A.; Chan, Clifford H.; Nie, Xingju; Maggioncalda, Emily; Valiulis, Grace; Lauer, Abigail; Hui, Edward S.; Jensen, Jens H.; Adkins, DeAnna L.			Sensitivity of diffusion MRI to perilesional reactive astrogliosis in focal ischemia	NMR IN BIOMEDICINE			English	Article						astrogliosis; diffusion; GFAP; imaging; ischemia; MRI; perilesional; stereology	CEREBRAL-BLOOD-FLOW; FIBRILLARY ACIDIC PROTEIN; GAUSSIAN WATER DIFFUSION; KURTOSIS; ENDOTHELIN-1; STROKE; QUANTIFICATION; ANISOTROPY; INTEGRITY; METRICS	Reactive astrogliosis is a response to injury in the central nervous system that plays an essential role in inflammation and tissue repair. It is characterized by hypertrophy of astrocytes, alterations in astrocyte gene expression and astrocyte proliferation. Reactive astrogliosis occurs in multiple neuropathologies, including stroke, traumatic brain injury and Alzheimer's disease, and it has been proposed as a possible source of the changes in diffusion magnetic resonance imaging (dMRI) metrics observed with these diseases. In this study, the sensitivity of dMRI to reactive astrogliosis was tested in an animal model of focal acute and subacute ischemia induced by the vasoconstricting peptide, endothelin-1. Reactive astrogliosis in perilesional cortex was quantified by calculating the astrocyte surface density as determined with a glial fibrillary acidic protein (GFAP) antibody, whereas perilesional diffusion changes were measured in vivo with diffusional kurtosis imaging. We found substantial changes in the surface density of GFAP-positive astrocyte processes and modest changes in dMRI metrics in the perilesional motor cortex following stroke. Although there are time point-specific correlations between dMRI and histological measures, there is no definitive evidence for a causal relationship.	[Weber, Rachel A.; Maggioncalda, Emily; Valiulis, Grace; Adkins, DeAnna L.] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Chan, Clifford H.; Jensen, Jens H.] Med Univ South Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [Chan, Clifford H.; Nie, Xingju; Jensen, Jens H.; Adkins, DeAnna L.] Med Univ South Carolina, Ctr Biomed Imaging, Charleston, SC 29425 USA; [Lauer, Abigail] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Hui, Edward S.] Univ Hong Kong, Dept Diagnost Radiol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Adkins, DeAnna L.] Med Univ South Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA		Jensen, JH (corresponding author), Med Univ South Carolina, Ctr Biomed Imaging, Dept Radiol & Radiol Sci, 96 Jonathan Lucas St,MSC 323, Charleston, SC 29425 USA.	jense@musc.edu	Jensen, Jens H/A-8334-2009	Jensen, Jens H/0000-0003-3219-4287; Adkins, DeAnna L/0000-0002-3063-5731; Hui, Sai Kam/0000-0002-1761-0169	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS085475, P20GM109040, T32GM008716]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109040, T32GM008716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS085475] Funding Source: NIH RePORTER	Technical assistance was provided by Elyse Clayton and Zac Manahan. We are grateful to Maria F. Falangola for helpful discussions. This work was supported, in part, by the National Institutes of Health research grants R21NS085475 (to J.H.J. and D.L.A.), P20GM109040 (to D.L.A.) and T32GM008716 (to P. Halushka).	Adkins DL, 2004, NEUROSCIENCE, V128, P473, DOI 10.1016/j.neuroscience.2004.07.019; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Biernaskie J, 2001, MAGNET RESON MED, V46, P827, DOI 10.1002/mrm.1263; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Carmichael ST, 2017, EXP NEUROL, V287, P384, DOI 10.1016/j.expneurol.2016.02.007; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fung SH, 2011, NEUROIMAG CLIN N AM, V21, P345, DOI 10.1016/j.nic.2011.03.001; Goveas J, 2015, MAGN RESON IMAGING, V33, P853, DOI 10.1016/j.mri.2015.04.006; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Hawrylak N, 1999, NEUROSCI LETT, V277, P57, DOI 10.1016/S0304-3940(99)00864-2; Hui ES, 2012, BRAIN RES, V1451, P100, DOI 10.1016/j.brainres.2012.02.044; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jensen JH, 2014, NMR BIOMED, V27, P363, DOI [10.1002/nbm.3094, 10.1002/nbm.3030]; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Li L, 2009, STROKE, V40, P936, DOI 10.1161/STROKEAHA.108.527713; Liu ZW, 2012, NEUROBIOL DIS, V45, P804, DOI 10.1016/j.nbd.2011.11.004; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Paxinos G, 1998, RAT ATLAS STEREOTAXI; ROBINSON MJ, 1990, NEUROSCI LETT, V118, P269, DOI 10.1016/0304-3940(90)90644-O; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Shemesh N, 2016, MAGN RESON MED, V75, P82, DOI 10.1002/mrm.25901; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhang S, 2016, MAGN RESON IMAGING, V34, P889, DOI 10.1016/j.mri.2016.04.016; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	40	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	JUL	2017	30	7							e3717	10.1002/nbm.3717			8	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	FA3EP	WOS:000405325100006	28272771	Green Submitted, Green Accepted			2022-02-06	
J	West, SL; Graham, CW; Temple, P				West, Steven L.; Graham, Carolyn W.; Temple, Peter			Rates and Correlates of Binge Drinking Among College Students With Disabilities, United States, 2013	PUBLIC HEALTH REPORTS			English	Article						students with disabilities; binge drinking; outcomes; alcohol use; substance use	TRAUMATIC BRAIN-INJURY; IDENTIFICATION TEST AUDIT; SPINAL-CORD-INJURY; PROBLEM-SCALE CAPS; SUBSTANCE-ABUSE; VALIDATION; OFFENDERS; DISORDER; OUTCOMES; QUALITY	Objective: Our objective was to provide the first comprehensive picture of alcohol use and binge drinking by US college students with disabilities (SWDs), who represent at least 11% (1.6 million) of the US college student population. Methods: In fall 2013, we used a stratified random sampling technique to identify and recruit 2440 SWDs from 122 US colleges and universities. A total of 1285 (53%) SWDs from 61 (50%) colleges and universities completed a survey of alcohol and other drug use and the use of substances by student peers. We conducted 4 multiple logistic regression analyses to compare binge-drinking and non-binge-drinking SWDs by potential correlates of such use and a final model that included only significant variables. Results: SWDs aged <21 vs >= 21 (odds ratio [OR] = 0.90; 95% confidence interval [CI], 0.82-0.99) who spent more time vs less time socializing (OR = 1.24; 95% CI, 1.11-1.38), who spent less time vs more time studying (OR = -0.89; 95% CI, -0.80 to -0.99), and who used vs did not use marijuana (OR = 1.44; 95% CI, 1.18-1.75) or amphetamines (OR = 1.82; 95% CI, 1.15-2.89) were significantly more likely to binge drink. SWDs who reported using barbiturates were less likely to binge drink than were those who did not use barbiturates (OR = -0.36; 95% CI, -0.21 to -0.61). In the final model, use of amphetamines (OR = 1.74; 95% CI, 1.15-2.65) or marijuana (OR = 1.60; 95% CI, 1.32-1.94) was the highest predictor of binge drinking. Conclusion: SWDs' reported rates of binge drinking, although high, were not as high as those of nondisabled college students. Nevertheless, prevention efforts should be targeted toward college SWDs.	[West, Steven L.] Univ Memphis, Dept Counseling Educ Psychol & Res, Ball Hall 100A, Memphis, TN 38152 USA; [Graham, Carolyn W.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Temple, Peter] Virginia Commonwealth Univ, Dept Special Educ & Disabil Policy, Richmond, VA USA		West, SL (corresponding author), Univ Memphis, Dept Counseling Educ Psychol & Res, Ball Hall 100A, Memphis, TN 38152 USA.	slwest@memphis.edu			National Institute on Disability, Independent Living and Rehabilitation ResearchUnited States Department of Health & Human Services [H133G080123]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by grant H133G080123 from the National Institute on Disability, Independent Living and Rehabilitation Research.	Baker D. A., 1998, J APPL REHABILITATIO, V29, P18; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Burgard JF, 2000, J PSYCHOACTIVE DRUGS, V32, P293, DOI 10.1080/02791072.2000.10400452; BUSS A, 1989, INCIDENCE ALCOHOL US; *COMM SUBST AB COL, 1994, RETH RIT PASS SUBST; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1111/j.1360-0443.1995.tb03552.x; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Drubach D A, 1993, Md Med J, V42, P989; FLEMING MF, 1991, INT J ADDICT, V26, P1173, DOI 10.3109/10826089109062153; Heinemann A. W., 1989, ALCOHOL HEALTH RES W, V13, P110; Henderson C, 2001, COLL FRESHMEN WITH D; Hingson R, 2005, ANNU REV PUBL HEALTH, V26, P259, DOI 10.1146/annurev.publhealth.26.021304.144652; Hingson RW, 2002, J STUD ALCOHOL, V63, P136, DOI 10.15288/jsa.2002.63.136; Hollar D, 2004, SUBST USE MISUSE, V39, P931, DOI 10.1081/JA-120030894; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Lindsay S, 2014, DISABIL REHABIL, V36, P2195, DOI 10.3109/09638288.2014.892158; LO CC, 1993, J DRUG ISSUES, V23, P715, DOI 10.1177/002204269302300410; Lysandropoulos AP, 2015, EUR J NEUROL, V22, P28, DOI 10.1111/ene.12801; Mason TC, 2009, J AM DEAF REHAB ASS, V42, P90; MCCRONE WP, 1994, J AM DEAFNESS REHABI, V28, P1; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; Mohler-Kuo M, 2004, J STUD ALCOHOL, V65, P37, DOI 10.15288/jsa.2004.65.37; MOORE D, 1991, INT J ADDICT, V26, P65, DOI 10.3109/10826089109056240; Moore D, 1989, ALCOHOL HEALTH RES W, V13, P118; Nelipovich M, 1998, J VISUAL IMPAIR BLIN, V92, P567, DOI 10.1177/0145482X9809200805; O'Hare T, 1999, J SUBST ABUSE TREAT, V17, P113, DOI 10.1016/S0740-5472(98)00063-4; O'Hare T, 1998, J ALCOHOL DRUG EDUC, V43, P75; OHare T, 1997, J SUBST ABUSE TREAT, V14, P383, DOI 10.1016/S0740-5472(97)00033-0; Paul S., 2000, COLL STUD J, V34, P200; Presley C A, 1994, J Am Coll Health, V42, P248; Raue K, 2011, STUDENTS DISABILITIE; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Snyder T.D., 2015, DIGEST ED STAT 2013; Substance Abuse and Mental Health Services Administration, 2011, HHS PUBL, V11-4658; Substance Abuse and Mental Health Services Administration, 2011, SUBST US DIS PEOPL P, V6, P1; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thomson L, 2014, DEV MED CHILD NEUROL, V56, P421, DOI 10.1111/dmcn.12335; Wechsler H, 1998, J AM COLL HEALTH, V47, P57, DOI 10.1080/07448489809595621; Weiss R. D., 1998, CLIN TXB ADDICTIVE D, P291; Weitzman ER, 2003, J ADOLESCENT HEALTH, V32, P26, DOI 10.1016/S1054-139X(02)00457-3; West S. L., 2001, J ALCOHOL DRUG EDUC, V46, P4; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Westermeyer J, 1996, AM J ADDICTION, V5, P23; White A, 2013, ALCOHOL RES-CURR REV, V35, P201; Wolf LE, 2001, ANN NY ACAD SCI, V931, P385	45	5	5	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-3549	1468-2877		PUBLIC HEALTH REP	Public Health Rep.	JUL-AUG	2017	132	4					496	504		10.1177/0033354917713470			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EZ8TO	WOS:000405001100013	28637382	Bronze, Green Published			2022-02-06	
J	Westermaier, T; Nickl, R; Koehler, S; Fricke, P; Stetter, C; Rueckriegel, SM; Ernestus, RI				Westermaier, Thomas; Nickl, Robert; Koehler, Stefan; Fricke, Patrick; Stetter, Christian; Rueckriegel, Stefan Mark; Ernestus, Ralf-Ingo			Selective Brain Cooling after Traumatic Brain Injury: Effects of Three Different Cooling Methods-Case Report	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						selective brain cooling; hypothermia; traumatic brain injury; TBI; intracranial pressure	COMBINATION-DRUG THERAPY; MILD HYPOTHERMIA; CEREBRAL HYPOTHERMIA; PERINATAL ASPHYXIA; NEUROPROTECTION; TEMPERATURE; BLOOD; INTRANASAL; ISCHEMIA; MODEL	Background In experimental models of neuronal damage, therapeutic hypothermia proved to be a powerful neuroprotective method. In clinical studies of traumatic brain injury (TBI), this very distinct effect was not reproducible. Several meta-analyses draw different conclusions about whether therapeutic hypothermia can improve outcome after TBI. Adverse side effects of systemic hypothermia, such as severe pneumonia, have been held responsible by some authors to counteract the neuroprotective effect. Selective brain cooling (SBC) attempts to take advantage of the protective effects of therapeutic hypothermia without the adverse side effects of systemic hypothermia. Methods Three different methods of SBC were applied in a patient who had severe TBI with recurrent increases of intracranial pressure (ICP) refractory to conventional forms of treatment: (1) external cooling of the scalp and neck using ice packs prior to hemicraniectomy, (2) external cooling of the craniectomy defect using ice packs after hemicraniectomy, and (3) cooling by epidural irrigation with cold Ringer solution after hemicraniectomy. Results External scalp cooling before hemicraniectomy, external cooling of the craniectomy defect, and epidural irrigation with cold fluid resulted in temperature differences (brain temperature to body temperature) of -0.2 degrees, -0.7 degrees, and -3.6 degrees C, respectively. ICP declined with decreasing brain temperature. Conclusion Previous external cooling attempts for SBC faced the problem that brain temperature could not be lowered without a simultaneous decrease of systemic temperature. After hemicraniectomy, epidural irrigation with cold fluid may be a simple and effective way to lower ICP and apply one of the most powerful methods of cerebroprotection after severe TBI.	[Westermaier, Thomas; Nickl, Robert; Koehler, Stefan; Fricke, Patrick; Stetter, Christian; Rueckriegel, Stefan Mark; Ernestus, Ralf-Ingo] Univ Hosp Wuerzburg, Dept Neurosurg, Josef Schneider Str 11, D-97265 Wurzburg, Germany		Westermaier, T (corresponding author), Univ Hosp Wuerzburg, Dept Neurosurg, Josef Schneider Str 11, D-97265 Wurzburg, Germany.	Westermaie_T@ukw.de	Nickl, Robert/AAE-6948-2019; Westermaier, Thomas/AAE-2701-2019; Rueckriegel, Stefan M./AAE-4002-2019				Busch HJ, 2010, RESUSCITATION, V81, P943, DOI 10.1016/j.resuscitation.2010.04.027; Cheng H, 2006, ACTA NEUROCHIR, V148, P559, DOI 10.1007/s00701-006-0735-3; Christian E, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E9; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Dvilevicius AE, 2008, ARQ NEURO-PSIQUIAT, V66, P391, DOI 10.1590/S0004-282X2008000300021; Esposito E, 2014, J CEREBR BLOOD F MET, V34, P743, DOI 10.1038/jcbfm.2014.29; Forte LV, 2009, ARQ NEURO-PSIQUIAT, V67, P480, DOI 10.1590/S0004-282X2009000300019; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Harris B, 2008, RESUSCITATION, V78, P102, DOI 10.1016/j.resuscitation.2008.02.013; Holzer M, 2002, NEW ENGL J MED, V346, P549; Horn AR, 2006, SAMJ S AFR MED J, V96, P976; Idris Zamzuri, 2014, Asian J Neurosurg, V9, P115, DOI 10.4103/1793-5482.142690; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; KULUZ JW, 1992, STROKE, V23, P1792, DOI 10.1161/01.STR.23.12.1792; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; Nybo L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00079; Prandini MN, 2005, ARQ NEURO-PSIQUIAT, V63, P779, DOI 10.1590/S0004-282X2005000500012; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Scholler K, 2004, BRAIN RES, V1023, P272, DOI 10.1016/j.brainres.2004.01.094; Schwartz AE, 1996, NEUROSURGERY, V39, P577; SOUREK K, 1970, J NEUROSURG, V33, P253, DOI 10.3171/jns.1970.33.3.0253; Straus D, 2011, ARQ NEURO-PSIQUIAT, V69, P981, DOI 10.1590/S0004-282X2011000700025; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Takeda Y, 2014, RESUSCITATION, V85, P1647, DOI 10.1016/j.resuscitation.2014.09.014; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wei G, 2008, J NEUROTRAUM, V25, P549, DOI 10.1089/neu.2007.0498; Zausinger S, 2003, STROKE, V34, P1526, DOI 10.1161/01.STR.0000070841.31224.29	29	5	5	0	5	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	JUL	2017	78	4					397	402		10.1055/s-0036-1596057			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FB2VT	WOS:000406002000013	28038481				2022-02-06	
J	Zhao, J; Yuan, Q; Cai, WH; Sun, P; Ding, LY; Jin, F				Zhao, Jin; Yuan, Quan; Cai, WeiHui; Sun, Pan; Ding, LiYan; Jin, Fang			Formulation, Optimization, Characterization, and Pharmacokinetics of Progesterone Intravenous Lipid Emulsion for Traumatic Brain Injury Therapy	AAPS PHARMSCITECH			English	Article						high homogenization; intravenous lipid emulsion; progesterone; stability; traumatic brain injury	PARTICLE-SIZE; INTRAMUSCULAR INJECTION; INJECTABLE EMULSIONS; FAT EMULSIONS; CRUDE-OIL; STABILITY; TRIAL; HOMOGENIZATION; MICROEMULSION; CHALLENGES	Traumatic brain injury (TBI) is a major cause of mortality and disability throughout the world. Progesterone (PROG) plays an important role in neurologic treatment. The aim of this study was to develop a progesterone formulation with good physical and chemical stability. Progesterone intravenous lipid emulsion (PILE) was prepared based on one-factor-at-a-time experiments and orthogonal design. The optimal PILE was evaluated for mean particle size, particle size distribution, zeta potential, morphology, pH, osmolarity, entrapment efficiency, storage stability, and pharmacokinetics in ICR mice compared with the commercial progesterone products. The droplets of PILE had the smallest possible diameters of 218.0 +/- 1.8 nm and adequate zeta potential of -41.1 +/- 0.9 mV. The volume percentage of droplets exceeding 5 mu m (PFAT(5)) of PILE was 0.003 +/- 0.0015% and much less than the specified standard. The TEM imaging proved that emulsion droplets had a smooth spherical appearance. Chemically and physically stable PILE was obtained with excellent entrapment efficiency that was up to 95.23%, with suitable pH at 7.15 +/- 0.01 and osmolarity at 301.3 +/- 1.2 mOsmol/l. Storage stability tests indicated that the emulsion was stable long term under ambient temperature conditions. Animal studies demonstrated that the emulsion was more effective with the higher progesterone concentration in the brain compared with commercial products. Therefore, the optimized PILE would offer great promise as a means of progesterone delivery for TBI therapy.	[Zhao, Jin; Yuan, Quan; Cai, WeiHui; Ding, LiYan; Jin, Fang] Shanghai Engn Res Ctr Lipid Emuls, Shanghai 201203, Peoples R China; [Zhao, Jin; Cai, WeiHui; Sun, Pan; Jin, Fang] Shanghai FrontHlth Pharmaceut Technol Co Ltd, Shanghai 201203, Peoples R China		Yuan, Q; Cai, WH (corresponding author), Shanghai Engn Res Ctr Lipid Emuls, Shanghai 201203, Peoples R China.; Cai, WH (corresponding author), Shanghai FrontHlth Pharmaceut Technol Co Ltd, Shanghai 201203, Peoples R China.	yqdna@hotmail.com; cwhfyjk@163.com			Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2013ZX09301302-002]	The financial support in the form of a grant from the Ministry of Science and Technology of China (Project No. 2013ZX09301302-002) is gratefully acknowledged.	Ashrafizadeh SN, 2010, J PETROL SCI ENG, V71, P205, DOI 10.1016/j.petrol.2010.02.005; Baker MT, 2005, ANESTHESIOLOGY, V103, P860, DOI 10.1097/00000542-200510000-00026; BOCK TK, 1994, EUR J PHARM BIOPHARM, V40, P157; Bollam S, 2011, AAPS PHARMSCITECH, V12, P422, DOI 10.1208/s12249-011-9604-3; Cai WH, 2012, INT J PHARMACEUT, V436, P536, DOI 10.1016/j.ijpharm.2012.07.008; Chang J, 2015, EXP NEUROL, V273, P225, DOI 10.1016/j.expneurol.2015.08.020; CHASSARD D, 1994, CRIT CARE MED, V22, P248, DOI 10.1097/00003246-199402000-00015; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Driscoll DF, 2006, PHARM RES-DORDR, V23, P1959, DOI 10.1007/s11095-006-9092-4; Driscoll DF, 2009, INT J PHARMACEUT, V379, P125, DOI 10.1016/j.ijpharm.2009.06.021; Floyd AG, 1999, PHARM SCI TECHNOL TO, V2, P134, DOI 10.1016/S1461-5347(99)00141-8; FUJITA T, 1971, EUR SURG RES, V3, P436, DOI 10.1159/000127590; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Garrett R, 2013, TRENDS ANAESTH CRIT, V3, P336, DOI 10.1016/j.tacc.2013.04.001; Ghambarian M, 2009, TALANTA, V78, P970, DOI 10.1016/j.talanta.2009.01.002; Gonyon T, 2007, INT J PHARM, V343, P208, DOI 10.1016/j.ijpharm.2007.05.038; Guo XF, 2014, FOOD HYDROCOLLOID, V35, P217, DOI 10.1016/j.foodhyd.2013.05.010; Hamamoto DT, 2000, BRAIN RES, V862, P217, DOI 10.1016/S0006-8993(00)02138-7; Hardy G, 2009, NUTR CLIN PRACT, V24, P616, DOI 10.1177/0884533609342445; Hippalgaonkar K, 2010, AAPS PHARMSCITECH, V11, P1526, DOI 10.1208/s12249-010-9526-5; Huang X, 2001, FOOD HYDROCOLLOID, V15, P533, DOI 10.1016/S0268-005X(01)00091-1; Innings F, 2001, METHOD HOMOGENIZATIO; Jain J, 2010, AAPS PHARMSCITECH, V11, P826, DOI 10.1208/s12249-010-9440-x; Johnsen EE, 2003, J PETROL SCI ENG, V38, P23, DOI 10.1016/S0920-4105(03)00020-2; LAVALJEANTET AM, 1982, INVEST RADIOL, V17, P617, DOI 10.1097/00004424-198211000-00016; Liu SQ, 2015, J PHYS CHEM SOLIDS, V79, P82, DOI 10.1016/j.jpcs.2014.12.009; Nii T, 2004, COLLOID SURFACE B, V39, P57, DOI 10.1016/j.colsurfb.2004.08.017; Nony P, 2001, VACCINE, V19, P3645, DOI 10.1016/S0264-410X(01)00098-6; Orafidiya LO, 2002, INT J PHARMACEUT, V237, P241, DOI 10.1016/S0378-5173(02)00051-0; PAL R, 1989, J RHEOL, V33, P1021, DOI 10.1122/1.550044; Peng J, 2015, J FOOD DRUG ANAL, V23, P828, DOI 10.1016/j.jfda.2015.04.004; Ruan XY, 2014, MATURITAS, V79, P248, DOI 10.1016/j.maturitas.2014.07.009; Salem HF, 2010, INT J NANOMED, V5, P943, DOI 10.2147/IJN.S12947; Shi S, 2009, INT J PHARMACEUT, V373, P147, DOI 10.1016/j.ijpharm.2009.02.006; Sila-On W, 2008, AAPS PHARMSCITECH, V9, P684, DOI 10.1208/s12249-008-9089-x; Silverberg KM, 2012, FERTIL STERIL, V97, P344, DOI 10.1016/j.fertnstert.2011.11.018; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Telessy IG, 2009, COLLOID SURFACE B, V72, P75, DOI 10.1016/j.colsurfb.2009.03.016; Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0; Wong R, 2012, J PHARM PHARMACOL, V64, P1614, DOI 10.1111/j.2042-7158.2012.01537.x; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wu X, 2011, APPL ENERG, V88, P3615, DOI 10.1016/j.apenergy.2011.04.041; Wutzler S, 2015, INJURY, V46, P1706, DOI 10.1016/j.injury.2015.02.013; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu YL, 2008, BIOL PHARM BULL, V31, P673, DOI 10.1248/bpb.31.673; Yue PF, 2009, AAPS PHARMSCITECH, V10, P376, DOI 10.1208/s12249-009-9216-3; ZhuD Birzniece V, 2004, BRIT J ANAESTH, V93, P560	50	5	6	3	18	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1530-9932			AAPS PHARMSCITECH	AAPS PharmSciTech	JUL	2017	18	5					1475	1487		10.1208/s12249-016-0637-5			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EZ2OW	WOS:000404549600007	27796907				2022-02-06	
J	Ding, X; Wu, HH; Ji, SJ; Cai, S; Dai, PW; Xu, ML; Zhang, JJ; Zhang, QX; Tian, Y; Ma, QH				Ding, Xin; Wu, Hao-Hao; Ji, Sheng-Jun; Cai, Shang; Dai, Pei-Wen; Xu, Mei-Ling; Zhang, Jun-Jun; Zhang, Qi-Xian; Tian, Ye; Ma, Quan-Hong			The p75 neurotrophin receptor regulates cranial irradiation-induced hippocampus-dependent cognitive dysfunction	ONCOTARGET			English	Article						hippocampus; cognitive dysfunction; neurogenesis; dendritic spine; p75(NTR)	LONG-TERM DEPRESSION; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; HUNTINGTONS-DISEASE; KNOCKOUT MICE; IN-VIVO; NEUROGENESIS IMPAIRMENT; SPINE MORPHOLOGY; P75(NTR); MEMORY	Cognitive deficits, characterized by progressive problems with hippocampus-dependent learning, memory and spatial processing, are the most serious complication of cranial irradiation. However, the underlying mechanisms remain obscure. The p75 neurotrophin receptor (p75(NTR)) is involved in a diverse arrays of cellular responses, including neurite outgrowth, neurogenesis, and negative regulation of spine density, which are associated with various neurological disorders. In this study, male Sprague-Dawley (SD) rats received 10 Gy cranial irradiation. Then, we evaluated the expression of p75NTR in the hippocampus after cranial irradiation and explored its potential role in radiation-induced synaptic dysfunction and memory deficits. We found that the expression of p75(NTR) was significantly increased in the irradiated rat hippocampus. Knockdown of p75(NTR) by intrahippocampal infusion of AAV8-shp75 ameliorated dendritic spine abnormalities, and restored synapse-related protein levels, thus preventing memory deficits, likely through normalization the phosphor-AKT activity. Moreover, viral-mediated overexpression of p75(NTR) in the normal hippocampus reproduced learning and memory deficits. Overall, this study demonstrates that p75(NTR) is an important mediator of irradiation-induced cognitive deficits by regulating dendritic development and synapse structure.	[Ding, Xin; Wu, Hao-Hao; Ji, Sheng-Jun; Cai, Shang; Dai, Pei-Wen; Xu, Mei-Ling; Zhang, Jun-Jun; Zhang, Qi-Xian; Tian, Ye] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China; [Ding, Xin; Wu, Hao-Hao; Cai, Shang; Dai, Pei-Wen; Xu, Mei-Ling; Zhang, Jun-Jun; Zhang, Qi-Xian; Tian, Ye] Soochow Univ, Inst Radiotherapy & Oncol, Suzhou, Peoples R China; [Ding, Xin; Wu, Hao-Hao; Cai, Shang; Dai, Pei-Wen; Xu, Mei-Ling; Zhang, Jun-Jun; Zhang, Qi-Xian; Tian, Ye] Suzhou Key Lab Radiat Oncol, Suzhou, Peoples R China; [Ji, Sheng-Jun] Nanjing Med Univ, Dept Radiotherapy & Oncol, Affiliated Suzhou Hosp, Suzhou, Peoples R China; [Ma, Quan-Hong] Soochow Univ, Jiangsu Key Lab Translat Res & Therapy Neuropsych, Suzhou, Peoples R China; [Ma, Quan-Hong] Soochow Univ, Inst Neurosci, Suzhou, Peoples R China		Tian, Y (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China.; Tian, Y (corresponding author), Soochow Univ, Inst Radiotherapy & Oncol, Suzhou, Peoples R China.; Tian, Y (corresponding author), Suzhou Key Lab Radiat Oncol, Suzhou, Peoples R China.	dryetian@126.com	Ji, Shengjun/AAZ-7635-2020	Ma, Quanhong/0000-0001-9392-8956	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372411, 81172128, 81402517]; Jiangsu Provincial Special Program of Clinical Medical Science [BL2014040]; Suzhou Science and Technology [SYS201651]; Graduate Scientific Research and Innovation Project of Soochow University [KYLX15_1229, KYLX14_1267]	This work was supported by the National Natural Science Foundation of China, Grant nos. 81372411, 81172128 and 81402517; Jiangsu Provincial Special Program of Clinical Medical Science No. BL2014040; Suzhou Science and Technology Project No. SYS201651; Graduate Scientific Research and Innovation Project of Soochow University No. KYLX15_1229 and KYLX14_1267. Jiangsu Provincial Medical Youth Talent QNRC2016234.	Barrett GL, 2010, HIPPOCAMPUS, V20, P145, DOI 10.1002/hipo.20598; Brito V, 2014, J CLIN INVEST, V124, P4411, DOI 10.1172/JCI74809; Cragnolini AB, 2008, TRENDS NEUROSCI, V31, P99, DOI 10.1016/j.tins.2007.11.005; Cragnolini AB, 2009, GLIA, V57, P1386, DOI 10.1002/glia.20857; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Egashira Y, 2010, J NEUROSCI RES, V88, P3433, DOI 10.1002/jnr.22505; Ferre S, 2007, BRAIN RES REV, V55, P55, DOI 10.1016/j.brainresrev.2007.01.007; Fike JR, 2009, SEMIN RADIAT ONCOL, V19, P122, DOI 10.1016/j.semradonc.2008.12.003; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; Greene-Schloesser D, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00073; Greferath U, 2000, EUR J NEUROSCI, V12, P885, DOI 10.1046/j.1460-9568.2000.00976.x; Guo JJ, 2013, STEM CELL RES, V11, P874, DOI 10.1016/j.scr.2013.05.004; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hu XY, 2002, EXP NEUROL, V178, P104, DOI 10.1006/exnr.2002.8018; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ji JF, 2014, BIOCHEM BIOPH RES CO, V443, P646, DOI 10.1016/j.bbrc.2013.12.031; Ji SJ, 2014, BRAIN RES, V1577, P77, DOI 10.1016/j.brainres.2014.06.035; Kitanishi T, 2009, CEREB CORTEX, V19, P2572, DOI 10.1093/cercor/bhp012; Knowles JK, 2013, NEUROBIOL AGING, V34, P2052, DOI 10.1016/j.neurobiolaging.2013.02.015; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Meeker R, 2014, J NEUROIMMUNE PHARM, V9, P615, DOI 10.1007/s11481-014-9566-9; Meeker RB, 2015, NEURAL REGEN RES, V10, P721, DOI 10.4103/1673-5374.156967; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; Nicolai S, 2015, AGING-US, V7, P1050, DOI 10.18632/aging.100858; Niklison-Chirou MV, 2013, P NATL ACAD SCI USA, V110, P18952, DOI 10.1073/pnas.1221172110; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; Nykjaer A, 2012, TRENDS NEUROSCI, V35, P261, DOI 10.1016/j.tins.2012.01.003; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724; Rao AAN, 2011, J NEURO-ONCOL, V105, P191, DOI 10.1007/s11060-011-0582-9; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Shu YH, 2015, BIOMED PHARMACOTHER, V76, P17, DOI 10.1016/j.biopha.2015.10.010; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Son Y, 2015, BRAIN BEHAV IMMUN, V45, P287, DOI 10.1016/j.bbi.2015.01.007; Son Y, 2014, EXP NEUROL, V254, P134, DOI 10.1016/j.expneurol.2014.01.018; Soussain C, 2009, LANCET, V374, P1639, DOI 10.1016/S0140-6736(09)61299-X; Titus ADJ, 2007, NEUROSCIENCE, V145, P265, DOI 10.1016/j.neuroscience.2006.11.037; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Verbeke S, 2010, CELL SIGNAL, V22, P1864, DOI 10.1016/j.cellsig.2010.07.014; White E, 1999, NATURE, V399, P734, DOI 10.1038/21539; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Woods GF, 2011, J NEUROSCI, V31, P12129, DOI 10.1523/JNEUROSCI.6662-10.2011; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005	52	5	5	1	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	JUN 20	2017	8	25					40544	40557		10.18632/oncotarget.16492			14	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	EY8YG	WOS:000404283700049	28380447	Green Published, gold, Green Submitted			2022-02-06	
J	Yu, ZZ; Jiang, SJ; Jia, ZS; Xiao, HY; Zhou, MQ				Yu, Zeng-Zhi; Jiang, Shu-Jun; Jia, Zi-Shan; Xiao, Hong-Yu; Zhou, Mei-Qi			Study on Language Rehabilitation for Aphasia	CHINESE MEDICAL JOURNAL			English	Article						Aphasia; Evidence-based; Rehabilitation; Stroke	POSTSTROKE APHASIA; THERAPY; STROKE; PROGRAMS; SPEECH; COMMUNICATION; MANAGEMENT; INTENSITY; OUTCOMES; QUALITY	Objective: The aim is to update our clinical recommendations for evidence-based language rehabilitation of people with aphasia, based on a systematic review of the literature from 1999 to 2015. Data Sources: Articles referred to in this systematic review of the Medline and PubMed published in English language literatures were from 1998 to 2015. The terms used in the literature searches were aphasia and evidenced-based. Study Selection: The task force initially identified citations for 51 published articles. Of the 51 articles, 44 studies were selected after further detailed review. Six articles, which were not written in English, and one study related to laryngectomy rehabilitation interventions, were excluded from the study. This study referred to all the important and English literature in full. Results: Aphasia is the linguistic disability, which usually results from injuries to the dominant hemisphere of the brain. The rehabilitation of aphasia is until in the process of being debated and researched. Evidence-based medicine (EBM), EBM based on the clinical evidence, promotes the practice of combining the clinicians' first-hand experience and the existing objective and scientific evidence encouraging making decisions based on both empirical evidence and the scientific evidence. Currently, EBM is being gradually implemented in the clinical practice as the aim of the development of modern medicine. Conclusions: At present, the research for the aphasia rehabilitation mainly focuses on the cognitive language rehabilitation and the intensive treatment and the precise treatment, etc. There is now sufficient information to support evidence-based protocols and implement empirically-supported treatments for linguistic disability after traumatic brain injury and stroke, which can be used to develop linguistic rehabilitation guidelines for patients with aphasia.	[Yu, Zeng-Zhi; Jia, Zi-Shan; Xiao, Hong-Yu; Zhou, Mei-Qi] Chinese Peoples Liberat Army Gen Hosp, Rehabil Med Ctr, Beijing 100853, Peoples R China; [Jiang, Shu-Jun] Navy Gen Hosp, Very Important Person Neurol Ward, Beijing 100048, Peoples R China		Jiang, SJ (corresponding author), Navy Gen Hosp, Very Important Person Neurol Ward, Beijing 100048, Peoples R China.	jsj_bj@126.com					Babbitt EM, 2013, TOP STROKE REHABIL, V20, P398, DOI 10.1310/tsr2005-398; Bakheit AMO, 2007, CLIN REHABIL, V21, P885, DOI 10.1177/0269215507078486; Baldo JV, 2005, BRAIN LANG, V92, P240, DOI 10.1016/j.bandl.2004.06.103; Beeson PM, 2006, NEUROPSYCHOL REV, V16, P161, DOI 10.1007/s11065-006-9013-7; Best W, 2008, INT J LANG COMM DIS, V43, P390, DOI 10.1080/13682820701608001; Chemey LR, 2013, INT J SPEECH-LANG PA, V15, P535, DOI [10.3109/17549507.2013.763289, DOI 10.3109/17549507.2013.763289]; Cherney LR, 2008, J SPEECH LANG HEAR R, V51, P1282, DOI 10.1044/1092-4388(2008/07-0206); Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Dash T, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/679706; de Oliveira FF, 2013, NEURAL REGEN RES, V8, P1236, DOI 10.3969/j.issn.1673-5374.2013.13.009; de Salles JF, 2012, ARQ NEURO-PSIQUIAT, V70, P718, DOI 10.1590/S0004-282X2012000900014; Doesborgh SJC, 2004, STROKE, V35, P141, DOI 10.1161/01.STR.0000105460.52928.A6; Foster A, 2015, INT J LANG COMM DIS, V50, P547, DOI 10.1111/1460-6984.12155; Greener J, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000425; Hersh D, 2010, INT J LANG COMM DIS, V45, P263, DOI 10.3109/13682820902994200; Hilari K, 2012, ARCH PHYS MED REHAB, V93, pS86, DOI 10.1016/j.apmr.2011.05.028; Hinckley JJ, 2013, AM J SPEECH-LANG PAT, V22, pS279, DOI 10.1044/1058-0360(2012/12-0092); Hula WD, 2013, TOP STROKE REHABIL, V20, P409, DOI 10.1310/tsr2005-409; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; LaFrance C, 2007, J COMMUN DISORD, V40, P215, DOI 10.1016/j.jcomdis.2006.06.010; Larrabee GJ, 2015, AM PSYCHOL, V70, P779, DOI 10.1037/a0039835; Leners J C, 2013, Bull Soc Sci Med Grand Duche Luxemb, P33; Li WB, 2013, CHINESE MED J-PEKING, V126, P4794, DOI 10.3760/cma.j.issn.0366-6999.20132430; Li WB, 2009, CHINESE MED J-PEKING, V122, P1901, DOI 10.3760/cma.j.issn.0366-6999.2009.16.012; Maddy K. M., 2014, Annals of Physical and Rehabilitation Medicine, V57, P254, DOI 10.1016/j.rehab.2014.03.002; Meinzer M, 2005, STROKE, V36, P1462, DOI 10.1161/01.STR.0000169941.29831.2a; Olness GS, 2012, SEMIN SPEECH LANG, V33, P55, DOI 10.1055/s-0031-1301163; Olofsson JK, 2013, BRAIN, V136, P1245, DOI 10.1093/brain/awt019; Persad C, 2013, TOP STROKE REHABIL, V20, P388, DOI 10.1310/tsr2005-388; Plowman E, 2012, J EVAL CLIN PRACT, V18, P689, DOI 10.1111/j.1365-2753.2011.01650.x; Poslawsky IE, 2010, J CLIN NURS, V19, P17, DOI 10.1111/j.1365-2702.2009.03023.x; Power E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007641; Ramsberger G, 2014, SEMIN SPEECH LANG, V35, P17, DOI 10.1055/s-0033-1362992; Rohde A, 2013, J EVAL CLIN PRACT, V19, P994, DOI 10.1111/jep.12023; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rose ML, 2013, TOP STROKE REHABIL, V20, P379, DOI 10.1310/tsr2005-379; Winans-Mitrik RL, 2014, AM J SPEECH-LANG PAT, V23, P330, DOI 10.1044/2014_AJSLP-13-0102; Wong ISY, 2013, REV NEUROSCIENCE, V24, P105, DOI 10.1515/revneuro-2012-0072; Xu XJ, 2004, CHINESE MED J-PEKING, V117, P1011; Yu ZZ, 2013, CHINESE MED J-PEKING, V126, P1252, DOI 10.3760/cma.j.issn.0366-6999.20121463	40	5	7	3	30	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JUN 20	2017	130	12					1491	1497		10.4103/0366-6999.207465			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6TA	WOS:000403373800017	28584214	gold, Green Published			2022-02-06	
J	Broglio, SP; Williams, R; Lapointe, A; Rettmann, A; Moore, B; Meehan, SK; Eckner, JT				Broglio, Steven P.; Williams, Richelle; Lapointe, Andrew; Rettmann, Ashley; Moore, Brandon; Meehan, Sean K.; Eckner, James T.			Brain Network Activation Technology Does Not Assist with Concussion Diagnosis and Return to Play in Football Athletes	FRONTIERS IN NEUROLOGY			English	Article						concussion; cognitive function; neuroelectric function; brain networking; neurostatus	SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; ERROR SCORING SYSTEM; POSTCONCUSSIVE SYMPTOMS; RELIABLE CHANGE; REACTION-TIME; HIGH-SCHOOL; INJURY; STATEMENT; ATTENTION	Background: Concussion diagnosis and management remains a largely subjective process. This investigation sought to evaluate the utility of a novel neuroelectric measure for concussion diagnosis and return to play decision-making. Hypothesis: Brain Network Activation (BNA) scores obtained within 72-h of injury will be lower than the athlete's preseason evaluation and that of a matched control athlete; and the BNA will demonstrate ongoing declines at the return to play and post-season time points, while standard measures will have returned to pre-injury and control athlete levels. Design: Case-control study. Methods: Football athletes with a diagnosed concussion (n = 8) and matched control football athletes (n = 8) completed a preseason evaluation of cognitive (i.e., Cogstate Computerized Cognitive Assessment Tool) and neuroelectric function (i.e., BNA), clinical reaction time, SCAT3 self-reported symptoms, and quality of life (i.e., Health Behavior Inventory and Satisfaction with Life Scale). Following a diagnosed concussion, injured and control athletes completed post-injury evaluations within 72-h, once asymptomatic, and at the conclusion of the football season. Results: Case analysis of the neuroelectric assessment failed to provide improved diagnostics beyond traditional clinical measures. Statistical analyses indicated significant BNA improvements in the concussed and control groups from baseline to the asymptomatic timepoint. Conclusion: With additional attention being placed on rapid and accurate concussion diagnostics and return to play decision-making, the addition of a novel neuroelectric assessment does not appear to provide additional clinical benefit at this time. Clinicians should continue to follow the recommendations for the clinical management of concussion with the assessment of the symptom, cognitive, and motor control domains.	[Broglio, Steven P.] Univ Michigan, Injury Ctr, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Williams, Richelle; Lapointe, Andrew; Rettmann, Ashley] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Moore, Brandon] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48109 USA; [Meehan, Sean K.] Univ Michigan, Human Sensorimotor Lab, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Michigan NeuroSport, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Broglio, SP (corresponding author), Univ Michigan, Injury Ctr, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA.	broglio@umich.edu	Lapointe, Andrew/L-5698-2019; Meehan, Sean K/N-6237-2018	Lapointe, Andrew/0000-0002-9360-6428; Meehan, Sean K/0000-0002-9848-8803; Williams, Richelle/0000-0003-4728-7443	National Institutes of Health: National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS081691-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS081691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024824] Funding Source: NIH RePORTER	This investigation was funded by the National Institutes of Health: National Institute of Neurological Disorders and Stroke (1R15NS081691-01) and BNA calculations were provided by ElMindA, Ltd.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Broglio SP, 2016, INT J SPORTS MED, V37, P714, DOI 10.1055/s-0042-107250; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Chamard E, 2014, PROG NEUROL SURG, V28, P75, DOI 10.1159/000358766; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Eckner JT, 2016, BRAIN INJURY, V30, P1075, DOI 10.3109/02699052.2016.1160152; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Henry LC, 2014, PROG NEUROL SURG, V28, P63, DOI 10.1159/000358763; Kiefer AW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00243; Kirmizi-Alsan E, 2006, BRAIN RES, V1104, P114, DOI 10.1016/j.brainres.2006.03.010; Kobau R, 2010, APPL PSYCHOL-HLTH WE, V2, P272, DOI 10.1111/j.1758-0854.2010.01035.x; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Maxwell SE., 1990, DESIGNING EXPT ANAL; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Reches A, 2017, BRAIN INJURY, V31, P237, DOI 10.1080/02699052.2016.1231343; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; SHELLEY AM, 1991, PSYCHOPHYSIOLOGY, V28, P496, DOI 10.1111/j.1469-8986.1991.tb01987.x; Stern Y, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00137; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082	54	5	5	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 6	2017	8								252	10.3389/fneur.2017.00252			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EX6YK	WOS:000403388000001	28634467	Green Published, gold			2022-02-06	
J	Adams, J; Moore, B				Adams, Joseph; Moore, Brian			Return to Meaningful Activities After a Multi-Modal Rehabilitation Programme among Individuals Who Experience Persistent Dizziness and Debility Longer Than 9 Months after Sustaining a Concussion: A Case Series	PHYSIOTHERAPY CANADA			English	Article						aerobic exercise; brain concussion; post-concussion syndrome; traumatic brain injury; vestibular rehabilitation	TRAUMATIC BRAIN-INJURY; FUNCTIONAL GAIT ASSESSMENT; SPORT-RELATED CONCUSSION; MILD HEAD-INJURY; VESTIBULAR REHABILITATION; SYMPTOMS QUESTIONNAIRE; BALANCE DISORDERS; RELIABILITY; VALIDITY; SCALE	Purpose: The authors explored changes in outcome measures and return to meaningful life activities in six individuals who participated in a home-based multi-modal rehabilitation programme to address persistent dizziness and debility that had continued for more than 9 months since a documented concussion. Methods: In a case series using a repeated-measures design, changes from pre-to post-treatment assessments were assessed after a 6-month intervention. The outcome measures used were the Rivermead Post-Concussion Symptoms Questionnaire's subsidiary scales (RPQ-3, RPQ-13), Dizziness Handicap Inventory (DHI), Activities-specific Balance Confidence Scale, Functional Gait Assessment, return to work or study, and return to activity. Results: Six months after the multi-modal rehabilitation programme, statistically significant differences were found on the RPQ-3 (p = 0.026), RPQ-13 (p = 0.037), and DHI (p = 0.033). In addition, four participants had returned to their previous work, and all six participants had been able to return to physical activity. Conclusion: A supervised home programme, provided in the context of a multi-modal rehabilitation programme, has the potential to improve outcomes even when rehabilitative services are delayed and persistent concussion-related symptoms continue for a significant amount of time after the onset of a concussion.	[Adams, Joseph] NYU, Langone Med Ctr, Rusk Rehabil, Dept Phys Therapy, New York, NY 10016 USA; [Moore, Brian] Calif State Univ Sacramento, Dept Phys Therapy, Sacramento, CA 95819 USA		Adams, J (corresponding author), NYU, Langone Med Ctr, Ambulatory Care Ctr, Rusk Rehabil, 240 East 38th St, New York, NY 10016 USA.	JosephThomasAdams@gmail.com					Alghwiri AA, 2012, ARCH PHYS MED REHAB, V93, P1822, DOI 10.1016/j.apmr.2012.03.017; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Brown KE, 2001, LARYNGOSCOPE, V111, P1812, DOI 10.1097/00005537-200110000-00027; *CDCP, 2003, TBI REP C MILD TRAUM; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gottshall K., NEUROREHABILITATION, DOI [10.1097/NPT.0B013E3181DDE568, DOI 10.1097/NPT.0B013E3181DDE568]; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Helminski JO, 2010, PHYS THER, V90, P663, DOI 10.2522/ptj.20090071; Herdman SJ., 1990, J HEAD TRAUMA REHAB, V5, P63, DOI 10.1097/00001199-199012000-00008; Herdman SJ, 2012, NEUROREHAB NEURAL RE, V26, P151, DOI 10.1177/1545968311407514; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; KEMP PM, 1995, J NEUROL NEUROSUR PS, V59, P368, DOI 10.1136/jnnp.59.4.368; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lin JH, 2010, STROKE, V41, P2021, DOI 10.1161/STROKEAHA.110.589739; Marchetti GF, 2014, J NEUROL PHYS THER, V38, P119, DOI 10.1097/NPT.0000000000000015; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; PAIGE GD, 1994, EXP BRAIN RES, V98, P355; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI [10.1097/NPT.0B013E3181DDE568, DOI 10.1097/NPT.0B013E3181DDE568]; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0; Wrisley DM, 2000, J ORTHOP SPORT PHYS, V30, P755, DOI 10.2519/jospt.2000.30.12.755; Yardley L, 2000, OTOLARYNG CLIN N AM, V33, P603, DOI 10.1016/S0030-6665(05)70229-2	52	5	5	0	9	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA	0300-0508	1708-8313		PHYSIOTHER CAN	Physiother. Can.	SUM	2017	69	3					249	259		10.3138/ptc.2015-81EP			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	FQ3KN	WOS:000418256100011	30275641	Green Published			2022-02-06	
J	Bentzer, P; Grande, PO				Bentzer, Peter; Grande, Per-Olof			Isolated Brain Trauma in Cats Triggers Rapid Onset of Hypovolemia	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Plasma volume; Fluid percussion trauma; Intracranial pressure; Blood pressure; Vascular leak	PLASMA-VOLUME EXPANSION; FLUID-PERCUSSION MODEL; 4-PERCENT GELATIN; 5-PERCENT ALBUMIN; SKELETAL-MUSCLE; HEAD-INJURY; RAT; HYPOALBUMINEMIA; PERMEABILITY; INFUSION	Background Hemodynamic instability responsive to fluid resuscitation is common after a traumatic brain injury (TBI), also in the absence of systemic hemorrhage. The present study tests if an isolated severe TBI induces a decrease in plasma volume (PV). Methods The study was performed in three groups of anesthetized and tracheostomized male cats (n = 21). In one group (n = 8), the cats were prepared with a cranial borehole (10 mm i.d) used to expose the brain to a fluid percussion brain injury (FPI) (1.90-2.20 bar), and two smaller cranial boreholes (4 mm i.d) for insertion of an intracranial pressure (ICP) and a microdialysis catheter. To differentiate the effect of FPI from that of the surgical preparation, a sham group was exposed to the same surgical preparation but no FPI trauma (n = 8). A control group had no brain trauma and no surgical preparation (n = 5). PV was determined by a I-125-albumin dilution technique. PV, electrolytes, pH, BE (base excess), hematocrit (Hct), PaO2, and PaCO2 were measured at baseline and after 3 h. Mean arterial pressure (MAP) was measured continuously. ICP was measured in the FPI and the sham group. Results In the FPI group, PV decreased by 11.2 mL/kg from 31.7 mL/kg (p < 0.01) with a simultaneous increase in Hct and decrease in pH. In the sham group, PV decreased by 5.7 mL/kg from 32.7 mL/kg (p < 0.01). The control group showed no PV reduction. Conclusions The results support that an isolated severe head trauma triggers a significant and rapid reduction in PV, most likely due to vascular leak.	[Bentzer, Peter] Lund Univ, Helsingborg Hosp, Dept Clin Sci Anesthesiol & Intens Care, Lund, Sweden; [Bentzer, Peter; Grande, Per-Olof] Lund Univ, Univ Lund Hosp, Dept Clin Sci Anesthesiol & Intens Care, S-22185 Lund, Sweden		Grande, PO (corresponding author), Lund Univ, Univ Lund Hosp, Dept Clin Sci Anesthesiol & Intens Care, S-22185 Lund, Sweden.	per-olof.grande@med.lu.se			Region Skane, ALF, Sweden [18401]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [11581]; Berger Foundation, Stockholm, Sweden	Financial support from Region Skane, ALF, Sweden (#18401); the Swedish Research Council (#11581); and Berger Foundation, Stockholm, Sweden.	Bansch P, 2012, J TRAUMA ACUTE CARE, V73, P1531, DOI 10.1097/TA.0b013e318266007b; Bark BP, 2013, CRIT CARE MED, V41, P857, DOI 10.1097/CCM.0b013e318274157e; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dubniks M, 2007, INTENS CARE MED, V33, P293, DOI 10.1007/s00134-006-0454-5; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; FLECK A, 1985, LANCET, V1, P781; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Margarson M, 2005, INTENS CARE MED, V31, P289, DOI 10.1007/s00134-004-2481-4; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MCCLAIN CJ, 1988, J NEUROSURG, V69, P386, DOI 10.3171/jns.1988.69.3.0386; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Persson J, 2006, CRIT CARE MED, V34, P2456, DOI 10.1097/01.CCM.0000233876.87978.AB; Rise IR, 1998, J NEUROSURG ANESTH, V10, P224; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	23	5	5	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2017	26	3					450	456		10.1007/s12028-016-0348-5			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EV9JA	WOS:000402101100019	27822741	Green Published, hybrid			2022-02-06	
J	Colon, GAT; Smith, S; Fucillo, J				Colon, Gabriel Alejandro Torres; Smith, Sharia; Fucillo, Jenny			Concussions and Risk Within Cultural Contexts of Play	QUALITATIVE HEALTH RESEARCH			English	Article						well-being; social issues; risk; pain; exercise; anthropology of health; cognition; decision making; qualitative; mixed methods; United States	MENTAL-HEALTH; SPORT; RACE; CONSENSUS; EXERCISE; ANTHROPOLOGY; ENVIRONMENT; EMBODIMENT; ETHNICITY; MODELS	Concussions are a type of traumatic injury caused by a jolting of the brain that disrupts normal brain function, and multiple concussions can lead to serious long-term health consequences. In this article, we examine the relationship between college students' understanding of concussions and their willingness to continue playing despite the possibility of sustaining multiple head injuries. We use a mixed-methods approach that includes participant observation, cultural domain analysis, and structured interviews. Our research finds that students hold a robust cognitive understanding of concussion yet discursively frame concussions as skeletomuscular injuries. More importantly, students affirm the importance of playing sports for themselves and others, so their decisions to risk multiple concussions must be understood within cultural and biocultural contexts of meaningful social play. We suggest that peoples' decision to risk multiple head injuries should be understood as a desire for meaningful social play rather than an uninformed health risk.	[Colon, Gabriel Alejandro Torres] Vanderbilt Univ, Amer Studies Program, 221 Kirkland Hall, Nashville, TN 37235 USA; [Smith, Sharia] Univ Notre Dame, Anthropol & Peace Studies, Notre Dame, IN 46556 USA; [Fucillo, Jenny] Univ Notre Dame, Anthropol & Prehlth, Notre Dame, IN USA		Colon, GAT (corresponding author), Vanderbilt Univ, 2301 Vanderbilt Pl,VU Stn B 350125, Nashville, TN 37235 USA.	gabriel.a.torres.colon@vanderbilt.edu					Anderson P. D., NFL CONCUSSION LITIG; Armelagos G J, 1992, Med Anthropol, V14, P35; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Benn Torres J., 2015, HUMAN BIOL OPEN ACCE, V87; Bernard H.R., 2010, ANAL QUALITATIVE DAT; Bernard H. R., 2002, RES METHODS ANTHR QU; Bishop FL, 2015, BRIT J HEALTH PSYCH, V20, P5, DOI 10.1111/bjhp.12122; Bodin M, 2003, PSYCHOL SPORT EXERC, V4, P141, DOI 10.1016/S1469-0292(01)00038-3; Boholm A, 2003, ETHNOS, V68, P159, DOI 10.1080/0014184032000097722; Borgatti S. P., 1998, ANTHROPAC VERSION 4; Borgatti Stephen P., 1994, J QUANTITATIVE ANTHR, V4, P261; Briggs CharlesL., 1986, LEARNING ASK SOCIOLI; Caddick N, 2015, QUAL HEALTH RES, V25, P76, DOI 10.1177/1049732314549477; Campbell Carolina J., 2007, PRIMATES PERSPECTIVE; Caplan P., 2000, RISK REVISITED; Centers for Disease Control and Prevention, CDC HEADS YOUTH SPOR; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Coakley J., 2008, SPORTS SOC ISSUES CO; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colon GAT, 2016, PLURALIST, V11, P126, DOI 10.5406/pluralist.11.1.0126; Cook PA, 2001, PUBLIC HEALTH, V115, P54, DOI 10.1016/S0033-3506(01)00414-0; Couch J. R., 2014, CURRENT TREATMENT OP, V16, P1; Cozolino L., 2014, NEUROSCIENCE HUMAN R, V2nd; CSORDAS TJ, 1990, ETHOS, V18, P5, DOI 10.1525/eth.1990.18.1.02a00010; D'Andrade R., 1995, DEV COGNITIVE ANTHR; DeJordy R, 2007, FIELD METHOD, V19, P239, DOI 10.1177/1525822X07302104; Douglas Mary., 1992, RISK BLAME ESSAYS CU; Dressler WW, 2005, ANNU REV ANTHROPOL, V34, P231, DOI 10.1146/annurev.anthro.34.081804.120505; Farnell B., 2013, HDB METHODS CULTURAL, P391; Faulkner G, 2001, J SPORT SCI, V19, P433, DOI 10.1080/026404101300149384; Fordyce L, 2012, RISK, REPRODUCTION, AND NARRATIVES OF EXPERIENCE, P1; Geertz C., 1973, INTERPRETATION CULTU; Geertz Clifford, 1983, LOCAL KNOWLEDGE FURT; Goldschmidt Walter, 2006, BRIDGE HUMANITY AFFE; Goldsmith PA, 2003, SOCIOL SPORT J, V20, P147, DOI 10.1123/ssj.20.2.147; Gravlee CC, 2009, AM J PHYS ANTHROPOL, V139, P47, DOI 10.1002/ajpa.20983; Handwerker WP, 1997, CURR ANTHROPOL, V38, P869, DOI 10.1086/204675; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Institute of Education Sciences, FAST FACTS ED ATT; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU; Jacobs-Huey L, 2002, AM ANTHROPOL, V104, P791, DOI 10.1525/aa.2002.104.3.791; Johnson RB., 2004, EDUC RESEARCHER, V33, P14, DOI [10.3102/0013189X033007014, DOI 10.3102/0013189X033007014]; Jolly A., 1985, EVOLUTION PRIMATE BE, V2nd; Kay MC, 2015, J SPORT REHABIL, V24, P210, DOI 10.1123/jsr.2013-0132; Konner Melvin, 2010, EVOLUTION CHILDHOOD; Lerner RM, 1998, ANNU REV PSYCHOL, V49, P413, DOI 10.1146/annurev.psych.49.1.413; Lupton Deborah., 1999, RISK; MacLachlan M, 2004, EMBODIMENT CLIN CRIT; MasciaLees FE, 2011, BLACKW COMPANION ANT, P1, DOI 10.1002/9781444340488; MCCLAURIN IRMA, 2001, BLACK FEMINIST ANTHR; McKenna JJ., 2008, EVOLUTIONARY MED HLT; Messner M., 2009, ITS ALL KIDS GENDER; Morse JM, 2010, QUAL INQ, V16, P483, DOI 10.1177/1077800410364741; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; Pelto PJ, 2015, QUAL HEALTH RES, V25, P734, DOI 10.1177/1049732315573209; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Richardson LD, 2010, MT SINAI J MED, V77, P166, DOI 10.1002/msj.20174; Rodseth L, 1998, AM ANTHROPOL, V100, P55, DOI 10.1525/aa.1998.100.1.55; ROMNEY AK, 1986, AM ANTHROPOL, V88, P313, DOI 10.1525/aa.1986.88.2.02a00020; Sands R, 1999, ANTHR SPORT CULTURE; Sands R.R., 2010, ANTHR SPORT HUMAN MO; Seidel J., ETHNOGRAPH VERSION 6; Shephard RJ, 1997, BRIT J SPORT MED, V31, P277, DOI 10.1136/bjsm.31.4.277; STARN ORIN, 2012, PASSION TIGER WOODS; Sutrop Urmas, 2001, FIELD METHOD, V13, P263, DOI [10.1177/1525822X0101300303, DOI 10.1177/1525822X0101300303]; Swora MG, 2003, CULT HEALTH SEX, V5, P339, DOI 10.1080/1369105011000028264; Thayer RE., 2003, CALM ENERGY PEOPLE R; Tomita Y, 2014, MED SCI SPORT EXER, V46, P491, DOI 10.1249/01.mss.0000494937.87423.6d; Voss LD, 2008, CHILD CARE HLTH DEV, V34, P470, DOI 10.1111/j.1365-2214.2008.00827.x; Weller SC, 2007, FIELD METHOD, V19, P339, DOI 10.1177/1525822X07303502; Wiley Andrea S, 2013, MED ANTHR BIOCULTURA; Wipfli B, 2011, SCAND J MED SCI SPOR, V21, P474, DOI 10.1111/j.1600-0838.2009.01049.x; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175; Young K., 2012, SPORT VIOLENCE SOC	76	5	5	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	JUN	2017	27	7			SI		1077	1089		10.1177/1049732316669339			13	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	EX4ZK	WOS:000403244800008	27651073				2022-02-06	
J	Harvey, LA; Mitchell, R; Brodaty, H; Draper, B; Close, JCT				Harvey, Lara A.; Mitchell, Rebecca; Brodaty, Henry; Draper, Brian; Close, Jacqueline C. T.			Comparison of fall-related traumatic brain injury in residential aged care and community-dwelling older people: A population-based study	AUSTRALASIAN JOURNAL ON AGEING			English	Article						falls; frail elderly; data linkage; traumatic brain injury	AUSTRALIA; ADULTS; IMPACT	ObjectiveTo compare trends, causes, and outcomes of fall-related traumatic brain injury (TBI) between community-dwelling (CD) individuals and residential aged care facility (RACF) residents. MethodsHospitalisation and RACF administrative data for 6635 individuals aged 65years admitted to all NSW hospitals for fall-related TBI from 2008-2009 to 2012-2013 were linked. ResultsOf the 6944 hospitalisations, 20.8% were for RACF residents. Age-standardised hospitalisation rates were almost fourfold higher for RACF residents than CD individuals (standardised rate ratio 3.7; 95% CI 3.4-4.1); but increased at a similar annual rate of 9.2% (95% CI 0.3-19.0) and 7.2% (95% CI 5.6-8.9), respectively. Compared to CD individuals: a higher proportion of falls in RACF residents were furniture-related (21.4% vs 9.9%); resulted in haemorrhage (82.5% vs 73.7%); and death (23.1% vs 14.9%). Overall, 7.7% of hospitalisations for CD individuals resulted in new permanent RACF placement. ConclusionResidential aged care facility residents have higher hospitalisation rates and poorer health outcomes than their CD counterparts.	[Harvey, Lara A.; Mitchell, Rebecca; Close, Jacqueline C. T.] Neurosci Res Australia, Falls Balance & Injury Res Ctr, Sydney, NSW, Australia; [Harvey, Lara A.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Mitchell, Rebecca] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia; [Brodaty, Henry; Draper, Brian] Dementia Collaborat Res Ctr Assessment & Better C, Sydney, NSW, Australia; [Brodaty, Henry; Draper, Brian] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Close, Jacqueline C. T.] Univ New South Wales Med, Prince Wales Clin Sch, Sydney, NSW, Australia		Harvey, LA (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	l.harvey@neura.edu.au	Mitchell, Rebecca/Z-5476-2019	Mitchell, Rebecca/0000-0003-1939-1761	Dementia Collaborative Research Centres-Assessment and Better Care; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This study was funded by the Dementia Collaborative Research Centres-Assessment and Better Care. LH was supported by a National Health and Medical Research Council Early Career Fellowship. The authors would like to thank the NSW Ministry of Health, and the Department of Health and Ageing for provision of the hospitalisation and residential aged care data extracts and the AIHW Data Linkage Unit for the provision of the unique identifiers used to link the data extracts. The authors declare no conflicts of interest.	Australian Bureau of Statistics, 2015, 3222 0 POP PROJ; Australian Bureau of Statistics, STAND POP DAT CUB; Australian Bureau of Statistics, 2015, 3235 0 POP AG SEX; Australian Government Department of Health and Ageing, 2013, AG CAR FUND INSTR AC; Australian Institute of Health and Welfare, 2012, RES AG CAR AUSTR 201; Australian Institute of Health and Welfare, 2015, RES AG CAR HOM CAR 2; Australian Institute of Health and Welfare, NAT AG CAR PLAC STOC; Authority NHP., 2013, HOSP PERF LENGTH STA; Berry J., 2006, GUIDE STAT METHODS I; Bradley C, 2013, TRENDS HOSP DUE FALL, V84; Carpenter W.R., 2014, LINKING DATA HLTH SE; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Karmel R, 2009, AUSTRALAS J AGEING, V28, P198, DOI 10.1111/j.1741-6612.2009.00376.x; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; McKenzie K, 2009, INJURY PREV, V15, P188, DOI 10.1136/ip.2008.020479; Mitra B, 2007, MED J AUSTRALIA, V186, P31, DOI 10.5694/j.1326-5377.2007.tb00785.x; Miu J, 2015, CHATSWOOD AGENCY CLI; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SAS Institute, 2013, SAS ENT GUID 6 1; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Senes S, 2007, MED CARDIOVASCULAR H; Smith Karen, 2012, JBI Libr Syst Rev, V10, P4610; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	30	5	5	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-6381	1741-6612		AUSTRALAS J AGEING	Australas. Ageing	JUN	2017	36	2					144	150		10.1111/ajag.12422			7	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	EY4GV	WOS:000403936500020	28635089				2022-02-06	
J	Kamboj, A; Chounthirath, T; Xiang, HY; Smith, GA				Kamboj, Alisha; Chounthirath, Thiphalak; Xiang, Huiyun; Smith, Gary A.			Traumatic Brain Injuries Associated With Consumer Products at Home Among US Children Younger Than 5 Years of Age	CLINICAL PEDIATRICS			English	Article						traumatic brain injury; residence; children; pediatric; emergency department	UNITED-STATES; OUTCOMES	This study investigated the epidemiology of traumatic brain injuries (TBIs) occurring to young children, associated with consumer products at home in the United States. Data from the National Electronic Injury Surveillance System were analyzed. There were an estimated 2292896 (95% CI = 1707891-2877900) children <5 years of age treated in US emergency departments for a TBI associated with a consumer product at home during 1991-2012, which equals an annual average of 104223 (95% CI = 77631-130814) children. During the 22-year study period, the number and rate of TBIs increased significantly by 283.3% (estimated annual rate of change, m = 7182.6; P < .001) and 266.5% (m = 0.35; P < .001), respectively. The number of TBIs decreased with increasing age of the child. Falls from household products were the leading mechanism of injury (53.7%). To our knowledge, this is the first nationally representative study of TBIs associated with consumer products at home among young children. These findings underscore the need for increased prevention efforts.	[Kamboj, Alisha; Chounthirath, Thiphalak; Xiang, Huiyun; Smith, Gary A.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA; [Kamboj, Alisha; Xiang, Huiyun; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org					Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; ASTM International, F116913 ASTM INT; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Centers for Disease Control and Prevention, 2017, SEV TBI; Centers for Disease Control and Prevention, PERC DISTR TBI REL E; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention, WHAT AR POT EFF TBI; Centers for Disease Control and Prevention (CDC), TBI GET THE FACTS; Centers for Disease Control Prevention, 1997, MMWR-MORBID MORTAL W, V46, P224; De Roo AC, 2013, PEDIATRICS, V132, P267, DOI 10.1542/peds.2013-1086; Faul M, 2010, TRAUMATIC BRAIN INJU; Flavin MP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-187; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gottesman BL, 2009, CLIN PEDIATR, V48, P851, DOI 10.1177/0009922809334352; Huisman TA, 2012, DIS BRAIN HEAD NECK, P268; Ibrahim NG, 2010, J NEUROSURG-PEDIATR, V6, P57, DOI 10.3171/2010.3.PEDS09357; Kurinsky RM, 2014, CLIN PEDIATR, V53, P372, DOI 10.1177/0009922813510599; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mao SJ, 2009, PEDIATRICS, V124, P541, DOI 10.1542/peds.2008-2489; Runyan CW, 2005, AM J PREV MED, V28, P80, DOI 10.1016/j.amepre.2004.09.017; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schroeder T., NEISS SAMPLE DESIGN; Shields BJ, 2006, PEDIATRICS, V117, pE452, DOI 10.1542/peds.2005-1916; *US CENS BUR, MONTHL POSTC RES POP; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeh ES, 2011, PEDIATRICS, V127, P479, DOI 10.1542/peds.2010-1537; Zielinski AE, 2012, PEDIATRICS, V129, P721, DOI 10.1542/peds.2011-2314; [No title captured]	29	5	5	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUN	2017	56	6					545	554		10.1177/0009922816664064			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	EU6OM	WOS:000401153300006	27600615				2022-02-06	
J	Lancioni, GE; Singh, NN; O'Reilly, MF; Sigafoos, J; D'Amico, F; Buonocunto, F; Navarro, J; Lanzilotti, C; Fiore, P; Megna, M; Damiani, S; Marvulli, R				Lancioni, Giulio E.; Singh, Nirbhay N.; O'Reilly, Mark F.; Sigafoos, Jeff; D'Amico, Fiora; Buonocunto, Francesca; Navarro, Jorge; Lanzilotti, Crocifissa; Fiore, Pietro; Megna, Marisa; Damiani, Sabino; Marvulli, Riccardo			Helping people in a minimally conscious state develop responding and stimulation control through a microswitch-aided program	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Self-help devices; Persistent vegetative state; Program evaluation	TRAUMATIC BRAIN-INJURY; MULTIPLE DISABILITIES; ASSISTIVE TECHNOLOGY; CONTINGENT STIMULATION; VEGETATIVE STATE; COMA RECOVERY; DISORDERS; INDIVIDUALS; COMMUNICATION; PERSPECTIVES	BACKGROUND: Postcoma persons in a minimally conscious state (MCS) and with extensive motor impairment cannot independently access and control environmental stimulation. AIM: Assessing the effects of a microswitch-aided program aimed at helping MCS persons develop responding and stimulation control and conducting a social validation/evaluation of the program. DESIGN: A single-subject AB design was used for each participant to determine the impact of the program on his or her responding. Staff interviews were used for the social validation/evaluation of the program. SETTING: Rehabilitation and care facilities that the participants attended. POPULATION: Eleven MCS persons with extensive motor impairment and lack of speech or any other functional communication. METHODS: For each participant, baseline (A) phases were alternated with intervention (B) phases during which the program was used. The program relied on microswitches to monitor participants' specific responses (e. g., prolonged eyelid closures) and on a computer system to enable those responses to control stimulation. In practice, the participants could use a simple response such as prolonged eyelid closure to generate a new stimulation input. Sixty-six staff people took part in the social validation of the program. They were to compare the program to basic and elaborate forms of externally controlled stimulation, scoring each of them on a six-item questionnaire. RESULTS: All participants showed increased response frequencies (and thus higher levels of independent stimulation input/control) during the B phases of the study. Their frequencies for each intervention phase more than doubled their frequencies for the preceding baseline phase with the difference between the two being clearly significant (P< 0.01). Staff involved in the social validation procedure provided significantly higher scoring (P< 0.01) for the program on five of the six questionnaire items. CONCLUSIONS: A microswitch-aided program can be an effective and socially acceptable tool in the work with MCS persons. CLINICAL REHABILITATION IMPACTPACT: The participants and staff's data can be taken as an encouragement for the use of a microswitch-aided program within care and rehabilitation settings for MCS persons.	[Lancioni, Giulio E.] Univ Bari, Dept Neurosci & Sense Organs, Corso Italia 23, I-70121 Bari, Italy; [Singh, Nirbhay N.] Augusta Univ, Med Coll Georgia, Augusta, GA USA; [O'Reilly, Mark F.] Univ Texas Austin, Dept Special Educ, Austin, TX 78712 USA; [Sigafoos, Jeff] Victoria Univ Wellington, Sch Educ, Wellington, New Zealand; [D'Amico, Fiora] Lega F DOro Res Ctr, Ancona, Italy; [D'Amico, Fiora] S Raffaele Care Ctr, Bari, Italy; [Buonocunto, Francesca; Navarro, Jorge; Lanzilotti, Crocifissa] S Raffaele Rehabil Ctr, Ceglie, Brindisi, Italy; [Fiore, Pietro; Megna, Marisa; Damiani, Sabino; Marvulli, Riccardo] Polyclin Bari, Dept Phys & Rehabil Med, Bari, Italy		Lancioni, GE (corresponding author), Univ Bari, Dept Neurosci & Sense Organs, Corso Italia 23, I-70121 Bari, Italy.	giulio.lancioni@uniba.it	Singh, Nouratan/N-9377-2017; Megna, Marisa/ABE-8907-2020; D'Amico, Fiora/AAB-8309-2019	Singh, Nouratan/0000-0002-8063-8375; Navarro solano, Jorge/0000-0003-1508-6727; Megna, Marisa/0000-0002-8486-103X			Abbate Carlo, 2014, Front Hum Neurosci, V8, P616, DOI 10.3389/fnhum.2014.00616; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Castellan N. J, 1988, NONPARAMETRIC STAT B; Catania A. C., 2012, LEARNING; Daveson B, 2010, J MUSIC THER, V47, P408, DOI 10.1093/jmt/47.4.408; Di Stefano C, 2012, BRAIN INJURY, V26, P1250, DOI 10.3109/02699052.2012.667588; Eifert B, 2013, ARCH PHYS MED REHAB, V94, P1924, DOI 10.1016/j.apmr.2013.03.030; Fischer T, 2008, J COGNITIVE NEUROSCI, V20, P1443, DOI 10.1162/jocn.2008.20101; Georgiopoulos M, 2010, STEREOT FUNCT NEUROS, V88, P199, DOI 10.1159/000314354; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; Gibson BE, 2012, DISABIL REHABIL, V34, P1894, DOI 10.3109/09638288.2012.670040; Gonzalez-Ortega D, 2014, COMPUT METH PROG BIO, V113, P620, DOI 10.1016/j.cmpb.2013.10.014; Hastie T, 2009, ELEMENTS STAT LEARNI, V2nd, DOI 10.1007/978-0-387-84858-7; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kazdin AE., 2011, SINGLE CASE RES DESI; Lancioni GE, 2008, EUR J PHYS REHAB MED, V44, P449; Lancioni GE, 2014, AUT CHILD PSYCHO, P1, DOI 10.1007/978-1-4899-8029-8; Lancioni GE, 2015, NEUROREHABILITATION, V37, P393, DOI 10.3233/NRE-151269; Lancioni GE, 2014, DEV NEUROREHABIL, V17, P251, DOI 10.3109/17518423.2013.793751; Lancioni GE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00048; Lancioni GE, 2012, COGN PROCESS, V13, P133, DOI 10.1007/s10339-011-0428-6; Lenker JA, 2013, DISABIL REHABIL-ASSI, V8, P373, DOI 10.3109/17483107.2012.749429; Lotze M, 2011, J REHABIL MED, V43, P230, DOI 10.2340/16501977-0653; Magee WL, 2007, BRAIN INJURY, V21, P593, DOI 10.1080/02699050701426907; Makel MC, 2014, EDUC RESEARCHER, V43, P304, DOI 10.3102/0013189X14545513; Man DWK, 2010, APPL RES QUAL LIFE, V5, P27, DOI 10.1007/s11482-009-9090-x; McNamee S, 2012, J HEAD TRAUMA REHAB, V27, P244, DOI 10.1097/HTR.0b013e31825e12c8; Muller-Putz GR, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S0129065712500372; Munde V, 2015, J INTELL DISABIL RES, V59, P284, DOI 10.1111/jir.12138; Munde VS, 2009, RES DEV DISABIL, V30, P462, DOI 10.1016/j.ridd.2008.07.003; Naslund R, 2013, DISABIL SOC, V28, P28, DOI 10.1080/09687599.2012.695528; O'Kelly J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00884; Pape TLB, 2015, NEUROREHAB NEURAL RE, V29, P537, DOI 10.1177/1545968314554626; Pape TLB, 2012, J REHABIL RES DEV, V49, P1137, DOI 10.1682/JRRD.2011.08.0154; Roche L, 2015, AUGMENT ALTERN COMM, V31, P246, DOI 10.3109/07434618.2015.1024888; Scherer MJ, 2011, DISABIL REHABIL, V33, P811, DOI 10.3109/09638288.2010.511418; Schiff ND, 2009, ARCH NEUROL-CHICAGO, V66, P697, DOI 10.1001/archneurol.2009.79; Schmelkin L.P., 1991, MEASUREMENT DESIGN A; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Shin SS, 2014, J NEUROSURG, V121, P1219, DOI 10.3171/2014.7.JNS131826; Stasolla F, 2015, COGN PROCESS, V16, P69, DOI 10.1007/s10339-014-0625-1; Sunderland N, 2009, DISABIL SOC, V24, P703, DOI 10.1080/09687590903160175; Whyte J, 2007, AM J PHYS MED REHAB, V86, P86, DOI 10.1097/PHM.0b013e31802f0434; Yamamoto T, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.04.010	48	5	5	0	2	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	JUN	2017	53	3					433	440		10.23736/S1973-9087.16.04324-0			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	FF4SQ	WOS:000408947300012	27585057	Green Published			2022-02-06	
J	Naturale, A; Lowney, LT; Brito, CS				Naturale, April; Lowney, Liam T.; Brito, Corina Sole			Lessons Learned from the Boston Marathon Bombing Victim Services Program	CLINICAL SOCIAL WORK JOURNAL			English	Article						Boston marathon bombing; Mass violence; Disasters; Terrorist attacks; Victims of crime; Traumatic stress	HURRICANE KATRINA; TRAUMATIC STRESS; SOCIAL SUPPORT; DISASTER; SURVIVORS; COMMUNITY; SPEAK	The Boston Marathon bombing of April 15, 2013 involved the detonation of pressure cooker bombs near the finish line of the Boston Marathon. Three people died at the scene and more than 200 others required medical attention. Many survivors received serious injuries including head injuries, hearing loss and severed limbs as a direct result of the blasts and 14 survivors required amputations. The media reports included graphic images of severely injured runners and spectators that were shown repeatedly and continuously for months thereafter. This intentional, human caused mass violence at an event attended by hundreds of thousands and accompanied by graphic, gruesome, and extensive media exposure exacerbated the behavioral health risks in the affected community as well as those who observed the events in the media. The Massachusetts Office for Victim Assistance provided an immediate response and continues to provide victim assistance, behavioral health counseling and other supports through a Department of Justice/Office for Victims of Crime Antiterrorism Emergency Assistance Program grant to help those most affected. Many lessons were learned about the need for preparation, close working relationships and an understanding of the powerful psychological impact of terrorist and mass violence events. This article shares what we currently know about traumatic stress reactions related to human caused mass violence events and provides program details, lessons learned and recommendations from the Marathon Bombing Victim Assistance program.	[Naturale, April; Brito, Corina Sole] ICF Int, 9300 Lee Highway, Fairfax, VA 22031 USA; [Lowney, Liam T.] Massachusetts Off Victim Assistance, 1 Ashburton Pl,Suite 1101, Boston, MA 02108 USA		Naturale, A (corresponding author), ICF Int, 9300 Lee Highway, Fairfax, VA 22031 USA.	April.Naturale@icfi.com; Liam.lowney@state.ma.us; Corina.SoleBrito@icf.com			MA Office for Victims Assistance from the Office for Victims of Crime, Office of Justice Programs, U.S. Department of Justice (OVC/OJP/DOJ) [2014-RF-GX-K002]; Massachusetts Office for Victim Assistance from the Office for Victims of Crime, Office of Justice Programs, U.S. Department of Justice [2014-RF-GX-K002]	The MA Office for Victim Assistance Marathon bombing response program services are offered for free and are (partially) supported by the MA Office for Victims Assistance through an Antiterrorism Emergency Assistance Program cooperative agreement number 2014-RF-GX-K002 from the Office for Victims of Crime, Office of Justice Programs, U.S. Department of Justice (OVC/OJP/DOJ). The article reflects the opinions of the authors and does not reflect the opinion of the OVC/OJP/DOJ. This project was (partially) supported by the Massachusetts Office for Victim Assistance through and Antiterrorism Emergency Assistance Program (AEAP) cooperative agreement number 2014-RF-GX-K002 from the Office for Victims of Crime, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, conclusions and recommendations expressed in this article are those of the authors and do not necessarily reflect the views of the State of Massachusetts or the Office of Justice Programs.	[Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; Boscarino Joseph A, 2002, Int J Emerg Ment Health, V4, P143; Center for Mental Health Services, 2001, EM MENT HLTH TRAUM S; Center for Mental Health Services (CMHS), 2004, DHHS PUB; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P38; Chemtob CM, 2010, CHILD DEV, V81, P1129, DOI 10.1111/j.1467-8624.2010.01458.x; DART Center for Journalism, COV JOURN COV BREAK; Draper J., 2006, MENTAL HLTH SERVICE; Dunmore E, 2001, BEHAV RES THER, V39, P1063, DOI 10.1016/S0005-7967(00)00088-7; Filipas H H, 2001, Violence Vict, V16, P673; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Germain C. B., 1995, ENCY SOCIAL WORK, V1, P816; Gibson L. E., 2006, J TRAUMA PRACTICE, V5; Gurwitch R. H., 2002, AM PSYCHOL ASS, P327; Hamblen JL, 2009, ADM POLICY MENT HLTH, V36, P206, DOI 10.1007/s10488-009-0213-3; Hopwood T. L., 2016, PSYCHOL VIOLENCE; KANIASTY K, 1995, AM J COMMUN PSYCHOL, V23, P447, DOI 10.1007/BF02506964; Kotz D, 2013, BOSTON GLOBE; MA Attorney General's Office (AGO), 2016, VICT ADV ASS; Marshall R., 2006, 9 11 MENTAL HLTH WAK; Morganstein J. C., 2016, MENT HLTH SOCIAL ISS; Myers D, 2005, DISASTER MENTAL HLTH; National Center for Post Traumatic Stress Disorder (NCPTSD), 2016, DIS TERR; Naturale A, 2006, MASS VIOLENCE EARLY; Neria Y., 2012, MENTAL HLTH DISASTER; Norris F. H., 2006, INTERVENTIONS FOLLOW, P343; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 1996, J PERS SOC PSYCHOL, V71, P498, DOI 10.1037/0022-3514.71.3.498; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; NORRIS FH, 2001, RISK FACTORS ADVERSE; Norris FH, 2009, ADM POLICY MENT HLTH, V36, P159, DOI 10.1007/s10488-009-0218-y; Salston M, 2003, J TRAUMA STRESS, V16, P167, DOI 10.1023/A:1022899207206; Substance Abuse and Mental Health Services Administration, 2014, TIPS SURV DIS OTH TR; Substance Abuse and Mental Health Services Administration Disaster Technical Assistance Center, 2014, CRIS COUNS ASS TRAIN; The National Child Traumatic Stress Network, 2016, COMM VIOL; Tosone C, 2011, J TRAUMA STRESS, V24, P546, DOI 10.1002/jts.20686; U.S. Dept. of Justice Office for Victims of Crime and the Center for Mental Health Services the Substance Abuse and Mental Health Services Administration, 2004, DHHS PUB; Wang PS, 2007, PSYCHIAT SERV, V58, P1403, DOI 10.1176/appi.ps.58.11.1403; Zoellner L. A., 1999, J TRAUMA STRESS, V12; Zoellner LA, 2011, DEPRESS ANXIETY, V28, P532, DOI 10.1002/da.20847	40	5	5	0	8	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0091-1674	1573-3343		CLIN SOC WORK J	Clin. Soc. Work J.	JUN	2017	45	2					111	123		10.1007/s10615-017-0624-7			13	Social Work	Social Science Citation Index (SSCI)	Social Work	EU5HX	WOS:000401063300003					2022-02-06	
J	Whyte, T; Gibson, T; Eager, D; Milthorpe, B				Whyte, Thomas; Gibson, Tom; Eager, David; Milthorpe, Bruce			Full-face motorcycle helmet protection from facial impacts: an investigation using THOR dummy impacts and SIMon finite element head model	INJURY PREVENTION			English	Article							TRAUMATIC BRAIN-INJURY; CHIN BAR; CONCUSSION; PREDICTORS	Objective Facial impacts are both common and injurious for helmeted motorcyclists who crash; however, there is no facial impact requirement in major motorcycle helmet standards. This study examined the effect of full-face motorcycle helmet protection on brain injury risk in facial impacts using a test device with biofidelic head and neck motion. A preliminary investigation of energy absorbing foam in the helmet chin bar was carried out. Method Flat-faced rigid pendulum impacts were performed on a THOR dummy in an unprotected (no helmet) and protected mode (two full-face helmet conditions). The head responses of the dummy were input into the simulated injury monitor finite element head model to analyse the risk of brain injury in these impacts. Results Full-face helmet protection provides a significant reduction in brain injury risk in facial impacts at increasing impact speeds compared with an unprotected rider (p<0.05). The effect of low-density crushable foam added to the chin bar could not be distinguished from an unpadded chin bar impact. Conclusions Despite the lack of an impact attenuation requirement for the face, full-face helmets do provide a reduction in head injury risk to the wearer in facial impacts. The specific helmet design factors that influence head injury risk in facial impacts need further investigation if improved protection for helmeted motorcyclists is to be achieved.	[Whyte, Thomas] Univ Technol Sydney, CB11-B4-107,15 Broadway, Ultimo, NSW 2007, Australia; [Gibson, Tom] Human Impact Engn, Sydney, NSW, Australia; [Eager, David] Univ Technol Sydney, Fac Engn Informat Technol, Sydney, NSW, Australia; [Milthorpe, Bruce] Univ Technol Sydney, Fac Sci, Sydney, NSW, Australia		Whyte, T (corresponding author), Univ Technol Sydney, CB11-B4-107,15 Broadway, Ultimo, NSW 2007, Australia.	Thomas.C.Whyte@student.uts.edu.au	Milthorpe, Bruce K/A-7014-2008; Milthorpe, Bruce/Z-1153-2019	Milthorpe, Bruce/0000-0002-0867-9586; Whyte, Tom/0000-0002-3562-3844			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Bandak F, 2001, 17 INT TECHN C ENH S; Bruyere K, 2000, Annu Proc Assoc Adv Automot Med, V44, P219; Chang CH, 2000, J BIOMECH ENG-T ASME, V122, P640, DOI 10.1115/1.1318905; Chang LT, 1999, JSME INT J A-SOLID M, V42, P294, DOI 10.1299/jsmea.42.294; Chinn B., 2001, COST 327 MOTORCYCLE; Corner J.P., 1987, MOTORCYCLE BICYCLE P; Dowdell B, 1988, STUDY HELMET DAMAGE; Gibson T., 2007, HELMET PROTECTION BA; Haworth N., 1997, CASE CONTROL STUDY M; Hurt HH, 1996, 40 ANN P ASS ADV AUT; Johnston P., 2008, FATAL SERIOUS ROAD C; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P835, DOI 10.1080/15389588.2013.774083; Melvin JW, 1989, P 12 EXPT SAF VEH C; Otte D., 1991, P 35 STAPP CAR CRASH, P335; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Whyte T, 2015, 24 INT TECHN C ENH S; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	29	5	5	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	JUN	2017	23	3					205	210		10.1136/injuryprev-2015-041925			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EW3AX	WOS:000402368200011	26940007				2022-02-06	
J	Anderson, AA; Smith, E; Chowdhry, FA; Thurm, A; Condy, E; Swineford, L; Manwaring, SS; Amyot, F; Matthews, D; Gandjbakhche, AH				Anderson, Afrouz A.; Smith, Elizabeth; Chowdhry, Fatima A.; Thurm, Audrey; Condy, Emma; Swineford, Lauren; Manwaring, Stacy S.; Amyot, Franck; Matthews, Dennis; Gandjbakhche, Amir H.			Prefrontal Hemodynamics in Toddlers at Rest: A Pilot Study of Developmental Variability	FRONTIERS IN NEUROSCIENCE			English	Article						Near-infrared spectroscopy; autoregulation; hemodynamics; toddler neuroimaging; cognitive development	NEAR-INFRARED SPECTROSCOPY; AUTISM SPECTRUM DISORDER; CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; FUNCTIONAL LATERALIZATION; LANGUAGE IMPAIRMENT; MIDDLE CHILDHOOD; HAND PREFERENCE; YOUNG-CHILDREN	Functional near infrared spectroscopy (fNIRS) is a non-invasive functional neuroimaging modality. Although, it is amenable to use in infants and young children, there is a lack of fNIRS research within the toddler age range. In this study, we used fNIRS to measure cerebral hemodynamics in the prefrontal cortex (PFC) in 18-36 months old toddlers (n = 29) as part of a longitudinal study that enrolled typically-developing toddlers as well as those "at risk" for language and other delays based on presence of early language delays. In these toddlers, we explored two hemodynamic response indices during periods of rest during which time audiovisual children's programming was presented. First, we investigate Lateralization Index, based on differences in oxy-hemoglobin saturation from left and right prefrontal cortex. Then, we measure oxygenation variability (OV) index, based on variability in oxygen saturation at frequencies attributed to cerebral autoregulation. Preliminary findings show that lower cognitive (including language) abilities are associated with fNIRS measures of both lower OV index and more extreme Lateralization index values. These preliminary findings show the feasibility of using fNIRS in toddlers, including those at risk for developmental delay, and lay the groundwork for future studies.	[Anderson, Afrouz A.; Smith, Elizabeth; Chowdhry, Fatima A.; Condy, Emma; Gandjbakhche, Amir H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Thurm, Audrey] NIMH, NIH, Bethesda, MD 20892 USA; [Swineford, Lauren] Washington State Univ, Elson S Floyd Coll Med, Dept Speech & Hearing Sci, Spokane, WA USA; [Manwaring, Stacy S.] Univ Utah, Commun Sci & Disorders, Salt Lake City, UT USA; [Amyot, Franck] Ctr Neurosci & Regenerat Med, Rockville, MD USA; [Amyot, Franck] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Matthews, Dennis] Univ Calif Davis, Sch Med, Dept Neurol Surg, Davis, CA 95616 USA		Gandjbakhche, AH (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	gandjbaa@mail.nih.gov		Manwaring, Stacy/0000-0002-0835-9398	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [NCT01339767, ZIAMH002868]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD008882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZICMH002961, ZIAMH002868] Funding Source: NIH RePORTER	We would like to thank all of the children and families who participated in this study as well as the staff of the Pediatrics and Developmental Neuroscience Branch who helped with this study. The study was supported by the Intramural Research Program of National Institute of Mental Health and Eunice Kennedy Shriver National Institute of Child Health and Human Development and was completed as part of protocol 11-M-0144, NCT01339767 under ZIAMH002868.	Amyot F, 2012, NEUROIMAGE, V60, P879, DOI 10.1016/j.neuroimage.2012.01.104; Anderson AA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00393; Aslin RN, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854672; Ayaz H., 2010, THESIS; Ayaz H, 2010, IEEE ENG MED BIO, P6567, DOI 10.1109/IEMBS.2010.5627113; Baird AA, 2002, NEUROIMAGE, V16, P1120, DOI 10.1006/nimg.2002.1170; Bassan H, 2005, PEDIATR RES, V57, P35, DOI 10.1203/01.PDR.0000147576.84092.F9; Bishop DVM, 2014, PEERJ, V2, DOI 10.7717/peerj.507; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; BOASHASH B, 1992, P IEEE, V80, P520, DOI 10.1109/5.135376; Boschin EA, 2015, P NATL ACAD SCI USA, V112, pE1020, DOI 10.1073/pnas.1419649112; Bryden PJ, 2000, BRAIN COGNITION, V44, P402, DOI 10.1006/brcg.1999.1201; Burgess P.W., 2013, PRINCIPLES FRONTAL L, P524; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Chernomordikl V, 2016, BRAIN RES, V1639, P194, DOI 10.1016/j.brainres.2016.02.018; CHIRON C, 1992, J NUCL MED, V33, P696; Christoff Kalina, 2009, P219; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Dumontheil I, 2008, DEV MED CHILD NEUROL, V50, P168, DOI 10.1111/j.1469-8749.2008.02026.x; Durston S, 2006, DEVELOPMENTAL SCI, V9, P1, DOI 10.1111/j.1467-7687.2005.00454.x; Elsabbagh M, 2009, J CHILD PSYCHOL PSYC, V50, P637, DOI 10.1111/j.1469-7610.2008.02051.x; Fekete T, 2014, NEUROIMAGE, V85, P345, DOI 10.1016/j.neuroimage.2013.07.022; Friedrich M, 2005, NEUROREPORT, V16, P1801, DOI 10.1097/01.wnr.0000185013.98821.62; Funane T, 2014, NEUROIMAGE, V85, P150, DOI 10.1016/j.neuroimage.2013.02.026; Gabard-Durnam L, 2015, J AUTISM DEV DISORD, V45, P473, DOI 10.1007/s10803-013-1926-4; Gratton E, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1854673; Greve D., 2009, P INT SOC MAGN RES M; HARE TA, 2005, COGNITION BRAIN BEHA, V9, P273; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Izzetoglu M, 2007, IEEE ENG MED BIOL, V26, P38, DOI 10.1109/MEMB.2007.384094; JENNINGS JR, 1992, PSYCHOPHYSIOLOGY, V29, P742, DOI 10.1111/j.1469-8986.1992.tb02052.x; Jentschke S, 2014, DEV COGN NEUROS-NETH, V9, P200, DOI 10.1016/j.dcn.2014.04.005; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Kawakubo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025944; Kawano M, 2016, J AFFECT DISORDERS, V205, P154, DOI 10.1016/j.jad.2016.07.013; Keehn B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00444; Kikuchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056087; Kilroy E, 2011, J COGN SCI, V12, P151; Kreplin U, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00879; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Li YW, 2017, DEV COGN NEUROS-NETH, V25, P138, DOI 10.1016/j.dcn.2016.07.002; Li YW, 2016, BRAIN COGNITION, V108, P47, DOI 10.1016/j.bandc.2016.07.006; Lindell AK, 2013, NEUROPSYCHOL REV, V23, P257, DOI 10.1007/s11065-013-9234-5; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Lloyd-Fox S, 2015, CEREB CORTEX, V25, P289, DOI 10.1093/cercor/bht207; Lloyd-Fox S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04740; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; Gomez DM, 2014, P NATL ACAD SCI USA, V111, P5837, DOI 10.1073/pnas.1318261111; May L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00222; Michelotti J, 2002, DEV MED CHILD NEUROL, V44, P812; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minagawa-Kawai Y, 2011, CEREB CORTEX, V21, P254, DOI 10.1093/cercor/bhq082; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Mullen E.M., 1995, MULLEN SCALES EARLY; Nakato E, 2009, HUM BRAIN MAPP, V30, P462, DOI 10.1002/hbm.20516; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; Nielsen JA, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-8; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Oliver B, 2004, J CHILD LANG, V31, P609, DOI 10.1017/S0305000904006221; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Perlman SB, 2016, CEREB CORTEX, V26, P2790, DOI 10.1093/cercor/bhv139; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Sassaroli A, 2006, NEUROIMAGE, V33, P505, DOI 10.1016/j.neuroimage.2006.07.006; Sassaroli A, 2012, IEEE J SEL TOP QUANT, V18, P1478, DOI 10.1109/JSTQE.2012.2183581; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Sato Y, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00070; Sato Y, 2010, J COGNITIVE NEUROSCI, V22, P2503, DOI 10.1162/jocn.2009.21377; Scharoun SM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00082; Scholkmann F, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.105004; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P827, DOI 10.1097/00004647-199609000-00007; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Tamura R, 2012, PSYCHIAT RES-NEUROIM, V203, P237, DOI 10.1016/j.pscychresns.2011.12.008; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Themelis G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2710250; Tierney AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039127; Tong YJ, 2011, J CEREBR BLOOD F MET, V31, P2352, DOI 10.1038/jcbfm.2011.100; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; Turalska M, 2008, ACTA NEUROCHIR SUPPL, V102, P43, DOI 10.1007/978-3-211-85578-2_9; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; VanHorn JD, 1996, BIOL PSYCHIAT, V39, P389, DOI 10.1016/0006-3223(95)00249-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Whitehouse AJO, 2008, BRAIN, V131, P3193, DOI 10.1093/brain/awn266; Wilcox T, 2012, NEUROIMAGE, V62, P1833, DOI 10.1016/j.neuroimage.2012.05.039; Wong FY, 2008, PEDIATRICS, V121, pE604, DOI 10.1542/peds.2007-1487; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Xu M, 2015, J NEUROLINGUIST, V33, P67, DOI 10.1016/j.jneuroling.2014.07.004; Yerys BE, 2009, HUM BRAIN MAPP, V30, P3426, DOI 10.1002/hbm.20767; Yeung MK, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00059; Yodh A., 2003, BIOMEDICAL PHOTONICS, V21, P21, DOI [10.1201/9780203008997.ch21, DOI 10.1201/9780203008997.CH21]; Yucel MA, 2016, BIOMED OPT EXPRESS, V7, P3078, DOI 10.1364/BOE.7.003078; Yue YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075058; Zhu HL, 2015, BIOMED OPT EXPRESS, V6, P690, DOI 10.1364/BOE.6.000690	97	5	5	6	14	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 30	2017	11								300	10.3389/fnins.2017.00300			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FC0LM	WOS:000406529800002	28611578	gold, Green Published			2022-02-06	
J	de Amorim, RLO; Brunoni, AR; de Oliveira, MAF; Zaninotto, ALC; Nagumo, MM; Guirado, VMD; Neville, IS; Benute, GRG; de Lucia, MCS; Paiva, WS; de Andrade, AF; Teixeira, MJ				Oliveira de Amorim, Robson Luis; Brunoni, Andre Russowsky; Furutani de Oliveira, Mirian Akiko; Costa Zaninotto, Ana Luiza; Nagumo, Marcia Mitie; de Paula Guirado, Vinicius Monteiro; Neville, Iuri Santana; Guerra Benute, Glaucia Rosana; Souza de Lucia, Mara Cristina; Paiva, Wellingson Silva; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen			Transcranial Direct Current Stimulation for Post-Concussion Syndrome: Study Protocol for a Randomized Crossover Trial	FRONTIERS IN NEUROLOGY			English	Article						brain injuries; post-concussion syndrome; transcranial direct current stimulation; non-invasive brain stimulation; crossover studies	TRAUMATIC BRAIN-INJURY; DORSOLATERAL PREFRONTAL CORTEX; WORKING-MEMORY; PARKINSONS-DISEASE; INHIBITORY CONTROL; STROKE PATIENTS; HEAD-INJURY; DEPRESSION; ATTENTION; SYMPTOMS	Background: Mild traumatic brain injury (MTBI) represents 70-80% of all treated brain injuries. A considerable proportion of MTBI patients experience post-concussion symptoms for a prolonged period after MTBI, and these symptoms are diagnosed as persistent post-concussion syndrome (PPCS). PPCS is defined as a range of physical, cognitive, and emotional symptoms. However, memory and executive dysfunction seems to be one of the most debilitating symptoms. Recently, non-invasive brain stimulation has been studied as a potential treatment method for traumatic brain injury (TBI) patients. Therefore, our primary goal is to verify the effects of transcranial direct current stimulation (tDCS) in patients with PPCS who demonstrate cognitive deficits in long-term episodic memory, working memory, and executive function following MTBI. Methods/design: This is a randomized crossover trial of patients with a history of MTBI with cognitive deficits in memory and executive function. Thirty adult patients will be randomized in a crossover manner to receive three weekly sessions of anodal tDCS (2mA) at left dorsolateral prefrontal cortex, left temporal cortex, and sham stimulation that will be performed at 7-day intervals (washout period). The clinical diagnosis of PPCS will be determined using the Rivermead Post-Concussion Symptoms Questionnaire. Patients who meet the inclusion criteria will be assessed with a neuropsychological evaluation. A new battery of computerized neuropsychological tests will be performed before and immediately after each stimulation. Statistical analysis will be performed to determine trends of cognitive improvement. Discussion: There is paucity of studies regarding the use of tDCS in TBI patients, and although recent results showed controversial data regarding the effects of tDCS in such patients, we will address specifically patients with PPCS and MTBI and no brain abnormalities on CT scan other than subarachnoid hemorrhage. Moreover, due to the missing information on literature regarding the best brain region to be studied, we will evaluate two different regions to find immediate effects of tDCS on memory and executive dysfunction.	[Oliveira de Amorim, Robson Luis; Nagumo, Marcia Mitie; de Paula Guirado, Vinicius Monteiro; Neville, Iuri Santana; Paiva, Wellingson Silva; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Med Sch, Div Neurosurg, Sao Paulo, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Univ Hosp, Div Psychiat & Psychol, Sao Paulo, Brazil; [Furutani de Oliveira, Mirian Akiko; Costa Zaninotto, Ana Luiza; Guerra Benute, Glaucia Rosana; Souza de Lucia, Mara Cristina] Univ Sao Paulo, Div Psychol, Med Sch, Sao Paulo, Brazil		de Amorim, RLO (corresponding author), Univ Sao Paulo, Med Sch, Div Neurosurg, Sao Paulo, Brazil.	amorim.robson@gmail.com	Zaninotto, Ana Luiza C./I-4095-2016; Neville, Iuri S/P-5360-2014; de Paula Guirado, Vinicius Monteiro/AAG-7299-2019; Amorim, Robson/AAK-1368-2021; Paiva, Wellingson S/G-5517-2013; Neville, Iuri/AAI-2852-2021; Brunoni, Andre R./H-8394-2012	Zaninotto, Ana Luiza C./0000-0003-0639-0612; Neville, Iuri S/0000-0002-8561-9069; de Paula Guirado, Vinicius Monteiro/0000-0002-7782-3609; Amorim, Robson/0000-0003-2391-7519; Paiva, Wellingson S/0000-0002-5165-7040; Neville, Iuri/0000-0002-8561-9069; Brunoni, Andre R./0000-0002-6310-3571; Guerra Benute, Glaucia Rosana/0000-0003-0781-1976			Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Bajaj JS, 2008, GASTROENTEROLOGY, V135, P1591, DOI 10.1053/j.gastro.2008.07.021; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Bonni S, 2013, NEUROL SCI, V34, P2053, DOI 10.1007/s10072-013-1412-y; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Bueno VF, 2011, NEUROCASE, V17, P318, DOI 10.1080/13554794.2010.509319; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Cotelli M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00038; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Dresler M, 2013, NEUROPHARMACOLOGY, V64, P529, DOI 10.1016/j.neuropharm.2012.07.002; Fecteau S, 2010, SUBST USE MISUSE, V45, P1766, DOI 10.3109/10826084.2010.482434; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goldman RL, 2011, APPETITE, V56, P741, DOI 10.1016/j.appet.2011.02.013; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Jones KT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121904; Kang EK, 2009, RESTOR NEUROL NEUROS, V27, P645, DOI 10.3233/RNN-2009-0514; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Park SH, 2013, J KOREAN NEUROSURG S, V54, P484, DOI 10.3340/jkns.2013.54.6.484; Pereira JB, 2013, BRAIN STIMUL, V6, P16, DOI 10.1016/j.brs.2012.01.006; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Van den Eynde F, 2010, BIOL PSYCHIAT, V67, P793, DOI 10.1016/j.biopsych.2009.11.023; Vanderhasselt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062219; Weschler D., 1997, WESCHLER ADULT INTEL; Wu YJ, 2014, BRAIN COGNITION, V91, P87, DOI 10.1016/j.bandc.2014.09.002; Yun GJ, 2015, J STROKE, V17, P354, DOI 10.5853/jos.2015.17.3.354	59	5	5	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 2	2017	8								164	10.3389/fneur.2017.00164			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET7WL	WOS:000400510000001	28512443	gold, Green Published			2022-02-06	
J	Bordes, J; Joubert, C; Esnault, P; Montcriol, A; Nguyen, C; Meaudre, E; Dulou, R; Dagain, A				Bordes, J.; Joubert, C.; Esnault, P.; Montcriol, A.; Nguyen, C.; Meaudre, E.; Dulou, R.; Dagain, A.			Coagulopathy and transfusion requirements in war related penetrating traumatic brain injury. A single centre study in a French role 3 medical treatment facility in Afghanistan	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Penetrating traumatic brain injury; Transfusion; Gunshots; Explosions; French lyophilized plasma; War injuries; Field hospital	HOSPITAL EXPERIENCE; LYOPHILIZED PLASMA; ARMED-FORCES; IRAQ; CASUALTIES; SEVERITY	Introduction: Traumatic brain injury associated coagulopathy is frequent, either in isolated traumatic brain injury in civilian practice and in combat traumatic brain injury. In war zone, it is a matter of concern because head and neck are the second most frequent site of wartime casualty burden. Data focusing on transfusion requirements in patients with war related TBI coagulopathy are limited. Materials and methods: A descriptive analysis was conducted of 77 penetrating traumatic brain injuries referred to a French role 3 medical treatment facility in Kabul, Afghanistan, deployed on the Kabul International Airport (KaIA), over a 30 months period. Results: On 77 patients, 23 died during the prehospital phase and were not included in the study. Severe traumatic brain injury represented 50% of patients. Explosions were the most common injury mechanism. Extracranial injuries were present in 72% of patients. Traumatic brain injury coagulopathy was diagnosed in 67% of patients at role 3 admission. Red blood cell units (RBCu) were transfused in 39 (72%) patients, French lyophilized plasma (FLYP) in 41 (76%), and fresh whole blood (FWB) in 17 (31%). Conclusion: The results of this study support previous observations of coagulopathy as a frequent complication of traumatic brain injury. The majority of patients with war related penetrating traumatic brain injury presented with extracranial lesions. Most of them required a high level of transfusion capacity. (C) 2016 Elsevier Ltd. All rights reserved.	[Bordes, J.; Esnault, P.; Montcriol, A.; Nguyen, C.; Meaudre, E.] St Anne Mil Teaching Hosp, Intens Care Unit, Blvd St Anne, F-83800 Toulon, France; [Joubert, C.; Dagain, A.] St Anne Mil Teaching Hosp, Neurosurg Unit, Toulon, France; [Meaudre, E.; Dulou, R.; Dagain, A.] French Mil Hlth Serv Acad, Ecole Val De Grace, Paris, France; [Dulou, R.] Val De Grace Mil Teaching Hosp, Neurosurg Unit, Paris, France		Bordes, J (corresponding author), St Anne Mil Teaching Hosp, Intens Care Unit, Blvd St Anne, F-83800 Toulon, France.	bordes.julien@neuf.fr	Esnault, Pierre/AAN-5792-2020; Joubert, Christophe/AAU-4807-2020	dagain, arnaud/0000-0001-8416-1976			Ausset S, 2009, ANAESTHESIA, V64, P1142, DOI 10.1111/j.1365-2044.2009.06087.x; Beekley AC, 2009, J TRAUMA, V66, pS129, DOI 10.1097/TA.0b013e31819d85e7; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Esnault P, 2013, ANN FR ANESTH, V32, P670, DOI 10.1016/j.annfar.2013.06.007; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hawley CA, 2015, J HEAD TRAUMA REHAB, V30, pE47, DOI 10.1097/HTR.0000000000000023; Hoencamp R, 2014, INJURY, V45, P1028, DOI 10.1016/j.injury.2014.02.012; Lustenberger T, 2012, WORLD J SURG, V36, P208, DOI 10.1007/s00268-011-1321-2; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mann-Salinas E A, 2016, J TRAUMA ACUTE CARE; Martinaud C, 2012, ANESTHESIOLOGY, V117, P339, DOI 10.1097/ALN.0b013e3182608cdd; Martinaud C, 2011, J TRAUMA, V71, P1761, DOI 10.1097/TA.0b013e31822f1285; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038	18	5	5	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2017	48	5					1047	1053		10.1016/j.injury.2016.11.023			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EW4QG	WOS:000402485400015	27938877				2022-02-06	
J	Davceva, N; Sivevski, A; Basheska, N				Davceva, N.; Sivevski, A.; Basheska, Neli			Traumatic axonal injury, a clinical-pathological correlation	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Traumatic axonal injury; Diffuse axonal injury; Closed head injury; beta-amyloid precursor protein	BETA-APP IMMUNOREACTIVITY; AMYLOID PRECURSOR PROTEIN; HEAD-INJURY; CLINICOPATHOLOGICAL ENTITY; FORENSIC PRACTICE; DIAGNOSIS; COMA	Traumatic axonal injury (TAI) is a distinct clinicopathological entity that can cause serious impairment of the brain function and can sometimes be found as a concrete cause of death. It has been discussed from the perspective of its biomechanical importance, and also from the standpoint of certain criteria for the pathological diagnosis of TAI. However, since the time when DAI (diffuse axonal injury) was initially described, there have been few, if any, discussions about the clinical-pathological correlation in TAI. This paper is an attempt to address this issue. For the purpose of certain pathological diagnoses of TAI, 63 cases with closed head injuries have been subjected to the complete forensic-neuropathological examination, involving immunohistochemistry with antibody against beta-APP. In the diagnosis of TAI strict criteria have been followed. Then, retrograde analysis of the clinical parameters has been performed in order to determine some clinical-pathological correlation. The following two most reliable parameters of the impairment of the brain function have been analyzed: the impairment of the consciousness and the time of survival. Comparing the two groups, the one with TAI and the other without TAI, and using appropriate statistical evaluation, our results show that TAI is not a significant contributing factor to the lethal outcome in the early post injury period (24 h), but it is undoubtedly a contributing factor for the severe impairment of the brain function indicated through the status of the consciousness. (C) 2017 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Davceva, N.] Inst Forens Med Criminol & Med Deontol, Mother Theresa 19, Skopje 1000, Macedonia; [Sivevski, A.] Ss Cyril & Methodius Univ Skopje, Univ Clin Gynecol & Obstet, Fac Med, Anesthesiol, Mother Theresa 17, Skopje 1000, Macedonia; [Basheska, Neli] Ss Cyril & Methodius Univ, Fac Med, Univ Clin Radiotherapy & Oncol, Dept Histopathol & Clin Cytol, Skopje, Macedonia		Davceva, N (corresponding author), Univ Skopje, Inst Forens Med Criminol & Med Deontol, Mother Theresa 19, Skopje 1000, Macedonia.	drdavcevamk@yahoo.com	Basheska, Neli T./P-7241-2014	Basheska, Neli T./0000-0002-7442-0409; Davceva, Natasha/0000-0001-8174-3145; Sivevski, Atanas/0000-0002-7431-1026			Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Davceva N, 2012, Soud Lek, V57, P2; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Di Mayo VS, 2001, FORENSIC PATHOLOGY, P165; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Omalu BI, 2004, AM J FOREN MED PATH, V25, P270, DOI 10.1097/01.paf.0000136642.17300.8b; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith C, 2003, ACTA NEUROPATHOL, V106, P97, DOI 10.1007/s00401-003-0703-4; TEASDALE G, 1974, LANCET, V2, P81; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	23	5	5	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	MAY	2017	48						35	40		10.1016/j.jflm.2017.04.004			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	EZ1LB	WOS:000404471400007	28437717				2022-02-06	
J	Ji, W; Liu, HZ; Liu, C; Shao, LF; Liu, YK; Fan, SC; Li, XH; Gong, LL; Zhu, SX; Gao, YL				Ji, Wei; Liu, Hanzhang; Liu, Chun; shao, Lifei; Liu, Yuankun; Fan, Shaochen; Li, Xiaohong; Gong, Lei Lei; Zhu, Shunxing; Gao, Yilu			Up-regulation of MCM3 Relates to Neuronal Apoptosis After Traumatic Brain Injury in Adult Rats	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						MCM3; Active caspase-3; BAX/Bcl-2; Neuronal apoptosis; TBI	CELL-CYCLE EVENTS; GLIAL PROLIFERATION; DNA-REPLICATION; CNS INJURY; DEATH; MCM2-7; DISEASE; BCL-2; BAX; NEUROPROTECTION	Minichromosome maintenance complex component 3, one of the minichromosome maintenance proteins, functions as a part of pre-replication complex to initiate DNA replication in eukaryotes. Minichromosome maintenance complex component 3 (MCM3) was mainly implied in cell proliferation and tumorigenesis. In addition, MCM3 might play an important role in neuronal apoptosis. However, the functions of MCM3 in central nervous system are still with limited acquaintance. In this study, we performed a traumatic brain injury (TBI) model in adult rats. Western blot and immunohistochemistry staining showed up-regulation of MCM3 in the peritrauma brain cortex. The expression patterns of active caspase-3 and Bax, Bcl-2 were parallel with that of MCM3. Immunofluorescent staining and terminal deoxynucleotidyl transferase-mediated biotinylated-dUTP nick-end labeling suggested that MCM3 was involved in neuronal apoptosis. In conclusion, our data indicated that MCM3 might play an important role in neuronal apoptosis following TBI. Further understanding of these insights could serve as the basis for broadening the therapeutic scope against TBI.	[Ji, Wei; shao, Lifei; Liu, Yuankun; Fan, Shaochen; Gao, Yilu] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China; [Liu, Hanzhang] Nantong Univ, Morphol Lab, Med Coll, Nantong 226001, Jiangsu, Peoples R China; [Liu, Chun; Zhu, Shunxing] Nantong Univ, Expt Anim Ctr, Med Coll, Nantong 226001, Jiangsu, Peoples R China; [Li, Xiaohong] Nantong Univ, Labortary Surg, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Gong, Lei Lei] Nantong Univ, Key Lab Nerve Regenerat, Nantong 226001, Jiangsu, Peoples R China		Gao, YL (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China.; Zhu, SX (corresponding author), Nantong Univ, Expt Anim Ctr, Med Coll, Nantong 226001, Jiangsu, Peoples R China.	ntdxzsx@163.com; ntdxgyl@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371335, 81200918]	This work was supported by the National Natural Science Foundation of China (81371335, 81200918).	Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bhuiyan MS, 2008, CARDIOVASC THER, V26, P224, DOI 10.1111/j.1755-5922.2008.00052.x; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Ino H, 2001, J NEUROSCI, V21, P6086, DOI 10.1523/JNEUROSCI.21-16-06086.2001; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lam SKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082177; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LOGAN A, 1992, J NEUROSCI, V12, P3828; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Sakurai M, 2000, STROKE, V31, P200, DOI 10.1161/01.STR.31.1.200; Schories B, 2004, CELL DEATH DIFFER, V11, P940, DOI 10.1038/sj.cdd.4401411; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Verdaguer E, 2002, NEUROREPORT, V13, P413, DOI 10.1097/00001756-200203250-00010; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yang Y, 2003, J NEUROSCI, V23, P2557; Yin MB, 1999, INT J CANCER, V83, P341, DOI 10.1002/(SICI)1097-0215(19991029)83:3<341::AID-IJC9>3.0.CO;2-3	37	5	9	1	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2017	37	4					683	693		10.1007/s10571-016-0404-x			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	ER7SK	WOS:000399013600010	27401074				2022-02-06	
J	Macciocchi, SN; Seel, RT; Yi, A; Small, S				Macciocchi, Stephen N.; Seel, Ronald T.; Yi, Angela; Small, Sarah			Medical Symptom Validity Test Performance Following Moderate-Severe Traumatic Brain Injury: Expectations Based on Orientation Log Classification	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Malingering/symptom validity testing; Forensic neuropsychology; Head injury; Traumatic brain injury	GALVESTON ORIENTATION; AMNESIA TEST; IMPAIRMENT; CLAIMANTS; SAMPLE	Objective: This study examined performance on the Medical Symptom Validity test (MSVT) during acute rehabilitation for moderate-severe traumatic brain injury (TBI) stratified by Orientation Log (O-Log) scores. Method: Participants were 77 prospectively enrolled persons who sustained moderate-severe TBI and were acutely hospitalized secondary to the cognitive, medical and physical sequelae of their TBI. Participants were administered neuropsychological metrics, the O-Log and the MSVT a mean of 44 days post injury. Results: Significantly lower neurocognitive test scores were observed among participants who remained in post-traumatic amnesia (O-Log scores ranging from 20 to 24) versus those who were oriented (O-Log scores ranging from 25 to 30). MSVT performance was lower among participants who remained in post-traumatic amnesia. When participants O-Log scores were unimpaired (30), performance on the MSVT was also unimpaired on immediate recognition (IR) and delayed recognition (DR). A small percentage of participants performed below MSVT interpretive expectations on CNS. As O-Log scores decreased, MSVT performance also declined on some, but not all MSVT metrics. The sample as a whole performed at or above expectations on MSVT criterion B2 (IR) = 96.6%; (DR) = 94.8%; consistency (CNS) = 92.9%; paired associate (PA) = 86.4% and delayed free recall (FR) = 46.8%. Conclusions: MSVT performance stratified by O-Log scores provides basal expectation levels for persons with acute, moderate-severe impairment in cognitive skills secondary to TBI. Our data demonstrate that persons with significant neurocognitive impairment who are oriented generally perform at or above MSVT interpretive guidelines.	[Macciocchi, Stephen N.] Atlanta Neuropsychol, Atlanta, GA USA; [Macciocchi, Stephen N.; Seel, Ronald T.; Yi, Angela; Small, Sarah] Shepherd Ctr, Atlanta, GA USA		Macciocchi, SN (corresponding author), POB 189, Marble Hill, GA 30148 USA.	snmphd@windstream.net					Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; DeFilippis N., 1997, BOOKLET CATEGORY TES, V2nd; Delis D. C., 2001, EXAMINERS MANUAL DEL; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2004, GREENS MED SYMPTOM; Green P., 2003, WORLD MEMORY TEST WI; Green P, 2016, APPL NEUROPSYCH-CHIL, V5, P25, DOI 10.1080/21622965.2014.935378; Green P, 2015, APPL NEUROPSYCH-ADUL, V22, P293, DOI 10.1080/23279095.2014.925903; Hamsher K., 1989, MULTILINGUAL APHASIA; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith A., 1982, SYMBOL DIGITS MODALI; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	27	5	5	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2017	32	3					339	348		10.1093/arclin/acw112			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EU2WN	WOS:000400890700009	28431035	Bronze			2022-02-06	
J	Way, DP; Panchal, AR; Finnegan, GI; Terndrup, TE				Way, David P.; Panchal, Ashish R.; Finnegan, Geoffrey I.; Terndrup, Thomas E.			AIRWAY MANAGEMENT PROFICIENCY CHECKLIST FOR ASSESSING PARAMEDIC PERFORMANCE	PREHOSPITAL EMERGENCY CARE			English	Article						airway management; patient simulation; emergency care; prehospital; evaluation research; educational needs assessment; emergency medical technicians	ENDOTRACHEAL INTUBATION; SIMULATION; SUCCESS; IMPROVES; SKILLS	Objective: To develop and derive an instrument for assessing airway management proficiency for paramedics. Methods: Using a validated difficult airway model simulation, we recorded responses to a standard traumatic brain injury scenario requiring airway management in 197 certified paramedics. Discrete items (N = 131) were developed by an expert panel, and referenced to three performance standard subscales (i.e., intubation, ventilation, and backup airway). Responses were scored and subjected to an iterative process to create a more practical number of items for the final Airway Management Proficiency Checklist (AMPC). Tetrachoric correlations were used to evaluate items for relevance. Kuder-Richardson Formula 20 reliabilities were used to assess internal consistency among checklist items. Finally, a Rasch analysis on each subscale was performed to evaluate items for measurement quality. Items were retained if they were determined to fit the Rasch Model. Results: Items were deleted from the final AMPC for lack of simulation fidelity (26 items), duplicity (15 items), and poor psychometric quality (39 items). In four additional iterations, items were dropped for lack of equipment options (e.g., single mask), lack of instructional clarity (e.g., calculation of GCS score), high inference on the part of the evaluator (6 items), or inadequate measurement of behavioral performance (e.g., passes blade through lips without contacting mouth or teeth). Thirty seven items and three outcome standards (first pass success of the endotracheal tube; assisted ventilation with no interruption of 30 seconds or greater; successful placement of a backup airway device within one attempt) were retained to form three hypothesized subscales. Conclusions: The AMPC represents a psychometrically derived instrument that identified important tasks required for comprehensive airway management. The 37-item instrument will contribute to improving training and measuring the performance of paramedic's airway management skills.	[Way, David P.; Panchal, Ashish R.; Finnegan, Geoffrey I.; Terndrup, Thomas E.] Ohio State Univ, Wexner Med Ctr, Dept Emergency Med, Columbus, OH 43210 USA; [Way, David P.; Panchal, Ashish R.; Finnegan, Geoffrey I.; Terndrup, Thomas E.] Ohio State Univ, Ctr EMS, Wexner Med Ctr, Columbus, OH 43210 USA		Terndrup, TE (corresponding author), Ohio State Univ, Dept Emergency Med, 750 Prior Hall,376 W 10th 10 Ave, Columbus, OH 43210 USA.	thomas.terndrup@osumc.edu	Way, David/AAE-7428-2020	terndrup, thomas/0000-0003-4376-2593; Panchal, Ashish/0000-0001-7382-982X	U.S. Department of Health and Human Services-Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [SR18HS021456-02]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R18HS021456] Funding Source: NIH RePORTER	This project was supported by a grant from the U.S. Department of Health and Human Services-Agency for Healthcare Research and Quality (SR18HS021456-02; Terndrup, PI).	Bischof JJ, 2016, PREHOSP DISASTER MED, V31, P465, DOI 10.1017/S1049023X16000534; Brown CA, 2015, ANN EMERG MED, V65, P363, DOI 10.1016/j.annemergmed.2014.10.036; Cook T, 2011, 4 NATL AUDIT PROJECT, P1; Davis DP, 2006, PREHOSP EMERG CARE, V10, P356, DOI 10.1080/10903120600725751; Diggs LA, 2014, RESUSCITATION, V85, P885, DOI 10.1016/j.resuscitation.2014.02.032; Glass G. V., 1984, STAT METHODS ED PSYC; Hall RE, 2005, ACAD EMERG MED, V12, P850, DOI 10.1197/j.aem.2005.04.007; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P515, DOI 10.3109/10903127.2010.497903; Hubble MW, 2010, PREHOSP EMERG CARE, V14, P377, DOI 10.3109/10903121003790173; Jarvis JL, 2015, PREHOSP EMERG CARE, V19, P482, DOI 10.3109/10903127.2015.1005259; Lammers RL, 2009, PREHOSP EMERG CARE, V13, P345, DOI 10.1080/10903120802706161; Levitan RM, 2004, AIRWAYCAM GUIDE INTU, P3; Linacre J. M., 2016, WINSTEPS VERSION 3 8; Lockey DJ, 2015, BRIT J ANAESTH, V114, P657, DOI 10.1093/bja/aeu412; McGaghie WC, 2015, MED EDUC, V49, P558, DOI 10.1111/medu.12679; Naito H, 2016, PREHOSP EMERG CARE, V20, P333, DOI 10.3109/10903127.2015.1111480; Nasim S, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-9; Panchenko A., 2016, 2016 IEEE 7 POW IND, P1; Prekker ME, 2014, CRIT CARE MED, V42, P1372, DOI 10.1097/CCM.0000000000000213; Reed T, 2016, SIMUL HEALTHC, V11, P173, DOI 10.1097/SIH.0000000000000154; van Tulder R, 2020, PREHOSP EMERG CARE, V24, P434, DOI 10.3109/10903127.2015.1129473; Walker M, 2013, EMERG MED J, V30, P334, DOI 10.1136/emermed-2011-200839; Walls RM, 2006, ROSENS EMERGENCY MED, P2; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858; Wright B, 1994, MEASUREMENT T, V8, P370	25	5	5	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	MAY-JUN	2017	21	3					354	361		10.1080/10903127.2016.1263368			8	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	ET6JU	WOS:000400398700010	28112989				2022-02-06	
J	Samaiya, PK; Narayan, G; Kumar, A; Krishnamurthy, S				Samaiya, Puneet K.; Narayan, Gopeshwar; Kumar, Ashok; Krishnamurthy, Sairam			Tempol (4 hydroxy-tempo) inhibits anoxia-induced progression of mitochondrial dysfunction and associated neurobehavioral impairment in neonatal rats	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Tempol; Mitochondrial dysfunction; Respiratory control ratio; Apoptosis; Neonatal anoxia	TRAUMATIC BRAIN-INJURY; OXIDATIVE DAMAGE; NITRIC-OXIDE; PEROXYNITRITE; ASSAY; DEHYDROGENASE; RESPIRATION; APOPTOSIS; ISCHEMIA; CORTEX	Background: Anoxia leads to a robust generation of reactive oxygen species/nitrogen species which can result in mitochondrial dysfunction and associated cell death in the cerebral cortex of neonates. Aim: The present study investigated the pharmacological role of tempol in the treatment of rat neonatal cortical mitochondrial dysfunction induced insult progression (day-1 to day-7) and associated neurobehavioral alterations post-anoxia. Methods: Rat pups of 30 h age or postnatal day 2 (PND2) were randomly divided into 5 groups (n = 5 per group): (1) Control; (2) Anoxia; (3) Anoxia + Tempol 75 mg/kg; (4) Anoxia + Tempol 150 mg/kg; and (5) Anoxia + Tempol 300 mg/kg, and subjected to two episode of anoxia (10 min each) at 24 h of time interval in an enclosed chamber supplied with 100% N-2. Results: Tempol significantly decreased nitric oxide (center dot NO) formation and simultaneously improved superoxide dismutase (SOD) and catalase (CAT) activities. Further, we observed a significantly (P < 0.05) improvement in mitochondrial respiration, complex enzyme activities, mitochondrial membrane potential (MMP) along with attenuation of transition pore opening (MPT) after treatment with tempol. Furthermore, tempol decreased expression of mitochondrial Bax, cytochrome-C, caspase-9 and caspase-3 while the increase in expression of cytoplasmic Bax, mitochondrial Bcl-2 on day-7 in cortical region indicating regulation of intrinsic pathway of apoptosis. Further, it improved anoxia-induced neurobehavioral outcome (hanging and reflex latencies). Conclusion: Biochemical, molecular and behavioral studies suggest the role of tempol in preserving mitochondrial function and associated neurobehavioral outcomes after neonatal anoxia. (C) 2017 Elsevier B.V. All rights reserved.	[Samaiya, Puneet K.; Krishnamurthy, Sairam] Banaras Hindu Univ, Indian Inst Technol, Dept Pharmaceut, Neurotherapeut Lab, Varanasi 221005, Uttar Pradesh, India; [Narayan, Gopeshwar] Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India; [Kumar, Ashok] Banaras Hindu Univ, Inst Med Sci, Dept Pediat, Varanasi, Uttar Pradesh, India		Krishnamurthy, S (corresponding author), Banaras Hindu Univ, Indian Inst Technol, Dept Pharmaceut, Pharmacol, Varanasi 221005, Uttar Pradesh, India.	saibliss@hotmail.com	KUMAR, ASHOK/AAF-4055-2021	KUMAR, ASHOK/0000-0002-9244-0622; SAMAIYA, PUNEET/0000-0001-7836-8807; Kumar Nadda, Ashok/0000-0001-9192-0774	Department of Biotechnology (DBT), New Delhi, IndiaDepartment of Biotechnology (DBT) India [102/IFD/SAN/4654/ 2011-2012]	SK is thankful to Department of Biotechnology (DBT), New Delhi, India for assistance regarding research grant [102/IFD/SAN/4654/ 2011-2012].	Alvarez MN, 2002, METHOD ENZYMOL, V359, P353; BEERS RF, 1952, J BIOL CHEM, V195, P133; Berman SB, 1999, J NEUROCHEM, V73, P1127, DOI 10.1046/j.1471-4159.1999.0731127.x; Blomgren K, 2003, BIOCHEM BIOPH RES CO, V304, P551, DOI 10.1016/S0006-291X(03)00628-4; Bolanos JP, 1998, BRAIN RES, V787, P117, DOI 10.1016/S0006-8993(97)01530-8; Borutaite V, 2013, FEBS J, V280, P4999, DOI 10.1111/febs.12353; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cobb CA, 2015, NEUROBIOL DIS, V84, P4, DOI 10.1016/j.nbd.2015.04.020; Fan LW, 2005, BEHAV BRAIN RES, V165, P80, DOI 10.1016/j.bbr.2005.06.033; Fan X., CURR NEUROPHARMACOL, V8; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; de Cerio FG, 2013, BRAIN SCI, V3, P191, DOI 10.3390/brainsci3010191; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GRIFFITHS DE, 1974, EUR J BIOCHEM, V46, P157, DOI 10.1111/j.1432-1033.1974.tb03608.x; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Hermans R. H. M., NEUROTOXICOL TERATOL, V14; Huang SG, 2002, J BIOMOL SCREEN, V7, P383, DOI 10.1177/108705710200700411; Iriyama T, 2009, NEUROSCI LETT, V451, P11, DOI 10.1016/j.neulet.2008.12.021; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Northington FJ, 2005, BRAIN RES REV, V50, P244, DOI 10.1016/j.brainresrev.2005.07.003; OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Popa-Wagner A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/963520; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rousset CI, 2012, J MATERN-FETAL NEO M, V25, P35, DOI 10.3109/14767058.2012.666398; Salvi A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5059043; Samaiya PK, 2016, INT J DEV NEUROSCI, V52, P55, DOI 10.1016/j.ijdevneu.2016.05.005; Samaiya PK, 2015, J BIOENERG BIOMEMBR, V47, P217, DOI 10.1007/s10863-015-9603-2; Schnackenberg CG, 2001, KIDNEY INT, V59, P1859, DOI 10.1046/j.1523-1755.2001.0590051859.x; SHAPIRO BL, 1979, P NATL ACAD SCI USA, V76, P2979, DOI 10.1073/pnas.76.6.2979; Singh I. N., J NEUROSCI RES, V85; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; SUNDERMAN FW, 1985, ANN CLIN LAB SCI, V15, P229; TEDESCHI H, 1958, BIOCHIM BIOPHYS ACTA, V28, P392, DOI 10.1016/0006-3002(58)90487-6; Titomanlio L, 2015, PEDIATR NEUROL, V52, P566, DOI 10.1016/j.pediatrneurol.2015.01.016; Tovmasyan A, 2015, FREE RADICAL BIO MED, V86, P308, DOI 10.1016/j.freeradbiomed.2015.05.018; Utkina-Sosunova IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062448; van Bel F, 2016, SEMIN PERINATOL, V40, P152, DOI 10.1053/j.semperi.2015.12.003; Verklan MT, 2009, J PERINAT NEONAT NUR, V23, P59, DOI 10.1097/01.JPN.0000346221.48202.7e; Wei ZZ, 2015, CELL TRANSPLANT, V24, P391, DOI 10.3727/096368915X686887; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, FREE RADICAL RES, V43, P604, DOI 10.1080/10715760902977432; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Yang WY, 2015, NEUROREPORT, V26, P842, DOI 10.1097/WNR.0000000000000434	52	5	5	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	APR 15	2017	375						58	67		10.1016/j.jns.2017.01.021			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER4EN	WOS:000398752000010	28320189				2022-02-06	
J	Adams, ZM; Fins, JJ				Adams, Zoe M.; Fins, Joseph J.			The historical origins of the vegetative state: Received wisdom and the utility of the text	JOURNAL OF THE HISTORY OF THE NEUROSCIENCES			English	Article						Antiquity; Aristotle; Hippocrates; minimally conscious state (MCS); persistent vegetative state (PVS); Plato; reception studies; traumatic brain injury (TBI)	BRAIN	The persistent vegetative state (PVS) is one of the most iconic and misunderstood phrases in clinical neuroscience. Coined as a diagnostic category by Scottish neurosurgeon Bryan Jennett and American neurologist Fred Plum in 1972, the phrase vegetative first appeared in Aristotle's treatise On the Soul (circa mid-fourth century BCE). Aristotle influenced neuroscientists of the nineteenth and early-twentieth centuries, Xavier Bichat and Walter Timme, and informed their conceptions of the vegetative nervous system. Plum credits Bichat and Timme in his use of the phrase, thus putting the ancient and modern in dialogue. In addition to exploring Aristotle's definition of the vegetative in the original Greek, we put Aristotle in conversation with his contemporariesPlato and the Hippocraticsto better apprehend theories of mind and consciousness in antiquity. Utilizing the discipline of reception studies in classics scholarship, we demonstrate the importance of etymology and historical origin when considering modern medical nosology.	[Adams, Zoe M.; Fins, Joseph J.] Weill Cornell Med Coll, Dept Neurol, CASBI, 1300 York Ave, New York, NY 10065 USA; [Adams, Zoe M.; Fins, Joseph J.] Weill Cornell Med Coll, Brain & Mind Res Inst, 1300 York Ave, New York, NY 10065 USA; [Fins, Joseph J.] Weill Cornell Med Coll, Div Med Eth, New York, NY 10065 USA; [Fins, Joseph J.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Fins, Joseph J.] Yale Law Sch, Solomon Ctr Hlth Law & Policy, New Haven, CT USA		Adams, ZM (corresponding author), Weill Cornell Med Coll, Dept Neurol, CASBI, 1300 York Ave, New York, NY 10065 USA.; Adams, ZM (corresponding author), Weill Cornell Med Coll, Brain & Mind Res Inst, 1300 York Ave, New York, NY 10065 USA.	zma2001@med.cornell.edu		Fins, Joseph/0000-0002-7221-0053			Aristotle, 1957, ON THE SOUL; ARISTOTLE, 1955, PARTS ANIMALS; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bichat X., 1800, RECHERCHES PHYSL VIE; CELESIA, 1993, ANN NEUROL, V33, P386; Crivellato E, 2007, BRAIN RES BULL, V71, P327, DOI 10.1016/j.brainresbull.2006.09.020; Cunliffe R., 2012, LEXICON HOMERIC DIAL; Fins JJ, 2015, EIDON, V44, P67, DOI 10.13184/eidon.44.2015.67-86; Fins JJ, 2015, RIGHTS COME MIND BRA; Fins JJ, 2008, AM J BIOETHICS, V8, P3, DOI 10.1080/15265160802318113; Fins JJ, 2007, NEUROLOGY, V68, P79, DOI 10.1212/01.wnl.0000253019.00880.72; Fins JJ, 2009, ANN NY ACAD SCI, V1157, P131, DOI 10.1111/j.1749-6632.2009.04473.x; Freud Sigmund, 1965, INTERPRETATION DREAM; GROSS CG, 1995, NEUROSCIENTIST, V1, P245, DOI DOI 10.1177/107385849500100408; Hardwick Lorna, 2008, COMPANION CLASSICAL; Hippocrates, 1923, SACRED DIS; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 2002, VEGETATIVE STATE MED; Liddell H. G., 1819, GREEK ENGLISH LEXICO; Lorenz H, 2009, STANFORD ENCY PHILOS; Mattern S. P., 2008, GALEN RHETORIC HEALI; Plato Timeaus, 2000, TIMEAUS; Plum F, 1998, PHILOS T ROY SOC B, V353, P1929, DOI 10.1098/rstb.1998.0345; Quinlan K, 1976, SUPREME COURT NEW JE; REEVE CDC, 2011, STANFORD ENCY PHILOS; Rowe CJ, 1986, PHAEDRUS; Timme W, 1928, P ASS NERV MENT DIS, VIX, P1; Watts G, 2008, LANCET, V371, P646, DOI 10.1016/S0140-6736(08)60293-7	28	5	6	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0964-704X	1744-5213		J HIST NEUROSCI	J. Hist. Neurosci.	APR-JUN	2017	26	2					140	153		10.1080/0964704X.2016.1184074			14	History & Philosophy Of Science; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	History & Philosophy of Science; Neurosciences & Neurology	ES5EA	WOS:000399558800003	27295518				2022-02-06	
J	Fadyl, JK; Channon, A; Theadom, A; McPherson, KM				Fadyl, Joanna K.; Channon, Alexis; Theadom, Alice; McPherson, Kathryn M.		TBI Experiences Res Grp	Optimising qualitative longitudinal analysis: Insights from a study of traumatic brain injury recovery and adaptation	NURSING INQUIRY			English	Article						data analysis; data management; qualitative longitudinal; qualitative methods	STROKE; EXPERIENCE; PEOPLE; TIME	Knowledge about aspects that influence recovery and adaptation in the postacute phase of disabling health events is key to understanding how best to provide appropriate rehabilitation and health services. Qualitative longitudinal research makes it possible to look for patterns, key time points and critical moments that could be vital for interventions and supports. However, strategies that support robust data management and analysis for longitudinal qualitative research in health-care are not well documented in the literature. This article reviews three challenges encountered in a large longitudinal qualitative descriptive study about experiences of recovery and adaptation after traumatic brain injury in New Zealand, and the strategies and technologies used to address them. These were (i) tracking coding and analysis decisions during an extended analysis period; (ii) navigating interpretations over time and in response to new data; and (iii) exploiting data volume and complexity. Concept mapping during coding review, a considered combination of information technologies, employing both cross-sectional and narrative analysis, and an expectation that subanalyses would be required for key topics helped us manage the study in a way that facilitated useful and novel insights. These strategies could be applied in other qualitative longitudinal studies in healthcare inquiry to optimise data analysis and stimulate important insights.	[Fadyl, Joanna K.; Channon, Alexis; Theadom, Alice; McPherson, Kathryn M.] Auckland Univ Technol, Ctr Person Ctr Res, Auckland, New Zealand; [Theadom, Alice] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand		Fadyl, JK (corresponding author), Auckland Univ Technol, Auckland, New Zealand.	jfadyl@aut.ac.nz	Levack, William Mark Magnus/F-9607-2018	Levack, William Mark Magnus/0000-0001-6631-908X; McPherson, Kath/0000-0003-0487-8497; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New ZealandHealth Research Council of New Zealand; Faculty of Environmental Sciences, Auckland University of Technology	Funding for the research was provided by the Health Research Council of New Zealand. We were also awarded a grant from the Faculty of Environmental Sciences, Auckland University of Technology, as financial support for preparation of the article. We acknowledge the following people who have provided valuable contributions to the project. We thank the participants for their time and energy in sharing their experiences. Input into the design or running of the project was contributed by William Levack, Nicola Kayes, Laura Wilkinson-Meyers, Nicola Starkey, Grant Christie, Valery Feigin, Kay Shannon, Kirsten Thomas, Dawn Willix-Payne, Claire Townson, Elisa Lavelle, Margaret Dudley and Thivasha Naidoo-Melis, the organisations that facilitated participant recruitment and the community reference group: Stephen Jenkins, Matire Harwood, Alison Forster and Suzanne Mudge. Greta Smith contributed financial management, data modelling and administrative support. Rean Fadyl and AcumenBI provided consultancy regarding database design and data visualisation software and development.	BECKER G, 1993, GERONTOLOGIST, V33, P148, DOI 10.1093/geront/33.2.148; Bidart C, 2013, TIME SOC, V22, P254, DOI 10.1177/0961463X12447493; Calman L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-14; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; Charmaz K, 1995, SOCIOL QUART, V36, P657, DOI 10.1111/j.1533-8525.1995.tb00459.x; Charmaz K., 2014, BROKERAGE CLOSURE IN; Corden A, 2007, SOC POLICY SOC, V6, P583, DOI 10.1017/S1474746407003910; Faircloth CA, 2004, J AGING STUD, V18, P399, DOI 10.1016/j.jaging.2004.06.006; Faircloth CA, 2004, SOCIOL HEALTH ILL, V26, P242, DOI 10.1111/j.1467-9566.2004.00388.x; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lloyd V, 2006, QUAL HEALTH RES, V16, P1386, DOI 10.1177/1049732306293846; Lowe M, 2011, LUNG CANCER, V74, P344, DOI 10.1016/j.lungcan.2011.03.011; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pinnock H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d142; Qlik, 2015, QLIKS ASS MOD SEEING; Rubin H.J., 2005, QUALITATIVE INTERVIE, V2nd; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Thomson R, 2003, INT J SOC RES METHOD, V6, P233, DOI DOI 10.1080/1364557032000091833; Thomson R, 2007, SOC POLICY SOC, V6, P571, DOI 10.1017/S1474746407003909; White JH, 2012, DISABIL REHABIL, V34, P1376, DOI 10.3109/09638288.2011.645111	21	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-7881	1440-1800		NURS INQ	Nurs. Inq.	APR	2017	24	2							e12170	10.1111/nin.12170			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	ES2ED	WOS:000399338300010	27905155	Green Submitted			2022-02-06	
J	Hamed, S; Metwalley, KA; Farghaly, HS; Sherief, T				Hamed, Sherifa; Metwalley, Kotb Abbass; Farghaly, Hekma Saad; Sherief, Tahra			Serum Levels of Neuron-Specific Enolase in Children With Diabetic Ketoacidosis	JOURNAL OF CHILD NEUROLOGY			English	Article						diabetic ketoacidosis; neuron-specific enolase; brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL EDEMA; YOUNG-CHILDREN; TYPE-1; MELLITUS; YOUTH; HYPERGLYCEMIA; DIAGNOSIS; EPIDEMIOLOGY; PREDICTOR	Neuron-specific enolase is a sensitive marker of neuronal damage in various neurologic disorders. This study aimed to measure serum neuron-specific enolase levels at different time points and severities of diabetic ketoacidosis. This study included 90 children (age 9.2 +/- 3.4 years) with diabetic ketoacidosis. Neuron-specific enolase was measured at 3 time points (baseline and after 12 and 24 hours of starting treatment). Among patients, 74.4% had diagnosis of new diabetes, 60% had Glasgow Coma Scale score <15, and 75.6% had moderate/severe diabetic ketoacidosis. Compared with controls (n = 30), children with diabetic ketoacidosis had higher neuron-specific enolase levels at the 3 time points (P = .0001). In multiple regression analysis, the factors associated with higher neuron-specific enolase levels were younger age, higher glucose, lower pH, and bicarbonate values. This study indicates that serum neuron-specific enolase is elevated in diabetic ketoacidosis and correlated with the severity of hyperglycemia, ketosis, and acidosis. This study indicates that diabetic ketoacidosis may cause neuronal injury from which the patients recovered partially but not completely.	[Hamed, Sherifa] Assiut Univ Hosp, Dept Neurol & Psychiat, Assiut, Egypt; [Metwalley, Kotb Abbass; Farghaly, Hekma Saad] Assiut Univ, Childrens Hosp, Dept Pediat, Assiut, Egypt; [Sherief, Tahra] Assiut Univ Hosp, Dept Clin Pathol, Assiut, Egypt		Metwalley, KA (corresponding author), Assiut Univ, Fac Med, Dept Pediat, Assiut, Egypt.	kotb72@gmail.com	Metwalley, Kotb Abbass/I-5506-2019; Hamed, Sherifa/ABF-2832-2020	Metwalley, Kotb Abbass/0000-0003-4763-488X; Hamed, Sherifa/0000-0002-1441-3530			Aye T, 2011, DIABETES CARE, V34, P1458, DOI 10.2337/dc10-2164; BASU A, 1993, DIABETIC MED, V10, P282, DOI 10.1111/j.1464-5491.1993.tb00060.x; Bui Thao P, 2002, Pediatr Diabetes, V3, P82, DOI 10.1034/j.1399-5448.2002.30204.x; Cameron FJ, 2014, DIABETES CARE, V37, P1554, DOI 10.2337/dc13-1904; Cato MA, 2016, J INT NEUROPSYCH SOC, V22, P293, DOI 10.1017/S1355617715001289; Chase H P, 1990, Pediatr Rev, V11, P297, DOI 10.1542/pir.11-10-297; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Cox DJ, 2005, DIABETES CARE, V28, P71, DOI 10.2337/diacare.28.1.71; Craig ME, 2009, PEDIATR DIABETES, V10, P3, DOI 10.1111/j.1399-5448.2009.00568.x; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Dabelea D, 2014, PEDIATRICS, V133, pE938, DOI 10.1542/peds.2013-2795; Dalton RR, 2003, ANN CLIN LAB SCI, V33, P435; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; Edge JA, 2001, ARCH DIS CHILD, V85, P16, DOI 10.1136/adc.85.1.16; El Samahy MH, 2015, DIABETES RES CLIN PR, V107, P370, DOI 10.1016/j.diabres.2015.01.004; El-Ziny MA, 2014, J CLIN RES PEDIATR E, V6, P9, DOI 10.4274/Jcrpe.1171; Ghetti S, 2010, J PEDIATR-US, V156, P109, DOI 10.1016/j.jpeds.2009.07.054; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Glaser N, 2014, PEDIATR DIABETES, V15, P484, DOI 10.1111/pedi.12114; Glaser N, 2012, DIABETES, V61, P1831, DOI 10.2337/db11-1286; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Hamed SA, 2012, J NEUROL NEUROSCI, P3; Hamed SA, 2013, INT J DIABETOL VASC, V1, P803; Hamed SA, 2013, J PEDIATR EPILEPSY, V2, P115, DOI 10.3233/PEP-13050; Herrmann M, 2003, RESTOR NEUROL NEUROS, V21, P177; Hoffman WH, 2003, CLIN IMMUNOL, V108, P175, DOI 10.1016/S1521-6616(03)00144-X; International Diabetes Federation, 2011, IDF DIAB ATL; Kim HB, 2003, J DIABETES COMPLICAT, V17, P29, DOI 10.1016/S1056-8727(02)00186-1; Kitabchi AE, 1999, AM FAM PHYSICIAN, V60, P455; Lee DM, 2002, J DIABETES COMPLICAT, V16, P294, DOI 10.1016/S1056-8727(01)00215-X; Li J, 2015, DIABETIC MED, V32, P102, DOI 10.1111/dme.12597; Lo W, 2016, PEDIATR DIABETES, V17, P127, DOI 10.1111/pedi.12251; de Siqueira LFM, 2011, ARQ BRAS ENDOCRINOL, V55, P288, DOI 10.1590/S0004-27302011000400009; Nadebaum C, 2012, PEDIATR DIABETES, V13, P632, DOI 10.1111/j.1399-5448.2012.00870.x; Nett ST, 2014, J PEDIAT INTENSIVE C, P3; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; PAUS E, 1989, CLIN CHEM, V35, P2034; Pell GS, 2012, DIABETES CARE, V35, P513, DOI 10.2337/dc11-1290; PINKNEY JH, 1994, DIABETOLOGIA, V37, P70; Rewers A, 2008, PEDIATRICS, V121, pE1258, DOI 10.1542/peds.2007-1105; Roe TF, 1996, J DIABETES COMPLICAT, V10, P100, DOI 10.1016/1056-8727(94)00058-1; RYAN CM, 1993, J CLIN EXP NEUROPSYC, V15, P685, DOI 10.1080/01688639308402589; Sandhu HS, 2008, ANN NY ACAD SCI, V1137, P258, DOI 10.1196/annals.1448.044; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Shera AS, 2008, PEDIATR DIABETES, V9, P401, DOI [10.1111/j.1399-5448.2008.00309.x, 10.1111/j.1399-5448.2007.00309.x]; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Toprak H, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150680; United States Census Bureau, 2013, INT DAT; Wolfsdorf J, 2007, PEDIATR DIABETES, V8, P28, DOI 10.1111/j.1399-5448.2007.00224.x; Wootton-Gorges SL, 2010, AM J NEURORADIOL, V31, P780, DOI 10.3174/ajnr.A1829	52	5	6	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	APR	2017	32	5					475	481		10.1177/0883073816686718			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	ET2GP	WOS:000400088200004	28056586				2022-02-06	
J	Jones, AR; Frazier, SK				Jones, Allison R.; Frazier, Susan K.			Consequences of Transfusing Blood Components in Patients With Trauma: A Conceptual Model	CRITICAL CARE NURSE			English	Article							ISCHEMIA-REPERFUSION INJURY; PLATELET STORAGE LESION; OF-THE-LITERATURE; CRITICALLY-ILL; CELL STORAGE; WHOLE-BLOOD; MASSIVE TRANSFUSION; ANAEROBIC STORAGE; MAJOR TRAUMA; BRAIN-INJURY	Transfusion of blood components is often required in resuscitation of patients with major trauma. Packed red blood cells and platelets break down and undergo chemical changes during storage (known as the storage lesion) that lead to an inflammatory response once the blood components are transfused to patients. Although some evidence supports a detrimental association between transfusion and a patient's outcome, the mechanisms connecting transfusion of stored components to outcomes remain unclear. The purpose of this review is to provide critical care nurses with a conceptual model to facilitate understanding of the relationship between the storage lesion and patients' outcomes after trauma; outcomes related to trauma, hemorrhage, and blood component transfusion are grouped according to those occurring in the short-term (<= 30 days) and the long-term (> 30 days). Complete understanding of these clinical implications is critical for practitioners in evaluating and treating patients given transfusions after traumatic injury.	[Jones, Allison R.] Univ Alabama Birmingham, Sch Nursing, Dept Acute Chron & Continuing Care, Birmingham, AL USA; [Frazier, Susan K.] Univ Kentucky, RICH Heart Program, Lexington, KY USA; [Frazier, Susan K.] Univ Kentucky, Coll Nursing, Lexington, KY USA		Jones, AR (corresponding author), 1407 16th Ave S, Birmingham, AL 35205 USA.	allisonjones3684@gmail.com					Almac E, 2007, BEST PRACT RES-CLIN, V21, P195, DOI 10.1016/j.bpa.2007.01.004; Anniss AM, 2006, TRANSFUSION, V46, P1561, DOI 10.1111/j.1537-2995.2006.00944.x; Aucar JA, 2012, SURGERY, V152, P697, DOI 10.1016/j.surg.2012.07.011; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Blasi B, 2012, TRANSFUSION MED, V22, P90, DOI 10.1111/j.1365-3148.2012.01139.x; Bohmer AB, 2014, CRIT CARE, V18, DOI 10.1186/cc13976; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Burnouf T, 2015, TRANSFUS APHER SCI, V53, P137, DOI 10.1016/j.transci.2015.10.010; Burnouf T, 2014, BLOOD REV, V28, P155, DOI 10.1016/j.blre.2014.04.002; Chaudhary R, 2012, BLOOD TRANSFUS-ITALY, V10, P59, DOI 10.2450/2011.0107-10; Chin-Yee IH, 2009, TRANSFUSION, V49, P2304, DOI 10.1111/j.1537-2995.2009.02315.x; Cotton BA, 2014, ANN SURG, V260, P178; Cotton BA, 2013, ANN SURG, V258, P527, DOI 10.1097/SLA.0b013e3182a4ffa0; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; D'Alessandro A, 2013, MOL BIOSYST, V9, P1196, DOI 10.1039/c3mb25575a; D'Alessandro A, 2010, BLOOD TRANSFUS-ITALY, V8, P82, DOI 10.2450/2009.0122-09; da Luz LT, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-29; Devine DV, 2010, CLIN LAB MED, V30, P475, DOI 10.1016/j.cll.2010.02.002; Dietrich HH, 2000, AM J PHYSIOL-HEART C, V278, pH1294, DOI 10.1152/ajpheart.2000.278.4.H1294; Dutton RP, 2006, J TRAUMA, V60, pS70, DOI 10.1097/01.ta.0000200856.47545.64; Eder AF, 2007, ARCH PATHOL LAB MED, V131, P708; Flatt JF, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00214; Gilliss BM, 2011, ANESTHESIOLOGY, V115, P635, DOI 10.1097/ALN.0b013e31822a22d9; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-236; Hallet J, 2013, CRIT CARE MED, V41, P2800, DOI 10.1097/CCM.0b013e31829a6ecb; Hampton DA, 2014, AM J SURG, V207, P642, DOI 10.1016/j.amjsurg.2013.12.009; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hoover L, 2006, J TRAUMA, V61, P310, DOI 10.1097/01.ta.0000229052.75460.c2; Huber-Wagner S, 2007, VOX SANG, V92, P69, DOI 10.1111/j.1423-0410.2006.00858.x; Hunt H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010438.pub2; Inaba K, 2011, J TRAUMA, V71, P1766, DOI 10.1097/TA.0b013e31823bdbf9; Jackson SP, 2010, BLOOD, V116, P2011, DOI 10.1182/blood-2010-01-261669; John M, 2014, ANAESTHESIA, V69, P623, DOI 10.1111/anae.12626; Jones AR, 2014, J TRAUMA NURS, V21, P22, DOI 10.1097/JTN.0000000000000025; Karon BS, 2012, BLOOD TRANSFUS-ITALY, V10, P453, DOI 10.2450/2012.0099-11; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Nguyen KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097082; Kor DJ, 2009, BOSNIAN J BASIC MED, V9, pS21, DOI 10.17305/bjbms.2009.2750; Kriebardis A, 2012, BLOOD TRANSFUS-ITALY, V10, pS25, DOI 10.2450/2012.006S; Kunimatsu T, 2011, J CLIN NEUROSCI, V18, P545, DOI 10.1016/j.jocn.2010.07.140; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Lelubre C, 2013, CRIT CARE, V17, DOI 10.1186/cc12600; Lutz J, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-27; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Marietta M, 2010, INTERN EMERG MED, V5, P521, DOI 10.1007/s11739-010-0396-3; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Mitra B, 2013, ANZ J SURG, V83, P918, DOI 10.1111/ans.12417; Morrell CN, 2011, HEMATOL-AM SOC HEMAT, P470, DOI 10.1182/asheducation-2011.1.470; Nessen SC, 2013, TRANSFUSION, V53, p107S, DOI 10.1111/trf.12044; O'Donnell ML, 2013, J CLIN PSYCHIAT, V74, pE137, DOI 10.4088/JCP.12m08011; Orlov D, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12891; Patel MB, 2006, J SURG RES, V135, P226, DOI 10.1016/j.jss.2006.04.037; Perel P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001664; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Perlow M, 2013, J INFUS MURS, V36, P336, DOI 10.1097/NAN.0b013e3182a1138d; Pidcoke HF, 2014, SHOCK, V41, P51, DOI 10.1097/SHK.0000000000000078; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Rowell SE, 2011, J TRAUMA, V71, pS353, DOI 10.1097/TA.0b013e318227ef53; Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Saunders C, 2013, VOX SANG, V105, P1, DOI 10.1111/vox.12013; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Semon G, THROMBOELASTOGRAPHY; Shashaty MGS, 2012, J CRIT CARE, V27, P496, DOI 10.1016/j.jcrc.2012.02.002; Shrivastava M, 2009, TRANSFUS APHER SCI, V41, P105, DOI 10.1016/j.transci.2009.07.002; Singh M, 2010, CARDIOVASC RES, V86, P20, DOI 10.1093/cvr/cvp402; Sparrow RL, 2015, TRANSFUS MED REV, V29, P120, DOI 10.1016/j.tmrv.2014.09.007; Spinella PC, 2012, ANESTH ANALG, V115, P751, DOI 10.1213/ANE.0b013e318261f40e; Stan Ana, 2009, Rom J Intern Med, V47, P173; Stapley R, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P231; Tan HY, 2015, CRIT CARE MED, V43, pE276, DOI 10.1097/CCM.0000000000001023; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Thorsen K, 2011, BRIT J SURG, V98, P894, DOI 10.1002/bjs.7497; Valparaiso AP, 2015, J SURG RES, V194, P220, DOI 10.1016/j.jss.2014.10.025; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; Watanabe S, 2013, WORK, V45, P273, DOI 10.3233/WOR-131594; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yoshida T, 2010, BLOOD TRANSFUS-ITALY, V8, P220, DOI 10.2450/2010.0022-10; Zhu SH, 2014, UPSALA J MED SCI, V119, P262, DOI 10.3109/03009734.2013.873502	84	5	6	0	3	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	APR	2017	37	2					18	30		10.4037/ccn2017965			13	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	EQ1YK	WOS:000397865300002	28365647				2022-02-06	
J	Osetinsky, LM; Hamilton, GS; Carlson, ML				Osetinsky, L. Mariel; Hamilton, Grant S.; Carlson, Matthew L.			Sport Injuries of the Ear and Temporal Bone	CLINICS IN SPORTS MEDICINE			English	Article						Sports; Trauma; Injury; Auricular; Temporal bone	ENLARGED VESTIBULAR AQUEDUCT; HEARING-LOSS; TRAUMA	In cases of head trauma, the ear should be evaluated in all of its components. A good understanding of otologic and skull base anatomy enables a thorough trauma assessment of this complex anatomic region. Auricular laceration, abrasion, avulsion, hematoma, frostbite, otitis externa, exostosis, tympanic membrane perforation, ossicular discontinuity, perilymphatic fistula, labyrinthine concussion, temporal bone fracture, facial nerve paresis, and sensorineural hearing loss are a few of the more common otologic injuries seen in active patients. Prevention of otologic trauma by wearing protective equipment during activity is the best way of maintaining the long-term health of the ear and audiovestibular function.	[Osetinsky, L. Mariel; Hamilton, Grant S.; Carlson, Matthew L.] Mayo Clin, Dept Otorhinolaryngol, 200 Ist St Southwest, Rochester, MN 55905 USA		Carlson, ML (corresponding author), Mayo Clin, Dept Otorhinolaryngol Head & Neck Surg, 200 1st St Southwest, Rochester, MN 55905 USA.	carlson.matthew@mayo.edu					Alemi AS, 2015, OTOLARYNG HEAD NECK, V153, P512, DOI 10.1177/0194599815596343; Bernal-Sprekelsen M, 2000, AM J RHINOL, V14, P257, DOI 10.2500/105065800779954473; Brodie HA, 1997, AM J OTOL, V18, P188; Brodie HA, 2015, CUMMINGS OTOLARYNGOL, P2220; Emerich K, 2010, SPORTS MED, V40, P361, DOI 10.2165/11530750-000000000-00000; Francis HW, 2015, CUMMINGS OTOLARYNGOL, P1977; Hill JD, 2015, CUMMINGS OTOLARYNGOL, P307; Hoosein MM, 2012, J EMERG MED, V43, pE331, DOI 10.1016/j.jemermed.2011.05.088; Irgens-Hansen K, 2015, INT ARCH OCC ENV HEA, V88, P641, DOI 10.1007/s00420-014-0988-8; Jacob SE, 2004, DERMATOL SURG, V30, P521, DOI 10.1111/j.1524-4725.2004.30168.x; Kalus R, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000123; Kamochi H, 2013, NEUROL MED-CHIR, V53, P217, DOI 10.2176/nmc.53.217; Kou B, 1998, J OTOLARYNGOL, V27, P64; Lonsbury-Martin B, 2015, CUMMINGS OTOLARYNGOL, P2345; Madden C, 2003, OTOL NEUROTOL, V24, P625, DOI 10.1097/00129492-200307000-00016; Ozturkcan S, 2014, CLIN DERMATOL, V32, P141, DOI 10.1016/j.clindermatol.2013.05.036; Ramakers GGJ, 2016, JAMA OTOLARYNGOL, V142, P551, DOI 10.1001/jamaoto.2016.0225; Rapley JH, 2001, ANN PLAS SURG, V46, P434, DOI 10.1097/00000637-200104000-00015; Steffen A, 2006, PLAST RECONSTR SURG, V118, P1358, DOI 10.1097/01.prs.0000239539.98956.b0	19	5	5	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	APR	2017	36	2					315	+		10.1016/j.csm.2016.11.005			22	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ES0ZP	WOS:000399258000008	28314420				2022-02-06	
J	Sours, C; Raghavan, P; Medina, AE; Roys, S; Jiang, L; Zhuo, JC; Gullapalli, RP				Sours, Chandler; Raghavan, Prashant; Medina, Alexandre E.; Roys, Steven; Jiang, Li; Zhuo, Jiachen; Gullapalli, Rao P.			Structural and Functional Integrity of the Intraparietal Sulcus in Moderate and Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; functional connectivity; intraparietal sulcus; traumatic brain injury	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; TENSOR IMAGING FINDINGS; SPATIAL WORKING-MEMORY; MULTISENSORY INTEGRATION; WHITE-MATTER; MILD TBI; CONNECTIVITY; ATTENTION; STIMULATION; PERFORMANCE	Severe andmoderate traumatic brain injury (sTBI) often results in long-termcognitive deficits such as reduced processing speed and attention. The intraparietal sulcus (IPS) is a neocortical structure that plays a crucial role in the deeply interrelated processes of multi-sensory processing and top down attention. Therefore, we hypothesized that disruptions in the functional and structural connections of the IPS may play a role in the development of such deficits. To examine these connections, we used resting state magnetic resonance imaging (rsfMRI and diffusion kurtosis imaging (DKI) in a cohort of 27 patients with sTBI (29.3 +/- 8.9 years) and 27 control participants (29.8 +/- 10.3 years). Participants were prospectively recruited and received rsfMRI and neuropsychological assessments including the Automated Neuropsychological Assessment Metrics (ANAM) at greater than 6 months post-injury. A subset of participants received a DKI scan. Results suggest that patients with sTBI performed worse than control participants on multiple subtests of the ANAM suggesting reduced cognitive performance. Reduced resting state functional connectivity between the IPS and cortical regions associated with multi-sensory processing and the dorsal attention network was observed in the patients with sTBI. The patients also showed reduced structural integrity of the superior longitudinal fasciculus (SLF), a key white matter tract connecting the IPS to anterior frontal areas, as measured by reduced mean kurtosis (MK) and fractional anisotropy (FA) and increased mean diffusivity (MD). Further, this reduced structural integrity of the SLF was associated with a reduction in overall cognitive performance. These findings suggest that disruptions in the structural and functional connectivity of the IPS may contribute to chronic cognitive deficits experienced by these patients.	[Sours, Chandler; Jiang, Li; Zhuo, Jiachen; Gullapalli, Rao P.] Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA; [Sours, Chandler; Raghavan, Prashant; Jiang, Li; Zhuo, Jiachen; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA; [Medina, Alexandre E.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA		Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA.	rpg@umm.edu		Medina, Alexandre/0000-0003-0517-7756	Department of DefenseUnited States Department of Defense [W81XWH-08-1-0725, W81XWH-12-1-0098]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R03NS088014-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS088014] Funding Source: NIH RePORTER	The authors would like to thank Joshua Betz, Jacqueline Janowich, Teodora Stoica, and Joseph Rosenberg for their help with patient recruitment and enrollment, and George Makris for his help with acquiring the data. Support for this work was in part provided by the Department of Defense (W81XWH-08-1-0725 & W81XWH-12-1-0098 to RPG) and the National Institutes of Health (1R03NS088014-01).	Anderson JS, 2010, P NATL ACAD SCI USA, V107, P20110, DOI 10.1073/pnas.1011616107; Bray S, 2015, CEREB CORTEX, V25, P1252, DOI 10.1093/cercor/bht320; Bray S, 2013, NEUROIMAGE, V82, P137, DOI 10.1016/j.neuroimage.2013.05.080; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Goltz D, 2015, J NEUROSCI, V35, P7938, DOI 10.1523/JNEUROSCI.3421-14.2015; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Johansson BB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00060; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Makuuchi M, 2005, J NEUROL NEUROSUR PS, V76, P25, DOI 10.1136/jnnp.2003.029165; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Reich S, 2005, VALIDATION ANAM TEST; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silk TJ, 2010, NEUROIMAGE, V53, P718, DOI 10.1016/j.neuroimage.2010.06.068; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang XH, 2016, BRAIN STRUCT FUNCT, V221, P2075, DOI 10.1007/s00429-015-1028-5; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yeatman JD, 2014, P NATL ACAD SCI USA, V111, pE5214, DOI 10.1073/pnas.1418503111	37	5	5	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1473	1481		10.1089/neu.2016.4570			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600017	27931179	Green Published			2022-02-06	
J	Callender, L; Brown, R; Driver, S; Dahdah, M; Collinsworth, A; Shafi, S				Callender, Librada; Brown, Rachel; Driver, Simon; Dahdah, Marie; Collinsworth, Ashley; Shafi, Shahid			Process for developing rehabilitation practice recommendations for individuals with traumatic brain injury	BMC NEUROLOGY			English	Article						Traumatic brain injury; Brain injury; Rehabilitation; Delphi; Clinical practice guideline; Evidence based medicine	CARE; QUALITY; OUTCOMES	Background: Attempts at measuring quality of rehabilitation care are hampered by a gap in knowledge translation of evidence-based approaches and lack of consensus on best practices. However, adoption of evidence-based best practices is needed to minimize variations and improve quality of care. Therefore, the objective of this project was to describe a process for assessing the quality of evidence of clinical practices in traumatic brain injury (TBI) rehabilitative care. Methods: A multidisciplinary team of clinicians developed discipline-specific clinical questions using the Population, Intervention, Control, Outcome process. A systematic review of the literature was conducted for each question using Pubmed, CINAHL, PsychInfo, and Allied Health Evidence databases. Team members assessed the quality, level, and applicability of evidence utilizing a modified Oxford scale, the Agency for Healthcare Research and Quality Methods Guide, and a modified version of the Grading of Recommendations, Assessment, Development, and Evaluation scale. Results: Draft recommendations for best-practice were formulated and shared with a Delphi panel of clinical representatives and stakeholders to obtain consensus. Conclusion: Evidence-based practice guidelines are essential to improve the quality of TBI rehabilitation care. By using a modified quality of evidence assessment tool, we established a process to gain consensus on practice recommendations for individuals with TBI undergoing rehabilitation.	[Callender, Librada] Baylor Inst Rehabil, Clin Res Coordinator, 909 N Washington Ave, Dallas, TX 75246 USA; [Brown, Rachel; Collinsworth, Ashley] Baylor Scott White Hlth, Dallas, TX USA; [Driver, Simon] Baylor Inst Rehabilitat, Dallas, TX USA; [Dahdah, Marie] Baylor Reg Med Ctr Plano, Ctr Med Psychol, Plano, TX USA; [Shafi, Shahid] Baylor Inst Rehabil, Dallas, TX USA		Callender, L (corresponding author), Baylor Inst Rehabil, Clin Res Coordinator, 909 N Washington Ave, Dallas, TX 75246 USA.	Librada.Callender@BSWHealth.org		driver, simon/0000-0003-2356-432X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0045-01-0]; Ginger Murchison Foundation Traumatic Brain Injury Research Fund	All personnel and the contents of this manuscript were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DP0045-01-0). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government. The project was also supported by the Ginger Murchison Foundation Traumatic Brain Injury Research Fund.	Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Atkins D, 2011, J CLIN EPIDEMIOL, V64, P1198, DOI 10.1016/j.jclinepi.2010.11.021; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Centers for Disease Control and Prevention, GET STATS TRAUM BRAI; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, C TRAUM BRAIN INJ US; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Eckardt KU, 2009, NAT REV NEPHROL, V5, P650, DOI 10.1038/nrneph.2009.153; Group OLoEW, 2011, OXFORD 2011 LEVELS E; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Shafi S, 2012, J TRAUMA ACUTE CARE, V72, P870, DOI 10.1097/TA.0b013e3182463e20	20	5	5	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	MAR 20	2017	17								54	10.1186/s12883-017-0828-z			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO7YK	WOS:000396905800003	28320346	Green Published, gold			2022-02-06	
J	Berginstrom, N; Nordstrom, P; Schuit, R; Nordstrom, A				Berginstrom, Nils; Nordstrom, Peter; Schuit, Robert; Nordstrom, Anna			The Effects of (-)-OSU6162 on Chronic Fatigue in Patients With Traumatic Brain Injury: A Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						clinical trials; fatigue; mental; randomized; traumatic brain injury	MONOAMINERGIC STABILIZER (-)-OSU6162; POST-CONCUSSION SYMPTOMS; HEAD-INJURY; MENTAL FATIGUE; QUESTIONNAIRE; RECOVERY; TOLERABILITY; PLACEBO; SCALE; TASK	Objective: To examine the effects of the monoaminergic stabilizer (-)-OSU6162 on mental fatigue in patients with traumatic brain injury. Setting: Single-center Neurorehabilitation Clinic. Design: Randomized, double-blind, placebo-controlled trial. Participants: Sixty-four subjects with traumatic brain injury were randomized to treatment (n = 33) and placebo (n = 31). Main Measures: The effects of (-)-OSU6162 at a dose of 15 mg twice a day were evaluated using self-assessment scales and neuropsychological tests measuring mental fatigue. Results: No difference between groups was observed on any scale at baseline. At follow-up, both groups showed significant improvement on the Fatigue Severity Scale and the Mental Fatigue Scale (both Ps < .01). Similarly, the performance of both groups increased significantly on many neuropsychological tests. However, no significant between-group difference in changes on these scales was observed before or after adjustment for confounders except for one neuropsychological test favoring the control group. Sensitivity analyses showed significantly greater changes in levels of prolactin and folic acid and heart rate (all Ps < .05) in the treatment group. The mean plasma concentration after 4 weeks of treatment was 0.14 (range, 0.01-0.32) mu M, which was lower than expected. Interpretation: Treatment with (-)-OSU6162 had no significant effect on mental fatigue in patients with traumatic brain injury compared with placebo.	[Berginstrom, Nils; Nordstrom, Peter] Umea Univ, Dept Community Med & Rehabil, Geriatr Med, S-90187 Umea, Sweden; [Schuit, Robert] Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, Amsterdam, Netherlands; [Nordstrom, Anna] Umea Univ, Dept Publ Hlth & Clin Med Occupat & Environm Med, Umea, Sweden		Berginstrom, N (corresponding author), Umea Univ, Dept Community Med & Rehabil, Geriatr Med, S-90187 Umea, Sweden.	nils.berginstrom@umu.se	Nordstrom, Anna/O-2504-2018; Nordstrom, Anna/F-2238-2010	Nordstrom, Anna/0000-0003-3534-456X; Nordstrom, Anna/0000-0003-3534-456X; Berginstrom, Nils/0000-0003-1192-4527	Umea; Vasterbotten County Council	Funding for this trial was provided through regional agreement between Umea University and Vasterbotten County Council on cooperation in the field of Medicine, Odontology, and Health. The authors thank Catharina Elback, Britta Stahl, Gustav Gezelius, Erik Edin, and Erika Burkvist for data acquisition and Lars Nyberg for comments on the manuscript.	Azmitia EC, 1999, NEUROPSYCHOPHARMACOL, V21, pS33; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Delis D.C., 2001, D KEFS DELIS KAPLAN; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kloberg A, 2014, ACTA NEUROPSYCHIATR, V26, P298, DOI 10.1017/neu.2014.16; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lee Bruce, 2005, NeuroRx, V2, P372; Moeller SJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.110; Nilsson MKL, 2013, NEUROPHARMACOLOGY, V75, P399, DOI 10.1016/j.neuropharm.2013.08.017; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rodriguez CA, 2004, J CLIN PHARMACOL, V44, P276, DOI 10.1177/0091270003262792; Rung JP, 2008, J NEURAL TRANSM, V115, P899, DOI 10.1007/s00702-008-0038-3; Sandford JA, 2009, IVA PLUS INTEGRATED; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tolboom N, 2015, NEUROPSYCHOPHARMACOL, V40, P472, DOI 10.1038/npp.2014.195; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	5	5	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E46	E54		10.1097/HTR.0000000000000236			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700006	27120292				2022-02-06	
J	Buckley, L; Chapman, RL				Buckley, Lisa; Chapman, Rebekah L.			Associations between self-reported concussion with later violence injury among Australian early adolescents	JOURNAL OF PUBLIC HEALTH			English	Article						concussion; fights; high school; injury; risk-taking behaviour; violence	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; POPULATION	Background There is growing research finding associations between adolescents' concussion and negative outcomes, including violence, rarely however are the experiences of community-based early adolescents considered. Methods This study examined associations between reports of concussion (Time-1) and reports of violence 1-year later (Time-2). Australian adolescents from 13 high-schools completed two identical surveys administered 12-months apart (n = 734 retained, initial mean age = 13.45). Results At the first survey, 91 students (13%) reported they had a concussion, and of these students, 40% reported seeing a doctor/attending hospital during the prior 3 months. Both self-reported experience of violent injury (from getting in a fight) and violent behaviour (getting in a fight) were predicted by reports of concussion in Year 9. This prediction held, when adding sex, Year 9 reports of violence, alcohol use, truancy and engagement in passenger and driving risk-taking to logistic regression models. Year 9 concussion was not predictive of later injury in other contexts, including transportation, falls or sports. Conclusion The study highlights the need to understand concussion among community-based early adolescents including consider associations with violence.	[Buckley, Lisa] Univ Michigan, Transportat Res Inst, 2901 Baxter Rd, Ann Arbor, MI 48109 USA; [Buckley, Lisa; Chapman, Rebekah L.] Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, 130 Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia		Buckley, L (corresponding author), Univ Michigan, Transportat Res Inst, 2901 Baxter Rd, Ann Arbor, MI 48109 USA.; Buckley, L (corresponding author), Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, 130 Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	lisadb@umich.edu	Buckley, Lisa/U-7467-2018	Buckley, Lisa/0000-0003-1542-938X	Australian Research CouncilAustralian Research Council [DP110105043]	The sponsor was Australian Research Council-Discovery Projects, DP110105043.	Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Barlow KM, 2014, J CHILD NEUROL, V126, pe374; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Centers for Disease Control and Prevention, 2012, YOUTH VIOL FACTS GLA; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control & Prevention, 2013, MMWR 2014, V63; Chapman R., 2011, Youth Studies Australia, V30, P49; Chapman R, 2011, HEALTH PROMOT J AUST, V22, P128, DOI 10.1071/HE11128; Collins R, 2012, TRAUMATIC BRAIN INJU, P223; Curcio AL, 2015, AUST J PSYCHOL, V67, P166, DOI 10.1111/ajpy.12075; Fazel S, 2009, J NEUROL, V256, P1591, DOI 10.1007/s00415-009-5134-2; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Inchley J., 2015, 19 HBSC; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; MAK AS, 1993, AUST J PSYCHOL, V45, P75, DOI 10.1080/00049539308259122; Mission Australia, 2010, NAT SURV YOUNG AUSTR; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Page JL, 2012, INJURY PREV, V18, P94, DOI 10.1136/injuryprev-2011-040029; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Stoddard SA, 2011, PEDIATRICS, V127, P1074, DOI 10.1542/peds.2010-2453; Trenchard SO, 2013, BRAIN INJURY, V27, P1217, DOI 10.3109/02699052.2013.812240; WHITE V, 2006, NATL DRUG STRATEGY M, V58; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	29	5	5	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1741-3842	1741-3850		J PUBLIC HEALTH-UK	J. Public Health	MAR	2017	39	1					52	57		10.1093/pubmed/fdw009			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EQ3VI	WOS:000398001000010	26872888	Bronze			2022-02-06	
J	Clark, JF; Elgendy-Peerman, HT; Divine, JG; Mangine, RE; Hasselfeld, KA; Khoury, JC; Colosimo, AJ				Clark, Joseph F.; Elgendy-Peerman, Hagar T.; Divine, Jon G.; Mangine, Robert E.; Hasselfeld, Kimberly A.; Khoury, Jane C.; Colosimo, Angelo J.			Lack of eye discipline during headers in high school girls soccer: A possible mechanism for increased concussion rates	MEDICAL HYPOTHESES			English	Article							STATES HIGH-SCHOOL; INJURY SURVEILLANCE SYSTEM; TRAUMATIC BRAIN-INJURY; DESCRIPTIVE EPIDEMIOLOGY; POSITION STATEMENT; SPORTS; SEX; PERFORMANCE; CHILDREN; EMOTION	The sport of soccer is the fastest growing and most popular sport worldwide. With this growth and popularity, attention needs to be given to this athletic population. Sports related concussions is a topic that has gained attention both in the media and by governmental organizations, with growing initiatives in diagnosis, prevention and treatment. The act of soccer heading is thought to contribute to increased concussion incidence. Current evidence reveals that within the high school soccer athletic population, female athletes incur a higher concussion rate than males. This is often attributed to many things including differing cervical spinal musculature, skull thickness, etc., but a definitive reason has not yet been found. Other behaviors, such as field awareness and eye discipline on the field of play, may also be contributing factors that result in females incurring a greater concussion rate.than males. For the purposes of this paper we define eye discipline (TM) as the ability to keep the eyes engaged in sporting activity with high risk potential. We present our hypothesis that high school female soccer players are more likely to have their eyes closed when in position for heading the ball as compared to high school male soccer players and this lack of visual awareness may increase the risk of concussion. Should these differences be substantiated between males and females, it may initiate and promote discussion of the need for vision training in the high school athletic setting. As a tool for injury prevention, vision training may improve specific visual parameters improving athletes' abilities to process the field of play and prepare for or avoid injury causing situations. Through ocular motor and visual conditioning, an athlete may become more eye disciplined (TM), and more likely to have their eyes open during heading of the ball, and more likely to avoid concussions. (C) 2017 Elsevier Ltd. All rights reserved.	[Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Elgendy-Peerman, Hagar T.; Divine, Jon G.; Hasselfeld, Kimberly A.; Colosimo, Angelo J.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Div Sports Med, Cincinnati, OH USA; [Mangine, Robert E.] Univ Cincinnati, Dept Athlet, NovaCare Rehabil, Cincinnati, OH USA; [Khoury, Jane C.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA		Clark, JF (corresponding author), Univ Cincinnati, 231 Albert Sabin Way,ML 0536, Cincinnati, OH 45267 USA.	CLARKJF@ucmail.uc.edu					Abernethy B, 1996, AM J SPORT MED, V24, pS89, DOI 10.1177/036354659602406S24; Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Agel J, 2007, J ATHL TRAINING, V42, P270; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bixenmann B, OPTOMETRY VISUAL PER; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BRADLEY MM, 1990, PSYCHOPHYSIOLOGY, V27, P513, DOI 10.1111/j.1469-8986.1990.tb01966.x; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Clark JF., 2015, OPTOM VIS PERFORM, P116; Clark JF, 2015, JOVE-J VIS EXP, DOI 10.3791/52648; Clark JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029109; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P278; Flynn DJ, 2013, DAILYCALLER; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hayes A, 2012, NEUROREHABILITATION, V31, P19, DOI 10.3233/NRE-2012-0771; Helveston EM, 2005, AM J OPHTHALMOL, V140, P903, DOI 10.1016/j.ajo.2005.06.003; Kauffman DC, 2015, J SPORT SCI, V33, P1117, DOI 10.1080/02640414.2014.987156; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Miles HC, 2012, COMPUT GRAPH-UK, V36, P714, DOI 10.1016/j.cag.2012.04.007; Moore LJ, 2012, PSYCHOPHYSIOLOGY, V49, P1005, DOI 10.1111/j.1469-8986.2012.01379.x; Powell JW, 2000, AM J SPORT MED, V28, P385, DOI 10.1177/03635465000280031801; Solomon J., 2013, COLL FOOTBALL CONCUS; Spering M, 2011, J NEUROPHYSIOL, V105, P1756, DOI 10.1152/jn.00344.2010; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; STINE CD, 1982, J AM OPTOM ASSOC, V53, P627; TORG JS, 1979, JAMA-J AM MED ASSOC, V241, P1477, DOI 10.1001/jama.241.14.1477; Tsubota K, 1996, ARCH OPHTHALMOL-CHIC, V114, P715, DOI 10.1001/archopht.1996.01100130707012; Wells AJ, 2014, J SPORT SCI MED, V13, P145; Wolverton B., 2013, CHRONICLE; Wood G, 2011, COGN PROCESS, V12, P257, DOI 10.1007/s10339-011-0393-0; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zupan M, 2011, TRAINING CONDITIONIN, V21, P11	52	5	5	0	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAR	2017	100						10	14		10.1016/j.mehy.2016.12.016			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	EP0JS	WOS:000397074200004	28236839				2022-02-06	
J	Daudet, L; Yadav, N; Perez, M; Poellabauer, C; Schneider, S; Huebner, A				Daudet, Louis; Yadav, Nikhil; Perez, Matthew; Poellabauer, Christian; Schneider, Sandra; Huebner, Alan			Portable mTBI Assessment Using Temporal and Frequency Analysis of Speech	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Concussions; portable diagnostics; speech analysis; voice pathology	SEGMENTAL DURATIONS; ACOUSTICS; INFANTS; SIGNALS; AUTISM; EVENTS	This paper shows that extraction and analysis of various acoustic features from speech using mobile devices can allow the detection of patterns that could be indicative of neurological trauma. This may pave the way for new types of biomarkers and diagnostic tools. Toward this end, we created a mobile application designed to diagnose mild traumatic brain injuries (mTBI) such as concussions. Using this application, data were collected from youth athletes from 47 high schools and colleges in the Midwestern United States. In this paper, we focus on the design of a methodology to collect speech data, the extraction of various temporal and frequency metrics from that data, and the statistical analysis of these metrics to find patterns that are indicative of a concussion. Our results suggest a strong correlation between certain temporal and frequency features and the likelihood of a concussion.	[Daudet, Louis; Perez, Matthew; Poellabauer, Christian] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Yadav, Nikhil] St Johns Univ, Div Comp Sci Math & Sci, Jamaica, NY 11439 USA; [Schneider, Sandra] St Marys Coll, Dept Commun Sci & Disorders, Notre Dame, IN 46556 USA; [Huebner, Alan] Univ Notre Dame, Dept Appl & Computat Math & Stat, Notre Dame, IN 46556 USA		Daudet, L (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	ldaudet@nd.edu; yadavn@stjohns.edu; mperez14@nd.edu; cpoellab@nd.edu; sschneider@saintmarys.edu; alan.huebner.10@nd.edu			GE HealthGeneral ElectricGE Healthcare; National Football League through the GE/NFL Head Health Challenge; National Science FoundationNational Science Foundation (NSF) [IIS-1450349]	This research was supported in part by the GE Health and the National Football League through the GE/NFL Head Health Challenge, and in part by the National Science Foundation under Grant IIS-1450349.	Brisson J, 2014, INFANT MENT HEALTH J, V35, P285, DOI 10.1002/imhj.21442; Brown J.R., 1975, MOTOR SPEECH DISORDE; CRYSTAL TH, 1988, J ACOUST SOC AM, V83, P1574, DOI 10.1121/1.395912; CRYSTAL TH, 1988, J ACOUST SOC AM, V83, P1553, DOI 10.1121/1.395911; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; Duffy, 2005, MOTOR SPEECH DISORDE; Enders C. K., 2010, APPL MISSING DATA AN; FALCONE M, 2013, P INT C AC SPEECH SI, P7577; Franco H., 2002, P 2 INT C HUM LANG T, P25; Gales M, 2007, FOUND TRENDS SIGNAL, V1, P195, DOI 10.1561/2000000004; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HOOKE R, 1961, J ACM, V8, P212, DOI 10.1145/321062.321069; Hosmer D W, 2013, APPL LOGISTIC REGRES, V398; Huggins-Daines D, 2006, INT CONF ACOUST SPEE, P185; Kohler T. W., 2005, P 9 EUR C SPEECH COM, P233; Lansford KL, 2014, J SPEECH LANG HEAR R, V57, P68, DOI 10.1044/1092-4388(2013/12-0263); LEE KF, 1990, IEEE T ACOUST SPEECH, V38, P35, DOI 10.1109/29.45616; Lei X, 2013, INTERSPEECH, P662; Liss JM, 2009, J SPEECH LANG HEAR R, V52, P1334, DOI 10.1044/1092-4388(2009/08-0208); Lopez K., 2012, P 4 INT C AMB ASS LI, P407, DOI DOI 10.1007/978-3-642-35395-6_55; McGraw I, 2016, INT CONF ACOUST SPEE, P5955, DOI 10.1109/ICASSP.2016.7472820; Paul D. B., 1990, Lincoln Laboratory Journal, V3, P41; PAUL DB, 1992, SPEECH AND NATURAL LANGUAGE, P357; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Placeway P., 1997, P DARPA SPEECH REC W, P85; Poellabauer C, 2015, IEEE ACCESS, V3, P1143, DOI 10.1109/ACCESS.2015.2457392; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sheinkopf SJ, 2012, AUTISM RES, V5, P331, DOI 10.1002/aur.1244; Skodda S, 2008, MOVEMENT DISORD, V23, P985, DOI 10.1002/mds.21996; Tao F, 2016, INTERSPEECH, P362, DOI 10.21437/Interspeech.2016-789; Varela A, 2003, LECT NOTES COMPUT SC, V2905, P251; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Waibel A, 2003, P HUM LANG TECHN N A, P29; Walker W., 2003, IEEE INT C AC SPEECH, VVol. 1, P2; Yadav N, 2014, 2014 IEEE Healthcare Innovation Conference (HIC), P335, DOI 10.1109/HIC.2014.7038943	35	5	5	0	7	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194	2168-2208		IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	MAR	2017	21	2					496	506		10.1109/JBHI.2016.2633509			11	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematical & Computational Biology; Medical Informatics	EP8LF	WOS:000397626200022	27913365	hybrid			2022-02-06	
J	Gather, A; Keil, H; Wolfl, C				Gather, A.; Keil, H.; Woelfl, C.			C - Pelvic sling, tourniquet, wound clamp. Stop the bleeding	NOTFALL & RETTUNGSMEDIZIN			German	Article						Hemorrhage; Medical devices; Severely injured patients; Limb injuries; Greater trochanter	EMERGENCY-ROOM; TRAUMA; HEMORRHAGE; MANAGEMENT; SURVIVAL; ITCLAMP	Uncontrollable bleeding is - beside severe traumatic brain injury - one of the most common causes of death in severely injured patients. In over 30% of cases, limb injuries are responsible. Decisive when using a medical device is the knowledge about its function and handling. The tourniquet provides an option to temporarily stop of the bleeding during severe hemorrhage, when other common measures are not adequate. The pelvic sling should always be applied in case of an appropriate accident mechanism, pain in the pelvic area, or bruises during hemodynamic instability. It should be positioned at the level of the greater trochanter. The wound clamp finds its use in case of unstoppable bleeding on the head and trunk. In this case, the blood flow remains distal to the wound. In conclusion, there are different medical products which can achieve adequate blood control, when used for the right injury.	[Gather, A.; Keil, H.] BG Klin Ludwigshafen, Ludwigshafen, Germany; [Woelfl, C.] Krankenhaus Hetzelstift, Neustadt An Der Weinstra, Germany		Wolfl, C (corresponding author), Krankenhaus Hetzelstift, Neustadt An Der Weinstra, Germany.	c.woelfl@new.marienhaus-gmbh.de	Keil, Holger/AAE-1264-2020	Keil, Holger/0000-0002-5006-8420			Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; Brodie Steven, 2007, J R Army Med Corps, V153, P310; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Croce MA, 2007, J AM COLL SURGEONS, V204, P935, DOI 10.1016/j.jamcollsurg.2007.01.059; (Dgu) DGFU, 2012, JAHR 2012; Hamilton J R, 2005, Forensic Sci Med Pathol, V1, P267, DOI 10.1385/FSMP:1:4:267; Holley Joe, 2014, JEMS, V39, P38; Hossfeldt B, 2016, ANASTH INTENSIVMED, V57, P698; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; Lee C, 2007, EMERG MED J, V24, P584, DOI 10.1136/emj.2007.046359; Mottet K, 2014, J TRAUMA ACUTE CARE, V76, P791, DOI 10.1097/TA.0000000000000043; Neitzel C, 2015, SPRINGERLINK BUCHER; Pehle B, 2003, UNFALLCHIRURG, V106, P642, DOI 10.1007/s00113-003-0629-2; Schweigkofler U, 2016, Z ORTHOP UNFALLCHIR, V154, P470, DOI 10.1055/s-0042-105768; Tan ECTH, 2016, INJURY, V47, P1012, DOI 10.1016/j.injury.2015.12.017	18	5	5	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	MAR	2017	20	2					127	131		10.1007/s10049-017-0277-7			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EP7OJ	WOS:000397566800006					2022-02-06	
J	Hermans, L; Beeckmans, K; Michiels, K; Lafosse, C; Sunaert, S; Coxon, JP; Swinnen, SP; Leunissen, I				Hermans, Lize; Beeckmans, Kurt; Michiels, Karla; Lafosse, Christophe; Sunaert, Stefan; Coxon, James P.; Swinnen, Stephan P.; Leunissen, Inge			Proactive Response Inhibition and Subcortical Gray Matter Integrity in Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						brain injuries; shape analysis; basal ganglia; proactive inhibition; reactive inhibition; stop signal	DEFAULT MODE NETWORK; BASAL GANGLIA; STOP-SIGNAL; SELECTIVE-INHIBITION; SALIENCE NETWORK; PERFORMANCE; STRIATUM; THALAMUS; CHILDREN; MRI	Background. Traumatic brain injury (TBI) has been associated with impairments in inhibiting prepotent motor responses triggered by infrequent external signals (ie, reactive inhibition). It is unclear whether proactive preparation to inhibit upcoming responses is also affected (ie, proactive inhibition). Successful inhibition relies on frontosubcortical interactions; therefore, impairments might be linked with gray matter atrophy in subcortical structures. Objective. We investigated reactive and proactive inhibition in TBI and control groups, and their relationship with subcortical gray matter. Methods. Participants performed a response inhibition task in which the probability of stopping was manipulated. Reactive inhibition was measured as the stop-signal reaction time (SSRT) when the probability of stopping was low. Proactive inhibition was measured as the change in SSRT and in go response time with increasing probability of stopping. Subcortical gray matter structures were automatically segmented with FSL-FIRST. Group differences in subregional volume and associations with reactive and proactive inhibition efficiency were investigated using shape analysis. Results. Reactive inhibition was impaired in TBI, as indicated by longer SSRTs. Moreover, the degree of atrophy in subregions of subcortical structures was predictive for SSRT in TBI. In contrast, proactive inhibition was not affected because both groups showed no response time slowing as a function of stopping probability. Proactive inhibition efficiency could be predicted by local volume in the anterior left putamen, bilateral pallidum, and right thalamus in controls but not in TBI. Conclusions. Our results reveal that proactive inhibition seems unaffected in TBI and that volume of subregions of subcortical nuclei is predictive for response inhibition proficiency and of clinical relevance in TBI.	[Hermans, Lize; Swinnen, Stephan P.; Leunissen, Inge] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Biomed Sci Grp, Tervuursevest 101, B-3001 Heverlee, Belgium; [Beeckmans, Kurt] Ctr Epilepsy & Acquired Brain Injury CEPOS, Duffel, Belgium; [Michiels, Karla] Univ Hosp Leuven, Dept Phys Med & Rehabil, Campus Pellenberg, Lubbeek, Belgium; [Lafosse, Christophe] Rehabil Hosp RevArte, Edegem, Belgium; [Sunaert, Stefan] Katholieke Univ Leuven, Grp Biomed Sci, Med Imaging Ctr, Heverlee, Belgium; [Coxon, James P.] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Coxon, James P.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Swinnen, Stephan P.] Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium		Leunissen, I (corresponding author), Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Biomed Sci Grp, Tervuursevest 101, B-3001 Heverlee, Belgium.	inge.leunissen@kuleuven.be	Coxon, James/S-1286-2019	Coxon, James/0000-0003-2351-8489; Leunissen, Inge/0000-0002-3977-3620	Research Foundation-Flanders (FWO)FWO [G.0708.14, G.0721.12]; Interuniversity Attraction Poles program of the Belgian federal governmentBelgian Federal Science Policy Office; Special Research Fund KU Leuven [C16/15/070]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Research Program of the Research Foundation-Flanders (FWO; G.0708.14 and G.0721.12), the Interuniversity Attraction Poles program of the Belgian federal government (P7/11), and Special Research Fund KU Leuven (C16/15/070). IL is funded by a postdoctoral fellowship of the Research Foundation-Flanders (FWO).	Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Coxon JP, 2007, J NEUROPHYSIOL, V97, P2480, DOI 10.1152/jn.01284.2006; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Coxon JP, 2016, CEREB CORTEX, V26, P12, DOI 10.1093/cercor/bhu165; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dunovan K, 2015, ELIFE, V4, DOI 10.7554/eLife.08723; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Jahfari S, 2012, J NEUROSCI, V32, P10870, DOI 10.1523/JNEUROSCI.0902-12.2012; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kohl S, 2015, J NEUROL, V262, P1741, DOI 10.1007/s00415-015-7768-6; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Leotti LA, 2010, J EXP PSYCHOL HUMAN, V36, P430, DOI 10.1037/a0016802; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Majid DSA, 2013, J NEUROSCI, V33, P13259, DOI 10.1523/JNEUROSCI.5651-12.2013; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Picazio S, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.043; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramautar JR, 2006, BRAIN RES, V1105, P143, DOI 10.1016/j.brainres.2006.02.091; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smittenaar P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140383; Smittenaar P, 2013, J NEUROSCI, V33, P18087, DOI 10.1523/JNEUROSCI.2167-13.2013; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; Van Belle J, 2014, NEUROIMAGE, V103, P65, DOI 10.1016/j.neuroimage.2014.09.014; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Vink M, 2005, HUM BRAIN MAPP, V25, P336, DOI 10.1002/hbm.20111; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Zandbelt BB, 2013, HUM BRAIN MAPP, V34, P2015, DOI 10.1002/hbm.22047; Zandbelt BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013848	47	5	5	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAR	2017	31	3					228	239		10.1177/1545968316675429			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ES7DQ	WOS:000399710200003	27794134	Bronze			2022-02-06	
J	Newcomb, AB; Hymes, RA				Newcomb, Anna B.; Hymes, Robert A.			Life Interrupted: The Trauma Caregiver Experience	JOURNAL OF TRAUMA NURSING			English	Article						Caregiver burden; Family experience; Family needs; Trauma caregiver	INTENSIVE-CARE-UNIT; BRAIN-INJURY; PSYCHOLOGICAL DISTRESS; ALZHEIMERS-DISEASE; STRESS PROCESS; MENTAL-HEALTH; FAMILIES; INDIVIDUALS; POLYTRAUMA; PARTNERS	Traumatic injury frequently leads to an abrupt change in physical and psychological functioning; informal caregivers play a significant role in the recovery process in the hospital and at home. The purpose of this study was to describe the range of stressors and burdens experienced by orthopedic trauma family caregivers in the acute care setting, as well as responses and strategies employed. Qualitative, in-depth interviews were conducted in the hospital with 12 family caregivers of severely injured orthopedic trauma patients. Interviews were audiotaped, transcribed, and analyzed to identify the range of experiences and common themes. Data were organized into 4 categories: stressors and needs; barriers; resources; and response. Stressors and barriers included the confusion and turmoil of life in the hospital, exposure to tragedy, difficulty obtaining and understanding information, and a sense that the family was not considered an integral part of the care plan. Factors influencing caregiver coping included access to the patient, provider communication, caregiver internal and external resources, and the presence of staff assisting in negotiation of the complex and unfamiliar hospital system. Understanding the caregiver experience enables nursing providers to build trust and offer effective support and guidance; caregiver-centered systems of information from admission to discharge may facilitate adaptation and improved caregiving.	[Newcomb, Anna B.] VCU, Sch Med, Trauma Serv, Inova Fairfax Med Campus, Falls Church, VA USA; [Hymes, Robert A.] VCU, Sch Med, Dept Orthoped Surg, Inova Fairfax Med Campus, Falls Church, VA USA		Newcomb, AB (corresponding author), VCU, Sch Med, Trauma Serv, Inova Fairfax Med Campus,3300 Gallows Rd, Falls Church, VA 22042 USA.	anna.newcomb@inova.org					Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; American Heart Association, 2012, POL RES FACT SHEETS; American Trauma Society, 2014, TRAUM SURV NETW; Barber-Parker ED, 2002, PATIENT EDUC COUNS, V48, P107, DOI 10.1016/S0738-3991(02)00024-1; Bergen GS., 2008, INJURY US 2007 CHART; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Bradford AN, 2011, J TRAUMA, V70, P1557, DOI 10.1097/TA.0b013e3182196e7e; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Brilli RJ, 2001, CRIT CARE MED, V29, P2007, DOI 10.1097/00003246-200110000-00026; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; D'Amour Danielle, 2005, J Interprof Care, V19 Suppl 1, P116, DOI 10.1080/13561820500082529; Davies N, 2000, J ADV NURS, V32, P318, DOI 10.1046/j.1365-2648.2000.01479.x; Davis LL, 1992, FAM COMMUNITY HEALTH, V15, P1; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Goode KT, 1998, HEALTH PSYCHOL, V17, P190, DOI 10.1037/0278-6133.17.2.190; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Holden J, 2002, J CLIN NURS, V11, P140, DOI 10.1046/j.1365-2702.2002.00581.x; Horowitz R., 1998, FAMILIES SYSTEMS HLT, V16, P71; Horwitz A., 1985, ANN REV GERONTOLOGY, V5, P194; Hsiao-Yu C., 2009, J CLIN NURS, V18, P174; Jastremski CA, 2000, CRIT CARE CLIN, V16, P723, DOI 10.1016/S0749-0704(05)70143-3; Kutash M, 2007, J ADV NURS, V60, P384, DOI 10.1111/j.1365-2648.2007.04388.x; Lawlor MC, 1998, AM J OCCUP THER, V52, P259, DOI 10.5014/ajot.52.4.259; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; LYNNMCHALE DJ, 2000, J FAM NURS, V6, P210; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; MacKenzie Ellen J, 2006, J Am Acad Orthop Surg, V14, pS205; Manguno-Mire G, 2007, J NERV MENT DIS, V195, P144, DOI 10.1097/01.nmd.0000254755.53549.69; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Morse J. M., 2002, README 1 USERS GUIDE; Mousavi B, 2015, REHABIL NURS, V40, P139, DOI 10.1002/rnj.159; National Cancer Institute, 2007, MED AG CANC PAT DIAG; Nijboer C, 1999, CANCER, V86, P577, DOI 10.1002/(SICI)1097-0142(19990815)86:4<577::AID-CNCR6>3.0.CO;2-S; Orthopedic Trauma Association, 2009, ACS RES DOC ORTH TRA; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Smith LM, 1995, FAMILY SUPPORT PROGR; Sohiberg M. M., 2001, J HEAD TRAUMA REHAB, V16, P498; Thorogood N, 2004, QUALITATIVE METHODS; VITALIANO PP, 1991, PSYCHOL AGING, V6, P392, DOI 10.1037/0882-7974.6.3.392; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Ziran BH, 2009, J TRAUMA, V66, P536, DOI 10.1097/TA.0b013e31817db0bf	45	5	5	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	MAR-APR	2017	24	2					125	133		10.1097/JTN.0000000000000278			9	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	EN3ZR	WOS:000395947100012	28272187				2022-02-06	
J	Norup, A; Kristensen, KS; Poulsen, I; Mortensen, EL				Norup, Anne; Kristensen, Karin Spangsberg; Poulsen, Ingrid; Mortensen, Erik Lykke			Evaluating clinically significant changes in health-related quality of life: A sample of relatives of patients with severe traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						TBI; HRQoL; Sub-acute rehabilitation; TBI-caregivers; Reliable change index; Clinically significant change	CAREGIVER BURDEN; HEAD-INJURY; INDIVIDUALS; REHABILITATION; PERSPECTIVE; POPULATION; DEPRESSION; DISTRESS; ANXIETY; IMPACT	The objective of the study was to investigate change and predictors of change in health-related quality of life (HRQoL) in relatives of patients with severe traumatic brain injury (TBI) during rehabilitation, and to analyse associations between changes in HRQoL and symptoms of anxiety and depression. The Vitality (VT), Mental Health (MH), Social Function (SF) and the Role Emotional (RE) scales from the Short Form 36, and the anxiety and depression scales from the Symptom Checklist-90 - Revised were used. Of the 62 relatives, 24.6% experienced a reliable improvement on the VT scale, 53.2% on the MH scale, 27.4% on the SF scale and 16.1% on the RE scale. Of the relatives, 24.0% experienced clinically significant change (CSC) on the VT scale, 19.6% on the MH scale, 21.6% on the SF scale, and 19.2% on the RE scale. Relatives' age and higher patient Glasgow Coma Scale score predicted the experience of CSC in RE, and change on the Functional Independence Measure in patients predicted CSC on the MH scale. Improvements in VT as well as MH were associated with improvement in symptoms of anxiety and depression, and improvement in SF was associated with improvement in symptoms of depression. About one-fifth of the sample experienced a CSC on one of the four HRQoL measures. Relatives experiencing CSC tended to be related to patients who showed more improvement during rehabilitation. Improvements in HRQoL were associated with improvements in symptoms of anxiety and depression.	[Norup, Anne; Kristensen, Karin Spangsberg; Poulsen, Ingrid] Rigshosp, Copenhagen Univ Hosp, Traumat Brain Injury Unit, RUBRIC,Clin Neurorehabil, Copenhagen, Denmark; [Norup, Anne] Rigshosp, Copenhagen Univ Hosp, Dept Neurol, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Ageing, Copenhagen, Denmark		Norup, A (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Neurol, Copenhagen, Denmark.	anne.norup@regionh.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Norup, Anne/0000-0002-5598-6116	Aase and Ejnar Danielsen's Foundation; Danish Brain Injury Association	AN has received grants from Aase and Ejnar Danielsen's Foundation and the Danish Brain Injury Association.	Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Bauer S, 2004, J PERS ASSESS, V82, P60, DOI 10.1207/s15327752jpa8201_11; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bjorner JB., 1997, DANISH MANUAL SF 36; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Derogatis LR, 1994, SCL 90 R SYMPTOM CHE; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Ferguson RJ, 2002, QUAL LIFE RES, V11, P509, DOI 10.1023/A:1016350431190; Field A., 2017, DISCOVERING STAT USI, V5th; Hagen C., 1972, LEVELS COGNITI UNPUB; Hays RD, 2005, EVAL HEALTH PROF, V28, P160, DOI 10.1177/0163278705275339; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Moules S, 1999, BRAIN INJURY, V13, P983; Norup A, 2013, AUST J REHABIL COUNS, V19, P71, DOI 10.1017/jrc.2013.12; Norup A, 2013, J REHABIL MED, V45, P820, DOI 10.2340/16501977-1190; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Norup A, 2011, NEUROPSYCHOL REHABIL, V21, P306, DOI 10.1080/09602011.2011.558766; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; Obidoa CA, 2010, J SOCIAL BEHAV HLTH, V4, P30, DOI DOI 10.5590/JSBHS.2010.04.1.02; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Olsen LR, 2006, ACTA PSYCHIAT SCAND, V113, P477, DOI 10.1111/j.1600-0447.2005.00743.x; Revicki DA, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-70; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; TEASDALE G, 1974, LANCET, V2, P81; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Walters S J, 2001, J Biopharm Stat, V11, P155, DOI 10.1081/BIP-100107655; Ware JE., 1997, SF 36 HLTH SURVEY MA	38	5	5	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR	2017	27	2					196	215		10.1080/09602011.2015.1076484			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EK4CD	WOS:000393873800002	26299841				2022-02-06	
J	Onakomaiya, MM; Kruger, SE; Highland, KB; Kodosky, PN; Pape, MM; Roy, MJ				Onakomaiya, Marie M.; Kruger, Sarah E.; Highland, Krista B.; Kodosky, Paula N.; Pape, Marcy M.; Roy, Michael J.			Expanding Clinical Assessment for Traumatic Brain Injury and Comorbid Post-Traumatic Stress Disorder: A Retrospective Analysis of Virtual Environment Tasks in the Computer-Assisted Rehabilitation Environment	MILITARY MEDICINE			English	Article							REALITY; PTSD; SYMPTOMS; COMBAT; IMPROVEMENTS; DIZZINESS; EXPOSURE; THERAPY; RISK	The objective of this study was to determine whether physical performance during virtual environment (VE) tasks in the Computer-Assisted Rehabilitation Environment (CAREN) could differentiate between service members (SMs) with a history of traumatic brain injury (TBI) with and without comorbid post-traumatic stress disorder (PTSD). Data were obtained by independent review of clinical notes, objective outcomes, and validated questionnaires from 214 SMs (208 males) with a history of TBI assessed in the CAREN from 2010 to 2015. Three preliminary VEs acclimatized patients to the CAREN: Balance Balls, weight shifting on a static platform (timed); Balance Cubes, step shifting with and without platform motion (timed); and Continuous Road, flat ambulation (self-selected speed). Multiple regression analyses revealed that patients with comorbid TBI-PTSD were significantly slower in completing the VE tasks than patients without PTSD. Logistic regression showed that the Balance Cubes VE without platform motion significantly predicted diagnostic category (i.e., no PTSD vs. comorbid PTSD). In conclusion, in SMs with a history of TBI, physical performance on the CAREN effectively distinguished those with comorbid PTSD, as their performance was significantly slower than SMs without PTSD. These results portray the potential of the CAREN as a novel assessment tool in SMs with a history of TBI.	[Onakomaiya, Marie M.; Kruger, Sarah E.; Kodosky, Paula N.; Pape, Marcy M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 4860 S Palmer Rd, Bethesda, MD 20889 USA; [Highland, Krista B.; Roy, Michael J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Highland, Krista B.; Roy, Michael J.] Uniformed Serv Univ Hlth Sci, Dept Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Onakomaiya, Marie M.] Cherokee Nation Technol Solut, 777 W Cherokee St, Catoosa, OK 74015 USA; [Highland, Krista B.] Henry M Jackson Fdn, 6704-A Rockledge Dr,Suite 100, Bethesda, MD 20817 USA		Onakomaiya, MM (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 4860 S Palmer Rd, Bethesda, MD 20889 USA.; Onakomaiya, MM (corresponding author), Cherokee Nation Technol Solut, 777 W Cherokee St, Catoosa, OK 74015 USA.			Highland, Krista/0000-0003-3815-2571	CDMRP-MRMC - NICoE Network Research Program (NNRP) Infrastructure [W81XWH-14-C-0139]	We thank Paula Bellini and Mary Coughlin for their quality assurance reviews of the CAREN data and clinical diagnoses. We also thank the clinicians in the NICoE Rehabilitation Department (other than MMP and PNK) who referred patients for assessment in the CAREN. We thank the NICoE Informatics Department for compiling the diagnostic clinical notes and questionnaires. This study was supported by CDMRP-MRMC Contract no. W81XWH-14-C-0139 - NICoE Network Research Program (NNRP) Infrastructure.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beurskens R, 2014, J BIOMECH, V47, P3072, DOI 10.1016/j.jbiomech.2014.06.041; Blake DD., CLIN ADM PTSD SCALE; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Collins JD, 2015, WORK, V50, P121, DOI 10.3233/WOR-141927; Costanzo ME, 2014, PSYCHOSOM MED, V76, P670, DOI 10.1097/PSY.0000000000000109; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; DVBIC, 2015, DOD WORLDW NUMB TBI; Edwards J, 2014, APPL NEUROPSYCH-ADUL, V21, P220, DOI 10.1080/09084282.2013.796554; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Gottshall KR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00106; Grant G., 2016, TRANSLATIONAL RES TR; Highland KB, 2015, STUD HEALTH TECHNOL, V219, P23, DOI 10.3233/978-1-61499-595-1-23; Highland KB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00256; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kruger SE, 2011, INT J DISABIL HUM DE, V10, P313; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Rizzo A, 2015, J CONTEMP PSYCHOTHER, V45, P255, DOI 10.1007/s10879-015-9306-3; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Roy MJ, 2014, STUD HEALTH TECHNOL, V199, P61, DOI 10.3233/978-1-61499-401-5-61; Roy MJ, 2013, STUD HEALTH TECHNOL, V191, P115, DOI 10.3233/978-1-61499-282-0-115; Roy MJ, 2012, STUD HEALTH TECHNOL, V181, P149, DOI 10.3233/978-1-61499-121-2-149; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steer, 1993, MANUAL BECK ANXIETY; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warren AM, 2015, J TRAUMA ACUTE CARE, V79, P1062, DOI 10.1097/TA.0000000000000875; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	47	5	5	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			128	136		10.7205/MILMED-D-16-00054			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER6VN	WOS:000398947100022	28291464	Bronze			2022-02-06	
J	Russo, AC; Fingerhut, EC				Russo, Arthur C.; Fingerhut, Esther C.			Consistency of Self-Reported Neurocognitive Symptoms, Post-Traumatic Stress Disorder Symptoms, and Concussive Events From End of First Deployment to Veteran Health Administration Comprehensive Traumatic Brain Injury Evaluation by Operations Enduring Freedom/Iraqi Freedom/New Dawn Veterans	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Veterans; Traumatic brain injury; PTSD; Assessment	PERSISTENT POSTCONCUSSIVE SYMPTOMS; WAR VETERANS; MEMORY; PTSD; COMPLAINTS; MILITARY; VALIDITY; IRAQ; CARE	Objective: This study examined the consistency of self-reported symptoms and concussive events in combat veterans who reported experiencing concussive events. Method: One hundred and forty, single deployed, Operation Enduring Freedom, Operation Iraqi Freedom and Operation New Dawn combat veterans with Veteran Health Administration (VHA) Comprehensive Traumatic Brain Injury Evaluations (CTBIE) and no post-deployment head injury were examined to assess consistency of self-reported (a) traumatic brain injury (TBI)-related symptoms, (b) post-traumatic stress disorder (PTSD)-related symptoms, and (c) TBI-related concussive events from soon after deployment to time of VHA CTBIE. Results: Compared to their self-report of symptoms and traumatic events at the time of their Post-Deployment Health Assessment, at the time of their comprehensive VHA evaluation, subjects reported significantly greater impairment in concentration, decision making, memory, headache, and sleep. In addition, although half the subjects denied any PTSD symptoms post-deployment, approximately three quarters reported experiencing all four PTSD screening symptoms near the time of the VHA CTBIEs. At the latter time, subjects also reported significantly more TBI-related concussive events, as well as more post-concussive sequelae such as loss of consciousness immediately following these concussive events. Finally, although 84% reported a level of impairment so severe as to render all but the simplest activity doable, the vast majority simultaneously reported working and/or attending college. Conclusions: These findings raise questions regarding the accuracy of veteran self-report of both near and distant traumatic events, and argue for the inclusion of contemporaneous Department of Defense (DOD) records in veteran assessment and treatment planning.	[Russo, Arthur C.] VA New York Harbor Healthcare Syst, Dept Psychol, Brooklyn Campus,800 Poly Pl, Brooklyn, NY 11209 USA; [Fingerhut, Esther C.] Fordham Univ, Bronx, NY 10458 USA		Russo, AC (corresponding author), VA New York Harbor Healthcare Syst, Dept Psychol, Brooklyn Campus,800 Poly Pl, Brooklyn, NY 11209 USA.	Arthur.Russo@va.gov					Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Bliese P.D., 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brundage John F, 2015, MSMR, V22, P2; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Center for Disease Control and Prevention/ National Institute of Health, 2013, REPO C TRAUM BRAIN I; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collins S. T., 2009, THESIS; Dasse MN, 2015, MIL PSYCHOL, V27, P354, DOI 10.1037/mil0000094; Department of Defense, 2003, ENH POSTD HLTH ASS; Department of Defense, 2002, MCM000602 DEP DEF JO; Department of Defense, 2006, INSTR 649 03 DEPL HL; Department of Defense, 2012, DOD POL GUID MAN MIL; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Frueh BC, 2005, BRIT J PSYCHIAT, V186, P467, DOI 10.1192/bjp.186.6.467; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge C., 2010, ONCE WARRIOR ALWAYS; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Institute of Medicine, 2009, GULF WAR HLTH, V7; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; King DW, 2000, J ABNORM PSYCHOL, V109, P624, DOI 10.1037//0021-843X.109.4.624; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; McNally RJ, 2003, BIOL PSYCHIAT, V53, P779, DOI 10.1016/S0006-3223(02)01663-3; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Roth R. S., 2013, INT J PHYS MED REHAB, V1, P1, DOI [10.4172/2329-9096.1000105, DOI 10.4172/2329-9096.1000105]; Rubin DC, 2008, PSYCHOL REV, V115, P985, DOI 10.1037/a0013397; Russo AC, 2014, PSYCHOL INJ LAW, V7, P178, DOI 10.1007/s12207-014-9190-2; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; van Giezen AE, 2005, CLIN PSYCHOL REV, V25, P935, DOI 10.1016/j.cpr.2005.04.011; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Veterans Health Administration, 2010, TRAUMATIC BRAIN INJU	45	5	5	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2017	32	2					184	197		10.1093/arclin/acw093			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EQ4EG	WOS:000398026400005	28365745	hybrid			2022-02-06	
J	Stracciolini, A; Sugimoto, D; Howell, DR				Stracciolini, Andrea; Sugimoto, Dai; Howell, David R.			Injury Prevention in Youth Sports	PEDIATRIC ANNALS			English	Article							CRUCIATE LIGAMENT INJURY; NEUROMUSCULAR TRAINING INTERVENTION; RANDOMIZED-CONTROLLED-TRIAL; HIGH-SCHOOL SPORTS; OVERUSE INJURIES; KNEE-ABDUCTION; PATELLOFEMORAL PAIN; POSITION STATEMENT; RISK-REDUCTION; CONCUSSION	Children and adolescents are now participating in competitive sports at younger ages and with increasing intensity. As a result, increasing numbers of young athletes are presenting to pediatricians for care of sports-related injuries and advice about prevention. Understanding and identifying modifiable risk factors for injury in the young athletic population is a critical first step in injury prevention. Risk factors vary by sport, age, and sex. This article reviews the most common risk factors for injury and the evidence to support proposed strategies for prevention.	[Stracciolini, Andrea] Boston Childrens Hosp, Div Sports Med, Primary Care Sports Med Physician, Boston, MA USA; [Stracciolini, Andrea] Boston Childrens Hosp, Div Sports Med, Director Sect Performing Arts, Boston, MA USA; [Stracciolini, Andrea; Sugimoto, Dai] Harvard Med Sch, Pediat, Boston, MA USA; [Stracciolini, Andrea] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Sugimoto, Dai] Micheli Ctr Sports Injury Prevent, Director Clin Res, Waltham, MA USA; [Sugimoto, Dai] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Howell, David R.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Stracciolini, A (corresponding author), Boston Childrens Hosp, Dept Orthopaed Surg, Div Sports Med, 300 Longwood Ave, Boston, MA 02115 USA.	andrea.stracciolini@childrens.harvard.edu					American Academy of Pediatrics, COUNC SPORTS MED FIT; Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Boguszewski DV, 2015, AM J SPORT MED, V43, P2982, DOI 10.1177/0363546515608478; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; CAINE D, 1989, AM J SPORT MED, V17, P811, DOI 10.1177/036354658901700616; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Chang SP, 2015, J SPORT MED PHYS FIT, V55, P1234; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, NATL HIGH SCH SPORTS; Cowley HR, 2006, J ATHL TRAINING, V41, P67; Cross KM, 2003, CLIN SPORT MED, V22, P639, DOI 10.1016/S0278-5919(02)00099-6; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; DiFiori JP, 2002, CLIN J SPORT MED, V12, P348, DOI 10.1097/00042752-200211000-00005; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Faulkner RA, 2006, J BONE MINER RES, V21, P1864, DOI 10.1359/JBMR.060907; Ford KR, 2010, MED SCI SPORT EXER, V42, P1923, DOI 10.1249/MSS.0b013e3181dc99b1; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J, 2008, AM J SPORT MED, V36, P1476, DOI 10.1177/0363546508318188; Hall R, 2015, J SPORT REHABIL, V24, P31, DOI 10.1123/jsr.2013-0101; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hewett TE, 2015, MED SCI SPORT EXER, V47, P2579, DOI 10.1249/MSS.0000000000000700; Hosea TM, 2000, CLIN ORTHOP RELAT R, P45; Jayanthi N, 2013, SPORTS HEALTH, V5, P251, DOI 10.1177/1941738112464626; Jayanthi NA, 2015, AM J SPORT MED, V43, P794, DOI 10.1177/0363546514567298; Khayambashi K, 2016, AM J SPORT MED, V44, P355, DOI 10.1177/0363546515616237; Kucera KL, 2005, BRIT J SPORT MED, V39, P462, DOI 10.1136/bjsm.2004.013672; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; LaBella CR, 2014, PEDIATRICS, V133, pE1437, DOI 10.1542/peds.2014-0623; LaBella CR, 2011, ARCH PEDIAT ADOL MED, V165, P1033, DOI 10.1001/archpediatrics.2011.168; LaBella CR, 2009, CLIN PEDIATR, V48, P327, DOI 10.1177/0009922808323903; Luke A, 2011, CLIN J SPORT MED, V21, P307, DOI 10.1097/JSM.0b013e3182218f71; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Messina DF, 1999, AM J SPORT MED, V27, P294, DOI 10.1177/03635465990270030401; Micheli LJ, 2000, CLIN SPORT MED, V19, P821, DOI 10.1016/S0278-5919(05)70239-8; MICHELI LJ, 1992, CLIN SPORT MED, V11, P713; MICHELI LJ, 1983, ORTHOP CLIN N AM, V14, P337; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Myer GD, 2008, CLIN SPORT MED, V27, P425, DOI 10.1016/j.csm.2008.02.006; Myer GD, 2015, SPORTS HEALTH, V7, P437, DOI 10.1177/1941738115598747; Myer GD, 2014, J ATHL TRAINING, V49, P389, DOI 10.4085/1062-6050-49.2.17; Myer GD, 2013, AM J SPORT MED, V41, P203, DOI 10.1177/0363546512460637; Powell JW, 2000, AM J SPORT MED, V28, P385, DOI 10.1177/03635465000280031801; Shea KG, 2015, J BONE JOINT SURG AM, V97A, P672, DOI 10.2106/JBJS.N.01257; Stracciolini A, 2015, SPORTS HEALTH, V7, P130, DOI 10.1177/1941738114554768; Stracciolini A, 2015, CLIN J SPORT MED, V25, P30, DOI 10.1097/JSM.0000000000000105; Stracciolini A, 2014, AM J SPORT MED, V42, P965, DOI 10.1177/0363546514522393; Stracciolini A, 2013, AM J SPORT MED, V41, P1922, DOI 10.1177/0363546513490644; Sugimoto Dai, 2015, Curr Phys Med Rehabil Rep, V3, P43; Sugimoto D, 2015, BRIT J SPORT MED, V49, P282, DOI 10.1136/bjsports-2014-093461; Sugimoto D, 2014, SPORTS MED, V44, P551, DOI 10.1007/s40279-013-0135-9; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P1364, DOI 10.1111/sms.12735; Waterman BR, 2011, AM J SPORT MED, V39, P992, DOI 10.1177/0363546510391462; Weaver NL, 2002, PATIENT EDUC COUNS, V46, P199, DOI 10.1016/S0738-3991(01)00213-0; Willson JD, 2012, CLIN BIOMECH, V27, P1052, DOI 10.1016/j.clinbiomech.2012.08.008; Willy RW, 2012, MED SCI SPORT EXER, V44, P2165, DOI 10.1249/MSS.0b013e3182629215; 2000, PEDIATRICS 1, V106, P154	63	5	6	1	26	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	MAR	2017	46	3					E99	E105		10.3928/19382359-20170223-01			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EQ5FQ	WOS:000398108200006	28287683				2022-02-06	
J	Williams, JL; McDevitt-Murphy, ME; Murphy, JG; Crouse, EM				Williams, Joah L.; McDevitt-Murphy, Meghan E.; Murphy, James G.; Crouse, Ellen M.			Postconcussive Symptoms, PTSD, and Medical Disease Burden in Treatment-Seeking OEF/OIF/OND Veterans	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; WAR VETERANS; HEALTH-CARE; COGNITIVE DYSFUNCTION; IRAQ; AFGHANISTAN; DEPRESSION; DEPLOYMENT; COMPLAINTS	Introduction: The most common psychological and cognitive sequelae associated with deployments to Afghanistan (Operation Enduring Freedom) and Iraq (Operation Iraqi Freedom) are mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD). High rates of PTSD are often observed among Veterans with a history of mTBI, and persistent postconcussive symptoms commonly endorsed after mTBI are known to be associated with PTSD. Therefore, this study examined whether PTSD mediates relations between postconcussive symptoms and 2 indices of medical disease burden: 1) the number of disease categories positive for a diagnosis, or system disease burden, and 2) total number of physical diagnoses, or cumulative disease burden. Materials and Methods: Participants were 91 Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn Veterans seeking treatment at a Veterans Affairs Medical Center who screened positive for mTBI and later attended a follow-up Polytrauma clinic evaluation for neuropsychiatric assessment. Medical records were reviewed for a history of mTBI, postconcussive symptoms, and physician diagnoses, which were used to derive system and cumulative disease burden variables. Mediation was tested using bootstrapping procedures. Participants provided written informed consent and all study procedures were approved by both the VA and university institutional review boards. Results: Postconcussive symptoms (r = 0.53) and PTSD symptoms (r = 0.32) were both associated with cumulative disease burden. Only postconcussive symptoms were associated with system disease burden (r = 0.32). Results of our follow-up mediation analysis suggest that PTSD did not mediate relations between postconcussive symptoms and cumulative disease burden (bootstrap coefficient = -0.02, 95% confidence interval [-0.05 to 0.01]). Conclusion: These findings join an emerging body of literature suggesting that postconcussive symptoms have a direct impact on Veterans' health above and beyond the effects of PTSD. Strengths of this study include the use of objective, clinician-diagnosed medical conditions as an indicator of health, whereas limitations include the use of self-report measures to assess postconcussive and PTSD symptoms. This study underscores the need for more original research on the impact of mTBI on the longterm health and readjustment of returning Veterans. Furthermore, this study highlights the need for additional research on the psychosocial and pathophysiological mechanisms underlying the link between mTBI and poor health.	[Williams, Joah L.] Univ Missouri, Dept Psychol, 5030 Cherry St,Room 310, Kansas City, MO 64110 USA; [Williams, Joah L.; McDevitt-Murphy, Meghan E.; Murphy, James G.] Univ Memphis, Dept Psychol, 202 Psychol Bldg, Memphis, TN 38152 USA; [Williams, Joah L.; McDevitt-Murphy, Meghan E.; Murphy, James G.; Crouse, Ellen M.] Memphis Vet Affairs Med Ctr, 1030 Jefferson Ave, Memphis, TN 38104 USA; [Crouse, Ellen M.] Univ Tennessee, Hlth Sci Ctr, Dept Psychiat, 1030 Jefferson Ave, Memphis, TN 38104 USA		Williams, JL (corresponding author), Univ Missouri, Dept Psychol, 5030 Cherry St,Room 310, Kansas City, MO 64110 USA.; Williams, JL (corresponding author), Univ Memphis, Dept Psychol, 202 Psychol Bldg, Memphis, TN 38152 USA.; Williams, JL (corresponding author), Memphis Vet Affairs Med Ctr, 1030 Jefferson Ave, Memphis, TN 38104 USA.				Office of Research and Development, Memphis Veterans Affairs Medical Center; National Institutes of Health/National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K23 AA016120]; Memphis VAMC Office of Research and Development; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K23AA016120] Funding Source: NIH RePORTER	This work was conducted with support from the Office of Research and Development, Memphis Veterans Affairs Medical Center. This research was supported by the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (K23 AA016120) and by the Memphis VAMC Office of Research and Development.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Gizzi M, 2003, J HEAD TRAUMA REHAB, V18, P398, DOI 10.1097/00001199-200309000-00002; Grieger TA, 2007, MIL MED, V172, P451, DOI 10.7205/MILMED.172.5.451; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Mallinckrodt B, 2006, J COUNS PSYCHOL, V53, P372, DOI 10.1037/0022-0167.53.3.372; McDevitt-Murphy ME, 2014, J CONSULT CLIN PSYCH, V82, P562, DOI 10.1037/a0036714; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Department of Health and Human Services, 1991, DHHS PUBL; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Weathers F, 1993, PTSD CHECKLIST PCL	28	5	5	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2017	182	3-4					E1645	E1650		10.7205/MILMED-D-16-00221			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER6WA	WOS:000398948700014	28290938	Bronze, Green Accepted			2022-02-06	
J	Wunderlich, KL; Vollmer, TR; Zabala, KA				Wunderlich, Kara L.; Vollmer, Timothy R.; Zabala, Karla A.			ASSESSMENT AND TREATMENT OF AUTOMATICALLY REINFORCED SELF-INDUCED EMESIS	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						behavioral processes; emesis; fidelity; integrity; intellectual disability; response blocking; traumatic brain injury; vomiting	RESPONSE BLOCKING; FUNCTIONAL-ANALYSIS; EXTINCTION; BEHAVIOR	Frequent emesis can cause substantial deleterious effects to a child's health and environment. We conducted a functional analysis of a 3-year-old girl's self-induced emesis and confirmed that emesis was maintained by automatic reinforcement. In a reversal design, we evaluated the efficacy of implementing response blocking at 100% and 50% treatment integrity levels on both attempts and successful production of emesis. One hundred percent blocking, but not 50% blocking, was successful in reducing attempts and emesis below baseline levels.	[Wunderlich, Kara L.; Zabala, Karla A.] Univ Georgia, Athens, GA 30602 USA; [Vollmer, Timothy R.] Univ Florida, Gainesville, FL 32611 USA		Wunderlich, KL (corresponding author), Univ Georgia, Dept Commun Sci & Special Educ, 110 Carlton St, Athens, GA 30602 USA.	kwunder@uga.edu		Zabala, Karla/0000-0001-5399-1686			Doughty SS, 2007, J EXP ANAL BEHAV, V87, P325, DOI 10.1901/jeab.2007.39-05; IWATA BA, 1994, J APPL BEHAV ANAL, V27, P197, DOI 10.1901/jaba.1994.27-197; Lalli JS, 1996, J APPL BEHAV ANAL, V29, P129, DOI 10.1901/jaba.1996.29-129; LeBlanc LA, 1997, RES DEV DISABIL, V18, P215, DOI 10.1016/S0891-4222(97)00004-8; Lerman DC, 1996, J APPL BEHAV ANAL, V29, P231, DOI 10.1901/jaba.1996.29-231; Mehler PS, 2011, INT J EAT DISORDER, V44, P95, DOI 10.1002/eat.20825; Mudford OC, 2009, J APPL BEHAV ANAL, V42, P165, DOI 10.1901/jaba.2009.42-165; REID DH, 1993, J APPL BEHAV ANAL, V26, P139, DOI 10.1901/jaba.1993.26-139; Smith RG, 1999, J APPL BEHAV ANAL, V32, P367, DOI 10.1901/jaba.1999.32-367	9	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8855	1938-3703		J APPL BEHAV ANAL	J. Appl. Behav. Anal.	SPR	2017	50	2					418	423		10.1002/jaba.371			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	FA2AI	WOS:000405242500017	28177122				2022-02-06	
J	Das, C; Wang, GC; Sun, Q; Ledden, B				Das, Champak; Wang, Guochun; Sun, Qian; Ledden, Bradley			Multiplexed and fully automated detection of metabolic biomarkers using microdialysis probe	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Microdialysis; Real-time analysis; Metabolic biomarkers; Automated instrumentation; Collection efficiency; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; HEAD-INJURY; CEREBRAL MICRODIALYSIS; NEUROINTENSIVE CARE; PRESSURE; LACTATE; ONLINE; FLUID	We report here, the design and development of an automated near real-time continuous detection system for lactate, glutamate, pyruvate and glucose using microdialysis probe. The system developed can automatically push perfusate through microdialysis probe (20, 100 and 1000 kDa MWCO cutoff probe) at low to medium flow rate of 0.5-2 mu L/min with almost 100% fluid recovery. The microdialysate collected from the probe is analyzed automatically for these four metabolite biomarkers. It operates in a continuous mode with measurements of all four biomarkers once every 20 min. The dynamic range for these different markers covers the entire clinical range of traumatic brain injury. The prototype shows a low variation of similar to 7-10% across the entire clinical range for all the biomarkers with fairly good accuracy of similar to 95%. The instrument canrun continuously for 24 h without user intervention. With a long tubing of 1 m to and from the microdialysis probe and associated dead volume, the total lag time for actual event at the probe site versusreported concentration is roughly 1 h. (C) 2016 Elsevier B.V. All rights reserved.	[Das, Champak; Wang, Guochun; Sun, Qian; Ledden, Bradley] SFC Fluid Inc, Fayetteville, AR 72701 USA		Das, C (corresponding author), SFC Fluid Inc, Fayetteville, AR 72701 USA.	champakdas@gmail.com		Ledden, Bradley/0000-0003-4649-0466	National Institute of Neurological Disorders And Stroke (NINDS) of the National Institutes of Health [R44NS076167]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS076167] Funding Source: NIH RePORTER	Research reported in this publication is supported by the National Institute of Neurological Disorders And Stroke (NINDS) of the National Institutes of Health under Award Number R44NS076167. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We would like to thank our collaborators Dr. Claudia Robertson from Baylor College of Medicine, TX and Dr. Julie Stenken from University of Arkansas, AR for insightful discussion in developing this instrument and subsequent testing at their laboratories.	[Anonymous], 2016, MDIALYSIS ISCUS CLIN; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bielecka-Grzela S, 2003, J CLIN PHARM THER, V28, P465, DOI 10.1046/j.0269-4727.2003.00516.x; BioAssaySystems, 2009, ENZYCHROM GLUT ASS K; BioAssaySystems, 2013, ENZYCHROM GLUC ASS K; BioAssaySystems, 2007, ENZYCHROM LACT ASS K; BioAssaySystems, 2013, ENZYCHROM PYR ASS KI; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Huang HF, 2008, J CHROMATOGR B, V874, P77, DOI 10.1016/j.jchromb.2008.09.005; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Richards DA, 2007, AMINO ACIDS, V33, P429, DOI 10.1007/s00726-006-0480-1; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Schierenbeck Fanny, 2012, J Diabetes Sci Technol, V6, P1365; Schltz KN, 2008, ANNU REV ANAL CHEM, V1, P627, DOI 10.1146/annurev.anchem.1.031207.113047; Shackman HM, 2007, J NEUROSCI METH, V159, P86, DOI 10.1016/j.jneumeth.2006.06.020; Takeuchi T, 2003, ANAL BIOANAL CHEM, V375, P26, DOI 10.1007/s00216-002-1619-x; Huynh T, 2012, ANAL CHEM, V84, P9988, DOI 10.1021/ac302430b; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Woo KL, 2008, J PHARMACEUT BIOMED, V48, P20, DOI 10.1016/j.jpba.2008.04.019; Zhu T, 2003, J PHARM SCI, V92, P1947, DOI 10.1002/jps.10457	25	5	5	0	9	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND		0925-4005		SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	FEB	2017	238						633	640		10.1016/j.snb.2016.07.097			8	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry; Instruments & Instrumentation	ED6EN	WOS:000388948600078	28090149	Green Accepted			2022-02-06	
J	Lenzi, J; Caporlingua, F; Caporlingua, A; Anichini, G; Nardone, A; Passacantilli, E; Santoro, A				Lenzi, Jacopo; Caporlingua, Federico; Caporlingua, Alessandro; Anichini, Giulio; Nardone, Antonio; Passacantilli, Emiliano; Santoro, Antonio			Relevancy of positive trends in mortality and functional recovery after surgical treatment of acute subdural hematomas. Our 10-year experience	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Subdural hemorrhage; traumatic brain injury; surgery; anticoagulant therapy; thrombocyte-aggregation inhibitors therapy	ORAL ANTICOAGULANT-THERAPY; TRAUMATIC BRAIN-INJURY; OUTCOME PREDICTION; COMATOSE PATIENTS; RISK-FACTORS; HEAD-INJURY; AGE; CLASSIFICATION; HEMORRHAGE; SYSTEM	Background: Among traumatic brain injuries, acute subdural hematoma (aSDH) is considered one of the most devastating still retaining poor surgical outcomes in a considerable percentage of affected patients. However, according to results drawn from published samples of aSDH patients, overall mortality and functional recovery have been progressively ameliorating during the last decades. Methods: We present a retrospective analysis of 316 consecutive cases of post-traumatic aSDH operated on between 2003 and 2011 at our institution. Results: Mortality was 67% (n = 212); a useful recovery was achieved in 16.4% cases (n=52). Age > 65 years, a preoperative Glasgow coma scale (GCS) <= 8, specific pre-existing medical comorbidities (hypertension, heart diseases) were found to be strong indicators of unfavorable outcomes and death during hospitalization. Conclusion: Our results, compared with those of the inherent literature, led the authors to question both the "aggressiveness" of neurosurgical care indications in certain subpopulations of patients being known to fare worse or even die regardless of the treatment administered and the relevance of the results concerning mortality and functional recovery reported by third authors.	[Lenzi, Jacopo; Caporlingua, Federico; Caporlingua, Alessandro; Anichini, Giulio; Nardone, Antonio; Passacantilli, Emiliano; Santoro, Antonio] Sapienza Univ Rome, Dept Neurol & Psychiat, Neurosurg, Via Policlin 155, I-00161 Rome, Italy; [Anichini, Giulio] Charing Cross Hosp, Imperial Coll London, Dept Neurosurg, London, England		Caporlingua, F (corresponding author), Sapienza Univ Rome, Dept Neurol & Psychiat, Neurosurg, Via Policlin 155, I-00161 Rome, Italy.	caporlingua87@gmail.com	Nardone, Antonio/ABH-1196-2020; Nardone, Antonio/J-8733-2016	Nardone, Antonio/0000-0002-9547-1774; Nardone, Antonio/0000-0002-9547-1774; Caporlingua, Alessandro/0000-0003-2776-5399; Anichini, Giulio/0000-0001-6608-3310			AMACHER AL, 1987, NEUROSURGERY, V20, P954; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Collett D., 2014, MODELLING SURVIVAL D, P1; D'Amato L, 2007, J Neurosurg Sci, V51, P107; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; FELL DA, 1975, J NEUROSURG, V42, P37, DOI 10.3171/jns.1975.42.1.0037; Frontera JA, 2011, NEUROCRIT CARE, V14, P260, DOI 10.1007/s12028-010-9418-2; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Hanif S, 2009, Ir Med J, V102, P255; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P191, DOI 10.1007/BF01808958; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; KLUN B, 1984, ACTA NEUROCHIR, V71, P171, DOI 10.1007/BF01401312; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; LONG DM, 1985, NEUROSURGERY, V17, P348, DOI 10.1227/00006123-198508000-00022; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; MCKISSOCK W, 1960, LANCET, V275, P1365; MCLAURIN RL, 1961, J NEUROSURG, V18, P61, DOI 10.3171/jns.1961.18.1.0061; Mendelow AD, 2006, IND J NEUROTRAUMA, V3, P95; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Oake N, 2008, CAN MED ASSOC J, V179, P235, DOI 10.1503/cmaj.080171; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; PERLMUTTER I, 1961, JAMA-J AM MED ASSOC, V176, P212, DOI 10.1001/jama.1961.63040160001006; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; RICHARDS T, 1974, SURGERY, V75, P253; ROSENORN J, 1978, J NEUROSURG, V48, P345, DOI 10.3171/jns.1978.48.3.0345; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Saito T, 2003, ACTA NEUROCHIR SUPPL, V86, P351; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Torn M, 2009, ARCH INTERN MED, V169, P1203, DOI 10.1001/archinternmed.2009.176; Vollmer DG, 1991, J NEUROSURG S, V75, P37; WHITTEMORE SR, 1985, DEV BRAIN RES, V20, P169, DOI 10.1016/0165-3806(85)90102-6; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yanaka Kiyoyuki, 1993, Neurologia Medico-Chirurgica, V33, P552, DOI 10.2176/nmc.33.552	44	5	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2017	31	1					78	83		10.1080/02688697.2016.1226253			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EL1QZ	WOS:000394397400017	27596026				2022-02-06	
J	Sahoo, S; Sheshadri, V; Sriganesh, K; Reddy, KRM; Radhakrishnan, M; Rao, GSU				Sahoo, Sarasa; Sheshadri, Veena; Sriganesh, Kamath; Reddy, K. R. Madhsudana; Radhakrishnan, Muthuchellappan; Rao, Ganne Sesha Umamaheswara			Effect of Hyperoxia on Cerebral Blood Flow Velocity and Regional Oxygen Saturation in Patients Operated on for Severe Traumatic Brain Injury-The Influence of Cerebral Blood Flow Autoregulation	WORLD NEUROSURGERY			English	Article						Cerebral autoregulation; Cerebral blood flow; Cerebral oxygenation; Hyperoxia; Traumatic brain injury	SEVERE HEAD-INJURY; HYPEREMIC RESPONSE TEST; NORMOBARIC HYPEROXIA; ARTERIAL HYPEROXIA; INTRACRANIAL-PRESSURE; METABOLISM; COHORT; METAANALYSIS; ASSOCIATION; IMPROVEMENT	BACKGROUND: The effect of normobaric hyperoxia on brain oxygenation in the presence or absence of intact autoregulation has not been studied previously in acute traumatic brain injury (TBI). METHODS: In this prospective clinical investigation of 50 patients operated on for severe TBI, cerebral blood flow (CBF) velocity in the middle cerebral artery was measured using transcranial Doppler. Regional cerebral oxygen saturation using near-infrared spectroscopy at 3 different fractions of inspired oxygen (FiO(2)) (0.4, 0.6, and 1) was measured in the last 25 of these patients. RESULTS: There was no difference in the hemodynamic and respiratory variables except for PaO2, which increased with increasing FiO(2). The CBF velocities and pulsatility indices did not vary at different levels of FiO(2) (0.4, 0.6, and 1) both on the operated and on the nonoperated side. The regional cerebral oxygen saturation as evaluated by bifrontal near-infrared spectroscopy sensors increased with increasing FiO(2) on the operated (pathologic) side with impaired cerebral autoregulation and not with intact autoregulation. CONCLUSIONS: In severe TBI, middle cerebral artery CBF velocity is not affected by hyperoxia in both the pathologic and the normal side. The cerebral oxygen saturation increased with increasing arterial hyperoxia in the operated cerebral hemisphere and remained within baseline range in the nonoperated hemisphere. Impairment in the cerebral autoregulation in the pathologic hemisphere contributes to this luxury oxygenation.	[Sahoo, Sarasa; Sriganesh, Kamath; Reddy, K. R. Madhsudana; Radhakrishnan, Muthuchellappan; Rao, Ganne Sesha Umamaheswara] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuroanaesthesia, Bangalore, Karnataka, India; [Sheshadri, Veena] Univ Toronto, Dept Anaesthesia, Toronto, ON, Canada		Rao, GSU (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuroanaesthesia, Bangalore, Karnataka, India.	gsuma123@yahoo.com					Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Lin CM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/529580; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Mahajan RP, 1998, ANESTH ANALG, V87, P843, DOI 10.1097/00000539-199810000-00018; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rostami E, 2013, RESP PHYSIOL NEUROBI, V189, P537, DOI 10.1016/j.resp.2013.08.010; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Tibble RK, 2001, ANESTH ANALG, V93, P171; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Veenith TV, 2014, J CEREBR BLOOD F MET, V34, P1622, DOI 10.1038/jcbfm.2014.123; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720	26	5	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2017	98						211	216		10.1016/j.wneu.2016.10.116			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EO9SL	WOS:000397028300019	27810458				2022-02-06	
J	Walter, A; Finelli, K; Bai, X; Arnett, P; Bream, T; Seidenberg, P; Lynch, S; Johnson, B; Slobounov, S				Walter, A.; Finelli, K.; Bai, X.; Arnett, P.; Bream, T.; Seidenberg, P.; Lynch, S.; Johnson, B.; Slobounov, S.			Effect of Enzogenol (R) Supplementation on Cognitive, Executive, and Vestibular/Balance Functioning in Chronic Phase of Concussion	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-RESOLUTION EEG; MENTAL FATIGUE; BARK EXTRACT; THETA; ALPHA; PERFORMANCE; TASK; SYMPTOMS; INDEXES	This study examined the feasibility of Enzogenol (R) as a potential treatment modality for concussed individuals with residual symptoms in the chronic phase. Forty-two student-athletes with history of sport-related concussion were enrolled, comparing Enzogenol (R) versus placebo. Testing was conducted using virtual reality (VR) and electroencephalography (EEG), with neuropsychological (NP) tasks primarily used to induce cognitive challenges. After six weeks, the Enzogenol (R) group showed enhanced frontal-midline theta, and decreased parietal theta power, indicating reduced mental fatigue. Subjects enrolled in the Enzogenol (R) group also self-reported reduced mental fatigue and sleep problems. This suggests that Enzogenol (R) has the potential to improve brain functioning in the chronic phase of concussion.	[Walter, A.; Finelli, K.; Seidenberg, P.; Lynch, S.; Johnson, B.; Slobounov, S.] Penn State Univ, Penn State Ctr Sport Concuss, University Pk, PA 16802 USA; [Walter, A.; Finelli, K.; Johnson, B.; Slobounov, S.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Bai, X.; Arnett, P.] Penn State Univ, Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA; [Bream, T.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Seidenberg, P.; Lynch, S.] Penn State Univ, Intercollegiate Athlet, University Pk, PA 16802 USA		Slobounov, S (corresponding author), Penn State Ctr Sports Concuss, 19 Recreat Bldg, University Pk, PA 16802 USA.	sms18@psu.edu			ENZO Nutraceutical Ltd.; HeadRehab.com	This study was funded by generous support from ENZO Nutraceutical Ltd. and HeadRehab.com. All contributing authors disclose no financial interest while reporting these findings.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Arnett P., 2014, CONCUSSION ATHLETICS, P35; Ashbaugh A, 2016, CURR SPORT MED REP, V15, P16, DOI 10.1249/JSR.0000000000000219; Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cegalis J. A., 1994, VIGIL W CONTINUOUS; Chayasirisobhon S, 2006, HEADACHE, V46, P788, DOI 10.1111/j.1526-4610.2006.00454.x; Cooper PS, 2015, NEUROIMAGE, V108, P354, DOI 10.1016/j.neuroimage.2014.12.028; Corsi-Cabrera M, 2003, INT J PSYCHOPHYSIOL, V50, P213, DOI 10.1016/S0167-8760(03)00168-5; Del Percio C, 2007, NEUROIMAGE, V36, P822, DOI 10.1016/j.neuroimage.2007.02.054; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Frevel MAE, 2012, FOOD CHEM TOXICOL, V50, P4316, DOI 10.1016/j.fct.2012.08.051; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Helmich I, 2016, MED SCI SPORT EXER, V48, P2362, DOI 10.1249/MSS.0000000000001028; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lorist MM, 2009, BRAIN RES, V1270, P95, DOI 10.1016/j.brainres.2009.03.015; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Makeig S, 1995, NEUROREPORT, V7, P213, DOI 10.1097/00001756-199512000-00051; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Slobounov SM, 2000, COGNITIVE BRAIN RES, V9, P287, DOI 10.1016/S0926-6410(00)00009-4; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith ME, 1999, COGNITIVE BRAIN RES, V7, P389, DOI 10.1016/S0926-6410(98)00043-3; Spencer JPE, 2010, P NUTR SOC, V69, P244, DOI 10.1017/S0029665110000054; Theadom A, 2013, EUR J NEUROL, V20, P1135, DOI 10.1111/ene.12099; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wascher E, 2014, BIOL PSYCHOL, V96, P57, DOI 10.1016/j.biopsycho.2013.11.010; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wood JE, 2002, FOOD CHEM, V77, P155, DOI 10.1016/S0308-8146(01)00329-6	42	5	5	1	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	FEB	2017	42	2			SI		93	103		10.1080/87565641.2016.1256404			11	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	ET6JJ	WOS:000400397500005	28452602				2022-02-06	
J	Zou, RY; Li, D; Wang, G; Zhang, M; Zhao, YL; Yang, ZY				Zou, Ruyi; Li, Da; Wang, Gang; Zhang, Mo; Zhao, Yili; Yang, Zeyu			TAZ Activator Is Involved in IL-10-Mediated Muscle Responses in an Animal Model of Traumatic Brain Injury	INFLAMMATION			English	Article						traumatic brain injury; muscle responses; interleukin-10; macrophage	HIPPO SIGNALING PATHWAY; CELL-BASED ASSAY; MYOGENIC DIFFERENTIATION; C2C12 CELLS; REGENERATION; CANCER; PROLIFERATION; COMPOUND; ENHANCE; REPAIR	The transcriptional coactivator with PDZ-binding motif (TAZ) functions as a downstream regulatory target in the Hippo signaling pathway that plays various roles. We previously developed a cell-based assay and identified the TAZ activator IBS008738 as a potential therapeutic target for glucocorticoid-induced atrophy. To further explore the application of IBS008738 in various muscle-related diseases, we examined the function of IBS008738 in inflammatory cytokine-mediated mouse muscle responses after traumatic brain injury (TBI). Preliminary screening suggested that IBS008738 treatments increased the levels of IL-10 in C2C12 cells. In TBI and sham control mice, we compared the effect of IBS008738 treatments on TNF alpha, IL-6, and IL-10 mRNA levels, muscle morphologic changes, and macrophage phenotype changes. Our findings support that the TAZ activator IBS008738 decreases muscle wasting by upregulating IL-10 and inhibiting TNF alpha and IL-6, and this process is implemented by changing the macrophage phenotypes. These results indicate a new mechanism of the TAZ activator as a potential therapy for atrophy.	[Zou, Ruyi] Benxi Iron & Steel CO LTD, Gen Hosp, Dept Neurosurg, Benxi 117000, Peoples R China; [Li, Da] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang 110004, Peoples R China; [Wang, Gang] China Med Univ, Shengjing Hosp, Dept Emergency Med, Shenyang 110004, Peoples R China; [Zhang, Mo] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang 110004, Peoples R China; [Zhao, Yili] Eastern Virginia Med Sch, Dept Obstet & Gynecol, Norfolk, VA 23507 USA; [Yang, Zeyu] China Med Univ, Shengjing Hosp, Dept Ultrasound, 36 Sanhao St, Shenyang 110004, Peoples R China		Yang, ZY (corresponding author), China Med Univ, Shengjing Hosp, Dept Ultrasound, 36 Sanhao St, Shenyang 110004, Peoples R China.	yangzy1@sj-hospital.org			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401143]	We are grateful for Hata Yutaka (Tokyo Medical and Dental University) for materials and advice. This study was supported by Grant from the National Natural Science Foundation of China (No. 81401143).	Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; Bencze M, 2012, MOL THER, V20, P2168, DOI 10.1038/mt.2012.189; Carey Alison J, 2012, JAKSTAT, V1, P159, DOI 10.4161/jkst.19918; Cisterna BA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00405; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Ehmer U, 2016, MOL CANCER RES, V14, P127, DOI 10.1158/1541-7786.MCR-15-0305; Gabriel BM, 2016, J APPL PHYSIOL, V120, P1105, DOI 10.1152/japplphysiol.01076.2015; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Jang EJ, 2012, BRIT J PHARMACOL, V165, P1584, DOI 10.1111/j.1476-5381.2011.01664.x; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kawano S, 2015, J BIOCHEM, V158, P413, DOI 10.1093/jb/mvv051; Kodaka M, 2015, EXP CELL RES, V336, P171, DOI 10.1016/j.yexcr.2015.06.015; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Meador BM, 2008, J APPL PHYSIOL, V104, P991, DOI 10.1152/japplphysiol.01079.2007; Nitahara-Kasahara Y, 2014, HUM MOL GENET, V23, P3990, DOI 10.1093/hmg/ddu113; Palus S, 2014, INT J CARDIOL, V176, P640, DOI 10.1016/j.ijcard.2014.08.086; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park GH, 2014, BRIT J PHARMACOL, V171, P4051, DOI 10.1111/bph.12755; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zoranovic Tamara, 2013, JAKSTAT, V2, pe25408, DOI 10.4161/jkst.25408	25	5	6	2	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	FEB	2017	40	1					100	105		10.1007/s10753-016-0457-5			6	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	EK0ZL	WOS:000393655500010	27718096				2022-02-06	
J	Meehan, SK; Mirdamadi, JL; Martini, DN; Broglio, SP				Meehan, Sean K.; Mirdamadi, Jasmine L.; Martini, Douglas N.; Broglio, Steven P.			Changes in Cortical Plasticity in Relation to a History of Concussion during Adolescence	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						concussion; mild traumatic brain injury; plasticity; neurophysiology; transcranial magnetic stimulation; intracortical facilitation; short-intracortical inhibition	TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; THETA-BURST-STIMULATION; PROFESSIONAL FOOTBALL PLAYERS; PRIMARY MOTOR CORTEX; SPORTS CONCUSSION; NEUROCOGNITIVE PERFORMANCE; INTRACORTICAL INHIBITION; RECURRENT CONCUSSION; HEAD-INJURY	Adolescence and early adulthood is a critical period for neurophysiological development potentially characterized by an increased susceptibility to the long-term effects of traumatic brain injury. The current study investigated differences in motor cortical physiology and neuroplastic potential across a cohort of young adults with adolescent concussion history and those without. Transcranial magnetic stimulation (TMS) was used to assess motor evoked potential (MEP) amplitude, short-interval cortical inhibition (SICI) and intracortical facilitation (ICF) before and after intermittent theta burst stimulation (iTBS). Pre-iTBS, MEP amplitude, but not SICI or ICF, was greater in the concussion history group. Post-iTBS, the expected increase in MEP amplitude and ICF was tempered in the concussion history group. Change in SICI was variable within the concussion history group. Post hoc assessment revealed that SICI was significantly lower in individuals whose concussion was not diagnosed at the time of injury compared to both those without a concussion history or whose concussion was medically diagnosed. Concussive impacts during adolescence appear to result in a persistent reduction of the ability to modulate facilitatory motor networks. Failure to report/identify concussive impacts close to injury during adolescence also appears to produce persistent change in inhibitory networks. These findings highlight the potential long-term impact of adolescent concussion upon motor cortical physiology.	[Meehan, Sean K.; Mirdamadi, Jasmine L.; Martini, Douglas N.; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Meehan, SK (corresponding author), Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA.	skmeehan@umich.edu	Meehan, Sean K/N-6237-2018	Meehan, Sean K/0000-0002-9848-8803	University of Michigan Injury Center [CE002099]; KL2 Scholar award from the Claude D. Pepper Older Americans Independence Center at the University of Michigan [P30AG024824]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE002099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024824] Funding Source: NIH RePORTER	This work was funded through the University of Michigan Injury Center (#CE002099). SKM was supported by a KL2 Scholar award from the Claude D. Pepper Older Americans Independence Center at the University of Michigan (P30AG024824). JLM is currently a doctoral student in the Department of Kinesiology at Indiana University-Bloomington. DNM is currently a post-doctoral fellow in the Neurology Department at the Oregon Health and Science University.	Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Bernard JA, 2012, NEUROBIOL AGING, V33, P1890, DOI 10.1016/j.neurobiolaging.2011.06.021; Brodie SM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00143; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Coxon JP, 2014, J NEUROPHYSIOL, V112, P156, DOI 10.1152/jn.00893.2013; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Fuhrmann D, 2015, TRENDS COGN SCI, V19, P558, DOI 10.1016/j.tics.2015.07.008; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Heise KF, 2013, J NEUROSCI, V33, P9039, DOI 10.1523/JNEUROSCI.4094-12.2013; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Lefebvre G, 2015, BRAIN INJURY, V29, P1032, DOI 10.3109/02699052.2015.1028447; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan SK, 2011, NEUROSCI LETT, V500, P26, DOI 10.1016/j.neulet.2011.05.237; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Murase N, 2015, BRAIN STIMUL, V8, P105, DOI 10.1016/j.brs.2014.09.010; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Tremblay S, 2015, RESTOR NEUROL NEUROS, V33, P611, DOI 10.3233/RNN-140459; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	60	5	5	0	29	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JAN 17	2017	11								5	10.3389/fnhum.2017.00005			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	EH8IM	WOS:000392015400001	28144218	Green Published, gold			2022-02-06	
J	Liu, PC; Cai, M				Liu, Pengcheng; Cai, Ming			Leptin Influences Healing in the Sprague Dawley Rat Fracture Model	MEDICAL SCIENCE MONITOR			English	Article						Femur; Fracture Healing; Leptin; Rats, Sprague-Dawley	BONE-MINERAL DENSITY; TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; SPINAL-CORD-INJURY; ENDOCHONDRAL OSSIFICATION; SERUM LEPTIN; REPAIR; TIBIA; MICE; DIFFERENTIATION	Background: Leptin plays a crucial role in bone metabolism, and its level is related to bone callus formation in the fracture repair process. The objective of this study was to evaluate the effect of recombinant leptin on the healing process of femoral fractures in rats. Material/Methods: Forty-eight male Sprague Dawley (SD) rats with an average body weight of 389 g (range: 376-398 g) and an average age of 10 weeks were included in this animal research, and all rats were randomly divided into two major groups. Then standardized femur fracture models were implemented in all SD rats. Rats in the control group were treated with only 0.5 mL of physiological saline, and rats in the experimental group were treated with recombinant leptin 5 mu g/kg/d along with the same 0.5 mL of physiological saline for 42 days intraperitoneally. At the same time, each major group was evenly divided into three parallel subgroups for each parallel bone evaluation separately at the second, fourth, and sixth weeks. Each subgroup included eight rats. Results: The total radiological evaluation results showed that the healing progress of femoral fracture in the experimental group was superior to that in the control group from the fourth week. At the sixth week, experimental group rats began to present significantly better femoral fracture healing progress than that of the control group rats. Results of biomechanics show the ultimate load (N) and deflection ultimate load (mm) of the experimental group rats was significantly increased compared with that of the control group rats from the fourth week. Conclusions: Our results suggest that leptin may have a positive effect on SD rat femur fracture healing.	[Liu, Pengcheng; Cai, Ming] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Orthoped, Shanghai, Peoples R China		Cai, M (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Orthoped, Shanghai, Peoples R China.	orthopedics_dsyy@163.com			Natural Science Foundation of Shanghai, ChinaNatural Science Foundation of Shanghai [14ZR1432600]	This work was supported by the Natural Science Foundation of Shanghai, China (grant no. 14ZR1432600)	Akkaya S, 2012, EKLEM HAST CERRAHISI, V23, P44; Aydin K, 2011, EKLEM HAST CERRAHISI, V22, P160; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; Beil FT, 2011, J TRAUMA, V70, P857, DOI 10.1097/TA.0b013e3181de3dd9; Bertoni L, 2009, J ANAT, V215, P577, DOI 10.1111/j.1469-7580.2009.01134.x; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Cebesoy O, 2007, JOINT BONE SPINE, V74, P590, DOI 10.1016/j.jbspin.2007.01.034; Chen XX, 2015, J BONE MINER METAB, V33, P474, DOI 10.1007/s00774-014-0569-7; Cornish J, 2002, J ENDOCRINOL, V175, P405, DOI 10.1677/joe.0.1750405; Dimitri P, 2015, J CLIN ENDOCR METAB, V100, P594, DOI 10.1210/jc.2014-3199; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Kerimoglu G, 2013, EKLEM HAST CERRAHISI, V24, P102, DOI 10.5606/ehc.2013.23; Kerimoglu S, 2009, J SURG RES, V152, P281, DOI 10.1016/j.jss.2008.02.028; Khan SN, 2013, J ORTHOP TRAUMA, V27, P656, DOI 10.1097/BOT.0b013e3182847968; Kishida Y, 2005, BONE, V37, P607, DOI 10.1016/j.bone.2005.05.009; Kume K, 2002, J HISTOCHEM CYTOCHEM, V50, P159, DOI 10.1177/002215540205000204; LANE JM, 1987, ORTHOP CLIN N AM, V18, P213; Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870; Liu K, 2015, CLIN CHIM ACTA, V444, P260, DOI 10.1016/j.cca.2015.02.040; Oheim R, 2012, J TRAUMA ACUTE CARE, V72, P720, DOI 10.1097/TA.0b013e318238b3bd; Pogoda P, 2006, J BONE MINER RES, V21, P1591, DOI 10.1359/JBMR.060709; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Roszer T, 2014, CELL TISSUE RES, V356, P195, DOI 10.1007/s00441-013-1768-6; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Wang L, 2015, BOSNIAN J BASIC MED, V15, P69, DOI 10.17305/bjbms.2015.693; Wang L, 2011, J SPINAL CORD MED, V34, P501, DOI 10.1179/2045772311Y.0000000034; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Yamauchi M, 2001, CLIN ENDOCRINOL, V55, P341, DOI 10.1046/j.1365-2265.2001.01361.x; Yan H, 2013, NEUROL RES, V35, P537, DOI 10.1179/1743132813Y.0000000201; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng BY, 2015, CELL TISSUE RES, V361, P845, DOI 10.1007/s00441-015-2167-y; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	37	5	5	0	10	INT SCIENTIFIC LITERATURE, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JAN 15	2017	23						258	265		10.12659/MSM.899259			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EH7WZ	WOS:000391984600002	28088810	Green Published			2022-02-06	
J	Toyinbo, PA; Vanderploeg, RD; Belanger, HG; Spehar, AM; Lapcevic, WA; Scott, SG				Toyinbo, Peter A.; Vanderploeg, Rodney D.; Belanger, Heather G.; Spehar, Andrea M.; Lapcevic, William A.; Scott, Steven G.			A Systems Science Approach to Understanding Polytrauma and Blast-Related Injury: Bayesian Network Model of Data From a Survey of the Florida National Guard	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						Bayesian network; blast injuries; concussion; mild traumatic brain injury; military; postconcussion syndrome; posttraumatic stress disorder; traumatic brain injury	GRAPHICAL MODELS; KNOWLEDGE; DISORDER; SOLDIERS	We sought to further define the epidemiology of the complex, multiple injuries collectively known as polytrauma/ blast-related injury (PT/BRI). Using a systems science approach, we performed Bayesian network modeling to find the most accurate representation of the complex system of PT/BRI and identify key variables for understanding the subsequent effects of blast exposure in a sample of Florida National Guard members (1,443 deployed to Operation Enduring Freedom/Operation Iraqi Freedom and 1,655 not deployed) who completed an online survey during the period from 2009 to 2010. We found that postdeployment symptoms reported as present at the time of the survey were largely independent of deployment per se. Blast exposure, not mild traumatic brain injury (TBI), acted as the primary military deployment-related driver of PT/BRI symptoms. Blast exposure was indirectly linked to mild TBI via other deployment-related traumas and was a significant risk for a high level of posttraumatic stress disorder (PTSD) arousal symptoms. PTSD arousal symptoms and tinnitus were directly dependent upon blast exposure, with both acting as bridge symptoms to other postdeployment mental health and physical symptoms, respectively. Neurobehavioral or postconcussion-like symptoms had no significant dependence relationship with mild TBI, but they were synergistic with blast exposure in influencing PTSD arousal symptoms. A replication of this analysis using a larger PT/BRI database is warranted.	[Toyinbo, Peter A.; Vanderploeg, Rodney D.; Belanger, Heather G.; Spehar, Andrea M.; Lapcevic, William A.; Scott, Steven G.] James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res, Hlth Serv Res & Dev, 8900 Grand Oak Circle, Tampa, FL 33637 USA; [Toyinbo, Peter A.] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley Vet Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.; Scott, Steven G.] US Dept Def & Vet Affairs, Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Scott, Steven G.] James A Haley Vet Hosp, Dept Phys Med & Rehabil, Tampa, FL USA; [Scott, Steven G.] Univ S Florida, Coll Med, Dept Neurol, Tampa, FL USA		Toyinbo, PA (corresponding author), James A Haley Vet Hosp, Ctr Innovat Disabil & Rehabil Res, Hlth Serv Res & Dev, 8900 Grand Oak Circle, Tampa, FL 33637 USA.	Peter.toyinbo@va.gov		Toyinbo, Peter/0000-0003-3387-3943	Department of Veterans Affairs, Veterans Health AdministrationUS Department of Veterans Affairs; Veterans Administration Health Services Research and Development [CCN 06-164]; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	This material is the result of work supported by the Department of Veterans Affairs, Veterans Health Administration, and Veterans Administration Health Services Research and Development (grant CCN 06-164 to S.G.S.). Further support was provided by the James A. Haley Veterans' Hospital.	Andersen S. K., 1989, IJCAI-89 Proceedings of the Eleventh International Joint Conference on Artificial Intelligence, P1080; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bouckaert R.R., 1995, BAYESIAN BELIEF NETW; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Broom BM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S10; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Claeskens G., 2008, MODEL SELECTION MODE; Committee on Gulf War and Health: Long-Term Effects of Blast Exposures Institute of Medicine, 2014, GULF WAR HLTH, V9; Conchita J, 2011, AM COMMUNITY SURVEY; Donald MR, 2014, AUST NZ J STAT, V56, P407, DOI 10.1111/anzs.12095; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Fenton N., 2012, RISK ASSESSMENT DECI; Friedman N, 2013, ARXIV13016695CSSTAT; Gronewold A, 2008, EPIDEMIOLOGY, V19, pS228; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hojsgaard S, 2012, USE R, P1, DOI 10.1007/978-1-4614-2299-0; Flores MJ, 2011, ARTIF INTELL MED, V53, P181, DOI 10.1016/j.artmed.2011.08.004; Kalisch M, 2012, J STAT SOFTW, V47, P1; KORB K, 2011, BAYESIAN ARTIFICIAL; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lewis FI, 2012, AM J EPIDEMIOL, V176, P1051, DOI 10.1093/aje/kws183; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Mancini F, 2011, METHOD INFORM MED, V50, P349, DOI 10.3414/ME09-01-0039; Nagarajan R, 2013, BAYESIAN NETWORKS R; Onisko A, 2013, ARTIF INTELL MED, V57, P197, DOI 10.1016/j.artmed.2013.01.004; Pourret O., 2008, BAYESIAN NETWORKS PR; R Core Team, 2014, R LANG ENV STAT COMP; Scutari M, 2013, ARTIF INTELL MED, V57, P207, DOI 10.1016/j.artmed.2012.12.006; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Twardy C.R., 2006, ELECT J HLTH INF, V1, P1; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Walsh MG, 2009, AM J EPIDEMIOL, V169, P150, DOI 10.1093/aje/kwn378; Wang KJ, 2014, COMPUT BIOL MED, V47, P147, DOI 10.1016/j.compbiomed.2014.02.002	35	5	5	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JAN 15	2017	185	2					135	146		10.1093/aje/kww074			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EP2WM	WOS:000397244300007	27986702	hybrid			2022-02-06	
S	Allen, CF; Shaw, PJ; Ferraiuolo, L		ElKhamisy, S		Allen, Chloe F.; Shaw, Pamela J.; Ferraiuolo, Laura			Can Astrocytes Be a Target for Precision Medicine?	PERSONALISED MEDICINE: LESSONS FROM NEURODEGENERATION TO CANCER	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Astrocytes; Neurodegeneration; Inflammation; Non-cell autonomous mechanism; Biomarkers; Transcriptomic analysis; High-throughput screening; Precision medicine	AMYOTROPHIC-LATERAL-SCLEROSIS; PLURIPOTENT STEM-CELLS; MOTOR-NEURON DEATH; LEVODOPA-INDUCED DYSKINESIA; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; DIRECT CONVERSION; NEURODEGENERATIVE DISEASES; GLUCOCEREBROSIDASE GENE	Astrocytes are the most abundant non-neural cell type residing within the central nervous system (CNS) displaying tremendous heterogeneity depending on their location. Once believed to be 'passive support cells for electrically active neurons', astrocytes are now recognised to play an active role in brain homeostasis by forming connections with the surrounding neurons, microglia and endothelial cells. Most importantly, they provide an optimum microenvironment for functional neurons through regulation of the blood brain barrier, energy supply and removal of debris and toxic waste. Their dysfunction has been identified as a potential contributing factor for several neurodegenerative disorders, from Alzheimer's Disease to Amyotrophic Lateral Sclerosis. In this chapter, we will explore the implications of astrocyte dysfunction in neurodegenerative diseases and how these cells can be used as therapeutic targets in precision medicine.	[Allen, Chloe F.; Shaw, Pamela J.; Ferraiuolo, Laura] Univ Sheffield, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield S10 2HQ, S Yorkshire, England		Ferraiuolo, L (corresponding author), Univ Sheffield, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield S10 2HQ, S Yorkshire, England.	l.ferraiuolo@Sheffield.ac.uk	Ferraiuolo, Laura/E-5834-2010	Ferraiuolo, Laura/0000-0001-9118-5714; Shaw, Pamela/0000-0002-8925-2567	Parkinson&apos;s UKParkinson&apos;s UK [K-1506] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [1812144] Funding Source: UKRI; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [SBF002\\1142] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [1812144] Funding Source: researchfish; Parkinson&quot;s UKParkinson&apos;s UK [K-1506] Funding Source: researchfish		Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abou-Gharbia M, 2014, J MED CHEM, V57, P5525, DOI 10.1021/jm401564r; Al-Ali H, 2015, ACS CHEM BIOL, V10, P1939, DOI 10.1021/acschembio.5b00289; Anderl JL, 2009, JOVE-J VIS EXP, V27, P1; Aronica E, 2015, NEUROBIOL DIS, V74, P359, DOI 10.1016/j.nbd.2014.12.002; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Baker DJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00410; Biswas S, 2016, CLIN ONCOL-UK, V28, P73, DOI 10.1016/j.clon.2015.11.001; Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002; Bolognesi ML, 2016, J MED CHEM, V59, P7759, DOI 10.1021/acs.jmedchem.6b00151; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bucchia M, 2015, CLIN THER, V37, P668, DOI 10.1016/j.clinthera.2014.12.020; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cacabelos Ramon, 2007, Neuropsychiatr Dis Treat, V3, P303; Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002; Chandrasekaran A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00215; Chestkov IV, 2014, ACTA NATURAE, V6, P54, DOI 10.32607/20758251-2014-6-1-54-60; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Chiurchiu V, 2014, ATHEROSCLEROSIS, V233, P55, DOI 10.1016/j.atherosclerosis.2013.12.042; Clark LN, 2007, NEUROLOGY, V69, P1270, DOI 10.1212/01.wnl.0000276989.17578.02; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Collins CD, 2006, VASC PHARMACOL, V45, P258, DOI 10.1016/j.vph.2006.08.003; Cruz NF, 2010, ASN NEURO, V2, DOI 10.1042/AN20100017; Das MM, 2016, EXP NEUROL, V280, P41, DOI 10.1016/j.expneurol.2016.03.023; Davies SJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017328; del Barrio L, 2011, TOXICOL SCI, V123, P193, DOI 10.1093/toxsci/kfr163; Denk J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126423; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dong L, 2014, INT J ONCOL, V45, P746, DOI 10.3892/ijo.2014.2459; Dosay-Akbulut M., 2016, International Journal of Biology, V8, P32; Drozdzik M, 2013, CURR GENOMICS, V14, P568, DOI 10.2174/1389202914666131210212521; Efremova L, 2015, BRIT J PHARMACOL, V172, P4119, DOI 10.1111/bph.13193; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Emdad L, 2012, STEM CELLS DEV, V21, P404, DOI 10.1089/scd.2010.0560; Erdo F, 2017, J CEREBR BLOOD F MET, V37, P4, DOI 10.1177/0271678X16679420; Ferraiuolo L, 2016, P NATL ACAD SCI USA, V113, pE6496, DOI 10.1073/pnas.1607496113; Ferraiuolo L, 2011, BRAIN, V134, P2627, DOI 10.1093/brain/awr193; Foltynie T, 2009, J NEUROL NEUROSUR PS, V80, P141, DOI 10.1136/jnnp.2008.154294; Frakes AE, 2017, ANN CLIN TRANSL NEUR, V4, P76, DOI 10.1002/acn3.375; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Frangogiannis NG, 2012, TRANSL RES, V159, P197, DOI 10.1016/j.trsl.2012.01.023; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Gimsa U, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/320519; Glajch KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164103; Gotovac K, 2014, MOL DIAGN THER, V18, P17, DOI 10.1007/s40291-013-0058-z; Guillot F, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0348-y; Gulyas B, 2011, NEUROCHEM INT, V58, P60, DOI 10.1016/j.neuint.2010.10.013; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Halliday MR, 2016, J CEREBR BLOOD F MET, V36, P216, DOI 10.1038/jcbfm.2015.44; Harada R, 2016, J NUCL MED, V57, P208, DOI 10.2967/jnumed.115.164848; Harrison JF, 2007, GLIA, V55, P1416, DOI 10.1002/glia.20556; Heales SJR, 2004, NEUROCHEM RES, V29, P513, DOI 10.1023/B:NERE.0000014822.69384.0f; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Isobe T, 2015, STEM CELL RES, V15, P459, DOI 10.1016/j.scr.2015.09.006; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Juric DM, 2016, PHARMACOL RES, V111, P774, DOI 10.1016/j.phrs.2016.07.035; Khoo SK, 2012, J PARKINSON DIS, V2, P321, DOI 10.3233/JPD-012144; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kondo T, 2014, STEM CELL REP, V3, P242, DOI 10.1016/j.stemcr.2014.05.017; Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lashley T, 2015, NEUROPATH APPL NEURO, V41, P858, DOI 10.1111/nan.12250; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Li WZ, 2016, J NEUROIMMUNE PHARM, V11, P484, DOI 10.1007/s11481-016-9686-5; Limpert AS, 2013, BEILSTEIN J ORG CHEM, V9, P717, DOI 10.3762/bjoc.9.82; Lin JJ, 2007, J NEUROL SCI, V252, P130, DOI 10.1016/j.jns.2006.10.018; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; Lorenz C, 2017, CELL STEM CELL, V20, P659, DOI 10.1016/j.stem.2016.12.013; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Mason NS, 2013, J LABELLED COMPD RAD, V56, P89, DOI 10.1002/jlcr.2989; McGivern JV, 2014, ADV DRUG DELIVER REV, V69, P170, DOI 10.1016/j.addr.2013.11.012; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Molchadski I, 2011, ACTA NEUROL SCAND, V123, P117, DOI 10.1111/j.1600-0404.2010.01352.x; Nizzardo M, 2016, HUM MOL GENET, V25, P3152, DOI 10.1093/hmg/ddw163; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Parisi C, 2016, CELL DEATH DIFFER, V23, P531, DOI 10.1038/cdd.2015.153; Parpura V, 2012, CROAT MED J, V53, P518, DOI 10.3325/cmj.2012.53.518; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Philips T, 2014, EXP NEUROL, V262, P111, DOI 10.1016/j.expneurol.2014.05.015; Poutiainen P, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00085; Proschel C, 2014, EMBO MOL MED, V6, P504, DOI 10.1002/emmm.201302878; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rinaldi F, 2017, MOL CELL NEUROSCI, V80, P180, DOI 10.1016/j.mcn.2016.12.001; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Schitine C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00076; Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110; Shepheard SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087398; Shichinohe H, 2004, BRAIN RES, V1029, P200, DOI 10.1016/j.brainres.2004.09.055; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Simpson JE, 2011, NEUROBIOL AGING, V32, P1795, DOI 10.1016/j.neurobiolaging.2011.04.013; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Strong JA, 2006, MOVEMENT DISORD, V21, P654, DOI 10.1002/mds.20785; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan RH, 2015, BRAIN, V138, P3110, DOI 10.1093/brain/awv220; Terrasso AP, 2017, J PHARMACOL TOX MET, V83, P72, DOI 10.1016/j.vascn.2016.10.001; Turkman N, 2011, BIOORGAN MED CHEM, V19, P5698, DOI 10.1016/j.bmc.2011.07.062; Vandeputte C, 2011, J NUCL MED, V52, P1102, DOI 10.2967/jnumed.110.084426; Veitinger M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-65; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2; Villemagne VL, 2014, EUR J NUCL MED MOL I, V41, P816, DOI 10.1007/s00259-013-2681-7; Waller R, 2016, J NEUROIMMUNOL, V299, P139, DOI 10.1016/j.jneuroim.2016.09.010; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang H, 2014, TRENDS ENDOCRIN MET, V25, P8, DOI 10.1016/j.tem.2013.10.003; Wang MH, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0355-3; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061; Yeh CY, 2011, ASN NEURO, V3, DOI 10.1042/AN20110025; Zhao YH, 2014, MOL NEUROBIOL, V50, P97, DOI 10.1007/s12035-013-8595-3; Zou ZY, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2016.01.16	125	5	6	1	6	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-319-60733-7; 978-3-319-60731-3	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2017	1007						111	128		10.1007/978-3-319-60733-7_7	10.1007/978-3-319-60733-7		18	Biochemistry & Molecular Biology; Genetics & Heredity; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity; Research & Experimental Medicine	BK4ZD	WOS:000437927100008	28840555	Green Accepted			2022-02-06	
J	Anderson, LB; Jaroh, R; Smith, H; Strong, CAH; Donders, J				Anderson, Luke B.; Jaroh, Rebekah; Smith, Hillary; Strong, Carrie-Ann H.; Donders, Jacobus			Criterion validity of the D-KEFS color-word and verbal fluency switching paradigms following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Classification accuracy; clinical utility; criterion validity executive functioning; neuropsychological assessment; traumatic brain injury	EXECUTIVE FUNCTION; OLDER-ADULTS; COGNITIVE DECLINE; INTERFERENCE TEST; FRONTAL LOBES; INHIBITION; SYSTEM	The present study was composed of two parts examining the clinical utility of the Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency and Color-Word subtests in traumatic brain injury (TBI). In the first part, the performance of 128 outpatients with mild to severe TBI on the Verbal Fluency and Color-Word subtests was examined in relation to two primary indicators of TBI severity: length of coma and the presence of intracranial lesions on neuroimaging through regression analysis. After controlling for education, ethnicity, and complicating premorbid and comorbid factors, length of coma predicted performance on the Color-Word Inhibition/Switching subtest, whereas the presence of diffuse lesions was related to Verbal Fluency Category Switching performance. In the second part of this study, performance on the Category Switching and Inhibition/Switching subtests was compared between a group of 28 participants with moderate-to-severe TBI and demographically matched groups with mild-uncomplicated TBI (n=28) and neurologically healthy control participants (n=56). The moderate-to-severe TBI group performed significantly worse on both subtests than the mild-uncomplicated TBI and control groups, and the latter groups did not differ from each other on these subtests. Logistic regression analysis showed that the combined group classification accuracy of these subtests was 66.07%, with an area under the curve (AUC) of .70 and a likelihood ratio of 1.93. The findings provide modest support for the clinical utility of the Color-Word Inhibition/Switching subtest in the cognitive assessment of TBI, while also replicating prior research suggesting clinical utility of the Category Switching subtest in this population.	[Anderson, Luke B.; Strong, Carrie-Ann H.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [Jaroh, Rebekah] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA; [Smith, Hillary] Hope Coll, Dept Psychol, Holland, MI 49423 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com			Campbell Foundation [MFBJD2016]; Mary Free Bed Guild Fund [191]	This work was supported by the Campbell Foundation [grant number MFBJD2016]; and the Mary Free Bed Guild Fund [grant number 191].	Adolfsdottir S, 2014, NEUROPSYCHOLOGY, V28, P859, DOI 10.1037/neu0000082; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson P. J., 2008, EXECUTIVE FUNCTIONS, P3; Baumeister RF, 2011, HDB SELF REGULATION, P300; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Berg JL, 2016, J CLIN EXP NEUROPSYC, V38, P745, DOI 10.1080/13803395.2016.1161734; Cicerone K. D., 2005, REHABILITATION TRAUM, P71; Clark LR, 2012, J INT NEUROPSYCH SOC, V18, P118, DOI 10.1017/S1355617711001524; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Fine EM, 2008, AM J GERIAT PSYCHIAT, V16, P366, DOI 10.1097/JGP.0b013e3181629957; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Keifer E, 2013, J CLIN EXP NEUROPSYC, V35, P1048, DOI 10.1080/13803395.2013.854319; Lippa SM, 2010, ARCH CLIN NEUROPSYCH, V25, P146, DOI 10.1093/arclin/acq001; Lucas J.A., 2006, CLIN NEUROPSYCHOLOGY, V2nd ed., P351; McDonald S, 2010, STUD NEUROPSYCHOL NE, P471; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Stuss DT, 2006, J INT NEUROPSYCH SOC, V12, P261, DOI 10.1017/S1355617706060358; Tombaugh T.N., 1996, TEST MEMORY MALINGER	22	5	5	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2017	39	9					890	899		10.1080/13803395.2016.1277513			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FH1DM	WOS:000410879900006	28095735				2022-02-06	
J	Arango-Lasprilla, JC; Rivera, D; Trapp, S; Jimenez-Perez, C; Carrillo, CLH; Amador, SP; Vergara-Moragues, E; Rodriguez-Agudelo, Y; Rodriguez-Irizarry, W; de la Cadena, CG; Galvao-Carmona, A; Galarza-del-Angel, J; Espezua, XL; Cabrera, NT; Flor-Caravia, P; Arelis, AA; Schwartzman, MS; Casimiro, RB; Albaladejo-Blazquez, N				Arango-Lasprilla, J. C.; Rivera, D.; Trapp, S.; Jimenez-Perez, C.; Hernandez Carrillo, C. L.; Pohlenz Amador, S.; Vergara-Moragues, E.; Rodriguez-Agudelo, Y.; Rodriguez-Irizarry, W.; Garcia de la Cadena, C.; Galvao-Carmona, A.; Galarza-del-Angel, J.; Llerena Espezua, X.; Torales Cabrera, N.; Flor-Caravia, P.; Aguayo Arelis, A.; Saracostti Schwartzman, M.; Barranco Casimiro, R.; Albaladejo-Blazquez, N.			Symbol Digit Modalities Test: Normative data for Spanish-speaking pediatric population	NEUROREHABILITATION			English	Article						Symbol Digit Modalities Test; neuropsychology; Spanish-speaking populations; pediatric population	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; VISUOSPATIAL SPAN; ADULT-POPULATION; NATIONAL-SURVEY; PROJECT NORMS; VERBAL SPAN; CHILDREN; PERFORMANCE; TRAIL	OBJECTIVE: To generate normative data for the Symbol Digit Modalities Test (SDMT) in Spanish-speaking pediatric populations. METHOD: The sample consisted of 4,373 healthy children from nine countries in Latin America (Chile, Cuba, Ecuador, Guatemala, Honduras, Mexico, Paraguay, Peru, and Puerto Rico) and Spain. Each participant was administered the SDMT as part of a larger neuropsychological battery. SDMT scores were normed using multiple linear regressions and standard deviations of residual values. Age, age(2), sex, and mean level of parental education (MLPE) were included as predictors in the analyses. RESULTS: The final multiple linear regression models showed main effects for age in all countries, such that score increased linearly as a function of age. In addition, age(2) had a significant effect in all countries, except in Honduras and Puerto Rico. Models indicated that children whose parent(s) had a MLPE >12 years of education obtained higher score compared to children whose parent(s) had a MLPE <= 12 years for Chile, Guatemala, Mexico, and Spain. Sex affected SDMT score for Paraguay and Spain. CONCLUSIONS: This is the largest Spanish-speaking pediatric normative study in the world, and it will allow neuropsychologists from these countries to have a more accurate interpretation of the SDMT with pediatric populations.	[Arango-Lasprilla, J. C.] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Arango-Lasprilla, J. C.; Rivera, D.] Cruces Univ Hosp, BioCruces Hlth Res Inst, Baracaldo, Spain; [Trapp, S.] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA; [Jimenez-Perez, C.] Univ Granada, CIMCYC Mind Brain & Behav Res Ctr, Granada, Spain; [Hernandez Carrillo, C. L.] Natl Inst Neurol & Neurosurg INN, Havana, Cuba; [Pohlenz Amador, S.] Univ Nacl Autonoma Honduras, Escuela Ciencias Psicol, Tegucigalpa, Honduras; [Vergara-Moragues, E.] Univ Int Rioja UNIR, Logrono, Spain; [Rodriguez-Agudelo, Y.] Inst Nacl Neurol & Neurocirug, MVS, Ciudad De Mexico, Mexico; [Rodriguez-Irizarry, W.] Univ Interamericana Puerto Rico, Recinto San German, PR USA; [Garcia de la Cadena, C.] Univ Valle Guatemala, Dept Psicol, Guatemala City, Guatemala; [Galvao-Carmona, A.] Univ Loyola Andalucia, Dept Psychol, Seville, Spain; [Galarza-del-Angel, J.] Univ Autonoma Baja California, Fac Ciencias Humanas, Lab Psicofisiol, Mexicali, Baja California, Mexico; [Llerena Espezua, X.] Univ Catolica San Pablo, Arequipa, Peru; [Torales Cabrera, N.] UAA, Asuncion, Paraguay; [Flor-Caravia, P.] Univ Las Amer, Escuela Psicol, Quito, Ecuador; [Aguayo Arelis, A.] Univ Enrique Diaz de Leon, Dept Invest Psicol, Guadalajara, Jalisco, Mexico; [Saracostti Schwartzman, M.] Univ la Frontera, Temuco, Chile; [Barranco Casimiro, R.] Almeria Univ, Res Ctr CERNEP, Almeria, Spain; [Albaladejo-Blazquez, N.] Univ Alicante, Dept Hlth Psychol, Alicante, Spain		Arango-Lasprilla, JC (corresponding author), Ikerbasque, Cruces Univ Hosp, BioCruces Hlth Res Inst, Basque Fdn Sci, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.	jcalasprilla@gmail.com	Natalia, Albaladejo-Blazquez/U-3453-2017; Blanco, Leire/O-5114-2017; Galvao-Carmona, Alejandro/A-1725-2015; Vergara-Moragues, Esperanza/H-9787-2015; Galarza-del-Angel, Javier/AAS-4113-2021; Arango-Lasprilla, Juan Carlos/AAB-5407-2019; aguayo, adriana/L-5255-2019; Rivera, Diego/U-8872-2017	Natalia, Albaladejo-Blazquez/0000-0002-9116-9092; Galvao-Carmona, Alejandro/0000-0002-5126-1273; Vergara-Moragues, Esperanza/0000-0003-2669-631X; Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; aguayo, adriana/0000-0001-6826-8976; Rivera, Diego/0000-0001-7477-1893; Galarza-del-Angel, Javier/0000-0001-5865-5198; Saracostti, Mahia/0000-0002-9673-5727			Amodio P, 2002, AGING CLIN EXP RES, V14, P117, DOI 10.1007/BF03324425; Arango-Lasprilla JC, 2015, NEUROREHABILITATION, V37, P625, DOI 10.3233/NRE-151282; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Benedict RHB, 2008, MULT SCLER J, V14, P940, DOI 10.1177/1352458508090923; Berrigan LI, 2014, CLIN NEUROPSYCHOL, V28, P281, DOI 10.1080/13854046.2013.871337; Bowler R., 1992, CLIN NEUROPSYCHOL, V6, P103, DOI [10.1080/13854049208404123, DOI 10.1080/13854049208404123]; Brown L., 2009, TEST INTELIGENCIA VE; Arango-Lasprilla JC, 2017, APPL NEUROPSYCH-ADUL, V24, P318, DOI 10.1080/23279095.2016.1185423; Charvet LE, 2014, J NEUROL SCI, V341, P79, DOI 10.1016/j.jns.2014.04.006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Drake AS, 2010, MULT SCLER J, V16, P228, DOI 10.1177/1352458509354552; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; GILMORE GC, 1983, J CLIN PSYCHOL, V39, P114, DOI 10.1002/1097-4679(198301)39:1<114::AID-JCLP2270390122>3.0.CO;2-6; Gonzalez HM, 2007, ARCH CLIN NEUROPSYCH, V22, P605, DOI 10.1016/j.acn.2007.04.002; Katz L. J., 2011, ARCH CLIN NEUROPSYCH; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kovacs M., 1992, CHILDRENS DEPRESSION; Kutner M.H., 2005, APPL LINEAR STAT MOD, V5th edn; Lai JS, 2015, EPILEPSY BEHAV, V46, P209, DOI 10.1016/j.yebeh.2015.02.038; Langdon DW, 2012, MULT SCLER J, V18, P891, DOI 10.1177/1352458511431076; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Newman JB, 2013, CLIN NEUROPSYCHOL, V27, P779, DOI 10.1080/13854046.2013.789552; Olabarrieta-Landa L, 2016, CLIN NEUROPSYCHOL, V30, P1335, DOI 10.1080/13854046.2016.1183049; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Portaccio E, 2009, MULT SCLER J, V15, P620, DOI 10.1177/1352458508101950; Richardson ED, 1996, CLIN NEUROPSYCHOL, V10, P375, DOI 10.1080/13854049608406698; Rivera D, 2017, NEUROREHABILITATION, V41, P581, DOI 10.3233/NRE-172275; Rodriguez O. E. Utria, 2015, NEUROPSICOLOGIA COLO, P223; Sands SA, 2012, J CLIN ONCOL, V30, P943, DOI 10.1200/JCO.2011.35.7533; SELNES OA, 1991, PERCEPT MOTOR SKILL, V73, P539, DOI 10.2466/PMS.73.5.539-550; Smerbeck AM, 2011, CLIN NEUROPSYCHOL, V25, P402, DOI 10.1080/13854046.2011.554445; Smith A., 2013, SYMBOL DIGIT MODALIT; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith A, 1968, LEARNING DISORDERS; Smith A., 2002, MANUAL TEST SIMBOLOS; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tamayo F, 2012, NEUROLOGIA, V27, P319, DOI 10.1016/j.nrl.2011.12.020; UCHIYAMA CL, 1994, CLIN NEUROPSYCHOL, V8, P209, DOI 10.1080/13854049408401558; Vogel A, 2013, AGING NEUROPSYCHOL C, V20, P370, DOI 10.1080/13825585.2012.725126; West S. G., 1991, MULTIPLE REGRESSION	41	5	5	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	41	3					639	647		10.3233/NRE-172243			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK5IK	WOS:000413531000007	28946593	Bronze, Green Published			2022-02-06	
J	Armistead-Jehle, P; Lange, BJ; Green, P				Armistead-Jehle, Patrick; Lange, Beth J.; Green, Paul			Comparison of Neuropsychological and Balance Performance Validity Testing	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Computerized dynamic posturography; disability seeking; performance validity testing; symptom exaggeration; word memory test	TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; SYMPTOM VALIDITY; MILITARY SAMPLE; RESPONSE BIAS; POOR EFFORT; BASE RATES; POSTUROGRAPHY; MALINGERERS; FAILURE	Performance validity testing in the context of neuropsychological assessment is well established. While such measures are also available with balance testing, little research has investigated these two domains in concert. The purpose of this study was to compare scores on two measures of performance validity across cognitive and balance modalities. Seventy-eight subjects independently evaluated by a neuropsychologist and an otolaryngologist in the context of disability evaluations were administered the Word Memory Test and Computerized Dynamic Posturography. Results of the measures were significantly correlated (r(phi)=0.35, p=.002) and demonstrated 70.5% agreement. These data suggest that if symptom exaggeration occurs within one modality, other modalities may also be exaggerated and should be independently evaluated.	[Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, 550 Pope Ave, Ft Leavenworth, KS 66027 USA; [Lange, Beth J.] Univ Calgary, Neurovestibular Program, Calgary, AB, Canada		Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, Concuss Clin, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	patrick.j.armistead-jehle.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P415, DOI 10.1080/23279095.2014.953678; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CEVETTE MJ, 1995, OTOLARYNG HEAD NECK, V112, P676, DOI 10.1016/S0194-5998(95)70175-3; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Chafetz MD, 2011, ARCH CLIN NEUROPSYCH, V26, P306, DOI 10.1093/arclin/acr030; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gianoli G, 2000, OTOLARYNG HEAD NECK, V122, P11, DOI 10.1016/S0194-5998(00)70137-9; Goebel JA, 1997, OTOLARYNG HEAD NECK, V117, P293, DOI 10.1016/S0194-5998(97)70116-5; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P, 1996, MANUAL COMPUTERIZED; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kemple G. A., 1998, AM J OTOL, V19, P619; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Monsell EM, 1997, OTOLARYNG HEAD NECK, V117, P394, DOI 10.1016/S0194-5998(97)70132-3; Morgan SS, 2002, OTOL NEUROTOL, V23, P214, DOI 10.1097/00129492-200203000-00018; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; [No title captured]	34	5	5	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	2					190	197		10.1080/23279095.2015.1132219			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	EM1CJ	WOS:000395055400012	27078046				2022-02-06	
J	Bailey, NW; Rogasch, NC; Hoy, KE; Maller, JJ; Segrave, RA; Sullivan, CM; Fitzgerald, PB				Bailey, Neil W.; Rogasch, Nigel C.; Hoy, Kate E.; Maller, Jerome J.; Segrave, Rebecca A.; Sullivan, Caley M.; Fitzgerald, Paul B.			Increased gamma connectivity during working memory retention following traumatic brain injury	BRAIN INJURY			English	Article						Gamma; EEG connectivity; major depression; traumatic brain injury	INDEPENDENT COMPONENT ANALYSIS; CLOSED-HEAD INJURY; FUNCTIONAL CONNECTIVITY; EEG COHERENCE; CORTICAL CONNECTIVITY; MAJOR DEPRESSION; AXONAL INJURY; NETWORKS; SYNCHRONIZATION; IMPAIRMENT	Primary objective: Alterations to functional connectivity following a traumatic brain injury (TBI) may lead to impaired cognitive performance and major depressive disorder (MDD). In particular, functional gamma band connectivity is thought to reflect information binding important for working memory. The objective of this study was to determine whether altered functional gamma connectivity may be a factor in MDD following TBI (TBI-MDD). Research design: This study assessed individuals with TBI-MDD, as well as individuals with TBI alone and MDD alone using electroencephalographic recordings while participants performed a working memory task to assess differences in functional connectivity between these groups. Methods and procedures: Functional connectivity was compared using the debiased weighted phase lag index (wPLI). wPLI was measured from a group of healthy controls (n = 31), participants with MDD (n = 17), participants with TBI (n = 20) and participants with TBI-MDD (n = 15). Main outcomes and results: Contrary to the predictions, this study found both the groups with TBI and TBI-MDD showed higher gamma connectivity from posterior regions during WM retention. Conclusions: This may reflect dysfunctional functional connectivity in these groups, as a result of maladaptive neuroplastic reorganization.	[Bailey, Neil W.; Hoy, Kate E.; Maller, Jerome J.; Segrave, Rebecca A.; Sullivan, Caley M.; Fitzgerald, Paul B.] Monash Univ, Alfred Hosp, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Bailey, Neil W.; Hoy, Kate E.; Maller, Jerome J.; Segrave, Rebecca A.; Sullivan, Caley M.; Fitzgerald, Paul B.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Rogasch, Nigel C.] Monash Univ, Monash Clin & Imaging Neurosci, Sch Psychol Sci, Melbourne, Vic, Australia; [Rogasch, Nigel C.] Monash Univ, Monash Biomed Imaging, Melbourne, Vic, Australia		Bailey, NW (corresponding author), Monash Alfred Psychiat Res Ctr, Level 4,607 St Kilda Rd, Melbourne, Vic 3004, Australia.	neilwbailey@gmail.com	Fitzgerald, Paul B/A-1225-2008; Maller, Jerome J/H-4963-2014; Bailey, Neil/AAB-2741-2021; Segrave, Rebecca/H-4554-2014	Fitzgerald, Paul B/0000-0003-4217-8096; Maller, Jerome J/0000-0003-4685-1508; Rogasch, Nigel/0000-0002-4484-1069; Segrave, Rebecca/0000-0002-1839-0794; Hoy, Kate/0000-0003-0694-9674; Bailey, Neil/0000-0002-8483-1068	Monash UniversityMonash University; Victorian Neurotrauma Initiative; Neurosciences Victoria Clinical Neurobiology of Psychiatry Platform; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; NHMRCNational Health and Medical Research Council of Australia; Cervel Neurotech	Funding for this study was provided by Monash University and the Victorian Neurotrauma Initiative. Equipment funding was provided in part by the Neurosciences Victoria Clinical Neurobiology of Psychiatry Platform. PBF is supported by a Practitioner Fellowship grant from the National Health and Medical Research Council (NHMRC). RAS and NCR are supported by Early Career Fellowships from NHMRC. KEH and JJM are supported by Career Development Fellowships from the NHMRC.; PBF has received equipment for research from Medtronic Ltd, Magventure A/S and Brainsway Ltd and funding for research from Cervel Neurotech. NWB, RAS, KEH, JJM, NCR and CMS report no conflicts of interest.	Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Bailey NW, 2014, BIOL PSYCHOL, V99, P115, DOI 10.1016/j.biopsycho.2014.03.008; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Beck AT., 1979, COGNITIVE THERAPY DE; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fingelkurts AA, 2007, HUM BRAIN MAPP, V28, P247, DOI 10.1002/hbm.20275; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hardmeier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108648; Headway, 2001, HEAD INJ HIDD DIS; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Knott V, 2001, PSYCHIAT RES-NEUROIM, V106, P123, DOI 10.1016/S0925-4927(00)00080-9; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Leuchter AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032508; Locatelli T, 1998, ELECTROEN CLIN NEURO, V106, P229, DOI 10.1016/S0013-4694(97)00129-6; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Mayberg HS., 1998, J NEUROPSYCHIAT, V9, P471; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silberstein RB, 2004, BRAIN TOPOGR, V16, P249; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Thatcher RW, 2007, CLIN EEG NEUROSCI, V38, P35, DOI 10.1177/155005940703800109; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 1989, ELECTROENCEPHALOGRAP, V73, P73; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	61	5	5	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					379	389		10.1080/02699052.2016.1239273			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900015	28095052				2022-02-06	
S	Balofsky, A; George, J; Papadakos, P		Wijdicks, EFM; Kramer, AH		Balofsky, A.; George, J.; Papadakos, P.			Neuropulmonology	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; NEUROGENIC PULMONARY-EDEMA; ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; ANEURYSMAL SUBARACHNOID HEMORRHAGE; VENTILATOR-ASSOCIATED PNEUMONIA; SEVERE HEAD-INJURY; END-EXPIRATORY PRESSURE; EXTRACEREBRAL ORGAN DYSFUNCTION; ABNORMAL BREATHING PATTERNS	Neuropulmonology refers to the complex interconnection between the central nervous system and the respiratory system. Neurologic injury includes traumatic brain injury, hemorrhage, stroke, and seizures, and in each there are far-reaching effects that can result in pulmonary dysfunction. Systemic changes can induce impairment of pulmonary function due to changes in the core structure and function of the lung. The conditions and disorders that often occur in these patients include aspiration pneumonia, neurogenic pulmonary edema, and acute respiratory distress syndrome, but also several abnormal respiratory patterns and sleep-disordered breathing. Lung infections, pulmonary edema - neurogenic or cardiogenic - and pulmonary embolus all are a serious barrier to recovery and can have significant effects on outcomes such as hospital course, prognosis, and mortality. This review presents the spectrum of pulmonary abnormalities seen in neurocritical care.	[Balofsky, A.; Papadakos, P.] Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604, Rochester, NY 14642 USA; [George, J.; Papadakos, P.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Papadakos, P.] Univ Rochester, Med Ctr, Dept Surg, Rochester, NY 14642 USA; [Papadakos, P.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA		Papadakos, P (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, 601 Elmwood Ave,Box 604, Rochester, NY 14642 USA.	Peter_Papadakos@urmc.rochester.edu					Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Bassetti C, 1997, STROKE, V28, P1765, DOI 10.1161/01.STR.28.9.1765; Bassetti CL, 2006, STROKE, V37, P967, DOI 10.1161/01.STR.0000208215.49243.c3; Bateman LM, 2008, BRAIN, V131, P3239, DOI 10.1093/brain/awn277; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Bein T, 2002, INTENS CARE MED, V28, P554, DOI 10.1007/s00134-002-1273-y; Bennett M. H., 2012, COCHRANE DATABASE SY, V12; BERGREN DR, 1975, J TRAUMA, V15, P336, DOI 10.1097/00005373-197504000-00010; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bianchi AL, 2009, RESP PHYSIOL NEUROBI, V168, P4, DOI 10.1016/j.resp.2009.04.019; Blum AS, 2009, J CLIN NEUROPHYSIOL, V26, P309, DOI 10.1097/WNP.0b013e3181b7f14d; Brown LK, 2010, CLIN CHEST MED, V31, P249, DOI 10.1016/j.ccm.2010.03.002; BRUEGGEMANN MW, 1976, J TRAUMA, V16, P16, DOI 10.1097/00005373-197601000-00002; BUISSERET P, 1982, BRIT J DIS CHEST, V76, P194, DOI 10.1016/S0007-0971(82)80059-4; Busl KM, 2015, CRIT CARE MED, V43, P1710, DOI 10.1097/CCM.0000000000001101; Carrera E, 2010, J NEUROL NEUROSUR PS, V81, P793, DOI 10.1136/jnnp.2009.174425; Cecchetti C, 2013, MINERVA ANESTESIOL, V79, P1140; Chang WTW, 2013, NEUROSURG CLIN N AM, V24, P407, DOI 10.1016/j.nec.2013.02.004; Chen GS, 2016, J NEUROTRAUM, V33, P1263, DOI 10.1089/neu.2015.4063; Chen GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/729831; Chen S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/858496; Chen WL, 2016, AM J EMERG MED, V34, P79, DOI 10.1016/j.ajem.2015.09.032; Cherniack NS, 2005, NEUROCRIT CARE, V3, P271, DOI 10.1385/NCC:3:3:271; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; COLICE GL, 1984, AM REV RESPIR DIS, V130, P941; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Coritsidis G, 2015, J CLIN NEUROSCI, V22, P1332, DOI 10.1016/j.jocn.2015.02.025; dos Reis HFC, 2013, J BRAS PNEUMOL, V39, P330, DOI 10.1590/S1806-37132013000300010; CRITTENDEN DJ, 1982, J TRAUMA, V22, P766, DOI 10.1097/00005373-198209000-00008; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; DARNELL JC, 1982, EPILEPSIA, V23, P71, DOI 10.1111/j.1528-1157.1982.tb05054.x; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Davison DL, 2012, CHEST, V141, P793, DOI 10.1378/chest.11-0789; Deak MC, 2014, CLIN CHEST MED, V35, P547, DOI 10.1016/j.ccm.2014.06.009; Devinsky O, 2011, NEW ENGL J MED, V365, P1801, DOI 10.1056/NEJMra1010481; El-Khatib Mohamad F, 2003, Respir Care, V48, P956; Quilez ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10230; Ezeugwu VE, 2013, PHYSIOTHER RES INT, V18, P212, DOI 10.1002/pri.1547; Faraji Rad Elnaz, 2015, Iran J Otorhinolaryngol, V27, P63; Friedman JA, 2003, NEUROSURGERY, V52, P1025, DOI 10.1227/01.NEU.0000058222.59289.F1; FUGLMEYER AR, 1983, SCAND J REHABIL MED, P118; Gandia-Martinez F, 2010, NEUROCIRUGIA, V21, P211; Garcia AJ, 2011, PROG BRAIN RES, V188, P31, DOI 10.1016/B978-0-444-53825-3.00008-5; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Gibson GJ, 2004, THORAX, V59, P361, DOI 10.1136/thx.2003.020040; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; GROMYSZ H, 1980, ACTA NEUROBIOL EXP, V40, P985; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Harbison J, 2002, QJM-INT J MED, V95, P741, DOI 10.1093/qjmed/95.11.741; Hellweg S, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/768456; Hoesch RE, 2012, CRIT CARE MED, V40, P587, DOI 10.1097/CCM.0b013e3182329617; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Howard RS, 2001, POSTGRAD MED J, V77, P700, DOI 10.1136/pmj.77.913.700; HUDGEL DW, 1993, CHEST, V104, P1503, DOI 10.1378/chest.104.5.1503; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Jergovic I, 2010, ACTA MED CROATICA, V64, P29; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Jung KJ, 2014, ANN REHABIL MED-ARM, V38, P29, DOI 10.5535/arm.2014.38.1.29; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kapnadak SG, 2010, NEUROCRIT CARE, V12, P395, DOI 10.1007/s12028-009-9321-x; Karanjia N, 2011, NEUROCRIT CARE, V15, P4, DOI 10.1007/s12028-011-9528-5; Kerwin AJ, 2000, J TRAUMA, V48, P878, DOI 10.1097/00005373-200005000-00011; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Khademi Shadi, 2015, BMC Physiology, V15, P4, DOI 10.1186/s12899-015-0018-4; Khedr EM, 2000, EUR J NEUROL, V7, P323, DOI 10.1046/j.1468-1331.2000.00078.x; Kitamura Y, 2010, NEUROL MED-CHIR, V50, P456, DOI 10.2176/nmc.50.456; KNUDSEN F, 1991, NEUROSURGERY, V29, P269, DOI 10.1227/00006123-199108000-00019; Kocaeli H, 2008, ACTA NEUROCHIR, V150, P1263, DOI 10.1007/s00701-008-0153-9; Koskinen LOD, 2014, NEUROSCIENCE, V283, P245, DOI 10.1016/j.neuroscience.2014.06.039; Koutsoukou Antonia, 2016, World J Crit Care Med, V5, P65, DOI 10.5492/wjccm.v5.i1.65; Kramer AH, 2009, NEUROCRIT CARE, V10, P20, DOI 10.1007/s12028-008-9137-0; Kraus J, 1999, CLIN NEUROL NEUROSUR, V101, P196, DOI 10.1016/S0303-8467(99)00023-2; Krebs J, 2014, CRIT CARE, V18, DOI 10.1186/cc13813; Kuechler JN, 2015, CLIN NEUROL NEUROSUR, V137, P137, DOI 10.1016/j.clineuro.2015.07.007; Kumar S, 2009, INDIAN J CRIT CARE M, V13, P28, DOI 10.4103/0972-5229.53113; Lazaridis C, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.018; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Lo Benjamin W Y, 2015, Surg Neurol Int, V6, P136, DOI 10.4103/2152-7806.162677; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Lopez-Aguilar J, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.02.24; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Lou MQ, 2012, BRAIN INJURY, V26, P887, DOI 10.3109/02699052.2012.660514; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Malhotra A, 2010, RESP CARE, V55, P1168; MALIK AB, 1985, CIRC RES, V57, P1; Marin-Sanabria EA, 2006, J CLIN NEUROSCI, V13, P370, DOI 10.1016/j.jocn.2005.03.038; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Massey CA, 2014, NAT REV NEUROL, V10, P271, DOI 10.1038/nrneurol.2014.64; McHenry MA, 2001, BRAIN INJURY, V15, P741, DOI 10.1080/02699050010013932; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Mendoza M, 2013, NEUROLOGY, V80, pE13, DOI 10.1212/WNL.0b013e31827b9096; Milanchi S, 2008, J TRAUMA, V65, P73, DOI 10.1097/TA.0b013e31814693f2; Mirski MA, 2008, CRIT CARE CLIN, V24, P115, DOI 10.1016/j.ccc.2007.11.005; Molkov YI, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00016; Moris G, 2012, J NEUROL, V259, P966, DOI 10.1007/s00415-011-6260-1; Mrozek Segolene, 2015, World J Crit Care Med, V4, P163, DOI 10.5492/wjccm.v4.i3.163; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Muroi C, 2008, J NEUROSURG ANESTH, V20, P188, DOI 10.1097/ANA.0b013e3181778156; Muzumdar H, 2008, SLEEP MED CLIN, V3, P601, DOI 10.1016/j.jsmc.2008.08.006; Naidech AM, 2009, NEUROCRIT CARE, V11, P177, DOI 10.1007/s12028-009-9223-y; Narotam PK, 2013, CRIT CARE, V17, DOI 10.1186/cc13065; Nemer SN, 2011, J CRIT CARE, V26, P22, DOI 10.1016/j.jcrc.2010.04.015; Nemer SN, 2015, J CRIT CARE, V30, P1263, DOI 10.1016/j.jcrc.2015.07.019; Neto AS, 2015, CRIT CARE MED, V43, P2155, DOI 10.1097/CCM.0000000000001189; Nopmaneejumruslers C, 2005, AM J RESP CRIT CARE, V171, P1048, DOI 10.1164/rccm.200411-1591OC; NORTH JB, 1974, ARCH NEUROL-CHICAGO, V31, P338, DOI 10.1001/archneur.1974.00490410086010; O'Phelan Kristine H, 2015, World J Crit Care Med, V4, P296, DOI 10.5492/wjccm.v4.i4.296; O'Sullivan RJ, 2008, MULT SCLER J, V14, P705, DOI 10.1177/1352458507085802; Ochiai H, 2001, NEUROL MED-CHIR, V41, P529, DOI 10.2176/nmc.41.529; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Olson DM, 2007, NEUROCRIT CARE, V6, P100, DOI 10.1007/s12028-007-0015-y; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; PACHT ER, 1988, J NATL MED ASSOC, V80, P337; Patman S, 2009, INTENS CARE MED, V35, P258, DOI 10.1007/s00134-008-1278-2; Pelosi P, 2005, CURR OPIN CRIT CARE, V11, P37, DOI 10.1097/00075198-200502000-00006; Pelosi P, 2008, CHEST, V134, P101, DOI 10.1378/chest.07-2546; Pelosi P, 2013, CRIT CARE, V17, DOI 10.1186/cc12862; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; PLUM F, 1963, J APPL PHYSIOL, V18, P1139, DOI 10.1152/jappl.1963.18.6.1139; PLUM F, 1959, ARCH NEURO PSYCHIATR, V81, P535, DOI 10.1001/archneurpsyc.1959.02340170001001; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Posner JB, 2007, PLUM POSNERS DIAGNOS, P38; Probasco John C, 2014, J Neurol Transl Neurosci, V2, P1040; Quilez ME, 2012, CURR OPIN CRIT CARE, V18, P23, DOI 10.1097/MCC.0b013e32834ef3ea; Radolf S, 2014, TRANSL STROKE RES, V5, P278, DOI 10.1007/s12975-013-0292-z; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Rincon F, 2014, J INTENSIVE CARE MED, V29, P357, DOI 10.1177/0885066613491919; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Roffe C, 2003, STROKE, V34, P2641, DOI 10.1161/01.STR.0000095188.65567.4F; Rowat AM, 2007, J NEUROL NEUROSUR PS, V78, P277, DOI 10.1136/jnnp.2006.102228; Rowat AM, 2006, CEREBROVASC DIS, V21, P340, DOI 10.1159/000091540; Rybak IA, 2007, PROG BRAIN RES, V165, P201, DOI 10.1016/S0079-6123(06)65013-9; Saito Y, 1999, DEV MED CHILD NEUROL, V41, P560, DOI 10.1017/S0012162299001188; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Sarrafzadeh A, 2011, STROKE, V42, P53, DOI 10.1161/STROKEAHA.110.594705; Satoh E, 2014, J NIPPON MED SCH, V81, P305, DOI 10.1272/jnms.81.305; Schestatsky P, 2004, ARQ NEURO-PSIQUIAT, V62, P523, DOI 10.1590/S0004-282X2004000300027; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schuiling WJ, 2005, NEUROCRIT CARE, V3, P1, DOI 10.1385/NCC:3:1:001; Sedy J, 2008, PHYSIOL RES, V57, P499, DOI 10.33549/physiolres.931432; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; SEXTON JD, 1975, P SOC EXP BIOL MED, V148, P679; Seyal M, 2012, EPILEPSIA, V53, P825, DOI 10.1111/j.1528-1167.2012.03443.x; Seyal M, 2010, EPILEPSIA, V51, P1359, DOI 10.1111/j.1528-1167.2009.02518.x; Siccoli MM, 2008, J NEUROL, V255, P1687, DOI 10.1007/s00415-008-0981-9; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Similowski T, 1996, AM J RESP CRIT CARE, V154, P436, DOI 10.1164/ajrccm.154.2.8756819; Smith JC, 2007, J NEUROPHYSIOL, V98, P3370, DOI 10.1152/jn.00985.2007; Sofi K, 2010, SAUDI J ANAESTH, V4, P2, DOI 10.4103/1658-354X.62606; Solaiman O, 2013, J NEUROSURG ANESTH, V25, P254, DOI 10.1097/ANA.0b013e3182806465; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Stevens RD, 2008, NEUROL CLIN, V26, P543, DOI 10.1016/j.ncl.2008.03.014; Stevens RD, 2007, J NEUROL SCI, V261, P143, DOI 10.1016/j.jns.2007.04.047; Suzuki H, 2011, ACTA NEUROCHIR SUPPL, V111, P129, DOI 10.1007/978-3-7091-0693-8_21; Tarulli AW, 2005, ARCH NEUROL-CHICAGO, V62, P1632, DOI 10.1001/archneur.62.10.1632; TEPLINSKY K, 1986, ARCH INTERN MED, V146, P801, DOI 10.1001/archinte.146.4.801; THEODORE J, 1976, AM REV RESPIR DIS, V113, P405; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; Tsivgoulis G, 2011, STROKE, V42, P1030, DOI 10.1161/STROKEAHA.110.600221; Ulvi H, 2013, ARCH MED SCI, V9, P1125, DOI 10.5114/aoms.2013.39227; van der Jagt Mathieu, 2012, Recent Pat Cardiovasc Drug Discov, V7, P141; Veeravagu A, 2014, WORLD NEUROSURG, V82, pE235, DOI 10.1016/j.wneu.2014.02.030; Vermaelen J, 2015, CRIT CARE CLIN, V31, P551, DOI 10.1016/j.ccc.2015.03.012; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Vespa PM, 2004, NEUROCRIT CARE, V1, P157, DOI 10.1385/NCC:1:2:157; Vrettou CS, 2013, CRIT CARE, V17, DOI 10.1186/cc12815; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; WANG WG, 1993, J APPL PHYSIOL, V74, P2801, DOI 10.1152/jappl.1993.74.6.2801; Wartenberg KE, 2010, NEUROSURG CLIN N AM, V21, P325, DOI 10.1016/j.nec.2009.10.012; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Wijdicks EFM, 2007, J NEUROL NEUROSUR PS, V78, P512, DOI 10.1136/jnnp.2006.104919; Wilken B, 1997, J PEDIATR-US, V130, P89, DOI 10.1016/S0022-3476(97)70315-9; Williamson CA, 2015, NEUROCRIT CARE, V23, P330, DOI 10.1007/s12028-015-0138-5; Winklewski PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0213-4; WOHNS RNW, 1985, CRIT CARE MED, V13, P210, DOI 10.1097/00003246-198503000-00016; Wu MN, 2011, NEUROL SCI, V32, P487, DOI 10.1007/s10072-011-0501-z; Wu S, 2006, EXP NEUROL, V200, P245, DOI 10.1016/j.expneurol.2006.01.027; Yidirim E, 2005, J TRAUMA, V58, P1252, DOI 10.1097/01.TA.0000169803.09482.F8; Yildirim E, 2004, J HEART LUNG TRANSPL, V23, P1423, DOI 10.1016/j.healun.2003.10.006; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; Young NH, 2011, NEUROCRIT CARE, V15, P623, DOI 10.1007/s12028-011-9550-7; Zanata ID, 2014, INT ARCH OTORHINOLAR, V18, P108, DOI 10.1055/s-0033-1363467; Zhang XY, 2011, AM J EMERG MED, V29, P699, DOI 10.1016/j.ajem.2010.01.042; Zhu L, 2007, ANN CLIN LAB SCI, V37, P356; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	194	5	5	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						33	48		10.1016/B978-0-444-63600-3.00003-9			16	Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500005	28187807				2022-02-06	
J	Brett, BL; Solomon, GS				Brett, Benjamin L.; Solomon, Gary S.			The influence of validity criteria on Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) test-retest reliability among high school athletes	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Concussion testing; Neuropsychological testing; Head injuries; Reliable change; Baseline testing; Validity criteria	LINE TEST-PERFORMANCE; CONSTRUCT-VALIDITY; MEMORY; BATTERY; SCORES; PAPER	Objective: Research findings to date on the stability of Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) Composite scores have been inconsistent, requiring further investigation. The use of test validity criteria across these studies also has been inconsistent. Using multiple measures of stability, we examined test-retest reliability of repeated ImPACT baseline assessments in high school athletes across various validity criteria reported in previous studies. Method: A total of 1146 high school athletes completed baseline cognitive testing using the online ImPACT test battery at two time periods of approximately two-year intervals. No participant sustained a concussion between assessments. Five forms of validity criteria used in previous test-retest studies were applied to the data, and differences in reliability were compared. Results: Intraclass correlation coefficients (ICCs) ranged in composite scores from.47 (95% confidence interval, CI [.38, .54]) to .83 (95% CI [.81, .85]) and showed little change across a two-year interval for all five sets of validity criteria. Regression based methods (RBMs) examining the test-retest stability demonstrated a lack of significant change in composite scores across the two-year interval for all forms of validity criteria, with no cases falling outside the expected range of 90% confidence intervals. Conclusion: The application of more stringent validity criteria does not alter test-retest reliability, nor does it account for some of the variation observed across previously performed studies. As such, use of the ImPACT manual validity criteria should be utilized in the determination of test validity and in the individualized approach to concussion management. Potential future efforts to improve test-retest reliability are discussed.	[Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, Memphis, TN 38152 USA; [Brett, Benjamin L.; Solomon, Gary S.] Vanderbilt Sports Concuss Ctr, Nashville, TN USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA		Brett, BL (corresponding author), Univ Memphis, 100 Ball Hall, Memphis, TN 38152 USA.	blbrett@memphis.edu	Solomon, Gary/K-9011-2019				Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Immediate Post- Concussion Assessment and Cognitive Testing (ImPACT), 2012, IMM POSTC ASS TEST I; Isbell E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00696; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; L?ders H., 1993, CLIN NEUROPSYCHOL, V7, P300, DOI DOI 10.1080/13854049308401901; Lovell MR, 2007, IMPACT VERSION 6 0 C; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P69, DOI 10.1080/87565641.2015.1014089; Maril A, 2010, NEUROLOGY, V75, P2110, DOI 10.1212/WNL.0b013e318201526e; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schneider W, 2002, J EDUC PSYCHOL, V94, P751, DOI 10.1037//0022-0663.94.4.751; Spreen E., 2006, COMPENDIUM NEUROPSYC, P1; Thangavel D, 2014, J CLIN DIAGN RES, V8, pBC1, DOI [10.7860/JCDR/2014/7452.4390, 10.7860/JCDR/2014/10727.5080]; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066; Womble MN, 2016, ARCH CLIN NEUROPSYCH, V31, P305, DOI 10.1093/arclin/acw011	42	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2017	39	3					286	295		10.1080/13803395.2016.1224322			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EQ6HP	WOS:000398182700006	27585635				2022-02-06	
J	Bruce, JM; Echemendia, RJ; Meeuwisse, W; Hutchison, MG; Aubry, M; Comper, P				Bruce, Jared M.; Echemendia, Ruben J.; Meeuwisse, Willem; Hutchison, Michael G.; Aubry, Mark; Comper, Paul			Measuring cognitive change with ImPACT: the aggregate baseline approach	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; ImPACT; reliability; mild traumatic brain injury; baseline	TEST-RETEST RELIABILITY; SPORTS-RELATED CONCUSSION; PROFESSIONAL ICE HOCKEY; HIGH-SCHOOL; MANAGEMENT	Objective: The Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) is commonly used to assess baseline and post-injury cognition among athletes in North America. Despite this, several studies have questioned the reliability of ImPACT when given at intervals employed in clinical practice. Poor test-retest reliability reduces test sensitivity to cognitive decline, increasing the likelihood that concussed athletes will be returned to play prematurely. We recently showed that the reliability of ImPACT can be increased when using a new composite structure and the aggregate of two baselines to predict subsequent performance. The purpose of the present study was to confirm our previous findings and determine whether the addition of a third baseline would further increase the test-retest reliability of ImPACT. Methods: Data from 97 English speaking professional hockey players who had received at least 4 ImPACT baseline evaluations were extracted from a National Hockey League Concussion Program database. Linear regression was used to determine whether each of the first three testing sessions accounted for unique variance in the fourth testing session. Results: Results confirmed that the aggregate baseline approach improves the psychometric properties of ImPACT, with most indices demonstrating adequate or better test-retest reliability for clinical use. Conclusions: The aggregate baseline approach provides a modest clinical benefit when recent baselines are available - and a more substantial benefit when compared to approaches that obtain baseline measures only once during the course of a multi-year playing career. Pending confirmation in diverse samples, neuropsychologists are encouraged to use the aggregate baseline approach to best quantify cognitive change following sports concussion.	[Bruce, Jared M.; Echemendia, Ruben J.] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Echemendia, Ruben J.] Psychol & Neurobehav Associates, State Coll, PA USA; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Hutchison, Michael G.; Comper, Paul] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada		Bruce, JM (corresponding author), Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA.	brucejm@umkc.edu	Echemendia, Ruben/R-6939-2019				Andrews G, 2001, MEASUREMENT CONSUMER; Baumgatner T., 2001, MEAS PHYS EDUC EXERC, V5, P179, DOI [10.1207/S15327841MPEE0503_4, DOI 10.1207/S15327841MPEE0503_4]; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; BURLINGAME GM, 1995, J MENT HEALTH ADMIN, V22, P226, DOI 10.1007/BF02521118; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Field A., 2017, DISCOVERING STAT USI, V5th; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2017, APPL NEUROPSYCH-CHIL, V6, P166, DOI 10.1080/21622965.2016.1138310; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Quanthockey. com, 2017, AV LENGTH NHL PLAY C; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Slick DJ, 2006, COMPENDIUM NEUROPSYC, P3; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	22	5	5	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	8					1329	1340		10.1080/13854046.2017.1311375			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FM2JR	WOS:000414811500005	28397546				2022-02-06	
J	Cancio, LC; Sheridan, RL; Dent, R; Hjalmarson, SG; Gardner, E; Matherly, AF; Bebarta, VS; Palmieri, T				Cancio, Leopoldo C.; Sheridan, Robert L.; Dent, Rob; Hjalmarson, Sarah Gene; Gardner, Emmie; Matherly, Annette F.; Bebarta, Vikhyat S.; Palmieri, Tina			Guidelines for Burn Care Under Austere Conditions: Special Etiologies: Blast, Radiation, and Chemical Injuries	JOURNAL OF BURN CARE & RESEARCH			English	Article							INDUCED LUNG INJURY; TRAUMATIC BRAIN-INJURY; HYDROGEN-SULFIDE; CHLORINE GAS; SULFUR MUSTARD; COMBAT EXPLOSIONS; ENDURING FREEDOM; INHALATION; IRAQ; AFGHANISTAN		[Cancio, Leopoldo C.; Bebarta, Vikhyat S.] US Army Inst Surg Res, Ft Sam Houston, TX USA; [Sheridan, Robert L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Dent, Rob; Matherly, Annette F.] Univ Utah, Burn Ctr, Salt Lake City, UT USA; [Hjalmarson, Sarah Gene] Primary Childrens Med Ctr, Salt Lake City, UT USA; [Gardner, Emmie] Intermt Hlth Care, Salt Lake City, UT USA; [Palmieri, Tina] Univ Calif Davis, Reg Burn Ctr, Sacramento, CA 95817 USA; [Palmieri, Tina] Shriners Hosp Children, Sacramento, CA 95817 USA		Palmieri, T (corresponding author), Univ Calif Davis, Reg Burn Ctr, Sacramento, CA 95817 USA.; Palmieri, T (corresponding author), Shriners Hosp Children, Sacramento, CA 95817 USA.	tina.palmieri@ucdmc.ucdavis.edu			U.S. Department of EnergyUnited States Department of Energy (DOE) [DE-AC05-06OR23100]	Special thanks to Doran M. Christensen, Senior Medical Advisor, at the Radiation Emergency Assistance Center/Training Site (REAC/TS) for his assistance with this article. Work provided by Dr. Christensen and REAC/TS were provided under contract with the U.S. Department of Energy, Contract # DE-AC05-06OR23100.	Anderson DR, 2006, MIL MED, V171, P448, DOI 10.7205/MILMED.171.5.448; [Anonymous], ADV RAD MED; [Anonymous], 2012, MILITARY ACUTE CONCU; [Anonymous], 2006, BURN CTR REF CRIT; Anonymous, 1984, S16433 UN; [Anonymous], 1998, IAEA SAF REP SER, V2; Barrett AM, 2011, RISK ANAL, V31, P1243, DOI 10.1111/j.1539-6924.2011.01596.x; Batchinsky AL, 2006, J TRAUMA, V60, P944, DOI 10.1097/01.ta.0000205862.57701.48; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; BOSSE GM, 1994, J TOXICOL-CLIN TOXIC, V32, P233, DOI 10.3109/15563659409017956; Bowen IG, 1968, 2113 DASA, P1477; Cancio LC, 2005, J BURN CARE REHABIL, V26, P151, DOI 10.1097/01.BCR.0000155540.31879.FB; CANCIO LC, 1993, MIL MED, V158, P1; Cancio LC, 2004, INT J DISASTER MED, V2, P114; CARAVATI EM, 1988, AM J EMERG MED, V6, P143, DOI 10.1016/0735-6757(88)90053-8; Caro AA, 2011, CELL BIOL TOXICOL, V27, P439, DOI 10.1007/s10565-011-9198-2; Cave D, 2007, NY TIMES, P956; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Coleman CN, 2011, DISASTER MED PUBLIC, V5, pS111, DOI 10.1001/dmp.2011.22; Collins JJ, 2011, J OCCUP ENVIRON MED, V53, P239, DOI 10.1097/JOM.0b013e31820c90cf; Darley DS, 2010, DISASTER MED PUBLIC, V4, P145, DOI 10.1001/dmphp.D-08-00057R2; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Doucet JJ, 2011, J TRAUMA, V70, P1241, DOI 10.1097/TA.0b013e3182095b52; Duncan MA, 2011, J MED TOXICOL, V7, P85, DOI 10.1007/s13181-010-0130-6; Emery T, 2012, NY TIMES; Emmen HH, 2000, REGUL TOXICOL PHARM, V32, P22, DOI 10.1006/rtph.2000.1402; Engel A, 2009, AM J ROENTGENOL, V193, P1212, DOI 10.2214/AJR.09.2375; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Fanucchi MV, 2012, AM J RESP CELL MOL, V46, P599, DOI 10.1165/rcmb.2011-0196OC; Farahat SA, 2010, TOXICOL IND HEALTH, V26, P229, DOI 10.1177/0748233710364966; Fujita Y, 2011, J ANAL TOXICOL, V35, P119, DOI 10.1093/anatox/35.2.119; Garner J, 2010, ANN SURG, V251, P1131, DOI 10.1097/SLA.0b013e3181e00fcb; Gilchrist H.L., 1928, COMP STUDY WORLD WAR; Grainge C, 2010, CLIN TOXICOL, V48, P497, DOI 10.3109/15563650.2010.506877; Guy RJ, 2011, BRIT J SURG, V98, P1033, DOI 10.1002/bjs.7610; INSTITUTE OF MEDICINE, 2009, GUID EST CRIS STAND; Ivey KM, 2012, J TRAUMA ACUTE CARE, V73, pS514, DOI TA.0b013e3182754654; Ji L, 2010, INHAL TOXICOL, V22, P535, DOI 10.3109/08958370903525183; Kauvar DS, 2006, BURNS, V32, P853, DOI 10.1016/j.burns.2006.03.008; Kilburn KH, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/565690; Kirkman E, 2011, PHILOS T R SOC B, V366, P286, DOI 10.1098/rstb.2010.0249; Kirkman E, 2011, PHILOS T R SOC B, V366, P144, DOI 10.1098/rstb.2010.0240; Klingerman CM, 2013, AM J PHYSIOL-REG I, V305, pR630, DOI 10.1152/ajpregu.00218.2013; Laskin JD, 2010, ANN NY ACAD SCI, V1203, P92, DOI 10.1111/j.1749-6632.2010.05605.x; Latenser BA, 2000, J BURN CARE REHABIL, V21, P40, DOI 10.1097/00004630-200021010-00008; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MCDOUGAL JN, 1993, TOXICOL LETT, V68, P31, DOI 10.1016/0378-4274(93)90116-F; MEISENBERG BR, 1993, MIL MED, V158, P470, DOI 10.1093/milmed/158.7.470; MISRA NP, 1987, INDIAN J MED RES, V86, P11; NCRP, 2008, HANDBOOK; Ohnishi M, 2001, EXP PHYSIOL, V86, P357, DOI 10.1113/eph8602145; Okpala N, 2011, MIL MED, V176, P1306; ORZEL RA, 1993, OCCUP MED, V8, P415; Owers C, 2011, BRIT J SURG, V98, P168, DOI 10.1002/bjs.7268; Peters P, 2011, MIL MED, V176, P110, DOI 10.7205/MILMED-D-10-00300; Radiation Emergency Medical Management (REMM), DEC PROC; Radiation Emergency Medical Management (REMM), MAN ARS WHIT CELL GR; Raja AS, 2010, J TRAUMA, V68, P1421, DOI 10.1097/TA.0b013e3181cf7d32; Ritchie JV, 2012, MIL MED, V177, P174, DOI 10.7205/MILMED-D-11-00217; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sciuto AM, 2004, INHAL TOXICOL, V16, P565, DOI 10.1080/08958370490442584; Shakarjian MP, 2010, TOXICOL SCI, V114, P5, DOI 10.1093/toxsci/kfp253; Sjoblom E, 1999, J TOXICOL-CLIN TOXIC, V37, P59; Slichter Sherrill J, 2007, Hematology Am Soc Hematol Educ Program, P172, DOI 10.1182/asheducation-2007.1.172; Smiley S, 2005, ABSTR HEMATOL ONCOL, V8, P20; Solomon Jay, 2011, WALL STREET J; Sotiropoulos G, 1998, J Emerg Med, V16, P409, DOI 10.1016/S0736-4679(98)00005-5; Sugarman S, 2012, RAPID INTERNAL EXTER; Sunil VR, 2012, TOXICOL APPL PHARM, V261, P22, DOI 10.1016/j.taap.2012.03.004; Sunil VR, 2011, TOXICOL APPL PHARM, V250, P245, DOI 10.1016/j.taap.2010.10.027; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tewari-Singh N, 2011, J PHARMACOL EXP THER, V336, P450, DOI 10.1124/jpet.110.173708; Truong DH, 2007, TOXICOLOGY, V242, P16, DOI 10.1016/j.tox.2007.09.009; Tsonis L, 2008, J BURN CARE RES, V29, P852, DOI 10.1097/BCR.0b013e3181848b7a; Tuorinsky Shirley D., 2008, MED ASPECTS CHEM WAR; US Department of Health and Human Services, TRIAG TOOLS; van Aalst JA, 2000, J BURN CARE REHABIL, V21, P248, DOI 10.1097/00004630-200021030-00011; Van Sickle D, 2009, AM J EMERG MED, V27, P1, DOI 10.1016/j.ajem.2007.12.006; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Wang J, 2005, ACTA ANAESTH SCAND, V49, P183, DOI 10.1111/j.1399-6576.2004.00563.x; Wang JP, 2004, J TRAUMA, V56, P850, DOI 10.1097/01.TA.0000078689.45384.8B; Wang JP, 2002, INTENS CARE MED, V28, P352, DOI 10.1007/s00134-001-1175-4; Weibrecht K, 2012, ANN EMERG MED, V59, P70, DOI 10.1016/j.annemergmed.2011.07.023; Weisskopf MG, 2003, J OCCUP ENVIRON MED, V45, P197, DOI 10.1097/01.jom.0000048168.87707.8b; White CE, 2007, J BURN CARE RES, V28, P922, DOI 10.1097/BCR.0b013e318159a44e; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wood GW, 2013, INJURY PREV, V19, P19, DOI 10.1136/injuryprev-2011-040277; Wu N, 2011, CLIN TOXICOL, V49, P161, DOI 10.3109/15563650.2011.565419; Yadav Amit K, 2010, Proc Am Thorac Soc, V7, P278, DOI 10.1513/pats.201001-009SM; Yeh DD, 2012, WORLD J SURG, V36, P966, DOI 10.1007/s00268-012-1500-9; Zarogiannis SG, 2011, AM J RESP CELL MOL, V45, P386, DOI 10.1165/rcmb.2010-0432OC; Zierold D, 2012, MIL MED, V177, P108, DOI 10.7205/MILMED-D-11-00165	97	5	5	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1559-047X	1559-0488		J BURN CARE RES	J. Burn Care Res.	JAN-FEB	2017	38	1					E482	E496		10.1097/BCR.0000000000000367			15	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	EH6FF	WOS:000391867500061	27355658	Bronze			2022-02-06	
S	Ch'ang, J; Claassen, J		Wijdicks, EFM; Kramer, AH		Ch'ang, J.; Claassen, J.			Seizures in the critically ill	CRITICAL CARE NEUROLOGY, PT II	Handbook of Clinical Neurology		English	Article; Book Chapter							REFRACTORY STATUS EPILEPTICUS; NONCONVULSIVE STATUS EPILEPTICUS; CONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; QUALITY STANDARDS SUBCOMMITTEE; NEW-ONSET SEIZURES; CARDIAC-ARREST; DOUBLE-BLIND; CONTINUOUS ELECTROENCEPHALOGRAPHY; INTRAVENOUS LEVETIRACETAM	Critically ill patients with seizures are either admitted to the intensive care unit because of uncontrolled seizures requiring aggressive treatment or are admitted for other reasons and develop seizures secondarily. These patients may have multiorgan failure and severe metabolic and electrolyte disarrangements, and may require complex medication regimens and interventions. Seizures can be seen as a result of an acute systemic illness, a primary neurologic pathology, or a medication side-effect and can present in a wide array of symptoms from convulsive activity, subtle twitching, to lethargy. In this population, untreated isolated seizures can quickly escalate to generalized convulsive status epilepticus or, more frequently, nonconvulsive status epileptics, which is associated with a high morbidity and mortality. Status epilepticus (SE) arises from a failure of inhibitory mechanisms and an enhancement of excitatory pathways causing permanent neuronal injury and other systemic sequelae. Carrying a high 30-day mortality rate, SE can be very difficult to treat in this complex setting, and a portion of these patients will become refractory, requiring narcotics and anesthetic medications. The most significant factor in successfully treating status epilepticus is initiating antiepileptic drugs as soon as possible, thus attentiveness and recognition of this disease are critical.	[Ch'ang, J.; Claassen, J.] Columbia Univ, Neurol Inst, 177 Ft Washington Ave,MHB 8 Ctr,Room 300, New York, NY 10032 USA		Claassen, J (corresponding author), Columbia Univ, Neurol Inst, 177 Ft Washington Ave,MHB 8 Ctr,Room 300, New York, NY 10032 USA.	jc1439@columbia.edu	Claassen, Jan/AAA-5451-2020				Abou Khaled KJ, 2006, CRIT CARE CLIN, V22, P637, DOI 10.1016/j.ccc.2006.06.004; Albers JM, 2011, SEIZURE-EUR J EPILEP, V20, P428, DOI 10.1016/j.seizure.2011.01.017; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; BLECK TP, 1991, CLIN NEUROPHARMACOL, V14, P191, DOI 10.1097/00002826-199106000-00001; BOGGS JG, 1993, EPILEPSY RES, V14, P87, DOI 10.1016/0920-1211(93)90077-K; Broomall E, 2014, ANN NEUROL, V76, P911, DOI 10.1002/ana.24295; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chen JWY, 2006, LANCET NEUROL, V5, P246, DOI 10.1016/S1474-4422(06)70374-X; Chin RFM, 2006, LANCET, V368, P222, DOI 10.1016/S0140-6736(06)69043-0; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2003, J NEUROL SCI, V211, P37, DOI 10.1016/S0022-510X(03)00036-4; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; Claassen J, 2001, NEUROLOGY, V57, P1036, DOI 10.1212/WNL.57.6.1036; Claassen J, 2002, NEUROLOGY, V58, P139, DOI 10.1212/WNL.58.1.139; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2016, LANCET NEUROL, V15, P23, DOI 10.1016/S1474-4422(15)00333-6; Claassen J, 2015, NEUROCRIT CARE, V23, pS136, DOI 10.1007/s12028-015-0172-3; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Claassen J, 2012, NEUROCRIT CARE, V17, P73, DOI 10.1007/s12028-012-9758-1; Claassen J, 2009, NEUROCRIT CARE, V11, P437, DOI 10.1007/s12028-009-9295-8; Cock HR, 2011, EPILEPSIA, V52, P50, DOI 10.1111/j.1528-1167.2011.03237.x; Cock HR, 2002, EPILEPSY RES, V48, P157, DOI 10.1016/S0920-1211(01)00334-5; CONN RD, 1967, AM HEART J, V73, P500, DOI 10.1016/0002-8703(67)90205-0; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Corry JJ, 2008, NEUROCRIT CARE, V9, P189, DOI 10.1007/s12028-008-9092-9; CRANFORD RE, 1978, NEUROLOGY, V28, P874, DOI 10.1212/WNL.28.9.874; Cuero MR, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0594-5; Dangayach NS, 2016, INTENS CARE MED, V42, P1168, DOI 10.1007/s00134-015-4137-y; De Marchis GM, 2016, NEUROLOGY, V86, P253, DOI 10.1212/WNL.0000000000002281; DeLorenzo RJ, 1999, EPILEPSIA, V40, P164, DOI 10.1111/j.1528-1157.1999.tb02070.x; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; DEVLIN EG, 1994, BRIT J ANAESTH, V73, P315, DOI 10.1093/bja/73.3.315; DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854; Errington AC, 2006, NEUROPHARMACOLOGY, V50, P1016, DOI 10.1016/j.neuropharm.2006.02.002; Farhidvash F, 2009, SEIZURE-EUR J EPILEP, V18, P644, DOI 10.1016/j.seizure.2009.08.001; Farina L, 2004, NEURORADIOLOGY, V46, P251, DOI 10.1007/s00234-003-1122-x; Fernandez A, 2014, NEUROLOGY, V82, P359, DOI 10.1212/WNL.0000000000000054; Fujikawa DG, 1996, BRAIN RES, V725, P11, DOI 10.1016/0006-8993(96)00203-X; Gaspard N, 2013, EPILEPSIA, V54, P1498, DOI 10.1111/epi.12247; Geocadin RG, 2002, RESUSCITATION, V55, P193, DOI 10.1016/S0300-9572(02)00196-X; Gottwald MD, 1999, AM J EMERG MED, V17, P333, DOI 10.1016/S0735-6757(99)90079-7; Halasz P, 2009, EPILEPSIA, V50, P443, DOI 10.1111/j.1528-1167.2008.01951.x; HAUSER WA, 1990, NEUROLOGY, V40, P9; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hesdorffer DC, 2007, NEUROLOGY, V69, P73, DOI 10.1212/01.wnl.0000265056.31752.ff; Hocker S, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0452-x; Hsieh CY, 2010, CLIN NEUROPHARMACOL, V33, P165, DOI 10.1097/WNF.0b013e3181d1e3cd; Husain AM, 2003, J NEUROL NEUROSUR PS, V74, P189, DOI 10.1136/jnnp.74.2.189; JAGODA A, 1993, ANN EMERG MED, V22, P1337, DOI 10.1016/S0196-0644(05)80120-9; Jenssen S, 2006, EPILEPSIA, V47, P1499, DOI 10.1111/j.1528-1167.2006.00622.x; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Kapur J, 1997, J NEUROSCI, V17, P7532, DOI 10.1523/jneurosci.17-19-07532.1997; Kim JA, 2001, AM J NEURORADIOL, V22, P1149; Knake S, 2008, J NEUROL NEUROSUR PS, V79, P588, DOI 10.1136/jnnp.2007.130260; Knake S, 2009, EPILEPSY BEHAV, V15, P10, DOI 10.1016/j.yebeh.2009.02.027; Ko SB, 2011, ARCH NEUROL-CHICAGO, V68, P1323, DOI 10.1001/archneurol.2011.240; KOFKE WA, 1989, ANESTHESIOLOGY, V71, P653, DOI 10.1097/00000542-198911000-00005; Koubeissi M, 2007, NEUROLOGY, V69, P886, DOI 10.1212/01.wnl.0000269791.96189.70; Krishnamurthy KB, 1999, EPILEPSIA, V40, P759, DOI 10.1111/j.1528-1157.1999.tb00775.x; Kumar MA, 2005, NEUROCRIT CARE, V3, P257, DOI 10.1385/NCC:3:3:257; Kurtz P, 2014, INTENS CARE MED, V40, P228, DOI 10.1007/s00134-013-3149-8; LAI ML, 1993, BIOPHARM DRUG DISPOS, V14, P365, DOI 10.1002/bdd.2510140409; LEPPIK IE, 1983, JAMA-J AM MED ASSOC, V249, P1452, DOI 10.1001/jama.249.11.1452; Liu HT, 1999, P NATL ACAD SCI USA, V96, P5286, DOI 10.1073/pnas.96.9.5286; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; LOUIS S, 1967, AM HEART J, V74, P523, DOI 10.1016/0002-8703(67)90011-7; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; LOWENSTEIN DH, 1993, NEUROLOGY, V43, P483, DOI 10.1212/WNL.43.3_Part_1.483; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Manno EM, 2005, ANN NEUROL, V58, P954, DOI 10.1002/ana.20677; Martin BS, 2008, EPILEPSIA, V49, P248, DOI 10.1111/j.1528-1167.2007.01384.x; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Mazarati A. M., 1997, EPILEPSIA S3, V38, P178; Mazarati AM, 1998, BRAIN RES, V814, P179, DOI 10.1016/S0006-8993(98)01080-4; Mazarati AM, 1998, J NEUROSCI, V18, P10070; Mazarati AM, 1999, J NEUROSCI, V256, P187; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Meldrum BS, 1999, EPILEPSIA, V40, P123, DOI 10.1111/j.1528-1157.1999.tb02001.x; Mewasingh LD, 2003, SEIZURE-EUR J EPILEP, V12, P483, DOI 10.1016/S1059-1311(03)00028-1; Mirsattari SM, 2004, ARCH NEUROL-CHICAGO, V61, P1254, DOI 10.1001/archneur.61.8.1254; Mirski MA, 2008, CRIT CARE CLIN, V24, P115, DOI 10.1016/j.ccc.2007.11.005; Misra UK, 2006, NEUROLOGY, V67, P340, DOI 10.1212/01.wnl.0000224880.35053.26; Moddel G, 2009, J NEUROL NEUROSUR PS, V80, P689, DOI 10.1136/jnnp.2008.145458; Navarro V, 2016, LANCET NEUROL, V15, P47, DOI 10.1016/S1474-4422(15)00296-3; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Niespodziany I, 2003, NEUROREPORT, V14, P1273, DOI 10.1097/00001756-200307010-00017; Novy J, 2010, EPILEPSIA, V51, P251, DOI 10.1111/j.1528-1167.2009.02323.x; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; OSORIO I, 1989, EPILEPSIA, V30, P464, DOI 10.1111/j.1528-1157.1989.tb05327.x; Pallin DJ, 2008, INT J EMERG MED, V1, P97, DOI 10.1007/s12245-008-0024-4; PASCUAL J, 1992, J NEUROL NEUROSUR PS, V55, P49, DOI 10.1136/jnnp.55.1.49; PERUCCA E, 1980, CLIN PHARMACOL THER, V28, P779, DOI 10.1038/clpt.1980.235; Prasad A, 2001, EPILEPSIA, V42, P380, DOI 10.1046/j.1528-1157.2001.27500.x; Prasad AN, 1996, EPILEPSIA, V37, pS81, DOI 10.1111/j.1528-1157.1996.tb06026.x; Pugin D, 2014, CRIT CARE, V18, DOI 10.1186/cc13883; RABINOWICZ AL, 1995, EPILEPSIA, V36, P475, DOI 10.1111/j.1528-1157.1995.tb00489.x; RASHKIN MC, 1987, NEUROLOGY, V37, P500, DOI 10.1212/WNL.37.3.500; Reddy K, 2013, EPILEPSIA, V54, P81, DOI 10.1111/epi.12286; Riviello JJ, 2013, NEUROCRIT CARE, V18, P193, DOI 10.1007/s12028-012-9790-1; Rogawski MA, 2013, EPILEPSIA, V54, P93, DOI 10.1111/epi.12289; Rossetti AO, 2011, NEUROCRIT CARE, V14, P4, DOI 10.1007/s12028-010-9445-z; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Rossetti AO, 2008, J NEUROL, V255, P1561, DOI 10.1007/s00415-008-0989-1; Rossetti AO, 2005, ARCH NEUROL-CHICAGO, V62, P1698, DOI 10.1001/archneur.62.11.1698; Rossetti AO, 2004, EPILEPSIA, V45, P757, DOI 10.1111/j.0013-9580.2004.01904.x; Shinnar S, 2001, ANN NEUROL, V49, P659, DOI 10.1002/ana.1018.abs; Shorvon S, 2007, EPILEPSIA, V48, P35, DOI 10.1111/j.1528-1167.2007.01344.x; Silbergleit R, 2012, NEW ENGL J MED, V366, P591, DOI 10.1056/NEJMoa1107494; SIMON RP, 1985, EPILEPSIA, V26, pS58, DOI 10.1111/j.1528-1157.1985.tb05725.x; SINGH BM, 1980, ANN NEUROL, V8, P155, DOI 10.1002/ana.410080205; SPERK G, 1986, NEUROSCIENCE, V17, P1117, DOI 10.1016/0306-4522(86)90081-3; Stecker MM, 1998, EPILEPSIA, V39, P18, DOI 10.1111/j.1528-1157.1998.tb01269.x; Sutter R, 2014, NEUROLOGY, V82, P656, DOI 10.1212/WNL.0000000000000009; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; THEODORE WH, 1994, NEUROLOGY, V44, P1403, DOI 10.1212/WNL.44.8.1403; Tian L, 2015, ACTA NEUROL SCAND, V132, P1, DOI 10.1111/ane.12336; TOMSON T, 1992, EPILEPSIA, V33, P829, DOI 10.1111/j.1528-1157.1992.tb02190.x; Towne AR, 2003, NEUROLOGY, V60, P332, DOI 10.1212/01.WNL.0000042783.86439.27; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Treiman DM, 1999, EPILEPSIA, V40, P243; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Trinka E, 2015, EPILEPSY BEHAV, V49, P203, DOI 10.1016/j.yebeh.2015.05.005; Varelas PN, 2003, NEUROLOGY, V61, P702, DOI 10.1212/01.WNL.0000078812.36581.97; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; VICEDOMINI JP, 1987, EXP NEUROL, V96, P681, DOI 10.1016/0014-4886(87)90229-9; WASTERLAIN CG, 1993, EPILEPSIA, V34, pS37, DOI 10.1111/j.1528-1157.1993.tb05905.x; Waterhouse EJ, 1999, EPILEPSIA, V40, P752, DOI 10.1111/j.1528-1157.1999.tb00774.x; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wilder B J, 1983, Adv Neurol, V34, P441; YAFFE K, 1993, NEUROLOGY, V43, P895, DOI 10.1212/WNL.43.5.895; Yasiry Z, 2014, SEIZURE-EUR J EPILEP, V23, P167, DOI 10.1016/j.seizure.2013.12.007; YORK RC, 1988, AM J EMERG MED, V6, P255, DOI 10.1016/0735-6757(88)90012-5; YOUNG GB, 1980, CAN J NEUROL SCI, V7, P291, DOI 10.1017/S0317167100022769; Young GB, 1996, NEUROLOGY, V47, P83; Zeiler FA, 2014, NEUROCRIT CARE, V20, P502, DOI 10.1007/s12028-013-9939-6	149	5	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803562-7; 978-0-44-463599-0	HAND CLINIC			2017	141						507	529		10.1016/B978-0-444-63599-0.00028-4			23	Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology	BJ3DK	WOS:000422931200007	28190433				2022-02-06	
J	Chen, CY; Zhou, CP; Cavanaugh, JM; Kallakuri, S; Desai, A; Zhang, LY; King, AI				Chen, Chaoyang; Zhou, Chengpeng; Cavanaugh, John M.; Kallakuri, Srinivasu; Desai, Alok; Zhang, Liying; King, Albert I.			Quantitative electroencephalography in a swine model of blast-induced brain injury	BRAIN INJURY			English	Article						Animal models; electroencephalography; brain injury; blast	POSTCONCUSSIONAL-SYNDROME; AMERICAN ACADEMY; CONTINUOUS EEG; MOUSE MODEL; BLOOD-FLOW; CONCUSSION; RESPONSES; NEUROLOGY; PROPOFOL; SEQUELAE	Objective: Electroencephalography (EEG) was used to examine brain activity abnormalities earlier after, blast exposure using a swine model to develop a qEEG data analysis protocol. Methods: Anaesthetized swine were exposed to 420-450 Kpa blast overpressure and survived for 3 days after blast. EEG recordings were performed at 15 minutes before the blast and 15 minutes, 30 minutes, 2 hours and 1, 2 and 3 days post-blast using surface recording electrodes and a Biopac 4-channel data acquisition system. Off-line quantitative EEG (qEEG) data analysis was performed' to determine qEEG changes. Results: Blast induced qEEG changes earlier after blast exposure, including a decrease of mean amplitude (MAMP), an increase of delta band power, a decrease of alpha band root mean square (RMS) and a decrease of 90% spectral edge frequency (SEF90). Conclusions: This study demonstrated that qEEG is sensitive for cerebral injury. The changes of qEEG earlier after the blast indicate the potential of utilization of multiple parameters of gEEG for diagnosis of blast-induced brain injury. Early detection of blast induced brain injury will allow early screening and assessment of brain abnormalities in soldiers to enable timely therapeutic intervention.	[Chen, Chaoyang; Zhou, Chengpeng; Cavanaugh, John M.; Kallakuri, Srinivasu; Desai, Alok; Zhang, Liying; King, Albert I.] Wayne State Univ, Dept Biomed Engn, 818 West Hancock Ave, Detroit, MI 48202 USA		Chen, CY (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 West Hancock Ave, Detroit, MI 48202 USA.	cchen@wayne.edu	Chen, Chaoyang/H-3605-2012	Chen, Chaoyang/0000-0003-0838-2245	MRMC [W81XWH-12-2-0038]; US ArmyUnited States Department of Defense	This research was supported by MRMC Contract No. W81XWH-12-2-0038, US Army. The views, opinions and/or findings contained in this paper are those of the authors and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation. The authors report no conflicts of interest.	Airoldi L, 1999, J CLIN NEUROPHYSIOL, V16, P456, DOI 10.1097/00004691-199909000-00007; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1113, DOI 10.1016/j.clinph.2006.01.020; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bojak I, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00022; Brown L, 2010, IEEE ENG MED BIO, P4197, DOI 10.1109/IEMBS.2010.5627393; Cao C, 2008, IEEE T NEUR SYS REH, V16, P327, DOI 10.1109/TNSRE.2008.918422; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Chen Xi-Ping, 2006, Neurosci Bull, V22, P165; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Ciraulo DL, 2006, J AM COLL SURGEONS, V203, P942, DOI 10.1016/j.jamcollsurg.2006.07.028; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fraga FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072240; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Geets W, 1985, Rev Electroencephalogr Neurophysiol Clin, V14, P333; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; HERREGODS L, 1989, INT J CLIN MONIT COM, V6, P67, DOI 10.1007/BF01720415; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hua Y, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/928236; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lee SJ, 2009, J PHYSIOL-LONDON, V587, P2033, DOI 10.1113/jphysiol.2009.166983; Li BC, 2014, NEUROL RES, V36, P974, DOI 10.1179/1743132813Y.0000000314; MCCLELLAND RJ, 1994, J ROY SOC MED, V87, P508; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sanborn B, 2012, J BIOMECH, V45, P434, DOI 10.1016/j.jbiomech.2011.12.017; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Tebano M.T., 1988, CLIN NEUROPHYSIOL, V70, P185; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 1999, CLIN ELECTROENCEPHAL, V30, P94, DOI 10.1177/155005949903000304; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Weenink RP, 2012, CLIN NEUROPHYSIOL, V123, P411, DOI 10.1016/j.clinph.2011.06.028; Zhang L, 2015, J NEUROTRAUM, V32, pB2; Zhang LY, 2015, J NEUROTRAUM, V32, pA105; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	54	5	5	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					120	126		10.1080/02699052.2016.1216603			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600015	27830938				2022-02-06	
J	Duda, I; Krzych, L; Jedrzejowska-Szypulka, H; Lewin-Kowalik, J				Duda, Izabela; Krzych, Lukasz; Jedrzejowska-Szypulka, Halina; Lewin-Kowalik, Joanna			Serum levels of the S100B protein and neuron-specific enolase are associated with mortality in critically ill patients	ACTA BIOCHIMICA POLONICA			English	Article						S100B; neuron-specific enolase; mortality; critically ill	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE UNITS; CELL LUNG-CANCER; S-100B PROTEIN; SEPTIC ENCEPHALOPATHY; SEVERE SEPSIS; HEAD-INJURY; BIOMARKER; MARKERS; SHOCK	Introduction. Evaluation of the prognostic potential of the S100B protein and neuron-specific enolase (NSE) as predictors of mortality in critically ill patients in intensive care units (ICU). Materials and Methods. The study was conducted on 62 patients. Basic clinical variables and blood samples for S100B and NSE level testing were obtained during the first four days after admission. Mortality was described as the patient's death during hospitalization in the ICU. Results. 35% of the patients had died. The level of S100B and NSE was significantly higher in non-survivors in comparison with survivors (p= 0.007 and p= 0.02, respectively). Mortality risk was significantly higher in patients with higher levels of biomarkers than the reference values for S100B (OR 9.00; 95% CI 2.38-33.99; p<0.001) as well as for NSE (OR 5.75; 95% CI 1.31-25.27; p=0.016).Receiver operating characteristic proved that S100B is a better mortality predictor than NSE (AUC 0.76 for S100B and 0.68 for NSE). From all the other variables, the Apache II score turned out to be the only significant predictor of mortality (AUC 0.88). Conclusion. There is a significant correlation between mortality in the ICU and increased serum concentration of S100B and NSE. This correlation is stronger for S100B. Testing for serum levels of S100B and NSE may be useful for prediction of treatment outcomes in the ICU patients.	[Duda, Izabela; Krzych, Lukasz] Med Univ Silesia, Sch Med Katowice, Dept Anesthesiol & Intens Care, Katowice, Poland; [Jedrzejowska-Szypulka, Halina; Lewin-Kowalik, Joanna] Med Univ Silesia, Sch Med Katowice, Dept Physiol, Katowice, Poland		Duda, I (corresponding author), Med Univ Silesia, Sch Med Katowice, Dept Anesthesiol & Intens Care, Katowice, Poland.	izaduda@neostrada.pl		Krzych, Lukasz/0000-0002-5252-8398; Lewin-Kowalik, Joanna/0000-0002-7971-449X; Duda, Izabela/0000-0002-8272-8948	Medical University of Silesia, Katowice, Poland [KNW-1-074/N/3/0]	Medical University of Silesia, Katowice, Poland (KNW-1-074/N/3/0).	Adamski J, 2015, ANAESTH INTENSIVE TH, V47, P117, DOI 10.5603/AIT.a2015.0010; Anderson RE, 2001, NEUROSURGERY, V49, P1492, DOI 10.1097/00006123-200112000-00056; BARONE FC, 1993, BRAIN RES, V623, P77, DOI 10.1016/0006-8993(93)90012-C; Cruz DN, 2010, INTENS CARE MED, V36, P444, DOI 10.1007/s00134-009-1711-1; Del Bufalo C, 1995, Respir Care, V40, P1042; DIEZ M, 1993, ONCOLOGY, V50, P127; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Ebersoldt M, 2007, INTENS CARE MED, V33, P941, DOI 10.1007/s00134-007-0622-2; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Hamed SA, 2009, NEUROPEDIATRICS, V40, P66, DOI 10.1055/s-0029-1231054; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Iacobone Emanuele, 2009, Crit Care Med, V37, pS331, DOI 10.1097/CCM.0b013e3181b6ed58; Jensen JU, 2006, CRIT CARE MED, V34, P2596, DOI 10.1097/01.CCM.0000239116.01855.61; Karnak D, 2005, AM J CLIN ONCOL-CANC, V28, P586, DOI 10.1097/01.coc.0000177915.51805.6e; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Krzych LJ, 2015, ANAESTH INTENSIVE TH, V47, P320, DOI 10.5603/AIT.2015.0041; Liu X, 2016, OPEN MED-WARSAW, V11, P59, DOI 10.1515/med-2016-0012; Macedo RC, 2013, REV BRAS PSIQUIATR, V35, P267; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Nguyen HB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-6; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Pfortmueller CA, 2016, PLOS ONE, V31; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Satoh H, 2002, ONCOL REP, V9, P581; Siman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028938; Stocchetti N, 2005, ANESTH ANALG, V101, P1463, DOI 10.1213/01.ANE.0000181337.03655.0C; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Weigand MA, 2000, ANESTHESIOLOGY, V92, P905, DOI 10.1097/00000542-200003000-00057; Weigl W, 2017, INTENS CARE MED, V43, P1430, DOI 10.1007/s00134-017-4804-2; Yao B, 2014, NEUROCHEM RES, V39, P1263, DOI 10.1007/s11064-014-1308-0; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	38	5	5	0	4	ACTA BIOCHIMICA POLONICA	WARSAW	PASTEURA 3, 02-093 WARSAW, POLAND	0001-527X	1734-154X		ACTA BIOCHIM POL	Acta Biochim. Pol.		2017	64	4					647	652		10.18388/abp.2017_1619			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ2AJ	WOS:000418158700010	29222857	Bronze			2022-02-06	
J	Gomez, PA; Castano-Leon, AM; Lora, D; Cepeda, S; Lagares, A				Gomez, Pedro A.; Castano-Leon, Ana M.; Lora, David; Cepeda, Santiago; Lagares, Alfonso			Trends in computed tomography characteristics, intracranial pressure monitoring and surgical management in severe traumatic brain injury: Analysis of a data base of the past 25 years in a neurosurgery department	NEUROCIRUGIA			Spanish	Article						Severe traumatic brain injury; Computerized tomography; Craniotomy; Decompressive craniectomy; Intracranial pressure; Guidelines	SEVERE HEAD-INJURY; ACUTE SUBDURAL HEMATOMAS; INTRACEREBRAL HEMORRHAGE; INTENSIVE-CARE; DECOMPRESSIVE CRANIECTOMY; CONSORTIUM SURVEY; RISK-FACTORS; CT FINDINGS; CLASSIFICATION; EPIDEMIOLOGY	Objective: To describe the radiological characteristics, surgical indications, procedures, and intracranial pressure monitoring of a representative cohort of severe traumatic brain injury (sTBI) cases collected over the past 25 years, and to analyse the changes that have occurred by dividing the period into 3 equal time periods. Methods: An observational cohort study was conducted on consecutive adult patients (> 14 years of age) with severe closed TBI (Glasgow Coma Scale score [GCS] <= 8) who were admitted during the first 48 hours after injury to the Hospital 12 de Octubre from 1987 to 2012. The most relevant radiological findings, surgical procedures, and intracranial monitoring indications reported in the literature were defined and compared in 3 equal time periods (1987-1995, 1996-2004, and 2005-2014). Results: A significant increase was observed in subdural haematomas with lesions over 25 cc, and midline shift in the last period of time. The incidence of subarachnoid haemorrhage increased significantly with time. There was a progression to a worse computed tomography (CT) classification from the initial CT scan in 33% of cases. Surgery was performed on 721 (39.4%) patients. Early surgery (< 12 hours) was performed on 585 (81.1%) patients, with the most frequent being for extra-cerebral mass lesions (subdural and epidural haematomas), whereas delayed surgery (> 12 hours) was most frequently performed due to an intracerebral haematoma. Surgical treatment, both early and late was significantly lower with respect to the first time period. Decompressive craniectomy with evacuation of the mass lesion was the preferred procedure in the last time period. Intracranial pressure monitoring (ICP) was carried out on 1049 (57.3%) patients, with a significantly higher frequency in the second period of time. There was adherence to Guidelines in 64.4% of cases. Elevated/uncontrolled ICP was more significant in the first time period. Conclusions: As a result of the epidemiological changes seen in traumatic brain injury, a different pattern of morphological injury is described, as depicted in the CT, leading to a difference in practice during this period of observation. (C) 2016 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Gomez, Pedro A.; Castano-Leon, Ana M.; Cepeda, Santiago; Lagares, Alfonso] Univ Complutense UCM, Hosp Univ 12 Octubre, Serv Neurocirugia, Madrid, Spain; [Lora, David] Hosp Univ 12 Octubre, Unidad Invest Clin Unit, CIBERESP, IMAS12, Madrid, Spain		Gomez, PA (corresponding author), Univ Complutense UCM, Hosp Univ 12 Octubre, Serv Neurocirugia, Madrid, Spain.	pagolopez@gmail.com	Gomez, Pedro/N-5051-2019; Castano-Leon, Ana M/ABF-6322-2020; Lagares, Alfonso/B-2969-2011; Cepeda, Santiago/AAE-3200-2021	Gomez, Pedro/0000-0002-4185-5238; Castano-Leon, Ana M/0000-0002-7918-5049; Lagares, Alfonso/0000-0003-3996-0554; Cepeda, Santiago/0000-0003-1667-8548			Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arikan F, 2005, NEUROCIRUGIA, V16, P108; Boto GR, 2009, NEUROSURG REV, V32, P343, DOI 10.1007/s10143-008-0178-9; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cepeda S, 2016, J NEUROTRAUM, V33, P1034, DOI 10.1089/neu.2015.4153; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Faul M, 2010, TRAUMATIC BRAIN INJU; Flynn-O'Brien KT, 2015, NEUROSURGERY, V76, P451, DOI 10.1227/NEU.0000000000000693; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lobato RD, 2005, NEUROCIRUGIA, V16, P217; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Wijayatilake DS, 2015, J NEUROSURG ANESTH, V27, P241, DOI 10.1097/ANA.0000000000000143	62	5	5	0	10	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	JAN-FEB	2017	28	1					1	14		10.1016/j.neucir.2016.11.002			14	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EJ6VJ	WOS:000393357600001	28007486				2022-02-06	
J	Gupta, D; Singla, R; Mazzeo, AT; Schnieder, EB; Tandon, V; Kale, SS; Mahapatra, AK				Gupta, Deepak; Singla, Raghav; Mazzeo, Anna T.; Schnieder, Eric B.; Tandon, Vivek; Kale, S. S.; Mahapatra, A. K.			Detection of metabolic pattern following decompressive craniectomy in severe traumatic brain injury: A microdialysis study	BRAIN INJURY			English	Article						Acute care; decompressive craniectomy; ischaemia; microdialysis; mitochondrial dysfunction; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; MITOCHONDRIAL PERMEABILITY TRANSITION; DIFFUSE AXONAL INJURY; INTRACRANIAL-PRESSURE; CYCLOSPORINE-A; INTRACEREBRAL MICRODIALYSIS; DYSFUNCTION; ISCHEMIA; PORE; OXYGENATION	Objective: The aim of the study was to detect mitochondrial dysfunction and ischaemia in severe traumatic brain injury and their relationship with outcome.Methods: Forty-one patients with severe traumatic brain injury (TBI) who underwent decompressive craniectomy were prospectively monitored with intracerebral microdialysis catheters (MD). Variables related to energy metabolism were studied using microdialysis.Results: Twentysix patients (63.4%) had a good outcome in terms of Glasgow outcome score (GOS) at 6 months while the rest (15 patients) had poor GOS at 6 months. Mitochondrial dysfunction was defined as Lactate Pyruvate ratio (LP ratio) > 25 and pyruvate <70 while ischaemia was defined as LP ratio > 25 and pyruvate >70. The poor outcome group showed significantly higher proportion of mitochondrial dysfunction 65.9% vs. 55.9% (p<0.001) and ischemia 13.9% vs. 7.2% (p<0.001)Conclusions: After decompressive craniectomy in severe TBI, patients with higher incidence of mitochondrial dysfunction and ischaemia were more likely to have poorer outcome with ischaemia having a more profound effect.Abbreviations: Traumatic brain injury (TBI), microdialysis (MD), lactate pyruvate ratio (LP ratio), Glasgow coma scale (GCS), Glasgow outcome scale (GOS), cerebral perfusion pressure (CPP), intracranial pressure (ICP), mitochondrial transition pore (MTP), non-contrast computed tomography (NCCT), traumatic axonal injury (TAI).	[Gupta, Deepak; Singla, Raghav; Tandon, Vivek; Kale, S. S.; Mahapatra, A. K.] All India Inst Med Sci, Dept Neurosurg, New Delhi, India; [Mazzeo, Anna T.] Univ Turin, Anesthesia & Intens Care Sect, Dept Surg Sci, Turin, Italy; [Schnieder, Eric B.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA USA; [Schnieder, Eric B.] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA		Gupta, D (corresponding author), All India Inst Med Sci, Neurosci Ctr, Neurosurg, Room 714, New Delhi, India.; Gupta, D (corresponding author), All India Inst Med Sci, Neurosci Ctr, Paediat Neurosurg Sect, Room 714, New Delhi, India.; Gupta, D (corresponding author), All India Inst Med Sci, Associated JPN Apex Trauma Ctr, New Delhi, India.	drdeepakgupta@gmail.com		Mazzeo, Anna Teresa/0000-0002-8454-7243; Singla, Raghav/0000-0003-4426-5089	AIIMS (All India Institute of Medical Sciences, New Delhi, India)	This research was partly funded by an intra-mural grant from AIIMS (All India Institute of Medical Sciences, New Delhi, India). No competing financial interests exist.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BARTUS RT, 1995, NEUROL RES, V17, P249, DOI 10.1080/01616412.1995.11740322; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gupta DK, 2016, NEUROL INDIA, V64, P259, DOI 10.4103/0028-3886.177617; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hejcl A, 2012, J NEUROL SURG PART A, V73, P10, DOI 10.1055/s-0032-1304500; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2003, SCAND CARDIOVASC J, V37, P13, DOI 10.1080/14017430310006974; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nikaina I, 2012, J CRIT CARE, V27, P83, DOI 10.1016/j.jcrc.2011.04.004; Nordstrom CH, 2016, ACTA NEUROCHIR, V158, P1231, DOI 10.1007/s00701-016-2835-z; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Povlishock JT, 2001, HEAD TRAUMA, P281; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Reinstrup P, 2011, NEUROCRIT CARE, V14, P441, DOI 10.1007/s12028-010-9486-3; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Singla R, 2016, INDIAN J NEUROTRAUM, V13, P59, DOI 10.1055/s-0036-1585092; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Valtysson J, 1998, ACTA NEUROCHIR, V140, P387, DOI 10.1007/s007010050113; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Ye R, 2011, NEUROSCIENCE, V178, P169, DOI 10.1016/j.neuroscience.2011.01.007; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812	60	5	5	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1660	1666		10.1080/02699052.2017.1370553			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200014	28925731				2022-02-06	
J	Haller, CS				Haller, Chiara S.			Twelve-month prospective cohort study of patients with severe traumatic brain injury and their relatives: Coping, satisfaction with life and neurological functioning	BRAIN INJURY			English	Article						Severe traumatic brain injury; coping; quality of life; recovery trajectory; relatives	QUALITY-OF-LIFE; CAREGIVER BURDEN; SOCIAL SUPPORT; TRAJECTORIES; DEPRESSION; MODERATE; CARE; SURVIVORS; STRESS; SCALE	Background: To examine the associations between the functioning of patients with severe traumatic brain injury (TBI), and their relatives' coping style and quality of life across 12 months post-injury.& para;& para;Methods: Prospective, population-based cohort study assessing 188 patients with severe TBI (Abbreviated Injury Scale of the head region [HAIS] score >3), and their relatives, 3, 6 and 12 months post-injury. Data were drawn from a larger national study run in Switzerland (2007-2011). Patient assessment: Glasgow Coma Outcome Scale Extended (GOSE), Patient Competency Rating Scale for Neurorehabiiitation (PCRS-NR). Relative assessment: Health-Related Quality of Life (HRQoL; 12-item short form health survey [SF-12]), Coping Inventory for Stressful Situations (CISS). Mixed linear models were run separately for ages >50 and less than or similar to 50 (i.e. bimodal distribution).& para;& para;Results: Patients' GOSE score was associated with relatives' reported mental SF-12 scores across age (ps < 0.01). Relatives' CISS was associated with patients' PCRS score (age > 50 years): Total and cognitive functioning decreased as emotion-oriented coping increased (ps = 0.01), while interpersonal functioning increased as task-oriented coping increased (p = 0.01) and decreased as avoidance-oriented coping increased (p = 0.02).& para;& para;Conclusion: Patients' functioning and relatives' mental HRQoL and coping strategies are associated with each other.	[Haller, Chiara S.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Haller, Chiara S.] Massachusetts Mental Hlth Ctr, Div Publ Psychiat, Boston, MA 02115 USA		Haller, CS (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	haller@fas.harvard.edu			PEBITA team	Many thanks to the PEBITA team for their passion and support (www.pebita.ch). Great thanks to all the participants, and profound thanks to Arthur Cropley for his continuous advice and mentoring.	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Dick WF, 1999, RESUSCITATION, V42, P81, DOI 10.1016/S0300-9572(99)00102-1; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844; Farin A, 2004, ACT NEUR S, V89, P101; Gelrnan A, 2007, DATA ANAL USING REGR; Giovannetti AM, 2015, ACTA NEUROL SCAND, V132, P259, DOI 10.1111/ane.12392; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Haller CS, 2017, J PERS, V85, P481, DOI 10.1111/jopy.12254; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Haller CS, 2017, QUAL LIFE RES, V26, P893, DOI 10.1007/s11136-016-1416-1; Haller CS, 2016, SWISS ARCH NEUROL PS, V4, P114; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hurt CS, 2012, INT PSYCHOGERIATR, V24, P1656, DOI 10.1017/S1041610212000749; Jakobsson U, 2007, AGING CLIN EXP RES, V19, P457; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Klonoff PS, 2014, FAMILY PSYCHOTHERAPY, P179; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Leonardi M, 2012, BRAIN INJURY, V26, P1201, DOI 10.3109/02699052.2012.667589; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MONAT A, 1991, STRESS COPING ANTHOL; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Pagani M, 2014, CLIN PSYCHOL PSYCHOT, V21, P420, DOI 10.1002/cpp.1848; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Pielmaier L, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.8749; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rossi-Mossuti F, 2014, J NEUROL SURG CENTRA, V75, P67; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Sebo P, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14072; Smeets SM, 2012, ARCH PHYS MED REHAB, V93, P834, DOI 10.1016/j.apmr.2011.10.029; Talbot LR, 2014, J MULTIDISCIP HEALTH, V7, P313, DOI 10.2147/JMDH.S64897; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Ware JE., 2002, SF 12V2 SCORE VERSIO; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	53	5	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1903	1909		10.1080/02699052.2017.1346295			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500024	28829653				2022-02-06	
J	Haslam, C; Wagner, J; Wegener, S; Malouf, T				Haslam, Catherine; Wagner, Joseph; Wegener, Signy; Malouf, Tania			Elaborative encoding through self-generation enhances outcomes with errorless learning: Findings from the Skypekids memory study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Errorless learning; Brain injury; Children; Self-generation; Skype	FACE-NAME ASSOCIATIONS; TRAUMATIC BRAIN-INJURY; TRIAL-AND-ERROR; COGNITIVE REHABILITATION; ALZHEIMERS-DISEASE; CHILDREN; DISCRIMINATION; DEMENTIA; INDIVIDUALS; IMPAIRMENT	Errorless learning has demonstrated efficacy in the treatment of memory impairment in adults and older adults with acquired brain injury. In the same population, use of elaborative encoding through supported self-generation in errorless paradigms has been shown to further enhance memory performance. However, the evidence base relevant to application of both standard and self-generation forms of errorless learning in children is far weaker. We address this limitation in the present study to examine recall performance in children with brain injury (n = 16) who were taught novel age-appropriate science and social science facts through the medium of Skype. All participants were taught these facts under conditions of standard errorless learning, errorless learning with self-generation, and trial-and-error learning after which memory was tested at 5-minute, 30-minute, 1-hour and 24-hour delays. Analysis revealed no main effect of time, with participants retaining most information acquired over the 24-hour testing period, but a significant effect of condition. Notably, self-generation proved more effective than both standard errorless and trial-and-error learning. Further analysis of the data revealed that severity of attentional impairment was less detrimental to recall performance under errorless conditions. This study extends the literature to provide further evidence of the value of errorless learning methods in children with ABI and the first demonstration of the effectiveness of self-generation when delivered via the Internet.	[Haslam, Catherine; Wagner, Joseph] Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia; [Wegener, Signy; Malouf, Tania] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia		Haslam, C (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia.	c.haslam@uq.edu.au	Haslam, Catherine/Y-5763-2018	Haslam, Catherine/0000-0003-0124-9601; Wegener, Signy/0000-0001-5364-0202	Royal Children's Hospital	We would like to thank clients and families for their time in taking part in the study and the Royal Children's Hospital in supporting recruitment. Additional thanks go to Dr Lynne McKinlay, Prof Roslyn Boyd, and Dr Suncica Lah for the support and advice in initial planning of the study. The authors declare no conflict of interest and no sources of financial support.	BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Bennett-Levy J., 2010, OXFORD GUIDE LOW INT, DOI 10.1017/S1352465810000238; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Brebion G, 2000, J PSYCHIATR RES, V34, P121, DOI 10.1016/S0022-3956(99)00050-3; Buckley S., 1993, DOWN SYNDROME RES PR, V1, P34, DOI DOI 10.3104/PERSPECTIVES.9; Cipani E., 1986, CANADIAN JOURNAL FOR, V3, P39; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; DUFFY L, 1987, BRIT J EDUC PSYCHOL, V57, P265, DOI 10.1111/j.2044-8279.1987.tb00856.x; Duffy L. A., 1994, DOWN SYNDROME RES PR, V2, P51, DOI [10.3104/reports.30, DOI 10.3104/REPORTS.30]; Dunn J, 2007, NEUROPSYCHOL REHABIL, V17, P735, DOI 10.1080/09602010701218317; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Glueckauf RL, 2003, PROF PSYCHOL-RES PR, V34, P159, DOI 10.1037/0735-7028.34.2.159; Guild EB, 2012, AGING NEUROPSYCHOL C, V19, P592, DOI 10.1080/13825585.2011.639869; Hamann SB, 1995, BEHAV NEUROSCI, V109, P1027, DOI 10.1037/0735-7044.109.6.1027; Haslam C, 2006, NEUROPSYCHOL REHABIL, V16, P505, DOI 10.1080/09602010500231867; Haslam C, 2012, NEUROPSYCHOL REHABIL, V22, P697, DOI 10.1080/09602011.2012.686820; Haslam C, 2011, J CLIN EXP NEUROPSYC, V33, P432, DOI 10.1080/13803395.2010.533155; Haslam C, 2010, J CLIN EXP NEUROPSYC, V32, P973, DOI 10.1080/13803391003662686; Hunkin NM, 1998, NEUROPSYCHOLOGIA, V36, P25, DOI 10.1016/S0028-3932(97)00106-1; Kessels RPC, 2007, CLIN REHABIL, V21, P905, DOI 10.1177/0269215507077309; Komatsu S, 2000, NEUROPSYCHOL REHABIL, V10, P113, DOI 10.1080/096020100389200; Laffan AJ, 2010, NEUROPSYCHOL REHABIL, V20, P197, DOI 10.1080/09602010903202432; Landis J, 2006, ARCH PHYS MED REHAB, V87, P799, DOI 10.1016/j.apmr.2006.02.017; Li RJ, 2012, INT J REHABIL RES, V35, P292, DOI 10.1097/MRR.0b013e32835a2435; Lubinsky T, 2009, J INT NEUROPSYCH SOC, V15, P704, DOI 10.1017/S1355617709990270; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; MOORE R, 1964, J EXP ANAL BEHAV, V7, P269, DOI 10.1901/jeab.1964.7-269; Mueller MM, 2007, PSYCHOL SCHOOLS, V44, P691, DOI 10.1002/pits.20258; Page M, 2006, NEUROPSYCHOLOGIA, V44, P90, DOI 10.1016/j.neuropsychologia.2005.04.004; Ruis C, 2005, AGING CLIN EXP RES, V17, P514, DOI 10.1007/BF03327420; SCHIEMEK N, 1983, SCH PSYCHOL REV, V12, P101; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; SIDMAN M, 1967, J EXP ANAL BEHAV, V10, P3, DOI 10.1901/jeab.1967.10-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8	37	5	6	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	1					60	79		10.1080/09602011.2015.1053947			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EB0SL	WOS:000387055700005	26095199				2022-02-06	
J	Imhoff, S; Lavalliere, M; Germain-Robitaille, M; Teasdale-, N; Fait, P				Imhoff, Sarah; Lavalliere, Martin; Germain-Robitaille, Mathieu; Teasdale-, Normand; Fait, Philippe			Training driving ability in a traumatic brain-injured individual using a driving simulator: a case report	INTERNATIONAL MEDICAL CASE REPORTS JOURNAL			English	Article						traumatic brain injury; rehabilitation; driving; simulator; assessment	YOUNG NOVICE; EXPERIENCE; DRIVERS; AWARENESS; RISK; PREDICTORS; PERCEPTION; ACCIDENTS; BEHAVIOR; SEARCH	Background: Traumatic brain injury (TBI) causes functional deficits that may significantly interfere with numerous activities of daily living such as driving. We report the case of a 20-year-old woman having lost her driver's license after sustaining a moderate TBI. Objective: We aimed to evaluate the effectiveness of an in-simulator training program with automated feedback on driving performance in a TBI individual. Methods: The participant underwent an initial and a final in-simulator driving assessment and 11 in-simulator training sessions with driving-specific automated feedbacks. Driving performance (simulation duration, speed regulation and lateral positioning) was measured in the driving simulator. Results: Speeding duration decreased during training sessions from 1.50 +/- 0.80 min (4.16 +/- 2.22%) to 0.45 +/- 0.15 min (0.44 +/- 0.42%) but returned to initial duration after removal of feedbacks for the final assessment. Proper lateral positioning improved with training and was maintained at the final assessment. Time spent in an incorrect lateral position decreased from 18.85 min (53.61%) in the initial assessment to 1.51 min (4.64%) on the final assessment. Conclusion: Driving simulators represent an interesting therapeutic avenue. Considerable research efforts are needed to confirm the effectiveness of this method for driving rehabilitation of individuals who have sustained a TBI.	[Imhoff, Sarah; Fait, Philippe] Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ G9A 5H7, Canada; [Imhoff, Sarah; Fait, Philippe] Univ Quebec Trois Rivieres, Res Grp Neuromusculoskeletal Dysfunct GRAN, Trois Rivieres, PQ G9A 5H7, Canada; [Lavalliere, Martin] MIT, AgeLab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lavalliere, Martin] Univ Quebec Chicoutimi, Dept Hlth Sci, Program Kinesiol, Chicoutimi, PQ, Canada; [Germain-Robitaille, Mathieu; Teasdale-, Normand] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada; [Teasdale-, Normand] Univ Laval, Grp Rech Anal Mouvement & Ergon, Quebec City, PQ, Canada; [Teasdale-, Normand] Univ Laval, CHU Quebec, Ctr Excellence Vieillissement Quebec, Quebec City, PQ, Canada; [Fait, Philippe] Res Ctr Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada		Fait, P (corresponding author), Univ Quebec Trois Rivieres, 3351 Blvd Forges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	philippe.fait@uqtr.ca	Imhoff, Sarah/Q-5182-2016	Imhoff, Sarah/0000-0003-0960-4524; Fait, Philippe/0000-0002-2554-9273; Imhoff, Sarah/0000-0003-3826-1073	Recherche en securite routiere: Fonds de recherche du Quebec - Societe et culture (FRQSC); Societe de l'assurance automobile du Quebec (SAAQ); Fonds de recherche du Quebec - Sante (FRQS)Fonds de la Recherche en Sante du Quebec	Sarah Imhoff was supported by a research grant - Recherche en securite routiere: Fonds de recherche du Quebec - Societe et culture (FRQSC), Societe de l'assurance automobile du Quebec (SAAQ), Fonds de recherche du Quebec - Sante (FRQS). Martin Lavalliere was supported by a postdoctoral research grant - Recherche en securite routiere: Fonds de recherche du Quebec - Societe et culture (FRQSC), Societe de l'assurance automobile du Quebec (SAAQ), Fonds de recherche du Quebec - Sante (FRQS).	Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Berger JT, 2000, J GEN INTERN MED, V15, P667, DOI 10.1046/j.1525-1497.2000.04309.x; Bivona U, 2012, J HEAD TRAUMA REHAB, V27, P210, DOI 10.1097/HTR.0b013e31822178a9; Borowsky A, 2013, ACCIDENT ANAL PREV, V59, P548, DOI 10.1016/j.aap.2013.07.008; Bottari C, 2012, REHABIL RES PRACT, P13; Canadian Council of Motor Transport Administrators, 2013, DET DRIV FITN CAN 1, P1; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Chan E, 2010, TRANSPORT RES F-TRAF, V13, P343, DOI 10.1016/j.trf.2010.04.001; Chapman PR, 1998, PERCEPTION, V27, P951, DOI 10.1068/p270951; Classen S, 2014, OCCUP THER HEALTH CA, V28, P154, DOI 10.3109/07380577.2014.901590; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Durbin DR, 2014, ACCIDENT ANAL PREV, V72, P433, DOI 10.1016/j.aap.2014.07.033; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Fisher DL, 2002, HUM FACTORS, V44, P287, DOI 10.1518/0018720024497853; Fisk GD, 1998, BRAIN INJURY, V12, P683; Gamache PL, 2011, BRAIN INJURY, V25, P416, DOI 10.3109/02699052.2011.558039; Groeger JA, 2007, ERGONOMICS, V50, P1250, DOI 10.1080/00140130701318723; Hoffman L, 2010, PSYCHOL AGING, V25, P741, DOI 10.1037/a0019198; Laapotti S, 2001, ACCIDENT ANAL PREV, V33, P759, DOI 10.1016/S0001-4575(00)00090-7; Lavalliere M, 2013, 23 CAN MULT ROAD SAF; Lehtonen E, 2014, ACCIDENT ANAL PREV, V70, P195, DOI 10.1016/j.aap.2014.04.002; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; McKnight AJ, 2003, ACCIDENT ANAL PREV, V35, P921, DOI 10.1016/S0001-4575(02)00100-8; MICHON JA, 1989, ACCIDENT ANAL PREV, V21, P341, DOI 10.1016/0001-4575(89)90025-0; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Parmet Y, 2015, HUM FACTORS, V57, P311, DOI 10.1177/0018720814548220; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Ross V, 2014, ACCIDENT ANAL PREV, V62, P377, DOI 10.1016/j.aap.2013.06.032; Scialfa CT, 2012, ACCIDENT ANAL PREV, V45, P547, DOI 10.1016/j.aap.2011.09.005; Scott H, 2013, J SAFETY RES, V45, P111, DOI 10.1016/j.jsr.2013.01.004; TEASDALE G, 1974, LANCET, V2, P81; Underwood G, 2013, ACCIDENT ANAL PREV, V58, P235, DOI 10.1016/j.aap.2012.03.019	37	5	5	1	8	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-142X			INT MED CASE REP J	INT. MED. CASE REP. J.		2017	10						41	45		10.2147/IMCRJ.S120918			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EK3KQ	WOS:000393825600001	28243152	Green Published, gold, Green Submitted, Green Accepted			2022-02-06	
J	Imhoff, S; Malenfant, S; Nadreau, E; Poirier, P; Bailey, DM; Brassard, P				Imhoff, Sarah; Malenfant, Simon; Nadreau, Eric; Poirier, Paul; Bailey, Damian M.; Brassard, Patrice			Uncoupling between cerebral perfusion and oxygenation during incremental exercise in an athlete with postconcussion syndrome: a case report	PHYSIOLOGICAL REPORTS			English	Article						Cerebral oxygenation; cerebral perfusion; exercise; postconcussion syndrome	TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR REACTIVITY; BLOOD-FLOW; CONCUSSION; SPORT; ENCEPHALOPATHY; PATHOPHYSIOLOGY; INDIVIDUALS; DYSFUNCTION; STATEMENT	High-intensity exercise may pose a risk to patients with postconcussion syndrome (PCS) when symptomatic during exertion. The case of a paralympic athlete with PCS who experienced a succession of convulsion-awakening periods and reported a marked increase in postconcussion symptoms after undergoing a graded symptom-limited aerobic exercise protocol is presented. Potential mechanisms of cerebrovascular function failure are then discussed.	[Imhoff, Sarah; Brassard, Patrice] Univ Laval, Dept Kinesiol, Fac Med, Quebec City, PQ, Canada; [Imhoff, Sarah; Malenfant, Simon; Nadreau, Eric; Poirier, Paul; Brassard, Patrice] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Res Ctr, Quebec City, PQ, Canada; [Malenfant, Simon] Univ Laval, Quebec Heart & Lungs Inst, Pulm Hypertens Res Grp, Res Ctr, Quebec City, PQ, Canada; [Bailey, Damian M.] Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Newport, South Wales, Wales; [Bailey, Damian M.] Univ Provence Marseille, Sondes Mol Biol, Lab Chim Provence, UMR 6264,CNRS, Marseille, France		Brassard, P (corresponding author), PEPS Univ Laval, Dept Kinesiol, 2300 Rue Terrasse,Room 0290-H, Quebec City, PQ G1V 0A6, Canada.	patrice.brassard@kin.ulaval.ca	Malenfant, Simon/AAQ-5587-2020; Imhoff, Sarah/Q-5182-2016; Bailey, Damian Miles/AAQ-1840-2020; Brassard, Patrice/H-6115-2019	Imhoff, Sarah/0000-0003-0960-4524; Malenfant, Simon/0000-0002-3911-3702; Imhoff, Sarah/0000-0003-3826-1073			Amonette WE, 2013, J HEAD TRAUMA REHAB, V28, pE13, DOI 10.1097/HTR.0b013e31826463a1; Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Brugniaux JV, 2014, J CEREBR BLOOD F MET, V34, P1873, DOI 10.1038/jcbfm.2014.142; Chan ST, 2015, BRAIN INJURY, V29, P403, DOI 10.3109/02699052.2014.974209; Clausen M., 2015, J HEAD TRAUMA REHAB, V19, P19; Colier WNJM, 1997, CLIN PHYSIOL, V17, P83; Conder RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00890; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Fugate JE, 2015, LANCET NEUROL, V14, P914, DOI 10.1016/S1474-4422(15)00111-8; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harms MPM, 2000, STROKE, V31, P1608, DOI 10.1161/01.STR.31.7.1608; Imhoff S, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13131; Kay VL, 2016, AM J PHYSIOL-REG I, V310, pR375, DOI 10.1152/ajpregu.00367.2015; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Madsen P, 1998, ACTA PHYSIOL SCAND, V162, P501; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Neki NS, 2013, NATL MED J INDIA, V26, P282; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Ontario Neurotrauma Fondation, 2013, GUID CONC MTBI PERS; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Svaldi D. O., 2016, BRAIN IMAGING BEHAV; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Willie CK, 2011, J NEUROSCI METH, V198, P270, DOI 10.1016/j.jneumeth.2011.03.017; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Zemek R., 2014, GUIDELINE DIAGNOSING	51	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2051-817X			PHYSIOL REP	PHYSIOL. REP.	JAN	2017	5	2							e13131	10.14814/phy2.13131			6	Physiology	Emerging Sources Citation Index (ESCI)	Physiology	EK3VE	WOS:000393855700013	28122826	Green Published, gold			2022-02-06	
J	Jackson, CE; Nordstrom, L; Fonda, JR; Fortier, CB; Milberg, WP; McGlinchey, RE				Jackson, Colleen E.; Nordstrom, Leslie; Fonda, Jennifer R.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.			Reporting of symptoms associated with concussion by OEF/OIF/OND Veterans: Comparison between research and clinical contexts	BRAIN INJURY			English	Article						Mild traumatic brain injury; Post-concussive symptoms; Neurobehavioral Symptom Inventory; Veteran	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; IRAQI FREEDOM; POSTCONCUSSIVE SYMPTOMS; PERFORMANCE VALIDITY; HEAD-INJURY; MEMORY TEST; INDIVIDUALS; RECOGNITION; EXPECTATION	Objective: Veterans from recent military conflicts frequently report persisting symptoms associated with concussion well beyond the expected period of recovery following mild traumatic brain injury. This study examined differences in the reporting of symptoms associated with concussion between clinical and research contexts. Methods: This naturalistic comparison included 91 Veterans from Operations Enduring Freedom (OEF), Iraqi Freedom (OIF) and New Dawn (OND). All participants were enrolled in a longitudinal study focused on traumatic brain injury and stress-related disorders and had also completed a VHA Comprehensive TBI Evaluation. Individuals completed the Neurobehavioral Symptom Inventory (NSI) during their research and clinical evaluations; additional measures of performance and symptom validity were also available for a subset of participants. Results: NSI mean total and subscale scores were significantly higher when assessed in the clinical compared to the research setting, irrespective of the order and duration of time between evaluations. Rates of over-reporting on the NSI and performance validity test failure were also higher during the clinical evaluation. Conclusion: Clinicians and researchers must appreciate the possible effects of context on the reporting of symptoms commonly associated with concussion. Future research identifying and mitigating factors influencing the effect of context on symptom reporting is needed.	[Jackson, Colleen E.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Jackson, Colleen E.; Nordstrom, Leslie; Fonda, Jennifer R.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Jackson, Colleen E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Boston, MA USA		Jackson, CE (corresponding author), VA Boston Healthcare Syst 116B, Geriatr Res Educ & Clin Ctr GRECC, 150 South Huntington Ave, Boston, MA 02130 USA.; Jackson, CE (corresponding author), VA Boston Healthcare Syst 116B, Translat Res Ctr TBI & Stress Disorders TRACTS, 150 South Huntington Ave, Boston, MA 02130 USA.	Colleen.Jackson@va.gov	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904; Jackson, Colleen/0000-0002-9927-2684	Translational Research Center for TBI and Stress Disorders (TRACTS) VA Rehabilitation Research and Development Center [B6796-C]; Department of Veterans Affairs Fellowship in Advanced Geriatrics	This work was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS) VA Rehabilitation Research and Development Center Grant [B6796-C] awarded to Dr Regina McGlinchey. Dr Colleen Jackson was supported by a Department of Veterans Affairs Fellowship in Advanced Geriatrics.	BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Delis D.C., 2000, CALIFORNIA VERBAL LE; Elhai JD, 2012, PTSD MILD TRAUMATIC, P174; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Green P., 2008, GREENS MED SYMPTOM V; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Leark RA, 2007, TEST VARIABLES ATTEN; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Veterans Health Administration, SCREEN EV POSS TRAUM; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11	38	5	5	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	4					485	492		10.1080/02699052.2017.1280740			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ES9TD	WOS:000399902900007	28287287				2022-02-06	
J	Jang, SH; Lee, HD				Jang, Sung Ho; Lee, Han Do			Abundant unusual neural branches from the fornix in patients with mild traumatic brain injury: A diffusion tensor tractography study	BRAIN INJURY			English	Article						Mild traumatic brain injury; fornix; memory; diffusion tensor imaging	BILATERAL INJURY; CONNECTIVITY; BODY	Objectives: Since the introduction of diffusion tensor tractography (DTT), several studies have been reported on the mechanisms for the recovery of an injured fornix in patients with traumatic brain injury (TBI). We report on patients who showed abundant unusual neural branches from the fornix following mild TBI using DTT.Methods: Five patients with mild TBI who complained of memory impairment and showed preserved integrity of the fornix with abundant unusual neural branches on DTT, and eight normal subjects were recruited. DTT parameters (fractional anisotropy [FA] and fibre number) of the fornix were measured.Results: All five patients showed memory impairment on only one subscale of the Memory Assessment Scale (MAS), although the global MAS was within the normal range. The FN of the fornix was increased by more than two standard deviations in all five patients compared with that of normal subjects, while the FA value was within two standard deviations of that of normal subjects. On the DTT for the fornix of the patients, three types of unusual neural tracts from the fornix not observed in normal subjects were observed in patients.Conclusion: The abundant unusual neural branches from the fornix might be a recovery phenomenon of a mildly injured fornix, although the integrity of the fornix was preserved in these patients.	[Jang, Sung Ho; Lee, Han Do] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea		Lee, HD (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	lhd890221@hanmail.net			DGIST R&D Program of the Ministry of Science, ICT and Future Planning [17-BD-0401]	This work was supported by the DGIST R&D Program of the Ministry of Science, ICT and Future Planning (17-BD-0401).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BACHYRITA P, 1981, ARCH PHYS MED REHAB, V62, P413; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE75, DOI 10.1097/PHM.0000000000000451; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE14, DOI 10.1097/PHM.0000000000000390; Jang SH, 2014, NEUROSCI LETT, V559, P72, DOI 10.1016/j.neulet.2013.11.040; Jang SH, 2013, NEUROSCI LETT, V549, P116, DOI 10.1016/j.neulet.2013.06.017; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lee HD, 2014, BRAIN INJURY, V28, P1485, DOI 10.3109/02699052.2014.930178; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Williams JM., 1991, MAS MEMORY ASSESSMEN; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2012, INT J NEUROSCI, V122, P195, DOI 10.3109/00207454.2011.639469	19	5	5	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1530	1533		10.1080/02699052.2017.1350997			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200017	28829662				2022-02-06	
J	Julien, J; Tinawi, S; Anderson, K; Frenette, LC; Audrit, H; Ferland, MC; Feyz, M; De Guise, E				Julien, J.; Tinawi, S.; Anderson, K.; Frenette, L. C.; Audrit, H.; Ferland, M. C.; Feyz, M.; De Guise, E.			Highlighting the differences in post-traumatic symptoms between patients with complicated and uncomplicated mild traumatic brain injury and injured controls	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; headaches; sleep; mood; injured controls; post-traumatic symptoms	HEAD-INJURY; POSTCONCUSSION SYNDROME; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; MEDICAL OUTCOMES; CHRONIC PAIN; RISK-FACTORS; SLEEP; INSOMNIA; PREVALENCE	Objective: The goal of the current study is to explore the difference In acute post-concussive symptoms (PCS), headaches, sleep and mood complaints between groups o f patients with complicated and uncomplicated mild traumatic brain injuries (mTBIs) and a comparable group of injured controls. Interactions among the following four factors were studied: presence of (1) PCS; (2) headaches; (3) sleep disorders; and (4) psychological status. Methods'. A total of 198 patients, followed at the outpatient mTBI clinic of the MUHC-MGH, completed questionnaires and a brief neurological assessment two weeks post-trauma. Results: Whether they had a TBI or not, all patients presented PCS, headaches, sleep and mood complaints. No significant differences between groups in terms o f reported symptoms were found. Variables such as depression and anxiety symptoms, as well as sleep difficulties and headaches were found to correlate with PCS. The high rate of PCS In trauma patients was observed Independently of traumatic brain Injury status. This study has also shown that patients with complicated mTBI were more likely to have vestibular Impairment after their injury. Conclusion: The vestibular function should be assessed systematically after a complicated mTBI. Furthermore, the mTBI diagnosis should be based on operational criteria, and not on reported symptoms.	[Julien, J.; Anderson, K.; Frenette, L. C.; Audrit, H.; Ferland, M. C.; De Guise, E.] Univ Montreal, Dept Psychol, Campus Laval,1700,Rue Jacques Tetreault,Bur 6230, Montreal, PQ H7N 0B6, Canada; [Julien, J.; Anderson, K.; Frenette, L. C.; Audrit, H.; Ferland, M. C.; De Guise, E.] Ctr Rech Interdisciplinaire Radaptat Montreal Metr, Montreal, PQ, Canada; [Tinawi, S.; Feyz, M.] McGill Univ, Hlth Ctr, TBI Program, Montreal, PQ, Canada; [De Guise, E.] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada		De Guise, E (corresponding author), Univ Montreal, Dept Psychol, Campus Laval,1700,Rue Jacques Tetreault,Bur 6230, Montreal, PQ H7N 0B6, Canada.	elaine.de.guise@umontreal.ca	Frenette, Lucie C./C-9579-2017		Research Institute of the McGill University Health Center; Centre de recherche interdisciplinaire en readaptation du Montreal metropolitain (CRIR)	The authors thank the Centre de recherche interdisciplinaire en readaptation du Montreal metropolitain (CRIR) and the Research Institute of the McGill University Health Center for their support.	Allen RP, 2009, SLEEP MED, V10, P531, DOI 10.1016/j.sleep.2008.06.003; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; [Anonymous], 2001, HIT 6 SCOR INT ENGL; Australian Bureau of Statistics, 2008, AUSTR SOC TRENDS; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; De Monte VE, 2010, J CLIN EXP NEUROPSYC, V32, P28, DOI 10.1080/13803390902806519; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hays RD, 2005, SLEEP MED, V6, P41, DOI 10.1016/j.sleep.2004.07.006; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2006, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; McMillan TM, 1993, J NEUROL NEUROSUR PS, V50, P393; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver MJ, 2005, TXB TRAUMATIC BRAIN; Steer, 1990, MANUAL BECK ANXIETY; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	89	5	5	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1846	1855		10.1080/02699052.2017.1346289			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500017	28816563				2022-02-06	
J	Kalkstein, S; Scott, JC; Biester, R; Brownlow, JA; Harpaz-Rotem, I; Gur, RC				Kalkstein, Solomon; Scott, J. Cobb; Biester, Rosette; Brownlow, Janeese A.; Harpaz-Rotem, Ilan; Gur, Ruben C.			Comparison of blast-exposed OEF/OIF veterans with and without a history of TBI symptoms on a brief computerized neuropsychological battery	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Blast; cognitive; neuropsychological; posttraumatic stress disorder; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TEST-PERFORMANCE; NEUROCOGNITIVE BATTERY; MILD TBI; METAANALYSIS; DISORDER; SEQUELAE; MODERATE; OUTCOMES	Mild traumatic brain injuries (mild TBIs) resulting from exposure to Improvised Explosive Devices (IEDs) are highly prevalent among veterans of the wars in Iraq and Afghanistan. This exploratory study compared the neurocognitive performance of blast-exposed veterans with (n=19) and without (n=15) reported symptoms of mild TBI. All subjects had diagnoses of posttraumatic stress disorder (PTSD). Neurocognitive testing was administered using a well-established computerized battery, the Penn Computerized Neuropsychological Battery (CNB), and groups were well matched on age, race, education, and time since most recent blast exposure. Although differences were not observed on CNB accuracy scores, MANOVAs revealed slower processing speed in the mTBI group when answering correctly on tests of simple and sustained attention, with large effect sizes. Results suggest a potential speed-accuracy tradeoff in blast-related mild TBI, which should be further examined in larger samples.	[Kalkstein, Solomon; Scott, J. Cobb; Biester, Rosette; Brownlow, Janeese A.; Gur, Ruben C.] Philadelphia Vet Affairs Med Ctr, 3900 Woodland Ave, Philadelphia, PA 19104 USA; [Kalkstein, Solomon; Scott, J. Cobb; Biester, Rosette; Brownlow, Janeese A.; Gur, Ruben C.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Scott, J. Cobb; Gur, Ruben C.] Philadelphia Vet Affairs Med Ctr, VISN4 Mental Illness Res Educ & Clin Ctr, Philadelphia, PA USA; [Harpaz-Rotem, Ilan] Yale Univ, Sch Med, New Haven, CT USA; [Harpaz-Rotem, Ilan] Natl Ctr PTSD, Vet Affairs Connecticut Hlth Care Syst, Clin Neurosciences Div, West Haven, CT USA		Kalkstein, S (corresponding author), Philadelphia Vet Affairs Med Ctr, 3900 Woodland Ave, Philadelphia, PA 19104 USA.	solomon.kalkstein@va.gov	Gur, Ruben/K-1999-2019	Gur, Ruben/0000-0002-9657-1996; Scott, J. Cobb/0000-0001-6538-9043; harpaz-rotem, ilan/0000-0002-6066-9406	Philadelphia VA Parkinson's Disease Research, Education, & Clinical Center; Department of Veterans AffairsUS Department of Veterans Affairs [IK2CX000772]; Veterans AffairsUS Department of Veterans Affairs [IK2CX000772] Funding Source: NIH RePORTER	This work was supported by a Pilot Project Award from the Philadelphia VA Parkinson's Disease Research, Education, & Clinical Center. Dr. Scott's participation was supported by a Department of Veterans Affairs Career Development Award (IK2CX000772).	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Congressional Research Service, 2014, GUID US MIL CAS STAT; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gur RC, 2010, J NEUROSCI METH, V187, P254, DOI 10.1016/j.jneumeth.2009.11.017; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Moore TM, 2015, NEUROPSYCHOLOGY, V29, P235, DOI 10.1037/neu0000093; Roalf DR, 2014, NEUROPSYCHOLOGY, V28, P161, DOI 10.1037/neu0000011; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358	26	5	5	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	1					92	97		10.1080/23279095.2015.1119693			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EC3KW	WOS:000388026000010	27045712				2022-02-06	
J	Kannan, N; Quistberg, A; Wang, J; Groner, JI; Mink, RB; Wainwright, MS; Bell, MJ; Giza, CC; Zatzick, DF; Ellenbogen, RG; Boyle, LN; Mitchell, PH; Vavilala, MS				Kannan, Nithya; Quistberg, Alex; Wang, Jin; Groner, Jonathan I.; Mink, Richard B.; Wainwright, Mark S.; Bell, Michael J.; Giza, Christopher C.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Vavilala, Monica S.			Frequency of and factors associated with emergency department intracranial pressure monitor placement in severe paediatric traumatic brain injury	BRAIN INJURY			English	Article						Emergency department; intracranial pressure monitor; paediatrics; traumatic brain injury	COMMON OUTCOMES; CHILDREN; MANAGEMENT; TRIAL	Objective: To examine the frequency of and factors associated with emergency department (ED) intracranial pressure (ICP) monitor placement in severe paediatric traumatic brain injury (TBI).& para;& para;Methods: Retrospective, multicentre cohort study of children <18 years admitted to the ED with severe TBI and intubated for >48 hours from 2007 to 2011.& para;& para;Results: Two hundred and twenty-four children had severe TBI and 75% underwent either ED, operating room (OR) or paediatric intensive care unit (PICU) ICP monitor placement. Four out of five centres placed ICP monitors in the ED, mostly (83%) fibreoptic. Nearly 40% of the patients who received ICP monitors get it placed in the ED (29% overall). Factors associated with ED ICP monitor placement were as follows: age 13 to <18year olds compared to infants (aRR 2.02; 95% Cl 1.37,2.98), longer ED length of stay (LOS) (aRR 1.15; 95% Cl 1.08,1.21), trauma centre designation paediatric only l/ll compared to adult/paediatric l/ll (aRR 1.71; 95% Cl 1.48, 1.98) and higher mean paediatric TBI patient volume (aRR 1.88;95% Cl 1.68, 2.11). Adjusted for centre, higher bedside ED staff was associated with longer ED LOS (aRR 2.10; 95% Cl 1.06, 4.14).& para;& para;Conclusion: ICP monitors are frequently placed in the ED at paediatric trauma centres caring for children with severe TBI. Both patient and organizational level factors are associated with ED ICP monitor placement.	[Kannan, Nithya] Univ Washington, Dept Epidemiol, 325 9th Ave,Box 359960, Seattle, WA 98104 USA; [Quistberg, Alex; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98104 USA; [Quistberg, Alex; Vavilala, Monica S.] Univ Washington, Dept Pain Med, Seattle, WA 98104 USA; [Wang, Jin] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA; [Mink, Richard B.] Harbor UCLA, Dept Pediat, Torrance, CA USA; [Mink, Richard B.] Los Angeles BioMed Res Inst, Torrance, CA USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Giza, Christopher C.] UCLA, Mattel Childrens Hosp, Dept Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] UCLA, Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Ellenbogen, Richard G.; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Ellenbogen, Richard G.; Vavilala, Monica S.] Univ Washington, Dept Global Hlth Med, Seattle, WA 98104 USA; [Boyle, Linda Ng] Univ Washington, Dept Ind Engn, Seattle, WA 98104 USA; [Boyle, Linda Ng] Univ Washington, Dept Syst Engn, Seattle, WA 98104 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Seattle, WA 98104 USA		Kannan, N (corresponding author), Univ Washington, Dept Epidemiol, 325 9th Ave,Box 359960, Seattle, WA 98104 USA.	nithyak@uw.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this paper. This study was funded by the National Institute of Neurological Disorders and Stroke (NINDS) R01 NS072308-06.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Ajdari A, 2017, J HEALTHC QUAL, V39, P334, DOI 10.1097/JHQ.0000000000000052; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Bailey BM, 2012, J TRAUMA ACUTE CARE, V72, P263, DOI 10.1097/TA.0b013e31822a9512; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Brolliar SM, 2016, J NEUROTRAUM, V33, P1554, DOI 10.1089/neu.2015.4183; Buck CJ, 2010, INT CLASSIFICATION D; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Coronado VG, 2012, BRAIN INJ MED PRINCI, V84; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Elliott DJ, 2015, JT COMM J QUAL PATIE, V41, P542, DOI 10.1016/S1553-7250(15)41071-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; JENNETT B, 1976, LANCET, V1, P1031; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS11, DOI 10.1097/PCC.0b013e31823f440c; Marion DW, 2006, NEUROSURGERY, V58, P655; McConnell KJ, 2005, ANN EMERG MED, V45, P471, DOI 10.1016/j.annemergmed.2004.10.032; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Ries BS, 2013, ASSESSING CLIN CARE, P1536; StataCorp, 2015, STAT STAT SOFTW REL; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	30	5	5	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1745	1752		10.1080/02699052.2017.1346296			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500006	28829632	Green Accepted			2022-02-06	
J	Kimmel, LA; Holland, AE; Lannin, N; Edwards, ER; Page, RS; Bucknill, A; Hau, R; Gabbe, BJ				Kimmel, Lara A.; Holland, Anne E.; Lannin, Natasha; Edwards, Elton R.; Page, Richard S.; Bucknill, Andrew; Hau, Raphael; Gabbe, Belinda J.			Clinicians' perceptions of decision making regarding discharge from public hospitals to in-patient rehabilitation following trauma	AUSTRALIAN HEALTH REVIEW			English	Article							LOWER-LIMB FRACTURE; BRAIN-INJURY; CARE; PREDICTORS; AUSTRALIA; RECOVERY; SERVICES; PATIENT; MODEL	Objective The aim of the present study was to investigate the perceptions of consultant surgeons, allied health clinicians and rehabilitation consultants regarding discharge destination decision making from the acute hospital following trauma. Methods A qualitative study was performed using individual in-depth interviews of clinicians in Victoria (Australia) between April 2013 and September 2014. Thematic analysis was used to derive important themes. Case studies provided quantitative information to enhance the information gained via interviews. Results Thirteen rehabilitation consultants, eight consultant surgeons and 13 allied health clinicians were interviewed. Key themes that emerged included the importance of financial considerations as drivers of decision making and the perceived lack of involvement of medical staff in decisions regarding discharge destination following trauma. Other themes included the lack of consistency of factors thought to be important drivers of discharge and the difficulty in acting on trauma patients' requests in terms of discharge destination. Importantly, as the complexity of the patient increases in terms of acquired brain injury, the options for rehabilitation become scarcer. Conclusions The information gained in the present study highlights the large variation in discharge practises between and within clinical groups. Further consultation with stakeholders involved in the care of trauma patients, as well as government bodies involved in hospital funding, is needed to derive a more consistent approach to discharge destination decision making. What is known about the topic? Little is known about the drivers for referral to, or acceptance at, in-patient rehabilitation following acute hospital care for traumatic injury in Victoria, Australia, including who makes these decisions of behalf of patients and how these decisions are made. What does this paper add? This paper provides information regarding the perceptions of acute hospital consultant surgeons and allied health, as well as rehabilitation clinicians, in terms of discharge destination decision making from the acute hospital following trauma. The use of case studies further highlights differences between, and within, these specialities with regard to this decision making. This research also highlights the importance of financial considerations as drivers of decision making, and the lack of consistency of the factors thought to be important drivers of discharge between these different clinical groupings. What are the implications for practitioners? This research shows that financial factors are significant drivers of discharge destination decision making for trauma patients. The present study highlights opportunities to engage with stakeholders (acute care, rehabilitation, administration, government and patients) to develop more consistent discharge processes that optimise the use of rehabilitation resources for those patients who could benefit from in-patient rehabilitation.	[Kimmel, Lara A.; Edwards, Elton R.; Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Kimmel, Lara A.] Alfred, Dept Physiotherapy, Commercial Rd, Prahran, Vic 3181, Australia; [Holland, Anne E.; Lannin, Natasha] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic 3086, Australia; [Edwards, Elton R.] Alfred, Dept Orthopaed, Commercial Rd, Prahran, Vic 3181, Australia; [Page, Richard S.] Barwon Hlth, Dept Orthopaed, Geelong, Vic 3220, Australia; [Page, Richard S.] St John God, Geelong, Vic 3220, Australia; [Page, Richard S.] Deakin Univ, Sch Med, Geelong, Vic 3220, Australia; [Bucknill, Andrew] Royal Melbourne Hosp, Dept Orthopaed, Melbourne, Vic 3050, Australia; [Bucknill, Andrew] Univ Melbourne, Dept Surg, Melbourne, Vic 3050, Australia; [Hau, Raphael] Northern Hosp, Dept Orthopaed, Epping, Vic 3076, Australia		Kimmel, LA (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.; Kimmel, LA (corresponding author), Alfred, Dept Physiotherapy, Commercial Rd, Prahran, Vic 3181, Australia.	L.kimmel@alfred.org.au; A.holland@latrobe.edu.au; N.lannin@latrobe.edu.au; ere@bigpond.net.au; richardpage@geelongortho.com.au; a.bucknill@mh.org.au; raphael.hau@hotmail.com; belinda.gabbe@monash.edu	Page, Richard/K-6327-2015; Holland, Anne/AAB-3055-2019; Lannin, Natasha A/A-4195-2013; Edwards, Elton R/AAP-4279-2020	Page, Richard/0000-0002-2225-7144; Lannin, Natasha A/0000-0002-2066-8345; Edwards, Elton R/0000-0002-9455-8069; Gabbe, Belinda/0000-0001-7096-7688; Kimmel, Lara/0000-0002-9921-7829	Transport Accident Commission (TAC) via the Institute for Safety Compensation and Recovery Research (ISCRR); Institute for Safety, Compensation and Recovery Research Institute	The Victorian Orthopaedic Trauma Outcomes Registry (VOTOR) is funded by the Transport Accident Commission (TAC) via the Institute for Safety Compensation and Recovery Research (ISCRR). We would like to thank the VOTOR telephone interviewers, VOTOR Steering Committee and the participating hospitals of the VOTOR. This project received funding from the Institute for Safety, Compensation and Recovery Research Institute to support the qualitative interviews with Rehabilitation Physicians.	Australian Bureau of Statistics, 2012, HLTH CAR DEL FIN; Australian Government, 2015, AUSTR HOSP 2013 14 G; Australian Government, 2013, DEV NAT CONS SUB NON; Australian Government Department of Health, 2013, GUID REC PRIV HOSP R; Beckett K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005668; BRODY BA, 1988, ARCH PHYS MED REHAB, V69, P333; Curtis K, 2014, INJURY, V45, P279, DOI 10.1016/j.injury.2012.10.002; Duckett SJ, 1998, MED J AUSTRALIA, V169, pS17, DOI 10.5694/j.1326-5377.1998.tb123470.x; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Gabbe BJ, 2013, MED J AUSTRALIA, V198, P149, DOI 10.5694/mja12.11179; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holtslag HR, 2007, INJURY, V38, P280, DOI 10.1016/j.injury.2006.10.026; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Khan F, 2012, BRIT J SURG, V99, P88, DOI 10.1002/bjs.7776; Kimmel LA, 2014, PHYS THER, V94, P1005, DOI 10.2522/ptj.20130413; Kimmel LA, 2012, INJURY, V43, P829, DOI 10.1016/j.injury.2011.09.027; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Mitus AJ, 2008, PROF CASE MANAG, V13, P228, DOI 10.1097/01.PCAMA.0000327413.01849.04; Niemeijer GC, 2010, J TRAUMA, V69, P614, DOI 10.1097/TA.0b013e3181e70f90; Nirula R, 2009, J TRAUMA, V66, P255, DOI 10.1097/TA.0b013e31815ede46; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pope CM, 2006, RES HLTH CARE; Poulos Christopher J, 2007, Aust New Zealand Health Policy, V4, P3, DOI 10.1186/1743-8462-4-3; Ta'eed G, 2013, BRAIN IMPAIR, V14, P222, DOI 10.1017/BrImp.2013.21; TOBIS JS, 1982, SCAND J REHABIL MED, V14, P83; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; Unsworth CA, 2001, INT J REHABIL RES, V24, P103; Victorian Government, 2016, FEES CHARG AC HLTH S; Williamson OD, 2009, J ORTHOP TRAUMA, V23, P139, DOI 10.1097/BOT.0b013e3181962e29; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149	31	5	5	0	1	CSIRO PUBLISHING	CLAYTON	UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA	0156-5788	1449-8944		AUST HEALTH REV	Aust. Health Rev.		2017	41	2					192	200		10.1071/AH16031			9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	ER1EO	WOS:000398532700014	27144728				2022-02-06	
J	Klores, M; Moon, JT; Duncan, KA				Klores, Molly; Moon, John T.; Duncan, Kelli A.			Expression of glial CBP in steroid mediated neuroprotection in male and female zebra finches	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						Astrocytes; Songbird; Estrogens; Neuroprotection; Inflammation; Coactivators; NF-kappa B	TRAUMATIC BRAIN-INJURY; FACTOR-KAPPA-B; ESTROGEN-RECEPTOR-ALPHA; ELEMENT-BINDING PROTEIN; AROMATASE EXPRESSION; RESPONSE ELEMENT; CROSS-TALK; ANDROGEN; ASTROCYTES; WOMEN	Under neurodegenerative conditions, reactive astrocytes upregulate both aromatase (estrogen synthase) as well as estrogen and androgen receptors. This increased steroidogenic signal promotes neuroprotection and repair by promoting neurogenesis and decreasing cell death, but also by modulating the release of inflammatory molecules. Thus, endocrine - immune cross-talk is an essential component of estrogen mediated neuroprotection following brain injury. However, the exact mechanisms underlying this crosstalk remains unknown. cAMP response element-binding protein-binding protein (CBP) may be involved in the modulation of both the endocrine and inflammatory response following injury. CBP acts as both an estrogen receptor (ER) coactivator and as a promotor for NF-kappa B (nuclear factor kappa-light-chain-enhancer of activated B cells) target genes and previous data suggests that ER and NF-kappa B compete for CBP. When CBP is displaced, target genes for NF-kappa B are repressed and inflammation is decreased. To test the role of CBP following injury, we examined CBP expression following penetrating injury in adult male and female zebra finches. Using immunohistochemistry, we were able to specifically examine glial CBP expression, as glial cells are important mediators of the neuroendocrine response to damage. Male but not female zebra finches upregulated glial CBP following damage to the brain. To determine if this upregulation was estrogen dependent, we decreased local estrogen levels with fadrozole (aromatase inhibitor) and reexamined glial CBP expression following injury. Aromatase inhibition resulted in no change in overall glial CBP expression suggesting that circulating estrogens do not mediate the upregulation of glial CBP following injury. Thus CBP may play a role in the both the estrogen and immune response to injury. (C) 2016 Elsevier B.V. All rights reserved.	[Klores, Molly; Moon, John T.; Duncan, Kelli A.] Vassar Coll, Poughkeepsie, NY 12604 USA; [Duncan, Kelli A.] Dept Biol, Poughkeepsie, NY 12604 USA		Duncan, KA (corresponding author), Vassar Coll, Poughkeepsie, NY 12604 USA.; Duncan, KA (corresponding author), Dept Biol, Poughkeepsie, NY 12604 USA.	molly.klores@gmail.com; jomoon@alum.vassar.edu; keduncan@vassar.edu			Vassar College; Vassar College Salmon Fund	This work was supported by Vassar College and the Vassar College Salmon Fund. The authors would also like to thank Katie Blackshear for technical assistance.	Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo M. A., 2012, HORM BEHAV; Auger AP, 2002, ENDOCRINOLOGY, V143, P3009, DOI 10.1210/en.143.8.3009; Auger CJ, 2002, J NEUROENDOCRINOL, V14, P805, DOI 10.1046/j.1365-2826.2002.00842.x; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Bushnell CD, 2008, NEUROL CLIN, V26, P1161, DOI 10.1016/j.ncl.2008.05.009; Carruth L.L., 2008, AN 1 NUAL SOC NEUR M; Choudhry MA, 2008, J LEUKOCYTE BIOL, V83, P518, DOI 10.1189/jlb.0607369; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Duncan KA, 2013, J NEUROTRAUM, V30, P1919, DOI 10.1089/neu.2013.2951; Duncan KA, 2013, HORM BEHAV, V63, P208, DOI 10.1016/j.yhbeh.2012.02.026; Duncan KA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-81; Duncan KA, 2011, FRONT NEUROENDOCRIN, V32, P84, DOI 10.1016/j.yfrne.2010.11.001; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; Gahr M, 1999, J NEUROSCI, V19, P2628; Garcia-Segura LM, 2008, J NEUROENDOCRINOL, V20, P705, DOI 10.1111/j.1365-2826.2008.01713.x; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Gionet N, 2009, J CELL BIOCHEM, V107, P448, DOI 10.1002/jcb.22141; Harnish DC, 2000, ENDOCRINOLOGY, V141, P3403, DOI 10.1210/en.141.9.3403; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Lewis DK, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.007; Mehos CJ, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12348; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Donnell ME, 2006, J CEREBR BLOOD F MET, V26, P1234, DOI 10.1038/sj.jcbfm.9600278; Peterson RS, 2004, J COMP NEUROL, V475, P261, DOI 10.1002/cne.20157; Pradhan M, 2012, MOL CELL BIOL, V32, P569, DOI 10.1128/MCB.05869-11; Quaedackers ME, 2007, MOL CELL ENDOCRINOL, V273, P42, DOI 10.1016/j.mce.2007.05.002; Roselli CF, 2007, J STEROID BIOCHEM, V106, P143, DOI 10.1016/j.jsbmb.2007.05.014; Saldanha CJ, 2013, J NEUROENDOCRINOL, V25, P1032, DOI 10.1111/jne.12067; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Saldanha CJ, 2005, J NEUROBIOL, V64, P192, DOI 10.1002/neu.20147; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Selvamani A, 2010, NEUROBIOL AGING, V31, P1618, DOI 10.1016/j.neurobiolaging.2008.08.014; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; Shi J, 2001, STROKE, V32, P987, DOI 10.1161/01.STR.32.4.987; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Speir E, 2000, CIRC RES, V87, P1006, DOI 10.1161/01.RES.87.11.1006; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Towfighi A, 2007, NEUROLOGY, V69, P1898, DOI 10.1212/01.wnl.0000268491.89956.c2; WADE J, 1994, GEN COMP ENDOCR, V94, P53, DOI 10.1006/gcen.1994.1059; Walters BJ, 2011, DEV NEUROBIOL, V71, P170, DOI 10.1002/dneu.20839; Wynne RD, 2004, J NEUROENDOCRINOL, V16, P676, DOI 10.1111/j.1365-2826.2004.01217.x; Wynne RD, 2008, GLIA, V56, P97, DOI 10.1002/glia.20594; Zhang Y, 2004, J NEUROSCI, V24, P5315, DOI 10.1523/JNEUROSCI.0913-04.2004	51	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	JAN	2017	79						32	37		10.1016/j.jchemneu.2016.11.002			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EI5WM	WOS:000392567000004	27826038				2022-02-06	
J	Kotlinska-Hasiec, E; Makara-Studzinska, M; Czajkowski, M; Rzecki, Z; Olszewski, K; Stadnik, A; Pilat, J; Rybojad, B; Dabrowski, W				Kotlinska-Hasiec, Edyta; Makara-Studzinska, Marta; Czajkowski, Marek; Rzecki, Ziemowit; Olszewski, Krzysztof; Stadnik, Adam; Pilat, Jacek; Rybojad, Beata; Dabrowski, Wojciech			Plasma magnesium concentration in patients undergoing coronary artery bypass grafting	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						magnesium; supplementation; age; profession; community education	TRAUMATIC BRAIN-INJURY; ATRIAL-FIBRILLATION; SERUM MAGNESIUM; SUPPLEMENTATION; DISORDERS	Introduction. Magnesium (Mg) plays a crucial role in cell physiology and its deficiency may cause many disorders which often require intensive treatment. The aim of this study was to analyse some factors affecting preoperative plasma Mg concentration in patients undergoing coronary artery bypass grafting (CABG). Materials and method. Adult patients scheduled for elective CABG with cardio-pulmonary bypass (CPB) under general anaesthesia were studied. Plasma Mg concentration was analysed before surgery in accordance with age, domicile, profession, tobacco smoking and preoperative Mg supplementation. Blood samples were obtained from the radial artery just before the administration of anaesthesia. Results. 150 patients were studied. Mean preoperative plasma Mg concentration was 0.93 +/- 0.17 mmol/L; mean concentration in patients -1.02 +/- 0.16; preoperative Mg supplementation was significantly higher than in patients without such supplementation. Moreover, intellectual workers supplemented Mg more frequently and had higher plasma Mg concentration than physical workers. Plasma Mg concentration decreases in elderly patients. Patients living in cities, on average, had the highest plasma Mg concentration. Smokers had significantly lower plasma Mg concentration than non-smokers. Conclusions. 1. Preoperative magnesium supplementation increases its plasma concentration. 2. Intellectual workers frequently supplement magnesium. 3. Smoking cigarettes decreases plasma magnesium concentration.	[Kotlinska-Hasiec, Edyta; Rzecki, Ziemowit; Rybojad, Beata; Dabrowski, Wojciech] Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, Lublin, Poland; [Makara-Studzinska, Marta] Jagiellonian Univ, Coll Med, Dept Hlth Psychol, Krakow, Poland; [Czajkowski, Marek; Olszewski, Krzysztof; Stadnik, Adam] Med Univ Lublin, Dept Cardiac Surg, Lublin, Poland; [Pilat, Jacek] Med Univ Lublin, Dept Gen Surg Transplantol & Clin Nutr, Lublin, Poland		Dabrowski, W (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, Lublin, Poland.	w.dabrowski5@yahoo.com	Dabrowski, Wojciech/AAN-8425-2020; Stadnik, Adam/AAN-3166-2021; stadnik, adam/AAN-3160-2021	Dabrowski, Wojciech/0000-0003-0449-2375; Stadnik, Adam/0000-0002-3578-0268; Olszewski, Krzysztof/0000-0002-5437-2761; MAKARA-STUDZINSKA, Marta/0000-0001-7374-528X			Abdel-Massih TE, 2012, INT J CARDIOL, V160, P114, DOI 10.1016/j.ijcard.2011.04.015; Chakraborti S, 2002, MOL CELL BIOCHEM, V238, P163, DOI 10.1023/A:1019998702946; Dabrowski W, 2008, MAGNESIUM RES, V21, P205; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Furukawa Y, 2009, MAGNESIUM RES, V22, p174S, DOI 10.1684/mrh.2009.0179; Gu WJ, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-41; HAIGNEY MCP, 1995, CIRCULATION, V92, P2190, DOI 10.1161/01.CIR.92.8.2190; Ichikawa S, 1998, Jpn J Thorac Cardiovasc Surg, V46, P287; Inoue Soichiro, 2004, J Anesth, V18, P216; Khan AM, 2013, CIRCULATION, V127, P33, DOI 10.1161/CIRCULATIONAHA.111.082511; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Panda NB, 2013, J CLIN ANESTH, V25, P92, DOI 10.1016/j.jclinane.2012.06.016; Pasternak K, 2006, MAGNESIUM RES, V19, P113; Pasternak K, 2006, MAGNESIUM RES, V19, P107; Pasternak K, 2005, MAGNESIUM RES, V18, P245; Pasternak K, 2010, J ELEMENTOL, V15, P601; Pham PCT, 2005, CLIN NEPHROL, V63, P429; Polderman KH, 2004, CRIT CARE, V8, pR459, DOI 10.1186/cc2973; Runge A, 2012, PRACE GEOGRAFICZNE Z, P83; SATUR CMR, 1994, ANN THORAC SURG, V58, P1674, DOI 10.1016/0003-4975(94)91657-8; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Watanabe J, 1998, J MOL CELL CARDIOL, V30, P2307, DOI 10.1006/jmcc.1998.0791; Weglicki W, 2005, CLIN EXP HYPERTENS, V27, P95, DOI 10.1081/CEH-200044275; WHANG R, 1994, ANN PHARMACOTHER, V28, P220, DOI 10.1177/106002809402800213; Yorulmaz H, 2013, BIOL TRACE ELEM RES, V151, P256, DOI 10.1007/s12011-012-9546-y	25	5	5	0	4	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.		2017	24	2					181	184		10.5604/12321966.1232762			4	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	EX8NJ	WOS:000403506900005	28664690	Green Submitted, gold			2022-02-06	
J	Li, YM; Chen, F; Zhang, JR; Li, G; Yang, XG; Lu, Q; Xia, X; Zhang, XY; Qiu, J; Zhang, JP; Zhou, J; Kuang, YQ; Gu, JW				Li, Yunming; Chen, Fuqin; Zhang, Junran; Li, Gang; Yang, Xiaoguang; Lu, Qiang; Xia, Xun; Zhang, Xinyan; Qiu, Jun; Zhang, Junpeng; Zhou, Jihong; Kuang, Yongqin; Gu, Jianwen			Epidemiological characteristics of Chinese paediatric traumatic brain injury inpatients	BRAIN INJURY			English	Article						Traumatic brain injury; paediatric; epidemiology; nationwide database; China	UNITED-STATES; CIVILIAN INPATIENTS; MILITARY HOSPITALS; HEAD-INJURY; CHILDREN; ADOLESCENTS; PREVALENCE; TRENDS	Primary, objective: To investigate the epidemiological characteristics of paediatric inpatients, with traumatic brain injury (TBI) in China. Research design: The Chinese Trauma Database (CTD), a nationwide register system based on hospital admission data; contains diagnosis and treatment information for trauma inpatients in over 200 military-managed public-service hospitals in China. Using the ICD-9 coding, the data for Children with TBI aged 0-17 years between 2001 and 2007 were retrieved'. Methods and procedures: The demographic characteristics, admission time, injury cause, severity and treatment outcomes of paediatric inpatients with TBI were analysed. Main outcomes and results: A total of 26,028 paediatric inpatients with TBI (69.52% male, 30.48% female) were included in the CTD. Motor vehicle traffic (MVT) accidents, falls and assaults were the primary causes of injury. Falls were, the leading cause of TBI in children aged 0-4 years, and MVT was the leading cause of TBI in children aged 5-17 years. According to the abbreviated injury scale, 37.20% of the TBI cases were mild, 25.15% were moderate, 24.81% were severe and 12.84% were critically severe. Conclusion: Chinese authorities, should develop targeted measures to reduce children injuries based on the leading causes of TBI in the different age groups, particularly MVT, falls and assaults.	[Li, Yunming; Li, Gang; Yang, Xiaoguang; Lu, Qiang; Xia, Xun; Zhang, Xinyan; Kuang, Yongqin] Peoples Liberat Army, Chengdu Mil Gen Hosp, Chengdu, Sichuan, Peoples R China; [Chen, Fuqin; Zhang, Junran; Zhang, Junpeng] Sichuan Univ, Sch Elect Engn & Informat, Chengdu, Sichuan, Peoples R China; [Qiu, Jun; Zhou, Jihong] Peoples Liberat Army, Mil Med Univ 3, Daping Hosp, Chongqing, Peoples R China; [Gu, Jianwen] Peoples Liberat Army, Hosp 306, Beijing 100101, Peoples R China		Gu, JW (corresponding author), Peoples Liberat Army, Hosp 306, Beijing 100101, Peoples R China.	gu031702556@126.com		Li, Yunming/0000-0001-6363-4869	53rd China postdoctoral science foundation projects [2013M532123]; Chengdu Military Command General Hospital [2013YG-B021]	This work was supported by the 53rd China postdoctoral science foundation projects (No. 2013M532123) and the Chengdu Military Command General Hospital first funded research talents (No. 2013YG-B021). The authors report no conflicts of interest.	Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Carroll Christopher P, 2010, Ann Adv Automot Med, V54, P233; Chen Hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P307; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; JAMISON DL, 1974, ARCH DIS CHILD, V49, P376, DOI 10.1136/adc.49.5.376; Kim HB, 2012, J KOREAN MED SCI, V27, P437, DOI 10.3346/jkms.2012.27.4.437; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shao JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048127; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yao Y, 2011, BURNS, V37, P1023, DOI 10.1016/j.burns.2011.03.021; Zhang YH, 2007, INT J MED INFORM, V76, P614, DOI 10.1016/j.ijmedinf.2006.05.003; Zhao YD, 2001, WORLD J SURG, V25, P1202; Zhu HP, 2014, INT J ENV RES PUB HE, V11, P3493, DOI 10.3390/ijerph110403493	33	5	5	2	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	8					1094	1101		10.1080/02699052.2017.1298004			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FC3JI	WOS:000406734500009	28506081				2022-02-06	
J	Libin, AV; Schladen, MM; Danford, E; Cichon, S; Bruner, D; Scholten, J; Llorente, M; Zapata, S; Dromerick, AW; Blackman, MR; Magruder, KM				Libin, Alexander V.; Schladen, Manon Maitland; Danford, Ellen; Cichon, Samantha; Bruner, Dwan; Scholten, Joel; Llorente, Maria; Zapata, Slavomir; Dromerick, Alexander W.; Blackman, Marc R.; Magruder, Kathryn M.			Perspectives of Veterans With Mild Traumatic Brain Injury on Community Reintegration: Making Sense of Unplanned Separation From Service	AMERICAN JOURNAL OF ORTHOPSYCHIATRY			English	Article						veterans; community reintegration; PTSD; TBI; war-related trauma	REHABILITATION; IRAQ	For veterans separated from the military as a result of acquired mild traumatic brain injury (mTBI), the transition from a military identity to a civilian one is complicated by health, cognitive, and psychosocial factors. We conducted in-depth interviews with 8 veterans with mTBI to understand how they perceived the experience of departure from the military, rehabilitation services provided at a Department of Veterans Affairs (VA) Polytrauma Network Site, and reentry into civilian life. Two distinct patterns of thinking about community reintegration emerged. The first pattern was characterized by the perception of a need to fade one's military identity. The second pattern, conversely, advanced the perception of a need to maintain the integrity of one's military identity though living in a civilian world. These perceptions may be linked to individuals' roles while in the military and whether violent acts were committed in carrying out the mission of service, acts not consonant with positive self-appraisal in the civilian world. The crisis of unplanned, involuntary separation from the military was universally perceived as a crisis equal to that of the precipitating injury itself. The perception that civilians lacked understanding of veterans' military past and their current transition set up expectations for interactions with health care providers, as well as greatly impacting relationships with friend and family. Our veterans' shared perceptions support existing mandates for greater dissemination of military culture training to health care providers serving veterans both at VA and military facilities as well as in the civilian community at large.	[Libin, Alexander V.; Schladen, Manon Maitland; Danford, Ellen; Cichon, Samantha; Bruner, Dwan; Scholten, Joel; Llorente, Maria; Zapata, Slavomir; Blackman, Marc R.] Washington DC Vet Affairs Med Ctr, 50 Irving St NW, Washington, DC 20422 USA; [Libin, Alexander V.; Schladen, Manon Maitland; Scholten, Joel; Dromerick, Alexander W.; Blackman, Marc R.] Georgetown Univ, Med Ctr, Dept Med & Rehabil Med, Washington, DC 20057 USA; [Dromerick, Alexander W.] MedStar Natl Rehabil Hosp, Washington, DC USA; [Magruder, Kathryn M.] Med Univ South Carolina, Dept Psychiat, Charleston, SC USA		Libin, AV (corresponding author), Washington DC Vet Affairs Med Ctr, 50 Irving St NW, Washington, DC 20422 USA.	aviklibin@gmail.com	Libin, Alexander V./W-8641-2019; Blackman, Marc/AAT-5771-2021; Magruder, Kathryn/V-1576-2019	Libin, Alexander V./0000-0001-7847-3463; 	U.S. Department of Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [I 01 RX000637-01-A3]; National Center for Advancing Translational Sciences, the National Institutes of Health [UL1TR000101]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001409] Funding Source: NIH RePORTER	This work was supported by Merit Review Award I 01 RX000637-01-A3 from the U.S. Department of Veterans Affairs Rehabilitation Research and Development Service. Statistical support for this project was provided through the MedStar Health Research Institute, a component of the GeorgetownHoward Universities Center for Clinical and Translational Science, and supported in part with federal funds (UL1TR000101, previously UL1RR031975) from the National Center for Advancing Translational Sciences, the National Institutes of Health, through the Clinical and Translational Science Awards Program, a trademark of U.S. Department of Health and Human Services, part of the Roadmap Initiative, "Re- Engineering the Clinical Research Enterprise." The contents do not necessarily represent the views of the U.S. Department of Veterans Affairs or the U.S. government.	Baechtold M., 2009, NEW DIRECTIONS STUDE, V2009, P35, DOI [https://doi.org/10.1002/ss.314, DOI 10.1002/SS.314]; Defense & Veterans Brain Injury Center, 2015, DOD NUMB TRAUM BRIAN; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; DiRamio D., 2011, VETERANS HIGHER ED J, V37; Drescher K, 2011, TRAUMATOLOGY, V17, P8, DOI DOI 10.1177/1534765610395615; Duca K., 2013, WALKING WOUNDED HERE, P33; Ebaugh Helen Rose Fuchs, 1988, BECOMING EX PROCESS; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Evans N.J., 1998, STUDENT DEV COLL THE, V1st ed; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Jones K. C., 2013, QUALITATIVE REPORT, V18, P1; Libin A., 2008, DIFFERENTIAL PSYCHOL; Libin AV, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0061-2; Marton F., 1986, J THOUGHT, V21, P28, DOI DOI 10.2307/42589189; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Morse JM, 2002, INT J QUAL METH, V1, P13, DOI DOI 10.1177/160940690200100202; Naphan DE, 2015, QUAL REP, V20, P36; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; QSR International, 2014, NVIVO 10 COMP SOFTW; Reigeluth CM, 1999, INSTRUCTIONAL-DESIGN THEORIES AND MODELS, VOL II, P633; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schiavone V., 2013, THESIS; SCHLOSSBERG NK, 1981, COUNS PSYCHOL, V9, P2, DOI 10.1177/001100008100900202; Tanielian T., 2014, READY SERVE COMMUNIT; U. S. Department of Veterans Affairs, 2013, DEP VET AFF ED PROGR; Uniformed Services University of the Health Sciences Center for Deployment Psychology, 2013, MILITARY CULTURE COR; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519	30	5	5	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0002-9432	1939-0025		AM J ORTHOPSYCHIAT	Am. J. Orthopsychiatr.		2017	87	2			SI		129	138		10.1037/ort0000253			10	Psychiatry; Social Work	Social Science Citation Index (SSCI)	Psychiatry; Social Work	EN2SD	WOS:000395859400003	28206800				2022-02-06	
J	Lopez-Rolon, A; Vogler, J; Howell, K; Shock, J; Czermak, S; Heck, S; Straube, A; Bender, A				Lopez-Rolon, Alex; Vogler, Jana; Howell, Kaitlen; Shock, Jonathan; Czermak, Stefan; Heck, Suzette; Straube, Andreas; Bender, Andreas			Severe disorders of consciousness after acquired brain injury: A single-centre long-term follow-up study	NEUROREHABILITATION			English	Article						Acquired brain injury; disorders of consciousness; long-term outcome; health-related quality of life	QUALITY-OF-LIFE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; PROLONGED DISORDERS; POSITIVE ILLUSIONS; BARTHEL-INDEX; REHABILITATION; HEALTH; OUTCOMES; SCALE; INSTRUMENTS	OBJECTIVES: To assess long-term clinical outcome, functional independence and health-related quality of life (HRQOL) in acquired brain injury (ABI) patients with a disorder of consciousness at admission to inpatient rehabilitation. METHODS: We selected patients from a cohort of ABI patients from a single centre. In addition to mortality, we measured level of consciousness with the Coma Remission Scale, functional independence with the Barthel Index, as well as generic and condition-specific HRQOL with the EQ5D and the "Quality of Life after Brain Injury" (QOLIBRI) respectively. RESULTS: Half of the obtained sample had died by follow-up. Survivors were younger at onset, in a minimally conscious state (MCS) at admission and had spent longer time in rehabilitation. Patients in a MCS were more likely to survive, and be in a state better than MCS over the follow-up time than patients with an unresponsive wakefulness syndrome (UWS). A small proportion of patients with UWS at admission emerged from MCS at follow-up. Emergence from MCS was associated with traumatic brain injury (TBI) and higher functional independence. CONCLUSION: Clinical outcome is mostly concordant with previous findings. Survivors' rehabilitation duration suggest revision of current standards. HRQOL results indicate a correlation with functional independence and that condition-specific HRQOL should not be neglected.	[Lopez-Rolon, Alex; Vogler, Jana; Czermak, Stefan; Heck, Suzette; Straube, Andreas; Bender, Andreas] Univ Munich, Dept Neurol, Munich, Germany; [Howell, Kaitlen] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Shock, Jonathan] Univ Cape Town, Dept Math & Appl Math, Cape Town, South Africa; [Bender, Andreas] Therapiezentrum Burgau, Dept Neurol, Burgau, Germany		Lopez-Rolon, A (corresponding author), Klinikum LMU Muenchen Grosshadern, Neurol Klin, Stn I2, Marchioninistr 15, D-81377 Munich, Germany.	alopezr@med.lmu.de		Bender, Andreas/0000-0002-6328-7104			Bender A, 2012, J NEUROL, V259, P2481, DOI 10.1007/s00415-012-6573-8; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; COLVIN CR, 1994, PSYCHOL BULL, V116, P3, DOI 10.1037/0033-2909.116.1.3; Cruzado JA, 2013, BRAIN INJURY, V27, P793, DOI 10.3109/02699052.2013.793402; Di Perri C, 2014, EPILEPSY BEHAV, V30, P28, DOI 10.1016/j.yebeh.2013.09.014; Fingelkurts Andrew A, 2016, Open Neuroimag J, V10, P69, DOI 10.2174/1874440001610010069; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Graf J.-M., 1998, GESUNDHEITSWISSENSCH, V6, P3; Grill E, 2013, ARCH PHYS MED REHAB, V94, P1870, DOI 10.1016/j.apmr.2012.10.040; Gudex C, 1996, QUAL LIFE RES, V5, P521, DOI 10.1007/BF00439226; Hansen H.-C., 2013, BEWUSSTSEINSSTORUNGE, P219; Herschbach P, 2002, PSYCHOTHER PSYCH MED, V52, P141, DOI 10.1055/s-2002-24953; Heuschmann PU, 2005, FORTSCHR NEUROL PSYC, V73, P74, DOI 10.1055/s-2004-830172; Hinz A, 2006, PSYCHOTHER PSYCH MED, V56, P42, DOI 10.1055/s-2005-867061; Howell K, 2013, RESUSCITATION, V84, P1409, DOI 10.1016/j.resuscitation.2013.05.015; IBM Corp, 2015, IBM SPSS STAT MAC VE; James W, 1894, PSYCHOL REV, V1, P516, DOI [10.1037/h0065078, DOI 10.1037/H0065078]; Klein AM, 2013, CLIN NEUROL NEUROSUR, V115, P2136, DOI 10.1016/j.clineuro.2013.08.004; Klein AM, 2013, J NEUROTRAUM, V30, P1476, DOI 10.1089/neu.2012.2735; MAHONEY F I, 1965, Md State Med J, V14, P61; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Ortega-Suhrkamp E, 2002, ACT NEUR S, V79, P11; Petersen C, 2005, PROG BRAIN RES, V150, P545, DOI 10.1016/S0079-6123(05)50038-4; Posner JB, 2007, PLUM POSNERS DIAGNOS; Richardson J, 2015, MED DECIS MAKING, V35, P276, DOI 10.1177/0272989X14543107; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Staudinger UM, 2000, PSYCHOL RUNDSCH, V51, P185, DOI 10.1026//0033-3042.51.4.185; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson M, 2014, RESUSCITATION, V85, P795, DOI 10.1016/j.resuscitation.2014.02.008; Wong GKC, 2014, J CLIN NEUROSCI, V21, P954, DOI 10.1016/j.jocn.2013.09.010	36	5	6	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	40	4					509	517		10.3233/NRE-171438			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EX7SC	WOS:000403447500006	28222568				2022-02-06	
J	Majercik, S; Bledsoe, J; Ryser, D; Hopkins, RO; Fair, JE; Frost, RB; MacDonald, J; Barrett, R; Horn, S; Pisani, D; Bigler, ED; Gardner, S; Stevens, M; Larson, MJ				Majercik, Sarah; Bledsoe, Joseph; Ryser, David; Hopkins, Ramona O.; Fair, Joseph E.; Frost, R. Brock; MacDonald, Joel; Barrett, Ryan; Horn, Susan; Pisani, David; Bigler, Erin D.; Gardner, Scott; Stevens, Mark; Larson, Michael J.			Volumetric analysis of day of injury computed tomography is associated with rehabilitation outcomes after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	74th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 09-12, 2015	Las Vegas, NV	Amer Assoc Surg Trauma		Traumatic brain injury; outcomes; volumetric analysis of computed tomography; rehabilitation outcomes	SEVERE HEAD-INJURY; UNITED-STATES; PREDICTION; CLASSIFICATION; IMPACT; VALIDATION; DATABASE; ATROPHY; DISABILITY; MODELS	BACKGROUND: Day-of-injury (DOI) brain lesion volumes in traumatic brain injury (TBI) patients are rarely used to predict long-term outcomes in the acute setting. The purpose of this study was to investigate the relationship between acute brain injury lesion volume and rehabilitation outcomes in patients with TBI at a level one trauma center. METHODS: Patients with TBI who were admitted to our rehabilitation unit after the acute care trauma service from February 2009-July 2011 were eligible for the study. Demographic data and outcome variables including cognitive andmotor Functional Independence Measure (FIM) scores, length of stay (LOS) in the rehabilitation unit, and ability to return to home were obtained. The DOI quantitative injury lesion volumes and degree of midline shift were obtained from DOI brain computed tomography scans. A multiple stepwise regression model including 13 independent variables was created. This model was used to predict postrehabilitation outcomes, including FIM scores and ability to return to home. A p value less than 0.05 was considered significant. RESULTS: Ninety-six patients were enrolled in the study. Mean age was 43 +/- 21 years, admission Glasgow Coma Score was 8.4 +/- 4.8, Injury Severity Score was 24.7 +/- 9.9, and head Abbreviated Injury Scale score was 3.73 +/- 0.97. Acute hospital LOS was 12.3 +/- 8.9 days, and rehabilitation LOS was 15.9 +/- 9.3 days. Day-of-injury TBI lesion volumes were inversely associated with cognitive FIM scores at rehabilitation admission (p = 0.004) and discharge (p = 0.004) and inversely associated with ability to be discharged to home after rehabilitation (p = 0.006). CONCLUSION: In a cohort of patients with moderate to severe TBI requiring a rehabilitation unit stay after the acute care hospital stay, DOI brain injury lesion volumes are associated with worse cognitive FIM scores at the time of rehabilitation admission and discharge. Smaller-injury volumes were associated with eventual discharge to home. Volumetric neuroimaging in the acute injury phase may improve surgeons' ultimate outcome predictions in TBI patients. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Majercik, Sarah; Stevens, Mark] Intermt Med Ctr, Div Trauma Serv & Surg Crit Care, Murray, UT USA; [Bledsoe, Joseph] Intermt Med Ctr, Dept Emergency Med, Murray, UT USA; [Ryser, David] Intermt Med Ctr, Dept Rehabil Med, Murray, UT USA; [Hopkins, Ramona O.] Intermt Med Ctr, Dept Med, Pulm & Crit Care Div, Murray, UT USA; Intermt Med, Ctr Humanizing Crit Care, Murray, UT USA; [Hopkins, Ramona O.; Fair, Joseph E.; Frost, R. Brock; Bigler, Erin D.; Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.; Bigler, Erin D.; Larson, Michael J.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Frost, R. Brock] Univ New Mexico, Coll Med, Dept Psychiat, Albuquerque, NM 87131 USA; [MacDonald, Joel] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; Intermt Med Ctr, Murray, UT USA; [Barrett, Ryan; Horn, Susan] Inst Clin Outcomes Res, Salt Lake City, UT USA; [Pisani, David] Intermt Med Ctr, Dept Radiol, Murray, UT USA; [Gardner, Scott] Intermt Med Ctr, Div Trauma Serv, Murray, UT USA		Majercik, S (corresponding author), Intermt Med Ctr, Div Trauma Serv, 5121 South Cottonwood St, Salt Lake City, UT 84157 USA.	sarah.majercik@imail.org	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	Intermountain Research and Medical Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Ontario Neurotrauma Foundation; National Institute for Disability and Rehabilitation Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	This research funded by a grant from the Intermountain Research and Medical Foundation and grants from National Institutes of Health, the Ontario Neurotrauma Foundation, and the National Institute for Disability and Rehabilitation Research.	Athinoula A., MARTINOS CTR BIOMEDI; Barker MD, 2014, J HEAD TRAUMA REHAB, V29, P400, DOI 10.1097/HTR.0b013e31828a0a45; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bigler ED, 2014, NEUROLOGY, V83, P1226, DOI 10.1212/WNL.0000000000000848; Centers for Disease Control and Prevention, 2013, 10 LEAD CAUS DEATH A; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gardizi E, 2014, ARCH PHYS MED REHAB, V95, P2396, DOI 10.1016/j.apmr.2014.06.004; Granberg T, 2015, J NEUROIMAGING, V25, P996, DOI 10.1111/jon.12237; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hamilton BB, 1987, REHABILITATION OUTCO; Hopkins RO, 2012, NEUROREHABILITATION, V31, P319, DOI 10.3233/NRE-2012-0799; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS173, DOI 10.1016/j.apmr.2015.03.027; Lange N, 2015, AUTISM RES, V8, P82, DOI 10.1002/aur.1427; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Reider-Groswasser II, 2002, BRAIN INJURY, V16, P517, DOI 10.1080/02699050110119141; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Seghier ML, 2014, STROKE, V45, P877, DOI 10.1161/STROKEAHA.113.003587; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	36	5	6	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2017	82	1					80	90		10.1097/TA.0000000000001263			11	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EH5ZT	WOS:000391852600019	27805992	Green Accepted			2022-02-06	
J	Martinez-Valverde, T; Sanchez-Guerrero, A; Vidal-Jorge, M; Torne, R; Castro, L; Gandara, D; Munar, F; Poca, MA; Sahuquillo, J				Martinez-Valverde, Tamara; Sanchez-Guerrero, Angela; Vidal-Jorge, Marian; Torne, Ramon; Castro, Lidia; Gandara, Dario; Munar, Francisca; Poca, Maria-Antonia; Sahuquillo, Juan			Characterization of the Ionic Profile of the Extracellular Space of the Injured and Ischemic Brain: A Microdialysis Study	JOURNAL OF NEUROTRAUMA			English	Article						brain microdialysis; ischemic stroke; potassium; sodium; TBI	CEREBRAL CONTUSION; NEUROCRITICAL PATIENTS; CORTICAL POTASSIUM; EDEMA; SODIUM; TISSUE; PATHOPHYSIOLOGY; GLYCEROL; CHLORIDE; MRI	Traumatic brain injury (TBI) and ischemic stroke cause a variable disruption of ionic homeostasis and massive ionic fluxes with subsequent osmotic water movement across the cells that causes edema, brain swelling, and deformation of the damaged tissue. Although cerebral microdialysis (CMD) has been used to study the brain neurochemistry, the ionic profiles of brain interstitial space fluid have rarely been reported in humans. We studied the ionic profile in injured areas of the brain by using CMD. As a control group, we included seven patients who had undergone surgical treatment of posterior fossa lesions, without abnormalities in the supratentorial compartment. Inductively coupled plasma mass spectrometry (ICP-MS) was used for ion determination. No significant differences were found in the [Na+](o), [K+](o), and [Cl-](o) between normal injured brains and controls. The ionic profile of the ischemic core was characterized by very high [K+](o) and an increase in [Na+](o), whereas [Cl-](o) was linearly related to [Na+](o). In the traumatic core (TC), significantly higher levels of [Na+](o), [Cl-](o), and [K+](o) were found. The main finding in the penumbra was a completely normal ionic profile for [Na+](o) and [K+](o) in 60% of the samples. ICP-MS coupled to ionic assays creates a powerful tool for a better understanding of the complex ionic disturbances that occur after severe TBI and ischemic stroke.	[Martinez-Valverde, Tamara; Sanchez-Guerrero, Angela; Vidal-Jorge, Marian; Torne, Ramon; Castro, Lidia; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain; [Torne, Ramon; Gandara, Dario; Poca, Maria-Antonia; Sahuquillo, Juan] Univ Autonoma Barcelona, Dept Neurosurg, Vall dHebron Univ Hosp, Barcelona, Spain; [Munar, Francisca] Univ Autonoma Barcelona, Dept Anesthesiol, Vall dHebron Univ Hosp, Barcelona, Spain		Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg & Neurotraumatol, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.; Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Neurosurg Res Unit UNINN, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net	Torne, Ramon/ABI-3299-2020; Castro, Lidia/J-3976-2017; Vidal-Jorge, Marian/D-4402-2017; Poca, Maria A./B-8475-2008; Sahuquillo, Juan/B-3577-2008; Bauza, Francisca Munar/AAB-6682-2019; Sabatini, Dario Fabian Gandara/AAB-6699-2019	Torne, Ramon/0000-0001-7932-2528; Castro, Lidia/0000-0001-8513-7388; Vidal-Jorge, Marian/0000-0002-3459-9336; Poca, Maria A./0000-0002-3831-0536; Sahuquillo, Juan/0000-0003-0713-5875; Bauza, Francisca Munar/0000-0003-4579-3027; Sabatini, Dario Fabian Gandara/0000-0003-1303-9847	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [SGR 2014-844]; Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) - European Regional Development Fund (ERDF) [PI10/00302, FIS PI11/00700]; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [FI11/00195, FI12/00074]	We are grateful to J. Marc Simard from the Department of Neurosurgery, University of Maryland for critically reviewing the manuscript and providing relevant scientific input. The Neurotraumatology and Neurosurgery Research Unit is supported by a grant from the Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (SGR 2014-844). This work has been supported in part by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) with grants PI10/00302 and FIS PI11/00700, which were co-financed by the European Regional Development Fund (ERDF) and awarded to Drs. Poca and Sahuquillo, respectively. T. Martinez-Valverde and A. Sanchez-Guerrero are the recipients of personal pre-doctoral grants from the Instituto de Salud Carlos III (grants number FI11/00195 and FI12/00074, respectively).	Antunes AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13916; BETZ AL, 1994, J CEREBR BLOOD F MET, V14, P29, DOI 10.1038/jcbfm.1994.5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Doppenberg EMR, 1999, ACT NEUR S, V75, P31; Ehling S, 2010, J AOAC INT, V93, P628; Eisele P., 2015, MULT SCLER; Elmquist WF, 1997, PHARMACEUT RES, V14, P267, DOI 10.1023/A:1012081501464; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Goodman JC, 1999, ACT NEUR S, V75, P35; Gorji A, 2006, EPILEPSIA, V47, P297, DOI 10.1111/j.1528-1167.2006.00421.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Harrington MG, 2006, HEADACHE, V46, P1128, DOI 10.1111/j.1526-4610.2006.00445.x; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Katayama Y, 1998, ACT NEUR S, V71, P289; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kawamata T, 2007, PROG BRAIN RES, V161, P235, DOI 10.1016/S0079-6123(06)61016-9; Kitagawa R, 2013, NEUROSURG CLIN N AM, V24, P417, DOI 10.1016/j.nec.2013.02.002; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; LaVerde GC, 2009, J MAGN RESON IMAGING, V30, P219, DOI 10.1002/jmri.21723; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Lieutaud T., 2007, HDB MICRODIALYSIS ME, p[xiv, 697]; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; Maeda T, 2003, ACT NEUR S, V86, P329; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P7, DOI 10.1089/neu.2014.3473; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Mori K, 2002, J NEUROTRAUM, V19, P1261, DOI 10.1089/08977150260338047; NATTIE EE, 1980, J APPL PHYSIOL, V49, P95, DOI 10.1152/jappl.1980.49.1.95; Nguyen MK, 1985, J APPL PHYSIOL, V100, P1293, DOI [10.1152/japplphysiol.01274.2005, DOI 10.1152/JAPPLPHYSIOL.01274.2005]; O'Donnell Martha E, 2014, Adv Pharmacol, V71, P113, DOI 10.1016/bs.apha.2014.06.011; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Poca MA, 2006, J NEUROTRAUM, V23, P1510, DOI 10.1089/neu.2006.23.1510; Prabhakar H, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010026.pub2; Purves W. K., 2004, LIFE SCI BIOL, P87; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sahuquillo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102540; Sick TJ, 1998, J CEREBR BLOOD F MET, V18, P1114, DOI 10.1097/00004647-199810000-00008; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simard JM, 2004, J NEUROSURG ANESTH, V16, P98, DOI 10.1097/00008506-200401000-00021; Somjen GG, 2004, IONS BRAIN NORMAL FU; Strong AJ, 2005, ADV TECH STAND NEUR, V30, P3, DOI 10.1007/3-211-27208-9_1; Torto N, 2009, CHROMATOGRAPHIA, V70, P1305, DOI 10.1365/s10337-009-1335-1; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Wetterling F, 2015, J CEREBR BLOOD F MET, V35, P103, DOI 10.1038/jcbfm.2014.174; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	53	5	5	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					74	85		10.1089/neu.2015.4334			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100010	27220951				2022-02-06	
J	Mealings, M; Douglas, J; Olver, J				Mealings, Margaret; Douglas, Jacinta; Olver, John			Beyond academic performance: Practice implications for working with students following traumatic brain injury	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Traumatic brain injury; students; education; rehabilitation	SELF-ESTEEM; SOCIAL CONNECTION; YOUNG-ADULTS; SCHOOL; CHILDREN; TBI; ADOLESCENTS; REHABILITATION; CHILDHOOD; QUALITY	Purpose: Speech-language pathologists (SLPs) have a key role in supporting educational participation for secondary and tertiary students with traumatic brain injury (TBI). This article aims to (i) explore issues identified by students with TBI that affect educational participation beyond their academic performance, (ii) offer a framework based on research evidence to guide the practice of SLPs and (iii) explore strategies that may expand the traditional roles of SLPs to support students beyond academic performance. Method: Data were drawn from an earlier qualitative research project in which three adolescent males were interviewed about their experiences of returning to education after severe TBI. Interviews were recorded, transcribed verbatim and analysed using a grounded theory approach. Result: Six themes were identified that had a substantial impact beyond academic performance: poor community awareness of TBI, the invisible nature of TBI, getting back to everyday life, planning to return to education, being accepted and adjusting to long-term changes. Incorporating these factors, a clinical framework is put forward to guide SLPs in developing strategies for promoting positive educational participation. Conclusion: By considering factors beyond academic performance and addressing these in intervention, SLPs may significantly improve the overall educational success and wellbeing of students living with TBI.	[Mealings, Margaret; Douglas, Jacinta] La Trobe Univ, Dept Community & Clin Allied Hlth, Bundoora, Vic, Australia; [Mealings, Margaret; Olver, John] Epworth Healtchare, Epworth Rehabil, Richmond, Australia; [Douglas, Jacinta] Summer Fdn, Box Hill, Vic, Australia; [Olver, John] Epworth Monash Rehabil Med Unit, Richmond, Australia		Mealings, M (corresponding author), Epworth Rehabil, Community Integrat Team, 89 Bridge Rd, Richmond, Vic 3121, Australia.	margaret.mealings@epworth.org.au		Olver, John/0000-0001-7069-1191; Douglas, Jacinta/0000-0003-0940-6624	Epworth Healthcare and Victorian Brain Injury Recovery Association/East Kew Branch of the Community Bendigo Bank Research Scholarship	This research was supported by scholarships awarded to the first author by Epworth Healthcare and Victorian Brain Injury Recovery Association/East Kew Branch of the Community Bendigo Bank Research Scholarship.	Anderson Downing J., 2007, INTERV SCH CLIN, V42, P300, DOI [10.1177/10534512070420050701, DOI 10.1177/10534512070420050701]; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Ball H, 2013, EDUC PSYCHOL PRACT, V29, P69, DOI 10.1080/02667363.2012.755460; Barber BK, 2004, J ADOLESCENT RES, V19, P3, DOI 10.1177/0743558403258113; BOULDIN K. V., 2005, ENGL J, V94, P52; BROWNE J, 2004, HDB RES METHODS NURS; Bullock LM, 2005, PREV SCH FAIL, V49, P6, DOI 10.3200/PSFL.49.4.6-10; Bush E, 2011, J POSTSECOND EDUC DI, V24, P231; Cahill SM, 2014, CAN J OCCUP THER, V81, P93, DOI 10.1177/0008417414533185; Charmaz K., 2014, BROKERAGE CLOSURE IN; Chesire DJ, 2011, J APPL SCH PSYCHOL, V27, P60, DOI 10.1080/15377903.2011.540513; Ciccia AH, 2015, INT J LANG COMM DIS, V50, P436, DOI 10.1111/1460-6984.12153; Clegg Sue, 2010, BRIT J SOCIOL EDUC, V31/6, P719, DOI DOI 10.1080/01425692.2010.515102; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Douglas J, 2015, RETHINKING REHABILIT; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Edwards TC, 2003, J PEDIATR PSYCHOL, V28, P233, DOI 10.1093/jpepsy/jsg011; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Feeney T., 1997, STUDENTS ACQUIRED BR; Foster L, 2013, BRAIN INJURY, V27, P485, DOI 10.3109/02699052.2012.750747; Fuller A., 2000, RAISING REAL PEOPLE; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Good D, 2012, BRAIN INJURY, V26, P699; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Grigas L., 2015, COLLABORATION BEGINS; Hawley CA, 2012, NEUROREHABILITATION, V30, P173, DOI 10.3233/NRE-2012-0742; Hazel CE, 2013, PSYCHOL SCHOOLS, V50, P689, DOI 10.1002/pits.21703; Helps Y., 2008, INJURY RES STAT SERI; Hughes S, 2014, LANG SPEECH HEAR SER, V45, P3, DOI 10.1044/2013_LSHSS-13-0013; Kaffenberger C., 2006, PROFESSIONAL SCH COU, V9, P223, DOI [10.5330/prsc.9.3.xr27748161346325, DOI 10.5330/PRSC.9.3.XR27748161346325]; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Kranke D, 2013, J POSTSECOND EDUC DI, V26, P35; Krause M, 2015, SEMIN SPEECH LANG, V36, P60, DOI 10.1055/s-0034-1396447; Lan W., 2003, J ED STUDENTS PLACED, V8, P309, DOI DOI 10.1207/S15327671ESPR0803_2; Lavoie R., 2002, 20 TIPS PROMOTE POSI; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Murphy S. V, 2013, THESIS; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Sahota H., 2012, IBIA 9 WORLD C BRAIN; Schilling EJ, 2012, TEACH EXCEPT CHILD, V45, P54, DOI 10.1177/004005991204500108; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Shanahan L., 2004, LANGUAGE HEARING, V6, P26; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Sirois K, 2012, BRAIN INJURY, V26, P545; Speech Pathology Australia, 2011, COMP BAS OCC STAND S; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Thomson MM, 2012, SUPPORT LEARN, V27, P158, DOI 10.1111/1467-9604.12004; Venville A, 2016, INT J DISABIL DEV ED, V63, P571, DOI 10.1080/1034912X.2016.1153050; Vickerman P, 2010, DISABIL SOC, V25, P21, DOI 10.1080/09687590903363290; Walker S, 2005, ED CHILDREN ACQUIRED; Willer B., 2012, WHATEVER IT TAKES; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Wlodarczyk K, 2012, BRAIN INJURY, V26, P701; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; [No title captured]	66	5	5	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.		2017	19	5					441	453		10.1080/17549507.2016.1221453			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FE0PF	WOS:000407921500001	27778519				2022-02-06	
J	Narad, ME; Taylor, HG; Yeates, KO; Stancin, T; Kirkwood, MW; Wade, SL				Narad, Megan E.; Taylor, H. Gerry; Yeates, Keith O.; Stancin, Terry; Kirkwood, Michael W.; Wade, Shari L.			Internet-based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT): Protocol for a multi-site randomized controlled trial of an internet-based parenting intervention	DIGITAL HEALTH			English	Article						Pediatric traumatic brain injury; telehealth; parenting intervention; live coaching	TRAUMATIC BRAIN-INJURY; TERM BEHAVIOR PROBLEMS; PRELIMINARY EFFICACY; SKILLS PROGRAM; FAMILY INTERVENTION; CONDUCT PROBLEMS; YOUNG-CHILDREN; ADOLESCENTS; PREDICTORS; OUTCOMES	Objectives: We discuss the rationale and description of the Internet-Based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT), a telehealth intervention designed to promote positive parenting skills through live in-session skills practice and coaching. A second objective is to describe the protocol of a three-armed (Internet Resource Comparison, I-InTERACT, and I-InTERACT Express) multi-site randomized controlled trial (RCT) designed to examine intervention effectiveness. Method: Participants included parents of children ages 3-9 who sustained a moderate or severe traumatic brain injury (TBI) any time since birth. Measures assessing parenting behaviors, parent-child interaction, parent/family factors, and child factors were collected prior to intervention, 3 months after enrollment and 6-months after enrollment. Results: This protocol manuscript was submitted before the completion of data collection and prior to any data analysis. It is expected that the I-InTERACT and I-InTERACT Express interventions will be associated with an increase in positive parenting behaviors, and a decrease in negative parenting behaviors, parental distress, and child behavior problems. Finally it is expected that socioeconomic status, life stressors, and social resources will moderate treatment effects. Conclusions: The study described in this protocol paper represents one of the first large multi-site RCTs of a parenting intervention designed to promote positive parenting skills in families with young children who sustained a TBI. We plan to disseminate findings to patients and families as well as clinical and research professionals, and begin to develop a research base for this telehealth intervention.	[Narad, Megan E.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA; [Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol,Hotchkiss Brain Inst, Calgary, AB, Canada; [Stancin, Terry] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019		National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research grant [H133B090010]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This publication was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research grant number H133B090010. Clinicaltrials.gov assigned identifier: NCT01214694.	Achenbach TM, 2001, ASEBA SCH AGE FORMS; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Antonini TN, 2012, J TELEMED TELECARE, V18, P333, DOI 10.1258/jtt.2012.120404; BOGGS SR, 1990, J CLIN CHILD PSYCHOL, V19, P75, DOI 10.1207/s15374424jccp1901_9; Bothroyd SR., 1997, PRELIMINARY MANUAL C; Bradley RH, 2007, DEV PSYCHOL, V43, P1390, DOI 10.1037/0012-1649.43.6.1390; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; BURNS GL, 1991, PSYCHOL ASSESSMENT J, V3, P202, DOI DOI 10.1037/1040-3590.3.2.202; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; Eyberg S., 1988, CHILD FAMILY BEHAV T, V10, P33, DOI [10.1300/J019v10n01_04, DOI 10.1300/J019V10N01_04]; Eyberg SM, 2005, MANUAL DYDACTIC PARE; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gross D, 2003, J CONSULT CLIN PSYCH, V71, P261, DOI 10.1037/0022-006X.71.2.261; Gurwitch RH, 2016, CHILD ABUSE NEGLECT, V53, P138, DOI 10.1016/j.chiabu.2015.10.016; Hartman RR, 2003, J CHILD PSYCHOL PSYC, V44, P388, DOI 10.1111/1469-7610.00129; Hudson A, 2001, HELP FAM CHANG C BRI; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; KAZDIN AE, 1993, J CLIN CHILD PSYCHOL, V22, P2, DOI 10.1207/s15374424jccp2201_1; KAZDIN AE, 1995, J FAM PSYCHOL, V9, P402; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Lorenz F. O., 1994, FAMILIES TROUBLED TI, P21; LOYD BH, 1985, J PEDIATR PSYCHOL, V10, P169, DOI 10.1093/jpepsy/10.2.169; Max JE, 1998, BRAIN INJURY, V12, P41; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOOS R, 1988, LIFE STRESSORS SOCIA; Newman MG, 2004, J CLIN PSYCHOL, V60, P141, DOI 10.1002/jclp.10240; Nowak C, 2008, CLIN CHILD FAM PSYCH, V11, P114, DOI 10.1007/s10567-008-0033-0; Owens PL, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00013; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Schuhmann EM, 1998, J CLIN CHILD PSYCHOL, V27, P34, DOI 10.1207/s15374424jccp2701_4; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Tate DF, 2004, J CLIN PSYCHOL, V60, P209, DOI 10.1002/jclp.10247; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Thomas KM, 2004, J COGNITIVE NEUROSCI, V16, P1339, DOI 10.1162/0898929042304688; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; US Department of Health and Human Services, 2010, TRAUMATIC BRAIN INJU; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Webster-Stratton C, 1999, J CHILD PSYCHOL PSYC, V40, P917, DOI 10.1111/1469-7610.00509; Webster-Stratton C, 2008, J CHILD PSYCHOL PSYC, V49, P471, DOI 10.1111/j.1469-7610.2007.01861.x; Wiggins TL, 2009, FAM PROCESS, V48, P517, DOI 10.1111/j.1545-5300.2009.01299.x; Woods D., 2014, SOCIAL CARE NEURODIS, V5, P51, DOI [10.1108/SCN-01-2013-0002, DOI 10.1108/SCN-01-2013-0002]; Woods D., 2014, SOC CARE NEURODIS, V5, P145, DOI DOI 10.1108/SCN-03-2013-0006; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	67	5	5	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2055-2076			DIGIT HEALTH	Digit. Health	JAN-DEC	2017	3								2055207617719423	10.1177/2055207617719423			11	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Medical Informatics	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Medical Informatics	GQ8TD	WOS:000442031000030	29942608	Green Published, gold			2022-02-06	
J	Qannam, H; Mahmoud, H; Ben Mortenson, W				Qannam, Hazem; Mahmoud, Husam; Ben Mortenson, W.			Traumatic brain injury rehabilitation in Riyadh, Saudi Arabia: Time to rehabilitation admission, length of stay and functional outcome	BRAIN INJURY			English	Article						Traumatic brain injury; rehabilitation; length of stay; time to rehabilitation admission; functional independence measure	INDEPENDENCE MEASURE; INPATIENT REHABILITATION; OLDER-ADULTS; ALCOHOL; CHARGES; EPIDEMIOLOGY; VARIABLES; PATTERNS; CHILDREN	Objectives: (1) Describe trends in time to rehabilitation admission and rehabilitation length of stay (LOS), (2) compare functional independence at discharge from rehabilitation between patients who arrived directly from acute care versus those from elsewhere and (3) identify independent predictors of functional outcomes following rehabilitation.Setting: Traumatic brain injuries rehabilitation unit of King Fahad Medical City, Riyadh, Saudi Arabia.Methods: We collected information on time from injury to rehabilitation admission, rehabilitation LOS, functional independence measure (FIM) score (admission and discharge) and demographic variables for 66 patients who arrived to rehabilitation from acute care and 142 patients who arrived from elsewhere. A mixed model analysis of variance measured change in FIM score between groups. Hierarchical regression was employed to investigate variables associated with FIM score at rehabilitation discharge.Results: Patients arriving directly from acute care had a time from injury to rehabilitation admission 1/3 that of, and a higher discharge FIM score than, patients arriving from elsewhere. For the latter group, increasing time from injury to rehabilitation admission was associated with lower rehabilitation discharge FIM score.Conclusions: Reducing time from injury to rehabilitation admission and promoting enrolment to inpatient traumatic brain injury rehabilitation directly from acute care may improve functional outcome at discharge from rehabilitation.	[Qannam, Hazem] King Fahad Med City Rehabil Hosp, Occupat Therapy Unit, Riyadh, Saudi Arabia; [Mahmoud, Husam] King Fahad Med City Rehabil Hosp, Comprehens Rehabil Care Dept, Riyadh 11525, Saudi Arabia; [Ben Mortenson, W.] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC, Canada; [Ben Mortenson, W.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Ben Mortenson, W.] Int Collaborat Repair Discoveries, Vancouver, BC, Canada		Qannam, H (corresponding author), King Fahad Med City Rehabil Hosp, Comprehens Rehabil Care Dept, Riyadh 11525, Saudi Arabia.	hqannam@kfmc.med.sa	Mortenson, W. Ben/L-7441-2013	Mortenson, W. Ben/0000-0002-0183-6163	King Fahad Medical City Intramural Research Fund (IRF) [015-004]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	The authors acknowledge the research sponsorship of the King Fahad Medical City Intramural Research Fund (IRF# 015-004). W. Ben Mortenson is supported by a New Investigator Award from the Canadian Institutes of Health Research. The authors report no conflicts of interest.	Al-Habib A, 2013, ANN SAUDI MED, V33, P351, DOI 10.5144/0256-4947.2013.351; Al-Jadid MS, 2012, SAUDI MED J, V33, P326; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Avesani R, 2012, EUR J PHYS REHAB MED, V48, P433; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Central Intelligence Agency, 2016, WORLD FACTB 2016 17; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; deGuise E, 2012, RELATIONSHIP ACUTE F; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Faul M, 2010, TRAUMATIC BRAIN INJU; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Greiss C, 2016, J TRAUMA ACUTE CARE, V80, P70, DOI 10.1097/TA.0000000000000890; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hawkins ML, 2005, AM SURGEON, V71, P920; Hawkins ML, 2003, AM SURGEON, V69, P497; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; LANGOIS JA, 2006, TRAUMATIC BRAIN INJU; Mazaux JM, 2001, J REHABIL MED, V33, P99; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Popescu C, 2015, J Med Life, V8, P272; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saffle JR, 2005, AM SURGEON, V71, P929; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Stallion A, 2007, J TRAUMA, V62, P1262; Steiner Emanuel, 2016, J Trauma Manag Outcomes, V10, P5, DOI 10.1186/s13032-016-0035-8; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; The Lancet, 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Toschlog EA, 2003, AM SURGEON, V69, P491; Valk-Kleibeuker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087414; Whiteneck G, 2011, J SPINAL CORD MED, V34, P133, DOI 10.1179/107902611X12971826988011; WHITLOCK J A JR, 1992, Brain Injury, V6, P447, DOI 10.3109/02699059209008140; World Health Organization, 2016, GLOB HLTH OBS DAT RE; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zampolini M, 2012, BRAIN INJURY, V26, P27, DOI 10.3109/02699052.2011.635358; Zbogar D, 2016, SPINAL CORD; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x	50	5	5	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	5					702	708		10.1080/02699052.2017.1286386			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV8OA	WOS:000402039900016	28362120	Green Accepted			2022-02-06	
J	Reznik, JE; Biros, E; Sacher, Y; Kibrik, O; Milanese, S; Gordon, S; Galea, MP				Reznik, J. E.; Biros, E.; Sacher, Y.; Kibrik, O.; Milanese, S.; Gordon, S.; Galea, M. P.			A preliminary investigation on the effect of extracorporeal shock wave therapy as a treatment for neurogenic heterotopic ossification following traumatic brain injury. Part II: Effects on function	BRAIN INJURY			English	Article						Traumatic brain injury; neurogenic heterotopic ossification; Extracorporeal shock wave therapy	SPINAL-CORD-INJURY; MANAGEMENT; ESWT	Introduction: Neurogenic heterotopic ossification (NHO) occurs as a complication of traumatic brain injury (TBI). Management of clinically significant NHO remains variable. Complications of mature NHO include limitation of mobility. The effect of the extracorporeal shock wave therapy (ESWT) on range of motion at hip and knee, and function in patients with TBI with chronic NHO was investigated. Methods: A series of single-case studies applying ESWT to chronic NHO at the hip or knee of 11 patients with TBI were undertaken at a rehabilitation hospital. Participants received four applications of high-energy EWST delivered to the affected hip or knee over a period of 8 weeks. Two-weekly follow-up assessments were carried out; final assessments were made 3 and 6 months post-intervention. Range of motion (ROM) and Functional Reach (FR) or Modified Functional Reach (MFR) were measured. Results: Application of high-energy ESWT was associated with significant improvement in ROM (flexion) of the NHO-affected knee (Tau = 0.833, 95% CI 0.391-1.276, p = 0.002) and significant improvement of FR (Overall Tau 0.486, 95% CI 0.141-0.832, p = 0.006); no significant improvement in hip ROM or MFR. Conclusions: ESWT may improve mobility and balance of patients with TBI who have chronic NHO.	[Reznik, J. E.; Gordon, S.; Galea, M. P.] James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia; [Reznik, J. E.; Galea, M. P.] James Cook Univ, Div Trop Hlth & Med, Townsville, Qld 4811, Australia; [Biros, E.] James Cook Univ, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld, Australia; [Sacher, Y.] Tel Aviv Univ, Sackler Fac Med, Brain Injury Unit, Raanana, Israel; [Kibrik, O.] Tel Aviv Univ, Sackler Fac Med, Loewenstein Rehabil Ctr, Raanana, Israel; [Milanese, S.] Univ South Australia, Discipline Physiotherapy, Adelaide, SA, Australia; [Gordon, S.] Flinders Univ S Australia, Sch Hlth Sci, Bedford Pk, SA, Australia; [Galea, M. P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia		Reznik, JE (corresponding author), James Cook Univ, Div Trop Hlth & Med, Townsville, Qld 4811, Australia.	jackie.reznik@jcu.edu.au	Galea, Mary/F-4242-2010; Milanese, Steve/F-3898-2013	Galea, Mary/0000-0003-0045-7978; Milanese, Steve/0000-0002-6470-3296; Gordon, Susan/0000-0002-4760-1212			Akbar M, 2007, PHYS MED REHAB KUROR, V17, P156, DOI 10.1055/s-2007-956519; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Banovac K, 1997, SPINAL CORD, V35, P158, DOI 10.1038/sj.sc.3100380; Banovac Kresimir, 2004, J Spinal Cord Med, V27, P376; Brissot R., 2005, Annales de Readaptation et de Medecine Physique, V48, P581, DOI 10.1016/j.annrmp.2005.04.014; Burtis CA., 2012, TIETZ TXB CLIN CHEM, V5th; Buselli P, 2010, ULTRASOUND MED BIOL, V36, P397, DOI 10.1016/j.ultrasmedbio.2009.11.007; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Haake M, 2002, JOINT BONE SPINE, V69, P344, DOI 10.1016/S1297-319X(02)00408-6; Katz-Leurer M, 2009, DISABIL REHABIL, V31, P243, DOI 10.1080/09638280801927830; KJAERSGAARDANDERSEN P, 1988, CLIN ORTHOP RELAT R, P102; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Norkin C C, 2016, MEASUREMENT JOINT MO; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; Pfeil U, 1997, ORTHOPADE, V26, P528; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Reznik JE, 2013, BRAIN INJURY, V27, P242, DOI 10.3109/02699052.2012.729293; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Siebert Werner, 2003, MMW Fortschr Med, V145, P18; Silver JR, 2011, SPINAL CORD, V49, P482, DOI 10.1038/sc.2010.133; Silver J R, 1969, Paraplegia, V7, P220; Smith JD, 2012, PSYCHOL METHODS, V17, P510, DOI 10.1037/a0029312; Speed CA, 2004, J BONE JOINT SURG BR, V86B, P165, DOI 10.1302/0301-620X.86B2.14253; Torrance David Allen, 2011, J Can Chiropr Assoc, V55, P240; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11	30	5	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	4					533	541		10.1080/02699052.2017.1283060			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ES9TD	WOS:000399902900012	28340312	Green Accepted			2022-02-06	
J	Roessler, RT; Rumrill, PD; Rumrill, SP; Minton, DL; Hendricks, DJ; Sampson, E; Stauffer, C; Scherer, MJ; Nardone, A; Leopold, A; Jacobs, K; Elias, E				Roessler, Richard T.; Rumrill, Phillip D., Jr.; Rumrill, Stuart P.; Minton, Deborah L.; Hendricks, Deborah J.; Sampson, Elaine; Stauffer, Callista; Scherer, Marcia J.; Nardone, Amanda; Leopold, Anne; Jacobs, Karen; Elias, Eileen			Qualitative case studies of professional level workers with traumatic brain injuries: A contextual approach to job accommodation and retention	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Traumatic brain injury; workplace accommodations; needs assessment; job retention	TRANSITION; PEOPLE; REHABILITATION; EMPLOYMENT; OUTCOMES; COMMUNITY; ISSUES	BACKGROUND: Traumatic brain injury (TBI) is a multi-systemic disability that causes a wide range of difficulties with personal and social functioning. METHODS: Four individuals with TBI participated in an evaluation of barriers to their continued employment following graduation from college. A trained interviewer completed the Work Experience Survey (WES) in teleconsultation sessions with each participant. RESULTS: Researchers applied a qualitative case study research design. Participants reported a wide range of difficulties in performing essential functions of their jobs (3 to 24) that have the potential to significantly affect their productivity. Career mastery problems reflected outcomes associated with TBI such as 'believing that others think I do a good job' and 'having the resources (e.g., knowledge, tools, supplies, and equipment) needed to do the job.' Indicative of their wish to continue their current employment, participants reported high levels of job satisfaction. CONCLUSIONS: The WES is a cost-effective needs assessment tool to aid health and rehabilitation professionals in providing on-the-job supports to workers with TBI.	[Rumrill, Phillip D., Jr.; Minton, Deborah L.; Stauffer, Callista] Kent State Univ, Kent, OH 44242 USA; [Rumrill, Stuart P.] Univ Arkansas, Fayetteville, AR 72701 USA; [Hendricks, Deborah J.; Sampson, Elaine] West Virginia Univ, Morgantown, WV USA; [Scherer, Marcia J.] Univ Rochester, Rochester, NY USA; [Nardone, Amanda; Jacobs, Karen] Boston Univ, Boston, MA 02215 USA; [Leopold, Anne; Elias, Eileen] JBS Int, North Bethesda, MD USA		Rumrill, PD (corresponding author), Kent State Univ, Ctr Disabil Studies, 413 White Hall,POB 5190, Kent, OH 44242 USA.	prumrill@kent.edu		Jacobs, Karen/0000-0002-4718-990X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0062-01-00]	The contents of this article were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR, grant number 90DP0062-01-00). NIDILRR is a Center within the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, or HHS, and the reader should not assume endorsement by the federal government.	Allaire SH, 2003, REHABIL COUNS BULL, V46, P147, DOI 10.1177/00343552030460030301; Bishop M, 2015, WORK, V52, P723, DOI 10.3233/WOR-152199; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Ciccia AH, 2015, INT J LANG COMM DIS, V50, P436, DOI 10.1111/1460-6984.12153; Cotton GS, 2012, OCCUP THER HEALTH CA, V26, P270, DOI 10.3109/07380577.2012.726759; Crites J., 1990, CAREER MASTERY INVEN; Dillahunt-Aspillaga C., 2015, J APPL REHABIL COUS, V46, P3, DOI [10.1891/0047-2220.46.1.3, DOI 10.1891/0047-2220.46.1.3]; Fakolade A, 2017, BRIT J OCCUP THER, V80, P259, DOI 10.1177/0308022617690405; Hall A, 2012, BRAIN IMPAIR, V13, P85, DOI 10.1017/BrImp.2012.7; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hendricks DJ, 2015, NEUROREHABILITATION, V37, P449, DOI 10.3233/NRE-151273; Jakobsen K, 2016, WORK, V53, P57, DOI 10.3233/WOR-152215; Koch LC, 2008, WORK, V31, P357; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Power P. W., 2011, GUIDE CAREER MANAGEM; Roessler R., 2015, ENHANCING PRODUCTIVI; Roessler R., 1995, WORK EXPERIENCE SURV; Roessler RT, 1998, J VOCAT REHABIL, V10, P219, DOI DOI 10.1016/S1052-2263(98)00018-X; Rubin S., 2016, FDN VOCATIONAL REHAB; Ruddle Jean Jean, 2011, SOCIAL CARE NEURODIS, V2, P200, DOI [10.1108/20420911111188452, DOI 10.1108/20420911111188452]; Ruh D, 2009, J POSTSECOND EDUC DI, V22, P67; Rumrill P., 2004, J VOCATIONAL REHABIL, V29, P177; Rumrill P.D., 2017, RES REHABILITATION C; Rumrill P, 2016, J HEAD TRAUMA REHAB, V31, P288, DOI 10.1097/HTR.0000000000000186; Saunders SL, 2014, J OCCUP REHABIL, V24, P100, DOI 10.1007/s10926-013-9436-y; Stergiou-Kita M, 2012, J OCCUP REHABIL, V22, P166, DOI 10.1007/s10926-011-9332-2; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Strauser D. R., 2013, CAREER DEV EMPLOYMEN; Swanson J. L., 2013, CAREER DEV COUNSELIN, V2nd, P29; Wehman P., 2013, LIFE CLASSROOM; Wright CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156826	32	5	5	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2017	58	1					3	14		10.3233/WOR-162601			12	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FJ0XW	WOS:000412435600002	28922180	Bronze			2022-02-06	
J	Rosario, ER; Espinoza, L; Kaplan, S; Khonsari, S; Thurndyke, E; Bustos, M; Vickers, K; Navarro, B; Scudder, B				Rosario, Emily R.; Espinoza, Laura; Kaplan, Stephanie; Khonsari, Sepehr; Thurndyke, Earl; Bustos, Melissa; Vickers, Kayla; Navarro, Brittney; Scudder, Bonnie			Patient navigation for traumatic brain injury promotes community re-integration and reduces re-hospitalizations	BRAIN INJURY			English	Article						Activities of daily living; brain injury; cognition; community integration; depression; outcomes; patient navigation; rehabilitation; re-hospitalizations; social work	QUALITY-OF-LIFE; SUBSTANCE-ABUSE TREATMENT; HEAD-INJURY; FOLLOW-UP; INPATIENT REHABILITATION; MULTICENTER ANALYSIS; CANCER-MORTALITY; OUTCOME MEASURES; BREAST-CANCER; UNITED-STATES	Objective: To determine the effectiveness of a Navigation programme for patients with traumatic brain injury.Design: Prospective programme evaluation.Setting: Inpatient rehabilitation facility and community settings.Participants: Eighteen individuals who suffered a traumatic brain injury (TBI), were between the ages of 16-70 years, and had a Rancho Score greater than IV.Intervention: Patient navigation programme focused on identifying and addressing barriers to positive outcomes, including coordination of care and facilitating communication among the family and healthcare providers, psychosocial support, caregiver support, adherence to treatment, education, community resources and financial issues.Main outcome measures: Functional status, re-hospitalizations, falls, neurobehavioral symptom inventory, neuroendocrine status, activities of daily living, community integration and caregiver burden.Results: There was a significant reduction in re-hospitalization and fall rate when comparing individuals who received navigation services and those who did not. We also observed improved adherence treatment plans and a significant increase in community integration, independence level and functional abilities.Conclusions: This study begins to highlight the effectiveness of a patient navigation programme for individuals with TBI. Future research with a larger sample will continue to help us refine patient navigation for chronic disabling conditions and determine its sustainability.	[Rosario, Emily R.; Espinoza, Laura; Kaplan, Stephanie; Khonsari, Sepehr; Thurndyke, Earl; Scudder, Bonnie] Casa Colina Hosp & Ctr Healthcare, Res Inst, 255 East Bonita Ave, Pomona, CA 91767 USA; [Bustos, Melissa; Vickers, Kayla; Navarro, Brittney] Univ LaVerne, La Verne, CA USA		Rosario, ER (corresponding author), Casa Colina Hosp & Ctr Healthcare, Res Inst, 255 East Bonita Ave, Pomona, CA 91767 USA.	erosario@casacolina.org			Casa Colina Foundation	The authors would like to thank Dr Loverso, the Casa Colina Board of Directors, and the Casa Colina Foundation for supporting this research. We would also like to thank all the clinicians and research assistants who contributed to this study including Dr Adeel Popalzai, Dr Diem Ha Hoang, Dr Elizabeth Cisneros, Dr David Patterson, Dr Kelli McSwan, Dr Jose Fuentes, Cathy Temple, and Susie Wong-Okomoto.	Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; Andraweera N, 2015, AUST HLTH REV; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner JA, 1997, J HEAD TRAUMA REHAB, V12, P57, DOI 10.1097/00001199-199710000-00006; Brawley OW, 2008, CANCER-AM CANCER SOC, V113, P1744, DOI 10.1002/cncr.23800; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Byers T, 2010, ANNU REV PUBL HEALTH, V31, P121, DOI 10.1146/annurev.publhealth.121208.131047; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2005, PSYCHOL ADDICT BEHAV, V19, P131, DOI 10.1037/0893-164X.19.2.131; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cusick CP, 2003, BRAIN INJURY, V17, P931, DOI 10.1080/0269905031000110391; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Faul M, 2010, TRAUMATIC BRAIN INJU; Freeman HP, 2006, J CANCER EDUC, V21, pS11, DOI 10.1207/s15430154jce2101s_4; Freeman Harold P, 2005, Surg Oncol Clin N Am, V14, P655, DOI 10.1016/j.soc.2005.06.002; Freeman Harold P, 2011, Cancer, V117, P3539, DOI 10.1002/cncr.26262; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Jaracz K, 2008, NEUROL NEUROCHIR POL, V42, P525; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Paskett ED, 2011, CA-CANCER J CLIN, V61, P237, DOI 10.3322/caac.20111; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shavelle R, 2000, J Insur Med, V32, P163; Vargas RB, 2008, CANCER-AM CANCER SOC, V113, P426, DOI 10.1002/cncr.23547; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	55	5	5	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1340	1347		10.1080/02699052.2017.1325937			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800011	28650255				2022-02-06	
J	Schonberger, M; Reutens, D; Beare, R; O'Sullivan, R; Rajaratnam, SMW; Ponsford, J				Schoenberger, Michael; Reutens, David; Beare, Richard; O'Sullivan, Richard; Rajaratnam, Shantha M. W.; Ponsford, Jennie			Brain lesion correlates of fatigue in individuals with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; fatigue; fatigability; vigilance; magnetic resonance imaging	EPWORTH SLEEPINESS SCALE; SUSTAINED-ATTENTION; DAYTIME SLEEPINESS; MRI; DEPRESSION; DISORDERS; NETWORKS; CORTEX; ASSOCIATION; WAKEFULNESS	The purpose of this study was to investigate the neurological correlates of both subjective fatigue as well as objective fatigability in individuals with traumatic brain injury (TBI). The study has a cross-sectional design. Participants (N=53) with TBI (77% male, mean age at injury 38 years, mean time since injury 1.8 years) underwent a structural magnetic resonance imaging (MRI) scan and completed the Fatigue Severity Scale (FSS), while a subsample (N=36) was also tested with a vigilance task. While subjective fatigue (FSS) was not related to measures of brain lesions, multilevel analyses showed that a change in the participants' decision time was significantly predicted by grey matter (GM) lesions in the right frontal lobe. The time-dependent development of the participants' error rate was predicted by total brain white matter (WM) lesion volumes, as well as right temporal GM and WM lesion volumes. These findings could be explained by decreased functional connectivity of attentional networks, which results in accelerated exhaustion during cognitive task performance. The disparate nature of objectively measurable fatigability on the one hand and the subjective experience of fatigue on the other needs further investigation.	[Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, Engelberger Str 41, D-79106 Freiburg, Germany; [Schoenberger, Michael; Rajaratnam, Shantha M. W.; Ponsford, Jennie] Monash Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Schoenberger, Michael; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Reutens, David; Beare, Richard] Monash Univ Melbourne, Dept Med, Monash Med Ctr, Melbourne, Vic, Australia; [Reutens, David] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia; [Beare, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [O'Sullivan, Richard] Epworth Med Fdn, Symb Imaging, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Schonberger, M (corresponding author), Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, Engelberger Str 41, D-79106 Freiburg, Germany.	michael.schoenberger@psychologie.uni-freiburg.de	Reutens, David/C-7226-2018; Ponsford, Jennie/H-8341-2014	Beare, Richard/0000-0002-7530-5664; Rajaratnam, Shantha/0000-0001-7527-8558; Reutens, David/0000-0002-1652-9369; Ponsford, Jennie/0000-0003-0430-125X	NHMRCNational Health and Medical Research Council of Australia [334002]	The study was funded by NHMRC grant [334002].	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aston-Jones G, 2005, J COMP NEUROL, V493, P99, DOI 10.1002/cne.20723; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Claros-Salinas D, 2013, NEUROPSYCHOL REHABIL, V23, P182, DOI 10.1080/09602011.2012.726925; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Harrington ME, 2012, PROG NEUROBIOL, V99, P93, DOI 10.1016/j.pneurobio.2012.07.004; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Koski L, 2001, NEUROPSYCHOLOGIA, V39, P268, DOI 10.1016/S0028-3932(00)00110-X; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FAT MULT SCLER EV BA; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Parasuraman R, 1998, ATTENTIVE BRAIN, P221; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Parkes JD, 1998, J SLEEP RES, V7, P41, DOI 10.1046/j.1365-2869.1998.00093.x; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Rueckert L, 1998, NEUROPSYCHOLOGIA, V36, P653, DOI 10.1016/S0028-3932(97)00150-4; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Snaith R., 1983, HOSP ANXIETY DEPRESS; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	59	5	5	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	7					1056	1070		10.1080/09602011.2016.1154875			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	FB4WK	WOS:000406142500006	26957190				2022-02-06	
J	Schonfeld, L; Jahanshahi, A; Lemmens, E; Bauwens, M; Hescham, SA; Schipper, S; Lagiere, M; Hendrix, S; Temel, Y				Schonfeld, Lisa-Maria; Jahanshahi, Ali; Lemmens, Evi; Bauwens, Matthias; Hescham, Sarah-Anna; Schipper, Sandra; Lagiere, Melanie; Hendrix, Sven; Temel, Yasin			Motor cortex stimulation does not lead to functional recovery after experimental cortical injury in rats	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Motor cortex stimulation; motor impairment; rehabilitation; behavioral tests; PET	TRAUMATIC BRAIN-INJURY; EPIDURAL ELECTRICAL-STIMULATION; FOCAL CEREBRAL-ISCHEMIA; MIGRATION; INFARCT; STROKE; FEASIBILITY; PLASTICITY; PROMOTES; CELLS	Background: Motor impairments are among the major complications that develop after cortical damage caused by either stroke or traumatic brain injury. Motor cortex stimulation (MCS) can improve motor functions in animal models of stroke by inducing neuroplasticity. Objective: In the current study, the therapeutic effect of chronic MCS was assessed in a rat model of severe cortical damage. Methods: A controlled cortical impact (CCI) was applied to the forelimb area of the motor cortex followed by implantation of a flat electrode covering the lesioned area. Forelimb function was assessed using the Montoya staircase test and the cylinder test before and after a period of chronic MCS. Furthermore, the effect of MCS on tissue metabolism and lesion size was measured using [F-18]-fluorodesoxyglucose (FDG) mu PET scanning. Results: CCI caused a considerable lesion at the level of the motor cortex and dorsal striatum together with a long-lasting behavioral phenotype of forelimb impairment. However, MCS applied to the CCI lesion did not lead to any improvement in limb functioning when compared to non-stimulated control rats. Also, MCS neither changed lesion size nor distribution of FDG. Conclusion: The use of MCS as a standalone treatment did not improve motor impairments in a rat model of severe cortical damage using our specific treatment modalities.	[Schonfeld, Lisa-Maria; Jahanshahi, Ali; Hescham, Sarah-Anna; Schipper, Sandra; Lagiere, Melanie; Temel, Yasin] Maastricht Univ, Dept Neurosci, Maastricht, Netherlands; [Schonfeld, Lisa-Maria; Lemmens, Evi; Hendrix, Sven] Hasselt Univ, Biomed Res Inst BIOMED, Dept Morphol, Hasselt, Belgium; [Bauwens, Matthias] Maastricht Univ, Med Ctr, Dept Nucl Med, Maastricht, Netherlands; [Schipper, Sandra] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Jahanshahi, Ali; Temel, Yasin] Maastricht Univ, Med Ctr, Dept Neurosurg, Maastricht, Netherlands		Jahanshahi, A (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurosci, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.; Hendrix, S (corresponding author), Hasselt Univ, Dept Morphol, Biomed Res Inst, Martelarenlaan 42, B-3500 Hasselt, Belgium.	a.jahanshahianvar@maastrichtuniversity.nl; sven.hendrix@uhasselt.be	Hendrix, Sven/F-4059-2010	Hendrix, Sven/0000-0003-2344-7369; Lemmens, Evi/0000-0001-6044-5659	Hasselt University [BOF11603BOFMO]; Medtronic EuropeMedtronic [A1196117]; Hersenstichting Nederland	This work was supported in part by a grant from Hasselt University (BOF11603BOFMO) to SH and a grant from the Hersenstichting Nederland and Medtronic Europe (A1196117) to YT and AJ.	Adkins DL, 2006, EXP NEUROL, V200, P356, DOI 10.1016/j.expneurol.2006.02.131; Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; Babona-Pilipos R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0049-6; Babona-Pilipos R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023808; Boychuk JA, 2011, NEUROREHAB NEURAL RE, V25, P88, DOI 10.1177/1545968310385126; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Cheng X, 2012, BRAIN RES BULL, V89, P124, DOI 10.1016/j.brainresbull.2012.07.009; Feng JF, 2012, STEM CELLS, V30, P349, DOI 10.1002/stem.779; Gobel B, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-50; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Jahanshahi A, 2014, MOL NEUROBIOL, V49, P1005, DOI 10.1007/s12035-013-8575-7; Jahanshahi A, 2013, EXP BRAIN RES, V231, P165, DOI 10.1007/s00221-013-3680-4; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; Kang C, 2013, ANN REHABIL MED-ARM, V37, P301, DOI 10.5535/arm.2013.37.3.301; Keuters MH, 2015, NMR BIOMED, V28, P231, DOI 10.1002/nbm.3244; Levy R, 2008, J NEUROSURG, V108, P707, DOI 10.3171/JNS/2008/108/4/0707; Levy RM, 2016, NEUROREHAB NEURAL RE, V30, P107, DOI 10.1177/1545968315575613; Liu J, 2015, EXP NEUROL, V263, P113, DOI 10.1016/j.expneurol.2014.09.014; Lopez MS, 2015, NEUROCHEM INT, V89, P75, DOI 10.1016/j.neuint.2015.08.009; MacLellan CL, 2013, NEUROREHAB NEURAL RE, V27, P900, DOI 10.1177/1545968313496323; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Moon SK, 2009, NEUROSCI LETT, V460, P152, DOI 10.1016/j.neulet.2009.05.029; Morimoto T, 2011, CELL TRANSPLANT, V20, P1049, DOI 10.3727/096368910X544915; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; O'Bryant AJ, 2016, NEUROREHAB NEURAL RE, V30, P143, DOI 10.1177/1545968314562112; Parker V M, 1986, Int Rehabil Med, V8, P69; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Rueger MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043776; Schonfeld LM, 2017, J NEUROTRAUM, V34, P505, DOI 10.1089/neu.2016.4440; Shijo K, 2015, BRAIN RES, V1614, P94, DOI 10.1016/j.brainres.2015.04.022; Shin SS, 2014, J NEUROSURG, V121, P1219, DOI 10.3171/2014.7.JNS131826; Starkey ML, 2012, BRAIN, V135, P3265, DOI 10.1093/brain/aws270; Teskey GC, 2003, NEUROL RES, V25, P794, DOI 10.1179/016164103771953871; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Yoon YS, 2015, ANN REHABIL MED-ARM, V39, P416, DOI 10.5535/arm.2015.39.3.416; Yoon YS, 2012, ANN REHABIL MED-ARM, V36, P596, DOI 10.5535/arm.2012.36.5.596; Zhou Q, 2010, BRAIN RES, V1311, P148, DOI 10.1016/j.brainres.2009.11.022	41	5	5	1	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2017	35	3					295	305		10.3233/RNN-160703			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX7VJ	WOS:000403457200004	28506001	Green Published			2022-02-06	
J	Senapathi, TGA; Wiryana, M; Sinardja, K; Nada, KW; Sutawan, IBKJ; Ryalino, C; Alphonso, A				Senapathi, Tjokorda Gde Agung; Wiryana, Made; Sinardja, Ketut; Nada, Ketut Wibawa; Sutawan, Ida Bagus Krisna Jaya; Ryalino, Christopher; Alphonso, Aloysius			Jugular bulb oxygen saturation correlates with Full Outline of Responsiveness score in severe traumatic brain injury patients	OPEN ACCESS EMERGENCY MEDICINE			English	Article						jugular vein; unconsciousness; Full Outline of Responsiveness; mortality predictor	HEAD-INJURY	Background: Maintaining brain oxygenation status is the main goal of treatment in severe traumatic brain injury (TBI). Jugular venous oxygen saturation (SjvO(2)) monitoring is a technique to estimate global balance between cerebral oxygen supply and its metabolic requirement. Full Outline of Responsiveness (FOUR) score, a new consciousness measurement scoring, is expected to become an alternative for Glasgow Coma Scale (GCS) in evaluating neurologic status of patients with severe traumatic head injury, especially for those under mechanical ventilation. Methods: A total of 63 patients with severe TBI admitted to emergency department (ED) were included in this study. SjvO(2) sampling was taken every 24 hours, until 72 hours after arrival. The assessment of FOUR score was conducted directly after each blood sample for SjvO(2) was taken. Spearman's rank correlation was used to determine the correlation between SjvO(2) and FOUR score. Regression analysis was used to determine mortality predictors. Results: From the 63 patients, a weak positive correlation between SjvO(2) and FOUR score (r=0.246, p=0.052) was found upon admission. Meanwhile, strong and moderate negative correlation values were found in 48 hours (r=-0.751, p<0.001) and 72 hours (r=-0.49, p=0.002) after admission. Both FOUR score (p<0.001) and SjvO(2) (p=0.04) were found to be independent mortality predictors in severe TBI. Conclusion: There was a negative correlation between the value of SjvO(2) and FOUR score at 48 and 72 hours after admission. Both SjvO(2) and FOUR score are independent mortality predictors in severe TBI.	[Senapathi, Tjokorda Gde Agung; Wiryana, Made; Sinardja, Ketut; Nada, Ketut Wibawa; Sutawan, Ida Bagus Krisna Jaya; Ryalino, Christopher; Alphonso, Aloysius] Udayana Univ, Sanglah Gen Hosp, Dept Anesthesiol & Intens Care, Jl Diponegoro, Denpasar 80114, Bali, Indonesia		Ryalino, C (corresponding author), Udayana Univ, Sanglah Gen Hosp, Dept Anesthesiol & Intens Care, Jl Diponegoro, Denpasar 80114, Bali, Indonesia.	ryalino@gmail.com	Ryalino, Christopher/K-1673-2019; Senapathi, Tjokorda Gde Agung/I-4232-2016	Ryalino, Christopher/0000-0001-9618-6230; Senapathi, Tjokorda Gde Agung/0000-0002-7479-6190			Bhardwaj A, 2015, J NEU ROANAESTHESIOL, V2, P225; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Jalali R, 2014, CRIT CARE RES PRACT, V2014, P4; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Senapathi TGA, 2017, OPEN ACCESS EMERG M, V9, P43, DOI 10.2147/OAEM.S130643; Sharf MS, 2013, EGYPT J ANAESTH, V29, P267, DOI 10.1016/j.egja.2013.02.008; Wijdicks EF, 2015, ANN NEUROL, V58, P585	11	5	6	1	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1500			OPEN ACCESS EMERG M	Open Access Emerg. Med.		2017	9						69	72		10.2147/OAEM.S144722			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	FE9ZM	WOS:000408562000001	28919828	Green Published, gold, Green Submitted			2022-02-06	
J	Serinelli, S; Arunkumar, P; Filkins, JA; Gitto, L				Serinelli, Serenella; Arunkumar, Ponni; Filkins, James A.; Gitto, Lorenzo			Deaths Due to Child Abuse: A 6-Year Review of Cases in The Cook County Medical Examiner's Office	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; child abuse; homicide; intracranial findings; ocular hemorrhages; spinal cord injuries; abusive head trauma	TRAUMATIC BRAIN-INJURY; INFLICTED HEAD-INJURY; RETINAL HEMORRHAGES; CARDIOPULMONARY-RESUSCITATION; YOUNG-CHILDREN; INFANTS; NEUROPATHOLOGY; FRACTURES; PATTERNS; VICTIMS	Case files from the Cook County Medical Examiner's Office from 2007 to 2012 were reviewed to analyze homicides due to physical child abuse in children <3 years old. Fatal cases mostly involved younger subjects. Intracranial injuries were the leading cause of death, while death due to extracranial injuries was uncommon. Eyes were involved in most of the cases. Spinal cord was involved in about 1/3 of the cases, mostly in the thoracic area. In some cases, previous injuries were present. There were significant differences in the pattern of injuries between age groups. Subjects showing signs of impact to the head and subjects with no evidence of an impact showed no significant difference in internal injuries. The association of multiple injuries is highly suggestive of child abuse. In suspected child abuse, a postmortem examination including neuropathological, ophthalmological, and radiological information should be always evaluated, together with investigative reports and the medical history.	[Serinelli, Serenella; Gitto, Lorenzo] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped, Viale Regina Elena 336, I-00185 Rome, Italy; [Arunkumar, Ponni; Filkins, James A.] Cook Cty Med Examiners Off, 2121 W Harrison St, Chicago, IL 60612 USA		Serinelli, S (corresponding author), Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped, Viale Regina Elena 336, I-00185 Rome, Italy.	s.serinelli@gmail.com	Gitto, Lorenzo/W-2080-2019; Serinelli, Serenella/AAH-6010-2020	Gitto, Lorenzo/0000-0002-1435-1819; 			Adams G, 2004, EYE, V18, P795, DOI 10.1038/sj.eye.6701643; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Banaschak S, 2015, INT J LEGAL MED, V129, P1091, DOI 10.1007/s00414-015-1144-z; Beers MH, 2004, THE MERCK MANUAL; Bilo RAC, 2010, FORENSIC ASPECTS OF PAEDIATRIC FRACTURES: DIFFERENTIATING ACCIDENTAL TRAUMA FROM CHILD ABUSE, P1, DOI 10.1007/978-3-540-78716-7; Binenbaum G, 2014, PEDIATR RADIOL, V44, P571, DOI 10.1007/s00247-014-3107-9; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; BUDENZ DL, 1994, OPHTHALMOLOGY, V101, P559; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Case ME, 2014, PEDIATR RADIOL, V44, P632, DOI 10.1007/s00247-014-3061-6; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Dettmeyer R., 2011, FORENSIC HISTOPATHOL, P347; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Emerson MV, 2007, OPHTHALMOLOGY, V114, P1384, DOI 10.1016/j.ophtha.2007.04.015; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2008, PEDIATR EMERG CARE, V24, P222, DOI 10.1097/PEC.0b013e31816b7aa4; Flaherty EG, 2014, PEDIATRICS, V133, pE477, DOI 10.1542/peds.2013-3793; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Giardino AP, 2010, PRACTICAL GUIDE TO THE EVALUATION OF CHILD PHYSICAL ABUSE AND NEGLECT, P1; Gilbert-Barness E., 2005, HDB PEDIAT AUTOPSY P, P61; Gill JR, 2014, ACAD FOREN PATHOL J, V4, P206; GILLILAND MGF, 1993, AM J FOREN MED PATH, V14, P187, DOI 10.1097/00000433-199309000-00003; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Pham H, 2013, AM J FOREN MED PATH, V34, P122, DOI 10.1097/PAF.0b013e31828c38f9; Hobbs C. J., 1999, CHILD ABUSE NEGLECT; Hymel KP, 2001, CHILD ABUSE MED DIAG, P1; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jayakumar P, 2010, J BONE JOINT SURG BR, V92B, P189, DOI 10.1302/0301-620X.92B2.22923; Jenny C, 2006, ARCH DIS CHILD, V91, P265, DOI 10.1136/adc.2004.066696; Jenny C, 2010, CHILD ABUSE NEGLECT; John SM, 2013, AM J FOREN MED PATH, V34, P277, DOI 10.1097/PAF.0b013e3182a187e9; Judkins AR, 2004, AM J FOREN MED PATH, V25, P29, DOI 10.1097/01.paf.0000113811.85110.54; KANTER RK, 1986, J PEDIATR-US, V108, P430, DOI 10.1016/S0022-3476(86)80890-3; Keeling JW, 2005, PAEDIAT FORENSIC MED; Kemp AM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1518; KLEINMAN PK, 1995, AM J ROENTGENOL, V165, P647, DOI 10.2214/ajr.165.3.7645487; Kleinman PK, 1998, DIAGNOSTIC IMAGING C, P285; KRAMER K, 1993, CLIN PEDIATR, V32, P366, DOI 10.1177/000992289303200610; Lane WG, 2012, CHILD ABUSE NEGLECT, V36, P142, DOI 10.1016/j.chiabu.2011.09.010; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Levin AV, 2010, PEDIATRICS, V126, P376, DOI 10.1542/peds.2010-1397; Love JC, 2011, SPRINGER FORENS LAB, P9, DOI 10.1007/978-1-61779-216-8_2; Love S., 2008, GREENFIELDS NEUROPAT; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Minns RA, 2014, HDB FORENSIC MED, P681; Odom A, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e3; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Roach JP, 2014, PEDIATR SURG INT, V30, P1103, DOI 10.1007/s00383-014-3598-3; Royal College of Ophthalmology Child Abuse Working Party, 1999, EYE, V13, P3; Sheaff MT, 2005, POSTMORTEM TECHNIQUE, P350; Shiau T, 2012, ARCH PEDIAT ADOL MED, V166, P623, DOI 10.1001/archpediatrics.2012.46; Shugerman RP, 1996, PEDIATRICS, V97, P664; Spitz WU., 2006, SPITZ FISHERS MEDICO, P343; Steven C, 2011, W J EMERG MED, V12, P144; US Department of Health and Human Services, 2013, CHILD MALTREATMENT; Walters BL, 2009, HDB AUTOPSY PRACTICE	62	5	5	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	JAN	2017	62	1					107	118		10.1111/1556-4029.13219			12	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Legal Medicine	EH7KU	WOS:000391952600014	27787884				2022-02-06	
J	Shu, AH; Liu, XS; Wang, Q; Chen, XB; Zhan, LY				Shu, Aihua; Liu, Xuesong; Wang, Qiang; Chen, Xiabo; Zhan, Leyun			Study on cerebral protective effect of dexmedetomidine during anesthesia in cardiac valve replacement surgery	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Cardiac valve replacement surgery; dexmedetomidine; cardiopulmonary bypass; cerebral protection	TRAUMATIC BRAIN-INJURY; BYPASS GRAFT-SURGERY; DELIRIUM; METAANALYSIS; HYPOTHERMIA; PREVENTION; ISCHEMIA; NSE	Objective: To evaluate the cerebral protection of Dexmedetomidine during anesthesia of cardiac valve replacement surgery. Methods: 60 patients who underwent elective cardiac valve replacement surgery under cardiopulmonary bypass (CPB) in our hospital were randomly divided into Dexmedetomidine group and control group (30 cases in each group); patients in Dexmedetomidine group were injected with Dexmedetomidine 1.0 mu g/kg intravenously at 10 min before routine anesthesia induction, then injected with 0.5 mu g/kg/h till surgery finished; the control group received equal volume of normal saline with the same infusion speed. Heart rate (HR) and blood pressure were recorded at T1 (establish of CPB), T2 (end of CPB) and T3 (end of surgery), in the meanwhile, the doses of vasoactive agents used during operation were also recorded. Jugular venous oxygen saturation (SjvO(2)), Arterial venous oxygen content difference (Da-jvO(2)) and cerebral extraction of oxygen (CERO2) at T1-T3 were monitored analyzed. Central venous blood was drawn at time points of T1-T3 to detect the concentrations of plasma S-100 beta protein, TNF-alpha and serum neuronspecific enolase (NSE) by ELISA. Mini-Mental State Examination (MMSE) and Delirium Rating Scale (DRS) were used to assess postoperative cognitive function and postoperative delirium, respectively. Results: Compared with the control group, the amount of Phenylephrine, Dopamine, Adrenaline used in Dexmedetomidine group was significantly reduced (94 mu g vs. 185 mu g; 24 mu g vs. 44 mu g; 6.3% vs. 21%), while the volume of Atropine was significantly increased (18% vs. 6.1%), the differences were statistically significant (all P < 0.05); the SjvO(2) of two groups of patients at T2 was significantly higher than that at T1 while Da-jvO2 and CERO2 were significantly lower than those at T1. Moreover, by comparing with control group, the SjvO2 of Dexmedetomidine group at T2 and T3 was significantly higher while Da-jvO2 and CERO2 were significantly lower (all P < 0.05). The postoperative delirium score of dexmedetomidine group (15.8 +/- 4.2) was significantly lower than that of control group (18.6 +/- 6.2), the difference was statistically significant (P < 0.05); there was a significant difference in MMSE score (P < 0.05) between two groups at postoperative 1 week; the concentrations of TNF-alpha, S-100 beta protein and NSE level of both groups at T2 and T3 were significantly increased (P < 0.05) by comparing with the values at T1, and the levels in dexmedetomidine group were significantly lower than those of control group (P < 0.05) at T2 and T3. Conclusion: Dexmedetomidine could improve brain oxygen metabolism and reduce intraoperative cerebral ischemia and hypoxia during cardiac valve replacement surgery under CPB; to a certain extent, Dexmedetomidine has cerebral protective effect.	[Shu, Aihua; Wang, Qiang; Chen, Xiabo; Zhan, Leyun] Three Gorges Univ Peoples Hosp, First Peoples Hosp Yichang, Dept Anesthesiol, NO 2 Jiefang Rd, Yichang 44300, Hubei, Peoples R China; [Liu, Xuesong] Changyang Tujia Autonomous Cty Peoples Hosp, Dept Anesthesiol, Yichang, Peoples R China		Zhan, LY (corresponding author), Three Gorges Univ Peoples Hosp, First Peoples Hosp Yichang, Dept Anesthesiol, NO 2 Jiefang Rd, Yichang 44300, Hubei, Peoples R China.	lyz1_2016@163.com					Augoustides JGT, 2012, J CARDIOTHOR VASC AN, V26, P952, DOI 10.1053/j.jvca.2012.05.001; Chen SL, 2015, INT J CLIN EXP MED, V8, P21166; De Somer Filip, 2012, Recent Pat Cardiovasc Drug Discov, V7, P180; Ding XD, 2016, INT J NEUROSCI, V126, P249, DOI 10.3109/00207454.2015.1005291; Evered L, 2011, ANESTH ANALG, V112, P1179, DOI 10.1213/ANE.0b013e318215217e; Ford AH, 2015, MATURITAS, V81, P287, DOI 10.1016/j.maturitas.2015.03.024; Guo JR, 2014, HEPATO-GASTROENTEROL, V61, P2321, DOI 10.5754/hge14721; Ji FH, 2013, CIRCULATION, V127, P1576, DOI 10.1161/CIRCULATIONAHA.112.000936; Karaman Y, 2015, J ANESTH, V29, P522, DOI 10.1007/s00540-015-1975-2; Lundblad M, 2016, PEDIATR ANESTH, V26, P232, DOI 10.1111/pan.12825; Luo XH, 2016, CLIN NEUROL NEUROSUR, V146, P105, DOI 10.1016/j.clineuro.2016.05.004; Mo Y, 2013, ANN PHARMACOTHER, V47, P869, DOI 10.1345/aph.1AR708; Pouard Philippe, 2013, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V16, P59, DOI 10.1053/j.pcsu.2013.01.010; Priye S, 2015, SAUDI J ANAESTH, V9, P353, DOI 10.4103/1658-354X.154715; Sato K, 2010, ACTA ANAESTH SCAND, V54, P377, DOI 10.1111/j.1399-6576.2009.02139.x; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Sun JQ, 2012, ACTA PAEDIATR, V101, pe316, DOI 10.1111/j.1651-2227.2012.02679.x; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Zamani MM, 2016, J CRIT CARE, V32, P93, DOI 10.1016/j.jcrc.2015.11.013; Zhang H, 2013, CRIT CARE, V17, DOI 10.1186/cc12566; Zhang XK, 2015, INT J CLIN EXP MED, V8, P19353; Zheng L, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0050-0	22	5	5	2	5	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2017	10	1					1066	1072					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EO2CE	WOS:000396503400119					2022-02-06	
J	Simon, D; Evaldt, J; Nabinger, DD; Fontana, MF; Klein, MG; Gomes, JD; Regner, A				Simon, Daniel; Evaldt, Joice; Nabinger, Debora Dreher; Fontana, Mariano Feraboli; Klein, Mirelli Gabardo; Gomes, Julia do Amaral; Regner, Andrea			Plasma matrix metalloproteinase-9 levels predict intensive care unit mortality early after severe traumatic brain injury	BRAIN INJURY			English	Article						Severe TBI; MMP-9; biomarker; outcome	SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ACUTE ISCHEMIC-STROKE; SEVERE HEAD-INJURY; GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; CEREBRAL-ISCHEMIA; DOWN-REGULATION; BLOOD; INTERLEUKIN-6; ACTIVATION	Objectives: Matrix metalloproteinase-9 (MMP-9) is an inducible metalloproteinase that can degrade the cerebrovascular matrix leading to disruption of the blood brain barrier and exacerbation of oedema in netirotrauma. Therefore, our aim, was to determine whether MMP-9 plasma levels were associated with intensive care unit (ICU) mortality after severe traumatic brain injury (TBI) despite the presence of extracerebral injuries. Methods: This cohort enrolled 80 patients who suffered severe TBI (Glasgow Coma Scale: 3-8 at hospital admissibM. The plasma MMP-9 level was determined by enzyme-linked immunosorbent assay assay at ICU admission. Results: Severe TBI was associated with a 32.5% ICU mortality rate. There was no association between the presence of extracerebral injuries (72.5% of the patients) and ICU mortality (P = 0.419). Higher plasma MMP-9 concentrations were associated with fatal Outcome: 181.1 +/- 16.0 ng/mL far survivors and 257.0 +/- 23.2 ng/mL for nansurvivors (mean +/- S.E,M., P = 0.009). In contrast, there was no significant difference between MMP-9 levels and associated lesions: 220.8 +/- 26.3 ng/ml for isolated TBI and 196.8 +/- 15.8 ng/mL for patients with extracerebral injuries (P = 0.397). Conclusion: Increased plasma MMP-9 levels predicted short-term fatal outcome following severe TBI, regardless the presence of extracerebral injuries.	[Simon, Daniel; Evaldt, Joice; Regner, Andrea] Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicada Saud, Ave Farroupilha,8001 Predio 22,5 Andar, BR-92425900 Canoas, RS, Brazil; [Nabinger, Debora Dreher; Fontana, Mariano Feraboli; Klein, Mirelli Gabardo; Gomes, Julia do Amaral; Regner, Andrea] Univ Luterana Brasil, Lab Biomarcadores Trauma, Canoas, Brazil; [Regner, Andrea] Univ Luterana Brasil, Curso Med, Canoas, Brazil		Regner, A (corresponding author), Univ Luterana Brasil, Programa Posgrad Biol Celular & Mol Aplicada Saud, Ave Farroupilha,8001 Predio 22,5 Andar, BR-92425900 Canoas, RS, Brazil.	regner@uol.com.br	Simon, Daniel/A-9087-2011; Nabinger, Debora/F-6466-2019; Regner, Andrea/M-2596-2014	Simon, Daniel/0000-0003-1122-8468; Nabinger, Debora/0000-0001-9988-9046; Regner, Andrea/0000-0002-6657-7991	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [568691/2008-3]; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [09/0041-5, 1630-25.51/09-0]	The present study received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; research grant 568691/2008-3) and from Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS; research grant 09/0041-5, 1630-25.51/09-0).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Copin JC, 2012, SCAND J TRAUMA RESUS, V18, P20; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; del Zoppo GJ, 2012, J CEREBR BLOOD F MET, V32, P919, DOI 10.1038/jcbfm.2012.11; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Florczak-Rzepka M, 2012, CEREBROVASC DIS, V34, P249, DOI 10.1159/000341686; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GOTTSCHALL PE, 1995, J NEUROSCI RES, V42, P335, DOI 10.1002/jnr.490420307; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Harkness KA, 2000, BRAIN, V123, P698, DOI 10.1093/brain/123.4.698; Hirose Wataru, 2003, Leg Med (Tokyo), V5 Suppl 1, pS360, DOI 10.1016/S1344-6223(02)00133-5; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; Liu YP, 2015, J CLIN NEUROSCI, V22, P291, DOI 10.1016/j.jocn.2014.05.042; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Morancho A, 2010, ANN NY ACAD SCI, V1207, P123, DOI 10.1111/j.1749-6632.2010.05734.x; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Crespo ART, 2007, BRAIN INJURY, V21, P441, DOI 10.1080/02699050701311125; Ramos-Fernandez M, 2011, J STROKE CEREBROVASC, V20, P47, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.008; Regner A, 2001, NEUROREPORT, V12, P691, DOI 10.1097/00001756-200103260-00015; Rodrigues EM, 2014, J NEUROTRAUM, V31, P1639, DOI 10.1089/neu.2013.3178; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Seo JH, 2013, J CLIN INVEST, V123, P782, DOI 10.1172/JCI65863; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Suofu Y, 2012, NEUROSCIENCE, V212, P180, DOI 10.1016/j.neuroscience.2012.03.036; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Zhao HD, 2014, J STROKE CEREBROVASC, V23, P2788, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.001	46	5	6	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					390	395		10.1080/02699052.2016.1259501			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900016	28156136				2022-02-06	
J	Singh, A				Singh, Anita			Extent of impaired axoplasmic transport and neurofilament compaction in traumatically injured axon at various strains and strain rates	BRAIN INJURY			English	Article						Impaired axoplasmic transport; neurofilament changes; secondary axotomy; strain; strain rate; traumatic axonal injury	AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD INJURY; OPTIC-NERVE FIBERS; BRAIN-INJURY; AXOLEMMAL PERMEABILITY; STRETCH-INJURY; WHITE-MATTER; CYTOCHEMICAL EVIDENCE; BETA-APP; DAMAGE	Primary objective: Secondary axotomy is more prevalent than the primary axotomy and involves subtle intraaxonal changes in response to the injury leading to cytoskeletal disruptions including neurofilament (NF) misalignment and compaction, which is associated with the genesis of impaired axoplasmic transport (IAT). Recent studies have reported two differential axonal responses to injury, one associated with the cytoskeletal collapse and another with the IAT. The objective of this study was to determine the extent of IAT and early NF changes in axons that were subjected to a stretch of various degrees at different strain rates.Research design and methods: Fifty-six L5 dorsal spinal nerve roots were subjected to a predetermined strain at a specified displacement rate (0.01 and 15 mm/second) only once. The histological changes were determined by performing standard immunohistochemical procedures using beta amyloid precursor protein ( APP) and NF-68 kDa antibodies.Results and conclusions: No significant differences in the occurrence rate of either of the staining in the axons were observed when subjected to similar loading conditions, and the occurrence rate of both APP and NF68 staining was strain and rate-dependent.	[Singh, Anita] Widener Univ, Dept Biomed Engn, One Univ Pl, Chester, PA 19013 USA		Singh, A (corresponding author), Widener Univ, Dept Biomed Engn, One Univ Pl, Chester, PA 19013 USA.	asingh2@mail.widener.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Bain A.C., 1999, P 43 STAPP CAR CRASH, P295, DOI [10.4271/99sc19, DOI 10.4271/99SC19]; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Giometto B, 1997, ANN NEUROL, V42, P34, DOI 10.1002/ana.410420108; GLASS JD, 1994, J NEUROCHEM, V62, P2472, DOI 10.1046/j.1471-4159.1994.62062472.x; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Li SH, 2006, NEUROSCI LETT, V409, P182, DOI 10.1016/j.neulet.2006.09.054; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marmarou CR, J NEUROTRAUMA, V2205, P1066; MAX W, 1990, INQUIRY-J HEALTH CAR, V27, P332; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NIXON RA, 1986, J NEUROSCI, V6, P1252; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pierce JES, 1996, J NEUROSCI, V16, P1083; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Singh A, 2009, J NEUROTRAUM, V26, P1; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Singh A, 2006, J BIOMECH, V39, P1669, DOI 10.1016/j.jbiomech.2005.04.023; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	66	5	5	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1387	1395		10.1080/02699052.2017.1321781			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800018	28650256				2022-02-06	
J	Sumiyoshi, K; Hayakawa, T; Yatsushige, H; Shigeta, K; Momose, T; Enomoto, M; Sato, S; Takasato, Y				Sumiyoshi, Kyoko; Hayakawa, Takanori; Yatsushige, Hiroshi; Shigeta, Keigo; Momose, Toshiya; Enomoto, Masaya; Sato, Shin; Takasato, Yoshio			Outcome of traumatic brain injury in patients on antiplatelet agents: a retrospective 20-year observational study in a single neurosurgery unit	BRAIN INJURY			English	Article						Antiplatelet agents; traumatic brain injury; traumatic head injury; cerebral haemorrhage; mortality	HEAD COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; PREINJURY ANTIPLATELET; PLATELET TRANSFUSION; ELDERLY-PATIENTS; PATIENTS OLDER; MORTALITY; THERAPY; ANTICOAGULANT; CLOPIDOGREL	Objective: To evaluate the outcomes after Traumatic Brain Injury (TBI) in patients taking Antiplatelet Agents (APAs).Methods: We reviewed the clinical records of 934 patients with TBI between 1995 and 2014. Multivariate analysis was performed to correlate patient outcome with various factors, including pre-injury APA intake. Cause of death was compared among groups stratified according to APA dose.Results: Increasing doses of APAs were positively associated with mortality rates, however, differences were primarily due to non-traumatic causes. APA therapy before injury was independent of both overall and non-traumatic mortality. In multivariate analysis, mortality was significantly correlated with the Charlson Comorbidity Index (CCI), pupillary abnormalities, age, Glasgow Coma Scale (GCS), head Abbreviated Injury Scale (AIS) and additional AIS >2. Conversely, non-traumatic mortality was associated with age, GCS, additional AIS >2 and CCI, though only CCI was correlated with increasing APA dose. Furthermore, no significant difference was observed when comparing mortalities according to CCI score among APA groups. Thus, mortalities were associated with the severity of pre-existing conditions rather than APA dose.Conclusions: The outcome of patients with TBI, who were on APAs may be determined by the severity of pre-existing conditions. Aggressive TBI treatment should be implemented when tolerable, regardless of pre-existing APA treatment status.	[Sumiyoshi, Kyoko; Hayakawa, Takanori; Yatsushige, Hiroshi; Shigeta, Keigo; Momose, Toshiya; Enomoto, Masaya; Sato, Shin; Takasato, Yoshio] Natl Hosp Org, Disaster Med Ctr, Div Neurosurg, Tokyo, Japan		Sumiyoshi, K (corresponding author), Natl Disaster Med Ctr, Div Neurosurg, 3256 Midori Cho, Tokyo, Japan.	kyokosumiyoshi@gmail.com					Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bansal V, 2011, J TRAUMA, V70, P65, DOI 10.1097/TA.0b013e318204fdae; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cull JD, 2015, AM SURGEON, V81, P128; de Gans K, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-19; Di Minno MND, 2009, INTERN EMERG MED, V4, P279, DOI 10.1007/s11739-009-0265-0; Downey DM, 2009, AM SURGEON, V75, P1100; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; Ferraris VA, 2012, J TRAUMA ACUTE CARE, V73, P492, DOI 10.1097/TA.0b013e31825b85f1; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Hodgkinson S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g104; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jacobs JM, 2014, REJUV RES, V17, P499, DOI 10.1089/rej.2014.1587; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P417, DOI 10.1097/TA.0000000000000372; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2014, J SURG RES, V186, P287, DOI 10.1016/j.jss.2013.08.009; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Korte W, 2011, THROMB HAEMOSTASIS, V105, P743, DOI 10.1160/TH10-04-0217; Laor A, 2016, AM SURGEON, V82, P22; Lau D, 2012, J NEUROSURG, V116, P234, DOI 10.3171/2011.7.JNS11396; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Meislin H, 1997, J TRAUMA, V43, P433, DOI 10.1097/00005373-199709000-00008; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Nishijima DK, 2013, AM J EMERG MED, V31, P1244, DOI 10.1016/j.ajem.2013.04.035; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Osler T, 2008, ANN SURG, V247, P1041, DOI 10.1097/SLA.0b013e31816ffb3f; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Powner DJ, 2005, NEUROSURGERY, V57, P823, DOI 10.1227/01.NEU.0000179915.74429.b2; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; Tykocki T, 2016, WORLD NEUROSURG, V89, P497, DOI 10.1016/j.wneu.2016.01.063; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	51	5	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1445	1454		10.1080/02699052.2017.1377349			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200006	28991499				2022-02-06	
J	Tettamanti, G; Shu, XC; Fahmideh, MA; Schuz, J; Roosli, M; Tynes, T; Grotzer, M; Johansen, C; Klaeboe, L; Kuehni, CE; Lannering, B; Schmidt, LS; Vienneau, D; Feychting, M				Tettamanti, Giorgio; Shu, Xiaochen; Fahmideh, Maral Adel; Schuz, Joachim; Roosli, Martin; Tynes, Tore; Grotzer, Michael; Johansen, Christoffer; Klaeboe, Lars; Kuehni, Claudia E.; Lannering, Birgitta; Schmidt, Lisbeth S.; Vienneau, Danielle; Feychting, Maria			Prenatal and Postnatal Medical Conditions and the Risk of Brain Tumors in Children and Adolescents: An International Multicenter Case-Control Study	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							X-RAY-EXPOSURE; CHILDHOOD-CANCER; COMPUTED-TOMOGRAPHY; SUBSEQUENT RISK; CT SCANS; RADIATION; EPIDEMIOLOGY; INJURY; GLIOMA; COHORT	Background: Previous studies have evaluated the effect of medical diagnostic radiation on brain tumors. Recent cohort studies have reported an increased risk associated with exposure to head CT scans. Methods: Information regarding medical conditions, including prenatal and postnatal exposure to medical diagnostic radiation, was obtained from CEFALO, a multicenter case-control study performed in Denmark, Norway, Sweden, and Switzerland through face-to-face interview. Eligible cases of childhood and adolescent brain tumors (CABT) were ages 7 to 19 years, diagnosed between January 1, 2004 and August 31, 2008, and living in the participating countries (n = 352). The cases were matched by age, sex, and region to 646 population-based controls. Results: Prenatal exposure to medical diagnostic radiation and postnatal exposure to X-rays were not associated with CABTs. A higher risk estimate of CABTs, although not statistically significant, was found for exposure to head CT scan (OR, 1.86; 95% confidence interval, 0.82-4.22). The associations with head injury, febrile seizure, fever in the first 12 weeks, and general anesthesia were close to unity. Conclusions: Prenatal or postnatal medical conditions, including medical diagnostic radiation, were not associated with CABTs. On the basis of small numbers of exposed children, we observed a nonsignificant increased risk for CT scans of the head. Impact: We have presented additional evidence, suggesting that exposure to head CT scan may be associated with the occurrence of CABTs. (C)2016 AACR.	[Tettamanti, Giorgio; Shu, Xiaochen; Fahmideh, Maral Adel; Feychting, Maria] Karolinska Inst, Inst Environm Med, Epidemiol Unit, Stockholm, Sweden; [Shu, Xiaochen] Soochow Univ, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China; [Schuz, Joachim] Int Agcy Res Canc, Sect Environm & Radiat, Lyon, France; [Roosli, Martin; Vienneau, Danielle] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Roosli, Martin; Vienneau, Danielle] Univ Basel, Basel, Switzerland; [Tynes, Tore] Natl Inst Occupat Hlth, Oslo, Norway; [Tynes, Tore; Klaeboe, Lars] Canc Registry Norway, Oslo, Norway; [Grotzer, Michael] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Johansen, Christoffer] Finsen Ctr, Oncol Clin, Copenhagen, Denmark; [Johansen, Christoffer; Schmidt, Lisbeth S.] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Klaeboe, Lars] Norwegian Radiat Protect Author, Oslo, Norway; [Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, CH-3012 Bern, Switzerland; [Lannering, Birgitta] Univ Gothenburg, Dept Clin Sci, Pediat Oncol, Gothenburg, Sweden		Tettamanti, G (corresponding author), Karolinska Inst, Nobels Vag 13, S-17177 Stockholm, Sweden.	giorgio.tettamanti@ki.se	Johansen, Christoffer/AAG-7916-2020; Adel Fahmideh, Maral/AAZ-6264-2021; Roosli, Martin/A-2658-2008; Vienneau, Danielle/L-1558-2019	Johansen, Christoffer/0000-0002-4384-206X; Adel Fahmideh, Maral/0000-0002-9930-8288; Roosli, Martin/0000-0002-7475-1531; Tettamanti, Giorgio/0000-0002-5210-7219; Vienneau, Danielle/0000-0002-6309-6439; Grotzer, Michael/0000-0002-1154-2732	Swedish Council for Working Life and Social ResearchSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte) [20040504, 2007-0224]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2008-70X-15366-043]; Swedish Cancer SocietySwedish Cancer Society [09 0666]; Swedish Childhood Cancer Society [PROJ06/050, PROJ09/086]; Swedish Radiation Protection Authority [SSI P 1572]; Danish Strategic Research CouncilDanske Strategiske Forskningsrad (DSF) [2103-05-0006, 2064-04-0010]; Swiss Federal Office of Public Health [05.001626]; Swiss Research Foundation on Mobile Communication [A2006.18]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [PDFMP3_122873]; Research Council of NorwayResearch Council of Norway [175163/V40]	The Swedish part of the CEFALO study was supported by grants from the Swedish Council for Working Life and Social Research (grant numbers 20040504 and 2007-0224), the Swedish Research Council (K2008-70X-15366-043), the Swedish Cancer Society (09 0666), the Swedish Childhood Cancer Society (grant numbers PROJ06/050 and PROJ09/086), and the Swedish Radiation Protection Authority (SSI P 1572; to M. Feychting). The Danish CEFALO study was supported by the Danish Strategic Research Council (grant numbers 2103-05-0006, 2064-04-0010; to J.H. Olsen). The Swiss part of the CEFALO study was supported by the Swiss Federal Office of Public Health (grant number 05.001626), the Swiss Research Foundation on Mobile Communication (grant number A2006.18), and the Swiss National Science Foundation (grant number PDFMP3_122873; to M. Roosli). The Norwegian CEFALO study was supported by the Research Council of Norway (grant number 175163/V40; to T. Tynes).	Aydin D, 2011, JNCI-J NATL CANCER I, V103, P1264, DOI 10.1093/jnci/djr244; Baldwin RT, 2004, TOXICOL APPL PHARM, V199, P118, DOI 10.1016/j.taap.2003.12.029; Blettner M, 2007, EUR J CANCER, V43, P1990, DOI 10.1016/j.ejca.2007.06.020; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Christensen JS, 2012, CANCER CAUSE CONTROL, V23, P1463, DOI 10.1007/s10552-012-0020-0; Davis F, 2011, RADIAT RES, V175, P790, DOI 10.1667/RR2186.1; Friis S, 2015, CANCER EPIDEMIOL, V39, pS107, DOI 10.1016/j.canep.2015.08.003; Gurney JG, 2001, CANCER INVEST, V19, P630, DOI 10.1081/CNV-100104291; Gurney JG, 1996, EPIDEMIOLOGY, V7, P485, DOI 10.1097/00001648-199609000-00006; HARVEY EB, 1985, NEW ENGL J MED, V312, P541, DOI 10.1056/NEJM198502283120903; Hu JF, 1998, CANCER DETECT PREV, V22, P100, DOI 10.1046/j.1525-1500.1998.CDOA22.x; Huang WY, 2014, BRIT J CANCER, V110, P2354, DOI 10.1038/bjc.2014.103; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; Johnson KJ, 2014, CANCER EPIDEM BIOMAR, V23, P2716, DOI 10.1158/1055-9965.EPI-14-0207; Journy N, 2015, BRIT J CANCER, V112, P185, DOI 10.1038/bjc.2014.526; Lee C, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150305; Linet MS, 2009, PEDIATR RADIOL, V39, pS4, DOI 10.1007/s00247-008-1026-3; MACMAHON B, 1962, JNCI-J NATL CANCER I, V28, P1173; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pollack IF, 2011, NAT REV NEUROL, V7, P495, DOI 10.1038/nrneurol.2011.110; Preston-Martin S, 1998, INT J EPIDEMIOL, V27, P579, DOI 10.1093/ije/27.4.579; RODVALL Y, 1990, INT J CANCER, V46, P362, DOI 10.1002/ijc.2910460304; Schmidt LS, 2011, PEDIATR BLOOD CANCER, V56, P65, DOI 10.1002/pbc.22585; Schulze-Rath R, 2008, RADIAT ENVIRON BIOPH, V47, P301, DOI 10.1007/s00411-008-0171-2; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; STEWART A, 1958, BRIT MED J, V1, P1495, DOI 10.1136/bmj.1.5086.1495	28	5	5	0	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	JAN	2017	26	1					110	115		10.1158/1055-9965.EPI-16-0451			6	Oncology; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Public, Environmental & Occupational Health	EK2JN	WOS:000393753700016	27624640	Bronze			2022-02-06	
J	Wadlington, C; DeOrnellas, K; Scott, SR				Wadlington, Charles; DeOrnellas, Kathy; Scott, Shannon R.			Developing Effective Transition Reports for Secondary Students: A Nationwide Survey of College and University Disability Support Personnel	EXCEPTIONALITY			English	Article								This exploratory study analyzes the perceptions of Disability Support Services (DSS) personnel regarding the transition process and documentation requirements to receive services for students with invisible disabilities in postsecondary settings. Invisible disabilities include attention-deficit/hyperactivity disorder, autism spectrum disorders, learning disabilities, and traumatic brain injury. DSS personnel from 408 postsecondary institutions across the United States completed the researcher-generated survey online. Results indicated a lack of consistent collaboration with secondary institutions and use of transition plans to determine eligibility for disability services. Participants reported a lackluster view of their usefulness, and analyses of their free responses revealed specific themes for what DSS personnel reported would make transition reports more useful. Results regarding currency requirements, qualified conductors of, responsible parties for, and location of assessments are presented. Applications of the findings of this research are discussed for the preparation of effective transition reports and transition goals.	[Wadlington, Charles] Abilene Christian Univ, POB 28011, Abilene, TX 79699 USA; [DeOrnellas, Kathy; Scott, Shannon R.] Texas Womans Univ, Denton, TX 76204 USA		Wadlington, C (corresponding author), Abilene Christian Univ, POB 28011, Abilene, TX 79699 USA.	Charles.Wadlington@acu.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2007, LEARN DISABILITY Q, V30, P265; Association on Higher Education and Disability [AHEAD], 2012, SUPP ACC REQ GUID DO; deFur SH, 2008, EXCEPTIONALITY, V16, P178, DOI 10.1080/09362830802412158; Gormley S., 2005, J POSTSECOND EDUC DI, V18, P63; Gregg N, 2000, J LEARN DISABIL, V33, P5, DOI 10.1177/002221940003300104; Hamblet EC, 2014, TEACH EXCEPT CHILD, V46, P53, DOI 10.1177/004005991404600306; McIntosh D., 2005, HDB SCH NEUROPSYCHOL, P265; Parker D, 1998, ALERT, V22, P42; Sitlington P., 2003, EXCEPTION SPECIAL ED, V11, P103, DOI [10.1207/S15327035EX1102_05, DOI 10.1207/S15327035EX1102_05]; Webb KW, 2008, EXCEPTIONALITY, V16, P192, DOI 10.1080/09362830802412182; Wrights Law, 2008, KEY DIFF SECT 504 AD	12	5	5	2	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0936-2835	1532-7035		EXCEPTIONALITY	Exceptionality		2017	25	3					207	215		10.1080/09362835.2017.1283623			9	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	EW6NQ	WOS:000402627700004					2022-02-06	
J	Xiao, J; Chen, L; Mao, GS; Gao, WY; Lu, M; He, XJ; Huang, HY				Xiao, Juan; Chen, Lin; Mao, Gengsheng; Gao, Wenyong; Lu, Ming; He, Xijing; Huang, Hongyun		Neurorestoratology Proffessional	Neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells	JOURNAL OF NEURORESTORATOLOGY			English	Article						standardization; cell culture; quality control; olfactory ensheathing glial cells; neurorestorative clinical application; neurorestoratology; translational medicine	LATERAL-SCLEROSIS PATIENTS; SPINAL-CORD; INTRACRANIAL TRANSPLANT; AXONAL GROWTH; GLIA; REGENERATION; THERAPY; REPAIR	Olfactory ensheathing cells (OECs) are a novel type of glial cell that can perform and promote many neurorestorative processes in vivo after transplant. To date, dozens of preclinical and clinical studies have confirmed that OECs have unique restoring effects in animal models and human subjects with neurological degeneration or damage, such as spinal cord injury, stroke, cerebral palsy, traumatic brain injury, and motor neuron disease (amyotrophic lateral sclerosis). To ensure the safety and effectiveness of clinical applications utilizing this type of cell, it is important to standardize cell-culture and quality-control processes. Based on a comprehensive review of published clinical studies, as well as existing methods of OEC culture and quality control currently utilized by hospitals and biomedical enterprises, the Chinese Association of Neurorestoratology has developed a set of standards for the culture and quality control of olfactory ensheathing cells for use in clinical applications. These guidelines include standardized training and management procedures for laboratory operators; standardized use and management of materials and equipment; standardized collection, culture, and proliferation of OECs obtained from fetal olfactory bulbs; standardized management for cell preservation, transport, and related safeguard measures; and the standardization of a clean environment, routine maintenance, and related tests and examinations. Our goal in publishing this set of standards is to promote the worldwide safety, effectiveness, and replicability of utilizing OECs obtained from fetal olfactory bulbs for neurorestorative clinical application.	[Xiao, Juan; Mao, Gengsheng; Gao, Wenyong; Huang, Hongyun] Chinese Peoples Armed Police Forces, Gen Hosp, Inst Neurorestoratol, 69 Yongding Rd, Beijing 100039, Peoples R China; [Xiao, Juan; Gao, Wenyong; Huang, Hongyun] Beijing Hongtianji Neurosci Acad, Cell Therapy Ctr, Beijing, Peoples R China; [Chen, Lin] Tsinghua Univ, Dept Neurosurg, Yuquan Hosp, Beijing, Peoples R China; [Lu, Ming] Hunan Normal Univ, Affiliated Hosp 2, Hosp PLA 163, Dept Neurosurg, Changsha, Hunan, Peoples R China; [He, Xijing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped, Xian, Shanxi, Peoples R China		Huang, HY (corresponding author), Chinese Peoples Armed Police Forces, Gen Hosp, Inst Neurorestoratol, 69 Yongding Rd, Beijing 100039, Peoples R China.	hongyunh@gmail.com	He, Xijing/AAE-7424-2021	He, Xijing/0000-0002-0465-5376			Chen L, 2014, CELL TRANSPLANT, V23, pS35, DOI 10.3727/096368914X685014; Chen L, 2013, CELL TRANSPLANT, V22, pS83, DOI 10.3727/096368913X672154; Chen L, 2012, CELL TRANSPLANT, V21, pS65, DOI 10.3727/096368912X633789; Chen L, 2010, CELL TRANSPLANT, V19, P185, DOI 10.3727/096368910X492652; Chinese Medical Doctor Association of Neurorestoratology Professional Committee; Chinese Branch of the International Association of Neurorestoratology, 2016, CHIN J CELL STEM CEL, V6, P1; DOUCETTE R, 1991, J COMP NEUROL, V312, P451, DOI 10.1002/cne.903120311; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; Franklin RJM, 1996, GLIA, V17, P217, DOI 10.1002/(SICI)1098-1136(199607)17:3<217::AID-GLIA4>3.0.CO;2-Y; Franklin Robin J M, 2003, Anat Rec B New Anat, V271, P71, DOI 10.1002/ar.b.10013; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Gobbel GT, 2010, J NEUROSURG, V113, P666, DOI 10.3171/2009.10.JNS09252; Higginson JR, 2011, EXP NEUROL, V229, P2, DOI 10.1016/j.expneurol.2010.08.020; Huang H., 2002, J GEN NAVAL HOSP P L, V15, P18; Huang H., 2002, CHIN J CLIN REHABIL, V6, P2027; Huang HY, 2008, CLIN TRANSPLANT, V22, P710, DOI 10.1111/j.1399-0012.2008.00865.x; Huang HY, 2017, J NEURORESTORATOLOGY, V5, DOI 10.2147/JN.S115756; Huang HY, 2012, CELL TRANSPLANT, V21, pS23, DOI 10.3727/096368912X633734; Huang HY, 2003, CHINESE MED J-PEKING, V116, P1488; Huang HY, 2009, ZHONGGUO XIU FU CHON, P23; Jiang XR, 2011, PROG ANAT SCI, V17, P424; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 2013, CELL TRANSPLANT, V22, pS51, DOI 10.3727/096368913X672208; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; Qian LM, 2006, PROG ANAT SCI, V12, P63; RAISMAN G, 1985, NEUROSCIENCE, V14, P237, DOI 10.1016/0306-4522(85)90176-9; Raisman G, 2007, NAT REV NEUROSCI, V8, P312, DOI 10.1038/nrn2099; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Ramon-Cueto A, 1998, BRAIN RES BULL, V46, P175, DOI 10.1016/S0361-9230(97)00463-2; Ramon-Cueto A, 2011, EXP NEUROL, V229, P181, DOI 10.1016/j.expneurol.2010.10.001; RAMONCUETO A, 1995, GLIA, V14, P163, DOI 10.1002/glia.440140302; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Rao YJ, 2013, CELL TRANSPLANT, V22, pS21, DOI 10.3727/096368913X672127; Ren YS, 2010, PROG ANAT SCI, V16, P97; [任玉水 Ren Yushui], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P3156; Richter MW, 2008, EXP NEUROL, V209, P353, DOI 10.1016/j.expneurol.2007.06.011; Su ZD, 2010, PROG NEUROBIOL, V92, P517, DOI 10.1016/j.pneurobio.2010.08.008; Tabakow P, 2014, CELL TRANSPLANT, V23, P1631, DOI 10.3727/096368914X685131; Tabakow P, 2013, CELL TRANSPLANT, V22, P1591, DOI 10.3727/096368912X663532; Wang S, 2016, CELL TRANSPLANT, V25, P141, DOI 10.3727/096368915X688065; Wu W, 2004, ZHONGHUA SHI YAN WAI, V21, P841; Xi HT, 2013, CELL TRANSPLANT, V22, pS93, DOI 10.3727/096368913X672145	42	5	6	1	6	TSINGHUA UNIV PRESS	BEIJING	B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA	2324-2426			J NEURORESTORATOLOGY	J. NEURORESSTORATOLOGY		2017	5						175	179		10.2147/JN.S148107			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FJ0AV	WOS:000412371800001		gold, Green Submitted			2022-02-06	
J	Yeh, ZT; Tsai, MC; Tsai, MD; Lo, CY; Wang, KC				Yeh, Zai-Ting; Tsai, Ming-Cheng; Tsai, Ming-Dar; Lo, Chiao-Yu; Wang, Kaw-Chen			The relationship between theory of mind and the executive functions: Evidence from patients with frontal lobe damage	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Executive functions; frontal lobe; theory of mind	TRAUMATIC BRAIN-INJURY; ASPERGER-SYNDROME; MENTAL STATE; FAUX PAS; DEFICITS; CHILDREN; AMYGDALA; LESIONS; ADULTS; PRESCHOOLERS	Theory of mind (ToM) refers to the ability to predict others' thoughts, intentions, beliefs, and feelings. Evidence from neuropsychology and functional imaging indicates that ToM is a domain-specific or modular architecture; however, research in development psychology has suggested that ToM is the full development of the executive functions in individuals. Therefore, the relationship between ToM and the executive functions needs to be clarified. Since the frontal lobe plays a critical role in the abilities of ToM and the executive functions, patients with frontal lobe damage were recruited for the present study. Assessments of ToM and the executive functions were performed on 23 patients with frontal lobe damage and 20 healthy controls. When controlling for the executive functions, significant differences between the patient and normal groups were found in the affective component of ToM, but not in the cognitive component. The present study suggests that in various social situations, executing ToM abilities requires logical reasoning processes provided by the executive functions. However, the reasoning processes of affective ToM are independent of executive functions.	[Yeh, Zai-Ting] Fu Jen Catholic Univ, Clin Psychol, Taipei, Taiwan; [Tsai, Ming-Cheng; Tsai, Ming-Dar] Shin Kong Wu Ho Mem Hosp, Neurosurg, Taipei, Taiwan; [Lo, Chiao-Yu; Wang, Kaw-Chen] Cardinal Tien Hosp, Neurol, Taipei, Taiwan		Yeh, ZT (corresponding author), Fu Jen Catholic Univ, Dept Clin Psychol, 510 Chung Cheng Rd, Taipei 24205, Taiwan.	yehzaiting@ntu.edu.tw			Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST-101-2410-H-030-039]	This work was supported by the Ministry of Science and Technology of Taiwan under Grant MOST-101-2410-H-030-039.	Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Chen L. Y., 2000, BECK DEPRESSION INVE; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frye D, 1995, COGNITIVE DEV, V10, P483, DOI 10.1016/0885-2014(95)90024-1; Frye D, 1999, DEVELOPING THEORIES OF INTENTION, P119; Frye D, 1996, DEV PSYCHOL, V32, P120, DOI 10.1037/0012-1649.32.1.120; FRYE D, 2000, CHILDRENS REASONING, P149; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hughes C, 1998, BRIT J DEV PSYCHOL, V16, P233, DOI 10.1111/j.2044-835X.1998.tb00921.x; Hughes C, 1998, DEV PSYCHOL, V34, P1326, DOI 10.1037/0012-1649.34.6.1326; Hughes C., 2002, CHILD ADOLESCENT MEN, V7, P131, DOI DOI 10.1111/1475-3588.00024; Lee TMC, 2010, NEUROPSYCHOLOGIA, V48, P1670, DOI 10.1016/j.neuropsychologia.2010.02.012; Leslie AM, 1998, DEVELOPMENTAL SCI, V1, P247, DOI 10.1111/1467-7687.00038; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; McKinnon MC, 2007, COGNITION, V102, P179, DOI 10.1016/j.cognition.2005.12.011; MUNDY P, 2001, NEURAL PLASTICITY JO, V23; Mundy P., 2000, AUTISM SPECTRUM DISO, P422; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; NORMAN D, 1980, 99 U CAL CTR HUM INF; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Perner J, 1999, DEVELOPING THEORIES OF INTENTION, P133; Perner J, 2002, INFANT CHILD DEV, V11, P141, DOI 10.1002/icd.302; Putko A, 2009, POL PSYCHOL B, V40, P156, DOI [10.2478/s10059-009-0010-6, DOI 10.2478/S10059-009-0010-6]; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Russell J., 1997, EXECUTIVE DISORDERS; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shallice T., 1991, HIGHER ORDER COGNITI; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2010, CORTEX, V46, P668, DOI 10.1016/j.cortex.2009.04.008; Shapiro, 1986, ATTENTION ACTION WIL, V4; Shaw P, 2004, BRAIN, V127, P1535, DOI 10.1093/brain/awh168; Spek AA, 2010, J AUTISM DEV DISORD, V40, P280, DOI 10.1007/s10803-009-0860-y; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Weed E, 2010, BRAIN LANG, V113, P65, DOI 10.1016/j.bandl.2010.01.009; Yeh ZT, 2013, AGING MENT HEALTH, V17, P527, DOI 10.1080/13607863.2012.758235; Yeh ZT, 2009, CHINESE J PSYCHOL, V51, P375, DOI [10.6129/CJP.2009.5103.06, DOI 10.6129/CJP.2009.5103.06]	48	5	5	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	4					342	349		10.1080/23279095.2016.1185425			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EW6FW	WOS:000402605300005	27282192				2022-02-06	
J	Chio, CC; Lin, MT; Chang, CP; Lin, HJ				Chio, Chung-Ching; Lin, Mao-Tsun; Chang, Ching-Ping; Lin, Hung-Jung			A positive correlation exists between neurotrauma and TGF-beta 1-containing microglia in rats	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION			English	Article						Astragaloside; neuro AiD (TM) (MLC601); transforming growth factor-beta 1; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TRADITIONAL CHINESE MEDICINE; TRANSFORMING GROWTH-FACTOR-BETA-1; INCREASES NEUROGENESIS; NEUROAID EFFICACY; STROKE; INHIBITION; PROTECTS; MODEL; NEUROPROTECTION	Background Transforming growth factor-beta 1 (TGF-beta 1) regulates many processes after traumatic brain injury (TBI). Both Neuro AiD (TM) (MLC601) and astragaloside (AST) attenuate microglia activation in rats with TBI. The purpose of this study was to investigate whether MLC601 or AST improves output of TBI by affecting microglial expression of TGF-beta 1. Materials and methods Adult male Sprague-Dawley rats (120 in number) were used to investigate the contribution of TGF-beta 1-containing microglia in the MLC601-mediated or the AST-mediated neuroprotection in the brain trauma condition using lateral fluid percussion injury. Results Pearson correlation analysis revealed that there was a positive correlation between brain injury (evidenced by both brain contused volume and neurological severity score) and the cortical numbers of TGF-beta 1-containing microglia for the rats (n = 12) 4 days post-TBI. MLC601 or AST significantly (P < 0.05) attenuated TBI-induced brain contused volume (119 +/- 14 mm(3) or 108 +/- 11 mm(3) vs. 160 +/- 21 mm(3)), neurological severity score (7.8 +/- 0.3 or 8.1 +/- 0.4 vs. 10.2 +/- 0.5) and numbers of TGF-beta 1-containing microglia (6% +/- 2% or 11% +/- 3% vs. 79% +/- 7%) for the rats 4 days post-TBI. Conclusions There was a positive correlation between TBI and cortical numbers of TGF-beta 1-containing microglia which could be significantly attenuated by astragaloside or NeuroAiD (TM) (MLC601) in rats.	[Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Tainan 710, Taiwan; [Lin, Mao-Tsun; Chang, Ching-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; [Lin, Hung-Jung] Chi Mei Med Ctr, Dept Emergency Med, Tainan 710, Taiwan; [Chang, Ching-Ping; Lin, Hung-Jung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan 710, Taiwan		Lin, HJ (corresponding author), Chi Mei Med Ctr, Dept Emergency Med, Tainan 710, Taiwan.; Lin, HJ (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan 710, Taiwan.	790001@mail.chimei.org.tw		Chang, Ching-Ping/0000-0003-0890-9414	Ministry of Science and Technology (Taiwan)Ministry of Science and Technology, Taiwan [NSC 102-2628-B-384-001-MY3, MOST 104-2314-B-384-003-MY3, MOST 104-2314-B-218-001-MY3, MOST 104-2320-B-384-002]; Chi Mei Medical Center (Taiwan) [CMFHT 10401]	This study is partially supported by Ministry of Science and Technology (Taiwan) under grant no. NSC 102-2628-B-384-001-MY3, MOST 104-2314-B-384-003-MY3, MOST 104-2314-B-218-001-MY3, MOST 104-2320-B-384-002 and Chi Mei Medical Center (Taiwan) grants CMFHT 10401.	Bao F, 2011, J NEUROTRAUM, V28, P1035, DOI 10.1089/neu.2010.1575; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Boche D, 2003, J CEREBR BLOOD F MET, V23, P1174, DOI 10.1097/01.WCB.0000090080.64176.44; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Buckwalter MS, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-10; Bye N, 2001, NEUROSCIENCE, V105, P853, DOI 10.1016/S0306-4522(01)00236-6; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; Chen CLH, 2013, STROKE, V44, P3580, DOI 10.1161/STROKEAHA.113.003226; Chen CLH, 2013, STROKE, V44, P2093, DOI 10.1161/STROKEAHA.113.002055; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; FINCH CE, 1993, J CELL BIOCHEM, V53, P314, DOI 10.1002/jcb.240530408; Florio P, 2007, ADV CLIN CHEM, V43, P117, DOI 10.1016/S0065-2423(06)43004-3; Gan R, 2008, CEREBROVASC DIS, V25, P450, DOI 10.1159/000126919; Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005; GROSS CE, 1993, STROKE, V24, P558, DOI 10.1161/01.STR.24.4.558; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Kandasamy M, 2010, J NEUROPATH EXP NEUR, V69, P717, DOI 10.1097/NEN.0b013e3181e4f733; Lei H, 2003, ACTA PHARMACOL SIN, V24, P230; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Liu Dong-mei, 2007, Zhongguo Yaolixue Tongbao, V23, P543; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Manaenko A, 2014, STROKE, V45, P828, DOI 10.1161/STROKEAHA.113.003754; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Neubert M, 2011, CELL DEATH DIFFER, V18, P1521, DOI 10.1038/cdd.2011.29; Nichols NR, 1999, J NEUROBIOL, V40, P585, DOI 10.1002/(SICI)1097-4695(19990915)40:4<585::AID-NEU13>3.0.CO;2-1; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Rimaniol AC, 1995, NEUROREPORT, V7, P133, DOI 10.1097/00001756-199512290-00032; Shahripour RB, 2011, EUR J INTERN MED, V22, P509, DOI 10.1016/j.ejim.2011.01.002; Stetler RA, 2012, J NEUROSCI, V32, P2667, DOI 10.1523/JNEUROSCI.5169-11.2012; Tohda C, 2006, BRIT J PHARMACOL, V149, P532, DOI 10.1038/sj.bjp.0706865; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Yang ST, 2014, AM J CHINESE MED, V42, P1357, DOI 10.1142/S0192415X14500852; [尹艳艳 YIN Yanyan], 2005, [中国药理学通报, Chinese Pharmacological Bulletin], V21, P1486; Young SHY, 2010, CEREBROVASC DIS, V30, P1, DOI 10.1159/000313398; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022	46	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2972	1365-2362		EUR J CLIN INVEST	Eur. J. Clin. Invest.	DEC	2016	46	12					1063	1069		10.1111/eci.12693			7	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	EJ2YQ	WOS:000393077900013	27759956				2022-02-06	
J	Chiou, KS; Genova, HM; Chiaravalloti, ND				Chiou, Kathy S.; Genova, Helen M.; Chiaravalloti, Nancy D.			Structural white matter differences underlying heterogeneous learning abilities after TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Verbal learning; Diffusion tensor imaging; Memory	TRAUMATIC BRAIN-INJURY; SELECTIVE REMINDING TEST; TERM-MEMORY FORMATION; AXONAL INJURY; MODERATE; ORGANIZATION; IMPAIRMENT; RETRIEVAL; INTEGRITY; ATTENTION	The existence of learning deficits after traumatic brain injury (TBI) is generally accepted; however, our understanding of the structural brain mechanisms underlying learning impairment after TBI is limited. Furthermore, our understanding of learning after TBI is often at risk for overgeneralization, as research often overlooks within sample heterogeneity in learning abilities. The present study examined differences in white matter integrity in a sample of adults with moderate to severe TBI who differed in learning abilities. Adults with moderate to severe TBI were grouped into learners and non-learners based upon achievement of the learning criterion of the open-trial Selective Reminding Test (SRT). Diffusion tensor imaging (DTI) was used to identify white matter differences between the learners and non-learners. Adults with TBI who were able to meet the learning criterion had greater white matter integrity (as indicated by higher fractional anisotropy [FA] values) in the right anterior thalamic radiation, forceps minor, inferior fronto-occipital fasciculus, and forceps minor than non-learners. The results of the study suggest that differences in white matter integrity may explain the observed heterogeneity in learning ability after moderate to severe TBI. This also supports emerging evidence for the involvement of the thalamus in higher order cognition, and the role of thalamo-cortical tracts in connecting functional networks associated with learning.	[Chiou, Kathy S.; Chiaravalloti, Nancy D.] Kessler Fdn, Traumat Brain Injury Res, W Orange, NJ 07936 USA; [Genova, Helen M.; Chiaravalloti, Nancy D.] Kessler Fdn, Neuropsychol & Neurosci Res, W Orange, NJ USA; [Chiou, Kathy S.; Genova, Helen M.; Chiaravalloti, Nancy D.] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA		Chiou, KS (corresponding author), Kessler Fdn, Traumat Brain Injury Res, W Orange, NJ 07936 USA.; Chiou, KS (corresponding author), Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA.	kchiou@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	Northern NJ TBI Model Systems [H133A070037]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133P090009]	Drs. Chiou, Genova, and Chiaravalloti declare that they have no conflict of interest. The contents of this manuscript were developed under Grant H133A070037 from the Northern NJ TBI Model Systems and a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number H133P090009). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, P623; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Chiaravalloti N., 2015, NEUROREHABILITATION; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Chiou KS, 2015, J CLIN EXP NEUROPSYC, V37, P1074, DOI 10.1080/13803395.2015.1078293; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Gillis M. M., 2014, BRAIN IMAGING BEHAV; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jankowski M. M., 2013, FRONTIERS SYSTEMS NE, V7, P1; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mori S, 2005, MRI ATLAS HUMAN WHIT; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Ranganath C, 2005, J COGNITIVE NEUROSCI, V17, P994, DOI 10.1162/0898929054475118; Saalmann YB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00083; Sallet J, 2013, J NEUROSCI, V33, P12255, DOI 10.1523/JNEUROSCI.5108-12.2013; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Whiting MD, 2008, BRAIN RES, V1213, P69, DOI 10.1016/j.brainres.2008.01.107; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; WRIGHT MJ, 2011, THE JOURNAL OF HEAD, V26, P182, DOI DOI 10.1097/HTR.0B013E318218DCF9	45	5	5	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2016	10	4					1274	1279		10.1007/s11682-015-9497-y			6	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EF0LC	WOS:000390015900032	26699142				2022-02-06	
J	Cui, JX; Ng, LJ; Volman, V				Cui, Jianxia; Ng, Laurel J.; Volman, Vladislav			Callosal dysfunction explains injury sequelae in a computational network model of axonal injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						axonal injury; traumatic brain injury; EEG; brain rhythms; computational model	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; HUMAN CORPUS-CALLOSUM; MINOR HEAD-INJURY; SPINAL-CORD; REACTION-TIME; IN-VITRO; INTERHEMISPHERIC COMMUNICATION; POSTCONCUSSION SYNDROME; RELEASE PROBABILITY	Mild traumatic brain injury (mTBI) often results in neurobehavioral aberrations such as impaired attention and increased reaction time. Diffusion imaging and postmortem analysis studies suggest that mTBI primarily affects myelinated axons in white matter tracts. In particular, corpus callosum, mediating interhemispheric information exchange, has been shown to be affected in mTBI. Yet little is known about the mechanisms linking the injury of myelinated callosal axons to the neurobehavioral sequelae of mTBI. To address this issue, we devised and studied a large, biologically plausible neuronal network model of cortical tissue. Importantly, the model architecture incorporated intra- and interhemispheric organization, including myelinated callosal axons and distance-dependent axonal conduction delays. In the resting state, the intact model network exhibited several salient features, including alpha-band (8-12 Hz) collective activity with low-frequency irregular spiking of individual neurons. The network model of callosal injury captured several clinical observations, including 1) "slowing down" of the network rhythms, manifested as an increased resting-state theta-to-alpha power ratio, 2) reduced response to attention-like network stimulation, manifested as a reduced spectral power of collective activity, and 3) increased population response time in response to stimulation. Importantly, these changes were positively correlated with injury severity, supporting proposals to use neurobehavioral indices as biomarkers for determining the severity of injury. Our modeling effort helps to understand the role played by the injury of callosal myelinated axons in defining the neurobehavioral sequelae of mTBI.	[Cui, Jianxia; Ng, Laurel J.; Volman, Vladislav] L 3 Appl Technol Inc, 10180 Barnes Canyon Rd,Suite 100, San Diego, CA 92121 USA		Volman, V (corresponding author), L 3 Appl Technol Inc, 10180 Barnes Canyon Rd,Suite 100, San Diego, CA 92121 USA.	vladislav.volman@l-3com.com			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-D-0011, W81XWH-16-C-0042]	This study was sponsored by the U.S. Army Medical Research and Materiel Command under contracts W81XWH-11-D-0011 and W81XWH-16-C-0042.	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; Aboitiz F., 1992, SCIENCE, V598, P143; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; BEAULIEU C, 1983, J COMP NEUROL, V217, P337, DOI 10.1002/cne.902170308; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Buffalo E, 2004, NEUR M PLANN SAN DIE; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Buzsaki Gyorgy, 2006, RHYTHMS BRAIN; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Chen Xi-Ping, 2006, Neurosci Bull, V22, P165; Crook SM, 1997, J COMPUT NEUROSCI, V4, P161, DOI 10.1023/A:1008843412952; Cui J, 2015, J NEUROTRAUM, V32, pA1; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Houzel JC, 2002, BRAZ J MED BIOL RES, V35, P1441, DOI 10.1590/S0100-879X2002001200005; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Innocenti G.M., 1986, SENSORY MOTOR AREAS, P291, DOI [DOI 10.1007/978-1-4613-2149-1_9, 10.1007/978-1-4613-2149-1_9]; Innocenti GM, 2014, CEREB CORTEX, V24, P2178, DOI 10.1093/cercor/bht070; INNOCENTI GM, 1994, BEHAV BRAIN RES, V64, P1, DOI 10.1016/0166-4328(94)90113-9; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lima B, 2010, CEREB CORTEX, V20, P1556, DOI 10.1093/cercor/bhp218; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Mann EO, 2009, J NEUROSCI, V29, P7513, DOI 10.1523/JNEUROSCI.6162-08.2009; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Mazzoni A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004584; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Moeller JJ, 2011, ARCH NEUROL-CHICAGO, V68, P1595, DOI 10.1001/archneurol.2011.1080; Morris C., 1981, J PHYSL, V35, P193, DOI DOI 10.1016/S0006-3495(81)84782-0; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Rickett T, 2011, J MED SYST, V35, P787, DOI 10.1007/s10916-010-9468-1; RINGO JL, 1994, CEREB CORTEX, V4, P331, DOI 10.1093/cercor/4.4.331; Rosenberg LJ, 1999, J NEUROSCI, V19, P6122, DOI 10.1523/JNEUROSCI.19-14-06122.1999; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Suarez R, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00497; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; SWADLOW HA, 1990, J NEUROPHYSIOL, V63, P1477, DOI 10.1152/jn.1990.63.6.1477; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tamamaki N, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00202; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Tebano M.T., 1988, CLIN NEUROPHYSIOL, V70, P185; Thatcher RW, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P241, DOI 10.1007/0-387-32565-4_11; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tokoro Kazuhiko, 2015, Brain Nerve, V67, P1471, DOI 10.11477/mf.1416200324; Toth Z, 1997, J NEUROSCI, V17, P8106; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Ursino M, 2006, J THEOR BIOL, V242, P171, DOI 10.1016/j.jtbi.2006.02.012; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Volman V, 2016, J NEUROPHYSIOL, V115, P1003, DOI 10.1152/jn.00912.2015; Volman V, 2014, J COMPUT NEUROSCI, V37, P439, DOI 10.1007/s10827-014-0515-7; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; von Stein A, 1999, CEREB CORTEX, V9, P137, DOI 10.1093/cercor/9.2.137; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Wang QY, 2010, PHYSICA A, V389, P3299, DOI 10.1016/j.physa.2010.03.031; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 1996, J NEUROSCI, V16, P6402; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	126	5	5	0	5	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	DEC	2016	116	6					2892	2908		10.1152/jn.00603.2016			17	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	EK6FE	WOS:000394019600006	27683891	Bronze, Green Published			2022-02-06	
J	Hsieh, T; Vaickus, MH; Stein, TD; Lussier, BL; Kim, J; Stepien, DM; Duffy, ER; Chiswick, EL; Remick, DG				Hsieh, Terry; Vaickus, Max H.; Stein, Thor D.; Lussier, Bethany L.; Kim, Jiyoun; Stepien, David M.; Duffy, Elizabeth R.; Chiswick, Evan L.; Remick, Daniel G.			The Role of Substance P in Pulmonary Clearance of Bacteria in Comparative Injury Models	AMERICAN JOURNAL OF PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; HUMAN-NEUTROPHILS; PERMEABILITY; EXPRESSION; SURVIVAL; STRESS; ASTHMA; DAMAGE	Neural input to the immune system can alter its ability to clear pathogens effectively. Patients suffering mild traumatic brain injury (mTBI) have shown reduced rates of pneumonia and a murine model replicated these findings, with better overall survival of TBI mice compared with sham-injured mice. To further investigate the mechanism of improved host response in TBI mice, this study developed and characterized a mild tail trauma model of similar severity to mild TBI. Both mild tail trauma and TBI induced similar systemic changes that normalized within 48 hours, including release of substance P. Examination of tissues showed that injuries are limited to the target tissue (ie, tail in tail trauma, brain in mTBI). Pneumonia challenge showed that mild TBI mice showed improved immune responses, characterized by the following: i) increased survival, ii) increased pulmonary neutrophil recruitment, iii) increased bacterial clearance, and iv) increased phagocytic cell killing of bacteria compared with tail trauma. Administration of a neurokinin-1-receptor antagonist to block substance P signaling eliminated the improved survival of mTBI mice. Neurokinin-1-receptor antagonism did not alter pneumonia mortality in tail trauma mice. These data show that immune benefits of trauma are specific to mTBI and that tail trauma is an appropriate control for future studies aimed at elucidating the mechanisms of improved innate immune responses in mTBI mice.	[Hsieh, Terry; Vaickus, Max H.; Stein, Thor D.; Lussier, Bethany L.; Kim, Jiyoun; Stepien, David M.; Duffy, Elizabeth R.; Chiswick, Evan L.; Remick, Daniel G.] Boston Univ, Sch Med, Dept Pathol & Lab Med, 670 Albany St,4th Floor, Boston, MA 02118 USA; [Stein, Thor D.] VA Boston Healthcare Syst, Boston, MA USA; [Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Stepien, David M.] Univ Michigan, Sch Med, Dept Surg, Sect Plast Surg, Ann Arbor, MI USA; [Duffy, Elizabeth R.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA; [Chiswick, Evan L.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA		Remick, DG (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, 670 Albany St,4th Floor, Boston, MA 02118 USA.	remickd@bu.edu		Stein, Thor/0000-0001-6954-4477; Stepien, David/0000-0002-3521-6210	 [R01 GM82962];  [R21 AI112887];  [R01 GM97320];  [T32 HL 007501];  [T32 GM 86308];  [T32 HL 007035];  [T32 AI 007309]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007035, T32HL007501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [T32AI007309, R21AI112887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086308, R01GM082962, R01GM097320] Funding Source: NIH RePORTER	Supported by grants R01 GM82962, R21 AI112887, R01 GM97320, T32 HL 007501, T32 GM 86308, T32 HL 007035, and T32 AI 007309.	Amadesi S, 2012, CIRCULATION, V125, P1774, DOI 10.1161/CIRCULATIONAHA.111.089763; BARSHAVIT Z, 1980, BIOCHEM BIOPH RES CO, V94, P1445, DOI 10.1016/0006-291X(80)90581-1; Bouchard JC, 2012, AM J PATHOL, V181, P845, DOI 10.1016/j.ajpath.2012.05.020; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Deptula A, 2010, ARCH MICROBIOL, V192, P79, DOI 10.1007/s00203-009-0528-1; dos Santos LV, 2012, JNCI-J NATL CANCER I, V104, P1280, DOI 10.1093/jnci/djs335; Douglas SD, 2011, ANN NY ACAD SCI, V1217, P83, DOI 10.1111/j.1749-6632.2010.05826.x; Fenwick N, 2009, CAN VET J, V50, P523; Hamer PW, 2002, J ANAT, V200, P69, DOI 10.1046/j.0021-8782.2001.00008.x; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hoth JJ, 2011, SHOCK, V35, P604, DOI 10.1097/SHK.0b013e3182144a50; Kim J, 2001, J IMMUNOL, V167, P2808, DOI 10.4049/jimmunol.167.5.2808; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Li HP, 2015, J TRAUMA ACUTE CARE, V78, P272, DOI 10.1097/TA.0000000000000509; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Mekontso-Dessap A, 2005, SHOCK, V24, P109, DOI 10.1097/01.shk.0000171871.50524.81; Napolitano LM, 1996, SHOCK, V5, P202, DOI 10.1097/00024382-199603000-00006; Nemzek-Hamlin JA, 2014, COMPARATIVE MED, V63, P398; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; SERRA MC, 1988, J IMMUNOL, V141, P2118; STEIN M, 1985, J IMMUNOL, V135, pS827; Sterner-Kock A, 1999, J LEUKOCYTE BIOL, V65, P834, DOI 10.1002/jlb.65.6.834; Sun J, 2007, AM J PHYSIOL-CELL PH, V293, pC696, DOI 10.1152/ajpcell.00060.2007; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tuluc F, 2009, TRENDS IMMUNOL, V30, P271, DOI 10.1016/j.it.2009.03.006; Ubagai T, 2015, INNATE IMMUN-LONDON, V21, P802, DOI 10.1177/1753425915605892; Vaickus LJ, 2010, AM J PATHOL, V177, P1861, DOI 10.2353/ajpath.2010.100053; Wang YP, 2012, ENDOCRINOLOGY, V153, P5972, DOI 10.1210/en.2012-1284; Yang S, 2014, CRIT CARE MED, V42, P2092, DOI 10.1097/CCM.0000000000000486	29	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	DEC	2016	186	12					3236	3245		10.1016/j.ajpath.2016.08.014			10	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	ED8EC	WOS:000389103800015	27876152	Green Published, Bronze			2022-02-06	
J	Jang, S; Jung, KI; Yoo, WK; Jung, MH; Ohn, SH				Jang, Soyeon; Jung, Kwang-Ik; Yoo, Woo-Kyoung; Jung, Myung Hun; Ohn, Suk Hoon			Risk Factors for Delirium During Acute and Subacute Stages of Various Disorders in Patients Admitted to Rehabilitation Units	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Delirium; Risk factors; Rehabilitation	ELDERLY MEDICAL PATIENTS; C-REACTIVE PROTEIN; POSTOPERATIVE DELIRIUM; PREDICTIVE MODEL; OLDER PATIENTS; HIP FRACTURE; BRAIN-INJURY; OUTCOMES; DIAGNOSIS; SURGERY	Objective To assess the risk factors for delirium in patients admitted to a rehabilitation unit for acute or subacute neurological or musculoskeletal disorders. Methods We reviewed the medical records of 537 patients admitted to a rehabilitation unit and selected 398 patients in the acute or subacute stage of various neurological or musculoskeletal disorders. Among them, patients who had suffered from delirium were categorized into the delirium group (n=65), and the other patients were categorized into the non-delirium group (n=333). As potential risk factors for delirium, the patients' diagnosis, underlying disease, demographic data, hospital stay duration, surgery, and laboratory findings were reviewed, and the differences between the two groups with respect to independent risk factors were analyzed. Results The average age in the delirium group was higher; the hospital stay and pre-transfer periods were longer. A large proportion of the patients were admitted for musculoskeletal disorders, and many patients had diabetes mellitus, dementia, and depression as underlying diseases. Laboratory tests revealed increases in the white blood cells (WBC), glucose, blood urea nitrogen (BUN), total bilirubin, aspartate transaminase (AST), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels in the delirium group, while the hemoglobin, calcium, phosphorus, protein, albumin, and potassium levels were decreased. Depression, musculoskeletal disorders, traumatic brain injury, elevated WBC, BUN, AST, and CRP levels, and decreased potassium and phosphorus levels were identified as independent risk factors for delirium. Conclusion Risk factors treatable before delirium onset were identified in rehabilitation patients in acute and subacute stages of various disorders. Early diagnosis and prevention of these risk factors could decrease delirium occurrence and increase rehabilitation effectiveness.	[Jang, Soyeon; Jung, Kwang-Ik; Yoo, Woo-Kyoung; Ohn, Suk Hoon] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Phys Med & Rehabil, 22 Gwanpyeong Ro 170beon Gil, Anyang 14068, South Korea; [Jung, Myung Hun] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Psychiat, Anyang, South Korea		Ohn, SH (corresponding author), Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Phys Med & Rehabil, 22 Gwanpyeong Ro 170beon Gil, Anyang 14068, South Korea.	ohnsh@hallym.ac.kr	Yoo, Woo-Kyoung/B-6356-2013	Yoo, Woo-Kyoung/0000-0002-1273-0647; Ohn, Suk Hoon/0000-0002-1139-1946; Jung, Myung Hun/0000-0003-2393-3930			Aldemir M, 2001, CRIT CARE, V5, P265, DOI 10.1186/cc1044; Ali Shahid, 2011, Innov Clin Neurosci, V8, P25; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, P596, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bickel H, 2008, DEMENT GERIATR COGN, V26, P26, DOI 10.1159/000140804; Brauer C, 2000, ARCH INTERN MED, V160, P1856, DOI 10.1001/archinte.160.12.1856; Caeiro L, 2004, J NEUROL, V251, P171, DOI 10.1007/s00415-004-0294-6; Clegg A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009537.pub2; de Lange E, 2013, INT J GERIATR PSYCH, V28, P127, DOI 10.1002/gps.3814; DICKSON LR, 1991, PSYCHOSOMATICS, V32, P317, DOI 10.1016/S0033-3182(91)72071-9; Elie M, 1998, J GEN INTERN MED, V13, P204, DOI 10.1046/j.1525-1497.1998.00047.x; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; 김창현, 2014, [Journal of Korean Geriatirc Psychiatry, 노인정신의학], V18, P39; Holroyd-Leduc JM, 2010, CAN MED ASSOC J, V182, P465, DOI 10.1503/cmaj.080519; Huai JP, 2014, GEN HOSP PSYCHIAT, V36, P488, DOI 10.1016/j.genhosppsych.2014.05.002; Hwang SW, 2002, J KOREAN ACAD FAM ME, V23, P112; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1993, ANN INTERN MED, V119, P474, DOI 10.7326/0003-4819-119-6-199309150-00005; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1994, AM J MED, V97, P278, DOI 10.1016/0002-9343(94)90011-6; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Inouye SK., 2009, FOCUS, V7, P53; Kamel HK, 2003, J GERONTOL A-BIOL, V58, P1042; Kennedy RE, 2003, PSYCHOSOMATICS, V44, P283, DOI 10.1176/appi.psy.44.4.283; Kim Na Young, 2015, [Brain & NeuroRehabilitation, 뇌신경재활], V8, P59; Ko HJ, 1997, J KOREAN NEUROPSYCHI, V36, P85; Lin YY, 2012, J CARDIAC SURG, V27, P481, DOI 10.1111/j.1540-8191.2012.01472.x; McManus J, 2007, AGE AGEING, V36, P613, DOI 10.1093/ageing/afm140; MYSIW WJ, 1995, NEUROREHABILITATION, V5, P197, DOI 10.3233/NRE-1995-5302; 정성원, 2006, Investigative and Clinical Urology, V47, P953; Pol RA, 2014, ANN VASC SURG, V28, P1923, DOI 10.1016/j.avsg.2014.07.004; POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x; Rah UW, 2014, BRAIN NEUROREHABI S1, V7, P1; Ritchie CW, 2014, INT PSYCHOGERIATR, V26, P717, DOI 10.1017/S1041610213002433; Roche V, 2003, AM J MED SCI, V325, P20, DOI 10.1097/00000441-200301000-00005; Schrier RW, 2008, CURR OPIN CRIT CARE, V14, P627, DOI 10.1097/MCC.0b013e32830e45e3; Tsai MC, 2013, INT J PSYCHIAT MED, V45, P45, DOI 10.2190/PM.45.1.d; Turco R, 2013, J GERIATR PSYCH NEUR, V26, P63, DOI 10.1177/0891988713481265; van Munster BC, 2014, CLIN MED, V14, P192, DOI 10.7861/clinmedicine.14-2-192; Yu K. D., 2005, J KOREAN GERIATR SOC, V9, P182	40	5	6	0	2	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	DEC	2016	40	6					1082	1091		10.5535/arm.2016.40.6.1082			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FG9ZN	WOS:000410798800015	28119839	Green Published, gold, Green Submitted			2022-02-06	
J	Lee, K; Jeong, D; Schindler, RC; Short, EJ				Lee, Kiju; Jeong, Donghwa; Schindler, Rachael C.; Short, Elizabeth J.			SIG-Blocks: Tangible game technology for automated cognitive assessment	COMPUTERS IN HUMAN BEHAVIOR			English	Article						Sensor-embedded blocks; Tangible user interface; Wireless sensor network; Cognitive assessment	TRAUMATIC BRAIN-INJURY; CHILDREN; SKILL	This paper presents the SIG-Blocks system developed for automated cognitive assessment via tangible geometric games (TAG-Games). Computerized game administration and real-time cognitive and behavior assessments were realized by wireless self-synchronization in communication, decentralized hybrid-sensing, assembly and motion detection, and graphical visualization. The measurable performance data included time and accuracy at each manipulation step, overall speed of manipulative motions, and the total number of rotational motions. For preliminary evaluation, three types of TAG-Games were designed: TAG-Game(A) for assembly, TAG-Game(S) for shape matching, and TAG-Game(M) for memory. As a part of the game design, a computational measure of play complexity was defined for each TAG Game based on the geometric properties and the number of blocks in the item. An evaluation with 86 participants assessed both reliability of the TAG-Game items using split-half and test-retest reliability tests and validity of the proposed complexity measures by comparing the results with three subtests of the Wechsler Adults Intelligence Scale 4th Edition (WAIS-IV), i.e. Block Design (BD), Matrix Reasoning (MR), and Digit Span (DS). The high reliability coefficients showed that TAG-Games were reliable. Regarding validity, correlations were found between TAG-Game(A) and BD and between TAG-Game(S) and MR. Behavioral analysis also showed that the TAG-Game performance was positively correlated with the manipulation speed, but not correlated with the total number of rotations applied to the blocks. (C) 2016 Elsevier Ltd. All rights reserved.	[Lee, Kiju; Jeong, Donghwa] Case Western Reserve Univ, Dept Mech & Aerosp Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Schindler, Rachael C.; Short, Elizabeth J.] Case Western Reserve Univ, Dept Psychol Sci, Cleveland, OH 44106 USA		Lee, K (corresponding author), Case Western Reserve Univ, Dept Mech & Aerosp Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kiju.lee@case.edu; donghwa.jeong@case.edu; rdc55@case.edu; Elizabeth.Short@case.edu	Lee, Kiju/Z-6280-2019; Short, Elizabeth/AAE-9241-2020; Lee, Kiju/A-3065-2008	Lee, Kiju/0000-0002-8526-9142; Lee, Kiju/0000-0002-8526-9142	National Science FoundationNational Science Foundation (NSF) [1109270, 1445012]; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1445012] Funding Source: National Science Foundation	This project was funded by National Science Foundation under Award No. 1109270 and 1445012.	Alers S. H. M., 2009, MULTIAGENT PLATFORM, P47; Bernmark E, 2002, APPL ERGON, V33, P541, DOI 10.1016/S0003-6870(02)00072-8; Bors DA, 1998, EDUC PSYCHOL MEAS, V58, P382, DOI 10.1177/0013164498058003002; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; Donghwa Jeong, 2010, 2010 IEEE International Conference on Multisensor Fusion and Integration for Intelligent Systems (MFI 2010), P32, DOI 10.1109/MFI.2010.5604479; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Jeong D, 2016, SPRINGER TRAC ADV RO, V112, P405, DOI 10.1007/978-4-431-55879-8_28; Kulp MT, 1999, OPTOMETRY VISION SCI, V76, P159, DOI 10.1097/00006324-199903000-00015; Lee K. H., 2014, GERIATR GERONTOL INT, P1; Lee K, 2008, INT J ROBOT RES, V27, P387, DOI 10.1177/0278364907084982; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lockman JJ, 2000, CHILD DEV, V71, P137, DOI 10.1111/1467-8624.00127; Lund H. H., 2011, 2011 8th International Conference on Ubiquitous Robots and Ambient Intelligence (URAI 2011), P253, DOI 10.1109/URAI.2011.6145971; McNerney Timothy S., 1999, THESIS; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Pehoski C, 1997, AM J OCCUP THER, V51, P719, DOI 10.5014/ajot.51.9.719; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Polatajko Helene J, 2005, Semin Pediatr Neurol, V12, P250; Pressley M., 1989, COGNITIVE STRATEGY R, P33; Raven J.C., 1998, RAVENS PROGR MATRICE; Sanderson A, 1984, ROB AUT P 1984 IEEE, P600; Schoemaker M. M., 2003, Neural Plasticity, V10, P155, DOI 10.1155/NP.2003.155; Schweikardt Eric, 2006, P 8 INT C MULT INT, P72; Sharlin E., 2002, Conference Proceedings. Conference on Human Factors in Computing Systems. CHI 2002, P347; Silverman W, 2010, INTELLIGENCE, V38, P242, DOI 10.1016/j.intell.2009.12.005; Sparrow SS, 2000, J CHILD PSYCHOL PSYC, V41, P117, DOI 10.1111/1469-7610.00552; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sun Emily, 2012, P 2012 ACM ANN C HUM, P1015, DOI DOI 10.1145/2212776.2212374; Suzuki H, 1995, PROCEEDINGS OF CSCL '95 - THE FIRST INTERNATIONAL CONFERENCE ON COMPUTER SUPPORT FOR COLLABORATIVE LEARNING, P349; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Terrenghi L, 2006, PERS UBIQUIT COMPUT, V10, P153, DOI 10.1007/s00779-005-0025-8; Willingham DB, 1996, NEUROPSYCHOLOGY, V10, P315, DOI 10.1037/0894-4105.10.3.315; Wong WY, 2008, GAIT POSTURE, V27, P168, DOI 10.1016/j.gaitpost.2007.03.001; Wright FV, 2008, DEV MED CHILD NEUROL, V50, P283, DOI 10.1111/j.1469-8749.2008.02037.x; Wyeth P, 2001, HUMAN-COMPUTER INTERACTION - INTERACT'01, P496	35	5	5	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0747-5632	1873-7692		COMPUT HUM BEHAV	Comput. Hum. Behav.	DEC	2016	65						163	175		10.1016/j.chb.2016.08.023			13	Psychology, Multidisciplinary; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	EA9SW	WOS:000386986000019		Bronze			2022-02-06	
J	Liu, ZL; Dong, J; Zhao, XH; Chen, XR; Lippa, SM; Caroselli, JS; Fang, X				Liu, Zilong; Dong, Juan; Zhao, Xiaohong; Chen, Xiaorui; Lippa, Sara M.; Caroselli, Jerome S.; Fang, Xiang			Assessment of feigned cognitive impairment in severe traumatic brain injury patients with the Forced-choice Graphics Memory Test	Brain and Behavior			English	Article						malingering; performance validity; response bias	SYMPTOM VALIDITY TEST; REY 15-ITEM TEST; HEAD-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; INADEQUATE EFFORT; MALINGERING TOMM; RECOGNITION TEST; RESPONSE BIAS; DIGIT SPAN; EXAGGERATION	Introduction: The Forced-choice Graphics Memory Test (FGMT) is a newly developed measure to assess feigned cognitive impairment. This study investigated the ability and reliability of FGMT for identification of malingering in patients with traumatic brain injury (TBI). Methods: The FGMT was administered to 40 healthy volunteers instructed to respond validly (Healthy Control, H-C), 40 healthy volunteers instructed to feign cognitive impairment (Healthy Malingering, H-M), 40 severe TBI patients who responded validly (TBI control, TBI-C), and 30 severe TBI patients who evidenced invalid performance (TBI malingering, TBI-M). Results: Both malingering groups (H-M and TBI-M) performed much more poorly than the nonmalingering groups (H-C and TBI-C). The FGMT overall total score, score on easy items, and score on hard items differed significantly across the four groups. The total score showed the highest classification accuracy in differentiating malingering from nonmalingering. A cutoff of less than 18 (total items) successfully identified 95% of TBI-C and 93.3% of TBI-M participants. The FGMT also demonstrated high test-retest reliability and internal consistency. FGMT scores were not affected by TBI patients' education, gender, age, or intelligence. Conclusion: Our results suggest that the FGMT can be used as a fast and reliable tool for identification of feigned cognitive impairment in patients with TBI.	[Liu, Zilong; Dong, Juan; Zhao, Xiaohong; Chen, Xiaorui] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan, Hubei, Peoples R China; [Lippa, Sara M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Caroselli, Jerome S.] TIRR Mem Hermann Hosp, Dept Psychol Neuropsychol, Houston, TX USA; [Fang, Xiang] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA		Liu, ZL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan, Hubei, Peoples R China.	liuzilongfy@hust.edu.cn			Fundamental Research Funds from the Central Universities of China [HUST2012QN001]	Fundamental Research Funds from the Central Universities of China, Grant/Award Number: HUST2012QN001	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Avila R, 2009, INT PSYCHOGERIATR, V21, P560, DOI 10.1017/S1041610209008928; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; Castiel M, 2012, NEUROPSYCHOL REHABIL, V22, P734, DOI 10.1080/09602011.2012.686884; Chakrabarti A., 2013, PSYCHOLOGY, V4, P410, DOI [10.4236/psych.2013.44058, DOI 10.4236/PSYCH.2013.44058]; Chu Y., 2010, CHINA J HLTH PSYCHOL, V18, P518; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Frazier TW, 2007, ARCH CLIN NEUROPSYCH, V22, P197, DOI 10.1016/j.acn.2006.12.007; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; [高北陵 Gao Beilin], 2002, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V10, P256; [高北陵 Gao Beiling], 2003, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V11, P99; Gouse H, 2013, ARCH CLIN NEUROPSYCH, V28, P38, DOI 10.1093/arclin/acs100; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1994, PERCEPT MOTOR SKILL, V78, P1179, DOI 10.2466/pms.1994.78.3c.1179; Gunner JH, 2012, ARCH CLIN NEUROPSYCH, V27, P1, DOI 10.1093/arclin/acr089; Gunstad J, 2001, CLIN NEUROPSYCHOL, V15, P397, DOI 10.1076/clin.15.3.397.10271; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lezak M. D., 2012, NEUROPSYCHOLOGICAL A, P831; Liu R., 2001, CHINESE J CLIN PSYCH, V9, P173; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Love CM, 2014, ASSESSMENT, V21, P618, DOI 10.1177/1073191114528028; Lynch W, 2004, J HEAD TRAUMA REHAB, V19, P277, DOI 10.1097/00001199-200405000-00008; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Mungkhetklang C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00683; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Paivio A., 1971, IMAGERY VERBAL PROCE; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Shandera AL, 2010, PSYCHOL ASSESSMENT, V22, P50, DOI 10.1037/a0016585; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sweet JJ, 2013, BEHAV SCI LAW, V31, P756, DOI 10.1002/bsl.2088; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Vilar-Lopez R, 2007, ARCH CLIN NEUROPSYCH, V22, P379, DOI 10.1016/j.acn.2007.01.012; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P721, DOI 10.1080/13803395.2010.550602; Yao SQ, 2007, PSYCHIAT CLIN NEUROS, V61, P379, DOI 10.1111/j.1440-1819.2007.01672.x; Zhang X., 2009, MED RES ED, V26, P53; [No title captured]	68	5	6	0	10	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2016	6	12							e00593	10.1002/brb3.593			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	EI7VL	WOS:000392712000018	28032009	gold, Green Published			2022-02-06	
J	Mangan, KI; Kingsbury, TD; Mazzone, BN; Wyatt, MP; Kuhn, KM				Mangan, Katharine I.; Kingsbury, Trevor D.; Mazzone, Brittney N.; Wyatt, Marilynn P.; Kuhn, Kevin M.			Limb Salvage With Intrepid Dynamic Exoskeletal Orthosis Versus Transtibial Amputation: A Comparison of Functional Gait Outcomes	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						limb salvage; transtibial amputation; Intrepid Dynamic Exoskeletal Orthosis	LOWER-EXTREMITY TRAUMA; PROSTHETIC FEET; WALKING; RECONSTRUCTION; DESIGN; STANCE; RETURN	Objectives: To determine if there is a difference in functional gait outcomes between patients with limb injuries treated with either transtibial amputation or limb preservation with the Intrepid Dynamic Exoskeletal Orthosis. Design: Retrospective prognostic study. Setting: Tertiary referral military hospital. Patients: This study included 10 transtibial amputees and 10 limb preservation patients using the Intrepid Dynamic Exoskeletal Orthosis who were matched by body mass index after excluding for non-traumatic, proximal ipsilateral, contralateral, spine, or traumatic brain injuries. Transtibial amputation patients were also excluded if they did not have a gait study between 6 and 12 months after independent ambulation. Limb preservation were excluded if they did not complete the "Return to Run" program. Interventions: An observational study of functional outcomes using instrumented gait analysis. Outcome Measures: Spatiotemporal, kinetic (vertical ground reaction force), unified deformable power, work, and efficiency. Results: Limb preservation patients walked with a significantly slower cadence (P = 0.036) and spent less time on their affected limb in stance (P = 0.045), and longer in swing (P = 0.019). Amputees had significantly increased maximum positive power in both limbs (P = 0.004 and P = 0.029) and increased maximum negative power on the unaffected limb (P = 0.035). Amputees had significantly increased positive and negative work in the affected limb (P = 0.0009 and P = 0.014) and positive work in the unaffected limb (P = 0.042). There was no significant difference in the kinetic data or efficiency. Conclusions: Limb preservation patients spend less time on their affected limb as a percentage of the gait cycle. The unified deformable power demonstrated more dynamic gait in amputees, with peak values closer to normative data.	[Mangan, Katharine I.] Naval Hosp Oak Harbor, Dept Orthopaed Surg, Oak Harbor, WA USA; [Kingsbury, Trevor D.; Mazzone, Brittney N.; Wyatt, Marilynn P.] Naval Med Ctr San Diego, Gait Anal Lab, Dept Phys & Occupat Therapy, Chiropract Serv, San Diego, CA USA; [Kingsbury, Trevor D.; Mazzone, Brittney N.; Wyatt, Marilynn P.] Naval Med Ctr San Diego, Sports Med, San Diego, CA USA; [Mazzone, Brittney N.] Univ Delaware, BADER Consortium, Newark, DE USA; [Kuhn, Kevin M.] Naval Med Ctr San Diego, Dept Orthopaed Surg, San Diego, CA USA		Mangan, KI (corresponding author), Naval Hosp Oak Harbor, Dept Orthopaed Surg, Specialty Clin, 3475 N Saratoga St, Oak Harbor, WA 98278 USA.	Katharine.I.Mangan.mil@mail.mil		Kingsbury, Trevor/0000-0001-5298-8725	BADER Consortium via Congressionally Directed Medical Research Programs (CDMRP) [W81XWH-11-2-0222]	Support was provided by the BADER Consortium via Congressionally Directed Medical Research Programs (CDMRP) award W81XWH-11-2-0222.	BARR AE, 1992, PHYS THER, V72, P344, DOI 10.1093/ptj/72.5.344; Bartonek A, 2007, DEV MED CHILD NEUROL, V49, P615, DOI 10.1111/j.1469-8749.2007.00615.x; Bedigrew KM, 2014, CLIN ORTHOP RELAT R, V472, P3017, DOI 10.1007/s11999-014-3609-7; Blair JA, 2014, J ORTHOP TRAUMA, V28, pE70, DOI 10.1097/BOT.0000000000000006; Bleyenheuft C., 2008, Annales de Readaptation et de Medecine Physique, V51, P154, DOI 10.1016/j.annrmp.2007.12.005; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; Czerniecki JM, 2012, ARCH PHYS MED REHAB, V93, P1766, DOI 10.1016/j.apmr.2012.04.011; Doukas WC, 2013, J BONE JOINT SURG AM, V95A, P138, DOI 10.2106/JBJS.K.00734; Fergason J, 2010, FOOT ANKLE CLIN, V15, P151, DOI 10.1016/j.fcl.2009.10.001; Ferreira RC, 2010, FOOT ANKLE INT, V31, P113, DOI 10.3113/FAI.2010.0113; Graham LE, 2007, ARCH PHYS MED REHAB, V88, P801, DOI 10.1016/j.apmr.2007.02.028; Harvey Zach T, 2012, J Surg Orthop Adv, V21, P58; Hsu MJ, 2006, ARCH PHYS MED REHAB, V87, P123, DOI 10.1016/j.apmr.2005.07.310; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kuo AD, 2007, HUM MOVEMENT SCI, V26, P617, DOI 10.1016/j.humov.2007.04.003; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; MacKenzie EJ, 2007, J BONE JOINT SURG AM, V89A, P1685, DOI 10.2106/JBJS.F.01350; Owens JG, 2011, J TRAUMA, V71, pS120, DOI 10.1097/TA.0b013e3182219225; Patzkowski JC, 2012, J BONE JOINT SURG AM, V94A, P507, DOI 10.2106/JBJS.K.00254; Patzkowski Jeanne C, 2011, J Surg Orthop Adv, V20, P8; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Schoenfeld AJ, 2013, INJURY, V44, P1866, DOI 10.1016/j.injury.2013.08.001; Takahashi KZ, 2012, J BIOMECH, V45, P2662, DOI 10.1016/j.jbiomech.2012.08.017; Wolf SI, 2008, GAIT POSTURE, V28, P175, DOI 10.1016/j.gaitpost.2007.11.012	24	5	5	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	DEC	2016	30	12					E390	E395		10.1097/BOT.0000000000000688			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	ED6CG	WOS:000388941600003	27870693				2022-02-06	
J	Mihuta, ME; Green, HJ; Man, DWK; Shum, DHK				Mihuta, Mary E.; Green, Heather J.; Man, David W. K.; Shum, David H. K.			Correspondence between Subjective and Objective Cognitive Functioning Following Chemotherapy for Breast Cancer	BRAIN IMPAIRMENT			English	Article						Attention; processing speed; executive function; medical; surgical; memory; quality of life; cancer	TRAUMATIC BRAIN-INJURY; PROSPECTIVE MEMORY PERFORMANCE; VIRTUAL-REALITY; ADJUVANT CHEMOTHERAPY; MENOPAUSAL SYMPTOMS; OLDER-ADULTS; EVENT; WOMEN; IMPAIRMENT; SURVIVORS	This study examined subjective and objective cognitive functioning in 26 female breast cancer survivors (BCS) who received chemotherapy treatment that finished .5 to 5 years prior to testing and compared their results to 25 demographically matched women with no history of cancer. Participants were assessed on prospective memory (PM) tasks; neuropsychological tests of processing speed, attentional flexibility with greater cognitive load, executive function, and verbal memory; self-report measures of cognitive dysfunction and PM failures; and distress. The BCS group showed significantly slower speed of processing and reduced attentional flexibility, and reported significantly more cognitive complaints and PM failures than the control group on five of six self-report measures. The groups did not differ on other PM or neuropsychological measures or on a measure of distress. Subjective cognition correlated with some neuropsychological tests and with a virtual reality PM task. Objective cognitive impairments were associated with reduced quality of life in the BCS group. The results provide some evidence of both self-reported impairment and objective cognitive dysfunction following chemotherapy treatment.	[Mihuta, Mary E.; Green, Heather J.; Shum, David H. K.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Australia; [Mihuta, Mary E.; Green, Heather J.; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Gold Coast Campus, Gold Coast, Qld 4222, Australia; [Man, David W. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China		Green, HJ (corresponding author), Griffith Univ, Sch Appl Psychol, Gold Coast Campus, Gold Coast, Qld 4222, Australia.	h.green@griffith.edu.au	Green, Heather/C-1169-2008; Shum, David H. K./A-3914-2008	Green, Heather/0000-0003-4254-4076; Shum, David H. K./0000-0002-4810-9262	Griffith Health Institute	The project was partly supported by a grant awarded by the Griffith Health Institute to David H. K. Shum.	Ahles TA, 2002, J CLIN ONCOL, V20, P485, DOI 10.1200/JCO.2002.20.2.485; Ahles TA, 2010, J CLIN ONCOL, V28, P4434, DOI 10.1200/JCO.2009.27.0827; Azzopardi B, 2015, INTELLIGENCE, V52, P24, DOI 10.1016/j.intell.2015.06.007; Benton A., 1978, MULTILINGUAL APHASIA; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Canty AL, 2014, NEUROPSYCHOL REHABIL, V24, P238, DOI 10.1080/09602011.2014.881746; Cheng HD, 2013, PSYCHO-ONCOLOGY, V22, P2391, DOI 10.1002/pon.3291; Collins B, 2017, PSYCHO-ONCOLOGY, V26, P109, DOI 10.1002/pon.4012; Collins B, 2013, PSYCHO-ONCOLOGY, V22, P1517, DOI 10.1002/pon.3163; Fan HGM, 2005, J CLIN ONCOL, V23, P8025, DOI 10.1200/JCO.2005.01.6550; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Green H. J., 2005, PSYCHOL HEALTH MED, V10, P145, DOI [10.1080/13548500500093308, DOI 10.1080/13548500500093308]; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Hutchinson AD, 2012, CANCER TREAT REV, V38, P926, DOI 10.1016/j.ctrv.2012.05.002; Ihle A, 2013, PSYCHOL AGING, V28, P714, DOI 10.1037/a0033653; Janelsins MC, 2014, INT REV PSYCHIATR, V26, P102, DOI 10.3109/09540261.2013.864260; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; King S, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00072; Kliegel M, 2008, DEV PSYCHOL, V44, P612, DOI 10.1037/0012-1649.44.2.612; Knight RG, 2009, BRAIN IMPAIR, V10, P3, DOI 10.1375/brim.10.1.3; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Lai JS, 2009, J PAIN SYMPTOM MANAG, V37, P982, DOI 10.1016/j.jpainsymman.2008.07.012; Man D. W. K., 2011, VIRTUAL REALITY SHOP; Man DWK, 2011, NEUROPSYCHOL REHABIL, V21, P884, DOI 10.1080/09602011.2011.627270; Marsh RL, 1998, J EXP PSYCHOL LEARN, V24, P336, DOI 10.1037/0278-7393.24.2.336; Marsh RL, 2002, PSYCHON B REV, V9, P604, DOI 10.3758/BF03196319; McDonald-Miszczak L, 2009, J APPL GERONTOL, V28, P560, DOI 10.1177/0733464808330821; Meyers CA, 2013, JNCI-J NATL CANCER I, V105, P761, DOI 10.1093/jnci/djt091; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Munir F, 2010, J CLIN NURS, V19, P1362, DOI 10.1111/j.1365-2702.2009.03006.x; Myers JS, 2015, SUPPORT CARE CANCER, V23, P3219, DOI 10.1007/s00520-015-2708-7; Ono M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00059; Paquet L, 2013, BREAST, V22, P455, DOI 10.1016/j.breast.2013.04.002; Phillips KM, 2012, CANCER-AM CANCER SOC, V118, P1925, DOI 10.1002/cncr.26432; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; Reid-Arndt SA, 2012, J CLIN PSYCHOL MED S, V19, P127, DOI 10.1007/s10880-011-9274-z; Reitan R, 1985, HALSTEAD REITAN NEUR; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; Shilling V, 2007, EUR J ONCOL NURS, V11, P6, DOI 10.1016/j.ejon.2006.02.005; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Tchen N, 2003, J CLIN ONCOL, V21, P4175, DOI 10.1200/JCO.2003.01.119; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; Uttl B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001568; Vedhara K, 2004, PSYCHOL HEALTH MED, V9, P17, DOI [DOI 10.1080/13548500310001637724, 10.1080/13548500310001637724]; Wagner L.I., 2009, SUPPORT ONCOL, V7, pW32, DOI DOI 10.1016/J.JPAINSYMMAN.2014.08.012; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Zeintl M, 2006, DEMENT GERIATR COGN, V22, P209, DOI 10.1159/000094915	49	5	5	1	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2016	17	3					222	232		10.1017/BrImp.2016.16			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EF5MN	WOS:000390374400003					2022-02-06	
J	Nemes, O; Kovacs, N; Szujo, S; Bodis, B; Bajnok, L; Buki, A; Doczi, T; Czeiter, E; Mezosi, E				Nemes, O.; Kovacs, N.; Szujo, Sz.; Bodis, B.; Bajnok, L.; Buki, A.; Doczi, T.; Czeiter, E.; Mezosi, E.			Can early clinical parameters predict post-traumatic pituitary dysfunction in severe traumatic brain injury?	ACTA NEUROCHIRURGICA			English	Article						Severe traumatic brain injury; Hypopituitarism; Endocrine dysfunction; Growth hormone deficiency	ANEURYSMAL SUBARACHNOID HEMORRHAGE; HYPOPITUITARISM; PREVALENCE; INSUFFICIENCY	Post-traumatic hypopituitarism is a major complication after severe head trauma. The aim of our study was to evaluate the possible role of early clinical parameters in the development of endocrine deficits. Data on endocrine function, on-admission clinical-, laboratory-, and ICU-monitored parameters were available in 63 patients of the surviving 86 severe head injury patients (post-resuscitation GCS under 8) treated at one neurosurgical center during a 10-year period. Hypopituitarism was diagnosed in 68.3 % of the patients. The most frequently affected pituitary axis was the growth hormone (GH): GH deficiency or insufficiency was present in 50.8 %. Central hypogonadism affected 23.8 % of male patients; hypothyroidism and secondary adrenal failure were found in 22.2 and 9.5 % of the investigated population, respectively. Early onset (within 1 year of brain injury) hypopituitarism was found in 24 patients. No connection was found between the development of hypopituitarism and any of the clinical parameters assessed on-admission or at ICU. Significant correlations were found between early endocrine dysfunctions and surgical intervention (OR: 4.64) and the diagnosis of subdural hematoma (OR: 12). In our population, after road traffic accidents, the development of late-onset hypopituitarism was less prevalent (OR: 0.22). Since our results do not indicate any reliable predictive parameter for the development of endocrine dysfunction in a cohort of patients with severe traumatic brain injury, regular endocrine screening of this specific patient population seems obligatory.	[Nemes, O.; Szujo, Sz.; Bodis, B.; Bajnok, L.; Mezosi, E.] Univ Pecs, Dept Internal Med 1, 13 Ifjusag, H-7624 Pecs, Hungary; [Kovacs, N.; Buki, A.; Doczi, T.; Czeiter, E.] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, A.; Czeiter, E.] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Buki, A.; Czeiter, E.] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary		Mezosi, E (corresponding author), Univ Pecs, Dept Internal Med 1, 13 Ifjusag, H-7624 Pecs, Hungary.	mezosi.emese@pte.hu	Czeiter, Endre/B-1404-2009	Czeiter, Endre/0000-0002-9578-6944	Hungarian Brain Research Program [KTIA_13_NAP-A-II/8]	The present study was supported by the Hungarian Brain Research Program - Grant No. KTIA_13_NAP-A-II/8. The present scientific contribution is dedicated to the 650th anniversary of the foundation of the University of Pecs, Hungary.	Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Masel BE, 2015, J NEUROTRAUM, V32, P1902, DOI 10.1089/neu.2014.3526; Munoz A, 2013, CURR OPIN ENDOCRINOL, V20, P354, DOI 10.1097/MED.0b013e32836318ba; Nemes O, 2014, HORMONES, V14, P383; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; van der Eerden AW, 2010, EUR J ENDOCRINOL, V162, P19, DOI 10.1530/EJE-09-0436; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	20	5	5	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2016	158	12					2347	2353		10.1007/s00701-016-2995-x			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EC4OS	WOS:000388113100017	27778105				2022-02-06	
J	Ng, RHC				Ng, Rachel H. C.			Post-traumatic transient cortical blindness in a child with occipital bone fracture	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Children; Cortical blindness; Head injury; Neurosurgery		Cortical blindness as sequelae of trauma has been reported in literature but mostly in the setting of occipital cortex or visual tract damages. We present a case of transient cortical blindness in a child following a closed head injury with a non-displaced occipital bone fracture and underlying occipital lobe contusion. We discuss the pathophysiology behind Post-traumatic transient cortical blindness, relevant investigations, and current management. (C) 2016 Elsevier Ltd. All rights reserved.	[Ng, Rachel H. C.] Lady Cilento Childrens Hosp, Neurosurg, 501 Stanley St, South Brisbane, Qld 4101, Australia		Ng, RHC (corresponding author), Lady Cilento Childrens Hosp, Neurosurg, 501 Stanley St, South Brisbane, Qld 4101, Australia.	jaytomato@hotmail.com					FELBER SR, 1993, J MAGN RESON IMAGING, V3, P921, DOI 10.1002/jmri.1880030621; GLEESON AP, 1994, J ACCID EMERG MED, V11, P250; GRIFFITH JF, 1968, NEW ENGL J MED, V278, P648, DOI 10.1056/NEJM196803212781203; Lim S, 2013, INJURY EXTRA, P54; Liu T, 2006, J EMERG CRIT CARE, V17, P4; YAMAMOTO LG, 1988, CLIN PEDIATR, V27, P479, DOI 10.1177/000992288802701003	6	5	5	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2016	34						225	227		10.1016/j.jocn.2016.08.010			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED8AE	WOS:000389093300051	27707613				2022-02-06	
J	Park, A; Chapman, M; McCredie, VA; Debicki, D; Gofton, T; Norton, L; Boyd, JG				Park, Andrea; Chapman, Martin; McCredie, Victoria A.; Debicki, Derek; Gofton, Teneille; Norton, Loretta; Boyd, J. Gordon			EEG utilization in Canadian intensive care units: A multicentre prospective observational study	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						EEG; Continuous EEG; Non-convulsive seizures; Non-convulsive status epilepticus; Neurocritical care; Resource utilization	CONSENSUS STATEMENT; GUIDELINES; MANAGEMENT; ICU	Purpose: We have previously shown that electroencephalography (EEG) may be an underutilized monitoring modality in a single general medical-surgical ICU, that does not have a specific neurocritical care consultation service or neurocritical care unit. The present study was designed to describe the pattern of EEG utilization across 3 academic ICUs in Ontario, Canada that use different models of neurocritical care. Method: In this prospective multicentre observational study, ICU patients were screened weekly for 6 non-consecutive weeks to determine if they met the ESICM's recommendations or suggestions for EEG monitoring. If EEGs were performed, the results were recorded. Three models of neurocritical care provision were examined in 3 academic tertiary ICUs. Site 1 is an intensivist-led, medical-surgical ICU with no specific neurocritical care consultation service. The second site is also an intensivist led medical surgical ICU, but with a formal neurocritical care consultation service. The third site is a virtual neurological and neurotrauma ICU within a medical-surgical ICU, staffed by rotating neurointensivists and general intensivists. Results: Of the 375 patients who were screened, 127 patients (34%) met at least one ESICM indication for EEG monitoring. Among the 127 patients, 46 patients (37%) had an EEG performed. Site 1 had the highest proportion of EEGs performed. The most common indication for EEG monitoring was for patients with unexplained altered level of consciousness, in the absence of primary brain injury. For the EEGs performed per ESICM indication, the majority of epileptiform abnormalities were found in patients admitted with status epilepticus. Conclusions: EEG may be underutilized in Canadian ICUs. The impact on patient management and outcomes are unknown. (C) 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Park, Andrea; Boyd, J. Gordon] Queens Univ, Dept Crit Care Med, Kingston, ON, Canada; [Chapman, Martin; McCredie, Victoria A.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Debicki, Derek; Gofton, Teneille; Norton, Loretta] Western Univ, Dept Clin Neurol Sci, London, ON, Canada; [Boyd, J. Gordon] Queens Univ, Dept Med Neurol, Kingston, ON, Canada		Boyd, JG (corresponding author), Queens Univ, Kingston Gen Hosp, Dept Med Neurol, Davies 2,76 Stuart St, Kingston, ON K7L 2V7, Canada.; Boyd, JG (corresponding author), Queens Univ, Kingston Gen Hosp, Dept Crit Care Med, Davies 2,76 Stuart St, Kingston, ON K7L 2V7, Canada.	boydj@kgh.kari.net	Boyd, J. Gordon/L-3060-2019	Norton, Loretta/0000-0002-6651-1837			Barr J, 2013, AM J HEALTH-SYST PH, V70, P53, DOI 10.1093/ajhp/70.1.53; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hofmeijer J, 2016, CLIN NEUROPHYSIOL, V127, P2047, DOI 10.1016/j.clinph.2016.02.002; Hovland A, 2006, RESUSCITATION, V68, P143, DOI 10.1016/j.resuscitation.2005.05.019; Howes D, 2016, RESUSCITATION, V98, P48, DOI 10.1016/j.resuscitation.2015.07.052; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; Khan OI, 2014, EPILEPTIC DISORD, V16, P439, DOI 10.1684/epd.2014.0715; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Park A, 2015, INTENS CARE MED, V41, P1869, DOI 10.1007/s00134-015-3990-z; Rittenberger JC, 2012, NEUROCRIT CARE, V16, P114, DOI 10.1007/s12028-011-9565-0; Tanner AEJ, 2014, J CLIN NEUROPHYSIOL, V31, P181, DOI 10.1097/WNP.0000000000000049; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Young GB, 1998, ARCH NEUROL-CHICAGO, V55, P117, DOI 10.1001/archneur.55.1.117	18	5	5	0	4	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	DEC	2016	43						42	47		10.1016/j.seizure.2016.10.021			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EG9ZE	WOS:000391420200009	27886628	Bronze			2022-02-06	
J	Riggio, S; Jagoda, A				Riggio, Silvana; Jagoda, Andy			Concussion and its neurobehavioural sequelae	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Concussion; mild traumatic brain injury; post-concussive syndrome; head computed tomography; neuropsychologic testing	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CHRONIC PAIN; PSYCHIATRIC-DISORDERS; HEAD-INJURY; ASSOCIATION; SYMPTOMS; RISK; CLASSIFICATION; ADOLESCENTS	A concussion results from a force to the brain that results in a transient loss of connectivity within the brain. Sport psychiatrists are increasingly called to be part of the concussion team and need to be prepared to manage issues related to concussion and its behavioural sequelae. Objectively, the best evidence available suggests that deficits in attention and/or in balance are the most reliable objective findings that a concussion has occurred. Prognosis after a concussion is generally very good, although a sub-set of patients that are yet well defined seem pre-disposed to delayed recovery. Neither head CT nor MRI are sufficiently sensitive to diagnose the type of injuries that pre-dispose patients to the neurobehavioural sequelae that have been associated with a concussion; confounding this is the finding that many of these signs and symptoms associated with concussion occur in other types of non-head injuries. Brain biomarkers and functional MRI ( fMRI) hold promise in both diagnosis and prognosis of concussion, but are still research tools without validated clinical utility at this time. Finally, neurocognitive testing holds promise as a diagnostic criterion to demonstrate injury but, unfortunately, these tests are also limited in their prognostic utility and are of limited value.	[Riggio, Silvana] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Riggio, Silvana] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Riggio, Silvana] James J Peters Vet Adm, Dept Psychiat, Bronx, NY USA; [Jagoda, Andy] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA		Riggio, S (corresponding author), Mt Sinai, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA.	silvana.riggio@mssm.edu	Hassan, Randa/AAW-3624-2021				American Psychiatric Association DSM-5 Task Force., 2013, DIAGNOSTIC STAT MANU, V5th, P624; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Borg Jorgen, 2004, Journal of Rehabilitation Medicine Supplement, P76; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruff RM, 1996, BRAIN INJURY, V8, P61; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; World Health Organization, 1992, ICD 10 CLASSIFICATIO	37	5	6	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	DEC	2016	28	6			SI		579	586		10.1080/09540261.2016.1220927			8	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	ED1HM	WOS:000388595900007	27671123				2022-02-06	
J	Romaine, A; DeFreese, JD; Guskiewicz, K; Register-Mihalik, J				Romaine, Andrew; DeFreese, J. D.; Guskiewicz, Kevin; Register-Mihalik, Johna			Sport Parent Perceptions of American Youth Football Costs, Benefits, and Safety	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						achievement outcomes; expectancy-value theory; youth sport safety	ACHIEVEMENT TASK VALUES; RECURRENT CONCUSSION; COMMITMENT; MOTIVATION; SOCIALIZATION; SATISFACTION; ENJOYMENT; BELIEFS; ABILITY; INJURY	As head injuries in American football have received increasing publicity, the safety of the sport has become a great concern for parents nationwide. The purpose of this study was to examine perceived safety concerns in youth football using Eccles' expectancy-value model (Eccles et al., 1983). We hypothesized perceived safety concerns to moderate relationships between parent perceptions of parent cost/benefit, child cost/benefit, and child motivation and enjoyment outcomes for football. Youth football parents (N = 105, M-age = 42) completed valid and reliable online assessments of study variables. Regression analyses revealed child safety concerns (as rated by parents) to mediate, rather than moderate, the relationship between parent safety concerns and child cost perceptions (as rated by parents). Furthermore, safety concerns did not significantly associate with child achievement outcomes of motivation and enjoyment. Results provide valuable insight into parent and child attitudes toward youth football safety. Such knowledge may inform future educational interventions targeting sport safety promotion.	[Romaine, Andrew; DeFreese, J. D.; Guskiewicz, Kevin; Register-Mihalik, Johna] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Romaine, A (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA.	aromaine075@gmail.com					BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Cox AE, 2004, J APPL SPORT PSYCHOL, V16, P103, DOI 10.1080/10413200490437930; Dillman DA., 2007, MAIL INTERNET SURVEY; DORAN GA, 1984, J SPORT MED PHYS FIT, V24, P90; Dunn JGH, 1999, J SPORT EXERCISE PSY, V21, P259, DOI 10.1123/jsep.21.3.259; Eccles J., 1991, J APPL SPORT PSYCHOL, V3, P7, DOI [10.1080/10413209108406432, DOI 10.1080/10413209108406432]; Eccles J.S., 1983, ACHIEVEMENT ACHIEVEM, P75, DOI DOI 10.1007/S11251-015-9352-Y; Eccles J. S., 1998, HDB CHILD PSYCHOL, V3, P1017; ECCLES JS, 1989, J PERS, V57, P283, DOI 10.1111/j.1467-6494.1989.tb00484.x; ECCLES JS, 1993, NEBR S MOT 1992 DEV, P145; ECCLES JS, 1995, PERSONALITY SOCIAL P, V21, P215, DOI DOI 10.1177/0146167295213003; Eisenberg N, 1998, PSYCHOL INQ, V9, P317, DOI 10.1207/s15327965pli0904_1; ESPNW/ The Aspen Institute, 2014, PROJ PLAY SURV PAR Y; Fredricks JA, 2005, J SPORT EXERCISE PSY, V27, P3, DOI 10.1123/jsep.27.1.3; Fredricks JA, 2002, DEV PSYCHOL, V38, P519, DOI 10.1037/0012-1649.38.4.519; Gould D., 1988, CHILDREN IN SPORT, V3, P161; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harwood C, 2009, PSYCHOL SPORT EXERC, V10, P447, DOI 10.1016/j.psychsport.2009.01.005; JACOBS JE, 1992, J PERS SOC PSYCHOL, V63, P932, DOI 10.1037/0022-3514.63.6.932; Kaartina S, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0234-4; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kontos AP, 2000, J SPORT EXERCISE PSY, V22, pS10; Kontos AP, 2004, J PEDIATR PSYCHOL, V29, P447, DOI 10.1093/jpepsy/jsh048; Maccoby E.E., 1983, HDB CHILD PSYCHOL VO, V4, P1; PELLETIER LG, 1995, J SPORT EXERCISE PSY, V17, P35, DOI 10.1123/jsep.17.1.35; Raedeke TD, 1997, J SPORT EXERCISE PSY, V19, P396, DOI 10.1123/jsep.19.4.396; Raedeke TD, 2007, J APPL SPORT PSYCHOL, V19, P105, DOI 10.1080/10413200601113638; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; RUSBULT CE, 1983, J APPL PSYCHOL, V68, P429, DOI 10.1037/0021-9010.68.3.429; RUSBULT CE, 1980, J EXP SOC PSYCHOL, V16, P172, DOI 10.1016/0022-1031(80)90007-4; Sage G. H., 1977, INTRO MOT BEHAV NEUR; Sarrazin P, 2002, EUR J SOC PSYCHOL, V32, P395, DOI 10.1002/ejsp.98; Scanlan T.K., 1993, PEDIATR EXERC SCI, V5, P275, DOI 10.1123/pes.5.3.275; Schwarz Alan, 2007, NY TIMES; Short S. E., 2005, ATHLETIC INSIGHT, V6, P38; Stein G. L., 1992, PEDIATR EXERC SCI, V4, P150, DOI [10.1123/pes.4.2.150, DOI 10.1123/PES.4.2.150]; Tabachnick G. G., 2007, EXPT DESIGNS USING A; USA Football, 2014, US FOOTB 2014 ANN RE, P22; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Weiss M. R., 1989, PEDIATRIC EXERCISE S, V1, P195, DOI DOI 10.1123/PES.1.3.195; Weiss WM, 2010, J SPORT SCI, V28, P423, DOI 10.1080/02640410903536442; Weiss WM, 2003, J SPORT EXERCISE PSY, V25, P229, DOI 10.1123/jsep.25.2.229; West S. G., 1991, MULTIPLE REGRESSION; WIGFIELD A, 1992, DEV REV, V12, P265, DOI 10.1016/0273-2297(92)90011-P; Wigfield A, 1994, EDUC PSYCHOL REV, V6, P49, DOI 10.1007/BF02209024	46	5	5	1	17	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	DEC	2016	10	4					253	271		10.1123/jcsp.2016-0018			19	Psychology, Applied	Social Science Citation Index (SSCI)	Psychology	EQ8WV	WOS:000398367100001					2022-02-06	
J	Todt, M; Awe, M; Roesler, B; Germerott, T; Debertin, AS; Fieguth, A				Todt, M.; Awe, M.; Roesler, B.; Germerott, T.; Debertin, A. S.; Fieguth, A.			Domestic violence. Information, facts and challenges	RECHTSMEDIZIN			German	Article						Spouse abuse; Physical examination; Netzwerk ProBeweis; Evidence; Wounds and injuries	FEMALE VICTIMS; WOMEN	Background. The consequences of domestic violence are often life-threatening injuries. In order to protect the victim and ensure sufficient prosecution, forensic assessments, thorough documentation of injuries and correct securing of biological traces are of eminent importance. Objective. The complexity, extent and characteristics of domestic violence and its consequences were assessed and evaluated to illustrate the indispensable importance of forensic medical expertise. Material and methods. A retrospective statistical analysis of forensic physical examinations at the Institute of Forensic Medicine at the Hanover Medical School (MHH) in the years 2001-2010 was conducted. Cases that were investigated as part of criminal proceedings following domestic violence were scientifically analyzed. Results. From 1 January 2001 to 31 December 2010 a total of 3098 forensic physical examinations were conducted. In 216 cases the victim had been physically and/or sexually assaulted by the partner (7 %). Of the victims 25% had a medical background, indications of alcohol consumption, drugs or medication abuse. Women (92.1%) were disproportionately overrepresented in comparison tomen (7.9%) and repeatedly subjected to violence by the partner (41 %). In 80.6% of cases the forensic physical examination was conducted within 48 h of the incident. In 91.7% of the patients the detected injuries were predominantly located on the upper extremities (67.1%), head (55.1%) and neck (45.8 %) and were often caused by life-threatening actions (50.5%). These were mostly due to blunt force (70.8%), sexual assault (31 %) and violence to the neck. Of the victims 82.8% expressed subjective complaints during and/or after having been subjected to violence on the neck and in 74.7% visible injuries to the neck or petechiae in the facial region could be detected. As a result of sexual violence by the partner only unspecific, insignificant anogenital findings could be detected. Conclusion. A forensic physical examination of the victim shortly after the incident is of eminent importance to ensure correct documentation of injuries and collection of biological traces, which can be used as evidence in court. Apart from the forensic physical examination for the police/public prosecution department, the Institute of Forensic Medicine of the MMH provides victims with a documentation of injuries and securing of evidence free of charge with the project "Netzwerk ProBeweis", thereby closing a gap in the healthcare system.	[Todt, M.; Roesler, B.; Germerott, T.; Debertin, A. S.; Fieguth, A.] Hannover Med Sch, Inst Rechtsmed, Hannover, Germany; [Awe, M.] Hannover Med Sch, Klin Augenheilkunde, Hannover, Germany		Todt, M (corresponding author), Hannover Med Sch, Inst Rechtsmed, Hannover, Germany.	todt.melanie@mh-hannover.de	Germerott, Tanja/AAC-5743-2019				Banaschak S, 2014, RECHTSMEDIZIN, V24, P405, DOI 10.1007/s00194-014-0976-z; Bowyer L, 1997, BRIT J OBSTET GYNAEC, V104, P617, DOI 10.1111/j.1471-0528.1997.tb11543.x; Brzank P, 2009, BUNDESGESUNDHEITSBLA, V52, P330, DOI 10.1007/s00103-009-0795-7; Davis JW, 2003, J TRAUMA, V54, P352, DOI 10.1097/01.TA.0000042021.47579.B6; European Union Agency for Fundamental Rights Europaische Union Agentur fur Grundrechte, 2014, VIOL WOM EU WID SURV; Fladung R, 2015, DATENSCHUTZ KOOPERAT; Franke B, 2004, RECHTSMEDIZIN, V14, P193; Germerott T, 2013, NIEDERSACHS ARZTEBL, V4, P8; Gologan R, 2014, UNFALLCHIRURG, V117, P528, DOI 10.1007/s00113-013-2365-6; Hagemann-White C, 2001, VIOLENCE AGAINST WOM, V7, P732, DOI 10.1177/10778010122182712; Hilden M, 2005, FORENSIC SCI INT, V154, P200, DOI 10.1016/j.forsciint.2004.10.010; Jungbluth P, 2012, RECHTSMEDIZIN, V22, P163, DOI 10.1007/s00194-012-0821-1; Klopfstein U, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13047; Lau C. L., 2008, Hong Kong Medical Journal, V14, P451; Muller U., 2004, LEBENSSITUATION SICH; Niedersachsisches Ministerium fur Soziales Gesundheit und Gleichstellung, 2015, ANZ GEW FRAU MADCH K, V202; Pfeiffer H., 2014, BERICHT GEWALTERFAHR; Seifert D, 2006, RECHTSMEDIZIN, V16, P205; Seifert D., 2004, RECHTSMEDIZIN, V14, P182, DOI [10.1007/s00194-004-0262-6, DOI 10.1007/S00194-004-0262-6]; Sharps PW, 2001, AM J ADDICTION, V10, P122; Walby S., 2004, RES STUDY; Wieners K, 2002, NOTFALLRETTUNGSMED, V15, P65; Wieners K, 2016, BUNDESGESUNDHEITSBLA, V59, P73, DOI 10.1007/s00103-015-2260-0; Wischmann M, 2013, RECHTSMEDIZIN, V23, P466, DOI 10.1007/s00194-013-0922-5; World Health Organisation, 2013, GLOB REG EST VIOL WO	25	5	5	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	DEC	2016	26	6					499	506		10.1007/s00194-016-0126-x			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	EJ5XQ	WOS:000393292600003					2022-02-06	
J	Zakhari, R; Sterrett, SE				Zakhari, Raymond; Sterrett, Susan E.			Attitudes toward evidence-based clinical decision support tools to reduce exposure to ionizing radiation: The Canadian CT Head Rule	JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS			English	Article						Clinical practice guidelines; clinical decision-making; traumatic brain injury; evidence-based practice	NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; STAFF TURNOVER; INJURY; COMA	Background and purposeA large degree of variation in clinical practice exists among clinicians evaluating and treating individuals with minor head injuries. Noncontrast head computerized tomography (CT) scans are commonly used to assess for intracranial damage in patients presenting with head injury. This practice is not supported by the evidence and poses harm to patients by increasing exposure to ionizing radiation. This form of radiation exposure increases the risk of developing cancers over the course of the individual's life, and further strains the limited resources of the healthcare system. Project summaryThis article describes the findings of an evidence-based practice project assessing the attitudes of clinicians toward an evidence-based clinical decision support tool (Canadian CT Head Rule [CCHR]). The CCHR has 100% sensitivity in detecting all clinically important brain injuries and any injury requiring neurosurgical intervention. This clinical decision support (CDS) tool is designed to help guide clinicians in the prudent use of head CT scans in people ages 16-64 that have sustained minor head injuries. The Evidence-Based Attitude Scale was also used to identify which domains were most influential on willingness to adopt into clinical practice. ConclusionsThe results revealed an 84% increase in clinician knowledge of the use of the CCHR. A majority (83%) of participants reported moderate likelihood of adoption of the CDS tool into clinical practice if they found the tool appealing, and it was required by a governing authority. The use of CDS tools can help healthcare providers mitigate the risk associated with caring for complex patients. CDS tools provide a systematic method to evaluate patients with minor head injuries while assuring consistency of care and quality outcomes. This practice of assuring consistency and good patient outcomes is foundational to the concept of standard of care, which serves to improve clinical practice.	[Zakhari, Raymond] New York Presbyterian Hosp, Payne Whitney Clin, 525 East 68th St, New York, NY 10065 USA; [Sterrett, Susan E.] Chatham Univ, Pittsburgh, PA USA		Zakhari, R (corresponding author), New York Presbyterian Hosp, Payne Whitney Clin, 525 East 68th St, New York, NY 10065 USA.	raz9001@nyp.org		Zakhari, Raymond/0000-0001-7910-2234			Aarons G.A., 2004, MENT HLTH SERV RES, V6, P61, DOI [10.1023/b:mhsr.0000024351.12294.65, DOI 10.1023/B:MHSR.0000024351.12294.65]; Aarons GA, 2007, ADM POLICY MENT HLTH, V34, P465, DOI 10.1007/s10488-007-0127-x; Aarons GA, 2006, ADM POLICY MENT HLTH, V33, P289, DOI 10.1007/s10488-006-0039-1; Aarons Gregory A, 2006, Psychol Serv, V3, P61; Aarons GA, 2010, PSYCHOL ASSESSMENT, V22, P356, DOI 10.1037/a0019188; Aarons GA, 2009, J CONSULT CLIN PSYCH, V77, P270, DOI 10.1037/a0013223; American Association of Physicists in Medicine, 2014, IM GENTL DEV PED CT; Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Bernier MO, 2012, BRIT J RADIOL, V85, P53, DOI 10.1259/bjr/90758403; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Broder J, 2007, J EMERG MED, V33, P161, DOI 10.1016/j.jemermed.2006.12.035; Choosing Wisely, 2012, IM TESTS HEAD YOU NE; Clement CM, 2006, ANN EMERG MED, V48, P245, DOI 10.1016/j.annemergmed.2006.04.008; Institute of Medicine, 2011, BREAST CANC ENV PRIO; Institute of Medicine, 1999, ERR IS HUMAN; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Mahesh Mahadevappa, 2009, J Am Coll Radiol, V6, P890, DOI 10.1016/j.jacr.2009.09.014; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Miglioretti DL, 2011, AM FAM PHYSICIAN, V83, P1252; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Royal HD, 2008, SEMIN NUCL MED, V38, P392, DOI 10.1053/j.semnuclmed.2008.05.006; Schlegel PM, 2005, ROFO-FORTSCHR RONTG, V177, P872, DOI 10.1055/s-2005-858042; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tahan H., 2011, FRAMEWORK EVIDENCE B; TEASDALE G, 1974, LANCET, V2, P81; United Nations Scientific Committee on the Effects of Atomic Radiation-Anexo B, 2010, SOURC EFF ION RAD EX, VI	30	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2327-6886	2327-6924		J AM ASSOC NURSE PRA	J. Am. Assoc. Nurs. Pract.	DEC	2016	28	12					659	667		10.1002/2327-6924.12402			9	Health Care Sciences & Services; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing	EE2MB	WOS:000389417300005	27717240				2022-02-06	
J	Zane, KL; Gfeller, JD; Roskos, PT; Bucholz, RD				Zane, Katherine L.; Gfeller, Jeffrey D.; Roskos, P. Tyler; Bucholz, Richard D.			The Clinical Utility of the Conners' Continuous Performance Test-II in Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Continuous performance tests; Neuropsychological assessment; Attention; Traumatic brain injury	SUSTAINED ATTENTION; VALIDITY; HYPERACTIVITY; RELIABILITY; DISORDER; ADULTS	Objective: The Conners' Continuous Performance Test Second Edition (CPT-II) is a measure commonly used in persons with suspected attentional deficits. Our study examined the utility of the CPT-II as a measure of attention in adults with traumatic brain injury (TBI) of varying severity. Method: As part of a larger investigation, several measures of cognitive functioning, including the CPT-II, were administered to 30 healthy control participants (HCP), 30 mild TBI participants (M-TBI), and 30 moderate to severe TBI participants (MS-TBI). Multivariate and correlational analyses compared group performances and examined convergent and divergent relationships between the CPT-II and various measures, including other tests of attention and neuropsychological function. Results: Group differences were found for four of six CPT-II variables, with the MS-TBI group exhibiting greater impairment, relative to M-TBI and HCP. In addition, the CPT-II commission and detectability variables were found to correlate significantly with TBI severity. The CPT-II variables also demonstrated correlations of varying magnitude between commonly used neuropsychological measures. Conclusions: These findings support the utility of the CPT-II for assessing attentional abilities in persons with TBI of varying severity, particularly those with moderate to severe status. Moreover, the current study also demonstrates relationships that are consistent with convergent validity but inconsistent findings with regard to divergent validity. As a result, the CPT-II measures components of attention that is unique to other commonly used neuropsychological measures of attentive functioning. Further research examining CPT-II performance in TBI populations is recommended.	[Zane, Katherine L.; Gfeller, Jeffrey D.] St Louis Univ, Dept Psychol, 3700 Lindell Blvd, St Louis, MO 63108 USA; [Roskos, P. Tyler] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil Oakwood, Detroit, MI 48201 USA; [Bucholz, Richard D.] St Louis Univ, Sch Med, Dept Neurosurg, St Louis, MO 63104 USA		Zane, KL (corresponding author), St Louis Univ, Dept Psychol, 3700 Lindell Blvd, St Louis, MO 63108 USA.	zanekl@slu.edu			Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0191]	This project was supported by the Congressionally Directed Medical Research Program, Contract Number W81XWH-08-2-0191, Principal Investigator: Richard Bucholz.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Cohen Andrew L, 2007, J Atten Disord, V11, P49, DOI 10.1177/1087054706292162; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Conners C.K., 2004, CONNERS CONTINUOUS P; Conners C. K., 2000, CONNERS CONTINUOUS P; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Epstein JN, 1998, CLIN NEUROPSYCHOL, V12, P155, DOI 10.1076/clin.12.2.155.2000; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Golden CJ, 1978, STROOP COLOR WORD TE; Golden CJ., 2002, STROOP COLOR WORD TE; Goldstein G, 1989, CLIN NEUROPSYCHOL, V3, P265, DOI DOI 10.1080/13854048908404088; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Heaton RK, 1991, COMPREHENSIVE NORMS; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kallitsoglou A, 2013, EUR J SPEC NEEDS EDU, V28, P348, DOI 10.1080/08856257.2013.797707; LAM CM, 1991, REM SPEC EDUC, V12, P40, DOI 10.1177/074193259101200208; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P89; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lin HY, 2015, J INT NEUROPSYCH SOC, V21, P271, DOI 10.1017/S135561771500020X; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Ogg P. Z., 2008, MAGNETIC RESONANCE I, V26, P504; Ponsford J., 1992, CLIN EXPT NEUROPSYCH, V14, P822; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; *PSYCH CORP, 1997, WECHSL AD INT SCAL W; Rabin L. A., 2016, ARCH CLIN NEUROPSYCH, P1; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Randolph C., 1998, REPEATABLE BATTERY A; Raz S, 2014, ASSESSMENT, V21, P108, DOI 10.1177/1073191112443409; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reitan R, 1985, HALSTEAD REITAN NEUR; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rueckert L, 1998, NEUROPSYCHOLOGIA, V36, P653, DOI 10.1016/S0028-3932(97)00150-4; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Wolfson, 1993, HALSTEAD REITAN NEUR; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	59	5	5	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2016	31	8					996	1005		10.1093/arclin/acw078			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EJ1MM	WOS:000392974600016	27650713	Bronze			2022-02-06	
J	Yu, H; Li, LS; Liu, R; Shu, B; Chen, HZ; Huang, H; Hua, RR; Jiang, FJ; An, YH				Yu, Hao; Li, Lusheng; Liu, Raynald; Shu, Bing; Chen, Huizi; Huang, Hua; Hua, Rongrong; Jiang, Fenjun; An, Yihua			Autophagy in long propriospinal neurons is activated after spinal cord injury in adult rats	NEUROSCIENCE LETTERS			English	Article						Spinal cord injury; Long propriospinal neurons; Autophagy; Apoptosis	CELL-DEATH; NEURODEGENERATIVE DISEASE; UP-REGULATION; RECOVERY; BRAIN; CONNECTIONS; PLASTICITY; BECLIN-1; PATHWAY	Spinal cord injury (SCI) is a common disease worldwide that causes permanent neuronal dysfunction without an effective treatment. Long propriospinal neurons (LPSNs) that are spared from injury play a key role in spontaneous recovery after SCI. Traumatic injury of the central nervous system can activate autophagy, which could be a target in the development of a new therapeutic strategy to prevent neuronal loss. Our research focused on whether autophagy is involved in the loss of LPSNs after introducing spinal cord injury in adult rats. Different sacrifice time points were chosen to characterize autophagy and apoptosis. Autophagy and a blocked autophagy flux reached their peaks at 3 d after injury, while apoptosis reached its peak at 7 d after injury when the number of LPSNs significantly decreased. Both autophagy and apoptosis contributed to the loss of LPSNs, and apoptosis was the main cause of cell death. However, autophagy may prevent programmed LPSN cell death (apoptosis), which could promote cell survival. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Yu, Hao; Li, Lusheng; Shu, Bing; Chen, Huizi; An, Yihua] Capital Med Univ, Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China; [Li, Lusheng; Jiang, Fenjun; An, Yihua] Gen Hosp Chinese Peoples Armed Police Forces, Dept Funct Neurosurg & Cytotherapy, Beijing 100039, Peoples R China; [Huang, Hua] Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Hua, Rongrong] Capital Med Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing 100069, Peoples R China		An, YH (corresponding author), Capital Med Univ, Sanbo Brain Hosp, Dept Neurosurg, Beijing 100093, Peoples R China.	jackrry@163.com; riveran2016@163.com		An, Yihua/0000-0003-0033-2999; Hua, Rongrong/0000-0001-5102-115X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571165, 81341043]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7122028]	This study was supported by the National Natural Science Foundation of China (81571165, 81341043) and Beijing Natural Science Foundation (7122028). The authors declared that they have no competing interests.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; HALL ED, 1992, J NEUROTRAUM, V9, pS425; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030461; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liang P, 2014, CELL TRANSPLANT, V23, pS45, DOI 10.3727/096368914X684989; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lipinski MM, 2015, NEURAL REGEN RES, V10, P892, DOI 10.4103/1673-5374.158344; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Siracusa R., 2015, MOL NEUROBIOL; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Wang Y, 2014, NEUROSCIENCE, V266, P91, DOI 10.1016/j.neuroscience.2014.02.007; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Xu YQ, 2013, AUTOPHAGY, V9, P1418, DOI 10.4161/auto.25080; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44	35	5	7	2	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 10	2016	634						138	145		10.1016/j.neulet.2016.10.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC3UM	WOS:000388052300023	27743799				2022-02-06	
J	Raj, R; Bendel, S; Reinikainen, M; Hoppu, S; Luoto, T; Ala-Kokko, T; Tetri, S; Laitio, R; Koivisto, T; Rinne, J; Kivisaari, R; Siironen, J; Skrifvars, MB				Raj, Rahul; Bendel, Stepani; Reinikainen, Matti; Hoppu, Sanna; Luoto, Teemu; Ala-Kokko, Tero; Tetri, Sami; Laitio, Ruut; Koivisto, Timo; Rinne, Jaakko; Kivisaari, Riku; Siironen, Jari; Skrifvars, Markus B.			Traumatic brain injury patient volume and mortality in neurosurgical intensive care units: a Finnish nationwide study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							DIRECT TRANSPORT; EPIDEMIOLOGY; OUTCOMES; IMPACT; CLASSIFICATION; REDUCTION; SEVERITY; SURVIVAL; PROTOCOL; CENTERS	Background: Differences in outcomes after traumatic brain injury (TBI) between neurosurgical centers exist, although the reasons for this are not clear. Thus, our aim was to assess the association between the annual volume of TBI patients and mortality in neurosurgical intensive care units (NICUs). Methods: We collected data on all patients treated in the five Finnish university hospitals to examine all patients with TBI treated in NICUs in Finland from 2009 to 2012. We used a random effect logistic regression model to adjust for important prognostic factors to assess the independent effect of ICU volume on 6-month mortality. Subgroup analyses were performed for patients with severe TBI, moderate-to-severe TBI, and those who were undergoing mechanical ventilation or intracranial pressure monitoring. Results: Altogether 2,328 TBI patients were treated during the study period in five NICUs. The annual TBI patient volume ranged from 61 to 206 patients between the NICUs. Univariate analysis, showed no association between the NICUs' annual TBI patient volume and 6-month mortality (p = 0.063). The random effect model showed no independent association between the NICUs' annual TBI patient volume and 6-month mortality (OR = 1.000, 95% CI = 0.996-1.004, p = 0.876). None of the pre-defined subgroup analyses indicated any association between NICU volume and patient mortality (p > 0.05 for all). Discussion and Conclusion: We did not find any association between annual TBI patient volume and 6-month mortality in NICUs. These findings should be interpreted taking into account that we only included NICUs, which by international standards all treated high volumes of TBI patients, and that we were not able to study the effect of NICU volume on neurological outcome.	[Raj, Rahul; Kivisaari, Riku; Siironen, Jari] Univ Helsinki, Dept Neurosurg, Topeliuksenkatu 5,PB-266, FI-00029 Hus Helsinki, Finland; [Raj, Rahul; Kivisaari, Riku; Siironen, Jari] Helsinki Univ Hosp, Topeliuksenkatu 5,PB-266, FI-00029 Hus Helsinki, Finland; [Bendel, Stepani] Kuopio Univ Hosp, Div Intens Care, Puijonlaaksontie 2,PB-100, FI-70029 Kys Kuopio, Finland; [Reinikainen, Matti] North Karelia Cent Hosp, Div Intens Care, Tikkamaentie 16, Joensuu 80210, Finland; [Hoppu, Sanna] Tampere Univ Hosp, Dept Anaesthesiol Intens Care & Pain Med, Teiskontie 35,PB-2000, FI-33521 Tampere, Finland; [Luoto, Teemu] Univ Tampere, Dept Neurosurg, Sch Med, Teiskontie 35,PB-2000, FI-33521 Tampere, Finland; [Luoto, Teemu] Tampere Univ Hosp, Teiskontie 35,PB-2000, FI-33521 Tampere, Finland; [Ala-Kokko, Tero] Oulu Univ Hosp, Div Intens Care, Dept Anaesthesiol, Oulu, Finland; [Ala-Kokko, Tero] Oulu Univ, Med Res Ctr, Oulu, Finland; [Ala-Kokko, Tero] Univ Oulu, Fac Med, Res Grp Surg Anaesthesia & Intens Care, PB-22 OUH, FI-90029 Oulu, Finland; [Tetri, Sami] Oulu Univ Hosp, Dept Neurosurg, Kajaanintie 50, Oulu 90220, Finland; [Laitio, Ruut] Turku Univ Hosp, Dept Perioperat Serv Intens Care & Pain Med, Turku, Finland; [Koivisto, Timo] Kuopio Univ Hosp, Dept Neurosurg, Puijonlaaksontie 2,PB-100, FI-70029 Kys Kuopio, Finland; [Rinne, Jaakko] Turku Univ Hosp, Dept Neurosurg, Hameentie 11,PB-52, FI-20251 Turku, Finland; [Rinne, Jaakko] Univ Turku, Hameentie 11,PB-52, FI-20251 Turku, Finland; [Skrifvars, Markus B.] Univ Helsinki, Dept Anaesthesiol Intens Care & Pain Med, Haartmaninkatu 4,PB-340, FI-00029 Hus Helsinki, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Haartmaninkatu 4,PB-340, FI-00029 Hus Helsinki, Finland; [Skrifvars, Markus B.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia		Raj, R (corresponding author), Univ Helsinki, Dept Neurosurg, Topeliuksenkatu 5,PB-266, FI-00029 Hus Helsinki, Finland.; Raj, R (corresponding author), Helsinki Univ Hosp, Topeliuksenkatu 5,PB-266, FI-00029 Hus Helsinki, Finland.	rahul.raj@hus.fi	Luoto, Teemu/W-6468-2018; Raj, Rahul/K-7693-2012	Luoto, Teemu/0000-0002-7329-3284; Raj, Rahul/0000-0003-4243-9591; Reinikainen, Matti/0000-0001-6878-3740			Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kristiansen T, 2014, INJURY, V45, P23, DOI 10.1016/j.injury.2013.07.007; Li BY, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-77; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Minei JP, 2014, ANN SURG, V260, P456, DOI 10.1097/SLA.0000000000000873; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Reinikainen M, 2012, ACTA ANAESTH SCAND, V56, P1114, DOI 10.1111/j.1399-6576.2012.02669.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sakr Y, 2015, CRIT CARE MED, V43, P519, DOI 10.1097/CCM.0000000000000754; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Sasabuchi Y, 2015, CRIT CARE MED, V43, P1239, DOI 10.1097/CCM.0000000000000943; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Sosiaali-ja terveysministerio, 2013, KOT JA VAP AJ TAP EH; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; von Elm E, 2007, BMJ-BRIT MED J, V335, P806	37	5	5	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 8	2016	24								133	10.1186/s13049-016-0320-6			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EC4VJ	WOS:000388132100001	27821129	Green Published, gold			2022-02-06	
J	Dixon, KJ; Mier, J; Gajavelli, S; Turbic, A; Bullock, R; Turnley, AM; Liebl, DJ				Dixon, Kirsty J.; Mier, Jose; Gajavelli, Shyam; Turbic, Alisa; Bullock, Ross; Turnley, Ann M.; Liebl, Daniel J.			EphrinB3 restricts endogenous neural stem cell migration after traumatic brain injury	STEM CELL RESEARCH			English	Article						Traumatic brain injury; Neuroblast; Migration; EphrinB3	DEPENDENCE RECEPTOR FUNCTIONS; ADULT HUMAN BRAIN; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; NEURONAL PRECURSORS; ADHESION MOLECULE; TYROSINE KINASES; PROGENITOR CELLS; PROLIFERATION; INTEGRIN	Traumatic brain injury (TBI) leads to a series of pathological events that can have profound influences on motor, sensory and cognitive functions. Conversely, TBI can also stimulate neural stem/progenitor cell proliferation leading to increased numbers of neuroblasts migrating outside their restrictive neurogenic zone to areas of damage in support of tissue integrity. Unfortunately, the factors that regulate migration are poorly understood. Here, we examine whether ephrinB3 functions to restrict neuroblasts from migrating outside the subventricular zone (SVZ) and rostral migratory stream (RMS). We have previously shown that ephrinB3 is expressed in tissues surrounding these regions, including the overlying corpus callosum (CC), and is reduced after controlled cortical impact (CCI) injury. Our current study takes advantage of ephrinB3 knockout mice to examine the influences of ephrinB3 on neuroblast migration into CC and cortex tissues after CCI injury. Both injury and/or ephrinB3 deficiency led to increased neuroblast numbers and enhanced migration outside the SVZ/RMS zones. Application of soluble ephrinB3-Fc molecules reduced neuroblast migration into the CC after injury and limited neuroblast chain migration in cultured SVZ explants. Our findings suggest that ephrinB3 expression in tissues surrounding neurogenic regions functions to restrict neuroblast migration outside the RMS by limiting chain migration. (C) 2016 The Authors. Published by Elsevier B.V.	[Dixon, Kirsty J.; Mier, Jose; Gajavelli, Shyam; Bullock, Ross; Liebl, Daniel J.] Univ Miami, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace, Miami, FL 33136 USA; [Dixon, Kirsty J.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 1101 East Marshall St, Richmond, VA 23298 USA; [Turbic, Alisa; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia		Liebl, DJ (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	Kirsty.dixon@vcuhealth.org; jmier2@med.miami.edu; sgajavel@med.miami.edu; alisa@unimelb.edu.au; rbullock@med.miami.edu; turnley@unimelb.edu.au; dliebl@med.miami.edu	Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973	Miami Project to Cure Paralysis; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049545, NS30291]; NHMRC fellowshipNational Health and Medical Research Council of Australia [628344]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS049545] Funding Source: NIH RePORTER	We thank Melissa Carballosa-Gautam in the Miami Project to Cure Paralysis Imaging Core. This design, experimentation, data analysis and manuscript writing was supported by the Miami Project to Cure Paralysis; NIH/NINDS (DJL: NS049545 and NS30291); and an NH&MRC fellowship (AMT: 628344).	Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1997, J NEUROSCI, V17, P5046; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Li B, 2010, BRAIN RES, V1327, P91, DOI 10.1016/j.brainres.2010.02.030; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; MIRAGALL F, 1990, J NEUROCYTOL, V19, P899, DOI 10.1007/BF01186818; Mobley AK, 2011, GLIA, V59, P1579, DOI 10.1002/glia.21199; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parmentier-Batteur S, 2011, J NEUROCHEM, V118, P1016, DOI 10.1111/j.1471-4159.2011.07375.x; Puschmann TB, 2010, J NEUROCHEM, V113, P881, DOI 10.1111/j.1471-4159.2010.06655.x; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Santiago A, 2002, DEVELOPMENT, V129, P3621; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Sun W, 2010, ANAT CELL BIOL, V43, P269, DOI 10.5115/acb.2010.43.4.269; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; van Strien ME, 2011, CELL RES, V21, P1523, DOI 10.1038/cr.2011.101; Xue LP, 2014, CELL BIOCHEM BIOPHYS, V70, P1609, DOI 10.1007/s12013-014-0103-5; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	43	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	NOV	2016	17	3					504	513		10.1016/j.scr.2016.09.029			10	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology	EJ4MM	WOS:000393191300010	27771498	Green Accepted, gold			2022-02-06	
J	Fine, MS; Lum, PS; Brokaw, EB; Caywood, MS; Metzger, AJ; Libin, AV; Terner, J; Tsao, JW; Norris, JN; Milzman, D; Williams, D; Colombe, J; Dromerick, AW				Fine, Michael S.; Lum, Peter S.; Brokaw, Elizabeth B.; Caywood, Matthew S.; Metzger, Anthony J.; Libin, Alexander V.; Terner, Jill; Tsao, Jack W.; Norris, Jacob N.; Milzman, David; Williams, Diane; Colombe, Jeff; Dromerick, Alexander W.			Dynamic motor tracking is sensitive to subacute mTBI	EXPERIMENTAL BRAIN RESEARCH			English	Article						mTBI; Concussion; Visuomotor tracking; Head trauma	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; NORMATIVE DATA; GRIP FORCE; CONCUSSION; DEFICITS; PERFORMANCE; DEPRESSION; SYMPTOMS; MOVEMENT	Effective screening for mild traumatic brain injury (mTBI) is critical to accurate diagnosis, intervention, and improving outcomes. However, detecting mTBI using conventional clinical techniques is difficult, time intensive, and subject to observer bias. We examine the use of a simple visuomotor tracking task as a screening tool for mTBI. Thirty participants, 16 with clinically diagnosed mTBI (mean time since injury: 36.4 +/- A 20.9 days (95 % confidence interval); median = 20 days) were asked to squeeze a hand dynamometer and vary their grip force to match a visual, variable target force for 3 min. We found that controls outperformed individuals with mTBI; participants with mTBI moved with increased variability, as quantified by the standard deviation of the tracking error. We modeled participants' feedback response-how participants changed their grip force in response to errors in position and velocity-and used model parameters to classify mTBI with a sensitivity of 87 % and a specificity of 93 %, higher than several standard clinical scales. Our findings suggest that visuomotor tracking could be an effective supplement to conventional assessment tools to screen for mTBI and track mTBI symptoms during recovery.	[Fine, Michael S.; Brokaw, Elizabeth B.; Caywood, Matthew S.; Colombe, Jeff] Mitre Corp, 7525 Colshire Dr,M-S H205, Mclean, VA 22102 USA; [Lum, Peter S.; Metzger, Anthony J.; Libin, Alexander V.; Terner, Jill; Milzman, David; Dromerick, Alexander W.] MedStar Natl Rehabil Hosp, 102 Irving St, Washington, DC 20010 USA; [Lum, Peter S.; Metzger, Anthony J.] Catholic Univ Amer, Biomed Engn, Pangborn Hall,Room 131,620 Michigan Ave NE, Washington, DC 20064 USA; [Libin, Alexander V.; Milzman, David; Dromerick, Alexander W.] Georgetown Univ, Sch Med, 3900 Reservoir Rd NW, Washington, DC 20007 USA; [Lum, Peter S.; Libin, Alexander V.; Dromerick, Alexander W.] Washington DC Vet Affairs Med Ctr, Washington, DC 20010 USA; [Williams, Diane] Naval Hlth Res Ctr, 160 Sylvester Rd, San Diego, CA 92106 USA; [Norris, Jacob N.] Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Tsao, Jack W.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd,Room A1036, Bethesda, MD 20814 USA; [Tsao, Jack W.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA		Fine, MS (corresponding author), Mitre Corp, 7525 Colshire Dr,M-S H205, Mclean, VA 22102 USA.	mfine@mitre.org; lum@cua.edu; ebrokaw@mitre.org; caywood@gmail.com; Metzgera@gmail.com; Alexander.Libin@medstar.net; jill.terner@gmail.com; jack.tsao@usuhs.edu; Jacob.n.norris.mil@mail.mil; milzmand@georgetown.edu; Diane.Williams44.civ@mail.mil; jcolombe@mitre.org; Alexander.W.Dromerick@Medstar.net	Libin, Alexander V./W-8641-2019	Libin, Alexander V./0000-0001-7847-3463; Fine, Michael/0000-0001-5717-179X; milzman, dave/0000-0002-3917-7239	Navy [QW911QY-09-0041-004]; USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0632]; MITRE Corporation	Funding was provided by Navy Contract Number QW911QY-09-0041-004, USAMRMC W81XWH-11-1-0632, and internal funding from the MITRE Corporation. The study protocol was approved by the MedStar Health Research Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Dr. Norris, Dr. Williams, and Dr. Tsao are employees of the US Government. This work was prepared as part of their official duties. Title 17 U.S.C. 105 provides that 'Copyright protection under this title is not available for any work of the United States Government.' Title 17 U.S.C. 101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person's official duties. The views expressed here are those of the author(s) and should not be construed as the official policy or position of the Department of the Navy, Department of Defense, nor the US Government.	Army Individual Test Battery, 1944, MAN DIR SCOR; Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2009, J HEAD TRAUMA REHAB, V24, P363, DOI 10.1097/HTR.0b013e3181af0810; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Dafotakis M, 2008, BRAIN RES, V1228, P73, DOI 10.1016/j.brainres.2008.06.027; Defense Centers of Excellence, 2012, IND COND NEUR DYSF S; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Fine MS, 2007, J NEUROPHYSIOL, V98, P1392, DOI 10.1152/jn.00196.2007; Fischer TD, 2015, J NEUROTRAUM, DOI [10.1089/neu.2015.3990, DOI 10.1089/NEU.2015.3990]; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Fumeya Hiroshi, 1994, Neurologia Medico-Chirurgica, V34, P612, DOI 10.2176/nmc.34.612; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Jordan M.I., 1999, COGNITIVE NEUROSCIEN, P601; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KAWATO M, 1992, BIOL CYBERN, V68, P95, DOI 10.1007/BF00201431; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li KZH, 2002, NEUROSCI BIOBEHAV R, V26, P777, DOI 10.1016/S0149-7634(02)00073-8; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; McCrea M, 2001, J ATHL TRAINING, V36, P274; McFarlane AC, 2010, WORLD PSYCHIATRY, V9, P3; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Prodoehl J, 2009, NEUROSCI BIOBEHAV R, V33, P900, DOI 10.1016/j.neubiorev.2009.03.004; Rasmussen C. E., 2004, GAUSSIAN PROCESSES M, DOI DOI 10.1142/S0129065704001899; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Taber Katherine H, 2009, J Neuropsychiatry Clin Neurosci, V21, P1, DOI 10.1176/appi.neuropsych.21.1.iv; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; US Department of Veterans Affairs and National Center for PTSD, 2014, US PTSD CHECKL DSM 4; Weathers F, 1994, P ANN CONV INT SOC T, P24	45	5	5	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	NOV	2016	234	11					3173	3184		10.1007/s00221-016-4714-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EA4TO	WOS:000386607900009	27392948				2022-02-06	
J	Ganzer, CA				Ganzer, Christine Anne			Veteran Women: Mental Health-Related Consequences of Military Service	AMERICAN JOURNAL OF NURSING			English	Article						female veterans; mental health; military; military sexual trauma; posttraumatic stress disorder; suicide; traumatic brain injury; veteran women	POSTTRAUMATIC-STRESS-DISORDER; SEXUAL TRAUMA; ASSESS RISK; COMBAT; IRAQ; AFGHANISTAN; WAR; DEPLOYMENT; RESILIENCE; SUICIDE	The last two decades have seen increasing numbers of women entering all branches of the U.S. armed forces. Now that women in the military are no longer prohibited from holding direct combat positions, they are often exposed to traumatic events that place them at higher risk for mental health conditions. Nurses working within the Veterans Affairs (VA) system and those working in non-VA settings are likely to encounter female veterans. It's essential for all nurses to be knowledgeable about the mental health issues commonly seen in this population, and to understand the importance of screening, not only for mental health issues but also for physical conditions that may be related to service. Numerous studies have focused on the mental health effects of deployment among military men, but very few have been conducted among military women. To learn more, the literature was searched for relevant articles published between January 2005 and December 2015. The research supports the contention that both active-duty and veteran women are at increased risk for postdeployment mental health problems, including posttraumatic stress disorder, military sexual trauma, and suicide. This article discusses the relevant research; identifies gaps in the literature; and addresses the nursing practice implications, including screening.	[Ganzer, Christine Anne] CUNY, Hunter Bellevue Sch Nursing, New York, NY 10017 USA; [Ganzer, Christine Anne] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA		Ganzer, CA (corresponding author), CUNY, Hunter Bellevue Sch Nursing, New York, NY 10017 USA.	cganzer@hunter.cuny.edu					[Advisory Committee on Women Veterans Department of Veterans Affairs], 2014, WOM VET PROUDL BREAK; [Advisory Committee on Women Veterans Department of Veterans Affairs], 2008, REC WOM VET AM HER; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Burgess AW, 2013, J PSYCHOSOC NURS MEN, V51, P20, DOI 10.3928/02793695-20130109-03; Burns B, 2014, AM J PUBLIC HEALTH, V104, P345, DOI 10.2105/AJPH.2013.301576; Center for Disease Prevention and Control, 2014, 10 LEAD CAUS DEATH A; Cohen BE, 2012, WOMEN HEALTH ISS, V22, pE461, DOI 10.1016/j.whi.2012.06.005; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Conard PL, 2014, NURS FORUM, V49, P1, DOI 10.1111/nuf.12049; Department of Defense, 2014, DEP DEF ANN REP SEX; Department of Defense, 2014, 2014 DEM PROF MIL CO; Department of Defense, 2010, REP IMP DEPL MEMB AR; Department of Veterans Affairs, MENT HLTH MIL SEX TR; Department of Veterans Affairs, VA HEALTHC VISN 4 WH; Department of Veterans Affairs, 2016, FED REGISTER, P33155; Department of Veterans Affairs, PUBL HLTH MIL EXP; Department of Veterans Affairs, 2010, VHA HDB; Department of Veterans Affairs, 2015, WOM VET HLTH CAR WOM; Dutra L, 2011, J TRAUMA DISSOCIATIO, V12, P25, DOI 10.1080/15299732.2010.496141; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Erbes CR, 2012, J TRAUMA STRESS, V25, P187, DOI 10.1002/jts.21689; Fargo J, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110112; FARLEY DO, 2002, IMPLEMENTING POSTDEP; Gamache G, 2003, AM J PUBLIC HEALTH, V93, P1132, DOI 10.2105/AJPH.93.7.1132; Hamilton AB, 2011, WOMEN HEALTH ISS, V21, pS203, DOI 10.1016/j.whi.2011.04.005; Health Resources and Services Administration, 2010, REG NURS POP FIND 20; Henry M., 2014, 2014 ANN HOMELESS 1; Hoge CW, 2007, INT J EPIDEMIOL, V36, P327, DOI 10.1093/ije/dym013; Huang PY, 2004, HEALTH SERV RES, V39, P887, DOI 10.1111/j.1475-6773.2004.00263.x; Kaplan MS, 2009, J TRAUMA, V67, P503, DOI 10.1097/TA.0b013e3181b36521; Katz LS, 2007, PSYCHOL SERV, V4, P239, DOI DOI 10.1037/1541-1559.4.4.239; Kelly UA, 2011, RES NURS HEALTH, V34, P457, DOI 10.1002/nur.20453; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; MacGregor AJ, 2012, AM J PUBLIC HEALTH, V102, pS55, DOI 10.2105/AJPH.2011.300341; Maisel NC, 2015, MED CARE, V53, pS39, DOI 10.1097/MLR.0000000000000298; Manski R, 2014, MIL MED, V179, P645, DOI 10.7205/MILMED-D-13-00302; Mattocks KM, 2012, SOC SCI MED, V74, P537, DOI 10.1016/j.socscimed.2011.10.039; Mattocks KM, 2010, J WOMENS HEALTH, V19, P2159, DOI 10.1089/jwh.2009.1892; Murdoch M, 2006, J GEN INTERN MED, V21, pS5, DOI 10.1111/j.1525-1497.2006.00368.x; National Coalition for the Homeless, 2009, MENT ILLN HOM; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Resnick EM, 2012, J WOMENS HEALTH, V21, P895, DOI 10.1089/jwh.2012.3644; Robrecht DT, 2008, J REPROD MED, V53, P862; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seelig AD, 2012, AM J EPIDEMIOL, V176, P135, DOI 10.1093/aje/kwr496; Shinseki EK, 2011, STATEMENT HONORABLE; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Valente S, 2007, MIL MED, V172, P259, DOI 10.7205/MILMED.172.3.259; [Veterans and Their Families Board on the Health of Select Populations Institute of Medicine of the National Academies Committee on the Assessment of Readjustment Needs of Military Personnel], 2013, RET HOM IR AFGH ASS; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker S, 2010, J PSYCHIATR MENT HLT, V17, P790, DOI 10.1111/j.1365-2850.2010.01603.x; Washington DL, 2010, J HEALTH CARE POOR U, V21, P81, DOI 10.1353/hpu.0.0237	59	5	5	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0002-936X	1538-7488		AM J NURS	Am. J. Nurs.	NOV	2016	116	11					32	39		10.1097/01.NAJ.0000505583.09590.d4			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	EB4SW	WOS:000387364900018	27755002				2022-02-06	
J	Vadivelu, S; Rekate, HL; Esernio-Jenssen, D; Mittler, MA; Schneider, SJ				Vadivelu, Sudhakar; Rekate, Harold L.; Esernio-Jenssen, Debra; Mittler, Mark A.; Schneider, Steven J.			Hydrocephalus associated with childhood nonaccidental head trauma	NEUROSURGICAL FOCUS			English	Article						biomarker; child abuse; excitotoxicity; hypoxia-ischemia; shaken baby syndrome; traumatic brain injury	SHAKEN BABY SYNDROME; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; CHILDREN; INFANTS	OBJECTIVE The incidence of posttraumatic ventriculomegaly (PTV) and shunt-dependent hydrocephalus after nonaccidental head trauma (NAHT) is unknown. In the present study, the authors assessed the timing of PTV development, the relationship between PTV and decompressive craniectomy (DC), and whether PTV necessitated placement of a permanent shunt. Also, NAHT/PTV cases were categorized into a temporal profile of delay in admission and evaluated for association with outcomes at discharge. METHODS The authors retrospectively reviewed the cases of patients diagnosed with NAHT throughout a 10-year period. Cases in which sequential CT scans had been obtained (n = 28) were evaluated for Evans' index to determine the earliest time ventricular dilation was observed. Discharge outcomes were assessed using the King's Outcome Scale for Childhood Head Injury score. RESULTS Thirty-nine percent (11 of 28) of the patients developed PTV. A low admission Glasgow Coma Scale (GCS) score predicted early PTV presentation (within < 3 days) versus a high GCS score (> 1 week). A majority of PTV/NAHT patients presented with a subdural hematoma (both convexity and interhemispheric) and ischemic stroke, but subarachnoid hemorrhage was significantly associated with PTV/NAHT (p = 0.011). Of 6 patients undergoing a DC for intractable intracranial pressure, 4 (67%) developed PTV (p = 0.0366). These patients tended to present with lower GCS scores and develop ventriculomegaly early. Only 2 patients developed hydrocephalus requiring shunt placement. CONCLUSIONS PTV presents early after NAHT, particularly after a DC has been performed. However, the authors found that only a few PTV/NAHT patients developed shunt-dependent hydrocephalus.	[Vadivelu, Sudhakar; Rekate, Harold L.; Mittler, Mark A.; Schneider, Steven J.] Cohen Childrens Med Ctr, Hofstra Northwell Sch Med, Cushing Neurosci Inst, Manhasset, NY USA; [Vadivelu, Sudhakar; Rekate, Harold L.; Mittler, Mark A.; Schneider, Steven J.] Cohen Childrens Med Ctr, Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY USA; [Vadivelu, Sudhakar; Rekate, Harold L.; Mittler, Mark A.; Schneider, Steven J.] Northwell Hlth Syst, Manhasset, NY USA; [Esernio-Jenssen, Debra] Univ Florida, Sch Med, Dept Pediat, Shands Childrens Hosp, Gainesville, FL USA		Vadivelu, S (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Neurosurg, 3333 Burnett Ave, Cincinnati, OH 45040 USA.	sudhakar.vadivelu@cchmc.org					Calvert S, 2008, DEV MED CHILD NEUROL, V50, P426, DOI 10.1111/j.1469-8749.2008.02061.x; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Dias MS, 1998, PEDIATR NEUROSURG, V29, P77, DOI 10.1159/000028694; Esernio-Jenssen D, 2011, PEDIATRICS, V127, P649, DOI 10.1542/peds.2010-1770; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; HOCHWALD GM, 1973, J NEUROSURG, V39, P694, DOI 10.3171/jns.1973.39.6.0694; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Ragan DK, 2015, J NEUROSURG-PEDIATR, V15, P547, DOI 10.3171/2014.10.PEDS14209; REKATE HL, 1988, PEDIATR NEUROSCI, V14, P77, DOI 10.1159/000120367; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Vadivelu S, 2015, WORLD NEUROSURG, V84, P1340, DOI 10.1016/j.wneu.2015.06.023; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37	22	5	5	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2016	41	5							E8	10.3171/2016.8.FOCUS16266			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EC0LU	WOS:000387793400008	27798981	gold			2022-02-06	
J	Li, D; Tong, L; Kawano, H; Liu, N; Liu, L; Li, HP				Li, Dan; Tong, Lei; Kawano, Hitoshi; Liu, Nan; Liu, Lu; Li, Hong-Peng			Protective effects of batroxobin on a nigrostriatal pathway injury in mice	BRAIN RESEARCH BULLETIN			English	Article						Nigrostriatal pathway injury; Batroxobin; Neuronal apoptosis; Inflammatory; Scar formation	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; INFLAMMATION-MEDIATED NEURODEGENERATION; AXON REGENERATION; SCAR; GROWTH; CNS; NEUROPROTECTION; INHIBITION; ASTROCYTES	Traumatic brain injury triggers a series of damaged processes, such as neuronal death and apoptosis, inflammation and scar formation, which contribute to evolution of brain injury. The present study investigated the neuroprotective effects of batroxobin, a drug widely used clinically for ischemia, in a nigrostriatal pathway injury model. Mice subjected to the nigrostriatal pathway injury were injected with batroxobin (30 BU/kg) or vehicle immediately after injury. The behavioral studies showed that batroxobin could improve the motor function in injured mice in long term. Batroxobin also reduced neuronal apoptosis and inflammation at the acute stage. Moreover, administration of batroxobin attenuated the scar formation and reduced the lesion size at 4 and 14 days after brain injury. These results suggest that batroxobin has beneficial effects on the nigrostriatal pathway injury, indicating a potential clinical application. (C) 2016 Elsevier Inc. All rights reserved.	[Li, Dan; Tong, Lei; Liu, Nan; Liu, Lu; Li, Hong-Peng] China Med Univ, Dept Human Anat, Coll Basic Med Sci, Shenyang, Peoples R China; [Kawano, Hitoshi] Teikyo Heisei Univ, Fac Hlth & Med Sci, Dept Hlth & Dietet, Tokyo 1708445, Japan		Li, HP (corresponding author), China Med Univ, Dept Human Anat, Coll Basic Med Sci, Shenyang, Peoples R China.	377317599@qq.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [NSFC-81171248]	The authors would like to thank Professor Tong for the integrity of the data and the accuracy of the data analysis. This research was supported by National Natural Science Foundation of China (NSFC), Grants No: NSFC-81171248.	Adams RA, 2004, MOL INTERV, V4, P163; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Bell WR, 1997, DRUGS, V54, P18, DOI 10.2165/00003495-199700543-00005; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; Bunker DJL, 2014, J BURN CARE RES, V35, P261, DOI 10.1097/BCR.0b013e31829b0037; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115694; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fan H, 2013, NEUROSCI BULL, V29, P501, DOI 10.1007/s12264-013-1354-7; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Finnie JW, 2011, AUST VET J, V89, P243, DOI 10.1111/j.1751-0813.2011.00792.x; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Gusev EI, 2006, ZH NEVROL PSIKHIATR, V106, P31; Kawano H, 2005, J NEUROSCI RES, V80, P191, DOI 10.1002/jnr.20441; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Khuwaja Ali Khan, 2011, J Prev Med Public Health, V44, P210, DOI 10.3961/jpmph.2011.44.5.210; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tovar-y-Romo LB, 2016, J NEUROCHEM, V136, P13, DOI 10.1111/jnc.13362; Yang Y, 2011, CELL MOL NEUROBIOL, V31, P437, DOI 10.1007/s10571-010-9637-2; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoshioka N, 2011, J NEUROSCI RES, V89, P381, DOI 10.1002/jnr.22552; Yoshioka N, 2010, J COMP NEUROL, V518, P3867, DOI 10.1002/cne.22431; You WK, 2004, FEBS LETT, V571, P67, DOI 10.1016/j.febslet.2004.06.060; Yu H, 2015, EXP THER MED, V9, P1631, DOI 10.3892/etm.2015.2368	32	5	7	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	OCT	2016	127						195	201		10.1016/j.brainresbull.2016.09.014			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED7YH	WOS:000389088100024	27679398				2022-02-06	
J	Mahdavi, ZK; Olson, DM; Figueroa, SA				Mahdavi, Zakraus K.; Olson, DaiWai M.; Figueroa, Stephen A.			Association Patterns of Simultaneous Intraventricular and Intraparenchymal Intracranial Pressure Measurements	NEUROSURGERY			English	Article						External ventricular drain; Intensive care unit monitoring; Intracranial pressure; Intraparenchymal monitors; Traumatic brain injury	CLINICAL-PRACTICE; DEVICE	BACKGROUND: The process of measuring intracranial pressure (ICP) can be accomplished using a variety of monitors placed primarily either in the ventricles or brain parenchyma. OBJECTIVE: There is inadequate data to support the conclusion that ICP measured simultaneously from 2 different sites using 2 different devices produces similar findings in the same subject. The purpose of this study was to identify the correlation between simultaneous measurements from both an external ventricular drain (EVD) and an intraparenchymal monitor (IPM). METHODS: In this retrospective observational study, manual chart abstraction was used to obtain time-indexed ICP values during a period of 2 years from patients diagnosed with severe traumatic brain injury who had received simultaneous EVD and IPM placement. RESULTS: When all time points were compared, the correlation between EVD and IPM was strong (r(2) = 0.6955). However, when limiting the ICP values to be,20 or,25 in either the EVD or the IPM, the correlation was noted to be weaker (r(2) = 0.3576 and r(2) = 0.4232, respectively). CONCLUSION: There is inadequate evidence to support that intraparenchymal ICP values can be treated in a similar manner to ICP values obtained from an EVD.	[Mahdavi, Zakraus K.; Olson, DaiWai M.; Figueroa, Stephen A.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dept Neurosurg, Div Neurocrit Care, Dallas, TX 75390 USA		Figueroa, SA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Div Neurocrit Care, Dept Neurol, Dept Neurosurg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	stephen.figueroa@UTSouthwestern.edu	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X; Figueroa, Stephen/0000-0002-6363-8496			ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cecconi M, 2007, CURR OPIN CRIT CARE, V13, P294, DOI 10.1097/MCC.0b013e328149af80; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Munch E, 1998, ACTA NEUROCHIR, V140, P1113, DOI 10.1007/s007010050224; Olson DM, 2014, NEUROCRIT CARE, V20, P15, DOI 10.1007/s12028-013-9847-9; Olson DM, 2013, J NEUROSCI NURS, V45, P186, DOI 10.1097/JNN.0b013e3182986400; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; SCHICKNER DJ, 1992, SURG NEUROL, V37, P251, DOI 10.1016/0090-3019(92)90147-F	17	5	5	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2016	79	4					561	566		10.1227/NEU.0000000000001265			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DX5RK	WOS:000384439200031	27244464				2022-02-06	
J	Por, ED; Choi, JH; Lund, BJ				Por, Elaine D.; Choi, Jae-Hyek; Lund, Brian J.			Low-Level Blast Exposure Increases Transient Receptor Potential Vanilloid 1 (TRPV1) Expression in the Rat Cornea	CURRENT EYE RESEARCH			English	Article						Blast injury; cornea; inflammation; ocular trauma; pain	TRAUMATIC BRAIN-INJURY; INDUCED OCULAR TRAUMA; CAPSAICIN RECEPTOR; MOUSE MODEL; PAIN; RESPONSES; MILITARY; CGRP; PATHOPHYSIOLOGY; INTERLEUKIN-6	Background: Blast-related ocular injuries sustained by military personnel have led to rigorous efforts to elucidate the effects of blast exposure on neurosensory function. Recent studies have provided some insight into cognitive and visual deficits sustained following blast exposure; however, limited data are available on the effects of blast on pain and inflammatory processes. Investigation of these secondary effects of blast exposure is necessary to fully comprehend the complex pathophysiology of blast-related injuries. The overall purpose of this study is to determine the effects of single and repeated blast exposure on pain and inflammatory mediators in ocular tissues.Methods: A compressed air shock tube was used to deliver a single or repeated blast (68.0 2.7 kPa) to anesthetized rats daily for 5 days. Immunohistochemistry was performed on ocular tissues to determine the expression of the transient receptor potential vanilloid 1 (TRPV1) channel, calcitonin gene-related peptide (CGRP), substance P (SP), and endothelin-1 (ET-1) following single and repeated blast exposure. Neutrophil infiltration and myeloperoxidase (MPO) expression were also assessed in blast tissues via immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) analysis, respectively.Results: TRPV1 expression was increased in rat corneas exposed to both single and repeated blast. Increased secretion of CGRP, SP, and ET-1 was also detected in rat corneas as compared to control. Moreover, repeated blast exposure resulted in neutrophil infiltration in the cornea and stromal layer as compared to control animals.Conclusion: Single and repeated blast exposure resulted in increased expression of TRPV1, CGRP, SP, and ET-1 as well as neutrophil infiltration. Collectively, these findings provide novel insight into the activation of pain and inflammation signaling mediators following blast exposure.	[Por, Elaine D.; Choi, Jae-Hyek; Lund, Brian J.] US Army Inst Surg Res, Ocular Trauma, Jbsa Ft Sam Houston, TX USA		Por, ED (corresponding author), US Army Inst Surg Res, Ocular Trauma, 3698 Chambers Pass Ave,Bldg 3611, Ft Sam Houston, TX 78234 USA.	elaine.d.por.mil@mail.mil			U.S. Army Military Operational Medicine Research Program (MOMRP); Clinical Rehabilitative Medicine Research Program (CRMRP)	This work was supported by U.S. Army Military Operational Medicine Research Program (MOMRP) and Clinical Rehabilitative Medicine Research Program (CRMRP).	Avwioro G, 2011, J PHARM CLIN SCI, V1, P24; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Bruno PP, 2007, EUR REV MED PHARMACO, V11, P245; Burns AR, 2005, OCUL SURF, V3, pS173; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chichorro JG, 2010, BRAIN RES, V1345, P73, DOI 10.1016/j.brainres.2010.04.075; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Deby-Dupont G, 1998, VET IMMUNOL IMMUNOP, V66, P257, DOI 10.1016/S0165-2427(98)00192-5; Del Fiacco M, 2015, J NEUROL NEUROSUR PS, V86, P393, DOI 10.1136/jnnp-2014-308813; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Leonelli M, 2009, INT J DEV NEUROSCI, V27, P709, DOI 10.1016/j.ijdevneu.2009.07.003; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Meents J, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0539-z; Mergler S, 2014, OPHTHALMIC RES, V52, P151, DOI 10.1159/000365334; Motta EM, 2009, NEUROSCI LETT, V457, P146, DOI 10.1016/j.neulet.2009.03.055; Murata Y, 2006, BRAIN RES, V1085, P87, DOI 10.1016/j.brainres.2006.02.035; Nakamura A, 2007, J CHEM NEUROANAT, V34, P95, DOI 10.1016/j.jchemneu.2007.05.005; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; Rigoni M, 2003, BRIT J PHARMACOL, V138, P977, DOI 10.1038/sj.bjp.0705110; Rowan MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093688; Sakamoto K, 2014, EUR J PHARMACOL, V733, P13, DOI 10.1016/j.ejphar.2014.03.035; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; Schicho R, 2005, BRAIN RES, V1039, P108, DOI 10.1016/j.brainres.2005.01.050; Schumacher MA, 2000, J BIOL CHEM, V275, P2756, DOI 10.1074/jbc.275.4.2756; Silberstein SD, 2015, J NEUROL NEUROSUR PS, V86, P361, DOI 10.1136/jnnp-2014-309295; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Sumioka T, 2014, INVEST OPHTH VIS SCI, V55, P3295, DOI 10.1167/iovs.13-13077; Suzuki M, 1999, J BIOL CHEM, V274, P6330, DOI 10.1074/jbc.274.10.6330; Thomas R, 2009, J TRAUMA, V66, pS99, DOI 10.1097/TA.0b013e31819d8695; Tian W, 2006, AM J PHYSIOL-RENAL, V290, pF117, DOI 10.1152/ajprenal.00143.2005; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wang FZ, 2015, NEUROL SCI, V36, P535, DOI 10.1007/s10072-014-2010-3; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Yamamoto T, 2013, J DENT RES, V92, P335, DOI 10.1177/0022034513478428; Yan J, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-6; Yang YQ, 2013, EXP EYE RES, V107, P121, DOI 10.1016/j.exer.2012.11.004; Yang YX, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.340.5470	50	5	5	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0271-3683	1460-2202		CURR EYE RES	Curr. Eye Res.	OCT	2016	41	10					1294	1301		10.3109/02713683.2015.1122812			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EA1DF	WOS:000386332000006	27049881	Green Published, hybrid			2022-02-06	
J	Schwed, AC; Boggs, MM; Watanabe, D; Plurad, DS; Putnam, BA; Kim, DY				Schwed, Alexander C.; Boggs, Monica M.; Watanabe, Drew; Plurad, David S.; Putnam, Brant A.; Kim, Dennis Y.			Admission Variables Associated with a Favorable Outcome after Mild Traumatic Brain Injury	AMERICAN SURGEON			English	Article							REPEAT HEAD CT; MANAGEMENT	Consensus is lacking for ideal management of mild traumatic brain injury (mTBI) with intracranial hemorrhage (ICH). Patients are often monitored in the intensive care unit (ICU) without additional interventions. We sought to identify admission variables associated with a favorable outcome (ICU admission for 24 hours, no neurosurgical interventions, no complications or mortality) to divert these patients to a non-ICU setting in the future. We reviewed all patients with mTBI [Glasgow Coma Scale (GCS) = 13-15] and concomitant ICH between July 1, 2012, and June 30, 2015. Variables collected included demographics, vital signs, neurologic examination, imaging results, ICU course, mortality, and disposition. Of 201 patients, 78 (39%) had a favorable outcome. On univariate analysis, these patients were younger, more often had an isolated subarachnoid hemorrhage, and were more likely to have a GCS of 15 at admission. On multivariate regression analysis, after controlling for admission blood pressure, time to CT scan, and Marshall Score, age <55, GCS of 15 on arrival to the ICU, and isolated subarachnoid hemorrhage remained independent predictors of a favorable outcome. Patients meeting these criteria after mTBI with ICH likely do not require ICU-level care.	[Schwed, Alexander C.; Boggs, Monica M.; Watanabe, Drew; Plurad, David S.; Putnam, Brant A.; Kim, Dennis Y.] Harbor UCLA Med Ctr, Dept Surg, Div Trauma Acute Care Surg Surg Crit Care, Torrance, CA 90509 USA		Kim, DY (corresponding author), 1000 West Carson St,Box 42, Torrance, CA 90502 USA.	dekim@dhs.lacounty.gov		Schwed, Alexander/0000-0001-8025-5764			Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention (CDC), TRAUM BRAIN INJ GET; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	14	5	5	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2016	82	10					898	902					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EB7RY	WOS:000387589100008	27779969				2022-02-06	
J	Vieira, G; de Albuquerque, LAF; de Avellar, ABCC; Pereira, JLB; Dellaretti, M; Miranda, PAC; Macedo, RAP; da Silva, LAQ; Gusmao, SNS				Vieira, Gerival, Jr.; Freitas de Albuquerque, Lucas Alverne; Camilo Castilho de Avellar, Ariane Bernardes; Barbosa Pereira, Julio Leonardo; Dellaretti, Marcos; Carvalho Miranda, Paulo Augusto; Paiva Macedo, Rodrigo Alvares; Quintino da Silva, Laura Amaral; Silva Gusmao, Sebastiao Nataniel			Long-Term Follow-Up of Anterior Pituitary Deficiency after Aneurysmal Subarachnoid Hemorrhage: Prospective Cohort	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Subarachnoid hemorrhage; intracranial aneurysms; pituitary anterior lobe; hypopituitarism	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEUROENDOCRINE DYSFUNCTION; HIGH-RISK; HYPOPITUITARISM; PREVALENCE; MORTALITY; SURVIVORS; UNCOMMON	Objective: The aim of this study was to evaluate the prevalence of hypopituitarism in the acute stage after aneurysmal subarachnoid hemorrhage (SAH) as well at the chronic stage, at least 1 year after bleeding, to assess its implications and correlation with clinical features of the studied population. Patients and Methods: This was a prospective cohort study that evaluated patients admitted between December 2009 and May 2011 with a diagnosis of SAH secondary to cerebral aneurysm rupture. Clinical and endocrine assessment was performed during the acute stage after hospital admission and before treatment at a mean of 7.5 days (SD +/- 3.8) following SAH, and also at the follow-up visit at a mean of 25.5 months (range: 1255 months) after the bleeding. Results: Out of the 119 patients initially assessed, 92 were enrolled for acute stage, 82 underwent hormonal levels analysis, and 68 (82.9%) were followed up in both acute and chronic phases. The mean age and median age were lower among patients with dysfunction in the acute phase compared to those without dysfunction (P<.05). The prevalence of dysfunction in the acute phase was higher among patients with hydrocephalus on admission computed tomography (57.9%) than among those without it (P <.05). At chronic phase, there was an association between dysfunction and Hunt & Hess scale score greater than 2 (P <.05). Conclusions: We believe that there is not enough literature evidence to incorporate routine endocrinological evaluation for patient victims of SAH, but we should always keep this differential diagnosis in mind when conducting long-term assessments of this population.	[Vieira, Gerival, Jr.; Freitas de Albuquerque, Lucas Alverne; Camilo Castilho de Avellar, Ariane Bernardes; Barbosa Pereira, Julio Leonardo; Dellaretti, Marcos] Santa Casa Hosp, Dept Neurosurg, Ave Francisco Sales, BR-30150221 Belo Horizonte, MG, Brazil; [Vieira, Gerival, Jr.; Silva Gusmao, Sebastiao Nataniel] Univ Fed Minas Gerais, Dept Neurosurg, Fac Med, Belo Horizonte, MG, Brazil; [Dellaretti, Marcos; Paiva Macedo, Rodrigo Alvares; Quintino da Silva, Laura Amaral] Minas Gerais FCMMG, Fac Med Sci, Belo Horizonte, MG, Brazil; [Carvalho Miranda, Paulo Augusto] Santa Casa Hosp, Dept Endocrinol, Belo Horizonte, MG, Brazil		Vieira, G (corresponding author), Santa Casa Hosp, Dept Neurosurg, Ave Francisco Sales, BR-30150221 Belo Horizonte, MG, Brazil.	vieiragjr@gmail.com	Dellaretti, Marcos/G-4664-2012				Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Pereira JLB, 2013, CLINICS, V68, P745, DOI 10.6061/clinics/2013(06)04; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Blijdorp K, 2013, EUR J ENDOCRINOL, V169, P497, DOI 10.1530/EJE-13-0436; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Darzy K H, 2005, J Endocrinol Invest, V28, P78; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; Inagawa T, 1997, SURG NEUROL, V47, P47, DOI 10.1016/S0090-3019(96)00370-9; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khajeh L, 2015, J NEUROL NEUROSUR PS, V86, P905, DOI 10.1136/jnnp-2014-307897; Khajeh L, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0205-0; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Kronvall E, 2015, WORLD NEUROSURG, V83, P574, DOI 10.1016/j.wneu.2014.12.007; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Lammert A, 2011, EXP CLIN ENDOCR DIAB, V119, P111, DOI 10.1055/s-0030-1262815; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sharshar T, 2011, CRIT CARE, V15, DOI 10.1186/cc10010; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x	30	5	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	OCT	2016	25	10					2405	2414		10.1016/j.jstrokecerebrovasdis.2016.06.011			10	Neurosciences; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	DX0AS	WOS:000384024500024	27425177				2022-02-06	
J	Steward, KA; Gerstenecker, A; Triebel, KL; Kennedy, R; Novack, TA; Dreer, LE; Marson, DC				Steward, Kayla A.; Gerstenecker, Adam; Triebel, Kristen L.; Kennedy, Richard; Novack, Thomas A.; Dreer, Laura E.; Marson, Daniel C.			Twelve-month recovery of medical decision-making capacity following traumatic brain injury	NEUROLOGY			English	Article							HEAD-INJURY; MILD; CONSENT; COMPETENCE	Objective:To investigate recovery of medical decision-making capacity (MDC) over the first year following traumatic brain injury (TBI).Methods:A total of 177 participants (111 persons with TBI and 66 healthy controls) were recruited from an inpatient/outpatient TBI rehabilitation unit and outpatient neurology department. Participants with TBI were classified by injury severity into subgroups: mild TBI (mTBI; n = 28), complicated mild TBI (cmTBI; n = 23), and moderate/severe TBI (msevTBI; n = 60). Control and TBI groups were compared at 1 month (t1), 6 months (t2), and 12 months (t3) postinjury using the Capacity to Consent to Treatment Instrument (CCTI), which evaluates MDC using 5 consent standards: expressing choice, reasonable choice, appreciation, reasoning, and understanding.Results:Relative to controls, no TBI group displayed impairment on CCTI expressing choice or reasonable choice at any timepoint. Those with mTBI had reduced appreciation and understanding at t1, which resolved by t2. The cmTBI and msevTBI groups were impaired on all 3 complex consent standards at t1. While patients with cmTBI improved to a level similar to controls by t3, those with msevTBI remained impaired on reasoning and understanding. Across all TBI groups, notable MDC improvement only occurred over the first 6 months postinjury.Conclusions:Over 1 year, most individuals with mTBI or cmTBI regain MDC, while many individuals with msevTBI have lingering deficits in reasoning and comprehension of treatment information. Clinical recovery of MDC occurs primarily during the first 6 months post-TBI regardless of injury severity. Clinicians can therefore identify MDC outcomes in TBI at 6 months postinjury.	[Steward, Kayla A.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Gerstenecker, Adam; Triebel, Kristen L.; Marson, Daniel C.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Kennedy, Richard] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	dmarson@uab.edu	Steward, Kayla/AAS-8792-2021; triebel, kristen/A-6569-2019; Kennedy, Richard/K-1525-2018	triebel, kristen/0000-0001-9161-7847; Kennedy, Richard/0000-0003-4638-126X	National Institute on Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD053074]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021927] Funding Source: NIH RePORTER	Supported by the National Institute on Child Health and Human Development (grant no. 1R01HD053074) (Dr. Marson, PI).	APPELBAUM PS, 1995, LAW HUMAN BEHAV, V19, P105, DOI 10.1007/BF01499321; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; McCrea M., 2008, MILD TRAUMATIC BRAIN; MCKINLAY W, 1999, REHABILITATION ADULT, P74; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Pentland B, 1999, REHABILITATION ADULT, P42; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Triebel KL, 2016, J HEAD TRAUMA REHAB, V31, pE49, DOI 10.1097/HTR.0000000000000163; Triebel KL, 2014, ARCH PHYS MED REHAB, V95, P2296, DOI 10.1016/j.apmr.2014.07.413; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	33	5	5	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 6	2016	87	10					1052	1059		10.1212/WNL.0000000000003079			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DW9LV	WOS:000383982200026	27511180	Green Published			2022-02-06	
J	Hashemi, B; Amanat, M; Baratloo, A; Forouzanfar, MM; Rahmati, F; Motamedi, M; Safari, S				Hashemi, Behrooz; Amanat, Mahnaz; Baratloo, Alireza; Forouzanfar, Mohammad Mehdi; Rahmati, Farhad; Motamedi, Maryam; Safari, Saeed			Validation of CRASH Model in Prediction of 14-day Mortality and 6-month Unfavorable Outcome of Head Trauma Patients	EMERGENCY			English	Article						Prognosis; head injuries; closed; multiple trauma; patient outcome assessment; decision support techniques.	INJURY EXTERNAL VALIDATION; BRAIN-INJURY; IMPACT; PROGNOSIS; MODERATE	Introduction: To date, many prognostic models have been proposed to predict the outcome of patients with traumatic brain injuries. External validation of these models in different populations is of great importance for their generalization. The present study was designed, aiming to determine the value of CRASH prognostic model in prediction of 14-day mortality (14-DM) and 6-month unfavorable outcome (6-MUO) of patients with traumatic brain injury. Methods: In the present prospective diagnostic test study, calibration and discrimination of CRASH model were evaluated in head trauma patients referred to the emergency department. Variables required for calculating CRASH expected risks (ER), and observed 14-DM and 6-MUO were gathered. Then ER of 14-DM and 6-MUO were calculated. The patients were followed for 6 months and their 14-DM and 6-MUO were recorded. Finally, the correlation of CRASH ER and the observed outcome of the patients was evaluated. The data were analyzed using STATA version 11.0. Results: In this study, 323 patients with the mean age of 34.0 As 19.4 years were evaluated (87.3% male). Calibration of the basic and CT models in prediction of 14-day and 6-month outcome were in the desirable range (P < 0.05). Area under the curve in the basic model for prediction of 14-DM and 6-MUO were 0.92 (95% CI: 0.89-0.96) and 0.92 (95% CI: 0.90-0.95), respectively. In addition, area under the curve in the CT model for prediction of 14-DM and 6-MUO were 0.93 (95% CI: 0.91-0.97) and 0.93 (95% CI: 0.91-0.96), respectively. There was no significant difference between the discriminations of the two models in prediction of 14-DM (p = 0.11) and 6-MUO (p = 0.1). Conclusion: The results of the present study showed that CRASH prediction model has proper discrimination and calibration in predicting 14-DMand 6-MUO of head trauma patients. Since there was no difference between the values of the basic and CT models, using the basic model is recommended to simplify the risk calculations.	[Hashemi, Behrooz; Amanat, Mahnaz; Baratloo, Alireza; Forouzanfar, Mohammad Mehdi; Rahmati, Farhad; Motamedi, Maryam; Safari, Saeed] Shahid Beheshti Univ Med Sci, Shohadaye Tajrish Hosp, Clin Res Dev Ctr, Tehran, Iran		Amanat, M (corresponding author), Shahid Beheshti Univ Med Sci, Shohadaye Tajrish Hosp, Emergency Dept, Tehran, Iran.	mah.amanat@yahoo.com	Safari, Saeed/J-4604-2017; Baratloo, Alireza/E-3293-2017; RAHMATI, FARHAD/AAH-7375-2021; forouzanfar, mohammadmehdi/ABA-5064-2020; hashemi, behrouz/T-2130-2018	Safari, Saeed/0000-0002-7407-1739; Baratloo, Alireza/0000-0002-4383-7738; RAHMATI, FARHAD/0000-0002-4859-6179; hashemi, behrouz/0000-0002-5077-8545			Bigler ED, 2009, TXB ALZHEIMER DIS OT, P229; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kumar A, 2008, INDIAN J NEUROTRAUM, V5, P63, DOI 10.1016/S0973-0508(08)80002-0; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Majdzadeh R, 2008, ACCIDENT ANAL PREV, V40, P17, DOI 10.1016/j.aap.2007.03.019; Menon D, 2008, BMJ-BRIT MED J, V336, P397, DOI 10.1136/bmj.39461.616991.80; Montazeri A, 2004, PUBLIC HEALTH, V118, P110, DOI 10.1016/S0033-3506(03)00173-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Young NH, 2008, PLOS MED, V5, P1186, DOI 10.1371/journal.pmed.0050168	19	5	5	0	0	SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED	TEHRAN	SCH MEDICINE, KOODAK-YAR ST, PO BOX 19359, TEHRAN, 4618, IRAN	2345-4571			EMERGENCY	Emergency	FAL	2016	4	4					196	201					6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	FD3ZF	WOS:000407470200006	27800540				2022-02-06	
J	Kapapa, T; Brand, C; Wirtz, CR; Woischneck, D				Kapapa, Thomas; Brand, Christine; Wirtz, Christian Rainer; Woischneck, Dieter			Outcome After Decompressive Craniectomy in Different Pathologies	WORLD NEUROSURGERY			English	Article						Indication; Malignant cerebral infarction; Stroke; Subarachnoid hemorrhage; Survival	MIDDLE CEREBRAL-ARTERY; MALIGNANT INFARCTION; INTRACEREBRAL HEMORRHAGE; HEMICRANIECTOMY; SURGERY; INJURY; CLASSIFICATION; BENEFITS	BACKGROUND: We compare the outcome after decompressive craniectomy for various neurologic diseases with the final common pathway of coma, compression of the basal cisterns, a midline shift, or refractory intracranial hypertension. METHODS: Between January 2005 and June 2009, 134 patients underwent decompressive craniectomy for traumatic brain injury (n = 74), intracerebral hemorrhage (n = 21), spontaneous subarachnoid hemorrhage (n = 11), malignant cerebral infarction (n = 27), or encephalitis (n= 1). The outcome was classified at discharge and up to 12 months after treatment in accordance with the Glasgow Outcome Scale (GOS), as well as the Glasgow Coma Scale, Marshall classification, or National Institutes of Health Stroke Scale. Significance was established as P <= 0.05. RESULTS: Median and mean scores on the Glasgow Coma Scale at time of neurosurgical assessment in all patients were <= 7. Midline shift was reduced in each subset as a result of surgery (mean, 0.26-0.46 cm; P <= 0.049). Overall outcome based on the median GOS score at discharge ranged from death to severe disability. After 12 months, the median range narrowed to a range of death to persistent vegetative state. At various time points, mean GOS score was not found to differ significantly between the subsets. Unfavorable outcome after 3 months was found in a smaller group of patients after traumatic brain injury than was found in patients with other diseases (P = 0.016). CONCLUSIONS: The outcome after decompressive craniectomy does not differ significantly in different diseases once the final pathophysiologic pathway of refractory intracranial hypertension, coma, compression of the basal cisterns, or midline shift has been reached.	[Kapapa, Thomas; Brand, Christine; Wirtz, Christian Rainer] Univ Ulm Klinikum, Neurochirurg Klin, Ulm, Germany; [Woischneck, Dieter] Klinikum Landshut, Neurochirurg Klin, Landshut, Germany		Kapapa, T (corresponding author), Univ Ulm Klinikum, Neurochirurg Klin, Ulm, Germany.	thomas.kapapa@uniklinik-ulm.de					Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Heuts SG, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1326; Honeybul S, 2014, AUST CRIT CARE, V27, P85, DOI 10.1016/j.aucc.2013.06.001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENNETT B, 1975, LANCET, V1, P480; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Klein A, 2012, NEUROCRIT CARE, V16, P456, DOI 10.1007/s12028-012-9677-1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mendelow AD, 2005, LANCET, V365, P387; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Rincon F, 2013, NEUROCRIT CARE, V18, P45, DOI 10.1007/s12028-012-9779-9; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Wilson JTL, 2005, STROKE, V36, P777, DOI 10.1161/01.STR.0000157596.13234.95; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011; ZWECKBERGER K, 2014, REV CEREBROVASC DIS, V38, P313, DOI DOI 10.1159/000365864	31	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2016	93						389	397		10.1016/j.wneu.2016.06.075			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5DX	WOS:000390352000056	27353556				2022-02-06	
J	Lu, ZF; Bing, L; Peng, Q; Jiang, JY				Lu Zhaofeng; Bing, Li; Peng, Qiao; Jiang Jiyao			Surgical Treatment of Traumatic Bifrontal Contusions: When and How?	WORLD NEUROSURGERY			English	Article						Bifrontal contusions; Bifrontal decompression craniotomy; Timing of operation	DECOMPRESSIVE CRANIECTOMY; BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; MANAGEMENT; MODERATE; TALK	OBJECTIVE: The study aimed to investigate optimal surgical timing, methods, and clinical efficacy of bifrontal decompression craniotomy (BDC) on traumatic bifrontal contusions (TBC). METHODS: A retrospective analysis was performed of 98 patients with TBC who underwent BDC of 2510 patients with traumatic brain injury. The operation-timing score was used to determine surgical timing. RESULTS: Ninety-eight cases (19%) underwent amended BDC. Initial Glasgow Coma Score was 13-15 in 52 cases (61%). Initial computed tomography showed hematoma volumes of 15.1 +/- 5.2 mL in 73 cases (74%). Preoperative hematoma (80.2 +/- 20.5 mL; P < 0.05) was significantly enlarged. Fluctuation in the surgery-timing curve is timing for surgery. Average operation time was 4.5 +/- 3.4 days after admission. Hematoma was totally evacuated and Glasgow Coma Score significantly increased (P < 0.05) in all cases. In the follow-up Glasgow Outcome Score, 79 patients (81%) recovered well. CONCLUSIONS: TBC progressed gradually and deteriorated rapidly; this should be strictly and dynamically observed, and patients should be operated on in a timely manner. Changing the operation-timing score is the gold standard for surgery. Amended BDC can significantly improve the prognosis of patients.	[Lu Zhaofeng; Bing, Li; Peng, Qiao] Henan Univ Sci & Technol, Affiliated Hosp 1, Intens Care Unit, Dept Neurosurg, Luoyang, Peoples R China; [Jiang Jiyao] Shanghai Jiao Tong Univ, Renji Hosp, Dept Neurosurg, Shanghai, Peoples R China		Lu, ZF (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Intens Care Unit, Dept Neurosurg, Luoyang, Peoples R China.	zhaofenglu001@163.com			Henan University of Science and Technology;  [2015GJB021]	Henan University of Science and Technology provided financial support in the form of high-level scientific research project funding. The sponsor had no role in the design or conduct of this research (Project number: 2015GJB021).	Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bokhari I, 2014, J SURG PAKISTAN INT, V19, P108; Cepeda S, 2016, J NEUROTRAUM, V33, P1034, DOI 10.1089/neu.2015.4153; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Elwatidy S, 2009, BRIT J NEUROSURG, V23, P56, DOI 10.1080/02688690802571094; Gao L, 2013, WORLD NEUROSURG, V80, P879, DOI 10.1016/j.wneu.2013.01.020; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Hung KS, 2004, J CLIN NEUROSCI, V11, P849, DOI 10.1016/j.jocn.2003.06.009; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Neville IS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/879286; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Ong YK, 2002, CHILD NERV SYST, V18, P340, DOI 10.1007/s00381-002-0597-9; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; SERVADEI F, 1988, J NEUROL NEUROSUR PS, V51, P526, DOI 10.1136/jnnp.51.4.526; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	27	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2016	93						261	269		10.1016/j.wneu.2016.06.021			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5DX	WOS:000390352000039	27312389				2022-02-06	
J	Mrozek, S; Luzi, A; Gonzalez, L; Kerhuel, L; Fourcade, O; Geeraerts, T				Mrozek, Segolene; Luzi, Aymeric; Gonzalez, Leslie; Kerhuel, Lionel; Fourcade, Olivier; Geeraerts, Thomas			Cerebral and extracerebral vulnerability to hypoxic insults after diffuse traumatic brain injury in rats	BRAIN RESEARCH			English	Article						Hypoxia-hypotension; Posttraumatic vulnerability; Brain-organ crosstalk; Tissue hypoxia	SEVERE HEAD-INJURY; ISCHEMIC BRAIN; EXTRACRANIAL COMPLICATIONS; INTRACRANIAL-PRESSURE; LUNG INFLAMMATION; ORGAN DYSFUNCTION; HUMAN TUMORS; CELL-DEATH; HYPOTENSION; DAMAGE	The post-traumatic brain vulnerability suggests that after traumatic brain injury (TBI), the brain may be more susceptible to posttraumatic hypoxic insults. This concept could be extended to 'peripheral' organs, as non-neurologic organ failure is common after TBI. This study aims to characterize and quantify cerebral and extracerebral tissue hypoxia with pimonidazole resulting from a standardized hypoxia-hypotension (HH) phase occurring after a diffuse experimental TBI in rats. Rats were allocated to Sham (n=5), TBI (n=7), HH (n=7) and TBI+HH (n=7) groups. Then, pimonidazole was injected and brain, liver, heart and kidneys were analysed. In the cerebral cortex, post-treatment hypoxia was higher in TBI+HH group than Sham group (p = 0.003), HH group (p=0.003) and TBI group (p=0.002). large trends in thalamus, hippocampus and striatum for the TBI+HH group compared to the other groups were observed. For the heart and liver, the 4 groups were comparable. For the kidneys, post-treatment hypoxia was higher in the TBI group compared to the Sham and HH groups, but not more than TBI + HH group. This study reveals that a posttraumatic hypoxic insult occurring after a severe TBI has major hypoxic consequences on brain structures. However, TBI by itself appears to induce renal hypoxia that is not enhanced by posttraumatic hypoxic insult. (C) 2016 Elsevier B.V. All rights reserved.	[Mrozek, Segolene; Luzi, Aymeric; Gonzalez, Leslie; Kerhuel, Lionel; Fourcade, Olivier; Geeraerts, Thomas] Univ Toulouse 3, Equipe Accueil Modelisat Aggress Tissulaire & Noc, Toulouse, France; [Mrozek, Segolene; Luzi, Aymeric; Gonzalez, Leslie; Kerhuel, Lionel; Fourcade, Olivier; Geeraerts, Thomas] Univ Hosp Toulouse, Dept Anesthesiol & Crit Care, Toulouse, France		Mrozek, S (corresponding author), Hop Pierre Paul Riquet, Pole Anesthesie Reanimat, F-31059 Toulouse 9, France.	mrozek.s@chu-toulouse.fr; aymericluzi@yahoo.com; gonzalez.l@chu-toulouse.fr; lionel.kerhuel@gmail.com; fourcade.o@chu-toulouse.fr; geeraerts.t@chu-toulouse.fr					Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bache M, 2008, CURR MED CHEM, V15, P322, DOI 10.2174/092986708783497391; Beaumont A, 2002, ACT NEUR S, V81, P217; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blanie A, 2012, J NEUROTRAUM, V29, P2782, DOI 10.1089/neu.2012.2381; Calabresi P, 2003, LANCET NEUROL, V2, P622, DOI 10.1016/S1474-4422(03)00532-5; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Cobelens PM, 2010, CRIT CARE, V14, DOI 10.1186/cc9232; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Dubois L, 2004, BRIT J CANCER, V91, P1947, DOI 10.1038/sj.bjc.6602219; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Geeraerts T, 2006, J NEUROTRAUM, V23, P1059, DOI 10.1089/neu.2006.23.1059; Ghafar MA, 2002, LAB INVEST, V82, P903, DOI 10.1097/01.LAB.0000021135.87203.92; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Haustermans K, 2000, RADIOTHER ONCOL, V55, P325, DOI 10.1016/S0167-8140(00)00206-1; Heuer JF, 2012, J NEUROL SURG PART A, V73, P289, DOI 10.1055/s-0032-1304813; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; Huang RQ, 2010, NEUROSCI LETT, V473, P22, DOI 10.1016/j.neulet.2010.02.011; Huttemann E, 2002, INTENS CARE MED, V28, P1084, DOI 10.1007/s00134-002-1355-x; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; KIRKEBY OJ, 1995, J NEUROSURG, V83, P1067, DOI 10.3171/jns.1995.83.6.1067; KITA H, 1994, ACTA NEUROCHIR, P452; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Liu BY, 2008, NEUROL RES, V30, P594, DOI 10.1179/174313208X310296; Liu Y, 2009, J RADIAT RES, V50, P233, DOI 10.1269/jrr.08112; Ljungkvist ASE, 2007, RADIAT RES, V167, P127, DOI 10.1667/RR0719.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Mazzeo AT, 2013, MINERVA ANESTESIOL, V79, P299; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; NOVITZKY D, 1986, ANN THORAC SURG, V41, P520, DOI 10.1016/S0003-4975(10)63032-9; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; PAXINOS J, 1982, RAT BRAIN STEREOTAXI; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; Ract C, 2001, J NEUROTRAUM, V18, P1247, DOI 10.1089/089771501317095287; Raleigh JA, 2001, INT J RADIAT ONCOL, V49, P569, DOI 10.1016/S0360-3016(00)01505-4; ROBERTS JT, 1986, BRIT J RADIOL, V59, P107, DOI 10.1259/0007-1285-59-698-107; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Takada M, 1998, TRANSPLANTATION, V65, P1533, DOI 10.1097/00007890-199806270-00001; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Wahlstrom MR, 2009, ACTA ANAESTH SCAND, V53, P18, DOI 10.1111/j.1399-6576.2008.01798.x; Westbury CB, 2007, BRIT J RADIOL, V80, P934, DOI 10.1259/bjr/25046649; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2003, J CRIT CARE, V18, P238, DOI 10.1016/j.jcrc.2003.10.007	64	5	5	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 1	2016	1646						334	341		10.1016/j.brainres.2016.06.007			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT9TH	WOS:000381844700037	27302136				2022-02-06	
J	Muise, DP; MacKenzie, SJ; Sutherland, TM				Muise, Daniel P.; MacKenzie, Sasho J.; Sutherland, Tara M.			Frequency and Magnitude of Head Accelerations in a Canadian Interuniversity Sport Football Team's Training Camp and Season	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						mTBI; concussion; biomechanics; sport	IMPACT EXPOSURES; UNITED-STATES; PLAYERS; INJURY; CONCUSSION; HELMETS	The increased awareness of concussion in sport has led to an examination of head impacts and the associated biomechanics that occur during these sporting events. The high rate of concussions in football makes it particularly relevant.(1) The purpose of this study was to examine how frequently, and to what magnitude, Canadian University football players get hit in training camp and how this compares to practices and games in regular season. An ANOVA with repeated measures indicated that, on average, players were hit significantly more in games (45.2 hits) than training camp sessions (17.7 hits) and practices (8.0 hits), while training camp was associated with significantly more hits than practices (p < . 001,eta(2) = .392). Multiple positional differences were found. In particular, significantly more hits were experienced by offensive linemen (36.7 hits) and defensive linemen (31.6 hits) compared with all other positions (p < .001, eta(2) = .247). Study outcomes determined players/positions most at risk for concussion due to head impacts, which is beneficial in forming concussion prevention and assessment strategies.	[Muise, Daniel P.; MacKenzie, Sasho J.; Sutherland, Tara M.] St Francis Xavier Univ, Dept Human Kinet, Antigonish, NS, Canada		Muise, DP (corresponding author), St Francis Xavier Univ, Dept Human Kinet, Antigonish, NS, Canada.						Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Campbell K., 2014, 2259 EL THES DISS RE; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hardy, 2003, P INT RES C BIOM IMP; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; McCrory P., 2009, S AFRICAN J SPORTS M, V21; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454	20	5	5	0	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	SEP	2016	21	5					36	41		10.1123/ijatt.2016-0005			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	DW7CG	WOS:000383808200006					2022-02-06	
J	Quan, FS; Chen, J; Zhong, Y; Ren, WZ				Quan, Fu-Shi; Chen, Jian; Zhong, Yuan; Ren, Wen-Zhi			Comparative effect of immature neuronal or glial cell transplantation on motor functional recovery following experimental traumatic brain injury in rats	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						neuron; glia; transplantation; motor functional recovery; traumatic brain injury	ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC STEM-CELLS; MARROW STROMAL CELLS; COGNITIVE DEFICITS; CEREBRAL-ISCHEMIA; ADULT-RATS; NERVOUS-SYSTEM; IN-VITRO; SURVIVAL; NEUROGENESIS	The present study evaluated the comparative effect of stereotaxically transplanted immature neuronal or glial cells in brain on motor functional recovery and cytokine expression after cold-induced traumatic brain injury (TBI) in adult rats. A total of 60 rats were divided into four groups (n=15/group): Sham group; TBI only group; TBI plus neuronal cells-transplanted group (NC-G); and TBI plus glial cells-transplanted group (GC-G). Cortical lesions were induced by a touching metal stamp, frozen with liquid nitrogen, to the dura mater over the motor cortex of adult rats. Neuronal and glial cells were isolated from rat embryonic and newborn cortices, respectively, and cultured in culture flasks. Rats received neurons or glia grafts (similar to 1x10(6) cells) 5 days after TBI was induced. Motor functional evaluation was performed with the rotarod test prior to and following glial and neural cell grafts. Five rats from each group were sacrificed at 2, 4 and 6 weeks post-cell transplantation. Immunofluorescence staining was performed on brain section to identify the transplanted neuronal or glial cells using neural and astrocytic markers. The expression levels of cytokines, including transforming growth factor-, glial cell-derived neurotrophic factor and vascular endothelial growth factor, which have key roles in the proliferation, differentiation and survival of neural cells, were analyzed by immunohistochemistry and western blotting. A localized cortical lesion was evoked in all injured rats, resulting in significant motor deficits. Transplanted cells successfully migrated and survived in the injured brain lesion, and the expression of neuronal and astrocyte markers were detected in the NC-G and GC-G groups, respectively. Rats in the NC-G and GC-G cell-transplanted groups exhibited significant motor functional recovery and reduced histopathologic lesions, as compared with the TBI-G rats that did not receive neural cells (P<0.05, respectively). Furthermore, GC-G treatment induced significantly improved motor functional recovery, as compared with the NC-G group (P<0.05). Increased cytokine expression levels were detected in the NC-G and GC-G groups, as compared with the TBI-G; however, no differences were found between the two groups. These data suggested that transplanted immature neural cells may promote the survival of neural cells in cortical lesion and motor functional recovery. Furthermore, transplanted glial cells may be used as an effective therapeutic tool for TBI patients with abnormalities in motor functional recovery and cytokine expression.	[Quan, Fu-Shi; Chen, Jian; Zhong, Yuan; Ren, Wen-Zhi] Jilin Univ, Coll Anim Sci, Lab Anim Ctr, 5333 Xian Rd, Changchun 130062, Jilin, Peoples R China		Ren, WZ (corresponding author), Jilin Univ, Coll Anim Sci, Lab Anim Ctr, 5333 Xian Rd, Changchun 130062, Jilin, Peoples R China.	renwenzhi_l@163.com	Quan, Fu-Shi/V-1826-2019		Youth Research Fund Project of Jilin Province [2014-0520170JH]; National Technology Support Project [2015-BAI07B02]	The present study was supported by the Youth Research Fund Project of Jilin Province (grant no. 2014-0520170JH) and the National Technology Support Project (grant no. 2015-BAI07B02).	Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; [Anonymous], 1994, NEUROREHABILITATION, V4, P222; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Bentz K, 2007, J NEUROSCI RES, V85, P1057, DOI 10.1002/jnr.21219; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cho YH, 2006, ACTA NEUROCHIR SUPPL, V99, P125, DOI 10.1007/978-3-211-35205-2_24; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fee DB, 2004, BRAIN RES, V1012, P52, DOI 10.1016/j.brainres.2004.03.028; Gao DK, 2006, LIFE SCI, V78, P2564, DOI 10.1016/j.lfs.2005.10.030; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Ji YC, 2005, J KOREAN MED SCI, V20, P291, DOI 10.3346/jkms.2005.20.2.291; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kerr DA, 2001, J NEUROSCI, V15, P5131; KESSLAK JP, 1986, EXP NEUROL, V94, P615, DOI 10.1016/0014-4886(86)90241-4; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lee CS, 2005, EXP NEUROL, V191, P65, DOI 10.1016/j.expneurol.2004.08.025; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McFarlin K, 2006, WOUND REPAIR REGEN, V14, P471, DOI 10.1111/j.1743-6109.2006.00153.x; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403; NETTO CA, 1993, BEHAV BRAIN RES, V58, P107, DOI 10.1016/0166-4328(93)90095-8; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Philips MF, 1999, J NEUROSURG, V90, P116, DOI 10.3171/jns.1999.90.1.0116; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Skold MK, 2004, EXP NEUROL, V188, P20, DOI 10.1016/j.expneurol.2004.03.024; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; STEIN DG, 1988, BEHAV NEUROSCI, V102, P260, DOI 10.1037/0735-7044.102.2.260; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Wei HF, 1997, MOL CHEM NEUROPATHOL, V30, P25, DOI 10.1007/BF02815148; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	55	5	5	0	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2016	12	3					1671	1680		10.3892/etm.2016.3527			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DU8EL	WOS:000382446000067	27602084	Green Published, Green Submitted, gold			2022-02-06	
J	Schiehser, DM; Filoteo, JV; Litvan, I; Pirogovsky-Turk, E; Lessig, SL; Song, DS				Schiehser, Dawn M.; Filoteo, J. Vincent; Litvan, Irene; Pirogovsky-Turk, Eva; Lessig, Stephanie L.; Song, David S.			Cognitive functioning in individuals with Parkinson's disease and traumatic brain injury: A longitudinal study	PARKINSONISM & RELATED DISORDERS			English	Article						Neuropsychology; Parkinson's disease; Traumatic brain injury; Cognition; Longitudinal	SCALE	Objective: To examine longitudinal changes in cognition in individuals with Parkinson's disease (PD) with and without a history of traumatic brain injury (TBI). Methods: Twenty-five PD participants with a history of mild-moderate post-acute (>9 months) TBI and 25 demographically-matched PD controls without a history of TBI were administered measures of cognition (Mattis Dementia Rating Scale), mood, and motor functioning at baseline and at a two-year follow-up evaluation. Results: Individuals with PD and a history of TBI evidenced significantly greater decrements in overall cognition over the two year follow-up period compared to those without a history of TBI. Secondary subscale analyses suggest cognitive decrements may be mainly in the area of executive function, while a trend for group differences on the memory subscale was also observed. Groups did not differ on demographic, motor function, disease severity, cognitive, and mood profiles at baseline and evidenced comparable changes in mood and motor symptoms from baseline to follow-up. Conclusion: Findings suggest that a history of mild-moderate TBI is a risk factor for cognitive decline in individuals with PD. Published by Elsevier Ltd.	[Schiehser, Dawn M.; Filoteo, J. Vincent; Pirogovsky-Turk, Eva; Lessig, Stephanie L.; Song, David S.] VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Schiehser, Dawn M.; Filoteo, J. Vincent; Pirogovsky-Turk, Eva] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Litvan, Irene; Lessig, Stephanie L.; Song, David S.] Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA		Schiehser, DM (corresponding author), VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	dschiehser@ucsd.edu	Litvan, Irene/X-9319-2018	Litvan, Irene/0000-0002-3485-3445	VA Merit Review AwardsUS Department of Veterans Affairs [1 I01 RX001691-01A1, 5I01CX000813-04]	This study was supported by VA Merit Review Awards to DMS (1 I01 RX001691-01A1) and to JVF (5I01CX000813-04).	Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Mattis S, 1988, DEMENTIA RATING SCAL; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Rogers JM, 2015, BRAIN INJURY, V29, P343, DOI 10.3109/02699052.2014.976273; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	12	5	5	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	SEP	2016	30						58	61		10.1016/j.parkreldis.2016.05.024			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DW3FJ	WOS:000383527200011	27260791				2022-02-06	
J	Silverberg, ND; Panenka, W; Iverson, GL; Brubacher, JR; Shewchuk, JR; Heran, MKS; Oh, GCS; Honer, WG; Lange, RT				Silverberg, Noah D.; Panenka, William; Iverson, Grant L.; Brubacher, Jeffrey R.; Shewchuk, Jason R.; Heran, Manraj K. S.; Oh, Gary C. S.; Honer, William G.; Lange, Rael T.			Alcohol Consumption Does not Impede Recovery from Mild to Moderate Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Craniocerebral trauma; Postconcussion symptoms; Neuropsychological tests; Magnetic resonance imaging; Diffusion tensor imaging; Alcohol drinking; Alcohol-related disorders	NEUROPSYCHOLOGICAL ASSESSMENT BATTERY; WHITE-MATTER; SUBSTANCE-ABUSE; HEAD-INJURY; DRUG-USE; INTOXICATION; DRINKING; LEVEL; TIME; REPRODUCIBILITY	Objectives: To examine the effect of pre-injury alcohol use, acute alcohol intoxication, and post-injury alcohol use on outcome from mild to moderate traumatic brain injury (TBI). Methods: Prospective inception cohort of patients who presented to the Emergency Department with mild to moderate TBI and had a blood alcohol level (BAL) taken for clinical purposes. Those who completed the 1-year outcome assessment were eligible for this study (N=91). Outcomes of interest were the count of post-concussion symptoms (British Columbia Post-Concussion Symptom Inventory), low neuropsychological test scores (Neuropsychological Assessment Battery), and abnormal regions of interest on diffusion tensor imaging (low fractional anisotropy). The main predictors were pre-injury alcohol consumption (Cognitive Lifetime Drinking History interview), BAL, and post-injury alcohol use. Results: The alcohol use variables were moderately to strongly inter-correlated. None of the alcohol use variables (whether continuous or categorical) were related to 1-year TBI outcomes in generalized linear modeling. Participants in this cohort generally had a good clinical outcome, regardless of their pre-, peri-, and post-injury alcohol use. Conclusions: Alcohol may not significantly alter long-term outcome from mild to moderate TBI.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada; [Silverberg, Noah D.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Silverberg, Noah D.; Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Silverberg, Noah D.; Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Panenka, William] Univ British Columbia, British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Panenka, William; Iverson, Grant L.; Honer, William G.; Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Brubacher, Jeffrey R.] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada; [Shewchuk, Jason R.; Heran, Manraj K. S.; Oh, Gary C. S.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Brubacher, Jeffrey/0000-0002-4866-4231; Panenka, William/0000-0001-7143-6512; Iverson, Grant/0000-0001-7348-9570	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [200903MOP-200377-BSB-CAAA-161276]; Vancouver Coastal Health Research Institute; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]	Primary funding for this study was provided by the Canadian Institutes of Health Research (200903MOP-200377-BSB-CAAA-161276), to RTL as the Principal Applicant. NDS received salary support from the Vancouver Coastal Health Research Institute. GLI notes that he was supported in part by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD).	Allen DN, 2009, APPL NEUROPSYCHOL, V16, P186, DOI 10.1080/09084280903098687; Altura BM, 1999, ALCOHOL, V19, P119, DOI 10.1016/S0741-8329(99)00025-7; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Beaulieu-Bonneau S., 2014, ARCH PHYS MED REHABI; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Buhler M, 2011, ALCOHOL CLIN EXP RES, V35, P1771, DOI 10.1111/j.1530-0277.2011.01540.x; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cherpitel CJ, 2012, ADDICTION, V107, P1263, DOI 10.1111/j.1360-0443.2012.03793.x; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Donders J, 2012, ARCH CLIN NEUROPSYCH, V27, P440, DOI 10.1093/arclin/acs043; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Joseph B., 2014, J TRAUMA ACUTE CARE, V78, P403; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Le Berre AP, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00354; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mori S., 2005, MRI ATLAS HUMAN WHIT, P931; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; National Institute on Alcohol Abuse and Alcoholism, 2015, WHAT IS STAND DRINK; O'Dell KM, 2012, J HEAD TRAUMA REHAB, V27, P361, DOI 10.1097/HTR.0b013e318266735c; PFEFFERBAUM A, 1988, ALCOHOL CLIN EXP RES, V12, P81, DOI 10.1111/j.1530-0277.1988.tb00137.x; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1111/j.1530-0277.2000.tb02086.x; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Roberts CM, 2016, J HEAD TRAUMA REHAB, V31, pE71, DOI 10.1097/HTR.0000000000000154; Russell M, 1997, AM J EPIDEMIOL, V146, P975; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Tate PS, 1999, BRAIN INJURY, V13, P767; Taylor AN, 2015, BRAIN NEUROTRAUMA MO; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Taylor TR, 2009, BRIT J NEUROSURG, V23, P622, DOI 10.3109/02688690903215666; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Turner AP, 2006, REHABIL PSYCHOL, V51, P78, DOI 10.1037/0090-5550.51.1.78; Tweedly L, 2012, J HEAD TRAUMA REHAB, V27, P331, DOI 10.1097/HTR.0b013e318262200a; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; World Health Organization, 2014, WHO GLOB STAT REP AL; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zgaljardic DJ, 2010, APPL NEUROPSYCHOL, V17, P283, DOI 10.1080/09084282.2010.525118; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	77	5	5	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2016	22	8					816	827		10.1017/S1355617716000692			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	DX4BU	WOS:000384324800003	27534259				2022-02-06	
J	Wee, JZ; Yang, YRJ; Lee, QYR; Cao, K; Chong, CT				Wee, Jing Zhong; Yang, Yun Rui Jasmine; Lee, Qian Yi Ruth; Cao, Kelly; Chong, Chin Ted			Demographic profile and extent of healthcare resource utilisation of patients with severe traumatic brain injury: still a major public health problem	SINGAPORE MEDICAL JOURNAL			English	Article						demographics; healthcare utilisation; traumatic brain injury	EPIDEMIOLOGY; IMPACT; REHABILITATION; PERSPECTIVE	INTRODUCTION Trauma is the fifth principal cause of death in Singapore, with traumatic brain injury (TBI) being the leading specific subordinate cause. METHODS This study was an eight-year retrospective review of the demographic profiles of patients with severe TBI who were admitted to the neurointensive care unit (NICU) of the National Neuroscience Institute at Tan Tock Seng Hospital, Singapore, between 2004 and 2011. RESULTS A total of 780 TBI patients were admitted during the study period; 365 (46.8%) patients sustained severe TBI (i.e. Glasgow Coma Scale score <= 8), with the majority (75.3%) being male. The ages of patients with severe TBI ranged from 14-93 years, with a bimodal preponderance in young adults (i.e. 21-40 years) and elderly persons (i.e. > 60 years). Motor vehicle accidents (48.8%) and falls (42.5%) were the main mechanisms of injury. Invasive line monitoring was frequently employed; invasive arterial blood pressure monitoring and central venous pressure monitoring were used in 81.6% and 60.0% of the patients, respectively, while intracranial pressure (ICP) measurement was required in 47.4% of the patients. The use of tiered therapy to control ICP (e.g. sedation, osmotherapy, cerebrospinal fluid drainage, moderate hyperventilation and barbiturate-induced coma) converged with international practices. CONCLUSION The high-risk groups for severe TBI were young adults and elderly persons involved in motor vehicle accidents and falls, respectively. In the NICU, the care of patients with severe TBI requires heavy utilisation of resources. The healthcare burden of these patients extends beyond the acute critical care phase.	[Wee, Jing Zhong; Yang, Yun Rui Jasmine; Lee, Qian Yi Ruth; Cao, Kelly; Chong, Chin Ted] Tan Tock Seng Hosp, Dept Anaesthesiol Intens Care & Pain Med, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore		Wee, JZ (corresponding author), Tan Tock Seng Hosp, Dept Anaesthesiol Intens Care & Pain Med, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	wee_jingzhong@hotmail.com					Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cutler H, SPINNING OUT CONTROL; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee K. K., 2006, SMJ Singapore Medical Journal, V47, P31; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Ministry of Manpower, 2012, FOR WORKF NUMMB; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vollmer DG, 1991, NEUROSURGERY, V75, P37; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wong ZH, 2009, ANN ACAD MED SINGAP, V38, P594	22	5	5	0	7	SINGAPORE MEDICAL ASSOC	SINGAPORE	2985 JALAN BUKIT MERAH, #02-2C, SMF BUILDING, SINGAPORE, SINGAPORE	0037-5675			SINGAP MED J	Singap. Med. J.	SEP	2016	57	9					491	496		10.11622/smedj.2015162			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY3GJ	WOS:000384978500004	26768061	Green Published, Bronze			2022-02-06	
J	Xu, K; Yang, ZC; Shi, RC; Luo, CX; Zhang, ZR				Xu, Kai; Yang, Zicheng; Shi, Rongchen; Luo, Chunxia; Zhang, Zhiren			Expression of aryl hydrocarbon receptor in rat brain lesions following traumatic brain injury	DIAGNOSTIC PATHOLOGY			English	Article						Traumatic brain injury; T lymphocytes; Aryl hydrocarbon receptor	CENTRAL-NERVOUS-SYSTEM; T-CELLS; NUCLEAR TRANSLOCATOR; DIFFERENTIATION; APOPTOSIS; IMMUNITY; PROTEIN; STROKE; STEM	Background: Aryl Hydrocarbon Receptor (AhR) is a ligand-activated transcription factor with multiple functions operating in a variety of organs, including the brain. Recent studies have revealed that AhR played a functional role in traumatic injuries. This paper aims to study the expression of AhR during the early phase following a traumatic brain injury (TBI) in rat brains by immunohistochemistry. Methods: Weight-drop induced TBI was performed in rats. The expression of AhR in brain of TBI rats were examined by immunohistochemistry. Results: Neuron expression of AhR in the rat brains of experiment group had been upregulated since day 3 in lesional hemisphere compared to that of the control group and mainly located in the cytoplasm, indicating an inactivated state. Interestingly, the accumulation of AhR(+) non-neuron cells became significant as early as 18 h after injury, which had kept increasing until 24 h post injury and then decreased slowly. For AhR(+) non-neuron cells, the AhR mainly located in cell nucleus, indicating a reactive status. Furthermore, double staining showed that most AhR(+) non-neuron cells co-localized with W3/13, a marker for T lymphocytes, but not with ED-1 (for activated microglia/macrophages) or GFAP (for activated astrocytes), suggesting that most AhR(+) non-neuron cells were T lymphocytes. Conclusion: This is the first study concerning AhR expression in brains following TBI, and our data demonstrated that AhR was upregulated and activated in T lymphocytes following TBI. More research is needed to make a more conclusive conclusion.	[Xu, Kai; Yang, Zicheng; Shi, Rongchen; Zhang, Zhiren] Third Mil Med Univ PLA, Inst Immunol, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China; [Luo, Chunxia] Third Mil Med Univ, Southwest Hosp, Dept Neurol, Chongqing 400038, Peoples R China		Zhang, ZR (corresponding author), Third Mil Med Univ PLA, Inst Immunol, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China.	zhangzhiren@yahoo.com			National Science and Technology Major Projects of New Drugs [2012ZX09103301035]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471190]	This research was supported by the National Science and Technology Major Projects of New Drugs (2012ZX09103301035) and the National Natural Science Foundation of China (No. 81471190). Both fundings supported the collection, analysis, and interpretation of data and the writing of the manuscript.	Akahoshi Eiichi, 2006, Environ Health, V5, P24, DOI 10.1186/1476-069X-5-24; Arumugam TV, 2005, NEUROMOL MED, V7, P229, DOI 10.1385/NMM:7:3:229; Baban B, 2012, AM J PHYSIOL-REG I, V303, pR1136, DOI 10.1152/ajpregu.00315.2012; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bock KW, 2009, BIOL CHEM, V390, P1225, DOI 10.1515/BC.2009.138; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fraccalvieri D, 2013, BIOCHEMISTRY-US, V52, P714, DOI 10.1021/bi301457f; Funatake CJ, 2008, J IMMUNOTOXICOL, V5, P81, DOI 10.1080/15476910802019037; Gramatzki D, 2009, ONCOGENE, V28, P2593, DOI 10.1038/onc.2009.104; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Jones TB, 2004, J NEUROSCI, V24, P3752, DOI 10.1523/JNEUROSCI.0406-04.2004; Kajta M, 2009, NEUROSCIENCE, V158, P811, DOI 10.1016/j.neuroscience.2008.10.045; Kipnis J, 2003, J NEUROTRAUM, V20, P559, DOI 10.1089/089771503767168483; Lavin AL, 1998, ARCH BIOCHEM BIOPHYS, V352, P9, DOI 10.1006/abbi.1998.0587; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Negishi T, 2005, J IMMUNOL, V175, P7348, DOI 10.4049/jimmunol.175.11.7348; Petersen SL, 2000, J COMP NEUROL, V427, P428, DOI 10.1002/1096-9861(20001120)427:3<428::AID-CNE9>3.0.CO;2-P; Price CJS, 2003, J NEUROL NEUROSUR PS, V74, P1476, DOI 10.1136/jnnp.74.11.1476; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Shivanna B, 2011, FREE RADICAL BIO MED, V51, P1910, DOI 10.1016/j.freeradbiomed.2011.08.013; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; Veldhoen M, 2010, CURR OPIN IMMUNOL, V22, P747, DOI 10.1016/j.coi.2010.09.001; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Walsh JT, 2014, IMMUNOLOGY, V141, P340, DOI 10.1111/imm.12187; Zhang ZR, 2006, EXP NEUROL, V197, P252, DOI 10.1016/j.expneurol.2005.09.015	30	5	5	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1746-1596			DIAGN PATHOL	Diagn. Pathol.	AUG 9	2016	11								72	10.1186/s13000-016-0522-2			6	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	DS7WJ	WOS:000380993300001	27506546	Green Published, gold			2022-02-06	
J	Armistead-Jehle, P; Hansen, CL				Armistead-Jehle, Patrick; Hansen, Christopher L.			Factor Analysis of the MSVT, NV-MSVT, and RBANS Memory Subtests	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Performance validity testing; MSVT; NV-MSVT; RBANS; Factor analysis	WORD MEMORY; BRAIN-INJURY; VALIDITY	Objective: The current investigation sought to define the relationship between established performance validity tests and measures of memory via a factor analytic strategy first published by Heyanka, Thaler, Linck, Pastorek, Miller, Romesser, & Sim (2015). A Factor analytic approach to the validation of theWord Memory Test and Test of Memory Malingering as measures of effort and not memory. Archives of Clinical Neuropsychology, 30, 369-376. Method: The full range of Medical Symptom Validity Test (MSVT) and Non-Verbal Medical Symptom Validity Test (NV-MSVT) subtests were factor analyzed with the memory scales of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in a sample of 346 service members with a history of concussion. Results: A two-factor solution was extracted with the MSVT and NV-MSVT effort and paired associate subtests loading on one factor and the RBANS subtests loading on a second factor. Conclusions: Results support the conclusion that the effort subtests of the MSVT and NV-MSVT tap a different construct from established memory measures.	[Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, 550 Pope Ave, Ft Leavenworth, KS 66027 USA; [Hansen, Christopher L.] Washington DC Vet Affairs Med Ctr, War Related Illness & Injury Study Ctr, Washington, DC USA		Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, Concuss Clin, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	patrick.j.armistead-jehle.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P415, DOI 10.1080/23279095.2014.953678; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone Dominic A, 2009, Appl Neuropsychol, V16, P309, DOI 10.1080/09084280903297883; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donders J, 2013, J CLIN EXP NEUROPSYC, V35, P827, DOI 10.1080/13803395.2013.824557; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; GREEN P, 2003, MANUAL WORLD MEMORY; Green P, 2004, GREENS MED SYMPTOM V; Green P.J.E., 2008, MANUAL NONVERBAL MED; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heyanka DJ, 2015, ARCH CLIN NEUROPSYCH, V30, P369, DOI 10.1093/arclin/acv025; Kline R.B., 2013, APPL QUANTITATIVE AN, P171; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Randolph C., 1998, REPEATABLE BATTERY A; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wager John G, 2010, Appl Neuropsychol, V17, P305, DOI 10.1080/09084282.2010.525093; Williamson DJ, 2004, EPILEPSIA, V45, P179; Willis PF, 2011, MIL MED, V176, P1426, DOI 10.7205/MILMED-D-11-00168; [No title captured]	25	5	5	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2016	31	5					465	471		10.1093/arclin/acw033			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	DU0LF	WOS:000381895200009	27267088	hybrid			2022-02-06	
J	Caccese, JB; Buckley, TA; Kaminski, TW				Caccese, Jaclyn B.; Buckley, Thomas A.; Kaminski, Thomas W.			Sway Area and Velocity Correlated with MobileMat Balance Error Scoring System (BESS) Scores	JOURNAL OF APPLIED BIOMECHANICS			English	Article						approximate entropy; sample entropy; concussion; balance; postural stability	MANAGEMENT PRACTICE PATTERNS; COLLEGIATE FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; POSTURAL-CONTROL; APPROXIMATE ENTROPY; CEREBRAL CONCUSSION; ATHLETIC TRAINERS; SAMPLE ENTROPY; HEALTHY-YOUNG	The Balance Error Scoring System (BESS) is often used for sport-related concussion balance assessment. However, moderate intratester and intertester reliability may cause low initial sensitivity, suggesting that a more objective balance assessment method is needed. The MobileMat BESS was designed for objective BESS scoring, but the outcome measures must be validated with reliable balance measures. Thus, the purpose of this investigation was to compare MobileMat BESS scores to linear and nonlinear measures of balance. Eighty-eight healthy collegiate student-athletes (age: 20.0 +/- 1.4 y, height: 177.7 +/- 10.7 cm, mass: 74.8 +/- 13.7 kg) completed the MobileMat BESS. MobileMat BESS scores were compared with 95% area, sway velocity, approximate entropy, and sample entropy. MobileMat BESS scores were significantly correlated with 95% area for single-leg (r=.332) and tandem firm (r=.474), and double-leg foam (r=.660); and with sway velocity for single-leg (r=.406) and tandem firm (r=.601), and double-leg (r=.575) and single-leg foam (r=.434). MobileMat BESS scores were not correlated with approximate or sample entropy. MobileMat BESS scores were low to moderately correlated with linear measures, suggesting the ability to identify changes in the center of mass-center of pressure relationship, but not higher-order processing associated with nonlinear measures. These results suggest that the MobileMat BESS may be a clinically-useful tool that provides objective linear balance measures.	[Caccese, Jaclyn B.; Buckley, Thomas A.; Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA; [Caccese, Jaclyn B.; Buckley, Thomas A.; Kaminski, Thomas W.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE 19716 USA		Caccese, JB (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA.; Caccese, JB (corresponding author), Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE 19716 USA.	jcaccese@udel.edu	Caccese, Jaclyn B./AAH-4571-2020; Caccese, Jaclyn/O-2315-2016; Buckley, Thomas A/B-7525-2016	Caccese, Jaclyn B./0000-0003-2329-3603; Buckley, Thomas A/0000-0002-0515-0150			Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2014, GAIT BIOMETRICS BASI, P141; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Erkmen N, 2009, ISOKINET EXERC SCI, V17, P121, DOI 10.3233/IES-2009-0343; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; [高静 Gao Jing], 2011, [化工新型材料, New Chemical Materials], V39, P6; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manor B, 1985, J APPL PHYS, V109, P1786, DOI DOI 10.1152/JAPPLPHYSI01.00390.2010; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meshkati Z, 2011, J SPORT REHABIL, V20, P442, DOI 10.1123/jsr.20.4.442; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	37	5	5	1	13	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	AUG	2016	32	4					329	334		10.1123/jab.2015-0273			6	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	DT4SR	WOS:000381471700001	26957482				2022-02-06	
J	Caswell, SV; Ausborn, A; Diao, GQ; Johnson, DC; Johnson, TS; Atkins, R; Ambegaonkar, JP; Cortes, N				Caswell, Shane V.; Ausborn, Ashley; Diao, Guoqing; Johnson, David C.; Johnson, Timothy S.; Atkins, Rickie; Ambegaonkar, Jatin P.; Cortes, Nelson			Anthropometrics, Physical Performance, and Injury Characteristics of Youth American Football	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						youth football; physical performance; injury	TIME-LOSS INJURIES; RISK-FACTORS; HIGH-SCHOOL; PLAYERS; SPORTS; SOCCER; CONCUSSION; POSITION; FITNESS; VISITS	Background: Prior research has described the anthropometric and physical performance characteristics of professional, collegiate, and high school American football players. Yet, little research has described these factors in American youth football and their potential relationship with injury. Purpose: To characterize anthropometric and physical performance measures, describe the epidemiology of injury, and examine the association of physical performance measures with injury among children participating within age-based divisions of a large metropolitan American youth football league. Study Design: Case-control study; Level of evidence, 3. Methods: Demographic, anthropometric, and physical performance characteristics and injuries of 819 male children were collected over a 2-year period (2011-2012). Injury data were collected by the league athletic trainer (AT) and coaches. Descriptive analysis of demographic, anthropometric, and physical performance measures (40-yard sprint, pro-agility, push-ups, and vertical jump) were conducted. Incidence rates were computed for all reported injuries; rates were calculated as the number of injuries per 1000 athlete-exposures (AEs). Multinomial logistic regression was used to identify whether the categories of no injury, no-time-loss (NTL) injury, and time-loss (TL) injury were associated with physical performance measures. Results: Of the 819 original participants, 760 (92.8%) completed preseason anthropometric measures (mean SD: age, 11.8 +/- 1.2 years; height, 157.4 +/- 10.7 cm; weight, 48.7 +/- 13.3 kg; experience, 2.0 +/- 1.8 years); 640 (78.1%) players completed physical performance measures. The mean (+/- SD) 40-yard sprint and pro-agility measures of the players were 6.5 +/- 0.6 and 5.7 +/- 0.5 seconds, respectively; the number of push-ups and maximal vertical jump height were 16.5 +/- 9.3 repetitions and 42.3 +/- 8.4 cm, respectively. Players assigned to different teams within age divisions demonstrated no differences in anthropometric measures; 40-yard dash and pro-agility times differed significantly (P < .05) between players assigned to different teams. A total of 261 NTL and TL injuries were reported during 35,957 AEs (games: 22%, n = 7982 AEs; practices: 78%, n = 27,975 AEs). The overall incidence rate was 7.26 per 1000 AEs (95% CI, 6.37-8.14). Physical performance measures did not predict NTL or TL injuries (P > .05). Conclusion: No practically meaningful differences existed in anthropometric or physical performance measures between teams within age-based levels of play. Findings suggest that age-only criterion for player groupings can evenly match in terms of physical performance.	[Caswell, Shane V.; Ausborn, Ashley; Diao, Guoqing; Johnson, David C.; Johnson, Timothy S.; Atkins, Rickie; Ambegaonkar, Jatin P.; Cortes, Nelson] George Mason Univ, Manassas, VA USA; [Caswell, Shane V.; Ausborn, Ashley; Atkins, Rickie; Ambegaonkar, Jatin P.; Cortes, Nelson] George Mason Univ, SMART, Manassas, VA USA; [Diao, Guoqing] George Mason Univ, Dept Stat, Fairfax, VA 22030 USA; [Johnson, David C.; Johnson, Timothy S.] Natl Sports Med Inst, Lansdowne, VA USA		Caswell, SV (corresponding author), George Mason Univ, SMART Lab, 10900 Univ Blvd,Bull Run Hall,MSN 4E5,Suite 213, Manassas, VA 20110 USA.	scaswell@gmu.edu		Cortes, Nelson/0000-0001-8762-3144; Ambegaonkar, Jatin/0000-0002-3790-915X; Johnson, Timothy/0000-0003-3731-9632	Central Loudoun Youth Football League; Potomac Health Foundation	This study was funded in part by a nonrestrictive grant from the Central Loudoun Youth Football League and the Potomac Health Foundation.	Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Agresti A., 2010, ANAL ORDINAL CATEGOR, V2nd; Beachy G, 1997, AM J SPORT MED, V25, P675, DOI 10.1177/036354659702500515; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Burt CW, 2001, ANN EMERG MED, V37, P301, DOI 10.1067/mem.2001.111707; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; DIAMOND FB, 1994, CLIN PEDIATR, V33, P172, DOI 10.1177/000992289403300311; Dompier TP, 2007, J ATHL TRAINING, V42, P395; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Dupler TL, 2010, J STRENGTH COND RES, V24, P1975, DOI 10.1519/JSC.0b013e3181e4f9ec; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Fragoso I, 2015, INT J SPORTS MED, V36, P16, DOI 10.1055/s-0034-1384548; Gains GL, 2010, J STRENGTH COND RES, V24, P2613, DOI 10.1519/JSC.0b013e3181eccdf8; Ghigiarelli JJ, 2011, J STRENGTH COND RES, V25, P1193, DOI 10.1519/JSC.0b013e318215f546; GOLDBERG B, 1988, PEDIATRICS, V81, P255; Jackowski SA, 2011, BONE, V48, P1178, DOI 10.1016/j.bone.2011.02.010; Jacobson BH, 2013, J STRENGTH COND RES, V27, P2347, DOI 10.1519/JSC.0b013e31827fcc7d; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Krause LM, 2015, J SCI MED SPORT, V18, P358, DOI 10.1016/j.jsams.2014.05.012; Malina RM, 2005, MED SCI SPORT EXER, V37, P1044, DOI 10.1249/01.mss.0000171622.45134.cb; Malina RM, 2005, CLIN J SPORT MED, V15, P125, DOI 10.1097/01.jsm.0000164287.42066.63; Malina RM., 2004, GROWTH MATURATION PH, V2nd ed; Malina RM, 2007, J PEDIATR-US, V151, P378, DOI 10.1016/j.jpeds.2007.03.044; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; Mayhew JL, 2010, J STRENGTH COND RES, V24, P447, DOI 10.1519/JSC.0b013e3181c08860; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Nuzzo JL, 2011, J STRENGTH COND RES, V25, P2580, DOI 10.1519/JSC.0b013e3181fee650; Powell JW, 2004, J ATHL TRAINING, V39, P56; R Core Team, 2012, R LANG ENV STAT COMP; Robbins DW, 2012, J STRENGTH COND RES, V26, P226, DOI 10.1519/JSC.0b013e31821d5e1b; Robert Morris University, RMU POOL SHOWS GROW; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; Till K, 2013, J SCI MED SPORT, V16, P438, DOI 10.1016/j.jsams.2012.09.002; Torres-Unda J, 2013, J SPORT SCI, V31, P196, DOI 10.1080/02640414.2012.725133; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Wallerson R, 2014, DOW JONES I NEW 0131; Wong PL, 2009, J STRENGTH COND RES, V23, P1204, DOI 10.1519/JSC.0b013e31819f1e52; Yard EE, 2010, J PHYS ACT HEALTH, V8, P182	38	5	5	2	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	AUG	2016	4	8							2325967116662251	10.1177/2325967116662251			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DV6II	WOS:000383037100003	27583256	gold, Green Published			2022-02-06	
J	Hicks, CW; Canner, JK; Zarkowsky, DS; Arhuidese, I; Obeid, T; Malas, MB				Hicks, Caitlin W.; Canner, Joseph K.; Zarkowsky, Devin S.; Arhuidese, Isibor; Obeid, Tammam; Malas, Mahmoud B.			Racial disparities after vascular trauma are age-dependent	JOURNAL OF VASCULAR SURGERY			English	Article							INJURY SEVERITY SCORE; LOWER-EXTREMITY ISCHEMIA; ICD-9 DIAGNOSIS CODES; NATIONAL TRAUMA; DATA-BANK; PEDIATRIC TRAUMA; INSURANCE STATUS; FUNCTIONAL OUTCOMES; BRAIN-INJURY; RISK-FACTORS	Objective: Different racial disparities exist between white and black all-cause trauma patients depending on their age group; however, the effects of race and age on outcomes after vascular trauma are unknown. We assessed whether the previously described age-dependent racial disparities after all-cause trauma persist in the vascular trauma population. Methods: Vascular trauma patients were identified from the Nationwide Inpatient Sample (January 2005 to December 2012) using International Classification of Diseases-Ninth Edition codes. Univariable and multivariable analyses were used to compare in-hospital mortality and amputation for blacks vs whites for younger (16-64 years) and older ( years) age groups. Results: Black patients (n = 937) were younger, more frequently male, without insurance, and suffered from more penetrating and nonaccidental injuries than white patients (n = 1486; P < .001). On univariable analysis, blacks had a significantly higher risk of death (odds ratio, [OR], 1.78; 95% confidence interval [CI], 1.16-2.74) and a significantly lower risk of amputation (OR, 0.54; 95% CI, 0.38-0.77), but these differences were not sustained after adjusting for baseline differences between groups. When stratified by age, there were significant racial disparities in mortality and amputation on univariable analysis. After risk adjustment, these differences persisted in the older group (mortality: OR, 5.95; 95% CI, 1.42-25.0; amputation: OR, 4.21; 95% CI, 1.28-13.6; P < .001) but not the younger group (mortality: OR, 1.31; 95% CI, 0.71-2.42; amputation: OR, 0.92; 95% CI, 0.58-1.46; P = not significant). Differences in survival and amputation after vascular trauma appear to be related to a higher prevalence of nonaccidental penetrating injuries in the younger black population. Race was the single greatest predictor of poor outcomes in the older population (P <= .008). Conclusions: Older black patients are nearly five-times more likely to experience death or amputation after vascular trauma than their white counterparts. Contrary to reports suggesting that younger white patients have better outcomes after all-cause trauma than younger black patients, racial disparities among patients with traumatic vascular injuries appear to be confined to the older age group after risk adjustment.	[Hicks, Caitlin W.; Canner, Joseph K.; Zarkowsky, Devin S.; Arhuidese, Isibor; Obeid, Tammam; Malas, Mahmoud B.] Johns Hopkins Med Inst, Div Vasc & Endovasc Therapy, Baltimore, MD 21205 USA; [Zarkowsky, Devin S.] Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03766 USA		Malas, MB (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Vasc & Endovasc Surg, 4940 Eastern Ave,Bldg A-5,Ste 547, Baltimore, MD 21224 USA.	bmalas1@jhmi.edu		Hicks, Caitlin/0000-0001-7638-1936			Agency for Healthcare Research and Quality Healthcare cost and Utilization Project (HCUP), NAT NAT INP SAMPL; Arthur M, 2008, MED CARE, V46, P192, DOI 10.1097/MLR.0b013e31815b9d8e; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes LL, 2008, AM J PUBLIC HEALTH, V98, P1241, DOI 10.2105/AJPH.2007.114397; Bolorunduro OB, 2013, AM J SURG, V205, P365, DOI 10.1016/j.amjsurg.2012.10.026; Centers for Disease Control and Prevention (CDC), TABL 2 EXT CAUS INJ; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark DE., ICDPIC STATA MODULE; Crandall M, 2011, SURGERY, V150, P656, DOI 10.1016/j.surg.2011.07.052; Davidovic LB, 2005, VASCULAR, V13, P141; Dua A, 2014, ANN VASC SURG, V28, P108, DOI 10.1016/j.avsg.2013.06.017; Eslami MH, 2007, J VASC SURG, V45, P55, DOI 10.1016/j.jvs.2006.09.044; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Glance LG, 2013, HEALTH SERV RES, V48, P1684, DOI 10.1111/1475-6773.12064; Glance LG, 2012, J AM COLL SURGEONS, V215, P372, DOI 10.1016/j.jamcollsurg.2012.03.018; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Haider A H, 2013, J AM COLL SURGEONS, V216, P482; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Haider AH, 2013, ANN SURG, V258, P572, DOI 10.1097/SLA.0b013e3182a50148; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Henry AJ, 2011, J VASC SURG, V53; Hicks CW, 2015, ANN SURG, V262, P179, DOI 10.1097/SLA.0000000000000809; Hicks CW, 2014, JAMA SURG, V149, P642, DOI 10.1001/jamasurg.2014.166; Hughes K, 2014, VASC ENDOVASC SURG, V48, P34, DOI 10.1177/1538574413510618; Kauvar DS, 2011, J VASC SURG, V53, P1598, DOI 10.1016/j.jvs.2011.01.056; Konstantinidis A, 2011, J TRAUMA, V71, P909, DOI 10.1097/TA.0b013e318204104e; Lefebvre KM, 2015, VASC MED, V20, P51, DOI 10.1177/1358863X14565373; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Loh SA, 2011, J VASC SURG, V53, P359, DOI 10.1016/j.jvs.2010.08.074; Maybury RS, 2010, SURGERY, V148, P202, DOI 10.1016/j.surg.2010.05.010; Niven DJ, 2012, AM J SURG, V204, P151, DOI 10.1016/j.amjsurg.2012.02.014; Ogola GO, 2015, J TRAUMA ACUTE CARE, V79, P444, DOI 10.1097/TA.0000000000000787; Perkins ZB, 2012, EUR J VASC ENDOVASC, V44, P203, DOI 10.1016/j.ejvs.2012.05.013; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Rutledge R, 1997, J TRAUMA, V42, P477, DOI 10.1097/00005373-199703000-00016; Schoell SL, 2015, INJURY, V46, P558, DOI 10.1016/j.injury.2014.11.036; Schoenfeld AJ, 2013, SPINE J, V13, P1766, DOI 10.1016/j.spinee.2013.03.024; Scott VK, 2013, J SURG RES, V184, P480, DOI 10.1016/j.jss.2013.04.080; Selvarajah S, 2014, J SURG RES, V190, P335, DOI 10.1016/j.jss.2014.04.029; Shavers VL, 2012, AM J PUBLIC HEALTH, V102, P953, DOI 10.2105/AJPH.2012.300773; Stagg V, CHARLSON STATA MODUL; Stallion A, 2007, J TRAUMA, V62, P1262; Taha AG, 2015, J VASC SURG, V61, P147, DOI 10.1016/j.jvs.2014.06.109; Topal AE, 2010, VASC HEALTH RISK MAN, V6, P1103, DOI 10.2147/VHRM.S15316	46	5	5	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	AUG	2016	64	2					418	424		10.1016/j.jvs.2016.01.049			7	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery; Cardiovascular System & Cardiology	DS4LT	WOS:000380753300022	26993377	Bronze			2022-02-06	
J	Kania, K; Shaikh, KA; White, IK; Ackerman, LL				Kania, Katarzyna; Shaikh, Kashif Ajaz; White, Ian Kainoa; Ackerman, Laurie L.			Follow-up issues in children with mild traumatic brain injuries	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; concussion; head injury; patient outcome assessment; acute concussion evaluation; trauma	ACUTE CONCUSSION EVALUATION; SPORTS; STATEMENT	OBJECTIVE Concerns about mild traumatic brain injury (mTBI) have increased in recent years, and neurosurgical consultation is often requested for patients with radiographic abnormalities or clinical findings suspicious for mTBI. However, to the authors' knowledge, no study has used the Acute Concussion Evaluation (ACE) tool to systematically evaluate the evolution of symptoms in patients with mTBI during neurosurgical follow-up. The goal in this study was to evaluate symptom progression in pediatric patients referred for neurosurgical consultation by using the ACE, as endorsed by the Centers for Disease Control and Prevention. METHODS The authors performed a retrospective review of records of consecutive pediatric patients who had presented to the emergency department, were diagnosed with possible mTBI, and were referred for neurosurgical consultation. Outpatient follow-up for these patients included serial assessment using the ACE. Data collected included the mechanisms of the patients' injuries, symptoms, follow-up duration, and premorbid conditions that might potentially contribute to protracted recovery. RESULTS Of 91 patients identified with mTBI, 58 met the inclusion criteria, and 33 of these had sufficient follow-up data to be included in the study. Mechanisms of injury included sports injury (15 patients), isolated falls (10), and motor vehicle collisions (8). Ages ranged from 5 to 17 years (mean age 11.6 years), and 29 of the 33 patients were male. Six patients had preinjury developmental and/or psychiatric diagnoses such as attention deficit hyperactivity disorder. Seventeen had negative findings on head CT scans. The first follow-up evaluation occurred at a mean of 30 days after injury. The mean number of symptoms reported on the ACE inventory at first follow-up were 3.2; 12 patients were symptom free. Patients with positive head CT findings required longer follow-up: these patients needed 14.59 weeks, versus 7.87 weeks of follow-up in patients with negative findings on head CT scans (p < 0.05). CONCLUSIONS The data suggest that patients with mTBI, particularly those with developmental and/or psychiatric comorbidities and concurrent cerebral or extracranial injury, often report symptoms for several weeks after their initial injury. Serial ACE assessment permits systematic identification of patients who are experiencing continued symptoms, leading to appropriate patient management and referral.	[Kania, Katarzyna; Shaikh, Kashif Ajaz; White, Ian Kainoa; Ackerman, Laurie L.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Shaikh, Kashif Ajaz; White, Ian Kainoa; Ackerman, Laurie L.] Indiana Univ, Dept Neurol Surg, Goodman Campbell Brain & Spine, Indianapolis, IN 46204 USA		Ackerman, LL (corresponding author), Indiana Univ, James Whitcomb Riley Hosp Children, Goodman Campbell Brain & Spine, 705 Riley Hosp Dr,Rm 1134, Indianapolis, IN 46202 USA.	lackerma@iupui.edu					[Anonymous], TRAUM BRAIN INJ US F; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Centers for Disease Control and Prevention, HEADS FACTS PHYS MIL; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; GOODMAN JC, 1994, SEMIN NEUROL, V14, P19, DOI 10.1055/s-2008-1041054; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McCrory P, 2011, CLIN SPORT MED, V30, P201, DOI 10.1016/j.csm.2010.08.002; Neal Matthew T, 2012, Surg Neurol Int, V3, P16, DOI 10.4103/2152-7806.92930; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	15	5	5	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2016	18	2					224	230		10.3171/2016.1.PEDS15511			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DS4LX	WOS:000380753700015	27058458	hybrid			2022-02-06	
J	Kwon, CS; Hasegawa, H; Sokratous, G; U-King-Im, JM; Samuel, M; Ashkan, K				Kwon, Churl-Su; Hasegawa, Harutomo; Sokratous, Giannis; U-King-Im, Jean-Marie; Samuel, Michael; Ashkan, Keyoumars			Globus Pallidus Internus Deep Brain Stimulation for Traumatic Hemidystonia Following Penetrating Head Injury	WORLD NEUROSURGERY			English	Article						Deep brain stimulation; Globus pallidus internus; Penetrating head injury; Secondary hemidystonia	BASAL GANGLIA; DYSTONIA	BACKGROUND: Deep brain stimulation (DBS) has been a major advance in the treatment of dystonias. Outcomes are, however, less predictable for secondary dystonias, predominantly due to progression of disease or specific brain lesions. There are few cases reported of globus pallidus internus (GPi)-DBS for posttraumatic dystonia. We describe the successful use of unilateral GPi-DBS in a patient with hemidystonia following penetrating head injury. To our knowledge, this is the first description of the use of DBS following penetrating head injury. CASE DESCRIPTION: We present the case of a 47-year-old man with phasic hemidystonia. At the age of 3 years he suffered a penetrating head injury from a welding needle. The patient developed dystonic and phasic right-sided movements. Preoperative Burke-Fahn-Marsden score was 26. Magnetic resonance imaging showed a linear encephalomalacic track extending from the cortex in the left parieto-occipital region, traversing just superolateral to the left trigone into the left thalamus and ending in the region of left cerebral peduncle and subthalamic nucleus. There was no left GPi lesion. A left GPi-DBS electrode was inserted. At 6 months' follow-up, the patient's arm was more relaxed and his spasms lessened in their severity and frequency. Although the Burke-Fahn-Marsden score of 21 had improved modestly by 20%, pain and comfort levels had significantly improved with 50% improvement in visual analog scale score, translating in better quality of life. There were no complications. The clinical benefit persists at 5 years post surgery. CONCLUSION: Selected patients with posttraumatic hemidystonia, including following penetrating head injury, represent one group of secondary dystonias that might benefit from DBS surgery.	[Kwon, Churl-Su; Hasegawa, Harutomo; Sokratous, Giannis; Ashkan, Keyoumars] Kings Coll Hosp London, Dept Neurosurg, London, England; [U-King-Im, Jean-Marie] Kings Coll Hosp London, Dept Neuroradiol, London, England; [Samuel, Michael] Kings Coll Hosp London, Dept Neurol, London, England		Kwon, CS (corresponding author), Kings Coll Hosp London, Dept Neurosurg, London, England.	churlsu.kwon@gmail.com		Sokratous, Giannis/0000-0003-0901-1366; Hasegawa, Harutomo/0000-0002-3711-6790	MedtronicMedtronic; St. Jude Children's Research Hospital	Keyoumars Ashkan and Michael Samuel have received educational grants from Medtronic and St. Jude Children's Research Hospital. No other authors have any conflicts of interest.	BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Chang JW, 2002, J NEUROL NEUROSUR PS, V73, P588, DOI 10.1136/jnnp.73.5.588; Chuang C, 2002, J NEUROL NEUROSUR PS, V72, P59, DOI 10.1136/jnnp.72.1.59; Goto S, 2008, NEUROLOGY, V70, P1500, DOI 10.1212/01.wnl.0000310430.00743.11; Holloway KL, 2006, NEUROMODULATION, V9, P253, DOI 10.1111/j.1525-1403.2006.00067.x; Kim JP, 2012, ACTA NEUROCHIR, V154, P823, DOI 10.1007/s00701-012-1306-4; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; Lehericy S, 1996, ARCH NEUROL-CHICAGO, V53, P241, DOI 10.1001/archneur.1996.00550030051022; Loher TJ, 2000, J NEUROSURG, V92, P457, DOI 10.3171/jns.2000.92.3.0457; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; SELLAL F, 1993, MOVEMENT DISORD, V8, P515, DOI 10.1002/mds.870080418; Trottenberg T, 2001, MOVEMENT DISORD, V16, P769, DOI 10.1002/mds.1119; Yianni J, 2003, EUR J NEUROL, V10, P239, DOI 10.1046/j.1468-1331.2003.00592.x; Zhang JG, 2006, CHINESE MED J-PEKING, V119, P2069, DOI 10.1097/00029330-200612020-00008	15	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2016	92								5860	10.1016/j.wneu.2016.05.014			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DX1XI	WOS:000384160300115	27184900				2022-02-06	
J	Maksimowski, MB; Tampi, RR				Maksimowski, Michael B.; Tampi, Rajesh R.			Efficacy of stimulants for psychiatric symptoms in individuals with traumatic brain injury	ANNALS OF CLINICAL PSYCHIATRY			English	Article							DOUBLE-BLIND; METHYLPHENIDATE TREATMENT; PSYCHOPHARMACOLOGICAL TREATMENT; VITAL SIGNS; ATTENTION; PLACEBO; MODERATE; REHABILITATION; DEPRESSION; COMPLAINTS	BACKGROUND: The objective of this systematic review is to summarize data from published randomized controlled trials (RCTs) on the efficacy of stimulants for psychiatric symptoms in individuals with traumatic brain injury (TBI). METHODS: A literature search was conducted of 5 major databases (PubMed, MEDLINE, PsycINFO, Embase, and Cochrane Collaboration) that identified RCTs on the use of stimulants for human patients with a diagnosis of TBI. RESULTS: A total of 176 articles were identified, of which 18 matched the inclusion criteria and were reviewed in their entirety. The majority (17) of studies assessed methylphenidate (MPH), 1 assessed dextroamphetamine and MPH, and 1 assessed modafinil. One study showed significant improvement in depressive symptoms with MPH. Seven studies showed significant improvement in reaction time, whereas 4 studies showed significant improvement in accuracy with MPH compared with placebo. Of the 2 studies that included follow-up, only 1 found significant differences in disability ratings, attention-concentration, and motor memory at 30 days but not 90 days between the stimulant and placebo groups. The majority of studies demonstrated significant treatment effects immediately (ie, within minutes to hours) after first-time stimulant administration. Five of the 18 studies (3 adult, 2 pediatric) did not find benefit for stimulants when compared with placebo. Two studies that evaluated self-reported side effects found no significant difference between treatment groups, although 1 study showed a significant increase in mean arterial pressure in the stimulant group. CONCLUSIONS: There is limited evidence to suggest efficacy of stimulants for psychiatric symptoms in individuals with TBI. However, stimulants appear to improve attention after first-time administration and for short time periods in these individuals.	[Maksimowski, Michael B.; Tampi, Rajesh R.] MetroHealth, Dept Psychiat, Cleveland, OH USA		Tampi, RR (corresponding author), Case Western Reserve Univ, Sch Med, Dept Psychiat, MetroHlth, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	rajesh.tampi@gmail.com					Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BENSON DF, 1982, PSYCHIAT ASPECTS NEU; Brennan AR, 2008, ANN NY ACAD SCI, V1129, P236, DOI 10.1196/annals.1417.007; Capruso D. X., 2000, HEAD INJURY, P525; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Colorado Division of Workers' Compensation, TRAUM BRAIN INJ MED; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Gultekin R, 2016, INJURY, V47, P516, DOI 10.1016/j.injury.2015.10.011; Harbeck-Seu A, 2011, CURR OPIN ANESTHESIO, V24, P144, DOI 10.1097/ACO.0b013e328344587f; Hart T, 2009, NEUROPSYCHOLOGY, V23, P729, DOI 10.1037/a0016153; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kajs-Wyllie Marylyn, 2002, J Neurosci Nurs, V34, P303; Khalili HA, 2008, PROGR NEUROTHERAPEUT, V3, P189; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Long D, 2003, QJM-INT J MED, V96, P673, DOI 10.1093/qjmed/hcg113; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Marr A., 2004, CENTRAL NERVOUS SYST; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI 10.14306/renhyd.20.2.223; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Napolitano E, 2005, MED SCI MONITOR, V11, pRA212; National Resource Center on AD/HD, MAN MED AD ADHD; Nikles CJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-54; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Prigatano GE, PRINCIPLES NEUROPSYC; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schiffer WK, 2006, SYNAPSE, V59, P243, DOI 10.1002/syn.20235; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Willmott C, 2009, J REHABIL MED, V41, P585, DOI 10.2340/16501977-0369; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Zomeren AH, 1994, CLINICALNEUROPSYCHOL	58	5	6	0	13	QUADRANT HEALTHCOM INC	PARSIPPANY	7 CENTURY DRIVE, STE 302, PARSIPPANY, NJ 07054-4603 USA	1040-1237	1547-3325		ANN CLIN PSYCHIATRY	Ann. Clin. Psychiatry	AUG	2016	28	3					156	166					11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	DV1VL	WOS:000382710100002	27490831				2022-02-06	
J	Raup, VT; Eswara, JR; Vetter, JM; Brandes, SB				Raup, Valary T.; Eswara, Jairam R.; Vetter, Joel M.; Brandes, Steven B.			Epidemiology of Traumatic Adrenal Injuries Requiring Surgery	UROLOGY			English	Article							BLUNT ABDOMINAL-TRAUMA	OBJECTIVE To analyze adrenal injuries using the National Trauma Data Bank. Adrenal trauma is rare and current literature is lacking in data from large case series. METHODS A retrospective analysis of the National Trauma Data Bank from the years 2007-2011 was performed. Patient demographics, Injury Severity Score (ISS), mechanism of injury, type of trauma, associated injuries, and development of shock were assessed. Multivariable models were used to determine association with outcomes, such as characterization of injury, need for adrenalectomy, intensive care unit admission, and death. RESULTS Of the 1,766,606 trauma cases recorded, 7791 involved 1 or both adrenal glands (0.44%). Common associated injuries were to the ribs (50.9%), thorax (50.0%), and liver (41.6%). Eighty adrenal injuries required surgery (80/7791, 1.0%), none of which were isolated adrenal injuries (0/120, P = .63). Higher ISS (P = .009), Black race (P = .031), penetrating injury (P < .001), and splenic (P < .001) and intestinal injuries (P = .018) were associated with need for adrenalectomy. No isolated adrenal injuries were associated with death (12% vs 0%, P < .0001). Older age (P < .001), higher ISS (P < .001), chronic kidney disease (P = .009), penetrating injuries (P < .001), and injuries to the aorta/vena cava (P = .008), peripheral vasculature (P < .0001), thorax (P = .029), brain/spinal cord (P < .001), and abdominal polytrauma (P = .005) were associated with mortality. CONCLUSIONS Adrenal injuries are rare, comprising 0.44% of recorded traumatic injuries. Isolated adrenal injuries were not fatal and did not require surgery, and thus should be managed conservatively. Detection of adrenal injury in polytrauma patients is key, particularly penetrating trauma and concurrent splenic and/or intestinal injuries, as these patients are more likely to require adrenalectomy. (C) 2016 Elsevier Inc.	Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Urol, Boston, MA USA; Washington Univ, Sch Med, Barnes Jewish Hosp, Div Urol,Dept Surg, St Louis, MO USA; Columbia Univ Coll Phys & Surg, Dept Urol, New York Presbyterian Hosp, Columbia Univ Med Ctr, New York, NY 10032 USA		Raup, VT (corresponding author), Brigham & Womens Hosp, 45 Francis St, Boston, MA 02115 USA.	vraup@partners.org		Raup, Valary/0000-0001-6014-8785			Abdullah KG, 2012, J EMERG MED, V43, pE215, DOI 10.1016/j.jemermed.2009.11.022; Adaji SE, 2013, INT UROGYNECOL J, V24, P1057, DOI 10.1007/s00192-012-1879-8; FEUERSTEIN B, 1991, ANN INTERN MED, V115, P785, DOI 10.7326/0003-4819-115-10-785; Gabal-Shehab L, 2005, J UROLOGY, V173, P1330, DOI 10.1097/01.ju.0000155459.11926.61; GOMEZ RG, 1993, J TRAUMA, V35, P870, DOI 10.1097/00005373-199312000-00012; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; HUBENS A, 1984, J TRAUMA, V24, P765, DOI 10.1097/00005373-198408000-00015; Lee YS, 2010, WORLD J SURG, V34, P1971, DOI 10.1007/s00268-010-0537-x; Mehrazin R, 2007, UROLOGY, V70, P851, DOI 10.1016/j.urology.2007.07.004; Radomski M, 2016, J INTENSIVE CARE MED, V31, P307, DOI 10.1177/0885066615571895; Safioleas M, 2008, CHIRURGIA-BUCHAREST, V103, P107; Sinelnikov AO, 2007, EMERG RADIOL, V13, P313, DOI 10.1007/s10140-006-0563-z; Stawicki SP, 2009, ENDOKRYNOL POL, V60, P2; Stawicki Stanislaw P, 2003, Curr Surg, V60, P431, DOI 10.1016/S0149-7944(02)00796-1; To'o KJ, 2012, EMERG RADIOL, V19, P499, DOI 10.1007/s10140-012-1063-y; You JS, 2007, AM J EMERG MED, V25, P857, DOI 10.1016/j.ajem.2007.06.002	16	5	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-4295	1527-9995		UROLOGY	Urology	AUG	2016	94						227	231		10.1016/j.urology.2016.03.022			5	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	DW5OU	WOS:000383696400057	27017900				2022-02-06	
J	Reed, N; Taha, T; Monette, G; Keightley, M				Reed, N.; Taha, T.; Monette, G.; Keightley, M.			A Preliminary Exploration of Concussion and Strength Performance in Youth Ice Hockey Players	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; pediatric; return to play	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL OUTCOMES; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SPORT HELD; FOOTBALL; CHILDREN; ZURICH; MEMORY; RETURN	The objective of this study was to describe the effect of concussion on upper and lower body strength in children and youth athletes. The participant group was made up of 178 unique male and female ice hockey players (ages 8-14 years). Using a 3-year prospective longitudinal research design, baseline and post-concussion data on hand grip strength, jump tests, and leg maximal voluntary contraction were collected. Using a linear mixed-effects model, no significant differences were found when comparing the baseline strength performance of individuals who went on to experience a concussion and those who did not. When accounting for sex, multiple concussions, and ongoing changes in strength associated with age, weaker hand grip scores were found following concussion while participants were still symptomatic. Lower squat jump heights were achieved while participants were symptomatic as well as when they were no longer self-reporting symptoms associated with concussion. This study represents an initial step towards better understanding strength performance following concussion that may limit the on and off ice performance of youth ice hockey players, as well as predispose youth to subsequent injuries.	[Reed, N.] Bloorview Res Inst, Holland Bloorview Kids Rehabil Hosp, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Taha, T.] Univ Toronto, Fac Phys Educ & Hlth, Toronto, ON, Canada; [Monette, G.] York Univ, Dept Math & Stat, Toronto, ON, Canada; [Keightley, M.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Reed, N (corresponding author), Bloorview Res Inst, Holland Bloorview Kids Rehabil Hosp, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	nreed@hollandbloorview.ca			Ontario Neurotrauma Foundation (ONF)	This study was financially supported by the Ontario Neurotrauma Foundation (ONF). The authors would like to acknowledge all participants, their families and their sport organizations for taking part in this study. Further, we appreciate all of the efforts put forth by many members of the BrainFit Lab (University of Toronto) and the Concussion Research Centre (Bloorview Research Institute), in particular Katherine Wilson. In addition, we would like to thank Dr. Alex Mihailidis (University of Toronto), Dr. Scott Thomas (University of Toronto), Dr. Karl Zabjek (University of Toronto), Dr. Michael Noseworthy (McMaster University) and Dr. Eric Roy (University of Waterloo) for their guidance and review of this manuscript.	Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Castro-Pinero J, 2010, BRIT J SPORT MED, V44, P934, DOI 10.1136/bjsm.2009.058321; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Forward KE, 2014, PAED CHILD HEALT-CAN, V19, P418, DOI 10.1093/pch/19.8.418; Guy J A, 2001, J Am Acad Orthop Surg, V9, P29; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Hockey Canada, 2014, 2013 ANN REP; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Katz-Leurer M, 2009, GAIT POSTURE, V29, P154, DOI 10.1016/j.gaitpost.2008.06.013; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Killington MJ, 2010, BRAIN INJURY, V24, P970, DOI 10.3109/02699052.2010.489792; Knapik Joseph J, 2015, J Spec Oper Med, V15, P123; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; MASCARO T, 1992, Journal of Orthopaedic and Sports Physical Therapy, V15, P92; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Peyer KL, 2011, J STRENGTH COND RES, V25, P1183, DOI 10.1519/JSC.0b013e318217650a; R Development Core Team, 2010, LANG ENV STAT COMP; Spiering BA, 2008, CONDITIONING STRENGT, P273; Twist P, 2007, COMPLETE CONDITIONIN; USA Hockey, 2014, 2012 2013 ANN REP; Wasserman EB, AM J SPORTS MED, V43, P1127	32	5	5	2	13	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	AUG	2016	37	9					708	713		10.1055/s-0042-104199			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DS4UP	WOS:000380777400006	27191209				2022-02-06	
J	Ren, WQ; Yin, F; Zhang, JN; Lu, WS; Liang, YK; Adlerberth, J; Tian, ZM				Ren, Wen-Qing; Yin, Feng; Zhang, Jian-Ning; Lu, Wang-Sheng; Liang, Ying-Kui; Adlerberth, Josefin; Tian, Zeng-Min			Neural stem cell transplantation for the treatment of primary torsion dystonia: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						primary torsion spasm; torsion dystonia-1; frameless stereotactic surgery; neural stem cells; transplantation	TRAUMATIC BRAIN-INJURY; PARKINSON-DISEASE; GENERALIZED DYSTONIA; THERAPY; STROKE; DIFFERENTIATION; PROLIFERATION; DISORDERS; MIGRATION; PATHWAY	Primary torsion dystonia (PTD) occurs due to a genetic mutation and often advances gradually. Currently, there is no therapy available that is able to inhibit progression. Neural stem cells (NSCs) are being investigated as potential therapies for neurodegenerative diseases, such as stroke and trauma. The present study evaluated the clinical effectiveness of NSC transplantation in an 18-year-old male patient with PTD, to assess the ability of this therapy to inhibit PTD progression. Genetic testing of the patient revealed a mutation in the torsion dystonia-1 (DYT1) gene (907-909 delGAG). NSCs were bilaterally implanted in the globus pallidus of the patient through stereotactic surgery. Prior to surgery, the patient's Burke-Fahn-Marsden dystonia movement score (BFMDMS) was 21, which progressively decreased after surgery to 18, 17, 15 and 13 at 1, 2, 3 and 4 postoperative years, respectively. BFMDMS was improved by 38.1% over the 4 postoperative years. Although computed tomography and magnetic resonance imaging examinations showed no significant changes prior to and following surgery, postoperative brain positron emission tomography scans revealed increased glucose metabolism in the transplanted region. The clinical efficacy of NSC transplantation in this patient suggests its potential for the treatment of DYT1-positive patients with PTD.	[Ren, Wen-Qing; Yin, Feng; Zhang, Jian-Ning; Lu, Wang-Sheng; Tian, Zeng-Min] PLA Navy Gen Hosp, Inst Neurosurg, 6 Fucheng Rd, Beijing 100048, Peoples R China; [Liang, Ying-Kui] PLA Navy Gen Hosp, PET Ctr, Beijing 100048, Peoples R China; [Adlerberth, Josefin] Lund Univ, Dept Pure & Appl Biochem, S-22100 Lund, Scania, Sweden		Tian, ZM (corresponding author), PLA Navy Gen Hosp, Inst Neurosurg, 6 Fucheng Rd, Beijing 100048, Peoples R China.	tianzengmin@vip.sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81172383]	This study was supported by a grant from the National Natural Science Foundation of China (No. 81172383).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Al Hashem G, 2011, MED PRIN PRACT, V20, P213, DOI 10.1159/000321242; Andres RH, 2008, REGEN MED, V3, P893, DOI 10.2217/17460751.3.6.893; Bacigaluppi M, 2008, J NEUROL SCI, V265, P73, DOI 10.1016/j.jns.2007.06.012; BARKER CF, 1977, ADV IMMUNOL, V25, P1; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; BURKE RE, 1986, NEUROLOGY, V36, P160, DOI 10.1212/WNL.36.2.160; Carbon M, 2010, EUR J NEUROL, V17, P58, DOI 10.1111/j.1468-1331.2010.03054.x; Carbon M, 2009, NEUROSCIENCE, V164, P220, DOI 10.1016/j.neuroscience.2008.12.041; Fahn S, 1988, Adv Neurol, V50, P1; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Germano I, 2010, NEUROPHARMACOLOGY, V58, P903, DOI 10.1016/j.neuropharm.2009.12.019; Gonzalez-Alegre P, 2005, J NEUROSCI, V25, P10502, DOI 10.1523/JNEUROSCI.3016-05.2005; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Isacson O, 2003, LANCET NEUROL, V2, P417, DOI 10.1016/S1474-4422(03)00437-X; Kenney Christopher, 2006, Expert Rev Neurother, V6, P7, DOI 10.1586/14737175.6.1.7; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Lehericy S, 2013, MOVEMENT DISORD, V28, P944, DOI 10.1002/mds.25527; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lozano AM, 1997, MOVEMENT DISORD, V12, P865, DOI 10.1002/mds.870120606; Lu WS, 2008, ZHONGHUA SHEN JING W, V7, P502; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Nakao N, 2001, J NEUROSURG, V95, P275, DOI 10.3171/jns.2001.95.2.0275; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Pachter JS, 2003, J NEUROPATH EXP NEUR, V62, P593, DOI 10.1093/jnen/62.6.593; Rabinovich SS, 2005, B EXP BIOL MED+, V139, P126, DOI 10.1007/s10517-005-0229-y; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Savitz Sean I, 2004, NeuroRx, V1, P406; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; Spatola Marianna, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS158, DOI 10.1016/S1353-8020(11)70049-9; Standaert DG, 2011, NEUROBIOL DIS, V42, P148, DOI 10.1016/j.nbd.2011.01.012; Suchowersky O, 2008, NAT CLIN PRACT NEURO, V4, P465, DOI 10.1038/ncpneuro0898; Tian Zeng-min, 2007, Zhonghua Wai Ke Za Zhi, V45, P702; Tian ZM, 2003, DI ER JUNYI DAXUE XU, V24, P954; Tian ZM, 2004, DI ER JUNYI DAXUE XU, V25, P933; Tian ZM, 2003, DI ER JUNYI DAXUE XU, p[24, 957]; Trost M, 2002, ANN NEUROL, V52, P853, DOI 10.1002/ana.10418; Ubiali F, 2007, INT IMMUNOL, V19, P1063, DOI 10.1093/intimm/dxm079; van den Berge SA, 2013, EUR J PHARMACOL, V719, P117, DOI 10.1016/j.ejphar.2013.04.058; Vidailhet M, 2007, LANCET NEUROL, V6, P223, DOI 10.1016/S1474-4422(07)70035-2; Walton NM, 2009, STEM CELLS, V27, P280, DOI 10.1634/stemcells.2008-0842; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Woon K, 2007, BRIT J NEUROSURG, V21, P355, DOI 10.1080/02688690701392899; YAMADA S, 1995, J NUCL MED, V36, P1301; Yin F, 2007, TRANSPL IMMUNOL, V18, P126; Yin F, 2012, CNS NEUROSCI THER, V18, P1012, DOI 10.1111/cns.12025	47	5	5	1	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	AUG	2016	12	2					661	666		10.3892/etm.2016.3392			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DS0IM	WOS:000380278900019	27446258	Green Published, Green Submitted, gold			2022-02-06	
J	Stone, J; Hoeritzauer, I; Gelauff, J; Lehn, A; Gardiner, P; van Gils, A; Carson, A				Stone, Jon; Hoeritzauer, Ingrid; Gelauff, Jeannette; Lehn, Alex; Gardiner, Paula; van Gils, Anne; Carson, Alan			Functional Disorders in Neurology: Case Studies	NEUROLOGIC CLINICS			English	Article						Functional; Psychogenic; Conversion disorder; Nonepileptic seizures; Movement disorder; Dizziness; Physiotherapy; Psychotherapy	PSYCHOGENIC NONEPILEPTIC SEIZURES; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; REGIONAL PAIN SYNDROME; PROPRIOSPINAL MYOCLONUS; POSTCONCUSSION SYNDROME; SYMPTOMS; REHABILITATION; PHYSIOTHERAPY; DIZZINESS	Functional, often called psychogenic, disorders are common in neurological practice. We illustrate clinical issues and highlight some recent research findings using six case studies of functional neurological disorders. We discuss dizziness as a functional disorder, describing the relatively new consensus term Persistent Posturo-Perceptual Dizziness (PPPD), axial jerking/myoclonus as a functional movement disorder, functional speech symptoms, post-concussion disorder with functional cognitive symptoms and finally advances in treatment of dissociative seizures and functional motor disorders.	[Stone, Jon; Hoeritzauer, Ingrid; Gardiner, Paula; Carson, Alan] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Gelauff, Jeannette] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Lehn, Alex] Mater Ctr Neurosci, 551 Stanley St, South Brisbane, Qld 4101, Australia; [Lehn, Alex] Univ Queensland, Sch Med, St Lucia, Qld 4072, Australia; [van Gils, Anne] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Carson, Alan] Univ Edinburgh, Western Gen Hosp, Dept Psychol Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland		Stone, J (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	Jon.Stone@ed.ac.uk	Stone, Jon/C-3119-2014	Stone, Jon/0000-0001-9829-8092			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Baizabal-Carvallo JF, 2015, J NEUROL, V262, P2420, DOI 10.1007/s00415-015-7856-7; Baumgartner J., 1997, J MED SPEECH-LANG PA, V5, P75; Binder LM, 2012, ARCH CLIN NEUROPSYCH, V27, P557, DOI 10.1093/arclin/acs051; Blad H, 2015, NEUROLOGY, V85, P2006, DOI 10.1212/WNL.0000000000002184; BRANDT T, 1986, MUNCHEN MED WOCHEN, V128, P247; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carson AJ, 2012, J NEUROL NEUROSUR PS, V83, P842, DOI 10.1136/jnnp-2011-301860; Czarnecki K, 2012, PARKINSONISM RELAT D, V18, P247, DOI 10.1016/j.parkreldis.2011.10.011; Duffy JR., 2013, MOTOR SPEECH DISORDE; Edwards MJ, 2014, MOVEMENT DISORD, V29, P849, DOI 10.1002/mds.25562; Erro R, 2014, PARKINSONISM RELAT D, V20, P596, DOI 10.1016/j.parkreldis.2014.02.026; Erro R, 2013, MOVEMENT DISORD, V28, P1868, DOI 10.1002/mds.25627; Fahn S, 2014, MOVEMENT DISORD, V29, P853, DOI 10.1002/mds.25899; Goldstein LH, 2010, NEUROLOGY, V74, P1986, DOI 10.1212/WNL.0b013e3181e39658; Goldstein LH, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0350-0; Goldstein LH, 2006, J NEUROL NEUROSUR PS, V77, P616, DOI 10.1136/jnnp.2005.066878; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Harden RN, 2013, PAIN MED, V14, P180, DOI 10.1111/pme.12033; Hawley JS, 2011, NEUROLOGY, V77, P496, DOI 10.1212/WNL.0b013e3182287aaf; Hendrickson R, 2014, EPILEPSY BEHAV, V37, P210, DOI 10.1016/j.yebeh.2014.06.026; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jordbru AA, 2014, J REHABIL MED, V46, P181, DOI 10.2340/16501977-1246; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; Lahmann C, 2015, J NEUROL NEUROSUR PS, V86, P302, DOI 10.1136/jnnp-2014-307601; Lehn A, 2016, J NEUROL, V263, P611, DOI 10.1007/s00415-015-7893-2; Nielsen G, 2015, J NEUROL, V262, P674, DOI 10.1007/s00415-014-7631-1; Nielsen G, 2015, J NEUROL NEUROSUR PS, V86, P1113, DOI 10.1136/jnnp-2014-309255; Nielsen G, 2013, J PSYCHOSOM RES, V75, P93, DOI 10.1016/j.jpsychores.2013.05.006; Radziej K, 2015, J PSYCHOSOM RES, V79, P123, DOI 10.1016/j.jpsychores.2015.05.005; Reuben A, 2014, EMERG MED J, V31, P72, DOI 10.1136/emermed-2012-201667; Reuber M, 2011, EPILEPSIA, V52, P2028, DOI 10.1111/j.1528-1167.2011.03162.x; Reuber M, 2009, EPILEPSY BEHAV, V16, P139, DOI 10.1016/j.yebeh.2009.07.018; Sa DS, 2003, MOVEMENT DISORD, V18, P1482, DOI 10.1002/mds.10594; Schmid G, 2011, J NEUROL NEUROSUR PS, V82, P601, DOI 10.1136/jnnp.2010.237388; Schrag A, 2004, BRAIN, V127, P2360, DOI 10.1093/brain/awh262; Scottish Intercollegiate Guidelines Network (SIGN), 2013, BRAIN INJ REH AD; Staab Jeffrey P, 2012, Continuum (Minneap Minn), V18, P1118, DOI 10.1212/01.CON.0000421622.56525.58; Stone J, 2006, NEUROL CLIN, V24, P385, DOI 10.1016/j.ncl.2006.01.008; Stone J, 2015, J ALZHEIMERS DIS, V48, pS5, DOI 10.3233/JAD-150430; Stone Jon, 2015, Continuum (Minneap Minn), V21, P818, DOI 10.1212/01.CON.0000466669.02477.45; Stone J, 2013, J NEUROL NEUROSUR PS, V84, P822, DOI 10.1136/jnnp-2012-304842; Terkelsen AJ, 2008, ANESTHESIOLOGY, V109, P297, DOI 10.1097/ALN.0b013e31817f4c9d; Thompson KJ, 2015, J VESTIBUL RES-EQUIL, V25, P97, DOI 10.3233/VES-150551; Tschan R, 2013, J NERV MENT DIS, V201, P629, DOI 10.1097/NMD.0b013e3182982995; van der Salm SMA, 2014, NEUROLOGY, V83, P1862, DOI 10.1212/WNL.0000000000000982; van der Salm SMA, 2010, J NEUROL, V257, P1349, DOI 10.1007/s00415-010-5531-6; Verdugo RJ, 2000, MUSCLE NERVE, V23, P198; Wolfsegger T, 2013, J NEUROL SCI, V334, P14, DOI 10.1016/j.jns.2013.07.006	49	5	5	0	26	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2016	34	3					667	+		10.1016/j.ncl.2016.04.013			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DT8CA	WOS:000381715400011	27445247	Green Submitted			2022-02-06	
J	Beirne, K; Rozanowska, M; Votruba, M				Beirne, Kathy; Rozanowska, Malgorzata; Votruba, Marcela			Red Light Treatment in an Axotomy Model of Neurodegeneration	PHOTOCHEMISTRY AND PHOTOBIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; MOUSE MODEL; PHOTOBIOMODULATION; DEGENERATION; DISEASE; NEURONS; SYSTEM; MICE; INFLAMMATION	Red light has been shown to provide neuroprotective effects. Axotomizing the optic nerve initiates retinal ganglion cell (RGC) degeneration, and an early marker of this is dendritic pruning. We hypothesized that 670nm light can delay axotomy-induced dendritic pruning in the retinal explant. To test this hypothesis, we monitored the effects of 670nm light (radiant exposure of 31.7Jcm(-2)), on RGC dendritic pruning in retinal explants from C57BL/6J mice, at 40min, 8h and 16h post axotomy. For sham-treated retinae, area under the Sholl curve, peak of the Sholl curve and dendritic length at 8h post axotomy showed statistically significant reductions by 42.3% (P=0.008), 29.8% (P=0.007) and 38.4% (P=0.038), respectively, which were further reduced after 16h by 40.56% (P<0.008), 33.9% (P<0.007), 45.43% (P<0.006), respectively. Dendritic field area was also significantly reduced after 16h, by 44.23% (P<0.019). Such statistically significant reductions were not seen in light-treated RGCs at 8 or 16h post axotomy. The results demonstrate the ability of 670nm light to partially prevent exvivo dendropathy in the mouse retina, suggesting that it is worthexploring as a treatment option for dendropathy-associatedneurodegenerative diseases, including glaucoma and Alzheimer's disease.	[Beirne, Kathy; Rozanowska, Malgorzata; Votruba, Marcela] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Beirne, Kathy; Rozanowska, Malgorzata; Votruba, Marcela] Cardiff Univ, Cardiff Inst Tissue Engn & Repair, Cardiff, S Glam, Wales; [Votruba, Marcela] Univ Wales Hosp, Cardiff Eye Unit, Cardiff, S Glam, Wales		Votruba, M (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.; Votruba, M (corresponding author), Cardiff Univ, Cardiff Inst Tissue Engn & Repair, Cardiff, S Glam, Wales.; Votruba, M (corresponding author), Univ Wales Hosp, Cardiff Eye Unit, Cardiff, S Glam, Wales.	VotrubaM@cardiff.ac.uk	Rozanowska, Malgorzata/AAD-4806-2021; Rozanowska, Malgorzata B/B-7860-2014; Votruba, Marcela/B-7306-2015	Rozanowska, Malgorzata/0000-0003-2913-8954; Rozanowska, Malgorzata B/0000-0003-2913-8954; Votruba, Marcela/0000-0002-7680-9135	Fight for Sight, UK; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0700949] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700949] Funding Source: researchfish; Fight for Sight [1423/24] Funding Source: researchfish	This study was supported by Fight for Sight, UK. We thank Nick White for help with confocal microscopy and 3D image analysis. We also thank Dr. Pratyusha Ganne for her assistance with retinal dissections.	Albarracin R, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-125; Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Ando T., 2013, HDB PHOTOMEDICINE, P631; Baloyannis SJ, 2009, J NEUROL SCI, V283, P153, DOI 10.1016/j.jns.2009.02.370; Barbosa M, 2014, BIOMED OPT EXPRESS, V5, P2317, DOI 10.1364/BOE.5.002317; Begum R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057828; Berry RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144341; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Calaza KC, 2015, NEUROBIOL AGING, V36, P2869, DOI 10.1016/j.neurobiolaging.2015.06.010; DisPolo A., 2015, NEURAL REGEN RES, V10, P559; Dong T., 2015, SPIE BIOS; Ferraresi C, 2015, J BIOPHOTONICS, V8, P740, DOI 10.1002/jbio.201400087; Ferraresi C, 2015, LASER MED SCI, V30, P1259, DOI 10.1007/s10103-015-1723-8; Fitzgerald M, 2013, REV NEUROSCIENCE, V24, P205, DOI 10.1515/revneuro-2012-0086; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Giacci MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104565; Hamblin M.R., 2006, P SOC PHOTO-OPT INS, V6140, P1, DOI DOI 10.1117/12.646294; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Karu T., 2008, PHOTOBIOLOGICAL SCI; Karu T., 2013, HDB PHOTOMEDICINE, P521; Kim IJ, 2002, J NEUROSCI, V22, P4530, DOI 10.1523/JNEUROSCI.22-11-04530.2002; Koike T, 2008, NEUROCHEM INT, V52, P751, DOI 10.1016/j.neuint.2007.09.007; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Langhammer CG, 2010, CYTOM PART A, V77A, P1160, DOI 10.1002/cyto.a.20954; Liu M, 2010, INVEST OPHTH VIS SCI, V51; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Magharious MM, 2011, JOVE-J VIS EXP, DOI 10.3791/2241; Muili KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067358; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Natoli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072135; Oueslati A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140880; Parizotto N. A., 2013, HDB PHOTOMEDICINE, P645; PATT S, 1991, HISTOL HISTOPATHOL, V6, P373; Pavlidis M, 2003, INVEST OPHTH VIS SCI, V44, P5196, DOI 10.1167/iovs.03-0614; Peoples C., 2012, ISRN NEUROLOGY, V2012; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Fernandes KPS, 2015, J PHOTOCH PHOTOBIO B, V153, P344, DOI 10.1016/j.jphotobiol.2015.10.015; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SHOLL DA, 1953, J ANAT, V87, P387; Sonis ST, 2016, ORAL ONCOL, V54, P7, DOI 10.1016/j.oraloncology.2016.01.005; Sperandio FF, 2013, J BIOPHOTONICS, V6, P839, DOI 10.1002/jbio.201300015; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Tang J, 2013, INVEST OPHTH VIS SCI, V54, P3681, DOI 10.1167/iovs.12-11018; Votruba M., 2012, INVEST OPHTH VIS SCI, V53, P4650; Williams PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072282; Williams PA, 2013, NEUROBIOL AGING, V34, P1799, DOI 10.1016/j.neurobiolaging.2013.01.006; Williams PA, 2010, BRAIN, V133, P2942, DOI 10.1093/brain/awq218; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069	54	5	5	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-8655	1751-1097		PHOTOCHEM PHOTOBIOL	Photochem. Photobiol.	JUL-AUG	2016	92	4					624	631		10.1111/php.12606			8	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	DS6RX	WOS:000380911200017	27276065	Green Accepted			2022-02-06	
J	Browne, GJ; Dimou, S				Browne, Gary J.; Dimou, Stefan			Concussive head injury in children and adolescents	AUSTRALIAN FAMILY PHYSICIAN			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; UNITED-STATES; POSTCONCUSSION SYNDROME; MANAGEMENT; EPIDEMIOLOGY; RECOVERY; SYMPTOMS; ATHLETE	Background Awareness of concussive head injury continues to grow, aided by greater understanding of the neurobiological underpinnings of concussions and its short-term and long-term consequences. Younger players who are in the midst of their neurodevelopmental trajectory continue to be placed at risk; therefore, more must be done to educate clinicians, parents, coaches and players alike in this area. Our understanding of concussive injury is evolving and more integrated models of care are being developed so as to provide patients with the holistic model of care needed in the post-concussive context. Objectives In this article, we outline a contemporary perspective on concussion, and address an evidence-based approach to children and adolescents who have suffered a concussive injury. Discussion Good clinical care of a patient with concussion by the primary care physician is the best prevention of adverse outcomes. The ability of the primary care physician to recognise when to treat and when to refer will be an important agent for change in this field.	[Browne, Gary J.; Dimou, Stefan] Childrens Hosp Westmead, Sydney Childrens Hosp Network, Childrens Hosp Inst Sports Med CHISM, Concuss Serv, Westmead, NSW, Australia; [Dimou, Stefan] Westmead Hosp, Westmead, NSW, Australia		Browne, GJ (corresponding author), Childrens Hosp Westmead, Sydney Childrens Hosp Network, Childrens Hosp Inst Sports Med CHISM, Concuss Serv, Westmead, NSW, Australia.	gary.browne@health.nsw.gov.au					Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Centers for Disease Control and Prevention, 2015, HEADS HEALTHC PROV; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Elkington L, AUSTR I SPORT AUSTR; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1570, DOI 10.1212/01.CON.0000458973.71142.7d; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hayter C, 2016, APPL NEUROPSYCHOL AD; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matuszuk JM, 2016, SPORTS HLTH; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Resch JE, 2015, J CHILD NEUROL, V30, P1686, DOI 10.1177/0883073815574335; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152; Willer BS, 2016, ACAD EMERG MED, V23, P495, DOI 10.1111/acem.12940	44	5	5	0	10	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	0300-8495			AUST FAM PHYSICIAN	Aust. Fam. Physician	JUL	2016	45	7					470	476					7	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS5BJ	WOS:000380795200008	27610428				2022-02-06	
J	Carney, NA; Petroni, GJ; Lujan, SB; Ballarini, NM; Faguaga, GA; du Coudray, HEM; Huddleston, AE; Baggio, GM; Becerra, JM; Busso, LO; Dikmen, SS; Falcone, R; Garcia, ME; Carrillo, ORG; Medici, PL; Quaglino, MB; Randisi, CA; Saenz, SS; Temkin, NR; Vanella, EE				Carney, Nancy A.; Petroni, Gustavo J.; Lujan, Silvia B.; Ballarini, Nicolas M.; Faguaga, Gabriela A.; du Coudray, Hugo E. M.; Huddleston, Amy E.; Baggio, Gloria M.; Becerra, Juan M.; Busso, Leonardo O.; Dikmen, Sureyya S.; Falcone, Roberto; Garcia, Mirta E.; Gonzalez Carrillo, Osvaldo R.; Medici, Paula L.; Quaglino, Marta B.; Randisi, Carina A.; Saenz, Silvia S.; Temkin, Nancy R.; Vanella, Elida E.			Postdischarge Care of Pediatric Traumatic Brain Injury in Argentina: A Multicenter Randomized Controlled Trial	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						family systems; home care; Latin America; outcomes; pediatrics; traumatic brain injury	GENERIC-CORE-SCALES; OF-LIFE INVENTORY; LATIN-AMERICA; INTENSIVE-CARE; VALIDITY; PEDSQL(TM)-4.0; RELIABILITY; CHILDREN; VERSION; IMPACT	Objective: To develop, in partnership with families of children with traumatic brain injury, a postdischarge intervention that is effective, simple, and sustainable. Design: Randomized Controlled Trial. Setting: Seven Level 1 Pediatric Trauma Centers in Argentina. Patients: Persons less than 19 years of age admitted to one of the study hospitals with a diagnosis of severe, moderate, or complicated mild traumatic brain injury and were discharged alive. Interventions: Patients were randomly assigned to either the intervention or standard care group. A specially trained Community Resource Coordinator was assigned to each family in the intervention group. We hypothesized that children with severe, moderate, and complicated mild traumatic brain injury who received the intervention would have significantly better functional outcomes at 6 months post discharge than those who received standard care. We further hypothesized that there would be a direct correlation between patient outcome and measures of family function. Measurements and Main Results: The primary outcome measure was a composite measured at 6 months post injury. There were 308 patients included in the study (61% men). Forty-four percent sustained a complicated mild traumatic brain injury, 18% moderate, and 38% severe. Sixty-five percent of the patients were 8 years old or younger, and over 70% were transported to the hospital without ambulance assistance. There was no significant difference between groups on the primary outcome measure. There was a statistically significant correlation between the primary outcome measure and the scores on the Family Impact Module of the Pediatric Quality of Life Inventory (rho = 0.57; p < 0.0001). Children with better outcomes lived with families reporting better function at 6 months post injury. Conclusions: Although no significant effect of the intervention was demonstrated, this study represents the first conducted in Latin America that documents the complete course of treatment for pediatric patients with traumatic brain injury spanning hospital transport through hospital care and into the postdischarge setting.	[Carney, Nancy A.; du Coudray, Hugo E. M.; Huddleston, Amy E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Petroni, Gustavo J.; Lujan, Silvia B.; Ballarini, Nicolas M.; Faguaga, Gabriela A.] Ctr Informat & Invest Clin, Rosario, Santa Fe, Argentina; [Ballarini, Nicolas M.; Quaglino, Marta B.] Univ Nacl Rosario, Rosario, Santa Fe, Argentina; [Faguaga, Gabriela A.; Baggio, Gloria M.] Hosp Ninos Victor J Vilela, Rosario, Santa Fe, Argentina; [du Coudray, Hugo E. M.] Portland State Univ, Dept Psychol, Portland, OR 97207 USA; [Becerra, Juan M.; Randisi, Carina A.] Sistema Integrado Emergencia Sanitaria, Rosario, Santa Fe, Argentina; [Busso, Leonardo O.] Hosp El Cruce, Florencio Varela, Argentina; [Dikmen, Sureyya S.; Temkin, Nancy R.] Univ Washington, Seattle, WA 98195 USA; [Falcone, Roberto; Medici, Paula L.] Hosp Interzonal Especializado Materno Infantil Dr, Mar Del Plata, Buenos Aires, Argentina; [Garcia, Mirta E.] Hosp Ninos Sor Maria Ludovica, La Plata, Buenos Aires, Argentina; [Gonzalez Carrillo, Osvaldo R.] Hosp Ninos Dr Orlando Alassia, Santa Fe, Argentina; [Saenz, Silvia S.] Hosp Ninos Santisima Trinidad, Cordoba, Argentina; [Vanella, Elida E.] Hosp Pediat Dr Humberto Notti, Mendoza, Argentina		Carney, NA (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	carneyn@ohsu.edu		Ballarini, Nicolas/0000-0002-3432-8931	Eunice Kennedy Schriber National Institute on Child Health and Human Development; Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [5R01-HD060570]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NICHD/FIC [1 R01 HD060570]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; DoDUnited States Department of Defense; CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD060570] Funding Source: NIH RePORTER	This project was funded by the Eunice Kennedy Schriber National Institute on Child Health and Human Development, and the Fogarty International Center of the National Institutes of Health (5R01-HD060570).; Dr. Carney received support for article research from the National Institutes of Health (NIH). Her institution received grant support. Drs. Petroni, Lujan, Ballarini, Faguaga, du Coudray, Huddleston, Baggio, Becerra, Busso, Dikmen, Falcone, Garciav, Gonzalez Carrillo, Medici, Quaglino, Randisi, Saenz, and Vanella received support for article research from the NIH. Their institutions received grant support from NICHD/FIC (grant number 1 R01 HD060570). Dr. Temkin consulted for multiple pharmaceutical companies (DSMB membership, none related to the topic of this paper) and received support for article research from the NIH. Her institution received grant support from NICHD/FIC (Grant number 1 R01 HD060570) and from NIH, DoD, and the CDC (multiple grants, none related the topic of this paper).	[Anonymous], 1971, JAMA-J AM MED ASSOC, V215, P277; BRAGA LW, 2006, CHILD TRAUMATIC BRAI; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chesnut RM, 2012, NEUROSURGERY, V71, P1055, DOI 10.1227/NEU.0b013e31827276b7; Cohen J., 2013, STAT POWER ANAL BEHA; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kruse S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0168-2; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Murgio A, 1999, J Neurosurg Sci, V43, P15; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Roizen M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-59; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Schmidt AT, 2010, BRAIN INJURY, V24, P1550, DOI 10.3109/02699052.2010.523047; TEASDALE G, 1974, LANCET, V2, P81; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003	22	5	6	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2016	17	7					658	666		10.1097/PCC.0000000000000772			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	DR0LV	WOS:000379599900012	27243414	Green Accepted			2022-02-06	
J	Hendrick, LE; Schroeppel, TJ; Sharpe, JP; Alsbrook, D; Magnotti, LJ; Weinberg, JA; Johnson, BP; Lewis, RH; Clement, LP; Croce, MA; Fabian, TC				Hendrick, Leah E.; Schroeppel, Thomas J.; Sharpe, John P.; Alsbrook, Diana; Magnotti, Louis J.; Weinberg, Jordan A.; Johnson, Benjamin P.; Lewis, Richard H.; Clement, L. Paige; Croce, Martin A.; Fabian, Timothy C.			Impact of Beta-Blockers on Nonhead Injured Trauma Patients	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting of the Southeastern-Surgical-Congress (SESC)	FEB 05-26, 2016	Atlanta, GA	SE Surg Congress			BLUNT HEAD-INJURY; BRAIN-INJURY; IMPROVED OUTCOMES; EARLY PROPRANOLOL; MORTALITY; BLOCKADE; EXPOSURE; DEATH	Catecholamine surge after traumatic injury may lead to dysautonomia with increased morbidity. Small retrospective studies have shown potential benefit of beta-blockers (BB) in trauma patients with and without traumatic brain injury (TBI). This study evaluates a large multiply injured cohort without TBI that received BB. Patientswere identified from the trauma registry fromJanuary 1, 2003 to December 31, 2011. Patients who received > 1 dose of BB were compared to controls. Patients with TBI, length of stay (LOS) < 2 days, and prehospital BB were excluded. Outcomes were mortality, intensive care unit (ICU) LOS, and LOS. Stepwise multivariable regression was used to identify variables significantly associated with mortality. During the study period, 19,151 eligible patients were admitted. The mean age was 39 years. Most were male (74%) and most sustained blunt mechanism (75%). A total of 1854 (11%) patients received BB. BB patients had longer LOS (16 vs 6 days), ICU LOS (7 vs 1 days), and higher mortality (2.8 vs 0.5%) (all P < 0.001). Multivariable regression demonstrated no benefit to BB after adjusting for potential confounding characteristics [ odds ratio (OR) 0.952; confidence interval (CI) 0.620-1.461]. In conclusion, in this largest study to date, patients receiving BB were older, more severely injured, and had a higher mortality. Unlike TBI patients, multivariable regression showed no benefit from BB in this population.	[Hendrick, Leah E.; Schroeppel, Thomas J.; Sharpe, John P.; Alsbrook, Diana; Magnotti, Louis J.; Weinberg, Jordan A.; Johnson, Benjamin P.; Lewis, Richard H.; Croce, Martin A.; Fabian, Timothy C.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN USA; [Clement, L. Paige] Reg One Hlth, Dept Pharm, Memphis, TN USA		Schroeppel, TJ (corresponding author), Dept Surg, 910 Madison Bldg,Suite 220, Memphis, TN 38163 USA.	tschroep@uthsc.edu		Schroeppel, Thomas/0000-0001-9164-5004			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Arbabi S, 2004, J TRAUMA, V56, P265, DOI 10.1097/01.TA.0000109859.91202.C8; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bukur M, 2012, AM J SURG, V204, P697, DOI 10.1016/j.amjsurg.2012.02.007; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; JAATTELA A, 1975, BRIT J SURG, V62, P177, DOI 10.1002/bjs.1800620303; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; MCLEOD AA, 1982, BRIT HEART J, V47, P221; Murry JS, 2016, J SURG RES, V200, P221, DOI 10.1016/j.jss.2015.06.045; Neideen T, 2008, J TRAUMA, V65, P1016, DOI 10.1097/TA.0b013e3181897eac; Nunez-Villaveiran T, 2015, MED INTENSIVA, V39, P101, DOI 10.1016/j.medin.2014.08.002; Rough J, 2009, SURGERY, V145, P235, DOI 10.1016/j.surg.2008.09.013; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899	23	5	5	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JUL	2016	82	7					575	579					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	DV9NM	WOS:000383267500021	27457854				2022-02-06	
J	Kircelli, A; Ozel, O; Can, H; Sari, R; Cansever, T; Elmaci, I				Kircelli, Atilla; Ozel, Omer; Can, Halil; Sari, Ramazan; Cansever, Tufan; Elmaci, Ilhan			Is the presence of linear fracture a predictor of delayed posterior fossa epidural hematoma?	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Delayed epidural hematoma; head trauma; posterior cranial fossa	SEVERE HEAD-INJURY; EXTRADURAL HEMATOMA; MANAGEMENT	BACKGROUND: Though traumatic posterior fossa epidural hematoma (PFEDH) is rare, the associated rates of morbidity and mortality are higher than those of supratentorial epidural hematoma (SEDH). Signs and symptoms may be silent and slow, but rapid deterioration may set in, resulting in death. With the more frequent use of computed tomography (CT), early diagnosis can be achieved in patients with cranial fractures who have suffered traumatic injury to the posterior fossa. However, some hematomas appear insignificant or are absent on initial tomography scans, and can only be detected by serial CT scans. These are called delayed epidural hematomas (EDHs). The association of EDHs in the supratentorial-infratentorial compartments with linear fracture and delayed EDH (DEDH) was presently investigated. METHODS: A total of 212 patients with SEDH and 22 with PFEDH diagnosed and treated in Goztepe Training and Research Hospital Neurosurgery Clinic between 1995 and 2005 were included. Of the PFEDH patients, 21 underwent surgery, and 1 was followed with conservative treatment. In this group, 4 patients underwent surgery for delayed posterior fossa epidural hematoma (DPFEDH). RESULTS: Mean age of patients with PFEDH was 12 years, and that of the patients with SEDH was 18 years. Classification made according to localization on cranial CT, in order of increasing frequency, revealed of EDHs that were parietal (27%), temporal (16%), and located in the posterior fossa regions (approximately 8%). Fracture line was detected on direct radiographs in 48% of SEDHs and 68% of PFEDHs. Incidence of DPFEDH in the infratentorial compartment was statistically significantly higher than incidence in the supratentorial compartment (p=0.007). Review of the entire EDH series revealed that the likelihood of DEDH development in the infratentorial compartment was 10.27 times higher in patients with linear fractures than in patients with supratentorial fractures (p<0.05). CONCLUSION: DPFEDH, combined with clinical deterioration, can be fatal. Accurate diagnosis and selection of surgery modality can be lifesaving. The high risk of EDH development in patients with a fracture line in the posterior fossa on direct radiographs should be kept in mind. These patients should be kept under close observation, and serial CT scans should be conducted when necessary.	[Kircelli, Atilla; Cansever, Tufan] Baskent Univ, Fac Med, Dept Neurosurg, Istanbul, Turkey; [Ozel, Omer] Baskent Univ, Fac Med, Dept Orthopaed Surg, Istanbul, Turkey; [Can, Halil] Private Med Hosp, Dept Neurosurg, Istanbul, Turkey; [Sari, Ramazan] Mem Hizmet Hosp, Dept Neurosurg, Istanbul, Turkey; [Elmaci, Ilhan] Mem Sisli Hosp, Dept Neurosurg, Istanbul, Turkey		Kircelli, A (corresponding author), Baskent Univ Istanbul Hastanesi, Oymaci Sok 7, TR-34662 Istanbul, Turkey.	atillakircelli@gmail.com	Elmaci, Ilhan/AAF-3459-2021	Elmaci, Ilhan/0000-0001-9433-0307; Kircelli, Atilla/0000-0003-2109-1274			Abdul-Azeim Sayed A, 2002, Neurosciences (Riyadh), V7, P198; ADELOYE A, 1980, E AFR MED J, V57, P289; AMMIRATI M, 1984, NEUROSURGERY, V14, P541, DOI 10.1227/00006123-198405000-00002; BAYKANER K, 1988, SURG NEUROL, V30, P339, DOI 10.1016/0090-3019(88)90195-4; Bozbuga M, 1999, NEUROSURG REV, V22, P34, DOI 10.1007/s101430050006; CAMPBELL E, 1953, ANN SURG, V138, P509, DOI 10.1097/00000658-195310000-00003; CHANDRASEKARAN S, 1993, AUST NZ J SURG, V63, P780, DOI 10.1111/j.1445-2197.1993.tb00340.x; COLEMAN CC, 1941, SURGERY, V10, P985; d'Avella D, 2000, ACTA NEUROCHIR, V142, P717, DOI 10.1007/s007010070120; DOMENICUCCI M, 1995, NEUROSURG REV, V18, P109, DOI 10.1007/BF00417668; Duthie G, 2009, BRIT J NEUROSURG, V23, P596, DOI 10.3109/02688690902978157; ERSAHIN Y, 1993, CHILD NERV SYST, V9, P96, DOI 10.1007/BF00305316; FANKHAUSER H, 1983, NEUROCHIRURGIE, V29, P255; FANKHAUSER H, 1982, ACTA NEUROCHIR, V60, P29, DOI 10.1007/BF01401747; FISHER RG, 1958, JAMA-J AM MED ASSOC, V167, P176, DOI 10.1001/jama.1958.02990190030007; GOODKIN R, 1978, J NEUROSURG, V48, P479, DOI 10.3171/jns.1978.48.3.0479; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; HOOPER R, 1959, BRIT J SURG, V47, P71, DOI 10.1002/bjs.18004720114; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; Kabatas Serdar, 2004, Ulus Travma Acil Cerrahi Derg, V10, P208; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; KOULOURIS S, 1980, NEUROSURGERY, V7, P608, DOI 10.1227/00006123-198012000-00014; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Onal MB, 2012, ULUS TRAVMA ACIL CER, V18, P524, DOI 10.5505/tjtes.2012.91129; PETIT-DUTAILLIS D, 1956, Neurochirurgie, V2, P221; POON WS, 1992, NEUROSURGERY, V30, P681; ROBERSON FC, 1979, SURG NEUROL, V12, P161; RODA JM, 1983, SURG NEUROL, V19, P419, DOI 10.1016/0090-3019(83)90138-6	28	5	7	0	1	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JUL	2016	22	4					355	360		10.5505/tjtes.2015.52563			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DP7LP	WOS:000378681000009	27598608				2022-02-06	
